B-Diagnostic_tool	0	10	Heidelberg
I-Diagnostic_tool	11	17	retina
I-Diagnostic_tool	18	28	tomography
O	29	32	and
B-Diagnostic_tool	33	40	optical
I-Diagnostic_tool	41	50	coherence
I-Diagnostic_tool	51	61	tomography
O	62	64	in
O	65	71	normal
O	71	72	,
B-Disease	73	79	ocular
I-Disease	79	80	-
I-Disease	80	92	hypertensive
O	92	93	,
O	94	97	and
B-Disease	98	110	glaucomatous
B-Anatomy	111	115	eyes
O	115	116	.

O	118	120	To
O	121	129	evaluate
B-Anatomy	130	135	optic
I-Anatomy	136	140	disc
O	141	144	and
B-Anatomy	145	152	retinal
I-Anatomy	153	158	nerve
I-Anatomy	159	164	fiber
I-Anatomy	165	170	layer
O	171	172	(
B-Anatomy	172	176	RNFL
O	176	177	)
O	178	188	appearance
O	189	191	in
O	192	198	normal
O	198	199	,
B-Disease	200	206	ocular
I-Disease	206	207	-
I-Disease	207	219	hypertensive
O	219	220	,
O	221	224	and
B-Disease	225	237	glaucomatous
B-Anatomy	238	242	eyes
O	243	253	undergoing
B-Diagnostic_tool	254	262	confocal
I-Diagnostic_tool	263	271	scanning
I-Diagnostic_tool	272	277	laser
I-Diagnostic_tool	278	292	ophthalmoscopy
O	293	296	and
B-Diagnostic_tool	297	304	optical
I-Diagnostic_tool	305	314	coherence
I-Diagnostic_tool	315	325	tomography
O	326	327	(
B-Diagnostic_tool	327	330	OCT
O	330	331	)
O	331	332	.

O	333	344	Prospective
O	344	345	,
O	346	351	cross
O	351	352	-
O	352	361	sectional
O	362	367	study
O	367	368	.

O	369	376	Seventy
O	376	377	-
O	377	382	eight
O	383	387	eyes
O	388	390	of
O	391	393	78
O	394	405	consecutive
O	406	412	normal
O	413	414	(
O	414	415	n
O	416	417	=
O	418	420	17
O	420	421	)
O	421	422	,
B-Disease	423	429	ocular
I-Disease	429	430	-
I-Disease	430	442	hypertensive
O	443	444	(
O	444	445	n
O	446	447	=
O	448	450	23
O	450	451	)
O	451	452	,
O	453	456	and
B-Disease	457	469	glaucomatous
O	470	478	subjects
O	479	480	(
O	480	481	n
O	482	483	=
O	484	486	38
O	486	487	)
O	488	492	were
O	493	501	enrolled
O	501	502	.

O	503	507	Each
O	508	515	patient
O	516	525	underwent
O	526	534	complete
B-Diagnostic_tool	535	545	ophthalmic
I-Diagnostic_tool	546	557	examination
O	557	558	,
B-Diagnostic_tool	559	569	achromatic
I-Diagnostic_tool	570	579	automated
I-Diagnostic_tool	580	589	perimetry
O	589	590	,
B-Diagnostic_tool	591	599	confocal
I-Diagnostic_tool	600	608	scanning
I-Diagnostic_tool	609	614	laser
I-Diagnostic_tool	615	629	ophthalmoscopy
O	630	631	(
B-Diagnostic_tool	631	641	Heidelberg
I-Diagnostic_tool	642	649	Retinal
I-Diagnostic_tool	650	660	Tomography
O	661	662	[
B-Diagnostic_tool	662	665	HRT
O	665	666	]
O	666	667	)
O	667	668	,
O	669	672	and
B-Diagnostic_tool	673	676	OCT
O	676	677	.

B-Characteristic	678	689	Topographic
I-Characteristic	690	693	HRT
I-Characteristic	694	704	parameters
O	705	706	(
B-Characteristic	706	710	disc
I-Characteristic	711	715	area
O	715	716	,
B-Characteristic	717	720	cup
I-Characteristic	720	721	-
I-Characteristic	721	725	disc
I-Characteristic	726	731	ratio
O	731	732	,
B-Characteristic	733	736	rim
I-Characteristic	737	741	area
O	741	742	,
B-Characteristic	743	746	rim
I-Characteristic	747	753	volume
O	753	754	,
B-Characteristic	755	758	cup
I-Characteristic	759	764	shape
I-Characteristic	765	772	measure
O	772	773	,
B-Characteristic	774	778	mean
I-Characteristic	779	783	RNFL
I-Characteristic	784	793	thickness
O	793	794	,
O	795	798	and
B-Characteristic	799	804	cross
I-Characteristic	804	805	-
I-Characteristic	805	814	sectional
I-Characteristic	815	819	area
O	819	820	)
O	821	824	and
B-Characteristic	825	829	mean
I-Characteristic	830	833	OCT
I-Characteristic	833	834	-
I-Characteristic	834	843	generated
I-Characteristic	844	848	RNFL
I-Characteristic	849	858	thickness
O	859	863	were
O	864	873	evaluated
O	874	876	in
O	877	881	each
O	882	887	group
O	887	888	.

B-Diagnostic_tool	889	892	OCT
O	893	896	and
B-Diagnostic_tool	897	900	HRT
O	901	911	assessment
O	912	914	of
B-Anatomy	915	920	optic
I-Anatomy	921	925	disc
O	926	929	and
B-Anatomy	930	934	RNFL
O	935	942	anatomy
O	942	943	.

B-Characteristic	944	947	OCT
I-Characteristic	948	952	RNFL
I-Characteristic	953	962	thickness
O	963	969	showed
O	970	972	no
O	973	983	difference
O	984	991	between
O	992	998	normal
O	999	1002	and
B-Disease	1003	1009	ocular
I-Disease	1009	1010	-
I-Disease	1010	1022	hypertensive
B-Anatomy	1023	1027	eyes
O	1028	1029	(
O	1029	1030	P
O	1031	1032	=
O	1033	1034	0
O	1034	1035	.
O	1035	1037	15
O	1037	1038	)
O	1039	1042	but
O	1043	1046	was
O	1047	1060	significantly
O	1061	1065	less
O	1066	1068	in
B-Disease	1069	1081	glaucomatous
B-Anatomy	1082	1086	eyes
O	1087	1088	(
O	1088	1089	P
O	1091	1092	<
O	1094	1095	0
O	1095	1096	.
O	1096	1099	001
O	1099	1100	)
O	1100	1101	.

B-Diagnostic_tool	1102	1105	HRT
O	1106	1118	measurements
O	1119	1121	of
B-Characteristic	1122	1125	rim
I-Characteristic	1126	1130	area
O	1130	1131	,
B-Characteristic	1132	1135	cup
I-Characteristic	1135	1136	-
I-Characteristic	1136	1140	disc
I-Characteristic	1141	1146	ratio
O	1146	1147	,
B-Characteristic	1148	1151	cup
I-Characteristic	1152	1157	shape
I-Characteristic	1158	1165	measure
O	1165	1166	,
B-Characteristic	1167	1171	RNFL
I-Characteristic	1172	1181	thickness
O	1181	1182	,
O	1183	1186	and
B-Characteristic	1187	1191	RNFL
I-Characteristic	1192	1197	cross
I-Characteristic	1197	1198	-
I-Characteristic	1198	1207	sectional
I-Characteristic	1208	1212	area
O	1213	1217	were
O	1218	1231	significantly
O	1232	1236	less
O	1237	1239	in
B-Disease	1240	1252	glaucomatous
B-Anatomy	1253	1257	eyes
O	1258	1259	(
O	1259	1262	all
O	1263	1264	P
O	1266	1267	<
O	1269	1270	0
O	1270	1271	.
O	1271	1274	005
O	1274	1275	)
O	1276	1279	and
O	1280	1284	were
O	1285	1295	correlated
O	1296	1300	with
B-Characteristic	1301	1305	mean
I-Characteristic	1306	1309	OCT
I-Characteristic	1310	1314	RNFL
I-Characteristic	1315	1324	thickness
O	1325	1326	(
O	1326	1329	all
O	1330	1331	P
O	1333	1334	<
O	1336	1337	0
O	1337	1338	.
O	1338	1340	02
O	1340	1341	)
O	1341	1342	.

B-Characteristic	1343	1347	RNFL
I-Characteristic	1348	1357	thickness
O	1358	1363	using
B-Diagnostic_tool	1364	1367	OCT
O	1368	1370	or
B-Diagnostic_tool	1371	1374	HRT
O	1375	1378	was
O	1379	1385	highly
O	1386	1396	correlated
O	1397	1401	with
B-Symptom	1402	1408	visual
I-Symptom	1409	1414	field
I-Symptom	1415	1419	mean
I-Symptom	1420	1426	defect
O	1427	1433	during
B-Diagnostic_tool	1434	1444	achromatic
I-Diagnostic_tool	1445	1454	perimetry
O	1455	1456	(
O	1456	1457	P
O	1459	1460	<
O	1462	1463	0
O	1463	1464	.
O	1464	1468	0001
O	1468	1469	)
O	1469	1470	.

O	1471	1475	Both
B-Diagnostic_tool	1476	1479	HRT
O	1480	1483	and
B-Diagnostic_tool	1484	1487	OCT
O	1488	1491	can
O	1492	1505	differentiate
B-Disease	1506	1518	glaucomatous
O	1519	1523	from
O	1524	1539	nonglaucomatous
B-Anatomy	1540	1544	eyes
O	1544	1545	.

B-Characteristic	1546	1550	RNFL
I-Characteristic	1551	1560	thickness
O	1561	1573	measurements
O	1574	1579	using
B-Diagnostic_tool	1580	1583	OCT
O	1584	1594	correspond
O	1595	1597	to
B-Characteristic	1598	1602	disc
I-Characteristic	1603	1614	topographic
I-Characteristic	1615	1625	parameters
O	1626	1631	using
B-Diagnostic_tool	1632	1635	HRT
O	1635	1636	.

O	0	7	Methods
O	8	11	for
O	12	22	evaluation
O	23	25	of
B-Symptom	26	33	retinal
I-Symptom	34	47	microvascular
I-Symptom	48	61	abnormalities
O	62	72	associated
O	73	77	with
B-Disease	78	90	hypertension
I-Disease	90	91	/
I-Disease	91	100	sclerosis
O	101	103	in
O	104	107	the
B-Disease	108	123	Atherosclerosis
O	124	128	Risk
O	129	131	in
O	132	143	Communities
O	144	149	Study
O	149	150	.

O	152	154	To
O	155	162	develop
O	163	172	protocols
O	173	175	to
O	176	186	photograph
O	187	190	and
O	191	199	evaluate
B-Symptom	200	207	retinal
I-Symptom	208	216	vascular
I-Symptom	217	230	abnormalities
O	231	233	in
O	234	237	the
B-Disease	238	253	Atherosclerosis
O	254	258	Risk
O	259	261	in
O	262	273	Communities
O	274	275	(
O	275	279	ARIC
O	279	280	)
O	281	286	Study
O	286	287	;
O	288	290	to
O	291	295	test
O	296	311	reproducibility
O	312	314	of
O	315	318	the
O	319	326	grading
O	327	333	system
O	333	334	;
O	335	338	and
O	339	341	to
O	342	349	explore
O	350	353	the
O	354	366	relationship
O	367	369	of
O	370	375	these
B-Symptom	376	389	microvascular
I-Symptom	390	397	changes
O	398	402	with
B-Characteristic	403	408	blood
I-Characteristic	409	417	pressure
O	417	418	.

O	419	429	Population
O	429	430	-
O	430	435	based
O	435	436	,
O	437	442	cross
O	442	443	-
O	443	452	sectional
O	453	458	study
O	458	459	.

O	460	465	Among
O	466	467	4
O	468	479	examination
O	480	487	centers
O	487	488	,
O	489	491	11
O	491	492	,
O	492	495	114
O	496	508	participants
O	509	510	(
B-Characteristic	510	512	48
I-Characteristic	512	513	-
I-Characteristic	513	515	73
I-Characteristic	516	521	years
I-Characteristic	522	524	of
I-Characteristic	525	528	age
O	528	529	)
O	530	532	at
O	533	538	their
O	539	544	third
O	545	554	triennial
O	555	566	examination
O	566	567	,
O	568	573	after
O	574	583	excluding
O	584	591	persons
O	592	596	with
B-Disease	597	605	diabetes
O	606	610	from
O	611	615	this
O	616	624	analysis
O	624	625	.

O	626	629	One
B-Anatomy	630	633	eye
O	634	636	of
O	637	641	each
O	642	653	participant
O	654	657	was
O	658	670	photographed
O	671	673	by
O	674	685	technicians
O	686	690	with
B-Diagnostic_tool	691	703	nonmydriatic
I-Diagnostic_tool	704	710	fundus
I-Diagnostic_tool	711	718	cameras
O	718	719	.

O	720	727	Reading
O	728	734	center
O	735	742	graders
O	743	752	evaluated
B-Symptom	753	758	focal
I-Symptom	759	769	arteriolar
I-Symptom	770	779	narrowing
O	779	780	,
B-Symptom	781	794	arteriovenous
I-Symptom	795	796	(
I-Symptom	796	798	AV
I-Symptom	798	799	)
I-Symptom	800	807	nicking
O	807	808	,
O	809	812	and
B-Disease	813	824	retinopathy
O	825	827	by
O	828	837	examining
O	838	844	slides
O	845	847	on
O	848	849	a
O	850	855	light
O	856	859	box
O	860	863	and
O	864	872	measured
B-Characteristic	873	882	diameters
I-Characteristic	883	885	of
I-Characteristic	886	889	all
I-Characteristic	890	897	vessels
O	898	900	in
O	901	902	a
B-Anatomy	903	907	zone
I-Anatomy	908	919	surrounding
I-Anatomy	920	923	the
I-Anatomy	924	929	optic
I-Anatomy	930	934	disc
O	935	937	on
O	938	946	enhanced
O	947	956	digitized
O	957	963	images
O	963	964	.

O	965	967	To
O	968	973	gauge
O	974	985	generalized
O	986	995	narrowing
O	995	996	,
B-Characteristic	997	1003	vessel
I-Characteristic	1004	1013	diameters
O	1014	1018	were
O	1019	1027	combined
O	1028	1032	into
B-Anatomy	1033	1040	central
I-Anatomy	1041	1051	arteriolar
O	1052	1055	and
B-Anatomy	1056	1063	venular
O	1064	1075	equivalents
O	1076	1080	with
O	1081	1089	formulas
O	1090	1099	adjusting
O	1100	1103	for
O	1104	1113	branching
O	1113	1114	,
O	1115	1118	and
O	1119	1122	the
B-Characteristic	1123	1128	ratio
I-Characteristic	1129	1131	of
I-Characteristic	1132	1143	equivalents
O	1144	1145	(
B-Characteristic	1145	1146	A
I-Characteristic	1146	1147	/
I-Characteristic	1147	1148	V
I-Characteristic	1149	1154	ratio
O	1154	1155	)
O	1156	1159	was
O	1160	1170	calculated
O	1170	1171	.

B-Symptom	1172	1179	Retinal
I-Symptom	1180	1188	vascular
I-Symptom	1189	1202	abnormalities
O	1202	1203	,
B-Characteristic	1204	1208	mean
I-Characteristic	1209	1219	arteriolar
I-Characteristic	1220	1225	blood
I-Characteristic	1226	1234	pressure
O	1235	1236	(
B-Characteristic	1236	1240	MABP
O	1240	1241	)
O	1241	1242	.

O	1243	1248	Among
O	1249	1251	11
O	1251	1252	,
O	1252	1255	114
O	1256	1268	participants
O	1268	1269	,
O	1270	1281	photographs
O	1282	1286	were
O	1287	1295	obtained
O	1296	1298	of
O	1299	1301	99
O	1301	1302	%
O	1302	1303	,
O	1304	1308	with
O	1309	1316	quality
O	1317	1327	sufficient
O	1328	1330	to
O	1331	1338	perform
B-Anatomy	1339	1346	retinal
O	1347	1358	evaluations
O	1359	1361	in
O	1362	1364	81
O	1364	1365	%
O	1365	1366	.

O	1367	1369	In
O	1370	1373	the
O	1374	1378	9040
O	1379	1387	subjects
O	1388	1392	with
O	1393	1399	usable
O	1400	1411	photographs
O	1411	1412	,
B-Characteristic	1413	1414	A
I-Characteristic	1414	1415	/
I-Characteristic	1415	1416	V
I-Characteristic	1417	1422	ratio
O	1423	1424	(
O	1424	1429	lower
O	1430	1436	values
O	1437	1445	indicate
B-Symptom	1446	1457	generalized
I-Symptom	1458	1468	arteriolar
I-Symptom	1469	1478	narrowing
O	1478	1479	)
O	1480	1486	ranged
O	1487	1491	from
O	1492	1493	0
O	1493	1494	.
O	1494	1496	57
O	1497	1499	to
O	1500	1501	1
O	1501	1502	.
O	1502	1504	22
O	1505	1506	(
O	1506	1512	median
O	1513	1514	=
O	1515	1516	0
O	1516	1517	.
O	1517	1519	84
O	1519	1520	,
O	1521	1534	interquartile
O	1535	1540	range
O	1541	1542	=
O	1543	1544	0
O	1544	1545	.
O	1545	1547	10
O	1547	1548	)
O	1548	1549	,
B-Symptom	1550	1555	focal
I-Symptom	1556	1566	arteriolar
I-Symptom	1567	1576	narrowing
O	1577	1580	was
O	1581	1586	found
O	1587	1589	in
O	1590	1591	7
O	1591	1592	%
O	1592	1593	,
B-Symptom	1594	1596	AV
I-Symptom	1597	1604	nicking
O	1605	1607	in
O	1608	1609	6
O	1609	1610	%
O	1610	1611	,
O	1612	1615	and
B-Disease	1616	1627	retinopathy
O	1628	1630	in
O	1631	1632	4
O	1632	1633	%
O	1633	1634	.

O	1635	1642	Because
O	1643	1645	of
O	1646	1655	attrition
O	1656	1658	of
O	1659	1667	subjects
O	1668	1671	and
O	1672	1682	limitation
O	1683	1685	of
O	1686	1693	methods
O	1693	1694	,
O	1695	1705	prevalence
O	1706	1708	of
O	1709	1720	abnormality
O	1721	1724	was
O	1725	1731	likely
O	1732	1746	underestimated
O	1746	1747	.

O	1748	1759	Controlling
O	1760	1763	for
B-Characteristic	1764	1770	gender
O	1770	1771	,
B-Characteristic	1772	1776	race
O	1776	1777	,
B-Characteristic	1778	1781	age
O	1781	1782	,
O	1783	1786	and
B-Characteristic	1787	1794	smoking
I-Characteristic	1795	1801	status
O	1801	1802	,
O	1803	1808	these
B-Symptom	1809	1816	retinal
I-Symptom	1817	1824	changes
O	1825	1829	were
O	1830	1840	associated
O	1841	1845	with
B-Characteristic	1846	1852	higher
I-Characteristic	1853	1858	blood
I-Characteristic	1859	1867	pressure
O	1867	1868	.

O	1869	1872	For
O	1873	1878	every
O	1879	1881	10
O	1881	1882	-
O	1882	1886	mmHg
O	1887	1895	increase
O	1896	1898	in
B-Characteristic	1899	1903	MABP
O	1903	1904	,
B-Characteristic	1905	1906	A
I-Characteristic	1906	1907	/
I-Characteristic	1907	1908	V
I-Characteristic	1909	1914	ratio
O	1915	1924	decreased
O	1925	1927	by
O	1928	1929	0
O	1929	1930	.
O	1930	1932	02
O	1933	1937	unit
O	1938	1939	(
O	1939	1940	P
O	1942	1943	<
O	1945	1946	0
O	1946	1947	.
O	1947	1951	0001
O	1951	1952	)
O	1952	1953	,
B-Symptom	1954	1959	focal
I-Symptom	1960	1970	arteriolar
I-Symptom	1971	1980	narrowing
O	1981	1984	had
O	1985	1987	an
O	1988	1992	odds
O	1993	1998	ratio
O	1999	2000	(
O	2000	2002	OR
O	2002	2003	)
O	2004	2006	of
O	2007	2008	2
O	2008	2009	.
O	2009	2011	00
O	2012	2013	(
O	2013	2015	95
O	2015	2016	%
O	2017	2027	confidence
O	2028	2036	interval
O	2037	2038	[
O	2038	2040	CI
O	2040	2041	]
O	2042	2043	=
O	2044	2045	1
O	2045	2046	.
O	2046	2048	87
O	2048	2049	-
O	2049	2050	2
O	2050	2051	.
O	2051	2053	14
O	2053	2054	)
O	2054	2055	,
B-Symptom	2056	2058	AV
I-Symptom	2059	2066	nicking
O	2067	2070	had
O	2071	2073	an
O	2074	2076	OR
O	2077	2079	of
O	2080	2081	1
O	2081	2082	.
O	2082	2084	25
O	2085	2086	(
O	2086	2088	95
O	2088	2089	%
O	2090	2092	CI
O	2093	2094	=
O	2095	2096	1
O	2096	2097	.
O	2097	2099	16
O	2099	2100	-
O	2100	2101	1
O	2101	2102	.
O	2102	2104	34
O	2104	2105	)
O	2105	2106	,
O	2107	2110	and
B-Disease	2111	2122	retinopathy
O	2123	2126	had
O	2127	2129	an
O	2130	2132	OR
O	2133	2135	of
O	2136	2137	1
O	2137	2138	.
O	2138	2140	25
O	2141	2142	(
O	2142	2144	95
O	2144	2145	%
O	2146	2148	CI
O	2149	2150	=
O	2151	2152	1
O	2152	2153	.
O	2153	2155	15
O	2155	2156	-
O	2156	2157	1
O	2157	2158	.
O	2158	2160	37
O	2160	2161	)
O	2161	2162	.

O	2163	2166	For
O	2167	2170	any
O	2171	2177	degree
O	2178	2180	of
B-Symptom	2181	2192	generalized
I-Symptom	2193	2202	narrowing
O	2202	2203	,
O	2204	2215	individuals
O	2216	2220	with
B-Symptom	2221	2226	focal
I-Symptom	2227	2236	narrowing
O	2237	2240	had
B-Characteristic	2241	2245	MABP
O	2246	2259	approximately
O	2260	2261	8
O	2262	2266	mmHg
O	2267	2273	higher
O	2274	2278	than
O	2279	2284	those
O	2285	2292	without
O	2293	2294	(
O	2294	2295	P
O	2297	2298	<
O	2300	2301	0
O	2301	2302	.
O	2302	2306	0001
O	2306	2307	)
O	2307	2308	.

O	2309	2315	Masked
O	2316	2325	replicate
O	2326	2336	assessment
O	2337	2339	of
O	2340	2341	a
O	2342	2348	sample
O	2349	2354	found
O	2355	2358	the
O	2359	2368	following
O	2369	2384	reproducibility
O	2384	2385	:
O	2386	2389	for
B-Characteristic	2390	2391	A
I-Characteristic	2391	2392	/
I-Characteristic	2392	2393	V
I-Characteristic	2394	2399	ratio
O	2399	2400	,
O	2401	2412	correlation
O	2413	2424	coefficient
O	2425	2426	=
O	2427	2428	0
O	2428	2429	.
O	2429	2431	79
O	2432	2435	and
O	2436	2442	median
O	2443	2451	absolute
O	2452	2462	difference
O	2463	2464	=
O	2465	2466	0
O	2466	2467	.
O	2467	2469	03
O	2469	2470	;
O	2471	2474	for
B-Symptom	2475	2480	focal
I-Symptom	2481	2491	arteriolar
I-Symptom	2492	2501	narrowing
O	2501	2502	,
O	2503	2508	kappa
O	2509	2510	=
O	2511	2512	0
O	2512	2513	.
O	2513	2515	45
O	2515	2516	;
O	2517	2520	for
B-Symptom	2521	2523	AV
I-Symptom	2524	2531	nicking
O	2531	2532	,
O	2533	2538	kappa
O	2539	2540	=
O	2541	2542	0
O	2542	2543	.
O	2543	2545	61
O	2545	2546	;
O	2547	2550	and
O	2551	2554	for
B-Disease	2555	2566	retinopathy
O	2566	2567	,
O	2568	2573	kappa
O	2574	2575	=
O	2576	2577	0
O	2577	2578	.
O	2578	2580	89
O	2580	2581	.

O	2582	2591	Protocols
O	2592	2596	have
O	2597	2601	been
O	2602	2611	developed
O	2612	2615	for
B-Diagnostic_tool	2616	2628	nonmydriatic
I-Diagnostic_tool	2629	2635	fundus
I-Diagnostic_tool	2636	2647	photography
O	2648	2651	and
O	2652	2655	for
O	2656	2666	evaluation
O	2667	2669	of
B-Symptom	2670	2677	retinal
I-Symptom	2678	2686	vascular
I-Symptom	2687	2700	abnormalities
O	2700	2701	.

O	2702	2709	Several
B-Symptom	2710	2723	microvascular
I-Symptom	2724	2731	changes
O	2732	2736	were
O	2737	2750	significantly
O	2751	2761	associated
O	2762	2766	with
B-Characteristic	2767	2773	higher
I-Characteristic	2774	2779	blood
I-Characteristic	2780	2788	pressure
O	2788	2789	;
O	2790	2796	follow
O	2796	2797	-
O	2797	2799	up
O	2800	2804	will
O	2805	2809	show
O	2810	2817	whether
O	2818	2823	these
O	2824	2827	are
O	2828	2838	predictive
O	2839	2841	of
B-Disease	2842	2847	later
I-Disease	2848	2863	cerebrovascular
I-Disease	2864	2866	or
I-Disease	2867	2881	cardiovascular
I-Disease	2882	2889	disease
O	2890	2903	independently
O	2904	2906	of
O	2907	2912	other
O	2913	2918	known
O	2919	2923	risk
O	2924	2931	factors
O	2931	2932	.

O	0	1	A
O	2	11	screening
O	12	20	approach
O	21	23	to
O	24	27	the
O	28	40	surveillance
O	41	43	of
O	44	52	patients
O	53	57	with
B-Disease	58	66	diabetes
O	67	70	for
O	71	74	the
O	75	83	presence
O	84	86	of
B-Disease	87	93	vision
I-Disease	93	94	-
I-Disease	94	105	threatening
I-Disease	106	117	retinopathy
O	117	118	.

O	120	122	To
O	123	130	provide
O	131	145	scientifically
O	146	151	based
O	152	161	screening
O	162	167	rules
O	168	171	for
O	172	175	the
O	176	183	primary
O	184	188	care
O	189	196	setting
O	197	205	designed
O	206	208	to
O	209	217	identify
O	217	218	,
O	219	226	through
O	227	237	evaluation
O	238	240	of
O	241	242	a
O	243	253	prescribed
O	254	257	and
O	258	265	limited
O	266	273	portion
O	274	276	of
O	277	280	the
B-Anatomy	281	290	posterior
I-Anatomy	291	297	fundus
O	297	298	,
O	299	304	those
O	305	313	patients
O	314	318	with
B-Disease	319	327	diabetes
O	328	331	who
O	332	336	have
B-Disease	337	348	retinopathy
O	349	355	severe
O	356	362	enough
O	363	365	to
O	366	370	need
O	371	379	referral
O	380	382	to
B-Anatomy	383	386	eye
O	387	391	care
O	392	403	specialists
O	403	404	.

O	405	418	Retrospective
O	419	427	analysis
O	428	430	of
O	431	434	the
B-Classification_system	435	440	Early
I-Classification_system	441	450	Treatment
I-Classification_system	451	459	Diabetic
I-Classification_system	460	471	Retinopathy
I-Classification_system	472	477	Study
O	478	479	(
B-Classification_system	479	484	ETDRS
O	484	485	)
O	486	498	photographic
O	499	503	data
O	504	508	base
O	508	509	.

O	510	513	The
B-Diagnostic_tool	514	520	fundus
I-Diagnostic_tool	521	533	photographic
O	534	541	grading
O	542	546	data
O	547	551	from
O	552	556	3711
O	557	565	patients
O	566	570	with
B-Disease	571	579	diabetes
O	580	588	enrolled
O	589	591	in
O	592	595	the
B-Classification_system	596	601	ETDRS
O	601	602	.

O	603	615	Multivariate
O	616	626	regression
O	627	637	techniques
O	638	642	were
O	643	647	used
O	648	650	to
O	651	659	identify
B-Symptom	660	671	retinopathy
I-Symptom	672	679	lesions
O	680	682	in
O	683	695	photographic
O	696	702	fields
O	703	704	1
O	704	705	,
O	706	707	2
O	707	708	,
O	709	710	3
O	710	711	,
O	712	714	or
O	715	716	a
O	717	728	combination
O	729	736	thereof
O	737	741	that
O	742	749	predict
B-Disease	750	763	proliferative
I-Disease	764	772	diabetic
I-Disease	773	784	retinopathy
O	785	786	(
B-Disease	786	789	PDR
O	789	790	)
O	791	793	or
B-Disease	794	804	clinically
I-Disease	805	816	significant
I-Disease	817	824	macular
I-Disease	825	830	edema
O	831	832	(
B-Disease	832	836	CSME
O	836	837	)
O	838	844	within
O	845	848	the
O	849	854	seven
O	855	863	standard
O	864	870	fields
O	870	871	.

O	872	877	These
O	878	882	were
O	883	887	used
O	888	890	to
O	891	900	construct
O	901	902	a
O	903	909	family
O	910	912	of
O	913	922	screening
O	923	928	rules
O	929	933	with
O	934	941	optimal
O	942	950	combined
O	951	962	sensitivity
O	963	966	and
O	967	978	specificity
O	979	981	on
O	982	987	which
O	988	990	to
O	991	995	base
O	996	1005	referrals
O	1006	1008	to
B-Anatomy	1009	1012	eye
O	1013	1017	care
O	1018	1029	specialists
O	1029	1030	.

O	1031	1039	Presence
O	1040	1042	of
B-Disease	1043	1051	moderate
I-Disease	1052	1054	to
I-Disease	1055	1061	severe
I-Disease	1062	1078	nonproliferative
I-Disease	1079	1087	diabetic
I-Disease	1088	1099	retinopathy
O	1100	1101	(
B-Disease	1101	1105	NPDR
O	1105	1106	)
O	1106	1107	,
B-Disease	1108	1111	PDR
O	1111	1112	,
O	1113	1115	or
B-Disease	1116	1120	CSME
O	1121	1123	in
O	1124	1130	graded
B-Diagnostic_tool	1131	1137	fundus
I-Diagnostic_tool	1138	1149	photographs
O	1149	1150	.

B-Symptom	1151	1162	Hemorrhages
I-Symptom	1163	1166	and
I-Symptom	1167	1181	microaneurysms
I-Symptom	1182	1183	(
I-Symptom	1183	1184	h
I-Symptom	1184	1185	/
I-Symptom	1185	1187	ma
I-Symptom	1187	1188	)
I-Symptom	1189	1197	temporal
I-Symptom	1198	1200	to
I-Symptom	1201	1204	the
I-Symptom	1205	1211	macula
O	1212	1213	(
O	1213	1225	photographic
O	1226	1231	field
O	1232	1233	3
O	1233	1234	)
O	1234	1235	,
O	1236	1238	as
O	1239	1245	severe
O	1246	1248	as
O	1249	1251	or
O	1252	1256	more
O	1257	1263	severe
O	1264	1268	than
B-Classification_system	1269	1274	ETDRS
O	1275	1283	standard
O	1284	1294	photograph
O	1295	1296	1
O	1297	1298	(
B-Symptom	1298	1299	h
I-Symptom	1299	1300	/
I-Symptom	1300	1302	ma
B-Dimension	1303	1304	3
I-Dimension	1306	1307	>
I-Dimension	1309	1311	or
I-Dimension	1312	1313	=
I-Dimension	1314	1315	3
O	1315	1316	)
O	1316	1317	,
O	1318	1328	identified
O	1329	1331	87
O	1331	1332	%
O	1333	1335	to
O	1336	1338	89
O	1338	1339	%
O	1340	1342	of
B-Anatomy	1343	1347	eyes
O	1348	1352	with
B-Disease	1353	1356	PDR
O	1357	1360	and
O	1361	1363	92
O	1363	1364	%
O	1365	1367	to
O	1368	1370	93
O	1370	1371	%
O	1372	1374	of
B-Anatomy	1375	1379	eyes
O	1380	1384	with
B-Disease	1385	1395	moderately
I-Disease	1396	1402	severe
I-Disease	1403	1405	to
I-Disease	1406	1412	severe
I-Disease	1413	1417	NPDR
O	1417	1418	,
O	1419	1424	which
O	1425	1428	are
O	1429	1431	at
O	1432	1436	high
O	1437	1441	risk
O	1442	1445	for
O	1446	1456	developing
B-Disease	1457	1460	PDR
O	1460	1461	.

O	1462	1475	Extrapolating
O	1476	1479	the
O	1480	1487	results
O	1488	1493	using
B-Disease	1494	1505	retinopathy
O	1506	1516	prevalence
O	1517	1521	data
O	1522	1526	from
O	1527	1540	epidemiologic
O	1541	1548	studies
O	1549	1552	for
O	1553	1556	the
O	1557	1564	general
B-Characteristic	1565	1570	older
I-Characteristic	1571	1576	onset
I-Characteristic	1577	1585	diabetic
I-Characteristic	1586	1596	population
O	1596	1597	,
O	1598	1601	the
O	1602	1612	calculated
O	1613	1624	sensitivity
O	1625	1628	for
O	1629	1638	detecting
B-Disease	1639	1642	PDR
O	1643	1645	on
O	1646	1647	a
O	1648	1654	single
O	1655	1666	examination
O	1667	1669	is
O	1670	1672	87
O	1672	1673	%
O	1673	1674	,
O	1675	1678	the
O	1679	1690	specificity
O	1691	1693	80
O	1693	1694	%
O	1694	1695	;
O	1696	1699	for
B-Disease	1700	1708	moderate
I-Disease	1709	1713	NPDR
O	1714	1716	or
O	1717	1722	worse
O	1722	1723	,
O	1724	1727	the
O	1728	1739	sensitivity
O	1740	1742	is
O	1743	1745	81
O	1746	1747	%
O	1747	1748	,
O	1749	1760	specificity
O	1761	1763	93
O	1763	1764	%
O	1764	1765	.

O	1766	1774	Applying
O	1775	1778	the
O	1779	1787	presence
O	1788	1790	of
B-Symptom	1791	1792	h
I-Symptom	1792	1793	/
I-Symptom	1793	1795	ma
B-Dimension	1796	1797	3
I-Dimension	1799	1800	>
I-Dimension	1802	1804	or
I-Dimension	1805	1806	=
I-Dimension	1807	1808	3
O	1809	1811	as
O	1812	1813	a
O	1814	1823	screening
O	1824	1828	rule
O	1829	1831	to
O	1832	1835	the
B-Characteristic	1836	1841	older
I-Characteristic	1842	1847	onset
I-Characteristic	1848	1858	population
O	1858	1859	,
O	1860	1862	26
O	1862	1863	.
O	1863	1864	5
O	1864	1865	%
O	1866	1868	of
O	1869	1877	patients
O	1878	1883	would
O	1884	1886	be
O	1887	1895	referred
O	1896	1899	and
O	1900	1902	73
O	1902	1903	.
O	1903	1904	5
O	1904	1905	%
O	1906	1911	would
O	1912	1915	not
O	1916	1918	be
O	1919	1927	referred
O	1927	1928	.

O	1929	1932	Any
B-Symptom	1933	1937	hard
I-Symptom	1938	1945	exudate
I-Symptom	1946	1952	within
I-Symptom	1953	1956	one
I-Symptom	1957	1961	disc
I-Symptom	1962	1970	diameter
I-Symptom	1971	1973	of
I-Symptom	1974	1977	the
I-Symptom	1978	1985	macular
I-Symptom	1986	1992	center
O	1993	2000	detects
B-Disease	2001	2005	CSME
O	2006	2010	with
O	2011	2022	sensitivity
O	2023	2025	94
O	2025	2026	%
O	2026	2027	,
O	2028	2039	specificity
O	2040	2042	54
O	2042	2043	%
O	2043	2044	.

B-Symptom	2045	2049	Hard
I-Symptom	2050	2057	exudate
I-Symptom	2058	2060	of
I-Symptom	2061	2069	moderate
I-Symptom	2070	2072	or
I-Symptom	2073	2078	worse
I-Symptom	2079	2087	severity
I-Symptom	2088	2096	anywhere
I-Symptom	2097	2099	in
I-Symptom	2100	2103	the
I-Symptom	2104	2111	macular
I-Symptom	2112	2118	region
O	2119	2120	(
O	2120	2125	field
O	2126	2127	2
O	2127	2128	)
O	2129	2137	predicts
B-Disease	2138	2142	CSME
O	2143	2147	with
O	2148	2159	sensitivity
O	2160	2162	89
O	2162	2163	%
O	2163	2164	,
O	2165	2176	specificity
O	2177	2179	58
O	2179	2180	%
O	2180	2181	.

O	2182	2191	Screening
O	2192	2201	protocols
O	2202	2207	based
O	2208	2210	on
O	2211	2220	assessing
B-Symptom	2221	2232	retinopathy
I-Symptom	2233	2239	lesion
O	2240	2248	severity
O	2249	2251	in
O	2252	2255	the
B-Anatomy	2256	2265	posterior
I-Anatomy	2266	2272	fundus
O	2273	2277	have
O	2278	2281	the
O	2282	2291	potential
O	2292	2294	to
O	2295	2303	identify
O	2304	2308	most
B-Disease	2309	2317	diabetic
O	2318	2326	patients
O	2327	2331	with
B-Disease	2332	2338	vision
I-Disease	2338	2339	-
I-Disease	2339	2350	threatening
I-Disease	2351	2362	retinopathy
O	2362	2363	.

O	2364	2366	If
O	2367	2370	the
O	2371	2380	protocols
O	2381	2384	can
O	2385	2387	be
O	2388	2399	implemented
O	2400	2411	effectively
O	2412	2414	in
O	2415	2416	a
O	2417	2424	primary
O	2425	2429	care
O	2430	2437	setting
O	2437	2438	,
O	2439	2447	patients
O	2448	2457	requiring
O	2458	2466	referral
O	2467	2470	for
O	2471	2480	specialty
O	2481	2485	care
O	2486	2491	could
O	2492	2494	be
O	2495	2503	reliably
O	2504	2514	identified
O	2514	2515	,
O	2516	2519	and
O	2520	2523	the
O	2524	2529	total
O	2530	2536	number
O	2537	2539	of
O	2540	2548	patients
O	2549	2556	needing
O	2557	2566	specialty
O	2567	2575	referral
O	2576	2581	could
O	2582	2584	be
O	2585	2598	substantially
O	2599	2606	reduced
O	2607	2611	from
O	2612	2619	current
O	2620	2630	guidelines
O	2630	2631	.

B-Disease	0	13	Circumscribed
I-Disease	14	23	choroidal
I-Disease	24	34	hemangioma
O	34	35	:
O	36	50	characteristic
O	51	59	features
O	60	64	with
B-Diagnostic_tool	65	76	indocyanine
I-Diagnostic_tool	77	82	green
I-Diagnostic_tool	83	99	videoangiography
O	99	100	.

O	102	104	To
O	105	114	determine
O	115	118	the
O	119	133	characteristic
O	134	142	features
O	143	145	of
B-Diagnostic_tool	146	157	indocyanine
I-Diagnostic_tool	158	163	green
I-Diagnostic_tool	164	180	videoangiography
O	181	182	(
B-Diagnostic_tool	182	185	ICG
I-Diagnostic_tool	185	186	-
I-Diagnostic_tool	186	187	V
O	187	188	)
O	189	191	of
B-Disease	192	205	circumscribed
I-Disease	206	215	choroidal
I-Disease	216	226	hemangioma
O	226	227	.

O	228	239	Prospective
O	239	240	,
O	241	254	observational
O	255	259	case
O	260	266	series
O	266	267	.

O	268	274	Twenty
O	274	275	-
O	275	279	five
B-Anatomy	280	284	eyes
O	285	287	of
O	288	290	25
O	291	302	consecutive
O	303	311	patients
O	312	316	with
B-Disease	317	330	circumscribed
I-Disease	331	340	choroidal
I-Disease	341	351	hemangioma
O	351	352	.

B-Diagnostic_tool	353	364	Indocyanine
I-Diagnostic_tool	365	370	green
I-Diagnostic_tool	371	387	videoangiography
O	388	391	and
B-Diagnostic_tool	392	403	intravenous
I-Diagnostic_tool	404	415	fluorescein
I-Diagnostic_tool	416	427	angiography
O	428	429	(
B-Diagnostic_tool	429	433	IVFA
O	433	434	)
O	435	439	were
O	440	453	prospectively
O	454	463	performed
O	464	467	and
O	468	476	reviewed
O	476	477	.

O	478	481	The
O	482	490	specific
O	491	499	features
O	500	502	on
B-Diagnostic_tool	503	506	ICG
I-Diagnostic_tool	506	507	-
I-Diagnostic_tool	507	508	V
O	509	513	were
O	514	522	compared
O	523	527	with
O	528	536	features
O	537	539	of
B-Diagnostic_tool	540	544	IVFA
O	544	545	.

O	546	549	The
O	550	558	behavior
O	559	561	of
B-Disease	562	575	circumscribed
I-Disease	576	585	choroidal
I-Disease	586	596	hemangioma
O	597	602	cases
O	603	606	was
O	607	615	observed
O	616	620	with
B-Diagnostic_tool	621	624	ICG
I-Diagnostic_tool	624	625	-
I-Diagnostic_tool	625	626	V
O	627	630	and
B-Diagnostic_tool	631	635	IVFA
O	635	636	.

O	637	639	On
B-Diagnostic_tool	640	643	ICG
I-Diagnostic_tool	643	644	-
I-Diagnostic_tool	644	645	V
O	645	646	,
O	647	655	earliest
B-Characteristic	656	673	hyperfluorescence
O	674	676	of
B-Disease	677	690	circumscribed
I-Disease	691	700	choroidal
I-Disease	701	711	hemangioma
O	712	715	was
O	716	724	achieved
O	725	727	at
O	728	729	a
O	730	734	mean
O	735	737	of
O	738	740	27
O	740	741	.
O	741	742	6
O	743	750	seconds
O	751	752	(
O	752	757	range
O	757	758	,
O	759	761	13
O	761	762	-
O	762	764	62
O	765	772	seconds
O	772	773	)
O	773	774	,
O	775	782	whereas
O	783	790	maximum
O	791	808	hyperfluorescence
O	809	817	occurred
O	818	820	at
O	821	824	222
O	825	832	seconds
O	833	834	(
O	834	839	range
O	839	840	,
O	841	843	33
O	843	844	-
O	844	847	707
O	848	855	seconds
O	855	856	)
O	856	857	.

O	858	860	In
O	861	864	the
O	865	869	late
O	870	876	frames
O	876	877	,
O	878	881	all
B-Anatomy	882	886	eyes
O	887	899	demonstrated
O	900	901	a
O	902	910	relative
O	911	919	decrease
O	920	922	in
O	923	935	fluorescence
O	935	936	,
O	937	946	including
O	947	949	18
B-Anatomy	950	954	eyes
O	955	956	(
O	956	958	72
O	958	959	%
O	959	960	)
O	961	965	that
O	966	978	demonstrated
O	980	981	"
O	982	989	washout
O	990	991	"
O	993	995	of
O	996	999	the
O	1000	1003	dye
O	1003	1004	.

O	1005	1010	Other
O	1011	1019	findings
O	1020	1022	on
B-Diagnostic_tool	1023	1026	ICG
I-Diagnostic_tool	1026	1027	-
I-Diagnostic_tool	1027	1028	V
O	1029	1037	included
B-Characteristic	1038	1047	intrinsic
I-Characteristic	1048	1055	vessels
O	1056	1058	in
O	1059	1061	19
B-Anatomy	1062	1066	eyes
O	1067	1068	(
O	1068	1070	76
O	1070	1071	%
O	1071	1072	)
O	1072	1073	,
O	1074	1075	a
B-Characteristic	1076	1080	late
I-Characteristic	1081	1097	hyperfluorescent
I-Characteristic	1098	1101	rim
O	1102	1104	in
O	1105	1107	19
B-Anatomy	1108	1112	eyes
O	1113	1114	(
O	1114	1116	76
O	1116	1117	%
O	1117	1118	)
O	1118	1119	,
O	1120	1123	and
B-Characteristic	1124	1128	late
I-Characteristic	1129	1134	frame
I-Characteristic	1135	1138	hot
I-Characteristic	1139	1144	spots
O	1145	1147	in
O	1148	1150	14
B-Anatomy	1151	1155	eyes
O	1156	1157	(
O	1157	1159	56
O	1159	1160	%
O	1160	1161	)
O	1161	1162	.

O	1163	1165	On
B-Diagnostic_tool	1166	1170	IVFA
O	1170	1171	,
O	1172	1175	the
O	1176	1184	earliest
B-Characteristic	1185	1202	hyperfluorescence
O	1203	1206	was
O	1207	1215	achieved
O	1216	1218	at
O	1219	1220	a
O	1221	1225	mean
O	1226	1228	of
O	1229	1231	24
O	1232	1239	seconds
O	1240	1241	(
O	1241	1246	range
O	1246	1247	,
O	1248	1250	10
O	1250	1251	-
O	1251	1253	66
O	1254	1261	seconds
O	1261	1262	)
O	1262	1263	,
O	1264	1271	whereas
O	1272	1279	maximum
B-Characteristic	1280	1297	hyperfluorescence
O	1298	1306	occurred
O	1307	1309	at
O	1310	1311	a
O	1312	1316	mean
O	1317	1319	of
O	1320	1322	76
O	1322	1323	.
O	1323	1324	3
O	1325	1332	seconds
O	1333	1334	(
O	1334	1339	range
O	1339	1340	,
O	1341	1343	21
O	1343	1344	-
O	1344	1347	720
O	1348	1355	seconds
O	1355	1356	)
O	1356	1357	.

O	1358	1368	Increasing
B-Characteristic	1369	1386	hyperfluorescence
O	1387	1389	in
O	1390	1393	the
O	1394	1398	late
O	1399	1405	frames
O	1406	1409	was
O	1410	1415	found
O	1416	1418	in
O	1419	1422	all
O	1423	1428	cases
O	1428	1429	.

O	1430	1435	Other
O	1436	1444	findings
O	1445	1453	included
B-Characteristic	1454	1463	intrinsic
I-Characteristic	1464	1471	vessels
O	1472	1474	in
O	1475	1477	12
B-Anatomy	1478	1482	eyes
O	1483	1484	(
O	1484	1486	48
O	1486	1487	%
O	1487	1488	)
O	1489	1492	and
B-Characteristic	1493	1496	hot
I-Characteristic	1497	1502	spots
O	1503	1505	in
O	1506	1509	the
O	1510	1514	late
O	1515	1521	frames
O	1522	1524	in
O	1525	1526	9
B-Anatomy	1527	1531	eyes
O	1532	1533	(
O	1533	1535	36
O	1535	1536	%
O	1536	1537	)
O	1537	1538	.

B-Disease	1539	1552	Circumscribed
I-Disease	1553	1562	choroidal
I-Disease	1563	1573	hemangioma
O	1574	1578	have
O	1579	1587	specific
O	1588	1603	characteristics
O	1604	1606	on
B-Diagnostic_tool	1607	1610	ICG
I-Diagnostic_tool	1610	1611	-
I-Diagnostic_tool	1611	1612	V
O	1613	1617	that
O	1618	1621	are
O	1622	1625	not
O	1626	1636	visualized
O	1637	1641	with
B-Diagnostic_tool	1642	1646	IVFA
O	1646	1647	.

O	1648	1650	We
O	1651	1658	believe
O	1659	1663	that
B-Diagnostic_tool	1664	1667	ICG
I-Diagnostic_tool	1667	1668	-
I-Diagnostic_tool	1668	1669	V
O	1670	1673	may
O	1674	1680	become
O	1681	1683	an
O	1684	1693	important
O	1694	1705	noninvasive
O	1706	1710	tool
O	1711	1714	for
O	1715	1718	the
O	1719	1728	diagnosis
O	1729	1731	of
B-Disease	1732	1741	choroidal
I-Disease	1742	1752	hemangioma
O	1752	1753	.

O	0	10	Comparison
O	11	18	between
B-Diagnostic_tool	19	26	optical
I-Diagnostic_tool	27	36	coherence
I-Diagnostic_tool	37	47	tomography
O	48	51	and
B-Diagnostic_tool	52	58	fundus
I-Diagnostic_tool	59	70	fluorescein
I-Diagnostic_tool	71	82	angiography
O	83	86	for
O	87	90	the
O	91	100	detection
O	101	103	of
B-Disease	104	111	cystoid
I-Disease	112	119	macular
I-Disease	120	125	edema
O	126	128	in
O	129	137	patients
O	138	142	with
B-Disease	143	150	uveitis
O	150	151	.

O	153	155	To
O	156	163	compare
B-Diagnostic_tool	164	171	optical
I-Diagnostic_tool	172	181	coherence
I-Diagnostic_tool	182	192	tomography
O	193	194	(
B-Diagnostic_tool	194	197	OCT
O	197	198	)
O	199	203	with
B-Diagnostic_tool	204	210	fundus
I-Diagnostic_tool	211	222	fluorescein
I-Diagnostic_tool	223	234	angiography
O	235	236	(
B-Diagnostic_tool	236	239	FFA
O	239	240	)
O	241	244	for
O	245	248	the
O	249	258	detection
O	259	261	of
B-Disease	262	269	cystoid
I-Disease	270	277	macular
I-Disease	278	283	edema
O	284	285	(
B-Disease	285	288	CME
O	288	289	)
O	290	292	in
O	293	301	patients
O	302	306	with
B-Disease	307	314	uveitis
O	314	315	.

O	316	327	Prospective
O	328	339	comparative
O	340	353	observational
O	354	360	series
O	360	361	.

O	362	365	One
O	366	373	hundred
O	374	380	twenty
O	380	381	-
O	381	384	one
B-Anatomy	385	389	eyes
O	390	392	of
O	393	395	58
O	396	404	patients
O	405	409	with
B-Disease	410	417	uveitis
O	418	420	of
O	421	427	varied
O	428	434	causes
O	435	436	(
O	436	441	seven
O	442	450	patients
O	451	455	were
O	456	463	studied
O	464	469	twice
O	469	470	)
O	470	471	.

O	472	480	Patients
O	481	485	with
O	486	495	suspected
B-Disease	496	499	CME
O	500	509	underwent
B-Diagnostic_tool	510	513	OCT
I-Diagnostic_tool	514	522	scanning
O	523	531	followed
O	532	534	by
B-Diagnostic_tool	535	538	FFA
O	539	541	at
O	542	545	the
O	546	550	same
O	551	556	visit
O	556	557	.

O	558	567	Detection
O	568	571	and
O	572	584	distribution
O	585	587	of
B-Disease	588	595	macular
I-Disease	596	601	edema
O	601	602	.

O	603	606	One
O	607	614	hundred
O	615	620	eight
B-Anatomy	621	625	eyes
O	626	629	had
O	630	637	similar
O	638	645	results
O	646	648	on
O	649	653	both
B-Diagnostic_tool	654	657	OCT
O	658	661	and
B-Diagnostic_tool	662	665	FFA
O	666	668	in
O	669	673	that
O	674	676	67
B-Anatomy	677	681	eyes
O	682	685	had
B-Disease	686	689	CME
O	690	693	and
O	694	696	41
B-Anatomy	697	701	eyes
O	702	705	had
O	706	708	no
B-Disease	709	712	CME
O	712	713	.

O	714	716	In
O	717	719	10
B-Anatomy	720	724	eyes
B-Symptom	725	735	subretinal
I-Symptom	736	741	fluid
O	742	745	was
O	746	754	detected
O	755	757	on
B-Diagnostic_tool	758	761	OCT
O	762	765	but
O	766	769	not
B-Diagnostic_tool	770	773	FFA
O	773	774	.

O	775	779	Five
O	780	782	of
O	783	788	these
B-Anatomy	789	793	eyes
O	794	797	had
B-Disease	798	801	CME
O	802	804	on
B-Diagnostic_tool	805	808	FFA
O	809	812	but
O	813	816	not
B-Diagnostic_tool	817	820	OCT
O	820	821	.

O	822	827	Three
O	828	833	other
B-Anatomy	834	838	eyes
O	839	842	had
B-Disease	843	846	CME
O	847	851	that
O	852	855	was
O	856	864	detected
O	865	867	by
B-Diagnostic_tool	868	871	FFA
O	872	875	but
O	876	879	not
O	880	882	by
B-Diagnostic_tool	883	886	OCT
O	886	887	.

O	888	896	Compared
O	897	901	with
B-Diagnostic_tool	902	905	FFA
O	905	906	,
O	907	910	the
B-Diagnostic_tool	911	914	OCT
O	915	926	sensitivity
O	927	930	for
O	931	940	detecting
B-Disease	941	944	CME
O	945	948	was
O	949	951	96
O	951	952	%
O	953	954	(
O	954	963	including
O	964	967	the
B-Anatomy	968	972	eyes
O	973	977	with
B-Symptom	978	988	subretinal
I-Symptom	989	994	fluid
O	994	995	)
O	995	996	,
O	997	1000	and
O	1001	1004	the
B-Diagnostic_tool	1005	1008	OCT
O	1009	1020	specificity
O	1021	1024	was
O	1025	1028	100
O	1028	1029	%
O	1029	1030	.

B-Diagnostic_tool	1031	1034	OCT
O	1035	1037	is
O	1038	1040	as
O	1041	1050	effective
O	1051	1053	at
O	1054	1063	detecting
B-Disease	1064	1067	CME
O	1068	1070	as
O	1071	1073	is
B-Diagnostic_tool	1074	1077	FFA
O	1078	1081	but
O	1082	1084	is
O	1085	1093	superior
O	1094	1096	in
O	1097	1110	demonstrating
O	1111	1116	axial
O	1117	1129	distribution
O	1130	1132	of
O	1133	1138	fluid
O	1138	1139	.

B-Diagnostic_tool	0	8	Entoptic
I-Diagnostic_tool	9	18	perimetry
O	19	28	screening
O	29	32	for
B-Symptom	33	40	central
I-Symptom	41	49	diabetic
I-Symptom	50	58	scotomas
O	59	62	and
B-Disease	63	70	macular
I-Disease	71	76	edema
O	76	77	.

O	79	82	The
O	83	86	aim
O	87	89	of
O	90	94	this
O	95	100	study
O	101	104	was
O	105	107	to
O	108	115	compare
B-Diagnostic_tool	116	124	entoptic
I-Diagnostic_tool	125	134	perimetry
O	134	135	,
O	136	141	using
B-Diagnostic_tool	142	154	conventional
I-Diagnostic_tool	155	165	television
O	165	166	,
O	167	169	to
B-Diagnostic_tool	170	176	Amsler
I-Diagnostic_tool	177	181	grid
O	182	185	and
B-Symptom	186	193	patient
I-Symptom	193	194	-
I-Symptom	194	202	reported
I-Symptom	203	209	visual
I-Symptom	210	214	loss
O	215	218	for
O	219	222	the
O	223	232	detection
O	233	235	of
B-Disease	236	246	functional
I-Disease	247	255	diabetic
I-Disease	256	267	maculopathy
O	268	271	and
B-Disease	272	279	macular
I-Disease	280	285	edema
O	285	286	.

O	287	300	Observational
O	301	305	case
O	306	312	series
O	312	313	.

O	314	315	A
O	316	322	single
B-Anatomy	323	326	eye
O	327	331	from
O	332	336	each
O	337	339	of
O	340	343	104
O	344	355	consecutive
O	356	364	patients
O	365	369	with
B-Disease	370	378	diabetes
O	379	381	in
O	382	384	an
O	385	393	academic
B-Anatomy	394	400	retina
O	401	407	clinic
O	407	408	.

O	409	413	Each
B-Anatomy	414	417	eye
O	418	421	was
O	422	430	screened
O	431	433	by
B-Diagnostic_tool	434	440	Amsler
I-Diagnostic_tool	441	445	grid
O	445	446	,
B-Diagnostic_tool	447	455	entoptic
I-Diagnostic_tool	456	465	perimetry
O	465	466	,
O	467	470	and
B-Diagnostic_tool	471	479	Humphrey
I-Diagnostic_tool	480	482	10
I-Diagnostic_tool	482	483	-
I-Diagnostic_tool	483	484	2
I-Diagnostic_tool	485	494	threshold
I-Diagnostic_tool	495	501	visual
I-Diagnostic_tool	502	507	field
I-Diagnostic_tool	508	515	testing
O	516	517	(
B-Diagnostic_tool	517	520	HVF
I-Diagnostic_tool	521	523	10
I-Diagnostic_tool	523	524	-
I-Diagnostic_tool	524	525	2
O	525	526	;
O	527	535	Humphrey
O	536	547	Instruments
O	548	551	Inc
O	551	552	.
O	552	553	,
O	554	557	San
O	558	565	Leandro
O	565	566	,
O	567	569	CA
O	569	570	)
O	571	573	in
O	574	580	random
O	581	586	order
O	586	587	.

B-Anatomy	588	592	Eyes
O	593	597	were
O	598	602	then
O	603	611	examined
O	612	622	clinically
O	622	623	.

O	624	627	The
O	628	636	presence
O	637	639	or
O	640	647	absence
O	648	650	of
O	651	654	new
B-Symptom	655	661	visual
I-Symptom	662	669	decline
O	670	675	since
O	676	679	the
O	680	687	patient
O	687	688	'
O	688	689	s
O	690	694	last
O	695	703	clinical
O	704	715	examination
O	715	716	,
O	717	720	the
O	721	729	presence
O	730	732	or
O	733	740	absence
O	741	743	of
B-Symptom	744	751	central
I-Symptom	752	758	visual
I-Symptom	759	764	field
I-Symptom	765	778	abnormalities
O	779	784	using
O	785	787	an
B-Diagnostic_tool	788	794	Amsler
I-Diagnostic_tool	795	799	grid
O	799	800	,
B-Diagnostic_tool	801	809	entoptic
I-Diagnostic_tool	810	819	perimetry
O	819	820	,
B-Diagnostic_tool	821	824	HVF
I-Diagnostic_tool	825	827	10
I-Diagnostic_tool	827	828	-
I-Diagnostic_tool	828	829	2
O	829	830	,
O	831	834	and
O	835	838	the
O	839	847	presence
O	848	850	or
O	851	858	absence
O	859	861	of
B-Disease	862	872	clinically
I-Disease	873	884	significant
I-Disease	885	892	macular
I-Disease	893	898	edema
O	899	900	(
B-Disease	900	904	CSME
O	904	905	)
O	905	906	.

O	907	910	The
O	911	924	sensitivities
O	925	928	and
O	929	942	specificities
O	943	946	for
O	947	950	the
O	951	960	detection
O	961	963	of
B-Symptom	964	971	central
I-Symptom	972	980	diabetic
I-Symptom	981	989	scotomas
O	990	992	as
O	993	1002	evidenced
O	1003	1005	by
B-Diagnostic_tool	1006	1009	HVF
I-Diagnostic_tool	1010	1012	10
I-Diagnostic_tool	1012	1013	-
I-Diagnostic_tool	1013	1014	2
O	1015	1028	abnormalities
O	1029	1033	were
O	1033	1034	:
O	1035	1045	subjective
O	1046	1056	impression
O	1056	1057	,
O	1058	1060	31
O	1061	1063	of
O	1064	1066	90
B-Anatomy	1067	1071	eyes
O	1072	1073	(
O	1073	1075	34
O	1075	1076	.
O	1076	1077	4
O	1077	1078	%
O	1078	1079	)
O	1080	1083	and
O	1084	1086	11
O	1087	1089	of
O	1090	1092	14
B-Anatomy	1093	1097	eyes
O	1098	1099	(
O	1099	1101	78
O	1101	1102	.
O	1102	1103	6
O	1103	1104	%
O	1104	1105	)
O	1105	1106	;
B-Diagnostic_tool	1107	1113	Amsler
I-Diagnostic_tool	1114	1118	grid
O	1118	1119	,
O	1120	1122	29
O	1123	1125	of
O	1126	1128	90
B-Anatomy	1129	1133	eyes
O	1134	1135	(
O	1135	1137	32
O	1137	1138	.
O	1138	1139	2
O	1139	1140	%
O	1140	1141	)
O	1142	1145	and
O	1146	1148	13
O	1149	1151	of
O	1152	1154	14
B-Anatomy	1155	1159	eyes
O	1160	1161	(
O	1161	1163	92
O	1163	1164	.
O	1164	1165	9
O	1165	1166	%
O	1166	1167	)
O	1167	1168	;
O	1169	1172	and
B-Diagnostic_tool	1173	1181	entoptic
I-Diagnostic_tool	1182	1191	perimetry
O	1191	1192	,
O	1193	1195	58
O	1196	1198	of
O	1199	1201	90
B-Anatomy	1202	1206	eyes
O	1207	1208	(
O	1208	1210	64
O	1210	1211	.
O	1211	1212	4
O	1212	1213	%
O	1213	1214	)
O	1215	1218	and
O	1219	1221	11
O	1222	1224	of
O	1225	1227	14
B-Anatomy	1228	1232	eyes
O	1233	1234	(
O	1234	1236	78
O	1236	1237	.
O	1237	1238	6
O	1238	1239	%
O	1239	1240	)
O	1240	1241	.

B-Diagnostic_tool	1242	1250	Entoptic
I-Diagnostic_tool	1251	1260	perimetry
O	1261	1264	was
O	1265	1278	statistically
O	1279	1283	more
O	1284	1293	sensitive
O	1294	1298	than
O	1299	1303	both
O	1304	1314	subjective
O	1315	1325	impression
O	1326	1327	(
O	1327	1328	P
O	1330	1331	<
O	1333	1334	0
O	1334	1335	.
O	1335	1338	001
O	1338	1339	)
O	1340	1343	and
B-Diagnostic_tool	1344	1350	Amsler
I-Diagnostic_tool	1351	1355	grid
O	1356	1357	(
O	1357	1358	P
O	1360	1361	<
O	1363	1364	0
O	1364	1365	.
O	1365	1368	001
O	1368	1369	)
O	1369	1370	,
O	1371	1374	but
O	1375	1378	the
O	1379	1392	specificities
O	1393	1397	were
O	1398	1411	statistically
O	1412	1429	indistinguishable
O	1429	1430	.

O	1431	1434	The
O	1435	1448	sensitivities
O	1449	1452	and
O	1453	1466	specificities
O	1467	1470	for
O	1471	1474	the
O	1475	1484	detection
O	1485	1487	of
B-Disease	1488	1492	CSME
O	1493	1497	were
O	1497	1498	:
O	1499	1509	subjective
O	1510	1520	impression
O	1520	1521	,
O	1522	1523	6
O	1524	1526	of
O	1527	1529	24
B-Anatomy	1530	1534	eyes
O	1535	1536	(
O	1536	1538	25
O	1538	1539	.
O	1539	1540	0
O	1540	1541	%
O	1541	1542	)
O	1543	1546	and
O	1547	1549	52
O	1550	1552	of
O	1553	1555	80
B-Anatomy	1556	1560	eyes
O	1561	1562	(
O	1562	1564	65
O	1564	1565	.
O	1565	1566	0
O	1566	1567	%
O	1567	1568	)
O	1568	1569	;
B-Diagnostic_tool	1570	1576	Amsler
I-Diagnostic_tool	1577	1581	grid
O	1581	1582	,
O	1583	1584	9
O	1585	1587	of
O	1588	1590	24
B-Anatomy	1591	1595	eyes
O	1596	1597	(
O	1597	1599	37
O	1599	1600	.
O	1600	1601	5
O	1601	1602	%
O	1602	1603	)
O	1604	1607	and
O	1608	1610	59
O	1611	1613	of
O	1614	1616	80
B-Anatomy	1617	1621	eyes
O	1622	1623	(
O	1623	1625	73
O	1625	1626	.
O	1626	1627	8
O	1627	1628	%
O	1628	1629	)
O	1629	1630	;
O	1631	1634	and
B-Diagnostic_tool	1635	1643	entoptic
I-Diagnostic_tool	1644	1653	perimetry
O	1653	1654	,
O	1655	1657	17
O	1658	1660	of
O	1661	1663	24
B-Anatomy	1664	1668	eyes
O	1669	1670	(
O	1670	1672	70
O	1672	1673	.
O	1673	1674	8
O	1674	1675	%
O	1675	1676	)
O	1677	1680	and
O	1681	1683	44
O	1684	1686	of
O	1687	1689	80
O	1690	1691	(
O	1691	1693	55
O	1693	1694	.
O	1694	1695	0
O	1695	1696	%
O	1696	1697	)
B-Anatomy	1698	1702	eyes
O	1702	1703	.

O	1704	1709	These
O	1710	1717	results
O	1718	1721	are
O	1722	1726	also
O	1727	1740	statistically
O	1741	1752	significant
O	1752	1753	,
O	1754	1758	with
B-Diagnostic_tool	1759	1767	entoptic
I-Diagnostic_tool	1768	1777	perimetry
O	1778	1783	being
O	1784	1788	more
O	1789	1798	sensitive
O	1799	1802	and
O	1803	1807	less
O	1808	1816	specific
O	1817	1821	than
O	1822	1826	both
O	1827	1837	subjective
O	1838	1848	impression
O	1849	1850	(
O	1850	1851	P
O	1852	1853	=
O	1854	1855	0
O	1855	1856	.
O	1856	1859	007
O	1860	1863	and
O	1864	1865	P
O	1866	1867	=
O	1868	1869	0
O	1869	1870	.
O	1870	1873	011
O	1873	1874	,
O	1875	1887	respectively
O	1887	1888	)
O	1889	1892	and
B-Diagnostic_tool	1893	1899	Amsler
I-Diagnostic_tool	1900	1904	grid
O	1905	1906	(
O	1906	1907	P
O	1908	1909	=
O	1910	1911	0
O	1911	1912	.
O	1912	1915	008
O	1916	1919	and
O	1920	1921	P
O	1923	1924	<
O	1926	1927	0
O	1927	1928	.
O	1928	1931	001
O	1931	1932	,
O	1933	1945	respectively
O	1945	1946	)
O	1947	1949	in
O	1950	1954	this
O	1955	1961	subset
O	1962	1964	of
O	1965	1973	patients
O	1973	1974	.

B-Diagnostic_tool	1975	1983	Entoptic
I-Diagnostic_tool	1984	1993	perimetry
O	1994	1996	is
O	1997	1999	87
O	1999	2000	%
O	2001	2005	more
O	2006	2015	sensitive
O	2016	2020	than
O	2021	2024	the
O	2025	2035	subjective
O	2036	2046	impression
O	2047	2049	of
B-Symptom	2050	2056	visual
I-Symptom	2057	2064	decline
O	2065	2066	(
O	2066	2067	P
O	2069	2070	<
O	2072	2073	0
O	2073	2074	.
O	2074	2077	001
O	2077	2078	)
O	2079	2082	and
O	2083	2086	100
O	2086	2087	%
O	2088	2092	more
O	2093	2102	sensitive
O	2103	2107	than
B-Diagnostic_tool	2108	2114	Amsler
I-Diagnostic_tool	2115	2119	grid
O	2120	2121	(
O	2121	2122	P
O	2124	2125	<
O	2127	2128	0
O	2128	2129	.
O	2129	2132	001
O	2132	2133	)
O	2134	2137	for
O	2138	2141	the
O	2142	2151	detection
O	2152	2154	of
B-Symptom	2155	2162	central
I-Symptom	2163	2171	scotomas
O	2172	2174	in
B-Disease	2175	2183	diabetic
O	2184	2192	patients
O	2192	2193	.

O	2194	2197	For
O	2198	2201	the
O	2202	2211	detection
O	2212	2214	of
B-Disease	2215	2219	CSME
O	2219	2220	,
B-Diagnostic_tool	2221	2229	entoptic
I-Diagnostic_tool	2230	2239	perimetry
O	2240	2242	is
O	2243	2246	183
O	2246	2247	%
O	2248	2252	more
O	2253	2262	sensitive
O	2263	2267	than
O	2268	2278	subjective
O	2279	2289	impression
O	2290	2291	(
O	2291	2292	P
O	2293	2294	=
O	2295	2296	0
O	2296	2297	.
O	2297	2300	007
O	2300	2301	)
O	2302	2305	and
O	2306	2308	89
O	2308	2309	%
O	2310	2314	more
O	2315	2324	sensitive
O	2325	2329	than
B-Diagnostic_tool	2330	2336	Amsler
I-Diagnostic_tool	2337	2341	grid
O	2342	2343	(
O	2343	2344	P
O	2345	2346	=
O	2347	2348	0
O	2348	2349	.
O	2349	2352	008
O	2352	2353	)
O	2353	2354	.

O	2355	2360	Hence
O	2360	2361	,
B-Diagnostic_tool	2362	2370	entoptic
I-Diagnostic_tool	2371	2380	perimetry
O	2380	2381	,
O	2382	2391	performed
O	2392	2397	using
B-Diagnostic_tool	2398	2410	conventional
I-Diagnostic_tool	2411	2421	television
O	2421	2422	,
O	2423	2426	has
O	2427	2430	the
O	2431	2440	potential
O	2441	2443	to
O	2444	2446	be
O	2447	2449	an
O	2450	2459	effective
O	2459	2460	,
O	2461	2472	inexpensive
O	2472	2473	,
O	2474	2477	and
O	2478	2488	widespread
O	2489	2496	adjunct
O	2497	2499	to
O	2500	2512	surveillance
O	2513	2525	examinations
O	2526	2529	for
O	2530	2533	the
O	2534	2539	early
O	2540	2549	detection
O	2550	2552	of
B-Disease	2553	2561	diabetic
I-Disease	2562	2573	maculopathy
O	2573	2574	.

B-Diagnostic_tool	0	12	Computerized
I-Diagnostic_tool	13	30	stereochronoscopy
I-Diagnostic_tool	31	34	and
I-Diagnostic_tool	35	46	alternation
I-Diagnostic_tool	47	54	flicker
O	55	57	to
O	58	64	detect
B-Symptom	65	70	optic
I-Symptom	71	76	nerve
I-Symptom	77	81	head
I-Symptom	82	89	contour
I-Symptom	90	96	change
O	96	97	.

B-Diagnostic_tool	99	116	Stereochronoscopy
O	116	117	,
O	118	119	a
O	120	129	technique
O	130	140	previously
O	141	149	explored
O	150	153	but
O	154	163	abandoned
O	164	167	for
B-Disease	168	176	glaucoma
O	177	186	diagnosis
O	186	187	,
O	188	194	viewed
B-Diagnostic_tool	195	200	optic
I-Diagnostic_tool	201	206	nerve
I-Diagnostic_tool	207	213	images
O	214	222	acquired
O	223	225	at
O	226	234	separate
O	235	241	points
O	242	244	in
O	245	249	time
O	250	252	as
O	253	255	if
O	256	257	a
O	258	264	stereo
O	265	269	pair
O	269	270	.

O	271	276	Prior
O	277	284	efforts
O	285	287	to
O	288	295	exploit
O	296	300	this
O	301	310	technique
O	311	315	were
O	316	324	impaired
O	325	327	by
O	328	329	a
O	330	334	lack
O	335	337	of
O	338	355	superimposability
O	356	359	for
O	360	370	sequential
B-Diagnostic_tool	371	376	optic
I-Diagnostic_tool	377	382	nerve
I-Diagnostic_tool	383	389	images
O	389	390	.

O	391	393	We
O	394	406	investigated
B-Diagnostic_tool	407	419	computerized
I-Diagnostic_tool	420	432	registration
I-Diagnostic_tool	433	443	techniques
O	444	447	for
O	448	456	aligning
B-Diagnostic_tool	457	467	sequential
I-Diagnostic_tool	467	468	,
I-Diagnostic_tool	469	479	monoscopic
I-Diagnostic_tool	480	485	optic
I-Diagnostic_tool	486	490	disc
I-Diagnostic_tool	491	497	images
O	498	500	to
O	501	511	facilitate
O	512	521	sensitive
O	522	531	detection
O	532	534	of
B-Symptom	535	540	optic
I-Symptom	541	546	nerve
I-Symptom	547	551	head
I-Symptom	552	559	contour
I-Symptom	560	567	changes
O	568	570	in
B-Disease	571	579	glaucoma
O	579	580	.

O	581	590	Algorithm
O	591	594	and
O	595	603	software
O	604	615	development
O	615	616	.

O	617	628	Comparisons
O	629	633	with
O	634	642	standard
O	643	653	techniques
O	653	654	.

O	655	663	Existing
O	664	671	patient
O	672	679	records
O	680	684	from
O	685	688	the
B-Disease	689	697	Glaucoma
O	698	705	Service
O	705	706	,
O	707	713	Scheie
O	714	717	Eye
O	718	727	Institute
O	727	728	,
O	729	739	University
O	740	742	of
O	743	755	Pennsylvania
O	755	756	.

O	757	760	Two
O	761	765	sets
O	766	768	of
B-Diagnostic_tool	769	774	optic
I-Diagnostic_tool	775	779	disc
I-Diagnostic_tool	780	791	photographs
O	791	792	,
O	793	802	separated
O	803	805	in
O	806	810	time
O	811	813	by
O	814	815	1
O	816	818	to
O	819	821	18
O	822	827	years
O	827	828	,
O	829	831	of
O	832	834	25
B-Anatomy	835	839	eyes
O	840	844	with
O	845	848	and
O	849	856	without
B-Symptom	857	869	glaucomatous
I-Symptom	870	875	optic
I-Symptom	876	880	disc
I-Symptom	881	892	progression
O	893	897	were
O	898	907	digitized
O	907	908	.

O	909	911	We
O	912	921	developed
O	922	928	custom
O	929	937	software
O	938	941	for
O	942	950	accurate
O	951	956	image
O	957	966	alignment
O	966	967	.

B-Symptom	968	974	Change
I-Symptom	975	977	in
I-Symptom	978	982	disc
I-Symptom	983	993	morphology
O	994	997	was
O	998	1002	then
O	1003	1009	judged
O	1010	1012	by
B-Diagnostic_tool	1013	1020	digital
I-Diagnostic_tool	1021	1038	stereochronoscopy
O	1039	1042	and
B-Diagnostic_tool	1043	1047	user
I-Diagnostic_tool	1047	1048	-
I-Diagnostic_tool	1048	1058	controlled
I-Diagnostic_tool	1059	1070	alternation
I-Diagnostic_tool	1071	1078	flicker
I-Diagnostic_tool	1079	1081	of
I-Diagnostic_tool	1082	1094	superimposed
I-Diagnostic_tool	1094	1095	,
I-Diagnostic_tool	1096	1100	time
I-Diagnostic_tool	1100	1101	-
I-Diagnostic_tool	1101	1110	separated
I-Diagnostic_tool	1111	1117	images
O	1118	1120	on
O	1121	1122	a
O	1123	1131	computer
O	1132	1139	monitor
O	1139	1140	.

O	1141	1152	Comparisons
O	1153	1157	were
O	1158	1162	made
O	1163	1167	with
O	1168	1176	standard
O	1177	1189	stereoscopic
O	1190	1200	comparison
O	1200	1201	.

O	1202	1216	Identification
O	1217	1219	of
O	1220	1226	change
O	1227	1229	or
O	1230	1232	no
B-Symptom	1233	1239	change
I-Symptom	1240	1242	in
I-Symptom	1243	1248	optic
I-Symptom	1249	1254	nerve
I-Symptom	1255	1259	head
I-Symptom	1260	1267	contour
O	1268	1271	for
O	1272	1278	images
O	1279	1287	acquired
O	1288	1290	at
O	1291	1299	separate
O	1300	1306	points
O	1307	1309	in
O	1310	1314	time
O	1314	1315	.

O	1316	1321	Image
O	1322	1332	processing
O	1333	1336	and
O	1337	1349	registration
O	1350	1357	permits
O	1358	1366	accurate
O	1367	1376	alignment
O	1377	1379	of
B-Diagnostic_tool	1380	1385	optic
I-Diagnostic_tool	1386	1390	disc
I-Diagnostic_tool	1391	1402	photographs
O	1402	1403	.

B-Diagnostic_tool	1404	1415	Alternation
I-Diagnostic_tool	1416	1423	flicker
I-Diagnostic_tool	1424	1426	of
I-Diagnostic_tool	1427	1439	superimposed
I-Diagnostic_tool	1439	1440	,
I-Diagnostic_tool	1441	1451	sequential
I-Diagnostic_tool	1452	1458	images
O	1459	1470	facilitates
O	1471	1476	image
O	1477	1487	comparison
O	1488	1491	and
O	1492	1501	detection
O	1502	1504	of
O	1505	1511	change
O	1512	1514	as
O	1515	1524	indicated
O	1525	1527	by
B-Characteristic	1528	1534	change
I-Characteristic	1535	1537	in
I-Characteristic	1538	1544	vessel
I-Characteristic	1545	1553	position
I-Characteristic	1553	1554	,
I-Characteristic	1555	1560	color
I-Characteristic	1560	1561	,
I-Characteristic	1562	1565	and
I-Characteristic	1566	1571	other
I-Characteristic	1572	1576	cues
I-Characteristic	1577	1580	for
I-Characteristic	1581	1588	contour
I-Characteristic	1589	1595	change
O	1595	1596	.

O	1597	1598	A
O	1599	1603	high
O	1604	1615	concordance
O	1616	1619	was
O	1620	1625	found
O	1626	1633	between
B-Diagnostic_tool	1634	1642	standard
I-Diagnostic_tool	1643	1655	stereoscopic
I-Diagnostic_tool	1656	1666	comparison
O	1667	1670	and
B-Diagnostic_tool	1671	1682	alternation
I-Diagnostic_tool	1683	1690	flicker
O	1690	1691	.

O	1692	1694	In
O	1695	1702	several
O	1703	1708	cases
O	1708	1709	,
O	1710	1722	reinspection
O	1723	1725	of
O	1726	1732	stereo
O	1733	1743	comparison
O	1744	1747	led
O	1748	1750	to
O	1751	1752	a
O	1753	1760	revised
O	1761	1769	judgment
O	1770	1772	on
O	1773	1776	the
O	1777	1782	basis
O	1783	1785	of
B-Symptom	1786	1790	disc
I-Symptom	1791	1798	changes
O	1799	1807	rendered
O	1808	1812	more
O	1813	1820	obvious
O	1821	1825	with
B-Diagnostic_tool	1826	1837	alternation
I-Diagnostic_tool	1838	1845	flicker
O	1845	1846	.

B-Diagnostic_tool	1847	1854	Digital
I-Diagnostic_tool	1855	1872	stereochronoscopy
O	1873	1876	was
O	1877	1881	less
O	1882	1892	concordant
O	1893	1897	with
O	1898	1906	standard
O	1907	1917	techniques
O	1917	1918	.

B-Diagnostic_tool	1919	1926	Digital
I-Diagnostic_tool	1927	1932	image
I-Diagnostic_tool	1933	1943	processing
I-Diagnostic_tool	1944	1954	techniques
I-Diagnostic_tool	1955	1958	and
I-Diagnostic_tool	1959	1970	alternation
I-Diagnostic_tool	1971	1978	flicker
O	1979	1986	provide
O	1987	1988	a
O	1989	1995	simple
O	1995	1996	,
O	1997	2006	sensitive
O	2006	2007	,
O	2008	2016	software
O	2016	2017	-
O	2017	2022	based
O	2023	2029	method
O	2030	2033	for
O	2034	2043	detecting
B-Symptom	2044	2056	glaucomatous
I-Symptom	2057	2062	optic
I-Symptom	2063	2067	disc
I-Symptom	2068	2074	change
O	2074	2075	.

O	0	1	A
O	2	12	comparison
O	13	15	of
B-Diagnostic_tool	16	28	stereoscopic
I-Diagnostic_tool	29	40	fluorescein
I-Diagnostic_tool	41	52	angiography
O	53	57	with
B-Diagnostic_tool	58	69	indocyanine
I-Diagnostic_tool	70	75	green
I-Diagnostic_tool	76	92	videoangiography
O	93	95	in
B-Disease	96	99	age
I-Disease	99	100	-
I-Disease	100	107	related
I-Disease	108	115	macular
I-Disease	116	128	degeneration
O	128	129	.

O	131	133	To
O	134	143	correlate
O	144	152	features
O	153	155	of
B-Diagnostic_tool	156	167	indocyanine
I-Diagnostic_tool	168	173	green
I-Diagnostic_tool	174	175	(
I-Diagnostic_tool	175	178	ICG
I-Diagnostic_tool	178	179	)
I-Diagnostic_tool	180	196	videoangiography
O	197	201	with
B-Diagnostic_tool	202	208	stereo
I-Diagnostic_tool	209	213	film
I-Diagnostic_tool	214	225	fluorescein
I-Diagnostic_tool	226	237	angiography
O	238	239	(
B-Diagnostic_tool	239	241	FA
O	241	242	)
O	243	245	in
O	246	249	the
O	250	258	analysis
O	259	261	of
B-Disease	262	265	age
I-Disease	265	266	-
I-Disease	266	273	related
I-Disease	274	281	macular
I-Disease	282	294	degeneration
O	295	296	(
B-Disease	296	299	AMD
O	299	300	)
O	300	301	.

O	302	303	A
O	304	317	retrospective
O	318	323	study
O	324	328	with
O	329	339	concurrent
O	340	350	comparison
O	351	353	of
O	354	357	two
O	358	365	methods
O	366	368	of
O	369	379	assessment
O	380	382	on
O	383	386	one
O	387	390	set
O	391	393	of
O	394	402	patients
O	403	407	with
B-Disease	408	411	AMD
O	412	422	undergoing
O	423	433	sequential
B-Diagnostic_tool	434	436	FA
O	436	437	-
B-Diagnostic_tool	437	440	ICG
I-Diagnostic_tool	441	457	videoangiography
O	457	458	.

O	459	462	One
O	463	470	hundred
O	471	475	four
O	476	484	patients
O	485	489	with
B-Disease	490	493	AMD
O	494	497	who
O	498	501	had
O	502	511	undergone
O	512	523	immediately
O	524	534	sequential
B-Diagnostic_tool	535	537	FA
O	537	538	-
B-Diagnostic_tool	538	541	ICG
I-Diagnostic_tool	542	558	videoangiography
O	559	563	were
O	564	572	selected
O	573	575	in
O	576	577	a
O	578	589	consecutive
O	590	597	fashion
O	598	602	from
O	603	606	the
O	607	619	photographic
O	620	625	files
O	626	628	of
O	629	632	the
O	633	638	Casey
O	639	642	Eye
O	643	652	Institute
O	652	653	.

O	654	659	Three
O	660	672	interpreters
O	673	686	independently
O	687	693	graded
O	694	696	in
O	697	699	an
O	700	708	unbiased
O	709	716	fashion
O	717	720	the
B-Characteristic	721	723	FA
I-Characteristic	724	732	features
O	733	735	of
B-Disease	736	739	AMD
O	739	740	.

O	741	746	These
O	747	751	were
O	752	760	compared
O	761	765	with
B-Characteristic	766	769	ICG
I-Characteristic	770	786	videoangiography
I-Characteristic	787	795	features
O	796	798	of
B-Characteristic	799	814	hypocyanescence
O	815	816	(
B-Characteristic	816	819	ICG
I-Characteristic	820	836	videoangiography
I-Characteristic	837	853	hypofluorescence
O	853	854	)
O	854	855	,
B-Characteristic	856	864	moderate
I-Characteristic	865	867	or
I-Characteristic	868	875	intense
I-Characteristic	876	892	hypercyanescence
O	893	894	(
B-Characteristic	894	897	ICG
I-Characteristic	898	914	videoangiography
I-Characteristic	915	932	hyperfluorescence
O	932	933	)
O	933	934	,
O	935	937	or
B-Characteristic	938	945	absence
I-Characteristic	946	948	of
I-Characteristic	949	961	fluorescence
I-Characteristic	962	966	over
I-Characteristic	967	977	background
O	978	979	(
B-Characteristic	979	982	ICG
I-Characteristic	983	999	videoangiography
I-Characteristic	1000	1014	isocyanescence
O	1014	1015	)
O	1015	1016	.

O	1017	1019	We
O	1020	1024	also
O	1025	1033	assessed
B-Characteristic	1034	1037	ICG
I-Characteristic	1038	1054	videoangiography
I-Characteristic	1055	1063	features
O	1064	1066	in
O	1067	1070	the
O	1071	1079	opposite
B-Anatomy	1080	1083	eye
O	1084	1086	of
O	1087	1092	those
O	1093	1097	with
B-Symptom	1098	1107	choroidal
I-Symptom	1108	1126	neovascularization
O	1127	1128	(
B-Symptom	1128	1131	CNV
O	1131	1132	)
O	1133	1135	by
B-Diagnostic_tool	1136	1138	FA
O	1139	1141	in
O	1142	1145	one
B-Anatomy	1146	1149	eye
O	1150	1152	by
O	1153	1162	examining
O	1163	1165	an
O	1166	1176	additional
O	1177	1179	96
B-Diagnostic_tool	1180	1182	FA
O	1182	1183	-
B-Diagnostic_tool	1183	1186	ICG
I-Diagnostic_tool	1187	1203	videoangiography
O	1204	1209	scans
O	1209	1210	.

O	1211	1219	Outcomes
O	1220	1224	were
O	1225	1228	the
B-Diagnostic_tool	1229	1232	ICG
I-Diagnostic_tool	1233	1249	videoangiography
O	1250	1265	characteristics
O	1266	1268	of
B-Symptom	1269	1276	classic
I-Symptom	1277	1280	and
I-Symptom	1281	1287	occult
I-Symptom	1288	1291	CNV
O	1291	1292	,
B-Symptom	1293	1299	serous
I-Symptom	1300	1307	pigment
I-Symptom	1308	1318	epithelial
I-Symptom	1319	1330	detachments
I-Symptom	1331	1332	(
I-Symptom	1332	1337	SPEDs
I-Symptom	1337	1338	)
I-Symptom	1339	1343	both
I-Symptom	1344	1348	with
I-Symptom	1349	1352	and
I-Symptom	1353	1360	without
I-Symptom	1361	1364	CNV
O	1364	1365	,
B-Symptom	1366	1373	macular
I-Symptom	1374	1384	hemorrhage
O	1384	1385	,
O	1386	1389	and
O	1390	1393	the
O	1394	1405	comparative
O	1406	1410	size
O	1411	1413	of
O	1414	1419	these
O	1420	1428	features
O	1428	1429	.

O	1430	1435	There
O	1436	1440	were
O	1441	1443	25
B-Anatomy	1444	1448	eyes
O	1449	1453	that
O	1454	1457	had
O	1458	1469	significant
B-Symptom	1470	1477	macular
I-Symptom	1478	1488	hemorrhage
O	1489	1491	by
B-Diagnostic_tool	1492	1494	FA
O	1494	1495	.

O	1496	1498	Of
O	1499	1504	these
O	1504	1505	,
O	1506	1509	the
B-Diagnostic_tool	1510	1512	FA
O	1513	1521	revealed
B-Symptom	1522	1525	CNV
O	1526	1528	in
O	1529	1532	its
O	1533	1541	entirety
O	1542	1547	under
O	1548	1550	or
O	1551	1555	near
O	1556	1559	the
B-Symptom	1560	1570	hemorrhage
O	1571	1573	in
O	1574	1576	11
O	1576	1577	.

O	1578	1581	The
B-Diagnostic_tool	1582	1585	ICG
O	1586	1597	examination
O	1598	1606	revealed
O	1607	1610	all
O	1611	1613	11
O	1614	1618	plus
O	1619	1621	an
O	1622	1632	additional
O	1633	1635	12
B-Characteristic	1636	1651	hypercyanescent
I-Characteristic	1652	1660	features
O	1661	1665	that
O	1666	1670	were
O	1671	1674	not
O	1675	1682	visible
O	1683	1685	by
B-Diagnostic_tool	1686	1688	FA
O	1688	1689	.

O	1690	1698	Although
O	1699	1701	26
O	1702	1704	of
O	1705	1707	32
B-Symptom	1708	1713	SPEDs
O	1714	1717	had
B-Symptom	1718	1721	CNV
O	1722	1724	by
B-Diagnostic_tool	1725	1727	FA
O	1728	1736	analysis
O	1736	1737	,
O	1738	1740	31
O	1741	1743	of
O	1744	1746	32
O	1747	1750	had
O	1751	1755	well
O	1755	1756	-
O	1756	1763	defined
B-Characteristic	1764	1780	hypercyanescence
O	1781	1786	under
O	1787	1789	or
O	1790	1792	at
O	1793	1796	the
B-Symptom	1797	1801	SPED
O	1802	1806	edge
O	1807	1809	by
B-Diagnostic_tool	1810	1813	ICG
I-Diagnostic_tool	1814	1830	videoangiography
O	1830	1831	.

O	1832	1838	Eighty
O	1838	1839	-
O	1839	1844	seven
O	1845	1852	percent
O	1853	1855	of
B-Anatomy	1856	1860	eyes
O	1861	1865	with
B-Symptom	1866	1873	classic
I-Symptom	1874	1883	choroidal
I-Symptom	1884	1895	neovascular
I-Symptom	1896	1905	membranes
O	1906	1907	(
B-Symptom	1907	1911	CCNV
O	1911	1912	;
O	1913	1915	20
O	1916	1918	of
O	1919	1921	23
O	1921	1922	)
O	1923	1926	and
O	1927	1929	93
O	1929	1930	%
O	1931	1933	of
B-Anatomy	1934	1938	eyes
O	1939	1943	with
B-Symptom	1944	1957	fibrovascular
I-Symptom	1958	1965	pigment
I-Symptom	1966	1976	epithelial
I-Symptom	1977	1988	detachments
O	1989	1990	(
B-Symptom	1990	1995	FVPED
O	1995	1996	;
O	1997	1999	66
O	2000	2002	of
O	2003	2005	71
O	2005	2006	)
O	2007	2011	were
B-Characteristic	2012	2027	hypercyanescent
O	2028	2032	with
O	2033	2041	distinct
O	2042	2047	edges
O	2047	2048	.

O	2049	2054	Fifty
O	2055	2062	percent
O	2063	2065	of
B-Anatomy	2066	2070	eyes
O	2071	2075	with
O	2076	2080	only
B-Symptom	2081	2085	late
I-Symptom	2086	2093	leakage
I-Symptom	2094	2096	of
I-Symptom	2097	2109	undetermined
I-Symptom	2110	2116	source
O	2117	2118	(
B-Symptom	2118	2122	LLUS
O	2122	2123	)
O	2124	2128	were
B-Characteristic	2129	2144	hypercyanescent
O	2144	2145	,
O	2146	2153	whereas
O	2154	2156	50
O	2156	2157	%
O	2158	2162	were
B-Characteristic	2163	2176	isocyanescent
O	2177	2179	on
B-Diagnostic_tool	2180	2183	ICG
I-Diagnostic_tool	2184	2200	videoangiography
O	2200	2201	.

O	2202	2207	There
O	2208	2212	were
O	2213	2217	four
O	2218	2220	of
O	2221	2224	104
B-Anatomy	2225	2229	eyes
O	2230	2232	in
O	2233	2238	which
B-Diagnostic_tool	2239	2242	ICG
I-Diagnostic_tool	2243	2259	videoangiography
O	2260	2268	revealed
O	2269	2275	poorly
O	2276	2283	defined
B-Characteristic	2284	2299	hypercyanescent
O	2300	2305	areas
O	2306	2310	when
O	2310	2311	,
O	2312	2314	by
B-Diagnostic_tool	2315	2317	FA
O	2317	2318	,
O	2319	2324	there
O	2325	2329	were
O	2330	2334	only
B-Symptom	2335	2341	drusen
O	2342	2344	or
B-Symptom	2345	2353	elevated
I-Symptom	2354	2361	blocked
I-Symptom	2362	2374	fluorescence
O	2374	2375	.

B-Diagnostic_tool	2376	2387	Indocyanine
I-Diagnostic_tool	2388	2393	green
I-Diagnostic_tool	2394	2410	videoangiography
O	2411	2419	revealed
O	2420	2424	only
O	2425	2430	three
B-Anatomy	2431	2435	eyes
O	2436	2440	with
O	2441	2447	poorly
O	2448	2455	defined
B-Characteristic	2456	2472	hypercyanescence
O	2473	2475	of
O	2476	2479	200
O	2480	2486	fellow
B-Anatomy	2487	2491	eyes
O	2492	2494	in
O	2495	2503	patients
O	2504	2508	with
O	2509	2519	unilateral
B-Disease	2520	2523	AMD
O	2523	2524	.

B-Diagnostic_tool	2525	2536	Indocyanine
I-Diagnostic_tool	2537	2542	green
I-Diagnostic_tool	2543	2559	videoangiography
O	2560	2570	correlated
O	2571	2577	fairly
O	2578	2582	well
O	2583	2587	with
B-Diagnostic_tool	2588	2600	stereoscopic
I-Diagnostic_tool	2601	2603	FA
O	2604	2607	for
O	2608	2611	the
O	2612	2620	presence
O	2621	2623	of
B-Symptom	2624	2628	CCNV
O	2629	2631	or
B-Symptom	2632	2637	FVPED
O	2637	2638	,
O	2639	2642	but
O	2643	2653	correlated
O	2654	2660	poorly
O	2661	2665	when
B-Symptom	2666	2670	LLUS
O	2671	2674	was
O	2675	2682	present
O	2682	2683	.

O	2684	2686	In
O	2687	2694	certain
O	2695	2700	cases
O	2701	2706	where
B-Symptom	2707	2710	CNV
O	2711	2714	was
O	2715	2725	associated
O	2726	2730	with
B-Symptom	2731	2735	SPED
O	2736	2738	or
B-Symptom	2739	2746	macular
I-Symptom	2747	2757	hemorrhage
O	2757	2758	,
B-Diagnostic_tool	2759	2762	ICG
I-Diagnostic_tool	2763	2779	videoangiography
O	2780	2792	demonstrated
O	2793	2801	features
O	2802	2805	not
O	2806	2814	apparent
O	2815	2817	on
B-Diagnostic_tool	2818	2820	FA
O	2820	2821	.

O	0	8	Patterns
O	9	11	of
O	12	21	adherence
O	22	24	to
B-Disease	25	33	diabetes
O	34	40	vision
O	41	45	care
O	46	56	guidelines
O	56	57	:
O	58	66	baseline
O	67	75	findings
O	76	80	from
O	81	84	the
B-Disease	85	93	Diabetic
I-Disease	94	105	Retinopathy
O	106	115	Awareness
O	116	123	Program
O	123	124	.

O	126	127	(
O	127	128	1
O	128	129	)
O	130	132	To
O	133	141	describe
O	142	150	baseline
O	151	159	patterns
O	160	162	of
O	163	172	adherence
O	173	175	to
O	176	184	American
B-Disease	185	193	Diabetes
O	194	205	Association
O	206	209	and
B-Classification_system	210	218	American
I-Classification_system	219	226	Academy
I-Classification_system	227	229	of
I-Classification_system	230	243	Ophthalmology
I-Classification_system	244	250	vision
I-Classification_system	251	255	care
I-Classification_system	256	266	guidelines
O	267	270	for
B-Disease	271	279	diabetes
O	280	282	in
O	283	286	the
B-Disease	287	295	Diabetic
I-Disease	296	307	Retinopathy
O	308	317	Awareness
O	318	325	Program
O	325	326	,
O	327	330	and
O	331	332	(
O	332	333	2
O	333	334	)
O	335	337	to
O	338	346	evaluate
O	347	354	factors
O	355	365	associated
O	366	370	with
O	371	383	nonadherence
O	383	384	.

O	385	389	This
O	390	395	paper
O	396	405	describes
O	406	409	the
O	410	418	baseline
O	419	434	characteristics
O	435	437	of
O	438	439	a
O	440	450	population
O	451	459	enrolled
O	460	462	in
O	463	464	a
O	465	476	prospective
O	476	477	,
O	478	488	randomized
O	489	497	clinical
O	498	503	trial
O	503	504	.

O	505	510	Cross
O	510	511	-
O	511	520	sectional
O	521	526	study
O	526	527	.

O	528	535	Between
O	536	543	October
O	544	548	1993
O	549	552	and
O	553	556	May
O	557	561	1994
O	561	562	,
O	563	566	the
O	567	572	study
O	573	583	identified
O	584	588	2308
O	589	596	persons
O	597	601	with
B-Disease	602	610	diabetes
O	610	611	,
B-Characteristic	612	614	18
I-Characteristic	615	620	years
I-Characteristic	621	623	of
I-Characteristic	624	627	age
I-Characteristic	628	630	or
I-Characteristic	631	636	older
O	636	637	,
O	638	641	who
O	642	646	were
B-Characteristic	647	656	residents
I-Characteristic	657	659	of
I-Characteristic	660	667	Suffolk
I-Characteristic	668	674	County
I-Characteristic	674	675	,
I-Characteristic	676	679	New
I-Characteristic	680	684	York
O	684	685	,
O	686	689	via
O	690	691	a
O	692	702	multimedia
O	703	712	community
O	712	713	-
O	713	717	wide
O	718	729	recruitment
O	730	738	campaign
O	738	739	.

O	740	751	Eligibility
O	752	755	for
O	756	759	the
O	760	765	trial
O	766	769	was
O	770	780	determined
O	781	787	during
O	788	789	a
O	790	792	20
O	792	793	-
O	793	799	minute
O	800	805	phone
O	806	815	interview
O	815	816	,
O	817	822	which
O	823	831	included
O	832	841	questions
O	842	847	about
O	848	854	vision
O	855	859	care
O	860	869	practices
O	869	870	;
B-Disease	871	879	diabetes
O	880	890	management
O	890	891	;
O	892	895	and
O	896	905	knowledge
O	905	906	,
O	907	916	attitudes
O	916	917	,
O	918	921	and
O	922	929	beliefs
O	930	935	about
B-Disease	936	944	diabetes
O	944	945	,
O	946	952	vision
O	952	953	,
O	954	957	and
B-Disease	958	966	diabetic
I-Disease	967	978	retinopathy
O	978	979	.

O	980	984	This
O	985	990	paper
O	991	1000	describes
O	1001	1006	these
O	1007	1014	patient
O	1015	1030	characteristics
O	1031	1033	at
O	1034	1042	baseline
O	1042	1043	.

O	1044	1052	Eligible
O	1053	1061	patients
O	1062	1067	would
O	1068	1070	be
O	1071	1081	randomized
O	1082	1094	subsequently
O	1095	1097	to
O	1098	1099	a
O	1100	1101	2
O	1101	1102	-
O	1102	1106	year
B-Disease	1107	1115	diabetes
O	1116	1127	educational
O	1128	1140	intervention
O	1141	1144	arm
O	1144	1145	,
O	1146	1151	which
O	1152	1160	included
O	1161	1167	mailed
O	1168	1175	packets
O	1176	1179	and
O	1180	1191	newsletters
O	1192	1199	focused
O	1200	1202	on
O	1203	1209	vision
O	1210	1214	care
O	1214	1215	,
O	1216	1218	or
O	1219	1221	to
O	1222	1223	a
O	1224	1231	control
O	1232	1247	nonintervention
O	1248	1251	arm
O	1251	1252	.

O	1253	1265	Nonadherence
O	1266	1268	to
O	1269	1279	guidelines
O	1280	1282	at
O	1283	1291	baseline
O	1292	1295	was
O	1296	1303	defined
O	1304	1306	as
O	1307	1310	the
O	1311	1318	absence
O	1319	1321	of
O	1322	1323	a
O	1324	1331	dilated
B-Anatomy	1332	1335	eye
O	1336	1347	examination
O	1348	1354	during
O	1355	1358	the
O	1359	1363	year
O	1364	1370	before
O	1371	1382	recruitment
O	1383	1387	into
O	1388	1391	the
O	1392	1397	study
O	1397	1398	.

O	1399	1401	Of
O	1402	1405	the
O	1406	1410	2308
O	1411	1418	persons
O	1419	1430	interviewed
O	1430	1431	,
O	1432	1435	813
O	1436	1437	(
O	1437	1439	35
O	1439	1440	%
O	1440	1441	)
O	1442	1445	did
O	1446	1449	not
O	1450	1456	follow
O	1457	1460	the
O	1461	1467	vision
O	1468	1472	care
O	1473	1483	guidelines
O	1483	1484	;
O	1485	1488	two
O	1489	1495	thirds
O	1496	1498	of
O	1499	1503	this
O	1504	1509	group
O	1510	1518	reported
O	1519	1521	no
B-Anatomy	1522	1525	eye
O	1526	1537	examination
O	1538	1540	in
O	1541	1544	the
O	1545	1549	year
O	1550	1556	before
O	1557	1560	the
O	1561	1570	interview
O	1570	1571	,
O	1572	1575	and
O	1576	1579	one
O	1580	1585	third
O	1586	1589	had
O	1590	1592	an
O	1593	1602	undilated
O	1603	1614	examination
O	1614	1615	.

O	1616	1632	Ophthalmologists
O	1633	1642	performed
O	1643	1645	49
O	1645	1646	%
O	1647	1649	of
O	1650	1653	the
O	1654	1666	examinations
O	1667	1669	in
O	1670	1673	the
O	1674	1685	nonadherent
O	1686	1691	group
O	1691	1692	,
O	1693	1699	versus
O	1700	1702	86
O	1702	1703	%
O	1704	1706	in
O	1707	1710	the
O	1711	1719	adherent
O	1720	1725	group
O	1725	1726	.

O	1727	1729	In
O	1730	1738	logistic
O	1739	1749	regression
O	1750	1758	analyses
O	1758	1759	,
O	1760	1767	factors
O	1768	1775	related
O	1776	1778	to
O	1779	1791	nonadherence
O	1792	1796	were
O	1796	1797	:
B-Characteristic	1798	1805	younger
I-Characteristic	1806	1809	age
O	1810	1811	(
O	1811	1815	odds
O	1816	1821	ratio
O	1822	1823	[
O	1823	1825	OR
O	1825	1826	]
O	1827	1828	=
O	1829	1830	0
O	1830	1831	.
O	1831	1833	97
O	1833	1834	)
O	1834	1835	,
B-Disease	1836	1840	type
I-Disease	1841	1842	2
I-Disease	1843	1851	diabetes
O	1852	1856	with
O	1857	1859	or
O	1860	1867	without
O	1868	1875	insulin
O	1876	1879	use
O	1880	1881	(
O	1881	1883	OR
O	1884	1885	=
O	1886	1887	1
O	1887	1888	.
O	1888	1890	62
O	1891	1894	and
O	1895	1896	1
O	1896	1897	.
O	1897	1899	99
O	1899	1900	,
O	1901	1913	respectively
O	1913	1914	)
O	1914	1915	,
O	1916	1923	shorter
B-Characteristic	1924	1932	diabetes
I-Characteristic	1933	1941	duration
O	1942	1943	(
O	1943	1945	OR
O	1946	1947	=
O	1948	1949	0
O	1949	1950	.
O	1950	1952	97
O	1952	1953	)
O	1953	1954	,
O	1955	1959	last
B-Characteristic	1960	1963	eye
I-Characteristic	1964	1975	examination
I-Characteristic	1976	1985	performed
I-Characteristic	1986	1988	by
I-Characteristic	1989	1991	an
I-Characteristic	1992	2003	optometrist
O	2004	2005	(
O	2005	2007	OR
O	2008	2009	=
O	2010	2011	5
O	2011	2012	.
O	2012	2014	32
O	2014	2015	)
O	2016	2018	or
O	2019	2024	other
O	2025	2043	nonophthalmologist
O	2044	2045	(
O	2045	2047	OR
O	2048	2049	=
O	2050	2051	4
O	2051	2052	.
O	2052	2054	29
O	2054	2055	)
O	2055	2056	,
O	2057	2061	less
B-Characteristic	2062	2071	practical
I-Characteristic	2072	2081	knowledge
I-Characteristic	2082	2087	about
I-Characteristic	2088	2096	diabetes
O	2097	2098	(
O	2098	2100	OR
O	2101	2102	=
O	2103	2104	1
O	2104	2105	.
O	2105	2107	57
O	2107	2108	)
O	2108	2109	,
O	2110	2113	and
O	2114	2116	no
B-Characteristic	2117	2122	prior
I-Characteristic	2123	2129	formal
I-Characteristic	2130	2138	diabetes
I-Characteristic	2139	2148	education
O	2149	2150	(
O	2150	2152	OR
O	2153	2154	=
O	2155	2156	1
O	2156	2157	.
O	2157	2159	30
O	2159	2160	)
O	2160	2161	.

O	2162	2168	Within
O	2169	2173	this
O	2174	2184	population
O	2184	2185	,
O	2186	2190	more
O	2191	2195	than
O	2196	2199	one
O	2200	2205	third
O	2206	2208	of
O	2209	2221	participants
O	2222	2225	had
O	2226	2229	not
O	2230	2234	been
O	2235	2244	following
O	2245	2251	vision
O	2252	2256	care
O	2257	2267	guidelines
O	2267	2268	.

O	2269	2281	Nonadherence
O	2282	2285	was
O	2286	2292	linked
O	2293	2295	to
O	2296	2303	several
O	2304	2315	potentially
O	2316	2326	modifiable
O	2327	2334	factors
O	2334	2335	;
O	2336	2343	changes
O	2344	2346	in
O	2347	2352	these
O	2353	2360	factors
O	2361	2366	could
O	2367	2374	enhance
O	2375	2378	the
O	2379	2384	early
O	2385	2394	detection
O	2395	2397	of
B-Disease	2398	2406	diabetic
I-Disease	2407	2418	retinopathy
O	2418	2419	.

B-Diagnostic_tool	0	6	Stereo
I-Diagnostic_tool	7	19	nonmydriatic
I-Diagnostic_tool	20	27	digital
I-Diagnostic_tool	27	28	-
I-Diagnostic_tool	28	33	video
I-Diagnostic_tool	34	39	color
I-Diagnostic_tool	40	47	retinal
I-Diagnostic_tool	48	55	imaging
O	56	64	compared
O	65	69	with
B-Classification_system	70	75	Early
I-Classification_system	76	85	Treatment
I-Classification_system	86	94	Diabetic
I-Classification_system	95	106	Retinopathy
I-Classification_system	107	112	Study
O	113	118	seven
B-Diagnostic_tool	119	127	standard
I-Diagnostic_tool	128	133	field
I-Diagnostic_tool	134	136	35
I-Diagnostic_tool	136	137	-
I-Diagnostic_tool	137	139	mm
I-Diagnostic_tool	140	146	stereo
I-Diagnostic_tool	147	152	color
I-Diagnostic_tool	153	159	photos
O	160	163	for
O	164	175	determining
O	176	181	level
O	182	184	of
B-Disease	185	193	diabetic
I-Disease	194	205	retinopathy
O	205	206	.

O	208	210	To
O	211	219	evaluate
O	220	223	the
O	224	231	ability
O	232	234	to
O	235	244	determine
O	245	253	clinical
O	254	260	levels
O	261	263	of
B-Disease	264	272	diabetic
I-Disease	273	284	retinopathy
O	284	285	,
O	286	292	timing
O	293	295	of
O	296	300	next
O	301	312	appropriate
O	313	320	retinal
O	321	331	evaluation
O	331	332	,
O	333	336	and
O	337	346	necessity
O	347	349	of
O	350	358	referral
O	359	361	to
O	362	375	ophthalmology
O	376	387	specialists
O	388	393	using
B-Diagnostic_tool	394	406	stereoscopic
I-Diagnostic_tool	407	419	nonmydriatic
I-Diagnostic_tool	420	427	digital
I-Diagnostic_tool	427	428	-
I-Diagnostic_tool	428	433	video
I-Diagnostic_tool	434	439	color
I-Diagnostic_tool	440	447	retinal
I-Diagnostic_tool	448	454	images
O	455	457	as
O	458	466	compared
O	467	471	with
B-Classification_system	472	477	Early
I-Classification_system	478	487	Treatment
I-Classification_system	488	496	Diabetic
I-Classification_system	497	508	Retinopathy
I-Classification_system	509	514	Study
O	515	516	(
B-Classification_system	516	521	ETDRS
O	521	522	)
O	523	528	seven
B-Diagnostic_tool	529	537	standard
I-Diagnostic_tool	538	543	field
I-Diagnostic_tool	544	546	35
I-Diagnostic_tool	546	547	-
I-Diagnostic_tool	547	549	mm
I-Diagnostic_tool	550	562	stereoscopic
I-Diagnostic_tool	563	568	color
I-Diagnostic_tool	569	575	fundus
I-Diagnostic_tool	576	587	photographs
O	587	588	.

O	589	600	Prospective
O	600	601	,
O	602	608	clinic
O	608	609	-
O	609	614	based
O	614	615	,
O	616	627	comparative
O	628	638	instrument
O	639	649	validation
O	650	655	study
O	655	656	.

O	657	662	Fifty
O	662	663	-
O	663	667	four
O	668	676	patients
O	677	678	(
O	678	681	108
B-Anatomy	682	686	eyes
O	686	687	)
O	688	692	with
B-Disease	693	697	type
I-Disease	698	699	1
I-Disease	700	702	or
I-Disease	703	707	type
I-Disease	708	709	2
I-Disease	710	718	diabetes
I-Disease	719	727	mellitus
O	728	736	selected
O	737	742	after
O	743	748	chart
O	749	755	review
O	756	760	from
O	761	762	a
O	763	769	single
O	770	776	center
O	777	779	to
O	780	787	include
O	788	791	the
O	792	796	full
O	797	805	spectrum
O	806	808	of
B-Disease	809	817	diabetic
I-Disease	818	829	retinopathy
O	829	830	.

B-Diagnostic_tool	831	846	Nonsimultaneous
I-Diagnostic_tool	847	849	45
I-Diagnostic_tool	850	857	degrees
I-Diagnostic_tool	858	859	-
I-Diagnostic_tool	859	864	field
I-Diagnostic_tool	865	877	stereoscopic
I-Diagnostic_tool	878	885	digital
I-Diagnostic_tool	885	886	-
I-Diagnostic_tool	886	891	video
I-Diagnostic_tool	892	897	color
I-Diagnostic_tool	898	904	images
O	905	906	(
B-Diagnostic_tool	906	909	JVN
I-Diagnostic_tool	910	916	images
O	916	917	)
O	918	922	were
O	923	931	obtained
O	932	936	from
O	937	942	three
O	943	949	fields
O	950	954	with
O	955	958	the
B-Diagnostic_tool	959	965	Joslin
I-Diagnostic_tool	966	972	Vision
I-Diagnostic_tool	973	980	Network
O	981	982	(
B-Diagnostic_tool	982	985	JVN
O	985	986	)
O	987	993	system
O	994	1000	before
B-Anatomy	1001	1006	pupil
O	1007	1015	dilation
O	1015	1016	.

O	1017	1026	Following
B-Anatomy	1027	1032	pupil
O	1033	1041	dilation
O	1041	1042	,
B-Classification_system	1043	1048	ETDRS
O	1049	1054	seven
B-Diagnostic_tool	1055	1063	standard
I-Diagnostic_tool	1064	1069	field
I-Diagnostic_tool	1070	1072	35
I-Diagnostic_tool	1072	1073	-
I-Diagnostic_tool	1073	1075	mm
I-Diagnostic_tool	1076	1088	stereoscopic
I-Diagnostic_tool	1089	1094	color
I-Diagnostic_tool	1095	1097	30
I-Diagnostic_tool	1098	1105	degrees
I-Diagnostic_tool	1106	1112	fundus
I-Diagnostic_tool	1113	1124	photographs
O	1125	1126	(
B-Diagnostic_tool	1126	1131	ETDRS
I-Diagnostic_tool	1132	1138	photos
O	1138	1139	)
O	1140	1144	were
O	1145	1153	obtained
O	1153	1154	.

B-Diagnostic_tool	1155	1161	Joslin
I-Diagnostic_tool	1162	1168	Vision
I-Diagnostic_tool	1169	1176	Network
I-Diagnostic_tool	1177	1183	images
O	1184	1187	and
B-Diagnostic_tool	1188	1193	ETDRS
I-Diagnostic_tool	1194	1200	photos
O	1201	1205	were
O	1206	1212	graded
O	1213	1215	on
O	1216	1217	a
O	1218	1224	lesion
O	1224	1225	-
O	1225	1227	by
O	1227	1228	-
O	1228	1234	lesion
O	1235	1240	basis
O	1241	1243	by
O	1244	1247	two
O	1248	1259	independent
O	1259	1260	,
O	1261	1267	masked
O	1268	1275	readers
O	1276	1278	to
O	1279	1285	assess
B-Classification_system	1286	1291	ETDRS
O	1292	1300	clinical
O	1301	1306	level
O	1307	1309	of
B-Disease	1310	1318	diabetic
I-Disease	1319	1330	retinopathy
O	1330	1331	.

O	1332	1334	An
O	1335	1346	independent
O	1347	1360	ophthalmology
O	1361	1367	retina
O	1368	1378	specialist
O	1379	1390	adjudicated
O	1391	1402	interreader
O	1403	1416	disagreements
O	1417	1419	in
O	1420	1421	a
O	1422	1428	masked
O	1429	1436	fashion
O	1436	1437	.

O	1438	1451	Determination
O	1452	1454	of
B-Classification_system	1455	1460	ETDRS
O	1461	1469	clinical
O	1470	1475	level
O	1476	1478	of
B-Disease	1479	1487	diabetic
I-Disease	1488	1499	retinopathy
O	1499	1500	,
O	1501	1507	timing
O	1508	1510	of
O	1511	1515	next
O	1516	1526	ophthalmic
O	1527	1537	evaluation
O	1538	1540	of
B-Disease	1541	1549	diabetic
I-Disease	1550	1561	retinopathy
O	1561	1562	,
O	1563	1566	and
O	1567	1571	need
O	1572	1575	for
O	1576	1582	prompt
O	1583	1591	referral
O	1592	1594	to
O	1595	1608	ophthalmology
O	1609	1619	specialist
O	1619	1620	.

O	1621	1626	There
O	1627	1630	was
O	1631	1642	substantial
O	1643	1652	agreement
O	1653	1654	(
O	1654	1659	kappa
O	1660	1661	=
O	1662	1663	0
O	1663	1664	.
O	1664	1666	65
O	1666	1667	)
O	1668	1675	between
O	1676	1679	the
O	1680	1688	clinical
O	1689	1694	level
O	1695	1697	of
B-Disease	1698	1706	diabetic
I-Disease	1707	1718	retinopathy
O	1719	1727	assessed
O	1728	1732	from
O	1733	1736	the
B-Diagnostic_tool	1737	1746	undilated
I-Diagnostic_tool	1747	1750	JVN
I-Diagnostic_tool	1751	1757	images
O	1758	1761	and
O	1762	1765	the
B-Diagnostic_tool	1766	1773	dilated
I-Diagnostic_tool	1774	1779	ETDRS
I-Diagnostic_tool	1780	1786	photos
O	1786	1787	.

O	1788	1797	Agreement
O	1798	1801	was
O	1802	1811	excellent
O	1812	1813	(
O	1813	1818	kappa
O	1819	1820	=
O	1821	1822	0
O	1822	1823	.
O	1823	1825	87
O	1825	1826	)
O	1827	1830	for
O	1831	1840	suggested
O	1841	1849	referral
O	1850	1852	to
O	1853	1866	ophthalmology
O	1867	1878	specialists
O	1879	1882	for
B-Anatomy	1883	1886	eye
O	1887	1899	examinations
O	1899	1900	.

O	1901	1911	Comparison
O	1912	1914	of
O	1915	1925	individual
O	1926	1933	lesions
O	1934	1941	between
O	1942	1945	the
B-Diagnostic_tool	1946	1949	JVN
I-Diagnostic_tool	1950	1956	images
O	1957	1960	and
O	1961	1964	the
B-Diagnostic_tool	1965	1970	ETDRS
I-Diagnostic_tool	1971	1977	photos
O	1978	1981	and
O	1982	1985	for
O	1986	1997	interreader
O	1998	2009	comparisons
O	2010	2014	were
O	2015	2025	comparable
O	2026	2028	to
O	2029	2032	the
O	2033	2038	prior
B-Classification_system	2039	2044	ETDRS
O	2045	2050	study
O	2050	2051	.

B-Diagnostic_tool	2052	2061	Undilated
I-Diagnostic_tool	2062	2069	digital
I-Diagnostic_tool	2069	2070	-
I-Diagnostic_tool	2070	2075	video
I-Diagnostic_tool	2076	2082	images
O	2083	2088	using
O	2089	2092	the
B-Diagnostic_tool	2093	2096	JVN
O	2097	2103	system
O	2104	2108	were
O	2109	2119	comparable
O	2120	2131	photographs
O	2132	2135	for
O	2136	2139	the
O	2140	2153	determination
O	2154	2156	of
B-Disease	2157	2165	diabetic
I-Disease	2166	2177	retinopathy
O	2178	2183	level
O	2183	2184	.

O	2185	2188	The
O	2189	2196	results
O	2197	2205	validate
O	2206	2209	the
O	2210	2219	agreement
O	2220	2227	between
B-Diagnostic_tool	2228	2240	nonmydriatic
I-Diagnostic_tool	2241	2244	JVN
I-Diagnostic_tool	2245	2251	images
O	2252	2255	and
B-Diagnostic_tool	2256	2263	dilated
I-Diagnostic_tool	2264	2269	ETDRS
I-Diagnostic_tool	2270	2281	photographs
O	2282	2285	and
O	2286	2293	suggest
O	2294	2298	that
O	2299	2303	this
O	2304	2311	digital
O	2312	2321	technique
O	2322	2325	may
O	2326	2328	be
O	2329	2331	an
O	2332	2341	effective
O	2342	2354	telemedicine
O	2355	2359	tool
O	2360	2363	for
O	2364	2372	remotely
O	2373	2384	determining
O	2385	2388	the
O	2389	2394	level
O	2395	2397	of
B-Disease	2398	2406	diabetic
I-Disease	2407	2418	retinopathy
O	2418	2419	,
O	2420	2430	suggesting
O	2431	2437	timing
O	2438	2440	of
O	2441	2445	next
O	2446	2453	retinal
O	2454	2464	evaluation
O	2465	2468	and
O	2469	2480	identifying
O	2481	2484	the
O	2485	2489	need
O	2490	2493	for
O	2494	2500	prompt
O	2501	2509	referral
O	2510	2512	to
O	2513	2526	ophthalmology
O	2527	2538	specialists
O	2538	2539	.

O	2540	2544	Thus
O	2544	2545	,
O	2546	2549	the
B-Diagnostic_tool	2550	2553	JVN
O	2554	2560	system
O	2561	2566	would
O	2567	2569	be
O	2570	2572	an
O	2573	2584	appropriate
O	2585	2589	tool
O	2590	2593	for
O	2594	2606	facilitating
O	2607	2616	increased
O	2617	2623	access
O	2624	2626	of
B-Disease	2627	2635	diabetic
O	2636	2644	patients
O	2645	2649	into
O	2650	2661	recommended
B-Anatomy	2662	2665	eye
O	2666	2677	evaluations
O	2677	2678	,
O	2679	2682	but
O	2683	2689	should
O	2690	2693	not
O	2694	2696	be
O	2697	2706	construed
O	2707	2709	as
O	2710	2711	a
O	2712	2720	paradigm
O	2721	2725	that
O	2726	2731	would
O	2732	2739	replace
O	2740	2743	the
O	2744	2748	need
O	2749	2752	for
O	2753	2766	comprehensive
B-Anatomy	2767	2770	eye
O	2771	2783	examinations
O	2783	2784	.

O	0	7	Quality
O	8	10	of
O	11	15	life
O	16	18	in
O	19	24	newly
O	25	34	diagnosed
B-Disease	35	43	glaucoma
O	44	52	patients
O	53	54	:
O	55	58	The
O	59	72	Collaborative
O	73	80	Initial
B-Disease	81	89	Glaucoma
O	90	99	Treatment
O	100	105	Study
O	105	106	.

O	108	111	The
O	112	125	Collaborative
O	126	133	Initial
B-Disease	134	142	Glaucoma
O	143	152	Treatment
O	153	158	Study
O	159	160	(
O	160	165	CIGTS
O	165	166	)
O	167	170	was
O	171	179	designed
O	180	182	to
O	183	192	determine
O	193	200	whether
O	201	209	patients
O	210	214	with
O	215	220	newly
O	221	230	diagnosed
B-Disease	231	235	open
I-Disease	235	236	-
I-Disease	236	241	angle
I-Disease	242	250	glaucoma
O	251	254	are
O	255	261	better
O	262	269	treated
O	270	279	initially
O	280	282	by
O	283	291	medicine
O	292	294	or
O	295	304	immediate
O	305	314	filtering
O	315	322	surgery
O	322	323	.

O	324	328	This
O	329	334	paper
O	335	344	describes
O	345	348	the
O	349	356	quality
O	356	357	-
O	357	359	of
O	359	360	-
O	360	364	life
O	365	366	(
O	366	369	QOL
O	369	370	)
O	371	382	measurement
O	383	391	approach
O	391	392	,
O	393	404	instruments
O	405	413	included
O	413	414	,
O	415	418	and
O	419	422	the
O	423	428	CIGTS
O	429	441	participants
O	441	442	'
O	443	446	QOL
O	447	455	findings
O	456	458	at
O	459	462	the
O	463	467	time
O	468	470	of
O	471	480	diagnosis
O	480	481	.

O	482	490	Baseline
O	491	498	results
O	499	503	from
O	504	505	a
O	506	516	randomized
O	516	517	,
O	518	528	controlled
O	529	537	clinical
O	538	543	trial
O	543	544	.

O	545	548	Six
O	549	556	hundred
O	557	562	seven
O	563	571	patients
O	572	576	from
O	577	579	14
O	580	588	clinical
O	589	596	centers
O	597	601	were
O	602	610	enrolled
O	610	611	.

O	612	620	Patients
O	621	631	randomized
O	632	634	to
O	635	642	initial
O	643	653	medication
O	654	662	received
O	663	664	a
O	665	672	stepped
O	673	680	medical
O	681	688	regimen
O	689	690	(
O	690	691	n
O	692	693	=
O	694	697	307
O	697	698	)
O	698	699	.

O	700	705	Those
O	706	716	randomized
O	717	719	to
O	720	727	initial
O	728	735	surgery
O	736	745	underwent
O	746	747	a
O	748	762	trabeculectomy
O	763	764	(
O	764	765	n
O	766	767	=
O	768	771	300
O	771	772	)
O	772	773	.

O	774	777	The
O	778	786	baseline
O	787	796	interview
O	797	800	was
O	801	810	conducted
O	811	817	before
O	818	827	treatment
O	828	838	initiation
O	838	839	.

O	840	843	All
O	844	852	baseline
O	853	856	and
O	857	870	posttreatment
O	871	874	QOL
O	875	886	assessments
O	887	891	were
O	892	901	conducted
O	902	904	by
O	905	914	telephone
O	915	919	from
O	920	921	a
O	922	933	centralized
O	934	946	interviewing
O	947	953	center
O	953	954	.

O	955	958	The
O	959	966	primary
O	967	974	outcome
O	975	982	measure
O	983	992	described
O	993	995	in
O	996	1000	this
O	1001	1006	paper
O	1007	1010	was
O	1011	1014	QOL
O	1014	1015	.

O	1016	1019	The
B-Diagnostic_tool	1020	1023	QOL
I-Diagnostic_tool	1024	1034	instrument
O	1035	1037	is
O	1038	1054	multidimensional
O	1055	1058	and
O	1059	1071	incorporates
O	1072	1076	both
O	1077	1084	disease
O	1084	1085	-
O	1085	1093	specific
O	1094	1097	and
O	1098	1105	generic
O	1106	1114	measures
O	1114	1115	,
O	1116	1125	including
O	1126	1129	the
B-Diagnostic_tool	1130	1136	Visual
I-Diagnostic_tool	1137	1147	Activities
I-Diagnostic_tool	1148	1161	Questionnaire
O	1161	1162	,
O	1163	1171	Sickness
O	1172	1178	Impact
O	1179	1186	Profile
O	1186	1187	,
O	1188	1191	and
O	1192	1193	a
O	1194	1201	Symptom
O	1202	1205	and
O	1206	1212	Health
O	1213	1220	Problem
O	1221	1230	CHECKLIST
O	1230	1231	:
O	1232	1235	The
O	1236	1248	correlations
O	1249	1256	between
O	1257	1260	QOL
O	1261	1269	measures
O	1270	1273	and
O	1274	1282	clinical
O	1283	1291	outcomes
O	1292	1296	were
O	1297	1299	in
O	1300	1303	the
O	1304	1312	expected
O	1313	1322	direction
O	1322	1323	,
O	1324	1327	but
O	1328	1338	relatively
O	1339	1343	weak
O	1343	1344	.

O	1345	1347	At
O	1348	1355	initial
O	1356	1365	diagnosis
O	1365	1366	,
O	1367	1377	difficulty
O	1378	1382	with
O	1383	1389	bright
O	1390	1396	lights
O	1397	1400	and
O	1401	1405	with
O	1406	1411	light
O	1412	1415	and
O	1416	1420	dark
O	1421	1431	adaptation
O	1432	1436	were
O	1437	1440	the
O	1441	1445	most
O	1446	1456	frequently
O	1457	1465	reported
O	1466	1474	symptoms
O	1475	1482	related
O	1483	1485	to
B-Characteristic	1486	1492	visual
I-Characteristic	1493	1501	function
O	1501	1502	,
O	1503	1510	whereas
B-Symptom	1511	1517	visual
I-Symptom	1518	1528	distortion
O	1529	1532	was
O	1533	1536	the
O	1537	1541	most
O	1542	1552	bothersome
O	1552	1553	.

O	1554	1567	Approximately
O	1568	1572	half
O	1573	1575	of
O	1576	1579	the
O	1580	1588	patients
O	1589	1597	reported
O	1598	1600	at
O	1601	1606	least
O	1607	1611	some
O	1612	1617	worry
O	1618	1620	or
O	1621	1628	concern
O	1629	1634	about
O	1635	1638	the
O	1639	1650	possibility
O	1651	1653	of
B-Symptom	1654	1663	blindness
O	1663	1664	.

O	1665	1671	Within
O	1672	1675	the
B-Diagnostic_tool	1676	1682	Visual
I-Diagnostic_tool	1683	1693	Activities
I-Diagnostic_tool	1694	1707	Questionnaire
O	1707	1708	,
O	1709	1715	higher
O	1716	1722	scores
O	1723	1725	on
O	1726	1729	the
B-Diagnostic_tool	1730	1740	Peripheral
I-Diagnostic_tool	1741	1747	Vision
I-Diagnostic_tool	1748	1756	subscale
O	1757	1761	were
O	1762	1772	associated
O	1773	1777	with
O	1778	1782	more
B-Symptom	1783	1788	field
I-Symptom	1789	1793	loss
O	1794	1795	(
O	1795	1796	P
O	1798	1799	<
O	1801	1802	0
O	1802	1803	.
O	1803	1805	01
O	1805	1806	)
O	1806	1807	.

O	1808	1810	In
O	1811	1821	regression
O	1822	1830	analyses
O	1831	1842	controlling
O	1843	1846	for
B-Characteristic	1847	1864	sociodemographics
O	1865	1868	and
B-Symptom	1869	1878	nonocular
I-Symptom	1879	1892	comorbidities
O	1892	1893	,
O	1894	1903	increased
B-Symptom	1904	1910	visual
I-Symptom	1911	1916	field
I-Symptom	1917	1921	loss
O	1922	1925	was
O	1926	1939	significantly
O	1940	1950	associated
O	1951	1955	with
O	1956	1962	higher
O	1963	1974	dysfunction
O	1975	1980	among
O	1981	1985	five
O	1986	1993	disease
O	1993	1994	-
O	1994	2002	specific
O	2003	2006	QOL
O	2007	2015	measures
O	2016	2017	(
O	2017	2018	P
O	2020	2021	<
O	2023	2024	0
O	2024	2025	.
O	2025	2027	05
O	2027	2028	)
O	2028	2029	.

O	2030	2035	Newly
O	2036	2045	diagnosed
B-Disease	2046	2054	glaucoma
O	2055	2063	patients
O	2064	2072	reported
O	2073	2085	experiencing
O	2086	2090	some
B-Symptom	2091	2097	visual
I-Symptom	2098	2106	function
I-Symptom	2107	2115	symptoms
O	2116	2118	at
O	2119	2122	the
O	2123	2127	time
O	2128	2130	of
O	2131	2140	diagnosis
O	2141	2145	that
O	2146	2151	would
O	2152	2155	not
O	2156	2158	be
O	2159	2170	intuitively
O	2171	2179	expected
O	2180	2185	based
O	2186	2188	on
O	2189	2197	clinical
O	2198	2205	testing
O	2205	2206	.

O	2207	2211	Some
O	2212	2222	discussion
O	2223	2228	about
O	2229	2232	the
O	2233	2244	association
O	2245	2252	between
O	2253	2261	clinical
O	2262	2274	presentation
O	2275	2278	and
O	2279	2284	worry
O	2285	2290	about
B-Symptom	2291	2300	blindness
O	2301	2304	may
O	2305	2311	reduce
O	2312	2323	unnecessary
O	2324	2331	concern
O	2331	2332	.

O	2333	2338	These
O	2339	2346	results
O	2347	2354	provide
O	2355	2358	the
O	2359	2364	basis
O	2365	2368	for
O	2369	2373	long
O	2373	2374	-
O	2374	2378	term
O	2379	2390	comparisons
O	2391	2393	of
O	2394	2397	the
O	2398	2401	QOL
O	2402	2409	effects
O	2410	2412	of
O	2413	2420	initial
O	2421	2428	medical
O	2429	2432	and
O	2433	2441	surgical
O	2442	2451	treatment
O	2452	2455	for
B-Disease	2456	2460	open
I-Disease	2460	2461	-
I-Disease	2461	2466	angle
I-Disease	2467	2475	glaucoma
O	2475	2476	.

O	3	12	Incidence
O	13	16	and
O	17	28	progression
O	29	34	rates
O	35	37	of
B-Disease	38	41	age
I-Disease	41	42	-
I-Disease	42	49	related
I-Disease	50	61	maculopathy
O	61	62	:
O	63	66	the
O	67	76	Rotterdam
O	77	82	Study

O	84	91	Purpose
O	91	92	:
O	93	95	To
O	96	104	describe
O	105	108	the
O	109	118	incidence
O	119	123	rate
O	124	126	of
B-Disease	127	130	age
I-Disease	130	131	-
I-Disease	131	138	related
I-Disease	139	146	macular
I-Disease	147	159	degeneration
O	160	161	(
B-Disease	161	164	AMD
O	164	165	)
O	166	169	and
O	170	173	the
O	174	185	progression
O	186	191	rates
O	192	194	of
B-Disease	195	200	early
I-Disease	201	207	stages
I-Disease	208	210	of
I-Disease	211	214	age
I-Disease	214	215	-
I-Disease	215	222	related
I-Disease	223	234	maculopathy
O	235	236	(
B-Disease	236	239	ARM
O	239	240	)
O	240	241	,
O	242	245	and
O	246	248	to
O	249	254	study
O	255	258	the
O	259	268	hierarchy
O	269	271	of
B-Anatomy	272	278	fundus
O	279	287	features
O	288	292	that
O	293	302	determine
O	303	314	progression
O	314	315	.

O	317	324	Methods
O	324	325	:
O	326	327	A
O	328	333	group
O	334	336	of
O	337	341	4953
O	342	350	subjects
B-Characteristic	351	355	aged
I-Characteristic	356	358	55
I-Characteristic	359	364	years
I-Characteristic	365	368	and
I-Characteristic	369	374	older
I-Characteristic	375	381	living
I-Characteristic	382	384	in
I-Characteristic	385	394	Rotterdam
O	394	395	,
B-Characteristic	396	399	The
I-Characteristic	400	411	Netherlands
O	411	412	,
O	413	416	was
O	417	424	studied
O	425	427	at
O	428	436	baseline
O	437	440	and
O	441	443	at
O	444	445	2
O	445	446	-
O	446	450	year
O	451	457	follow
O	457	458	-
O	458	460	up
O	461	463	to
O	464	473	determine
O	474	477	the
O	478	487	incidence
O	488	490	of
B-Disease	491	502	neovascular
I-Disease	503	506	and
I-Disease	507	515	atrophic
I-Disease	516	519	AMD
O	519	520	.

O	521	522	A
O	523	531	subgroup
O	532	534	of
O	535	539	1244
O	540	548	subjects
O	549	552	was
O	553	560	studied
O	561	564	for
O	565	576	progression
O	577	579	of
B-Disease	580	585	early
I-Disease	586	592	stages
I-Disease	593	595	of
I-Disease	596	599	ARM
O	599	600	.

B-Diagnostic_tool	601	607	Fundus
I-Diagnostic_tool	608	622	transparencies
O	623	627	were
O	628	634	graded
O	635	638	for
O	639	647	features
O	648	650	of
B-Disease	651	654	ARM
O	655	660	using
O	661	664	the
B-Classification_system	665	678	International
I-Classification_system	679	693	Classification
I-Classification_system	694	700	System
O	700	701	.

B-Disease	702	705	ARM
O	706	709	was
O	710	720	stratified
O	721	723	in
O	724	728	four
O	729	738	exclusive
O	739	745	stages
O	745	746	,
O	747	756	according
O	757	759	to
O	760	764	type
O	765	767	of
B-Symptom	768	774	drusen
O	775	778	and
O	779	787	presence
O	788	790	of
B-Symptom	791	801	pigmentary
I-Symptom	802	816	irregularities
O	816	817	.

O	819	826	Results
O	826	827	:
O	828	831	The
O	832	839	overall
O	840	841	2
O	841	842	-
O	842	846	year
O	847	857	cumulative
O	858	867	incidence
O	868	870	of
B-Disease	871	874	AMD
O	875	878	was
O	879	880	0
O	880	881	.
O	881	882	2
O	882	883	%
O	883	884	,
O	885	895	increasing
O	896	898	to
O	899	900	1
O	900	901	.
O	901	902	8
O	902	903	%
O	904	906	in
O	907	915	subjects
O	916	918	of
B-Characteristic	919	921	85
I-Characteristic	922	927	years
I-Characteristic	928	931	and
I-Characteristic	932	937	older
I-Characteristic	937	938	.

O	939	941	Of
O	942	947	those
O	948	950	in
O	951	954	the
O	955	960	early
O	961	967	stages
O	967	968	,
O	969	972	one
O	973	979	fourth
O	980	986	showed
O	987	998	progression
O	999	1001	to
O	1002	1003	a
O	1004	1008	more
O	1009	1015	severe
O	1016	1021	stage
O	1021	1022	.

O	1023	1026	The
O	1027	1031	most
O	1032	1041	important
O	1042	1052	predictors
O	1053	1056	for
O	1057	1068	progression
O	1069	1073	were
B-Symptom	1074	1078	more
I-Symptom	1079	1083	than
I-Symptom	1084	1086	10
I-Symptom	1086	1087	%
I-Symptom	1088	1090	of
I-Symptom	1091	1098	macular
I-Symptom	1099	1103	area
I-Symptom	1104	1111	covered
I-Symptom	1112	1114	by
I-Symptom	1115	1121	drusen
O	1122	1123	(
O	1123	1127	odds
O	1128	1133	ratio
O	1134	1135	[
O	1135	1137	OR
O	1137	1138	]
O	1139	1140	5
O	1140	1141	.
O	1141	1142	7
O	1142	1143	,
O	1144	1146	95
O	1146	1147	%
O	1148	1158	confidence
O	1159	1167	interval
O	1168	1169	[
O	1169	1171	CI
O	1171	1172	]
O	1173	1174	2
O	1174	1175	.
O	1175	1176	9
O	1176	1177	-
O	1177	1179	11
O	1179	1180	.
O	1180	1181	3
O	1181	1182	)
O	1182	1183	,
O	1184	1192	presence
O	1193	1195	of
B-Symptom	1196	1210	depigmentation
O	1211	1212	(
O	1212	1214	OR
O	1215	1216	4
O	1216	1217	.
O	1217	1218	0
O	1218	1219	,
O	1220	1222	95
O	1222	1223	%
O	1224	1226	CI
O	1227	1228	2
O	1228	1229	.
O	1229	1230	5
O	1230	1231	-
O	1231	1232	6
O	1232	1233	.
O	1233	1234	4
O	1234	1235	)
O	1235	1236	,
O	1237	1240	and
B-Symptom	1241	1258	hyperpigmentation
O	1259	1260	(
O	1260	1262	OR
O	1263	1264	3
O	1264	1265	.
O	1265	1266	4
O	1266	1267	,
O	1268	1270	95
O	1270	1271	%
O	1272	1274	CI
O	1275	1276	2
O	1276	1277	.
O	1277	1278	1
O	1278	1279	-
O	1279	1280	5
O	1280	1281	.
O	1281	1282	4
O	1282	1283	)
O	1283	1284	.

O	1286	1297	Conclusions
O	1297	1298	:
O	1299	1302	The
O	1303	1312	incidence
O	1313	1315	of
B-Disease	1316	1319	AMD
O	1320	1327	appears
O	1328	1330	to
O	1331	1333	be
O	1334	1339	lower
O	1340	1342	in
B-Characteristic	1343	1346	The
I-Characteristic	1347	1358	Netherlands
O	1359	1363	than
O	1364	1366	in
O	1367	1370	the
B-Characteristic	1371	1377	United
I-Characteristic	1378	1384	States
O	1384	1385	.

O	1386	1397	Progression
O	1398	1400	of
B-Disease	1401	1406	early
I-Disease	1407	1410	ARM
I-Disease	1411	1417	stages
O	1418	1424	occurs
O	1425	1427	in
O	1428	1429	a
O	1430	1438	distinct
O	1439	1446	pattern
O	1447	1449	at
O	1450	1451	a
O	1452	1458	stable
O	1459	1463	rate
O	1463	1464	,
O	1465	1469	with
O	1470	1471	a
B-Symptom	1472	1477	large
I-Symptom	1478	1482	area
I-Symptom	1483	1485	of
I-Symptom	1486	1492	drusen
O	1493	1496	and
O	1497	1505	presence
O	1506	1508	of
B-Symptom	1509	1519	pigmentary
I-Symptom	1520	1527	changes
O	1528	1530	as
O	1531	1534	the
O	1535	1539	most
O	1540	1549	important
O	1550	1560	predictors
O	1560	1561	.

B-Diagnostic_tool	0	4	High
I-Diagnostic_tool	4	5	-
I-Diagnostic_tool	5	15	resolution
I-Diagnostic_tool	16	28	stereoscopic
I-Diagnostic_tool	29	36	digital
I-Diagnostic_tool	37	43	fundus
I-Diagnostic_tool	44	55	photography
O	56	62	versus
B-Diagnostic_tool	63	70	contact
I-Diagnostic_tool	71	75	lens
I-Diagnostic_tool	76	89	biomicroscopy
O	90	93	for
O	94	97	the
O	98	107	detection
O	108	110	of
B-Disease	111	121	clinically
I-Disease	122	133	significant
I-Disease	134	141	macular
I-Disease	142	147	edema
O	147	148	.

O	150	153	The
O	154	161	purpose
O	162	164	of
O	165	169	this
O	170	175	study
O	176	179	was
O	180	182	to
O	183	190	compare
B-Diagnostic_tool	191	195	high
I-Diagnostic_tool	195	196	-
I-Diagnostic_tool	196	206	resolution
I-Diagnostic_tool	207	219	stereoscopic
I-Diagnostic_tool	220	227	digital
I-Diagnostic_tool	228	239	photography
O	240	242	to
B-Diagnostic_tool	243	250	contact
I-Diagnostic_tool	251	255	lens
I-Diagnostic_tool	256	269	biomicroscopy
O	270	271	(
B-Diagnostic_tool	271	275	CLBM
O	275	276	)
O	277	280	for
O	281	284	the
O	285	294	diagnosis
O	295	297	of
B-Disease	298	308	clinically
I-Disease	309	320	significant
I-Disease	321	328	macular
I-Disease	329	334	edema
O	334	335	.

O	336	347	Comparative
O	347	348	,
O	349	360	prospective
O	360	361	,
O	362	375	observational
O	376	380	case
O	381	387	series
O	387	388	.

O	389	392	One
O	393	400	hundred
O	401	407	twenty
B-Disease	408	416	diabetic
O	417	425	patients
O	425	426	.

O	427	435	Patients
O	436	445	underwent
O	446	454	clinical
O	455	462	retinal
O	463	474	examination
O	475	479	with
B-Diagnostic_tool	480	484	CLBM
O	485	487	by
O	488	489	a
O	490	497	retinal
O	498	508	specialist
O	508	509	.

O	510	512	On
O	513	516	the
O	517	521	same
O	522	525	day
O	526	528	as
O	529	537	clinical
O	538	545	grading
O	545	546	,
O	547	555	patients
O	556	564	received
B-Diagnostic_tool	565	569	high
I-Diagnostic_tool	569	570	-
I-Diagnostic_tool	570	580	resolution
I-Diagnostic_tool	581	593	stereoscopic
I-Diagnostic_tool	594	601	digital
I-Diagnostic_tool	602	609	imaging
I-Diagnostic_tool	610	612	of
I-Diagnostic_tool	613	616	the
I-Diagnostic_tool	617	623	macula
O	623	624	.

O	625	628	The
B-Diagnostic_tool	629	641	stereoscopic
I-Diagnostic_tool	642	649	digital
I-Diagnostic_tool	650	656	images
O	657	661	were
O	662	668	viewed
O	669	674	using
O	675	681	liquid
O	682	689	crystal
O	690	697	shutter
O	698	705	goggles
O	706	708	at
O	709	714	least
O	715	716	2
O	717	723	months
O	724	729	after
O	730	738	clinical
O	739	750	examination
O	751	753	by
O	754	755	a
O	756	762	single
O	763	769	masked
O	770	776	grader
O	777	780	for
O	781	784	the
O	785	793	presence
O	794	796	or
O	797	804	absence
O	805	807	of
B-Disease	808	816	diabetic
I-Disease	817	828	retinopathy
O	828	829	.

O	830	838	Presence
O	839	841	or
O	842	849	absence
O	850	852	of
O	853	856	the
O	857	862	Early
O	863	872	Treatment
O	873	875	of
B-Disease	876	884	Diabetic
I-Disease	885	896	Retinopathy
O	897	902	Study
O	903	911	criteria
O	912	915	for
B-Disease	916	926	clinically
I-Disease	927	938	significant
I-Disease	939	946	macular
I-Disease	947	952	edema
O	953	954	(
B-Disease	954	958	CSME
O	958	959	)
O	960	967	overall
O	967	968	,
B-Disease	969	973	CSME
I-Disease	974	975	1
O	975	976	,
B-Disease	977	981	CSME
I-Disease	982	983	2
O	983	984	,
B-Disease	985	989	CSME
I-Disease	990	991	3
O	991	992	,
B-Disease	993	1000	macular
I-Disease	1001	1006	edema
O	1006	1007	,
B-Symptom	1008	1022	microaneurysms
O	1022	1023	,
B-Symptom	1024	1036	intraretinal
I-Symptom	1037	1047	hemorrhage
O	1047	1048	,
O	1049	1052	and
B-Symptom	1053	1057	hard
I-Symptom	1058	1065	exudate
O	1065	1066	.

O	1067	1070	Two
O	1071	1078	hundred
O	1079	1084	seven
B-Anatomy	1085	1089	eyes
O	1090	1092	of
O	1093	1096	105
O	1097	1105	patients
O	1106	1109	had
O	1110	1118	complete
O	1119	1123	data
O	1124	1128	sets
O	1129	1133	from
O	1134	1138	both
O	1139	1149	diagnostic
O	1150	1160	modalities
O	1160	1161	.

O	1162	1167	Exact
O	1168	1177	agreement
O	1178	1181	was
O	1182	1186	high
O	1187	1190	for
O	1191	1194	all
O	1195	1205	identified
O	1206	1216	pathologic
O	1217	1227	conditions
O	1227	1228	:
B-Disease	1229	1233	CSME
O	1234	1241	overall
O	1241	1242	,
O	1243	1245	83
O	1245	1246	.
O	1246	1247	6
O	1247	1248	%
O	1248	1249	;
B-Disease	1250	1254	CSME
I-Disease	1255	1256	1
O	1256	1257	,
O	1258	1260	83
O	1260	1261	.
O	1261	1262	6
O	1262	1263	%
O	1263	1264	;
B-Disease	1265	1269	CSME
I-Disease	1270	1271	2
O	1271	1272	,
O	1273	1275	96
O	1275	1276	.
O	1276	1277	1
O	1277	1278	%
O	1278	1279	;
B-Disease	1280	1284	CSME
I-Disease	1285	1286	3
O	1286	1287	,
O	1288	1290	88
O	1290	1291	.
O	1291	1292	5
O	1292	1293	%
O	1293	1294	;
B-Disease	1295	1302	macular
I-Disease	1303	1308	edema
O	1308	1309	,
O	1310	1312	75
O	1312	1313	.
O	1313	1314	0
O	1314	1315	%
O	1315	1316	;
B-Symptom	1317	1331	microaneurysms
O	1331	1332	,
O	1333	1335	77
O	1335	1336	.
O	1336	1337	9
O	1337	1338	%
O	1338	1339	;
B-Symptom	1340	1352	intraretinal
I-Symptom	1353	1363	hemorrhage
O	1363	1364	,
O	1365	1367	83
O	1367	1368	.
O	1368	1369	7
O	1369	1370	%
O	1370	1371	;
O	1372	1375	and
B-Symptom	1376	1380	hard
I-Symptom	1381	1388	exudate
O	1388	1389	,
O	1390	1392	73
O	1392	1393	.
O	1393	1394	1
O	1394	1395	%
O	1395	1396	.

O	1397	1408	Sensitivity
O	1409	1415	ranged
O	1416	1420	from
O	1421	1423	50
O	1423	1424	.
O	1424	1425	0
O	1425	1426	%
O	1427	1428	(
B-Disease	1428	1432	CSME
I-Disease	1433	1434	2
O	1434	1435	)
O	1436	1438	to
O	1439	1441	90
O	1441	1442	.
O	1442	1443	6
O	1443	1444	%
O	1445	1446	(
B-Disease	1446	1450	CSME
O	1451	1458	overall
O	1458	1459	)
O	1459	1460	.

O	1461	1472	Specificity
O	1473	1479	ranged
O	1480	1484	from
O	1485	1487	90
O	1487	1488	.
O	1488	1489	0
O	1489	1490	%
O	1491	1492	(
B-Disease	1492	1499	macular
I-Disease	1500	1505	edema
O	1505	1506	)
O	1507	1509	to
O	1510	1512	99
O	1512	1513	.
O	1513	1514	0
O	1514	1515	%
O	1516	1517	(
B-Disease	1517	1521	CSME
I-Disease	1522	1523	2
O	1523	1524	)
O	1524	1525	.

B-Diagnostic_tool	1526	1530	High
I-Diagnostic_tool	1530	1531	-
I-Diagnostic_tool	1531	1541	resolution
I-Diagnostic_tool	1542	1554	stereoscopic
I-Diagnostic_tool	1555	1562	digital
I-Diagnostic_tool	1563	1574	photography
O	1575	1577	is
O	1578	1582	both
O	1583	1592	sensitive
O	1593	1596	and
O	1597	1605	specific
O	1606	1610	when
O	1611	1622	identifying
B-Disease	1623	1627	CSME
O	1628	1631	and
O	1632	1642	correlates
O	1643	1647	well
O	1648	1652	with
O	1653	1656	the
O	1657	1665	accepted
O	1666	1674	standard
O	1675	1677	of
B-Diagnostic_tool	1678	1682	CLBM
O	1683	1686	for
O	1687	1690	the
O	1691	1700	diagnosis
O	1701	1703	of
B-Disease	1704	1708	CSME
O	1708	1709	.

B-Diagnostic_tool	0	8	Vitreous
I-Diagnostic_tool	9	25	fluorophotometry
O	26	28	in
B-Disease	29	37	diabetes
I-Disease	38	46	mellitus
O	46	47	.

B-Diagnostic_tool	49	57	Vitreous
I-Diagnostic_tool	58	74	fluorophotometry
O	75	78	has
O	79	85	proved
O	86	88	to
O	89	91	be
O	92	93	a
O	94	100	useful
O	101	107	method
O	108	110	to
O	111	119	evaluate
O	120	123	the
B-Characteristic	124	133	integrity
I-Characteristic	134	136	of
I-Characteristic	137	140	the
I-Characteristic	141	146	blood
I-Characteristic	146	147	-
I-Characteristic	147	153	ocular
I-Characteristic	154	161	barrier
I-Characteristic	162	164	to
I-Characteristic	165	176	fluorescein
O	177	179	in
O	180	188	clinical
O	189	192	and
O	193	205	experimental
B-Disease	206	214	diabetes
I-Disease	215	223	mellitus
O	223	224	.

B-Disease	225	233	Diabetic
O	234	242	patients
O	243	247	with
O	248	250	or
O	251	258	without
B-Disease	259	269	background
I-Disease	270	281	retinopathy
O	282	285	had
B-Symptom	286	295	increased
I-Symptom	296	304	vitreous
I-Symptom	305	317	accumulation
I-Symptom	318	320	of
I-Symptom	321	332	fluorescein
O	333	338	after
O	339	350	intravenous
O	351	360	injection
O	361	365	when
O	366	374	compared
O	375	379	with
B-Characteristic	380	383	age
O	383	384	-
O	384	391	matched
O	392	400	controls
O	400	401	.

B-Disease	402	416	Streptozotocin
I-Disease	416	417	-
I-Disease	417	424	induced
I-Disease	425	433	diabetes
O	434	436	in
O	437	441	rats
O	442	450	increase
B-Characteristic	451	459	vitreous
I-Characteristic	460	471	fluorescein
O	472	478	levels
O	478	479	.

O	480	482	In
O	483	486	the
O	487	490	rat
O	490	491	,
O	492	496	this
O	497	508	abnormality
O	509	512	was
O	513	521	reversed
O	522	526	with
O	527	534	insulin
O	535	542	therapy
O	543	546	and
O	547	551	with
B-Anatomy	552	562	pancreatic
I-Anatomy	563	568	islet
O	569	584	transplantation
O	584	585	.

O	586	589	The
B-Symptom	590	599	breakdown
I-Symptom	600	602	of
I-Symptom	603	606	the
I-Symptom	607	612	blood
I-Symptom	612	613	-
I-Symptom	613	619	ocular
I-Symptom	620	627	barrier
I-Symptom	628	630	to
I-Symptom	631	642	fluorescein
O	643	650	appears
O	651	653	to
O	654	656	be
O	657	660	the
O	661	669	earliest
O	670	680	detectable
O	681	687	ocular
O	688	699	abnormality
O	700	702	of
B-Disease	703	711	diabetes
O	711	712	.

O	0	1	A
O	2	5	new
B-Diagnostic_tool	6	14	optotype
I-Diagnostic_tool	15	20	chart
O	21	24	for
O	25	34	detection
O	35	37	of
B-Symptom	38	48	nonorganic
I-Symptom	49	55	visual
I-Symptom	56	60	loss
O	60	61	.

O	63	65	To
O	66	73	develop
O	74	75	a
O	76	79	new
B-Diagnostic_tool	80	88	optotype
I-Diagnostic_tool	89	94	chart
O	95	98	for
O	99	108	detection
O	109	111	of
B-Symptom	112	122	nonorganic
I-Symptom	123	132	decreased
I-Symptom	133	139	vision
O	139	140	.

O	141	152	Comparative
O	153	166	observational
O	167	171	case
O	172	178	series
O	178	179	.

B-Characteristic	180	188	Optotype
I-Characteristic	189	199	thresholds
O	200	213	determination
O	214	216	in
O	217	222	three
B-Characteristic	223	229	normal
I-Characteristic	230	238	subjects
O	239	242	and
O	243	250	testing
O	251	253	on
O	254	256	30
O	257	268	consecutive
O	269	277	patients
O	278	282	with
O	283	290	unclear
B-Symptom	291	297	visual
I-Symptom	298	304	acuity
I-Symptom	305	309	loss
O	309	310	.

O	311	312	A
O	313	316	new
B-Diagnostic_tool	317	325	optotype
I-Diagnostic_tool	326	331	chart
O	332	335	was
O	336	345	developed
O	345	346	,
O	347	351	with
O	352	354	an
B-Diagnostic_tool	355	363	optotype
O	364	371	minimum
O	372	377	angle
O	378	380	of
O	381	391	resolution
O	392	396	that
O	397	399	is
O	400	411	independent
O	412	414	of
O	415	419	size
O	419	420	.

O	421	423	In
O	424	429	three
B-Characteristic	430	436	normal
I-Characteristic	437	445	subjects
O	446	450	rank
O	451	462	correlation
O	463	466	was
O	467	477	calculated
O	478	485	between
O	486	489	the
B-Diagnostic_tool	490	498	optotype
O	499	509	thresholds
O	510	513	and
O	514	517	the
B-Diagnostic_tool	518	526	optotype
O	527	532	sizes
O	532	533	.

O	534	535	A
B-Diagnostic_tool	536	542	pocket
I-Diagnostic_tool	543	548	chart
O	549	552	was
O	553	559	tested
O	560	562	in
O	563	564	a
O	565	571	masked
O	572	578	manner
O	579	581	on
O	582	584	30
O	585	596	consecutive
O	597	605	patients
O	606	614	referred
O	615	622	because
O	623	625	of
O	626	633	unclear
B-Symptom	634	640	visual
I-Symptom	641	647	acuity
I-Symptom	648	652	loss
O	652	653	.

B-Characteristic	654	662	Optotype
I-Characteristic	663	673	thresholds
O	674	677	and
O	678	688	usefulness
O	689	691	in
O	692	700	clinical
O	701	708	routine
O	709	710	(
O	710	718	positive
O	719	722	and
O	723	731	negative
O	732	742	predictive
O	743	749	values
O	750	759	including
O	760	762	95
O	762	763	%
O	764	774	confidence
O	775	784	intervals
O	785	786	[
O	786	788	CI
O	788	789	]
O	789	790	)
O	790	791	.

O	792	795	The
B-Characteristic	796	804	optotype
I-Characteristic	805	815	thresholds
O	816	819	did
O	820	823	not
O	824	833	correlate
O	834	838	with
O	839	842	the
B-Diagnostic_tool	843	851	optotype
O	852	857	sizes
O	857	858	.

O	859	862	Ten
O	863	870	percent
O	871	872	(
O	872	873	3
O	874	876	of
O	877	879	30
O	879	880	)
O	881	883	of
O	884	887	the
O	888	896	patients
O	897	905	referred
O	906	913	because
O	914	916	of
O	917	924	unclear
B-Symptom	925	931	visual
I-Symptom	932	938	acuity
I-Symptom	939	943	loss
O	944	947	had
O	948	950	to
O	951	953	be
O	954	962	excluded
O	962	963	,
O	964	971	because
O	972	977	their
O	978	987	diagnosis
O	988	996	remained
O	997	1004	unclear
O	1004	1005	.

O	1006	1009	All
O	1010	1018	patients
O	1019	1020	(
O	1020	1022	16
O	1023	1025	of
O	1026	1028	16
O	1028	1029	)
O	1030	1034	with
B-Symptom	1035	1042	organic
I-Symptom	1043	1049	visual
I-Symptom	1050	1054	loss
O	1055	1058	saw
O	1059	1062	all
B-Diagnostic_tool	1063	1072	optotypes
O	1073	1078	sizes
O	1078	1079	.

O	1080	1086	Eighty
O	1086	1087	-
O	1087	1091	nine
O	1092	1099	percent
O	1100	1101	(
O	1101	1103	10
O	1104	1106	of
O	1107	1109	11
O	1109	1110	)
O	1111	1113	of
O	1114	1122	patients
O	1123	1127	with
B-Symptom	1128	1138	nonorganic
I-Symptom	1139	1145	visual
I-Symptom	1146	1150	loss
O	1151	1158	claimed
O	1159	1161	to
O	1162	1165	see
O	1166	1170	only
O	1171	1174	the
O	1175	1181	larger
B-Diagnostic_tool	1182	1191	optotypes
O	1191	1192	.

O	1193	1196	The
O	1197	1205	positive
O	1206	1216	predictive
O	1217	1222	value
O	1223	1226	for
B-Symptom	1227	1237	nonorganic
I-Symptom	1238	1244	visual
I-Symptom	1245	1249	loss
O	1250	1252	of
O	1253	1256	the
O	1257	1260	new
B-Diagnostic_tool	1261	1267	pocket
I-Diagnostic_tool	1268	1273	chart
O	1274	1277	was
O	1278	1281	100
O	1281	1282	%
O	1283	1284	(
O	1284	1286	CI
O	1286	1287	,
O	1288	1290	74
O	1290	1291	%
O	1291	1292	-
O	1292	1295	100
O	1295	1296	%
O	1296	1297	)
O	1297	1298	;
O	1299	1302	the
O	1303	1311	negative
O	1312	1322	predictive
O	1323	1328	value
O	1329	1332	was
O	1333	1335	94
O	1335	1336	%
O	1337	1338	(
O	1338	1340	CI
O	1340	1341	,
O	1342	1344	75
O	1344	1345	%
O	1345	1346	-
O	1346	1349	100
O	1349	1350	%
O	1350	1351	)
O	1351	1352	.

O	1353	1356	The
O	1357	1360	new
B-Diagnostic_tool	1361	1367	pocket
I-Diagnostic_tool	1368	1373	chart
O	1374	1379	seems
O	1380	1382	to
O	1383	1385	be
O	1386	1392	useful
O	1393	1396	for
O	1397	1406	detection
O	1407	1409	of
B-Symptom	1410	1416	visual
I-Symptom	1417	1421	loss
O	1422	1428	caused
O	1429	1431	by
O	1432	1442	nonorganic
O	1443	1450	disease
O	1450	1451	.

O	0	9	Detection
O	10	12	of
B-Disease	13	18	optic
I-Disease	19	29	neuropathy
O	30	32	in
B-Disease	33	45	glaucomatous
B-Anatomy	46	50	eyes
O	51	55	with
B-Characteristic	56	62	normal
I-Characteristic	63	71	standard
I-Characteristic	72	78	visual
I-Characteristic	79	85	fields
O	86	91	using
O	92	93	a
O	94	98	test
O	99	106	battery
O	107	109	of
B-Diagnostic_tool	110	115	short
I-Diagnostic_tool	115	116	-
I-Diagnostic_tool	116	126	wavelength
I-Diagnostic_tool	127	136	automated
I-Diagnostic_tool	137	146	perimetry
O	147	150	and
B-Diagnostic_tool	151	158	pattern
I-Diagnostic_tool	159	178	electroretinography
O	178	179	.

O	181	183	To
O	184	192	evaluate
O	193	196	the
O	197	205	clinical
O	206	209	use
O	210	212	of
O	213	214	a
O	215	219	test
O	220	227	battery
O	228	230	of
B-Diagnostic_tool	231	236	short
I-Diagnostic_tool	236	237	-
I-Diagnostic_tool	237	247	wavelength
I-Diagnostic_tool	248	257	automated
I-Diagnostic_tool	258	267	perimetry
O	268	269	(
B-Diagnostic_tool	269	273	SWAP
O	273	274	)
O	274	275	,
B-Diagnostic_tool	276	285	frequency
I-Diagnostic_tool	285	286	-
I-Diagnostic_tool	286	294	doubling
I-Diagnostic_tool	295	305	technology
I-Diagnostic_tool	306	307	(
I-Diagnostic_tool	307	310	FDT
I-Diagnostic_tool	310	311	)
I-Diagnostic_tool	312	321	perimetry
O	321	322	,
O	323	326	and
B-Diagnostic_tool	327	334	pattern
I-Diagnostic_tool	334	335	-
I-Diagnostic_tool	335	354	electroretinography
O	355	356	(
B-Diagnostic_tool	356	360	PERG
O	360	361	)
O	362	364	in
O	365	373	patients
O	374	378	with
O	379	387	definite
B-Disease	388	395	primary
I-Disease	396	400	open
I-Disease	400	401	-
I-Disease	401	406	angle
I-Disease	407	415	glaucoma
O	416	417	(
B-Disease	417	421	POAG
O	421	422	)
O	423	426	but
O	427	433	normal
O	434	441	results
O	442	444	on
B-Diagnostic_tool	445	453	standard
I-Diagnostic_tool	454	463	automated
I-Diagnostic_tool	464	473	perimetry
O	474	475	(
B-Diagnostic_tool	475	478	SAP
O	478	479	)
O	479	480	.

O	481	492	Prospective
O	492	493	,
O	494	505	comparative
O	505	506	,
O	507	520	observational
O	521	525	case
O	526	532	series
O	532	533	.

O	534	540	Thirty
O	540	541	-
O	541	544	six
O	545	553	patients
O	554	558	with
B-Disease	559	563	POAG
O	564	568	with
O	569	577	standard
B-Symptom	578	584	visual
I-Symptom	585	590	field
I-Symptom	591	598	defects
O	599	601	in
O	602	605	one
B-Anatomy	606	609	eye
O	610	613	and
B-Characteristic	614	620	normal
I-Characteristic	621	629	standard
I-Characteristic	630	636	visual
I-Characteristic	637	643	fields
O	644	646	in
O	647	650	the
O	651	664	contralateral
B-Anatomy	665	668	eye
O	669	672	and
O	673	675	36
O	676	682	normal
O	683	691	controls
O	692	696	were
O	697	705	enrolled
O	705	706	.

B-Diagnostic_tool	707	711	SWAP
O	711	712	,
B-Diagnostic_tool	713	717	PERG
O	717	718	,
B-Diagnostic_tool	719	722	FDT
O	722	723	,
O	724	727	and
B-Diagnostic_tool	728	731	SAP
O	732	736	were
O	737	746	performed
O	747	749	in
O	750	753	all
B-Anatomy	754	758	eyes
O	758	759	,
O	760	763	and
O	764	770	global
O	771	778	indices
O	779	782	and
O	783	793	amplitudes
O	794	798	were
O	799	803	used
O	804	807	for
O	808	819	statistical
O	820	828	analysis
O	828	829	.

O	830	834	When
O	835	848	contralateral
B-Disease	849	853	POAG
B-Anatomy	854	858	eyes
O	859	863	with
B-Symptom	864	874	asymmetric
I-Symptom	875	887	glaucomatous
I-Symptom	888	894	damage
O	895	898	was
O	899	907	compared
O	907	908	,
O	909	910	a
O	911	917	paired
O	918	919	t
O	920	924	test
O	925	931	showed
O	932	943	significant
O	944	955	differences
O	956	958	in
B-Characteristic	959	962	SAP
I-Characteristic	963	967	mean
I-Characteristic	968	977	deviation
O	978	979	(
O	979	981	MD
O	981	982	)
O	983	984	(
O	984	985	P
O	987	988	<
O	990	991	0
O	991	992	.
O	992	996	0001
O	996	997	)
O	997	998	,
B-Characteristic	999	1003	SWAP
I-Characteristic	1003	1004	-
I-Characteristic	1004	1006	MD
O	1007	1008	(
O	1008	1009	P
O	1010	1011	=
O	1012	1013	0
O	1013	1014	.
O	1014	1018	0003
O	1018	1019	)
O	1019	1020	,
B-Characteristic	1021	1024	FDT
I-Characteristic	1024	1025	-
I-Characteristic	1025	1027	MD
O	1028	1029	(
O	1029	1030	P
O	1031	1032	=
O	1033	1034	0
O	1034	1035	.
O	1035	1039	0008
O	1039	1040	)
O	1040	1041	,
O	1042	1045	and
B-Characteristic	1046	1050	PERG
I-Characteristic	1051	1061	amplitudes
O	1062	1063	(
O	1063	1064	P
O	1066	1067	<
O	1069	1070	0
O	1070	1071	.
O	1071	1075	0001
O	1075	1076	)
O	1076	1077	.

O	1078	1082	When
O	1083	1092	comparing
O	1093	1100	between
B-Disease	1101	1105	POAG
B-Anatomy	1106	1110	eyes
O	1111	1115	with
O	1116	1122	normal
O	1123	1130	results
O	1131	1133	on
B-Diagnostic_tool	1134	1137	SAP
O	1138	1141	and
O	1142	1148	normal
O	1149	1157	controls
O	1157	1158	,
O	1159	1166	Student
O	1166	1167	'
O	1167	1168	s
O	1169	1170	t
O	1171	1175	test
O	1176	1182	showed
O	1183	1194	significant
O	1195	1206	differences
O	1207	1210	for
B-Characteristic	1211	1215	SWAP
I-Characteristic	1215	1216	-
I-Characteristic	1216	1218	MD
O	1219	1220	(
O	1220	1221	P
O	1223	1224	<
O	1226	1227	0
O	1227	1228	.
O	1228	1232	0001
O	1232	1233	)
O	1233	1234	,
B-Characteristic	1235	1238	FDT
I-Characteristic	1238	1239	-
I-Characteristic	1239	1241	MD
O	1242	1243	(
O	1243	1244	P
O	1245	1246	=
O	1247	1248	0
O	1248	1249	.
O	1249	1253	0006
O	1253	1254	)
O	1254	1255	,
B-Characteristic	1256	1260	PERG
I-Characteristic	1261	1265	N1P1
I-Characteristic	1265	1266	-
I-Characteristic	1266	1275	amplitude
O	1276	1277	(
O	1277	1278	P
O	1279	1280	=
O	1281	1282	0
O	1282	1283	.
O	1283	1287	0486
O	1287	1288	)
O	1289	1292	and
B-Characteristic	1293	1297	P1N2
I-Characteristic	1297	1298	-
I-Characteristic	1298	1307	amplitude
O	1308	1309	(
O	1309	1310	P
O	1312	1313	<
O	1315	1316	0
O	1316	1317	.
O	1317	1321	0001
O	1321	1322	)
O	1322	1323	;
O	1324	1332	receiver
O	1333	1342	operating
O	1343	1357	characteristic
O	1358	1366	analysis
O	1367	1375	revealed
O	1376	1385	promising
O	1386	1394	accuracy
O	1395	1398	for
B-Characteristic	1399	1403	SWAP
I-Characteristic	1403	1404	-
I-Characteristic	1404	1406	MD
O	1407	1409	of
O	1410	1412	73
O	1412	1413	.
O	1413	1414	6
O	1414	1415	%
O	1416	1417	(
O	1417	1418	P
O	1420	1421	<
O	1423	1424	0
O	1424	1425	.
O	1425	1429	0001
O	1429	1430	)
O	1430	1431	.

B-Characteristic	1432	1436	SWAP
I-Characteristic	1436	1437	-
I-Characteristic	1437	1439	MD
O	1440	1441	(
O	1441	1442	P
O	1444	1445	<
O	1447	1448	0
O	1448	1449	.
O	1449	1453	0001
O	1453	1454	)
O	1455	1458	and
B-Characteristic	1459	1462	FDT
I-Characteristic	1462	1463	-
I-Characteristic	1463	1465	MD
O	1466	1467	(
O	1467	1468	P
O	1470	1471	<
O	1473	1474	0
O	1474	1475	.
O	1475	1479	0001
O	1479	1480	)
O	1481	1491	correlated
O	1492	1505	significantly
O	1506	1510	with
B-Characteristic	1511	1514	SAP
I-Characteristic	1514	1515	-
I-Characteristic	1515	1517	MD
O	1518	1521	and
O	1522	1526	with
O	1527	1531	each
O	1532	1537	other
O	1538	1539	(
O	1539	1544	range
O	1544	1545	,
O	1546	1547	P
O	1549	1550	<
O	1552	1553	0
O	1553	1554	.
O	1554	1558	0001
O	1559	1561	to
O	1562	1563	P
O	1564	1565	=
O	1566	1567	0
O	1567	1568	.
O	1568	1572	0020
O	1572	1573	)
O	1573	1574	.

O	1575	1585	Regression
O	1586	1594	analysis
O	1595	1603	revealed
O	1604	1608	that
B-Characteristic	1609	1613	PERG
I-Characteristic	1614	1618	P1N2
I-Characteristic	1618	1619	-
I-Characteristic	1619	1628	amplitude
O	1629	1634	could
O	1635	1642	improve
O	1643	1646	the
O	1647	1652	power
O	1653	1655	of
B-Characteristic	1656	1660	SWAP
I-Characteristic	1660	1661	-
I-Characteristic	1661	1663	MD
O	1664	1668	from
O	1669	1671	73
O	1671	1672	.
O	1672	1673	6
O	1673	1674	%
O	1675	1677	to
O	1678	1684	detect
B-Disease	1685	1690	early
I-Disease	1691	1695	POAG
O	1696	1698	in
B-Anatomy	1699	1703	eyes
O	1704	1708	with
O	1709	1715	normal
O	1716	1723	results
O	1724	1726	on
B-Diagnostic_tool	1727	1730	SAP
O	1731	1733	to
O	1734	1736	an
O	1737	1745	accuracy
O	1746	1748	of
O	1749	1751	81
O	1751	1752	.
O	1752	1753	9
O	1753	1754	%
O	1754	1755	.

O	1756	1757	A
O	1758	1762	test
O	1763	1770	battery
O	1771	1773	of
B-Characteristic	1774	1778	SWAP
I-Characteristic	1778	1779	-
I-Characteristic	1779	1781	MD
O	1782	1785	and
B-Characteristic	1786	1790	PERG
I-Characteristic	1791	1795	P1N2
I-Characteristic	1795	1796	-
I-Characteristic	1796	1805	amplitude
O	1806	1811	could
O	1812	1818	detect
B-Disease	1819	1831	glaucomatous
I-Disease	1832	1837	optic
I-Disease	1838	1848	neuropathy
O	1849	1851	in
B-Disease	1852	1856	POAG
B-Anatomy	1857	1861	eyes
O	1862	1866	with
B-Characteristic	1867	1873	normal
I-Characteristic	1874	1882	standard
I-Characteristic	1883	1889	visual
I-Characteristic	1890	1896	fields
O	1896	1897	,
O	1898	1905	whereas
B-Characteristic	1906	1909	FDT
I-Characteristic	1909	1910	-
I-Characteristic	1910	1912	MD
O	1913	1916	and
B-Characteristic	1917	1921	SWAP
I-Characteristic	1921	1922	-
I-Characteristic	1922	1924	MD
O	1925	1938	significantly
O	1939	1949	correlated
O	1950	1954	with
O	1955	1959	each
O	1960	1965	other
O	1966	1969	and
O	1970	1974	with
B-Characteristic	1975	1978	SAP
I-Characteristic	1978	1979	-
I-Characteristic	1979	1981	MD
O	1981	1982	.

O	1983	1986	All
O	1987	1992	tests
O	1993	1997	were
O	1998	2002	able
O	2003	2005	to
O	2006	2012	detect
O	2013	2016	the
B-Anatomy	2017	2020	eye
O	2021	2025	with
O	2026	2029	the
O	2030	2034	more
O	2035	2041	severe
B-Disease	2042	2054	glaucomatous
I-Disease	2055	2060	optic
I-Disease	2061	2071	neuropathy
O	2072	2074	in
O	2075	2083	patients
O	2084	2088	with
B-Disease	2089	2099	asymmetric
I-Disease	2100	2104	POAG
O	2104	2105	.

O	0	15	Reproducibility
O	16	18	of
O	19	29	evaluation
O	30	32	of
B-Anatomy	33	38	optic
I-Anatomy	39	43	disc
O	44	50	change
O	51	54	for
B-Disease	55	63	glaucoma
O	64	68	with
B-Diagnostic_tool	69	75	stereo
I-Diagnostic_tool	76	81	optic
I-Diagnostic_tool	82	86	disc
I-Diagnostic_tool	87	98	photographs
O	98	99	.

O	101	103	To
O	104	113	determine
O	114	117	the
O	118	133	reproducibility
O	134	136	of
O	137	140	the
O	141	151	assessment
O	152	155	for
B-Symptom	156	168	glaucomatous
I-Symptom	169	175	change
O	176	178	in
B-Diagnostic_tool	179	185	serial
I-Diagnostic_tool	186	191	optic
I-Diagnostic_tool	192	196	disc
I-Diagnostic_tool	197	203	stereo
I-Diagnostic_tool	203	204	-
I-Diagnostic_tool	204	210	slides
O	210	211	.

O	212	218	Masked
O	219	232	interobserver
O	233	244	variability
O	245	250	study
O	250	251	.

B-Diagnostic_tool	252	258	Serial
I-Diagnostic_tool	259	264	optic
I-Diagnostic_tool	265	269	disc
I-Diagnostic_tool	270	276	stereo
I-Diagnostic_tool	276	277	-
I-Diagnostic_tool	277	283	slides
O	284	288	from
O	289	291	40
O	292	300	patients
O	300	301	.

O	302	307	Three
O	308	319	independent
O	320	336	ophthalmologists
O	337	346	evaluated
O	347	350	for
O	351	357	change
O	358	359	a
O	360	363	set
O	364	366	of
O	367	370	two
B-Diagnostic_tool	371	377	serial
I-Diagnostic_tool	378	380	20
I-Diagnostic_tool	381	388	degrees
I-Diagnostic_tool	389	394	optic
I-Diagnostic_tool	395	399	disc
I-Diagnostic_tool	400	405	color
I-Diagnostic_tool	406	412	stereo
I-Diagnostic_tool	412	413	-
I-Diagnostic_tool	413	419	slides
O	420	422	of
O	423	425	40
O	426	434	patients
O	434	435	.

O	436	440	This
O	441	445	test
O	446	449	set
O	450	453	was
O	454	457	not
O	458	462	from
O	463	471	European
B-Disease	472	480	Glaucoma
O	481	491	Prevention
O	492	497	Study
O	498	499	(
O	499	503	EGPS
O	503	504	)
O	505	513	patients
O	513	514	.

O	515	519	Each
O	520	528	observer
O	529	538	performed
O	539	542	two
O	543	554	evaluations
O	555	557	at
O	558	563	least
O	564	566	30
O	567	571	days
O	572	577	apart
O	578	581	and
O	582	585	was
O	586	592	masked
O	593	597	from
O	598	601	the
O	602	610	temporal
O	611	619	sequence
O	620	622	of
O	623	626	the
O	627	633	slides
O	634	637	and
O	638	641	his
O	642	644	or
O	645	648	her
O	649	657	previous
O	658	668	evaluation
O	668	669	.

O	670	674	Each
O	675	682	patient
O	683	686	was
O	687	693	graded
O	694	696	as
O	697	704	changed
O	705	707	or
O	708	714	stable
O	715	717	by
O	718	721	two
O	721	722	-
O	722	725	out
O	725	726	-
O	726	728	of
O	728	729	-
O	729	734	three
O	735	744	agreement
O	744	745	.

O	746	747	A
O	748	753	kappa
O	754	763	statistic
O	764	767	was
O	768	772	used
O	773	775	to
O	776	785	calculate
O	786	789	the
O	790	795	intra
O	795	796	-
O	797	800	and
O	801	814	interobserver
O	815	830	reproducibility
O	831	833	as
O	834	838	well
O	839	841	as
O	842	845	the
O	846	856	assignment
O	857	872	reproducibility
O	873	874	(
O	874	879	first
O	880	889	consensus
O	890	896	versus
O	897	903	second
O	904	913	consensus
O	913	914	)
O	914	915	.

O	916	919	The
O	920	924	same
O	925	934	procedure
O	935	938	was
O	939	947	followed
O	948	950	to
O	951	955	test
O	956	959	the
O	960	975	reproducibility
O	976	980	when
O	981	988	another
O	989	1000	experienced
O	1001	1016	ophthalmologist
O	1017	1020	was
O	1021	1026	added
O	1027	1029	to
O	1030	1033	one
O	1034	1036	of
O	1037	1040	the
O	1041	1046	three
O	1047	1054	reading
O	1055	1062	centers
O	1062	1063	.

O	1064	1079	Reproducibility
O	1080	1082	in
O	1083	1093	evaluating
B-Symptom	1094	1106	glaucomatous
I-Symptom	1107	1112	optic
I-Symptom	1113	1117	disc
I-Symptom	1118	1124	change
O	1124	1125	.

O	1126	1129	The
O	1130	1143	intraobserver
O	1144	1159	reproducibility
O	1160	1161	(
O	1161	1163	95
O	1163	1164	%
O	1165	1175	confidence
O	1176	1184	interval
O	1185	1186	[
O	1186	1188	CI
O	1188	1189	]
O	1189	1190	)
O	1191	1193	in
O	1194	1197	the
O	1198	1208	evaluation
O	1209	1211	of
O	1212	1218	change
O	1219	1225	ranged
O	1226	1233	between
O	1234	1235	0
O	1235	1236	.
O	1236	1238	79
O	1239	1240	(
O	1240	1241	0
O	1241	1242	.
O	1242	1244	45
O	1244	1245	-
O	1245	1246	1
O	1246	1247	.
O	1247	1249	14
O	1249	1250	)
O	1251	1254	and
O	1255	1256	1
O	1256	1257	.
O	1257	1259	00
O	1260	1261	(
O	1261	1262	0
O	1262	1263	.
O	1263	1265	69
O	1265	1266	-
O	1266	1267	1
O	1267	1268	.
O	1268	1270	31
O	1270	1271	)
O	1271	1272	.

O	1273	1276	The
O	1277	1290	interobserver
O	1291	1306	reproducibility
O	1307	1308	(
O	1308	1310	95
O	1310	1311	%
O	1312	1314	CI
O	1314	1315	)
O	1316	1318	in
O	1319	1322	the
O	1323	1333	evaluation
O	1334	1336	of
O	1337	1343	change
O	1344	1350	ranged
O	1351	1358	between
O	1359	1360	0
O	1360	1361	.
O	1361	1363	45
O	1364	1365	(
O	1365	1366	0
O	1366	1367	.
O	1367	1369	15
O	1369	1370	-
O	1370	1371	0
O	1371	1372	.
O	1372	1374	75
O	1374	1375	)
O	1376	1379	and
O	1380	1381	0
O	1381	1382	.
O	1382	1384	75
O	1385	1386	(
O	1386	1387	0
O	1387	1388	.
O	1388	1390	44
O	1390	1391	-
O	1391	1392	1
O	1392	1393	.
O	1393	1395	06
O	1395	1396	)
O	1396	1397	.

O	1398	1401	The
O	1402	1412	assignment
O	1413	1428	reproducibility
O	1429	1430	(
O	1430	1435	first
O	1436	1445	consensus
O	1446	1452	versus
O	1453	1459	second
O	1460	1469	consensus
O	1470	1472	in
O	1473	1476	the
O	1477	1487	evaluation
O	1488	1490	of
O	1491	1497	change
O	1497	1498	)
O	1499	1506	between
O	1507	1510	the
O	1511	1517	senior
O	1518	1522	EGPS
O	1523	1530	readers
O	1531	1534	was
O	1535	1536	0
O	1536	1537	.
O	1537	1539	94
O	1540	1541	(
O	1541	1542	0
O	1542	1543	.
O	1543	1545	63
O	1545	1546	-
O	1546	1547	1
O	1547	1548	.
O	1548	1550	25
O	1550	1551	)
O	1551	1552	.

O	1553	1556	The
O	1557	1567	assignment
O	1568	1583	reproducibility
O	1584	1588	when
O	1589	1596	another
O	1597	1608	experienced
O	1609	1624	ophthalmologist
O	1625	1633	replaced
O	1634	1637	one
O	1638	1640	of
O	1641	1644	the
O	1645	1652	readers
O	1653	1656	was
O	1657	1658	0
O	1658	1659	.
O	1659	1661	94
O	1662	1663	(
O	1663	1664	0
O	1664	1665	.
O	1665	1667	63
O	1667	1668	-
O	1668	1669	1
O	1669	1670	.
O	1670	1672	25
O	1672	1673	)
O	1673	1674	.

O	1675	1678	The
O	1679	1689	assignment
O	1690	1705	reproducibility
O	1706	1708	of
O	1709	1714	three
O	1715	1721	expert
O	1722	1729	readers
O	1730	1737	looking
O	1738	1741	for
B-Symptom	1742	1754	glaucomatous
I-Symptom	1755	1761	change
O	1762	1764	in
B-Diagnostic_tool	1765	1771	serial
I-Diagnostic_tool	1772	1777	optic
I-Diagnostic_tool	1778	1782	disc
I-Diagnostic_tool	1783	1789	stereo
I-Diagnostic_tool	1789	1790	-
I-Diagnostic_tool	1790	1796	slides
O	1797	1800	was
O	1801	1810	excellent
O	1810	1811	.

O	1812	1814	It
O	1815	1823	remained
O	1824	1826	so
O	1827	1831	when
O	1832	1835	one
O	1836	1838	of
O	1839	1842	the
O	1843	1848	three
O	1849	1856	experts
O	1857	1860	was
O	1861	1869	replaced
O	1870	1872	by
O	1873	1880	another
O	1881	1892	experienced
O	1893	1899	reader
O	1899	1900	.

O	3	6	The
O	7	11	risk
O	12	15	and
O	16	23	natural
O	24	30	course
O	31	33	of
B-Disease	34	37	age
I-Disease	37	38	-
I-Disease	38	45	related
I-Disease	46	57	maculopathy
O	57	58	:
O	59	65	follow
O	65	66	-
O	66	68	up
O	69	71	at
O	72	73	6
O	74	75	1
O	75	76	/
O	76	77	2
O	78	83	years
O	84	86	in
O	87	90	the
O	91	100	Rotterdam
O	101	106	study

O	108	118	Objectives
O	118	119	:
O	120	122	To
O	123	131	evaluate
O	132	135	the
O	136	143	natural
O	144	150	course
O	151	153	of
B-Disease	154	157	age
I-Disease	157	158	-
I-Disease	158	165	related
I-Disease	166	177	maculopathy
O	178	179	(
B-Disease	179	182	ARM
O	182	183	)
O	184	187	and
O	188	190	to
O	191	197	assess
O	198	201	the
O	202	211	incidence
O	212	215	and
O	216	224	absolute
O	225	229	risk
O	230	232	of
O	233	236	its
O	237	242	final
O	243	248	stage
O	248	249	,
B-Disease	250	253	age
I-Disease	253	254	-
I-Disease	254	261	related
I-Disease	262	269	macular
I-Disease	270	282	degeneration
O	283	284	(
B-Disease	284	287	AMD
O	287	288	)
O	288	289	.

O	291	298	Methods
O	298	299	:
O	300	302	In
O	303	304	a
O	305	315	population
O	315	316	-
O	316	321	based
O	322	333	prospective
O	334	340	cohort
O	341	346	study
O	347	349	of
O	350	354	6418
O	355	362	persons
B-Characteristic	363	365	55
I-Characteristic	366	371	years
I-Characteristic	372	375	and
I-Characteristic	376	381	older
O	381	382	,
O	383	385	we
O	386	393	studied
O	394	397	the
O	398	407	incidence
O	408	411	and
O	412	419	natural
O	420	426	course
O	427	429	of
B-Disease	430	433	ARM
O	433	434	.

O	435	443	Subjects
O	444	453	underwent
O	454	463	identical
O	464	476	examinations
O	476	477	,
O	478	487	including
B-Diagnostic_tool	488	500	stereoscopic
I-Diagnostic_tool	501	507	fundus
I-Diagnostic_tool	508	519	photography
O	519	520	,
O	521	523	at
O	524	532	baseline
O	533	536	and
O	537	539	at
O	540	541	2
O	541	542	.
O	542	543	0
O	544	547	and
O	548	549	6
O	549	550	(
O	550	551	1
O	551	552	/
O	552	553	2
O	553	554	)
O	555	560	years
O	560	561	'
O	562	568	follow
O	568	569	-
O	569	571	up
O	571	572	.

B-Disease	573	576	Age
I-Disease	576	577	-
I-Disease	577	584	related
I-Disease	585	596	maculopathy
O	597	600	was
O	601	607	graded
O	608	617	according
O	618	620	to
O	621	624	the
B-Classification_system	625	638	International
I-Classification_system	639	653	Classification
I-Classification_system	654	657	and
I-Classification_system	658	665	Grading
I-Classification_system	666	672	System
O	673	676	for
B-Disease	677	680	ARM
O	681	684	and
B-Disease	685	688	AMD
O	688	689	,
O	690	693	and
O	694	704	stratified
O	705	709	into
O	710	711	5
O	712	721	exclusive
O	722	728	stages
O	728	729	.

O	730	739	Incidence
O	740	743	was
O	744	753	expressed
O	754	756	in
O	757	762	rates
O	763	766	and
O	767	768	5
O	768	769	-
O	769	773	year
O	774	782	absolute
O	783	788	risks
O	788	789	.

O	791	798	Results
O	798	799	:
O	800	802	At
O	803	809	follow
O	809	810	-
O	810	812	up
O	812	813	,
O	814	816	47
O	817	820	new
O	821	826	cases
O	827	829	of
B-Disease	830	833	AMD
O	834	838	were
O	839	849	identified
O	849	850	,
O	851	855	with
O	856	857	a
O	858	863	ratio
O	864	866	of
B-Disease	867	878	neovascular
I-Disease	878	879	-
I-Disease	879	887	atrophic
I-Disease	888	891	AMD
O	892	894	of
O	895	896	1
O	896	897	.
O	897	898	4
O	898	899	:
O	899	900	1
O	900	901	.

O	902	905	The
O	906	907	5
O	907	908	-
O	908	912	year
O	913	917	risk
O	918	920	of
B-Disease	921	924	AMD
O	925	934	increased
O	935	939	with
O	940	944	more
O	945	951	severe
O	952	958	stages
O	959	961	to
O	962	964	28
O	964	965	.
O	965	966	0
O	966	967	%
O	968	971	for
O	972	980	subjects
B-Characteristic	981	983	55
I-Characteristic	984	989	years
I-Characteristic	990	993	and
I-Characteristic	994	999	older
O	1000	1004	with
B-Symptom	1005	1015	indistinct
I-Symptom	1016	1022	drusen
O	1023	1026	and
B-Symptom	1027	1037	pigmentary
I-Symptom	1038	1052	irregularities
O	1053	1054	(
B-Disease	1054	1059	stage
I-Disease	1060	1061	3
O	1061	1062	)
O	1062	1063	.

B-Characteristic	1064	1067	Age
O	1067	1068	,
O	1069	1072	but
O	1073	1076	not
B-Characteristic	1077	1080	sex
O	1080	1081	,
O	1082	1095	independently
O	1096	1105	increased
O	1106	1110	this
O	1111	1115	risk
O	1116	1118	to
O	1119	1120	a
O	1121	1128	maximum
O	1129	1131	of
O	1132	1134	42
O	1134	1135	.
O	1135	1136	0
O	1136	1137	%
O	1138	1141	for
O	1142	1150	subjects
O	1151	1155	with
B-Disease	1156	1161	stage
I-Disease	1162	1163	3
I-Disease	1164	1167	ARM
O	1168	1171	who
O	1172	1176	were
B-Characteristic	1177	1179	80
I-Characteristic	1180	1185	years
I-Characteristic	1186	1189	and
I-Characteristic	1190	1195	older
O	1195	1196	.

O	1197	1207	Individual
B-Disease	1208	1211	ARM
B-Symptom	1212	1218	fundus
I-Symptom	1219	1224	signs
O	1225	1229	that
O	1230	1239	predicted
O	1240	1244	best
O	1245	1248	the
O	1249	1260	development
O	1261	1263	of
B-Disease	1264	1267	AMD
O	1268	1272	were
B-Symptom	1273	1275	10
I-Symptom	1276	1278	or
I-Symptom	1279	1283	more
I-Symptom	1284	1289	large
I-Symptom	1290	1296	drusen
O	1297	1298	(
B-Dimension	1298	1299	>
I-Dimension	1300	1302	or
I-Dimension	1303	1304	=
I-Dimension	1304	1307	125
I-Dimension	1308	1314	microm
O	1314	1315	)
O	1316	1319	and
B-Symptom	1320	1322	10
I-Symptom	1322	1323	%
I-Symptom	1324	1326	or
I-Symptom	1327	1331	more
I-Symptom	1332	1334	of
I-Symptom	1335	1338	the
I-Symptom	1339	1343	grid
I-Symptom	1344	1348	area
I-Symptom	1349	1356	covered
I-Symptom	1357	1359	by
I-Symptom	1360	1366	drusen
O	1366	1367	.

O	1368	1376	Subjects
O	1377	1380	who
O	1381	1390	developed
B-Disease	1391	1399	atrophic
I-Disease	1400	1403	AMD
O	1404	1410	showed
O	1411	1413	no
O	1414	1425	significant
O	1426	1427	(
O	1427	1428	P
O	1429	1430	=
O	1430	1431	.
O	1431	1433	25
O	1433	1434	)
O	1435	1446	differences
O	1447	1449	in
O	1450	1458	baseline
B-Symptom	1459	1465	fundus
I-Symptom	1466	1471	signs
O	1472	1475	and
O	1476	1483	natural
O	1484	1490	course
O	1491	1499	compared
O	1500	1504	with
O	1505	1513	subjects
O	1514	1517	who
O	1518	1527	developed
B-Disease	1528	1539	neovascular
I-Disease	1540	1543	AMD
O	1543	1544	.

O	1546	1557	Conclusions
O	1557	1558	:
O	1559	1561	We
O	1562	1570	provided
O	1571	1574	the
O	1575	1583	absolute
O	1584	1588	risk
O	1589	1591	of
B-Disease	1592	1595	AMD
O	1596	1598	as
O	1599	1600	a
O	1601	1609	function
O	1610	1612	of
B-Characteristic	1613	1616	age
O	1617	1620	and
B-Symptom	1621	1626	early
I-Symptom	1627	1630	ARM
I-Symptom	1631	1637	fundus
I-Symptom	1638	1643	signs
O	1643	1644	,
O	1645	1648	and
O	1649	1655	showed
O	1656	1660	that
O	1661	1665	both
O	1666	1669	are
O	1670	1679	prominent
O	1680	1691	independent
O	1692	1696	risk
O	1697	1704	factors
O	1704	1705	.

O	1706	1709	The
O	1710	1721	progression
O	1722	1724	of
B-Disease	1725	1728	ARM
O	1729	1735	stages
O	1736	1743	follows
O	1743	1744	,
O	1745	1750	after
O	1751	1754	the
O	1755	1765	appearance
O	1766	1768	of
O	1769	1772	the
B-Symptom	1773	1778	first
I-Symptom	1779	1783	soft
I-Symptom	1784	1790	drusen
O	1790	1791	,
O	1792	1793	a
O	1794	1802	distinct
O	1803	1809	course
O	1810	1812	at
O	1813	1814	a
O	1815	1822	gradual
O	1823	1827	pace
O	1828	1832	that
O	1833	1844	accelerates
O	1845	1849	with
O	1850	1860	increasing
B-Characteristic	1861	1864	age
O	1864	1865	.

O	0	7	Grading
O	8	10	of
B-Disease	11	14	age
I-Disease	14	15	-
I-Disease	15	22	related
I-Disease	23	34	maculopathy
O	35	38	for
O	39	54	epidemiological
O	55	62	studies
O	62	63	:
O	64	66	is
B-Diagnostic_tool	67	74	digital
I-Diagnostic_tool	75	82	imaging
O	83	85	as
O	86	90	good
O	91	93	as
B-Diagnostic_tool	94	96	35
I-Diagnostic_tool	96	97	-
I-Diagnostic_tool	97	99	mm
I-Diagnostic_tool	100	104	film
O	104	105	?

O	107	109	To
O	110	117	compare
B-Diagnostic_tool	118	124	stereo
I-Diagnostic_tool	125	132	digital
I-Diagnostic_tool	133	139	images
O	140	144	with
B-Diagnostic_tool	145	151	stereo
I-Diagnostic_tool	152	154	35
I-Diagnostic_tool	154	155	-
I-Diagnostic_tool	155	157	mm
I-Diagnostic_tool	158	163	color
I-Diagnostic_tool	164	178	transparencies
O	179	181	as
O	182	184	to
O	185	188	the
O	189	196	quality
O	197	200	and
O	201	212	reliability
O	213	215	of
O	216	223	grading
B-Disease	224	227	age
I-Disease	227	228	-
I-Disease	228	235	related
I-Disease	236	247	maculopathy
O	248	249	(
B-Disease	249	252	ARM
O	252	253	)
O	254	256	in
O	257	260	the
O	261	268	context
O	269	271	of
O	272	273	a
O	274	285	multicenter
O	286	294	European
O	295	308	epidemiologic
O	309	314	study
O	315	316	(
O	316	319	the
O	320	326	EUREYE
O	327	332	Study
O	332	333	)
O	333	334	.

O	335	345	Instrument
O	346	356	validation
O	357	362	study
O	362	363	.

O	364	370	Ninety
O	370	371	-
O	371	374	one
O	375	383	subjects
O	384	385	(
O	385	388	137
B-Anatomy	389	393	eyes
O	393	394	)
O	395	399	with
O	400	407	varying
O	408	415	degrees
O	416	418	of
B-Disease	419	422	ARM
O	422	423	,
O	424	433	including
O	434	436	no
B-Disease	437	440	ARM
O	440	441	.

O	442	446	From
O	447	451	both
B-Anatomy	452	456	eyes
O	457	459	of
O	460	463	the
O	464	476	participants
O	476	477	,
B-Diagnostic_tool	478	480	35
I-Diagnostic_tool	480	481	-
I-Diagnostic_tool	481	483	mm
I-Diagnostic_tool	484	488	film
O	489	492	and
B-Diagnostic_tool	493	500	digital
I-Diagnostic_tool	501	513	stereoscopic
I-Diagnostic_tool	514	520	fundus
I-Diagnostic_tool	521	527	images
O	528	532	were
O	533	541	obtained
O	542	546	with
O	547	550	two
O	551	560	identical
B-Diagnostic_tool	561	567	Topcon
I-Diagnostic_tool	568	574	fundus
I-Diagnostic_tool	575	582	cameras
O	582	583	.

O	584	587	Two
O	588	599	experienced
O	600	607	graders
O	608	618	classified
O	619	622	all
O	623	628	signs
O	629	631	of
B-Disease	632	635	ARM
O	636	645	according
O	646	648	to
O	649	652	the
B-Classification_system	653	666	International
I-Classification_system	667	681	Classification
I-Classification_system	682	688	System
O	688	689	.

O	690	699	Agreement
O	700	707	between
O	708	715	imaging
O	716	726	techniques
O	727	730	and
O	731	738	between
O	739	746	graders
O	747	750	was
O	751	761	calculated
O	762	767	using
O	768	771	the
O	772	780	weighted
O	781	786	kappa
O	787	796	statistic
O	796	797	.

O	798	803	Signs
O	804	806	of
B-Disease	807	810	ARM
O	811	812	(
O	812	818	number
O	818	819	,
O	820	824	size
O	824	825	,
O	826	829	and
B-Symptom	830	841	morphologic
I-Symptom	842	857	characteristics
I-Symptom	858	860	of
I-Symptom	861	867	drusen
I-Symptom	867	868	;
I-Symptom	869	879	pigmentary
I-Symptom	880	887	changes
O	887	888	;
B-Symptom	889	899	geographic
I-Symptom	900	907	atrophy
O	907	908	;
O	909	912	and
B-Symptom	913	924	neovascular
I-Symptom	925	932	macular
I-Symptom	933	945	degeneration
O	945	946	)
O	947	949	as
O	950	954	well
O	955	957	as
O	958	960	an
O	961	968	overall
O	969	976	staging
O	977	983	system
O	984	986	of
O	987	997	increasing
B-Disease	998	1001	ARM
O	1002	1010	severity
O	1010	1011	.

O	1012	1015	The
O	1016	1024	weighted
O	1025	1030	kappa
O	1031	1036	value
O	1037	1040	for
O	1041	1048	between
O	1048	1049	-
O	1049	1058	technique
O	1059	1068	agreement
O	1069	1075	ranged
O	1076	1080	from
O	1081	1082	0
O	1082	1083	.
O	1083	1085	41
O	1086	1089	for
O	1090	1096	number
O	1097	1099	of
B-Symptom	1100	1106	drusen
B-Dimension	1108	1109	<
I-Dimension	1110	1112	63
I-Dimension	1113	1119	microm
O	1120	1122	to
O	1123	1124	0
O	1124	1125	.
O	1125	1127	79
O	1128	1131	for
B-Symptom	1132	1138	drusen
I-Symptom	1139	1143	type
O	1144	1147	and
B-Symptom	1148	1153	total
I-Symptom	1154	1158	area
I-Symptom	1159	1167	occupied
I-Symptom	1168	1170	by
I-Symptom	1171	1177	drusen
O	1177	1178	.

O	1179	1182	The
O	1183	1188	kappa
O	1189	1195	values
O	1196	1199	for
B-Disease	1200	1208	atrophic
I-Disease	1209	1212	and
I-Disease	1213	1224	neovascular
I-Disease	1225	1228	end
I-Disease	1228	1229	-
I-Disease	1229	1234	stage
I-Disease	1235	1238	ARM
O	1239	1243	were
O	1244	1245	0
O	1245	1246	.
O	1246	1248	87
O	1249	1252	and
O	1253	1254	0
O	1254	1255	.
O	1255	1257	94
O	1257	1258	,
O	1259	1271	respectively
O	1271	1272	.

O	1273	1276	The
O	1277	1284	between
O	1284	1285	-
O	1285	1294	technique
O	1295	1304	agreement
O	1305	1307	on
O	1308	1314	stages
O	1315	1317	of
B-Disease	1318	1321	ARM
O	1322	1325	was
O	1326	1339	approximately
O	1340	1341	0
O	1341	1342	.
O	1342	1344	76
O	1344	1345	.

O	1346	1349	The
O	1350	1359	agreement
O	1360	1367	between
O	1368	1375	graders
O	1376	1379	was
O	1380	1387	largely
O	1388	1391	the
O	1392	1396	same
O	1397	1400	for
O	1401	1405	both
O	1406	1416	techniques
O	1417	1419	of
O	1420	1427	imaging
O	1427	1428	.

O	1429	1431	In
O	1432	1435	the
O	1436	1445	described
O	1446	1453	setting
O	1453	1454	,
B-Diagnostic_tool	1455	1462	digital
I-Diagnostic_tool	1463	1469	images
O	1470	1474	were
O	1475	1477	as
O	1478	1482	good
O	1483	1485	as
B-Diagnostic_tool	1486	1488	35
I-Diagnostic_tool	1488	1489	-
I-Diagnostic_tool	1489	1491	mm
I-Diagnostic_tool	1492	1496	film
O	1497	1500	for
O	1501	1504	the
O	1505	1512	grading
O	1513	1515	of
B-Disease	1516	1519	ARM
O	1519	1520	.

O	1521	1532	Considering
O	1533	1536	the
O	1537	1546	practical
O	1547	1557	advantages
O	1558	1560	of
B-Diagnostic_tool	1561	1568	digital
I-Diagnostic_tool	1569	1576	imaging
O	1576	1577	,
O	1578	1582	this
O	1583	1592	technique
O	1593	1596	may
O	1597	1602	serve
O	1603	1607	well
O	1608	1610	in
O	1611	1624	epidemiologic
O	1625	1632	studies
O	1633	1635	of
B-Disease	1636	1639	ARM
O	1639	1640	.

O	0	8	Proposed
O	9	22	international
O	23	31	clinical
B-Disease	32	40	diabetic
I-Disease	41	52	retinopathy
O	53	56	and
B-Disease	57	65	diabetic
I-Disease	66	73	macular
I-Disease	74	79	edema
O	80	87	disease
O	88	96	severity
O	97	103	scales
O	103	104	.

O	106	108	To
O	109	116	develop
O	117	126	consensus
O	127	136	regarding
O	137	145	clinical
O	146	153	disease
O	154	162	severity
O	163	177	classification
O	178	185	systems
O	186	189	for
B-Disease	190	198	diabetic
I-Disease	199	210	retinopathy
O	211	214	and
B-Disease	215	223	diabetic
I-Disease	224	231	macular
I-Disease	232	237	edema
O	238	242	that
O	243	246	can
O	247	249	be
O	250	254	used
O	255	261	around
O	262	265	the
O	266	271	world
O	271	272	,
O	273	276	and
O	277	279	to
O	280	287	improve
O	288	301	communication
O	302	305	and
O	306	318	coordination
O	319	321	of
O	322	326	care
O	327	332	among
O	333	343	physicians
O	344	347	who
O	348	352	care
O	353	356	for
O	357	365	patients
O	366	370	with
B-Disease	371	379	diabetes
O	379	380	.

O	381	387	Report
O	388	397	regarding
O	398	401	the
O	402	413	development
O	414	416	of
O	417	425	clinical
B-Disease	426	434	diabetic
I-Disease	435	446	retinopathy
O	447	454	disease
O	455	463	severity
O	464	470	scales
O	470	471	.

O	472	473	A
O	474	479	group
O	480	482	of
O	483	485	31
O	486	497	individuals
O	498	502	from
O	503	505	16
O	506	515	countries
O	515	516	,
O	517	529	representing
O	530	543	comprehensive
O	544	557	ophthalmology
O	557	558	,
B-Anatomy	559	565	retina
O	566	580	subspecialties
O	580	581	,
O	582	595	endocrinology
O	595	596	,
O	597	600	and
O	601	613	epidemiology
O	613	614	.

O	615	617	An
O	618	625	initial
O	626	634	clinical
O	635	649	classification
O	650	656	system
O	656	657	,
O	658	663	based
O	664	666	on
O	667	670	the
O	671	676	Early
O	677	686	Treatment
B-Disease	687	695	Diabetic
I-Disease	696	707	Retinopathy
O	708	713	Study
O	714	717	and
O	718	721	the
B-Characteristic	722	731	Wisconsin
O	732	745	Epidemiologic
O	746	751	Study
O	752	754	of
B-Disease	755	763	Diabetic
I-Disease	764	775	Retinopathy
O	776	788	publications
O	788	789	,
O	790	793	was
O	794	804	circulated
O	805	807	to
O	808	811	the
O	812	817	group
O	818	820	in
O	821	828	advance
O	829	831	of
O	832	833	a
O	834	842	workshop
O	842	843	.

O	844	848	Each
O	849	855	member
O	856	864	reviewed
O	865	869	this
O	870	875	using
O	876	877	e
O	877	878	-
O	878	882	mail
O	882	883	,
O	884	887	and
O	888	889	a
O	890	898	modified
O	899	905	Delphi
O	906	912	system
O	913	916	was
O	917	921	used
O	922	924	to
O	925	933	stratify
O	934	943	responses
O	943	944	.

O	945	947	At
O	948	949	a
O	950	955	later
O	956	964	workshop
O	964	965	,
O	966	974	separate
O	975	982	systems
O	983	986	for
B-Disease	987	995	diabetic
I-Disease	996	1007	retinopathy
O	1008	1011	and
B-Disease	1012	1019	macular
I-Disease	1020	1025	edema
O	1026	1030	were
O	1031	1040	developed
O	1040	1041	.

O	1042	1047	These
O	1048	1052	were
O	1053	1057	then
O	1058	1069	reevaluated
O	1070	1072	by
O	1073	1078	group
O	1079	1086	members
O	1086	1087	,
O	1088	1091	and
O	1092	1095	the
O	1096	1104	modified
O	1105	1111	Delphi
O	1112	1118	system
O	1119	1122	was
O	1123	1128	again
O	1129	1133	used
O	1134	1136	to
O	1137	1144	measure
O	1145	1152	degrees
O	1153	1155	of
O	1156	1165	agreement
O	1165	1166	.

O	1167	1176	Consensus
O	1177	1186	regarding
O	1187	1195	specific
O	1196	1210	classification
O	1211	1218	systems
O	1219	1222	was
O	1223	1231	achieved
O	1231	1232	.

O	1233	1234	A
O	1235	1239	five
O	1239	1240	-
O	1240	1245	stage
O	1246	1253	disease
O	1254	1262	severity
O	1263	1277	classification
O	1278	1281	for
B-Disease	1282	1290	diabetic
I-Disease	1291	1302	retinopathy
O	1303	1311	includes
B-Characteristic	1312	1317	three
I-Characteristic	1318	1324	stages
I-Characteristic	1325	1327	of
I-Characteristic	1328	1331	low
I-Characteristic	1332	1336	risk
O	1336	1337	,
O	1338	1339	a
O	1340	1346	fourth
O	1347	1352	stage
O	1353	1355	of
B-Disease	1356	1362	severe
I-Disease	1363	1379	nonproliferative
I-Disease	1380	1391	retinopathy
O	1391	1392	,
O	1393	1396	and
O	1397	1398	a
O	1399	1404	fifth
O	1405	1410	stage
O	1411	1413	of
B-Disease	1414	1427	proliferative
I-Disease	1428	1439	retinopathy
O	1439	1440	.

B-Disease	1441	1449	Diabetic
I-Disease	1450	1457	macular
I-Disease	1458	1463	edema
O	1464	1466	is
O	1467	1477	classified
O	1478	1480	as
O	1481	1491	apparently
O	1492	1499	present
O	1500	1502	or
O	1503	1513	apparently
O	1514	1520	absent
O	1520	1521	.

O	1522	1524	If
O	1525	1533	training
O	1534	1537	and
O	1538	1547	equipment
O	1548	1553	allow
O	1554	1557	the
O	1558	1566	screener
O	1567	1569	to
O	1570	1574	make
O	1575	1576	a
O	1577	1582	valid
O	1583	1591	decision
O	1591	1592	,
B-Disease	1593	1600	macular
I-Disease	1601	1606	edema
O	1607	1609	is
O	1610	1617	further
O	1618	1629	categorized
O	1630	1632	as
O	1633	1634	a
O	1635	1643	function
O	1644	1646	of
O	1647	1650	its
B-Anatomy	1651	1659	distance
I-Anatomy	1660	1664	from
I-Anatomy	1665	1668	the
I-Anatomy	1669	1676	central
I-Anatomy	1677	1683	macula
O	1683	1684	.

O	1685	1690	There
O	1691	1696	seems
O	1697	1699	to
O	1700	1702	be
O	1703	1704	a
O	1705	1712	genuine
O	1713	1717	need
O	1718	1721	for
O	1722	1732	consistent
O	1733	1746	international
O	1747	1755	clinical
O	1756	1770	classification
O	1771	1778	systems
O	1779	1782	for
B-Disease	1783	1791	diabetic
I-Disease	1792	1803	retinopathy
O	1804	1807	and
B-Disease	1808	1816	diabetic
I-Disease	1817	1824	macular
I-Disease	1825	1830	edema
O	1831	1835	that
O	1836	1839	are
O	1840	1849	supported
O	1850	1854	with
O	1855	1860	solid
O	1861	1869	evidence
O	1869	1870	.

O	1871	1874	The
O	1875	1883	proposed
O	1884	1892	clinical
O	1893	1907	classification
O	1908	1915	systems
O	1916	1923	provide
O	1924	1925	a
O	1926	1931	means
O	1932	1934	of
O	1935	1948	appropriately
O	1949	1961	categorizing
B-Disease	1962	1970	diabetic
I-Disease	1971	1982	retinopathy
O	1983	1986	and
B-Disease	1987	1994	macular
I-Disease	1995	2000	edema
O	2000	2001	.

O	2002	2004	It
O	2005	2007	is
O	2008	2013	hoped
O	2014	2018	that
O	2019	2024	these
O	2025	2032	systems
O	2033	2037	will
O	2038	2040	be
O	2041	2049	valuable
O	2050	2052	in
O	2053	2062	improving
O	2063	2067	both
O	2068	2077	screening
O	2078	2080	of
O	2081	2092	individuals
O	2093	2097	with
B-Disease	2098	2106	diabetes
O	2107	2110	and
O	2111	2124	communication
O	2125	2128	and
O	2129	2139	discussion
O	2140	2145	among
O	2146	2157	individuals
O	2158	2164	caring
O	2165	2168	for
O	2169	2174	these
O	2175	2183	patients
O	2183	2184	.

O	0	6	Trypan
O	7	11	blue
O	12	20	staining
O	21	23	in
O	24	37	vitreoretinal
O	38	45	surgery
O	45	46	.

O	48	50	To
O	51	59	evaluate
O	60	63	the
O	64	72	efficacy
O	73	75	of
O	76	82	trypan
O	83	87	blue
O	88	91	for
O	92	100	staining
O	101	104	the
B-Anatomy	105	113	internal
I-Anatomy	114	122	limiting
I-Anatomy	123	131	membrane
O	132	133	(
B-Anatomy	133	136	ILM
O	136	137	)
O	138	141	and
B-Symptom	142	152	epiretinal
I-Symptom	153	162	membranes
O	163	164	(
B-Symptom	164	167	ERM
O	167	168	)
O	169	171	in
O	172	185	vitreoretinal
O	186	193	surgery
O	193	194	.

O	195	206	Prospective
O	207	221	noncomparative
O	222	226	case
O	227	233	series
O	233	234	.

O	235	240	Fifty
B-Anatomy	241	245	eyes
O	246	248	of
O	249	251	50
O	252	260	patients
O	261	265	with
B-Symptom	266	273	macular
I-Symptom	274	280	pucker
O	281	282	(
O	282	283	n
O	284	285	=
O	286	288	22
O	288	289	)
O	289	290	,
B-Symptom	291	298	macular
I-Symptom	299	303	hole
O	304	305	(
O	305	306	n
O	307	308	=
O	309	311	18
O	311	312	)
O	312	313	,
O	314	316	or
O	317	318	a
O	319	330	combination
O	331	332	(
O	332	333	n
O	334	335	=
O	336	337	2
O	337	338	)
O	338	339	,
B-Disease	340	353	proliferative
I-Disease	354	371	vitreoretinopathy
O	372	373	(
O	373	374	n
O	375	376	=
O	377	378	5
O	378	379	)
O	379	380	,
O	381	383	or
B-Disease	384	392	diabetic
I-Disease	393	404	retinopathy
O	405	406	(
O	406	407	n
O	408	409	=
O	410	411	3
O	411	412	)
O	412	413	.

O	414	420	Trypan
O	421	425	blue
O	426	427	0
O	427	428	.
O	428	429	2
O	429	430	%
O	431	434	was
O	435	439	used
O	440	442	to
O	443	448	stain
O	449	452	the
B-Anatomy	453	456	ILM
O	457	459	or
B-Symptom	460	463	ERM
O	464	470	during
O	471	484	vitreoretinal
O	485	492	surgery
O	492	493	.

O	494	497	The
O	498	512	intraoperative
O	513	523	visibility
O	524	526	of
O	527	530	the
O	531	540	membranes
O	541	544	was
O	545	551	scored
O	552	554	as
O	555	559	poor
O	559	560	,
O	561	569	moderate
O	569	570	,
O	571	575	good
O	575	576	,
O	577	579	or
O	580	589	excellent
O	589	590	.

O	591	594	The
O	595	606	application
O	607	609	of
O	610	616	trypan
O	617	621	blue
O	622	626	onto
O	627	630	the
B-Anatomy	631	634	ILM
O	635	637	or
O	638	641	the
B-Symptom	642	645	ERM
O	646	654	resulted
O	655	657	in
O	658	659	a
O	660	666	useful
O	667	673	bluish
O	674	682	staining
O	682	683	,
O	684	696	facilitating
O	697	700	the
O	701	715	identification
O	715	716	,
O	717	728	delineation
O	728	729	,
O	730	733	and
O	734	741	removal
O	742	744	of
O	745	748	the
O	749	758	membranes
O	759	761	in
O	762	765	all
O	766	775	surgeries
O	775	776	.

O	777	779	No
O	780	788	residual
O	789	797	staining
O	798	800	or
O	801	808	adverse
O	809	816	effects
O	817	824	related
O	825	827	to
O	828	831	the
O	832	835	dye
O	836	840	were
O	841	849	observed
O	849	850	.

O	851	857	Trypan
O	858	862	blue
O	863	869	stains
O	870	874	both
B-Anatomy	875	878	ILM
O	879	882	and
B-Symptom	883	886	ERM
O	887	890	and
O	891	896	might
O	897	899	be
O	900	902	an
O	903	909	useful
O	910	914	tool
O	915	917	in
O	918	931	vitreoretinal
O	932	939	surgery
O	939	940	.

O	0	4	What
O	5	7	is
O	8	12	lost
O	13	15	by
B-Diagnostic_tool	16	26	digitizing
I-Diagnostic_tool	27	39	stereoscopic
I-Diagnostic_tool	40	46	fundus
I-Diagnostic_tool	47	52	color
I-Diagnostic_tool	53	59	slides
O	60	63	for
B-Anatomy	64	71	macular
O	72	79	grading
O	80	82	in
B-Disease	83	86	age
I-Disease	86	87	-
I-Disease	87	94	related
I-Disease	95	106	maculopathy
I-Disease	107	110	and
I-Disease	111	123	degeneration
O	123	124	?

O	126	128	To
O	129	136	compare
B-Diagnostic_tool	137	139	35
I-Diagnostic_tool	139	140	-
I-Diagnostic_tool	140	142	mm
I-Diagnostic_tool	143	155	stereoscopic
I-Diagnostic_tool	156	161	slide
I-Diagnostic_tool	162	176	transparencies
O	177	181	with
B-Diagnostic_tool	182	191	digitized
I-Diagnostic_tool	192	207	nonstereoscopic
I-Diagnostic_tool	208	214	images
O	215	216	(
O	216	226	resolution
O	227	235	1024x768
O	236	242	pixels
O	242	243	)
O	244	247	for
O	248	255	grading
O	256	269	abnormalities
O	270	272	in
B-Disease	273	276	age
I-Disease	276	277	-
I-Disease	277	284	related
I-Disease	285	296	maculopathy
O	297	298	(
B-Disease	298	301	ARM
O	301	302	)
O	303	306	and
B-Disease	307	310	age
I-Disease	310	311	-
I-Disease	311	318	related
I-Disease	319	326	macular
I-Disease	327	339	degeneration
O	340	341	(
B-Disease	341	344	AMD
O	344	345	)
O	345	346	.

O	347	358	Comparative
O	359	372	observational
O	373	377	case
O	378	384	series
O	384	385	.

O	386	392	Twenty
O	392	393	-
O	393	397	five
O	398	406	patients
O	407	408	(
O	408	410	50
B-Anatomy	411	415	eyes
O	415	416	)
O	417	421	with
B-Disease	422	425	ARM
O	426	429	and
O	429	430	/
O	430	432	or
B-Disease	433	436	AMD
O	436	437	.

O	438	444	Twenty
O	444	445	-
O	445	449	five
O	450	458	patients
O	459	463	with
B-Disease	464	467	ARM
O	467	468	/
B-Disease	468	471	AMD
O	472	474	in
O	475	477	at
O	478	483	least
O	484	485	1
B-Anatomy	486	489	eye
O	490	494	were
O	495	503	randomly
O	504	512	selected
O	513	517	from
O	518	519	a
O	520	525	large
O	526	533	ongoing
O	534	544	collection
O	545	547	of
O	548	556	clinical
O	557	561	data
O	562	565	and
O	566	569	DNA
O	570	572	in
O	573	574	a
O	575	583	tertiary
O	584	592	referral
B-Characteristic	593	599	United
I-Characteristic	600	607	Kingdom
O	608	618	population
O	618	619	.

B-Diagnostic_tool	620	627	Retinal
I-Diagnostic_tool	628	639	photography
O	640	643	was
O	644	653	performed
O	654	658	with
B-Symptom	659	668	mydriasis
O	669	674	using
O	675	678	the
B-Diagnostic_tool	679	684	Zeiss
I-Diagnostic_tool	685	687	FF
I-Diagnostic_tool	687	688	-
I-Diagnostic_tool	688	694	series
I-Diagnostic_tool	695	697	30
I-Diagnostic_tool	698	705	degrees
I-Diagnostic_tool	706	712	fundus
I-Diagnostic_tool	713	719	camera
O	720	722	on
B-Diagnostic_tool	723	733	Ektachrome
I-Diagnostic_tool	734	739	slide
I-Diagnostic_tool	740	752	transparency
I-Diagnostic_tool	753	757	film
O	757	758	.

O	759	762	The
O	763	769	images
O	770	774	were
O	775	783	centered
O	784	786	on
O	787	790	the
B-Anatomy	791	797	macula
O	797	798	.

O	799	802	The
B-Diagnostic_tool	803	808	color
I-Diagnostic_tool	809	823	transparencies
O	824	828	were
O	829	833	then
O	834	843	digitized
O	843	844	.

O	845	848	The
O	849	856	grading
O	857	864	process
O	865	868	has
O	869	873	been
O	874	877	set
O	878	880	up
O	881	886	based
O	887	889	on
O	890	893	the
B-Classification_system	894	907	International
I-Classification_system	908	911	ARM
I-Classification_system	912	924	Epidemiology
I-Classification_system	925	930	Study
I-Classification_system	931	936	Group
O	936	937	.

O	938	941	All
O	942	948	images
O	949	953	were
O	954	967	independently
O	968	974	graded
O	975	977	by
O	978	979	3
B-Anatomy	980	987	retinal
O	988	999	specialists
O	999	1000	.

O	1001	1005	Both
O	1006	1011	kappa
O	1012	1022	statistics
O	1023	1026	and
O	1027	1032	exact
O	1033	1042	agreement
O	1043	1047	were
O	1048	1058	calculated
O	1059	1061	to
O	1062	1068	assess
O	1069	1078	agreement
O	1079	1086	between
O	1087	1090	and
O	1091	1097	within
O	1098	1107	observers
O	1108	1111	and
O	1112	1119	between
O	1120	1123	the
O	1124	1125	2
O	1126	1132	master
O	1133	1139	copies
O	1140	1147	derived
O	1148	1152	from
O	1153	1156	the
O	1157	1165	gradings
O	1166	1168	of
O	1169	1172	the
B-Diagnostic_tool	1173	1178	color
I-Diagnostic_tool	1179	1185	slides
O	1186	1189	and
B-Diagnostic_tool	1190	1199	digitized
I-Diagnostic_tool	1200	1206	images
O	1206	1207	.

O	1208	1217	Agreement
O	1218	1225	between
O	1226	1229	the
O	1230	1231	2
O	1232	1238	master
O	1239	1245	copies
O	1246	1253	derived
O	1254	1258	from
O	1259	1262	the
O	1263	1271	gradings
O	1272	1280	obtained
O	1281	1285	from
B-Diagnostic_tool	1286	1298	stereoscopic
I-Diagnostic_tool	1299	1304	slide
I-Diagnostic_tool	1305	1319	transparencies
O	1320	1323	and
B-Diagnostic_tool	1324	1333	digitized
I-Diagnostic_tool	1334	1349	nonstereoscopic
I-Diagnostic_tool	1350	1356	images
O	1356	1357	.

O	1358	1361	For
B-Symptom	1362	1367	small
I-Symptom	1368	1372	hard
I-Symptom	1373	1376	and
I-Symptom	1377	1389	intermediate
I-Symptom	1390	1394	soft
I-Symptom	1395	1401	drusen
O	1401	1402	,
O	1403	1412	agreement
O	1413	1419	ranged
O	1420	1427	between
O	1428	1430	77
O	1430	1431	%
O	1432	1435	and
O	1436	1438	91
O	1438	1439	%
O	1440	1441	(
O	1441	1446	kappa
O	1446	1447	,
O	1448	1449	0
O	1449	1450	.
O	1450	1452	56
O	1452	1453	-
O	1453	1454	0
O	1454	1455	.
O	1455	1457	72
O	1457	1458	)
O	1459	1462	and
O	1463	1465	83
O	1465	1466	%
O	1467	1470	and
O	1471	1473	93
O	1473	1474	%
O	1475	1476	(
O	1476	1481	kappa
O	1481	1482	,
O	1483	1484	0
O	1484	1485	.
O	1485	1487	31
O	1487	1488	-
O	1488	1489	0
O	1489	1490	.
O	1490	1492	64
O	1492	1493	)
O	1493	1494	,
O	1495	1507	respectively
O	1507	1508	,
O	1509	1512	for
O	1513	1516	the
B-Anatomy	1517	1518	3
I-Anatomy	1519	1526	macular
I-Anatomy	1527	1536	subfields
O	1536	1537	.

O	1538	1547	Agreement
O	1548	1551	for
O	1552	1555	the
O	1556	1564	presence
O	1565	1567	of
B-Symptom	1568	1585	hyperpigmentation
O	1586	1589	was
O	1590	1592	12
O	1592	1593	%
O	1594	1596	to
O	1597	1599	56
O	1599	1600	%
O	1601	1602	(
O	1602	1607	kappa
O	1607	1608	,
O	1609	1610	0
O	1610	1611	.
O	1611	1613	00
O	1613	1614	-
O	1614	1615	0
O	1615	1616	.
O	1616	1618	27
O	1618	1619	)
O	1619	1620	.

O	1621	1630	Agreement
O	1631	1634	was
O	1635	1637	94
O	1637	1638	%
O	1639	1641	to
O	1642	1644	96
O	1644	1645	%
O	1646	1647	(
O	1647	1652	kappa
O	1652	1653	,
O	1654	1655	0
O	1655	1656	.
O	1656	1658	80
O	1658	1659	-
O	1659	1660	0
O	1660	1661	.
O	1661	1663	82
O	1663	1664	)
O	1665	1668	for
O	1669	1672	the
O	1673	1681	presence
O	1682	1684	of
B-Symptom	1685	1695	geographic
I-Symptom	1696	1703	atrophy
O	1704	1707	and
O	1708	1710	93
O	1710	1711	%
O	1712	1713	(
O	1713	1718	kappa
O	1718	1719	,
O	1720	1721	0
O	1721	1722	.
O	1722	1724	78
O	1724	1725	)
O	1726	1729	for
O	1730	1733	the
O	1734	1738	area
O	1739	1746	covered
O	1746	1747	.

O	1748	1751	For
O	1752	1755	the
O	1756	1764	presence
O	1765	1767	of
B-Symptom	1768	1777	choroidal
I-Symptom	1778	1796	neovascularization
O	1797	1798	(
B-Symptom	1798	1801	CNV
O	1801	1802	)
O	1802	1803	,
O	1804	1813	agreement
O	1814	1817	was
O	1818	1820	94
O	1820	1821	%
O	1822	1824	to
O	1825	1827	98
O	1827	1828	%
O	1829	1830	(
O	1830	1835	kappa
O	1835	1836	,
O	1837	1838	0
O	1838	1839	.
O	1839	1841	81
O	1841	1842	-
O	1842	1843	0
O	1843	1844	.
O	1844	1846	88
O	1846	1847	)
O	1847	1848	,
O	1849	1852	and
O	1853	1855	it
O	1856	1859	was
O	1860	1862	95
O	1862	1863	%
O	1864	1865	(
O	1865	1870	kappa
O	1870	1871	,
O	1872	1873	0
O	1873	1874	.
O	1874	1876	83
O	1876	1877	)
O	1878	1881	for
O	1882	1885	the
O	1886	1890	area
O	1891	1898	covered
O	1898	1899	.

O	1900	1903	For
O	1904	1914	individual
O	1915	1923	features
O	1924	1926	of
B-Symptom	1927	1930	CNV
O	1930	1931	,
O	1932	1937	exact
O	1938	1947	agreement
O	1948	1951	was
O	1952	1954	88
O	1954	1955	%
O	1956	1958	to
O	1959	1961	96
O	1961	1962	%
O	1963	1964	(
O	1964	1969	kappa
O	1969	1970	,
O	1971	1972	0
O	1972	1973	.
O	1973	1975	22
O	1975	1976	-
O	1976	1977	0
O	1977	1978	.
O	1978	1980	49
O	1980	1981	)
O	1981	1982	.

O	1983	1985	In
O	1986	1987	3
O	1988	1993	cases
O	1994	1996	of
B-Symptom	1997	2007	geographic
I-Symptom	2008	2015	atrophy
O	2016	2019	and
O	2020	2021	2
O	2022	2027	cases
O	2028	2030	of
B-Symptom	2031	2034	CNV
O	2034	2035	,
O	2036	2039	the
O	2040	2046	lesion
O	2047	2050	was
O	2051	2057	missed
O	2058	2060	on
B-Diagnostic_tool	2061	2070	digitized
I-Diagnostic_tool	2071	2077	images
O	2077	2078	.

O	2079	2086	Because
O	2087	2089	of
O	2090	2093	the
O	2094	2099	close
O	2100	2109	agreement
O	2110	2113	for
O	2114	2118	most
O	2119	2129	categories
O	2130	2137	between
O	2138	2141	the
O	2142	2149	grading
O	2150	2152	of
B-Diagnostic_tool	2153	2165	stereoscopic
I-Diagnostic_tool	2166	2171	color
I-Diagnostic_tool	2172	2178	slides
O	2179	2182	and
B-Diagnostic_tool	2183	2192	digitized
I-Diagnostic_tool	2193	2199	images
O	2199	2200	,
B-Diagnostic_tool	2201	2210	digitized
I-Diagnostic_tool	2211	2226	nonstereoscopic
I-Diagnostic_tool	2227	2232	color
I-Diagnostic_tool	2233	2239	images
O	2240	2245	prove
O	2246	2248	to
O	2249	2251	be
O	2252	2258	useful
O	2259	2262	for
O	2263	2270	grading
B-Disease	2271	2274	ARM
O	2275	2278	and
B-Disease	2279	2282	AMD
O	2282	2283	.

O	0	14	Ophthalmologic
O	15	25	assessment
O	26	28	of
B-Characteristic	29	34	young
I-Characteristic	35	43	patients
O	44	48	with
B-Disease	49	55	Alport
I-Disease	56	64	syndrome
O	64	65	.

B-Disease	67	73	Alport
I-Disease	74	82	syndrome
O	83	85	is
O	86	88	an
B-Disease	89	90	X
I-Disease	90	91	-
I-Disease	91	97	linked
I-Disease	98	105	disease
O	106	115	affecting
B-Anatomy	116	124	basement
I-Anatomy	125	133	membrane
I-Anatomy	134	142	collagen
O	142	143	.

O	144	146	It
O	147	149	is
O	150	163	characterized
O	164	166	by
B-Disease	167	176	nephritis
O	177	187	associated
O	188	192	with
B-Symptom	193	197	high
I-Symptom	197	198	-
I-Symptom	198	202	tone
I-Symptom	203	216	sensorineural
I-Symptom	217	224	hearing
I-Symptom	225	235	impairment
O	236	239	and
B-Symptom	240	250	ophthalmic
I-Symptom	251	256	signs
O	256	257	.

O	258	266	Although
B-Symptom	267	273	ocular
I-Symptom	274	281	changes
O	282	286	have
O	287	291	been
O	292	301	described
O	302	304	in
B-Characteristic	305	311	adults
O	311	312	,
O	313	316	few
O	317	321	data
O	322	327	exist
O	328	337	regarding
O	338	341	the
O	342	351	incidence
O	352	354	of
B-Symptom	355	363	abnormal
I-Symptom	364	370	ocular
I-Symptom	371	379	features
O	380	382	in
B-Characteristic	383	394	adolescence
O	395	398	and
B-Characteristic	399	408	childhood
O	408	409	.

O	410	417	Fifteen
O	418	422	male
O	423	426	and
O	427	431	five
O	432	438	female
O	439	447	patients
O	448	452	with
B-Disease	453	459	Alport
I-Disease	460	468	syndrome
O	469	478	underwent
B-Diagnostic_tool	479	493	ophthalmologic
I-Diagnostic_tool	493	494	,
I-Diagnostic_tool	495	505	audiologic
I-Diagnostic_tool	505	506	,
I-Diagnostic_tool	507	510	and
I-Diagnostic_tool	511	522	nephrologic
I-Diagnostic_tool	523	534	assessments
O	534	535	.

O	536	539	All
O	540	548	patients
O	549	556	studied
O	557	560	had
B-Symptom	561	570	hematuria
O	571	574	and
O	575	576	a
O	577	585	positive
O	586	592	family
O	593	600	history
O	601	603	of
B-Disease	604	610	Alport
I-Disease	611	619	syndrome
O	619	620	.

O	621	629	Thirteen
O	630	638	patients
O	639	642	had
O	643	644	a
B-Diagnostic_tool	645	650	renal
I-Diagnostic_tool	651	657	biopsy
O	658	662	that
O	663	669	showed
O	670	684	characteristic
O	685	693	electron
O	694	705	microscopic
O	706	713	changes
O	714	716	of
O	717	720	the
O	721	728	disease
O	728	729	.

O	730	736	Eleven
O	737	745	patients
O	746	749	had
B-Symptom	750	754	high
I-Symptom	754	755	-
I-Symptom	755	759	tone
I-Symptom	760	773	sensorineural
I-Symptom	774	784	impairment
O	784	785	.

B-Diagnostic_tool	786	804	Electrophysiologic
I-Diagnostic_tool	805	819	investigations
O	820	829	performed
O	830	838	included
B-Diagnostic_tool	839	858	electroretinography
O	858	859	,
B-Diagnostic_tool	860	866	visual
I-Diagnostic_tool	866	867	-
I-Diagnostic_tool	867	873	evoked
I-Diagnostic_tool	874	884	potentials
O	884	885	,
O	886	889	and
B-Diagnostic_tool	890	897	electro
I-Diagnostic_tool	897	898	-
I-Diagnostic_tool	898	909	oculography
O	909	910	.

O	911	914	Two
O	915	923	patients
O	924	927	had
O	928	933	early
O	934	939	signs
O	940	942	of
B-Symptom	943	951	anterior
I-Symptom	952	962	lenticonus
O	962	963	,
O	964	969	three
O	970	973	had
B-Symptom	974	980	flecks
I-Symptom	981	983	in
I-Symptom	984	987	the
I-Symptom	988	994	retina
O	994	995	,
O	996	999	and
O	1000	1003	two
O	1004	1012	patients
O	1013	1017	also
O	1018	1021	had
B-Disease	1022	1031	posterior
I-Disease	1032	1043	subcapsular
I-Disease	1044	1053	cataracts
O	1053	1054	.

O	1055	1059	None
O	1060	1062	of
O	1063	1066	the
O	1067	1075	patients
O	1076	1079	had
O	1080	1091	significant
B-Symptom	1092	1110	electrophysiologic
I-Symptom	1111	1124	abnormalities
O	1124	1125	.

O	1126	1131	These
O	1132	1140	findings
O	1141	1149	indicate
O	1150	1154	that
B-Symptom	1155	1161	ocular
I-Symptom	1162	1169	changes
O	1170	1173	are
O	1174	1182	uncommon
O	1183	1186	and
O	1187	1193	subtle
O	1194	1196	in
B-Characteristic	1197	1202	young
O	1203	1211	patients
O	1212	1216	with
B-Disease	1217	1223	Alport
I-Disease	1224	1232	syndrome
O	1232	1233	,
O	1234	1237	and
O	1238	1245	suggest
O	1246	1250	that
O	1251	1254	the
O	1255	1260	signs
O	1261	1269	increase
O	1270	1272	in
O	1273	1282	frequency
O	1283	1286	and
O	1287	1295	severity
O	1296	1300	with
B-Characteristic	1301	1304	age
O	1304	1305	.

O	0	8	Variable
B-Anatomy	9	16	corneal
O	17	29	compensation
O	30	38	improves
O	39	53	discrimination
O	54	61	between
O	62	68	normal
O	69	72	and
B-Disease	73	85	glaucomatous
B-Anatomy	86	90	eyes
O	91	95	with
O	96	99	the
B-Diagnostic_tool	100	108	scanning
I-Diagnostic_tool	109	114	laser
I-Diagnostic_tool	115	126	polarimeter
O	126	127	.

O	129	132	The
O	133	142	presently
O	143	152	available
B-Diagnostic_tool	153	161	scanning
I-Diagnostic_tool	162	167	laser
I-Diagnostic_tool	168	179	polarimeter
O	180	181	(
B-Diagnostic_tool	181	184	SLP
O	184	185	)
O	186	189	has
O	190	191	a
O	192	197	fixed
B-Anatomy	198	205	corneal
O	206	217	compensator
O	218	219	(
O	219	222	FCC
O	222	223	)
O	224	228	that
O	229	240	neutralizes
B-Characteristic	241	248	corneal
I-Characteristic	249	262	birefringence
O	263	267	only
O	268	270	in
B-Anatomy	271	275	eyes
O	276	280	with
B-Characteristic	281	294	birefringence
O	295	299	that
O	300	307	matches
O	308	311	the
O	312	322	population
O	323	327	mode
O	327	328	.

O	329	330	A
O	331	340	prototype
O	341	349	variable
B-Anatomy	350	357	corneal
O	358	369	compensator
O	370	371	(
O	371	374	VCC
O	374	375	)
O	376	384	provides
O	385	399	neutralization
O	400	402	of
O	403	413	individual
B-Characteristic	414	421	corneal
I-Characteristic	422	435	birefringence
O	436	441	based
O	442	444	on
O	445	455	individual
B-Anatomy	456	463	macular
O	464	475	retardation
O	476	484	patterns
O	484	485	.

O	486	489	The
O	490	493	aim
O	494	496	of
O	497	501	this
O	502	507	study
O	508	511	was
O	512	514	to
O	515	523	evaluate
O	524	527	the
O	528	536	relative
O	537	544	ability
O	545	547	of
O	548	551	the
B-Diagnostic_tool	552	555	SLP
O	556	560	with
O	561	564	the
O	565	568	FCC
O	569	572	and
O	573	577	with
O	578	581	the
O	582	585	VCC
O	586	588	to
O	589	601	discriminate
O	602	609	between
O	610	616	normal
O	617	620	and
B-Disease	621	633	glaucomatous
B-Anatomy	634	638	eyes
O	638	639	.

O	640	651	Prospective
O	651	652	,
O	653	666	nonrandomized
O	666	667	,
O	668	679	comparative
O	680	684	case
O	685	691	series
O	691	692	.

O	693	702	Algorithm
O	702	703	-
O	703	713	generating
O	714	717	set
O	718	728	consisting
O	729	731	of
O	732	734	56
O	735	741	normal
B-Anatomy	742	746	eyes
O	747	750	and
O	751	753	55
B-Disease	754	766	glaucomatous
B-Anatomy	767	771	eyes
O	772	775	and
O	776	778	an
O	779	790	independent
O	791	795	data
O	796	799	set
O	800	810	consisting
O	811	813	of
O	814	816	83
O	817	823	normal
B-Anatomy	824	828	eyes
O	829	832	and
O	833	835	56
B-Disease	836	848	glaucomatous
B-Anatomy	849	853	eyes
O	853	854	.

O	855	862	Sixteen
O	863	874	retardation
O	875	887	measurements
O	888	892	were
O	893	901	obtained
O	902	906	with
O	907	910	the
B-Diagnostic_tool	911	914	SLP
O	915	919	with
O	920	923	the
O	924	927	FCC
O	928	931	and
O	932	935	the
O	936	939	VCC
O	940	944	from
O	945	948	all
O	949	957	subjects
O	957	958	.

O	959	969	Dependency
O	970	972	of
O	973	983	parameters
O	984	986	on
B-Characteristic	987	990	age
O	990	991	,
B-Characteristic	992	998	gender
O	998	999	,
B-Characteristic	1000	1006	ethnic
I-Characteristic	1007	1013	origin
O	1013	1014	,
O	1015	1018	and
B-Characteristic	1019	1022	eye
I-Characteristic	1023	1027	side
O	1028	1031	was
O	1032	1038	sought
O	1038	1039	.

O	1040	1048	Logistic
O	1049	1059	regression
O	1060	1063	was
O	1064	1068	used
O	1069	1071	to
O	1072	1080	evaluate
O	1081	1084	how
O	1085	1089	well
O	1090	1093	the
O	1094	1101	various
O	1102	1112	parameters
O	1113	1118	could
O	1119	1125	detect
B-Disease	1126	1134	glaucoma
O	1134	1135	.

O	1136	1148	Discriminant
O	1149	1158	functions
O	1159	1163	were
O	1164	1173	generated
O	1173	1174	,
O	1175	1178	and
O	1179	1182	the
O	1183	1187	area
O	1188	1193	under
O	1194	1197	the
O	1198	1206	receiver
O	1207	1216	operating
O	1217	1231	characteristic
O	1232	1233	(
O	1233	1236	ROC
O	1236	1237	)
O	1238	1243	curve
O	1244	1247	was
O	1248	1258	determined
O	1258	1259	.

O	1260	1274	Discrimination
O	1275	1282	between
O	1283	1289	normal
O	1290	1293	and
B-Disease	1294	1306	glaucomatous
B-Anatomy	1307	1311	eyes
O	1312	1314	on
O	1315	1318	the
O	1319	1324	basis
O	1325	1327	of
O	1328	1334	single
O	1335	1345	parameters
O	1346	1349	was
O	1350	1363	significantly
O	1364	1370	better
O	1371	1375	with
O	1376	1379	the
O	1380	1383	VCC
O	1384	1388	than
O	1389	1393	with
O	1394	1397	the
O	1398	1401	FCC
O	1402	1405	for
O	1406	1407	6
O	1408	1419	retardation
O	1420	1430	parameters
O	1430	1431	:
O	1432	1437	nasal
O	1438	1445	average
O	1446	1447	(
O	1447	1448	P
O	1449	1450	=
O	1451	1452	0
O	1452	1453	.
O	1453	1457	0003
O	1457	1458	)
O	1458	1459	,
O	1460	1468	superior
O	1469	1476	maximum
O	1477	1478	(
O	1478	1479	P
O	1480	1481	=
O	1482	1483	0
O	1483	1484	.
O	1484	1488	0003
O	1488	1489	)
O	1489	1490	,
O	1491	1498	ellipse
O	1499	1506	average
O	1507	1508	(
O	1508	1509	P
O	1510	1511	=
O	1512	1513	0
O	1513	1514	.
O	1514	1517	002
O	1517	1518	)
O	1518	1519	,
O	1520	1527	average
O	1528	1537	thickness
O	1538	1539	(
O	1539	1540	P
O	1541	1542	=
O	1543	1544	0
O	1544	1545	.
O	1545	1548	003
O	1548	1549	)
O	1549	1550	,
O	1551	1559	superior
O	1560	1567	average
O	1568	1569	(
O	1569	1570	P
O	1571	1572	=
O	1573	1574	0
O	1574	1575	.
O	1575	1578	010
O	1578	1579	)
O	1579	1580	,
O	1581	1584	and
O	1585	1593	inferior
O	1594	1601	average
O	1602	1603	(
O	1603	1604	P
O	1605	1606	=
O	1607	1608	0
O	1608	1609	.
O	1609	1612	010
O	1612	1613	)
O	1613	1614	.

O	1615	1627	Discriminant
O	1628	1636	analysis
O	1637	1647	identified
O	1648	1651	the
O	1652	1659	optimal
O	1660	1671	combination
O	1672	1674	of
O	1675	1685	parameters
O	1686	1689	for
O	1690	1693	the
O	1694	1697	FCC
O	1698	1701	and
O	1702	1705	for
O	1706	1709	the
O	1710	1713	VCC
O	1713	1714	.

O	1715	1719	When
O	1720	1723	the
O	1724	1736	discriminant
O	1737	1746	functions
O	1747	1751	were
O	1752	1759	applied
O	1760	1762	to
O	1763	1766	the
O	1767	1778	independent
O	1779	1783	data
O	1784	1787	set
O	1787	1788	,
O	1789	1794	areas
O	1795	1800	under
O	1801	1804	the
O	1805	1808	ROC
O	1809	1814	curve
O	1815	1819	were
O	1820	1821	0
O	1821	1822	.
O	1822	1824	84
O	1825	1828	for
O	1829	1832	the
O	1833	1836	FCC
O	1837	1840	and
O	1841	1842	0
O	1842	1843	.
O	1843	1845	90
O	1846	1849	for
O	1850	1853	the
O	1854	1857	VCC
O	1858	1859	(
O	1859	1860	P
O	1861	1862	<
O	1863	1864	0
O	1864	1865	.
O	1865	1868	021
O	1868	1869	)
O	1869	1870	.

O	1871	1875	When
O	1876	1879	the
O	1880	1892	discriminant
O	1893	1902	functions
O	1903	1907	were
O	1908	1915	applied
O	1916	1918	to
O	1919	1920	a
O	1921	1927	subset
O	1928	1930	of
O	1931	1939	patients
O	1940	1944	with
O	1945	1950	early
B-Symptom	1951	1957	visual
I-Symptom	1958	1963	field
I-Symptom	1964	1968	loss
O	1968	1969	,
O	1970	1975	areas
O	1976	1981	under
O	1982	1985	the
O	1986	1989	ROC
O	1990	1995	curve
O	1996	2000	were
O	2001	2002	0
O	2002	2003	.
O	2003	2005	82
O	2006	2009	for
O	2010	2013	the
O	2014	2017	FCC
O	2018	2021	and
O	2022	2023	0
O	2023	2024	.
O	2024	2026	90
O	2027	2030	for
O	2031	2034	the
O	2035	2038	VCC
O	2039	2040	(
O	2040	2041	P
O	2042	2043	<
O	2044	2045	0
O	2045	2046	.
O	2046	2049	016
O	2049	2050	)
O	2050	2051	.

O	2052	2062	Individual
O	2063	2073	correction
O	2074	2077	for
B-Characteristic	2078	2085	corneal
I-Characteristic	2086	2099	birefringence
O	2100	2104	with
O	2105	2108	the
O	2109	2112	VCC
O	2113	2126	significantly
O	2127	2135	improved
O	2136	2139	the
O	2140	2147	ability
O	2148	2150	of
O	2151	2154	the
B-Diagnostic_tool	2155	2158	SLP
O	2159	2161	to
O	2162	2173	distinguish
O	2174	2181	between
O	2182	2188	normal
O	2189	2192	and
B-Disease	2193	2205	glaucomatous
B-Anatomy	2206	2210	eyes
O	2211	2214	and
O	2215	2222	enabled
O	2223	2232	detection
O	2233	2235	of
O	2236	2244	patients
O	2245	2249	with
B-Disease	2250	2255	early
I-Disease	2256	2264	glaucoma
O	2264	2265	.

O	0	10	Comparison
O	11	13	of
O	14	17	the
O	18	26	clinical
O	27	36	diagnosis
O	37	39	of
B-Disease	40	48	diabetic
I-Disease	49	56	macular
I-Disease	57	62	edema
O	63	67	with
O	68	77	diagnosis
O	78	80	by
B-Diagnostic_tool	81	88	optical
I-Diagnostic_tool	89	98	coherence
I-Diagnostic_tool	99	109	tomography
O	109	110	.

O	112	114	To
O	115	122	compare
O	123	126	the
O	127	136	diagnosis
O	137	139	of
B-Disease	140	148	diabetic
I-Disease	149	156	macular
I-Disease	157	162	edema
O	163	164	(
B-Disease	164	167	DME
O	167	168	)
O	169	171	by
B-Diagnostic_tool	172	184	stereoscopic
I-Diagnostic_tool	185	189	slit
I-Diagnostic_tool	189	190	-
I-Diagnostic_tool	190	194	lamp
I-Diagnostic_tool	195	209	biomicroscopic
I-Diagnostic_tool	210	221	examination
O	222	224	of
O	225	228	the
O	229	235	fundus
O	236	240	with
O	241	242	a
O	243	245	78
O	245	246	-
O	246	253	diopter
O	254	264	noncontact
O	265	269	lens
O	270	274	with
O	275	284	diagnosis
O	285	287	by
B-Diagnostic_tool	288	295	optical
I-Diagnostic_tool	296	305	coherence
I-Diagnostic_tool	306	316	tomography
O	317	318	(
B-Diagnostic_tool	318	321	OCT
O	321	322	)
O	322	323	.

O	324	335	Prospective
O	335	336	,
O	337	343	double
O	343	344	-
O	344	350	masked
O	350	351	,
O	352	369	noninterventional
O	370	380	diagnostic
O	381	386	study
O	386	387	.

O	388	396	Analysis
O	397	399	of
B-Diagnostic_tool	400	404	slit
I-Diagnostic_tool	404	405	-
I-Diagnostic_tool	405	409	lamp
I-Diagnostic_tool	410	424	biomicroscopic
O	425	433	findings
O	434	442	compared
O	443	447	with
B-Diagnostic_tool	448	451	OCT
O	452	464	measurements
O	464	465	.

O	466	474	Patients
O	475	479	with
B-Disease	480	483	DME
O	484	488	from
O	489	490	a
O	491	498	private
B-Anatomy	499	505	retina
O	506	514	practice
O	514	515	.

O	516	524	Presence
O	525	527	or
O	528	535	absence
O	536	538	of
B-Symptom	539	546	macular
I-Symptom	547	557	thickening
O	557	558	.

O	559	562	The
O	563	572	reference
O	573	578	range
O	579	582	for
O	583	587	this
O	588	594	clinic
O	595	598	was
O	599	609	comparable
O	610	612	to
O	613	622	reference
O	623	629	ranges
O	630	639	published
O	640	644	from
O	645	650	other
O	651	658	clinics
O	658	659	.

O	660	663	The
O	664	672	clinical
O	673	682	detection
O	683	685	of
B-Disease	686	689	DME
O	690	693	was
O	694	698	less
O	699	703	than
O	704	713	detection
O	714	716	by
B-Diagnostic_tool	717	720	OCT
O	720	721	.

O	722	728	Chance
O	728	729	-
O	729	738	corrected
O	739	749	agreements
O	750	751	(
O	751	756	kappa
O	757	766	statistic
O	766	767	)
O	768	770	of
O	771	774	the
O	775	776	2
O	777	784	methods
O	785	789	were
O	790	791	0
O	791	792	.
O	792	794	63
O	795	798	for
O	799	802	the
B-Anatomy	803	809	foveal
O	810	814	zone
O	815	818	and
O	819	820	0
O	820	821	.
O	821	823	36
O	824	826	to
O	827	828	0
O	828	829	.
O	829	831	42
O	832	835	for
O	836	839	the
O	840	841	4
B-Anatomy	842	852	parafoveal
O	853	858	zones
O	858	859	.

O	860	863	The
O	864	870	errors
O	871	880	committed
O	881	883	in
O	884	892	clinical
O	893	904	examination
O	905	909	were
O	910	919	primarily
O	920	922	of
O	923	926	the
O	927	931	type
O	932	934	in
O	935	940	which
O	941	949	clinical
O	950	961	examination
O	962	965	did
O	966	969	not
O	970	976	detect
B-Disease	977	980	DME
O	981	984	but
B-Diagnostic_tool	985	988	OCT
O	989	992	did
O	993	994	(
O	994	996	58
O	996	997	%
O	997	998	-
O	998	1000	90
O	1000	1001	%
O	1001	1002	)
O	1003	1006	for
O	1007	1010	the
O	1011	1012	5
O	1013	1018	zones
O	1019	1027	analyzed
O	1027	1028	.

O	1029	1038	Reference
O	1039	1045	ranges
O	1046	1049	for
B-Diagnostic_tool	1050	1053	OCT
O	1054	1058	seem
O	1059	1061	to
O	1062	1064	be
O	1065	1072	similar
O	1073	1076	for
O	1077	1086	different
O	1087	1095	clinical
O	1096	1104	settings
O	1104	1105	,
O	1106	1116	suggesting
O	1117	1120	the
O	1121	1131	usefulness
O	1132	1134	of
B-Diagnostic_tool	1135	1138	OCT
O	1139	1141	in
O	1142	1153	multicenter
O	1154	1161	studies
O	1161	1162	.

O	1163	1166	The
O	1167	1174	current
O	1175	1183	standard
O	1184	1186	of
O	1187	1191	care
O	1192	1195	for
B-Disease	1196	1199	DME
O	1200	1209	detection
O	1209	1210	,
B-Diagnostic_tool	1211	1223	stereoscopic
I-Diagnostic_tool	1224	1228	slit
I-Diagnostic_tool	1228	1229	-
I-Diagnostic_tool	1229	1233	lamp
I-Diagnostic_tool	1234	1245	examination
O	1246	1248	of
O	1249	1252	the
B-Anatomy	1253	1259	fundus
O	1259	1260	,
O	1261	1263	is
O	1264	1268	less
O	1269	1278	sensitive
O	1279	1283	than
B-Diagnostic_tool	1284	1287	OCT
O	1288	1291	for
O	1292	1301	detection
O	1302	1304	of
B-Disease	1305	1308	DME
O	1308	1309	.

O	1310	1317	Because
O	1318	1321	the
O	1322	1331	principal
O	1332	1339	therapy
O	1340	1343	for
B-Disease	1344	1347	DME
O	1347	1348	,
O	1349	1354	focal
O	1355	1360	laser
O	1361	1377	photocoagulation
O	1377	1378	,
O	1379	1381	is
O	1382	1388	mainly
O	1389	1394	sight
O	1395	1405	preserving
O	1406	1409	and
O	1410	1413	not
O	1414	1419	sight
O	1420	1429	restoring
O	1429	1430	,
O	1431	1434	the
O	1435	1440	wider
O	1441	1444	use
O	1445	1447	of
B-Diagnostic_tool	1448	1451	OCT
O	1452	1455	may
O	1456	1468	beneficially
O	1469	1475	impact
B-Symptom	1476	1482	visual
I-Symptom	1483	1493	disability
O	1494	1498	from
B-Disease	1499	1502	DME
O	1502	1503	.

B-Disease	0	8	Birdshot
I-Disease	9	26	chorioretinopathy
O	26	27	:
O	28	32	long
O	32	33	-
O	33	37	term
O	38	52	manifestations
O	53	56	and
O	57	63	visual
O	64	73	prognosis
O	73	74	.

O	76	78	To
O	79	88	ascertain
O	89	92	the
O	93	101	clinical
O	102	110	features
O	111	114	and
O	115	119	long
O	119	120	-
O	120	124	term
O	125	131	visual
O	132	141	prognosis
O	142	144	of
B-Disease	145	153	birdshot
I-Disease	154	171	chorioretinopathy
O	172	173	(
B-Disease	173	176	BCR
O	176	177	)
O	177	178	,
O	179	182	and
O	183	185	to
O	186	194	identify
O	195	203	patients
O	204	206	at
O	207	211	risk
O	212	214	of
B-Symptom	215	221	visual
I-Symptom	222	226	loss
O	226	227	.

O	228	241	Retrospective
O	242	256	noncomparative
O	257	261	case
O	262	268	series
O	268	269	.

O	270	275	Fifty
O	275	276	-
O	276	280	five
O	281	292	consecutive
O	293	301	patients
O	302	306	with
B-Characteristic	307	310	HLA
I-Characteristic	310	311	-
I-Characteristic	311	314	A29
I-Characteristic	314	315	-
I-Characteristic	315	323	positive
B-Disease	324	327	BCR
O	328	331	who
O	332	336	were
O	337	347	identified
O	348	350	in
O	351	364	ophthalmology
O	365	376	departments
O	377	379	of
O	380	383	the
O	384	394	University
O	395	402	Medical
O	403	409	Center
O	410	412	of
O	413	420	Utrecht
O	421	424	and
O	425	428	The
B-Anatomy	429	432	Eye
O	433	441	Hospital
O	442	451	Rotterdam
O	451	452	,
O	453	455	of
O	456	460	whom
O	461	463	37
O	464	468	were
O	469	477	observed
O	478	481	for
O	482	484	at
O	485	490	least
O	491	492	5
O	493	498	years
O	498	499	.

O	500	501	A
O	502	508	review
O	509	511	of
O	512	515	the
O	516	523	medical
O	524	527	and
B-Diagnostic_tool	528	540	photographic
I-Diagnostic_tool	541	544	and
I-Diagnostic_tool	544	545	/
I-Diagnostic_tool	545	547	or
I-Diagnostic_tool	548	560	angiographic
I-Diagnostic_tool	561	568	records
O	569	571	of
O	572	574	55
O	575	583	patients
O	584	588	with
B-Characteristic	589	592	HLA
I-Characteristic	592	593	-
I-Characteristic	593	596	A29
I-Characteristic	596	597	-
I-Characteristic	597	605	positive
B-Disease	606	609	BCR
O	609	610	.

O	611	619	Numerous
O	620	629	variables
O	630	634	were
O	635	643	compared
O	643	644	,
O	645	654	including
O	655	658	age
O	659	662	and
O	663	669	gender
O	670	682	distribution
O	682	683	,
O	684	689	onset
O	690	693	and
O	694	700	course
O	701	703	of
B-Disease	704	707	BCR
O	707	708	,
O	709	715	ocular
O	716	730	manifestations
O	730	731	,
O	732	743	therapeutic
O	744	754	strategies
O	755	758	and
O	759	764	their
O	765	773	outcomes
O	773	774	,
O	775	788	complications
O	788	789	,
O	790	798	systemic
O	799	807	diseases
O	807	808	,
B-Characteristic	809	815	visual
I-Characteristic	816	822	acuity
O	823	824	(
B-Characteristic	824	826	VA
O	826	827	)
O	827	828	,
O	829	832	and
O	833	841	features
O	842	852	associated
O	853	857	with
O	858	862	poor
O	863	869	visual
O	870	877	outcome
O	877	878	.

B-Symptom	879	883	Loss
I-Symptom	884	886	of
I-Symptom	887	889	VA
O	890	893	was
O	894	901	gradual
O	901	902	;
O	903	906	the
O	907	913	number
O	914	916	of
O	917	925	affected
B-Anatomy	926	930	eyes
O	931	935	with
B-Symptom	936	938	VA
I-Symptom	939	943	less
I-Symptom	944	948	than
I-Symptom	949	951	20
I-Symptom	951	952	/
I-Symptom	952	955	200
O	956	965	increased
O	966	970	from
O	971	972	9
O	973	975	of
O	976	979	108
O	980	981	(
O	981	982	8
O	982	983	%
O	983	984	)
O	985	987	at
O	988	993	onset
O	994	996	to
O	997	999	22
O	1000	1002	of
O	1003	1005	73
O	1006	1007	(
O	1007	1009	30
O	1009	1010	%
O	1010	1011	)
O	1012	1014	at
O	1015	1016	5
O	1017	1022	years
O	1023	1026	and
O	1027	1029	19
O	1030	1032	of
O	1033	1035	49
O	1036	1037	(
O	1037	1039	39
O	1039	1040	%
O	1040	1041	)
O	1042	1044	at
O	1045	1047	10
O	1048	1053	years
O	1054	1056	of
O	1057	1063	follow
O	1063	1064	-
O	1064	1066	up
O	1066	1067	.

O	1068	1071	The
O	1072	1077	cause
O	1078	1080	of
B-Symptom	1081	1092	compromised
I-Symptom	1093	1095	VA
O	1096	1099	was
O	1100	1113	predominantly
B-Symptom	1114	1121	macular
I-Symptom	1122	1127	edema
O	1128	1131	and
B-Symptom	1132	1139	macular
I-Symptom	1140	1147	atrophy
O	1148	1149	(
O	1149	1151	42
O	1152	1154	of
O	1155	1157	55
O	1158	1159	[
O	1159	1161	76
O	1161	1162	%
O	1163	1165	of
O	1166	1171	cases
O	1171	1172	]
O	1172	1173	)
O	1173	1174	.

O	1175	1177	We
O	1178	1183	found
O	1184	1190	strong
O	1191	1203	associations
O	1204	1211	between
O	1212	1215	the
B-Characteristic	1216	1218	VA
O	1219	1221	at
B-Disease	1222	1227	onset
O	1228	1231	and
B-Symptom	1232	1238	visual
I-Symptom	1239	1246	outcome
I-Symptom	1247	1252	after
I-Symptom	1253	1254	5
I-Symptom	1255	1258	and
I-Symptom	1259	1261	10
I-Symptom	1262	1267	years
O	1268	1269	(
O	1269	1270	P
O	1271	1272	=
O	1273	1274	0
O	1274	1275	.
O	1275	1278	005
O	1279	1282	and
O	1283	1284	P
O	1285	1286	=
O	1287	1288	0
O	1288	1289	.
O	1289	1292	006
O	1292	1293	,
O	1294	1306	respectively
O	1306	1307	)
O	1307	1308	.

B-Characteristic	1309	1313	Mean
I-Characteristic	1314	1316	VA
I-Characteristic	1317	1319	at
I-Characteristic	1320	1323	the
I-Characteristic	1324	1325	5
I-Characteristic	1325	1326	-
I-Characteristic	1326	1330	year
I-Characteristic	1331	1337	follow
I-Characteristic	1337	1338	-
I-Characteristic	1338	1340	up
I-Characteristic	1341	1344	was
I-Characteristic	1345	1358	significantly
I-Characteristic	1359	1364	lower
O	1365	1367	if
B-Symptom	1368	1375	macular
I-Symptom	1376	1383	leakage
O	1384	1387	was
O	1388	1396	observed
O	1397	1399	on
B-Diagnostic_tool	1400	1411	angiography
O	1412	1413	(
O	1413	1414	P
O	1415	1416	<
O	1417	1418	0
O	1418	1419	.
O	1419	1422	001
O	1422	1423	)
O	1423	1424	.

O	1425	1427	No
O	1428	1439	differences
O	1440	1442	in
O	1443	1449	annual
B-Symptom	1450	1454	loss
I-Symptom	1455	1457	of
I-Symptom	1458	1460	VA
O	1461	1465	were
O	1466	1474	observed
O	1475	1482	between
O	1483	1491	patients
O	1492	1499	treated
O	1500	1502	by
O	1503	1511	standard
O	1512	1523	therapeutic
O	1524	1534	modalities
O	1535	1538	and
O	1539	1548	untreated
O	1549	1557	patients
O	1557	1558	.

O	1559	1562	The
O	1563	1569	visual
O	1570	1579	prognosis
O	1580	1582	of
B-Disease	1583	1586	BCR
O	1587	1589	in
O	1590	1591	a
O	1592	1600	spectrum
O	1601	1603	of
B-Disease	1604	1611	uveitis
O	1612	1614	is
O	1615	1619	poor
O	1619	1620	,
O	1621	1624	and
O	1625	1628	the
O	1629	1640	recommended
O	1641	1652	therapeutic
O	1653	1661	regimens
O	1662	1666	have
O	1667	1670	had
O	1671	1673	no
O	1674	1680	effect
O	1681	1683	on
O	1684	1688	long
O	1688	1689	-
O	1689	1693	term
O	1694	1700	visual
O	1701	1710	prognosis
O	1710	1711	.

O	1712	1715	New
O	1716	1725	treatment
O	1726	1736	strategies
O	1737	1740	are
O	1741	1747	needed
O	1748	1751	for
O	1752	1756	this
B-Disease	1757	1765	blinding
I-Disease	1766	1774	disorder
O	1774	1775	.

B-Diagnostic_tool	0	11	Retinotopic
I-Diagnostic_tool	12	19	mapping
I-Diagnostic_tool	20	22	of
I-Diagnostic_tool	23	26	the
I-Diagnostic_tool	27	33	visual
I-Diagnostic_tool	34	40	cortex
I-Diagnostic_tool	41	46	using
I-Diagnostic_tool	47	57	functional
I-Diagnostic_tool	58	66	magnetic
I-Diagnostic_tool	67	76	resonance
I-Diagnostic_tool	77	84	imaging
O	85	87	in
O	88	89	a
O	90	97	patient
O	98	102	with
B-Symptom	103	110	central
I-Symptom	111	119	scotomas
O	120	124	from
B-Disease	125	133	atrophic
I-Disease	134	141	macular
I-Disease	142	154	degeneration
O	154	155	.

O	157	159	To
O	160	168	describe
B-Diagnostic_tool	169	180	retinotopic
I-Diagnostic_tool	181	188	mapping
I-Diagnostic_tool	189	191	of
I-Diagnostic_tool	192	195	the
I-Diagnostic_tool	196	202	visual
I-Diagnostic_tool	203	209	cortex
O	210	214	when
O	215	216	a
B-Symptom	217	224	central
I-Symptom	225	232	scotoma
O	233	235	is
O	236	243	present
O	243	244	.

O	245	251	Single
O	252	265	observational
O	266	270	case
O	271	277	report
O	277	278	.

B-Diagnostic_tool	279	287	Scanning
I-Diagnostic_tool	288	293	laser
I-Diagnostic_tool	294	308	ophthalmoscope
I-Diagnostic_tool	309	318	perimetry
O	319	322	was
O	323	327	used
O	328	330	to
O	331	337	define
O	338	341	the
O	342	346	site
O	347	350	and
O	351	360	stability
O	361	363	of
O	364	372	fixation
O	373	376	and
O	377	380	the
O	381	385	area
O	386	388	of
O	389	394	dense
B-Symptom	395	402	scotoma
O	402	403	.

B-Diagnostic_tool	404	414	Functional
I-Diagnostic_tool	415	423	magnetic
I-Diagnostic_tool	424	433	resonance
I-Diagnostic_tool	434	441	imaging
I-Diagnostic_tool	442	444	of
I-Diagnostic_tool	445	448	the
I-Diagnostic_tool	449	455	visual
I-Diagnostic_tool	456	462	cortex
O	463	466	was
O	467	476	performed
O	477	482	while
O	483	486	the
O	487	494	patient
O	495	501	viewed
O	502	504	an
O	505	514	expanding
O	515	522	annular
O	523	531	stimulus
O	531	532	.

B-Diagnostic_tool	533	544	Retinotopic
I-Diagnostic_tool	545	552	mapping
I-Diagnostic_tool	553	555	of
I-Diagnostic_tool	556	559	the
I-Diagnostic_tool	560	566	visual
I-Diagnostic_tool	567	573	cortex
O	574	577	for
O	578	579	a
O	580	587	patient
O	588	592	with
O	593	594	a
B-Symptom	595	604	horseshoe
I-Symptom	605	612	scotoma
I-Symptom	613	617	from
I-Symptom	618	628	geographic
I-Symptom	629	636	atrophy
I-Symptom	637	646	involving
I-Symptom	647	650	the
I-Symptom	651	658	macular
I-Symptom	659	665	region
O	666	672	showed
O	673	674	a
B-Symptom	675	679	loss
I-Symptom	680	682	of
I-Symptom	683	694	stimulation
I-Symptom	695	697	to
I-Symptom	698	701	the
I-Symptom	702	710	cortical
I-Symptom	711	716	areas
O	717	729	representing
O	730	733	the
O	734	738	site
O	739	741	of
O	742	745	the
B-Symptom	746	754	atrophic
I-Symptom	755	761	lesion
O	761	762	.

B-Diagnostic_tool	763	771	Cortical
I-Diagnostic_tool	772	783	retinotopic
I-Diagnostic_tool	784	791	mapping
O	792	795	can
O	796	798	be
O	799	808	performed
O	809	821	successfully
O	822	824	in
O	825	833	patients
O	834	838	with
B-Symptom	839	846	central
I-Symptom	847	855	scotomas
O	856	860	from
B-Disease	861	868	macular
I-Disease	869	876	disease
O	876	877	.

O	878	882	This
O	883	888	study
O	889	892	can
O	893	898	serve
O	899	901	as
O	902	903	a
O	904	909	basis
O	910	913	for
O	914	917	the
O	918	924	future
O	925	938	investigation
O	939	941	of
B-Anatomy	942	950	cortical
O	951	961	plasticity
O	962	964	in
B-Anatomy	965	971	visual
I-Anatomy	972	978	cortex
O	978	979	.

O	0	10	Diagnostic
O	11	19	accuracy
O	20	22	of
O	23	26	the
B-Diagnostic_tool	27	30	GDx
I-Diagnostic_tool	31	34	VCC
O	35	38	for
B-Disease	39	47	glaucoma
O	47	48	.

O	50	52	To
O	53	62	determine
O	63	66	the
O	67	77	diagnostic
O	78	86	accuracy
O	87	89	of
O	90	93	the
B-Diagnostic_tool	94	97	GDx
I-Diagnostic_tool	98	101	VCC
O	102	104	in
O	105	108	the
O	109	118	diagnosis
O	119	121	of
B-Disease	122	130	glaucoma
O	130	131	.

O	132	143	Prospective
O	143	144	,
O	145	156	comparative
O	156	157	,
O	158	171	observational
O	171	172	,
O	173	179	clinic
O	179	180	-
O	180	185	based
O	186	190	case
O	191	197	series
O	197	198	.

O	199	202	One
O	203	206	eye
O	207	211	each
O	212	214	of
O	215	217	77
O	218	225	healthy
O	226	234	subjects
O	235	238	and
O	239	242	162
O	243	251	patients
O	252	256	with
B-Disease	257	264	primary
I-Disease	265	269	open
I-Disease	269	270	-
I-Disease	270	275	angle
I-Disease	276	284	glaucoma
O	285	287	of
B-Characteristic	288	297	Caucasian
I-Characteristic	298	304	racial
I-Characteristic	305	311	origin
O	311	312	.

O	313	320	Healthy
O	321	329	subjects
O	330	333	had
B-Characteristic	334	340	normal
I-Characteristic	341	347	visual
I-Characteristic	348	354	fields
O	355	356	(
B-Characteristic	356	359	VFs
O	359	360	)
O	360	361	,
B-Characteristic	362	369	healthy
I-Characteristic	369	370	-
I-Characteristic	370	377	looking
I-Characteristic	378	383	optic
I-Characteristic	384	389	discs
O	389	390	,
O	391	394	and
B-Characteristic	395	406	intraocular
I-Characteristic	407	416	pressures
I-Characteristic	417	419	of
I-Characteristic	421	422	<
I-Characteristic	424	426	or
I-Characteristic	427	428	=
I-Characteristic	428	430	21
I-Characteristic	431	435	mmHg
I-Characteristic	436	438	in
I-Characteristic	439	443	both
I-Characteristic	444	448	eyes
O	448	449	.

B-Disease	450	458	Glaucoma
O	459	467	patients
O	468	471	had
O	472	473	a
B-Symptom	474	486	reproducible
I-Symptom	487	499	glaucomatous
I-Symptom	500	502	VF
I-Symptom	503	509	defect
O	510	513	and
O	514	515	a
B-Symptom	516	528	glaucomatous
I-Symptom	529	539	appearance
I-Symptom	540	542	of
I-Symptom	543	546	the
I-Symptom	547	552	optic
I-Symptom	553	557	disc
I-Symptom	558	560	in
I-Symptom	561	563	at
I-Symptom	564	569	least
I-Symptom	570	573	one
I-Symptom	574	577	eye
O	577	578	.

O	579	582	All
O	583	591	subjects
O	592	596	were
O	597	605	measured
O	606	610	with
O	611	614	the
B-Diagnostic_tool	615	618	GDx
I-Diagnostic_tool	619	622	VCC
I-Diagnostic_tool	623	627	with
I-Diagnostic_tool	628	630	an
I-Diagnostic_tool	631	640	automated
I-Diagnostic_tool	641	649	variable
I-Diagnostic_tool	650	657	corneal
I-Diagnostic_tool	658	669	compensator
O	669	670	.

O	671	673	We
O	674	685	constructed
O	686	694	receiver
O	695	704	operating
O	705	719	characteristic
O	720	721	(
O	721	724	ROC
O	724	725	)
O	726	732	curves
O	733	736	for
O	737	740	all
O	741	750	available
O	751	761	parameters
O	761	762	.

O	763	775	Subsequently
O	775	776	,
O	777	779	we
O	780	790	calculated
O	791	802	sensitivity
O	802	803	,
O	804	815	specificity
O	815	816	,
O	817	820	and
O	821	831	multilevel
O	832	842	likelihood
O	843	849	ratios
O	850	853	for
O	854	857	the
O	858	862	best
O	863	877	discriminating
O	878	887	parameter
O	888	890	in
O	891	894	the
O	895	901	entire
O	902	907	group
O	907	908	.

O	909	911	In
O	912	920	addition
O	920	921	,
O	922	924	we
O	925	935	calculated
O	936	947	sensitivity
O	948	951	and
O	952	963	specificity
O	964	966	in
O	967	975	patients
O	976	980	with
B-Symptom	981	985	mild
I-Symptom	985	986	,
I-Symptom	987	995	moderate
I-Symptom	995	996	,
I-Symptom	997	1000	and
I-Symptom	1001	1007	severe
I-Symptom	1008	1020	glaucomatous
I-Symptom	1021	1027	damage
O	1028	1038	separately
O	1038	1039	.

O	1040	1048	Software
O	1048	1049	-
O	1049	1056	derived
O	1057	1067	parameters
O	1068	1073	TSNIT
O	1074	1075	(
O	1075	1083	temporal
O	1083	1084	,
O	1085	1093	superior
O	1093	1094	,
O	1095	1100	nasal
O	1100	1101	,
O	1102	1110	inferior
O	1110	1111	,
O	1112	1120	temporal
O	1120	1121	)
O	1122	1129	Average
O	1129	1130	,
O	1131	1139	Superior
O	1140	1147	Average
O	1147	1148	,
O	1149	1157	Inferior
O	1158	1165	Average
O	1165	1166	,
O	1167	1172	TSNIT
O	1173	1176	Std
O	1176	1177	.

O	1178	1181	Dev
O	1181	1182	.

O	1183	1184	(
O	1184	1192	standard
O	1193	1202	deviation
O	1202	1203	)
O	1203	1204	,
O	1205	1208	and
O	1209	1214	Nerve
O	1215	1220	Fiber
O	1221	1230	Indicator
O	1231	1232	(
O	1232	1235	NFI
O	1235	1236	)
O	1236	1237	.

O	1238	1241	The
O	1242	1247	areas
O	1248	1253	under
O	1254	1257	the
O	1258	1261	ROC
O	1262	1267	curve
O	1268	1271	for
O	1272	1277	TSNIT
O	1278	1285	Average
O	1285	1286	,
O	1287	1295	Superior
O	1296	1303	Average
O	1303	1304	,
O	1305	1313	Inferior
O	1314	1321	Average
O	1321	1322	,
O	1323	1328	TSNIT
O	1329	1332	Std
O	1332	1333	.

O	1334	1337	Dev
O	1337	1338	.
O	1338	1339	,
O	1340	1343	and
O	1344	1347	NFI
O	1348	1352	were
O	1353	1354	0
O	1354	1355	.
O	1355	1357	93
O	1357	1358	,
O	1359	1360	0
O	1360	1361	.
O	1361	1363	94
O	1363	1364	,
O	1365	1366	0
O	1366	1367	.
O	1367	1369	90
O	1369	1370	,
O	1371	1372	0
O	1372	1373	.
O	1373	1375	92
O	1375	1376	,
O	1377	1380	and
O	1381	1382	0
O	1382	1383	.
O	1383	1385	98
O	1385	1386	,
O	1387	1399	respectively
O	1399	1400	.

O	1401	1404	For
O	1405	1408	the
O	1409	1413	best
O	1414	1428	discriminating
O	1429	1438	parameter
O	1439	1442	NFI
O	1442	1443	,
O	1444	1447	the
O	1448	1459	sensitivity
O	1460	1463	and
O	1464	1475	specificity
O	1476	1480	with
O	1481	1482	a
O	1483	1489	cutoff
O	1490	1495	point
O	1496	1498	of
O	1500	1501	>
O	1503	1505	or
O	1506	1507	=
O	1507	1509	40
O	1510	1514	were
O	1515	1517	89
O	1517	1518	.
O	1518	1519	0
O	1519	1520	%
O	1521	1524	and
O	1525	1527	95
O	1527	1528	.
O	1528	1529	9
O	1529	1530	%
O	1530	1531	,
O	1532	1544	respectively
O	1544	1545	.

O	1546	1549	The
O	1550	1560	multilevel
O	1561	1571	likelihood
O	1572	1578	ratios
O	1579	1582	for
B-Disease	1583	1591	glaucoma
O	1592	1596	were
O	1597	1598	0
O	1598	1599	.
O	1599	1601	07
O	1602	1604	at
O	1605	1608	NFI
O	1609	1615	values
O	1616	1618	of
O	1620	1621	<
O	1622	1624	35
O	1624	1625	,
O	1626	1627	1
O	1627	1628	.
O	1628	1630	30
O	1631	1633	at
O	1634	1640	values
O	1641	1648	between
O	1649	1651	35
O	1652	1655	and
O	1656	1658	44
O	1658	1659	,
O	1660	1663	and
O	1664	1666	61
O	1666	1667	.
O	1667	1669	50
O	1670	1672	at
O	1673	1679	values
O	1680	1682	of
O	1684	1685	>
O	1687	1689	or
O	1690	1691	=
O	1691	1693	44
O	1693	1694	.

O	1695	1697	At
O	1698	1701	the
O	1702	1708	cutoff
O	1709	1714	level
O	1715	1717	of
O	1719	1720	>
O	1722	1724	or
O	1725	1726	=
O	1726	1728	40
O	1728	1729	,
O	1730	1733	the
O	1734	1747	sensitivities
O	1748	1750	of
O	1751	1754	the
O	1755	1758	NFI
O	1759	1762	for
O	1763	1772	correctly
O	1773	1784	identifying
B-Disease	1785	1793	glaucoma
O	1794	1802	patients
O	1803	1807	with
B-Symptom	1808	1812	mild
I-Symptom	1812	1813	,
I-Symptom	1814	1822	moderate
I-Symptom	1822	1823	,
I-Symptom	1824	1827	and
I-Symptom	1828	1834	severe
I-Symptom	1835	1841	damage
O	1842	1846	were
O	1847	1849	83
O	1849	1850	.
O	1850	1851	8
O	1851	1852	%
O	1852	1853	,
O	1854	1856	92
O	1856	1857	.
O	1857	1858	9
O	1858	1859	%
O	1859	1860	,
O	1861	1864	and
O	1865	1867	90
O	1867	1868	.
O	1868	1869	1
O	1869	1870	%
O	1870	1871	,
O	1872	1884	respectively
O	1884	1885	.

O	1886	1889	The
B-Diagnostic_tool	1890	1893	GDx
I-Diagnostic_tool	1894	1897	VCC
O	1898	1905	allowed
O	1906	1910	easy
O	1910	1911	,
O	1912	1917	rapid
O	1917	1918	,
O	1919	1922	and
O	1923	1931	accurate
O	1932	1946	discrimination
O	1947	1954	between
O	1955	1962	healthy
O	1963	1966	and
B-Disease	1967	1979	glaucomatous
B-Anatomy	1980	1984	eyes
O	1984	1985	.

O	1986	1989	The
O	1990	1993	NFI
O	1994	1997	was
O	1998	2001	the
O	2002	2006	best
O	2007	2021	discriminating
O	2022	2031	parameter
O	2031	2032	.

O	2033	2036	The
B-Diagnostic_tool	2037	2040	GDx
I-Diagnostic_tool	2041	2044	VCC
O	2045	2050	seems
O	2051	2053	to
O	2054	2061	fulfill
O	2062	2070	criteria
O	2071	2074	for
O	2075	2076	a
B-Diagnostic_tool	2077	2085	glaucoma
I-Diagnostic_tool	2086	2095	screening
I-Diagnostic_tool	2096	2102	device
O	2102	2103	.

B-Diagnostic_tool	0	5	Short
I-Diagnostic_tool	5	6	-
I-Diagnostic_tool	6	16	wavelength
I-Diagnostic_tool	17	26	automated
I-Diagnostic_tool	27	36	perimetry
O	37	44	results
O	45	48	are
O	49	59	correlated
O	60	64	with
B-Diagnostic_tool	65	72	optical
I-Diagnostic_tool	73	82	coherence
I-Diagnostic_tool	83	93	tomography
B-Characteristic	94	101	retinal
I-Characteristic	102	107	nerve
I-Characteristic	108	113	fiber
I-Characteristic	114	119	layer
I-Characteristic	120	129	thickness
I-Characteristic	130	142	measurements
O	143	145	in
B-Disease	146	158	glaucomatous
B-Anatomy	159	163	eyes
O	163	164	.

O	166	168	To
O	169	178	determine
O	179	182	the
O	183	195	relationship
O	196	203	between
B-Characteristic	204	211	retinal
I-Characteristic	212	217	nerve
I-Characteristic	218	223	fiber
I-Characteristic	224	229	layer
I-Characteristic	230	231	(
I-Characteristic	231	235	RNFL
I-Characteristic	235	236	)
I-Characteristic	237	246	thickness
O	247	255	measured
O	256	261	using
B-Diagnostic_tool	262	269	optical
I-Diagnostic_tool	270	279	coherence
I-Diagnostic_tool	280	290	tomography
O	291	292	(
B-Diagnostic_tool	292	295	OCT
O	295	296	)
O	297	300	and
B-Characteristic	301	306	short
I-Characteristic	307	317	wavelength
I-Characteristic	317	318	-
I-Characteristic	318	327	sensitive
I-Characteristic	328	334	visual
I-Characteristic	335	343	function
O	344	352	measured
O	353	358	using
B-Diagnostic_tool	359	364	short
I-Diagnostic_tool	364	365	-
I-Diagnostic_tool	365	375	wavelength
I-Diagnostic_tool	376	385	automated
I-Diagnostic_tool	386	395	perimetry
O	396	397	(
B-Diagnostic_tool	397	401	SWAP
O	401	402	)
O	402	403	.

O	404	417	Retrospective
O	418	431	observational
O	432	436	case
O	437	443	series
O	443	444	.

O	445	453	Subjects
O	454	458	were
O	459	468	recruited
O	469	473	from
O	474	477	the
O	478	490	longitudinal
O	491	501	University
O	502	504	of
O	505	515	California
O	515	516	,
O	517	520	San
O	521	526	Diego
O	526	527	,
O	528	538	Diagnostic
O	539	550	Innovations
O	551	553	in
B-Disease	554	562	Glaucoma
O	563	568	Study
O	569	572	and
O	573	581	included
O	582	584	29
B-Disease	585	593	glaucoma
O	594	602	patients
O	603	607	with
B-Diagnostic_tool	608	611	OCT
I-Diagnostic_tool	612	619	imaging
O	620	623	and
O	624	632	reliable
B-Diagnostic_tool	633	637	SWAP
I-Diagnostic_tool	638	644	visual
I-Diagnostic_tool	645	650	field
I-Diagnostic_tool	651	652	(
I-Diagnostic_tool	652	654	VF
I-Diagnostic_tool	654	655	)
O	656	663	testing
O	664	670	within
O	671	672	a
O	673	674	6
O	674	675	-
O	675	680	month
O	681	687	window
O	687	688	.

O	689	701	Correlations
O	702	709	between
B-Characteristic	710	719	deviation
I-Characteristic	720	724	from
I-Characteristic	725	731	normal
I-Characteristic	732	733	(
I-Characteristic	733	740	thinner
I-Characteristic	741	745	than
I-Characteristic	746	748	97
I-Characteristic	748	749	.
I-Characteristic	749	750	5
I-Characteristic	750	751	%
I-Characteristic	752	754	of
I-Characteristic	755	761	normal
I-Characteristic	761	762	)
I-Characteristic	763	767	RNFL
I-Characteristic	768	780	measurements
O	781	786	taken
O	787	789	at
O	790	792	30
O	793	800	degrees
O	801	808	sectors
O	809	810	(
O	810	812	12
O	813	820	sectors
O	821	830	described
O	831	833	as
O	834	839	clock
O	840	845	hours
O	845	846	)
O	847	850	and
B-Characteristic	851	855	SWAP
I-Characteristic	856	863	average
I-Characteristic	864	871	pattern
I-Characteristic	872	881	deviation
I-Characteristic	882	888	within
I-Characteristic	889	891	21
I-Characteristic	892	894	VF
I-Characteristic	895	900	zones
O	901	905	were
O	906	916	determined
O	916	917	.

O	918	921	The
O	922	928	number
O	929	931	of
B-Characteristic	932	935	OCT
I-Characteristic	935	936	-
I-Characteristic	936	944	measured
I-Characteristic	945	949	RNFL
I-Characteristic	950	957	sectors
O	958	965	outside
O	966	968	of
O	969	975	normal
O	976	982	limits
O	983	986	and
O	987	990	the
O	991	997	number
O	998	1000	of
B-Characteristic	1001	1003	VF
I-Characteristic	1004	1009	zones
O	1010	1017	outside
O	1018	1020	of
O	1021	1027	normal
O	1028	1034	limits
O	1035	1039	also
O	1040	1044	were
O	1045	1053	compared
O	1053	1054	.

O	1055	1058	The
B-Characteristic	1059	1062	OCT
I-Characteristic	1063	1068	nerve
I-Characteristic	1069	1074	fiber
I-Characteristic	1075	1080	layer
I-Characteristic	1081	1090	thickness
O	1091	1094	was
O	1095	1102	outside
O	1103	1105	of
O	1106	1109	the
O	1110	1116	normal
O	1117	1123	limits
O	1124	1126	in
O	1127	1129	at
O	1130	1135	least
O	1136	1137	1
O	1138	1144	sector
O	1145	1147	in
O	1148	1150	26
O	1151	1152	(
O	1152	1154	89
O	1154	1155	.
O	1155	1156	6
O	1156	1157	%
O	1157	1158	)
O	1159	1167	patients
O	1167	1168	.

O	1169	1175	Twenty
O	1175	1176	-
O	1176	1181	eight
O	1182	1183	(
O	1183	1185	96
O	1185	1186	.
O	1186	1187	5
O	1187	1188	%
O	1188	1189	)
O	1190	1198	patients
O	1199	1202	had
O	1203	1205	at
O	1206	1211	least
O	1212	1213	1
B-Characteristic	1214	1218	SWAP
I-Characteristic	1219	1221	VF
I-Characteristic	1222	1226	zone
O	1227	1234	outside
O	1235	1237	of
O	1238	1244	normal
O	1245	1251	limits
O	1251	1252	.

B-Diagnostic_tool	1253	1260	Optical
I-Diagnostic_tool	1261	1270	coherence
I-Diagnostic_tool	1271	1281	tomography
O	1282	1289	sectors
O	1290	1291	6
O	1291	1292	-
O	1292	1293	o
O	1293	1294	'
O	1294	1299	clock
O	1299	1300	,
O	1301	1302	7
O	1302	1303	-
O	1303	1304	o
O	1304	1305	'
O	1305	1310	clock
O	1310	1311	,
O	1312	1315	and
O	1316	1317	8
O	1317	1318	-
O	1318	1319	o
O	1319	1320	'
O	1320	1325	clock
O	1326	1327	(
O	1327	1335	inferior
O	1336	1339	and
O	1340	1354	inferotemporal
O	1354	1355	)
O	1356	1359	and
B-Characteristic	1360	1364	SWAP
I-Characteristic	1365	1367	VF
I-Characteristic	1368	1373	zones
O	1374	1376	13
O	1376	1377	,
O	1378	1380	14
O	1380	1381	,
O	1382	1385	and
O	1386	1388	16
O	1389	1390	(
B-Anatomy	1390	1398	superior
I-Anatomy	1399	1408	hemifield
I-Anatomy	1409	1416	central
I-Anatomy	1417	1420	and
I-Anatomy	1421	1428	arcuate
I-Anatomy	1429	1434	areas
O	1434	1435	)
O	1436	1440	were
O	1441	1444	the
O	1445	1449	most
O	1450	1460	frequently
O	1461	1468	damaged
O	1468	1469	.

O	1470	1472	In
O	1473	1480	general
O	1480	1481	,
O	1482	1485	the
O	1486	1495	strongest
O	1496	1498	R2
O	1499	1511	associations
O	1512	1516	were
O	1517	1524	between
O	1525	1533	inferior
O	1534	1537	and
B-Characteristic	1538	1546	inferior
I-Characteristic	1547	1555	temporal
I-Characteristic	1556	1560	RNFL
I-Characteristic	1561	1568	sectors
O	1569	1570	(
O	1570	1571	e
O	1571	1572	.
O	1572	1573	g
O	1573	1574	.
O	1574	1575	,
O	1576	1577	6
O	1577	1578	-
O	1578	1579	o
O	1579	1580	'
O	1580	1585	clock
O	1585	1586	,
O	1587	1588	7
O	1588	1589	-
O	1589	1590	o
O	1590	1591	'
O	1591	1596	clock
O	1596	1597	)
O	1598	1601	and
B-Characteristic	1602	1610	superior
I-Characteristic	1611	1616	nasal
I-Characteristic	1616	1617	/
I-Characteristic	1617	1624	arcuate
I-Characteristic	1625	1627	VF
I-Characteristic	1628	1633	zones
O	1634	1635	(
O	1635	1636	e
O	1636	1637	.
O	1637	1638	g
O	1638	1639	.
O	1639	1640	,
O	1641	1646	zones
O	1647	1649	13
O	1649	1650	,
O	1651	1653	14
O	1653	1654	,
O	1655	1657	15
O	1657	1658	)
O	1659	1662	and
O	1663	1670	between
B-Characteristic	1671	1679	superior
I-Characteristic	1680	1683	and
I-Characteristic	1684	1692	superior
I-Characteristic	1693	1701	temporal
I-Characteristic	1702	1706	RNFL
I-Characteristic	1707	1714	sectors
O	1715	1716	(
O	1716	1717	e
O	1717	1718	.
O	1718	1719	g
O	1719	1720	.
O	1720	1721	,
O	1722	1724	12
O	1724	1725	-
O	1725	1726	o
O	1726	1727	'
O	1727	1732	clock
O	1732	1733	,
O	1734	1736	11
O	1736	1737	-
O	1737	1738	o
O	1738	1739	'
O	1739	1744	clock
O	1744	1745	)
O	1746	1749	and
B-Characteristic	1750	1758	inferior
I-Characteristic	1759	1766	central
I-Characteristic	1767	1770	and
I-Characteristic	1771	1778	arcuate
I-Characteristic	1779	1781	VF
I-Characteristic	1782	1787	zones
O	1788	1789	(
O	1789	1790	e
O	1790	1791	.
O	1791	1792	g
O	1792	1793	.
O	1793	1794	,
O	1795	1800	zones
O	1801	1802	5
O	1802	1803	,
O	1804	1805	6
O	1805	1806	,
O	1807	1808	7
O	1808	1809	)
O	1810	1811	(
O	1811	1813	R2
O	1814	1819	range
O	1820	1821	=
O	1822	1824	24
O	1824	1825	.
O	1825	1826	3
O	1826	1827	%
O	1827	1828	-
O	1828	1830	37
O	1830	1831	.
O	1831	1832	3
O	1832	1833	%
O	1833	1834	,
O	1835	1838	all
O	1839	1841	Ps
O	1843	1844	<
O	1846	1848	or
O	1849	1850	=
O	1851	1852	0
O	1852	1853	.
O	1853	1856	005
O	1856	1857	)
O	1857	1858	.

O	1859	1863	Most
O	1864	1878	nonsignificant
O	1879	1891	associations
O	1892	1896	were
O	1897	1902	found
O	1903	1910	between
B-Characteristic	1911	1919	superior
I-Characteristic	1920	1924	RNFL
I-Characteristic	1925	1932	sectors
O	1933	1936	and
B-Characteristic	1937	1945	superior
I-Characteristic	1946	1948	VF
I-Characteristic	1949	1954	zones
O	1954	1955	.

B-Characteristic	1956	1963	Retinal
I-Characteristic	1964	1969	nerve
I-Characteristic	1970	1975	fiber
I-Characteristic	1976	1981	layer
I-Characteristic	1982	1991	thickness
O	1992	2000	measured
O	2001	2005	with
B-Diagnostic_tool	2006	2009	OCT
O	2010	2012	is
O	2013	2028	topographically
O	2029	2039	correlated
O	2040	2044	with
B-Symptom	2045	2057	glaucomatous
I-Symptom	2058	2060	VF
I-Symptom	2061	2068	defects
O	2069	2077	measured
O	2078	2082	with
B-Diagnostic_tool	2083	2087	SWAP
O	2087	2088	.

B-Diagnostic_tool	0	7	Digital
I-Diagnostic_tool	8	20	stereoscopic
I-Diagnostic_tool	21	29	analysis
I-Diagnostic_tool	30	32	of
I-Diagnostic_tool	33	36	the
I-Diagnostic_tool	37	42	optic
I-Diagnostic_tool	43	47	disc
O	47	48	:
O	49	59	evaluation
O	60	62	of
O	63	64	a
O	65	73	teaching
O	74	81	program
O	81	82	.

O	84	86	To
O	87	96	determine
O	97	99	if
O	100	101	a
O	102	110	computer
O	110	111	-
O	111	116	based
O	117	129	stereoscopic
O	130	138	teaching
O	139	146	program
O	147	152	could
O	153	160	improve
B-Characteristic	161	166	optic
I-Characteristic	167	170	cup
I-Characteristic	170	171	/
I-Characteristic	171	175	disc
I-Characteristic	176	181	ratio
O	182	183	(
B-Characteristic	183	186	CDR
O	186	187	)
O	188	197	agreement
O	198	205	between
O	206	213	student
O	214	223	observers
O	224	227	and
O	228	230	an
O	231	237	expert
O	237	238	.

O	239	251	Experimental
O	252	257	study
O	257	258	.

O	259	262	Six
O	263	270	student
O	271	280	observers
O	281	282	(
O	282	283	A
O	283	284	-
O	284	285	F
O	285	286	)
O	287	295	assessed
O	296	298	at
O	299	304	least
O	305	307	30
B-Diagnostic_tool	308	315	digital
I-Diagnostic_tool	316	328	stereoscopic
I-Diagnostic_tool	329	334	optic
I-Diagnostic_tool	335	339	disc
I-Diagnostic_tool	340	346	images
O	347	352	using
O	353	354	a
O	355	362	digital
O	363	375	stereoscopic
O	376	384	analysis
O	385	392	program
O	392	393	.

O	394	397	All
O	398	407	observers
O	408	412	made
O	413	415	36
B-Characteristic	416	419	CDR
O	420	432	measurements
O	433	434	(
O	434	439	every
O	440	442	10
O	443	450	degrees
O	451	452	)
O	453	456	for
O	457	461	each
B-Diagnostic_tool	462	466	disc
I-Diagnostic_tool	467	472	image
O	473	477	that
O	478	482	they
O	483	491	assessed
O	491	492	.

B-Diagnostic_tool	493	497	Disc
I-Diagnostic_tool	498	504	images
O	505	509	were
O	510	517	divided
O	518	522	into
O	523	524	3
O	525	529	sets
O	530	532	of
O	533	535	10
B-Diagnostic_tool	536	542	images
O	543	544	(
B-Diagnostic_tool	544	549	image
I-Diagnostic_tool	550	554	sets
O	555	556	1
O	556	557	,
O	558	559	2
O	559	560	,
O	561	564	and
O	565	566	3
O	566	567	)
O	567	568	.

O	569	578	Observers
O	579	580	A
O	580	581	,
O	582	583	B
O	583	584	,
O	585	588	and
O	589	590	C
O	591	601	determined
B-Characteristic	602	606	CDRs
O	607	610	for
O	611	614	all
O	615	616	3
B-Diagnostic_tool	617	622	image
I-Diagnostic_tool	623	627	sets
O	627	628	.

O	629	632	Set
O	633	634	1
O	635	638	was
O	639	647	examined
O	648	655	without
O	656	662	access
O	663	665	to
O	666	667	a
O	668	676	teaching
O	677	684	program
O	684	685	,
O	686	689	set
O	690	691	2
O	692	697	using
O	698	699	a
O	700	708	teaching
O	709	716	program
O	717	721	that
O	722	729	allowed
O	730	733	the
O	734	742	observer
O	743	745	to
O	746	750	view
O	751	753	an
O	754	760	expert
O	761	771	assessment
O	772	774	of
O	775	778	the
B-Anatomy	779	784	optic
I-Anatomy	785	789	disc
O	789	790	,
O	791	794	and
O	795	798	set
O	799	800	3
O	801	806	after
O	807	812	using
O	813	816	the
O	817	825	teaching
O	826	833	program
O	833	834	.

O	835	844	Observers
O	845	846	D
O	846	847	,
O	848	849	E
O	849	850	,
O	851	854	and
O	855	856	F
O	857	866	evaluated
O	867	872	image
O	873	877	sets
O	878	879	1
O	880	883	and
O	884	885	3
O	886	890	only
O	891	894	and
O	895	898	did
O	899	902	not
O	903	907	have
O	908	914	access
O	915	917	to
O	918	921	the
O	922	930	teaching
O	931	938	program
O	938	939	.

O	940	943	Ten
O	944	950	months
O	951	956	later
O	956	957	,
O	958	963	these
O	964	968	same
O	969	978	observers
O	979	980	(
O	980	981	D
O	981	982	-
O	982	983	F
O	983	984	)
O	985	991	viewed
O	992	997	image
O	998	1001	set
O	1002	1003	2
O	1004	1009	using
O	1010	1013	the
O	1014	1022	teaching
O	1023	1030	program
O	1031	1034	and
O	1035	1039	then
O	1040	1050	reassessed
O	1051	1056	image
O	1057	1060	set
O	1061	1062	3
O	1062	1063	.

O	1064	1072	Standard
O	1073	1082	deviation
O	1083	1084	(
O	1084	1086	SD
O	1086	1087	)
O	1088	1090	of
B-Characteristic	1091	1094	CDR
O	1095	1106	differences
O	1107	1114	between
O	1115	1124	observers
O	1125	1128	and
O	1129	1131	an
O	1132	1138	expert
O	1138	1139	,
O	1140	1143	the
O	1144	1154	percentage
O	1155	1157	of
B-Characteristic	1158	1161	CDR
O	1162	1174	observations
O	1175	1184	differing
O	1186	1187	>
O	1189	1191	or
O	1192	1193	=
O	1193	1194	0
O	1194	1195	.
O	1195	1197	20
O	1198	1202	from
O	1203	1208	those
O	1209	1211	of
O	1212	1215	the
O	1216	1222	expert
O	1222	1223	,
O	1224	1227	and
O	1228	1238	intraclass
O	1239	1250	correlation
O	1251	1263	coefficients
O	1264	1265	(
O	1265	1269	ICCs
O	1269	1270	)
O	1271	1278	between
O	1279	1288	observers
O	1288	1289	.

O	1290	1296	Before
O	1297	1305	teaching
O	1305	1306	,
O	1307	1310	the
O	1311	1318	average
O	1319	1321	SD
O	1322	1324	of
O	1325	1336	differences
O	1337	1344	between
O	1345	1348	all
O	1349	1358	observers
O	1359	1362	and
O	1363	1366	the
O	1367	1373	expert
O	1374	1377	was
O	1378	1379	0
O	1379	1380	.
O	1380	1382	10
O	1382	1383	.

O	1384	1389	After
O	1390	1398	teaching
O	1398	1399	,
O	1400	1403	the
O	1404	1411	average
O	1412	1414	SD
O	1415	1417	of
O	1418	1429	differences
O	1430	1437	between
O	1438	1441	all
O	1442	1451	observers
O	1452	1455	and
O	1456	1459	the
O	1460	1466	expert
O	1467	1470	was
O	1471	1472	0
O	1472	1473	.
O	1473	1476	057
O	1476	1477	.

O	1478	1481	For
O	1482	1491	observers
O	1492	1493	D
O	1493	1494	,
O	1495	1496	E
O	1496	1497	,
O	1498	1501	and
O	1502	1503	F
O	1503	1504	,
O	1505	1508	the
O	1509	1516	average
O	1517	1519	SD
O	1520	1522	of
O	1523	1534	differences
O	1535	1538	for
O	1539	1544	image
O	1545	1548	set
O	1549	1550	3
O	1551	1558	without
O	1559	1567	teaching
O	1568	1571	was
O	1572	1573	0
O	1573	1574	.
O	1574	1577	074
O	1577	1578	.

O	1579	1582	The
O	1583	1593	percentage
O	1594	1596	of
O	1597	1600	all
O	1601	1609	observer
O	1610	1622	measurements
O	1623	1627	that
O	1628	1636	differed
O	1638	1639	>
O	1641	1643	or
O	1644	1645	=
O	1645	1646	0
O	1646	1647	.
O	1647	1649	20
O	1650	1654	from
O	1655	1660	those
O	1661	1663	of
O	1664	1667	the
O	1668	1674	expert
O	1675	1678	for
O	1679	1684	image
O	1685	1688	set
O	1689	1690	1
O	1691	1694	was
O	1695	1697	16
O	1697	1698	.
O	1698	1699	7
O	1699	1700	%
O	1700	1701	;
O	1702	1705	for
O	1706	1709	set
O	1710	1711	3
O	1712	1717	after
O	1718	1726	teaching
O	1726	1727	,
O	1728	1729	1
O	1729	1730	.
O	1730	1731	7
O	1731	1732	%
O	1732	1733	;
O	1734	1737	and
O	1738	1741	for
O	1742	1745	set
O	1746	1747	3
O	1748	1751	for
O	1752	1761	observers
O	1762	1763	D
O	1763	1764	,
O	1765	1766	E
O	1766	1767	,
O	1768	1771	and
O	1772	1773	F
O	1774	1781	without
O	1782	1790	teaching
O	1790	1791	,
O	1792	1794	10
O	1794	1795	%
O	1795	1796	.

O	1797	1810	Interobserver
O	1811	1814	ICC
O	1815	1821	values
O	1822	1825	for
O	1826	1829	all
O	1830	1839	observers
O	1840	1844	were
O	1845	1846	0
O	1846	1847	.
O	1847	1849	37
O	1850	1856	before
O	1857	1865	teaching
O	1866	1869	and
O	1870	1871	0
O	1871	1872	.
O	1872	1874	76
O	1875	1880	after
O	1880	1881	.

O	1882	1885	For
O	1886	1895	observers
O	1896	1897	D
O	1897	1898	,
O	1899	1900	E
O	1900	1901	,
O	1902	1905	and
O	1906	1907	F
O	1907	1908	,
O	1909	1912	the
O	1913	1916	ICC
O	1917	1922	value
O	1923	1926	for
O	1927	1930	set
O	1931	1932	3
O	1933	1940	without
O	1941	1947	access
O	1948	1950	to
O	1951	1959	teaching
O	1960	1963	was
O	1964	1965	0
O	1965	1966	.
O	1966	1968	69
O	1968	1969	.

O	1970	1974	This
O	1975	1980	study
O	1981	1989	suggests
O	1990	1994	that
O	1995	1997	an
O	1998	2009	interactive
B-Diagnostic_tool	2010	2017	digital
I-Diagnostic_tool	2018	2030	stereoscopic
O	2031	2039	teaching
O	2040	2047	program
O	2048	2056	improves
O	2057	2066	agreement
O	2067	2074	between
O	2075	2084	observers
O	2085	2088	and
O	2089	2091	an
O	2092	2098	expert
O	2099	2103	when
O	2104	2113	assessing
B-Characteristic	2114	2118	CDRs
O	2118	2119	.

O	0	11	Statistical
O	12	22	evaluation
O	23	25	of
O	26	29	the
O	30	40	diagnostic
O	41	49	accuracy
O	50	52	of
O	53	60	methods
O	61	65	used
O	66	68	to
O	69	78	determine
O	79	82	the
O	83	94	progression
O	95	97	of
B-Symptom	98	104	visual
I-Symptom	105	110	field
I-Symptom	111	118	defects
O	119	121	in
B-Disease	122	130	glaucoma
O	130	131	.

O	133	135	To
O	136	144	evaluate
O	145	150	trend
O	150	151	-
O	151	155	type
O	156	164	analyses
O	165	167	to
O	168	173	judge
O	174	177	the
O	178	189	progression
O	190	192	of
B-Symptom	193	199	visual
I-Symptom	200	205	field
I-Symptom	206	212	damage
O	213	214	(
B-Symptom	214	217	VFD
O	217	218	)
O	219	221	of
B-Disease	222	230	glaucoma
O	231	233	in
O	234	239	terms
O	240	242	of
O	243	249	ratios
O	250	252	of
O	253	259	making
O	260	269	judgments
O	270	272	of
O	273	284	progression
O	285	288	and
O	289	300	specificity
O	300	301	,
O	302	305	and
O	306	308	to
O	309	315	report
O	316	317	a
O	318	321	new
O	322	328	method
O	328	329	.

O	330	343	Retrospective
O	344	352	analysis
O	353	355	of
B-Characteristic	356	362	visual
I-Characteristic	363	368	field
O	369	370	(
B-Characteristic	370	372	VF
O	372	373	)
O	374	381	results
O	382	384	of
O	385	391	actual
B-Disease	392	400	glaucoma
O	401	406	cases
O	407	410	and
O	411	416	those
O	417	426	simulated
O	427	429	by
O	430	438	computer
O	438	439	,
O	440	443	and
O	444	452	receiver
O	453	462	operating
O	463	477	characteristic
O	478	483	curve
O	484	492	analysis
O	493	495	of
O	496	507	performance
O	508	510	of
O	511	518	methods
O	519	521	to
O	522	527	judge
O	528	531	the
O	532	543	progression
O	544	546	of
B-Symptom	547	550	VFD
O	550	551	.

O	552	555	One
O	556	563	hundred
O	564	568	five
O	569	573	eyes
O	574	576	of
O	577	580	105
B-Disease	581	585	open
I-Disease	585	586	-
I-Disease	586	591	angle
I-Disease	592	600	glaucoma
O	601	602	(
B-Disease	602	605	OAG
O	605	606	)
O	607	615	patients
O	616	620	with
O	621	632	progressing
B-Symptom	633	636	VFD
O	637	640	and
O	641	644	355
B-Anatomy	645	649	eyes
O	650	652	of
O	653	656	355
O	657	667	clinically
O	668	674	stable
B-Disease	675	678	OAG
O	679	687	patients
O	688	691	for
B-Characteristic	692	694	VF
O	695	705	simulation
O	706	710	from
O	711	712	4
O	713	723	university
O	723	724	-
O	724	729	based
O	730	738	referral
O	739	748	practices
O	748	749	.

O	750	757	Methods
O	758	763	using
O	764	774	regression
O	775	783	analysis
O	784	786	of
O	787	792	total
O	793	802	deviation
O	803	804	(
O	804	806	TD
O	806	807	)
O	807	808	,
O	809	813	mean
O	814	823	deviation
O	824	825	(
O	825	827	MD
O	827	828	)
O	828	829	,
O	830	834	mean
O	835	837	TD
O	838	840	of
O	841	842	a
O	843	851	sectored
B-Characteristic	852	854	VF
O	854	855	,
O	856	859	and
O	860	868	original
O	869	876	scoring
O	877	881	used
O	882	884	in
O	885	888	the
B-Classification_system	889	897	Advanced
I-Classification_system	898	906	Glaucoma
I-Classification_system	907	919	Intervention
I-Classification_system	920	925	Study
O	926	927	(
B-Classification_system	927	931	AGIS
O	931	932	)
O	933	937	were
O	938	946	compared
O	946	947	.

O	948	949	A
B-Diagnostic_tool	950	952	VF
I-Diagnostic_tool	953	957	test
O	958	961	was
O	962	970	repeated
O	971	976	twice
O	977	979	in
O	980	981	a
O	982	987	short
O	988	994	period
O	995	997	on
O	998	1001	the
O	1002	1005	355
O	1006	1012	stable
B-Disease	1013	1016	OAG
B-Anatomy	1017	1021	eyes
O	1021	1022	,
O	1023	1026	and
O	1027	1031	test
O	1031	1032	-
O	1032	1038	retest
O	1039	1050	fluctuation
O	1050	1051	,
O	1052	1061	including
O	1062	1070	variance
O	1071	1073	at
O	1074	1078	each
O	1079	1083	test
O	1084	1089	point
O	1090	1093	and
O	1094	1104	covariance
O	1105	1112	between
O	1113	1114	2
O	1115	1119	test
O	1120	1126	points
O	1126	1127	,
O	1128	1131	was
O	1132	1142	calculated
O	1143	1145	to
O	1146	1154	simulate
O	1155	1161	stable
B-Characteristic	1162	1174	glaucomatous
I-Characteristic	1175	1177	VF
O	1178	1184	series
O	1185	1187	by
O	1188	1196	computer
O	1196	1197	.

O	1198	1201	The
O	1202	1213	sensitivity
O	1214	1216	of
O	1217	1221	each
O	1222	1228	method
O	1229	1232	was
O	1233	1243	calculated
O	1244	1248	with
O	1249	1252	105
O	1253	1264	progressing
B-Diagnostic_tool	1265	1267	VF
O	1268	1274	series
O	1274	1275	,
O	1276	1279	and
O	1280	1291	specificity
O	1292	1295	was
O	1296	1306	calculated
O	1307	1311	with
O	1312	1314	10
O	1314	1315	,
O	1315	1318	000
O	1319	1328	simulated
O	1329	1335	stable
B-Characteristic	1336	1348	glaucomatous
I-Characteristic	1349	1351	VF
O	1352	1358	series
O	1358	1359	.

O	1360	1371	Sensitivity
O	1372	1373	(
O	1373	1379	ratios
O	1380	1382	of
O	1383	1389	making
O	1390	1399	judgments
O	1400	1402	of
O	1403	1414	progression
O	1414	1415	)
O	1415	1416	,
O	1417	1428	specificity
O	1428	1429	,
O	1430	1433	and
O	1434	1444	diagnostic
O	1445	1450	power
O	1450	1451	.

O	1452	1455	The
O	1456	1463	methods
O	1464	1469	using
O	1470	1473	the
O	1474	1476	TD
O	1477	1482	slope
O	1483	1485	on
O	1486	1489	one
O	1490	1494	test
O	1495	1503	location
O	1504	1510	showed
O	1511	1512	a
O	1513	1524	sensitivity
O	1525	1527	of
O	1528	1529	0
O	1529	1530	.
O	1530	1533	848
O	1534	1536	to
O	1537	1538	1
O	1538	1539	.
O	1539	1542	000
O	1542	1543	,
O	1544	1548	with
O	1549	1550	a
O	1551	1562	specificity
O	1563	1565	of
O	1566	1567	0
O	1567	1568	.
O	1568	1571	105
O	1572	1574	to
O	1575	1576	0
O	1576	1577	.
O	1577	1580	721
O	1580	1581	,
O	1582	1585	and
O	1586	1588	on
O	1589	1590	2
O	1591	1599	adjacent
O	1600	1604	test
O	1605	1614	locations
O	1615	1621	showed
O	1622	1623	a
O	1624	1635	sensitivity
O	1636	1638	of
O	1639	1640	0
O	1640	1641	.
O	1641	1644	848
O	1644	1645	,
O	1646	1650	with
O	1651	1652	a
O	1653	1664	specificity
O	1665	1667	of
O	1668	1669	0
O	1669	1670	.
O	1670	1673	722
O	1673	1674	.

O	1675	1676	A
O	1677	1688	significant
O	1689	1697	negative
O	1698	1700	MD
O	1701	1706	slope
O	1707	1711	with
O	1712	1713	P
O	1714	1715	<
O	1716	1717	0
O	1717	1718	.
O	1718	1720	05
O	1721	1727	showed
O	1728	1729	a
O	1730	1741	sensitivity
O	1742	1744	of
O	1745	1746	0
O	1746	1747	.
O	1747	1750	524
O	1750	1751	,
O	1752	1756	with
O	1757	1758	a
O	1759	1770	specificity
O	1771	1773	of
O	1774	1775	0
O	1775	1776	.
O	1776	1779	945
O	1779	1780	.

O	1781	1784	The
O	1785	1791	method
O	1792	1797	using
O	1798	1799	a
O	1800	1808	sectored
B-Diagnostic_tool	1809	1811	VF
O	1812	1818	showed
O	1819	1820	a
O	1821	1832	sensitivity
O	1833	1835	of
O	1836	1837	0
O	1837	1838	.
O	1838	1841	695
O	1841	1842	,
O	1843	1847	with
O	1848	1849	a
O	1850	1854	high
O	1855	1866	specificity
O	1867	1869	of
O	1870	1871	0
O	1871	1872	.
O	1872	1875	946
O	1875	1876	.

O	1877	1880	The
B-Classification_system	1881	1885	AGIS
O	1886	1892	method
O	1893	1899	showed
O	1900	1901	a
O	1902	1913	sensitivity
O	1914	1916	of
O	1917	1918	0
O	1918	1919	.
O	1919	1922	305
O	1923	1925	to
O	1926	1927	0
O	1927	1928	.
O	1928	1931	467
O	1931	1932	,
O	1933	1937	with
O	1938	1939	a
O	1940	1944	very
O	1945	1949	high
O	1950	1961	specificity
O	1962	1964	of
O	1965	1966	0
O	1966	1967	.
O	1967	1970	999
O	1971	1973	to
O	1974	1975	1
O	1975	1976	.
O	1976	1979	000
O	1979	1980	.

O	1981	1984	The
O	1985	1991	method
O	1992	1997	using
O	1998	2008	previously
O	2009	2017	reported
O	2018	2032	mathematically
O	2033	2041	sectored
B-Diagnostic_tool	2042	2045	VFs
O	2046	2052	showed
O	2053	2054	a
O	2055	2066	sensitivity
O	2067	2069	of
O	2070	2071	0
O	2071	2072	.
O	2072	2075	790
O	2075	2076	,
O	2077	2081	with
O	2082	2083	a
O	2084	2095	specificity
O	2096	2098	of
O	2099	2100	0
O	2100	2101	.
O	2101	2104	900
O	2104	2105	,
O	2106	2109	and
O	2110	2116	higher
O	2117	2127	diagnostic
O	2128	2133	power
O	2134	2135	(
O	2135	2136	1
O	2136	2137	.
O	2137	2139	69
O	2139	2140	)
O	2141	2145	than
O	2146	2149	the
O	2150	2156	others
O	2157	2159	in
O	2160	2164	this
O	2165	2170	study
O	2171	2181	population
O	2181	2182	.

O	2183	2187	Most
O	2188	2190	of
O	2191	2194	the
O	2195	2202	methods
O	2203	2208	using
O	2209	2212	the
O	2213	2215	TD
O	2216	2221	slope
O	2222	2226	were
O	2227	2240	characterized
O	2241	2243	by
O	2244	2248	high
O	2249	2260	sensitivity
O	2260	2261	,
O	2262	2265	the
B-Classification_system	2266	2270	AGIS
O	2271	2277	method
O	2278	2281	had
O	2282	2283	a
O	2284	2288	very
O	2289	2293	high
O	2294	2305	specificity
O	2305	2306	,
O	2307	2310	and
O	2311	2316	those
O	2317	2322	using
B-Diagnostic_tool	2323	2325	VF
O	2326	2333	sectors
O	2334	2337	had
O	2338	2348	reasonable
O	2349	2360	sensitivity
O	2361	2364	and
O	2365	2376	specificity
O	2376	2377	.

B-Characteristic	0	7	Central
I-Characteristic	8	15	corneal
I-Characteristic	16	25	thickness
O	25	26	:
O	27	31	will
O	32	35	one
O	36	47	measurement
O	48	55	suffice
O	55	56	?

O	58	60	To
O	61	69	evaluate
O	70	73	the
O	74	85	measurement
O	86	88	of
B-Characteristic	89	96	central
I-Characteristic	97	104	corneal
I-Characteristic	105	114	thickness
O	115	116	(
B-Characteristic	116	119	CCT
O	119	120	)
O	121	123	in
O	124	125	a
O	126	132	cohort
O	133	135	of
B-Disease	136	144	glaucoma
O	145	153	patients
O	154	158	over
O	159	160	a
O	161	162	3
O	162	163	-
O	163	168	month
O	169	175	period
O	175	176	.

O	177	189	Measurements
O	190	194	were
O	195	199	then
O	200	207	applied
O	208	210	to
O	211	214	the
O	215	223	criteria
O	224	233	described
O	234	236	in
O	237	240	the
B-Disease	241	247	Ocular
I-Disease	248	260	Hypertension
O	261	270	Treatment
O	271	276	Study
O	277	278	(
O	278	282	OHTS
O	282	283	)
O	283	284	.

O	285	291	Cohort
O	292	297	study
O	297	298	.

O	299	304	Fifty
O	304	305	-
O	305	308	one
O	309	317	patients
O	318	322	were
O	323	332	recruited
O	333	337	from
O	338	339	a
B-Disease	340	348	glaucoma
O	349	355	clinic
O	356	358	at
O	359	369	Moorfields
B-Anatomy	370	373	Eye
O	374	382	Hospital
O	382	383	.

B-Characteristic	384	391	Central
I-Characteristic	392	399	corneal
I-Characteristic	400	409	thickness
O	410	413	was
O	414	422	measured
O	423	428	using
O	429	431	an
B-Diagnostic_tool	432	442	ultrasonic
I-Diagnostic_tool	443	451	handheld
I-Diagnostic_tool	452	462	pachymeter
O	463	465	by
O	466	467	a
O	468	475	trained
O	476	484	observer
O	484	485	.

O	486	494	Patients
O	494	495	'
B-Characteristic	496	500	CCTs
O	501	505	were
O	506	514	measured
O	515	517	at
O	518	519	2
O	520	531	consecutive
O	532	538	clinic
O	539	545	visits
O	545	546	.

B-Characteristic	547	551	Mean
I-Characteristic	552	559	central
I-Characteristic	560	567	corneal
I-Characteristic	568	577	thickness
O	577	578	.

O	579	582	The
O	583	591	readings
O	592	598	showed
O	599	604	clear
O	605	616	fluctuation
O	617	621	over
O	622	625	the
O	626	627	3
O	627	628	-
O	628	633	month
O	634	640	period
O	640	641	,
O	642	646	with
O	647	648	a
O	649	653	mean
O	654	664	difference
O	665	667	in
B-Characteristic	668	675	corneal
I-Characteristic	676	685	thickness
O	686	688	of
O	689	690	9
O	690	691	.
O	691	692	6
O	692	693	+
O	693	694	/
O	694	695	-
O	695	697	26
O	697	698	.
O	698	699	9
O	700	706	microm
O	707	709	in
O	710	713	the
O	714	719	right
B-Anatomy	720	723	eye
O	724	727	and
O	728	730	19
O	730	731	.
O	731	732	0
O	732	733	+
O	733	734	/
O	734	735	-
O	735	737	29
O	737	738	.
O	738	739	2
O	740	746	microm
O	747	749	in
O	750	753	the
O	754	758	left
B-Anatomy	759	762	eye
O	762	763	.

O	764	766	In
O	767	775	addition
O	775	776	,
O	777	782	there
O	783	786	was
O	787	788	a
O	789	799	systematic
O	800	804	bias
O	805	812	towards
O	813	822	increased
B-Characteristic	823	830	corneal
I-Characteristic	831	840	thickness
O	841	846	being
O	847	855	recorded
O	856	858	at
O	859	862	the
O	863	869	second
O	870	877	reading
O	878	880	in
O	881	885	both
B-Anatomy	886	890	eyes
O	890	891	.

O	892	896	This
O	897	904	reached
O	905	916	statistical
O	917	929	significance
O	930	932	in
O	933	937	both
O	938	941	the
O	942	947	right
B-Anatomy	948	951	eye
O	952	953	(
O	953	954	P
O	955	956	=
O	957	958	0
O	958	959	.
O	959	961	02
O	961	962	)
O	963	966	and
O	967	970	the
O	971	975	left
B-Anatomy	976	979	eye
O	980	981	(
O	981	982	P
O	983	984	=
O	985	986	0
O	986	987	.
O	987	991	0003
O	991	992	)
O	992	993	.

O	994	997	The
O	998	1006	criteria
O	1007	1011	used
O	1012	1014	to
O	1015	1025	categorize
O	1026	1029	the
O	1030	1034	risk
O	1035	1037	of
O	1038	1046	patients
O	1047	1057	developing
B-Disease	1058	1066	glaucoma
O	1067	1069	in
O	1070	1073	the
O	1074	1078	OHTS
O	1079	1083	were
O	1084	1088	then
O	1089	1096	applied
O	1097	1099	to
O	1100	1105	these
O	1106	1113	results
O	1113	1114	.

O	1115	1117	On
O	1118	1121	the
O	1122	1127	basis
O	1128	1130	of
O	1131	1134	the
O	1135	1141	second
O	1142	1149	reading
O	1149	1150	,
O	1151	1153	32
O	1153	1154	%
O	1155	1157	of
B-Anatomy	1158	1162	eyes
O	1163	1171	required
O	1172	1188	recategorization
O	1189	1191	in
O	1192	1196	both
O	1197	1200	the
O	1201	1206	right
O	1207	1210	and
O	1211	1215	left
B-Anatomy	1216	1220	eyes
O	1220	1221	.

O	1222	1234	Measurements
O	1235	1237	of
B-Characteristic	1238	1241	CCT
O	1242	1247	taken
O	1248	1254	within
O	1255	1256	a
O	1257	1265	clinical
O	1266	1273	setting
O	1274	1276	by
O	1277	1278	a
O	1279	1286	trained
O	1287	1295	observer
O	1296	1299	may
O	1300	1304	show
O	1305	1316	significant
O	1317	1328	variability
O	1328	1329	.

O	1330	1333	For
B-Characteristic	1334	1337	CCT
O	1338	1340	to
O	1341	1347	become
O	1348	1349	a
O	1350	1358	valuable
O	1359	1367	addition
O	1368	1370	to
O	1371	1374	the
O	1375	1385	assessment
O	1386	1388	of
B-Disease	1389	1397	glaucoma
O	1398	1406	suspects
O	1406	1407	,
O	1408	1412	more
O	1413	1417	than
O	1418	1421	one
O	1422	1429	reading
O	1430	1433	may
O	1434	1436	be
O	1437	1445	required
O	1445	1446	.

O	1447	1454	Failure
O	1455	1457	to
O	1458	1460	do
O	1461	1463	so
O	1464	1467	may
O	1468	1474	result
O	1475	1477	in
O	1478	1495	misclassification
O	1496	1499	and
O	1499	1500	,
O	1501	1505	thus
O	1505	1506	,
O	1507	1509	an
O	1510	1520	inaccurate
O	1521	1531	assignment
O	1532	1534	of
O	1535	1539	risk
O	1539	1540	.

O	0	10	Comparison
O	11	13	of
B-Characteristic	14	21	macular
I-Characteristic	22	25	and
I-Characteristic	26	39	peripapillary
I-Characteristic	40	52	measurements
O	53	56	for
O	57	60	the
O	61	70	detection
O	71	73	of
B-Disease	74	82	glaucoma
O	82	83	:
O	84	86	an
B-Diagnostic_tool	87	94	optical
I-Diagnostic_tool	95	104	coherence
I-Diagnostic_tool	105	115	tomography
O	116	121	study
O	121	122	.

O	124	126	To
O	127	135	evaluate
B-Characteristic	136	143	macular
I-Characteristic	144	149	nerve
I-Characteristic	150	155	fiber
I-Characteristic	156	161	layer
I-Characteristic	162	163	(
I-Characteristic	163	166	NFL
I-Characteristic	166	167	)
I-Characteristic	168	177	thickness
O	178	180	in
B-Symptom	181	193	glaucomatous
I-Symptom	194	200	damage
O	201	203	by
B-Diagnostic_tool	204	211	optical
I-Diagnostic_tool	212	221	coherence
I-Diagnostic_tool	222	232	tomography
O	233	234	(
B-Diagnostic_tool	234	237	OCT
O	237	238	)
O	239	242	and
O	243	245	to
O	246	253	compare
O	254	257	its
O	258	272	discriminating
O	273	278	power
O	279	282	for
B-Disease	283	291	glaucoma
O	292	295	and
B-Disease	296	304	glaucoma
I-Disease	305	313	suspects
O	314	318	with
O	319	323	that
O	324	326	of
B-Characteristic	327	332	total
I-Characteristic	333	340	macular
I-Characteristic	341	350	thickness
O	351	354	and
B-Characteristic	355	368	peripapillary
I-Characteristic	369	372	NFL
I-Characteristic	373	382	thickness
O	382	383	.

O	384	389	Cross
O	389	390	-
O	390	399	sectional
O	399	400	,
O	401	405	case
O	405	406	-
O	406	413	control
O	413	414	,
O	415	426	comparative
O	427	432	study
O	432	433	.

O	434	435	A
O	436	441	total
O	442	444	of
O	445	448	133
B-Anatomy	449	453	eyes
O	454	458	from
O	459	462	133
O	463	471	subjects
O	472	481	including
O	482	484	46
O	485	491	normal
B-Anatomy	492	496	eyes
O	496	497	,
O	498	500	48
B-Disease	501	509	glaucoma
I-Disease	509	510	-
I-Disease	510	517	suspect
B-Anatomy	518	522	eyes
O	522	523	,
O	524	527	and
O	528	530	39
B-Disease	531	539	glaucoma
B-Anatomy	540	544	eyes
O	545	549	were
O	550	558	enrolled
O	558	559	.

B-Characteristic	560	567	Macular
I-Characteristic	568	571	NFL
I-Characteristic	572	581	thickness
O	581	582	,
B-Characteristic	583	588	total
I-Characteristic	589	596	macular
I-Characteristic	597	606	thickness
O	606	607	,
O	608	611	and
B-Characteristic	612	625	peripapillary
I-Characteristic	626	629	NFL
I-Characteristic	630	639	thickness
O	640	644	were
O	645	653	measured
O	654	656	by
B-Diagnostic_tool	657	664	Stratus
I-Diagnostic_tool	665	668	OCT
O	669	671	in
O	672	676	each
O	677	687	diagnostic
O	688	693	group
O	693	694	.

O	695	698	The
O	699	707	patterns
O	708	711	and
O	712	724	measurements
O	725	727	of
B-Characteristic	728	735	macular
I-Characteristic	736	739	NFL
I-Characteristic	739	740	,
I-Characteristic	741	746	total
I-Characteristic	747	754	macular
I-Characteristic	754	755	,
I-Characteristic	756	759	and
I-Characteristic	760	773	peripapillary
I-Characteristic	774	777	NFL
I-Characteristic	778	787	thickness
O	788	790	in
O	791	796	total
O	797	801	mean
O	801	802	,
O	803	804	4
O	805	814	quadrants
O	814	815	,
O	816	819	and
O	820	822	12
O	823	828	clock
O	829	834	hours
O	834	835	.

O	836	839	The
O	840	854	discriminating
O	855	860	power
O	861	863	of
O	864	868	each
O	869	878	parameter
O	879	882	for
O	883	892	detection
O	893	895	of
B-Disease	896	904	glaucoma
I-Disease	905	913	suspects
O	914	917	and
B-Disease	918	926	glaucoma
O	927	930	was
O	931	940	evaluated
O	941	943	by
O	944	949	areas
O	950	955	under
O	956	959	the
O	960	968	receiver
O	969	978	operating
O	979	993	characteristic
O	994	999	curve
O	1000	1001	(
O	1001	1005	AROC
O	1005	1006	)
O	1006	1007	.

O	1008	1022	Correspondence
O	1023	1027	with
B-Characteristic	1028	1034	visual
I-Characteristic	1035	1040	field
I-Characteristic	1041	1049	function
O	1050	1053	was
O	1054	1061	studied
O	1062	1064	by
O	1065	1071	linear
O	1072	1082	regression
O	1083	1091	analysis
O	1091	1092	.

O	1093	1096	The
B-Characteristic	1097	1104	macular
I-Characteristic	1105	1108	NFL
I-Characteristic	1109	1116	profile
O	1117	1126	exhibited
O	1127	1128	a
O	1129	1135	double
O	1135	1136	-
O	1136	1140	hump
O	1141	1148	pattern
O	1149	1153	with
O	1154	1159	peaks
O	1160	1164	over
B-Anatomy	1165	1176	superonasal
I-Anatomy	1177	1180	and
I-Anatomy	1181	1192	inferonasal
I-Anatomy	1193	1200	sectors
O	1200	1201	.

O	1202	1203	A
O	1204	1215	significant
O	1216	1226	difference
O	1227	1229	in
B-Characteristic	1230	1237	macular
I-Characteristic	1238	1241	NFL
I-Characteristic	1242	1251	thickness
O	1252	1259	between
O	1260	1266	normal
O	1267	1270	and
B-Disease	1271	1279	glaucoma
I-Disease	1279	1280	-
I-Disease	1280	1287	suspect
O	1288	1294	groups
O	1295	1298	was
O	1299	1304	found
O	1305	1307	at
O	1308	1311	the
O	1312	1313	6
O	1313	1314	-
O	1314	1315	o
O	1315	1316	'
O	1316	1321	clock
O	1322	1330	position
O	1330	1331	,
O	1332	1339	whereas
O	1340	1341	a
O	1342	1352	difference
O	1353	1356	was
O	1357	1362	found
O	1363	1365	in
O	1366	1369	all
O	1370	1376	except
O	1377	1380	the
O	1381	1389	temporal
O	1390	1395	clock
O	1396	1401	hours
O	1402	1409	between
O	1410	1416	normal
O	1417	1420	and
B-Disease	1421	1429	glaucoma
O	1430	1438	subjects
O	1438	1439	.

O	1440	1442	No
O	1443	1454	significant
O	1455	1465	difference
O	1466	1468	in
O	1469	1474	AROCs
O	1475	1478	for
O	1479	1488	detection
O	1489	1491	of
B-Disease	1492	1500	glaucoma
I-Disease	1501	1509	suspects
O	1510	1512	or
B-Disease	1513	1521	glaucoma
O	1522	1525	was
O	1526	1531	found
O	1532	1536	when
B-Characteristic	1537	1544	macular
I-Characteristic	1545	1548	NFL
I-Characteristic	1549	1558	thickness
O	1559	1562	and
B-Characteristic	1563	1568	total
I-Characteristic	1569	1576	macular
I-Characteristic	1577	1586	thickness
O	1587	1599	measurements
O	1600	1604	were
O	1605	1613	compared
O	1613	1614	.

O	1615	1622	However
O	1622	1623	,
B-Characteristic	1624	1628	mean
I-Characteristic	1629	1636	macular
I-Characteristic	1637	1640	NFL
I-Characteristic	1641	1650	thickness
O	1651	1663	demonstrated
O	1664	1665	a
O	1666	1674	stronger
O	1675	1686	correlation
O	1687	1691	with
B-Characteristic	1692	1698	visual
I-Characteristic	1699	1707	function
O	1708	1712	than
B-Characteristic	1713	1717	mean
I-Characteristic	1718	1725	macular
I-Characteristic	1726	1735	thickness
O	1736	1737	(
O	1737	1738	r
O	1739	1740	=
O	1741	1742	0
O	1742	1743	.
O	1743	1745	39
O	1745	1746	/
O	1746	1748	R2
O	1749	1750	=
O	1751	1752	0
O	1752	1753	.
O	1753	1755	15
O	1756	1758	vs
O	1758	1759	.
O	1760	1761	r
O	1762	1763	=
O	1764	1765	0
O	1765	1766	.
O	1766	1768	23
O	1768	1769	/
O	1769	1771	R2
O	1772	1773	=
O	1774	1775	0
O	1775	1776	.
O	1776	1778	05
O	1778	1779	,
O	1780	1781	P
O	1782	1783	=
O	1783	1784	0
O	1784	1785	.
O	1785	1788	042
O	1788	1789	)
O	1789	1790	.

O	1791	1796	Among
O	1797	1800	all
O	1801	1804	the
O	1805	1813	findings
O	1813	1814	,
B-Characteristic	1815	1823	inferior
I-Characteristic	1824	1837	peripapillary
I-Characteristic	1838	1841	NFL
I-Characteristic	1842	1851	thickness
O	1852	1855	had
O	1856	1859	the
O	1860	1864	best
O	1865	1876	performance
O	1877	1879	in
O	1880	1894	discriminating
B-Disease	1895	1903	glaucoma
O	1904	1905	(
O	1905	1909	AROC
O	1909	1910	,
O	1911	1912	0
O	1912	1913	.
O	1913	1915	91
O	1915	1916	)
O	1917	1920	and
B-Disease	1921	1929	glaucoma
I-Disease	1930	1938	suspects
O	1939	1940	(
O	1940	1944	AROC
O	1944	1945	,
O	1946	1947	0
O	1947	1948	.
O	1948	1950	67
O	1950	1951	)
O	1951	1952	.

O	1953	1955	It
O	1956	1960	also
O	1961	1964	had
O	1965	1968	the
O	1969	1978	strongest
O	1979	1990	correlation
O	1991	1995	with
B-Characteristic	1996	2002	visual
I-Characteristic	2003	2011	function
O	2012	2013	(
O	2013	2014	r
O	2015	2016	=
O	2017	2018	0
O	2018	2019	.
O	2019	2021	60
O	2021	2022	/
O	2022	2024	R2
O	2025	2026	=
O	2027	2028	0
O	2028	2029	.
O	2029	2031	36
O	2031	2032	,
O	2033	2034	P
O	2035	2036	<
O	2037	2038	0
O	2038	2039	.
O	2039	2042	001
O	2042	2043	)
O	2043	2044	.

B-Characteristic	2045	2052	Macular
I-Characteristic	2053	2056	NFL
I-Characteristic	2057	2066	thickness
O	2067	2070	was
O	2071	2084	significantly
O	2085	2092	reduced
O	2093	2095	in
B-Disease	2096	2104	glaucoma
O	2104	2105	.

O	2106	2108	It
O	2109	2112	had
O	2113	2114	a
O	2115	2122	similar
O	2123	2137	discriminating
O	2138	2143	power
O	2144	2147	for
B-Disease	2148	2156	glaucoma
O	2157	2166	detection
O	2167	2170	but
O	2171	2172	a
O	2173	2181	stronger
O	2182	2193	correlation
O	2194	2198	with
B-Characteristic	2199	2205	visual
I-Characteristic	2206	2214	function
O	2215	2219	than
B-Characteristic	2220	2225	total
I-Characteristic	2226	2233	macular
I-Characteristic	2234	2243	thickness
O	2243	2244	.

B-Characteristic	2245	2258	Peripapillary
I-Characteristic	2259	2262	NFL
I-Characteristic	2263	2272	thickness
O	2272	2273	,
O	2274	2281	however
O	2281	2282	,
O	2283	2295	outperformed
O	2296	2300	both
B-Characteristic	2301	2306	total
I-Characteristic	2307	2314	macular
I-Characteristic	2315	2318	and
I-Characteristic	2319	2326	macular
I-Characteristic	2327	2330	NFL
I-Characteristic	2331	2340	thickness
O	2341	2343	in
O	2344	2349	terms
O	2350	2352	of
B-Disease	2353	2361	glaucoma
O	2362	2371	detection
O	2372	2375	and
B-Characteristic	2376	2382	visual
I-Characteristic	2383	2391	function
O	2392	2403	correlation
O	2403	2404	.

B-Characteristic	2405	2418	Peripapillary
I-Characteristic	2419	2422	NFL
I-Characteristic	2423	2432	thickness
O	2432	2433	,
O	2434	2436	as
O	2437	2438	a
B-Characteristic	2439	2444	total
I-Characteristic	2445	2456	measurement
I-Characteristic	2457	2459	of
I-Characteristic	2460	2464	both
I-Characteristic	2465	2472	macular
I-Characteristic	2473	2476	and
I-Characteristic	2477	2487	peripheral
I-Characteristic	2488	2491	NFL
O	2491	2492	,
O	2493	2495	is
O	2496	2501	still
O	2502	2505	the
O	2506	2510	best
O	2511	2520	surrogate
O	2521	2527	marker
O	2528	2530	in
B-Disease	2531	2539	glaucoma
O	2540	2550	assessment
O	2550	2551	.

B-Disease	0	5	Coats
I-Disease	5	6	'
I-Disease	7	14	disease
O	15	24	diagnosed
O	25	27	in
B-Characteristic	28	37	adulthood
O	37	38	.

O	40	42	To
O	43	54	investigate
O	55	58	the
O	59	73	manifestations
O	74	77	and
O	78	86	clinical
O	87	93	course
O	94	96	of
B-Disease	97	102	Coats
I-Disease	102	103	'
I-Disease	104	111	disease
O	112	121	diagnosed
O	122	124	in
B-Characteristic	125	134	adulthood
O	135	138	and
O	139	141	to
O	142	150	describe
O	151	154	the
O	155	170	characteristics
O	171	173	of
O	174	182	patients
O	183	186	who
O	187	194	develop
O	195	197	it
O	197	198	.

O	199	212	Retrospective
O	213	226	observational
O	227	231	case
O	232	238	series
O	238	239	.

O	240	248	Thirteen
B-Anatomy	249	253	eyes
O	254	256	of
O	257	259	13
O	260	268	patients
O	269	273	with
B-Disease	274	279	Coats
I-Disease	279	280	'
I-Disease	281	288	disease
O	289	298	diagnosed
B-Characteristic	299	304	after
I-Characteristic	305	308	age
I-Characteristic	309	311	35
I-Characteristic	312	317	years
O	317	318	.

O	319	322	All
O	323	331	patients
O	332	340	examined
O	341	343	in
O	344	347	the
O	348	355	authors
O	355	356	'
O	357	365	referral
O	366	375	practices
O	376	379	for
B-Disease	380	385	Coats
I-Disease	385	386	'
I-Disease	387	394	disease
O	395	404	diagnosed
B-Characteristic	405	410	after
I-Characteristic	411	414	the
I-Characteristic	415	418	age
I-Characteristic	419	421	of
I-Characteristic	422	424	35
I-Characteristic	425	430	years
O	431	435	were
O	436	446	identified
O	446	447	.

O	448	456	Patients
O	457	461	with
O	462	463	a
O	464	471	history
O	472	474	of
B-Characteristic	475	484	radiation
I-Characteristic	485	493	exposure
O	493	494	,
B-Characteristic	495	506	intraocular
I-Characteristic	507	519	inflammation
O	519	520	,
B-Characteristic	521	528	retinal
I-Characteristic	529	537	vascular
I-Characteristic	538	547	occlusion
O	547	548	,
O	549	551	or
B-Characteristic	552	557	Coats
I-Characteristic	557	558	'
I-Characteristic	559	567	response
O	568	572	were
O	573	581	excluded
O	581	582	.

O	583	584	A
O	585	591	review
O	592	594	of
O	595	600	their
O	601	611	historical
O	611	612	,
O	613	621	clinical
O	621	622	,
O	623	626	and
B-Diagnostic_tool	627	638	fluorescein
I-Diagnostic_tool	639	651	angiographic
O	652	660	features
O	661	664	and
B-Characteristic	665	677	demographics
O	678	681	was
O	682	691	performed
O	691	692	.

O	693	698	There
O	699	703	were
O	704	706	13
O	707	715	patients
O	716	720	with
O	721	722	a
O	723	727	mean
B-Characteristic	728	731	age
I-Characteristic	732	734	at
I-Characteristic	735	744	diagnosis
I-Characteristic	745	747	of
I-Characteristic	748	750	50
I-Characteristic	751	756	years
I-Characteristic	757	758	(
I-Characteristic	758	763	range
I-Characteristic	763	764	,
I-Characteristic	765	767	36
I-Characteristic	767	768	-
I-Characteristic	768	770	79
I-Characteristic	770	771	)
O	772	775	and
O	776	777	a
O	778	782	mean
B-Characteristic	783	789	follow
I-Characteristic	789	790	-
I-Characteristic	790	792	up
I-Characteristic	793	795	of
I-Characteristic	796	797	5
I-Characteristic	797	798	.
I-Characteristic	798	799	8
I-Characteristic	800	805	years
I-Characteristic	806	807	(
I-Characteristic	807	812	range
I-Characteristic	812	813	,
I-Characteristic	814	815	0
I-Characteristic	815	816	-
I-Characteristic	816	818	17
I-Characteristic	818	819	)
O	819	820	.

O	821	826	These
O	827	835	patients
O	836	846	manifested
O	847	851	many
O	852	860	findings
O	861	868	typical
O	869	871	of
B-Disease	872	877	Coats
I-Disease	877	878	'
I-Disease	879	886	disease
O	886	887	,
O	888	897	including
O	898	901	the
O	902	912	unilateral
O	913	919	nature
O	920	922	of
O	923	926	the
O	927	934	disease
O	935	936	(
O	936	938	13
O	938	939	/
O	939	941	13
O	942	950	patients
O	950	951	)
O	951	952	,
B-Characteristic	953	957	male
O	958	970	predominance
O	971	972	(
O	972	974	12
O	974	975	/
O	975	977	13
O	977	978	)
O	978	979	,
B-Symptom	980	988	vascular
I-Symptom	989	1003	telangiectasis
O	1003	1004	,
B-Symptom	1005	1010	lipid
I-Symptom	1011	1020	exudation
O	1020	1021	,
B-Symptom	1022	1029	macular
I-Symptom	1030	1035	edema
O	1035	1036	,
O	1037	1040	and
B-Symptom	1041	1046	areas
I-Symptom	1047	1049	of
I-Symptom	1050	1059	capillary
I-Symptom	1060	1072	nonperfusion
I-Symptom	1073	1077	with
I-Symptom	1078	1086	adjacent
I-Symptom	1087	1091	webs
I-Symptom	1092	1094	of
I-Symptom	1095	1107	filigreelike
I-Symptom	1108	1119	capillaries
O	1119	1120	.

O	1121	1128	Disease
O	1129	1132	was
O	1133	1140	limited
O	1141	1143	to
O	1145	1146	<
O	1148	1150	or
O	1151	1152	=
O	1152	1153	6
O	1154	1159	clock
O	1160	1165	hours
O	1166	1168	in
O	1169	1171	10
O	1172	1174	of
O	1175	1177	13
O	1178	1186	patients
O	1187	1188	(
O	1188	1190	76
O	1190	1191	.
O	1191	1192	9
O	1192	1193	%
O	1193	1194	)
O	1194	1195	,
O	1196	1199	did
O	1200	1203	not
O	1204	1213	generally
O	1214	1221	involve
O	1222	1225	the
B-Anatomy	1226	1233	retinal
I-Anatomy	1234	1245	vasculature
I-Anatomy	1246	1254	anterior
I-Anatomy	1255	1257	to
I-Anatomy	1258	1261	the
I-Anatomy	1262	1269	equator
O	1269	1270	,
O	1271	1274	and
O	1275	1281	showed
O	1282	1289	limited
O	1290	1299	potential
O	1300	1302	to
O	1303	1309	expand
O	1310	1316	during
O	1317	1320	the
O	1321	1327	follow
O	1327	1328	-
O	1328	1330	up
O	1331	1337	period
O	1337	1338	.

O	1339	1340	A
B-Symptom	1341	1350	localized
I-Symptom	1351	1361	hemorrhage
O	1362	1365	was
O	1366	1371	noted
O	1372	1374	in
O	1375	1377	10
O	1378	1380	of
O	1381	1383	13
O	1384	1392	patients
O	1393	1394	(
O	1394	1396	76
O	1396	1397	.
O	1397	1398	9
O	1398	1399	%
O	1399	1400	)
O	1400	1401	,
O	1402	1408	almost
O	1409	1415	always
O	1416	1420	near
B-Symptom	1421	1427	larger
I-Symptom	1428	1438	aneurysmal
I-Symptom	1439	1450	dilatations
O	1450	1451	.

B-Symptom	1452	1459	Limited
I-Symptom	1460	1469	exudative
I-Symptom	1470	1480	detachment
I-Symptom	1481	1483	of
I-Symptom	1484	1487	the
I-Symptom	1488	1494	retina
O	1495	1498	was
O	1499	1503	seen
O	1504	1506	in
O	1507	1508	4
B-Anatomy	1509	1513	eyes
O	1513	1514	,
O	1515	1516	3
O	1517	1519	of
O	1520	1525	which
O	1526	1535	responded
O	1536	1538	to
O	1539	1548	localized
O	1549	1554	laser
O	1555	1571	photocoagulation
O	1571	1572	.

O	1573	1576	One
O	1577	1584	patient
O	1585	1588	had
B-Symptom	1589	1599	subretinal
I-Symptom	1600	1605	fluid
O	1606	1610	seen
O	1611	1613	on
B-Diagnostic_tool	1614	1620	ocular
I-Diagnostic_tool	1621	1630	coherence
I-Diagnostic_tool	1631	1641	tomography
O	1642	1646	that
O	1647	1650	did
O	1651	1654	not
O	1655	1662	require
O	1663	1672	treatment
O	1672	1673	.

O	1674	1676	On
O	1677	1684	average
O	1684	1685	,
O	1686	1694	patients
O	1695	1699	lost
O	1700	1701	2
O	1701	1702	.
O	1702	1703	1
O	1704	1709	lines
O	1710	1712	of
B-Characteristic	1713	1719	visual
I-Characteristic	1720	1726	acuity
O	1727	1733	during
O	1734	1737	the
O	1738	1744	follow
O	1744	1745	-
O	1745	1747	up
O	1748	1754	period
O	1754	1755	;
O	1756	1757	6
O	1758	1766	patients
O	1767	1770	had
O	1771	1772	a
B-Symptom	1773	1780	decline
I-Symptom	1781	1783	in
I-Symptom	1784	1790	vision
O	1790	1791	,
O	1792	1793	2
O	1794	1802	patients
O	1803	1806	had
B-Symptom	1807	1815	improved
I-Symptom	1816	1822	vision
O	1822	1823	,
O	1824	1827	and
O	1828	1829	3
O	1830	1838	patients
O	1839	1842	had
B-Characteristic	1843	1849	stable
I-Characteristic	1850	1856	vision
O	1856	1857	.

O	1858	1860	No
O	1861	1868	patient
O	1869	1872	had
O	1873	1876	end
O	1876	1877	-
O	1877	1882	stage
O	1883	1891	findings
O	1892	1894	of
B-Disease	1895	1900	Coats
I-Disease	1900	1901	'
I-Disease	1902	1909	disease
O	1909	1910	,
O	1911	1915	such
O	1916	1918	as
B-Symptom	1919	1923	iris
I-Symptom	1924	1942	neovascularization
O	1943	1945	or
B-Symptom	1946	1951	total
I-Symptom	1952	1961	exudative
I-Symptom	1962	1972	detachment
O	1972	1973	.

B-Disease	1974	1979	Coats
I-Disease	1979	1980	'
I-Disease	1981	1988	disease
O	1989	1992	can
O	1993	1998	first
O	1999	2001	be
O	2002	2011	diagnosed
O	2012	2014	in
B-Characteristic	2015	2024	adulthood
O	2025	2029	with
B-Symptom	2030	2037	retinal
I-Symptom	2038	2046	vascular
I-Symptom	2047	2060	abnormalities
O	2061	2068	similar
O	2069	2071	to
O	2072	2077	those
O	2078	2082	seen
O	2083	2085	in
B-Characteristic	2086	2093	younger
I-Characteristic	2094	2102	patients
O	2102	2103	.

O	2104	2109	There
O	2110	2113	are
O	2114	2115	a
O	2116	2122	number
O	2123	2125	of
O	2126	2135	important
O	2136	2147	differences
O	2148	2150	in
O	2151	2158	disease
O	2159	2172	manifestation
O	2173	2175	in
B-Characteristic	2176	2182	adults
O	2182	2183	,
O	2184	2193	including
O	2194	2201	limited
O	2202	2206	area
O	2207	2209	of
O	2210	2221	involvement
O	2221	2222	,
O	2223	2229	slower
O	2230	2238	apparent
O	2239	2250	progression
O	2251	2253	of
O	2254	2261	disease
O	2261	2262	,
O	2263	2266	and
B-Symptom	2267	2277	hemorrhage
I-Symptom	2278	2282	near
I-Symptom	2283	2289	larger
I-Symptom	2290	2298	vascular
I-Symptom	2299	2310	dilatations
O	2310	2311	.

O	0	3	The
B-Disease	4	11	dragged
I-Disease	11	12	-
I-Disease	12	17	fovea
I-Disease	18	26	diplopia
I-Disease	27	35	syndrome
O	35	36	:
O	37	45	clinical
O	46	61	characteristics
O	61	62	,
O	63	72	diagnosis
O	72	73	,
O	74	77	and
O	78	87	treatment
O	87	88	.

O	90	92	To
O	93	101	identify
O	102	105	the
O	106	114	clinical
O	115	130	characteristics
O	131	133	of
O	134	137	the
B-Disease	138	145	dragged
I-Disease	145	146	-
I-Disease	146	151	fovea
I-Disease	152	160	diplopia
I-Disease	161	169	syndrome
O	169	170	,
O	171	173	to
O	174	183	introduce
O	184	185	a
O	186	192	simple
O	193	203	diagnostic
O	204	208	test
O	209	213	that
O	214	218	aids
O	219	221	in
O	222	225	the
O	226	236	evaluation
O	237	239	of
O	240	244	such
O	245	253	patients
O	253	254	,
O	255	258	and
O	259	261	to
O	262	269	provide
O	270	271	a
O	272	278	simple
O	279	288	treatment
O	289	295	option
O	296	298	to
O	299	306	improve
O	307	310	the
B-Disease	311	319	diplopia
O	320	322	in
O	323	327	some
O	328	330	of
O	331	336	these
O	337	345	patients
O	345	346	.

O	347	360	Retrospective
O	360	361	,
O	362	375	observational
O	376	380	case
O	381	387	series
O	387	388	.

O	389	395	Ninety
O	395	396	-
O	396	400	five
O	401	409	affected
B-Anatomy	410	414	eyes
O	415	417	in
O	418	420	83
O	421	432	consecutive
O	433	441	patients
O	442	446	seen
O	447	454	between
O	455	462	January
O	463	464	1
O	464	465	,
O	466	470	1993
O	470	471	,
O	472	475	and
O	476	482	August
O	483	484	9
O	484	485	,
O	486	490	2004
O	490	491	,
O	492	495	who
O	496	500	were
O	501	510	diagnosed
O	511	515	with
O	516	519	the
B-Disease	520	527	dragged
I-Disease	527	528	-
I-Disease	528	533	fovea
I-Disease	534	542	diplopia
I-Disease	543	551	syndrome
O	552	554	at
O	555	558	one
O	559	570	institution
O	570	571	.

O	572	574	We
O	575	583	reviewed
O	584	587	the
O	588	595	records
O	596	598	of
O	599	602	222
O	603	611	patients
O	612	615	who
O	616	620	have
O	621	625	been
O	626	630	seen
O	631	633	in
O	634	637	the
O	638	645	Krieger
O	646	654	Children
O	654	655	'
O	655	656	s
O	657	660	Eye
O	661	667	Center
O	668	670	at
O	671	674	The
O	675	681	Wilmer
O	682	691	Institute
O	692	697	since
O	698	702	1993
O	703	707	with
O	708	709	a
O	710	719	diagnosis
O	720	722	of
B-Disease	723	734	maculopathy
O	734	735	,
B-Disease	736	744	internal
I-Disease	745	753	limiting
I-Disease	754	762	membrane
O	762	763	,
O	764	766	or
B-Disease	767	774	dragged
I-Disease	775	780	fovea
O	780	781	.

O	782	784	We
O	785	794	collected
O	795	801	ocular
O	802	810	findings
O	811	814	and
O	815	822	history
O	823	826	for
O	827	832	those
O	833	841	patients
O	842	845	who
O	846	854	reported
B-Disease	855	864	binocular
I-Disease	865	873	diplopia
O	874	878	that
O	879	882	was
O	883	886	not
O	887	895	amenable
O	896	898	to
O	899	904	prism
O	905	912	therapy
O	913	916	and
O	917	920	not
O	921	930	secondary
O	931	933	to
B-Disease	934	942	acquired
I-Disease	943	953	strabismus
O	953	954	.

O	955	957	We
O	958	966	recorded
O	967	970	the
O	971	979	presence
O	980	982	of
B-Symptom	983	997	metamorphopsia
O	998	1000	on
B-Diagnostic_tool	1001	1007	Amsler
I-Diagnostic_tool	1008	1012	grid
O	1013	1020	testing
O	1021	1023	or
O	1024	1029	other
O	1030	1038	clinical
O	1039	1047	evidence
O	1048	1050	of
B-Symptom	1051	1058	macular
I-Symptom	1059	1068	wrinkling
O	1068	1069	,
O	1070	1078	response
O	1079	1081	to
O	1082	1087	prism
O	1088	1093	trial
O	1093	1094	,
O	1095	1103	response
O	1104	1106	to
O	1107	1110	the
B-Diagnostic_tool	1111	1116	small
I-Diagnostic_tool	1116	1117	-
I-Diagnostic_tool	1117	1122	field
I-Diagnostic_tool	1123	1130	central
I-Diagnostic_tool	1131	1137	fusion
I-Diagnostic_tool	1138	1142	test
O	1143	1144	(
B-Diagnostic_tool	1144	1150	lights
I-Diagnostic_tool	1151	1153	on
I-Diagnostic_tool	1153	1154	-
I-Diagnostic_tool	1154	1157	off
I-Diagnostic_tool	1158	1162	test
O	1162	1163	)
O	1163	1164	,
O	1165	1168	and
O	1169	1177	response
O	1178	1180	to
B-Diagnostic_tool	1181	1188	partial
I-Diagnostic_tool	1189	1198	occlusion
I-Diagnostic_tool	1199	1203	with
I-Diagnostic_tool	1204	1210	Scotch
I-Diagnostic_tool	1211	1216	Satin
I-Diagnostic_tool	1217	1221	tape
O	1222	1223	(
O	1223	1225	3M
O	1226	1228	Co
O	1228	1229	.
O	1229	1230	,
O	1231	1233	St
O	1233	1234	.
O	1235	1239	Paul
O	1239	1240	,
O	1241	1243	MN
O	1243	1244	)
O	1244	1245	.

O	1246	1252	Ninety
O	1252	1253	-
O	1253	1257	five
O	1258	1266	affected
B-Anatomy	1267	1271	eyes
O	1272	1274	in
O	1275	1277	83
O	1278	1286	patients
O	1287	1290	met
O	1291	1294	the
O	1295	1303	criteria
O	1304	1307	for
O	1308	1317	inclusion
O	1318	1320	in
O	1321	1324	the
O	1325	1330	study
O	1330	1331	.

O	1332	1335	All
O	1336	1344	patients
O	1345	1348	who
O	1349	1353	were
O	1354	1360	tested
O	1361	1365	with
O	1366	1369	the
B-Diagnostic_tool	1370	1376	lights
I-Diagnostic_tool	1377	1379	on
I-Diagnostic_tool	1379	1380	-
I-Diagnostic_tool	1380	1383	off
I-Diagnostic_tool	1384	1388	test
O	1389	1390	(
O	1390	1391	n
O	1392	1393	=
O	1394	1396	69
O	1396	1397	)
O	1398	1407	responded
O	1408	1418	positively
O	1418	1419	,
O	1420	1433	demonstrating
O	1434	1439	rapid
B-Characteristic	1440	1447	central
I-Characteristic	1448	1454	fusion
O	1455	1459	with
O	1460	1464	room
O	1465	1471	lights
O	1472	1475	off
O	1475	1476	,
O	1477	1480	and
O	1481	1491	recurrence
O	1492	1494	of
B-Disease	1495	1502	central
I-Disease	1503	1511	diplopia
O	1512	1516	with
B-Symptom	1517	1527	peripheral
I-Symptom	1528	1534	fusion
O	1535	1539	with
O	1540	1544	room
O	1545	1551	lights
O	1552	1554	on
O	1554	1555	.

O	1556	1561	Forty
O	1561	1562	-
O	1562	1565	six
O	1566	1574	patients
O	1575	1576	(
O	1576	1578	of
O	1579	1581	64
O	1582	1588	tested
O	1588	1589	)
O	1590	1594	were
O	1595	1604	receptive
O	1605	1607	to
B-Diagnostic_tool	1608	1617	monocular
I-Diagnostic_tool	1618	1627	occlusion
I-Diagnostic_tool	1628	1632	with
I-Diagnostic_tool	1633	1639	Scotch
I-Diagnostic_tool	1640	1645	Satin
I-Diagnostic_tool	1646	1650	tape
O	1650	1651	.

O	1652	1655	The
B-Disease	1656	1663	dragged
I-Disease	1663	1664	-
I-Disease	1664	1669	fovea
I-Disease	1670	1678	diplopia
I-Disease	1679	1687	syndrome
O	1688	1696	consists
O	1697	1699	of
B-Disease	1700	1707	central
I-Disease	1708	1716	diplopia
O	1717	1719	in
O	1720	1723	the
O	1724	1732	presence
O	1733	1735	of
B-Symptom	1736	1746	peripheral
I-Symptom	1747	1753	fusion
O	1753	1754	,
O	1755	1764	secondary
O	1765	1767	to
B-Symptom	1768	1776	dragging
I-Symptom	1777	1779	of
I-Symptom	1780	1783	the
I-Symptom	1784	1789	fovea
I-Symptom	1790	1792	in
I-Symptom	1793	1796	one
I-Symptom	1797	1799	or
I-Symptom	1800	1804	both
I-Symptom	1805	1809	eyes
O	1810	1812	by
B-Anatomy	1813	1820	retinal
O	1821	1828	disease
O	1828	1829	.

O	1830	1833	The
B-Symptom	1834	1841	central
I-Symptom	1842	1850	diplopia
O	1851	1857	cannot
O	1858	1860	be
O	1861	1871	eliminated
O	1872	1874	by
O	1875	1880	prism
O	1881	1888	therapy
O	1889	1891	or
B-Anatomy	1892	1895	eye
I-Anatomy	1896	1902	muscle
O	1903	1910	surgery
O	1910	1911	.

O	1912	1915	The
B-Diagnostic_tool	1916	1922	lights
I-Diagnostic_tool	1923	1925	on
I-Diagnostic_tool	1925	1926	-
I-Diagnostic_tool	1926	1929	off
I-Diagnostic_tool	1930	1934	test
O	1935	1938	has
O	1939	1945	proved
O	1946	1959	pathognomonic
O	1960	1963	for
O	1964	1968	this
O	1969	1977	syndrome
O	1977	1978	,
O	1979	1982	and
O	1983	1987	many
O	1988	1996	patients
O	1997	2001	have
O	2002	2011	benefited
O	2012	2016	from
B-Diagnostic_tool	2017	2024	partial
I-Diagnostic_tool	2025	2034	monocular
I-Diagnostic_tool	2035	2044	occlusion
I-Diagnostic_tool	2045	2049	with
I-Diagnostic_tool	2050	2056	Scotch
I-Diagnostic_tool	2057	2062	Satin
I-Diagnostic_tool	2063	2067	tape
O	2067	2068	.

O	3	6	The
B-Classification_system	7	10	Age
I-Classification_system	10	11	-
I-Classification_system	11	18	Related
I-Classification_system	19	22	Eye
I-Classification_system	23	30	Disease
I-Classification_system	31	36	Study
O	37	45	severity
O	46	51	scale
O	52	55	for
B-Disease	56	59	age
I-Disease	59	60	-
I-Disease	60	67	related
I-Disease	68	75	macular
I-Disease	76	88	degeneration
O	88	89	:
B-Classification_system	90	95	AREDS
O	96	102	Report
O	103	105	No
O	105	106	.
O	107	109	17

O	111	120	Objective
O	120	121	:
O	122	124	To
O	125	132	develop
O	133	134	a
B-Diagnostic_tool	135	141	fundus
I-Diagnostic_tool	142	154	photographic
O	155	163	severity
O	164	169	scale
O	170	173	for
B-Disease	174	177	age
I-Disease	177	178	-
I-Disease	178	185	related
I-Disease	186	193	macular
I-Disease	194	206	degeneration
O	207	208	(
B-Disease	208	211	AMD
O	211	212	)
O	212	213	.

O	215	222	Methods
O	222	223	:
O	224	226	In
O	227	230	the
B-Classification_system	231	234	Age
I-Classification_system	234	235	-
I-Classification_system	235	242	Related
I-Classification_system	243	246	Eye
I-Classification_system	247	254	Disease
I-Classification_system	255	260	Study
O	260	261	,
B-Diagnostic_tool	262	274	stereoscopic
I-Diagnostic_tool	275	280	color
I-Diagnostic_tool	281	287	fundus
I-Diagnostic_tool	288	299	photographs
O	300	304	were
O	305	310	taken
O	311	313	at
O	314	322	baseline
O	322	323	,
O	324	326	at
O	327	330	the
O	331	332	2
O	332	333	-
O	333	337	year
O	338	344	follow
O	344	345	-
O	345	347	up
O	348	353	visit
O	353	354	,
O	355	358	and
O	359	367	annually
O	368	378	thereafter
O	378	379	.

B-Diagnostic_tool	380	391	Photographs
O	392	396	were
O	397	403	graded
O	404	407	for
B-Symptom	408	414	drusen
O	415	430	characteristics
O	431	432	(
O	432	436	size
O	436	437	,
O	438	442	type
O	442	443	,
O	444	448	area
O	448	449	)
O	449	450	,
B-Symptom	451	461	pigmentary
I-Symptom	462	475	abnormalities
O	476	477	(
B-Symptom	477	486	increased
I-Symptom	487	494	pigment
O	494	495	,
B-Symptom	496	510	depigmentation
O	510	511	,
B-Symptom	512	522	geographic
I-Symptom	523	530	atrophy
O	530	531	)
O	531	532	,
O	533	536	and
O	537	545	presence
O	546	548	of
B-Symptom	549	562	abnormalities
O	563	577	characteristic
O	578	580	of
B-Disease	581	592	neovascular
I-Disease	593	596	AMD
O	597	598	(
B-Symptom	598	605	retinal
I-Symptom	606	613	pigment
I-Symptom	614	624	epithelial
I-Symptom	625	635	detachment
O	635	636	,
B-Symptom	637	643	serous
I-Symptom	644	646	or
I-Symptom	647	658	hemorrhagic
I-Symptom	659	666	sensory
I-Symptom	667	674	retinal
I-Symptom	675	685	detachment
O	685	686	,
B-Symptom	687	697	subretinal
I-Symptom	698	700	or
I-Symptom	701	704	sub
I-Symptom	704	705	-
I-Symptom	705	712	retinal
I-Symptom	713	720	pigment
I-Symptom	721	731	epithelial
I-Symptom	732	742	hemorrhage
O	742	743	,
B-Symptom	744	754	subretinal
I-Symptom	755	762	fibrous
I-Symptom	763	769	tissue
O	769	770	)
O	770	771	.

B-Disease	772	780	Advanced
I-Disease	781	784	AMD
O	785	788	was
O	789	796	defined
O	797	799	as
O	800	808	presence
O	809	811	of
B-Symptom	812	813	1
I-Symptom	814	816	or
I-Symptom	817	821	more
I-Symptom	822	833	neovascular
I-Symptom	834	837	AMD
I-Symptom	838	851	abnormalities
O	851	852	,
B-Symptom	853	869	photocoagulation
I-Symptom	870	873	for
I-Symptom	874	877	AMD
O	877	878	,
O	879	881	or
B-Symptom	882	892	geographic
I-Symptom	893	900	atrophy
I-Symptom	901	910	involving
I-Symptom	911	914	the
I-Symptom	915	921	center
I-Symptom	922	924	of
I-Symptom	925	928	the
I-Symptom	929	935	macula
O	935	936	.

O	937	939	We
O	940	948	explored
O	949	961	associations
O	962	967	among
B-Anatomy	968	973	right
I-Anatomy	974	978	eyes
O	979	981	of
O	982	986	3212
O	987	999	participants
O	1000	1007	between
O	1008	1016	severity
O	1017	1019	of
B-Symptom	1020	1026	drusen
O	1027	1042	characteristics
O	1043	1046	and
B-Symptom	1047	1057	pigmentary
I-Symptom	1058	1071	abnormalities
O	1072	1074	at
O	1075	1083	baseline
O	1084	1087	and
O	1088	1099	development
O	1100	1102	of
B-Disease	1103	1111	advanced
I-Disease	1112	1115	AMD
O	1116	1122	within
O	1123	1124	5
O	1125	1130	years
O	1131	1133	of
O	1134	1140	follow
O	1140	1141	-
O	1141	1143	up
O	1143	1144	.

O	1146	1153	Results
O	1153	1154	:
O	1155	1156	A
O	1157	1158	9
O	1158	1159	-
O	1159	1163	step
O	1164	1172	severity
O	1173	1178	scale
O	1179	1183	that
O	1184	1192	combines
O	1193	1194	a
O	1195	1196	6
O	1196	1197	-
O	1197	1201	step
B-Symptom	1202	1208	drusen
O	1209	1213	area
O	1214	1219	scale
O	1220	1224	with
O	1225	1226	a
O	1227	1228	5
O	1228	1229	-
O	1229	1233	step
B-Symptom	1234	1244	pigmentary
I-Symptom	1245	1256	abnormality
O	1257	1262	scale
O	1263	1266	was
O	1267	1276	developed
O	1276	1277	,
O	1278	1280	on
O	1281	1286	which
O	1287	1290	the
O	1291	1292	5
O	1292	1293	-
O	1293	1297	year
O	1298	1302	risk
O	1303	1305	of
B-Disease	1306	1314	advanced
I-Disease	1315	1318	AMD
O	1319	1328	increased
O	1329	1342	progressively
O	1343	1347	from
O	1348	1352	less
O	1353	1357	than
O	1358	1359	1
O	1359	1360	%
O	1361	1363	in
O	1364	1368	step
O	1369	1370	1
O	1371	1373	to
O	1374	1379	about
O	1380	1382	50
O	1382	1383	%
O	1384	1386	in
O	1387	1391	step
O	1392	1393	9
O	1393	1394	.

O	1395	1400	Among
O	1401	1404	the
O	1405	1408	334
B-Anatomy	1409	1413	eyes
O	1414	1418	that
O	1419	1422	had
O	1423	1425	at
O	1426	1431	least
O	1432	1433	a
O	1434	1435	3
O	1435	1436	-
O	1436	1440	step
O	1441	1452	progression
O	1453	1455	on
O	1456	1459	the
O	1460	1465	scale
O	1466	1473	between
O	1474	1477	the
O	1478	1486	baseline
O	1487	1490	and
O	1491	1492	5
O	1492	1493	-
O	1493	1497	year
O	1498	1504	visits
O	1504	1505	,
O	1506	1512	almost
O	1513	1517	half
O	1518	1524	showed
O	1525	1533	stepwise
O	1534	1545	progression
O	1546	1553	through
O	1554	1565	intervening
O	1566	1574	severity
O	1575	1581	levels
O	1582	1584	at
O	1585	1596	intervening
O	1597	1603	visits
O	1603	1604	.

O	1605	1614	Replicate
O	1615	1623	gradings
O	1624	1630	showed
O	1631	1640	agreement
O	1641	1647	within
O	1648	1649	1
O	1650	1654	step
O	1655	1657	on
O	1658	1661	the
O	1662	1667	scale
O	1668	1670	in
O	1671	1673	87
O	1673	1674	%
O	1675	1677	of
B-Anatomy	1678	1682	eyes
O	1682	1683	.

O	1685	1696	Conclusions
O	1696	1697	:
O	1698	1701	The
O	1702	1707	scale
O	1708	1716	provides
O	1717	1727	convenient
O	1728	1732	risk
O	1733	1743	categories
O	1744	1747	and
O	1748	1751	has
O	1752	1762	acceptable
O	1763	1778	reproducibility
O	1778	1779	.

O	1780	1791	Progression
O	1792	1797	along
O	1798	1800	it
O	1801	1804	may
O	1805	1810	prove
O	1811	1813	to
O	1814	1816	be
O	1817	1823	useful
O	1824	1826	as
O	1827	1828	a
O	1829	1838	surrogate
O	1839	1842	for
O	1843	1854	progression
O	1855	1857	to
B-Disease	1858	1866	advanced
I-Disease	1867	1870	AMD
O	1870	1871	.

O	2	3	A
O	4	14	simplified
O	15	23	severity
O	24	29	scale
O	30	33	for
B-Disease	34	37	age
I-Disease	37	38	-
I-Disease	38	45	related
I-Disease	46	53	macular
I-Disease	54	66	degeneration
O	66	67	:
B-Classification_system	68	73	AREDS
O	74	80	Report
O	81	83	No
O	83	84	.
O	85	87	18

O	89	98	Objective
O	98	99	:
O	100	102	To
O	103	110	develop
O	111	112	a
O	113	123	simplified
O	124	132	clinical
O	133	138	scale
O	139	147	defining
O	148	152	risk
O	153	163	categories
O	164	167	for
O	168	179	development
O	180	182	of
B-Disease	183	191	advanced
I-Disease	192	195	age
I-Disease	195	196	-
I-Disease	196	203	related
I-Disease	204	211	macular
I-Disease	212	224	degeneration
O	225	226	(
B-Disease	226	229	AMD
O	229	230	)
O	230	231	.

O	233	240	Methods
O	240	241	:
O	242	251	Following
O	252	263	development
O	264	266	of
O	267	268	a
O	269	277	detailed
O	278	283	scale
O	284	287	for
O	288	298	individual
B-Anatomy	299	303	eyes
O	304	309	based
O	310	312	on
O	313	321	gradings
O	322	324	of
B-Diagnostic_tool	325	331	fundus
I-Diagnostic_tool	332	343	photographs
O	344	346	in
O	347	350	the
B-Classification_system	351	354	Age
I-Classification_system	354	355	-
I-Classification_system	355	362	Related
I-Classification_system	363	366	Eye
I-Classification_system	367	374	Disease
I-Classification_system	375	380	Study
O	380	381	,
O	382	387	rates
O	388	390	of
O	391	402	progression
O	403	405	to
B-Disease	406	414	advanced
I-Disease	415	418	AMD
O	419	423	were
O	424	432	assessed
O	433	435	in
O	436	441	cross
O	441	442	-
O	442	453	tabulations
O	454	456	of
O	457	465	presence
O	466	468	or
O	469	476	absence
O	477	479	in
O	480	484	each
B-Anatomy	485	488	eye
O	489	491	of
O	492	493	2
O	494	500	easily
O	501	511	identified
B-Symptom	512	519	retinal
I-Symptom	520	533	abnormalities
O	533	534	,
B-Symptom	535	541	drusen
O	542	545	and
B-Symptom	546	553	pigment
I-Symptom	554	567	abnormalities
O	567	568	.

B-Symptom	569	574	Large
I-Symptom	575	581	drusen
O	582	585	and
O	586	589	any
B-Symptom	590	597	pigment
I-Symptom	598	605	changes
O	606	610	were
O	611	623	particularly
O	624	634	predictive
O	635	637	of
O	638	648	developing
B-Disease	649	657	advanced
I-Disease	658	661	AMD
O	661	662	.

O	664	671	Results
O	671	672	:
O	673	676	The
O	677	684	scoring
O	685	691	system
O	692	701	developed
O	702	705	for
O	706	714	patients
O	715	722	assigns
O	723	725	to
O	726	730	each
B-Anatomy	731	734	eye
O	735	736	1
O	737	741	risk
O	742	748	factor
O	749	752	for
O	753	756	the
O	757	765	presence
O	766	768	of
B-Symptom	769	770	1
I-Symptom	771	773	or
I-Symptom	774	778	more
I-Symptom	779	784	large
I-Symptom	785	786	(
I-Symptom	786	787	>
I-Symptom	788	790	or
I-Symptom	791	792	=
I-Symptom	793	796	125
I-Symptom	797	803	microm
I-Symptom	803	804	,
I-Symptom	805	810	width
I-Symptom	811	813	of
I-Symptom	814	815	a
I-Symptom	816	821	large
I-Symptom	822	826	vein
I-Symptom	827	829	at
I-Symptom	830	834	disc
I-Symptom	835	841	margin
I-Symptom	841	842	)
I-Symptom	843	849	drusen
O	850	853	and
O	854	855	1
O	856	860	risk
O	861	867	factor
O	868	871	for
O	872	875	the
O	876	884	presence
O	885	887	of
O	888	891	any
B-Symptom	892	899	pigment
I-Symptom	900	911	abnormality
O	911	912	.

O	913	917	Risk
O	918	925	factors
O	926	929	are
O	930	936	summed
O	937	943	across
O	944	948	both
B-Anatomy	949	953	eyes
O	953	954	,
O	955	963	yielding
O	964	965	a
O	966	967	5
O	967	968	-
O	968	972	step
O	973	978	scale
O	979	980	(
O	980	981	0
O	981	982	-
O	982	983	4
O	983	984	)
O	985	987	on
O	988	993	which
O	994	997	the
O	998	1009	approximate
O	1010	1011	5
O	1011	1012	-
O	1012	1016	year
O	1017	1021	risk
O	1022	1024	of
O	1025	1035	developing
B-Disease	1036	1044	advanced
I-Disease	1045	1048	AMD
O	1049	1051	in
O	1052	1054	at
O	1055	1060	least
O	1061	1064	one
B-Anatomy	1065	1068	eye
O	1069	1078	increases
O	1079	1081	in
O	1082	1086	this
O	1087	1093	easily
O	1094	1104	remembered
O	1105	1113	sequence
O	1113	1114	:
O	1115	1116	0
O	1117	1124	factors
O	1124	1125	,
O	1126	1127	0
O	1127	1128	.
O	1128	1129	5
O	1129	1130	%
O	1130	1131	;
O	1132	1133	1
O	1134	1140	factor
O	1140	1141	,
O	1142	1143	3
O	1143	1144	%
O	1144	1145	;
O	1146	1147	2
O	1148	1155	factors
O	1155	1156	,
O	1157	1159	12
O	1159	1160	%
O	1160	1161	;
O	1162	1163	3
O	1164	1171	factors
O	1171	1172	,
O	1173	1175	25
O	1175	1176	%
O	1176	1177	;
O	1178	1181	and
O	1182	1183	4
O	1184	1191	factors
O	1191	1192	,
O	1193	1195	50
O	1195	1196	%
O	1196	1197	.

O	1198	1201	For
O	1202	1209	persons
O	1210	1214	with
O	1215	1217	no
B-Symptom	1218	1223	large
I-Symptom	1224	1230	drusen
O	1230	1231	,
O	1232	1240	presence
O	1241	1243	of
B-Symptom	1244	1256	intermediate
I-Symptom	1257	1263	drusen
O	1264	1266	in
O	1267	1271	both
B-Anatomy	1272	1276	eyes
O	1277	1279	is
O	1280	1287	counted
O	1288	1290	as
O	1291	1292	1
O	1293	1297	risk
O	1298	1304	factor
O	1304	1305	.

O	1307	1317	Conclusion
O	1317	1318	:
O	1319	1323	This
O	1324	1334	simplified
O	1335	1340	scale
O	1341	1349	provides
O	1350	1360	convenient
O	1361	1365	risk
O	1366	1376	categories
O	1377	1380	for
O	1381	1392	development
O	1393	1395	of
B-Disease	1396	1404	advanced
I-Disease	1405	1408	AMD
O	1409	1413	that
O	1414	1417	can
O	1418	1420	be
O	1421	1431	determined
O	1432	1434	by
O	1435	1443	clinical
O	1444	1455	examination
O	1456	1458	or
O	1459	1461	by
O	1462	1466	less
O	1467	1476	demanding
B-Diagnostic_tool	1477	1489	photographic
I-Diagnostic_tool	1490	1500	procedures
O	1501	1505	than
O	1506	1510	used
O	1511	1513	in
O	1514	1517	the
B-Classification_system	1518	1521	Age
I-Classification_system	1521	1522	-
I-Classification_system	1522	1529	Related
I-Classification_system	1530	1533	Eye
I-Classification_system	1534	1541	Disease
I-Classification_system	1542	1547	Study
O	1547	1548	.

O	0	10	Evaluation
O	11	13	of
O	14	17	the
B-Classification_system	18	26	clinical
I-Classification_system	27	30	age
I-Classification_system	30	31	-
I-Classification_system	31	38	related
I-Classification_system	39	50	maculopathy
I-Classification_system	51	58	staging
O	59	65	system
O	65	66	.

O	68	70	To
O	71	79	evaluate
O	80	81	a
O	82	90	clinical
O	91	105	classification
O	106	112	system
O	112	113	,
O	114	117	the
B-Classification_system	118	126	Clinical
I-Classification_system	127	130	Age
I-Classification_system	130	131	-
I-Classification_system	131	138	Related
I-Classification_system	139	150	Maculopathy
I-Classification_system	151	158	Staging
O	159	160	(
B-Classification_system	160	165	CARMS
O	165	166	)
O	167	173	system
O	173	174	,
O	175	178	for
B-Disease	179	182	age
I-Disease	182	183	-
I-Disease	183	190	related
I-Disease	191	202	maculopathy
O	203	204	(
B-Disease	204	207	ARM
O	207	208	)
O	209	214	using
O	215	216	a
O	217	223	simple
O	224	231	grading
O	232	237	scale
O	238	246	designed
O	247	250	for
O	251	259	clinical
O	260	268	practice
O	269	272	and
O	273	281	clinical
O	282	290	research
O	291	300	protocols
O	300	301	.

O	302	305	Two
O	306	313	hundred
O	314	319	forty
O	319	320	-
O	320	323	six
O	324	328	male
O	329	332	and
O	333	339	female
O	340	352	participants
O	353	357	with
O	358	365	various
O	366	372	stages
O	373	375	of
B-Disease	376	379	ARM
O	380	383	who
O	384	388	were
O	389	397	enrolled
O	398	404	during
O	405	408	the
O	409	414	first
O	415	416	4
O	417	422	years
O	423	425	of
O	426	427	a
O	428	440	longitudinal
O	441	446	study
O	447	451	were
O	452	460	selected
O	461	464	for
O	465	468	the
O	469	479	evaluation
O	480	482	of
O	483	486	the
B-Classification_system	487	492	CARMS
O	493	499	system
O	499	500	.

O	501	506	Cross
O	506	507	-
O	507	516	sectional
O	517	527	comparison
O	528	533	study
O	533	534	.

O	535	538	The
B-Classification_system	539	544	CARMS
O	545	551	system
O	552	559	divides
O	560	568	patients
O	569	573	into
O	574	575	5
O	576	584	mutually
O	585	594	exclusive
O	595	605	categories
O	606	611	based
O	612	614	on
B-Diagnostic_tool	615	619	slit
I-Diagnostic_tool	619	620	-
I-Diagnostic_tool	620	624	lamp
I-Diagnostic_tool	625	635	assessment
O	636	638	of
B-Symptom	639	645	drusen
O	645	646	,
B-Symptom	647	654	retinal
I-Symptom	655	662	pigment
I-Symptom	663	673	epithelial
I-Symptom	674	688	irregularities
O	688	689	,
B-Symptom	690	700	geographic
I-Symptom	701	708	atrophy
O	708	709	,
B-Symptom	710	717	retinal
I-Symptom	718	725	pigment
I-Symptom	726	736	epithelial
I-Symptom	737	747	detachment
O	747	748	,
O	749	752	and
B-Symptom	753	762	choroidal
I-Symptom	763	781	neovascularization
O	781	782	.

B-Diagnostic_tool	783	789	Fundus
I-Diagnostic_tool	790	801	photographs
O	802	805	and
B-Diagnostic_tool	806	814	clinical
I-Diagnostic_tool	815	819	data
O	820	822	of
O	823	826	the
O	827	835	subjects
O	836	840	were
O	841	845	used
O	846	848	to
O	849	857	evaluate
O	858	862	this
O	863	868	scale
O	868	869	.

O	870	878	Clinical
O	879	885	grades
O	886	894	assigned
O	895	898	for
O	899	902	492
B-Anatomy	903	907	eyes
O	908	910	of
O	911	914	246
O	915	923	patients
O	924	928	with
O	929	936	varying
O	937	943	stages
O	944	946	of
B-Disease	947	950	ARM
O	951	955	were
O	956	964	compared
O	965	969	with
O	970	976	grades
O	977	985	obtained
O	986	990	from
B-Diagnostic_tool	991	1002	photographs
O	1003	1012	evaluated
O	1013	1015	by
O	1016	1017	a
O	1018	1025	reading
O	1026	1032	center
O	1032	1033	.

O	1034	1036	To
O	1037	1044	compare
O	1045	1051	grades
O	1052	1060	obtained
O	1061	1065	from
O	1066	1068	an
O	1069	1082	inexperienced
O	1083	1089	grader
O	1090	1094	with
O	1095	1100	those
O	1101	1103	of
O	1104	1106	an
O	1107	1118	experienced
O	1119	1125	grader
O	1125	1126	,
O	1127	1139	observations
O	1140	1145	based
O	1146	1148	on
B-Diagnostic_tool	1149	1160	photographs
O	1161	1165	from
O	1166	1168	50
O	1169	1177	randomly
O	1178	1186	selected
O	1187	1195	patients
O	1196	1200	were
O	1201	1209	reviewed
O	1209	1210	.

O	1211	1213	To
O	1214	1222	quantify
O	1223	1236	intraobserver
O	1237	1246	agreement
O	1247	1250	for
B-Characteristic	1251	1263	photographic
I-Characteristic	1264	1270	grades
O	1270	1271	,
O	1272	1284	observations
O	1285	1289	from
O	1290	1293	one
O	1294	1302	observer
O	1303	1307	were
O	1308	1316	compared
O	1317	1321	with
O	1322	1327	those
O	1328	1332	made
O	1333	1335	at
O	1336	1337	a
O	1338	1343	later
O	1344	1348	date
O	1349	1351	by
O	1352	1355	the
O	1356	1360	same
O	1361	1369	observer
O	1369	1370	.

O	1371	1382	Reliability
O	1383	1386	and
O	1387	1395	validity
O	1396	1398	of
O	1399	1402	the
B-Classification_system	1403	1408	CARMS
O	1409	1415	system
O	1416	1418	in
O	1419	1426	grading
O	1427	1434	various
O	1435	1441	stages
O	1442	1444	of
B-Disease	1445	1448	ARM
O	1449	1454	based
O	1455	1457	on
B-Diagnostic_tool	1458	1466	clinical
I-Diagnostic_tool	1467	1478	examination
O	1479	1482	and
B-Diagnostic_tool	1483	1494	photography
O	1494	1495	.

O	1496	1499	The
O	1500	1506	degree
O	1507	1509	of
O	1510	1517	overall
O	1518	1527	agreement
O	1528	1535	between
O	1536	1539	the
O	1540	1550	clinically
O	1551	1559	assigned
O	1560	1565	grade
O	1566	1569	and
O	1570	1582	photographic
O	1583	1593	assessment
O	1594	1597	for
O	1598	1601	492
B-Anatomy	1602	1606	eyes
O	1607	1610	was
O	1611	1622	substantial
O	1623	1624	(
O	1624	1629	exact
O	1630	1637	overall
O	1638	1647	agreement
O	1647	1648	,
O	1649	1651	75
O	1651	1652	%
O	1652	1653	;
O	1654	1664	unweighted
O	1665	1670	kappa
O	1670	1671	,
O	1672	1673	0
O	1673	1674	.
O	1674	1676	63
O	1676	1677	;
O	1678	1686	weighted
O	1687	1692	kappa
O	1692	1693	,
O	1694	1695	0
O	1695	1696	.
O	1696	1698	78
O	1698	1699	)
O	1699	1700	.

O	1701	1704	For
B-Disease	1705	1713	advanced
I-Disease	1714	1717	age
I-Disease	1717	1718	-
I-Disease	1718	1725	related
I-Disease	1726	1733	macular
I-Disease	1734	1746	degeneration
O	1746	1747	,
O	1748	1751	the
O	1752	1763	sensitivity
O	1764	1767	was
O	1768	1769	0
O	1769	1770	.
O	1770	1772	83
O	1772	1773	,
O	1774	1777	and
O	1778	1789	specificity
O	1790	1793	was
O	1794	1795	0
O	1795	1796	.
O	1796	1798	97
O	1798	1799	.

O	1800	1804	When
O	1805	1814	assessing
O	1815	1827	photographic
O	1828	1834	grades
O	1834	1835	,
O	1836	1839	the
O	1840	1846	degree
O	1847	1849	of
O	1850	1859	agreement
O	1860	1867	between
O	1868	1870	an
O	1871	1884	inexperienced
O	1885	1888	and
O	1889	1891	an
O	1892	1903	experienced
O	1904	1910	grader
O	1911	1914	was
O	1915	1919	very
O	1920	1924	high
O	1925	1926	(
O	1926	1936	unweighted
O	1937	1942	kappa
O	1942	1943	,
O	1944	1945	0
O	1945	1946	.
O	1946	1948	79
O	1948	1949	;
O	1950	1958	weighted
O	1959	1964	kappa
O	1964	1965	,
O	1966	1967	0
O	1967	1968	.
O	1968	1970	86
O	1970	1971	)
O	1971	1972	,
O	1973	1976	and
O	1977	1980	the
O	1981	1987	degree
O	1988	1990	of
O	1991	2004	intraobserver
O	2005	2014	agreement
O	2015	2018	was
O	2019	2028	excellent
O	2029	2030	(
O	2030	2040	unweighted
O	2041	2046	kappa
O	2046	2047	,
O	2048	2049	0
O	2049	2050	.
O	2050	2052	92
O	2052	2053	;
O	2054	2062	weighted
O	2063	2068	kappa
O	2068	2069	,
O	2070	2071	0
O	2071	2072	.
O	2072	2074	97
O	2074	2075	)
O	2075	2076	.

O	2077	2080	The
B-Classification_system	2081	2086	CARMS
O	2087	2093	system
O	2093	2094	,
O	2095	2096	a
O	2097	2098	5
O	2098	2099	-
O	2099	2104	level
O	2105	2113	clinical
O	2114	2119	scale
O	2119	2120	,
O	2121	2123	is
O	2124	2125	a
O	2126	2131	valid
O	2132	2135	and
O	2136	2144	reliable
O	2145	2152	staging
O	2153	2159	system
O	2160	2164	that
O	2165	2168	can
O	2169	2171	be
O	2172	2176	used
O	2177	2179	in
O	2180	2184	both
O	2185	2193	clinical
O	2194	2202	practice
O	2203	2206	and
O	2207	2209	in
O	2210	2218	clinical
O	2219	2227	research
O	2228	2237	protocols
O	2238	2247	involving
O	2248	2256	patients
O	2257	2261	with
O	2262	2265	all
O	2266	2272	stages
O	2273	2275	of
B-Disease	2276	2279	ARM
O	2279	2280	.

B-Disease	0	4	Long
I-Disease	4	5	-
I-Disease	5	13	standing
I-Disease	14	21	bullous
I-Disease	22	33	keratopathy
O	34	36	is
O	37	47	associated
O	48	52	with
B-Symptom	53	63	peripheral
I-Symptom	64	83	conjunctivalization
O	84	87	and
B-Symptom	88	94	limbal
I-Symptom	95	105	deficiency
O	105	106	.

O	108	110	To
O	111	122	investigate
O	123	130	whether
B-Symptom	131	141	peripheral
I-Symptom	142	149	corneal
I-Symptom	150	168	neovascularization
O	169	171	in
B-Disease	172	179	bullous
I-Disease	180	191	keratopathy
O	192	193	(
B-Disease	193	195	BK
O	195	196	)
O	197	199	is
O	200	203	due
O	204	206	to
B-Symptom	207	226	conjunctivalization
O	226	227	,
O	228	229	a
O	230	234	sign
O	235	237	of
B-Symptom	238	244	limbal
I-Symptom	245	249	stem
I-Symptom	250	254	cell
I-Symptom	255	265	deficiency
O	265	266	.

O	267	280	Observational
O	281	285	case
O	285	286	-
O	286	293	control
O	294	299	study
O	299	300	.

O	301	308	Sixteen
B-Disease	309	311	BK
O	312	320	patients
O	320	321	.

O	322	330	Patients
O	331	335	were
O	336	343	divided
O	344	348	into
O	349	350	2
O	351	357	groups
O	357	358	:
B-Disease	359	361	BK
O	362	369	without
B-Symptom	370	380	peripheral
I-Symptom	381	399	neovascularization
O	400	401	[
O	401	403	NV
O	403	404	(
O	404	405	-
O	405	406	)
O	407	412	group
O	412	413	;
O	414	415	5
O	416	424	patients
O	424	425	,
O	426	427	5
O	428	432	eyes
O	432	433	]
O	434	437	and
B-Disease	438	440	BK
O	441	445	with
B-Symptom	446	464	neovascularization
O	465	466	[
O	466	468	NV
O	468	469	(
O	469	470	+
O	470	471	)
O	472	477	group
O	477	478	;
O	479	481	11
O	482	490	patients
O	490	491	,
O	492	494	13
O	495	499	eyes
O	499	500	]
O	501	502	.

O	503	511	Evidence
O	512	514	of
B-Symptom	515	534	conjunctivalization
O	535	538	was
O	539	548	evaluated
O	549	551	by
O	552	560	periodic
B-Diagnostic_tool	561	565	acid
I-Diagnostic_tool	565	566	-
I-Diagnostic_tool	566	572	Schiff
I-Diagnostic_tool	573	581	staining
I-Diagnostic_tool	582	584	of
I-Diagnostic_tool	585	595	impression
I-Diagnostic_tool	596	604	cytology
O	605	612	samples
O	613	617	from
O	618	621	the
B-Symptom	622	632	peripheral
I-Symptom	633	645	vascularized
I-Symptom	646	652	cornea
O	652	653	.

O	654	657	The
O	658	659	2
O	660	666	groups
O	666	667	'
O	668	677	durations
O	678	680	of
O	681	688	disease
O	689	693	also
O	694	698	were
O	699	707	compared
O	707	708	.

O	709	720	Penetrating
O	721	733	keratoplasty
O	734	735	(
O	735	737	PK
O	737	738	)
O	739	742	was
O	743	752	performed
O	753	755	in
O	756	759	all
O	760	762	16
O	763	768	cases
O	768	769	,
O	770	773	and
O	774	777	the
O	778	779	2
O	780	786	groups
O	786	787	'
O	788	797	durations
O	798	800	of
O	801	820	reepithelialization
O	821	826	after
O	827	829	PK
O	830	834	were
O	835	843	compared
O	843	844	.

O	845	853	Presence
O	854	856	of
B-Anatomy	857	863	goblet
I-Anatomy	864	869	cells
O	870	875	using
B-Diagnostic_tool	876	886	impression
I-Diagnostic_tool	887	895	cytology
O	895	896	,
O	897	905	duration
O	906	908	of
B-Disease	909	911	BK
O	911	912	,
O	913	916	and
O	917	925	duration
O	926	928	of
O	929	942	postoperative
O	943	962	reepithelialization
O	962	963	.

B-Anatomy	964	970	Goblet
I-Anatomy	971	976	cells
O	977	981	were
O	982	987	found
O	988	990	on
O	991	994	the
B-Anatomy	995	1005	peripheral
I-Anatomy	1006	1013	corneal
I-Anatomy	1014	1021	surface
O	1022	1024	in
O	1025	1028	all
B-Anatomy	1029	1033	eyes
O	1034	1036	in
O	1037	1040	the
O	1041	1043	NV
O	1043	1044	(
O	1044	1045	+
O	1045	1046	)
O	1047	1052	group
O	1052	1053	.

O	1054	1061	However
O	1061	1062	,
O	1063	1066	all
B-Anatomy	1067	1071	eyes
O	1072	1074	in
O	1075	1078	the
O	1079	1081	NV
O	1081	1082	(
O	1082	1083	-
O	1083	1084	)
O	1085	1090	group
O	1091	1095	were
O	1096	1104	negative
O	1105	1108	for
B-Anatomy	1109	1115	goblet
I-Anatomy	1116	1121	cells
O	1122	1123	(
O	1123	1124	P
O	1125	1126	<
O	1127	1128	0
O	1128	1129	.
O	1129	1133	0001
O	1133	1134	)
O	1134	1135	.

O	1136	1144	Duration
O	1145	1147	of
O	1148	1155	disease
O	1156	1159	was
O	1160	1162	14
O	1162	1163	.
O	1163	1164	4
O	1164	1165	+
O	1165	1166	/
O	1166	1167	-
O	1167	1168	5
O	1168	1169	.
O	1169	1170	4
O	1171	1177	months
O	1178	1180	in
O	1181	1184	the
O	1185	1187	NV
O	1187	1188	(
O	1188	1189	-
O	1189	1190	)
O	1191	1196	group
O	1197	1200	and
O	1201	1203	66
O	1203	1204	.
O	1204	1205	2
O	1205	1206	+
O	1206	1207	/
O	1207	1208	-
O	1208	1210	65
O	1210	1211	.
O	1211	1212	5
O	1213	1219	months
O	1220	1222	in
O	1223	1226	the
O	1227	1229	NV
O	1229	1230	(
O	1230	1231	+
O	1231	1232	)
O	1233	1238	group
O	1239	1240	(
O	1240	1241	P
O	1242	1243	=
O	1244	1245	0
O	1245	1246	.
O	1246	1249	030
O	1249	1250	)
O	1250	1251	.

O	1252	1260	Duration
O	1261	1263	of
O	1264	1277	postoperative
O	1278	1295	epithelialization
O	1296	1299	was
O	1300	1301	6
O	1301	1302	.
O	1302	1303	2
O	1303	1304	+
O	1304	1305	/
O	1305	1306	-
O	1306	1307	2
O	1307	1308	.
O	1308	1309	2
O	1310	1314	days
O	1315	1317	in
O	1318	1321	the
O	1322	1324	NV
O	1324	1325	(
O	1325	1326	-
O	1326	1327	)
O	1328	1333	group
O	1334	1337	and
O	1338	1340	28
O	1340	1341	.
O	1341	1342	8
O	1342	1343	+
O	1343	1344	/
O	1344	1345	-
O	1345	1347	36
O	1347	1348	.
O	1348	1349	5
O	1350	1354	days
O	1355	1357	in
O	1358	1361	the
O	1362	1364	NV
O	1364	1365	(
O	1365	1366	+
O	1366	1367	)
O	1368	1373	group
O	1374	1375	(
O	1375	1376	P
O	1377	1378	=
O	1379	1380	0
O	1380	1381	.
O	1381	1384	046
O	1384	1385	)
O	1385	1386	.

O	1387	1406	Conjunctivalization
O	1407	1409	of
O	1410	1413	the
B-Anatomy	1414	1424	peripheral
I-Anatomy	1425	1431	cornea
O	1432	1435	and
O	1436	1443	delayed
O	1444	1457	postoperative
O	1458	1475	epithelialization
O	1476	1478	in
B-Disease	1479	1481	BK
O	1482	1490	patients
O	1491	1495	with
B-Symptom	1496	1498	NV
O	1499	1506	suggest
O	1507	1510	the
O	1511	1519	presence
O	1520	1522	of
B-Symptom	1523	1529	limbal
I-Symptom	1530	1534	stem
I-Symptom	1535	1539	cell
I-Symptom	1540	1550	deficiency
O	1551	1553	in
O	1554	1558	such
O	1559	1567	patients
O	1567	1568	.

O	1569	1577	Patients
O	1578	1582	with
O	1583	1587	long
O	1587	1588	-
O	1588	1596	standing
O	1597	1604	disease
O	1605	1609	were
O	1610	1615	found
O	1616	1618	to
O	1619	1621	be
O	1622	1626	more
O	1627	1632	prone
O	1633	1635	to
B-Symptom	1636	1654	neovascularization
O	1654	1655	.

O	1656	1659	For
O	1660	1664	this
O	1665	1671	reason
O	1671	1672	,
O	1673	1678	early
O	1679	1686	surgery
O	1687	1690	may
O	1691	1695	lead
O	1696	1698	to
O	1699	1700	a
O	1701	1707	better
O	1708	1716	surgical
O	1717	1724	outcome
O	1724	1725	.

O	0	10	Diagnostic
O	11	22	sensitivity
O	23	25	of
B-Diagnostic_tool	26	30	fast
I-Diagnostic_tool	31	35	blue
I-Diagnostic_tool	35	36	-
I-Diagnostic_tool	36	42	yellow
I-Diagnostic_tool	43	46	and
I-Diagnostic_tool	47	55	standard
I-Diagnostic_tool	56	65	automated
I-Diagnostic_tool	66	75	perimetry
O	76	78	in
B-Disease	79	84	early
I-Disease	85	93	glaucoma
O	93	94	:
O	95	96	a
O	97	107	comparison
O	108	115	between
O	116	125	different
O	126	130	test
O	131	139	programs
O	139	140	.

O	142	144	To
O	145	152	compare
O	153	156	the
O	157	164	ability
O	165	167	of
B-Diagnostic_tool	168	172	Fast
I-Diagnostic_tool	173	180	Swedish
I-Diagnostic_tool	181	192	interactive
I-Diagnostic_tool	193	202	threshold
I-Diagnostic_tool	203	212	algorithm
I-Diagnostic_tool	213	214	(
I-Diagnostic_tool	214	218	SITA
I-Diagnostic_tool	218	219	)
I-Diagnostic_tool	220	225	short
I-Diagnostic_tool	225	226	-
I-Diagnostic_tool	226	236	wavelength
I-Diagnostic_tool	237	246	automated
I-Diagnostic_tool	247	256	perimetry
O	257	258	(
B-Diagnostic_tool	258	262	SWAP
O	262	263	)
O	263	264	,
O	265	274	lengthier
B-Diagnostic_tool	275	279	full
I-Diagnostic_tool	279	280	-
I-Diagnostic_tool	280	289	threshold
I-Diagnostic_tool	290	294	SWAP
O	294	295	,
O	296	299	and
B-Diagnostic_tool	300	308	standard
I-Diagnostic_tool	309	318	automated
I-Diagnostic_tool	319	328	perimetry
I-Diagnostic_tool	329	330	(
I-Diagnostic_tool	330	333	SAP
I-Diagnostic_tool	333	334	)
I-Diagnostic_tool	335	340	using
I-Diagnostic_tool	341	344	the
I-Diagnostic_tool	345	349	SITA
I-Diagnostic_tool	350	354	Fast
I-Diagnostic_tool	355	362	program
O	363	365	to
O	366	372	detect
B-Symptom	373	378	early
I-Symptom	379	391	glaucomatous
I-Symptom	392	398	visual
I-Symptom	399	404	field
I-Symptom	405	409	loss
O	409	410	.

O	411	416	Cross
O	416	417	-
O	417	426	sectional
O	427	438	prospective
O	439	444	study
O	445	447	of
B-Characteristic	448	458	perimetric
I-Characteristic	459	469	diagnostic
I-Characteristic	470	481	sensitivity
O	482	484	as
O	485	492	defined
O	493	495	by
O	496	505	reference
O	506	512	limits
O	513	523	determined
O	524	526	in
O	527	530	the
O	531	535	same
B-Characteristic	536	543	healthy
I-Characteristic	544	556	participants
O	557	560	for
O	561	564	all
O	565	566	3
O	567	571	test
O	572	580	programs
O	580	581	.

O	582	585	One
O	586	593	hundred
O	594	597	one
O	598	606	patients
O	607	611	with
B-Disease	612	618	ocular
I-Disease	619	631	hypertension
O	631	632	,
O	633	635	or
O	636	643	suspect
O	644	646	or
B-Disease	647	652	early
I-Disease	653	661	manifest
I-Disease	662	670	glaucoma
O	670	671	.

O	672	675	One
B-Anatomy	676	679	eye
O	680	682	of
O	683	687	each
O	688	695	patient
O	696	699	was
O	700	706	tested
O	707	711	with
O	712	713	2
B-Diagnostic_tool	714	718	blue
I-Diagnostic_tool	718	719	-
I-Diagnostic_tool	719	725	yellow
I-Diagnostic_tool	726	736	perimetric
I-Diagnostic_tool	737	745	programs
O	745	746	:
O	747	750	the
B-Diagnostic_tool	751	755	SITA
I-Diagnostic_tool	756	759	and
I-Diagnostic_tool	760	764	full
I-Diagnostic_tool	764	765	-
I-Diagnostic_tool	765	774	threshold
I-Diagnostic_tool	775	779	SWAP
O	780	783	and
O	784	787	the
B-Diagnostic_tool	788	791	SAP
I-Diagnostic_tool	792	796	SITA
I-Diagnostic_tool	797	801	Fast
I-Diagnostic_tool	802	809	program
O	809	810	.

B-Symptom	811	823	Glaucomatous
I-Symptom	824	830	visual
I-Symptom	831	836	field
I-Symptom	837	841	loss
O	841	842	,
O	843	850	defined
O	851	853	as
O	854	860	number
O	861	863	of
O	864	877	significantly
O	878	887	depressed
O	888	892	test
O	893	898	point
O	899	908	locations
O	909	911	or
O	912	915	the
O	916	922	number
O	923	925	of
O	926	934	clusters
O	935	937	of
O	938	942	such
O	943	947	test
O	948	954	points
O	954	955	.

O	956	958	No
O	959	970	significant
O	971	981	difference
O	982	984	in
O	985	991	number
O	992	994	of
O	995	1008	significantly
O	1009	1018	depressed
O	1019	1023	test
O	1024	1029	point
O	1030	1039	locations
O	1040	1047	between
O	1048	1051	the
O	1052	1053	3
O	1054	1062	programs
O	1063	1068	could
O	1069	1071	be
O	1072	1080	detected
O	1080	1081	,
O	1082	1089	neither
O	1090	1092	at
O	1093	1096	the
O	1097	1098	P
O	1099	1100	<
O	1101	1102	5
O	1102	1103	%
O	1104	1109	limit
O	1110	1113	nor
O	1114	1116	at
O	1117	1120	the
O	1121	1122	P
O	1123	1124	<
O	1125	1126	2
O	1126	1127	%
O	1128	1133	limit
O	1133	1134	.

O	1135	1138	The
O	1139	1149	difference
O	1150	1152	in
O	1153	1159	number
O	1160	1162	of
O	1163	1169	points
O	1170	1179	depressed
O	1180	1185	below
O	1186	1189	the
O	1190	1195	fifth
O	1196	1206	percentile
O	1207	1210	was
O	1211	1212	0
O	1212	1213	.
O	1213	1214	5
O	1215	1222	between
B-Diagnostic_tool	1223	1227	full
I-Diagnostic_tool	1227	1228	-
I-Diagnostic_tool	1228	1237	threshold
I-Diagnostic_tool	1238	1242	SWAP
O	1243	1246	and
B-Diagnostic_tool	1247	1251	SITA
I-Diagnostic_tool	1252	1256	SWAP
O	1256	1257	,
O	1258	1259	1
O	1259	1260	.
O	1260	1262	09
O	1263	1270	between
B-Diagnostic_tool	1271	1275	full
I-Diagnostic_tool	1275	1276	-
I-Diagnostic_tool	1276	1285	threshold
I-Diagnostic_tool	1286	1290	SWAP
O	1291	1294	and
B-Diagnostic_tool	1295	1298	SAP
O	1298	1299	,
O	1300	1303	and
O	1304	1305	1
O	1305	1306	.
O	1306	1308	04
O	1309	1316	between
B-Diagnostic_tool	1317	1321	SITA
I-Diagnostic_tool	1322	1326	SWAP
O	1327	1330	and
B-Diagnostic_tool	1331	1334	SAP
O	1334	1335	.

O	1336	1339	The
O	1340	1346	number
O	1347	1349	of
B-Anatomy	1350	1354	eyes
O	1355	1362	showing
O	1363	1371	clusters
O	1372	1374	of
O	1375	1388	significantly
O	1389	1398	depressed
O	1399	1405	points
O	1406	1410	also
O	1411	1414	was
O	1415	1422	similar
O	1423	1427	with
O	1428	1431	the
O	1432	1433	3
O	1434	1438	test
O	1439	1447	programs
O	1447	1448	:
B-Diagnostic_tool	1449	1453	full
I-Diagnostic_tool	1453	1454	-
I-Diagnostic_tool	1454	1463	threshold
I-Diagnostic_tool	1464	1468	SWAP
O	1469	1479	identified
O	1480	1488	clusters
O	1489	1491	in
O	1492	1494	66
B-Anatomy	1495	1499	eyes
O	1499	1500	,
B-Diagnostic_tool	1501	1505	SITA
I-Diagnostic_tool	1506	1510	SWAP
O	1511	1521	identified
O	1522	1530	clusters
O	1531	1533	in
O	1534	1536	67
B-Anatomy	1537	1541	eyes
O	1541	1542	,
O	1543	1546	and
B-Diagnostic_tool	1547	1551	SITA
I-Diagnostic_tool	1552	1556	Fast
I-Diagnostic_tool	1557	1560	SAP
O	1561	1571	identified
O	1572	1580	clusters
O	1581	1583	in
O	1584	1586	65
B-Anatomy	1587	1591	eyes
O	1591	1592	.

O	1593	1600	Average
O	1601	1605	test
O	1606	1610	time
O	1611	1614	was
O	1615	1617	12
O	1617	1618	.
O	1618	1619	0
O	1620	1627	minutes
O	1628	1633	using
B-Diagnostic_tool	1634	1638	full
I-Diagnostic_tool	1638	1639	-
I-Diagnostic_tool	1639	1648	threshold
I-Diagnostic_tool	1649	1653	SWAP
O	1653	1654	,
O	1655	1656	4
O	1656	1657	.
O	1657	1658	1
O	1659	1666	minutes
O	1667	1671	with
B-Diagnostic_tool	1672	1676	SITA
I-Diagnostic_tool	1677	1681	SWAP
O	1681	1682	,
O	1683	1686	and
O	1687	1688	3
O	1688	1689	.
O	1689	1690	5
O	1691	1695	with
B-Diagnostic_tool	1696	1700	SITA
I-Diagnostic_tool	1701	1705	Fast
O	1705	1706	.

O	1707	1710	The
B-Diagnostic_tool	1711	1715	SITA
I-Diagnostic_tool	1716	1720	SWAP
O	1721	1731	identified
O	1732	1734	at
O	1735	1740	least
O	1741	1743	as
O	1744	1748	much
B-Symptom	1749	1761	glaucomatous
I-Symptom	1762	1768	visual
I-Symptom	1769	1774	field
I-Symptom	1775	1779	loss
O	1780	1782	as
O	1783	1786	the
O	1787	1792	older
B-Diagnostic_tool	1793	1797	full
I-Diagnostic_tool	1797	1798	-
I-Diagnostic_tool	1798	1807	threshold
I-Diagnostic_tool	1808	1812	SWAP
O	1812	1813	,
O	1814	1822	although
O	1823	1827	test
O	1828	1832	time
O	1833	1836	was
O	1837	1849	considerably
O	1850	1857	reduced
O	1857	1858	.

O	1859	1871	Conventional
B-Diagnostic_tool	1872	1875	SAP
I-Diagnostic_tool	1876	1881	using
I-Diagnostic_tool	1882	1886	SITA
I-Diagnostic_tool	1887	1891	Fast
O	1892	1895	was
O	1896	1899	not
O	1900	1913	significantly
O	1914	1918	less
O	1919	1928	sensitive
O	1929	1933	than
O	1934	1940	either
O	1941	1943	of
O	1944	1947	the
O	1948	1949	2
B-Diagnostic_tool	1950	1954	SWAP
O	1955	1963	programs
O	1963	1964	.

B-Characteristic	0	7	Retinal
I-Characteristic	8	16	vascular
I-Characteristic	17	24	caliber
O	25	27	in
O	28	35	persons
O	36	40	with
B-Disease	41	45	type
I-Disease	46	47	2
I-Disease	48	56	diabetes
O	56	57	:
O	58	61	the
B-Characteristic	62	71	Wisconsin
O	72	87	Epidemiological
O	88	93	Study
O	94	96	of
B-Disease	97	105	Diabetic
I-Disease	106	117	Retinopathy
O	117	118	:
O	119	121	XX
O	121	122	.

O	124	126	To
O	127	135	describe
B-Characteristic	136	143	retinal
I-Characteristic	144	152	vascular
I-Characteristic	153	160	caliber
O	161	164	and
O	165	175	correlates
O	176	178	in
O	179	185	people
O	186	190	with
B-Disease	191	195	type
I-Disease	196	197	2
I-Disease	198	206	diabetes
O	206	207	.

O	208	218	Population
O	218	219	-
O	219	224	based
O	225	230	study
O	230	231	.

O	232	240	Thirteen
O	241	248	hundred
O	249	256	seventy
O	257	264	persons
O	265	274	diagnosed
O	275	277	to
O	278	282	have
B-Disease	283	291	diabetes
B-Characteristic	292	294	at
I-Characteristic	295	297	or
I-Characteristic	298	303	after
I-Characteristic	304	306	30
I-Characteristic	307	312	years
I-Characteristic	313	315	of
I-Characteristic	316	319	age
O	320	322	in
O	323	325	an
O	326	328	11
O	328	329	-
O	329	335	county
O	336	340	area
O	341	343	in
B-Characteristic	344	349	south
I-Characteristic	350	357	central
I-Characteristic	358	367	Wisconsin
O	368	372	from
O	373	377	1980
O	378	380	to
O	381	385	1982
O	385	386	.

B-Diagnostic_tool	387	394	Retinal
I-Diagnostic_tool	395	406	photographs
O	407	409	of
O	410	411	7
O	412	420	standard
O	421	427	fields
O	428	432	were
O	433	438	taken
O	438	439	;
B-Diagnostic_tool	440	445	light
I-Diagnostic_tool	446	449	box
I-Diagnostic_tool	450	457	grading
O	458	461	was
O	462	466	done
O	467	469	to
O	470	479	determine
B-Disease	480	491	retinopathy
O	492	500	severity
O	500	501	.

O	502	510	Computer
O	510	511	-
O	511	519	assisted
O	520	527	grading
O	528	531	was
O	532	536	done
O	537	541	from
O	542	543	a
B-Diagnostic_tool	544	553	digitized
I-Diagnostic_tool	554	559	image
O	560	562	of
O	563	568	field
O	569	570	1
O	571	573	to
O	574	583	determine
O	584	587	the
B-Characteristic	588	595	central
I-Characteristic	596	603	retinal
I-Characteristic	604	614	arteriolar
I-Characteristic	615	625	equivalent
O	626	627	(
B-Characteristic	627	631	CRAE
O	631	632	;
B-Characteristic	633	643	arteriolar
I-Characteristic	644	651	caliber
O	651	652	)
O	653	656	and
B-Characteristic	657	664	central
I-Characteristic	665	672	retinal
I-Characteristic	673	680	venular
I-Characteristic	681	691	equivalent
O	692	693	(
B-Characteristic	693	697	CRVE
O	697	698	;
B-Characteristic	699	706	venular
I-Characteristic	707	714	caliber
O	714	715	)
O	715	716	.

B-Characteristic	717	724	Retinal
I-Characteristic	725	735	arteriolar
O	736	739	and
B-Characteristic	740	747	venular
I-Characteristic	748	756	calibers
O	756	757	.

O	758	760	In
O	761	774	multivariable
O	775	783	analyses
O	784	786	in
O	787	794	persons
O	795	799	with
B-Symptom	800	810	panretinal
I-Symptom	811	827	photocoagulation
O	828	836	excluded
O	836	837	,
O	838	843	while
O	844	855	controlling
O	856	859	for
O	860	870	refractive
O	871	876	error
O	876	877	,
B-Characteristic	878	882	CRAE
O	883	886	was
O	887	897	associated
O	898	911	independently
O	912	916	with
B-Characteristic	917	920	age
O	921	922	(
O	922	925	per
O	926	928	10
O	929	934	years
O	934	935	,
O	936	940	beta
O	941	942	=
O	943	944	-
O	944	945	2
O	945	946	.
O	946	947	0
O	948	954	microm
O	954	955	)
O	955	956	,
B-Characteristic	957	961	mean
I-Characteristic	962	970	arterial
I-Characteristic	971	976	blood
I-Characteristic	977	985	pressure
O	986	987	(
B-Characteristic	987	989	BP
O	989	990	)
O	991	992	(
O	992	995	per
O	996	998	10
O	999	1003	mmHg
O	1003	1004	,
O	1005	1009	beta
O	1010	1011	=
O	1012	1013	-
O	1013	1014	2
O	1014	1015	.
O	1015	1016	2
O	1017	1023	microm
O	1023	1024	)
O	1024	1025	,
B-Characteristic	1026	1033	smoking
I-Characteristic	1034	1040	status
O	1041	1042	(
O	1042	1049	current
O	1050	1052	vs
O	1052	1053	.
O	1054	1059	never
O	1060	1066	smoked
O	1066	1067	,
O	1068	1072	beta
O	1073	1074	=
O	1075	1076	5
O	1076	1077	.
O	1077	1078	6
O	1079	1085	microm
O	1085	1086	)
O	1086	1087	,
O	1088	1091	and
B-Characteristic	1092	1103	intraocular
I-Characteristic	1104	1112	pressure
O	1113	1114	(
B-Characteristic	1114	1117	IOP
O	1117	1118	)
O	1119	1120	(
O	1120	1123	per
O	1124	1125	1
O	1126	1130	mmHg
O	1130	1131	,
O	1132	1136	beta
O	1137	1138	=
O	1139	1140	0
O	1140	1141	.
O	1141	1142	2
O	1143	1149	microm
O	1149	1150	)
O	1150	1151	.

O	1152	1155	The
B-Characteristic	1156	1160	CRVE
O	1161	1164	was
O	1165	1175	associated
O	1176	1189	independently
O	1190	1194	with
B-Characteristic	1195	1198	age
O	1199	1200	(
O	1200	1203	per
O	1204	1206	10
O	1207	1212	years
O	1212	1213	,
O	1214	1218	beta
O	1219	1220	=
O	1221	1222	-
O	1222	1223	2
O	1223	1224	.
O	1224	1225	5
O	1226	1232	microm
O	1232	1233	)
O	1233	1234	,
B-Characteristic	1235	1239	mean
I-Characteristic	1240	1248	arterial
I-Characteristic	1249	1251	BP
O	1252	1253	(
O	1253	1256	per
O	1257	1259	10
O	1260	1264	mmHg
O	1264	1265	,
O	1266	1270	beta
O	1271	1272	=
O	1273	1274	-
O	1274	1275	2
O	1275	1276	.
O	1276	1277	1
O	1278	1284	microm
O	1284	1285	)
O	1285	1286	,
B-Characteristic	1287	1294	smoking
I-Characteristic	1295	1301	status
O	1302	1303	(
O	1303	1310	current
O	1311	1313	vs
O	1313	1314	.
O	1315	1320	never
O	1321	1327	smoked
O	1327	1328	,
O	1329	1333	beta
O	1334	1335	=
O	1336	1338	11
O	1338	1339	.
O	1339	1340	6
O	1341	1347	microm
O	1347	1348	)
O	1348	1349	,
B-Characteristic	1350	1354	pack
I-Characteristic	1354	1355	-
I-Characteristic	1355	1360	years
I-Characteristic	1361	1367	smoked
O	1368	1369	(
O	1369	1372	per
O	1373	1375	10
O	1376	1380	pack
O	1380	1381	-
O	1381	1386	years
O	1386	1387	,
O	1388	1392	beta
O	1393	1394	=
O	1395	1396	1
O	1396	1397	.
O	1397	1398	0
O	1399	1405	microm
O	1405	1406	)
O	1406	1407	,
B-Characteristic	1408	1412	body
I-Characteristic	1413	1417	mass
I-Characteristic	1418	1423	index
O	1424	1425	(
O	1425	1428	per
O	1429	1431	kg
O	1431	1432	/
O	1432	1434	m2
O	1434	1435	,
O	1436	1440	beta
O	1441	1442	=
O	1443	1444	0
O	1444	1445	.
O	1445	1446	3
O	1447	1449	mm
O	1449	1450	)
O	1450	1451	,
B-Characteristic	1452	1457	pulse
I-Characteristic	1458	1462	rate
O	1463	1464	(
O	1464	1467	per
O	1468	1470	10
O	1471	1476	beats
O	1476	1477	/
O	1477	1483	minute
O	1483	1484	,
O	1485	1489	beta
O	1490	1491	=
O	1492	1493	1
O	1493	1494	.
O	1494	1495	5
O	1496	1502	microm
O	1502	1503	)
O	1503	1504	,
B-Characteristic	1505	1516	retinopathy
I-Characteristic	1517	1525	severity
O	1526	1527	(
O	1527	1530	per
O	1531	1532	1
O	1533	1538	level
O	1538	1539	,
O	1540	1544	beta
O	1545	1546	=
O	1547	1548	1
O	1548	1549	.
O	1549	1551	05
O	1552	1558	microm
O	1558	1559	)
O	1559	1560	,
O	1561	1564	and
B-Characteristic	1565	1568	IOP
O	1569	1570	(
O	1570	1573	per
O	1574	1576	10
O	1577	1581	mmHg
O	1581	1582	,
O	1583	1587	beta
O	1588	1589	=
O	1590	1591	-
O	1591	1592	0
O	1592	1593	.
O	1593	1594	5
O	1595	1601	microm
O	1601	1602	)
O	1602	1603	.

B-Characteristic	1604	1611	Smaller
I-Characteristic	1612	1617	CRAEs
O	1618	1621	and
B-Characteristic	1622	1627	CRVEs
O	1628	1632	were
O	1633	1638	found
O	1639	1641	in
B-Anatomy	1642	1646	eyes
O	1647	1651	with
O	1652	1662	panretinal
O	1663	1679	photocoagulation
O	1680	1689	treatment
O	1690	1694	than
O	1695	1697	in
B-Anatomy	1698	1702	eyes
O	1703	1710	without
O	1711	1715	such
O	1716	1725	treatment
O	1725	1726	.

O	1727	1729	In
O	1730	1737	persons
O	1738	1742	with
B-Disease	1743	1747	type
I-Disease	1748	1749	2
I-Disease	1750	1758	diabetes
O	1758	1759	,
O	1760	1770	variations
O	1771	1773	in
B-Characteristic	1774	1781	retinal
I-Characteristic	1782	1790	vascular
I-Characteristic	1791	1798	caliber
O	1799	1802	are
O	1803	1810	related
O	1811	1813	to
O	1814	1821	various
O	1822	1830	systemic
O	1831	1834	and
O	1835	1841	ocular
O	1842	1849	factors
O	1849	1850	.

O	1851	1864	Understanding
O	1865	1870	these
O	1871	1884	relationships
O	1885	1888	may
O	1889	1896	provide
O	1897	1904	further
O	1905	1913	insights
O	1914	1918	into
B-Symptom	1919	1924	early
I-Symptom	1925	1932	retinal
I-Symptom	1933	1941	vascular
I-Symptom	1942	1949	changes
O	1950	1952	in
B-Disease	1953	1961	diabetes
O	1961	1962	.

O	0	10	Comparison
O	11	13	of
B-Symptom	14	20	visual
I-Symptom	21	27	acuity
I-Symptom	28	32	loss
O	33	35	in
O	36	44	patients
O	45	49	with
O	50	59	different
O	60	66	stages
O	67	69	of
B-Disease	70	79	Stargardt
I-Disease	79	80	'
I-Disease	80	81	s
I-Disease	82	89	disease
O	89	90	.

O	92	94	To
O	95	106	investigate
O	107	108	a
O	109	119	previously
O	120	128	reported
O	129	140	observation
O	141	145	that
O	146	149	the
O	150	158	presence
O	159	161	of
O	162	169	diffuse
O	169	170	,
O	171	173	as
O	174	182	compared
O	183	187	with
O	188	197	localized
O	197	198	,
B-Symptom	199	205	fundus
I-Symptom	206	212	flecks
O	213	215	is
O	216	218	an
O	219	228	indicator
O	229	231	of
O	232	233	a
O	234	238	more
O	239	245	severe
O	246	252	course
O	253	256	for
B-Symptom	257	263	visual
I-Symptom	264	270	acuity
I-Symptom	271	272	(
I-Symptom	272	274	VA
I-Symptom	274	275	)
I-Symptom	276	280	loss
I-Symptom	281	287	beyond
I-Symptom	288	290	20
I-Symptom	290	291	/
I-Symptom	291	294	200
O	295	297	in
O	298	306	patients
O	307	311	with
B-Disease	312	321	Stargardt
I-Disease	321	322	'
I-Disease	322	323	s
I-Disease	324	331	disease
O	331	332	.

O	333	346	Retrospective
O	347	353	clinic
O	353	354	-
O	354	359	based
O	360	365	cross
O	365	366	-
O	366	375	sectional
O	376	381	study
O	381	382	.

O	383	387	Four
O	388	395	hundred
O	396	400	five
O	401	409	patients
O	410	414	with
B-Disease	415	424	Stargardt
I-Disease	424	425	'
I-Disease	425	426	s
I-Disease	427	434	disease
O	434	435	.

B-Characteristic	436	442	Visual
I-Characteristic	443	449	acuity
O	450	452	in
O	453	456	405
O	457	465	patients
O	466	470	with
B-Disease	471	480	Stargardt
I-Disease	480	481	'
I-Disease	481	482	s
I-Disease	483	490	disease
O	491	494	was
O	495	503	analyzed
O	504	506	at
O	507	512	their
O	513	520	initial
O	521	524	and
O	525	529	most
O	530	536	recent
O	537	543	visits
O	543	544	.

O	545	548	The
O	549	554	stage
O	555	557	of
B-Disease	558	567	Stargardt
I-Disease	567	568	'
I-Disease	568	569	s
I-Disease	570	577	disease
O	578	581	and
B-Characteristic	582	592	appearance
I-Characteristic	593	595	of
I-Characteristic	596	599	the
I-Characteristic	600	606	macula
O	607	611	were
O	612	620	recorded
O	620	621	.

O	622	625	The
O	626	635	diagnosis
O	636	639	and
O	640	645	stage
O	646	648	of
B-Disease	649	658	Stargardt
I-Disease	658	659	'
I-Disease	659	660	s
I-Disease	661	668	disease
O	669	673	were
O	674	679	based
O	680	682	on
O	683	686	the
O	687	693	extent
O	694	697	and
O	698	708	appearance
O	709	711	of
B-Symptom	712	718	fundus
I-Symptom	719	725	flecks
O	725	726	.

B-Characteristic	727	731	Best
I-Characteristic	731	732	-
I-Characteristic	732	741	corrected
I-Characteristic	742	744	VA
O	744	745	,
O	746	751	stage
O	752	754	of
B-Disease	755	764	Stargardt
I-Disease	764	765	'
I-Disease	765	766	s
I-Disease	767	774	disease
O	774	775	,
O	776	779	and
B-Characteristic	780	790	appearance
I-Characteristic	791	793	of
I-Characteristic	794	797	the
I-Characteristic	798	804	macula
O	805	807	at
O	808	811	the
O	812	819	initial
O	820	823	and
O	824	828	most
O	829	835	recent
O	836	842	visits
O	843	847	were
O	848	852	used
O	853	855	in
O	856	859	the
O	860	865	cross
O	865	866	-
O	866	875	sectional
O	876	884	analysis
O	884	885	.

O	886	888	At
O	889	894	their
O	895	902	initial
O	903	908	visit
O	908	909	,
O	910	913	199
O	914	922	patients
O	923	927	were
O	928	938	identified
O	939	941	as
O	942	948	having
B-Disease	949	954	stage
I-Disease	955	956	1
I-Disease	957	966	Stargardt
I-Disease	966	967	'
I-Disease	967	968	s
I-Disease	969	976	disease
O	976	977	,
O	978	980	of
O	981	985	whom
O	986	988	97
O	988	989	.
O	989	990	5
O	990	991	%
O	992	1002	maintained
B-Symptom	1003	1005	20
I-Symptom	1005	1006	/
I-Symptom	1006	1009	200
I-Symptom	1010	1012	or
I-Symptom	1013	1019	better
I-Symptom	1020	1022	VA
O	1023	1025	in
O	1026	1028	at
O	1029	1034	least
O	1035	1038	one
B-Anatomy	1039	1042	eye
O	1042	1043	.

O	1044	1047	One
O	1048	1055	hundred
O	1056	1062	eighty
O	1062	1063	-
O	1063	1067	five
O	1068	1072	were
O	1073	1083	identified
O	1084	1086	as
O	1087	1093	having
B-Disease	1094	1099	stage
I-Disease	1100	1101	2
I-Disease	1102	1104	or
I-Disease	1105	1110	stage
I-Disease	1111	1112	2
I-Disease	1112	1113	-
I-Disease	1113	1114	3
I-Disease	1115	1124	Stargardt
I-Disease	1124	1125	'
I-Disease	1125	1126	s
I-Disease	1127	1134	disease
O	1135	1143	combined
O	1143	1144	,
O	1145	1147	of
O	1148	1152	whom
O	1153	1155	83
O	1155	1156	.
O	1156	1157	2
O	1157	1158	%
O	1159	1169	maintained
B-Symptom	1170	1172	20
I-Symptom	1172	1173	/
I-Symptom	1173	1176	200
I-Symptom	1177	1179	VA
I-Symptom	1180	1182	or
I-Symptom	1183	1189	better
O	1189	1190	.

O	1191	1199	Patients
O	1200	1204	with
B-Disease	1205	1210	stage
I-Disease	1211	1212	1
O	1213	1217	were
O	1218	1222	more
O	1223	1229	likely
O	1230	1232	to
O	1233	1241	maintain
B-Symptom	1242	1244	20
I-Symptom	1244	1245	/
I-Symptom	1245	1248	200
I-Symptom	1249	1251	or
I-Symptom	1252	1258	better
I-Symptom	1259	1261	VA
O	1262	1264	in
O	1265	1267	at
O	1268	1273	least
O	1274	1277	one
B-Anatomy	1278	1281	eye
O	1282	1286	when
O	1287	1295	compared
O	1296	1300	with
O	1301	1309	patients
O	1310	1314	with
B-Disease	1315	1320	stage
I-Disease	1321	1322	2
I-Disease	1322	1323	/
I-Disease	1323	1328	stage
I-Disease	1329	1330	2
I-Disease	1330	1331	-
I-Disease	1331	1332	3
I-Disease	1333	1342	Stargardt
I-Disease	1342	1343	'
I-Disease	1343	1344	s
I-Disease	1345	1352	disease
O	1353	1354	(
O	1354	1358	chi2
O	1358	1359	(
O	1359	1360	1
O	1360	1361	)
O	1362	1363	=
O	1364	1366	21
O	1366	1367	.
O	1367	1369	25
O	1369	1370	,
O	1371	1372	P
O	1373	1374	<
O	1375	1376	0
O	1376	1377	.
O	1377	1380	001
O	1380	1381	)
O	1381	1382	.

O	1383	1389	Ninety
O	1389	1390	-
O	1390	1394	nine
O	1395	1402	percent
O	1403	1405	of
B-Disease	1406	1411	stage
I-Disease	1412	1413	1
O	1414	1422	patients
O	1423	1426	and
O	1427	1429	94
O	1429	1430	.
O	1430	1431	1
O	1431	1432	%
O	1433	1435	of
B-Disease	1436	1441	stage
I-Disease	1442	1443	2
I-Disease	1443	1444	/
I-Disease	1444	1449	stage
I-Disease	1450	1451	2
I-Disease	1451	1452	-
I-Disease	1452	1453	3
O	1454	1462	patients
O	1463	1473	maintained
B-Symptom	1474	1476	20
I-Symptom	1476	1477	/
I-Symptom	1477	1480	400
I-Symptom	1481	1483	or
I-Symptom	1484	1490	better
I-Symptom	1491	1493	VA
I-Symptom	1494	1496	in
I-Symptom	1497	1499	at
I-Symptom	1500	1505	least
I-Symptom	1506	1509	one
I-Symptom	1510	1513	eye
O	1514	1515	(
O	1515	1519	chi2
O	1519	1520	(
O	1520	1521	1
O	1521	1522	)
O	1523	1524	=
O	1525	1526	5
O	1526	1527	.
O	1527	1529	72
O	1529	1530	,
O	1531	1532	P
O	1533	1534	=
O	1535	1536	0
O	1536	1537	.
O	1537	1540	017
O	1540	1541	)
O	1541	1542	.

O	1543	1551	Patients
O	1552	1556	with
B-Disease	1557	1562	stage
I-Disease	1563	1564	1
I-Disease	1565	1574	Stargardt
I-Disease	1574	1575	'
I-Disease	1575	1576	s
I-Disease	1577	1584	disease
O	1585	1595	exhibiting
B-Symptom	1596	1602	fundus
I-Symptom	1603	1609	flecks
O	1610	1617	limited
O	1618	1620	to
O	1621	1624	the
B-Anatomy	1625	1634	posterior
I-Anatomy	1635	1639	pole
O	1640	1643	are
O	1644	1648	more
O	1649	1655	likely
O	1656	1658	to
O	1659	1667	maintain
O	1668	1669	a
O	1670	1675	level
O	1676	1678	of
B-Symptom	1679	1681	VA
I-Symptom	1682	1684	at
I-Symptom	1685	1687	20
I-Symptom	1687	1688	/
I-Symptom	1688	1691	200
I-Symptom	1692	1694	or
I-Symptom	1695	1701	better
O	1702	1706	when
O	1707	1715	compared
O	1716	1720	with
O	1721	1729	patients
O	1730	1734	with
B-Disease	1735	1740	stage
I-Disease	1741	1742	2
I-Disease	1742	1743	/
I-Disease	1743	1748	stage
I-Disease	1749	1750	2
I-Disease	1750	1751	-
I-Disease	1751	1752	3
I-Disease	1753	1760	disease
O	1761	1764	who
O	1765	1769	have
B-Symptom	1770	1777	diffuse
I-Symptom	1778	1784	fundus
I-Symptom	1785	1791	flecks
O	1791	1792	.

O	1793	1805	Nevertheless
O	1805	1806	,
O	1807	1811	over
O	1812	1814	80
O	1814	1815	%
O	1816	1818	of
O	1819	1822	the
O	1823	1831	patients
O	1832	1836	with
B-Disease	1837	1842	stage
I-Disease	1843	1844	2
I-Disease	1844	1845	/
I-Disease	1845	1850	stage
I-Disease	1851	1852	2
I-Disease	1852	1853	-
I-Disease	1853	1854	3
I-Disease	1855	1864	Stargardt
I-Disease	1864	1865	'
I-Disease	1865	1866	s
I-Disease	1867	1874	disease
O	1875	1880	still
O	1881	1891	maintained
B-Symptom	1892	1894	VA
I-Symptom	1895	1897	of
I-Symptom	1898	1900	20
I-Symptom	1900	1901	/
I-Symptom	1901	1904	200
I-Symptom	1905	1907	or
I-Symptom	1908	1914	better
O	1914	1915	.

O	1916	1920	Only
O	1921	1922	5
O	1922	1923	.
O	1923	1924	9
O	1924	1925	%
O	1926	1928	of
O	1929	1937	patients
O	1938	1942	with
B-Disease	1943	1948	stage
I-Disease	1949	1950	2
I-Disease	1950	1951	/
I-Disease	1951	1956	stage
I-Disease	1957	1958	2
I-Disease	1958	1959	-
I-Disease	1959	1960	3
O	1961	1964	had
B-Symptom	1965	1967	VA
I-Symptom	1968	1974	levels
I-Symptom	1975	1980	worse
I-Symptom	1981	1985	than
I-Symptom	1986	1988	20
I-Symptom	1988	1989	/
I-Symptom	1989	1992	400
O	1992	1993	.

O	1994	1996	In
O	1997	2000	our
O	2001	2007	cohort
O	2008	2010	of
O	2011	2019	patients
O	2020	2024	with
B-Disease	2025	2034	Stargardt
I-Disease	2034	2035	'
I-Disease	2035	2036	s
I-Disease	2037	2044	disease
O	2045	2048	and
B-Symptom	2049	2056	diffuse
I-Symptom	2057	2063	fundus
I-Symptom	2064	2070	flecks
O	2070	2071	,
O	2072	2075	the
O	2076	2084	majority
O	2085	2087	of
O	2088	2096	patients
O	2097	2100	did
O	2101	2104	not
B-Symptom	2105	2109	lose
I-Symptom	2110	2112	VA
O	2113	2115	to
O	2116	2117	a
O	2118	2125	greater
O	2126	2132	extent
O	2133	2137	than
O	2138	2143	those
O	2144	2148	with
B-Symptom	2149	2158	localized
I-Symptom	2159	2165	flecks
O	2165	2166	.

O	0	12	Relationship
O	13	20	between
B-Diagnostic_tool	21	28	optical
I-Diagnostic_tool	29	38	coherence
I-Diagnostic_tool	39	49	tomography
O	49	50	-
O	50	58	measured
B-Characteristic	59	66	central
I-Characteristic	67	74	retinal
I-Characteristic	75	84	thickness
O	85	88	and
B-Characteristic	89	95	visual
I-Characteristic	96	102	acuity
O	103	105	in
B-Disease	106	114	diabetic
I-Disease	115	122	macular
I-Disease	123	128	edema
O	128	129	.

O	131	133	To
O	134	141	compare
B-Diagnostic_tool	142	149	optical
I-Diagnostic_tool	150	159	coherence
I-Diagnostic_tool	160	170	tomography
O	171	172	(
B-Diagnostic_tool	172	175	OCT
O	175	176	)
O	176	177	-
O	177	185	measured
B-Characteristic	186	193	retinal
I-Characteristic	194	203	thickness
O	204	207	and
B-Characteristic	208	214	visual
I-Characteristic	215	221	acuity
O	222	224	in
B-Anatomy	225	229	eyes
O	230	234	with
B-Disease	235	243	diabetic
I-Disease	244	251	macular
I-Disease	252	257	edema
O	258	259	(
B-Disease	259	262	DME
O	262	263	)
O	264	268	both
O	269	275	before
O	276	279	and
O	280	285	after
B-Anatomy	286	293	macular
O	294	299	laser
O	300	316	photocoagulation
O	316	317	.

O	318	323	Cross
O	323	324	-
O	324	333	sectional
O	334	337	and
O	338	350	longitudinal
O	351	356	study
O	356	357	.

O	358	361	Two
O	362	369	hundred
O	370	373	ten
O	374	382	patients
O	383	384	(
O	384	387	251
B-Anatomy	388	392	eyes
O	392	393	)
O	394	398	with
B-Disease	399	402	DME
O	403	411	enrolled
O	412	414	in
O	415	416	a
O	417	427	randomized
O	428	436	clinical
O	437	442	trial
O	443	445	of
O	446	451	laser
O	452	462	techniques
O	462	463	.

B-Characteristic	464	471	Retinal
I-Characteristic	472	481	thickness
O	482	485	was
O	486	494	measured
O	495	499	with
B-Diagnostic_tool	500	503	OCT
O	504	507	and
B-Characteristic	508	514	visual
I-Characteristic	515	521	acuity
O	522	525	was
O	526	534	measured
O	535	539	with
O	540	543	the
O	544	554	electronic
O	555	560	Early
O	561	570	Treatment
O	571	573	of
B-Disease	574	582	Diabetic
I-Disease	583	594	Retinopathy
O	595	604	procedure
O	604	605	.

B-Diagnostic_tool	606	613	Optical
I-Diagnostic_tool	614	623	coherence
I-Diagnostic_tool	624	634	tomography
O	634	635	-
O	635	643	measured
B-Characteristic	644	650	center
I-Characteristic	651	656	point
I-Characteristic	657	666	thickness
O	667	670	and
B-Characteristic	671	677	visual
I-Characteristic	678	684	acuity
O	684	685	.

O	686	689	The
O	690	701	correlation
O	702	714	coefficients
O	715	718	for
B-Characteristic	719	725	visual
I-Characteristic	726	732	acuity
O	733	739	versus
B-Characteristic	740	743	OCT
I-Characteristic	744	750	center
I-Characteristic	751	756	point
I-Characteristic	757	766	thickness
O	767	771	were
O	772	773	0
O	773	774	.
O	774	776	52
O	777	779	at
O	780	788	baseline
O	789	792	and
O	793	794	0
O	794	795	.
O	795	797	49
O	797	798	,
O	799	800	0
O	800	801	.
O	801	803	36
O	803	804	,
O	805	808	and
O	809	810	0
O	810	811	.
O	811	813	38
O	814	816	at
O	817	818	3
O	818	819	.
O	819	820	5
O	820	821	,
O	822	823	8
O	823	824	,
O	825	828	and
O	829	831	12
O	832	838	months
O	839	844	after
O	845	850	laser
O	851	867	photocoagulation
O	867	868	.

O	869	872	The
O	873	878	slope
O	879	881	of
O	882	885	the
O	886	890	best
O	891	894	fit
O	895	899	line
O	900	902	to
O	903	906	the
O	907	915	baseline
O	916	920	data
O	921	924	was
O	925	938	approximately
O	939	940	4
O	940	941	.
O	941	942	4
O	943	950	letters
O	951	952	(
O	952	954	95
O	954	955	%
O	956	966	confidence
O	967	975	interval
O	975	976	,
O	977	978	3
O	978	979	.
O	979	980	5
O	980	981	-
O	981	982	5
O	982	983	.
O	983	984	3
O	984	985	)
O	986	988	of
O	989	995	better
O	996	998	of
B-Characteristic	999	1005	visual
I-Characteristic	1006	1012	acuity
O	1013	1016	for
O	1017	1022	every
O	1023	1026	100
O	1026	1027	-
O	1027	1030	mum
O	1031	1039	decrease
O	1040	1042	in
B-Characteristic	1043	1049	center
I-Characteristic	1050	1055	point
I-Characteristic	1056	1065	thickness
O	1066	1068	at
O	1069	1077	baseline
O	1078	1082	with
O	1083	1085	no
O	1086	1095	important
O	1096	1106	difference
O	1107	1109	at
O	1110	1116	follow
O	1116	1117	-
O	1117	1119	up
O	1120	1126	visits
O	1126	1127	.

O	1128	1141	Approximately
O	1142	1145	one
O	1146	1151	third
O	1152	1154	of
O	1155	1158	the
O	1159	1168	variation
O	1169	1171	in
B-Characteristic	1172	1178	visual
I-Characteristic	1179	1185	acuity
O	1186	1191	could
O	1192	1194	be
O	1195	1204	predicted
O	1205	1207	by
O	1208	1209	a
O	1210	1216	linear
O	1217	1227	regression
O	1228	1233	model
O	1234	1238	that
O	1239	1251	incorporated
B-Characteristic	1252	1255	OCT
I-Characteristic	1256	1262	center
I-Characteristic	1263	1268	point
I-Characteristic	1269	1278	thickness
O	1278	1279	,
B-Characteristic	1280	1283	age
O	1283	1284	,
B-Characteristic	1285	1295	hemoglobin
I-Characteristic	1296	1299	A1C
O	1299	1300	,
O	1301	1304	and
B-Characteristic	1305	1313	severity
I-Characteristic	1314	1316	of
I-Characteristic	1317	1328	fluorescein
I-Characteristic	1329	1336	leakage
O	1336	1337	.

O	1338	1341	The
O	1342	1353	correlation
O	1354	1361	between
O	1362	1368	change
O	1369	1371	in
B-Characteristic	1372	1378	visual
I-Characteristic	1379	1385	acuity
O	1386	1389	and
O	1390	1396	change
O	1397	1399	in
B-Symptom	1400	1403	OCT
I-Symptom	1404	1410	center
I-Symptom	1411	1416	point
I-Symptom	1417	1427	thickening
O	1428	1429	3
O	1429	1430	.
O	1430	1431	5
O	1432	1438	months
O	1439	1444	after
O	1445	1450	laser
O	1451	1460	treatment
O	1461	1464	was
O	1465	1466	0
O	1466	1467	.
O	1467	1469	44
O	1469	1470	,
O	1471	1475	with
O	1476	1478	no
O	1479	1488	important
O	1489	1499	difference
O	1500	1502	at
O	1503	1506	the
O	1507	1512	other
O	1513	1519	follow
O	1519	1520	-
O	1520	1522	up
O	1523	1528	times
O	1528	1529	.

O	1530	1531	A
O	1532	1538	subset
O	1539	1541	of
B-Anatomy	1542	1546	eyes
O	1547	1553	showed
O	1554	1565	paradoxical
O	1566	1578	improvements
O	1579	1581	in
B-Characteristic	1582	1588	visual
I-Characteristic	1589	1595	acuity
O	1596	1600	with
O	1601	1610	increased
B-Symptom	1611	1617	center
I-Symptom	1618	1623	point
I-Symptom	1624	1634	thickening
O	1635	1636	(
O	1636	1637	7
O	1637	1638	%
O	1638	1639	-
O	1639	1641	17
O	1641	1642	%
O	1643	1645	at
O	1646	1649	the
O	1650	1651	3
O	1652	1656	time
O	1657	1663	points
O	1663	1664	)
O	1665	1667	or
O	1668	1679	paradoxical
O	1680	1689	worsening
O	1690	1692	of
B-Characteristic	1693	1699	visual
I-Characteristic	1700	1706	acuity
O	1707	1711	with
O	1712	1713	a
O	1714	1722	decrease
O	1723	1725	in
B-Symptom	1726	1732	center
I-Symptom	1733	1738	point
I-Symptom	1739	1749	thickening
O	1750	1751	(
O	1751	1753	18
O	1753	1754	%
O	1754	1755	-
O	1755	1757	26
O	1757	1758	%
O	1759	1761	at
O	1762	1765	the
O	1766	1767	3
O	1768	1772	time
O	1773	1779	points
O	1779	1780	)
O	1780	1781	.

O	1782	1787	There
O	1788	1790	is
O	1791	1797	modest
O	1798	1809	correlation
O	1810	1817	between
B-Characteristic	1818	1821	OCT
I-Characteristic	1821	1822	-
I-Characteristic	1822	1830	measured
I-Characteristic	1831	1837	center
I-Characteristic	1838	1843	point
I-Characteristic	1844	1853	thickness
O	1854	1857	and
B-Characteristic	1858	1864	visual
I-Characteristic	1865	1871	acuity
O	1871	1872	,
O	1873	1876	and
O	1877	1883	modest
O	1884	1895	correlation
O	1896	1898	of
O	1899	1906	changes
O	1907	1909	in
B-Characteristic	1910	1917	retinal
I-Characteristic	1918	1928	thickening
O	1929	1932	and
B-Characteristic	1933	1939	visual
I-Characteristic	1940	1946	acuity
O	1947	1952	after
O	1953	1958	focal
O	1959	1964	laser
O	1965	1974	treatment
O	1975	1978	for
B-Disease	1979	1982	DME
O	1982	1983	.

O	1984	1991	However
O	1991	1992	,
O	1993	1994	a
O	1995	1999	wide
O	2000	2005	range
O	2006	2008	of
B-Characteristic	2009	2015	visual
I-Characteristic	2016	2022	acuity
O	2023	2026	may
O	2027	2029	be
O	2030	2038	observed
O	2039	2042	for
O	2043	2044	a
O	2045	2050	given
O	2051	2057	degree
O	2058	2060	of
B-Disease	2061	2068	retinal
I-Disease	2069	2074	edema
O	2074	2075	.

O	2076	2080	Thus
O	2080	2081	,
O	2082	2090	although
B-Diagnostic_tool	2091	2094	OCT
O	2095	2107	measurements
O	2108	2110	of
B-Characteristic	2111	2118	retinal
I-Characteristic	2119	2128	thickness
O	2129	2138	represent
O	2139	2141	an
O	2142	2151	important
O	2152	2156	tool
O	2157	2159	in
O	2160	2168	clinical
O	2169	2179	evaluation
O	2179	2180	,
O	2181	2185	they
O	2186	2192	cannot
O	2193	2203	substitute
O	2204	2212	reliably
O	2213	2215	as
O	2216	2217	a
O	2218	2227	surrogate
O	2228	2231	for
B-Characteristic	2232	2238	visual
I-Characteristic	2239	2245	acuity
O	2246	2248	at
O	2249	2250	a
O	2251	2256	given
O	2257	2262	point
O	2263	2265	in
O	2266	2270	time
O	2270	2271	.

O	2272	2276	This
O	2277	2282	study
O	2283	2287	does
O	2288	2291	not
O	2292	2299	address
O	2300	2307	whether
O	2308	2313	short
O	2313	2314	-
O	2314	2318	term
O	2319	2326	changes
O	2327	2329	on
B-Diagnostic_tool	2330	2333	OCT
O	2334	2337	are
O	2338	2348	predictive
O	2349	2351	of
O	2352	2356	long
O	2356	2357	-
O	2357	2361	term
O	2362	2369	effects
O	2370	2372	on
B-Characteristic	2373	2379	visual
I-Characteristic	2380	2386	acuity
O	2386	2387	.

O	3	6	Ten
O	6	7	-
O	7	11	year
O	12	21	incidence
O	22	25	and
O	26	37	progression
O	38	40	of
B-Disease	41	44	age
I-Disease	44	45	-
I-Disease	45	52	related
I-Disease	53	64	maculopathy
O	64	65	:
O	66	69	the
O	70	74	blue
O	75	84	Mountains
O	85	88	Eye
O	89	94	Study

O	96	103	Purpose
O	103	104	:
O	105	107	To
O	108	114	assess
O	115	118	the
O	119	121	10
O	121	122	-
O	122	126	year
O	127	136	incidence
O	137	139	of
B-Disease	140	143	age
I-Disease	143	144	-
I-Disease	144	151	related
I-Disease	152	163	maculopathy
O	164	165	(
B-Disease	165	168	ARM
O	168	169	)
O	170	172	in
O	173	175	an
B-Characteristic	176	181	older
I-Characteristic	182	192	Australian
I-Characteristic	193	199	cohort
O	199	200	.

O	202	208	Design
O	208	209	:
O	210	220	Population
O	220	221	-
O	221	226	based
O	227	233	cohort
O	234	239	study
O	239	240	.

O	242	254	Participants
O	254	255	:
O	256	261	Three
O	262	270	thousand
O	271	274	six
O	275	282	hundred
O	283	288	fifty
O	288	289	-
O	289	293	four
O	294	298	Blue
O	299	308	Mountains
O	309	312	Eye
O	313	318	Study
O	319	331	participants
B-Characteristic	332	333	>
I-Characteristic	334	336	or
I-Characteristic	337	338	=
I-Characteristic	338	340	49
I-Characteristic	341	346	years
I-Characteristic	347	350	old
O	351	355	were
O	356	364	examined
O	365	371	during
O	372	376	1992
O	377	384	through
O	385	389	1994
O	389	390	;
O	391	395	2335
O	396	397	(
O	397	399	75
O	399	400	%
O	401	403	of
O	404	413	survivors
O	413	414	)
O	415	419	were
O	420	430	reexamined
O	431	436	after
O	437	438	5
O	439	444	years
O	445	446	(
O	446	450	1997
O	450	451	-
O	451	455	1999
O	455	456	)
O	457	460	and
O	461	465	1952
O	466	467	(
O	467	469	76
O	469	470	%
O	471	473	of
O	474	483	survivors
O	483	484	)
O	485	490	after
O	491	493	10
O	494	499	years
O	500	501	(
O	501	505	2002
O	505	506	-
O	506	510	2004
O	510	511	)
O	511	512	.

O	514	521	Methods
O	521	522	:
O	523	526	The
O	527	531	same
O	532	539	graders
O	540	549	performed
B-Diagnostic_tool	550	557	retinal
I-Diagnostic_tool	558	570	photographic
I-Diagnostic_tool	571	578	grading
O	579	581	in
O	582	585	all
O	586	598	examinations
O	598	599	,
O	600	605	using
O	606	609	the
B-Classification_system	610	619	Wisconsin
I-Classification_system	620	623	Age
I-Classification_system	623	624	-
I-Classification_system	624	631	Related
I-Classification_system	632	643	Maculopathy
I-Classification_system	644	651	Grading
O	652	658	System
O	658	659	.

B-Diagnostic_tool	660	671	Photographs
O	672	674	of
O	675	687	participants
O	688	692	with
B-Symptom	693	696	ARM
I-Symptom	697	704	lesions
O	705	707	at
O	708	711	any
O	712	714	of
O	715	718	the
O	719	731	examinations
O	732	736	were
O	737	749	subsequently
O	750	758	regraded
O	759	764	using
O	765	766	a
O	767	771	side
O	771	772	-
O	772	774	by
O	774	775	-
O	775	779	side
O	780	790	comparison
O	791	797	method
O	797	798	.

O	800	804	Main
O	805	812	outcome
O	813	821	measures
O	821	822	:
O	823	826	The
O	827	836	diagnosis
O	837	839	of
B-Disease	840	848	incident
I-Disease	849	853	late
I-Disease	854	857	ARM
O	858	861	was
O	862	867	given
O	868	870	if
B-Symptom	871	882	neovascular
I-Symptom	883	886	ARM
O	887	889	or
B-Symptom	890	900	geographic
I-Symptom	901	908	atrophy
O	909	912	was
O	913	921	detected
O	922	924	at
O	925	931	either
O	932	938	follow
O	938	939	-
O	939	941	up
O	942	953	examination
O	954	956	in
O	957	964	persons
O	965	969	free
O	970	972	of
O	973	978	these
O	979	986	lesions
O	987	989	at
O	990	998	baseline
O	998	999	.

B-Disease	1000	1008	Incident
I-Disease	1009	1014	early
I-Disease	1015	1018	ARM
O	1019	1022	was
O	1023	1032	diagnosed
O	1033	1035	if
B-Disease	1036	1041	early
I-Disease	1042	1045	ARM
O	1046	1047	(
B-Symptom	1047	1051	soft
I-Symptom	1052	1062	indistinct
I-Symptom	1063	1065	or
I-Symptom	1066	1075	reticular
I-Symptom	1076	1082	drusen
O	1083	1085	or
B-Symptom	1086	1094	combined
I-Symptom	1095	1099	soft
I-Symptom	1100	1108	distinct
I-Symptom	1109	1115	drusen
I-Symptom	1116	1119	and
I-Symptom	1120	1127	retinal
I-Symptom	1128	1135	pigment
I-Symptom	1136	1147	abnormality
O	1147	1148	)
O	1149	1152	was
O	1153	1160	present
O	1161	1163	in
O	1164	1171	persons
O	1172	1176	free
O	1177	1179	of
B-Disease	1180	1185	early
I-Disease	1186	1189	and
I-Disease	1190	1194	late
I-Disease	1195	1198	ARM
O	1199	1201	at
O	1202	1210	baseline
O	1210	1211	.

B-Disease	1212	1215	Age
I-Disease	1215	1216	-
I-Disease	1216	1223	related
I-Disease	1224	1235	maculopathy
O	1236	1245	incidence
O	1246	1249	was
O	1250	1260	calculated
O	1261	1266	using
O	1267	1273	Kaplan
O	1273	1274	-
O	1274	1279	Meier
O	1280	1287	methods
O	1288	1290	to
O	1291	1302	incorporate
O	1303	1314	information
O	1315	1319	from
O	1320	1324	both
O	1325	1326	5
O	1326	1327	-
O	1328	1331	and
O	1332	1334	10
O	1334	1335	-
O	1335	1339	year
O	1340	1352	examinations
O	1352	1353	.

O	1354	1362	Discrete
O	1363	1371	logistic
O	1372	1378	models
O	1379	1383	were
O	1384	1388	used
O	1389	1391	to
O	1392	1398	assess
O	1399	1402	the
O	1403	1407	risk
O	1408	1410	of
B-Disease	1411	1419	incident
I-Disease	1420	1424	late
I-Disease	1425	1428	ARM
O	1429	1438	according
O	1439	1441	to
O	1442	1449	various
O	1450	1458	baseline
O	1459	1466	factors
O	1466	1467	,
O	1468	1477	including
B-Symptom	1478	1483	early
I-Symptom	1484	1487	ARM
I-Symptom	1488	1494	lesion
O	1495	1510	characteristics
O	1510	1511	.

O	1513	1520	Results
O	1520	1521	:
O	1522	1527	After
O	1528	1537	excluding
O	1538	1540	72
B-Disease	1541	1545	late
I-Disease	1546	1549	ARM
O	1550	1555	cases
O	1556	1563	present
O	1564	1566	at
O	1567	1575	baseline
O	1575	1576	,
O	1577	1581	2395
O	1582	1584	of
O	1585	1589	3582
O	1590	1598	subjects
O	1599	1601	at
O	1602	1606	risk
O	1607	1609	of
B-Disease	1610	1614	late
I-Disease	1615	1618	ARM
O	1619	1620	(
O	1620	1622	67
O	1622	1623	%
O	1623	1624	)
O	1625	1629	were
O	1630	1640	reexamined
O	1641	1643	at
O	1644	1650	either
O	1651	1657	follow
O	1657	1658	-
O	1658	1660	up
O	1661	1665	time
O	1666	1671	point
O	1672	1674	or
O	1675	1679	both
O	1680	1686	follow
O	1686	1687	-
O	1687	1689	up
O	1690	1694	time
O	1695	1701	points
O	1701	1702	.

O	1703	1707	Over
O	1708	1711	the
O	1712	1714	10
O	1714	1715	-
O	1715	1719	year
O	1720	1726	period
O	1726	1727	,
O	1728	1730	72
O	1731	1733	of
O	1734	1738	2395
O	1739	1747	subjects
O	1748	1749	(
O	1749	1750	3
O	1750	1751	.
O	1751	1752	7
O	1752	1753	%
O	1753	1754	)
O	1755	1764	developed
B-Disease	1765	1769	late
I-Disease	1770	1773	ARM
O	1774	1777	and
O	1778	1781	266
O	1782	1784	of
O	1785	1789	2255
O	1790	1798	subjects
O	1799	1800	(
O	1800	1802	14
O	1802	1803	.
O	1803	1804	1
O	1804	1805	%
O	1805	1806	)
O	1807	1816	developed
B-Disease	1817	1822	early
I-Disease	1823	1826	ARM
O	1826	1827	.

O	1828	1833	After
O	1834	1837	age
O	1838	1853	standardization
O	1854	1856	to
O	1857	1860	the
O	1861	1867	Beaver
O	1868	1871	Dam
O	1872	1875	Eye
O	1876	1881	Study
O	1882	1892	population
O	1892	1893	,
O	1894	1897	our
O	1898	1900	10
O	1900	1901	-
O	1901	1905	year
O	1906	1916	incidences
O	1917	1919	of
B-Disease	1920	1924	late
I-Disease	1925	1928	and
I-Disease	1929	1934	early
I-Disease	1935	1938	ARM
O	1939	1943	were
O	1944	1945	2
O	1945	1946	.
O	1946	1947	8
O	1947	1948	%
O	1949	1952	and
O	1953	1955	10
O	1955	1956	.
O	1956	1957	8
O	1957	1958	%
O	1958	1959	,
O	1960	1972	respectively
O	1972	1973	.

O	1974	1982	Baseline
B-Characteristic	1983	1986	age
O	1987	1990	and
B-Symptom	1991	1996	early
I-Symptom	1997	2000	ARM
I-Symptom	2001	2007	lesion
O	2008	2023	characteristics
O	2024	2027	and
O	2028	2036	severity
O	2037	2041	were
O	2042	2048	strong
O	2049	2059	predictors
O	2060	2062	of
B-Disease	2063	2067	late
I-Disease	2068	2071	ARM
O	2072	2081	incidence
O	2081	2082	.

O	2084	2095	Conclusions
O	2095	2096	:
O	2097	2101	Long
O	2101	2102	-
O	2102	2106	term
O	2107	2113	follow
O	2113	2114	-
O	2114	2116	up
O	2117	2119	of
O	2120	2124	this
B-Characteristic	2125	2130	older
I-Characteristic	2131	2141	population
O	2142	2150	confirms
O	2151	2155	that
O	2156	2159	the
O	2160	2164	risk
O	2165	2167	of
B-Disease	2168	2171	ARM
O	2172	2183	progression
O	2184	2186	is
O	2187	2194	related
O	2195	2203	strongly
O	2204	2206	to
O	2207	2210	the
O	2211	2219	severity
O	2220	2222	of
B-Symptom	2223	2228	early
I-Symptom	2228	2229	-
I-Symptom	2229	2234	stage
I-Symptom	2235	2242	lesions
O	2242	2243	.

O	2244	2247	The
O	2248	2253	study
O	2254	2262	provides
O	2263	2271	evidence
O	2271	2272	-
O	2272	2277	based
O	2278	2286	criteria
O	2287	2290	for
O	2291	2302	identifying
O	2303	2310	persons
O	2311	2313	at
O	2314	2318	high
O	2319	2323	risk
O	2324	2326	of
O	2327	2337	developing
B-Disease	2338	2342	late
I-Disease	2343	2346	ARM
O	2346	2347	.

B-Symptom	0	7	Retinal
I-Symptom	8	13	nerve
I-Symptom	14	19	fiber
I-Symptom	20	25	layer
I-Symptom	26	32	damage
O	33	35	as
O	36	44	assessed
O	45	47	by
B-Diagnostic_tool	48	55	optical
I-Diagnostic_tool	56	65	coherence
I-Diagnostic_tool	66	76	tomography
O	77	79	in
B-Anatomy	80	84	eyes
O	85	89	with
O	90	91	a
B-Symptom	92	98	visual
I-Symptom	99	104	field
I-Symptom	105	111	defect
O	112	120	detected
O	121	123	by
B-Diagnostic_tool	124	133	frequency
I-Diagnostic_tool	134	142	doubling
I-Diagnostic_tool	143	153	technology
I-Diagnostic_tool	154	163	perimetry
O	164	167	but
O	168	171	not
O	172	174	by
B-Diagnostic_tool	175	183	standard
I-Diagnostic_tool	184	193	automated
I-Diagnostic_tool	194	203	perimetry
O	203	204	.

O	206	208	To
O	209	218	determine
O	219	226	whether
O	227	230	the
B-Symptom	231	237	visual
I-Symptom	238	243	field
I-Symptom	244	245	(
I-Symptom	245	247	VF
I-Symptom	247	248	)
I-Symptom	249	253	loss
O	254	262	detected
O	263	265	by
B-Diagnostic_tool	266	275	frequency
I-Diagnostic_tool	276	284	doubling
I-Diagnostic_tool	285	295	technology
I-Diagnostic_tool	296	305	perimetry
O	306	307	(
B-Diagnostic_tool	307	310	FDT
O	310	311	)
O	312	315	but
O	316	319	not
O	320	322	by
B-Diagnostic_tool	323	331	standard
I-Diagnostic_tool	332	341	automated
I-Diagnostic_tool	342	351	perimetry
O	352	353	(
B-Diagnostic_tool	353	356	SAP
O	356	357	)
O	358	360	is
O	361	371	associated
O	372	376	with
B-Symptom	377	384	retinal
I-Symptom	385	390	nerve
I-Symptom	391	396	fiber
I-Symptom	397	402	layer
I-Symptom	403	404	(
I-Symptom	404	408	RNFL
I-Symptom	408	409	)
I-Symptom	410	416	damage
O	417	425	measured
O	426	431	using
B-Diagnostic_tool	432	439	optical
I-Diagnostic_tool	440	449	coherence
I-Diagnostic_tool	450	460	tomography
O	461	462	(
B-Diagnostic_tool	462	465	OCT
O	465	466	)
O	466	467	.

O	468	481	Observational
O	482	486	case
O	486	487	-
O	487	494	control
O	495	500	study
O	500	501	.

O	502	508	Ninety
O	508	509	-
O	509	514	three
O	515	523	subjects
O	524	528	were
O	529	538	recruited
O	539	543	from
O	544	547	the
O	548	560	longitudinal
O	561	571	University
O	572	574	of
O	575	585	California
O	585	586	,
O	587	590	San
O	591	596	Diego
O	596	597	,
O	598	608	Diagnostic
O	609	620	Innovations
O	621	623	in
B-Disease	624	632	Glaucoma
O	633	638	Study
O	638	639	.

O	640	643	All
O	644	656	participants
O	657	660	had
O	662	663	>
O	665	667	or
O	668	669	=
O	669	670	2
O	671	679	reliable
B-Diagnostic_tool	680	683	SAP
I-Diagnostic_tool	683	684	-
I-Diagnostic_tool	684	691	Swedish
I-Diagnostic_tool	692	703	Interactive
I-Diagnostic_tool	704	711	Testing
I-Diagnostic_tool	712	721	Algorithm
O	722	725	and
B-Diagnostic_tool	726	729	FDT
I-Diagnostic_tool	730	732	24
I-Diagnostic_tool	732	733	-
I-Diagnostic_tool	733	734	2
I-Diagnostic_tool	735	740	tests
O	741	744	and
O	745	747	at
O	748	753	least
O	754	757	one
B-Diagnostic_tool	758	765	Stratus
I-Diagnostic_tool	766	769	OCT
I-Diagnostic_tool	770	774	test
O	774	775	,
O	776	779	all
O	780	789	conducted
O	790	796	within
O	797	798	a
O	799	800	6
O	800	801	-
O	801	806	month
O	807	811	time
O	812	818	window
O	818	819	.

B-Characteristic	820	827	Retinal
I-Characteristic	828	833	nerve
I-Characteristic	834	839	fiber
I-Characteristic	840	845	layer
I-Characteristic	846	855	thickness
O	856	864	measured
O	865	869	with
B-Diagnostic_tool	870	873	OCT
O	874	877	and
O	878	881	the
O	882	888	number
O	889	891	of
O	892	899	sectors
O	900	904	with
B-Diagnostic_tool	905	908	OCT
O	908	909	-
O	909	917	measured
B-Characteristic	918	922	RNFL
I-Characteristic	923	932	thickness
O	933	938	lower
O	939	943	than
O	944	947	the
O	948	950	95
O	950	951	%
O	952	962	confidence
O	963	971	interval
O	972	973	(
O	973	975	CI
O	975	976	)
O	977	979	or
O	980	982	99
O	982	983	%
O	984	986	CI
O	987	992	based
O	993	995	on
O	996	999	the
O	1000	1010	instrument
O	1010	1011	'
O	1011	1012	s
O	1013	1022	normative
O	1023	1031	database
O	1031	1032	.

O	1033	1041	Compared
O	1042	1046	with
O	1047	1052	those
O	1053	1057	with
O	1058	1064	normal
B-Diagnostic_tool	1065	1068	SAP
O	1069	1072	and
B-Diagnostic_tool	1073	1076	FDT
O	1077	1084	results
O	1084	1085	,
O	1086	1087	a
O	1088	1101	significantly
O	1102	1108	higher
O	1109	1119	proportion
O	1120	1122	of
O	1123	1131	subjects
O	1132	1136	with
O	1137	1143	normal
B-Diagnostic_tool	1144	1147	SAP
O	1148	1151	and
O	1152	1160	abnormal
B-Diagnostic_tool	1161	1164	FDT
O	1165	1172	results
O	1173	1176	had
B-Diagnostic_tool	1177	1180	OCT
O	1180	1181	-
O	1181	1189	measured
B-Characteristic	1190	1194	RNFL
I-Characteristic	1195	1204	thickness
O	1205	1212	outside
O	1213	1215	95
O	1215	1216	%
O	1217	1223	limits
O	1224	1226	in
O	1227	1230	the
O	1231	1239	inferior
O	1240	1243	and
O	1244	1252	superior
O	1253	1262	quadrants
O	1263	1264	(
O	1264	1265	P
O	1266	1267	=
O	1268	1269	0
O	1269	1270	.
O	1270	1273	048
O	1273	1274	)
O	1275	1278	and
O	1279	1286	outside
O	1287	1289	99
O	1289	1290	%
O	1291	1297	limits
O	1298	1300	in
O	1301	1304	the
O	1305	1313	inferior
O	1314	1322	quadrant
O	1323	1324	(
O	1324	1325	P
O	1326	1327	=
O	1328	1329	0
O	1329	1330	.
O	1330	1333	010
O	1333	1334	)
O	1334	1335	.

O	1336	1340	When
B-Diagnostic_tool	1341	1344	SAP
O	1345	1347	is
O	1348	1354	within
O	1355	1361	normal
O	1362	1367	range
O	1367	1368	,
O	1369	1373	some
O	1374	1382	patients
O	1383	1387	with
B-Symptom	1388	1390	VF
I-Symptom	1391	1395	loss
O	1396	1404	detected
O	1405	1407	by
B-Diagnostic_tool	1408	1411	FDT
O	1412	1416	show
O	1417	1418	a
B-Characteristic	1419	1428	decreased
I-Characteristic	1429	1433	RNFL
I-Characteristic	1434	1443	thickness
O	1443	1444	,
O	1445	1453	possibly
O	1454	1464	indicating
O	1465	1468	the
O	1469	1477	presence
O	1478	1480	of
B-Symptom	1481	1493	glaucomatous
I-Symptom	1494	1500	damage
O	1500	1501	.

O	1502	1507	These
O	1508	1515	results
O	1516	1523	support
O	1524	1527	the
O	1528	1536	validity
O	1537	1539	of
B-Diagnostic_tool	1540	1543	FDT
O	1544	1546	as
O	1547	1548	a
O	1549	1553	tool
O	1554	1556	to
O	1557	1563	detect
B-Disease	1564	1569	early
I-Disease	1570	1578	glaucoma
O	1578	1579	.

O	3	10	Fifteen
O	10	11	-
O	11	15	year
O	16	26	cumulative
O	27	36	incidence
O	37	39	of
B-Disease	40	43	age
I-Disease	43	44	-
I-Disease	44	51	related
I-Disease	52	59	macular
I-Disease	60	72	degeneration
O	72	73	:
O	74	77	the
O	78	84	Beaver
O	85	88	Dam
O	89	92	Eye
O	93	98	Study

O	100	107	Purpose
O	107	108	:
O	109	111	To
O	112	120	describe
O	121	124	the
O	125	127	15
O	127	128	-
O	128	132	year
O	133	143	cumulative
O	144	153	incidence
O	154	156	of
O	157	162	signs
O	163	165	of
B-Disease	166	171	early
I-Disease	172	175	and
I-Disease	176	180	late
I-Disease	181	184	age
I-Disease	184	185	-
I-Disease	185	192	related
I-Disease	193	200	macular
I-Disease	201	213	degeneration
O	214	215	(
B-Disease	215	218	AMD
O	218	219	)
O	219	220	.

O	222	228	Design
O	228	229	:
O	230	240	Population
O	240	241	-
O	241	246	based
O	247	253	cohort
O	254	259	study
O	259	260	.

O	262	274	Participants
O	274	275	:
O	276	278	We
O	279	287	included
O	288	292	3917
O	293	300	persons
O	300	301	,
B-Characteristic	302	304	43
I-Characteristic	305	307	to
I-Characteristic	308	310	86
I-Characteristic	311	316	years
I-Characteristic	317	319	of
I-Characteristic	320	323	age
O	324	326	at
O	327	330	the
O	331	335	time
O	336	338	of
O	339	340	a
O	341	349	baseline
O	350	361	examination
O	362	364	in
O	365	369	1988
O	370	377	through
O	378	382	1990
O	383	386	and
O	387	391	with
O	392	403	information
O	404	413	collected
O	414	416	in
O	417	423	follow
O	423	424	-
O	424	426	up
O	427	429	in
O	430	434	1993
O	435	442	through
O	443	447	1995
O	447	448	,
O	449	452	and
O	452	453	/
O	453	455	or
O	456	460	1998
O	461	468	through
O	469	473	2000
O	473	474	,
O	475	478	and
O	478	479	/
O	479	481	or
O	482	486	2003
O	487	494	through
O	495	499	2005
O	499	500	.

O	502	509	Methods
O	509	510	:
O	511	518	Grading
O	519	521	of
B-Diagnostic_tool	522	534	stereoscopic
I-Diagnostic_tool	535	541	fundus
I-Diagnostic_tool	542	553	photographs
O	554	559	using
O	560	563	the
B-Classification_system	564	573	Wisconsin
I-Classification_system	574	577	Age
I-Classification_system	577	578	-
I-Classification_system	578	585	Related
I-Classification_system	586	597	Maculopathy
I-Classification_system	598	605	Grading
I-Classification_system	606	612	System
O	612	613	.

O	615	619	Main
O	620	627	outcome
O	628	636	measures
O	636	637	:
O	638	648	Cumulative
O	649	658	incidence
O	659	661	of
B-Symptom	662	668	drusen
O	669	673	type
O	674	677	and
O	678	682	size
O	682	683	,
B-Symptom	684	694	pigmentary
I-Symptom	695	708	abnormalities
O	708	709	,
B-Symptom	710	720	geographic
I-Symptom	721	728	atrophy
O	728	729	,
O	730	733	and
B-Disease	734	743	exudative
I-Disease	744	747	AMD
O	748	758	accounting
O	759	762	for
O	763	772	competing
O	773	777	risk
O	778	780	of
O	781	786	death
O	786	787	.

O	789	796	Results
O	796	797	:
O	798	801	The
O	802	804	15
O	804	805	-
O	805	809	year
O	810	820	cumulative
O	821	830	incidence
O	831	834	was
O	835	837	14
O	837	838	.
O	838	839	3
O	839	840	%
O	841	844	for
B-Disease	845	850	early
I-Disease	851	854	AMD
O	855	856	(
O	856	859	the
O	860	868	presence
O	869	871	of
O	872	878	either
B-Symptom	879	883	soft
I-Symptom	884	894	indistinct
I-Symptom	895	901	drusen
O	902	904	or
O	905	908	the
O	909	917	presence
O	918	920	of
B-Symptom	921	931	pigmentary
I-Symptom	932	945	abnormalities
O	946	954	together
O	955	959	with
O	960	963	any
O	964	968	type
O	969	971	of
B-Symptom	972	978	drusen
O	978	979	)
O	980	983	and
O	984	985	3
O	985	986	.
O	986	987	1
O	987	988	%
O	989	992	for
B-Disease	993	997	late
I-Disease	998	1001	AMD
O	1002	1003	(
O	1003	1011	presence
O	1012	1014	of
B-Disease	1015	1024	exudative
I-Disease	1025	1028	AMD
O	1029	1031	or
B-Symptom	1032	1042	geographic
I-Symptom	1043	1050	atrophy
O	1050	1051	)
O	1051	1052	.

O	1053	1058	There
O	1059	1062	was
O	1063	1065	an
O	1066	1075	increased
O	1076	1085	incidence
O	1086	1088	of
B-Symptom	1089	1092	AMD
I-Symptom	1093	1100	lesions
O	1101	1105	with
B-Characteristic	1106	1109	age
O	1110	1111	(
O	1111	1112	P
O	1112	1113	<
O	1113	1114	0
O	1114	1115	.
O	1115	1117	05
O	1117	1118	)
O	1118	1119	.

O	1120	1131	Individuals
B-Characteristic	1132	1133	>
I-Characteristic	1134	1136	or
I-Characteristic	1137	1138	=
I-Characteristic	1139	1141	75
I-Characteristic	1142	1147	years
I-Characteristic	1148	1150	of
I-Characteristic	1151	1154	age
O	1155	1157	at
O	1158	1166	baseline
O	1167	1170	had
O	1171	1184	significantly
O	1185	1186	(
O	1186	1187	P
O	1187	1188	<
O	1188	1189	0
O	1189	1190	.
O	1190	1192	01
O	1192	1193	)
O	1194	1200	higher
O	1201	1203	15
O	1203	1204	-
O	1204	1208	year
O	1209	1219	incidences
O	1220	1222	of
O	1223	1226	the
O	1227	1236	following
O	1237	1252	characteristics
O	1253	1257	than
O	1258	1264	people
B-Characteristic	1265	1267	43
I-Characteristic	1268	1270	to
I-Characteristic	1271	1273	54
I-Characteristic	1274	1279	years
I-Characteristic	1280	1282	of
I-Characteristic	1283	1286	age
O	1286	1287	:
B-Symptom	1288	1294	larger
I-Symptom	1295	1301	drusen
O	1302	1303	(
B-Dimension	1303	1306	125
I-Dimension	1307	1310	mum
I-Dimension	1311	1313	in
I-Dimension	1314	1322	diameter
O	1322	1323	,
O	1324	1326	24
O	1326	1327	.
O	1327	1328	1
O	1328	1329	%
O	1330	1332	vs
O	1333	1335	10
O	1335	1336	.
O	1336	1337	6
O	1337	1338	%
O	1338	1339	)
O	1339	1340	,
B-Symptom	1341	1345	soft
I-Symptom	1346	1356	indistinct
I-Symptom	1357	1363	drusen
O	1364	1365	(
O	1365	1367	18
O	1367	1368	.
O	1368	1369	7
O	1369	1370	%
O	1371	1373	vs
O	1374	1375	6
O	1375	1376	.
O	1376	1377	5
O	1377	1378	%
O	1378	1379	)
O	1379	1380	,
B-Symptom	1381	1388	retinal
I-Symptom	1389	1399	pigmentary
I-Symptom	1400	1413	abnormalities
O	1414	1415	(
O	1415	1417	20
O	1417	1418	.
O	1418	1419	2
O	1419	1420	%
O	1421	1423	vs
O	1424	1425	3
O	1425	1426	.
O	1426	1427	7
O	1427	1428	%
O	1428	1429	)
O	1429	1430	,
B-Disease	1431	1440	exudative
I-Disease	1441	1448	macular
I-Disease	1449	1461	degeneration
O	1462	1463	(
O	1463	1464	4
O	1464	1465	.
O	1465	1466	4
O	1466	1467	%
O	1468	1470	vs
O	1471	1472	0
O	1472	1473	.
O	1473	1474	4
O	1474	1475	%
O	1475	1476	)
O	1476	1477	,
O	1478	1481	and
B-Symptom	1482	1486	pure
I-Symptom	1487	1497	geographic
I-Symptom	1498	1505	atrophy
O	1506	1507	(
O	1507	1508	3
O	1508	1509	.
O	1509	1510	2
O	1510	1511	%
O	1512	1514	vs
O	1515	1516	0
O	1516	1517	%
O	1517	1518	)
O	1518	1519	.

O	1520	1531	Controlling
O	1532	1535	for
B-Characteristic	1536	1539	age
O	1539	1540	,
O	1541	1549	compared
O	1550	1554	with
O	1555	1560	those
O	1561	1565	with
O	1566	1571	small
O	1572	1579	numbers
O	1580	1582	of
O	1583	1587	only
B-Symptom	1588	1593	small
I-Symptom	1594	1598	hard
I-Symptom	1599	1605	drusen
I-Symptom	1606	1607	(
I-Symptom	1607	1608	1
I-Symptom	1608	1609	-
I-Symptom	1609	1610	2
I-Symptom	1610	1611	)
O	1611	1612	,
O	1613	1618	those
O	1619	1623	with
O	1624	1629	large
O	1630	1637	numbers
O	1638	1640	of
O	1641	1645	only
B-Symptom	1646	1650	hard
I-Symptom	1651	1657	drusen
I-Symptom	1658	1659	(
I-Symptom	1659	1660	>
I-Symptom	1661	1663	or
I-Symptom	1664	1665	=
I-Symptom	1665	1666	8
I-Symptom	1666	1667	)
O	1668	1671	had
O	1672	1674	an
O	1675	1684	increased
O	1685	1687	15
O	1687	1688	-
O	1688	1692	year
O	1693	1696	age
O	1696	1697	-
O	1697	1705	adjusted
O	1706	1715	incidence
O	1716	1718	of
O	1719	1723	both
B-Symptom	1724	1728	soft
I-Symptom	1729	1739	indistinct
I-Symptom	1740	1746	drusen
O	1747	1748	(
O	1748	1750	16
O	1750	1751	.
O	1751	1752	3
O	1752	1753	%
O	1754	1756	vs
O	1757	1758	4
O	1758	1759	.
O	1759	1760	7
O	1760	1761	%
O	1761	1762	)
O	1763	1766	and
B-Symptom	1767	1777	pigmentary
I-Symptom	1778	1791	abnormalities
O	1792	1793	(
O	1793	1795	10
O	1795	1796	.
O	1796	1797	6
O	1797	1798	%
O	1799	1801	vs
O	1802	1803	2
O	1803	1804	.
O	1804	1805	7
O	1805	1806	%
O	1806	1807	)
O	1807	1808	.

B-Anatomy	1809	1813	Eyes
O	1814	1818	with
B-Symptom	1819	1823	soft
I-Symptom	1824	1834	indistinct
I-Symptom	1835	1841	drusen
O	1842	1844	or
B-Symptom	1845	1855	pigmentary
I-Symptom	1856	1869	abnormalities
O	1870	1872	at
O	1873	1881	baseline
O	1882	1886	were
O	1887	1891	more
O	1892	1898	likely
O	1899	1901	to
O	1902	1909	develop
B-Disease	1910	1914	late
I-Disease	1915	1918	AMD
O	1919	1921	at
O	1922	1928	follow
O	1928	1929	-
O	1929	1931	up
O	1932	1936	than
B-Anatomy	1937	1941	eyes
O	1942	1949	without
O	1950	1955	these
O	1956	1963	lesions
O	1964	1965	(
O	1965	1967	17
O	1967	1968	.
O	1968	1969	8
O	1969	1970	%
O	1971	1973	vs
O	1974	1975	1
O	1975	1976	.
O	1976	1977	2
O	1977	1978	%
O	1979	1982	and
O	1983	1985	12
O	1985	1986	.
O	1986	1987	9
O	1987	1988	%
O	1989	1991	vs
O	1992	1993	1
O	1993	1994	.
O	1994	1995	7
O	1995	1996	%
O	1996	1997	,
O	1998	2010	respectively
O	2010	2011	)
O	2011	2012	.

O	2014	2025	Conclusions
O	2025	2026	:
O	2027	2029	We
O	2030	2038	document
O	2039	2042	the
O	2043	2047	long
O	2047	2048	-
O	2048	2052	term
O	2053	2062	incidence
O	2063	2065	of
O	2066	2071	signs
O	2072	2074	of
B-Disease	2075	2078	AMD
O	2079	2082	and
O	2083	2084	a
O	2085	2094	continuum
O	2095	2099	from
B-Symptom	2100	2105	small
I-Symptom	2106	2110	hard
I-Symptom	2111	2117	drusen
O	2118	2120	to
B-Disease	2121	2125	late
I-Disease	2126	2129	AMD
O	2130	2132	in
B-Characteristic	2133	2138	older
I-Characteristic	2139	2146	persons
O	2147	2149	in
O	2150	2153	the
O	2154	2164	population
O	2164	2165	.

O	2166	2169	The
O	2170	2172	15
O	2172	2173	-
O	2173	2177	year
O	2178	2188	cumulative
O	2189	2198	incidence
O	2199	2201	of
B-Disease	2202	2206	late
I-Disease	2207	2210	AMD
O	2211	2213	in
O	2214	2220	people
B-Characteristic	2221	2222	>
I-Characteristic	2223	2225	or
I-Characteristic	2226	2227	=
I-Characteristic	2228	2230	75
I-Characteristic	2231	2236	years
I-Characteristic	2237	2239	of
I-Characteristic	2240	2243	age
O	2244	2245	(
O	2245	2246	8
O	2246	2247	%
O	2247	2248	)
O	2249	2258	indicates
O	2259	2260	a
O	2261	2267	public
O	2268	2274	health
O	2275	2282	problem
O	2283	2285	of
O	2286	2297	significant
O	2298	2309	proportions
O	2310	2317	because
O	2318	2321	the
B-Characteristic	2322	2328	United
I-Characteristic	2329	2335	States
I-Characteristic	2336	2346	population
O	2347	2351	this
B-Characteristic	2352	2355	age
O	2356	2358	is
O	2359	2367	expected
O	2368	2370	to
O	2371	2379	increase
O	2380	2382	by
O	2383	2385	54
O	2385	2386	%
O	2387	2394	between
O	2395	2399	2005
O	2400	2403	and
O	2404	2408	2025
O	2408	2409	.

B-Disease	0	8	Cataract
O	9	16	surgery
O	17	19	is
O	20	30	associated
O	31	35	with
O	36	37	a
O	38	44	higher
O	45	49	rate
O	50	52	of
O	53	65	photodynamic
O	66	73	therapy
O	74	77	for
B-Disease	78	81	age
I-Disease	81	82	-
I-Disease	82	89	related
I-Disease	90	97	macular
I-Disease	98	110	degeneration
O	110	111	.

O	113	115	To
O	116	127	investigate
O	128	131	the
O	132	143	association
O	144	151	between
B-Disease	152	160	cataract
O	161	168	surgery
O	169	172	and
O	173	176	the
O	177	181	rate
O	182	184	of
O	185	197	photodynamic
O	198	205	therapy
O	206	207	(
O	207	210	PDT
O	210	211	)
O	212	215	for
B-Disease	216	219	age
I-Disease	219	220	-
I-Disease	220	227	related
I-Disease	228	235	macular
I-Disease	236	248	degeneration
O	249	250	(
B-Disease	250	253	AMD
O	253	254	)
O	254	255	.

O	256	269	Observational
O	270	280	population
O	280	281	-
O	281	286	based
O	287	300	retrospective
O	301	305	case
O	305	306	-
O	306	313	control
O	314	319	study
O	319	320	.

O	321	324	All
O	325	332	members
O	333	335	in
O	336	337	a
O	338	346	district
O	347	349	of
O	350	353	the
O	354	361	largest
O	362	368	health
O	369	380	maintenance
O	381	393	organization
O	394	395	(
O	395	398	HMO
O	398	399	)
O	400	402	in
B-Characteristic	403	409	Israel
I-Characteristic	411	412	>
I-Characteristic	414	416	50
I-Characteristic	417	422	years
I-Characteristic	423	426	old
O	427	429	on
O	430	437	January
O	438	439	1
O	439	440	,
O	441	445	2001
O	445	446	,
O	447	450	who
O	451	454	did
O	455	458	not
O	459	468	terminate
O	469	474	their
O	475	485	membership
O	486	493	through
O	494	497	May
O	498	500	31
O	500	501	,
O	502	506	2005
O	507	508	(
O	508	511	139
O	512	515	894
O	516	523	members
O	523	524	)
O	524	525	.

O	526	529	All
O	530	533	PDT
O	534	544	procedures
O	545	548	for
B-Disease	549	552	AMD
O	553	562	performed
O	563	565	in
O	566	569	the
O	570	575	study
O	576	586	population
O	587	594	between
O	595	602	January
O	603	604	1
O	604	605	,
O	606	610	2001
O	611	614	and
O	615	618	May
O	619	621	31
O	621	622	,
O	623	627	2005
O	628	629	(
O	629	632	283
O	633	641	patients
O	641	642	)
O	643	646	and
O	647	650	all
B-Disease	651	659	cataract
O	660	669	surgeries
O	670	679	performed
O	680	687	between
O	688	695	January
O	696	697	1
O	697	698	,
O	699	703	2001
O	704	707	and
O	708	716	December
O	717	719	31
O	719	720	,
O	721	725	2003
O	726	727	(
O	727	731	5913
O	732	740	patients
O	740	741	)
O	742	746	were
O	747	757	documented
O	757	758	.

O	759	761	We
O	762	771	extracted
O	772	780	clinical
O	781	792	information
O	793	797	from
O	798	801	the
O	802	809	chronic
O	810	817	disease
O	818	826	registry
O	827	829	of
O	830	833	the
O	834	837	HMO
O	838	840	as
O	841	845	well
O	846	848	as
O	849	860	demographic
O	861	864	and
O	865	878	socioeconomic
O	879	890	information
O	890	891	.

O	892	895	For
O	896	900	each
O	901	908	patient
O	909	913	that
O	914	923	underwent
B-Disease	924	932	cataract
O	933	940	surgery
O	940	941	,
O	942	943	5
O	944	947	HMO
O	948	955	members
O	956	963	matched
O	964	966	in
B-Characteristic	967	970	age
O	970	971	,
B-Characteristic	972	978	gender
O	978	979	,
B-Disease	980	987	chronic
I-Disease	988	996	diseases
O	997	998	(
B-Disease	998	1006	systemic
I-Disease	1007	1019	hypertension
O	1019	1020	,
B-Disease	1021	1029	diabetes
O	1029	1030	,
B-Disease	1031	1043	hyperlipemia
O	1043	1044	,
O	1045	1048	and
B-Disease	1049	1057	ischemic
I-Disease	1058	1063	heart
I-Disease	1064	1071	disease
O	1071	1072	)
O	1072	1073	,
B-Characteristic	1074	1079	place
I-Characteristic	1080	1082	of
I-Characteristic	1083	1092	residence
O	1092	1093	,
B-Characteristic	1094	1101	country
I-Characteristic	1102	1104	of
I-Characteristic	1105	1110	birth
O	1111	1114	and
B-Characteristic	1115	1128	socioeconomic
I-Characteristic	1129	1135	status
O	1135	1136	,
O	1137	1140	who
O	1141	1144	did
O	1145	1148	not
O	1149	1156	undergo
B-Disease	1157	1165	cataract
O	1166	1173	surgery
O	1173	1174	,
O	1175	1179	were
O	1180	1188	randomly
O	1189	1195	chosen
O	1196	1198	as
O	1199	1207	controls
O	1208	1209	(
O	1209	1210	n
O	1211	1212	=
O	1213	1215	29
O	1216	1219	565
O	1219	1220	)
O	1220	1221	.

O	1222	1225	The
O	1226	1230	rate
O	1231	1234	for
O	1235	1245	undergoing
O	1246	1249	PDT
O	1250	1252	at
O	1253	1262	different
O	1263	1267	time
O	1268	1275	periods
O	1276	1281	after
B-Disease	1282	1290	cataract
O	1291	1298	surgery
O	1298	1299	.

O	1300	1305	Fifty
O	1306	1307	(
O	1307	1308	0
O	1308	1309	.
O	1309	1311	85
O	1311	1312	%
O	1312	1313	)
B-Disease	1314	1322	cataract
O	1323	1331	patients
O	1332	1335	and
O	1336	1338	94
O	1339	1346	control
O	1347	1352	cases
O	1353	1354	(
O	1354	1355	0
O	1355	1356	.
O	1356	1358	32
O	1358	1359	%
O	1359	1360	)
O	1361	1370	underwent
O	1371	1374	PDT
O	1375	1380	after
B-Disease	1381	1389	cataract
O	1390	1397	surgery
O	1398	1399	(
O	1399	1400	P
O	1401	1402	<
O	1403	1404	0
O	1404	1405	.
O	1405	1409	0001
O	1409	1410	,
O	1411	1414	chi
O	1414	1415	-
O	1415	1421	square
O	1422	1426	test
O	1426	1427	)
O	1427	1428	.

O	1429	1430	A
O	1431	1442	significant
O	1443	1447	rise
O	1448	1450	in
O	1451	1454	PDT
O	1455	1459	rate
O	1460	1463	was
O	1464	1471	noticed
O	1472	1474	in
B-Disease	1475	1483	cataract
O	1484	1492	patients
O	1493	1501	compared
O	1502	1504	to
O	1505	1513	controls
O	1514	1520	during
O	1521	1524	the
O	1525	1530	first
O	1531	1532	6
O	1533	1539	months
O	1540	1545	after
O	1546	1553	surgery
O	1554	1555	(
O	1555	1556	P
O	1557	1558	=
O	1559	1560	0
O	1560	1561	.
O	1561	1564	004
O	1564	1565	,
O	1566	1569	chi
O	1569	1570	-
O	1570	1576	square
O	1577	1581	test
O	1581	1582	)
O	1582	1583	.

O	1584	1591	Between
O	1592	1593	6
O	1594	1597	and
O	1598	1600	12
O	1601	1607	months
O	1608	1623	postoperatively
O	1623	1624	,
O	1625	1628	the
O	1629	1632	PDT
O	1633	1638	rates
O	1639	1643	were
O	1644	1651	similar
O	1652	1654	in
O	1655	1659	both
O	1660	1666	groups
O	1666	1667	.

O	1668	1675	However
O	1675	1676	,
O	1677	1678	a
O	1679	1683	more
O	1684	1695	significant
O	1696	1700	rise
O	1701	1703	in
O	1704	1707	PDT
O	1708	1713	rates
O	1714	1722	occurred
O	1723	1730	between
O	1731	1732	1
O	1733	1736	and
O	1737	1738	1
O	1738	1739	.
O	1739	1740	5
O	1741	1746	years
O	1747	1752	after
O	1753	1760	surgery
O	1761	1762	(
O	1762	1763	P
O	1764	1765	<
O	1766	1767	0
O	1767	1768	.
O	1768	1772	0001
O	1772	1773	,
O	1774	1777	chi
O	1777	1778	-
O	1778	1784	square
O	1785	1789	test
O	1789	1790	)
O	1790	1791	.

O	1792	1795	The
O	1796	1802	Kaplan
O	1802	1803	-
O	1803	1808	Meier
O	1809	1812	PDT
O	1812	1813	-
O	1813	1817	free
O	1818	1826	survival
O	1827	1832	curve
O	1833	1835	of
B-Disease	1836	1844	cataract
O	1845	1853	patients
O	1854	1857	was
O	1858	1871	significantly
O	1872	1877	worse
O	1878	1882	than
O	1883	1887	that
O	1888	1890	of
O	1891	1894	the
O	1895	1903	controls
O	1904	1905	(
O	1905	1906	P
O	1907	1908	<
O	1909	1910	0
O	1910	1911	.
O	1911	1915	0001
O	1915	1916	,
O	1917	1920	chi
O	1920	1921	-
O	1921	1927	square
O	1928	1932	test
O	1932	1933	;
O	1934	1935	P
O	1936	1937	=
O	1938	1940	33
O	1940	1941	.
O	1941	1942	7
O	1942	1943	,
O	1944	1947	log
O	1947	1948	-
O	1948	1952	rank
O	1953	1957	test
O	1957	1958	)
O	1958	1959	.

O	1960	1963	The
O	1964	1970	hazard
O	1971	1976	ratio
O	1977	1980	for
B-Disease	1981	1989	cataract
O	1990	1998	patients
O	1999	2007	compared
O	2008	2010	to
O	2011	2019	controls
O	2020	2022	to
O	2023	2030	undergo
O	2031	2034	PDT
O	2035	2040	after
O	2041	2048	surgery
O	2049	2052	was
O	2053	2054	2
O	2054	2055	.
O	2055	2056	7
O	2057	2058	(
O	2058	2068	confidence
O	2069	2077	interval
O	2078	2079	=
O	2080	2081	2
O	2081	2082	.
O	2082	2083	4
O	2083	2084	-
O	2084	2085	5
O	2085	2086	.
O	2086	2087	7
O	2087	2088	)
O	2088	2089	.

O	2090	2093	The
O	2094	2098	most
O	2099	2110	significant
O	2111	2118	factors
O	2119	2121	to
O	2122	2128	reduce
O	2129	2132	the
O	2133	2137	time
O	2138	2140	to
O	2141	2144	PDT
O	2145	2149	were
B-Characteristic	2150	2158	advanced
I-Characteristic	2159	2162	age
O	2163	2171	followed
O	2172	2174	by
O	2175	2181	having
O	2182	2185	had
B-Disease	2186	2194	cataract
O	2195	2202	surgery
O	2202	2203	,
B-Characteristic	2204	2209	place
I-Characteristic	2210	2212	of
I-Characteristic	2213	2218	birth
O	2218	2219	,
B-Characteristic	2220	2233	socioeconomic
I-Characteristic	2234	2240	status
O	2240	2241	,
O	2242	2245	and
B-Symptom	2246	2260	hyperlipidemia
O	2261	2262	(
O	2262	2265	Cox
O	2266	2278	proportional
O	2279	2286	hazards
O	2287	2295	survival
O	2296	2306	regression
O	2306	2307	)
O	2307	2308	.

O	2309	2311	We
O	2312	2322	identified
O	2323	2325	an
O	2326	2335	increased
O	2336	2340	rate
O	2341	2343	of
O	2344	2347	PDT
O	2347	2348	,
O	2349	2359	presumably
O	2360	2363	for
B-Disease	2364	2373	subfoveal
I-Disease	2374	2377	AMD
O	2377	2378	,
O	2379	2380	1
O	2381	2383	to
O	2384	2385	1
O	2385	2386	.
O	2386	2387	5
O	2388	2393	years
O	2394	2399	after
B-Disease	2400	2408	cataract
O	2409	2416	surgery
O	2416	2417	.

B-Diagnostic_tool	0	12	Angiographic
O	13	16	and
B-Diagnostic_tool	17	24	optical
I-Diagnostic_tool	25	34	coherence
I-Diagnostic_tool	35	46	tomographic
O	47	54	results
O	55	57	of
O	58	61	the
O	62	68	MARINA
O	69	74	study
O	75	77	of
O	78	89	ranibizumab
O	90	92	in
B-Disease	93	104	neovascular
I-Disease	105	108	age
I-Disease	108	109	-
I-Disease	109	116	related
I-Disease	117	124	macular
I-Disease	125	137	degeneration
O	137	138	.

O	140	142	To
O	143	149	assess
O	150	165	pharmacodynamic
O	166	175	responses
O	176	178	to
O	179	190	ranibizumab
O	190	191	,
O	192	194	an
O	195	204	inhibitor
O	205	207	of
O	208	216	vascular
O	217	228	endothelial
O	229	235	growth
O	236	242	factor
O	243	244	A
O	245	246	(
O	246	250	VEGF
O	250	251	-
O	251	252	A
O	252	253	)
O	253	254	,
O	255	257	in
O	258	259	a
O	260	265	study
O	266	268	of
O	269	272	the
O	273	282	treatment
O	283	285	of
O	286	295	minimally
O	296	303	classic
O	304	306	or
O	307	313	occult
O	314	318	with
O	319	321	no
B-Symptom	322	329	classic
I-Symptom	330	339	choroidal
I-Symptom	340	358	neovascularization
O	359	368	secondary
O	369	371	to
B-Disease	372	375	age
I-Disease	375	376	-
I-Disease	376	383	related
I-Disease	384	391	macular
I-Disease	392	404	degeneration
O	405	406	(
B-Disease	406	409	AMD
O	409	410	)
O	411	412	(
O	412	422	designated
O	423	429	MARINA
O	430	431	[
O	431	440	Minimally
O	441	448	Classic
O	448	449	/
O	449	455	Occult
O	456	461	Trial
O	462	464	of
O	465	468	the
O	469	473	Anti
O	473	474	-
O	474	478	VEGF
O	479	487	Antibody
O	488	499	Ranibizumab
O	500	502	in
O	503	506	the
O	507	516	Treatment
O	517	519	of
B-Disease	520	531	Neovascular
I-Disease	532	535	AMD
O	535	536	]
O	536	537	)
O	538	541	and
O	542	544	to
O	545	552	compare
O	553	558	these
O	559	568	responses
O	569	573	with
O	574	579	those
O	580	582	in
O	583	584	a
O	585	589	sham
O	589	590	-
O	590	599	injection
O	600	607	control
O	608	613	group
O	613	614	.

O	615	628	Retrospective
O	629	630	(
O	630	642	prespecified
O	643	646	and
O	647	649	ad
O	650	653	hoc
O	653	654	)
O	655	663	analyses
O	664	666	of
O	667	669	24
O	669	670	-
O	670	675	month
O	676	680	data
O	680	681	.

O	682	687	Seven
O	688	695	hundred
O	696	703	sixteen
O	704	712	patients
O	712	713	,
O	714	724	randomized
O	725	727	to
O	728	729	0
O	729	730	.
O	730	731	3
O	731	732	-
O	732	734	mg
O	735	746	ranibizumab
O	747	748	(
O	748	749	n
O	750	751	=
O	752	755	238
O	755	756	)
O	756	757	,
O	758	759	0
O	759	760	.
O	760	761	5
O	761	762	-
O	762	764	mg
O	765	776	ranibizumab
O	777	778	(
O	778	779	n
O	780	781	=
O	782	785	240
O	785	786	)
O	786	787	,
O	788	790	or
O	791	792	a
O	793	797	sham
O	798	807	injection
O	808	809	(
O	809	810	n
O	811	812	=
O	813	816	238
O	816	817	)
O	817	818	.

B-Diagnostic_tool	819	831	Stereoscopic
I-Diagnostic_tool	832	838	fundus
I-Diagnostic_tool	839	850	photography
O	851	854	and
B-Diagnostic_tool	855	866	fluorescein
I-Diagnostic_tool	867	878	angiography
O	879	880	(
B-Diagnostic_tool	880	882	FA
O	882	883	)
O	884	888	were
O	889	893	done
O	894	896	at
O	897	905	baseline
O	906	909	and
O	910	916	months
O	917	918	3
O	918	919	,
O	920	921	6
O	921	922	,
O	923	925	12
O	925	926	,
O	927	930	and
O	931	933	24
O	933	934	.

B-Diagnostic_tool	935	942	Optical
I-Diagnostic_tool	943	952	coherence
I-Diagnostic_tool	953	963	tomography
O	964	965	(
B-Diagnostic_tool	965	968	OCT
O	968	969	)
O	970	973	was
O	974	983	performed
O	984	986	at
O	987	988	a
O	989	995	subset
O	996	998	of
O	999	1012	investigative
O	1013	1018	sites
O	1019	1020	(
O	1020	1022	46
O	1023	1031	patients
O	1031	1032	)
O	1033	1035	at
O	1036	1044	baseline
O	1044	1045	,
O	1046	1049	day
O	1050	1051	7
O	1051	1052	,
O	1053	1056	and
O	1057	1063	months
O	1064	1065	1
O	1066	1069	and
O	1070	1072	12
O	1072	1073	.

O	1074	1086	Prespecified
O	1087	1096	secondary
O	1097	1100	end
O	1101	1107	points
O	1108	1112	were
O	1113	1117	mean
O	1118	1124	change
O	1125	1129	from
O	1130	1138	baseline
O	1139	1141	in
B-Characteristic	1142	1147	total
I-Characteristic	1148	1152	area
I-Characteristic	1153	1155	of
I-Characteristic	1156	1165	choroidal
I-Characteristic	1166	1184	neovascularization
O	1185	1188	and
B-Characteristic	1189	1194	total
I-Characteristic	1195	1199	area
I-Characteristic	1200	1202	of
I-Characteristic	1203	1210	leakage
I-Characteristic	1211	1215	from
I-Characteristic	1216	1225	choroidal
I-Characteristic	1226	1244	neovascularization
O	1245	1247	at
O	1248	1254	months
O	1255	1257	12
O	1258	1261	and
O	1262	1264	24
O	1264	1265	.

O	1266	1278	Prespecified
O	1279	1290	exploratory
B-Diagnostic_tool	1291	1293	FA
O	1294	1297	end
O	1298	1304	points
O	1305	1313	included
B-Characteristic	1314	1318	mean
I-Characteristic	1319	1325	change
I-Characteristic	1326	1330	from
I-Characteristic	1331	1339	baseline
I-Characteristic	1340	1342	in
I-Characteristic	1343	1346	the
I-Characteristic	1347	1352	areas
I-Characteristic	1353	1355	of
I-Characteristic	1356	1359	the
I-Characteristic	1360	1369	choroidal
I-Characteristic	1370	1388	neovascularization
I-Characteristic	1389	1395	lesion
O	1396	1399	and
B-Symptom	1400	1406	serous
I-Symptom	1407	1414	sensory
I-Symptom	1415	1422	retinal
I-Symptom	1423	1433	detachment
O	1434	1435	(
B-Symptom	1435	1439	SSRD
O	1439	1440	)
O	1441	1443	at
O	1444	1450	months
O	1451	1453	12
O	1454	1457	and
O	1458	1460	24
O	1460	1461	.

O	1462	1466	Post
O	1467	1470	hoc
O	1471	1482	exploratory
B-Diagnostic_tool	1483	1485	FA
O	1486	1493	outcome
O	1494	1502	measures
O	1503	1511	included
O	1512	1515	the
O	1516	1526	proportion
O	1527	1529	of
O	1530	1538	patients
O	1539	1543	with
O	1544	1546	no
B-Symptom	1547	1554	leakage
I-Symptom	1555	1559	from
I-Symptom	1560	1569	choroidal
I-Symptom	1570	1588	neovascularization
O	1589	1592	and
O	1593	1597	mean
O	1598	1604	change
O	1605	1609	from
O	1610	1618	baseline
O	1619	1623	over
O	1624	1628	time
O	1629	1631	in
O	1632	1635	the
O	1636	1640	area
O	1641	1643	of
B-Symptom	1644	1654	subretinal
I-Symptom	1655	1662	fibrous
I-Symptom	1663	1669	tissue
I-Symptom	1669	1670	/
I-Symptom	1670	1679	disciform
I-Symptom	1680	1684	scar
O	1684	1685	.

O	1686	1689	The
O	1690	1702	prespecified
O	1703	1714	exploratory
O	1715	1718	end
O	1719	1724	point
O	1725	1728	for
B-Diagnostic_tool	1729	1732	OCT
O	1733	1736	was
O	1737	1741	mean
O	1742	1748	change
O	1749	1753	from
O	1754	1762	baseline
O	1763	1767	over
O	1768	1772	time
O	1773	1775	in
B-Characteristic	1776	1782	center
I-Characteristic	1783	1788	point
I-Characteristic	1789	1798	thickness
O	1798	1799	.

O	1800	1802	At
O	1803	1805	12
O	1806	1809	and
O	1810	1812	24
O	1813	1819	months
O	1819	1820	,
O	1821	1834	statistically
O	1835	1846	significant
O	1847	1855	benefits
O	1856	1858	of
O	1859	1870	ranibizumab
O	1871	1875	over
O	1876	1880	sham
O	1881	1890	treatment
O	1891	1895	were
O	1896	1904	observed
O	1905	1908	for
O	1909	1913	mean
O	1914	1920	change
O	1921	1925	from
O	1926	1934	baseline
O	1935	1937	in
O	1938	1941	the
O	1942	1947	areas
O	1948	1950	of
B-Symptom	1951	1960	choroidal
I-Symptom	1961	1979	neovascularization
I-Symptom	1980	1986	lesion
O	1986	1987	,
B-Characteristic	1988	1993	total
I-Characteristic	1994	2003	choroidal
I-Characteristic	2004	2022	neovascularization
O	2022	2023	,
B-Symptom	2024	2031	leakage
I-Symptom	2032	2036	from
I-Symptom	2037	2046	choroidal
I-Symptom	2047	2065	neovascularization
O	2065	2066	,
B-Symptom	2067	2071	SSRD
O	2071	2072	,
O	2073	2076	and
B-Symptom	2077	2086	disciform
I-Symptom	2087	2091	scar
I-Symptom	2091	2092	/
I-Symptom	2092	2102	subretinal
I-Symptom	2103	2111	fibrosis
O	2111	2112	.

O	2113	2115	At
O	2116	2118	12
O	2119	2125	months
O	2126	2127	(
O	2127	2132	final
B-Diagnostic_tool	2133	2136	OCT
O	2136	2137	)
O	2137	2138	,
O	2139	2142	the
B-Characteristic	2143	2147	mean
I-Characteristic	2148	2154	change
I-Characteristic	2155	2157	in
I-Characteristic	2158	2164	foveal
I-Characteristic	2165	2171	center
I-Characteristic	2172	2177	point
I-Characteristic	2178	2187	thickness
O	2188	2190	on
B-Diagnostic_tool	2191	2194	OCT
O	2195	2198	was
O	2199	2200	a
O	2201	2212	significant
O	2213	2221	decrease
O	2222	2224	in
O	2225	2228	the
O	2229	2240	ranibizumab
O	2241	2246	group
O	2247	2255	compared
O	2256	2260	with
O	2261	2264	the
O	2265	2269	sham
O	2270	2275	group
O	2275	2276	.

O	2277	2285	Patients
O	2286	2290	with
O	2291	2300	minimally
O	2301	2308	classic
O	2309	2311	or
O	2312	2318	occult
O	2319	2323	with
O	2324	2326	no
B-Disease	2327	2334	classic
I-Disease	2335	2346	neovascular
I-Disease	2347	2350	AMD
O	2351	2358	treated
O	2359	2363	with
O	2364	2375	ranibizumab
O	2376	2388	demonstrated
O	2389	2400	improvement
O	2401	2405	that
O	2406	2409	was
O	2410	2420	consistent
O	2421	2424	for
B-Diagnostic_tool	2425	2431	visual
I-Diagnostic_tool	2432	2438	acuity
O	2438	2439	,
B-Diagnostic_tool	2440	2442	FA
O	2442	2443	,
O	2444	2447	and
B-Diagnostic_tool	2448	2451	OCT
O	2452	2460	outcomes
O	2461	2464	and
O	2465	2473	superior
O	2474	2476	to
O	2477	2481	that
O	2482	2484	in
O	2485	2489	sham
O	2489	2490	-
O	2490	2497	treated
O	2498	2506	patients
O	2506	2507	.

B-Diagnostic_tool	0	5	Three
I-Diagnostic_tool	5	6	-
I-Diagnostic_tool	6	17	dimensional
I-Diagnostic_tool	18	25	imaging
O	26	28	of
B-Disease	29	36	cystoid
I-Disease	37	44	macular
I-Disease	45	50	edema
O	51	53	in
B-Disease	54	61	retinal
I-Disease	62	66	vein
I-Disease	67	76	occlusion
O	76	77	.

O	79	81	To
O	82	87	study
O	88	91	the
O	92	108	pathomorphologic
O	109	117	features
O	118	120	of
B-Disease	121	128	cystoid
I-Disease	129	136	macular
I-Disease	137	142	edema
O	143	144	(
B-Disease	144	147	CME
O	147	148	)
O	149	159	associated
O	160	164	with
B-Disease	165	172	retinal
I-Disease	173	177	vein
I-Disease	178	187	occlusion
O	188	190	by
B-Diagnostic_tool	191	196	three
I-Diagnostic_tool	196	197	-
I-Diagnostic_tool	197	208	dimensional
I-Diagnostic_tool	209	210	(
I-Diagnostic_tool	210	212	3D
I-Diagnostic_tool	212	213	)
I-Diagnostic_tool	214	221	optical
I-Diagnostic_tool	222	231	coherence
I-Diagnostic_tool	232	242	tomography
O	243	244	(
B-Diagnostic_tool	244	247	OCT
O	247	248	)
O	249	252	and
O	253	255	to
O	256	261	study
O	262	265	the
O	266	278	relationship
O	279	281	of
O	282	285	the
O	286	292	ocular
O	293	301	findings
O	302	304	to
B-Characteristic	305	311	visual
I-Characteristic	312	320	function
O	320	321	.

O	322	335	Observational
O	336	340	case
O	341	347	series
O	347	348	.

O	349	355	Twenty
O	356	360	eyes
O	361	363	of
O	364	366	20
O	367	375	patients
O	376	380	with
B-Disease	381	388	retinal
I-Disease	389	393	vein
I-Disease	394	403	occlusion
O	403	404	.

O	405	406	A
O	407	416	prototype
B-Diagnostic_tool	417	419	3D
I-Diagnostic_tool	420	423	OCT
O	424	430	system
O	431	436	based
O	437	439	on
B-Diagnostic_tool	440	447	Fourier
I-Diagnostic_tool	447	448	-
I-Diagnostic_tool	448	454	domain
I-Diagnostic_tool	455	458	OCT
O	459	469	technology
O	470	473	was
O	474	484	fabricated
O	485	488	for
O	489	496	patient
O	497	508	examination
O	509	511	in
O	512	516	this
O	517	522	study
O	522	523	.

O	524	528	This
O	529	535	system
O	536	540	uses
O	541	542	a
O	543	559	superluminescent
O	560	565	diode
O	565	566	,
O	567	572	which
O	573	576	has
O	577	578	a
O	579	585	center
O	586	596	wavelength
O	597	599	of
O	600	603	830
O	604	606	nm
O	607	610	and
O	611	612	a
O	613	622	bandwidth
O	623	625	of
O	626	628	50
O	629	631	nm
O	631	632	,
O	633	635	as
O	636	639	the
O	640	645	light
O	646	652	source
O	652	653	,
O	654	663	resulting
O	664	666	in
O	667	668	4
O	668	669	.
O	669	670	3
O	670	671	-
O	671	677	microm
O	678	683	axial
O	684	694	resolution
O	695	697	in
O	698	704	tissue
O	704	705	.

O	706	710	Data
O	711	722	acquisition
O	723	728	rates
O	729	731	of
O	732	745	approximately
O	746	748	18
O	749	752	700
O	753	758	axial
O	759	764	scans
O	765	768	per
O	769	775	second
O	776	779	and
O	780	781	a
O	782	793	sensitivity
O	794	796	of
O	797	799	98
O	800	802	dB
O	803	807	were
O	808	816	achieved
O	816	817	.

B-Diagnostic_tool	818	823	Three
I-Diagnostic_tool	823	824	-
I-Diagnostic_tool	824	835	dimensional
I-Diagnostic_tool	836	843	imaging
O	844	847	was
O	848	857	performed
O	858	860	by
O	861	867	volume
O	868	877	rendering
O	878	883	based
O	884	886	on
O	887	890	the
O	891	893	3D
O	894	898	data
O	899	902	set
O	903	911	acquired
O	912	916	with
O	917	918	a
O	919	925	raster
O	926	930	scan
O	931	933	of
O	934	941	256x256
O	942	947	axial
O	948	953	scans
O	953	954	.

O	955	961	Images
O	962	964	of
B-Disease	965	968	CME
O	969	979	pathologic
O	980	988	features
O	989	997	obtained
O	998	1000	by
B-Diagnostic_tool	1001	1003	3D
I-Diagnostic_tool	1004	1007	OCT
O	1008	1011	and
O	1012	1014	by
B-Diagnostic_tool	1015	1022	Stratus
I-Diagnostic_tool	1023	1026	OCT
O	1027	1028	(
O	1028	1032	Carl
O	1033	1038	Zeiss
O	1038	1039	,
O	1040	1046	Dublin
O	1046	1047	,
O	1048	1050	CA
O	1050	1051	)
O	1051	1052	.

O	1053	1056	The
B-Diagnostic_tool	1057	1059	3D
I-Diagnostic_tool	1060	1063	OCT
I-Diagnostic_tool	1064	1071	imaging
O	1072	1078	system
O	1079	1088	generates
O	1089	1090	a
O	1091	1100	realistic
O	1101	1103	3D
O	1104	1109	image
O	1110	1112	of
B-Disease	1113	1116	CME
O	1117	1121	with
O	1122	1126	high
O	1127	1137	resolution
O	1137	1138	.

O	1139	1141	In
O	1142	1144	16
B-Anatomy	1145	1149	eyes
O	1149	1150	,
B-Diagnostic_tool	1151	1153	3D
I-Diagnostic_tool	1154	1157	OCT
O	1158	1164	showed
B-Symptom	1165	1170	large
I-Symptom	1171	1177	foveal
I-Symptom	1178	1185	cystoid
I-Symptom	1186	1192	spaces
O	1192	1193	,
O	1194	1198	most
O	1199	1201	of
O	1202	1207	which
O	1208	1212	were
O	1213	1224	accompanied
O	1225	1227	by
B-Symptom	1228	1233	small
I-Symptom	1234	1241	cystoid
I-Symptom	1242	1248	spaces
I-Symptom	1249	1251	in
I-Symptom	1252	1255	the
I-Symptom	1256	1266	parafoveal
I-Symptom	1267	1273	region
O	1273	1274	.

B-Symptom	1275	1282	Cystoid
I-Symptom	1283	1289	spaces
O	1290	1294	were
O	1295	1299	seen
O	1300	1305	often
O	1306	1308	in
O	1309	1312	the
B-Anatomy	1313	1318	inner
I-Anatomy	1319	1326	nuclear
I-Anatomy	1327	1332	layer
O	1333	1336	and
B-Anatomy	1337	1342	outer
I-Anatomy	1343	1352	plexiform
I-Anatomy	1353	1358	layer
O	1358	1359	,
O	1360	1363	but
O	1364	1368	were
O	1369	1377	detected
O	1378	1380	to
O	1381	1385	some
O	1386	1392	extent
O	1393	1395	in
O	1396	1399	all
B-Anatomy	1400	1407	retinal
I-Anatomy	1408	1414	layers
O	1414	1415	.

O	1416	1419	The
B-Diagnostic_tool	1420	1422	3D
I-Diagnostic_tool	1423	1426	OCT
O	1427	1433	showed
O	1434	1441	clearly
O	1442	1443	a
O	1444	1448	thin
O	1449	1453	back
O	1453	1454	-
O	1454	1464	reflecting
O	1465	1469	line
O	1470	1483	corresponding
O	1484	1486	to
O	1487	1490	the
B-Anatomy	1491	1499	external
I-Anatomy	1500	1508	limiting
I-Anatomy	1509	1517	membrane
O	1518	1519	(
B-Anatomy	1519	1522	ELM
O	1522	1523	)
O	1524	1526	in
O	1527	1529	18
B-Anatomy	1530	1534	eyes
O	1534	1535	;
O	1536	1538	of
O	1539	1544	these
O	1544	1545	,
B-Symptom	1546	1553	cystoid
I-Symptom	1554	1560	spaces
O	1561	1565	were
O	1566	1573	located
O	1574	1576	on
O	1577	1580	the
O	1581	1587	inside
O	1588	1590	of
O	1591	1594	the
B-Anatomy	1595	1598	ELM
O	1599	1601	in
O	1602	1603	7
B-Anatomy	1604	1608	eyes
O	1609	1612	and
O	1613	1621	appeared
O	1622	1624	to
O	1625	1627	be
O	1628	1630	in
O	1631	1638	contact
O	1639	1643	with
O	1644	1647	the
B-Anatomy	1648	1651	ELM
O	1652	1654	in
O	1655	1656	9
B-Anatomy	1657	1661	eyes
O	1661	1662	.

O	1663	1665	In
O	1666	1667	2
B-Anatomy	1668	1672	eyes
O	1672	1673	,
O	1674	1677	the
B-Anatomy	1678	1681	ELM
O	1682	1686	line
O	1687	1692	could
O	1693	1696	not
O	1697	1699	be
O	1700	1704	seen
O	1705	1712	clearly
O	1713	1720	beneath
O	1721	1724	the
B-Symptom	1725	1730	large
I-Symptom	1731	1737	foveal
I-Symptom	1738	1745	cystoid
I-Symptom	1746	1752	spaces
O	1752	1753	.

O	1754	1763	Integrity
O	1764	1766	of
O	1767	1770	the
B-Anatomy	1771	1774	ELM
O	1775	1777	in
O	1778	1781	the
B-Anatomy	1782	1788	foveal
I-Anatomy	1789	1795	region
O	1796	1799	had
O	1800	1801	a
O	1802	1808	direct
O	1809	1820	correlation
O	1821	1825	with
B-Characteristic	1826	1832	visual
I-Characteristic	1833	1839	acuity
O	1839	1840	.

O	1841	1852	Observation
O	1853	1855	of
B-Disease	1856	1859	CME
O	1860	1865	using
B-Diagnostic_tool	1866	1868	3D
I-Diagnostic_tool	1869	1872	OCT
O	1873	1880	enabled
O	1881	1894	visualization
O	1895	1897	of
O	1898	1901	its
O	1902	1909	spatial
O	1910	1916	extent
O	1917	1919	in
O	1920	1924	each
B-Anatomy	1925	1932	retinal
I-Anatomy	1933	1938	layer
O	1939	1942	and
O	1943	1954	discernment
O	1955	1957	of
O	1958	1961	its
O	1962	1974	relationship
O	1975	1977	to
O	1978	1981	the
B-Anatomy	1982	1985	ELM
O	1985	1986	.

O	1987	1990	The
O	1991	1994	use
O	1995	1997	of
B-Diagnostic_tool	1998	2000	3D
I-Diagnostic_tool	2001	2004	OCT
O	2005	2009	thus
O	2010	2013	may
O	2014	2021	improve
O	2022	2025	the
O	2026	2036	monitoring
O	2037	2039	of
B-Disease	2040	2043	CME
O	2044	2055	progression
O	2056	2059	and
O	2060	2063	its
O	2064	2072	response
O	2073	2075	to
O	2076	2085	treatment
O	2085	2086	.

O	0	10	Prevalence
O	11	13	of
B-Disease	14	21	plateau
I-Disease	22	26	iris
O	27	29	in
B-Disease	30	37	primary
I-Disease	38	43	angle
I-Disease	44	51	closure
I-Disease	52	60	suspects
O	61	63	an
B-Diagnostic_tool	64	74	ultrasound
I-Diagnostic_tool	75	88	biomicroscopy
O	89	94	study
O	94	95	.

O	97	99	To
O	100	109	determine
O	110	113	the
O	114	124	prevalence
O	125	127	of
B-Disease	128	135	plateau
I-Disease	136	140	iris
O	141	143	in
O	144	145	a
O	146	152	cohort
O	153	155	of
B-Disease	156	163	primary
I-Disease	164	169	angle
I-Disease	170	177	closure
I-Disease	178	186	suspects
O	187	188	(
B-Disease	188	193	PACSs
O	193	194	)
O	195	200	using
B-Diagnostic_tool	201	211	ultrasound
I-Diagnostic_tool	212	225	biomicroscopy
O	226	227	(
B-Diagnostic_tool	227	230	UBM
O	230	231	)
O	231	232	.

O	233	238	Cross
O	238	239	-
O	239	248	sectional
O	249	262	observational
O	263	268	study
O	268	269	.

O	270	278	Subjects
B-Characteristic	279	283	over
I-Characteristic	284	287	the
I-Characteristic	288	291	age
I-Characteristic	292	294	of
I-Characteristic	295	297	50
I-Characteristic	298	303	years
O	304	313	diagnosed
O	314	316	as
B-Disease	317	322	PACSs
O	322	323	.

O	324	332	Subjects
O	333	337	were
O	338	348	randomized
O	349	351	to
O	352	359	undergo
O	360	365	laser
O	366	376	peripheral
O	377	386	iridotomy
O	387	388	(
O	388	391	LPI
O	391	392	)
O	393	395	in
O	396	399	one
B-Anatomy	400	403	eye
O	403	404	.

B-Diagnostic_tool	405	415	Ultrasound
I-Diagnostic_tool	416	429	biomicroscopy
O	430	433	was
O	434	443	performed
O	444	450	before
O	451	454	and
O	455	456	a
O	457	461	week
O	462	467	after
O	468	471	LPI
O	471	472	.

B-Diagnostic_tool	473	483	Ultrasound
I-Diagnostic_tool	484	497	biomicroscopy
I-Diagnostic_tool	498	504	images
O	505	509	were
O	510	523	qualitatively
O	524	532	assessed
O	533	538	using
O	539	551	standardized
O	552	560	criteria
O	560	561	.

B-Disease	562	569	Plateau
I-Disease	570	574	iris
O	575	578	was
O	579	586	defined
O	587	589	in
O	590	591	a
O	592	600	quadrant
O	601	603	by
O	604	607	the
O	608	616	presence
O	617	619	of
O	620	622	an
B-Symptom	623	633	anteriorly
I-Symptom	634	642	directed
I-Symptom	643	650	ciliary
I-Symptom	651	655	body
O	655	656	,
O	657	659	an
B-Symptom	660	666	absent
I-Symptom	667	674	ciliary
I-Symptom	675	681	sulcus
O	681	682	,
O	683	684	a
B-Symptom	685	690	steep
I-Symptom	691	695	iris
I-Symptom	696	700	root
I-Symptom	701	705	from
I-Symptom	706	709	its
I-Symptom	710	715	point
I-Symptom	716	718	of
I-Symptom	719	728	insertion
I-Symptom	729	737	followed
I-Symptom	738	740	by
I-Symptom	741	742	a
I-Symptom	743	751	downward
I-Symptom	752	762	angulation
I-Symptom	763	767	from
I-Symptom	768	771	the
I-Symptom	772	785	corneoscleral
I-Symptom	786	790	wall
O	790	791	,
O	792	800	presence
O	801	803	of
O	804	805	a
B-Symptom	806	813	central
I-Symptom	814	818	flat
I-Symptom	819	823	iris
I-Symptom	824	829	plane
O	829	830	,
O	831	834	and
B-Symptom	835	840	irido
I-Symptom	840	841	-
I-Symptom	841	846	angle
I-Symptom	847	854	contact
O	854	855	.

O	856	858	At
O	859	864	least
O	865	866	2
O	867	876	quadrants
O	877	880	had
O	881	883	to
O	884	890	fulfil
O	891	894	the
O	895	900	above
O	901	909	criteria
O	910	913	for
O	914	916	an
B-Anatomy	917	920	eye
O	921	923	to
O	924	926	be
O	927	934	defined
O	935	937	as
B-Disease	938	945	plateau
I-Disease	946	950	iris
O	950	951	.

O	952	955	Two
O	956	963	hundred
O	964	968	five
O	969	977	subjects
O	978	982	were
O	983	991	enrolled
O	991	992	;
B-Diagnostic_tool	993	996	UBM
I-Diagnostic_tool	997	1003	images
O	1004	1006	of
O	1007	1010	167
O	1011	1019	subjects
O	1020	1024	were
O	1025	1034	available
O	1035	1038	for
O	1039	1047	analysis
O	1047	1048	.

B-Disease	1049	1056	Plateau
I-Disease	1057	1061	iris
O	1062	1065	was
O	1066	1071	found
O	1072	1074	in
O	1075	1077	54
O	1078	1080	of
O	1081	1084	167
O	1085	1086	(
O	1086	1088	32
O	1088	1089	.
O	1089	1090	3
O	1090	1091	%
O	1091	1092	)
B-Disease	1093	1097	PACS
B-Anatomy	1098	1102	eyes
O	1103	1108	after
O	1109	1112	LPI
O	1112	1113	.

O	1114	1126	Quadrantwise
O	1127	1135	analysis
O	1136	1142	showed
O	1143	1147	that
O	1148	1150	44
O	1151	1153	of
O	1154	1157	167
O	1158	1159	(
O	1159	1161	26
O	1161	1162	.
O	1162	1163	3
O	1163	1164	%
O	1164	1165	)
B-Anatomy	1166	1170	eyes
O	1171	1174	had
B-Disease	1175	1182	plateau
I-Disease	1183	1187	iris
O	1188	1190	in
O	1191	1192	1
O	1193	1201	quadrant
O	1201	1202	,
O	1203	1205	36
O	1206	1207	(
O	1207	1209	21
O	1209	1210	.
O	1210	1211	5
O	1211	1212	%
O	1212	1213	)
O	1214	1216	in
O	1217	1218	2
O	1219	1228	quadrants
O	1228	1229	,
O	1230	1232	16
O	1233	1234	(
O	1234	1235	9
O	1235	1236	.
O	1236	1237	5
O	1237	1238	%
O	1238	1239	)
O	1240	1242	in
O	1243	1244	3
O	1245	1254	quadrants
O	1254	1255	,
O	1256	1259	and
O	1260	1261	2
O	1262	1263	(
O	1263	1264	1
O	1264	1265	.
O	1265	1266	2
O	1266	1267	%
O	1267	1268	)
O	1269	1271	in
O	1272	1275	all
O	1276	1277	4
O	1278	1287	quadrants
O	1287	1288	.

B-Disease	1289	1296	Plateau
I-Disease	1297	1301	iris
O	1302	1305	was
O	1306	1310	most
O	1311	1319	commonly
O	1320	1328	observed
O	1329	1331	in
O	1332	1335	the
O	1336	1344	superior
O	1345	1348	and
O	1349	1357	inferior
O	1358	1367	quadrants
O	1367	1368	.

O	1369	1374	Using
O	1375	1387	standardized
B-Diagnostic_tool	1388	1391	UBM
O	1392	1400	criteria
O	1400	1401	,
B-Disease	1402	1409	plateau
I-Disease	1410	1414	iris
O	1415	1418	was
O	1419	1424	found
O	1425	1427	in
O	1428	1433	about
O	1434	1435	a
O	1436	1441	third
O	1442	1444	of
B-Disease	1445	1449	PACS
B-Anatomy	1450	1454	eyes
O	1455	1460	after
O	1461	1464	LPI
O	1464	1465	.

O	1466	1477	Prospective
O	1478	1490	longitudinal
O	1491	1498	studies
O	1499	1502	are
O	1503	1511	required
O	1512	1514	to
O	1515	1524	determine
O	1525	1528	the
O	1529	1537	clinical
O	1538	1550	significance
O	1551	1553	of
O	1554	1558	this
O	1559	1566	finding
O	1567	1570	for
O	1571	1574	the
O	1575	1585	management
O	1586	1588	of
B-Disease	1589	1594	PACSs
O	1594	1595	.

O	0	15	Reproducibility
O	16	18	of
B-Diagnostic_tool	19	26	pattern
I-Diagnostic_tool	27	44	electroretinogram
O	45	47	in
B-Disease	48	56	glaucoma
O	57	65	patients
O	66	70	with
O	71	72	a
O	73	78	range
O	79	81	of
O	82	90	severity
O	91	93	of
O	94	101	disease
O	102	106	with
O	107	110	the
O	111	114	new
B-Disease	115	123	glaucoma
O	124	132	paradigm
O	132	133	.

O	135	137	To
O	138	147	determine
O	148	151	the
O	152	167	reproducibility
O	168	170	of
O	171	174	the
B-Diagnostic_tool	175	182	pattern
I-Diagnostic_tool	183	200	electroretinogram
O	201	205	with
O	206	209	the
O	210	213	new
B-Diagnostic_tool	214	221	Pattern
I-Diagnostic_tool	222	239	Electroretinogram
I-Diagnostic_tool	240	243	for
I-Diagnostic_tool	244	252	Glaucoma
O	253	254	(
B-Diagnostic_tool	254	260	PERGLA
O	260	261	)
O	262	271	recording
O	272	280	paradigm
O	281	283	in
B-Disease	284	292	glaucoma
O	293	301	patients
O	302	306	with
O	307	308	a
O	309	314	range
O	315	317	of
O	318	326	severity
O	326	327	.

O	328	340	Experimental
O	341	346	study
O	346	347	.

O	348	353	Fifty
O	353	354	-
O	354	359	three
B-Disease	360	368	glaucoma
O	369	377	patients
O	378	382	were
O	383	392	recruited
O	393	396	for
O	397	400	the
O	401	406	study
O	407	408	(
B-Characteristic	408	412	mean
I-Characteristic	413	416	age
O	417	418	+
O	418	419	/
O	419	420	-
O	421	429	standard
O	430	439	deviation
O	440	441	[
O	441	443	SD
O	443	444	]
O	444	445	,
O	446	448	69
O	448	449	+
O	449	450	/
O	450	451	-
O	451	453	11
O	454	459	years
O	459	460	)
O	460	461	.

O	462	467	Their
B-Characteristic	468	472	mean
I-Characteristic	473	482	deviation
I-Characteristic	483	484	(
I-Characteristic	484	486	MD
I-Characteristic	486	487	)
I-Characteristic	488	494	global
I-Characteristic	495	502	indices
I-Characteristic	503	505	on
I-Characteristic	506	512	static
I-Characteristic	513	522	automatic
I-Characteristic	523	532	perimetry
O	533	539	ranged
O	540	544	from
O	545	546	2
O	546	547	.
O	547	549	16
O	550	552	to
O	553	554	-
O	554	556	31
O	556	557	.
O	557	559	36
O	560	568	decibels
O	569	570	(
O	570	574	mean
O	575	577	MD
O	577	578	,
O	579	580	-
O	580	581	9
O	581	582	.
O	582	584	05
O	584	585	)
O	585	586	.

O	587	590	All
O	591	599	patients
O	600	603	had
B-Diagnostic_tool	604	611	pattern
I-Diagnostic_tool	612	629	electroretinogram
I-Diagnostic_tool	630	640	recordings
O	641	645	done
O	646	647	5
O	648	653	times
O	654	656	by
O	657	660	the
O	661	665	same
O	666	674	operator
O	674	675	,
O	676	678	on
O	679	680	5
O	681	690	different
O	691	695	days
O	696	700	with
O	701	704	the
B-Diagnostic_tool	705	717	standardized
I-Diagnostic_tool	718	724	PERGLA
O	725	733	paradigm
O	733	734	.

B-Characteristic	735	742	Pattern
I-Characteristic	743	760	electroretinogram
I-Characteristic	761	770	amplitude
I-Characteristic	771	772	(
I-Characteristic	772	782	microvolts
I-Characteristic	782	783	)
O	783	784	,
B-Characteristic	785	790	phase
I-Characteristic	791	792	(
I-Characteristic	792	794	pi
I-Characteristic	795	802	radians
I-Characteristic	802	803	)
O	803	804	,
B-Characteristic	805	813	response
I-Characteristic	814	825	variability
I-Characteristic	826	827	(
I-Characteristic	827	838	coefficient
I-Characteristic	839	841	of
I-Characteristic	842	851	variation
I-Characteristic	852	853	[
I-Characteristic	853	855	CV
I-Characteristic	855	856	]
I-Characteristic	857	858	=
I-Characteristic	859	861	SD
I-Characteristic	861	862	/
I-Characteristic	862	866	mean
I-Characteristic	867	868	x
I-Characteristic	869	872	100
I-Characteristic	872	873	)
I-Characteristic	874	876	of
I-Characteristic	877	886	amplitude
I-Characteristic	887	890	and
I-Characteristic	891	896	phase
I-Characteristic	897	899	of
I-Characteristic	900	901	2
I-Characteristic	902	909	partial
I-Characteristic	910	918	averages
I-Characteristic	919	923	that
I-Characteristic	924	929	build
I-Characteristic	930	932	up
I-Characteristic	933	936	the
I-Characteristic	937	944	pattern
I-Characteristic	945	962	electroretinogram
I-Characteristic	963	971	waveform
O	971	972	,
B-Characteristic	973	984	interocular
I-Characteristic	985	994	asymmetry
I-Characteristic	995	997	in
I-Characteristic	998	1007	amplitude
I-Characteristic	1008	1011	and
I-Characteristic	1012	1017	phase
I-Characteristic	1018	1019	(
I-Characteristic	1019	1021	in
I-Characteristic	1022	1027	terms
I-Characteristic	1028	1030	of
I-Characteristic	1031	1034	the
I-Characteristic	1035	1037	CV
I-Characteristic	1038	1047	generated
I-Characteristic	1048	1050	by
I-Characteristic	1051	1054	the
I-Characteristic	1055	1062	pattern
I-Characteristic	1063	1080	electroretinogram
I-Characteristic	1081	1089	software
I-Characteristic	1089	1090	)
O	1090	1091	,
B-Characteristic	1092	1098	signal
I-Characteristic	1098	1099	-
I-Characteristic	1099	1101	to
I-Characteristic	1101	1102	-
I-Characteristic	1102	1107	noise
I-Characteristic	1108	1109	(
I-Characteristic	1109	1110	S
I-Characteristic	1110	1111	/
I-Characteristic	1111	1112	N
I-Characteristic	1112	1113	)
I-Characteristic	1114	1119	ratio
O	1119	1120	,
O	1121	1124	SDs
O	1124	1125	,
O	1126	1128	CV
O	1128	1129	,
O	1130	1133	and
B-Characteristic	1134	1144	intraclass
I-Characteristic	1145	1156	correlation
I-Characteristic	1157	1168	coefficient
O	1169	1170	(
B-Characteristic	1170	1173	ICC
O	1173	1174	)
O	1174	1175	.

O	1176	1179	All
O	1180	1188	analyses
O	1189	1193	were
O	1194	1198	done
O	1199	1201	on
O	1202	1205	one
B-Anatomy	1206	1209	eye
O	1210	1212	of
O	1213	1217	each
O	1218	1225	subject
O	1225	1226	,
O	1227	1233	except
O	1234	1238	when
B-Characteristic	1239	1250	interocular
I-Characteristic	1251	1260	asymmetry
O	1261	1264	was
O	1265	1272	studied
O	1272	1273	.

O	1274	1277	The
O	1278	1281	CVs
O	1282	1284	of
O	1285	1297	intrasession
O	1298	1311	variabilities
O	1312	1314	in
O	1315	1324	amplitude
O	1325	1328	and
O	1329	1334	phase
O	1335	1339	were
O	1340	1342	12
O	1342	1343	.
O	1343	1345	08
O	1345	1346	%
O	1347	1350	and
O	1351	1352	2
O	1352	1353	.
O	1353	1355	20
O	1355	1356	%
O	1356	1357	,
O	1358	1370	respectively
O	1370	1371	,
O	1372	1375	and
O	1376	1381	those
O	1382	1384	of
O	1385	1397	intersession
O	1398	1411	variabilities
O	1412	1416	were
O	1417	1419	20
O	1419	1420	.
O	1420	1422	82
O	1422	1423	%
O	1424	1427	and
O	1428	1429	4
O	1429	1430	.
O	1430	1432	17
O	1432	1433	%
O	1433	1434	.

O	1435	1438	The
B-Diagnostic_tool	1439	1446	pattern
I-Diagnostic_tool	1447	1464	electroretinogram
O	1465	1473	produced
O	1474	1486	intersession
B-Characteristic	1487	1491	ICCs
O	1492	1494	in
O	1495	1504	amplitude
O	1505	1508	and
O	1509	1514	phase
O	1515	1517	of
O	1518	1519	0
O	1519	1520	.
O	1520	1523	791
O	1524	1527	and
O	1528	1529	0
O	1529	1530	.
O	1530	1533	765
O	1533	1534	,
O	1535	1547	respectively
O	1547	1548	.

O	1549	1554	These
B-Characteristic	1555	1559	ICCs
O	1560	1564	were
O	1565	1578	significantly
O	1579	1585	higher
O	1586	1590	than
O	1591	1594	the
B-Characteristic	1595	1599	ICCs
I-Characteristic	1600	1603	for
I-Characteristic	1604	1611	pattern
I-Characteristic	1612	1629	electroretinogram
I-Characteristic	1630	1641	interocular
I-Characteristic	1642	1651	asymmetry
I-Characteristic	1652	1654	in
I-Characteristic	1655	1664	amplitude
I-Characteristic	1665	1668	and
I-Characteristic	1669	1674	phase
O	1675	1676	(
O	1676	1677	0
O	1677	1678	.
O	1678	1681	659
O	1682	1683	[
O	1683	1684	P
O	1685	1686	<
O	1687	1688	0
O	1688	1689	.
O	1689	1691	05
O	1691	1692	]
O	1693	1696	and
O	1697	1698	0
O	1698	1699	.
O	1699	1702	571
O	1703	1704	[
O	1704	1705	P
O	1706	1707	<
O	1708	1709	0
O	1709	1710	.
O	1710	1712	05
O	1712	1713	]
O	1713	1714	,
O	1715	1727	respectively
O	1727	1728	)
O	1728	1729	.

O	1730	1732	On
O	1733	1740	average
O	1740	1741	,
O	1742	1745	the
B-Characteristic	1746	1753	pattern
I-Characteristic	1754	1771	electroretinogram
I-Characteristic	1772	1773	S
I-Characteristic	1773	1774	/
I-Characteristic	1774	1775	N
I-Characteristic	1776	1781	ratio
O	1782	1784	in
B-Disease	1785	1797	glaucomatous
O	1798	1806	patients
O	1807	1810	was
O	1811	1816	about
O	1817	1818	5
O	1818	1819	:
O	1819	1820	1
O	1820	1821	.

O	1822	1825	The
O	1826	1841	reproducibility
O	1842	1844	of
B-Diagnostic_tool	1845	1851	PERGLA
O	1852	1854	in
B-Disease	1855	1867	glaucomatous
O	1868	1876	patients
O	1877	1879	is
O	1880	1892	sufficiently
O	1893	1897	good
O	1898	1901	for
O	1902	1904	it
O	1905	1907	to
O	1908	1910	be
O	1911	1921	considered
O	1922	1923	a
O	1924	1930	useful
O	1931	1944	complementary
O	1945	1953	clinical
O	1954	1958	tool
O	1958	1959	.

O	1960	1965	Being
O	1966	1970	more
O	1971	1983	reproducible
O	1983	1984	,
O	1985	1991	direct
O	1992	2000	measures
O	2001	2003	of
O	2004	2013	amplitude
O	2014	2017	and
O	2018	2023	phase
O	2024	2030	should
O	2031	2033	be
O	2034	2038	more
O	2039	2045	useful
O	2046	2048	in
O	2049	2059	monitoring
O	2060	2071	progression
O	2072	2076	than
B-Characteristic	2077	2088	interocular
I-Characteristic	2089	2098	asymmetry
O	2099	2110	comparisons
O	2110	2111	.

O	0	3	The
O	4	16	relationship
O	17	19	of
B-Characteristic	20	27	macular
I-Characteristic	28	37	thickness
O	38	40	to
O	41	51	clinically
O	52	58	graded
B-Disease	59	67	diabetic
I-Disease	68	79	retinopathy
O	80	88	severity
O	89	91	in
B-Anatomy	92	96	eyes
O	97	104	without
O	105	115	clinically
O	116	124	detected
B-Disease	125	133	diabetic
I-Disease	134	141	macular
I-Disease	142	147	edema
O	147	148	.

O	150	152	To
O	153	160	examine
O	161	164	the
O	165	177	relationship
O	178	180	of
B-Diagnostic_tool	181	188	optical
I-Diagnostic_tool	189	198	coherence
I-Diagnostic_tool	199	209	tomography
O	210	211	(
B-Diagnostic_tool	211	214	OCT
O	214	215	)
O	216	224	measured
B-Characteristic	225	232	macular
I-Characteristic	233	242	thickness
O	243	245	to
B-Disease	246	257	retinopathy
O	258	266	severity
O	267	269	in
O	270	278	patients
O	279	283	with
B-Disease	284	292	diabetes
O	293	296	and
O	297	299	no
O	300	310	clinically
O	311	321	detectable
B-Disease	322	329	macular
I-Disease	330	335	edema
O	335	336	.

O	337	350	Retrospective
O	351	364	observational
O	365	369	case
O	370	376	series
O	376	377	.

O	378	383	Three
O	384	391	hundred
O	392	398	eighty
O	398	399	-
O	399	404	three
B-Anatomy	405	409	eyes
O	410	412	of
O	413	416	383
O	417	425	patients
O	426	428	of
O	429	430	a
O	431	438	private
B-Anatomy	439	445	retina
O	446	454	practice
O	454	455	;
O	456	465	including
O	466	469	100
O	470	476	normal
B-Anatomy	477	481	eyes
O	482	484	of
O	485	493	patients
O	494	501	without
B-Disease	502	510	diabetes
O	510	511	,
O	512	515	100
B-Anatomy	516	520	eyes
O	521	523	of
B-Disease	524	533	diabetics
O	534	541	without
B-Disease	542	553	retinopathy
O	553	554	,
O	555	558	100
B-Anatomy	559	563	eyes
O	564	566	of
B-Disease	567	576	diabetics
O	577	581	with
B-Disease	582	586	mild
I-Disease	587	589	to
I-Disease	590	598	moderate
I-Disease	599	610	retinopathy
O	610	611	,
O	612	614	35
B-Anatomy	615	619	eyes
O	620	622	of
B-Disease	623	632	diabetics
O	633	637	with
B-Disease	638	644	severe
I-Disease	645	661	nonproliferative
I-Disease	662	664	or
I-Disease	665	678	proliferative
I-Disease	679	690	retinopathy
O	690	691	,
O	692	695	and
O	696	698	48
B-Anatomy	699	703	eyes
O	704	706	of
B-Disease	707	716	diabetics
O	717	721	with
B-Disease	722	731	regressed
I-Disease	732	745	proliferative
I-Disease	746	757	retinopathy
O	757	758	.

O	759	765	Review
O	766	768	of
O	769	777	clinical
O	778	784	charts
O	785	788	and
B-Diagnostic_tool	789	796	optical
I-Diagnostic_tool	797	806	coherence
I-Diagnostic_tool	807	817	tomography
O	818	830	measurements
O	830	831	.

B-Characteristic	832	839	Central
I-Characteristic	840	848	subfield
I-Characteristic	849	853	mean
I-Characteristic	854	863	thickness
O	864	865	(
B-Characteristic	865	869	CSMT
O	869	870	)
O	870	871	,
B-Characteristic	872	877	inner
I-Characteristic	878	881	and
I-Characteristic	882	887	outer
I-Characteristic	888	892	zone
I-Characteristic	893	905	measurements
O	905	906	,
O	907	910	and
B-Characteristic	911	916	total
I-Characteristic	917	924	macular
I-Characteristic	925	931	volume
O	931	932	.

B-Characteristic	933	940	Central
I-Characteristic	941	949	subfield
I-Characteristic	950	954	mean
I-Characteristic	955	966	thicknesses
O	967	968	(
O	968	972	mean
O	973	974	+
O	974	975	/
O	975	976	-
O	977	985	standard
O	986	995	deviation
O	995	996	)
O	997	1001	were
O	1002	1005	208
O	1005	1006	+
O	1006	1007	/
O	1007	1008	-
O	1008	1010	22
O	1010	1011	,
O	1012	1015	198
O	1015	1016	+
O	1016	1017	/
O	1017	1018	-
O	1018	1020	25
O	1020	1021	,
O	1022	1025	204
O	1025	1026	+
O	1026	1027	/
O	1027	1028	-
O	1028	1030	26
O	1030	1031	,
O	1032	1035	224
O	1035	1036	+
O	1036	1037	/
O	1037	1038	-
O	1038	1040	38
O	1040	1041	,
O	1042	1045	and
O	1046	1049	205
O	1049	1050	+
O	1050	1051	/
O	1051	1052	-
O	1052	1054	27
O	1055	1061	microm
O	1062	1065	for
O	1066	1073	normals
O	1073	1074	,
B-Anatomy	1075	1079	eyes
O	1080	1082	of
B-Disease	1083	1092	diabetics
O	1093	1100	without
B-Disease	1101	1112	retinopathy
O	1112	1113	,
B-Anatomy	1114	1118	eyes
O	1119	1123	with
B-Disease	1124	1128	mild
I-Disease	1129	1131	to
I-Disease	1132	1140	moderate
I-Disease	1141	1157	nonproliferative
I-Disease	1158	1169	retinopathy
O	1169	1170	,
B-Anatomy	1171	1175	eyes
O	1176	1180	with
B-Disease	1181	1187	severe
I-Disease	1188	1204	nonproliferative
I-Disease	1205	1207	to
I-Disease	1208	1221	proliferative
I-Disease	1222	1233	retinopathy
O	1233	1234	,
O	1235	1238	and
B-Anatomy	1239	1243	eyes
O	1244	1248	with
B-Disease	1249	1258	regressed
I-Disease	1259	1272	proliferative
I-Disease	1273	1284	retinopathy
O	1284	1285	,
O	1286	1298	respectively
O	1298	1299	.

O	1300	1303	For
O	1304	1307	all
O	1308	1314	groups
O	1314	1315	,
O	1316	1320	mean
B-Characteristic	1321	1325	CSMT
O	1326	1329	was
O	1330	1336	larger
O	1337	1339	in
O	1340	1345	males
O	1346	1350	than
O	1351	1353	in
O	1354	1361	females
O	1361	1362	.

O	1363	1376	Statistically
O	1377	1388	significant
O	1389	1400	differences
O	1401	1403	by
B-Characteristic	1404	1410	gender
O	1411	1415	were
O	1416	1424	observed
O	1425	1428	for
O	1429	1436	normals
O	1436	1437	,
B-Disease	1438	1447	diabetics
O	1448	1455	without
B-Disease	1456	1467	retinopathy
O	1467	1468	,
O	1469	1472	and
B-Disease	1473	1482	diabetics
O	1483	1487	with
B-Disease	1488	1492	mild
I-Disease	1493	1495	to
I-Disease	1496	1504	moderate
I-Disease	1505	1521	nonproliferative
I-Disease	1522	1533	retinopathy
O	1534	1535	(
O	1535	1539	mean
O	1540	1551	differences
O	1551	1552	,
O	1553	1555	12
O	1555	1556	,
O	1557	1559	14
O	1559	1560	,
O	1561	1564	and
O	1565	1567	18
O	1568	1574	microm
O	1574	1575	,
O	1576	1588	respectively
O	1588	1589	;
O	1590	1592	Ps
O	1593	1594	=
O	1595	1596	0
O	1596	1597	.
O	1597	1601	0057
O	1601	1602	,
O	1603	1604	0
O	1604	1605	.
O	1605	1609	0057
O	1609	1610	,
O	1611	1614	and
O	1615	1616	0
O	1616	1617	.
O	1617	1621	0002
O	1621	1622	)
O	1622	1623	.

O	1624	1627	For
O	1628	1638	increasing
B-Disease	1639	1650	retinopathy
O	1651	1659	severity
O	1659	1660	,
O	1661	1664	the
O	1665	1676	probability
O	1677	1679	of
B-Symptom	1680	1687	macular
I-Symptom	1688	1698	thickening
O	1699	1707	detected
O	1708	1710	by
B-Diagnostic_tool	1711	1714	OCT
O	1715	1718	but
O	1719	1722	not
O	1723	1731	detected
O	1732	1734	by
O	1735	1743	clinical
O	1744	1755	examination
O	1756	1765	increased
O	1765	1766	.

O	1767	1774	Fifteen
O	1775	1782	percent
O	1783	1785	of
B-Anatomy	1786	1790	eyes
O	1791	1795	with
B-Disease	1796	1802	severe
I-Disease	1803	1819	nonproliferative
I-Disease	1820	1822	or
I-Disease	1823	1836	proliferative
I-Disease	1837	1848	retinopathy
O	1849	1852	and
O	1853	1855	no
O	1856	1866	clinically
O	1867	1875	detected
B-Disease	1876	1881	edema
O	1882	1885	had
B-Diagnostic_tool	1886	1889	OCT
O	1889	1890	-
O	1890	1898	measured
B-Symptom	1899	1906	macular
I-Symptom	1907	1917	thickening
O	1917	1918	.

O	1919	1926	Because
B-Diagnostic_tool	1927	1930	OCT
O	1931	1943	measurements
O	1944	1947	are
O	1948	1954	gender
O	1955	1964	dependent
O	1964	1965	,
O	1966	1972	gender
O	1973	1980	balance
O	1981	1983	or
O	1984	1995	statistical
O	1996	2006	adjustment
O	2007	2010	for
O	2011	2017	gender
O	2018	2028	imbalances
O	2029	2031	of
O	2032	2040	compared
O	2041	2047	groups
O	2048	2050	in
B-Diagnostic_tool	2051	2054	OCT
O	2055	2062	studies
O	2063	2065	of
B-Disease	2066	2074	diabetic
I-Disease	2075	2082	macular
I-Disease	2083	2088	edema
O	2089	2091	is
O	2092	2101	important
O	2101	2102	.

O	2103	2105	As
B-Disease	2106	2117	retinopathy
O	2118	2126	severity
O	2127	2136	increases
O	2136	2137	,
O	2138	2141	the
O	2142	2153	probability
O	2154	2156	of
B-Disease	2157	2168	subclinical
I-Disease	2169	2174	edema
O	2175	2180	rises
O	2180	2181	.

O	2182	2188	Except
O	2189	2192	for
O	2193	2195	an
O	2196	2206	individual
O	2207	2215	baseline
O	2216	2227	measurement
O	2228	2236	possibly
O	2237	2243	useful
O	2244	2247	for
O	2248	2260	longitudinal
O	2261	2271	comparison
O	2271	2272	,
O	2273	2276	the
O	2277	2281	data
O	2282	2289	suggest
O	2290	2294	that
O	2295	2300	there
O	2301	2303	is
O	2304	2310	little
O	2311	2317	reason
O	2318	2327	routinely
O	2328	2330	to
O	2331	2337	obtain
B-Diagnostic_tool	2338	2341	OCT
O	2342	2344	in
B-Anatomy	2345	2349	eyes
O	2350	2354	with
B-Disease	2355	2363	diabetes
O	2364	2367	and
O	2368	2370	no
B-Disease	2371	2382	retinopathy
O	2383	2385	or
B-Disease	2386	2390	mild
I-Disease	2391	2393	to
I-Disease	2394	2402	moderate
I-Disease	2403	2411	diabetic
I-Disease	2412	2423	retinopathy
O	2424	2428	when
O	2429	2437	clinical
O	2438	2449	examination
O	2450	2455	fails
O	2456	2458	to
O	2459	2463	show
B-Disease	2464	2471	macular
I-Disease	2472	2477	edema
O	2477	2478	.

O	0	15	Characteristics
O	16	18	of
B-Symptom	19	23	disc
I-Symptom	24	34	hemorrhage
O	35	37	in
B-Disease	38	45	primary
I-Disease	46	51	angle
I-Disease	51	52	-
I-Disease	52	59	closure
I-Disease	60	68	glaucoma
O	68	69	.

O	71	73	To
O	74	81	analyze
O	82	85	the
O	86	101	characteristics
O	102	104	of
B-Symptom	105	109	disc
I-Symptom	110	120	hemorrhage
O	121	123	in
B-Disease	124	131	primary
I-Disease	132	137	angle
I-Disease	137	138	-
I-Disease	138	145	closure
I-Disease	146	154	glaucoma
O	155	156	(
B-Disease	156	160	PACG
O	160	161	)
O	161	162	.

O	163	176	Retrospective
O	177	191	noncomparative
O	192	196	case
O	197	203	series
O	203	204	.

O	205	213	Patients
O	214	218	seen
O	219	221	in
B-Disease	222	230	glaucoma
O	231	238	clinics
O	239	243	with
B-Disease	244	248	PACG
O	249	252	and
O	253	254	a
O	255	262	history
O	263	265	of
B-Symptom	266	270	disc
I-Symptom	271	281	hemorrhage
O	281	282	.

B-Diagnostic_tool	283	291	Goldmann
I-Diagnostic_tool	292	301	tonometry
O	301	302	,
B-Diagnostic_tool	303	313	gonioscopy
O	313	314	,
B-Diagnostic_tool	315	329	ophthalmoscopy
O	329	330	,
O	331	334	and
B-Diagnostic_tool	335	344	automated
I-Diagnostic_tool	345	354	perimetry
O	354	355	.

B-Characteristic	356	364	Location
I-Characteristic	364	365	,
I-Characteristic	366	372	number
I-Characteristic	373	375	of
I-Characteristic	376	384	episodes
I-Characteristic	384	385	,
I-Characteristic	386	389	and
I-Characteristic	390	398	duration
I-Characteristic	399	401	of
I-Characteristic	402	406	disc
I-Characteristic	407	417	hemorrhage
O	417	418	;
O	419	429	comparison
O	430	432	of
B-Characteristic	433	444	intraocular
I-Characteristic	445	453	pressure
O	454	455	(
B-Characteristic	455	458	IOP
O	458	459	)
O	460	463	and
B-Characteristic	464	467	cup
I-Characteristic	467	468	-
I-Characteristic	468	470	to
I-Characteristic	470	471	-
I-Characteristic	471	475	disc
I-Characteristic	476	481	ratio
O	482	483	(
B-Characteristic	483	486	CDR
O	486	487	)
O	488	490	in
B-Anatomy	491	495	eyes
O	496	500	with
O	501	504	and
O	505	511	fellow
B-Anatomy	512	516	eyes
O	517	524	without
B-Symptom	525	535	hemorrhage
O	535	536	;
O	537	540	and
O	541	548	changes
O	549	551	of
B-Characteristic	552	555	CDR
O	556	559	and
B-Characteristic	560	566	visual
I-Characteristic	567	573	fields
O	574	575	(
B-Characteristic	575	578	VFs
O	578	579	)
O	580	582	on
O	583	589	follow
O	589	590	-
O	590	592	up
O	592	593	.

O	594	597	The
O	598	602	mean
O	603	611	duration
O	612	614	of
O	615	621	follow
O	621	622	-
O	622	624	up
O	625	628	was
O	629	632	109
O	632	633	.
O	633	634	2
O	634	635	+
O	635	636	/
O	636	637	-
O	637	639	63
O	640	646	months
O	647	648	(
O	648	653	range
O	653	654	,
O	655	656	7
O	656	657	-
O	657	660	261
O	660	661	)
O	661	662	.

O	663	665	Of
O	666	669	770
O	670	678	patients
O	679	683	with
B-Disease	684	688	PACG
O	688	689	,
O	690	692	44
O	693	694	(
O	694	695	5
O	695	696	.
O	696	697	7
O	697	698	%
O	698	699	)
O	700	703	had
B-Symptom	704	708	disc
I-Symptom	709	719	hemorrhage
O	720	722	at
O	723	727	some
O	728	733	point
O	734	736	in
O	737	742	their
O	743	750	history
O	750	751	,
O	752	754	of
O	755	759	whom
O	760	762	30
O	763	764	(
O	764	766	68
O	766	767	%
O	767	768	)
O	769	772	had
O	773	783	unilateral
O	784	787	and
O	788	790	14
O	791	792	(
O	792	794	32
O	794	795	%
O	795	796	)
O	797	800	had
B-Symptom	801	810	bilateral
I-Symptom	811	822	hemorrhages
O	822	823	,
O	824	830	either
O	831	842	alternately
O	843	845	or
O	846	860	simultaneously
O	861	863	in
O	864	868	both
B-Anatomy	869	873	eyes
O	873	874	.

O	875	880	There
O	881	885	were
O	886	887	a
O	888	893	total
O	894	896	of
O	897	900	111
B-Symptom	901	912	hemorrhages
O	913	915	in
O	916	918	58
B-Anatomy	919	923	eyes
O	923	924	,
O	925	934	including
O	935	937	23
B-Anatomy	938	942	eyes
O	943	944	(
O	944	946	40
O	946	947	%
O	947	948	)
O	949	953	with
B-Symptom	954	963	recurrent
I-Symptom	964	975	hemorrhages
O	975	976	.

O	977	979	Of
O	980	983	the
O	984	987	111
O	988	993	total
B-Symptom	994	1005	hemorrhages
O	1005	1006	,
O	1007	1009	85
O	1010	1011	(
O	1011	1013	77
O	1013	1014	%
O	1014	1015	)
O	1016	1024	occurred
O	1025	1027	in
O	1028	1031	the
B-Anatomy	1032	1046	inferotemporal
I-Anatomy	1047	1050	and
I-Anatomy	1051	1053	19
I-Anatomy	1054	1055	(
I-Anatomy	1055	1057	17
I-Anatomy	1057	1058	%
I-Anatomy	1058	1059	)
I-Anatomy	1060	1062	in
I-Anatomy	1063	1066	the
I-Anatomy	1067	1081	superotemporal
I-Anatomy	1082	1088	sector
I-Anatomy	1089	1091	of
I-Anatomy	1092	1095	the
I-Anatomy	1096	1100	disc
O	1100	1101	.

O	1102	1107	Among
O	1108	1110	23
B-Anatomy	1111	1115	eyes
O	1116	1120	with
B-Symptom	1121	1130	recurrent
I-Symptom	1131	1135	disc
I-Symptom	1136	1147	hemorrhages
O	1147	1148	,
O	1149	1151	11
O	1152	1153	(
O	1153	1155	48
O	1155	1156	%
O	1156	1157	)
O	1158	1161	had
O	1162	1172	recurrence
O	1173	1175	in
O	1176	1179	the
O	1180	1184	same
O	1185	1191	sector
O	1192	1194	of
O	1195	1198	the
B-Anatomy	1199	1203	disc
O	1203	1204	.

O	1205	1208	The
O	1209	1216	average
O	1217	1225	duration
O	1226	1228	of
B-Symptom	1229	1240	hemorrhages
O	1241	1244	was
O	1245	1247	12
O	1247	1248	.
O	1248	1249	8
O	1249	1250	+
O	1250	1251	/
O	1251	1252	-
O	1252	1253	8
O	1253	1254	.
O	1254	1255	1
O	1256	1261	weeks
O	1261	1262	.

O	1263	1266	The
B-Characteristic	1267	1270	IOP
O	1271	1274	and
B-Characteristic	1275	1278	CDR
O	1279	1282	did
O	1283	1286	not
O	1287	1293	differ
O	1294	1307	significantly
O	1308	1315	between
B-Anatomy	1316	1320	eyes
O	1321	1325	with
O	1326	1329	and
O	1330	1336	fellow
B-Anatomy	1337	1341	eyes
O	1342	1349	without
B-Symptom	1350	1360	hemorrhage
O	1360	1361	.

O	1362	1365	For
O	1366	1374	patients
O	1375	1379	with
B-Symptom	1380	1390	unilateral
I-Symptom	1391	1395	disc
I-Symptom	1396	1406	hemorrhage
O	1406	1407	,
O	1408	1419	progressive
O	1420	1427	changes
O	1428	1430	in
O	1431	1434	the
B-Characteristic	1435	1438	CDR
O	1439	1443	were
O	1444	1449	found
O	1450	1452	in
O	1453	1457	both
O	1458	1461	the
B-Anatomy	1462	1466	eyes
O	1467	1471	with
O	1472	1475	and
O	1476	1482	fellow
B-Anatomy	1483	1487	eyes
O	1488	1495	without
B-Symptom	1496	1500	disc
I-Symptom	1501	1511	hemorrhage
O	1511	1512	,
O	1513	1516	but
B-Symptom	1517	1519	VF
I-Symptom	1520	1527	defects
O	1528	1536	worsened
O	1537	1541	only
O	1542	1544	in
B-Anatomy	1545	1549	eyes
O	1550	1554	with
B-Symptom	1555	1559	disc
I-Symptom	1560	1570	hemorrhage
O	1570	1571	.

O	1572	1575	The
O	1576	1585	incidence
O	1586	1588	of
B-Symptom	1589	1593	disc
I-Symptom	1594	1604	hemorrhage
O	1605	1607	in
O	1608	1616	patients
O	1617	1621	with
B-Disease	1622	1626	PACG
O	1627	1630	was
O	1631	1632	5
O	1632	1633	.
O	1633	1634	7
O	1634	1635	%
O	1636	1640	over
O	1641	1642	9
O	1643	1648	years
O	1649	1651	of
O	1652	1658	follow
O	1658	1659	-
O	1659	1661	up
O	1661	1662	.

O	1663	1670	Despite
O	1671	1674	its
O	1675	1683	relative
O	1684	1695	infrequency
O	1695	1696	,
B-Symptom	1697	1701	disc
I-Symptom	1702	1712	hemorrhage
O	1713	1715	in
B-Disease	1716	1720	PACG
O	1721	1724	was
O	1725	1735	associated
O	1736	1740	with
B-Symptom	1741	1752	progression
I-Symptom	1753	1755	of
I-Symptom	1756	1768	glaucomatous
I-Symptom	1769	1774	optic
I-Symptom	1775	1785	neuropathy
O	1786	1789	and
B-Symptom	1790	1792	VF
I-Symptom	1793	1800	defects
O	1800	1801	.

B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	coherence
I-Diagnostic_tool	18	28	tomography
O	29	41	measurements
O	42	45	and
O	46	54	analysis
O	55	62	methods
O	63	65	in
B-Diagnostic_tool	66	73	optical
I-Diagnostic_tool	74	83	coherence
I-Diagnostic_tool	84	94	tomography
O	95	102	studies
O	103	105	of
B-Disease	106	114	diabetic
I-Disease	115	122	macular
I-Disease	123	128	edema
O	128	129	.

O	131	133	To
O	134	142	evaluate
B-Diagnostic_tool	143	150	optical
I-Diagnostic_tool	151	160	coherence
I-Diagnostic_tool	161	171	tomography
O	172	173	(
B-Diagnostic_tool	173	176	OCT
O	176	177	)
O	178	190	measurements
O	191	194	and
O	195	202	methods
O	203	205	of
O	206	214	analysis
O	215	217	of
B-Diagnostic_tool	218	221	OCT
O	222	226	data
O	227	229	in
O	230	237	studies
O	238	240	of
B-Disease	241	249	diabetic
I-Disease	250	257	macular
I-Disease	258	263	edema
O	264	265	(
B-Disease	265	268	DME
O	268	269	)
O	269	270	.

O	271	283	Associations
O	284	286	of
O	287	292	pairs
O	293	295	of
B-Characteristic	296	299	OCT
I-Characteristic	300	309	variables
O	310	313	and
O	314	321	results
O	322	324	of
O	325	326	3
O	327	335	analysis
O	336	343	methods
O	344	349	using
O	350	354	data
O	355	359	from
O	360	361	2
O	362	369	studies
O	370	372	of
B-Disease	373	376	DME
O	376	377	.

O	378	381	Two
O	382	389	hundred
O	390	395	sixty
O	395	396	-
O	396	401	three
O	402	410	subjects
O	411	415	from
O	416	417	a
O	418	423	study
O	424	426	of
O	427	435	modified
O	436	441	Early
O	442	451	Treatment
O	452	454	of
B-Disease	455	463	Diabetic
I-Disease	464	475	Retinopathy
O	476	481	Study
O	482	483	(
O	483	489	mETDRS
O	489	490	)
O	491	497	versus
O	498	506	modified
B-Anatomy	507	514	macular
O	515	519	grid
O	520	521	(
O	521	524	MMG
O	524	525	)
O	526	542	photocoagulation
O	543	546	for
B-Disease	547	550	DME
O	551	554	and
O	555	557	96
O	558	566	subjects
O	567	571	from
O	572	573	a
O	574	579	study
O	580	582	of
O	583	590	diurnal
O	591	600	variation
O	601	603	of
B-Disease	604	607	DME
O	607	608	.

O	609	621	Correlations
O	622	626	were
O	627	637	calculated
O	638	641	for
O	642	647	pairs
O	648	650	of
B-Characteristic	651	654	OCT
I-Characteristic	655	664	variables
O	665	667	at
O	668	676	baseline
O	677	680	and
O	681	684	for
O	685	692	changes
O	693	695	in
O	696	699	the
O	700	709	variables
O	710	714	over
O	715	719	time
O	719	720	.

O	721	733	Distribution
O	734	736	of
B-Characteristic	737	740	OCT
I-Characteristic	741	752	measurement
I-Characteristic	753	760	changes
O	760	761	,
O	762	772	predictive
O	773	780	factors
O	781	784	for
B-Characteristic	785	788	OCT
I-Characteristic	789	800	measurement
I-Characteristic	801	808	changes
O	808	809	,
O	810	813	and
O	814	823	treatment
O	824	829	group
O	830	838	outcomes
O	839	843	were
O	844	852	compared
O	853	857	when
O	858	859	3
O	860	868	measures
O	869	871	of
B-Characteristic	872	878	change
I-Characteristic	879	881	in
I-Characteristic	882	889	macular
I-Characteristic	890	899	thickness
O	900	904	were
O	905	913	analyzed
O	913	914	:
B-Characteristic	915	923	absolute
I-Characteristic	924	930	change
I-Characteristic	931	933	in
I-Characteristic	934	941	retinal
I-Characteristic	942	951	thickness
O	951	952	,
B-Characteristic	953	961	relative
I-Characteristic	962	968	change
I-Characteristic	969	971	in
I-Characteristic	972	979	retinal
I-Characteristic	980	989	thickness
O	989	990	,
O	991	994	and
B-Characteristic	995	1003	relative
I-Characteristic	1004	1010	change
I-Characteristic	1011	1013	in
I-Characteristic	1014	1021	retinal
I-Characteristic	1022	1032	thickening
O	1032	1033	.

O	1034	1045	Concordance
O	1046	1048	of
O	1049	1056	results
O	1057	1062	using
O	1063	1072	different
B-Characteristic	1073	1076	OCT
I-Characteristic	1077	1086	variables
O	1087	1090	and
O	1091	1099	analysis
O	1100	1107	methods
O	1107	1108	.

B-Characteristic	1109	1115	Center
I-Characteristic	1116	1121	point
I-Characteristic	1122	1131	thickness
O	1132	1142	correlated
O	1143	1149	highly
O	1150	1154	with
B-Characteristic	1155	1162	central
I-Characteristic	1163	1171	subfield
I-Characteristic	1172	1176	mean
I-Characteristic	1177	1186	thickness
O	1187	1188	(
B-Characteristic	1188	1192	CSMT
O	1192	1193	)
O	1194	1196	at
O	1197	1205	baseline
O	1206	1207	(
O	1207	1208	0
O	1208	1209	.
O	1209	1211	98
O	1211	1212	-
O	1212	1213	0
O	1213	1214	.
O	1214	1216	99
O	1216	1217	)
O	1217	1218	.

O	1219	1222	The
O	1223	1236	distributions
O	1237	1239	of
O	1240	1247	changes
O	1248	1250	in
B-Characteristic	1251	1255	CSMT
O	1256	1260	were
O	1261	1274	approximately
O	1275	1283	normally
O	1284	1295	distributed
O	1296	1299	for
B-Characteristic	1300	1308	absolute
I-Characteristic	1309	1315	change
I-Characteristic	1316	1318	in
I-Characteristic	1319	1326	retinal
I-Characteristic	1327	1336	thickness
O	1337	1340	and
B-Characteristic	1341	1349	relative
I-Characteristic	1350	1356	change
I-Characteristic	1357	1359	in
I-Characteristic	1360	1367	retinal
I-Characteristic	1368	1377	thickness
O	1377	1378	,
O	1379	1382	but
O	1383	1386	not
O	1387	1390	for
B-Characteristic	1391	1399	relative
I-Characteristic	1400	1406	change
I-Characteristic	1407	1409	in
I-Characteristic	1410	1417	retinal
I-Characteristic	1418	1428	thickening
O	1428	1429	.

B-Symptom	1430	1437	Macular
I-Symptom	1438	1446	thinning
O	1447	1449	in
O	1450	1453	the
O	1454	1460	mETDRS
O	1461	1466	group
O	1467	1470	was
O	1471	1484	significantly
O	1485	1492	greater
O	1493	1497	than
O	1498	1500	in
O	1501	1504	the
O	1505	1508	MMG
O	1509	1514	group
O	1515	1519	when
B-Characteristic	1520	1528	absolute
I-Characteristic	1529	1535	change
I-Characteristic	1536	1538	in
I-Characteristic	1539	1546	retinal
I-Characteristic	1547	1556	thickness
O	1557	1560	was
O	1561	1565	used
O	1565	1566	,
O	1567	1570	but
O	1571	1574	not
O	1575	1579	when
B-Characteristic	1580	1588	relative
I-Characteristic	1589	1595	change
I-Characteristic	1596	1598	in
I-Characteristic	1599	1608	thickness
O	1609	1612	and
B-Characteristic	1613	1621	relative
I-Characteristic	1622	1628	change
I-Characteristic	1629	1631	in
I-Characteristic	1632	1642	thickening
O	1643	1647	were
O	1648	1652	used
O	1652	1653	.

O	1654	1662	Relative
O	1663	1669	change
O	1670	1672	in
B-Characteristic	1673	1680	macular
I-Characteristic	1681	1691	thickening
O	1692	1700	provides
O	1701	1709	unstable
O	1710	1714	data
O	1715	1717	in
B-Anatomy	1718	1722	eyes
O	1723	1727	with
O	1728	1732	mild
O	1733	1740	degrees
O	1741	1743	of
O	1744	1752	baseline
O	1753	1763	thickening
O	1763	1764	,
O	1765	1771	unlike
O	1772	1775	the
O	1776	1785	situation
O	1786	1790	with
B-Characteristic	1791	1799	absolute
I-Characteristic	1800	1802	or
I-Characteristic	1803	1811	relative
I-Characteristic	1812	1818	change
I-Characteristic	1819	1821	in
I-Characteristic	1822	1829	retinal
I-Characteristic	1830	1839	thickness
O	1839	1840	.

B-Characteristic	1841	1848	Central
I-Characteristic	1849	1857	subfield
I-Characteristic	1858	1862	mean
I-Characteristic	1863	1872	thickness
O	1873	1875	is
O	1876	1879	the
O	1880	1889	preferred
B-Characteristic	1890	1893	OCT
I-Characteristic	1894	1905	measurement
O	1906	1909	for
O	1910	1913	the
B-Anatomy	1914	1921	central
I-Anatomy	1922	1928	macula
O	1929	1936	because
O	1937	1939	of
O	1940	1943	its
O	1944	1950	higher
O	1951	1966	reproducibility
O	1967	1970	and
O	1971	1982	correlation
O	1983	1987	with
O	1988	1993	other
O	1994	2006	measurements
O	2007	2009	of
O	2010	2013	the
B-Anatomy	2014	2021	central
I-Anatomy	2022	2028	macula
O	2028	2029	.

B-Characteristic	2030	2035	Total
I-Characteristic	2036	2043	macular
I-Characteristic	2044	2050	volume
O	2051	2054	may
O	2055	2057	be
O	2058	2067	preferred
O	2068	2072	when
O	2073	2076	the
B-Anatomy	2077	2084	central
I-Anatomy	2085	2091	macula
O	2092	2094	is
O	2095	2099	less
O	2100	2109	important
O	2109	2110	.

B-Characteristic	2111	2119	Absolute
I-Characteristic	2120	2126	change
I-Characteristic	2127	2129	in
I-Characteristic	2130	2137	retinal
I-Characteristic	2138	2147	thickness
O	2148	2150	is
O	2151	2154	the
O	2155	2164	preferred
O	2165	2173	analysis
O	2174	2180	method
O	2181	2183	in
O	2184	2191	studies
O	2192	2201	involving
B-Anatomy	2202	2206	eyes
O	2207	2211	with
B-Characteristic	2212	2216	mild
I-Characteristic	2217	2224	macular
I-Characteristic	2225	2235	thickening
O	2235	2236	.

B-Characteristic	2237	2245	Relative
I-Characteristic	2246	2252	change
I-Characteristic	2253	2255	in
I-Characteristic	2256	2266	thickening
O	2267	2270	may
O	2271	2273	be
O	2274	2284	preferable
O	2285	2289	when
B-Characteristic	2290	2297	retinal
I-Characteristic	2298	2308	thickening
O	2309	2311	is
O	2312	2316	more
O	2317	2323	severe
O	2323	2324	.

B-Symptom	0	6	Drusen
I-Symptom	7	21	ultrastructure
O	22	29	imaging
O	30	34	with
B-Diagnostic_tool	35	43	spectral
I-Diagnostic_tool	44	50	domain
I-Diagnostic_tool	51	58	optical
I-Diagnostic_tool	59	68	coherence
I-Diagnostic_tool	69	79	tomography
O	80	82	in
B-Disease	83	86	age
I-Disease	86	87	-
I-Disease	87	94	related
I-Disease	95	102	macular
I-Disease	103	115	degeneration
O	115	116	.

O	118	120	To
O	121	131	categorize
B-Symptom	132	138	drusen
I-Symptom	139	153	ultrastructure
O	154	156	in
B-Disease	157	160	age
I-Disease	160	161	-
I-Disease	161	168	related
I-Disease	169	176	macular
I-Disease	177	189	degeneration
O	190	191	(
B-Disease	191	194	AMD
O	194	195	)
O	196	201	using
B-Diagnostic_tool	202	210	spectral
I-Diagnostic_tool	211	217	domain
I-Diagnostic_tool	218	225	optical
I-Diagnostic_tool	226	235	coherence
I-Diagnostic_tool	236	246	tomography
O	247	248	(
B-Diagnostic_tool	248	253	SDOCT
O	253	254	)
O	255	258	and
O	259	268	correlate
O	269	272	the
O	273	284	tomographic
O	285	288	and
O	289	301	photographic
B-Symptom	302	308	drusen
O	309	320	appearances
O	320	321	.

O	322	333	Prospective
O	334	338	case
O	339	345	series
O	345	346	.

O	347	353	Thirty
O	353	354	-
O	354	357	one
O	358	362	eyes
O	363	365	of
O	366	368	31
O	369	377	patients
O	378	382	with
B-Disease	383	386	non
I-Disease	386	387	-
I-Disease	387	398	neovascular
I-Disease	399	402	AMD
O	402	403	.

O	404	412	Subjects
O	413	417	with
B-Symptom	418	424	drusen
O	425	428	and
O	429	430	a
O	431	439	clinical
O	440	449	diagnosis
O	450	452	of
B-Disease	453	456	AMD
O	457	461	were
O	462	470	enrolled
O	471	473	in
O	474	476	an
B-Diagnostic_tool	477	482	SDOCT
O	483	490	imaging
O	491	496	study
O	497	501	from
O	502	508	August
O	509	511	of
O	512	516	2005
O	517	519	to
O	520	523	May
O	524	526	of
O	527	531	2007
O	531	532	.

B-Diagnostic_tool	533	539	Foveal
I-Diagnostic_tool	540	546	linear
I-Diagnostic_tool	547	552	scans
O	553	557	were
O	558	566	acquired
O	566	567	,
O	568	571	and
O	572	575	the
O	576	581	image
O	582	586	data
O	587	591	were
O	592	601	processed
O	602	605	for
O	606	614	analysis
O	614	615	.

B-Symptom	616	622	Drusen
O	623	627	were
O	628	634	scored
O	635	637	by
O	638	639	4
O	640	651	morphologic
O	652	662	categories
O	662	663	:
O	664	669	shape
O	669	670	,
O	671	682	predominant
O	683	691	internal
O	692	704	reflectivity
O	704	705	,
O	706	717	homogeneity
O	717	718	,
O	719	722	and
O	723	731	presence
O	732	734	of
B-Symptom	735	744	overlying
I-Symptom	745	750	hyper
I-Symptom	750	751	-
I-Symptom	751	761	reflective
I-Symptom	762	766	foci
O	766	767	.

O	768	771	The
O	772	783	prevalences
O	784	786	of
O	787	791	each
O	792	803	morphologic
O	804	811	pattern
O	812	815	and
O	816	828	combinations
O	829	831	of
O	832	843	morphologic
O	844	852	patterns
O	853	861	observed
O	862	866	were
O	867	877	calculated
O	877	878	.

O	879	882	The
O	883	895	photographic
O	896	906	appearance
O	907	909	of
O	910	914	each
B-Symptom	915	920	druse
O	921	924	was
O	925	933	compared
O	934	938	with
O	939	942	the
O	943	954	tomographic
O	955	969	classification
O	969	970	.

O	971	984	Interobserver
O	985	988	and
O	989	1002	intraobserver
O	1003	1012	agreement
O	1013	1021	analysis
O	1022	1025	was
O	1026	1035	performed
O	1035	1036	.

O	1037	1047	Prevalence
O	1048	1050	of
O	1051	1062	morphologic
O	1063	1073	parameters
O	1074	1079	using
B-Diagnostic_tool	1080	1085	SDOCT
O	1085	1086	.

O	1087	1093	Twenty
O	1093	1094	-
O	1094	1097	one
B-Anatomy	1098	1102	eyes
O	1103	1105	of
O	1106	1108	21
O	1109	1117	patients
O	1118	1121	had
B-Diagnostic_tool	1122	1127	SDOCT
I-Diagnostic_tool	1128	1129	B
I-Diagnostic_tool	1129	1130	-
I-Diagnostic_tool	1130	1135	scans
O	1136	1138	of
O	1139	1147	adequate
O	1148	1155	quality
O	1156	1159	for
O	1160	1168	analysis
O	1168	1169	.

O	1170	1172	On
O	1173	1176	the
O	1177	1182	basis
O	1183	1185	of
O	1186	1189	the
O	1190	1195	above
O	1196	1207	morphologic
O	1208	1218	categories
O	1218	1219	,
O	1220	1222	17
O	1223	1232	different
B-Symptom	1233	1239	drusen
O	1240	1248	patterns
O	1249	1253	were
O	1254	1259	found
O	1260	1262	in
O	1263	1266	120
O	1267	1272	total
B-Symptom	1273	1279	drusen
O	1279	1280	.

O	1281	1284	The
O	1285	1289	most
O	1290	1296	common
O	1297	1300	was
O	1301	1307	convex
O	1307	1308	,
O	1309	1320	homogeneous
O	1320	1321	,
O	1322	1326	with
O	1327	1333	medium
O	1334	1342	internal
O	1343	1355	reflectivity
O	1355	1356	,
O	1357	1360	and
O	1361	1368	without
B-Symptom	1369	1378	overlying
I-Symptom	1379	1384	hyper
I-Symptom	1384	1385	-
I-Symptom	1385	1395	reflective
I-Symptom	1396	1400	foci
O	1400	1401	,
O	1402	1409	present
O	1410	1412	in
O	1413	1415	17
O	1416	1418	of
O	1419	1421	21
B-Anatomy	1422	1426	eyes
O	1427	1428	(
O	1428	1430	81
O	1430	1431	%
O	1431	1432	)
O	1432	1433	.

O	1434	1436	Of
O	1437	1440	the
O	1441	1443	16
B-Anatomy	1444	1448	eyes
O	1449	1450	(
O	1450	1452	76
O	1452	1453	%
O	1453	1454	)
O	1455	1459	with
B-Symptom	1460	1474	nonhomogeneous
I-Symptom	1475	1481	drusen
O	1481	1482	,
O	1483	1484	5
O	1485	1488	had
O	1489	1490	a
O	1491	1499	distinct
O	1500	1505	hyper
O	1505	1506	-
O	1506	1516	reflective
O	1517	1521	core
O	1521	1522	.

B-Symptom	1523	1528	Hyper
I-Symptom	1528	1529	-
I-Symptom	1529	1539	reflective
I-Symptom	1540	1544	foci
I-Symptom	1545	1554	overlying
I-Symptom	1555	1561	drusen
O	1562	1566	were
O	1567	1569	in
O	1570	1571	7
B-Anatomy	1572	1576	eyes
O	1577	1578	(
O	1578	1580	33
O	1580	1581	%
O	1581	1582	)
O	1582	1583	.

O	1584	1592	Although
O	1593	1597	half
O	1598	1600	of
O	1601	1604	the
O	1605	1621	photographically
B-Symptom	1622	1626	soft
I-Symptom	1626	1627	-
I-Symptom	1627	1637	indistinct
I-Symptom	1638	1644	drusen
O	1645	1649	were
O	1650	1656	convex
O	1657	1661	with
O	1662	1668	medium
O	1669	1677	internal
O	1678	1690	reflectivity
O	1691	1694	and
O	1695	1706	homogeneous
O	1707	1714	without
B-Symptom	1715	1724	overlying
I-Symptom	1725	1730	hyper
I-Symptom	1730	1731	-
I-Symptom	1731	1741	reflective
I-Symptom	1742	1746	foci
O	1746	1747	,
O	1748	1751	the
O	1752	1757	other
O	1758	1762	half
O	1763	1766	had
O	1767	1778	significant
O	1779	1790	variability
O	1791	1793	in
O	1794	1799	their
O	1800	1811	tomographic
O	1812	1822	appearance
O	1822	1823	.

O	1824	1828	Both
O	1829	1842	interobserver
O	1843	1846	and
O	1847	1860	intraobserver
O	1861	1870	agreement
O	1871	1873	in
B-Symptom	1874	1880	drusen
O	1881	1888	grading
O	1889	1893	were
O	1894	1898	high
O	1898	1899	.

O	1900	1907	Readers
O	1908	1914	agreed
O	1915	1918	the
O	1919	1923	most
O	1924	1928	when
O	1929	1936	grading
B-Symptom	1937	1943	drusen
O	1944	1949	shape
O	1950	1953	and
O	1954	1966	reflectivity
O	1966	1967	,
O	1968	1975	whereas
O	1976	1979	the
O	1980	1985	least
O	1986	1995	agreement
O	1996	1999	was
O	2000	2003	for
B-Symptom	2004	2010	drusen
O	2011	2022	homogeneity
O	2022	2023	.

B-Symptom	2024	2030	Drusen
I-Symptom	2031	2045	ultrastructure
O	2046	2049	can
O	2050	2052	be
O	2053	2059	imaged
O	2060	2064	with
B-Diagnostic_tool	2065	2070	SDOCT
O	2071	2074	and
O	2075	2088	characterized
O	2089	2093	with
O	2094	2095	a
O	2096	2102	simple
O	2103	2110	grading
O	2111	2117	system
O	2117	2118	.

B-Diagnostic_tool	2119	2131	Photographic
O	2132	2142	appearance
O	2143	2146	may
O	2147	2154	predict
O	2155	2159	some
O	2160	2163	but
O	2164	2167	not
O	2168	2171	all
O	2172	2183	tomographic
O	2184	2195	appearances
O	2195	2196	.

O	2197	2204	Trained
O	2205	2214	observers
O	2215	2219	have
O	2220	2221	a
O	2222	2226	high
O	2227	2232	level
O	2233	2235	of
O	2236	2245	agreement
O	2246	2250	with
O	2251	2255	this
O	2256	2263	grading
O	2264	2270	system
O	2270	2271	.

O	2272	2277	These
O	2278	2280	in
O	2281	2285	vivo
O	2286	2297	morphologic
O	2298	2313	characteristics
O	2314	2320	imaged
O	2321	2325	with
B-Diagnostic_tool	2326	2331	SDOCT
O	2332	2335	may
O	2336	2338	be
O	2339	2347	distinct
O	2348	2358	subclasses
O	2359	2361	of
B-Symptom	2362	2368	drusen
O	2369	2374	types
O	2374	2375	,
O	2376	2379	may
O	2380	2386	relate
O	2387	2394	closely
O	2395	2397	to
B-Symptom	2398	2413	ultrastructural
I-Symptom	2414	2420	drusen
O	2421	2429	elements
O	2430	2440	identified
O	2441	2443	in
O	2444	2453	cadaveric
B-Anatomy	2454	2458	eyes
O	2458	2459	,
O	2460	2463	and
O	2464	2467	may
O	2468	2470	be
O	2471	2477	useful
O	2478	2485	imaging
O	2486	2496	biomarkers
O	2497	2500	for
O	2501	2508	disease
O	2509	2517	severity
O	2518	2520	or
O	2521	2525	risk
O	2526	2528	of
O	2529	2540	progression
O	2540	2541	.

O	2542	2546	This
O	2547	2551	will
O	2552	2559	require
O	2560	2570	validation
O	2571	2575	from
O	2576	2583	further
O	2584	2591	studies
O	2591	2592	.

O	0	12	Relationship
O	13	20	between
B-Characteristic	21	28	optical
I-Characteristic	29	38	coherence
I-Characteristic	39	49	tomography
I-Characteristic	50	57	retinal
I-Characteristic	58	68	parameters
O	69	72	and
B-Characteristic	73	79	visual
I-Characteristic	80	86	acuity
O	87	89	in
B-Disease	90	101	neovascular
I-Disease	102	105	age
I-Disease	105	106	-
I-Disease	106	113	related
I-Disease	114	121	macular
I-Disease	122	134	degeneration
O	134	135	.

O	137	139	To
O	140	151	investigate
O	152	155	the
O	156	168	relationship
O	169	176	between
B-Characteristic	177	184	optical
I-Characteristic	185	194	coherence
I-Characteristic	195	205	tomography
I-Characteristic	206	207	(
I-Characteristic	207	210	OCT
I-Characteristic	210	211	)
I-Characteristic	211	212	-
I-Characteristic	212	219	derived
I-Characteristic	220	232	measurements
I-Characteristic	233	235	of
I-Characteristic	236	243	retinal
I-Characteristic	244	254	morphology
O	255	258	and
B-Characteristic	259	265	visual
I-Characteristic	266	272	acuity
O	273	275	in
O	276	284	patients
O	285	289	with
B-Disease	290	301	neovascular
I-Disease	302	305	age
I-Disease	305	306	-
I-Disease	306	313	related
I-Disease	314	321	macular
I-Disease	322	334	degeneration
O	335	336	(
B-Disease	336	339	AMD
O	339	340	)
O	340	341	.

O	342	355	Retrospective
O	356	361	cross
O	361	362	-
O	362	371	sectional
O	372	377	study
O	377	378	.

O	379	380	A
O	381	386	total
O	387	389	of
O	390	393	216
O	394	405	consecutive
O	406	414	patients
O	415	416	(
O	416	419	216
B-Anatomy	420	424	eyes
O	424	425	)
O	426	431	newly
O	432	441	diagnosed
O	442	446	with
B-Disease	447	458	neovascular
I-Disease	459	462	AMD
O	463	466	who
O	467	476	underwent
B-Diagnostic_tool	477	487	StratusOCT
O	488	495	imaging
O	496	498	at
O	499	502	the
O	503	507	time
O	508	510	of
O	511	520	diagnosis
O	520	521	.

B-Characteristic	522	526	Best
I-Characteristic	526	527	-
I-Characteristic	527	536	corrected
I-Characteristic	537	544	Snellen
I-Characteristic	545	551	visual
I-Characteristic	552	558	acuity
O	559	562	was
O	563	571	recorded
O	572	575	for
O	576	580	each
O	581	588	patient
O	588	589	.

O	590	593	Raw
O	594	602	exported
B-Diagnostic_tool	603	613	StratusOCT
I-Diagnostic_tool	614	620	images
O	621	624	for
O	625	629	each
O	630	637	patient
O	638	642	were
O	643	651	analyzed
O	652	657	using
O	658	666	publicly
O	667	676	available
O	677	683	custom
O	684	692	software
O	693	701	entitled
O	703	704	"
B-Diagnostic_tool	705	710	OCTOR
O	710	711	,
O	712	713	"
O	715	720	which
O	721	727	allows
O	728	731	the
O	732	739	precise
O	740	751	positioning
O	752	754	of
O	755	767	prespecified
O	768	778	boundaries
O	779	781	on
O	782	792	individual
O	793	794	B
O	794	795	-
O	795	800	scans
O	800	801	.

O	802	811	Thickness
O	812	815	and
O	816	822	volume
O	823	827	were
O	828	838	calculated
O	839	842	for
B-Characteristic	843	854	morphologic
I-Characteristic	855	865	parameters
O	866	868	of
O	869	877	interest
O	877	878	:
B-Anatomy	879	891	neurosensory
I-Anatomy	892	898	retina
O	898	899	,
B-Symptom	900	910	subretinal
I-Symptom	911	916	fluid
O	916	917	,
B-Anatomy	918	928	subretinal
I-Anatomy	929	935	tissue
O	936	937	(
B-Anatomy	937	940	SRT
O	940	941	)
O	941	942	,
O	943	946	and
B-Symptom	947	954	pigment
I-Symptom	955	965	epithelial
I-Symptom	966	976	detachment
O	976	977	.

B-Characteristic	978	981	OCT
I-Characteristic	981	982	-
I-Characteristic	982	989	derived
I-Characteristic	990	1002	measurements
I-Characteristic	1003	1005	of
I-Characteristic	1006	1013	retinal
I-Characteristic	1014	1024	morphology
O	1025	1028	and
B-Characteristic	1029	1035	visual
I-Characteristic	1036	1042	acuity
O	1042	1043	.

O	1044	1046	An
B-Symptom	1047	1056	increased
I-Symptom	1057	1062	total
I-Symptom	1063	1069	volume
I-Symptom	1070	1072	of
I-Symptom	1073	1076	SRT
O	1077	1080	was
O	1081	1091	correlated
O	1092	1096	with
B-Symptom	1097	1106	decreased
I-Symptom	1107	1113	visual
I-Symptom	1114	1120	acuity
O	1121	1122	(
O	1122	1123	r
O	1124	1125	=
O	1126	1127	0
O	1127	1128	.
O	1128	1131	370
O	1131	1132	,
O	1133	1134	P
O	1135	1136	<
O	1137	1138	0
O	1138	1139	.
O	1139	1143	0001
O	1143	1144	)
O	1144	1145	.

B-Symptom	1146	1155	Decreased
I-Symptom	1156	1162	visual
I-Symptom	1163	1169	acuity
O	1170	1173	was
O	1174	1178	also
O	1179	1187	modestly
O	1188	1198	correlated
O	1199	1203	with
B-Symptom	1204	1213	increased
I-Symptom	1214	1223	thickness
I-Symptom	1224	1226	of
I-Symptom	1227	1230	the
I-Symptom	1231	1243	neurosensory
I-Symptom	1244	1250	retina
I-Symptom	1251	1253	at
I-Symptom	1254	1257	the
I-Symptom	1258	1264	foveal
I-Symptom	1265	1271	center
I-Symptom	1272	1277	point
O	1278	1279	(
O	1279	1280	r
O	1281	1282	=
O	1283	1284	0
O	1284	1285	.
O	1285	1288	245
O	1288	1289	,
O	1290	1291	P
O	1292	1293	=
O	1294	1295	0
O	1295	1296	.
O	1296	1300	0004
O	1300	1301	)
O	1301	1302	.

O	1303	1305	No
O	1306	1319	statistically
O	1320	1331	significant
O	1332	1343	association
O	1344	1347	was
O	1348	1356	detected
O	1357	1364	between
B-Characteristic	1365	1371	visual
I-Characteristic	1372	1378	acuity
O	1379	1382	and
O	1383	1386	the
B-Characteristic	1387	1392	total
I-Characteristic	1393	1399	volume
I-Characteristic	1400	1402	of
I-Characteristic	1403	1413	subretinal
I-Characteristic	1414	1419	fluid
O	1420	1422	or
B-Symptom	1423	1430	pigment
I-Symptom	1431	1441	epithelial
I-Symptom	1442	1452	detachment
O	1452	1453	.

O	1454	1457	The
O	1458	1469	association
O	1470	1477	between
B-Characteristic	1478	1484	visual
I-Characteristic	1485	1491	acuity
O	1492	1495	and
O	1496	1500	both
O	1501	1504	the
B-Anatomy	1505	1517	neurosensory
I-Anatomy	1518	1524	retina
O	1525	1528	and
O	1529	1532	the
B-Anatomy	1533	1536	SRT
O	1537	1540	was
O	1541	1549	stronger
O	1550	1553	for
O	1554	1561	lesions
O	1562	1572	classified
O	1573	1575	as
O	1576	1585	minimally
O	1586	1593	classic
O	1594	1596	or
O	1597	1603	occult
O	1604	1606	on
B-Diagnostic_tool	1607	1618	fluorescein
I-Diagnostic_tool	1619	1630	angiography
O	1630	1631	.

O	1632	1635	For
O	1636	1642	occult
O	1643	1650	lesions
O	1650	1651	,
O	1652	1654	20
O	1654	1655	%
O	1656	1658	of
O	1659	1662	the
O	1663	1672	variation
O	1673	1675	in
B-Characteristic	1676	1682	visual
I-Characteristic	1683	1689	acuity
O	1690	1695	could
O	1696	1698	be
O	1699	1708	predicted
O	1709	1711	by
O	1712	1713	a
O	1714	1722	multiple
O	1723	1733	regression
O	1734	1739	model
O	1740	1744	that
O	1745	1757	incorporated
B-Characteristic	1758	1761	age
O	1762	1765	and
B-Characteristic	1766	1769	SRT
I-Characteristic	1770	1776	volume
O	1776	1777	,
O	1778	1785	whereas
O	1785	1786	,
O	1787	1790	for
O	1791	1800	minimally
O	1801	1808	classic
O	1809	1816	lesions
O	1816	1817	,
O	1818	1820	62
O	1820	1821	%
O	1822	1824	of
O	1825	1828	the
O	1829	1838	variation
O	1839	1841	in
B-Characteristic	1842	1848	visual
I-Characteristic	1849	1855	acuity
O	1856	1861	could
O	1862	1864	be
O	1865	1874	predicted
O	1875	1877	by
O	1878	1879	a
O	1880	1888	multiple
O	1889	1899	regression
O	1900	1905	model
O	1906	1910	that
O	1911	1923	incorporated
B-Characteristic	1924	1927	age
O	1927	1928	,
B-Characteristic	1929	1934	total
I-Characteristic	1935	1947	neurosensory
I-Characteristic	1948	1955	retinal
I-Characteristic	1956	1962	volume
O	1962	1963	,
O	1964	1967	and
B-Characteristic	1968	1973	total
I-Characteristic	1974	1977	SRT
I-Characteristic	1978	1984	volume
O	1984	1985	.

O	1986	1989	The
O	1990	1998	presence
O	1999	2001	of
B-Symptom	2002	2011	increased
I-Symptom	2012	2015	SRT
I-Symptom	2016	2025	thickness
I-Symptom	2026	2029	and
I-Symptom	2030	2036	volume
O	2037	2039	on
B-Diagnostic_tool	2040	2043	OCT
O	2043	2044	,
O	2045	2048	and
O	2049	2051	to
O	2052	2053	a
O	2054	2060	lesser
O	2061	2067	extent
B-Symptom	2068	2077	increased
I-Symptom	2078	2090	neurosensory
I-Symptom	2091	2098	retinal
I-Symptom	2099	2108	thickness
I-Symptom	2109	2112	and
I-Symptom	2113	2119	volume
O	2119	2120	,
O	2121	2123	is
O	2124	2134	associated
O	2135	2139	with
B-Symptom	2140	2149	decreased
I-Symptom	2150	2156	visual
I-Symptom	2157	2163	acuity
O	2164	2166	in
B-Disease	2167	2178	neovascular
I-Disease	2179	2182	AMD
O	2182	2183	.

O	2184	2191	However
O	2191	2192	,
O	2193	2200	because
O	2201	2203	of
O	2204	2207	the
O	2208	2215	complex
O	2216	2231	pathophysiology
O	2232	2234	of
B-Disease	2235	2246	neovascular
I-Disease	2247	2250	AMD
O	2251	2254	and
O	2254	2255	,
O	2256	2258	in
O	2259	2263	part
O	2263	2264	,
O	2265	2268	the
O	2269	2280	limitations
O	2281	2283	of
B-Diagnostic_tool	2284	2294	StratusOCT
O	2294	2295	,
O	2296	2301	these
O	2302	2309	factors
O	2310	2314	only
O	2315	2322	account
O	2323	2326	for
O	2327	2328	a
O	2329	2334	small
O	2335	2341	degree
O	2342	2344	of
O	2345	2348	the
O	2349	2358	variation
O	2359	2361	in
B-Characteristic	2362	2368	visual
I-Characteristic	2369	2375	acuity
O	2376	2380	that
O	2381	2386	these
O	2387	2395	patients
O	2396	2403	exhibit
O	2403	2404	.

O	2405	2408	The
O	2409	2418	detection
O	2419	2421	of
O	2422	2430	stronger
O	2431	2443	correlations
O	2444	2451	between
B-Anatomy	2452	2459	retinal
I-Anatomy	2460	2467	anatomy
O	2468	2471	and
B-Characteristic	2472	2478	visual
I-Characteristic	2479	2485	acuity
O	2486	2488	is
O	2489	2495	likely
O	2496	2498	to
O	2499	2506	require
O	2507	2510	the
O	2511	2514	use
O	2515	2517	of
O	2518	2522	more
O	2523	2531	advanced
O	2532	2539	imaging
O	2540	2550	modalities
O	2550	2551	.

O	2552	2563	Proprietary
O	2564	2566	or
O	2567	2577	commercial
O	2578	2588	disclosure
O	2589	2592	may
O	2593	2595	be
O	2596	2601	found
O	2602	2607	after
O	2608	2611	the
O	2612	2622	references
O	2622	2623	.

O	0	10	Ophthalmic
O	11	19	features
O	20	22	of
B-Disease	23	30	Joubert
I-Disease	31	39	syndrome
O	39	40	.

B-Disease	42	49	Joubert
I-Disease	50	58	syndrome
O	59	60	(
O	60	66	Online
O	67	76	Mendelian
O	77	88	Inheritance
O	89	91	in
O	92	95	Man
O	96	102	213300
O	102	103	)
O	104	106	is
O	107	108	a
O	109	113	rare
B-Symptom	114	123	autosomal
I-Symptom	124	133	recessive
I-Symptom	134	144	congenital
I-Symptom	145	157	malformation
I-Symptom	158	160	of
I-Symptom	161	164	the
I-Symptom	165	174	brainstem
I-Symptom	175	178	and
I-Symptom	179	189	cerebellar
I-Symptom	190	196	vermis
O	196	197	.

O	198	207	Diagnosis
O	208	210	is
O	211	216	based
O	217	219	on
O	220	234	characteristic
O	235	243	clinical
O	244	252	features
O	253	254	(
O	254	255	e
O	255	256	.
O	256	257	g
O	257	258	.
O	258	259	,
B-Symptom	260	269	hypotonia
O	269	270	,
B-Symptom	271	279	episodic
I-Symptom	280	289	hyperpnea
O	289	290	,
B-Symptom	291	304	developmental
I-Symptom	305	310	delay
O	310	311	,
B-Symptom	312	323	progressive
I-Symptom	324	330	ataxia
O	330	331	)
O	332	335	and
O	336	338	is
O	339	348	confirmed
O	349	351	by
O	352	363	distinctive
B-Symptom	364	379	neuroradiologic
I-Symptom	380	388	findings
O	389	390	(
O	390	391	e
O	391	392	.
O	392	393	g
O	393	394	.
O	394	395	,
O	396	399	the
B-Symptom	401	402	"
I-Symptom	403	408	molar
I-Symptom	409	414	tooth
I-Symptom	415	416	"
I-Symptom	418	422	sign
O	422	423	)
O	423	424	.

O	425	433	Variable
O	434	444	ophthalmic
O	445	453	features
O	454	458	have
O	459	463	been
O	464	473	mentioned
O	474	476	in
O	477	482	prior
O	483	490	reports
O	490	491	;
O	492	499	however
O	499	500	,
O	501	505	most
O	506	508	do
O	509	512	not
O	513	519	detail
B-Anatomy	520	523	eye
O	524	532	findings
O	533	536	and
O	537	540	the
O	541	544	few
O	545	549	that
O	550	552	do
O	553	557	were
O	558	564	before
O	565	568	the
O	569	580	publication
O	581	583	of
O	584	593	suggested
O	594	604	diagnostic
O	605	613	criteria
O	613	614	.

O	615	618	The
O	619	628	objective
O	629	631	of
O	632	635	the
O	636	643	current
O	644	649	study
O	650	652	is
O	653	655	to
O	656	664	describe
O	665	668	the
O	669	679	ophthalmic
O	680	689	phenotype
O	690	692	in
O	693	694	a
O	695	701	cohort
O	702	704	of
O	705	713	patients
O	714	718	with
B-Disease	719	726	Joubert
I-Disease	727	735	syndrome
O	736	739	for
O	740	744	whom
O	745	748	the
O	749	758	diagnosis
O	759	762	was
O	763	767	made
O	768	773	using
O	774	781	current
O	782	792	diagnostic
O	793	801	criteria
O	801	802	.

O	803	814	Prospective
O	815	819	case
O	820	826	series
O	826	827	.

O	828	833	Eight
O	834	842	children
O	843	852	diagnosed
O	853	863	clinically
O	864	868	with
O	869	879	radiologic
O	880	892	confirmation
O	892	893	.

B-Diagnostic_tool	894	904	Ophthalmic
I-Diagnostic_tool	905	916	examination
O	917	920	and
B-Diagnostic_tool	921	927	visual
I-Diagnostic_tool	928	945	electrophysiology
O	945	946	.

B-Diagnostic_tool	947	953	Ocular
I-Diagnostic_tool	954	957	and
I-Diagnostic_tool	958	968	oculomotor
I-Diagnostic_tool	969	980	examination
O	981	982	(
O	982	984	as
O	985	992	allowed
O	993	995	by
O	996	1003	patient
O	1004	1015	cooperation
O	1015	1016	)
O	1016	1017	,
B-Diagnostic_tool	1018	1037	electroretinography
O	1037	1038	,
B-Diagnostic_tool	1039	1044	flash
I-Diagnostic_tool	1045	1051	visual
I-Diagnostic_tool	1051	1052	-
I-Diagnostic_tool	1052	1058	evoked
I-Diagnostic_tool	1059	1068	potential
O	1069	1070	(
B-Diagnostic_tool	1070	1074	fVEP
O	1074	1075	)
O	1075	1076	.

O	1077	1085	Patients
O	1085	1086	'
O	1087	1091	ages
O	1092	1098	ranged
O	1099	1103	from
B-Characteristic	1104	1105	7
I-Characteristic	1106	1112	months
I-Characteristic	1113	1115	to
I-Characteristic	1116	1118	10
I-Characteristic	1119	1124	years
O	1124	1125	.

B-Symptom	1126	1134	Saccadic
I-Symptom	1135	1146	dysfunction
O	1147	1150	was
O	1151	1159	observed
O	1160	1162	in
O	1163	1166	all
O	1167	1178	cooperative
O	1179	1187	patients
O	1188	1189	(
O	1189	1190	6
O	1190	1191	/
O	1191	1192	6
O	1192	1193	)
O	1193	1194	;
B-Symptom	1195	1207	compensatory
I-Symptom	1208	1212	head
I-Symptom	1213	1220	thrusts
I-Symptom	1221	1223	or
I-Symptom	1224	1229	turns
O	1230	1234	were
O	1235	1242	present
O	1243	1245	in
O	1246	1249	all
O	1250	1256	except
O	1257	1260	the
O	1261	1269	youngest
O	1270	1277	patient
O	1278	1279	(
B-Characteristic	1279	1280	7
I-Characteristic	1281	1287	months
I-Characteristic	1288	1290	of
I-Characteristic	1291	1294	age
O	1294	1295	)
O	1295	1296	.

O	1297	1301	Most
O	1302	1310	patients
O	1311	1312	(
O	1312	1313	5
O	1313	1314	/
O	1314	1315	8
O	1315	1316	)
O	1317	1320	had
B-Symptom	1321	1328	primary
I-Symptom	1328	1329	-
I-Symptom	1329	1337	position
I-Symptom	1338	1347	nystagmus
O	1348	1349	(
O	1349	1352	see
O	1352	1353	-
O	1353	1356	saw
O	1357	1359	in
O	1360	1361	3
O	1361	1362	/
O	1362	1363	5
O	1363	1364	)
O	1364	1365	.

B-Symptom	1366	1374	Abnormal
I-Symptom	1375	1382	pursuit
O	1383	1384	(
O	1384	1385	3
O	1385	1386	/
O	1386	1387	7
O	1387	1388	)
O	1389	1392	and
O	1393	1394	a
B-Symptom	1395	1405	dystrophic
I-Symptom	1406	1413	retinal
I-Symptom	1414	1424	appearance
O	1425	1426	(
O	1426	1427	3
O	1427	1428	/
O	1428	1429	8
O	1429	1430	)
O	1431	1435	were
O	1436	1440	also
O	1441	1445	seen
O	1445	1446	.

O	1447	1450	One
O	1451	1458	patient
O	1459	1462	had
B-Symptom	1463	1472	bilateral
I-Symptom	1473	1483	asymmetric
I-Symptom	1484	1490	ptosis
I-Symptom	1491	1495	with
I-Symptom	1496	1506	unilateral
I-Symptom	1507	1510	lid
I-Symptom	1511	1520	elevation
I-Symptom	1521	1527	during
I-Symptom	1528	1539	ipsilateral
I-Symptom	1540	1549	abduction
O	1549	1550	.

B-Diagnostic_tool	1551	1570	Electroretinography
O	1571	1579	findings
O	1580	1584	were
O	1585	1591	normal
O	1592	1595	for
O	1596	1599	all
O	1600	1601	8
O	1602	1610	patients
O	1610	1611	.

O	1612	1617	Seven
O	1618	1626	patients
O	1627	1636	underwent
B-Diagnostic_tool	1637	1641	fVEP
O	1641	1642	;
O	1643	1644	6
O	1645	1649	were
O	1650	1658	abnormal
O	1659	1660	(
O	1660	1670	asymmetric
O	1670	1671	)
O	1672	1675	and
O	1676	1679	one
O	1680	1683	was
O	1684	1687	not
O	1688	1701	interpretable
O	1702	1709	because
O	1710	1712	of
O	1713	1718	study
O	1719	1727	artifact
O	1727	1728	.

O	1729	1745	Ophthalmologists
O	1746	1752	should
O	1753	1755	be
O	1756	1761	aware
O	1762	1766	that
B-Symptom	1767	1775	saccadic
I-Symptom	1776	1787	dysfunction
I-Symptom	1788	1789	(
I-Symptom	1789	1798	typically
I-Symptom	1799	1803	with
I-Symptom	1804	1808	head
I-Symptom	1809	1816	thrusts
I-Symptom	1816	1817	)
O	1818	1821	and
B-Symptom	1822	1829	primary
I-Symptom	1830	1838	position
I-Symptom	1839	1848	nystagmus
I-Symptom	1849	1850	(
I-Symptom	1850	1859	typically
I-Symptom	1860	1863	see
I-Symptom	1863	1864	-
I-Symptom	1864	1867	saw
I-Symptom	1867	1868	)
O	1869	1871	in
O	1872	1873	a
B-Characteristic	1874	1889	developmentally
I-Characteristic	1890	1897	delayed
I-Characteristic	1898	1903	child
O	1904	1911	suggest
O	1912	1915	the
O	1916	1925	diagnosis
O	1926	1928	of
B-Disease	1929	1936	Joubert
I-Disease	1937	1945	syndrome
O	1945	1946	,
O	1947	1957	especially
O	1958	1960	if
O	1961	1962	a
B-Symptom	1963	1973	dystrophic
I-Symptom	1974	1981	retinal
I-Symptom	1982	1992	appearance
O	1993	1995	is
O	1996	2000	also
O	2001	2008	present
O	2008	2009	.

O	2010	2013	Our
O	2014	2022	findings
O	2023	2025	of
B-Symptom	2026	2036	asymmetric
I-Symptom	2037	2042	fVEPs
O	2043	2046	and
B-Symptom	2047	2050	see
I-Symptom	2050	2051	-
I-Symptom	2051	2054	saw
I-Symptom	2055	2064	nystagmus
O	2065	2072	suggest
O	2073	2075	an
B-Symptom	2076	2087	abnormality
I-Symptom	2088	2090	in
I-Symptom	2091	2096	optic
I-Symptom	2097	2102	nerve
I-Symptom	2103	2114	decussation
O	2114	2115	,
O	2116	2126	consistent
O	2127	2131	with
O	2132	2135	the
O	2136	2143	concept
O	2144	2148	that
B-Symptom	2149	2157	impaired
I-Symptom	2158	2164	axonal
I-Symptom	2165	2173	guidance
O	2174	2180	occurs
O	2181	2183	in
O	2184	2192	patients
O	2193	2197	with
B-Disease	2198	2205	Joubert
I-Disease	2206	2214	syndrome
O	2214	2215	.

O	2216	2219	The
O	2220	2226	author
O	2226	2227	(
O	2227	2228	s
O	2228	2229	)
O	2230	2234	have
O	2235	2237	no
O	2238	2249	proprietary
O	2250	2252	or
O	2253	2263	commercial
O	2264	2272	interest
O	2273	2275	in
O	2276	2279	any
O	2280	2289	materials
O	2290	2299	discussed
O	2300	2302	in
O	2303	2307	this
O	2308	2315	article
O	2315	2316	.

O	0	1	A
O	2	12	systematic
O	13	24	correlation
O	25	27	of
B-Diagnostic_tool	28	39	angiography
O	40	43	and
B-Diagnostic_tool	44	48	high
I-Diagnostic_tool	48	49	-
I-Diagnostic_tool	49	59	resolution
I-Diagnostic_tool	60	67	optical
I-Diagnostic_tool	68	77	coherence
I-Diagnostic_tool	78	88	tomography
O	89	91	in
B-Disease	92	100	diabetic
I-Disease	101	108	macular
I-Disease	109	114	edema
O	114	115	.

O	117	119	To
O	120	129	correlate
O	130	137	leakage
O	138	146	patterns
O	147	149	in
B-Diagnostic_tool	150	161	fluorescein
I-Diagnostic_tool	162	173	angiography
I-Diagnostic_tool	174	175	(
I-Diagnostic_tool	175	177	FA
I-Diagnostic_tool	177	178	)
I-Diagnostic_tool	179	185	images
O	186	189	and
B-Characteristic	190	197	retinal
I-Characteristic	198	209	morphologic
I-Characteristic	210	218	features
O	219	221	in
B-Diagnostic_tool	222	226	high
I-Diagnostic_tool	226	227	-
I-Diagnostic_tool	227	237	definition
I-Diagnostic_tool	238	245	optical
I-Diagnostic_tool	246	255	coherence
I-Diagnostic_tool	256	266	tomography
I-Diagnostic_tool	267	268	(
I-Diagnostic_tool	268	270	HD
I-Diagnostic_tool	271	274	OCT
I-Diagnostic_tool	274	275	)
I-Diagnostic_tool	276	282	images
O	283	285	in
B-Disease	286	294	diabetic
I-Disease	295	302	macular
I-Disease	303	308	edema
O	308	309	.

O	310	321	Prospective
O	322	327	pilot
O	328	333	study
O	334	337	and
O	338	342	case
O	343	349	series
O	349	350	.

O	351	355	Nine
O	356	367	consecutive
O	368	376	patients
O	377	378	(
O	378	380	10
B-Anatomy	381	385	eyes
O	385	386	)
O	387	391	with
B-Disease	392	400	diabetic
I-Disease	401	408	macular
I-Disease	409	414	edema
O	414	415	.

O	416	419	All
O	420	428	patients
O	429	433	were
O	434	442	examined
O	443	448	using
B-Diagnostic_tool	449	451	FA
O	452	453	(
O	453	456	HRA
O	457	458	2
O	458	459	;
O	460	470	Heidelberg
O	471	482	Engineering
O	482	483	)
O	484	487	and
B-Diagnostic_tool	488	490	HD
I-Diagnostic_tool	491	494	OCT
O	495	496	(
O	496	500	Carl
O	501	506	Zeiss
O	507	514	Meditec
O	514	515	;
O	516	526	resolution
O	526	527	,
O	528	535	512x128
O	536	542	pixels
O	542	543	,
O	544	545	5
O	545	546	.
O	546	549	8x5
O	549	550	.
O	550	551	8
O	552	554	mm
O	554	555	,
O	556	559	and
O	560	564	high
O	564	565	-
O	565	575	resolution
O	576	581	scans
O	582	592	consisting
O	593	595	of
O	596	600	4096
O	601	602	A
O	603	608	scans
O	608	609	)
O	610	612	on
O	613	616	the
O	617	621	same
O	622	625	day
O	625	626	.

O	627	632	Using
O	633	638	Adobe
O	639	648	Photoshop
O	649	650	(
O	650	653	CS2
O	654	661	Version
O	662	663	9
O	663	664	.
O	664	665	0
O	665	666	;
O	667	672	Adobe
O	673	680	Systems
O	681	693	Incorporated
O	693	694	,
O	695	698	San
O	699	703	Jose
O	703	704	,
O	705	707	CA
O	707	708	)
O	709	710	a
O	711	715	grid
O	716	726	containing
O	727	731	15x7
O	732	738	fields
O	739	742	was
O	743	755	superimposed
O	756	758	on
O	759	762	the
B-Diagnostic_tool	763	765	HD
I-Diagnostic_tool	766	769	OCT
I-Diagnostic_tool	770	772	en
I-Diagnostic_tool	773	777	face
I-Diagnostic_tool	778	783	image
O	784	787	and
O	788	789	a
B-Diagnostic_tool	790	794	late
I-Diagnostic_tool	794	795	-
I-Diagnostic_tool	795	800	phase
I-Diagnostic_tool	801	803	FA
I-Diagnostic_tool	804	809	image
O	810	819	according
O	820	822	to
B-Characteristic	823	830	retinal
I-Characteristic	831	840	landmarks
O	840	841	.

O	842	844	In
O	845	849	each
O	850	857	patient
O	857	858	,
O	859	860	a
O	861	873	standardized
O	874	882	analysis
O	883	885	of
O	886	889	105
O	890	899	subfields
O	900	903	was
O	904	913	performed
O	914	916	to
O	917	924	provide
O	925	926	a
O	927	943	characterization
O	944	946	of
O	947	950	the
B-Characteristic	951	955	type
I-Characteristic	956	958	of
I-Characteristic	959	967	vascular
I-Characteristic	968	975	leakage
I-Characteristic	976	978	in
I-Characteristic	979	981	FA
O	982	985	and
O	986	989	the
O	990	1000	associated
B-Characteristic	1001	1008	retinal
I-Characteristic	1009	1020	morphologic
I-Characteristic	1021	1028	changes
O	1029	1031	in
O	1032	1045	corresponding
O	1046	1055	locations
O	1055	1056	.

B-Characteristic	1057	1069	Angiographic
I-Characteristic	1070	1077	leakage
I-Characteristic	1078	1082	type
O	1083	1086	and
B-Characteristic	1087	1097	structural
I-Characteristic	1098	1108	alteration
I-Characteristic	1109	1111	in
I-Characteristic	1112	1119	retinal
I-Characteristic	1120	1131	morphologic
I-Characteristic	1132	1140	features
I-Characteristic	1141	1143	in
I-Characteristic	1144	1147	OCT
O	1147	1148	.

O	1149	1154	There
O	1155	1158	was
O	1159	1160	a
O	1161	1165	high
O	1166	1177	consistency
O	1178	1185	between
B-Diagnostic_tool	1186	1188	FA
O	1189	1192	and
B-Diagnostic_tool	1193	1196	OCT
O	1197	1199	in
O	1200	1203	the
B-Characteristic	1204	1212	petaloid
I-Characteristic	1213	1220	pattern
I-Characteristic	1221	1223	of
I-Characteristic	1224	1241	hyperfluorescence
O	1242	1246	that
O	1247	1257	correlated
O	1258	1262	with
O	1263	1266	the
O	1267	1275	presence
O	1276	1278	of
B-Characteristic	1279	1284	large
I-Characteristic	1285	1291	cystic
I-Characteristic	1292	1298	spaces
I-Characteristic	1299	1301	in
I-Characteristic	1302	1305	the
I-Characteristic	1306	1311	outer
I-Characteristic	1312	1319	nuclear
I-Characteristic	1320	1325	layer
I-Characteristic	1326	1327	(
I-Characteristic	1327	1330	ONL
I-Characteristic	1330	1331	)
I-Characteristic	1332	1335	and
I-Characteristic	1336	1339	the
I-Characteristic	1340	1345	outer
I-Characteristic	1346	1355	plexiform
I-Characteristic	1356	1361	layer
I-Characteristic	1362	1363	(
I-Characteristic	1363	1366	OPL
I-Characteristic	1366	1367	)
O	1368	1372	with
O	1373	1375	or
O	1376	1383	without
B-Symptom	1384	1394	subretinal
I-Symptom	1395	1400	fluid
O	1401	1403	in
O	1404	1406	30
O	1406	1407	.
O	1407	1408	4
O	1408	1409	%
O	1410	1413	and
O	1414	1416	69
O	1416	1417	.
O	1417	1418	6
O	1418	1419	%
O	1420	1422	of
O	1423	1429	graded
O	1430	1436	fields
O	1436	1437	,
O	1438	1450	respectively
O	1450	1451	.

O	1452	1453	A
B-Characteristic	1454	1467	honeycomblike
I-Characteristic	1468	1475	pattern
I-Characteristic	1476	1478	of
I-Characteristic	1479	1496	hyperfluorescence
O	1497	1500	was
O	1501	1511	associated
O	1512	1516	with
B-Characteristic	1517	1525	swelling
I-Characteristic	1526	1529	and
I-Characteristic	1530	1536	cystic
I-Characteristic	1537	1543	spaces
I-Characteristic	1544	1546	in
I-Characteristic	1547	1550	ONL
I-Characteristic	1550	1551	,
I-Characteristic	1552	1555	OPL
I-Characteristic	1555	1556	,
I-Characteristic	1557	1560	the
I-Characteristic	1561	1566	inner
I-Characteristic	1567	1574	nuclear
I-Characteristic	1574	1575	,
I-Characteristic	1576	1579	and
I-Characteristic	1580	1583	the
I-Characteristic	1584	1589	inner
I-Characteristic	1590	1599	plexiform
I-Characteristic	1600	1605	layer
O	1606	1608	in
O	1609	1611	71
O	1611	1612	.
O	1612	1613	4
O	1613	1614	%
O	1615	1617	of
O	1618	1624	graded
O	1625	1631	fields
O	1631	1632	.

B-Characteristic	1633	1640	Diffuse
I-Characteristic	1641	1649	patterns
I-Characteristic	1650	1652	of
I-Characteristic	1653	1670	hyperfluorescence
O	1671	1674	did
O	1675	1678	not
O	1679	1688	correlate
O	1689	1693	with
B-Characteristic	1694	1708	characteristic
I-Characteristic	1709	1716	retinal
I-Characteristic	1717	1724	changes
I-Characteristic	1725	1727	in
I-Characteristic	1728	1730	HD
I-Characteristic	1731	1734	OCT
O	1734	1735	,
O	1736	1739	but
O	1740	1746	rather
O	1747	1753	showed
O	1754	1763	diversity
O	1764	1766	in
O	1767	1770	the
O	1771	1775	type
O	1776	1778	of
O	1779	1790	morphologic
O	1791	1801	alteration
O	1801	1802	.

O	1803	1806	The
O	1807	1815	presence
O	1816	1818	of
B-Symptom	1819	1826	central
I-Symptom	1827	1832	fluid
I-Symptom	1833	1840	pooling
O	1840	1841	,
O	1842	1846	such
O	1847	1849	as
B-Symptom	1850	1860	subretinal
I-Symptom	1861	1866	fluid
O	1866	1867	,
O	1868	1873	could
O	1874	1876	be
O	1877	1887	identified
O	1888	1892	only
O	1893	1895	by
B-Diagnostic_tool	1896	1898	HD
I-Diagnostic_tool	1899	1902	OCT
O	1903	1906	and
O	1907	1910	not
O	1911	1913	by
B-Diagnostic_tool	1914	1916	FA
O	1916	1917	.

O	1918	1920	In
O	1921	1924	the
O	1925	1933	examined
O	1934	1942	patients
O	1942	1943	,
O	1944	1945	a
B-Characteristic	1946	1954	petaloid
I-Characteristic	1955	1962	pattern
I-Characteristic	1963	1966	and
I-Characteristic	1967	1968	a
I-Characteristic	1969	1978	honeycomb
I-Characteristic	1979	1986	pattern
I-Characteristic	1987	1989	of
I-Characteristic	1990	2007	hyperfluorescence
I-Characteristic	2008	2016	observed
I-Characteristic	2017	2019	in
I-Characteristic	2020	2022	FA
O	2023	2027	were
O	2028	2033	found
O	2034	2036	to
O	2037	2046	correlate
O	2047	2049	to
B-Characteristic	2050	2064	characteristic
I-Characteristic	2065	2072	changes
I-Characteristic	2073	2075	in
I-Characteristic	2076	2078	HD
I-Characteristic	2079	2082	OCT
I-Characteristic	2082	2083	,
O	2084	2091	whereas
O	2092	2093	a
B-Characteristic	2094	2101	diffuse
I-Characteristic	2102	2109	leakage
I-Characteristic	2110	2117	pattern
O	2118	2121	was
O	2122	2132	associated
O	2133	2137	with
B-Characteristic	2138	2148	nonuniform
I-Characteristic	2149	2156	changes
I-Characteristic	2157	2159	in
I-Characteristic	2160	2167	retinal
I-Characteristic	2168	2179	morphologic
I-Characteristic	2180	2188	features
O	2188	2189	.

O	2190	2193	The
O	2194	2200	author
O	2200	2201	(
O	2201	2202	s
O	2202	2203	)
O	2204	2208	have
O	2209	2211	no
O	2212	2223	proprietary
O	2224	2226	or
O	2227	2237	commercial
O	2238	2246	interest
O	2247	2249	in
O	2250	2253	any
O	2254	2263	materials
O	2264	2273	discussed
O	2274	2276	in
O	2277	2281	this
O	2282	2289	article
O	2289	2290	.

O	0	5	SCORE
O	6	11	Study
O	12	18	report
O	19	20	1
O	20	21	:
O	22	30	baseline
O	31	43	associations
O	44	51	between
B-Characteristic	52	59	central
I-Characteristic	60	67	retinal
I-Characteristic	68	77	thickness
O	78	81	and
B-Characteristic	82	88	visual
I-Characteristic	89	95	acuity
O	96	98	in
O	99	107	patients
O	108	112	with
B-Disease	113	120	retinal
I-Disease	121	125	vein
I-Disease	126	135	occlusion
O	135	136	.

O	138	140	To
O	141	152	investigate
O	153	156	the
O	157	169	relationship
O	170	177	between
O	178	186	baseline
B-Characteristic	187	193	center
I-Characteristic	194	199	point
I-Characteristic	200	207	retinal
I-Characteristic	208	217	thickness
O	218	226	measured
O	227	229	by
B-Diagnostic_tool	230	237	optical
I-Diagnostic_tool	238	247	coherence
I-Diagnostic_tool	248	258	tomography
O	259	260	(
B-Diagnostic_tool	260	263	OCT
O	263	264	)
O	265	268	and
B-Characteristic	269	273	best
I-Characteristic	273	274	-
I-Characteristic	274	283	corrected
I-Characteristic	284	290	visual
I-Characteristic	291	297	acuity
O	298	300	in
B-Anatomy	301	305	eyes
O	306	310	with
B-Symptom	311	318	macular
I-Symptom	319	324	edema
O	325	335	associated
O	336	340	with
B-Disease	341	348	retinal
I-Disease	349	353	vein
I-Disease	354	363	occlusion
O	364	367	and
O	368	370	to
O	371	382	investigate
O	383	388	other
O	389	396	factors
O	397	407	associated
O	408	412	with
O	413	421	baseline
B-Characteristic	422	428	visual
I-Characteristic	429	435	acuity
I-Characteristic	436	442	letter
I-Characteristic	443	448	score
O	448	449	.

O	450	453	The
O	454	462	Standard
O	463	467	Care
O	468	474	versus
O	475	489	COrticosteroid
O	490	493	for
B-Disease	494	501	REtinal
I-Disease	502	506	Vein
I-Disease	507	516	Occlusion
O	517	518	(
O	518	523	SCORE
O	523	524	)
O	525	530	Study
O	531	539	includes
O	540	541	2
O	542	553	multicenter
O	553	554	,
O	555	565	randomized
O	566	574	clinical
O	575	581	trials
O	581	582	:
O	583	586	one
O	587	597	evaluating
O	598	610	participants
O	611	615	with
B-Disease	616	623	central
I-Disease	624	631	retinal
I-Disease	632	636	vein
I-Disease	637	646	occlusion
O	647	648	(
B-Disease	648	652	CRVO
O	652	653	)
O	654	657	and
O	658	661	the
O	662	667	other
O	668	678	evaluating
O	679	691	participants
O	692	696	with
B-Disease	697	703	branch
I-Disease	704	711	retinal
I-Disease	712	716	vein
I-Disease	717	726	occlusion
O	727	728	(
B-Disease	728	732	BRVO
O	732	733	)
O	733	734	.

O	735	740	After
O	741	749	omitting
O	750	752	17
O	753	765	participants
O	766	770	with
O	771	778	missing
O	779	781	or
O	782	792	unreliable
B-Diagnostic_tool	793	796	OCT
O	797	809	measurements
O	809	810	,
O	811	819	analyses
O	820	829	proceeded
O	830	834	with
O	835	838	665
O	839	847	enrolled
O	848	853	SCORE
O	854	859	Study
O	860	872	participants
O	873	874	(
O	874	877	665
B-Anatomy	878	882	eyes
O	882	883	)
O	883	884	,
O	885	894	including
O	895	898	262
O	899	903	with
B-Disease	904	908	CRVO
O	909	912	and
O	913	916	403
O	917	921	with
B-Disease	922	926	BRVO
O	926	927	.

O	928	930	At
O	931	939	baseline
O	939	940	,
B-Characteristic	941	947	center
I-Characteristic	948	953	point
I-Characteristic	954	963	thickness
O	964	967	was
O	968	976	measured
O	977	979	by
B-Diagnostic_tool	980	983	OCT
O	984	985	(
B-Diagnostic_tool	985	992	Stratus
I-Diagnostic_tool	993	996	OCT
I-Diagnostic_tool	997	998	3
O	999	1000	[
O	1000	1001	n
O	1001	1002	=
O	1002	1005	663
O	1005	1006	]
O	1007	1010	and
B-Diagnostic_tool	1011	1015	OCT2
O	1016	1017	[
O	1017	1018	n
O	1018	1019	=
O	1019	1020	2
O	1020	1021	]
O	1022	1023	;
O	1024	1028	Carl
O	1029	1034	Zeiss
O	1035	1043	Meditech
O	1043	1044	,
O	1045	1051	Dublin
O	1051	1052	,
O	1053	1055	CA
O	1055	1056	)
O	1056	1057	,
O	1058	1061	and
B-Characteristic	1062	1068	visual
I-Characteristic	1069	1075	acuity
O	1076	1079	was
O	1080	1088	measured
O	1089	1091	by
O	1092	1095	the
O	1096	1106	electronic
O	1107	1112	Early
O	1113	1122	Treatment
B-Disease	1123	1131	Diabetic
I-Disease	1132	1143	Retinopathy
O	1144	1149	Study
O	1150	1151	(
O	1151	1152	E
O	1152	1153	-
O	1153	1158	ETDRS
O	1158	1159	)
O	1160	1171	methodology
O	1171	1172	.

B-Characteristic	1173	1179	Center
I-Characteristic	1180	1185	point
I-Characteristic	1186	1195	thickness
O	1196	1199	and
B-Characteristic	1200	1204	best
I-Characteristic	1204	1205	-
I-Characteristic	1205	1214	corrected
I-Characteristic	1215	1216	E
I-Characteristic	1216	1217	-
I-Characteristic	1217	1222	ETDRS
I-Characteristic	1223	1229	visual
I-Characteristic	1230	1236	acuity
I-Characteristic	1237	1243	letter
I-Characteristic	1244	1249	score
O	1249	1250	.

O	1251	1254	The
O	1255	1266	correlation
O	1267	1278	coefficient
O	1279	1282	for
O	1283	1286	the
O	1287	1298	association
O	1299	1306	between
O	1307	1315	baseline
B-Diagnostic_tool	1316	1319	OCT
O	1319	1320	-
O	1320	1328	measured
B-Characteristic	1329	1335	center
I-Characteristic	1336	1341	point
I-Characteristic	1342	1351	thickness
O	1352	1355	and
B-Characteristic	1356	1360	best
I-Characteristic	1360	1361	-
I-Characteristic	1361	1370	corrected
I-Characteristic	1371	1372	E
I-Characteristic	1372	1373	-
I-Characteristic	1373	1378	ETDRS
I-Characteristic	1379	1385	visual
I-Characteristic	1386	1392	acuity
I-Characteristic	1393	1399	letter
I-Characteristic	1400	1405	score
O	1406	1408	is
O	1409	1410	-
O	1410	1411	0
O	1411	1412	.
O	1412	1414	27
O	1415	1416	(
O	1416	1418	95
O	1418	1419	%
O	1420	1430	confidence
O	1431	1436	limit
O	1436	1437	:
O	1438	1439	-
O	1439	1440	0
O	1440	1441	.
O	1441	1443	38
O	1444	1446	to
O	1447	1448	-
O	1448	1449	0
O	1449	1450	.
O	1450	1452	16
O	1452	1453	)
O	1454	1457	for
O	1458	1470	participants
O	1471	1473	in
O	1474	1477	the
B-Disease	1478	1482	CRVO
O	1483	1488	trial
O	1489	1492	and
O	1493	1494	-
O	1494	1495	0
O	1495	1496	.
O	1496	1498	28
O	1499	1500	(
O	1500	1502	95
O	1502	1503	%
O	1504	1514	confidence
O	1515	1520	limit
O	1520	1521	:
O	1522	1523	-
O	1523	1524	0
O	1524	1525	.
O	1525	1527	37
O	1528	1530	to
O	1531	1532	-
O	1532	1533	0
O	1533	1534	.
O	1534	1536	19
O	1536	1537	)
O	1538	1540	in
O	1541	1544	the
B-Disease	1545	1549	BRVO
O	1550	1555	trial
O	1555	1556	.

O	1557	1567	Regression
O	1568	1576	modeling
O	1577	1586	estimated
O	1587	1590	the
O	1591	1600	following
O	1601	1609	decrease
O	1610	1612	in
O	1613	1621	baseline
B-Characteristic	1622	1628	visual
I-Characteristic	1629	1635	acuity
I-Characteristic	1636	1642	letter
I-Characteristic	1643	1648	score
O	1649	1652	for
O	1653	1658	every
O	1659	1662	100
O	1662	1663	-
O	1663	1669	microm
O	1670	1678	increase
O	1679	1681	in
B-Characteristic	1682	1685	OCT
I-Characteristic	1685	1686	-
I-Characteristic	1686	1694	measured
I-Characteristic	1695	1701	center
I-Characteristic	1702	1707	point
I-Characteristic	1708	1717	thickness
O	1717	1718	:
O	1719	1720	1
O	1720	1721	.
O	1721	1722	7
O	1723	1730	letters
O	1731	1732	(
O	1732	1733	P
O	1733	1734	=
O	1734	1735	0
O	1735	1736	.
O	1736	1740	0007
O	1740	1741	)
O	1742	1745	for
B-Disease	1746	1750	CRVO
O	1751	1754	and
O	1755	1756	1
O	1756	1757	.
O	1757	1758	9
O	1759	1766	letters
O	1767	1768	(
O	1768	1769	P
O	1770	1771	<
O	1772	1773	0
O	1773	1774	.
O	1774	1778	0001
O	1778	1779	)
O	1780	1783	for
B-Disease	1784	1788	BRVO
O	1788	1789	.

O	1790	1792	On
O	1793	1796	the
O	1797	1802	basis
O	1803	1805	of
O	1806	1818	multivariate
O	1819	1829	regression
O	1830	1836	models
O	1836	1837	,
O	1838	1846	baseline
O	1847	1854	factors
O	1855	1868	significantly
O	1869	1879	associated
O	1880	1881	(
O	1881	1882	P
O	1883	1884	<
O	1885	1886	0
O	1886	1887	.
O	1887	1889	05
O	1889	1890	,
O	1891	1896	after
O	1897	1906	adjusting
O	1907	1910	for
O	1911	1919	multiple
O	1920	1927	testing
O	1927	1928	)
O	1929	1933	with
O	1934	1942	baseline
B-Characteristic	1943	1949	visual
I-Characteristic	1950	1956	acuity
I-Characteristic	1957	1963	letter
I-Characteristic	1964	1969	score
O	1970	1977	include
B-Characteristic	1978	1981	age
O	1982	1985	and
B-Characteristic	1986	1994	duration
I-Characteristic	1995	1997	of
I-Characteristic	1998	2005	macular
I-Characteristic	2006	2011	edema
O	2012	2015	for
B-Disease	2016	2020	CRVO
O	2021	2033	participants
O	2034	2037	and
B-Characteristic	2038	2044	center
I-Characteristic	2045	2050	point
I-Characteristic	2051	2060	thickness
O	2061	2064	and
O	2065	2073	presence
O	2074	2076	of
B-Symptom	2077	2084	cystoid
I-Symptom	2085	2091	spaces
O	2092	2095	for
B-Disease	2096	2100	BRVO
O	2101	2113	participants
O	2113	2114	.

O	2115	2118	The
O	2119	2130	correlation
O	2131	2138	between
B-Characteristic	2139	2142	OCT
I-Characteristic	2142	2143	-
I-Characteristic	2143	2151	measured
I-Characteristic	2152	2158	center
I-Characteristic	2159	2164	point
I-Characteristic	2165	2174	thickness
O	2175	2178	and
B-Characteristic	2179	2185	visual
I-Characteristic	2186	2192	acuity
I-Characteristic	2193	2199	letter
I-Characteristic	2200	2205	score
O	2206	2208	is
O	2209	2215	modest
O	2215	2216	.

B-Characteristic	2217	2220	OCT
I-Characteristic	2220	2221	-
I-Characteristic	2221	2229	measured
I-Characteristic	2230	2236	center
I-Characteristic	2237	2242	point
I-Characteristic	2243	2252	thickness
O	2253	2263	represents
O	2264	2265	a
O	2266	2272	useful
O	2273	2277	tool
O	2278	2281	for
O	2282	2285	the
O	2286	2295	detection
O	2296	2299	and
O	2300	2310	monitoring
O	2311	2313	of
B-Symptom	2314	2321	macular
I-Symptom	2322	2327	edema
O	2328	2330	in
B-Disease	2331	2338	retinal
I-Disease	2339	2343	vein
I-Disease	2344	2353	occlusion
O	2353	2354	,
O	2355	2358	but
O	2359	2361	it
O	2362	2368	cannot
O	2369	2377	reliably
O	2378	2388	substitute
O	2389	2392	for
B-Characteristic	2393	2399	visual
I-Characteristic	2400	2406	acuity
O	2407	2419	measurements
O	2419	2420	.

O	0	10	Comparison
O	11	13	of
B-Diagnostic_tool	14	22	spectral
I-Diagnostic_tool	22	23	-
I-Diagnostic_tool	23	29	domain
I-Diagnostic_tool	30	36	versus
I-Diagnostic_tool	37	41	time
I-Diagnostic_tool	41	42	-
I-Diagnostic_tool	42	48	domain
I-Diagnostic_tool	49	56	optical
I-Diagnostic_tool	57	66	coherence
I-Diagnostic_tool	67	77	tomography
O	78	80	in
O	81	91	management
O	92	94	of
B-Disease	95	98	age
I-Disease	98	99	-
I-Disease	99	106	related
I-Disease	107	114	macular
I-Disease	115	127	degeneration
O	128	132	with
O	133	144	ranibizumab
O	144	145	.

O	147	149	To
O	150	157	compare
O	158	161	the
O	162	169	ability
O	170	172	to
O	173	182	delineate
O	183	186	and
O	187	193	detect
O	194	202	patterns
O	203	205	of
B-Symptom	206	215	choroidal
I-Symptom	216	234	neovascularization
O	235	236	(
B-Symptom	236	239	CNV
O	239	240	)
O	241	249	activity
O	250	252	in
O	253	261	patients
O	262	266	with
B-Disease	267	276	exudative
I-Disease	277	280	age
I-Disease	280	281	-
I-Disease	281	288	related
I-Disease	289	296	macular
I-Disease	297	309	degeneration
O	310	311	(
B-Disease	311	314	AMD
O	314	315	)
O	316	321	after
O	322	333	ranibizumab
O	334	343	treatment
O	344	351	between
B-Diagnostic_tool	352	356	time
I-Diagnostic_tool	356	357	-
I-Diagnostic_tool	357	363	domain
I-Diagnostic_tool	364	371	optical
I-Diagnostic_tool	372	381	coherence
I-Diagnostic_tool	382	392	tomography
O	393	394	(
B-Diagnostic_tool	394	396	TD
I-Diagnostic_tool	396	397	-
I-Diagnostic_tool	397	400	OCT
O	400	401	)
O	402	405	and
O	406	407	4
O	408	417	different
B-Diagnostic_tool	418	426	spectral
I-Diagnostic_tool	426	427	-
I-Diagnostic_tool	427	433	domain
I-Diagnostic_tool	434	441	optical
I-Diagnostic_tool	442	451	coherence
I-Diagnostic_tool	452	462	tomography
O	463	464	(
B-Diagnostic_tool	464	466	SD
I-Diagnostic_tool	466	467	-
I-Diagnostic_tool	467	470	OCT
O	470	471	)
O	472	479	devices
O	479	480	.

O	481	492	Prospective
O	492	493	,
O	494	505	consecutive
O	506	510	case
O	511	517	series
O	517	518	.

O	519	524	Sixty
O	524	525	-
O	525	528	one
B-Anatomy	529	533	eyes
O	534	536	of
O	537	539	58
O	540	548	patients
O	549	553	with
B-Disease	554	563	exudative
I-Disease	564	567	AMD
O	568	573	after
O	574	585	ranibizumab
O	586	595	treatment
O	596	600	were
O	601	609	included
O	610	612	in
O	613	617	this
O	618	623	study
O	623	624	.

O	625	628	All
O	629	637	patients
O	638	642	were
O	643	649	imaged
O	650	654	with
B-Diagnostic_tool	655	657	TD
I-Diagnostic_tool	657	658	-
I-Diagnostic_tool	658	661	OCT
O	662	665	and
O	666	668	at
O	669	674	least
O	675	676	1
O	677	679	of
O	680	681	4
O	682	691	different
B-Diagnostic_tool	692	694	SD
I-Diagnostic_tool	694	695	-
I-Diagnostic_tool	695	698	OCT
O	699	706	devices
O	707	709	at
O	710	713	the
O	714	718	same
O	719	724	visit
O	725	730	after
O	731	742	ranibizumab
O	743	752	treatment
O	752	753	.

O	754	757	The
B-Diagnostic_tool	758	761	OCT
I-Diagnostic_tool	762	768	images
O	769	773	were
O	774	782	analyzed
O	783	785	in
O	786	787	a
O	788	794	masked
O	795	802	fashion
O	803	805	by
O	806	807	2
O	808	819	independent
O	820	827	graders
O	828	829	(
O	829	831	KS
O	831	832	,
O	833	835	TY
O	835	836	)
O	837	839	to
O	840	849	delineate
O	850	853	and
O	854	860	detect
O	861	864	the
O	865	873	presence
O	874	876	of
B-Symptom	877	880	CNV
O	881	889	activity
O	890	897	defined
O	898	900	as
O	901	904	the
O	905	913	presence
O	914	916	of
B-Symptom	917	927	subretinal
I-Symptom	928	933	fluid
O	933	934	,
B-Symptom	935	947	intraretinal
I-Symptom	948	953	cysts
O	953	954	,
B-Symptom	955	967	intraretinal
I-Symptom	968	973	fluid
O	973	974	,
B-Symptom	975	978	sub
I-Symptom	978	979	-
I-Symptom	979	986	retinal
I-Symptom	987	994	pigment
I-Symptom	995	1005	epithelium
I-Symptom	1006	1007	(
I-Symptom	1007	1010	sub
I-Symptom	1010	1011	-
I-Symptom	1011	1014	RPE
I-Symptom	1014	1015	)
I-Symptom	1016	1021	fluid
O	1021	1022	,
O	1023	1025	or
O	1026	1027	a
O	1028	1039	combination
O	1040	1047	thereof
O	1047	1048	.

O	1049	1052	The
O	1053	1062	automated
O	1063	1073	evaluation
O	1074	1076	of
B-Characteristic	1077	1084	retinal
I-Characteristic	1085	1094	thickness
O	1095	1099	also
O	1100	1103	was
O	1104	1112	analyzed
O	1113	1120	between
O	1121	1128	devices
O	1128	1129	.

O	1130	1138	Evidence
O	1139	1141	of
B-Symptom	1142	1145	CNV
O	1146	1154	activity
O	1155	1157	on
O	1158	1164	linear
O	1165	1166	B
O	1166	1167	-
O	1167	1172	scans
O	1173	1176	and
O	1177	1178	3
O	1178	1179	-
O	1179	1190	dimensional
O	1191	1193	so
O	1193	1194	-
O	1194	1200	called
O	1201	1205	cube
O	1206	1211	scans
O	1212	1214	on
B-Diagnostic_tool	1215	1217	SD
I-Diagnostic_tool	1217	1218	-
I-Diagnostic_tool	1218	1221	OCT
O	1222	1225	and
O	1226	1232	linear
O	1233	1234	B
O	1234	1235	-
O	1235	1239	scan
O	1240	1242	on
B-Diagnostic_tool	1243	1245	TD
I-Diagnostic_tool	1245	1246	-
I-Diagnostic_tool	1246	1249	OCT
O	1249	1250	.

O	1251	1253	In
O	1254	1260	linear
O	1261	1262	B
O	1262	1263	-
O	1263	1267	scan
O	1268	1272	mode
O	1272	1273	,
O	1274	1277	all
O	1278	1279	4
B-Diagnostic_tool	1280	1282	SD
I-Diagnostic_tool	1282	1283	-
I-Diagnostic_tool	1283	1286	OCT
O	1287	1294	devices
O	1295	1299	were
O	1300	1308	superior
O	1309	1311	in
O	1312	1317	their
O	1318	1325	ability
O	1326	1328	to
O	1329	1338	delineate
B-Symptom	1339	1342	sub
I-Symptom	1342	1343	-
I-Symptom	1343	1346	RPE
I-Symptom	1347	1352	fluid
O	1353	1361	compared
O	1362	1366	with
B-Diagnostic_tool	1367	1369	TD
I-Diagnostic_tool	1369	1370	-
I-Diagnostic_tool	1370	1373	OCT
O	1374	1375	(
O	1375	1376	P
O	1377	1378	<
O	1379	1380	0
O	1380	1381	.
O	1381	1383	05
O	1383	1384	)
O	1384	1385	.

O	1386	1391	Three
O	1392	1394	of
O	1395	1396	4
B-Diagnostic_tool	1397	1399	SD
I-Diagnostic_tool	1399	1400	-
I-Diagnostic_tool	1400	1403	OCT
O	1404	1411	devices
O	1412	1416	were
O	1417	1425	superior
O	1426	1428	in
O	1429	1440	delineating
B-Symptom	1441	1453	intraretinal
I-Symptom	1454	1459	fluid
O	1459	1460	,
O	1461	1464	and
O	1465	1466	2
O	1467	1469	of
O	1470	1471	4
B-Diagnostic_tool	1472	1474	SD
I-Diagnostic_tool	1474	1475	-
I-Diagnostic_tool	1475	1478	OCT
O	1479	1486	devices
O	1487	1491	were
O	1492	1500	superior
O	1501	1503	in
O	1504	1515	delineating
B-Symptom	1516	1526	subretinal
I-Symptom	1527	1532	fluid
O	1533	1536	and
B-Symptom	1537	1549	intraretinal
I-Symptom	1550	1555	cysts
O	1556	1557	(
O	1557	1558	P
O	1559	1560	<
O	1561	1562	0
O	1562	1563	.
O	1563	1565	05
O	1565	1566	)
O	1566	1567	.

O	1568	1570	In
O	1571	1574	the
O	1575	1576	3
O	1576	1577	-
O	1577	1588	dimensional
O	1589	1591	so
O	1591	1592	-
O	1592	1598	called
O	1599	1603	cube
O	1604	1608	mode
O	1608	1609	,
O	1610	1613	all
O	1614	1615	4
B-Diagnostic_tool	1616	1618	SD
I-Diagnostic_tool	1618	1619	-
I-Diagnostic_tool	1619	1622	OCT
O	1623	1630	devices
O	1631	1635	were
O	1636	1644	superior
O	1645	1647	in
O	1648	1657	detecting
B-Symptom	1658	1668	subretinal
I-Symptom	1669	1674	fluid
O	1675	1678	and
O	1679	1680	2
O	1681	1683	of
O	1684	1685	4
B-Diagnostic_tool	1686	1688	SD
I-Diagnostic_tool	1688	1689	-
I-Diagnostic_tool	1689	1692	OCT
O	1693	1700	devices
O	1701	1705	were
O	1706	1714	superior
O	1715	1717	in
O	1718	1727	detecting
B-Symptom	1728	1731	sub
I-Symptom	1731	1732	-
I-Symptom	1732	1735	RPE
I-Symptom	1736	1739	and
I-Symptom	1740	1752	intraretinal
I-Symptom	1753	1758	fluid
O	1759	1760	(
O	1760	1761	P
O	1762	1763	<
O	1764	1765	0
O	1765	1766	.
O	1766	1768	05
O	1768	1769	)
O	1769	1770	.

O	1771	1776	There
O	1777	1781	were
O	1782	1793	significant
O	1794	1806	correlations
O	1807	1809	in
B-Characteristic	1810	1816	center
I-Characteristic	1817	1822	point
I-Characteristic	1823	1832	thickness
O	1833	1840	between
O	1841	1844	all
B-Diagnostic_tool	1845	1847	SD
I-Diagnostic_tool	1847	1848	-
I-Diagnostic_tool	1848	1851	OCT
O	1852	1859	devices
O	1860	1863	and
B-Diagnostic_tool	1864	1866	TD
I-Diagnostic_tool	1866	1867	-
I-Diagnostic_tool	1867	1870	OCT
O	1871	1872	(
O	1872	1873	P
O	1874	1875	<
O	1876	1877	0
O	1877	1878	.
O	1878	1880	01
O	1880	1881	)
O	1881	1882	,
O	1883	1886	and
O	1887	1888	3
O	1889	1891	of
O	1892	1893	4
O	1894	1897	and
O	1898	1899	1
O	1900	1902	of
O	1903	1904	3
B-Diagnostic_tool	1905	1907	SD
I-Diagnostic_tool	1907	1908	-
I-Diagnostic_tool	1908	1911	OCT
O	1912	1919	devices
O	1920	1926	showed
O	1927	1938	significant
O	1939	1950	differences
O	1951	1955	from
B-Diagnostic_tool	1956	1958	TD
I-Diagnostic_tool	1958	1959	-
I-Diagnostic_tool	1959	1962	OCT
O	1963	1965	in
B-Characteristic	1966	1972	center
I-Characteristic	1973	1978	point
I-Characteristic	1979	1988	thickness
O	1989	1990	(
O	1990	1991	P
O	1992	1993	<
O	1994	1995	0
O	1995	1996	.
O	1996	1998	01
O	1998	1999	)
O	2000	2003	and
B-Characteristic	2004	2010	center
I-Characteristic	2011	2019	subfield
I-Characteristic	2020	2029	thickness
O	2030	2031	(
O	2031	2032	P
O	2033	2034	<
O	2035	2036	0
O	2036	2037	.
O	2037	2040	001
O	2040	2041	)
O	2041	2042	,
O	2043	2055	respectively
O	2055	2056	.

B-Diagnostic_tool	2057	2059	SD
I-Diagnostic_tool	2059	2060	-
I-Diagnostic_tool	2060	2063	OCT
O	2064	2066	is
O	2067	2075	superior
O	2076	2078	to
B-Diagnostic_tool	2079	2081	TD
I-Diagnostic_tool	2081	2082	-
I-Diagnostic_tool	2082	2085	OCT
O	2086	2088	in
O	2089	2099	evaluating
O	2100	2103	for
B-Symptom	2104	2107	CNV
O	2108	2116	activity
O	2117	2119	in
O	2120	2128	patients
O	2129	2133	with
B-Disease	2134	2137	wet
I-Disease	2138	2141	AMD
O	2142	2147	after
O	2148	2159	ranibizumab
O	2160	2169	injection
O	2169	2170	.

B-Characteristic	2171	2178	Retinal
I-Characteristic	2179	2188	thickness
O	2189	2201	measurements
O	2202	2209	between
B-Diagnostic_tool	2210	2212	SD
I-Diagnostic_tool	2212	2213	-
I-Diagnostic_tool	2213	2216	OCT
O	2217	2220	and
B-Diagnostic_tool	2221	2223	TD
I-Diagnostic_tool	2223	2224	-
I-Diagnostic_tool	2224	2227	OCT
O	2228	2232	also
O	2233	2237	were
O	2238	2251	significantly
O	2252	2261	different
O	2261	2262	.

O	2263	2274	Proprietary
O	2275	2277	or
O	2278	2288	commercial
O	2289	2299	disclosure
O	2300	2303	may
O	2304	2306	be
O	2307	2312	found
O	2313	2318	after
O	2319	2322	the
O	2323	2333	references
O	2333	2334	.

O	0	6	Sector
O	6	7	-
O	7	12	based
O	13	21	analysis
O	22	26	with
O	27	30	the
B-Diagnostic_tool	31	41	Heidelberg
I-Diagnostic_tool	42	49	Retinal
I-Diagnostic_tool	50	59	Tomograph
I-Diagnostic_tool	60	61	3
O	62	68	across
O	69	73	disc
O	74	79	sizes
O	80	83	and
B-Disease	84	92	glaucoma
O	93	99	stages
O	99	100	:
O	101	102	a
O	103	114	multicenter
O	115	120	study
O	120	121	.

O	123	125	To
O	126	137	investigate
O	138	141	the
O	142	149	ability
O	150	152	of
O	153	162	sectorial
O	163	171	analysis
O	172	177	using
O	178	181	the
B-Diagnostic_tool	182	192	Heidelberg
I-Diagnostic_tool	193	200	Retinal
I-Diagnostic_tool	201	210	Tomograph
I-Diagnostic_tool	211	212	3
O	213	214	(
B-Diagnostic_tool	214	218	HRT3
O	218	219	)
O	220	222	to
O	223	235	discriminate
O	236	243	between
O	244	251	healthy
O	252	255	and
B-Disease	256	268	glaucomatous
B-Anatomy	269	273	eyes
O	274	277	and
O	278	280	to
O	281	290	determine
O	291	298	whether
O	299	303	this
O	304	306	is
O	307	315	affected
O	316	318	by
B-Characteristic	319	323	disc
I-Characteristic	324	328	size
O	329	332	and
B-Disease	333	341	glaucoma
O	342	350	severity
O	350	351	.

O	352	363	Multicenter
O	363	364	,
O	365	370	cross
O	370	371	-
O	371	380	sectional
O	381	391	evaluation
O	392	394	of
O	395	405	diagnostic
O	406	411	tests
O	411	412	.

O	413	416	Two
O	417	424	hundred
O	425	431	thirty
O	431	432	-
O	432	437	three
B-Anatomy	438	442	eyes
O	443	447	from
O	448	451	137
B-Characteristic	452	458	normal
I-Characteristic	459	467	subjects
O	468	471	and
O	472	474	96
B-Disease	475	483	glaucoma
O	484	492	patients
O	493	503	classified
O	504	506	by
O	507	510	the
O	511	519	presence
O	520	522	of
O	523	524	a
B-Symptom	525	535	repeatable
I-Symptom	536	542	visual
I-Symptom	543	548	field
I-Symptom	549	555	defect
O	555	556	.

O	557	569	Participants
O	570	579	underwent
O	580	587	imaging
O	588	592	with
O	593	596	the
B-Diagnostic_tool	597	601	HRT3
O	601	602	,
O	603	606	and
O	607	610	the
O	611	621	diagnostic
O	622	630	accuracy
O	631	633	of
B-Characteristic	634	646	stereometric
I-Characteristic	647	657	parameters
O	657	658	,
B-Characteristic	659	669	Moorfields
I-Characteristic	670	680	regression
I-Characteristic	681	689	analysis
O	690	691	(
B-Characteristic	691	694	MRA
O	694	695	)
O	695	696	,
O	697	700	and
B-Characteristic	701	709	glaucoma
I-Characteristic	710	721	probability
I-Characteristic	722	727	score
O	728	729	(
B-Characteristic	729	732	GPS
O	732	733	)
O	734	738	were
O	739	747	analyzed
O	748	759	sectorially
O	760	762	by
B-Disease	763	771	glaucoma
O	772	777	stage
O	778	781	and
B-Characteristic	782	787	optic
I-Characteristic	788	792	disc
I-Characteristic	793	797	size
O	797	798	.

O	799	810	Sensitivity
O	810	811	,
O	812	823	specificity
O	823	824	,
O	825	833	positive
O	834	837	and
O	838	846	negative
O	847	857	predictive
O	858	864	values
O	864	865	,
O	866	869	and
O	870	873	the
O	874	878	area
O	879	884	under
O	885	888	the
O	889	897	receiver
O	898	907	operating
O	908	923	characteristics
O	924	929	curve
O	930	931	(
O	931	934	AUC
O	934	935	)
O	935	936	.

O	937	939	Of
B-Characteristic	940	952	stereometric
I-Characteristic	953	963	parameters
O	963	964	,
O	965	968	the
B-Characteristic	969	972	cup
I-Characteristic	972	973	-
I-Characteristic	973	975	to
I-Characteristic	975	976	-
I-Characteristic	976	980	disc
I-Characteristic	981	985	area
I-Characteristic	986	991	ratio
I-Characteristic	992	994	of
I-Characteristic	995	998	the
I-Characteristic	999	1013	inferotemporal
I-Characteristic	1014	1020	sector
O	1021	1024	had
O	1025	1028	the
O	1029	1036	largest
O	1037	1040	AUC
O	1041	1042	(
O	1042	1045	AUC
O	1045	1046	,
O	1047	1048	0
O	1048	1049	.
O	1049	1051	74
O	1051	1052	)
O	1052	1053	.

O	1054	1058	Both
B-Characteristic	1059	1062	MRA
O	1063	1066	and
B-Characteristic	1067	1070	GPS
O	1071	1081	algorithms
O	1082	1088	showed
O	1089	1092	the
O	1093	1097	best
O	1098	1108	diagnostic
O	1109	1117	accuracy
O	1118	1120	in
O	1121	1124	the
B-Anatomy	1125	1139	inferotemporal
I-Anatomy	1140	1146	sector
O	1146	1147	,
O	1148	1152	with
O	1153	1154	a
O	1155	1166	sensitivity
O	1167	1170	and
O	1171	1182	specificity
O	1183	1185	of
O	1186	1188	63
O	1188	1189	%
O	1190	1193	and
O	1194	1196	88
O	1196	1197	%
O	1198	1201	for
B-Characteristic	1202	1205	MRA
O	1206	1209	and
O	1210	1212	80
O	1212	1213	%
O	1214	1217	and
O	1218	1220	62
O	1220	1221	%
O	1222	1225	for
B-Characteristic	1226	1229	GPS
O	1229	1230	,
O	1231	1243	respectively
O	1243	1244	.

O	1245	1247	In
O	1248	1253	small
O	1254	1259	discs
O	1259	1260	,
B-Diagnostic_tool	1261	1270	sectorial
I-Diagnostic_tool	1271	1274	MRA
I-Diagnostic_tool	1275	1283	analysis
O	1284	1287	had
O	1288	1294	higher
O	1295	1305	diagnostic
O	1306	1314	accuracy
O	1315	1319	than
O	1320	1323	the
B-Diagnostic_tool	1324	1330	global
I-Diagnostic_tool	1331	1336	optic
I-Diagnostic_tool	1337	1342	nerve
I-Diagnostic_tool	1343	1347	head
I-Diagnostic_tool	1348	1349	(
I-Diagnostic_tool	1349	1352	ONH
I-Diagnostic_tool	1352	1353	)
I-Diagnostic_tool	1354	1362	analysis
O	1363	1364	(
O	1364	1375	sensitivity
O	1376	1378	of
O	1379	1381	70
O	1381	1382	%
O	1383	1386	and
O	1387	1398	specificity
O	1399	1401	of
O	1402	1404	82
O	1404	1405	%
O	1406	1408	in
O	1409	1412	the
B-Anatomy	1413	1424	inferonasal
I-Anatomy	1425	1431	sector
O	1431	1432	)
O	1432	1433	,
O	1434	1437	and
O	1438	1443	these
O	1444	1452	findings
O	1453	1457	were
O	1458	1467	confirmed
O	1468	1470	in
O	1471	1475	very
O	1476	1481	large
O	1482	1487	discs
O	1488	1489	(
O	1489	1500	sensitivity
O	1501	1503	of
O	1504	1506	74
O	1506	1507	%
O	1508	1511	and
O	1512	1523	specificity
O	1524	1526	of
O	1527	1529	85
O	1529	1530	%
O	1531	1533	in
O	1534	1537	the
B-Anatomy	1538	1552	inferotemporal
I-Anatomy	1553	1559	sector
O	1559	1560	)
O	1560	1561	.

O	1562	1571	Similarly
O	1571	1572	,
B-Characteristic	1573	1585	stereometric
I-Characteristic	1586	1596	parameters
O	1597	1610	discriminated
O	1611	1617	better
O	1618	1629	sectorially
O	1630	1636	rather
O	1637	1641	than
O	1642	1650	globally
O	1650	1651	,
O	1652	1656	with
O	1657	1666	different
O	1667	1677	parameters
O	1678	1684	giving
O	1685	1688	the
O	1689	1693	best
O	1694	1701	results
O	1702	1704	in
O	1705	1714	different
B-Characteristic	1715	1720	optic
I-Characteristic	1721	1725	disc
I-Characteristic	1726	1730	size
O	1731	1740	subgroups
O	1740	1741	.

B-Characteristic	1742	1745	MRA
I-Characteristic	1746	1757	sensitivity
O	1758	1761	was
O	1762	1766	weak
O	1767	1769	in
O	1770	1773	the
B-Disease	1774	1779	early
I-Disease	1779	1780	-
I-Disease	1780	1788	glaucoma
O	1789	1794	stage
O	1794	1795	,
O	1796	1800	with
O	1801	1809	slightly
O	1810	1816	higher
O	1817	1824	figures
O	1825	1827	if
O	1828	1838	considered
O	1839	1850	sectorially
O	1851	1857	rather
O	1858	1862	than
O	1863	1871	globally
O	1871	1872	.

B-Characteristic	1873	1876	GPS
I-Characteristic	1877	1887	diagnostic
I-Characteristic	1888	1896	accuracy
O	1897	1900	was
O	1901	1905	very
O	1906	1916	consistent
O	1917	1923	across
B-Anatomy	1924	1927	ONH
I-Anatomy	1928	1935	sectors
O	1936	1938	in
O	1939	1943	each
B-Characteristic	1944	1948	disc
I-Characteristic	1949	1953	size
O	1954	1957	and
B-Disease	1958	1966	glaucoma
O	1967	1972	stage
O	1973	1981	subgroup
O	1981	1982	,
O	1983	1987	with
O	1988	1990	no
O	1991	1997	single
O	1998	2004	sector
O	2005	2018	demonstrating
O	2019	2025	better
O	2026	2036	diagnostic
O	2037	2045	accuracy
O	2046	2050	than
O	2051	2054	the
O	2055	2061	global
O	2062	2070	analysis
O	2070	2071	.

B-Diagnostic_tool	2072	2082	Heidelberg
I-Diagnostic_tool	2083	2090	Retinal
I-Diagnostic_tool	2091	2100	Tomograph
I-Diagnostic_tool	2101	2102	3
I-Diagnostic_tool	2103	2112	sectorial
I-Diagnostic_tool	2113	2121	analysis
O	2122	2128	showed
O	2129	2137	moderate
O	2138	2148	diagnostic
O	2149	2160	performance
O	2161	2164	and
O	2165	2168	may
O	2169	2174	offer
O	2175	2184	potential
O	2185	2195	advantages
O	2196	2200	over
O	2201	2207	global
O	2208	2216	analysis
O	2217	2219	in
O	2220	2223	the
O	2224	2232	clinical
O	2233	2243	diagnostic
O	2244	2251	process
O	2251	2252	.

B-Characteristic	2253	2258	Small
I-Characteristic	2259	2264	discs
O	2265	2268	are
O	2269	2279	classified
O	2280	2284	more
O	2285	2295	accurately
O	2296	2298	by
O	2299	2308	examining
O	2309	2312	the
B-Anatomy	2313	2324	inferonasal
I-Anatomy	2325	2331	sector
O	2331	2332	,
O	2333	2340	whereas
B-Characteristic	2341	2347	larger
I-Characteristic	2348	2353	discs
O	2354	2357	are
O	2358	2368	classified
O	2369	2373	more
O	2374	2384	accurately
O	2385	2387	by
O	2388	2397	examining
O	2398	2401	the
B-Anatomy	2402	2416	inferotemporal
I-Anatomy	2417	2423	sector
O	2423	2424	.

O	2425	2432	Neither
B-Characteristic	2433	2436	HRT
I-Characteristic	2437	2447	parameters
O	2448	2451	nor
B-Diagnostic_tool	2452	2466	classification
I-Diagnostic_tool	2467	2477	algorithms
O	2478	2482	seem
O	2483	2485	to
O	2486	2488	be
O	2489	2493	good
O	2494	2496	at
O	2497	2500	the
O	2501	2508	earlier
O	2509	2514	stage
O	2515	2517	of
O	2518	2521	the
O	2522	2529	disease
O	2529	2530	.

O	2531	2534	The
O	2535	2541	author
O	2541	2542	(
O	2542	2543	s
O	2543	2544	)
O	2545	2549	have
O	2550	2552	no
O	2553	2564	proprietary
O	2565	2567	or
O	2568	2578	commercial
O	2579	2587	interest
O	2588	2590	in
O	2591	2594	any
O	2595	2604	materials
O	2605	2614	discussed
O	2615	2617	in
O	2618	2622	this
O	2623	2630	article
O	2630	2631	.

O	0	9	Comparing
B-Characteristic	10	17	retinal
I-Characteristic	18	27	thickness
O	28	40	measurements
O	41	46	using
B-Diagnostic_tool	47	56	automated
I-Diagnostic_tool	57	61	fast
I-Diagnostic_tool	62	69	macular
I-Diagnostic_tool	70	79	thickness
I-Diagnostic_tool	80	83	map
O	84	90	versus
B-Diagnostic_tool	91	94	six
I-Diagnostic_tool	94	95	-
I-Diagnostic_tool	95	101	radial
I-Diagnostic_tool	102	106	line
I-Diagnostic_tool	107	112	scans
I-Diagnostic_tool	113	117	with
I-Diagnostic_tool	118	124	manual
I-Diagnostic_tool	125	137	measurements
O	137	138	.

O	140	142	To
O	143	150	compare
O	151	160	automated
B-Characteristic	161	168	retinal
I-Characteristic	169	178	thickness
O	179	185	values
O	186	195	generated
O	196	198	by
O	199	202	the
B-Diagnostic_tool	203	207	fast
I-Diagnostic_tool	208	215	macular
I-Diagnostic_tool	216	225	thickness
I-Diagnostic_tool	226	230	maps
O	231	232	(
B-Diagnostic_tool	232	236	FMTM
O	236	237	)
O	238	241	and
B-Diagnostic_tool	242	252	customized
I-Diagnostic_tool	253	254	6
I-Diagnostic_tool	254	255	-
I-Diagnostic_tool	255	261	radial
I-Diagnostic_tool	262	266	line
I-Diagnostic_tool	267	272	scans
O	273	274	(
B-Diagnostic_tool	274	277	RLS
O	277	278	)
O	279	285	versus
O	286	292	manual
B-Anatomy	293	300	retinal
O	301	313	measurements
O	314	316	on
B-Diagnostic_tool	317	324	Stratus
I-Diagnostic_tool	325	332	optical
I-Diagnostic_tool	333	342	coherence
I-Diagnostic_tool	343	353	tomography
O	354	355	(
B-Diagnostic_tool	355	358	OCT
O	358	359	)
O	360	361	(
O	361	365	Carl
O	366	371	Zeiss
O	372	379	Meditec
O	379	380	,
O	381	387	Dublin
O	387	388	,
O	389	391	CA
O	391	392	)
O	392	393	.

O	394	405	Prospective
O	405	406	,
O	407	420	observational
O	421	425	case
O	426	432	series
O	432	433	.

O	434	442	Patients
O	443	447	with
B-Symptom	448	457	subfoveal
I-Symptom	458	467	choroidal
I-Symptom	468	486	neovascularization
O	487	488	(
B-Symptom	488	491	CNV
O	491	492	)
O	493	499	caused
O	500	502	by
B-Disease	503	506	age
I-Disease	506	507	-
I-Disease	507	514	related
I-Disease	515	522	macular
I-Disease	523	535	degeneration
O	536	537	(
B-Disease	537	540	AMD
O	540	541	)
O	541	542	,
B-Disease	543	551	diabetic
I-Disease	552	559	macular
I-Disease	560	565	edema
O	566	567	(
B-Disease	567	570	DME
O	570	571	)
O	571	572	,
O	573	575	or
B-Disease	576	582	branch
I-Disease	582	583	/
I-Disease	583	590	central
I-Disease	591	598	retinal
I-Disease	599	603	vein
I-Disease	604	613	occlusion
O	614	615	(
B-Disease	615	618	RVO
O	618	619	)
O	619	620	.

O	621	629	Patients
O	630	634	were
O	635	648	prospectively
O	649	655	imaged
O	656	661	using
O	662	665	the
B-Diagnostic_tool	666	670	FMTM
O	671	674	and
O	675	685	customized
B-Diagnostic_tool	686	689	RLS
O	690	698	patterns
O	699	701	on
B-Diagnostic_tool	702	709	Stratus
I-Diagnostic_tool	710	713	OCT
O	714	716	at
O	717	720	the
O	721	725	same
O	726	733	sitting
O	733	734	.

O	735	739	Each
O	740	744	scan
O	745	748	was
O	749	758	evaluated
O	759	762	for
O	763	769	errors
O	770	772	in
B-Anatomy	773	780	retinal
O	781	793	segmentation
O	794	795	(
O	795	796	i
O	796	797	.
O	797	798	e
O	798	799	.
O	799	800	,
O	801	808	correct
B-Anatomy	809	816	retinal
O	817	827	boundaries
O	828	829	[
O	829	832	CRB
O	832	833	]
O	833	834	)
O	834	835	.

O	836	845	Automated
O	846	852	values
O	853	857	were
O	858	866	recorded
O	867	872	while
B-Characteristic	873	880	central
I-Characteristic	881	888	retinal
I-Characteristic	889	898	thickness
O	899	911	measurements
O	912	916	were
O	917	927	determined
O	928	936	manually
O	937	940	for
O	941	945	both
O	946	954	patterns
O	954	955	.

O	956	959	The
O	960	968	presence
O	969	971	or
O	972	979	absence
O	980	982	of
B-Symptom	983	993	epiretinal
I-Symptom	994	1004	phenomenon
O	1004	1005	,
B-Symptom	1006	1013	cystoid
I-Symptom	1014	1020	spaces
O	1020	1021	,
B-Symptom	1022	1029	pigment
I-Symptom	1030	1040	epithelial
I-Symptom	1041	1051	detachment
O	1051	1052	,
O	1053	1056	and
B-Symptom	1057	1067	subretinal
I-Symptom	1068	1073	fluid
O	1074	1077	was
O	1078	1082	also
O	1083	1088	noted
O	1088	1089	.

O	1090	1096	Errors
O	1097	1099	in
O	1100	1107	retinal
O	1108	1120	segmentation
O	1121	1123	at
O	1124	1127	and
O	1128	1135	outside
O	1136	1139	the
B-Anatomy	1140	1145	fovea
O	1146	1147	(
O	1147	1148	i
O	1148	1149	.
O	1149	1150	e
O	1150	1151	.
O	1151	1152	,
O	1153	1156	CRB
O	1156	1157	)
O	1158	1161	and
O	1162	1172	percentage
O	1173	1175	of
O	1176	1185	automated
O	1186	1192	values
O	1193	1199	within
O	1200	1201	a
O	1202	1212	clinically
O	1213	1223	acceptable
O	1224	1230	margin
O	1231	1232	(
O	1232	1233	+
O	1233	1234	/
O	1234	1235	-
O	1235	1237	25
O	1238	1241	mum
O	1241	1242	)
O	1243	1245	of
O	1246	1249	the
O	1250	1256	manual
B-Characteristic	1257	1264	central
I-Characteristic	1265	1272	retinal
I-Characteristic	1273	1282	thickness
O	1282	1283	.

O	1284	1285	A
O	1286	1291	total
O	1292	1294	of
O	1295	1298	147
B-Anatomy	1299	1303	eyes
O	1304	1306	of
O	1307	1310	147
O	1311	1319	patients
O	1320	1321	(
O	1321	1323	95
B-Anatomy	1324	1328	eyes
O	1329	1333	with
B-Disease	1334	1343	exudative
I-Disease	1344	1347	AMD
O	1347	1348	,
O	1349	1351	41
B-Anatomy	1352	1356	eyes
O	1357	1361	with
B-Disease	1362	1365	DME
O	1365	1366	,
O	1367	1370	and
O	1371	1373	11
B-Anatomy	1374	1378	eyes
O	1379	1383	with
B-Disease	1384	1391	macular
I-Disease	1392	1397	edema
O	1398	1404	caused
O	1405	1407	by
B-Disease	1408	1411	RVO
O	1411	1412	)
O	1413	1417	were
O	1418	1426	included
O	1426	1427	.

O	1428	1431	For
B-Disease	1432	1435	wet
I-Disease	1436	1439	AMD
O	1439	1440	,
O	1441	1444	the
O	1445	1450	total
O	1451	1457	number
O	1458	1460	of
O	1461	1464	CRB
O	1465	1467	at
O	1468	1471	the
B-Anatomy	1472	1477	fovea
O	1478	1481	and
B-Anatomy	1482	1489	outside
I-Anatomy	1490	1493	the
I-Anatomy	1494	1499	fovea
O	1500	1503	was
O	1504	1507	363
O	1508	1509	(
O	1509	1511	63
O	1511	1512	.
O	1512	1513	7
O	1513	1514	%
O	1514	1515	)
O	1516	1519	and
O	1520	1523	360
O	1524	1525	(
O	1525	1527	63
O	1527	1528	.
O	1528	1529	2
O	1529	1530	%
O	1530	1531	)
O	1531	1532	,
O	1533	1545	respectively
O	1545	1546	,
O	1547	1549	in
B-Diagnostic_tool	1550	1554	FMTM
O	1555	1558	and
O	1559	1562	428
O	1563	1564	(
O	1564	1566	75
O	1566	1567	.
O	1567	1568	1
O	1568	1569	%
O	1569	1570	)
O	1571	1574	and
O	1575	1578	426
O	1579	1580	(
O	1580	1582	74
O	1582	1583	.
O	1583	1584	7
O	1584	1585	%
O	1585	1586	)
O	1586	1587	,
O	1588	1600	respectively
O	1600	1601	,
O	1602	1604	in
B-Diagnostic_tool	1605	1608	RLS
O	1609	1610	(
O	1610	1611	P
O	1612	1613	<
O	1614	1615	0
O	1615	1616	.
O	1616	1620	0001
O	1621	1624	for
O	1625	1629	both
O	1629	1630	)
O	1630	1631	.

O	1632	1635	For
B-Disease	1636	1639	DME
O	1640	1643	and
B-Disease	1644	1647	RVO
O	1647	1648	,
O	1649	1652	the
O	1653	1658	total
O	1659	1665	number
O	1666	1668	of
O	1669	1672	CRB
O	1673	1675	at
O	1676	1679	the
B-Anatomy	1680	1685	fovea
O	1686	1689	and
B-Anatomy	1690	1697	outside
I-Anatomy	1698	1701	the
I-Anatomy	1702	1707	fovea
O	1708	1711	was
O	1712	1715	274
O	1716	1717	(
O	1717	1719	87
O	1719	1720	.
O	1720	1721	8
O	1721	1722	%
O	1722	1723	)
O	1724	1727	and
O	1728	1731	256
O	1732	1733	(
O	1733	1735	82
O	1735	1736	.
O	1736	1737	1
O	1737	1738	%
O	1738	1739	)
O	1739	1740	,
O	1741	1753	respectively
O	1753	1754	,
O	1755	1757	in
B-Diagnostic_tool	1758	1762	FMTM
O	1763	1766	and
O	1767	1770	287
O	1771	1772	(
O	1772	1774	92
O	1774	1775	.
O	1775	1776	0
O	1776	1777	%
O	1777	1778	)
O	1779	1782	and
O	1783	1786	270
O	1787	1788	(
O	1788	1790	86
O	1790	1791	.
O	1791	1792	5
O	1792	1793	%
O	1793	1794	)
O	1794	1795	,
O	1796	1808	respectively
O	1808	1809	,
O	1810	1812	in
B-Diagnostic_tool	1813	1816	RLS
O	1817	1818	(
O	1818	1819	P
O	1820	1821	=
O	1822	1823	0
O	1823	1824	.
O	1824	1826	11
O	1826	1827	,
O	1828	1829	P
O	1830	1831	=
O	1832	1833	0
O	1833	1834	.
O	1834	1836	15
O	1836	1837	,
O	1838	1850	respectively
O	1850	1851	)
O	1851	1852	.

O	1853	1857	Some
O	1858	1860	40
O	1860	1861	%
O	1862	1865	and
O	1866	1868	56
O	1868	1869	%
O	1870	1872	of
O	1873	1882	automated
B-Characteristic	1883	1889	foveal
I-Characteristic	1890	1896	center
I-Characteristic	1897	1902	point
I-Characteristic	1903	1914	thicknesses
O	1915	1917	on
B-Diagnostic_tool	1918	1922	FMTM
O	1923	1926	and
B-Diagnostic_tool	1927	1930	RLS
O	1930	1931	,
O	1932	1944	respectively
O	1944	1945	,
O	1946	1950	were
O	1951	1957	within
B-Dimension	1958	1959	+
I-Dimension	1959	1960	/
I-Dimension	1960	1961	-
I-Dimension	1961	1963	25
I-Dimension	1964	1967	mum
O	1968	1970	of
O	1971	1974	the
O	1975	1981	manual
B-Characteristic	1982	1989	central
I-Characteristic	1990	1997	retinal
I-Characteristic	1998	2007	thickness
O	2008	2011	for
B-Disease	2012	2015	AMD
O	2016	2017	(
O	2017	2018	P
O	2019	2020	=
O	2021	2022	0
O	2022	2023	.
O	2023	2026	042
O	2026	2027	)
O	2027	2028	,
O	2029	2035	versus
O	2036	2038	94
O	2038	2039	%
O	2040	2043	and
O	2044	2046	81
O	2046	2047	%
O	2048	2051	for
B-Disease	2052	2055	DME
O	2056	2059	and
B-Disease	2060	2063	RVO
O	2063	2064	,
O	2065	2077	respectively
O	2078	2079	(
O	2079	2080	P
O	2081	2082	=
O	2083	2084	0
O	2084	2085	.
O	2085	2087	07
O	2087	2088	)
O	2088	2089	.

O	2090	2093	For
B-Disease	2094	2103	exudative
I-Disease	2104	2107	AMD
O	2107	2108	,
O	2109	2112	the
B-Diagnostic_tool	2113	2116	RLS
O	2117	2125	protocol
O	2126	2134	provides
O	2135	2140	fewer
O	2141	2153	segmentation
O	2154	2160	errors
O	2161	2165	than
O	2166	2169	the
B-Diagnostic_tool	2170	2174	FMTM
O	2175	2183	protocol
O	2183	2184	,
O	2185	2188	and
O	2189	2192	its
O	2193	2202	automated
B-Characteristic	2203	2210	retinal
I-Characteristic	2211	2220	thickness
O	2221	2227	values
O	2228	2229	(
O	2229	2230	e
O	2230	2231	.
O	2231	2232	g
O	2232	2233	.
O	2233	2234	,
B-Characteristic	2235	2241	foveal
I-Characteristic	2242	2248	center
I-Characteristic	2249	2254	point
O	2254	2255	,
B-Characteristic	2256	2263	central
I-Characteristic	2264	2272	subfield
O	2272	2273	)
O	2274	2283	correlate
O	2284	2290	better
O	2291	2295	with
O	2296	2302	manual
B-Characteristic	2303	2310	retinal
I-Characteristic	2311	2320	thickness
O	2321	2332	measurement
O	2333	2337	than
B-Diagnostic_tool	2338	2342	FMTM
O	2342	2343	.

O	2344	2346	In
B-Disease	2347	2350	DME
O	2351	2354	and
B-Disease	2355	2358	RVO
O	2358	2359	,
O	2360	2367	however
O	2367	2368	,
O	2369	2373	both
O	2374	2383	protocols
O	2384	2391	provide
O	2392	2399	similar
O	2400	2403	and
O	2404	2407	low
O	2408	2420	segmentation
O	2421	2427	errors
O	2427	2428	,
O	2429	2432	and
O	2433	2438	their
O	2439	2448	automated
O	2449	2456	results
O	2457	2460	are
O	2461	2466	close
O	2467	2469	to
O	2470	2476	manual
O	2477	2489	measurements
O	2489	2490	.

O	2491	2502	Proprietary
O	2503	2505	or
O	2506	2516	commercial
O	2517	2527	disclosure
O	2528	2531	may
O	2532	2534	be
O	2535	2540	found
O	2541	2546	after
O	2547	2550	the
O	2551	2561	references
O	2561	2562	.

O	0	10	Comparison
O	11	13	of
B-Characteristic	14	21	retinal
I-Characteristic	22	27	nerve
I-Characteristic	28	33	fiber
I-Characteristic	34	39	layer
I-Characteristic	40	49	thickness
O	50	58	measured
O	59	61	by
B-Diagnostic_tool	62	68	Cirrus
I-Diagnostic_tool	69	71	HD
I-Diagnostic_tool	72	75	and
I-Diagnostic_tool	76	83	Stratus
I-Diagnostic_tool	84	91	optical
I-Diagnostic_tool	92	101	coherence
I-Diagnostic_tool	102	112	tomography
O	112	113	.

O	115	117	To
O	118	123	study
O	124	127	the
O	128	140	relationship
O	141	148	between
B-Characteristic	149	156	retinal
I-Characteristic	157	162	nerve
I-Characteristic	163	168	fiber
I-Characteristic	169	174	layer
I-Characteristic	175	176	(
I-Characteristic	176	180	RNFL
I-Characteristic	180	181	)
I-Characteristic	182	191	thickness
O	192	200	measured
O	201	203	by
B-Diagnostic_tool	204	208	time
I-Diagnostic_tool	209	215	domain
I-Diagnostic_tool	216	217	(
I-Diagnostic_tool	217	224	Stratus
I-Diagnostic_tool	224	225	)
I-Diagnostic_tool	226	229	and
I-Diagnostic_tool	230	238	spectral
I-Diagnostic_tool	239	245	domain
I-Diagnostic_tool	246	247	(
I-Diagnostic_tool	247	253	Cirrus
I-Diagnostic_tool	254	256	HD
I-Diagnostic_tool	256	257	)
I-Diagnostic_tool	258	265	optical
I-Diagnostic_tool	266	275	coherence
I-Diagnostic_tool	276	286	tomography
O	287	288	(
B-Diagnostic_tool	288	291	OCT
O	291	292	)
O	292	293	.

O	294	299	Cross
O	299	300	-
O	300	309	sectional
O	310	315	study
O	315	316	.

O	317	322	Sixty
B-Characteristic	323	330	healthy
I-Characteristic	331	343	participants
O	343	344	,
O	345	347	48
B-Disease	348	356	glaucoma
I-Disease	357	365	suspects
O	365	366	,
O	367	370	and
O	371	373	55
O	374	382	subjects
O	383	387	with
B-Disease	388	396	glaucoma
O	396	397	.

O	398	410	Participants
O	411	415	were
O	416	422	imaged
O	423	425	by
O	426	427	a
O	428	434	single
O	435	442	trained
O	443	451	operator
O	452	457	using
O	458	461	the
B-Diagnostic_tool	462	469	Stratus
I-Diagnostic_tool	470	473	OCT
O	474	475	(
O	475	479	fast
O	480	484	RNFL
O	485	489	scan
O	490	494	mode
O	494	495	)
O	496	499	and
B-Diagnostic_tool	500	506	Cirrus
I-Diagnostic_tool	507	509	HD
I-Diagnostic_tool	509	510	-
I-Diagnostic_tool	510	513	OCT
O	514	515	(
O	515	520	optic
O	521	525	disc
O	526	530	cube
O	531	535	mode
O	535	536	)
O	537	539	at
O	540	543	the
O	544	548	same
O	549	554	visit
O	554	555	.

O	556	559	The
B-Characteristic	560	564	RNFL
I-Characteristic	565	574	thickness
O	575	577	as
O	578	586	measured
O	587	589	by
O	590	593	the
B-Diagnostic_tool	594	601	Stratus
I-Diagnostic_tool	602	605	OCT
O	606	607	(
O	607	611	fast
O	612	616	RNFL
O	617	621	scan
O	622	626	mode
O	626	627	)
O	628	631	and
B-Diagnostic_tool	632	638	Cirrus
I-Diagnostic_tool	639	641	HD
I-Diagnostic_tool	641	642	-
I-Diagnostic_tool	642	645	OCT
O	646	647	(
O	647	652	optic
O	653	657	disc
O	658	662	cube
O	663	667	mode
O	667	668	)
O	669	672	was
O	673	681	compared
O	682	683	(
O	683	689	paired
O	690	691	t
O	692	696	test
O	696	697	)
O	697	698	.

O	699	702	The
O	703	715	relationship
O	716	723	between
B-Characteristic	724	728	RNFL
I-Characteristic	729	738	thickness
O	739	751	measurements
O	752	754	of
O	755	758	the
O	759	760	2
B-Diagnostic_tool	761	765	OCTs
O	766	770	were
O	771	780	evaluated
O	781	786	using
O	787	788	a
O	789	796	Pearson
O	797	808	correlation
O	809	817	analysis
O	817	818	.

O	819	822	The
O	823	831	presence
O	832	834	of
O	835	843	abnormal
O	844	858	classification
O	858	859	,
O	860	862	as
O	863	873	determined
O	874	876	by
O	877	882	using
O	883	885	an
O	886	894	internal
O	895	904	normative
O	905	909	data
O	910	914	base
O	915	917	in
O	918	922	each
O	923	930	machine
O	931	934	was
O	935	943	compared
O	944	945	(
O	945	948	chi
O	948	949	-
O	949	955	square
O	956	960	test
O	960	961	)
O	961	962	.

O	963	966	The
O	967	978	sensitivity
O	979	982	and
O	983	994	specificity
O	995	997	of
O	998	1007	normative
O	1008	1022	classification
O	1023	1025	of
O	1026	1027	2
B-Diagnostic_tool	1028	1031	OCT
O	1032	1044	measurements
O	1045	1049	were
O	1050	1060	calculated
O	1060	1061	.

B-Characteristic	1062	1069	Average
I-Characteristic	1070	1074	RNFL
I-Characteristic	1075	1084	thickness
O	1085	1087	as
O	1088	1098	determined
O	1099	1101	by
O	1102	1105	the
O	1106	1107	2
B-Diagnostic_tool	1108	1111	OCT
O	1112	1120	machines
O	1121	1124	was
O	1125	1135	correlated
O	1136	1137	(
O	1137	1138	r
O	1139	1140	=
O	1141	1142	0
O	1142	1143	.
O	1143	1145	94
O	1145	1146	;
O	1147	1148	P
O	1149	1150	<
O	1151	1152	0
O	1152	1153	.
O	1153	1156	001
O	1156	1157	)
O	1157	1158	,
O	1159	1162	but
O	1163	1166	was
O	1167	1180	significantly
O	1181	1190	different
O	1191	1195	with
O	1196	1199	the
O	1200	1201	2
O	1202	1210	machines
O	1211	1212	(
O	1212	1219	Stratus
O	1219	1220	,
O	1221	1223	98
O	1223	1224	.
O	1224	1225	0
O	1226	1229	mum
O	1229	1230	,
O	1231	1239	standard
O	1240	1249	deviation
O	1250	1251	[
O	1251	1253	SD
O	1253	1254	]
O	1255	1257	18
O	1257	1258	.
O	1258	1259	0
O	1259	1260	;
O	1261	1267	Cirrus
O	1267	1268	,
O	1269	1271	85
O	1271	1272	.
O	1272	1273	6
O	1274	1277	mum
O	1277	1278	,
O	1279	1281	SD
O	1282	1284	14
O	1284	1285	.
O	1285	1286	6
O	1286	1287	;
O	1288	1289	P
O	1290	1291	<
O	1292	1293	0
O	1293	1294	.
O	1294	1297	001
O	1297	1298	)
O	1298	1299	.

O	1300	1303	The
B-Diagnostic_tool	1304	1310	Cirrus
I-Diagnostic_tool	1311	1313	HD
I-Diagnostic_tool	1313	1314	-
I-Diagnostic_tool	1314	1317	OCT
O	1318	1328	classified
O	1329	1330	a
O	1331	1344	significantly
O	1345	1351	higher
O	1352	1362	percentage
O	1363	1365	of
B-Anatomy	1366	1370	eyes
O	1371	1373	as
O	1374	1382	abnormal
O	1383	1384	(
O	1384	1391	Stratus
O	1391	1392	,
O	1393	1395	12
O	1395	1396	.
O	1396	1397	9
O	1397	1398	%
O	1398	1399	;
O	1400	1406	Cirrus
O	1406	1407	,
O	1408	1410	23
O	1410	1411	.
O	1411	1412	3
O	1412	1413	%
O	1413	1414	;
O	1415	1416	P
O	1417	1418	<
O	1419	1420	0
O	1420	1421	.
O	1421	1424	001
O	1424	1425	)
O	1426	1428	in
B-Characteristic	1429	1436	average
I-Characteristic	1437	1441	RNFL
I-Characteristic	1442	1451	thickness
O	1451	1452	.

B-Diagnostic_tool	1453	1459	Cirrus
I-Diagnostic_tool	1460	1463	OCT
O	1464	1476	demonstrated
O	1477	1483	higher
O	1484	1495	sensitivity
O	1496	1499	and
O	1500	1511	specificity
O	1512	1513	(
O	1513	1515	63
O	1515	1516	.
O	1516	1517	6
O	1517	1518	%
O	1519	1522	and
O	1523	1526	100
O	1526	1527	%
O	1527	1528	)
O	1529	1533	than
B-Diagnostic_tool	1534	1541	Stratus
I-Diagnostic_tool	1542	1545	OCT
O	1546	1547	(
O	1547	1549	40
O	1549	1550	.
O	1550	1551	0
O	1551	1552	%
O	1553	1556	and
O	1557	1559	96
O	1559	1560	.
O	1560	1561	7
O	1561	1562	%
O	1562	1563	)
O	1564	1566	in
O	1567	1576	normative
O	1577	1591	classification
O	1592	1594	of
B-Characteristic	1595	1602	average
I-Characteristic	1603	1607	RNFL
I-Characteristic	1608	1617	thickness
O	1617	1618	.

O	1619	1624	There
O	1625	1629	were
O	1630	1641	significant
O	1642	1653	differences
O	1654	1656	in
B-Characteristic	1657	1661	RNFL
I-Characteristic	1662	1671	thickness
O	1672	1675	and
O	1676	1685	normative
O	1686	1700	classification
O	1701	1703	as
O	1704	1714	determined
O	1715	1717	by
B-Diagnostic_tool	1718	1725	Stratus
I-Diagnostic_tool	1726	1729	OCT
O	1730	1733	and
B-Diagnostic_tool	1734	1740	Cirrus
I-Diagnostic_tool	1741	1743	HD
I-Diagnostic_tool	1743	1744	-
I-Diagnostic_tool	1744	1747	OCT
O	1748	1755	despite
O	1756	1758	an
O	1759	1768	excellent
O	1769	1780	correlation
O	1781	1783	of
B-Characteristic	1784	1788	RNFL
I-Characteristic	1789	1798	thickness
O	1799	1810	measurement
O	1810	1811	.

O	1812	1819	Overall
O	1820	1831	sensitivity
O	1832	1835	and
O	1836	1847	specificity
O	1848	1852	were
O	1853	1859	higher
O	1860	1864	with
B-Diagnostic_tool	1865	1871	Cirrus
I-Diagnostic_tool	1872	1875	OCT
O	1875	1876	.

O	1877	1882	These
O	1883	1891	findings
O	1892	1895	are
O	1896	1908	particularly
O	1909	1917	relevant
O	1918	1922	when
O	1923	1925	an
O	1926	1936	individual
O	1937	1946	undergoes
O	1947	1959	longitudinal
O	1960	1966	follow
O	1966	1967	-
O	1967	1969	up
O	1970	1974	with
O	1975	1984	different
B-Diagnostic_tool	1985	1989	OCTs
O	1989	1990	.

O	0	9	Incidence
O	10	12	of
B-Disease	13	27	postvitrectomy
I-Disease	28	35	macular
I-Disease	36	41	edema
O	42	47	using
B-Diagnostic_tool	48	55	optical
I-Diagnostic_tool	56	65	coherence
I-Diagnostic_tool	66	76	tomography
O	76	77	.

O	79	81	To
O	82	90	evaluate
O	91	94	the
O	95	104	incidence
O	104	105	,
O	106	112	effect
O	113	115	on
O	116	122	visual
O	123	131	recovery
O	131	132	,
O	133	136	and
O	137	149	predisposing
O	150	154	risk
O	155	162	factors
O	163	165	of
B-Disease	166	180	postvitrectomy
I-Disease	181	188	macular
I-Disease	189	194	edema
O	195	196	(
B-Disease	196	198	ME
O	198	199	)
O	199	200	.

O	201	212	Prospective
O	213	219	cohort
O	220	225	study
O	225	226	.

O	227	230	One
O	230	231	-
O	231	238	hundred
O	239	243	nine
B-Anatomy	244	248	eyes
O	249	259	undergoing
O	260	271	nonemergent
O	272	282	vitrectomy
O	283	290	surgery
O	290	291	.

B-Anatomy	292	296	Eyes
O	297	301	were
O	302	311	evaluated
O	312	315	for
O	316	329	postoperative
O	330	333	day
O	334	335	1
B-Symptom	336	348	inflammation
O	348	349	,
O	350	351	1
O	351	352	-
O	352	357	month
B-Characteristic	358	365	retinal
I-Characteristic	366	375	thickness
O	376	381	using
B-Diagnostic_tool	382	389	optical
I-Diagnostic_tool	390	399	coherence
I-Diagnostic_tool	400	410	tomography
O	410	411	,
O	412	415	and
O	416	428	preoperative
O	429	432	and
O	433	434	1
O	434	435	-
O	435	440	month
O	441	454	postoperative
B-Characteristic	455	459	best
I-Characteristic	459	460	-
I-Characteristic	460	469	corrected
I-Characteristic	470	476	visual
I-Characteristic	477	483	acuity
O	484	485	(
B-Characteristic	485	489	BCVA
O	489	490	)
O	490	491	.

B-Disease	492	499	Macular
I-Disease	500	505	edema
O	506	509	was
O	510	517	defined
O	518	520	as
B-Symptom	521	528	central
I-Symptom	529	537	subfield
I-Symptom	538	547	thickness
B-Dimension	549	550	>
I-Dimension	552	554	or
I-Dimension	555	556	=
I-Dimension	556	559	272
I-Dimension	560	566	microm
O	566	567	.

B-Characteristic	568	575	Retinal
I-Characteristic	576	585	thickness
O	585	586	,
B-Symptom	587	599	inflammation
O	599	600	,
O	601	604	and
B-Characteristic	605	609	BCVA
O	609	610	.

O	611	620	Incidence
O	621	623	of
B-Disease	624	626	ME
O	627	629	on
B-Diagnostic_tool	630	637	optical
I-Diagnostic_tool	638	647	coherence
I-Diagnostic_tool	648	658	tomography
O	659	662	was
O	663	665	47
O	665	666	%
O	667	668	(
O	668	670	95
O	670	671	%
O	672	682	confidence
O	683	691	interval
O	692	693	[
O	693	695	CI
O	695	696	]
O	696	697	,
O	698	700	37
O	700	701	%
O	701	702	-
O	702	704	56
O	704	705	%
O	705	706	)
O	706	707	.

O	708	712	Mean
O	713	714	1
O	714	715	-
O	715	720	month
B-Characteristic	721	727	visual
I-Characteristic	728	734	acuity
O	735	743	improved
O	744	745	3
O	745	746	.
O	746	747	3
O	748	753	lines
O	754	755	(
O	755	756	0
O	756	757	.
O	757	759	33
O	760	769	logarithm
O	770	772	of
O	773	780	minimum
O	781	786	angle
O	787	789	of
O	790	800	resolution
O	801	802	[
O	802	808	logMAR
O	808	809	]
O	811	816	units
O	816	817	)
O	818	820	to
O	821	823	20
O	823	824	/
O	824	826	80
O	826	827	(
O	827	828	+
O	828	829	1
O	829	830	)
O	831	832	(
O	832	833	0
O	833	834	.
O	834	836	58
O	836	837	+
O	837	838	/
O	838	839	-
O	839	840	0
O	840	841	.
O	841	843	46
O	844	850	logMAR
O	851	856	units
O	856	857	)
O	858	862	from
O	863	865	20
O	865	866	/
O	866	869	150
O	869	870	(
O	870	871	-
O	871	872	2
O	872	873	)
O	874	875	(
O	875	876	0
O	876	877	.
O	877	879	91
O	879	880	+
O	880	881	/
O	881	882	-
O	882	883	0
O	883	884	.
O	884	886	63
O	887	893	logMAR
O	894	899	units
O	899	900	)
O	901	907	before
O	908	915	surgery
O	916	917	(
O	917	918	P
O	919	920	<
O	921	922	0
O	922	923	.
O	923	926	001
O	926	927	)
O	927	928	.

O	929	933	Mean
O	934	935	1
O	935	936	-
O	936	941	month
B-Characteristic	942	948	center
I-Characteristic	949	954	point
I-Characteristic	955	964	thickness
O	965	966	(
B-Characteristic	966	969	CPT
O	969	970	)
O	970	971	,
B-Characteristic	972	979	central
I-Characteristic	980	988	subfield
O	989	990	(
B-Characteristic	990	993	CSF
O	993	994	)
O	994	995	,
O	996	999	and
B-Characteristic	1000	1005	total
I-Characteristic	1006	1013	macular
I-Characteristic	1014	1020	volume
O	1021	1025	were
O	1026	1029	265
O	1029	1030	+
O	1030	1031	/
O	1031	1032	-
O	1032	1035	107
O	1036	1042	microm
O	1042	1043	,
O	1044	1047	288
O	1047	1048	+
O	1048	1049	/
O	1049	1050	-
O	1050	1052	94
O	1053	1059	microm
O	1059	1060	,
O	1061	1064	and
O	1065	1066	7
O	1066	1067	.
O	1067	1068	8
O	1068	1069	+
O	1069	1070	/
O	1070	1071	-
O	1071	1072	1
O	1072	1073	.
O	1073	1074	2
O	1075	1077	mm
O	1077	1078	(
O	1078	1079	3
O	1079	1080	)
O	1080	1081	,
O	1082	1094	respectively
O	1094	1095	.

O	1096	1104	Severity
O	1105	1107	of
B-Symptom	1108	1121	postoperative
I-Symptom	1122	1134	inflammation
O	1135	1144	predicted
B-Symptom	1145	1152	retinal
I-Symptom	1153	1162	thickness
O	1163	1165	at
O	1166	1167	1
O	1168	1173	month
O	1174	1175	(
O	1175	1176	P
O	1177	1178	<
O	1179	1180	0
O	1180	1181	.
O	1181	1183	05
O	1183	1184	)
O	1184	1185	.

B-Characteristic	1186	1200	Intraoperative
I-Characteristic	1201	1212	epinephrine
I-Characteristic	1213	1216	use
O	1217	1220	was
O	1221	1231	associated
O	1232	1236	with
O	1237	1246	increased
O	1247	1260	postoperative
B-Characteristic	1261	1273	inflammation
O	1274	1275	(
O	1275	1276	P
O	1277	1278	=
O	1279	1280	0
O	1280	1281	.
O	1281	1283	02
O	1283	1284	)
O	1284	1285	.

B-Anatomy	1286	1290	Eyes
O	1291	1295	with
O	1296	1303	greater
O	1304	1313	reduction
O	1314	1316	in
B-Characteristic	1317	1320	CSF
O	1321	1322	(
O	1322	1324	or
B-Characteristic	1325	1328	CPT
O	1328	1329	)
O	1330	1334	from
O	1335	1343	baseline
O	1344	1355	experienced
O	1356	1360	more
O	1361	1366	rapid
O	1367	1373	visual
O	1374	1382	recovery
O	1383	1384	(
O	1384	1385	r
O	1386	1387	=
O	1388	1389	-
O	1389	1390	0
O	1390	1391	.
O	1391	1393	36
O	1393	1394	;
O	1395	1397	95
O	1397	1398	%
O	1399	1401	CI
O	1401	1402	,
O	1403	1404	-
O	1404	1405	0
O	1405	1406	.
O	1406	1408	61
O	1409	1411	to
O	1412	1413	-
O	1413	1414	0
O	1414	1415	.
O	1415	1417	06
O	1417	1418	;
O	1419	1420	P
O	1421	1422	=
O	1423	1424	0
O	1424	1425	.
O	1425	1427	02
O	1427	1428	)
O	1428	1429	.

B-Disease	1430	1444	Postvitrectomy
I-Disease	1445	1447	ME
O	1448	1450	is
O	1451	1457	common
O	1458	1461	and
O	1462	1468	delays
O	1469	1475	visual
O	1476	1484	recovery
O	1484	1485	.

O	1486	1492	Degree
O	1493	1495	of
B-Symptom	1496	1509	postoperative
I-Symptom	1510	1522	inflammation
O	1523	1525	is
O	1526	1528	an
O	1529	1538	important
O	1539	1543	risk
O	1544	1550	factor
O	1551	1554	for
B-Disease	1555	1557	ME
O	1558	1561	and
O	1561	1562	,
O	1563	1565	in
O	1566	1570	this
O	1571	1577	series
O	1577	1578	,
O	1579	1582	was
O	1583	1592	increased
O	1593	1595	in
O	1596	1599	the
O	1600	1607	setting
O	1608	1610	of
O	1611	1622	intraocular
O	1623	1634	epinephrine
O	1634	1635	.

O	1636	1643	Efforts
O	1644	1646	to
O	1647	1653	reduce
O	1654	1656	or
O	1657	1664	prevent
B-Symptom	1665	1677	inflammation
O	1678	1683	after
O	1684	1694	vitrectomy
O	1695	1701	should
O	1702	1704	be
O	1705	1715	beneficial
O	1716	1719	and
O	1720	1729	therefore
O	1730	1733	are
O	1734	1744	encouraged
O	1744	1745	.

O	0	9	Detecting
O	10	13	and
O	14	22	treating
B-Disease	23	34	retinopathy
O	35	37	in
O	38	46	patients
O	47	51	with
B-Disease	52	56	type
I-Disease	57	58	I
I-Disease	59	67	diabetes
I-Disease	68	76	mellitus
O	76	77	.

O	78	85	Savings
O	86	96	associated
O	97	101	with
O	102	110	improved
O	111	125	implementation
O	126	128	of
O	129	136	current
O	137	147	guidelines
O	147	148	.

O	149	157	American
O	158	165	Academy
O	166	168	of
O	169	182	Ophthalmology
O	182	183	.

B-Disease	185	193	Diabetic
I-Disease	194	205	retinopathy
O	206	208	is
O	209	212	the
O	213	220	leading
O	221	226	cause
O	227	229	of
B-Symptom	230	238	acquired
I-Symptom	239	248	blindness
O	249	254	among
B-Characteristic	255	264	Americans
I-Characteristic	265	267	of
I-Characteristic	268	275	working
I-Characteristic	276	279	age
O	279	280	.

O	281	284	The
O	285	294	resulting
O	295	303	economic
O	304	307	and
O	308	316	societal
O	317	324	burdens
O	325	328	are
O	329	331	of
O	332	340	profound
O	341	350	magnitude
O	350	351	.

O	352	365	Epidemiologic
O	366	369	and
O	370	378	clinical
O	379	385	trials
O	386	390	data
O	391	395	were
O	396	400	used
O	401	403	to
O	404	411	analyze
O	412	415	the
O	416	422	impact
O	423	425	of
O	426	434	improved
O	435	446	recruitment
O	447	449	of
O	450	458	patients
O	459	463	with
B-Disease	464	468	Type
I-Disease	469	470	I
I-Disease	471	479	diabetes
I-Disease	480	488	mellitus
O	489	493	into
O	494	503	screening
O	504	507	and
O	508	517	treatment
O	518	526	programs
O	526	527	.

O	528	531	The
O	532	540	analysis
O	541	550	predicted
O	551	557	annual
O	558	565	savings
O	566	568	of
O	569	570	$
O	570	573	101
O	573	574	.
O	574	575	0
O	576	583	million
O	584	587	and
O	588	590	47
O	590	591	,
O	591	594	374
O	595	601	person
O	601	602	-
O	602	607	years
O	607	608	-
O	608	613	sight
O	614	616	at
O	617	620	the
O	621	630	currently
O	631	640	estimated
O	641	643	60
O	643	644	%
O	645	654	screening
O	655	658	and
O	659	668	treatment
O	669	683	implementation
O	684	689	level
O	689	690	.

O	691	693	If
O	694	697	all
O	698	706	patients
O	707	715	received
O	716	727	appropriate
B-Anatomy	728	731	eye
O	732	736	care
O	736	737	,
O	738	741	the
O	742	751	predicted
O	752	759	savings
O	760	766	exceed
O	767	770	167
O	770	771	.
O	771	772	0
O	773	780	million
O	781	784	and
O	785	787	79
O	787	788	,
O	788	791	236
O	792	798	person
O	798	799	-
O	799	804	years
O	804	805	-
O	805	810	sight
O	810	811	.

O	812	825	Approximately
O	826	829	two
O	830	836	thirds
O	837	839	of
O	840	843	all
O	844	851	savings
O	852	858	result
O	859	863	from
O	864	873	treatment
O	874	876	of
B-Disease	877	890	proliferative
I-Disease	891	899	diabetic
I-Disease	900	911	retinopathy
O	911	912	,
O	913	918	while
O	919	925	nearly
O	926	929	one
O	930	935	third
O	936	942	arises
O	943	947	from
O	948	957	treatment
O	958	960	of
B-Disease	961	971	clinically
I-Disease	972	983	significant
I-Disease	984	991	macular
I-Disease	992	997	edema
O	997	998	.

O	999	1009	Additional
O	1010	1017	savings
O	1018	1020	of
O	1021	1022	$
O	1022	1026	9571
O	1027	1030	are
O	1031	1039	realized
O	1040	1044	with
O	1045	1049	each
O	1050	1061	recruitment
O	1062	1064	of
O	1065	1066	a
O	1067	1072	newly
O	1073	1082	diagnosed
O	1083	1090	patient
O	1091	1095	with
B-Disease	1096	1104	diabetes
O	1104	1105	.

O	1106	1116	Initiating
O	1117	1126	screening
O	1127	1138	immediately
O	1139	1143	upon
O	1144	1153	diagnosis
O	1154	1156	of
B-Disease	1157	1165	diabetes
O	1165	1166	,
O	1167	1173	rather
O	1174	1178	than
O	1179	1182	the
O	1183	1192	currently
O	1193	1204	recommended
O	1205	1206	5
O	1206	1207	-
O	1207	1211	year
O	1212	1220	deferral
O	1220	1221	,
O	1222	1227	would
O	1228	1230	be
O	1231	1235	cost
O	1236	1245	effective
O	1246	1248	if
O	1249	1250	1
O	1251	1261	additional
O	1262	1272	individual
O	1273	1275	in
O	1276	1278	56
O	1279	1283	were
O	1284	1293	recruited
O	1293	1294	.

O	1295	1299	This
O	1300	1305	model
O	1306	1314	suggests
O	1315	1319	that
O	1320	1328	improved
O	1329	1337	delivery
O	1338	1340	of
O	1341	1351	ophthalmic
O	1352	1356	care
O	1357	1359	to
O	1360	1368	patients
O	1369	1373	with
B-Disease	1374	1382	diabetes
O	1383	1388	would
O	1389	1394	yield
O	1395	1406	substantial
O	1407	1416	financial
O	1417	1420	and
O	1421	1427	visual
O	1428	1435	savings
O	1435	1436	,
O	1437	1441	thus
O	1442	1448	making
O	1449	1454	major
O	1455	1466	recruitment
O	1467	1475	programs
O	1476	1480	such
O	1481	1483	as
O	1484	1487	the
O	1488	1496	National
O	1497	1500	Eye
O	1501	1510	Institute
O	1510	1511	'
O	1511	1512	s
O	1513	1521	National
O	1522	1525	Eye
O	1526	1532	Health
O	1533	1542	Education
O	1543	1550	Program
O	1551	1554	and
O	1555	1558	the
O	1559	1567	American
O	1568	1575	Academy
O	1576	1578	of
O	1579	1592	Ophthalmology
O	1592	1593	'
O	1593	1594	s
B-Disease	1595	1603	Diabetes
O	1604	1608	2000
O	1608	1609	,
O	1610	1614	both
O	1615	1627	economically
O	1628	1631	and
O	1632	1642	clinically
O	1643	1652	effective
O	1652	1653	.

B-Diagnostic_tool	0	8	Spectral
I-Diagnostic_tool	9	15	domain
I-Diagnostic_tool	16	23	optical
I-Diagnostic_tool	24	33	coherence
I-Diagnostic_tool	34	44	tomography
I-Diagnostic_tool	45	52	imaging
O	53	55	of
B-Symptom	56	66	geographic
I-Symptom	67	74	atrophy
O	75	82	margins
O	82	83	.

O	85	87	To
O	88	92	test
O	93	95	in
O	96	100	vivo
O	101	108	whether
B-Diagnostic_tool	109	117	spectral
I-Diagnostic_tool	118	124	domain
I-Diagnostic_tool	125	132	optical
I-Diagnostic_tool	133	142	coherence
I-Diagnostic_tool	143	153	tomography
O	154	155	(
B-Diagnostic_tool	155	157	SD
I-Diagnostic_tool	157	158	-
I-Diagnostic_tool	158	161	OCT
O	161	162	)
O	163	171	provides
O	172	180	adequate
O	181	191	resolution
O	192	195	for
O	196	208	reproducible
O	209	220	measurement
O	221	223	of
B-Anatomy	224	237	photoreceptor
I-Anatomy	238	239	(
I-Anatomy	239	241	PR
I-Anatomy	241	242	)
I-Anatomy	243	248	layer
O	249	251	at
O	252	255	the
O	256	263	margins
O	264	266	of
B-Symptom	267	277	geographic
I-Symptom	278	285	atrophy
O	286	287	(
B-Symptom	287	289	GA
O	289	290	)
O	290	291	,
O	292	295	and
O	296	298	if
O	299	301	it
O	302	312	delineates
O	313	316	the
O	317	329	relationship
O	330	337	between
B-Anatomy	338	340	PR
I-Anatomy	341	346	layer
O	347	350	and
B-Anatomy	351	358	retinal
I-Anatomy	359	366	pigment
I-Anatomy	367	377	epithelium
O	378	380	at
O	381	384	the
O	385	392	margins
O	393	395	of
B-Symptom	396	398	GA
O	398	399	.

O	400	411	Prospective
O	412	423	consecutive
O	424	428	case
O	429	435	series
O	435	436	.

O	437	445	Patients
O	446	450	with
B-Symptom	451	453	GA
O	454	463	secondary
O	464	466	to
B-Disease	467	481	nonneovascular
I-Disease	482	485	age
I-Disease	485	486	-
I-Disease	486	493	related
I-Disease	494	501	macular
I-Disease	502	514	degeneration
O	515	516	(
B-Disease	516	519	AMD
O	519	520	)
O	521	531	identified
O	532	538	during
O	539	546	routine
O	547	553	follow
O	553	554	-
O	554	556	up
O	557	559	at
O	560	564	Duke
B-Anatomy	565	568	Eye
O	569	575	Center
O	576	583	between
O	584	591	January
O	592	593	3
O	593	594	,
O	595	599	2006
O	599	600	,
O	601	604	and
O	605	609	June
O	610	611	3
O	611	612	,
O	613	617	2007
O	617	618	,
O	619	622	and
O	623	626	who
O	627	636	consented
O	637	639	to
O	640	651	participate
O	652	654	in
O	655	659	this
O	660	665	study
O	665	666	.

O	667	669	We
O	670	674	used
B-Diagnostic_tool	675	677	SD
I-Diagnostic_tool	677	678	-
I-Diagnostic_tool	678	681	OCT
O	682	684	to
O	685	690	image
B-Anatomy	691	695	eyes
O	695	696	.

O	697	705	Multiple
B-Diagnostic_tool	706	707	B
I-Diagnostic_tool	707	708	-
I-Diagnostic_tool	708	713	scans
O	714	718	from
O	719	723	each
B-Anatomy	724	727	eye
O	728	732	were
O	733	738	saved
O	739	742	and
O	743	756	independently
O	757	763	graded
O	764	766	by
O	767	768	2
O	769	776	graders
O	777	780	and
O	781	784	the
O	785	794	following
O	795	804	locations
O	805	809	were
O	810	816	marked
O	816	817	:
O	818	819	(
O	819	820	1
O	820	821	)
O	822	826	site
O	827	832	where
B-Characteristic	833	835	PR
I-Characteristic	836	845	thickness
O	846	851	began
O	852	854	to
O	855	862	decline
O	863	868	below
O	869	872	its
O	873	881	baseline
O	881	882	,
O	883	884	(
O	884	885	2
O	885	886	)
O	887	891	site
O	892	897	where
B-Anatomy	898	900	PR
I-Anatomy	901	906	layer
O	907	918	disappeared
O	918	919	,
O	920	923	and
O	924	925	(
O	925	926	3
O	926	927	)
O	928	932	site
O	933	935	of
O	936	939	the
B-Symptom	940	942	GA
O	943	949	margin
O	949	950	.

O	951	956	These
O	957	961	data
O	962	966	were
O	967	976	processed
O	977	979	to
O	980	989	calculate
O	990	993	the
O	994	1003	locations
O	1004	1006	of
B-Symptom	1007	1009	PR
I-Symptom	1010	1016	losses
O	1017	1025	relative
O	1026	1028	to
B-Symptom	1029	1031	GA
O	1032	1039	margins
O	1040	1043	and
O	1044	1048	were
O	1049	1060	categorized
O	1061	1063	as
O	1064	1065	(
O	1065	1066	A
O	1066	1067	)
O	1068	1076	bridging
O	1077	1083	across
B-Symptom	1084	1086	GA
O	1087	1094	margins
O	1094	1095	,
O	1096	1097	(
O	1097	1098	B
O	1098	1099	)
O	1100	1108	entirely
O	1109	1115	within
B-Symptom	1116	1118	GA
O	1119	1126	margins
O	1126	1127	,
O	1128	1130	or
O	1131	1132	(
O	1132	1133	C
O	1133	1134	)
O	1135	1143	entirely
O	1144	1151	outside
B-Symptom	1152	1154	GA
O	1155	1162	margins
O	1162	1163	.

O	1164	1172	Location
O	1173	1175	of
B-Symptom	1176	1178	PR
I-Symptom	1179	1183	loss
O	1184	1185	(
O	1185	1193	bridging
O	1194	1200	across
B-Symptom	1201	1203	GA
O	1204	1211	margins
O	1211	1212	,
O	1213	1221	entirely
O	1222	1228	within
B-Symptom	1229	1231	GA
O	1232	1239	margins
O	1239	1240	,
O	1241	1243	or
O	1244	1252	entirely
O	1253	1260	outside
B-Symptom	1261	1263	GA
O	1264	1271	margins
O	1271	1272	)
O	1273	1276	was
O	1277	1287	calculated
O	1287	1288	.

O	1289	1298	Distances
O	1299	1303	from
O	1304	1307	the
B-Symptom	1308	1310	GA
O	1311	1317	margin
O	1318	1322	were
O	1323	1331	measured
O	1332	1335	for
O	1336	1345	beginning
O	1346	1349	and
O	1350	1356	ending
O	1357	1359	of
B-Symptom	1360	1362	PR
I-Symptom	1363	1367	loss
O	1367	1368	.

O	1369	1382	Interobserver
O	1383	1392	agreement
O	1393	1396	was
O	1397	1407	determined
O	1408	1411	for
O	1412	1422	categories
O	1423	1425	of
B-Symptom	1426	1428	PR
I-Symptom	1429	1433	loss
O	1434	1436	as
O	1437	1441	well
O	1442	1444	as
O	1445	1454	locations
O	1455	1457	of
B-Symptom	1458	1460	PR
I-Symptom	1461	1465	loss
O	1466	1474	relative
O	1475	1477	to
O	1478	1481	the
B-Symptom	1482	1484	GA
O	1485	1491	margin
O	1491	1492	.

O	1493	1495	We
O	1496	1504	analyzed
O	1505	1508	500
O	1509	1515	unique
O	1516	1521	scans
O	1521	1522	.

O	1523	1526	The
B-Symptom	1527	1529	PR
I-Symptom	1530	1534	loss
O	1535	1543	occurred
O	1544	1548	most
O	1549	1559	frequently
O	1560	1568	bridging
O	1569	1575	across
O	1576	1579	the
B-Symptom	1580	1582	GA
O	1583	1589	margin
O	1590	1591	(
O	1591	1593	65
O	1593	1594	%
O	1595	1600	scans
O	1600	1601	)
O	1601	1602	,
O	1603	1609	second
O	1610	1614	most
O	1615	1625	frequently
O	1626	1634	entirely
O	1635	1641	inside
O	1642	1645	the
B-Symptom	1646	1648	GA
O	1649	1655	margin
O	1656	1657	(
O	1657	1659	29
O	1659	1660	%
O	1661	1666	scans
O	1666	1667	)
O	1667	1668	,
O	1669	1672	and
O	1673	1678	least
O	1679	1689	frequently
O	1690	1698	entirely
O	1699	1706	outside
O	1707	1710	the
B-Symptom	1711	1713	GA
O	1714	1720	margin
O	1721	1722	(
O	1722	1723	6
O	1723	1724	%
O	1725	1730	scans
O	1730	1731	)
O	1731	1732	.

B-Symptom	1733	1737	Loss
I-Symptom	1738	1740	of
I-Symptom	1741	1743	PR
O	1744	1751	started
O	1752	1754	an
O	1755	1762	average
O	1763	1765	of
B-Dimension	1766	1768	61
I-Dimension	1769	1775	microm
O	1776	1777	(
O	1777	1785	standard
O	1786	1795	deviation
O	1796	1797	[
O	1797	1799	SD
O	1799	1800	]
O	1801	1802	+
O	1802	1803	/
O	1803	1804	-
O	1805	1808	235
O	1808	1809	)
O	1810	1817	outside
O	1818	1821	the
B-Symptom	1822	1824	GA
O	1825	1831	margin
O	1831	1832	,
O	1833	1838	ended
O	1839	1841	an
O	1842	1849	average
O	1850	1852	of
B-Dimension	1853	1856	311
I-Dimension	1856	1857	+
I-Dimension	1857	1858	/
I-Dimension	1858	1859	-
I-Dimension	1859	1862	273
I-Dimension	1863	1869	microm
O	1870	1876	inside
O	1877	1880	the
B-Symptom	1881	1883	GA
O	1884	1890	margin
O	1890	1891	,
O	1892	1895	and
O	1896	1903	spanned
O	1904	1906	an
O	1907	1914	average
O	1915	1917	of
B-Dimension	1918	1921	372
I-Dimension	1921	1922	+
I-Dimension	1922	1923	/
I-Dimension	1923	1924	-
I-Dimension	1924	1927	179
I-Dimension	1928	1934	microm
O	1934	1935	.

O	1936	1944	Relative
O	1945	1947	to
B-Symptom	1948	1950	GA
O	1951	1958	margins
O	1959	1961	in
B-Disease	1962	1965	non
I-Disease	1965	1966	-
I-Disease	1966	1977	neovascular
I-Disease	1978	1981	AMD
O	1982	1986	with
B-Symptom	1987	1989	GA
O	1989	1990	,
B-Diagnostic_tool	1991	1993	SD
I-Diagnostic_tool	1993	1994	-
I-Diagnostic_tool	1994	1997	OCT
O	1998	2006	provides
O	2007	2015	adequate
O	2016	2026	resolution
O	2027	2030	for
O	2031	2042	quantifying
B-Symptom	2043	2045	PR
I-Symptom	2046	2050	loss
O	2050	2051	.

O	2052	2054	It
O	2055	2058	may
O	2059	2063	also
O	2064	2069	serve
O	2070	2072	as
O	2073	2074	a
O	2075	2080	means
O	2081	2083	of
O	2084	2092	tracking
O	2093	2100	disease
O	2101	2112	progression
O	2113	2115	in
O	2116	2122	future
O	2123	2137	interventional
O	2138	2144	trials
O	2144	2145	.

O	2146	2157	Proprietary
O	2158	2160	or
O	2161	2171	commercial
O	2172	2182	disclosure
O	2183	2186	may
O	2187	2189	be
O	2190	2195	found
O	2196	2201	after
O	2202	2205	the
O	2206	2216	references
O	2216	2217	.

B-Symptom	0	6	Foveal
I-Symptom	7	15	ganglion
I-Symptom	16	20	cell
I-Symptom	21	26	layer
I-Symptom	27	33	damage
O	34	36	in
B-Disease	37	45	ischemic
I-Disease	46	54	diabetic
I-Disease	55	66	maculopathy
O	66	67	:
O	68	79	correlation
O	80	82	of
B-Diagnostic_tool	83	90	optical
I-Diagnostic_tool	91	100	coherence
I-Diagnostic_tool	101	112	tomographic
O	113	116	and
O	117	125	anatomic
O	126	133	changes
O	133	134	.

O	136	138	To
O	139	147	describe
O	148	151	the
O	152	163	morphologic
O	164	172	features
O	173	175	of
B-Disease	176	184	ischemic
I-Disease	185	193	diabetic
I-Disease	194	205	maculopathy
O	206	208	by
B-Diagnostic_tool	209	213	high
I-Diagnostic_tool	213	214	-
I-Diagnostic_tool	214	224	resolution
I-Diagnostic_tool	225	232	optical
I-Diagnostic_tool	233	242	coherence
I-Diagnostic_tool	243	253	tomography
O	254	255	(
B-Diagnostic_tool	255	258	OCT
O	258	259	)
O	260	263	and
O	264	269	their
O	270	281	correlation
O	282	286	with
O	287	290	the
B-Symptom	291	298	damaged
I-Symptom	299	305	foveal
I-Symptom	306	315	avascular
I-Symptom	316	320	zone
O	321	322	(
B-Anatomy	322	325	FAZ
O	325	326	)
O	327	329	on
B-Diagnostic_tool	330	341	fluorescein
I-Diagnostic_tool	342	353	angiography
O	354	355	(
B-Diagnostic_tool	355	357	FA
O	357	358	)
O	358	359	.

O	360	373	Observational
O	374	378	case
O	379	385	series
O	385	386	.

O	387	390	One
O	391	398	hundred
O	399	405	twenty
O	405	406	-
O	406	410	four
B-Anatomy	411	415	eyes
O	416	418	of
O	419	421	63
O	422	430	patients
O	431	435	with
B-Disease	436	444	diabetic
I-Disease	445	456	retinopathy
O	457	460	and
O	461	471	acceptable
B-Diagnostic_tool	472	474	FA
O	475	478	and
B-Diagnostic_tool	479	482	OCT
I-Diagnostic_tool	483	489	images
O	490	494	were
O	495	502	studied
O	502	503	.

O	504	510	Twenty
O	510	511	-
O	511	516	three
B-Characteristic	517	523	normal
I-Characteristic	524	530	fellow
B-Anatomy	531	535	eyes
O	536	538	of
O	539	541	23
O	542	553	nondiabetic
O	554	562	patients
O	563	567	with
B-Disease	568	578	unilateral
I-Disease	579	584	acute
I-Disease	585	592	central
I-Disease	593	599	serous
I-Disease	600	613	choroidopathy
O	614	618	also
O	619	623	were
O	624	631	studied
O	631	632	.

B-Diagnostic_tool	633	637	High
I-Diagnostic_tool	637	638	-
I-Diagnostic_tool	638	643	speed
I-Diagnostic_tool	644	651	Fourier
I-Diagnostic_tool	651	652	-
I-Diagnostic_tool	652	658	domain
I-Diagnostic_tool	659	662	OCT
I-Diagnostic_tool	663	666	was
I-Diagnostic_tool	667	671	used
I-Diagnostic_tool	672	676	with
I-Diagnostic_tool	677	678	a
I-Diagnostic_tool	679	686	speckle
I-Diagnostic_tool	687	692	noise
I-Diagnostic_tool	692	693	-
I-Diagnostic_tool	693	702	reduction
I-Diagnostic_tool	703	712	technique
O	713	715	to
O	716	722	obtain
O	723	731	detailed
O	732	742	horizontal
O	743	746	and
O	747	755	vertical
O	756	762	images
O	763	770	through
O	771	774	the
B-Anatomy	775	781	center
I-Anatomy	782	784	of
I-Anatomy	785	788	the
I-Anatomy	789	794	fovea
O	795	798	and
O	799	809	horizontal
O	810	816	raster
O	817	822	scans
O	823	828	every
O	829	832	100
O	833	839	microm
O	839	840	.

B-Symptom	841	847	Foveal
I-Symptom	848	856	ganglion
I-Symptom	857	861	cell
I-Symptom	862	867	layer
I-Symptom	868	869	(
I-Symptom	869	872	GCL
I-Symptom	872	873	)
I-Symptom	874	880	damage
O	881	884	was
O	885	895	identified
O	896	898	on
B-Diagnostic_tool	899	902	OCT
O	903	905	as
O	906	908	an
B-Symptom	909	916	evident
I-Symptom	917	927	difference
I-Symptom	928	930	in
I-Symptom	931	937	foveal
I-Symptom	938	947	thickness
I-Symptom	948	951	and
I-Symptom	952	959	contour
I-Symptom	960	968	compared
I-Symptom	969	973	with
I-Symptom	974	975	a
I-Symptom	976	982	normal
I-Symptom	983	988	fovea
O	989	991	or
O	992	994	as
B-Symptom	995	1004	asymmetry
I-Symptom	1005	1011	within
I-Symptom	1012	1015	the
I-Symptom	1016	1021	fovea
O	1021	1022	.

B-Diagnostic_tool	1023	1034	Fluorescein
I-Diagnostic_tool	1035	1046	angiography
O	1047	1050	was
O	1051	1060	performed
O	1061	1063	by
B-Diagnostic_tool	1064	1072	confocal
I-Diagnostic_tool	1073	1081	scanning
I-Diagnostic_tool	1082	1087	laser
I-Diagnostic_tool	1088	1102	ophthalmoscope
O	1103	1104	(
B-Diagnostic_tool	1104	1107	HRA
I-Diagnostic_tool	1108	1109	2
O	1109	1110	;
O	1111	1121	Heidelberg
O	1122	1133	Engineering
O	1133	1134	,
O	1135	1145	Heidelberg
O	1145	1146	,
O	1147	1154	Germany
O	1154	1155	)
O	1155	1156	,
O	1157	1160	and
B-Symptom	1161	1164	FAZ
I-Symptom	1165	1171	damage
O	1172	1179	visible
O	1180	1186	during
O	1187	1190	the
B-Diagnostic_tool	1191	1193	FA
O	1194	1202	arterial
O	1203	1208	phase
O	1209	1212	was
O	1213	1219	graded
O	1220	1229	according
O	1230	1232	to
O	1233	1236	the
B-Classification_system	1237	1242	Early
I-Classification_system	1243	1252	Treatment
I-Classification_system	1253	1261	Diabetic
I-Classification_system	1262	1273	Retinopathy
I-Classification_system	1274	1279	Study
I-Classification_system	1280	1281	(
I-Classification_system	1281	1286	ETDRS
I-Classification_system	1286	1287	)
I-Classification_system	1288	1290	FA
I-Classification_system	1291	1298	grading
I-Classification_system	1299	1305	system
O	1305	1306	.

O	1307	1319	Correlations
O	1320	1324	were
O	1325	1331	sought
O	1332	1339	between
B-Symptom	1340	1346	foveal
I-Symptom	1347	1350	GCL
I-Symptom	1351	1357	damage
O	1358	1368	identified
O	1369	1371	on
B-Diagnostic_tool	1372	1375	OCT
O	1376	1379	and
B-Characteristic	1380	1382	FA
I-Characteristic	1383	1392	capillary
I-Characteristic	1393	1400	dropout
I-Characteristic	1401	1406	sites
O	1406	1407	.

B-Symptom	1408	1414	Foveal
I-Symptom	1415	1418	GCL
I-Symptom	1419	1425	damage
O	1426	1428	on
B-Diagnostic_tool	1429	1432	OCT
O	1432	1433	,
O	1434	1437	the
B-Characteristic	1438	1442	size
I-Characteristic	1443	1445	of
I-Characteristic	1446	1449	the
I-Characteristic	1450	1457	foveola
I-Characteristic	1458	1460	on
I-Characteristic	1461	1464	OCT
O	1465	1466	(
O	1466	1473	defined
O	1474	1476	as
O	1477	1480	the
B-Characteristic	1481	1485	area
I-Characteristic	1486	1488	of
I-Characteristic	1489	1492	GCL
I-Characteristic	1493	1502	thickness
O	1504	1505	<
O	1506	1508	10
O	1509	1515	microm
O	1515	1516	)
O	1516	1517	,
B-Characteristic	1518	1523	ETDRS
I-Characteristic	1524	1531	grading
I-Characteristic	1532	1534	of
I-Characteristic	1535	1538	FAZ
I-Characteristic	1539	1541	on
I-Characteristic	1542	1544	FA
O	1544	1545	,
O	1546	1549	and
B-Characteristic	1550	1556	visual
I-Characteristic	1557	1563	acuity
O	1563	1564	.

O	1565	1570	Among
O	1571	1574	the
O	1575	1578	124
B-Anatomy	1579	1583	eyes
O	1584	1588	with
B-Disease	1589	1597	diabetic
I-Disease	1598	1609	retinopathy
O	1609	1610	,
O	1611	1613	62
O	1614	1615	(
O	1615	1617	50
O	1617	1618	%
O	1618	1619	)
O	1620	1623	had
B-Diagnostic_tool	1624	1626	FA
O	1627	1635	evidence
O	1636	1638	of
O	1639	1645	either
B-Symptom	1646	1649	FAZ
I-Symptom	1650	1656	damage
O	1657	1663	higher
O	1664	1668	than
O	1669	1674	grade
O	1675	1676	1
O	1677	1679	or
B-Symptom	1680	1683	FAZ
I-Symptom	1684	1693	capillary
I-Symptom	1694	1698	loss
O	1698	1699	.

O	1700	1702	In
O	1703	1708	these
B-Anatomy	1709	1713	eyes
O	1713	1714	,
B-Symptom	1715	1721	damage
I-Symptom	1722	1724	to
I-Symptom	1725	1728	the
I-Symptom	1729	1732	FAZ
O	1733	1737	seen
O	1738	1740	on
B-Diagnostic_tool	1741	1743	FA
O	1744	1748	also
O	1749	1754	could
O	1755	1757	be
O	1758	1766	detected
O	1767	1769	on
B-Diagnostic_tool	1770	1773	OCT
O	1774	1775	(
O	1775	1783	positive
O	1784	1794	predictive
O	1795	1800	value
O	1800	1801	,
O	1802	1804	84
O	1804	1805	.
O	1805	1806	5
O	1806	1807	%
O	1807	1808	;
O	1809	1817	negative
O	1818	1828	predictive
O	1829	1834	value
O	1834	1835	,
O	1836	1838	72
O	1838	1839	.
O	1839	1840	9
O	1840	1841	%
O	1841	1842	)
O	1842	1843	,
O	1844	1847	and
O	1848	1857	locations
O	1858	1860	of
B-Symptom	1861	1864	FAZ
I-Symptom	1865	1871	damage
O	1872	1876	seen
O	1877	1879	on
B-Diagnostic_tool	1880	1882	FA
O	1883	1895	corresponded
O	1896	1900	well
O	1901	1905	with
O	1906	1911	sites
O	1912	1914	of
B-Symptom	1915	1921	foveal
I-Symptom	1922	1925	GCL
I-Symptom	1926	1932	damage
O	1933	1935	on
B-Diagnostic_tool	1936	1939	OCT
O	1939	1940	.

O	1941	1943	In
O	1944	1955	nondiabetic
O	1955	1956	,
O	1957	1963	normal
B-Anatomy	1964	1968	eyes
O	1968	1969	,
O	1970	1973	the
B-Characteristic	1974	1978	size
I-Characteristic	1979	1981	of
I-Characteristic	1982	1985	the
I-Characteristic	1986	1993	foveola
I-Characteristic	1994	1996	on
I-Characteristic	1997	2000	OCT
O	2001	2008	matched
O	2009	2012	the
B-Characteristic	2013	2017	size
I-Characteristic	2018	2020	of
I-Characteristic	2021	2024	the
I-Characteristic	2025	2028	FAZ
I-Characteristic	2029	2031	on
I-Characteristic	2032	2034	FA
O	2034	2035	.

O	2036	2044	Evidence
O	2045	2047	of
B-Symptom	2048	2054	foveal
I-Symptom	2055	2058	GCL
I-Symptom	2059	2065	damage
O	2066	2068	on
B-Diagnostic_tool	2069	2072	OCT
O	2073	2075	is
O	2076	2077	a
O	2078	2082	good
O	2083	2092	indicator
O	2093	2095	of
B-Symptom	2096	2103	macular
I-Symptom	2104	2112	ischemic
I-Symptom	2113	2119	damage
O	2120	2122	in
B-Anatomy	2123	2127	eyes
O	2128	2132	with
B-Disease	2133	2141	diabetic
I-Disease	2142	2153	retinopathy
O	2153	2154	.

O	2155	2163	Although
O	2164	2166	in
O	2167	2171	this
O	2172	2177	study
B-Diagnostic_tool	2178	2180	FA
O	2181	2184	was
O	2185	2189	more
O	2190	2199	sensitive
O	2200	2204	than
B-Diagnostic_tool	2205	2208	OCT
O	2209	2211	in
O	2212	2221	detecting
B-Symptom	2222	2230	vascular
I-Symptom	2231	2237	damage
O	2237	2238	,
B-Diagnostic_tool	2239	2242	OCT
O	2243	2251	provides
O	2252	2261	objective
O	2262	2269	results
O	2270	2273	and
O	2274	2279	seems
O	2280	2282	to
O	2283	2285	be
O	2286	2287	a
O	2288	2292	good
O	2293	2304	noninvasive
O	2305	2315	substitute
O	2316	2319	for
B-Diagnostic_tool	2320	2322	FA
O	2322	2323	.

O	0	4	Does
O	5	8	the
O	9	17	presence
O	18	20	of
O	21	23	an
B-Symptom	24	34	epiretinal
I-Symptom	35	43	membrane
O	44	49	alter
O	50	53	the
O	54	62	cleavage
O	63	68	plane
O	69	75	during
B-Anatomy	76	84	internal
I-Anatomy	85	93	limiting
I-Anatomy	94	102	membrane
O	103	110	peeling
O	110	111	?

O	113	115	To
O	116	125	determine
O	126	133	whether
O	134	137	the
O	138	146	presence
O	147	149	of
O	150	151	a
O	152	162	clinically
O	163	166	and
O	166	167	/
O	167	169	or
O	170	185	microscopically
O	186	196	detectable
B-Symptom	197	207	epiretinal
I-Symptom	208	216	membrane
O	217	218	(
B-Symptom	218	221	ERM
O	221	222	)
O	223	229	alters
O	230	233	the
O	234	242	cleavage
O	243	248	plane
O	249	255	during
B-Anatomy	256	264	internal
I-Anatomy	265	273	limiting
I-Anatomy	274	282	membrane
O	283	284	(
B-Anatomy	284	287	ILM
O	287	288	)
O	289	296	peeling
O	296	297	.

O	298	311	Retrospective
O	311	312	,
O	313	326	observational
O	326	327	,
O	328	347	immunohistochemical
O	348	353	study
O	354	356	of
B-Anatomy	357	360	ILM
O	361	370	specimens
O	371	376	using
O	377	385	archival
O	386	394	formalin
O	394	395	-
O	395	400	fixed
O	400	401	,
O	402	410	paraffin
O	410	411	-
O	411	419	embedded
O	420	426	tissue
O	426	427	.

O	428	433	Fifty
O	433	434	-
O	434	437	one
O	438	446	patients
O	447	450	who
O	451	454	had
O	455	458	had
B-Anatomy	459	462	ILM
O	463	471	excision
O	471	472	.

O	473	478	Fifty
O	478	479	-
O	479	482	one
B-Anatomy	483	486	ILM
O	487	496	specimens
O	497	503	peeled
O	504	510	during
O	511	521	vitrectomy
O	522	525	for
O	526	533	various
O	534	544	etiologies
O	545	549	were
O	550	558	examined
O	559	561	by
B-Diagnostic_tool	562	567	light
I-Diagnostic_tool	568	578	microscopy
O	578	579	.

O	580	583	The
O	584	591	removal
O	592	594	of
B-Anatomy	595	598	ILM
O	599	602	was
O	603	611	assisted
O	612	617	using
O	618	624	Trypan
O	625	629	blue
O	630	631	(
O	631	632	n
O	633	634	=
O	635	637	30
O	637	638	)
O	638	639	,
O	640	651	indocyanine
O	652	657	green
O	658	659	(
O	659	660	n
O	661	662	=
O	663	664	7
O	664	665	)
O	665	666	,
O	667	669	or
O	670	679	brilliant
O	680	684	blue
O	685	686	G
O	687	688	(
O	688	689	n
O	690	691	=
O	692	694	14
O	694	695	)
O	695	696	.

B-Characteristic	697	707	Monoclonal
I-Characteristic	708	718	antibodies
I-Characteristic	719	721	to
I-Characteristic	722	727	glial
I-Characteristic	728	738	fibrillary
I-Characteristic	739	745	acidic
I-Characteristic	746	753	protein
I-Characteristic	754	757	and
I-Characteristic	758	760	to
I-Characteristic	761	774	neurofilament
I-Characteristic	775	782	protein
O	783	787	were
O	788	792	used
O	793	795	to
O	796	802	detect
B-Anatomy	803	808	glial
I-Anatomy	809	811	or
I-Anatomy	812	820	neuronal
I-Anatomy	821	826	cells
O	827	839	respectively
O	840	842	on
O	843	846	the
B-Anatomy	847	855	vitreous
I-Anatomy	856	858	or
I-Anatomy	859	866	retinal
I-Anatomy	867	875	surfaces
I-Anatomy	876	878	of
I-Anatomy	879	882	the
I-Anatomy	883	886	ILM
O	886	887	.

O	888	897	Specimens
O	898	902	were
O	903	910	divided
O	911	915	into
O	916	917	2
O	918	924	groups
O	924	925	:
B-Anatomy	926	929	ILM
O	930	936	peeled
O	937	940	for
B-Characteristic	941	945	full
I-Characteristic	945	946	-
I-Characteristic	946	955	thickness
I-Characteristic	956	963	macular
I-Characteristic	964	968	hole
O	969	970	(
B-Characteristic	970	972	MH
O	972	973	;
O	974	975	n
O	976	977	=
O	978	980	31
O	980	981	)
O	982	985	and
B-Anatomy	986	989	ILM
O	990	996	peeled
O	997	1002	after
O	1003	1010	removal
O	1011	1013	of
O	1014	1024	clinically
O	1025	1035	detectable
B-Symptom	1036	1039	ERM
O	1040	1041	(
O	1041	1042	n
O	1043	1044	=
O	1045	1047	20
O	1047	1048	)
O	1048	1049	.

O	1050	1057	Primary
O	1058	1065	outcome
O	1066	1073	measure
O	1074	1077	was
O	1078	1081	the
O	1082	1094	localization
O	1095	1097	of
B-Characteristic	1098	1117	immunohistochemical
I-Characteristic	1118	1125	markers
O	1126	1128	to
B-Anatomy	1129	1137	neuronal
I-Anatomy	1138	1140	or
I-Anatomy	1141	1146	glial
I-Anatomy	1147	1152	cells
I-Anatomy	1153	1155	on
I-Anatomy	1156	1159	the
I-Anatomy	1160	1168	vitreous
I-Anatomy	1169	1171	or
I-Anatomy	1172	1179	retinal
I-Anatomy	1180	1188	surfaces
I-Anatomy	1189	1191	of
I-Anatomy	1192	1195	ILM
O	1195	1196	.

O	1197	1200	The
O	1201	1210	secondary
O	1211	1218	outcome
O	1219	1226	measure
O	1227	1230	was
O	1231	1234	the
O	1235	1246	correlation
O	1247	1249	of
O	1250	1253	the
O	1254	1261	results
O	1262	1264	of
O	1265	1268	the
O	1269	1276	primary
O	1277	1284	measure
O	1285	1289	with
O	1290	1293	the
O	1294	1298	dyes
O	1299	1303	used
O	1304	1306	to
O	1307	1317	facilitate
B-Anatomy	1318	1321	ILM
O	1322	1329	peeling
O	1329	1330	.

B-Anatomy	1331	1336	Glial
I-Anatomy	1337	1340	and
I-Anatomy	1340	1341	/
I-Anatomy	1341	1343	or
I-Anatomy	1344	1352	neuronal
I-Anatomy	1353	1358	cells
O	1359	1363	were
O	1364	1372	detected
O	1373	1375	on
O	1376	1379	the
B-Anatomy	1380	1387	retinal
I-Anatomy	1388	1395	surface
O	1396	1398	of
O	1399	1402	the
B-Anatomy	1403	1406	ILM
O	1407	1409	in
O	1410	1412	10
O	1413	1415	of
O	1416	1418	31
O	1419	1420	(
O	1420	1422	32
O	1422	1423	%
O	1423	1424	)
O	1425	1427	of
O	1428	1431	the
B-Characteristic	1432	1434	MH
I-Characteristic	1435	1438	ILM
O	1439	1448	specimens
O	1449	1452	and
O	1453	1455	in
O	1456	1458	13
O	1459	1461	of
O	1462	1464	20
O	1465	1466	(
O	1466	1468	65
O	1468	1469	%
O	1469	1470	)
O	1471	1473	of
O	1474	1477	the
B-Anatomy	1478	1481	ILM
O	1482	1488	peeled
O	1489	1494	after
B-Symptom	1495	1498	ERM
O	1499	1507	excision
O	1507	1508	;
O	1509	1512	the
O	1513	1523	difference
O	1524	1527	was
O	1528	1539	significant
O	1540	1541	(
O	1541	1542	P
O	1543	1544	=
O	1545	1546	0
O	1546	1547	.
O	1547	1549	02
O	1549	1550	)
O	1550	1551	.

O	1552	1557	There
O	1558	1561	was
O	1562	1564	no
O	1565	1576	association
O	1577	1584	between
O	1585	1588	the
O	1589	1597	presence
O	1598	1600	of
B-Anatomy	1601	1609	neuronal
I-Anatomy	1610	1613	and
I-Anatomy	1614	1619	glial
I-Anatomy	1620	1625	cells
O	1626	1630	with
O	1631	1634	the
O	1635	1639	type
O	1640	1642	of
O	1643	1646	dye
O	1647	1651	used
O	1652	1653	(
O	1653	1654	P
O	1655	1656	=
O	1657	1658	0
O	1658	1659	.
O	1659	1660	2
O	1660	1661	)
O	1661	1662	.

O	1663	1665	Of
O	1666	1669	the
O	1670	1672	23
B-Anatomy	1673	1676	ILM
O	1677	1686	specimens
O	1687	1691	with
O	1692	1697	cells
O	1698	1706	attached
O	1707	1709	to
O	1710	1713	the
B-Anatomy	1714	1721	retinal
I-Anatomy	1722	1729	surface
O	1729	1730	,
O	1731	1733	21
O	1734	1735	(
O	1735	1737	91
O	1737	1738	%
O	1738	1739	)
O	1740	1744	were
O	1745	1755	associated
O	1756	1760	with
O	1761	1769	clinical
O	1770	1773	and
O	1773	1774	/
O	1774	1776	or
O	1777	1787	histologic
O	1788	1796	evidence
O	1797	1799	of
B-Symptom	1800	1803	ERM
O	1804	1807	and
O	1808	1809	2
O	1810	1811	(
O	1811	1812	9
O	1812	1813	%
O	1813	1814	)
O	1815	1819	were
O	1820	1823	not
O	1823	1824	.

O	1825	1828	The
O	1829	1840	correlation
O	1841	1848	between
O	1849	1852	the
O	1853	1861	presence
O	1862	1864	of
B-Anatomy	1865	1870	cells
I-Anatomy	1871	1873	on
I-Anatomy	1874	1877	the
I-Anatomy	1878	1886	vitreous
I-Anatomy	1887	1890	and
I-Anatomy	1891	1894	the
I-Anatomy	1895	1902	retinal
I-Anatomy	1903	1911	surfaces
I-Anatomy	1912	1914	of
I-Anatomy	1915	1918	ILM
O	1919	1922	was
O	1923	1927	high
O	1928	1929	(
O	1929	1930	P
O	1931	1932	<
O	1933	1934	0
O	1934	1935	.
O	1935	1939	0001
O	1939	1940	)
O	1940	1941	.

O	1942	1945	The
O	1946	1954	findings
O	1955	1962	suggest
O	1963	1967	that
B-Symptom	1968	1971	ERM
O	1972	1975	may
O	1976	1978	be
O	1979	1989	associated
O	1990	1994	with
B-Characteristic	1995	1998	sub
I-Characteristic	1998	1999	-
I-Characteristic	1999	2002	ILM
I-Characteristic	2003	2010	changes
O	2011	2015	that
O	2016	2021	alter
O	2022	2025	the
O	2026	2031	plane
O	2032	2034	of
O	2035	2045	separation
O	2046	2052	during
B-Anatomy	2053	2056	ILM
O	2057	2064	peeling
O	2064	2065	.

O	2066	2070	This
O	2071	2076	study
O	2077	2081	does
O	2082	2085	not
O	2086	2093	confirm
O	2094	2097	any
O	2098	2107	influence
O	2108	2110	of
O	2111	2115	dyes
O	2116	2118	on
O	2119	2122	the
O	2123	2131	cleavage
O	2132	2137	plane
O	2138	2144	during
O	2145	2152	surgery
O	2152	2153	.

O	0	2	In
O	3	7	vivo
B-Anatomy	8	15	retinal
I-Anatomy	16	26	morphology
O	27	32	after
O	33	37	grid
O	38	43	laser
O	44	53	treatment
O	54	56	in
B-Disease	57	65	diabetic
I-Disease	66	73	macular
I-Disease	74	79	edema
O	79	80	.

O	82	84	To
O	85	92	analyze
O	93	102	immediate
O	103	105	in
O	106	110	vivo
B-Symptom	111	123	intraretinal
I-Symptom	124	135	morphologic
I-Symptom	136	143	changes
O	144	153	secondary
O	154	156	to
O	157	169	standardized
O	170	174	grid
O	175	191	photocoagulation
O	192	197	using
B-Diagnostic_tool	198	206	spectral
I-Diagnostic_tool	207	213	domain
I-Diagnostic_tool	214	221	optical
I-Diagnostic_tool	222	231	coherence
I-Diagnostic_tool	232	242	tomography
O	243	244	(
B-Diagnostic_tool	244	246	SD
I-Diagnostic_tool	247	250	OCT
O	250	251	)
O	251	252	.

O	253	264	Prospective
O	265	273	clinical
O	274	279	trial
O	279	280	.

O	281	289	Thirteen
O	290	301	consecutive
O	302	310	patients
O	311	315	with
O	316	325	treatment
O	325	326	-
O	326	328	na
O	328	329	
O	329	331	ve
O	332	342	clinically
O	343	354	significant
B-Disease	355	363	diabetic
I-Disease	364	371	macular
I-Disease	372	377	edema
O	378	379	(
B-Disease	379	382	DME
O	382	383	)
O	383	384	.

O	385	391	Before
O	392	395	and
O	396	397	1
O	398	401	day
O	402	407	after
O	408	420	standardized
O	421	425	grid
O	426	442	photocoagulation
O	443	448	using
O	449	452	the
O	453	459	PASCAL
O	460	466	system
O	467	468	(
O	468	475	Pattern
O	476	480	Scan
O	481	486	Laser
O	486	487	,
O	488	498	OptiMedica
O	499	510	Corporation
O	510	511	,
O	512	517	Santa
O	518	523	Clara
O	523	524	,
O	525	527	CA
O	527	528	)
O	528	529	,
B-Diagnostic_tool	530	540	Spectralis
I-Diagnostic_tool	541	544	OCT
O	545	546	(
O	546	556	Heidelberg
O	557	568	Engineering
O	568	569	,
O	570	580	Heidelberg
O	580	581	,
O	582	589	Germany
O	589	590	)
O	591	603	examinations
O	604	609	based
O	610	612	on
O	613	615	an
B-Diagnostic_tool	616	619	eye
I-Diagnostic_tool	619	620	-
I-Diagnostic_tool	620	628	tracking
I-Diagnostic_tool	629	635	system
O	635	636	,
B-Diagnostic_tool	637	645	infrared
I-Diagnostic_tool	646	652	fundus
I-Diagnostic_tool	653	660	imaging
O	660	661	,
B-Diagnostic_tool	662	667	color
I-Diagnostic_tool	668	674	fundus
I-Diagnostic_tool	675	686	photography
O	686	687	,
O	688	691	and
B-Diagnostic_tool	692	705	biomicroscopy
O	706	710	were
O	711	720	performed
O	720	721	.

O	722	723	A
O	724	736	standardized
B-Diagnostic_tool	737	743	visual
I-Diagnostic_tool	744	750	acuity
O	751	761	assessment
O	762	763	(
O	763	768	Early
O	769	778	Treatment
O	779	787	Diabetic
O	788	799	Retinopathy
O	800	805	Study
O	806	814	protocol
O	814	815	)
O	816	819	and
B-Diagnostic_tool	820	831	fluorescein
I-Diagnostic_tool	832	843	angiography
O	844	848	were
O	849	858	performed
O	859	861	at
O	862	870	baseline
O	870	871	.

B-Symptom	872	883	Morphologic
I-Symptom	884	891	changes
O	892	901	secondary
O	902	904	to
O	905	909	grid
O	910	915	laser
O	916	925	treatment
O	925	926	.

O	927	930	One
O	931	934	day
O	935	940	after
O	941	946	laser
O	947	954	therapy
O	954	955	,
O	956	965	immediate
O	966	977	morphologic
O	978	989	alterations
O	990	992	of
O	993	997	only
O	998	1001	the
B-Anatomy	1002	1007	outer
I-Anatomy	1008	1015	retinal
I-Anatomy	1016	1022	layers
O	1022	1023	,
O	1024	1028	that
O	1029	1031	is
O	1031	1032	,
O	1033	1036	the
B-Anatomy	1037	1044	retinal
I-Anatomy	1045	1052	pigment
I-Anatomy	1053	1063	epithelium
O	1064	1065	(
B-Anatomy	1065	1068	RPE
O	1068	1069	)
O	1069	1070	,
O	1071	1074	the
B-Anatomy	1075	1088	photoreceptor
I-Anatomy	1089	1094	layer
O	1095	1096	(
B-Anatomy	1096	1099	PRL
O	1099	1100	)
O	1100	1101	,
O	1102	1105	and
O	1106	1109	the
B-Anatomy	1110	1115	outer
I-Anatomy	1116	1123	nuclear
I-Anatomy	1124	1129	layer
O	1130	1131	(
B-Anatomy	1131	1134	ONL
O	1134	1135	)
O	1135	1136	,
O	1137	1141	were
O	1142	1150	observed
O	1150	1151	.

O	1152	1155	The
O	1156	1161	shape
O	1162	1164	of
O	1165	1168	the
O	1169	1174	laser
O	1174	1175	-
O	1175	1182	induced
O	1183	1190	lesions
O	1191	1194	did
O	1195	1198	not
O	1199	1203	show
O	1204	1205	a
O	1206	1214	sagittal
O	1215	1225	alteration
O	1226	1233	pattern
O	1234	1244	throughout
O	1245	1248	all
O	1249	1250	3
O	1251	1253	of
O	1254	1257	the
O	1258	1264	layers
O	1264	1265	,
O	1266	1273	however
O	1273	1274	,
O	1275	1278	but
O	1279	1285	rather
O	1286	1292	seemed
O	1293	1295	to
O	1296	1302	follow
O	1303	1305	an
O	1306	1313	oblique
O	1314	1321	pathway
O	1322	1332	throughout
O	1333	1336	the
B-Anatomy	1337	1340	ONL
O	1340	1341	,
O	1342	1350	changing
O	1351	1360	direction
O	1361	1363	at
O	1364	1367	the
O	1368	1373	level
O	1374	1376	of
O	1377	1380	the
B-Anatomy	1381	1389	external
I-Anatomy	1390	1398	limiting
I-Anatomy	1399	1407	membrane
O	1408	1411	and
O	1412	1422	proceeding
O	1423	1433	sagittally
O	1434	1441	through
O	1442	1445	the
B-Anatomy	1446	1449	PRL
O	1450	1453	and
B-Anatomy	1454	1457	RPE
O	1457	1458	.

O	1459	1464	These
B-Symptom	1465	1476	morphologic
I-Symptom	1477	1484	changes
O	1485	1489	also
O	1490	1497	induced
B-Symptom	1498	1507	biometric
I-Symptom	1508	1515	changes
O	1515	1516	,
O	1517	1521	such
O	1522	1524	as
O	1525	1526	a
O	1527	1535	decrease
O	1536	1538	in
B-Symptom	1539	1546	central
I-Symptom	1547	1554	retinal
I-Symptom	1555	1564	thickness
O	1565	1573	combined
O	1574	1578	with
B-Symptom	1579	1584	local
I-Symptom	1585	1595	thickening
I-Symptom	1596	1598	at
I-Symptom	1599	1602	the
I-Symptom	1603	1609	lesion
I-Symptom	1610	1614	site
O	1614	1615	,
O	1616	1626	especially
O	1627	1629	in
O	1630	1633	the
B-Anatomy	1634	1637	PRL
O	1637	1638	.

B-Diagnostic_tool	1639	1647	Spectral
I-Diagnostic_tool	1648	1654	domain
I-Diagnostic_tool	1655	1662	optical
I-Diagnostic_tool	1663	1672	coherence
I-Diagnostic_tool	1673	1683	tomography
O	1684	1692	provides
O	1693	1696	new
O	1697	1704	insight
O	1705	1709	into
O	1710	1713	the
O	1714	1723	immediate
B-Symptom	1724	1735	morphologic
I-Symptom	1736	1743	changes
O	1744	1749	after
O	1750	1755	laser
O	1756	1765	treatment
O	1766	1771	using
O	1772	1775	the
O	1776	1782	PASCAL
O	1783	1788	laser
O	1789	1795	system
O	1795	1796	.

O	1797	1809	Standardized
O	1810	1814	grid
O	1815	1831	photocoagulation
O	1832	1839	induces
O	1840	1854	characteristic
O	1855	1865	homogenous
O	1866	1876	alteration
O	1877	1879	in
O	1880	1883	the
B-Anatomy	1884	1897	neurosensoric
I-Anatomy	1898	1905	retinal
I-Anatomy	1906	1912	layers
O	1912	1913	.

B-Symptom	1914	1923	Biometric
I-Symptom	1924	1931	changes
O	1931	1932	,
O	1933	1943	indicating
O	1944	1946	an
O	1947	1956	immediate
O	1957	1963	effect
O	1963	1964	,
O	1965	1969	were
O	1970	1978	observed
O	1979	1985	within
O	1986	1987	1
O	1988	1991	day
O	1992	1997	after
O	1998	2007	treatment
O	2007	2008	.

B-Characteristic	0	7	Central
I-Characteristic	8	15	corneal
I-Characteristic	16	25	thickness
O	26	28	in
B-Characteristic	29	34	adult
I-Characteristic	35	40	South
I-Characteristic	41	48	Indians
O	48	49	:
O	50	53	the
O	54	61	Chennai
B-Disease	62	70	Glaucoma
O	71	76	Study
O	76	77	.

O	79	81	To
O	82	90	evaluate
O	91	94	the
O	95	110	characteristics
O	111	113	of
B-Characteristic	114	121	central
I-Characteristic	122	129	corneal
I-Characteristic	130	139	thickness
O	140	141	(
B-Characteristic	141	144	CCT
O	144	145	)
O	146	149	and
O	150	153	its
O	154	165	association
O	166	170	with
B-Characteristic	171	174	age
O	174	175	,
B-Characteristic	176	182	gender
O	182	183	,
O	184	187	and
B-Characteristic	188	199	intraocular
I-Characteristic	200	208	pressure
O	209	211	in
B-Characteristic	212	217	rural
I-Characteristic	218	221	and
I-Characteristic	222	227	urban
I-Characteristic	228	233	South
I-Characteristic	234	240	Indian
I-Characteristic	241	252	populations
O	252	253	.

O	254	264	Population
O	264	265	-
O	265	270	based
O	271	276	cross
O	276	277	-
O	277	286	sectional
O	287	292	study
O	292	293	.

O	294	299	Seven
O	300	308	thousand
O	309	314	seven
O	315	322	hundred
O	323	330	seventy
O	330	331	-
O	331	335	four
O	336	344	subjects
O	345	346	(
O	346	351	rural
O	351	352	-
O	352	354	to
O	354	355	-
O	355	360	urban
O	361	366	ratio
O	366	367	,
O	368	372	3924
O	372	373	:
O	373	377	3850
O	377	378	)
B-Characteristic	379	383	aged
I-Characteristic	384	386	40
I-Characteristic	387	392	years
I-Characteristic	393	396	and
I-Characteristic	397	402	older
O	403	407	were
O	408	416	examined
O	417	419	at
O	420	421	a
O	422	431	dedicated
O	432	440	facility
O	441	443	in
O	444	447	the
O	448	452	base
O	453	461	hospital
O	461	462	.

O	463	466	All
O	467	475	subjects
O	476	485	underwent
O	486	487	a
O	488	496	complete
B-Diagnostic_tool	497	507	ophthalmic
I-Diagnostic_tool	508	519	examination
O	520	524	that
O	525	533	included
B-Characteristic	534	537	CCT
O	538	550	measurements
O	551	555	with
O	556	558	an
B-Diagnostic_tool	559	569	ultrasonic
I-Diagnostic_tool	570	580	pachymeter
O	581	584	and
B-Diagnostic_tool	585	596	applanation
I-Diagnostic_tool	597	606	tonometry
O	606	607	.

B-Characteristic	608	615	Central
I-Characteristic	616	623	corneal
I-Characteristic	624	633	thickness
O	633	634	.

O	635	637	Of
O	638	641	the
O	642	646	7774
O	647	655	subjects
O	656	664	examined
O	664	665	,
O	666	669	974
O	670	673	had
O	674	683	undergone
B-Disease	684	692	cataract
O	693	700	surgery
O	701	704	and
O	705	709	were
O	710	718	excluded
O	718	719	.

O	720	723	The
O	724	733	remaining
O	734	738	6800
O	739	743	were
O	744	755	bilaterally
O	756	762	phakic
O	762	763	,
O	764	766	of
O	767	772	which
O	773	775	46
O	776	780	were
O	781	789	excluded
O	790	791	(
O	791	793	17
B-Disease	794	802	glaucoma
O	803	811	subjects
O	812	821	receiving
O	822	831	treatment
O	831	832	,
O	833	835	12
O	836	840	with
B-Characteristic	841	848	corneal
I-Characteristic	849	859	pathologic
I-Characteristic	860	868	features
O	869	872	and
O	873	875	17
O	876	880	with
O	881	891	incomplete
O	892	896	data
O	896	897	)
O	898	901	and
O	902	906	6754
O	907	915	subjects
O	916	920	data
O	921	925	were
O	926	934	analyzed
O	934	935	.

O	936	939	The
O	940	944	mean
B-Characteristic	945	948	CCT
O	949	952	for
O	953	956	the
O	957	967	population
O	968	971	was
O	972	975	511
O	975	976	.
O	976	977	4
O	977	978	+
O	978	979	/
O	979	980	-
O	980	982	33
O	982	983	.
O	983	984	5
O	985	991	microm
O	991	992	,
O	993	996	and
B-Characteristic	997	1000	CCT
O	1001	1003	in
B-Characteristic	1004	1009	males
O	1010	1011	(
O	1011	1014	515
O	1014	1015	.
O	1015	1016	6
O	1016	1017	+
O	1017	1018	/
O	1018	1019	-
O	1019	1021	33
O	1021	1022	.
O	1022	1023	8
O	1024	1030	microm
O	1030	1031	)
O	1032	1035	was
O	1036	1049	significantly
O	1050	1051	(
O	1051	1052	P
O	1053	1054	=
O	1055	1056	0
O	1056	1057	.
O	1057	1061	0001
O	1061	1062	)
O	1063	1070	greater
O	1071	1075	than
B-Characteristic	1076	1083	females
O	1084	1085	(
O	1085	1088	508
O	1088	1089	.
O	1089	1090	0
O	1090	1091	+
O	1091	1092	/
O	1092	1093	-
O	1093	1095	32
O	1095	1096	.
O	1096	1097	8
O	1098	1104	microm
O	1104	1105	)
O	1105	1106	.

O	1107	1110	The
B-Characteristic	1111	1114	CCT
O	1115	1118	was
O	1119	1132	significantly
O	1133	1140	greater
O	1141	1142	(
O	1142	1144	by
O	1145	1147	18
O	1148	1154	microm
O	1154	1155	)
O	1156	1158	in
O	1159	1162	the
B-Characteristic	1163	1168	urban
I-Characteristic	1169	1179	population
O	1180	1183	and
O	1184	1193	decreased
O	1194	1198	with
B-Characteristic	1199	1202	age
O	1203	1205	in
O	1206	1210	both
O	1211	1218	genders
O	1219	1220	(
O	1220	1221	P
O	1222	1223	<
O	1224	1225	0
O	1225	1226	.
O	1226	1230	0001
O	1230	1231	)
O	1231	1232	.

O	1233	1236	The
O	1237	1245	decrease
O	1246	1249	per
O	1250	1256	decade
O	1257	1260	was
O	1261	1262	4
O	1262	1263	.
O	1263	1265	34
O	1266	1272	microm
O	1273	1274	(
O	1274	1276	95
O	1276	1277	%
O	1278	1288	confidence
O	1289	1297	interval
O	1298	1299	[
O	1299	1301	CI
O	1301	1302	]
O	1302	1303	,
O	1304	1305	3
O	1305	1306	.
O	1306	1308	24
O	1308	1309	-
O	1309	1310	5
O	1310	1311	.
O	1311	1313	44
O	1313	1314	)
O	1315	1317	in
O	1318	1321	the
B-Characteristic	1322	1327	rural
I-Characteristic	1328	1338	population
O	1339	1342	and
O	1343	1344	2
O	1344	1345	.
O	1345	1347	41
O	1348	1354	microm
O	1355	1356	(
O	1356	1358	95
O	1358	1359	%
O	1360	1362	CI
O	1362	1363	,
O	1364	1365	1
O	1365	1366	.
O	1366	1368	25
O	1368	1369	-
O	1369	1370	3
O	1370	1371	.
O	1371	1373	53
O	1373	1374	)
O	1375	1377	in
O	1378	1381	the
B-Characteristic	1382	1387	urban
I-Characteristic	1388	1398	population
O	1398	1399	.

O	1400	1401	A
O	1402	1405	100
O	1405	1406	-
O	1406	1412	microm
O	1413	1421	increase
O	1422	1424	in
B-Characteristic	1425	1428	CCT
O	1429	1432	was
O	1433	1443	associated
O	1444	1448	with
O	1449	1450	a
O	1451	1452	1
O	1452	1453	.
O	1453	1455	96
O	1455	1456	-
O	1456	1460	mmHg
O	1461	1469	increase
O	1470	1472	in
B-Characteristic	1473	1484	intraocular
I-Characteristic	1485	1493	pressure
O	1494	1496	in
O	1497	1500	the
B-Characteristic	1501	1506	rural
I-Characteristic	1507	1517	population
O	1517	1518	,
O	1519	1525	versus
O	1526	1527	2
O	1527	1528	.
O	1528	1530	45
O	1531	1535	mmHg
O	1536	1539	for
O	1540	1545	every
O	1546	1549	100
O	1550	1556	microm
O	1557	1559	in
O	1560	1563	the
B-Characteristic	1564	1569	urban
I-Characteristic	1570	1580	population
O	1580	1581	.

O	1582	1584	In
O	1585	1589	this
O	1590	1600	population
O	1600	1601	-
O	1601	1606	based
O	1607	1612	study
O	1612	1613	,
B-Characteristic	1614	1621	females
O	1622	1625	and
O	1626	1634	subjects
O	1635	1641	living
O	1642	1644	in
O	1645	1646	a
B-Characteristic	1647	1652	rural
I-Characteristic	1653	1657	area
O	1658	1661	had
B-Symptom	1662	1669	thinner
I-Symptom	1670	1677	corneas
O	1677	1678	.

O	1679	1680	A
O	1681	1689	negative
O	1690	1701	association
O	1702	1706	with
B-Characteristic	1707	1710	age
O	1711	1714	and
O	1715	1716	a
O	1717	1725	positive
O	1726	1737	association
O	1738	1742	with
B-Characteristic	1743	1754	intraocular
I-Characteristic	1755	1763	pressure
O	1764	1768	were
O	1769	1773	seen
O	1773	1774	.

O	1775	1780	These
O	1781	1789	findings
O	1790	1794	will
O	1795	1799	have
O	1800	1812	implications
O	1813	1815	in
O	1816	1819	the
O	1820	1829	diagnosis
O	1830	1833	and
O	1834	1844	management
O	1845	1847	of
B-Disease	1848	1856	glaucoma
O	1857	1859	in
O	1860	1864	this
O	1865	1875	population
O	1875	1876	.

O	1877	1888	Proprietary
O	1889	1891	or
O	1892	1902	commercial
O	1903	1913	disclosure
O	1914	1917	may
O	1918	1920	be
O	1921	1926	found
O	1927	1932	after
O	1933	1936	the
O	1937	1947	references
O	1947	1948	.

O	0	1	A
O	2	10	proposed
O	11	17	method
O	18	20	of
O	21	32	logarithmic
O	33	47	transformation
O	48	50	of
B-Diagnostic_tool	51	58	optical
I-Diagnostic_tool	59	68	coherence
I-Diagnostic_tool	69	79	tomography
O	80	84	data
O	85	88	for
O	89	92	use
O	93	95	in
O	96	104	clinical
O	105	113	research
O	113	114	.

O	116	118	To
O	119	127	evaluate
O	128	129	a
O	130	141	logarithmic
O	142	156	transformation
O	157	159	of
B-Characteristic	160	167	retinal
I-Characteristic	168	177	thickness
O	178	190	measurements
O	191	195	from
B-Diagnostic_tool	196	203	optical
I-Diagnostic_tool	204	213	coherence
I-Diagnostic_tool	214	224	tomography
O	225	227	as
O	228	229	a
O	230	233	new
O	234	242	approach
O	243	245	to
O	246	252	assess
O	253	263	clinically
O	264	274	meaningful
O	275	282	changes
O	283	285	in
B-Characteristic	286	293	retinal
I-Characteristic	294	303	thickness
O	303	304	.

O	305	317	Methodologic
O	317	318	,
O	319	327	evidence
O	327	328	-
O	328	333	based
O	334	340	review
O	340	341	.

O	342	350	Standard
O	351	360	published
O	361	371	approaches
O	372	375	for
O	376	385	assessing
O	386	392	change
O	393	395	in
B-Characteristic	396	403	retinal
I-Characteristic	404	413	thickness
O	414	418	over
O	419	423	time
O	423	424	,
O	425	427	as
O	428	436	measured
O	437	439	by
B-Diagnostic_tool	440	447	optical
I-Diagnostic_tool	448	457	coherence
I-Diagnostic_tool	458	468	tomography
O	469	470	(
B-Diagnostic_tool	470	473	OCT
O	473	474	)
O	474	475	,
O	476	480	were
O	481	489	compared
O	490	494	with
O	495	496	a
O	497	500	new
O	501	509	approach
O	510	515	based
O	516	518	on
O	519	520	a
O	521	532	logarithmic
O	533	547	transformation
O	548	550	of
O	551	554	the
B-Characteristic	555	562	retinal
I-Characteristic	563	572	thickness
O	573	577	data
O	577	578	.

O	579	590	Comparative
O	591	599	examples
O	600	604	were
O	605	612	derived
O	613	618	using
O	619	628	published
O	629	633	data
O	634	638	from
O	639	640	a
O	641	649	clinical
O	650	655	trial
O	656	665	comparing
O	666	678	intravitreal
O	679	693	corticosteroid
O	694	704	injections
O	705	708	for
B-Disease	709	717	diabetic
I-Disease	718	725	macular
I-Disease	726	731	edema
O	732	736	with
O	737	745	standard
O	746	751	laser
O	752	761	treatment
O	761	762	.

O	763	774	Comparative
O	775	783	examples
O	784	789	using
B-Disease	790	798	Diabetic
I-Disease	799	810	Retinopathy
O	811	819	Clinical
O	820	828	Research
O	829	836	Network
O	837	841	data
O	841	842	.

O	843	854	Logarithmic
O	855	869	transformation
O	870	872	of
B-Characteristic	873	880	retinal
I-Characteristic	881	890	thickness
O	891	895	data
O	896	903	results
O	904	906	in
O	907	908	a
O	909	913	more
O	914	924	normalized
O	925	937	distribution
O	938	940	of
B-Diagnostic_tool	941	944	OCT
O	945	949	data
O	950	953	and
O	954	960	allows
O	961	964	for
O	965	969	data
O	970	978	analyses
O	979	988	assessing
O	989	1002	proportionate
O	1003	1010	changes
O	1011	1013	in
B-Characteristic	1014	1021	retinal
I-Characteristic	1022	1031	thickness
O	1032	1038	during
O	1039	1045	follow
O	1045	1046	-
O	1046	1048	up
O	1048	1049	.

O	1050	1053	For
O	1054	1062	analysis
O	1063	1065	of
O	1066	1073	grouped
O	1074	1078	data
O	1078	1079	,
O	1080	1081	a
B-Characteristic	1082	1093	logarithmic
I-Characteristic	1094	1108	transformation
I-Characteristic	1109	1111	of
I-Characteristic	1112	1115	the
I-Characteristic	1116	1119	OCT
I-Characteristic	1120	1127	retinal
I-Characteristic	1128	1137	thickness
I-Characteristic	1138	1150	measurements
O	1151	1152	(
B-Characteristic	1152	1158	logOCT
O	1158	1159	)
O	1160	1168	provides
O	1169	1176	several
O	1177	1185	analytic
O	1186	1196	advantages
O	1196	1197	.

O	1198	1211	Distributions
O	1212	1214	of
B-Characteristic	1215	1222	retinal
I-Characteristic	1223	1232	thickness
O	1233	1235	in
O	1236	1242	groups
O	1243	1245	of
B-Anatomy	1246	1250	eyes
O	1251	1255	with
B-Disease	1256	1264	diabetic
I-Disease	1265	1272	macular
I-Disease	1273	1278	edema
O	1278	1279	,
O	1280	1283	and
O	1284	1288	many
O	1289	1294	other
O	1295	1301	causes
O	1302	1304	of
B-Symptom	1305	1312	macular
I-Symptom	1313	1323	thickening
O	1323	1324	,
O	1325	1329	tend
O	1330	1332	to
O	1333	1335	be
O	1336	1342	skewed
O	1343	1345	to
O	1346	1349	the
O	1350	1355	right
O	1355	1356	;
O	1357	1360	the
B-Characteristic	1361	1367	logOCT
O	1368	1382	transformation
O	1383	1388	tends
O	1389	1391	to
O	1392	1401	normalize
O	1402	1407	these
O	1408	1421	distributions
O	1421	1422	,
O	1423	1428	which
O	1429	1432	has
O	1433	1438	value
O	1439	1442	for
O	1443	1454	statistical
O	1455	1466	comparisons
O	1466	1467	.

O	1468	1471	For
O	1472	1481	assessing
O	1482	1489	whether
O	1490	1493	the
O	1494	1502	observed
B-Diagnostic_tool	1503	1506	OCT
O	1507	1513	change
O	1514	1516	in
O	1517	1518	a
O	1519	1526	patient
O	1527	1529	is
O	1530	1534	real
O	1535	1536	(
O	1536	1539	and
O	1540	1543	not
O	1544	1547	due
O	1548	1550	to
O	1551	1558	testing
O	1559	1570	variability
O	1570	1571	)
O	1571	1572	,
O	1573	1574	a
O	1575	1576	1
O	1576	1577	-
O	1577	1581	step
O	1582	1585	log
O	1586	1591	scale
O	1592	1598	change
O	1599	1606	exceeds
O	1607	1610	the
O	1611	1622	measurement
O	1623	1628	error
O	1629	1632	for
O	1633	1636	all
O	1637	1644	degrees
O	1645	1647	of
B-Characteristic	1648	1655	retinal
I-Characteristic	1656	1665	thickness
O	1666	1668	in
O	1669	1676	current
O	1677	1688	instruments
O	1688	1689	.

O	1690	1692	In
O	1693	1701	addition
O	1701	1702	,
O	1703	1707	this
O	1708	1711	log
O	1712	1717	scale
O	1718	1720	is
O	1721	1728	similar
O	1729	1731	to
O	1732	1735	the
B-Characteristic	1736	1745	logarithm
I-Characteristic	1746	1748	of
I-Characteristic	1749	1752	the
I-Characteristic	1753	1760	minimum
I-Characteristic	1761	1766	angle
I-Characteristic	1767	1769	of
I-Characteristic	1770	1780	resolution
O	1781	1782	(
B-Characteristic	1782	1788	logMAR
O	1788	1789	)
O	1790	1795	scale
O	1796	1800	used
O	1801	1804	for
B-Characteristic	1805	1811	visual
I-Characteristic	1812	1818	acuity
O	1818	1819	.

O	1820	1825	Steps
O	1826	1828	on
O	1829	1832	the
O	1833	1836	log
O	1837	1842	scale
O	1843	1846	for
O	1847	1853	change
O	1854	1856	in
O	1857	1866	thickness
O	1867	1871	seem
O	1872	1874	to
O	1875	1877	be
O	1878	1884	better
O	1885	1892	related
O	1893	1895	to
O	1896	1904	clinical
O	1905	1915	importance
O	1916	1920	than
O	1921	1924	the
O	1925	1931	actual
O	1932	1938	change
O	1939	1941	in
O	1942	1949	microns
O	1950	1957	because
O	1958	1962	each
O	1963	1967	step
O	1968	1970	on
O	1971	1974	the
O	1975	1978	log
O	1979	1984	scale
O	1985	1987	is
O	1988	1991	the
O	1992	1996	same
O	1997	2010	proportionate
O	2011	2017	change
O	2018	2020	in
O	2021	2030	thickness
O	2030	2031	,
O	2032	2036	with
O	2037	2038	a
O	2039	2040	3
O	2040	2041	-
O	2041	2045	step
O	2046	2052	change
O	2053	2061	equaling
O	2062	2063	a
O	2064	2071	halving
O	2072	2074	or
O	2075	2083	doubling
O	2084	2086	of
O	2087	2096	thickness
O	2096	2097	,
O	2098	2108	regardless
O	2109	2111	of
O	2112	2115	the
O	2116	2124	baseline
O	2125	2130	value
O	2130	2131	.

O	2132	2146	Transformation
O	2147	2149	of
B-Characteristic	2150	2153	OCT
I-Characteristic	2154	2161	retinal
I-Characteristic	2162	2171	thickness
O	2172	2176	data
O	2177	2179	to
B-Characteristic	2180	2186	logOCT
O	2187	2190	may
O	2191	2197	assist
O	2198	2200	in
O	2201	2204	the
O	2205	2215	assessment
O	2216	2218	of
O	2219	2229	clinically
O	2230	2240	meaningful
O	2241	2248	changes
O	2249	2251	in
B-Characteristic	2252	2259	retinal
I-Characteristic	2260	2269	thickness
O	2270	2274	just
O	2275	2277	as
O	2278	2281	use
O	2282	2284	of
O	2285	2288	the
B-Characteristic	2289	2295	logMAR
O	2296	2301	scale
O	2302	2305	has
O	2306	2312	helped
O	2313	2315	to
O	2316	2322	assess
O	2323	2333	clinically
O	2334	2344	meaningful
O	2345	2352	changes
O	2353	2355	in
B-Characteristic	2356	2362	visual
I-Characteristic	2363	2369	acuity
O	2369	2370	.

O	0	9	Automated
O	10	15	early
O	16	25	detection
O	26	28	of
B-Disease	29	37	diabetic
I-Disease	38	49	retinopathy
O	49	50	.

O	52	54	To
O	55	62	compare
O	63	66	the
O	67	78	performance
O	79	81	of
O	82	91	automated
B-Disease	92	100	diabetic
I-Disease	101	112	retinopathy
O	113	114	(
B-Disease	114	116	DR
O	116	117	)
O	118	127	detection
O	127	128	,
O	129	134	using
O	135	138	the
B-Diagnostic_tool	139	148	algorithm
I-Diagnostic_tool	149	153	that
I-Diagnostic_tool	154	157	won
I-Diagnostic_tool	158	161	the
I-Diagnostic_tool	162	166	2009
I-Diagnostic_tool	167	178	Retinopathy
I-Diagnostic_tool	179	185	Online
I-Diagnostic_tool	186	195	Challenge
I-Diagnostic_tool	196	207	Competition
I-Diagnostic_tool	208	210	in
I-Diagnostic_tool	211	215	2009
O	215	216	,
O	217	220	the
B-Diagnostic_tool	221	234	Challenge2009
O	234	235	,
O	236	243	against
O	244	248	that
O	249	251	of
O	252	255	the
O	256	259	one
O	260	269	currently
O	270	274	used
O	275	277	in
B-Diagnostic_tool	278	286	EyeCheck
O	286	287	,
O	288	289	a
O	290	295	large
O	296	304	computer
O	304	305	-
O	305	310	aided
O	311	316	early
B-Disease	317	319	DR
O	320	329	detection
O	330	337	project
O	337	338	.

O	339	349	Evaluation
O	350	352	of
O	353	363	diagnostic
O	364	368	test
O	369	371	or
O	372	382	technology
O	382	383	.

B-Diagnostic_tool	384	390	Fundus
I-Diagnostic_tool	391	403	photographic
O	404	408	sets
O	408	409	,
O	410	420	consisting
O	421	423	of
O	424	425	2
B-Diagnostic_tool	426	432	fundus
I-Diagnostic_tool	433	439	images
O	440	444	from
O	445	449	each
B-Anatomy	450	453	eye
O	453	454	,
O	455	459	were
O	460	469	evaluated
O	470	474	from
O	475	480	16670
O	481	488	patient
O	489	495	visits
O	496	498	of
O	499	501	16
O	501	502	,
O	502	505	670
O	506	512	people
O	513	517	with
B-Disease	518	526	diabetes
O	527	530	who
O	531	534	had
O	535	538	not
O	539	549	previously
O	550	554	been
O	555	564	diagnosed
O	565	569	with
B-Disease	570	572	DR
O	572	573	.

O	574	577	The
B-Diagnostic_tool	578	584	fundus
I-Diagnostic_tool	585	597	photographic
O	598	601	set
O	602	606	from
O	607	611	each
O	612	617	visit
O	618	621	was
O	622	630	analyzed
O	631	633	by
O	634	635	a
O	636	642	single
B-Anatomy	643	650	retinal
O	651	657	expert
O	657	658	;
O	659	662	793
O	663	665	of
O	666	669	the
O	670	672	16
O	672	673	,
O	673	676	670
O	677	681	sets
O	682	686	were
O	687	697	classified
O	698	700	as
O	701	711	containing
O	712	716	more
O	717	721	than
O	722	729	minimal
B-Disease	730	732	DR
O	733	734	(
O	734	743	threshold
O	744	747	for
O	748	756	referral
O	756	757	)
O	757	758	.

O	759	762	The
O	763	771	outcomes
O	772	774	of
O	775	778	the
O	779	780	2
O	781	792	algorithmic
O	793	802	detectors
O	803	807	were
O	808	815	applied
O	816	826	separately
O	827	829	to
O	830	833	the
O	834	841	dataset
O	842	845	and
O	846	850	were
O	851	859	compared
O	860	862	by
O	863	871	standard
O	872	883	statistical
O	884	892	measures
O	892	893	.

O	894	897	The
B-Characteristic	898	902	area
I-Characteristic	903	908	under
I-Characteristic	909	912	the
I-Characteristic	913	921	receiver
I-Characteristic	922	931	operating
I-Characteristic	932	946	characteristic
I-Characteristic	947	952	curve
O	953	954	(
B-Characteristic	954	957	AUC
O	957	958	)
O	958	959	,
O	960	961	a
O	962	969	measure
O	970	972	of
O	973	976	the
O	977	988	sensitivity
O	989	992	and
O	993	1004	specificity
O	1005	1007	of
B-Disease	1008	1010	DR
O	1011	1020	detection
O	1020	1021	.

O	1022	1031	Agreement
O	1032	1035	was
O	1036	1040	high
O	1040	1041	,
O	1042	1045	and
O	1046	1057	examination
O	1058	1065	results
O	1066	1076	indicating
O	1077	1081	more
O	1082	1086	than
O	1087	1094	minimal
B-Disease	1095	1097	DR
O	1098	1102	were
O	1103	1111	detected
O	1112	1116	with
O	1117	1119	an
B-Characteristic	1120	1123	AUC
O	1124	1126	of
B-Dimension	1127	1128	0
I-Dimension	1128	1129	.
I-Dimension	1129	1132	839
O	1133	1135	by
O	1136	1139	the
B-Diagnostic_tool	1140	1148	EyeCheck
O	1149	1158	algorithm
O	1159	1162	and
O	1163	1165	an
B-Characteristic	1166	1169	AUC
O	1170	1172	of
B-Dimension	1173	1174	0
I-Dimension	1174	1175	.
I-Dimension	1175	1178	821
O	1179	1182	for
O	1183	1186	the
B-Diagnostic_tool	1187	1200	Challenge2009
I-Diagnostic_tool	1201	1210	algorithm
O	1210	1211	,
O	1212	1213	a
O	1214	1227	statistically
O	1228	1242	nonsignificant
O	1243	1253	difference
O	1254	1255	(
O	1255	1256	z
O	1256	1257	-
O	1257	1262	score
O	1262	1263	,
O	1264	1265	1
O	1265	1266	.
O	1266	1268	91
O	1268	1269	)
O	1269	1270	.

O	1271	1273	If
O	1274	1280	either
O	1281	1283	of
O	1284	1287	the
O	1288	1298	algorithms
O	1299	1307	detected
B-Disease	1308	1310	DR
O	1311	1313	in
O	1314	1325	combination
O	1325	1326	,
O	1327	1330	the
B-Characteristic	1331	1334	AUC
O	1335	1338	for
O	1339	1348	detection
O	1349	1352	was
O	1353	1354	0
O	1354	1355	.
O	1355	1357	86
O	1357	1358	,
O	1359	1362	the
O	1363	1367	same
O	1368	1370	as
O	1371	1374	the
O	1375	1388	theoretically
O	1389	1397	expected
O	1398	1405	maximum
O	1405	1406	.

O	1407	1409	At
O	1410	1412	90
O	1412	1413	%
O	1414	1425	sensitivity
O	1425	1426	,
O	1427	1430	the
O	1431	1442	specificity
O	1443	1445	of
O	1446	1449	the
B-Diagnostic_tool	1450	1458	EyeCheck
O	1459	1468	algorithm
O	1469	1472	was
O	1473	1475	47
O	1475	1476	.
O	1476	1477	7
O	1477	1478	%
O	1479	1482	and
O	1483	1487	that
O	1488	1490	of
O	1491	1494	the
B-Diagnostic_tool	1495	1508	Challenge2009
I-Diagnostic_tool	1509	1518	algorithm
O	1519	1522	was
O	1523	1525	43
O	1525	1526	.
O	1526	1527	6
O	1527	1528	%
O	1528	1529	.

B-Diagnostic_tool	1530	1538	Diabetic
I-Diagnostic_tool	1539	1550	retinopathy
I-Diagnostic_tool	1551	1560	detection
I-Diagnostic_tool	1561	1571	algorithms
O	1572	1576	seem
O	1577	1579	to
O	1580	1582	be
O	1583	1591	maturing
O	1591	1592	,
O	1593	1596	and
O	1597	1604	further
O	1605	1617	improvements
O	1618	1620	in
O	1621	1630	detection
O	1631	1642	performance
O	1643	1649	cannot
O	1650	1652	be
O	1653	1667	differentiated
O	1668	1672	from
O	1673	1677	best
O	1678	1686	clinical
O	1687	1696	practices
O	1696	1697	,
O	1698	1705	because
O	1706	1709	the
O	1710	1721	performance
O	1722	1724	of
O	1725	1736	competitive
O	1737	1746	algorithm
O	1747	1758	development
O	1759	1762	now
O	1763	1766	has
O	1767	1774	reached
O	1775	1778	the
O	1779	1784	human
O	1785	1796	intrareader
O	1797	1808	variability
O	1809	1814	limit
O	1814	1815	.

O	1816	1826	Additional
O	1827	1837	validation
O	1838	1845	studies
O	1846	1848	on
O	1849	1855	larger
O	1855	1856	,
O	1857	1861	well
O	1861	1862	-
O	1862	1869	defined
O	1869	1870	,
O	1871	1874	but
O	1875	1879	more
O	1880	1887	diverse
O	1888	1899	populations
O	1900	1902	of
O	1903	1911	patients
O	1912	1916	with
B-Disease	1917	1925	diabetes
O	1926	1929	are
O	1930	1936	needed
O	1937	1945	urgently
O	1945	1946	,
O	1947	1959	anticipating
O	1960	1964	cost
O	1964	1965	-
O	1965	1974	effective
O	1975	1980	early
O	1981	1990	detection
O	1991	1993	of
B-Disease	1994	1996	DR
O	1997	1999	in
O	2000	2008	millions
O	2009	2011	of
O	2012	2018	people
O	2019	2023	with
B-Disease	2024	2032	diabetes
O	2033	2035	to
O	2036	2042	triage
O	2043	2048	those
O	2049	2057	patients
O	2058	2061	who
O	2062	2066	need
O	2067	2074	further
O	2075	2079	care
O	2080	2082	at
O	2083	2084	a
O	2085	2089	time
O	2090	2094	when
O	2095	2099	they
O	2100	2104	have
O	2105	2110	early
O	2111	2117	rather
O	2118	2122	than
O	2123	2131	advanced
B-Disease	2132	2134	DR
O	2134	2135	.

O	3	13	Prevalence
O	14	17	and
O	18	30	significance
O	31	33	of
B-Symptom	34	44	subretinal
I-Symptom	45	54	drusenoid
I-Symptom	55	63	deposits
O	64	65	(
B-Symptom	65	74	reticular
I-Symptom	75	87	pseudodrusen
O	87	88	)
O	89	91	in
B-Disease	92	95	age
I-Disease	95	96	-
I-Disease	96	103	related
I-Disease	104	111	macular
I-Disease	112	124	degeneration

O	126	133	Purpose
O	133	134	:
O	135	137	To
O	138	147	determine
O	148	151	the
O	152	162	prevalence
O	163	166	and
O	167	179	significance
O	180	182	of
B-Symptom	183	193	subretinal
I-Symptom	194	203	drusenoid
I-Symptom	204	212	deposits
O	213	214	(
B-Symptom	214	223	reticular
I-Symptom	224	236	pseudodrusen
O	236	237	)
O	238	243	among
O	244	252	patients
O	253	257	with
B-Disease	258	261	age
I-Disease	261	262	-
I-Disease	262	269	related
I-Disease	270	277	macular
I-Disease	278	290	degeneration
O	291	292	(
B-Disease	292	295	AMD
O	295	296	)
O	296	297	.

O	299	305	Design
O	305	306	:
O	307	308	A
O	309	320	prospective
O	321	326	study
O	327	331	with
O	332	333	a
O	334	340	nested
O	341	345	case
O	345	346	-
O	346	353	control
O	354	359	study
O	360	362	of
O	363	374	consecutive
O	375	383	patients
O	384	388	with
B-Disease	389	392	AMD
O	393	397	seen
O	398	400	in
O	401	402	a
O	403	411	referral
O	412	419	retinal
O	420	428	practice
O	428	429	.

O	431	443	Participants
O	443	444	:
O	445	450	There
O	451	455	were
O	456	459	153
O	460	468	patients
O	469	473	with
B-Disease	474	477	AMD
O	477	478	,
O	479	482	131
O	483	485	of
O	486	490	whom
O	491	494	had
O	495	496	>
O	497	499	or
O	500	501	=
O	501	502	1
B-Anatomy	503	506	eye
O	507	511	with
B-Disease	512	516	late
I-Disease	517	520	AMD
O	520	521	,
O	522	527	which
O	528	531	was
O	532	539	defined
O	540	542	as
O	543	549	either
B-Symptom	550	557	central
I-Symptom	558	568	geographic
I-Symptom	569	576	atrophy
O	577	579	or
B-Symptom	580	589	choroidal
I-Symptom	590	608	neovascularization
O	608	609	.

O	610	613	The
O	614	621	control
O	622	627	group
O	628	637	consisted
O	638	640	of
O	641	644	101
O	645	653	patients
O	654	657	who
O	658	661	did
O	662	665	not
O	666	670	have
B-Disease	671	674	AMD
O	675	677	as
O	678	683	their
O	684	691	primary
O	692	701	diagnosis
O	701	702	,
B-Disease	703	710	central
I-Disease	711	717	serous
I-Disease	718	735	chorioretinopathy
O	735	736	,
B-Disease	737	741	high
I-Disease	742	748	myopia
O	748	749	,
B-Symptom	750	757	retinal
I-Symptom	758	768	detachment
O	768	769	,
O	770	772	or
O	773	778	laser
O	779	788	treatment
O	789	791	in
O	792	795	the
B-Anatomy	796	803	macular
I-Anatomy	804	808	area
I-Anatomy	808	809	.

O	811	818	Methods
O	818	819	:
O	820	823	The
O	824	832	presence
O	833	835	of
B-Symptom	836	846	subretinal
I-Symptom	847	856	drusenoid
I-Symptom	857	865	deposits
O	866	869	was
O	870	880	determined
O	881	883	by
O	884	885	2
O	886	893	methods
O	893	894	,
O	895	900	using
O	901	904	the
B-Diagnostic_tool	905	909	blue
I-Diagnostic_tool	910	917	channel
I-Diagnostic_tool	918	920	of
I-Diagnostic_tool	921	926	color
I-Diagnostic_tool	927	933	fundus
I-Diagnostic_tool	934	944	photograph
O	945	948	and
O	949	952	the
B-Diagnostic_tool	953	961	spectral
I-Diagnostic_tool	962	968	domain
I-Diagnostic_tool	969	976	optical
I-Diagnostic_tool	977	986	coherence
I-Diagnostic_tool	987	997	tomography
O	998	999	(
B-Diagnostic_tool	999	1001	SD
I-Diagnostic_tool	1001	1002	-
I-Diagnostic_tool	1002	1005	OCT
O	1005	1006	)
O	1007	1015	sections
O	1015	1016	.

B-Symptom	1017	1021	Soft
I-Symptom	1022	1028	drusen
O	1029	1033	were
O	1034	1044	determined
O	1045	1049	from
B-Diagnostic_tool	1050	1055	color
I-Diagnostic_tool	1056	1062	fundus
I-Diagnostic_tool	1063	1074	photographs
O	1075	1078	and
O	1079	1088	confirmed
O	1089	1091	by
B-Diagnostic_tool	1092	1094	SD
I-Diagnostic_tool	1094	1095	-
I-Diagnostic_tool	1095	1098	OCT
O	1098	1099	.

O	1101	1105	Main
O	1106	1113	outcome
O	1114	1122	measures
O	1122	1123	:
O	1124	1134	Prevalence
O	1135	1137	of
B-Symptom	1138	1144	ocular
I-Symptom	1145	1149	risk
I-Symptom	1150	1157	factors
O	1158	1161	and
B-Symptom	1162	1172	subretinal
I-Symptom	1173	1182	drusenoid
I-Symptom	1183	1191	deposits
I-Symptom	1192	1194	in
I-Symptom	1195	1199	eyes
O	1200	1204	with
B-Disease	1205	1208	AMD
O	1209	1212	and
O	1213	1218	their
O	1219	1230	association
O	1231	1235	with
B-Disease	1236	1240	late
I-Disease	1241	1244	AMD
O	1244	1245	.

O	1247	1254	Results
O	1254	1255	:
O	1256	1261	There
O	1262	1266	were
O	1267	1270	153
O	1271	1279	patients
O	1280	1283	who
O	1284	1287	had
O	1288	1291	any
O	1292	1296	form
O	1297	1299	of
B-Disease	1300	1303	AMD
O	1303	1304	,
O	1305	1309	with
O	1310	1311	a
B-Characteristic	1312	1316	mean
I-Characteristic	1317	1320	age
I-Characteristic	1321	1323	of
I-Characteristic	1324	1326	80
I-Characteristic	1326	1327	.
I-Characteristic	1327	1328	3
I-Characteristic	1329	1334	years
O	1334	1335	.

B-Symptom	1336	1346	Subretinal
I-Symptom	1347	1356	drusenoid
I-Symptom	1357	1365	deposits
O	1366	1370	were
O	1371	1380	diagnosed
O	1381	1383	in
O	1384	1387	the
O	1388	1392	case
O	1393	1398	group
O	1399	1401	in
O	1402	1404	13
O	1405	1406	(
O	1406	1407	8
O	1407	1408	.
O	1408	1409	7
O	1409	1410	%
O	1410	1411	)
O	1412	1414	of
O	1415	1420	right
O	1421	1424	and
O	1425	1427	18
O	1428	1429	(
O	1429	1431	12
O	1431	1432	.
O	1432	1433	0
O	1433	1434	%
O	1434	1435	)
O	1436	1438	of
B-Anatomy	1439	1443	left
I-Anatomy	1444	1448	eyes
O	1449	1454	using
O	1455	1458	the
B-Diagnostic_tool	1459	1463	blue
I-Diagnostic_tool	1464	1471	channel
I-Diagnostic_tool	1472	1474	of
I-Diagnostic_tool	1475	1478	the
I-Diagnostic_tool	1479	1484	color
I-Diagnostic_tool	1485	1495	photograph
O	1496	1499	and
O	1500	1502	in
O	1503	1505	58
O	1506	1507	(
O	1507	1509	38
O	1509	1510	.
O	1510	1511	4
O	1511	1512	%
O	1512	1513	)
O	1514	1516	of
O	1517	1522	right
O	1523	1526	and
O	1527	1529	54
O	1530	1531	(
O	1531	1533	35
O	1533	1534	.
O	1534	1535	8
O	1535	1536	%
O	1536	1537	)
O	1538	1540	of
B-Anatomy	1541	1545	left
I-Anatomy	1546	1550	eyes
O	1551	1556	using
B-Diagnostic_tool	1557	1559	SD
I-Diagnostic_tool	1559	1560	-
I-Diagnostic_tool	1560	1563	OCT
O	1563	1564	.

B-Symptom	1565	1569	Soft
I-Symptom	1570	1576	drusen
O	1577	1580	and
B-Symptom	1581	1591	subretinal
I-Symptom	1592	1601	drusenoid
I-Symptom	1602	1610	deposits
O	1611	1619	detected
O	1620	1622	by
B-Diagnostic_tool	1623	1625	SD
I-Diagnostic_tool	1625	1626	-
I-Diagnostic_tool	1626	1629	OCT
O	1630	1634	were
O	1635	1640	found
O	1641	1643	to
O	1644	1646	be
O	1647	1660	independently
O	1661	1671	correlated
O	1672	1676	with
B-Disease	1677	1681	late
I-Disease	1682	1685	AMD
O	1686	1687	(
B-Symptom	1687	1691	soft
I-Symptom	1692	1698	drusen
O	1699	1703	odds
O	1704	1709	ratio
O	1710	1711	=
O	1712	1714	16
O	1714	1715	.
O	1715	1717	66
O	1718	1719	[
O	1719	1720	P
O	1720	1721	<
O	1721	1722	0
O	1722	1723	.
O	1723	1726	001
O	1726	1727	]
O	1727	1728	;
B-Symptom	1729	1739	subretinal
I-Symptom	1740	1749	drusenoid
I-Symptom	1750	1758	deposits
O	1759	1761	as
O	1762	1770	detected
O	1771	1773	by
B-Diagnostic_tool	1774	1777	OCT
O	1778	1782	odds
O	1783	1788	ratio
O	1789	1790	=
O	1791	1792	2
O	1792	1793	.
O	1793	1795	64
O	1796	1797	[
O	1797	1798	P
O	1799	1800	=
O	1801	1802	0
O	1802	1803	.
O	1803	1806	034
O	1806	1807	]
O	1807	1808	)
O	1808	1809	.

O	1810	1812	In
O	1813	1816	the
O	1817	1824	control
O	1825	1830	group
O	1830	1831	,
B-Symptom	1832	1842	subretinal
I-Symptom	1843	1852	drusenoid
I-Symptom	1853	1861	deposits
O	1862	1866	were
O	1867	1876	diagnosed
O	1877	1879	in
O	1880	1881	6
O	1882	1883	(
O	1883	1884	6
O	1884	1885	.
O	1885	1886	5
O	1886	1887	%
O	1887	1888	)
O	1889	1891	of
O	1892	1897	right
O	1898	1901	and
O	1902	1903	6
O	1904	1905	(
O	1905	1906	6
O	1906	1907	.
O	1907	1908	3
O	1908	1909	%
O	1909	1910	)
O	1911	1913	of
B-Anatomy	1914	1918	left
I-Anatomy	1919	1923	eyes
O	1924	1929	using
B-Diagnostic_tool	1930	1932	SD
I-Diagnostic_tool	1932	1933	-
I-Diagnostic_tool	1933	1936	OCT
I-Diagnostic_tool	1936	1937	.

O	1939	1950	Conclusions
O	1950	1951	:
O	1952	1956	Both
B-Symptom	1957	1961	soft
I-Symptom	1962	1968	drusen
O	1969	1972	and
B-Symptom	1973	1983	subretinal
I-Symptom	1984	1993	drusenoid
I-Symptom	1994	2002	deposits
O	2003	2008	occur
O	2009	2011	in
O	2012	2020	patients
O	2021	2025	with
B-Disease	2026	2029	AMD
O	2030	2033	and
O	2034	2038	both
O	2039	2042	are
O	2043	2056	significantly
O	2057	2067	associated
O	2068	2072	with
B-Disease	2073	2077	late
I-Disease	2078	2081	AMD
O	2081	2082	.

O	2083	2088	These
O	2089	2097	findings
O	2098	2105	suggest
O	2106	2110	that
O	2111	2120	detection
O	2121	2124	and
O	2125	2139	classification
O	2140	2142	of
B-Symptom	2143	2149	drusen
O	2150	2153	and
O	2154	2166	consequently
O	2167	2177	assignment
O	2178	2180	of
O	2181	2185	risk
O	2186	2192	should
O	2193	2195	be
O	2196	2201	based
O	2202	2204	on
O	2205	2206	a
O	2207	2218	methodology
O	2219	2223	that
O	2224	2232	includes
B-Diagnostic_tool	2233	2235	SD
I-Diagnostic_tool	2235	2236	-
I-Diagnostic_tool	2236	2239	OCT
I-Diagnostic_tool	2239	2240	.

B-Symptom	0	6	Foveal
I-Symptom	7	14	cystoid
I-Symptom	15	21	spaces
O	22	25	are
O	26	36	associated
O	37	41	with
B-Symptom	42	50	enlarged
I-Symptom	51	57	foveal
I-Symptom	58	67	avascular
I-Symptom	68	72	zone
O	73	76	and
B-Symptom	77	91	microaneurysms
O	92	94	in
B-Disease	95	103	diabetic
I-Disease	104	111	macular
I-Disease	112	117	edema
O	117	118	.

O	120	122	To
O	123	128	study
O	129	132	the
O	133	144	association
O	145	152	between
B-Symptom	153	168	pathomorphology
I-Symptom	169	171	at
I-Symptom	172	175	the
I-Symptom	176	182	foveal
I-Symptom	183	189	center
O	190	200	delineated
O	201	203	by
B-Diagnostic_tool	204	212	spectral
I-Diagnostic_tool	213	219	domain
I-Diagnostic_tool	220	227	optical
I-Diagnostic_tool	228	237	coherence
I-Diagnostic_tool	238	248	tomography
O	249	250	(
B-Diagnostic_tool	250	252	SD
I-Diagnostic_tool	252	253	-
I-Diagnostic_tool	253	256	OCT
O	256	257	)
O	258	261	and
B-Symptom	262	270	vascular
I-Symptom	271	278	changes
I-Symptom	279	285	around
I-Symptom	286	289	the
I-Symptom	290	295	fovea
O	296	298	in
B-Diagnostic_tool	299	310	fluorescein
I-Diagnostic_tool	311	322	angiography
O	323	324	(
B-Diagnostic_tool	324	326	FA
O	326	327	)
O	328	330	in
O	331	339	patients
O	340	344	with
B-Disease	345	353	diabetic
I-Disease	354	361	macular
I-Disease	362	367	edema
O	368	369	(
B-Disease	369	372	DME
O	372	373	)
O	373	374	.

O	375	388	Retrospective
O	388	389	,
O	390	403	observational
O	403	404	,
O	405	410	cross
O	410	411	-
O	411	420	sectional
O	421	426	study
O	426	427	.

O	428	439	Consecutive
O	440	446	series
O	447	449	of
O	450	452	86
B-Anatomy	453	457	eyes
O	458	462	from
O	463	465	72
O	466	474	patients
O	475	479	with
B-Disease	480	490	clinically
I-Disease	491	502	significant
I-Disease	503	510	macular
I-Disease	511	516	edema
O	517	518	(
B-Disease	518	522	CSME
O	522	523	)
O	524	526	on
O	527	532	which
B-Diagnostic_tool	533	535	SD
I-Diagnostic_tool	535	536	-
I-Diagnostic_tool	536	539	OCT
O	540	543	and
B-Diagnostic_tool	544	546	FA
O	547	551	were
O	552	561	performed
O	562	564	on
O	565	568	the
O	569	573	same
O	574	577	day
O	577	578	.

B-Diagnostic_tool	579	590	Fluorescein
I-Diagnostic_tool	591	602	angiography
O	603	608	using
B-Diagnostic_tool	609	613	HRA2
O	614	615	(
O	615	625	Heidelberg
O	626	637	Engineering
O	637	638	,
O	639	649	Heidelberg
O	649	650	,
O	651	658	Germany
O	658	659	)
O	660	663	and
B-Diagnostic_tool	664	666	SD
I-Diagnostic_tool	666	667	-
I-Diagnostic_tool	667	670	OCT
I-Diagnostic_tool	671	677	images
O	678	683	using
B-Diagnostic_tool	684	694	Spectralis
I-Diagnostic_tool	695	698	OCT
O	699	700	(
O	700	710	Heidelberg
O	711	722	Engineering
O	722	723	)
O	724	728	were
O	729	737	obtained
O	738	741	for
O	742	745	all
O	746	754	patients
O	754	755	.

B-Symptom	756	770	Microaneurysms
O	771	772	(
B-Symptom	772	775	MAs
O	775	776	)
O	777	779	in
O	780	783	the
B-Anatomy	784	794	perifoveal
I-Anatomy	795	804	capillary
I-Anatomy	805	812	network
O	813	814	(
B-Anatomy	814	817	PCN
O	817	818	)
O	819	822	and
B-Anatomy	823	829	foveal
I-Anatomy	830	839	avascular
I-Anatomy	840	844	zone
O	845	846	(
B-Anatomy	846	849	FAZ
O	849	850	)
O	851	853	in
O	854	857	the
B-Diagnostic_tool	858	860	FA
I-Diagnostic_tool	861	867	images
O	868	872	were
O	873	883	quantified
O	883	884	.

O	885	888	The
B-Symptom	889	904	pathomorphology
I-Symptom	905	907	at
I-Symptom	908	911	the
I-Symptom	912	918	foveal
I-Symptom	919	925	center
O	926	929	was
O	930	939	evaluated
O	940	942	in
B-Diagnostic_tool	943	946	OCT
I-Diagnostic_tool	947	953	images
O	953	954	.

O	955	957	We
O	958	962	then
O	963	975	investigated
O	976	979	the
O	980	991	association
O	992	999	between
B-Symptom	1000	1010	pathologic
I-Symptom	1011	1021	perifoveal
I-Symptom	1022	1033	capillaries
O	1034	1036	in
B-Diagnostic_tool	1037	1039	FA
O	1040	1043	and
O	1044	1047	the
B-Characteristic	1048	1058	neuroglial
I-Characteristic	1059	1069	morphology
O	1070	1072	in
B-Diagnostic_tool	1073	1076	OCT
O	1076	1077	.

O	1078	1081	The
O	1082	1094	relationship
O	1095	1102	between
B-Symptom	1103	1113	pathologic
I-Symptom	1114	1121	changes
I-Symptom	1122	1124	in
I-Symptom	1125	1135	perifoveal
I-Symptom	1136	1147	capillaries
O	1148	1150	in
B-Diagnostic_tool	1151	1153	FA
O	1154	1157	and
B-Symptom	1158	1164	foveal
I-Symptom	1165	1180	pathomorphology
O	1181	1183	in
B-Diagnostic_tool	1184	1187	OCT
O	1187	1188	.

O	1189	1198	According
O	1199	1201	to
O	1202	1205	the
B-Characteristic	1206	1212	foveal
I-Characteristic	1213	1223	morphology
O	1224	1226	in
B-Diagnostic_tool	1227	1230	OCT
I-Diagnostic_tool	1231	1237	images
O	1237	1238	,
O	1239	1241	44
B-Anatomy	1242	1246	eyes
O	1247	1256	presented
B-Symptom	1257	1263	foveal
I-Symptom	1264	1271	cystoid
I-Symptom	1272	1278	spaces
O	1279	1280	(
B-Disease	1280	1287	cystoid
I-Disease	1288	1295	macular
I-Disease	1296	1301	edema
O	1302	1303	[
B-Disease	1303	1306	CME
O	1306	1307	]
O	1307	1308	)
O	1308	1309	,
O	1310	1312	25
B-Anatomy	1313	1317	eyes
O	1318	1321	had
B-Symptom	1322	1328	serous
I-Symptom	1329	1336	retinal
I-Symptom	1337	1347	detachment
O	1348	1349	(
B-Symptom	1349	1352	SRD
O	1352	1353	)
O	1354	1356	at
O	1357	1360	the
B-Anatomy	1361	1367	foveal
I-Anatomy	1368	1374	center
O	1374	1375	,
O	1376	1379	and
O	1380	1382	17
B-Anatomy	1383	1387	eyes
O	1388	1391	had
B-Symptom	1392	1398	foveal
I-Symptom	1399	1409	thickening
I-Symptom	1410	1417	without
I-Symptom	1418	1425	cystoid
I-Symptom	1426	1432	spaces
O	1433	1435	or
B-Symptom	1436	1443	retinal
I-Symptom	1444	1454	detachment
O	1455	1456	(
B-Symptom	1456	1463	retinal
I-Symptom	1464	1472	swelling
O	1472	1473	)
O	1473	1474	.

O	1475	1480	After
O	1481	1482	3
B-Anatomy	1483	1487	eyes
O	1488	1492	with
B-Disease	1493	1501	ischemic
I-Disease	1502	1513	maculopathy
O	1514	1518	were
O	1519	1527	excluded
O	1527	1528	,
O	1529	1532	the
O	1533	1545	relationship
O	1546	1549	was
O	1550	1559	evaluated
O	1559	1560	.

O	1561	1564	The
O	1565	1571	number
O	1572	1574	of
B-Symptom	1575	1578	MAs
O	1579	1581	in
O	1582	1585	the
B-Anatomy	1586	1589	PCN
O	1590	1593	was
O	1594	1607	significantly
O	1608	1615	greater
O	1616	1618	in
B-Anatomy	1619	1623	eyes
O	1624	1628	with
B-Disease	1629	1632	CME
O	1633	1634	(
O	1634	1635	3
O	1635	1636	.
O	1636	1638	20
O	1639	1640	
O	1641	1642	1
O	1642	1643	.
O	1643	1645	76
O	1645	1646	)
O	1647	1651	than
O	1652	1654	in
B-Anatomy	1655	1659	eyes
O	1660	1664	with
B-Symptom	1665	1668	SRD
O	1669	1670	(
O	1670	1671	0
O	1671	1672	.
O	1672	1674	40
O	1675	1676	
O	1677	1678	1
O	1678	1679	.
O	1679	1681	04
O	1681	1682	;
O	1683	1684	P
O	1686	1687	<
O	1689	1690	0
O	1690	1691	.
O	1691	1693	01
O	1693	1694	)
O	1695	1697	or
B-Symptom	1698	1705	retinal
I-Symptom	1706	1714	swelling
O	1715	1716	(
O	1716	1717	0
O	1717	1718	.
O	1718	1720	47
O	1721	1722	
O	1723	1724	0
O	1724	1725	.
O	1725	1727	72
O	1727	1728	;
O	1729	1730	P
O	1732	1733	<
O	1735	1736	0
O	1736	1737	.
O	1737	1739	01
O	1739	1740	)
O	1740	1741	.

O	1742	1744	In
O	1745	1753	addition
O	1753	1754	,
O	1755	1758	the
B-Anatomy	1759	1762	FAZ
O	1763	1765	in
O	1766	1769	the
B-Anatomy	1770	1774	eyes
O	1775	1779	with
B-Disease	1780	1783	CME
O	1784	1785	(
B-Dimension	1785	1786	0
I-Dimension	1786	1787	.
I-Dimension	1787	1790	553
I-Dimension	1791	1792	
I-Dimension	1793	1794	0
I-Dimension	1794	1795	.
I-Dimension	1795	1798	323
I-Dimension	1799	1801	mm
I-Dimension	1801	1802	(
I-Dimension	1802	1803	2
I-Dimension	1803	1804	)
O	1804	1805	)
O	1806	1809	was
O	1810	1823	significantly
O	1824	1830	larger
O	1831	1835	than
O	1836	1840	that
O	1841	1843	of
O	1844	1847	the
B-Anatomy	1848	1852	eyes
O	1853	1857	with
B-Symptom	1858	1861	SRD
O	1862	1863	(
B-Dimension	1863	1864	0
I-Dimension	1864	1865	.
I-Dimension	1865	1868	302
I-Dimension	1869	1870	
I-Dimension	1871	1872	0
I-Dimension	1872	1873	.
I-Dimension	1873	1876	245
I-Dimension	1877	1879	mm
I-Dimension	1879	1880	(
I-Dimension	1880	1881	2
I-Dimension	1881	1882	)
O	1882	1883	;
O	1884	1885	P
O	1887	1888	<
O	1890	1891	0
O	1891	1892	.
O	1892	1894	01
O	1894	1895	)
O	1896	1898	or
B-Symptom	1899	1906	retinal
I-Symptom	1907	1915	swelling
O	1916	1917	(
B-Dimension	1917	1918	0
I-Dimension	1918	1919	.
I-Dimension	1919	1922	268
I-Dimension	1923	1924	
I-Dimension	1925	1926	0
I-Dimension	1926	1927	.
I-Dimension	1927	1930	142
I-Dimension	1931	1933	mm
I-Dimension	1933	1934	(
I-Dimension	1934	1935	2
I-Dimension	1935	1936	)
O	1936	1937	;
O	1938	1939	P
O	1941	1942	<
O	1944	1945	0
O	1945	1946	.
O	1946	1948	01
O	1948	1949	)
O	1949	1950	.

O	1951	1956	These
O	1957	1969	associations
O	1970	1974	were
O	1975	1980	found
O	1981	1983	in
B-Anatomy	1984	1988	eyes
O	1989	1993	with
B-Symptom	1994	2003	thickened
I-Symptom	2004	2013	posterior
I-Symptom	2014	2021	hyaloid
I-Symptom	2022	2031	membranes
O	2031	2032	.

O	2033	2036	The
B-Anatomy	2037	2041	eyes
O	2042	2046	with
B-Symptom	2047	2054	cystoid
I-Symptom	2055	2061	spaces
I-Symptom	2062	2064	at
I-Symptom	2065	2068	the
I-Symptom	2069	2075	foveal
I-Symptom	2076	2082	center
O	2083	2093	delineated
O	2094	2096	by
B-Diagnostic_tool	2097	2100	OCT
O	2101	2104	had
O	2105	2109	more
B-Symptom	2110	2113	MAs
I-Symptom	2114	2116	in
I-Symptom	2117	2120	the
I-Symptom	2121	2124	PCN
O	2125	2128	and
B-Symptom	2129	2135	larger
I-Symptom	2136	2139	FAZ
O	2140	2142	in
B-Diagnostic_tool	2143	2145	FA
I-Diagnostic_tool	2146	2152	images
O	2152	2153	.

O	0	11	Progression
O	12	14	of
B-Symptom	15	25	geographic
I-Symptom	26	33	atrophy
O	34	36	in
B-Disease	37	40	age
I-Disease	40	41	-
I-Disease	41	48	related
I-Disease	49	56	macular
I-Disease	57	69	degeneration
O	70	76	imaged
O	77	81	with
B-Diagnostic_tool	82	90	spectral
I-Diagnostic_tool	91	97	domain
I-Diagnostic_tool	98	105	optical
I-Diagnostic_tool	106	115	coherence
I-Diagnostic_tool	116	126	tomography
O	126	127	.

O	129	131	To
O	132	141	determine
O	142	145	the
O	146	150	area
O	151	154	and
O	155	166	enlargement
O	167	171	rate
O	172	173	(
O	173	175	ER
O	175	176	)
O	177	179	of
B-Symptom	180	190	geographic
I-Symptom	191	198	atrophy
O	199	200	(
B-Symptom	200	202	GA
O	202	203	)
O	204	206	in
O	207	215	patients
O	216	220	with
B-Disease	221	224	age
I-Disease	224	225	-
I-Disease	225	232	related
I-Disease	233	240	macular
I-Disease	241	253	degeneration
O	254	255	(
B-Disease	255	258	AMD
O	258	259	)
O	260	265	using
O	266	269	the
B-Diagnostic_tool	270	278	spectral
I-Diagnostic_tool	279	285	domain
I-Diagnostic_tool	286	293	optical
I-Diagnostic_tool	294	303	coherence
I-Diagnostic_tool	304	314	tomography
I-Diagnostic_tool	315	316	(
I-Diagnostic_tool	316	318	SD
I-Diagnostic_tool	318	319	-
I-Diagnostic_tool	319	322	OCT
I-Diagnostic_tool	322	323	)
I-Diagnostic_tool	324	330	fundus
I-Diagnostic_tool	331	336	image
O	336	337	.

O	338	349	Prospective
O	349	350	,
O	351	363	longitudinal
O	363	364	,
O	365	372	natural
O	373	380	history
O	381	386	study
O	386	387	.

O	388	394	Eighty
O	394	395	-
O	395	398	six
B-Anatomy	399	403	eyes
O	404	406	of
O	407	409	64
O	410	418	patients
O	419	423	with
O	424	425	
O	425	426	6
O	427	433	months
O	434	436	of
O	437	443	follow
O	443	444	-
O	444	446	up
O	446	447	.

O	448	456	Patients
O	457	461	with
B-Symptom	462	464	GA
O	465	474	secondary
O	475	477	to
B-Disease	478	481	AMD
O	482	486	were
O	487	495	enrolled
O	496	498	in
O	499	503	this
O	504	509	study
O	509	510	.

B-Diagnostic_tool	511	518	Macular
I-Diagnostic_tool	519	524	scans
O	525	529	were
O	530	539	performed
O	540	545	using
O	546	549	the
B-Diagnostic_tool	550	556	Cirrus
I-Diagnostic_tool	557	559	SD
I-Diagnostic_tool	559	560	-
I-Diagnostic_tool	560	563	OCT
O	564	565	(
O	565	569	Carl
O	570	575	Zeiss
O	576	583	Meditec
O	583	584	,
O	585	591	Dublin
O	591	592	,
O	593	595	CA
O	595	596	)
O	596	597	.

O	598	601	The
O	602	607	areas
O	608	610	of
B-Symptom	611	613	GA
O	614	624	identified
O	625	627	on
O	628	631	the
B-Diagnostic_tool	632	634	SD
I-Diagnostic_tool	634	635	-
I-Diagnostic_tool	635	638	OCT
I-Diagnostic_tool	639	645	fundus
I-Diagnostic_tool	646	652	images
O	653	657	were
O	658	668	quantified
O	669	674	using
O	675	676	a
O	677	687	digitizing
O	688	694	tablet
O	694	695	.

O	696	711	Reproducibility
O	712	714	of
O	715	720	these
O	721	733	measurements
O	734	737	was
O	738	746	assessed
O	747	750	and
O	751	754	the
O	755	757	ER
O	758	760	of
B-Symptom	761	763	GA
O	764	767	was
O	768	778	calculated
O	778	779	.

O	780	783	The
O	784	794	usefulness
O	795	797	of
O	798	808	performing
O	809	815	square
O	816	820	root
O	821	836	transformations
O	837	839	of
O	840	843	the
O	844	850	lesion
O	851	855	area
O	856	868	measurements
O	869	872	was
O	873	881	explored
O	881	882	.

O	883	894	Enlargement
O	895	899	rate
O	900	902	of
B-Symptom	903	905	GA
O	905	906	.

O	907	909	At
O	910	918	baseline
O	918	919	,
O	920	922	27
O	922	923	%
O	924	926	of
B-Anatomy	927	931	eyes
O	932	935	had
O	936	937	a
O	938	944	single
O	945	949	area
O	950	952	of
B-Symptom	953	955	GA
O	955	956	.

O	957	960	The
O	961	965	mean
O	966	971	total
O	972	976	area
O	977	979	at
O	980	988	baseline
O	989	992	was
O	993	994	4
O	994	995	.
O	995	997	59
O	998	1000	mm
O	1000	1001	(
O	1001	1002	2
O	1002	1003	)
O	1004	1005	(
O	1005	1006	1
O	1006	1007	.
O	1007	1008	8
O	1009	1013	disc
O	1014	1019	areas
O	1020	1021	[
O	1021	1023	DA
O	1023	1024	]
O	1024	1025	)
O	1025	1026	.

O	1027	1030	The
O	1031	1035	mean
O	1036	1042	follow
O	1042	1043	-
O	1043	1045	up
O	1046	1050	time
O	1051	1054	was
O	1055	1056	1
O	1056	1057	.
O	1057	1059	24
O	1060	1065	years
O	1065	1066	.

O	1067	1082	Reproducibility
O	1082	1083	,
O	1084	1086	as
O	1087	1095	assessed
O	1096	1100	with
O	1101	1104	the
O	1105	1115	intraclass
O	1116	1127	correlation
O	1128	1139	coefficient
O	1140	1141	(
O	1141	1144	ICC
O	1144	1145	)
O	1145	1146	,
O	1147	1150	was
O	1151	1160	excellent
O	1161	1163	on
O	1164	1168	both
O	1169	1172	the
O	1173	1181	original
O	1182	1186	area
O	1187	1192	scale
O	1193	1194	(
O	1194	1197	ICC
O	1198	1199	=
O	1200	1201	0
O	1201	1202	.
O	1202	1205	995
O	1205	1206	)
O	1207	1210	and
O	1211	1214	the
O	1215	1221	square
O	1222	1226	root
O	1227	1232	scale
O	1233	1234	(
O	1234	1237	ICC
O	1238	1239	=
O	1240	1241	0
O	1241	1242	.
O	1242	1245	996
O	1245	1246	)
O	1246	1247	.

O	1248	1259	Intergrader
O	1260	1271	differences
O	1272	1276	were
O	1277	1280	not
O	1281	1283	an
O	1284	1293	important
O	1294	1300	source
O	1301	1303	of
O	1304	1315	variability
O	1316	1318	in
O	1319	1325	lesion
O	1326	1330	size
O	1331	1342	measurement
O	1343	1344	(
O	1344	1347	ICC
O	1348	1349	=
O	1350	1351	0
O	1351	1352	.
O	1352	1355	999
O	1355	1356	,
O	1357	1358	0
O	1358	1359	.
O	1359	1362	997
O	1362	1363	)
O	1363	1364	.

O	1365	1367	On
O	1368	1375	average
O	1375	1376	,
O	1377	1380	the
O	1381	1383	ER
O	1384	1386	of
B-Symptom	1387	1389	GA
O	1390	1393	per
O	1394	1398	year
O	1399	1402	was
O	1403	1404	1
O	1404	1405	.
O	1405	1406	2
O	1407	1409	mm
O	1409	1410	(
O	1410	1411	2
O	1411	1412	)
O	1413	1414	(
O	1414	1415	0
O	1415	1416	.
O	1416	1418	47
O	1419	1421	DA
O	1421	1422	;
O	1423	1428	range
O	1428	1429	,
O	1430	1431	0
O	1431	1432	.
O	1432	1434	01
O	1434	1435	-
O	1435	1436	3
O	1436	1437	.
O	1437	1439	62
O	1440	1442	mm
O	1442	1443	(
O	1443	1444	2
O	1444	1445	)
O	1445	1446	/
O	1446	1450	year
O	1450	1451	)
O	1451	1452	.

O	1453	1456	The
O	1457	1459	ER
O	1460	1470	correlated
O	1471	1475	with
O	1476	1479	the
O	1480	1487	initial
O	1488	1492	area
O	1493	1495	of
B-Symptom	1496	1498	GA
O	1499	1500	(
O	1500	1501	r
O	1502	1503	=
O	1504	1505	0
O	1505	1506	.
O	1506	1508	45
O	1508	1509	;
O	1510	1511	P
O	1512	1513	<
O	1514	1515	0
O	1515	1516	.
O	1516	1519	001
O	1519	1520	)
O	1520	1521	,
O	1522	1525	but
O	1526	1531	there
O	1532	1536	were
O	1537	1545	variable
O	1546	1552	growth
O	1553	1558	rates
O	1559	1562	for
O	1563	1566	any
O	1567	1572	given
O	1573	1581	baseline
O	1582	1586	area
O	1586	1587	.

O	1588	1592	When
O	1593	1596	the
O	1597	1603	square
O	1604	1608	root
O	1609	1623	transformation
O	1624	1626	of
O	1627	1630	the
O	1631	1637	lesion
O	1638	1642	area
O	1643	1655	measurements
O	1656	1659	was
O	1660	1664	used
O	1665	1667	as
O	1668	1669	a
O	1670	1677	measure
O	1678	1680	of
O	1681	1687	lesion
O	1688	1692	size
O	1692	1693	,
O	1694	1697	the
O	1698	1700	ER
O	1701	1702	(
O	1702	1703	0
O	1703	1704	.
O	1704	1706	28
O	1707	1709	mm
O	1709	1710	/
O	1710	1712	yr
O	1712	1713	)
O	1714	1717	was
O	1718	1721	not
O	1722	1732	correlated
O	1733	1737	with
O	1738	1746	baseline
O	1747	1751	size
O	1752	1753	(
O	1753	1754	r
O	1755	1756	=
O	1757	1758	-
O	1758	1759	0
O	1759	1760	.
O	1760	1762	09
O	1762	1763	;
O	1764	1765	P
O	1766	1767	=
O	1768	1769	0
O	1769	1770	.
O	1770	1772	40
O	1772	1773	)
O	1773	1774	.

O	1775	1777	In
O	1778	1782	this
O	1783	1789	cohort
O	1790	1792	of
O	1793	1800	lesions
O	1800	1801	,
O	1802	1804	no
O	1805	1816	correlation
O	1817	1820	was
O	1821	1826	found
O	1827	1834	between
O	1835	1837	ER
O	1838	1841	and
O	1842	1848	length
O	1849	1851	of
O	1852	1858	follow
O	1858	1859	-
O	1859	1861	up
O	1861	1862	.

O	1863	1869	Square
O	1870	1874	root
O	1875	1889	transformation
O	1890	1892	of
O	1893	1896	the
O	1897	1901	data
O	1902	1908	helped
O	1909	1911	to
O	1912	1922	facilitate
O	1923	1929	sample
O	1930	1934	size
O	1935	1944	estimates
O	1945	1948	for
O	1949	1959	controlled
O	1960	1968	clinical
O	1969	1975	trials
O	1976	1985	involving
B-Symptom	1986	1988	GA
O	1988	1989	.

O	1990	1993	The
B-Diagnostic_tool	1994	1996	SD
I-Diagnostic_tool	1996	1997	-
I-Diagnostic_tool	1997	2000	OCT
I-Diagnostic_tool	2001	2007	fundus
I-Diagnostic_tool	2008	2013	image
O	2014	2017	can
O	2018	2020	be
O	2021	2025	used
O	2026	2028	to
O	2029	2038	visualize
O	2039	2042	and
O	2043	2051	quantify
B-Symptom	2052	2054	GA
O	2054	2055	.

O	2056	2066	Advantages
O	2067	2069	of
O	2070	2074	this
O	2075	2083	approach
O	2084	2091	include
O	2092	2095	the
O	2096	2107	convenience
O	2108	2111	and
O	2112	2121	assurance
O	2122	2124	of
O	2125	2130	using
O	2131	2132	a
O	2133	2139	single
O	2140	2147	imaging
O	2148	2157	technique
O	2158	2162	that
O	2163	2170	permits
O	2171	2183	simultaneous
O	2184	2197	visualization
O	2198	2200	of
B-Symptom	2201	2203	GA
O	2204	2209	along
O	2210	2214	with
O	2215	2218	the
B-Symptom	2219	2223	loss
I-Symptom	2224	2226	of
I-Symptom	2227	2241	photoreceptors
I-Symptom	2242	2245	and
I-Symptom	2246	2249	the
I-Symptom	2250	2257	retinal
I-Symptom	2258	2265	pigment
I-Symptom	2266	2276	epithelium
O	2277	2281	that
O	2282	2288	should
O	2289	2298	correlate
O	2299	2303	with
O	2304	2307	the
B-Symptom	2308	2312	loss
I-Symptom	2313	2315	of
I-Symptom	2316	2322	visual
I-Symptom	2323	2331	function
O	2331	2332	.

O	0	9	Detecting
O	10	13	and
O	14	22	treating
B-Disease	23	34	retinopathy
O	35	37	in
O	38	46	patients
O	47	51	with
B-Disease	52	56	type
I-Disease	57	58	I
I-Disease	59	67	diabetes
I-Disease	68	76	mellitus
O	76	77	.

O	78	79	A
O	80	86	health
O	87	93	policy
O	94	99	model
O	99	100	.

B-Disease	102	110	Diabetic
I-Disease	111	122	retinopathy
O	123	125	is
O	126	129	the
O	130	135	major
O	136	141	cause
O	142	144	of
O	145	148	new
O	149	154	cases
O	155	157	of
B-Symptom	158	167	blindness
O	168	173	among
B-Characteristic	174	181	working
I-Characteristic	181	182	-
I-Characteristic	182	185	age
I-Characteristic	186	195	Americans
O	195	196	.

O	197	200	The
O	201	208	authors
O	209	217	analyzed
O	218	221	the
O	222	229	medical
O	230	233	and
O	234	242	economic
O	243	255	implications
O	256	258	of
O	259	270	alternative
O	271	280	screening
O	281	291	strategies
O	292	295	for
O	296	305	detecting
B-Disease	306	317	retinopathy
O	318	320	in
O	321	322	a
B-Characteristic	323	331	diabetic
I-Characteristic	332	342	population
O	342	343	.

O	344	347	The
O	348	358	approaches
O	359	367	compared
O	368	376	included
B-Diagnostic_tool	377	384	dilated
I-Diagnostic_tool	385	391	fundus
I-Diagnostic_tool	392	403	examination
O	404	406	at
O	407	408	6
O	408	409	-
O	409	410	,
O	411	413	12
O	413	414	-
O	414	415	,
O	416	419	and
O	420	422	24
O	422	423	-
O	423	428	month
O	429	438	intervals
O	439	443	with
O	444	447	and
O	448	455	without
B-Diagnostic_tool	456	462	fundus
I-Diagnostic_tool	463	474	photography
O	474	475	.

O	476	485	Potential
O	486	493	savings
O	494	498	from
O	499	508	screening
O	509	512	and
O	513	522	treatment
O	523	526	are
O	527	532	based
O	533	535	on
O	536	543	amounts
O	544	548	paid
O	549	551	by
O	552	555	the
O	556	563	federal
O	564	574	government
O	575	578	for
B-Symptom	579	588	blindness
I-Symptom	588	589	-
I-Symptom	589	596	related
I-Symptom	597	607	disability
O	607	608	.

O	609	618	Screening
O	619	622	for
O	623	626	and
O	627	635	treating
B-Disease	636	647	retinopathy
O	648	650	in
O	651	659	patients
O	660	664	with
B-Disease	665	669	type
I-Disease	670	671	I
I-Disease	672	680	diabetes
I-Disease	681	689	mellitus
O	690	693	was
O	694	698	cost
O	698	699	-
O	699	708	effective
O	709	714	using
O	715	718	all
O	719	728	screening
O	729	739	strategies
O	739	740	.

O	741	748	Between
O	749	751	71
O	751	752	,
O	752	755	474
O	756	759	and
O	760	762	85
O	762	763	,
O	763	766	315
O	767	773	person
O	774	779	years
O	780	782	of
O	783	788	sight
O	789	792	and
O	793	795	76
O	795	796	,
O	796	799	886
O	800	803	and
O	804	806	94
O	806	807	,
O	807	810	705
O	811	817	person
O	818	823	years
O	824	826	of
O	827	834	reading
O	835	841	vision
O	842	845	can
O	846	848	be
O	849	854	saved
O	855	858	for
O	859	863	each
O	864	870	annual
O	871	877	cohort
O	878	880	of
O	881	889	patients
O	890	894	with
B-Disease	895	899	type
I-Disease	900	901	I
I-Disease	902	910	diabetes
I-Disease	911	919	mellitus
O	920	924	when
O	925	931	proper
O	932	937	laser
O	938	954	photocoagulation
O	955	957	is
O	958	970	administered
O	970	971	.

O	972	976	This
O	977	984	results
O	985	987	in
O	988	989	a
O	990	994	cost
O	995	1002	savings
O	1003	1005	of
O	1006	1007	$
O	1007	1009	62
O	1009	1010	.
O	1010	1011	1
O	1012	1014	to
O	1015	1016	$
O	1016	1019	108
O	1019	1020	.
O	1020	1021	6
O	1022	1029	million
O	1029	1030	.

O	1031	1037	Annual
O	1038	1049	examination
O	1050	1052	of
O	1053	1056	all
B-Disease	1057	1065	diabetic
O	1066	1074	patients
O	1075	1078	and
O	1079	1083	semi
O	1083	1084	-
O	1084	1090	annual
O	1091	1102	examination
O	1103	1105	of
O	1106	1111	those
O	1112	1116	with
B-Disease	1117	1128	retinopathy
O	1129	1132	was
O	1133	1137	more
O	1138	1147	effective
O	1148	1152	than
O	1153	1159	annual
O	1160	1171	examination
O	1172	1176	with
B-Diagnostic_tool	1177	1183	fundus
I-Diagnostic_tool	1184	1195	photography
O	1195	1196	.

O	1197	1201	This
O	1202	1211	screening
O	1212	1220	strategy
O	1221	1223	is
O	1224	1234	consistent
O	1235	1239	with
O	1240	1243	the
O	1244	1253	Preferred
O	1254	1262	Practice
O	1263	1270	Pattern
O	1271	1274	for
B-Disease	1275	1283	Diabetic
I-Disease	1284	1295	Retinopathy
O	1296	1298	of
O	1299	1302	the
O	1303	1311	American
O	1312	1319	Academy
O	1320	1322	of
O	1323	1336	Ophthalmology
O	1336	1337	.

B-Characteristic	0	9	Choroidal
I-Characteristic	10	19	thickness
O	20	22	in
B-Disease	23	33	polypoidal
I-Disease	34	43	choroidal
I-Disease	44	56	vasculopathy
O	57	60	and
B-Disease	61	70	exudative
I-Disease	71	74	age
I-Disease	74	75	-
I-Disease	75	82	related
I-Disease	83	90	macular
I-Disease	91	103	degeneration
O	103	104	.

O	106	108	To
O	109	116	compare
B-Characteristic	117	126	choroidal
I-Characteristic	127	136	thickness
O	137	144	between
B-Anatomy	145	149	eyes
O	150	154	with
B-Disease	155	165	polypoidal
I-Disease	166	175	choroidal
I-Disease	176	188	vasculopathy
O	189	190	(
B-Disease	190	193	PCV
O	193	194	)
O	195	198	and
B-Anatomy	199	203	eyes
O	204	208	with
B-Disease	209	212	age
I-Disease	212	213	-
I-Disease	213	220	related
I-Disease	221	228	macular
I-Disease	229	241	degeneration
O	242	243	(
B-Disease	243	246	AMD
O	246	247	)
O	247	248	.

O	249	262	Observational
O	262	263	,
O	264	275	comparative
O	276	280	case
O	281	287	series
O	287	288	.

O	289	295	Twenty
O	295	296	-
O	296	300	five
B-Anatomy	301	305	eyes
O	306	310	with
B-Disease	311	314	PCV
O	314	315	,
O	316	318	14
O	319	329	uninvolved
O	330	336	fellow
B-Anatomy	337	341	eyes
O	342	346	with
B-Disease	347	350	PCV
O	350	351	,
O	352	354	30
B-Anatomy	355	359	eyes
O	360	364	with
B-Disease	365	374	exudative
I-Disease	375	378	AMD
O	378	379	,
O	380	382	17
B-Anatomy	383	387	eyes
O	388	392	with
B-Disease	393	398	early
I-Disease	399	402	AMD
O	402	403	,
O	404	407	and
O	408	410	20
B-Anatomy	411	415	eyes
O	416	418	of
B-Characteristic	419	422	age
I-Characteristic	422	423	-
I-Characteristic	423	430	matched
I-Characteristic	431	437	normal
I-Characteristic	438	446	subjects
O	446	447	.

B-Characteristic	448	457	Choroidal
I-Characteristic	458	467	thickness
O	468	471	was
O	472	480	measured
O	481	486	using
B-Diagnostic_tool	487	495	enhanced
I-Diagnostic_tool	495	496	-
I-Diagnostic_tool	496	501	depth
I-Diagnostic_tool	502	509	imaging
I-Diagnostic_tool	510	517	optical
I-Diagnostic_tool	518	527	coherence
I-Diagnostic_tool	528	538	tomography
O	538	539	.

B-Characteristic	540	549	Subfoveal
I-Characteristic	550	559	choroidal
I-Characteristic	560	569	thickness
O	570	572	in
O	573	577	each
B-Anatomy	578	581	eye
O	582	585	was
O	586	594	analyzed
O	595	597	by
O	598	609	measurement
O	610	612	of
O	613	616	the
B-Characteristic	617	625	vertical
I-Characteristic	626	634	distance
I-Characteristic	635	639	from
I-Characteristic	640	643	the
I-Characteristic	644	649	Bruch
I-Characteristic	649	650	'
I-Characteristic	650	651	s
I-Characteristic	652	660	membrane
I-Characteristic	661	663	to
I-Characteristic	664	667	the
I-Characteristic	668	677	innermost
I-Characteristic	678	685	scleral
I-Characteristic	686	691	layer
O	691	692	.

B-Characteristic	693	698	Nasal
I-Characteristic	698	699	,
I-Characteristic	700	708	superior
I-Characteristic	708	709	,
I-Characteristic	710	718	temporal
I-Characteristic	718	719	,
I-Characteristic	720	723	and
I-Characteristic	724	732	inferior
I-Characteristic	733	742	choroidal
I-Characteristic	743	754	thicknesses
O	754	755	,
O	756	760	1500
O	761	762	
O	762	763	m
O	764	769	apart
O	770	774	from
O	775	778	the
B-Anatomy	779	785	foveal
I-Anatomy	786	792	center
O	792	793	,
O	794	798	were
O	799	803	also
O	804	813	evaluated
O	814	816	in
O	817	820	all
B-Anatomy	821	825	eyes
O	825	826	.

B-Characteristic	827	836	Choroidal
I-Characteristic	837	846	thickness
O	847	849	in
O	850	854	each
O	855	860	group
O	860	861	.

B-Characteristic	862	866	Mean
I-Characteristic	867	868	(
I-Characteristic	868	869	
I-Characteristic	870	878	standard
I-Characteristic	879	888	deviation
I-Characteristic	888	889	)
I-Characteristic	890	899	subfoveal
I-Characteristic	900	909	choroidal
I-Characteristic	910	919	thickness
O	920	922	in
B-Anatomy	923	927	eyes
O	928	932	with
B-Disease	933	936	PCV
O	937	940	and
O	941	943	in
O	944	949	their
O	950	960	uninvolved
O	961	967	fellow
B-Anatomy	968	972	eyes
O	973	976	was
O	977	980	438
O	980	981	.
O	981	982	3
O	982	983	
O	983	985	87
O	985	986	.
O	986	987	8
O	988	989	
O	989	990	m
O	991	994	and
O	995	998	372
O	998	999	.
O	999	1000	9
O	1000	1001	
O	1001	1004	112
O	1004	1005	.
O	1005	1006	0
O	1007	1008	
O	1008	1009	m
O	1009	1010	,
O	1011	1023	respectively
O	1023	1024	,
O	1025	1030	which
O	1031	1034	was
O	1035	1048	significantly
O	1049	1056	greater
O	1057	1061	than
O	1062	1064	in
B-Anatomy	1065	1069	eyes
O	1070	1072	of
B-Characteristic	1073	1076	age
I-Characteristic	1076	1077	-
I-Characteristic	1077	1084	matched
I-Characteristic	1085	1091	normal
I-Characteristic	1092	1100	subjects
O	1101	1102	(
O	1102	1105	224
O	1105	1106	.
O	1106	1107	8
O	1107	1108	
O	1108	1110	52
O	1110	1111	.
O	1111	1112	9
O	1113	1114	
O	1114	1115	m
O	1115	1116	)
O	1117	1118	(
O	1118	1119	P
O	1120	1121	<
O	1122	1123	0
O	1123	1124	.
O	1124	1127	001
O	1128	1131	and
O	1132	1133	P
O	1134	1135	=
O	1136	1137	0
O	1137	1138	.
O	1138	1141	003
O	1141	1142	,
O	1143	1155	respectively
O	1155	1156	)
O	1156	1157	.

B-Characteristic	1158	1167	Subfoveal
I-Characteristic	1168	1177	choroidal
I-Characteristic	1178	1187	thickness
O	1188	1190	of
B-Anatomy	1191	1195	eyes
O	1196	1200	with
B-Disease	1201	1210	exudative
I-Disease	1211	1214	AMD
O	1215	1216	(
O	1216	1219	171
O	1219	1220	.
O	1220	1221	2
O	1221	1222	
O	1222	1224	38
O	1224	1225	.
O	1225	1226	5
O	1227	1228	
O	1228	1229	m
O	1229	1230	)
O	1231	1234	and
B-Anatomy	1235	1239	eyes
O	1240	1244	with
B-Disease	1245	1250	early
I-Disease	1251	1254	AMD
O	1255	1256	(
O	1256	1259	177
O	1259	1260	.
O	1260	1261	4
O	1261	1262	
O	1262	1264	49
O	1264	1265	.
O	1265	1266	7
O	1267	1268	
O	1268	1269	m
O	1269	1270	)
O	1271	1274	was
O	1275	1282	thinner
O	1283	1287	than
O	1288	1292	that
O	1293	1295	of
B-Characteristic	1296	1299	age
I-Characteristic	1299	1300	-
I-Characteristic	1300	1307	matched
I-Characteristic	1308	1314	normal
I-Characteristic	1315	1323	subjects
O	1324	1325	(
O	1325	1326	P
O	1327	1328	=
O	1329	1330	0
O	1330	1331	.
O	1331	1334	004
O	1335	1338	and
O	1339	1340	P
O	1341	1342	=
O	1343	1344	0
O	1344	1345	.
O	1345	1348	078
O	1348	1349	,
O	1350	1362	respectively
O	1362	1363	)
O	1363	1364	.

B-Characteristic	1365	1374	Choroidal
I-Characteristic	1375	1384	thickness
O	1385	1387	at
O	1388	1392	each
O	1393	1395	of
O	1396	1399	the
O	1400	1405	other
O	1406	1407	4
O	1408	1414	points
O	1415	1421	showed
O	1422	1423	a
O	1424	1431	similar
O	1432	1440	tendency
O	1440	1441	.

O	1442	1446	This
O	1447	1452	study
O	1453	1465	demonstrates
B-Characteristic	1466	1476	thickening
I-Characteristic	1477	1479	of
I-Characteristic	1480	1487	choroid
O	1488	1490	in
O	1491	1494	the
B-Anatomy	1495	1499	eyes
O	1500	1504	with
B-Disease	1505	1508	PCV
O	1508	1509	,
O	1510	1512	in
O	1513	1521	contrast
O	1522	1526	with
B-Characteristic	1527	1536	choroidal
I-Characteristic	1537	1545	thinning
O	1546	1554	observed
O	1555	1557	in
B-Anatomy	1558	1562	eyes
O	1563	1567	with
B-Disease	1568	1571	AMD
O	1571	1572	.

O	1573	1578	These
O	1579	1587	findings
O	1588	1595	suggest
O	1596	1607	involvement
O	1608	1610	of
O	1611	1620	different
O	1621	1631	pathogenic
O	1632	1642	mechanisms
O	1643	1645	in
B-Disease	1646	1649	PCV
O	1650	1654	from
O	1655	1660	those
O	1661	1663	in
B-Disease	1664	1673	exudative
I-Disease	1674	1677	AMD
O	1677	1678	.

O	0	10	Comparison
O	11	13	of
O	14	17	the
O	18	28	diagnostic
O	29	39	accuracies
O	40	42	of
O	43	46	the
B-Diagnostic_tool	47	57	Spectralis
I-Diagnostic_tool	57	58	,
I-Diagnostic_tool	59	65	Cirrus
I-Diagnostic_tool	65	66	,
I-Diagnostic_tool	67	70	and
I-Diagnostic_tool	71	76	RTVue
I-Diagnostic_tool	77	84	optical
I-Diagnostic_tool	85	94	coherence
I-Diagnostic_tool	95	105	tomography
O	106	113	devices
O	114	116	in
B-Disease	117	125	glaucoma
O	125	126	.

O	128	130	To
O	131	138	compare
O	139	142	the
O	143	153	diagnostic
O	154	164	accuracies
O	165	167	of
B-Characteristic	168	175	retinal
I-Characteristic	176	181	nerve
I-Characteristic	182	187	fiber
I-Characteristic	188	193	layer
I-Characteristic	194	195	(
I-Characteristic	195	199	RNFL
I-Characteristic	199	200	)
I-Characteristic	201	210	thickness
O	211	223	measurements
O	224	232	obtained
O	233	237	with
O	238	241	the
B-Diagnostic_tool	242	252	Spectralis
O	253	254	(
O	254	264	Heidelberg
O	265	276	Engineering
O	276	277	,
O	278	288	Dossenheim
O	288	289	,
O	290	297	Germany
O	297	298	)
O	298	299	,
B-Diagnostic_tool	300	306	Cirrus
O	307	308	(
O	308	312	Carl
O	313	318	Zeiss
O	319	326	Meditec
O	326	327	,
O	328	334	Dublin
O	334	335	,
O	336	338	CA
O	338	339	)
O	339	340	,
O	341	344	and
B-Diagnostic_tool	345	350	RTVue
O	351	352	(
O	352	359	Optovue
O	360	363	Inc
O	363	364	.
O	364	365	,
O	366	373	Fremont
O	373	374	,
O	375	377	CA
O	377	378	)
O	379	386	devices
O	387	390	for
O	391	394	the
O	395	404	detection
O	405	407	of
B-Disease	408	416	glaucoma
O	416	417	.

O	418	428	Diagnostic
O	428	429	,
O	430	434	case
O	434	435	-
O	435	442	control
O	443	448	study
O	448	449	.

O	450	451	A
O	452	457	total
O	458	460	of
O	461	464	233
O	465	466	(
O	466	469	107
O	470	477	healthy
O	477	478	,
O	479	482	126
B-Disease	483	495	glaucomatous
O	495	496	)
O	497	499	of
O	500	503	149
O	504	516	participants
O	517	521	from
O	522	525	the
O	526	538	longitudinal
O	539	549	Diagnostic
O	550	561	Innovations
O	562	564	in
B-Disease	565	573	Glaucoma
O	574	579	Study
O	580	581	(
O	581	585	DIGS
O	585	586	)
O	587	590	and
O	591	595	from
O	596	599	the
B-Characteristic	600	607	African
I-Characteristic	608	615	Descent
O	616	619	and
B-Disease	620	628	Glaucoma
O	629	639	Evaluation
O	640	645	Study
O	646	647	(
O	647	653	ADAGES
O	653	654	)
O	654	655	.

O	656	659	All
O	660	672	participants
O	673	682	underwent
B-Characteristic	683	687	RNFL
I-Characteristic	688	697	thickness
O	698	705	imaging
O	706	710	with
O	711	714	the
B-Diagnostic_tool	715	725	Spectralis
O	725	726	,
B-Diagnostic_tool	727	733	Cirrus
O	733	734	,
O	735	738	and
B-Diagnostic_tool	739	744	RTVue
O	745	752	devices
O	753	755	in
O	756	759	the
O	760	764	same
O	765	770	visit
O	770	771	.

O	772	780	Receiver
O	781	790	operating
O	791	805	characteristic
O	806	807	(
O	807	810	ROC
O	810	811	)
O	812	818	curves
O	819	827	adjusted
O	828	831	for
B-Characteristic	832	835	age
O	836	839	and
B-Characteristic	840	844	race
O	845	849	were
O	850	858	obtained
O	859	862	for
B-Characteristic	863	872	quadrants
I-Characteristic	873	874	(
I-Characteristic	874	882	superior
I-Characteristic	882	883	,
I-Characteristic	884	889	nasal
I-Characteristic	889	890	,
I-Characteristic	891	899	inferior
I-Characteristic	899	900	,
I-Characteristic	901	909	temporal
I-Characteristic	909	910	)
I-Characteristic	911	914	and
I-Characteristic	915	921	global
I-Characteristic	922	926	RNFL
I-Characteristic	927	936	thickness
O	937	940	for
O	941	944	all
O	945	956	instruments
O	956	957	.

O	958	963	Areas
O	964	969	under
O	970	973	ROC
O	974	975	(
O	975	978	AUC
O	978	979	)
O	980	983	and
O	984	997	sensitivities
O	998	1000	at
O	1001	1006	fixed
O	1007	1020	specificities
O	1021	1022	(
O	1022	1024	80
O	1024	1025	%
O	1026	1029	and
O	1030	1032	95
O	1032	1033	%
O	1033	1034	)
O	1035	1039	were
O	1040	1050	calculated
O	1051	1054	and
O	1055	1063	compared
O	1063	1064	.

O	1065	1075	Comparison
O	1076	1078	of
O	1079	1089	diagnostic
O	1090	1098	accuracy
O	1099	1104	using
O	1105	1109	AUCs
O	1110	1113	and
O	1114	1127	sensitivities
O	1128	1130	at
O	1131	1136	fixed
O	1137	1150	specificities
O	1151	1153	of
O	1154	1156	80
O	1156	1157	%
O	1158	1161	and
O	1162	1164	95
O	1164	1165	%
O	1165	1166	.

O	1167	1170	The
B-Characteristic	1171	1175	RNFL
I-Characteristic	1176	1185	thickness
O	1186	1195	parameter
O	1196	1200	with
O	1201	1204	the
O	1205	1212	largest
O	1213	1217	AUCs
O	1218	1221	was
O	1222	1225	the
B-Anatomy	1226	1234	superior
I-Anatomy	1235	1243	quadrant
O	1244	1247	for
O	1248	1251	the
B-Diagnostic_tool	1252	1262	Spectralis
O	1263	1264	(
O	1264	1265	0
O	1265	1266	.
O	1266	1268	88
O	1268	1269	)
O	1270	1273	and
O	1274	1277	the
B-Characteristic	1278	1284	global
I-Characteristic	1285	1289	RNFL
I-Characteristic	1290	1299	thickness
O	1300	1303	for
O	1304	1307	the
B-Diagnostic_tool	1308	1314	Cirrus
O	1315	1316	(
O	1316	1317	0
O	1317	1318	.
O	1318	1320	88
O	1320	1321	)
O	1322	1325	and
O	1326	1329	the
B-Diagnostic_tool	1330	1335	RTVue
O	1336	1337	(
O	1337	1338	0
O	1338	1339	.
O	1339	1341	87
O	1341	1342	)
O	1342	1343	.

O	1344	1347	The
O	1348	1356	pairwise
O	1357	1367	comparison
O	1368	1373	among
O	1374	1377	the
O	1378	1381	ROC
O	1382	1388	curves
O	1389	1395	showed
O	1396	1398	no
O	1399	1410	statistical
O	1411	1421	difference
O	1422	1425	for
O	1426	1429	all
O	1430	1440	parameters
O	1441	1447	except
O	1448	1451	for
O	1452	1455	the
B-Anatomy	1456	1461	nasal
I-Anatomy	1462	1470	quadrant
O	1470	1471	,
O	1472	1477	which
O	1478	1481	had
O	1482	1495	significantly
O	1496	1502	larger
O	1503	1506	AUC
O	1507	1509	in
O	1510	1513	the
B-Diagnostic_tool	1514	1524	Spectralis
O	1525	1528	and
B-Diagnostic_tool	1529	1534	RTVue
O	1535	1543	compared
O	1544	1548	with
O	1549	1552	the
B-Diagnostic_tool	1553	1559	Cirrus
O	1560	1561	(
O	1561	1562	P
O	1563	1564	<
O	1565	1566	0
O	1566	1567	.
O	1567	1569	03
O	1570	1573	for
O	1574	1578	both
O	1579	1590	comparisons
O	1590	1591	)
O	1591	1592	.

O	1593	1598	There
O	1599	1603	were
O	1604	1606	no
O	1607	1618	significant
O	1619	1630	differences
O	1631	1633	in
O	1634	1647	sensitivities
O	1648	1653	among
O	1654	1657	the
O	1658	1662	best
O	1663	1673	parameters
O	1674	1678	from
O	1679	1683	each
O	1684	1694	instrument
O	1695	1696	(
O	1696	1697	P
O	1698	1699	>
O	1700	1701	0
O	1701	1702	.
O	1702	1704	05
O	1704	1705	)
O	1705	1706	.

O	1707	1710	The
B-Characteristic	1711	1719	superior
I-Characteristic	1720	1728	quadrant
I-Characteristic	1729	1738	thickness
O	1739	1747	measured
O	1748	1752	with
O	1753	1756	the
B-Diagnostic_tool	1757	1767	Spectralis
O	1768	1771	had
O	1772	1783	sensitivity
O	1784	1786	of
O	1787	1789	81
O	1789	1790	.
O	1790	1791	9
O	1791	1792	%
O	1793	1795	at
O	1796	1797	a
O	1798	1803	fixed
O	1804	1815	specificity
O	1816	1818	of
O	1819	1821	80
O	1821	1822	%
O	1823	1826	and
O	1827	1829	70
O	1829	1830	%
O	1831	1833	at
O	1834	1835	a
O	1836	1841	fixed
O	1842	1853	specificity
O	1854	1856	of
O	1857	1859	95
O	1859	1860	%
O	1860	1861	.

O	1862	1865	The
B-Characteristic	1866	1872	global
I-Characteristic	1873	1882	thickness
O	1883	1891	measured
O	1892	1894	by
O	1895	1898	the
B-Diagnostic_tool	1899	1905	Cirrus
O	1906	1909	had
O	1910	1911	a
O	1912	1923	sensitivity
O	1924	1926	of
O	1927	1929	80
O	1929	1930	.
O	1930	1931	3
O	1931	1932	%
O	1933	1935	at
O	1936	1937	a
O	1938	1943	fixed
O	1944	1955	specificity
O	1956	1958	of
O	1959	1961	80
O	1961	1962	%
O	1963	1966	and
O	1967	1969	65
O	1969	1970	.
O	1970	1971	6
O	1971	1972	%
O	1973	1975	at
O	1976	1977	a
O	1978	1983	fixed
O	1984	1995	specificity
O	1996	1998	of
O	1999	2001	95
O	2001	2002	%
O	2002	2003	.

O	2004	2007	For
O	2008	2011	the
B-Diagnostic_tool	2012	2017	RTVue
O	2017	2018	,
O	2019	2022	the
B-Characteristic	2023	2029	global
I-Characteristic	2030	2039	thickness
O	2040	2043	had
O	2044	2045	a
O	2046	2057	sensitivity
O	2058	2060	of
O	2061	2063	77
O	2063	2064	.
O	2064	2065	9
O	2065	2066	%
O	2067	2069	at
O	2070	2071	a
O	2072	2077	fixed
O	2078	2089	specificity
O	2090	2092	of
O	2093	2095	80
O	2095	2096	%
O	2097	2100	and
O	2101	2103	62
O	2103	2104	.
O	2104	2105	1
O	2105	2106	%
O	2107	2109	at
O	2110	2111	a
O	2112	2117	fixed
O	2118	2129	specificity
O	2130	2132	of
O	2133	2135	95
O	2135	2136	%
O	2136	2137	.

O	2138	2146	Although
O	2147	2150	the
B-Diagnostic_tool	2151	2159	spectral
I-Diagnostic_tool	2159	2160	-
I-Diagnostic_tool	2160	2166	domain
I-Diagnostic_tool	2167	2172	optic
I-Diagnostic_tool	2173	2182	coherence
I-Diagnostic_tool	2183	2193	tomography
O	2194	2195	(
B-Diagnostic_tool	2195	2197	SD
I-Diagnostic_tool	2197	2198	-
I-Diagnostic_tool	2198	2201	OCT
O	2201	2202	)
O	2203	2214	instruments
O	2215	2219	have
O	2220	2229	different
O	2230	2240	resolution
O	2241	2244	and
O	2245	2256	acquisition
O	2257	2262	rates
O	2262	2263	,
O	2264	2269	their
O	2270	2277	ability
O	2278	2280	to
O	2281	2287	detect
B-Disease	2288	2296	glaucoma
O	2297	2300	was
O	2301	2308	similar
O	2308	2309	.

O	0	10	Evaluation
O	11	13	of
B-Symptom	14	21	retinal
I-Symptom	22	27	nerve
I-Symptom	28	33	fiber
I-Symptom	34	39	layer
I-Symptom	40	51	progression
O	52	54	in
B-Disease	55	63	glaucoma
O	64	65	a
O	66	77	prospective
O	78	86	analysis
O	87	91	with
B-Anatomy	92	104	neuroretinal
I-Anatomy	105	108	rim
O	109	112	and
B-Symptom	113	119	visual
I-Symptom	120	125	field
I-Symptom	126	137	progression
O	137	138	.

O	140	142	To
O	143	151	evaluate
O	152	155	the
O	156	167	performance
O	168	170	of
O	171	182	progression
O	183	192	detection
O	193	196	and
O	197	200	the
O	201	205	rate
O	206	208	of
O	209	215	change
O	216	218	of
B-Anatomy	219	226	retinal
I-Anatomy	227	232	nerve
I-Anatomy	233	238	fiber
I-Anatomy	239	244	layer
O	245	246	(
B-Anatomy	246	250	RNFL
O	250	251	)
O	251	252	,
B-Anatomy	253	265	neuroretinal
I-Anatomy	266	269	rim
O	269	270	,
O	271	274	and
B-Characteristic	275	281	visual
I-Characteristic	282	287	field
O	288	300	measurements
O	301	303	in
B-Disease	304	312	glaucoma
O	312	313	.

O	314	325	Prospective
O	326	331	study
O	331	332	.

O	333	336	One
O	337	344	hundred
O	345	350	eight
B-Anatomy	351	355	eyes
O	356	358	of
O	359	361	70
B-Disease	362	370	glaucoma
O	371	379	patients
O	379	380	.

O	381	389	Patients
O	390	394	were
O	395	403	followed
O	404	406	up
O	407	412	every
O	413	414	4
O	415	421	months
O	422	425	for
O	426	428	at
O	429	434	least
O	435	436	2
O	436	437	.
O	437	438	9
O	439	444	years
O	445	446	(
O	446	452	median
O	452	453	,
O	454	455	3
O	455	456	.
O	456	457	2
O	458	463	years
O	463	464	)
O	465	468	for
O	469	480	measurement
O	481	483	of
B-Characteristic	484	488	RNFL
I-Characteristic	489	498	thickness
O	499	503	with
O	504	507	the
B-Diagnostic_tool	508	515	Stratus
I-Diagnostic_tool	516	523	optical
I-Diagnostic_tool	524	533	coherence
I-Diagnostic_tool	534	543	tomograph
O	544	545	(
B-Diagnostic_tool	545	548	OCT
O	548	549	)
O	550	551	(
O	551	555	Carl
O	556	561	Zeiss
O	562	569	Meditec
O	569	570	,
O	571	577	Dublin
O	577	578	,
O	579	581	CA
O	581	582	)
O	582	583	,
B-Characteristic	584	596	neuroretinal
I-Characteristic	597	600	rim
I-Characteristic	601	605	area
O	606	610	with
O	611	614	the
B-Diagnostic_tool	615	625	Heidelberg
I-Diagnostic_tool	626	633	Retinal
I-Diagnostic_tool	634	643	Tomograph
O	644	645	(
B-Diagnostic_tool	645	648	HRT
O	649	650	3
O	650	651	;
O	652	662	Heidelberg
O	663	674	Engineering
O	674	675	,
O	676	680	GmbH
O	680	681	,
O	682	692	Dossenheim
O	692	693	,
O	694	701	Germany
O	701	702	)
O	702	703	,
O	704	707	and
B-Characteristic	708	714	visual
I-Characteristic	715	720	field
O	721	725	with
O	726	729	the
B-Diagnostic_tool	730	738	Humphrey
I-Diagnostic_tool	739	744	Field
I-Diagnostic_tool	745	753	Analyzer
I-Diagnostic_tool	754	756	II
O	757	758	(
O	758	762	Carl
O	763	768	Zeiss
O	769	776	Meditec
O	776	777	)
O	777	778	.

O	779	785	Linear
O	786	796	regression
O	797	805	analyses
O	806	810	were
O	811	820	performed
O	821	828	between
B-Characteristic	829	835	visual
I-Characteristic	836	841	field
I-Characteristic	842	847	index
O	848	849	(
B-Characteristic	849	852	VFI
O	852	853	)
O	853	854	,
B-Anatomy	855	859	RNFL
O	859	860	,
O	861	864	and
B-Anatomy	865	877	neuroretinal
I-Anatomy	878	881	rim
O	882	894	measurements
O	895	898	and
B-Characteristic	899	902	age
O	902	903	,
O	904	908	with
O	909	920	progression
O	921	928	defined
O	929	933	when
O	934	935	a
O	936	947	significant
O	948	956	negative
O	957	962	trend
O	963	966	was
O	967	975	detected
O	975	976	.

O	977	980	The
O	981	990	agreement
O	991	996	among
O	997	1007	structural
O	1008	1011	and
O	1012	1022	functional
O	1023	1035	measurements
O	1036	1039	was
O	1040	1049	evaluated
O	1050	1054	with
O	1055	1056	
O	1057	1067	statistics
O	1067	1068	.

O	1069	1072	The
O	1073	1077	mean
O	1078	1082	rate
O	1083	1085	of
O	1086	1092	change
O	1093	1096	was
O	1097	1106	estimated
O	1107	1111	with
O	1112	1118	linear
O	1119	1124	mixed
O	1125	1133	modeling
O	1133	1134	.

O	1135	1138	The
O	1139	1148	agreement
O	1149	1151	on
O	1152	1163	progression
O	1164	1173	detection
O	1174	1177	and
O	1178	1181	the
O	1182	1186	rate
O	1187	1189	of
O	1190	1196	change
O	1197	1199	of
B-Anatomy	1200	1204	RNFL
O	1204	1205	,
B-Anatomy	1206	1218	neuroretinal
I-Anatomy	1219	1222	rim
O	1222	1223	,
O	1224	1227	and
B-Characteristic	1228	1231	VFI
O	1232	1244	measurements
O	1244	1245	.

O	1246	1247	A
O	1248	1253	total
O	1254	1256	of
O	1257	1261	1105
B-Diagnostic_tool	1262	1265	OCT
O	1265	1266	,
O	1267	1271	1062
B-Diagnostic_tool	1272	1275	HRT
O	1275	1276	,
O	1277	1280	and
O	1281	1285	1099
B-Characteristic	1286	1292	visual
I-Characteristic	1293	1298	field
O	1299	1311	measurements
O	1312	1316	were
O	1317	1325	analyzed
O	1325	1326	.

O	1327	1330	The
O	1331	1340	agreement
O	1341	1343	of
O	1344	1355	progression
O	1356	1365	detection
O	1366	1371	among
O	1372	1375	the
O	1376	1377	3
O	1378	1392	investigations
O	1393	1396	was
O	1397	1401	poor
O	1402	1403	(
O	1403	1404	
O	1404	1405	
O	1405	1406	0
O	1406	1407	.
O	1407	1409	09
O	1409	1410	)
O	1410	1411	.

O	1412	1415	Ten
B-Anatomy	1416	1420	eyes
O	1421	1422	(
O	1422	1423	9
O	1423	1424	.
O	1424	1425	3
O	1425	1426	%
O	1426	1427	;
O	1428	1429	9
O	1430	1438	patients
O	1438	1439	)
O	1440	1446	showed
O	1447	1458	progression
O	1459	1461	by
O	1462	1469	average
B-Characteristic	1470	1474	RNFL
I-Characteristic	1475	1484	thickness
O	1484	1485	,
O	1486	1488	16
O	1489	1490	(
O	1490	1492	14
O	1492	1493	.
O	1493	1494	8
O	1494	1495	%
O	1495	1496	;
O	1497	1499	14
O	1500	1508	patients
O	1508	1509	)
O	1510	1512	by
O	1513	1519	global
B-Characteristic	1520	1532	neuroretinal
I-Characteristic	1533	1536	rim
I-Characteristic	1537	1541	area
O	1541	1542	,
O	1543	1546	and
O	1547	1549	35
O	1550	1551	(
O	1551	1553	32
O	1553	1554	.
O	1554	1555	4
O	1555	1556	%
O	1556	1557	;
O	1558	1560	31
O	1561	1569	patients
O	1569	1570	)
O	1571	1573	by
B-Characteristic	1574	1577	VFI
O	1577	1578	.

O	1579	1583	Only
O	1584	1585	1
B-Anatomy	1586	1589	eye
O	1590	1591	(
O	1591	1592	0
O	1592	1593	.
O	1593	1594	9
O	1594	1595	%
O	1595	1596	)
O	1597	1600	had
O	1601	1612	progression
O	1613	1621	detected
O	1622	1624	by
O	1625	1628	all
O	1629	1630	3
O	1631	1638	methods
O	1638	1639	.

O	1640	1645	There
O	1646	1650	were
O	1651	1656	large
O	1657	1667	variations
O	1668	1670	in
O	1671	1674	the
O	1675	1679	rate
O	1680	1682	of
O	1683	1689	change
O	1690	1692	of
B-Characteristic	1693	1696	VFI
O	1696	1697	,
O	1698	1705	average
B-Characteristic	1706	1710	RNFL
I-Characteristic	1711	1720	thickness
O	1720	1721	,
O	1722	1725	and
O	1726	1732	global
B-Characteristic	1733	1745	neuroretinal
I-Characteristic	1746	1749	rim
I-Characteristic	1750	1754	area
O	1754	1755	,
O	1756	1760	with
O	1761	1762	a
O	1763	1768	range
O	1769	1776	between
O	1777	1778	-
O	1778	1779	0
O	1779	1780	.
O	1780	1782	63
O	1782	1783	%
O	1784	1787	and
O	1788	1789	-
O	1789	1790	4
O	1790	1791	.
O	1791	1793	97
O	1793	1794	%
O	1795	1798	per
O	1799	1803	year
O	1803	1804	,
O	1805	1806	-
O	1806	1807	2
O	1807	1808	.
O	1808	1810	32
O	1810	1811	%
O	1812	1815	and
O	1816	1817	-
O	1817	1819	10
O	1819	1820	.
O	1820	1822	12
O	1822	1823	%
O	1824	1827	per
O	1828	1832	year
O	1832	1833	,
O	1834	1837	and
O	1838	1839	-
O	1839	1840	0
O	1840	1841	.
O	1841	1843	61
O	1843	1844	%
O	1845	1848	and
O	1849	1850	-
O	1850	1851	8
O	1851	1852	.
O	1852	1854	48
O	1854	1855	%
O	1856	1859	per
O	1860	1864	year
O	1864	1865	,
O	1866	1878	respectively
O	1878	1879	.

O	1880	1883	The
O	1884	1894	respective
O	1895	1899	mean
O	1900	1904	rate
O	1905	1914	estimates
O	1915	1919	were
O	1920	1921	-
O	1921	1922	1
O	1922	1923	.
O	1923	1925	15
O	1925	1926	%
O	1927	1930	per
O	1931	1935	year
O	1936	1937	(
O	1937	1939	95
O	1939	1940	%
O	1941	1951	confidence
O	1952	1960	interval
O	1961	1962	[
O	1962	1964	CI
O	1964	1965	]
O	1965	1966	,
O	1967	1968	-
O	1968	1969	1
O	1969	1970	.
O	1970	1972	56
O	1972	1973	%
O	1974	1976	to
O	1977	1978	-
O	1978	1979	0
O	1979	1980	.
O	1980	1982	73
O	1982	1983	%
O	1983	1984	)
O	1984	1985	,
O	1986	1987	-
O	1987	1988	0
O	1988	1989	.
O	1989	1991	70
O	1991	1992	%
O	1993	1996	per
O	1997	2001	year
O	2002	2003	(
O	2003	2005	95
O	2005	2006	%
O	2007	2009	CI
O	2009	2010	,
O	2011	2012	-
O	2012	2013	1
O	2013	2014	.
O	2014	2016	19
O	2016	2017	%
O	2018	2020	to
O	2021	2022	-
O	2022	2023	0
O	2023	2024	.
O	2024	2026	21
O	2026	2027	%
O	2027	2028	)
O	2028	2029	,
O	2030	2033	and
O	2034	2035	-
O	2035	2036	1
O	2036	2037	.
O	2037	2039	06
O	2039	2040	%
O	2041	2044	per
O	2045	2049	year
O	2050	2051	(
O	2051	2053	95
O	2053	2054	%
O	2055	2057	CI
O	2057	2058	,
O	2059	2060	-
O	2060	2061	1
O	2061	2062	.
O	2062	2064	56
O	2064	2065	%
O	2066	2068	to
O	2069	2070	-
O	2070	2071	0
O	2071	2072	.
O	2072	2074	55
O	2074	2075	%
O	2075	2076	)
O	2076	2077	.

O	2078	2081	The
O	2082	2091	agreement
O	2092	2094	of
O	2095	2106	progression
O	2107	2116	detection
O	2117	2122	among
B-Anatomy	2123	2127	RNFL
O	2127	2128	,
B-Anatomy	2129	2141	neuroretinal
I-Anatomy	2142	2145	rim
O	2145	2146	,
O	2147	2150	and
B-Characteristic	2151	2157	visual
I-Characteristic	2158	2163	field
O	2164	2176	measurements
O	2177	2180	was
O	2181	2185	poor
O	2185	2186	,
O	2187	2190	and
O	2191	2194	the
O	2195	2199	rate
O	2200	2202	of
B-Anatomy	2203	2207	RNFL
O	2207	2208	,
B-Anatomy	2209	2221	neuroretinal
I-Anatomy	2222	2225	rim
O	2225	2226	,
O	2227	2230	and
B-Characteristic	2231	2237	visual
I-Characteristic	2238	2243	field
O	2244	2255	progression
O	2256	2262	varied
O	2263	2275	considerably
O	2276	2282	within
O	2283	2286	and
O	2287	2294	between
O	2295	2303	subjects
O	2303	2304	.

O	2305	2310	Given
O	2311	2315	this
O	2316	2327	variability
O	2327	2328	,
O	2329	2343	interpretation
O	2344	2346	of
B-Anatomy	2347	2351	RNFL
O	2351	2352	,
B-Anatomy	2353	2365	neuroretinal
I-Anatomy	2366	2369	rim
O	2369	2370	,
O	2371	2374	and
B-Characteristic	2375	2378	VFI
O	2379	2390	progression
O	2391	2397	always
O	2398	2404	should
O	2405	2407	be
O	2408	2417	evaluated
O	2418	2420	on
O	2421	2423	an
O	2424	2434	individual
O	2435	2440	basis
O	2440	2441	.

O	2442	2453	Proprietary
O	2454	2456	or
O	2457	2467	commercial
O	2468	2478	disclosure
O	2479	2482	may
O	2483	2485	be
O	2486	2491	found
O	2492	2497	after
O	2498	2501	the
O	2502	2512	references
O	2512	2513	.

B-Characteristic	0	7	Retinal
I-Characteristic	8	13	nerve
I-Characteristic	14	19	fiber
I-Characteristic	20	25	layer
I-Characteristic	26	35	thickness
O	36	38	in
B-Disease	39	47	dominant
I-Disease	48	53	optic
I-Disease	54	61	atrophy
O	62	74	measurements
O	75	77	by
B-Diagnostic_tool	78	85	optical
I-Diagnostic_tool	86	95	coherence
I-Diagnostic_tool	96	106	tomography
O	107	110	and
O	111	122	correlation
O	123	127	with
B-Characteristic	128	131	age
O	131	132	.

O	134	136	To
O	137	144	measure
O	145	148	the
B-Characteristic	149	156	retinal
I-Characteristic	157	162	nerve
I-Characteristic	163	168	fiber
I-Characteristic	169	174	layer
I-Characteristic	175	176	(
I-Characteristic	176	180	RNFL
I-Characteristic	180	181	)
I-Characteristic	182	191	thickness
O	192	194	by
O	195	200	means
O	201	203	of
B-Diagnostic_tool	204	211	optical
I-Diagnostic_tool	212	221	coherence
I-Diagnostic_tool	222	232	tomography
O	233	234	(
B-Diagnostic_tool	234	237	OCT
O	237	238	)
O	239	241	in
O	242	250	patients
O	251	255	with
B-Disease	256	264	dominant
I-Disease	265	270	optic
I-Disease	271	278	atrophy
O	279	280	(
B-Disease	280	283	DOA
O	283	284	)
O	284	285	.

O	286	291	Cross
O	291	292	-
O	292	301	sectional
O	302	307	study
O	307	308	.

O	309	315	Thirty
O	315	316	-
O	316	321	three
O	322	330	patients
O	331	335	from
O	336	338	15
O	339	348	pedigrees
O	349	353	with
B-Disease	354	357	DOA
O	358	367	harboring
B-Characteristic	368	380	heterozygous
I-Characteristic	381	390	mutations
I-Characteristic	391	393	in
I-Characteristic	394	397	the
I-Characteristic	398	402	OPA1
I-Characteristic	403	407	gene
O	408	411	and
O	412	414	43
B-Characteristic	415	422	healthy
I-Characteristic	423	431	subjects
O	432	436	were
O	437	445	enrolled
O	445	446	.

O	447	450	The
B-Anatomy	451	456	RNFLs
O	457	459	of
B-Disease	460	463	DOA
O	464	472	patients
O	473	477	were
O	478	485	studied
O	486	488	by
B-Diagnostic_tool	489	492	OCT
O	493	496	and
O	497	505	compared
O	506	510	with
O	511	516	those
O	517	519	of
O	520	522	43
B-Characteristic	523	530	healthy
I-Characteristic	531	539	subjects
O	540	547	matched
O	548	551	for
B-Characteristic	552	555	age
O	556	559	and
B-Characteristic	560	565	optic
I-Characteristic	566	571	nerve
I-Characteristic	572	576	head
I-Characteristic	577	578	(
I-Characteristic	578	581	ONH
I-Characteristic	581	582	)
I-Characteristic	583	587	size
O	587	588	.

B-Characteristic	589	596	Retinal
I-Characteristic	597	602	nerve
I-Characteristic	603	608	fiber
I-Characteristic	609	614	layer
I-Characteristic	615	624	thickness
O	624	625	.

B-Disease	626	634	Dominant
I-Disease	635	640	optic
I-Disease	641	648	atrophy
O	649	657	patients
O	658	666	revealed
O	667	668	a
B-Symptom	669	680	significant
I-Symptom	681	685	RNFL
I-Symptom	686	695	thickness
I-Symptom	696	705	reduction
I-Symptom	706	708	in
I-Symptom	709	712	all
I-Symptom	713	722	quadrants
O	722	723	,
O	724	728	with
O	729	730	a
O	731	743	preferential
O	744	755	involvement
O	756	758	of
O	759	762	the
B-Anatomy	763	771	temporal
I-Anatomy	772	775	and
I-Anatomy	776	784	inferior
I-Anatomy	785	792	sectors
O	792	793	.

O	794	797	The
B-Symptom	798	809	progressive
I-Symptom	810	817	decline
I-Symptom	818	820	of
I-Symptom	821	825	RNFL
I-Symptom	826	835	thickness
I-Symptom	836	840	with
I-Symptom	841	844	age
O	845	848	was
O	849	856	similar
O	857	859	to
O	860	864	that
O	865	873	observed
O	874	876	in
B-Characteristic	877	884	healthy
I-Characteristic	885	893	subjects
O	894	897	and
O	898	901	was
O	902	906	more
O	907	914	evident
O	915	917	in
O	918	921	the
O	922	923	2
O	924	933	quadrants
O	934	938	with
B-Symptom	939	945	higher
I-Symptom	946	954	residual
I-Symptom	955	962	amounts
I-Symptom	963	965	of
I-Symptom	966	972	fibers
O	972	973	,
O	974	978	that
O	979	981	is
O	981	982	,
O	983	986	the
O	987	995	superior
O	996	999	and
O	1000	1003	the
O	1004	1012	inferior
O	1012	1013	.

O	1014	1017	The
B-Anatomy	1018	1026	temporal
I-Anatomy	1027	1035	quadrant
O	1036	1039	was
O	1040	1050	profoundly
B-Symptom	1051	1059	depleted
I-Symptom	1060	1062	of
I-Symptom	1063	1068	fiber
O	1069	1071	so
O	1072	1076	that
O	1077	1080	the
O	1081	1088	further
O	1089	1093	rate
O	1094	1096	of
B-Symptom	1097	1101	loss
I-Symptom	1102	1104	of
I-Symptom	1105	1112	microns
O	1113	1116	per
O	1117	1121	year
O	1122	1124	is
O	1125	1130	close
O	1131	1133	to
O	1134	1138	zero
O	1138	1139	,
O	1140	1147	whereas
O	1148	1151	the
B-Anatomy	1152	1157	nasal
I-Anatomy	1158	1166	quadrant
O	1167	1170	was
O	1171	1177	spared
O	1178	1181	the
O	1182	1186	most
O	1187	1189	by
B-Symptom	1190	1207	neurodegeneration
O	1207	1208	.

O	1209	1212	The
O	1213	1220	present
O	1221	1229	findings
O	1229	1230	,
O	1231	1236	taken
O	1237	1239	in
O	1240	1251	conjunction
O	1252	1256	with
O	1257	1260	the
O	1261	1268	authors
O	1268	1269	'
O	1270	1278	previous
O	1279	1290	description
O	1291	1293	of
B-Characteristic	1294	1299	small
I-Characteristic	1300	1303	ONH
I-Characteristic	1304	1308	size
O	1309	1311	in
B-Disease	1312	1315	DOA
O	1315	1316	,
O	1317	1325	strongly
O	1326	1333	suggest
O	1334	1338	that
O	1339	1347	patients
O	1348	1352	with
O	1353	1357	this
O	1358	1365	disease
O	1366	1369	are
B-Symptom	1370	1374	born
I-Symptom	1375	1379	with
I-Symptom	1380	1385	fewer
I-Symptom	1386	1391	optic
I-Symptom	1392	1397	nerve
I-Symptom	1398	1403	axons
O	1404	1407	and
O	1408	1415	support
O	1416	1419	the
O	1420	1430	hypothesis
O	1431	1435	that
O	1436	1446	subsequent
B-Symptom	1447	1453	visual
I-Symptom	1454	1458	loss
O	1459	1466	depends
O	1467	1469	on
O	1470	1477	further
B-Symptom	1478	1481	age
I-Symptom	1481	1482	-
I-Symptom	1482	1489	related
I-Symptom	1490	1494	loss
I-Symptom	1495	1497	of
I-Symptom	1498	1504	fibers
O	1504	1505	,
O	1506	1511	which
O	1512	1516	also
O	1517	1523	occurs
O	1524	1526	in
O	1527	1535	controls
O	1535	1536	.

O	1537	1540	The
O	1541	1547	author
O	1547	1548	(
O	1548	1549	s
O	1549	1550	)
O	1551	1555	have
O	1556	1558	no
O	1559	1570	proprietary
O	1571	1573	or
O	1574	1584	commercial
O	1585	1593	interest
O	1594	1596	in
O	1597	1600	any
O	1601	1610	materials
O	1611	1620	discussed
O	1621	1623	in
O	1624	1628	this
O	1629	1636	article
O	1636	1637	.

O	0	9	Adjusting
B-Characteristic	10	21	intraocular
I-Characteristic	22	30	pressure
O	31	34	for
B-Characteristic	35	42	central
I-Characteristic	43	50	corneal
I-Characteristic	51	60	thickness
O	61	65	does
O	66	69	not
O	70	77	improve
O	78	88	prediction
O	89	95	models
O	96	99	for
B-Disease	100	107	primary
I-Disease	108	112	open
I-Disease	112	113	-
I-Disease	113	118	angle
I-Disease	119	127	glaucoma
O	127	128	.

O	130	132	To
O	133	142	determine
O	143	145	if
O	146	149	the
O	150	158	accuracy
O	159	161	of
O	162	165	the
O	166	174	baseline
O	175	185	prediction
O	186	191	model
O	192	195	for
O	196	199	the
O	200	211	development
O	212	214	of
B-Disease	215	222	primary
I-Disease	223	227	open
I-Disease	227	228	-
I-Disease	228	233	angle
I-Disease	234	242	glaucoma
O	243	244	(
B-Disease	244	248	POAG
O	248	249	)
O	250	252	in
O	253	261	patients
O	262	266	with
B-Symptom	267	273	ocular
I-Symptom	274	286	hypertension
O	287	290	can
O	291	293	be
O	294	302	improved
O	303	305	by
O	306	316	correcting
B-Characteristic	317	328	intraocular
I-Characteristic	329	337	pressure
O	338	339	(
B-Characteristic	339	342	IOP
O	342	343	)
O	344	347	for
B-Characteristic	348	355	central
I-Characteristic	356	363	corneal
I-Characteristic	364	373	thickness
O	374	375	(
B-Characteristic	375	378	CCT
O	378	379	)
O	379	380	.

O	381	391	Reanalysis
O	392	394	of
O	395	398	the
O	399	407	baseline
O	408	418	prediction
O	419	424	model
O	425	428	for
O	429	432	the
O	433	444	development
O	445	447	of
B-Disease	448	452	POAG
O	453	457	from
O	458	461	the
O	462	468	Ocular
O	469	481	Hypertension
O	482	491	Treatment
O	492	497	Study
O	498	499	(
O	499	503	OHTS
O	503	504	)
O	505	517	substituting
B-Characteristic	518	521	IOP
O	522	530	adjusted
O	531	534	for
B-Characteristic	535	538	CCT
O	539	544	using
O	545	546	5
O	547	556	different
O	557	567	correction
O	568	576	formulae
O	577	580	for
O	581	591	unadjusted
B-Characteristic	592	595	IOP
O	595	596	.

O	597	598	A
O	599	604	total
O	605	607	of
O	608	612	1433
O	613	615	of
O	616	620	1636
O	621	633	participants
O	634	644	randomized
O	645	647	to
O	648	652	OHTS
O	653	656	who
O	657	660	had
O	661	669	complete
O	670	678	baseline
O	679	683	data
O	684	687	for
O	688	695	factors
O	696	698	in
O	699	702	the
O	703	713	prediction
O	714	719	model
O	719	720	:
B-Characteristic	721	724	age
O	724	725	,
B-Characteristic	726	729	IOP
O	729	730	,
B-Characteristic	731	734	CCT
O	734	735	,
B-Characteristic	736	744	vertical
I-Characteristic	745	748	cup
I-Characteristic	748	749	-
I-Characteristic	749	751	to
I-Characteristic	751	752	-
I-Characteristic	752	756	disc
I-Characteristic	757	762	ratio
O	763	764	(
B-Characteristic	764	768	VCDR
O	768	769	)
O	769	770	,
O	771	774	and
B-Characteristic	775	782	pattern
I-Characteristic	783	791	standard
I-Characteristic	792	801	deviation
O	802	803	(
B-Characteristic	803	806	PSD
O	806	807	)
O	807	808	.

O	809	819	Reanalysis
O	820	822	of
O	823	826	the
O	827	837	prediction
O	838	843	model
O	844	847	for
O	848	851	the
O	852	856	risk
O	857	859	of
O	860	870	developing
B-Disease	871	875	POAG
O	876	881	using
O	882	885	the
O	886	890	same
O	891	899	baseline
O	900	909	variables
O	910	911	(
B-Characteristic	911	914	age
O	914	915	,
B-Characteristic	916	919	IOP
O	919	920	,
B-Characteristic	921	924	CCT
O	924	925	,
B-Characteristic	926	930	VCDR
O	930	931	,
O	932	935	and
B-Characteristic	936	939	PSD
O	939	940	)
O	941	947	except
O	948	952	that
B-Characteristic	953	956	IOP
O	957	960	was
O	961	969	adjusted
O	970	973	for
B-Characteristic	974	977	CCT
O	978	983	using
O	984	994	correction
O	995	1003	formulae
O	1003	1004	.

O	1005	1006	A
O	1007	1015	separate
O	1016	1019	Cox
O	1020	1032	proportional
O	1033	1040	hazards
O	1041	1046	model
O	1047	1050	was
O	1051	1054	run
O	1055	1060	using
B-Characteristic	1061	1064	IOP
O	1065	1073	adjusted
O	1074	1077	for
B-Characteristic	1078	1081	CCT
O	1082	1084	by
O	1085	1089	each
O	1090	1092	of
O	1093	1096	the
O	1097	1098	5
O	1099	1107	formulae
O	1108	1117	published
O	1118	1120	to
O	1121	1125	date
O	1125	1126	.

O	1127	1133	Models
O	1134	1138	were
O	1139	1142	run
O	1143	1152	including
O	1153	1156	and
O	1157	1166	excluding
B-Characteristic	1167	1170	CCT
O	1170	1171	.

O	1172	1182	Predictive
O	1183	1191	accuracy
O	1192	1194	of
O	1195	1199	each
O	1200	1203	Cox
O	1204	1216	proportional
O	1217	1224	hazards
O	1225	1230	model
O	1231	1234	was
O	1235	1243	assessed
O	1244	1249	using
O	1250	1253	the
O	1254	1255	c
O	1255	1256	-
O	1256	1265	statistic
O	1266	1269	and
O	1270	1281	calibration
O	1282	1285	chi
O	1285	1286	-
O	1286	1292	square
O	1292	1293	.

O	1294	1295	C
O	1295	1296	-
O	1296	1306	statistics
O	1307	1310	for
O	1311	1321	prediction
O	1322	1328	models
O	1329	1333	that
O	1334	1338	used
B-Characteristic	1339	1342	IOP
O	1343	1351	adjusted
O	1352	1355	for
B-Characteristic	1356	1359	CCT
O	1360	1362	by
O	1363	1370	various
O	1371	1379	formulas
O	1380	1386	ranged
O	1387	1391	from
O	1392	1393	0
O	1393	1394	.
O	1394	1396	75
O	1397	1399	to
O	1400	1401	0
O	1401	1402	.
O	1402	1404	77
O	1404	1405	,
O	1406	1408	no
O	1409	1415	better
O	1416	1420	than
O	1421	1424	the
O	1425	1433	original
O	1434	1444	prediction
O	1445	1450	model
O	1451	1452	(
O	1452	1453	0
O	1453	1454	.
O	1454	1456	77
O	1456	1457	)
O	1458	1462	that
O	1463	1466	did
O	1467	1470	not
O	1471	1477	adjust
B-Characteristic	1478	1481	IOP
O	1482	1485	for
B-Characteristic	1486	1489	CCT
O	1489	1490	.

O	1491	1502	Calibration
O	1503	1506	chi
O	1506	1507	-
O	1507	1513	square
O	1514	1517	was
O	1518	1528	acceptable
O	1529	1532	for
O	1533	1536	all
O	1537	1543	models
O	1543	1544	.

O	1545	1553	Baseline
B-Characteristic	1554	1557	IOP
O	1557	1558	,
O	1559	1566	whether
O	1567	1575	adjusted
O	1576	1579	for
B-Characteristic	1580	1583	CCT
O	1584	1586	or
O	1587	1590	not
O	1590	1591	,
O	1592	1595	was
O	1596	1609	statistically
O	1610	1621	significant
O	1622	1624	in
O	1625	1628	all
O	1629	1635	models
O	1636	1645	including
O	1646	1651	those
O	1652	1656	with
B-Characteristic	1657	1660	CCT
O	1661	1663	in
O	1664	1667	the
O	1668	1672	same
O	1673	1678	model
O	1678	1679	.

O	1680	1683	The
B-Characteristic	1684	1687	CCT
O	1688	1691	was
O	1692	1705	statistically
O	1706	1717	significant
O	1718	1720	in
O	1721	1724	all
O	1725	1731	models
O	1732	1741	including
O	1742	1747	those
O	1748	1752	with
B-Characteristic	1753	1756	IOP
O	1757	1765	adjusted
O	1766	1769	for
B-Characteristic	1770	1773	CCT
O	1774	1776	in
O	1777	1780	the
O	1781	1785	same
O	1786	1791	model
O	1791	1792	.

O	1793	1796	The
O	1797	1808	calculation
O	1809	1811	of
O	1812	1822	individual
O	1823	1827	risk
O	1828	1831	for
O	1832	1842	developing
B-Disease	1843	1847	POAG
O	1848	1850	in
B-Symptom	1851	1857	ocular
I-Symptom	1858	1870	hypertensive
O	1871	1882	individuals
O	1883	1885	is
O	1886	1893	simpler
O	1894	1897	and
O	1898	1905	equally
O	1906	1914	accurate
O	1915	1920	using
B-Characteristic	1921	1924	IOP
O	1925	1928	and
B-Characteristic	1929	1932	CCT
O	1933	1935	as
O	1936	1944	measured
O	1944	1945	,
O	1946	1952	rather
O	1953	1957	than
O	1958	1966	applying
O	1967	1969	an
O	1970	1980	adjustment
O	1981	1988	formula
O	1989	1991	to
O	1992	1999	correct
B-Characteristic	2000	2003	IOP
O	2004	2007	for
B-Characteristic	2008	2011	CCT
O	2011	2012	.

O	0	7	Natural
O	8	15	history
O	16	18	of
B-Symptom	19	25	drusen
O	26	36	morphology
O	37	39	in
B-Disease	40	43	age
I-Disease	43	44	-
I-Disease	44	51	related
I-Disease	52	59	macular
I-Disease	60	72	degeneration
O	73	78	using
B-Diagnostic_tool	79	87	spectral
I-Diagnostic_tool	88	94	domain
I-Diagnostic_tool	95	102	optical
I-Diagnostic_tool	103	112	coherence
I-Diagnostic_tool	113	123	tomography
O	123	124	.

O	126	128	To
O	129	141	characterize
O	142	145	the
O	146	153	natural
O	154	161	history
O	162	164	of
B-Symptom	165	171	drusen
O	172	177	using
B-Diagnostic_tool	178	186	spectral
I-Diagnostic_tool	186	187	-
I-Diagnostic_tool	187	193	domain
I-Diagnostic_tool	194	201	optical
I-Diagnostic_tool	202	211	coherence
I-Diagnostic_tool	212	222	tomography
I-Diagnostic_tool	223	224	(
I-Diagnostic_tool	224	226	SD
I-Diagnostic_tool	226	227	-
I-Diagnostic_tool	227	230	OCT
I-Diagnostic_tool	230	231	)
I-Diagnostic_tool	232	239	imaging
O	240	242	of
B-Anatomy	243	247	eyes
O	248	252	from
O	253	261	patients
O	262	266	with
B-Disease	267	279	nonexudative
I-Disease	280	283	age
I-Disease	283	284	-
I-Disease	284	291	related
I-Disease	292	299	macular
I-Disease	300	312	degeneration
O	313	314	(
B-Disease	314	317	AMD
O	317	318	)
O	318	319	.

O	320	331	Prospective
O	331	332	,
O	333	345	longitudinal
O	345	346	,
O	347	354	natural
O	355	362	history
O	363	368	study
O	368	369	.

O	370	372	We
O	373	381	included
O	382	385	143
B-Anatomy	386	390	eyes
O	391	393	of
O	394	397	100
O	398	406	patients
O	407	411	with
O	412	414	at
O	415	420	least
O	421	422	6
O	423	429	months
O	430	432	of
O	433	439	follow
O	439	440	-
O	440	442	up
O	442	443	.

O	444	452	Patients
O	453	457	with
B-Symptom	458	464	drusen
O	465	474	secondary
O	475	477	to
B-Disease	478	490	nonexudative
I-Disease	491	494	AMD
O	495	499	were
O	500	507	scanned
O	508	513	using
O	514	517	the
B-Diagnostic_tool	518	524	Cirrus
I-Diagnostic_tool	525	527	SD
I-Diagnostic_tool	527	528	-
I-Diagnostic_tool	528	531	OCT
O	532	542	instrument
O	542	543	.

B-Anatomy	544	548	Eyes
O	549	553	were
O	554	560	imaged
O	561	566	using
O	567	570	the
O	571	574	200
O	575	576	
O	577	580	200
O	581	582	A
O	582	583	-
O	583	587	scan
O	588	594	raster
O	595	602	pattern
O	603	612	contained
O	613	619	within
O	620	621	a
O	622	623	6
O	624	625	
O	626	627	6
O	628	630	mm
O	631	635	area
O	635	636	.

O	637	643	Custom
O	644	652	software
O	653	656	was
O	657	661	used
O	662	664	to
O	665	673	quantify
O	674	684	volumetric
O	685	692	changes
O	693	695	in
B-Symptom	696	702	drusen
O	703	707	over
O	708	709	a
O	710	716	period
O	717	719	of
O	720	721	
O	722	723	6
O	724	730	months
O	731	734	and
O	735	738	for
O	739	741	as
O	742	746	long
O	747	749	as
O	750	752	24
O	753	759	months
O	759	760	.

B-Characteristic	761	767	Drusen
I-Characteristic	768	774	volume
O	775	778	and
B-Characteristic	779	785	drusen
I-Characteristic	786	790	area
O	791	795	were
O	796	804	measured
O	805	811	within
O	812	820	circular
O	821	828	regions
O	829	837	centered
O	838	840	at
O	841	844	the
B-Anatomy	845	850	fovea
O	851	857	having
O	858	867	diameters
O	868	870	of
O	871	872	3
O	873	876	and
O	877	878	5
O	879	881	mm
O	881	882	.

O	883	886	The
O	887	899	measurements
O	900	904	were
O	905	913	analyzed
O	914	919	using
O	920	921	a
O	922	930	suitable
O	931	936	scale
O	937	951	transformation
O	951	952	.

O	953	956	For
B-Characteristic	957	963	drusen
I-Characteristic	964	970	volume
O	970	971	,
O	972	973	a
O	974	978	cube
O	979	983	root
O	984	998	transformation
O	999	1007	strategy
O	1008	1011	was
O	1012	1016	used
O	1016	1017	.

O	1018	1024	Change
O	1025	1027	in
B-Characteristic	1028	1034	drusen
I-Characteristic	1035	1041	volume
O	1042	1045	and
O	1046	1050	area
O	1051	1055	over
O	1056	1060	time
O	1060	1061	.

O	1062	1064	We
O	1065	1073	analyzed
O	1074	1077	143
B-Anatomy	1078	1082	eyes
O	1083	1085	of
O	1086	1089	100
O	1090	1098	patients
O	1099	1103	with
O	1104	1106	69
B-Anatomy	1107	1111	eyes
O	1112	1120	followed
O	1121	1124	for
O	1125	1126	6
O	1127	1133	months
O	1133	1134	,
O	1135	1138	106
B-Anatomy	1139	1143	eyes
O	1144	1152	followed
O	1153	1156	for
O	1157	1159	12
O	1160	1166	months
O	1166	1167	,
O	1168	1170	48
B-Anatomy	1171	1175	eyes
O	1176	1184	followed
O	1185	1188	for
O	1189	1191	18
O	1192	1198	months
O	1198	1199	,
O	1200	1203	and
O	1204	1206	48
B-Anatomy	1207	1211	eyes
O	1212	1220	followed
O	1221	1224	for
O	1225	1227	24
O	1228	1234	months
O	1234	1235	.

O	1236	1239	The
O	1240	1241	3
O	1242	1244	mm
O	1245	1251	circle
O	1252	1260	baseline
B-Characteristic	1261	1267	drusen
I-Characteristic	1268	1274	volume
O	1275	1281	ranged
O	1282	1286	from
B-Dimension	1287	1288	0
I-Dimension	1288	1289	.
I-Dimension	1289	1293	0009
I-Dimension	1294	1296	to
I-Dimension	1297	1298	0
I-Dimension	1298	1299	.
I-Dimension	1299	1303	7479
I-Dimension	1304	1306	mm
I-Dimension	1306	1307	(
I-Dimension	1307	1308	3
I-Dimension	1308	1309	)
O	1310	1312	or
B-Dimension	1313	1314	0
I-Dimension	1314	1315	.
I-Dimension	1315	1317	10
I-Dimension	1318	1320	to
I-Dimension	1321	1322	0
I-Dimension	1322	1323	.
I-Dimension	1323	1325	91
I-Dimension	1326	1328	mm
O	1329	1334	using
O	1335	1338	the
O	1339	1343	cube
O	1344	1348	root
O	1349	1354	scale
O	1354	1355	.

O	1356	1358	On
O	1359	1366	average
O	1366	1367	,
B-Characteristic	1368	1374	drusen
I-Characteristic	1375	1381	volume
O	1382	1385	and
B-Characteristic	1386	1392	drusen
I-Characteristic	1393	1397	area
O	1398	1407	increased
O	1408	1412	over
O	1413	1417	time
O	1418	1422	with
O	1423	1426	the
O	1427	1436	magnitude
O	1437	1439	of
O	1440	1443	the
O	1444	1452	increase
O	1453	1462	dependent
O	1463	1465	on
O	1466	1469	the
O	1470	1476	length
O	1477	1479	of
O	1480	1486	follow
O	1486	1487	-
O	1487	1489	up
O	1490	1491	(
O	1491	1492	P
O	1493	1494	=
O	1495	1496	0
O	1496	1497	.
O	1497	1500	001
O	1500	1501	,
O	1502	1503	3
O	1504	1506	mm
O	1507	1513	circle
O	1513	1514	)
O	1514	1515	.

O	1516	1518	In
O	1519	1522	the
B-Anatomy	1523	1527	eyes
O	1528	1532	with
O	1533	1534	a
O	1535	1543	decrease
O	1544	1546	in
B-Characteristic	1547	1553	drusen
I-Characteristic	1554	1560	volume
O	1560	1561	,
O	1562	1565	the
O	1566	1575	magnitude
O	1576	1578	of
O	1579	1583	this
O	1584	1592	decrease
O	1593	1596	was
O	1597	1606	dependent
O	1607	1609	on
O	1610	1613	the
O	1614	1622	baseline
B-Characteristic	1623	1629	drusen
I-Characteristic	1630	1636	volume
O	1637	1638	(
O	1638	1639	P
O	1640	1641	=
O	1642	1643	0
O	1643	1644	.
O	1644	1647	001
O	1647	1648	,
O	1649	1650	3
O	1651	1653	mm
O	1654	1660	circle
O	1660	1661	)
O	1662	1665	and
O	1666	1677	independent
O	1678	1680	of
O	1681	1684	the
O	1685	1691	follow
O	1691	1692	-
O	1692	1694	up
O	1695	1703	interval
O	1703	1704	.

O	1705	1710	After
O	1711	1713	12
O	1714	1720	months
O	1720	1721	,
B-Characteristic	1722	1728	drusen
I-Characteristic	1729	1735	volume
O	1736	1745	increased
O	1746	1748	in
O	1749	1751	48
O	1751	1752	%
O	1753	1755	of
B-Anatomy	1756	1760	eyes
O	1760	1761	,
O	1762	1770	remained
O	1771	1777	stable
O	1778	1780	in
O	1781	1783	40
O	1783	1784	%
O	1784	1785	,
O	1786	1789	and
O	1790	1799	decreased
O	1800	1802	in
O	1803	1805	12
O	1805	1806	%
O	1806	1807	.

B-Diagnostic_tool	1808	1815	Imaging
I-Diagnostic_tool	1816	1820	with
I-Diagnostic_tool	1821	1823	SD
I-Diagnostic_tool	1823	1824	-
I-Diagnostic_tool	1824	1827	OCT
O	1828	1836	revealed
O	1837	1838	a
O	1839	1846	dynamic
O	1846	1847	,
O	1848	1858	undulating
O	1859	1865	growth
O	1866	1873	pattern
O	1874	1877	for
B-Symptom	1878	1884	drusen
O	1885	1889	with
O	1890	1891	a
O	1892	1900	tendency
O	1901	1904	for
B-Symptom	1905	1911	drusen
O	1912	1914	to
O	1915	1923	increase
O	1924	1926	in
O	1927	1933	volume
O	1934	1937	and
O	1938	1942	area
O	1943	1947	over
O	1948	1952	time
O	1952	1953	.

O	1954	1956	An
O	1957	1969	appreciation
O	1970	1972	of
O	1973	1976	the
O	1977	1989	quantitative
O	1990	1997	changes
O	1998	2000	in
B-Characteristic	2001	2007	drusen
I-Characteristic	2008	2014	volume
O	2015	2019	over
O	2020	2024	time
O	2025	2030	using
B-Diagnostic_tool	2031	2033	SD
I-Diagnostic_tool	2033	2034	-
I-Diagnostic_tool	2034	2037	OCT
I-Diagnostic_tool	2038	2045	imaging
O	2046	2054	provides
O	2055	2056	a
O	2057	2062	novel
O	2063	2071	strategy
O	2072	2075	for
O	2076	2085	following
O	2086	2092	normal
O	2093	2100	disease
O	2101	2112	progression
O	2113	2116	and
O	2117	2120	for
O	2121	2132	identifying
O	2133	2138	novel
O	2139	2147	clinical
O	2148	2153	trial
O	2154	2157	end
O	2158	2164	points
O	2165	2167	to
O	2168	2170	be
O	2171	2175	used
O	2176	2180	when
O	2181	2194	investigating
O	2195	2204	therapies
O	2205	2208	for
O	2209	2212	the
O	2213	2222	treatment
O	2223	2225	of
B-Disease	2226	2238	nonexudative
I-Disease	2239	2242	AMD
O	2242	2243	.

O	2244	2255	Proprietary
O	2256	2258	or
O	2259	2269	commercial
O	2270	2280	disclosure
O	2281	2284	may
O	2285	2287	be
O	2288	2293	found
O	2294	2299	after
O	2300	2303	the
O	2304	2314	references
O	2314	2315	.

O	0	12	Relationship
O	13	20	between
B-Symptom	21	32	fluorescein
I-Symptom	33	40	pooling
O	41	44	and
B-Diagnostic_tool	45	52	optical
I-Diagnostic_tool	53	62	coherence
I-Diagnostic_tool	63	74	tomographic
B-Characteristic	75	87	reflectivity
I-Characteristic	88	90	of
I-Characteristic	91	98	cystoid
I-Characteristic	99	105	spaces
O	106	108	in
B-Disease	109	117	diabetic
I-Disease	118	125	macular
I-Disease	126	131	edema
O	131	132	.

O	134	136	To
O	137	142	study
O	143	146	the
O	147	162	characteristics
O	163	165	of
O	166	169	the
B-Characteristic	170	182	reflectivity
I-Characteristic	183	185	of
I-Characteristic	186	189	the
I-Characteristic	190	197	cystoid
I-Characteristic	198	204	spaces
O	205	208	and
B-Symptom	209	215	serous
I-Symptom	216	223	retinal
I-Symptom	224	234	detachment
O	235	236	(
B-Symptom	236	239	SRD
O	239	240	)
O	241	243	on
B-Diagnostic_tool	244	252	spectral
I-Diagnostic_tool	252	253	-
I-Diagnostic_tool	253	259	domain
I-Diagnostic_tool	260	267	optical
I-Diagnostic_tool	268	277	coherence
I-Diagnostic_tool	278	288	tomography
O	289	290	(
B-Diagnostic_tool	290	292	SD
I-Diagnostic_tool	292	293	-
I-Diagnostic_tool	293	296	OCT
O	296	297	)
O	298	301	and
O	302	305	the
O	306	317	correlation
O	318	322	with
B-Symptom	323	334	fluorescein
I-Symptom	335	343	findings
O	344	346	in
B-Disease	347	355	diabetic
I-Disease	356	363	macular
I-Disease	364	369	edema
O	370	371	(
B-Disease	371	374	DME
O	374	375	)
O	375	376	.

O	377	390	Retrospective
O	390	391	,
O	392	405	observational
O	405	406	,
O	407	412	cross
O	412	413	-
O	413	422	sectional
O	423	428	study
O	428	429	.

O	430	441	Consecutive
O	442	445	134
O	446	450	eyes
O	451	453	of
O	454	457	114
O	458	466	patients
O	467	471	with
B-Disease	472	482	clinically
I-Disease	483	494	significant
I-Disease	495	502	macular
I-Disease	503	508	edema
O	509	512	for
O	513	517	whom
B-Diagnostic_tool	518	520	SD
I-Diagnostic_tool	520	521	-
I-Diagnostic_tool	521	524	OCT
O	525	528	and
B-Diagnostic_tool	529	540	fluorescein
I-Diagnostic_tool	541	552	angiography
O	553	554	(
B-Diagnostic_tool	554	556	FA
O	556	557	)
O	558	562	were
O	563	572	performed
O	573	575	on
O	576	579	the
O	580	584	same
O	585	588	day
O	588	589	.

B-Diagnostic_tool	590	601	Fluorescein
I-Diagnostic_tool	602	613	angiography
O	614	619	using
B-Diagnostic_tool	620	630	Heidelberg
I-Diagnostic_tool	631	637	Retina
I-Diagnostic_tool	638	648	Angiograph
I-Diagnostic_tool	649	650	2
O	651	652	(
O	652	662	Heidelberg
O	663	674	Engineering
O	674	675	,
O	676	686	Heidelberg
O	686	687	,
O	688	695	Germany
O	695	696	)
O	697	700	and
B-Diagnostic_tool	701	704	OCT
I-Diagnostic_tool	705	711	images
O	712	717	using
B-Diagnostic_tool	718	728	Spectralis
I-Diagnostic_tool	729	732	OCT
O	733	734	(
O	734	744	Heidelberg
O	745	756	Engineering
O	756	757	)
O	758	762	were
O	763	771	obtained
O	771	772	.

O	773	776	The
B-Characteristic	777	789	reflectivity
I-Characteristic	790	792	of
I-Characteristic	793	796	the
I-Characteristic	797	804	cystoid
I-Characteristic	805	811	spaces
O	812	815	and
B-Symptom	816	819	SRD
O	820	822	on
O	823	826	the
B-Diagnostic_tool	827	830	OCT
I-Diagnostic_tool	831	837	images
O	838	841	was
O	842	851	evaluated
O	852	865	qualitatively
O	866	869	and
O	870	884	quantitatively
O	885	888	and
O	889	897	compared
O	898	902	with
O	903	906	the
B-Symptom	907	918	fluorescein
I-Symptom	919	926	pooling
O	927	936	intensity
O	937	939	on
B-Diagnostic_tool	940	942	FA
I-Diagnostic_tool	943	949	images
O	949	950	.

O	951	954	The
O	955	967	relationship
O	968	975	between
O	976	979	the
B-Symptom	980	991	fluorescein
I-Symptom	992	999	pooling
O	1000	1003	and
O	1004	1007	the
B-Characteristic	1008	1020	reflectivity
I-Characteristic	1021	1036	characteristics
I-Characteristic	1037	1039	of
I-Characteristic	1040	1043	the
I-Characteristic	1044	1051	cystoid
I-Characteristic	1052	1058	spaces
O	1059	1061	on
B-Diagnostic_tool	1062	1064	SD
I-Diagnostic_tool	1064	1065	-
I-Diagnostic_tool	1065	1068	OCT
I-Diagnostic_tool	1069	1075	images
O	1075	1076	.

O	1077	1078	A
O	1079	1084	total
O	1085	1087	of
O	1088	1091	141
B-Symptom	1092	1099	cystoid
I-Symptom	1100	1106	spaces
O	1107	1109	in
O	1110	1113	101
B-Anatomy	1114	1118	eyes
O	1119	1123	were
O	1124	1134	delineated
O	1135	1137	on
B-Diagnostic_tool	1138	1141	OCT
I-Diagnostic_tool	1142	1148	images
O	1148	1149	,
O	1150	1153	and
O	1154	1157	138
O	1158	1164	spaces
O	1165	1166	(
O	1166	1168	97
O	1168	1169	.
O	1169	1170	9
O	1170	1171	%
O	1171	1172	)
O	1173	1176	had
B-Symptom	1177	1188	fluorescein
I-Symptom	1189	1196	pooling
O	1196	1197	.

O	1198	1203	Fifty
O	1203	1204	-
O	1204	1208	five
B-Symptom	1209	1216	cystoid
I-Symptom	1217	1223	spaces
O	1224	1225	(
O	1225	1227	39
O	1227	1228	.
O	1228	1229	9
O	1229	1230	%
O	1230	1231	)
O	1232	1236	with
O	1237	1243	marked
B-Symptom	1244	1255	fluorescein
I-Symptom	1256	1263	pooling
O	1264	1273	intensity
O	1274	1277	had
B-Characteristic	1278	1283	lower
I-Characteristic	1284	1296	reflectivity
O	1297	1299	on
B-Diagnostic_tool	1300	1303	OCT
I-Diagnostic_tool	1304	1310	images
O	1311	1315	than
O	1316	1321	those
O	1322	1326	with
O	1327	1333	modest
O	1334	1341	pooling
O	1342	1343	(
O	1343	1345	12
O	1345	1346	.
O	1346	1347	1
O	1347	1348	
O	1348	1350	10
O	1350	1351	.
O	1351	1352	4
O	1353	1355	vs
O	1355	1356	.
O	1357	1359	22
O	1359	1360	.
O	1360	1361	0
O	1361	1362	
O	1362	1364	15
O	1364	1365	.
O	1365	1366	4
O	1366	1367	,
O	1368	1369	P
O	1371	1372	<
O	1374	1375	0
O	1375	1376	.
O	1376	1379	001
O	1379	1380	)
O	1380	1381	.

O	1382	1385	The
O	1386	1399	heterogeneity
O	1400	1402	of
O	1403	1406	the
O	1407	1419	reflectivity
O	1420	1422	of
O	1423	1426	the
B-Symptom	1427	1434	cystoid
I-Symptom	1435	1441	spaces
O	1442	1444	on
O	1445	1448	the
B-Diagnostic_tool	1449	1452	OCT
I-Diagnostic_tool	1453	1459	images
O	1460	1463	was
O	1464	1474	associated
O	1475	1488	significantly
O	1489	1490	(
O	1490	1491	P
O	1493	1494	<
O	1496	1497	0
O	1497	1498	.
O	1498	1501	001
O	1501	1502	)
O	1503	1507	with
O	1508	1514	modest
B-Symptom	1515	1526	fluorescein
I-Symptom	1527	1534	pooling
O	1534	1535	.

O	1536	1539	The
B-Symptom	1540	1555	hyperreflective
I-Symptom	1556	1560	foci
I-Symptom	1561	1563	in
I-Symptom	1564	1567	the
I-Symptom	1568	1575	cystoid
I-Symptom	1576	1582	spaces
O	1583	1587	were
O	1588	1598	correlated
O	1599	1612	significantly
O	1613	1617	with
O	1618	1624	modest
B-Symptom	1625	1636	fluorescein
I-Symptom	1637	1644	pooling
O	1645	1648	and
B-Characteristic	1649	1655	higher
I-Characteristic	1656	1658	or
I-Characteristic	1659	1672	heterogeneous
I-Characteristic	1673	1685	reflectivity
O	1686	1688	on
B-Diagnostic_tool	1689	1692	OCT
I-Diagnostic_tool	1693	1699	images
O	1700	1701	(
O	1701	1702	P
O	1704	1705	<
O	1707	1708	0
O	1708	1709	.
O	1709	1712	001
O	1712	1713	,
O	1714	1715	P
O	1717	1718	<
O	1720	1721	0
O	1721	1722	.
O	1722	1725	001
O	1725	1726	,
O	1727	1730	and
O	1731	1732	P
O	1732	1733	=
O	1733	1734	0
O	1734	1735	.
O	1735	1738	005
O	1738	1739	,
O	1740	1752	respectively
O	1752	1753	)
O	1753	1754	.

O	1755	1757	In
O	1758	1766	addition
O	1766	1767	,
O	1768	1771	the
B-Symptom	1772	1779	cystoid
I-Symptom	1780	1786	spaces
I-Symptom	1787	1791	with
I-Symptom	1792	1806	microaneurysms
O	1807	1810	had
O	1811	1817	higher
O	1818	1820	or
B-Characteristic	1821	1834	heterogeneous
I-Characteristic	1835	1847	reflectivity
O	1848	1850	on
B-Diagnostic_tool	1851	1854	OCT
I-Diagnostic_tool	1855	1861	images
O	1862	1866	more
O	1867	1877	frequently
O	1878	1882	than
O	1883	1888	those
O	1889	1896	without
B-Symptom	1897	1911	microaneurysms
O	1912	1913	(
O	1913	1914	P
O	1916	1917	<
O	1919	1920	0
O	1920	1921	.
O	1921	1924	001
O	1925	1928	and
O	1929	1930	P
O	1930	1931	=
O	1931	1932	0
O	1932	1933	.
O	1933	1936	019
O	1936	1937	,
O	1938	1950	respectively
O	1950	1951	)
O	1951	1952	.

O	1953	1956	The
B-Characteristic	1957	1969	reflectivity
I-Characteristic	1970	1976	levels
I-Characteristic	1977	1979	in
I-Characteristic	1980	1983	the
I-Characteristic	1984	1987	SRD
O	1988	1992	were
O	1993	2006	significantly
O	2007	2008	(
O	2008	2009	P
O	2009	2010	=
O	2010	2011	0
O	2011	2012	.
O	2012	2015	005
O	2015	2016	)
O	2017	2022	lower
O	2023	2027	than
O	2028	2030	in
O	2031	2034	the
B-Symptom	2035	2042	cystoid
I-Symptom	2043	2049	spaces
O	2049	2050	,
O	2051	2054	and
O	2055	2059	only
O	2060	2061	1
B-Anatomy	2062	2065	eye
O	2066	2067	(
O	2067	2068	3
O	2068	2069	.
O	2069	2070	3
O	2070	2071	%
O	2071	2072	)
O	2073	2076	had
B-Characteristic	2077	2090	heterogeneous
I-Characteristic	2091	2103	reflectivity
O	2104	2106	on
B-Diagnostic_tool	2107	2110	OCT
I-Diagnostic_tool	2111	2117	images
O	2117	2118	.

O	2119	2122	The
O	2123	2130	results
O	2131	2139	provided
O	2140	2141	a
O	2142	2147	novel
O	2148	2162	interpretation
O	2163	2165	of
B-Symptom	2166	2177	fluorescein
I-Symptom	2178	2185	pooling
O	2186	2189	and
B-Diagnostic_tool	2190	2193	OCT
O	2194	2209	characteristics
O	2210	2212	of
B-Symptom	2213	2220	cystoid
I-Symptom	2221	2227	spaces
O	2228	2231	and
B-Symptom	2232	2235	SRD
O	2236	2238	in
B-Disease	2239	2242	DME
O	2243	2246	and
O	2247	2256	suggested
O	2257	2264	several
O	2265	2275	mechanisms
O	2276	2278	by
O	2279	2284	which
O	2285	2288	the
B-Anatomy	2289	2294	blood
I-Anatomy	2294	2295	-
I-Anatomy	2295	2302	retinal
I-Anatomy	2303	2310	barrier
O	2311	2313	is
O	2314	2323	disrupted
O	2324	2327	and
B-Symptom	2328	2339	concomitant
I-Symptom	2340	2349	edematous
I-Symptom	2350	2357	changes
O	2358	2365	develop
O	2365	2366	.

O	0	11	Correlation
O	12	14	of
B-Diagnostic_tool	15	21	fundus
I-Diagnostic_tool	22	38	autofluorescence
O	39	43	with
B-Diagnostic_tool	44	52	spectral
I-Diagnostic_tool	52	53	-
I-Diagnostic_tool	53	59	domain
I-Diagnostic_tool	60	67	optical
I-Diagnostic_tool	68	77	coherence
I-Diagnostic_tool	78	88	tomography
O	89	92	and
O	93	99	vision
O	100	102	in
B-Disease	103	111	diabetic
I-Disease	112	119	macular
I-Disease	120	125	edema
O	125	126	.

O	128	130	To
O	131	142	investigate
O	143	146	the
O	147	158	correlation
O	159	166	between
B-Diagnostic_tool	167	173	fundus
I-Diagnostic_tool	174	190	autofluorescence
O	191	192	(
B-Diagnostic_tool	192	195	FAF
O	195	196	)
O	197	200	and
O	201	204	the
O	205	212	results
O	213	215	of
B-Diagnostic_tool	216	224	spectral
I-Diagnostic_tool	224	225	-
I-Diagnostic_tool	225	231	domain
I-Diagnostic_tool	232	239	optical
I-Diagnostic_tool	240	249	coherence
I-Diagnostic_tool	250	260	tomography
O	261	262	(
B-Diagnostic_tool	262	264	SD
I-Diagnostic_tool	264	265	-
I-Diagnostic_tool	265	268	OCT
O	268	269	)
O	270	272	as
O	273	277	well
O	278	280	as
B-Diagnostic_tool	281	287	visual
I-Diagnostic_tool	288	294	acuity
O	295	296	(
B-Diagnostic_tool	296	298	VA
O	298	299	)
O	300	302	in
O	303	311	patients
O	312	316	with
B-Disease	317	325	diabetic
I-Disease	326	333	macular
I-Disease	334	339	edema
O	340	341	(
B-Disease	341	344	DME
O	344	345	)
O	346	349	and
O	350	352	to
O	353	362	determine
O	363	366	the
O	367	373	visual
O	374	384	prognostic
O	385	392	factors
O	392	393	.

O	394	407	Retrospective
O	407	408	,
O	409	423	interventional
O	424	428	case
O	429	435	series
O	435	436	.

O	437	442	Sixty
O	442	443	-
O	443	446	one
O	447	455	patients
O	456	460	with
B-Disease	461	464	DME
O	465	468	who
O	469	478	underwent
O	479	491	intravitreal
O	492	501	injection
O	502	504	of
O	505	516	bevacizumab
O	517	518	(
O	518	521	IVB
O	521	522	)
O	523	525	as
O	526	531	their
O	532	537	first
O	538	547	treatment
O	547	548	.

O	549	551	An
O	552	562	assessment
O	563	565	of
B-Diagnostic_tool	566	568	VA
O	569	572	and
B-Diagnostic_tool	573	576	FAF
O	577	580	and
B-Diagnostic_tool	581	583	SD
I-Diagnostic_tool	583	584	-
I-Diagnostic_tool	584	587	OCT
O	588	594	images
O	595	599	were
O	600	608	obtained
O	609	615	before
O	616	619	and
O	620	625	after
O	626	629	IVB
O	630	631	(
O	631	634	pre
O	634	635	-
O	636	639	and
O	640	644	post
O	644	645	-
O	645	648	IVB
O	648	649	)
O	649	650	.

B-Diagnostic_tool	651	657	Foveal
I-Diagnostic_tool	658	661	FAF
O	662	665	was
O	666	672	graded
O	673	675	on
O	676	677	a
O	678	683	scale
O	684	686	of
O	687	688	1
O	689	691	to
O	692	693	4
O	693	694	.

O	695	698	The
O	699	707	presence
O	708	710	or
O	711	718	absence
O	719	721	of
B-Diagnostic_tool	722	725	FAF
O	726	728	at
O	729	732	the
B-Anatomy	733	740	foveola
O	741	744	was
O	745	749	also
O	750	760	determined
O	760	761	.

O	762	765	The
O	766	777	association
O	778	780	of
B-Diagnostic_tool	781	784	FAF
O	785	789	with
B-Diagnostic_tool	790	792	VA
O	793	796	and
O	797	800	the
B-Diagnostic_tool	801	803	SD
I-Diagnostic_tool	803	804	-
I-Diagnostic_tool	804	807	OCT
O	808	815	results
O	815	816	,
O	817	826	including
B-Characteristic	827	834	central
I-Characteristic	835	842	macular
I-Characteristic	843	852	thickness
O	853	854	(
B-Characteristic	854	857	CMT
O	857	858	)
O	858	859	,
B-Characteristic	860	865	outer
I-Characteristic	866	873	nuclear
I-Characteristic	874	879	layer
I-Characteristic	880	889	thickness
O	889	890	,
O	891	894	the
B-Characteristic	895	904	integrity
I-Characteristic	905	907	of
I-Characteristic	908	911	the
I-Characteristic	912	920	external
I-Characteristic	921	929	limiting
I-Characteristic	930	938	membrane
O	939	940	(
B-Anatomy	940	943	ELM
O	943	944	)
O	944	945	,
O	946	949	and
O	950	953	the
B-Characteristic	954	963	integrity
I-Characteristic	964	966	of
I-Characteristic	967	970	the
I-Characteristic	971	979	junction
I-Characteristic	980	987	between
I-Characteristic	988	991	the
I-Characteristic	992	997	inner
I-Characteristic	998	1001	and
I-Characteristic	1002	1007	outer
I-Characteristic	1008	1015	segment
I-Characteristic	1016	1018	of
I-Characteristic	1019	1022	the
I-Characteristic	1023	1036	photoreceptor
O	1037	1038	(
B-Anatomy	1038	1040	IS
I-Anatomy	1040	1041	/
I-Anatomy	1041	1043	OS
O	1043	1044	)
O	1044	1045	.

B-Characteristic	1046	1052	Better
I-Characteristic	1053	1055	VA
O	1055	1056	,
B-Characteristic	1057	1069	preservation
I-Characteristic	1070	1072	of
I-Characteristic	1073	1076	the
I-Characteristic	1077	1080	ELM
I-Characteristic	1080	1081	,
I-Characteristic	1082	1085	and
I-Characteristic	1086	1088	IS
I-Characteristic	1088	1089	/
I-Characteristic	1089	1091	OS
O	1092	1095	pre
O	1095	1096	-
O	1096	1099	IVB
O	1100	1104	were
O	1105	1115	associated
O	1116	1120	with
B-Characteristic	1121	1127	better
I-Characteristic	1128	1130	VA
O	1131	1135	post
O	1135	1136	-
O	1136	1139	IVB
O	1139	1140	.

O	1141	1143	Of
O	1144	1147	the
O	1148	1153	types
O	1154	1156	of
B-Disease	1157	1160	DME
O	1160	1161	,
B-Disease	1162	1169	cystoid
I-Disease	1170	1177	macular
I-Disease	1178	1183	edema
O	1184	1197	significantly
O	1198	1208	correlated
O	1209	1213	with
B-Symptom	1214	1223	increased
I-Symptom	1224	1227	FAF
O	1228	1230	at
O	1231	1234	the
B-Anatomy	1235	1242	foveola
O	1242	1243	.

O	1244	1245	A
B-Symptom	1246	1252	higher
I-Symptom	1253	1258	level
I-Symptom	1259	1261	of
I-Symptom	1262	1265	FAF
O	1266	1269	was
O	1270	1271	5
O	1271	1272	.
O	1272	1273	6
O	1274	1279	times
O	1280	1284	more
O	1285	1291	likely
O	1292	1294	to
O	1295	1300	occur
O	1301	1303	in
B-Disease	1304	1307	DME
O	1308	1312	with
O	1313	1314	a
B-Symptom	1315	1321	defect
I-Symptom	1322	1324	in
I-Symptom	1325	1327	IS
I-Symptom	1327	1328	/
I-Symptom	1328	1330	OS
O	1331	1334	and
O	1335	1337	10
O	1338	1343	times
O	1344	1348	more
O	1349	1355	likely
O	1356	1358	to
O	1359	1364	occur
O	1365	1369	with
O	1370	1374	each
B-Dimension	1375	1377	10
I-Dimension	1377	1378	-
I-Dimension	1378	1379	
I-Dimension	1379	1380	m
O	1381	1389	increase
O	1390	1392	in
B-Characteristic	1393	1396	CMT
O	1396	1397	.

O	1398	1402	Each
O	1403	1411	increase
O	1412	1414	by
O	1415	1416	a
O	1417	1423	factor
O	1424	1426	of
O	1427	1428	0
O	1428	1429	.
O	1429	1430	1
O	1431	1433	in
O	1434	1437	the
B-Characteristic	1438	1447	logarithm
I-Characteristic	1448	1450	of
I-Characteristic	1451	1454	the
I-Characteristic	1455	1462	minimum
I-Characteristic	1463	1468	angle
I-Characteristic	1469	1471	of
I-Characteristic	1472	1482	resolution
O	1483	1484	(
B-Characteristic	1484	1490	logMAR
O	1490	1491	)
O	1492	1495	pre
O	1495	1496	-
O	1496	1499	IVB
O	1500	1509	increased
O	1510	1513	the
O	1514	1525	probability
O	1526	1528	of
B-Symptom	1529	1533	high
I-Symptom	1534	1537	FAF
O	1538	1540	by
O	1541	1542	a
O	1543	1549	factor
O	1550	1552	of
O	1553	1554	1
O	1554	1555	.
O	1555	1557	73
O	1557	1558	.

O	1559	1566	Despite
B-Disease	1567	1573	severe
I-Disease	1574	1577	DME
O	1577	1578	,
O	1579	1584	fewer
B-Anatomy	1585	1589	eyes
O	1590	1594	with
O	1595	1596	a
B-Symptom	1597	1600	low
I-Symptom	1601	1606	level
I-Symptom	1607	1609	of
I-Symptom	1610	1613	FAF
O	1614	1623	exhibited
O	1624	1626	an
B-Symptom	1627	1629	IS
I-Symptom	1629	1630	/
I-Symptom	1630	1632	OS
I-Symptom	1633	1639	defect
O	1640	1643	and
B-Symptom	1644	1649	large
I-Symptom	1650	1656	logMAR
I-Symptom	1657	1659	VA
O	1660	1664	than
B-Anatomy	1665	1669	eyes
O	1670	1674	with
O	1675	1676	a
B-Symptom	1677	1681	high
I-Symptom	1682	1687	level
I-Symptom	1688	1690	of
I-Symptom	1691	1694	FAF
O	1695	1699	with
B-Disease	1700	1706	severe
I-Disease	1707	1710	DME
O	1711	1714	pre
O	1714	1715	-
O	1715	1718	IVB
O	1718	1719	.

O	1720	1723	The
B-Characteristic	1724	1731	average
I-Characteristic	1732	1737	grade
I-Characteristic	1738	1740	of
I-Characteristic	1741	1744	FAF
O	1745	1748	pre
O	1748	1749	-
O	1749	1752	IVB
O	1753	1756	was
O	1757	1763	higher
O	1764	1766	in
O	1767	1775	patients
O	1776	1780	with
B-Symptom	1781	1790	decreased
I-Symptom	1791	1797	vision
O	1798	1804	during
O	1805	1811	follow
O	1811	1812	-
O	1812	1814	up
O	1815	1819	than
O	1820	1822	in
O	1823	1831	patients
O	1832	1836	with
O	1837	1846	increased
O	1847	1849	or
O	1850	1859	unchanged
B-Characteristic	1860	1864	good
I-Characteristic	1865	1871	vision
O	1871	1872	.

O	1873	1876	The
O	1877	1883	strong
O	1884	1895	association
O	1896	1898	of
B-Diagnostic_tool	1899	1902	FAF
O	1903	1907	with
B-Diagnostic_tool	1908	1910	SD
I-Diagnostic_tool	1910	1911	-
I-Diagnostic_tool	1911	1914	OCT
O	1915	1925	parameters
O	1926	1929	and
B-Diagnostic_tool	1930	1932	VA
O	1933	1935	in
O	1936	1944	patients
O	1945	1949	with
B-Disease	1950	1953	DME
O	1954	1959	could
O	1960	1963	aid
O	1964	1966	in
O	1967	1970	the
O	1971	1981	prediction
O	1982	1984	of
O	1985	1988	the
O	1989	2000	restoration
O	2001	2003	of
B-Characteristic	2004	2017	photoreceptor
I-Characteristic	2018	2027	integrity
O	2028	2031	and
O	2032	2042	subsequent
O	2043	2049	visual
O	2050	2058	recovery
O	2058	2059	,
O	2060	2070	especially
O	2071	2073	in
O	2074	2082	patients
O	2083	2087	with
B-Disease	2088	2094	severe
I-Disease	2095	2098	DME
O	2098	2099	,
O	2100	2102	in
O	2103	2107	whom
B-Characteristic	2108	2121	photoreceptor
I-Characteristic	2122	2131	integrity
O	2132	2138	before
O	2139	2148	treatment
O	2149	2154	could
O	2155	2158	not
O	2159	2161	be
O	2162	2172	adequately
O	2173	2182	evaluated
O	2182	2183	,
O	2184	2188	even
O	2189	2193	with
B-Diagnostic_tool	2194	2196	SD
I-Diagnostic_tool	2196	2197	-
I-Diagnostic_tool	2197	2200	OCT
O	2200	2201	.

B-Symptom	0	14	Hyporeflective
I-Symptom	15	20	wedge
I-Symptom	20	21	-
I-Symptom	21	27	shaped
I-Symptom	28	32	band
O	33	35	in
B-Symptom	36	46	geographic
I-Symptom	47	54	atrophy
O	55	64	secondary
O	65	67	to
B-Disease	68	71	age
I-Disease	71	72	-
I-Disease	72	79	related
I-Disease	80	87	macular
I-Disease	88	100	degeneration
O	100	101	:
O	102	104	an
O	105	118	underreported
O	119	126	finding
O	126	127	.

O	129	131	To
O	132	140	describe
O	141	144	and
O	145	154	interpret
O	155	158	the
O	159	169	frequently
O	170	178	observed
B-Diagnostic_tool	179	187	spectral
I-Diagnostic_tool	187	188	-
I-Diagnostic_tool	188	194	domain
I-Diagnostic_tool	195	202	optical
I-Diagnostic_tool	203	212	coherence
I-Diagnostic_tool	213	223	tomography
O	224	225	(
B-Diagnostic_tool	225	227	SD
I-Diagnostic_tool	227	228	-
I-Diagnostic_tool	228	231	OCT
O	231	232	)
O	233	240	finding
O	241	243	of
O	244	245	a
O	246	252	marked
B-Symptom	253	267	hyporeflective
I-Symptom	268	273	wedge
I-Symptom	273	274	-
I-Symptom	274	280	shaped
I-Symptom	281	290	structure
O	291	293	at
O	294	297	the
O	298	308	boundaries
O	309	311	of
O	312	315	the
O	316	321	areas
O	322	324	of
B-Symptom	325	332	atrophy
O	332	333	.

O	334	335	A
O	336	347	prospective
O	347	348	,
O	349	361	longitudinal
O	362	368	follow
O	368	369	-
O	369	371	up
O	372	377	study
O	377	378	.

O	379	390	Consecutive
O	391	399	patients
O	400	401	(
O	401	402	n
O	403	404	=
O	405	407	71
O	407	408	)
B-Characteristic	409	411	50
I-Characteristic	412	417	years
I-Characteristic	418	420	of
I-Characteristic	421	424	age
I-Characteristic	425	428	and
I-Characteristic	429	434	older
O	435	439	with
B-Symptom	440	450	geographic
I-Symptom	451	458	atrophy
O	459	460	(
B-Symptom	460	462	GA
O	462	463	)
O	464	473	secondary
O	474	476	to
B-Disease	477	480	age
I-Disease	480	481	-
I-Disease	481	488	related
I-Disease	489	496	macular
I-Disease	497	509	degeneration
O	510	511	(
B-Disease	511	514	AMD
O	514	515	)
O	516	520	were
O	521	529	examined
O	530	537	between
O	538	545	January
O	546	550	2010
O	551	554	and
O	555	559	June
O	560	564	2011
O	564	565	.

O	566	574	Patients
O	575	579	were
O	580	589	evaluated
O	590	594	with
O	595	598	the
O	599	602	use
O	603	605	of
O	606	613	imaging
O	614	624	techniques
O	625	629	that
O	630	638	included
B-Diagnostic_tool	639	641	35
I-Diagnostic_tool	641	642	
I-Diagnostic_tool	643	649	fundus
I-Diagnostic_tool	650	661	photography
O	661	662	,
B-Diagnostic_tool	663	671	infrared
O	671	672	,
B-Diagnostic_tool	673	679	fundus
I-Diagnostic_tool	680	696	autofluorescence
O	697	698	(
B-Diagnostic_tool	698	701	FAF
O	701	702	)
O	702	703	,
O	704	707	and
B-Diagnostic_tool	708	710	SD
I-Diagnostic_tool	710	711	-
I-Diagnostic_tool	711	714	OCT
O	714	715	.

O	716	729	Visualization
O	730	732	of
O	733	736	the
B-Anatomy	737	743	fundus
O	744	748	with
B-Diagnostic_tool	749	752	FAF
O	753	756	was
O	757	761	done
O	762	776	simultaneously
O	777	781	with
B-Diagnostic_tool	782	785	OCT
O	785	786	.

O	787	790	Two
O	791	802	acquisition
O	803	812	protocols
O	813	817	were
O	818	826	followed
O	826	827	:
O	828	829	a
B-Diagnostic_tool	830	837	macular
I-Diagnostic_tool	838	842	cube
I-Diagnostic_tool	843	846	for
I-Diagnostic_tool	847	855	coverage
O	856	857	(
B-Diagnostic_tool	857	859	19
I-Diagnostic_tool	860	870	horizontal
I-Diagnostic_tool	871	872	B
I-Diagnostic_tool	872	873	-
I-Diagnostic_tool	873	878	scans
I-Diagnostic_tool	879	887	centered
I-Diagnostic_tool	888	890	on
I-Diagnostic_tool	891	894	the
I-Diagnostic_tool	895	900	fovea
O	900	901	)
O	902	905	and
B-Diagnostic_tool	906	910	high
I-Diagnostic_tool	910	911	-
I-Diagnostic_tool	911	921	resolution
I-Diagnostic_tool	922	932	horizontal
I-Diagnostic_tool	933	934	B
I-Diagnostic_tool	934	935	-
I-Diagnostic_tool	935	939	scan
O	940	943	for
O	944	955	qualitative
B-Anatomy	956	962	foveal
O	963	969	detail
O	969	970	.

O	971	981	Estimation
O	982	984	of
O	985	988	the
O	989	999	prevalence
O	1000	1002	of
O	1003	1004	a
B-Symptom	1005	1019	hyporeflective
I-Symptom	1020	1025	wedge
I-Symptom	1025	1026	-
I-Symptom	1026	1032	shaped
I-Symptom	1033	1037	band
O	1038	1043	among
O	1044	1052	patients
O	1053	1057	with
B-Symptom	1058	1060	GA
O	1060	1061	.

O	1062	1063	A
O	1064	1070	marked
B-Symptom	1071	1085	hyporeflective
I-Symptom	1086	1091	wedge
I-Symptom	1091	1092	-
I-Symptom	1092	1098	shaped
I-Symptom	1099	1108	structure
O	1108	1109	,
O	1110	1114	with
O	1115	1118	its
O	1119	1123	base
O	1124	1126	on
B-Anatomy	1127	1132	Bruch
I-Anatomy	1132	1133	'
I-Anatomy	1133	1134	s
I-Anatomy	1135	1143	membrane
O	1144	1147	and
O	1148	1151	its
O	1152	1156	apex
O	1157	1165	pointing
O	1166	1172	toward
O	1173	1176	the
O	1177	1182	inner
O	1183	1188	limit
O	1189	1191	of
O	1192	1195	the
B-Anatomy	1196	1201	outer
I-Anatomy	1202	1211	plexiform
I-Anatomy	1212	1217	layer
O	1218	1219	(
B-Anatomy	1219	1222	OPL
O	1222	1223	)
O	1224	1232	adjacent
O	1233	1235	to
O	1236	1239	the
O	1240	1246	margin
O	1247	1254	between
O	1255	1258	the
O	1259	1268	atrophied
O	1269	1273	area
O	1274	1277	and
O	1278	1281	the
O	1282	1291	preserved
B-Anatomy	1292	1298	retina
O	1298	1299	,
O	1300	1303	was
O	1304	1312	observed
O	1313	1315	in
O	1316	1318	72
O	1318	1319	.
O	1319	1320	9
O	1320	1321	%
O	1322	1324	of
B-Anatomy	1325	1329	eyes
O	1330	1331	(
O	1331	1333	70
O	1333	1334	/
O	1334	1336	96
O	1336	1337	;
O	1338	1340	95
O	1340	1341	%
O	1342	1352	confidence
O	1353	1361	interval
O	1361	1362	,
O	1363	1365	63
O	1365	1366	.
O	1366	1367	9
O	1367	1368	-
O	1368	1370	82
O	1370	1371	.
O	1371	1372	0
O	1372	1373	)
O	1373	1374	.

O	1375	1379	This
B-Symptom	1380	1394	hyporeflective
I-Symptom	1395	1399	band
O	1400	1408	appeared
O	1409	1411	to
O	1412	1414	be
O	1415	1421	within
O	1422	1425	the
B-Anatomy	1426	1429	OPL
O	1429	1430	.

O	1431	1436	Using
B-Diagnostic_tool	1437	1446	eccentric
I-Diagnostic_tool	1447	1449	SD
I-Diagnostic_tool	1449	1450	-
I-Diagnostic_tool	1450	1453	OCT
I-Diagnostic_tool	1454	1465	acquisition
O	1465	1466	,
O	1467	1470	the
O	1471	1481	boundaries
O	1482	1489	between
O	1490	1493	the
B-Anatomy	1494	1499	outer
I-Anatomy	1500	1507	nuclear
I-Anatomy	1508	1513	layer
O	1514	1515	(
B-Anatomy	1515	1518	ONL
O	1518	1519	)
O	1520	1523	and
B-Anatomy	1524	1529	Henle
I-Anatomy	1529	1530	'
I-Anatomy	1530	1531	s
I-Anatomy	1532	1537	fiber
I-Anatomy	1538	1543	layer
O	1544	1545	(
B-Anatomy	1545	1548	HFL
O	1548	1549	)
O	1550	1554	were
O	1555	1559	well
O	1560	1567	defined
O	1567	1568	,
O	1569	1576	showing
O	1577	1581	that
O	1582	1585	the
B-Anatomy	1586	1589	ONL
O	1590	1594	ends
O	1595	1601	before
O	1602	1605	the
O	1606	1612	margin
O	1613	1615	of
B-Symptom	1616	1623	atrophy
I-Symptom	1624	1626	of
I-Symptom	1627	1630	the
I-Symptom	1631	1638	retinal
I-Symptom	1639	1646	pigment
I-Symptom	1647	1657	epithelium
O	1658	1659	(
B-Anatomy	1659	1662	RPE
O	1662	1663	)
O	1663	1664	.

O	1665	1666	A
B-Symptom	1667	1673	narrow
I-Symptom	1674	1689	hyperreflective
I-Symptom	1690	1694	band
O	1695	1704	separated
O	1705	1708	the
O	1709	1715	margin
O	1716	1718	of
O	1719	1722	the
B-Anatomy	1723	1726	ONL
O	1727	1730	and
B-Anatomy	1731	1734	RPE
O	1735	1739	from
O	1740	1743	the
B-Symptom	1744	1758	hyporeflective
I-Symptom	1759	1763	band
O	1763	1764	,
O	1765	1772	already
O	1773	1779	within
O	1780	1783	the
O	1784	1792	atrophic
O	1793	1797	area
O	1797	1798	.

O	1799	1800	A
B-Symptom	1801	1815	hyporeflective
I-Symptom	1816	1821	wedge
I-Symptom	1821	1822	-
I-Symptom	1822	1828	shaped
I-Symptom	1829	1838	structure
O	1839	1846	appears
O	1847	1857	frequently
O	1858	1864	within
O	1865	1868	the
O	1869	1879	boundaries
O	1880	1882	of
O	1883	1886	the
B-Anatomy	1887	1890	OPL
O	1891	1893	in
O	1894	1902	patients
O	1903	1907	with
B-Symptom	1908	1910	GA
O	1911	1920	secondary
O	1921	1923	to
B-Disease	1924	1927	AMD
O	1927	1928	,
O	1929	1942	corresponding
O	1943	1945	to
O	1946	1948	an
O	1949	1957	increase
O	1958	1960	in
O	1961	1964	the
O	1965	1970	width
O	1971	1973	of
O	1974	1977	the
B-Anatomy	1978	1981	HFL
O	1981	1982	,
O	1983	1993	presumably
O	1994	2001	because
O	2002	2004	of
B-Symptom	2005	2011	axonal
I-Symptom	2012	2020	swelling
O	2021	2023	or
B-Symptom	2024	2035	interaxonal
I-Symptom	2036	2041	edema
O	2041	2042	.

O	2043	2047	This
O	2048	2055	finding
O	2056	2059	may
O	2060	2067	improve
O	2068	2071	the
O	2072	2086	interpretation
O	2087	2089	of
B-Diagnostic_tool	2090	2092	SD
I-Diagnostic_tool	2092	2093	-
I-Diagnostic_tool	2093	2096	OCT
I-Diagnostic_tool	2097	2103	images
O	2104	2106	of
O	2107	2110	the
B-Anatomy	2111	2116	outer
I-Anatomy	2117	2123	layers
O	2123	2124	,
O	2125	2128	may
O	2129	2133	help
O	2134	2136	in
O	2137	2150	understanding
O	2151	2157	better
O	2158	2161	the
O	2162	2174	interactions
O	2175	2182	between
B-Anatomy	2183	2196	photoreceptor
I-Anatomy	2197	2202	cells
O	2203	2206	and
O	2207	2210	the
B-Anatomy	2211	2214	RPE
O	2214	2215	,
O	2216	2219	and
O	2220	2223	may
O	2224	2228	help
O	2229	2231	in
O	2232	2235	the
O	2236	2247	development
O	2248	2250	of
O	2251	2261	monitoring
O	2262	2272	techniques
O	2273	2276	and
O	2277	2286	therapies
O	2287	2290	for
B-Symptom	2291	2293	GA
O	2294	2303	secondary
O	2304	2306	to
B-Disease	2307	2310	AMD
O	2310	2311	.

B-Diagnostic_tool	0	5	Optic
I-Diagnostic_tool	6	10	disc
I-Diagnostic_tool	11	18	imaging
O	19	23	with
B-Diagnostic_tool	24	32	spectral
I-Diagnostic_tool	32	33	-
I-Diagnostic_tool	33	39	domain
I-Diagnostic_tool	40	47	optical
I-Diagnostic_tool	48	57	coherence
I-Diagnostic_tool	58	68	tomography
O	68	69	:
O	70	81	variability
O	82	85	and
O	86	95	agreement
O	96	101	study
O	102	106	with
B-Diagnostic_tool	107	117	Heidelberg
I-Diagnostic_tool	118	125	retinal
I-Diagnostic_tool	126	135	tomograph
O	135	136	.

O	138	140	To
O	141	149	evaluate
O	150	153	the
O	154	163	agreement
O	164	166	of
B-Anatomy	167	172	optic
I-Anatomy	173	177	disc
O	178	190	measurements
O	191	199	obtained
O	200	204	with
O	205	208	the
B-Diagnostic_tool	209	215	Cirrus
I-Diagnostic_tool	216	220	high
I-Diagnostic_tool	220	221	-
I-Diagnostic_tool	221	228	density
I-Diagnostic_tool	229	236	optical
I-Diagnostic_tool	237	246	coherence
I-Diagnostic_tool	247	257	tomography
O	258	259	(
B-Diagnostic_tool	259	261	HD
I-Diagnostic_tool	261	262	-
I-Diagnostic_tool	262	265	OCT
O	265	266	)
O	267	270	and
O	271	274	the
B-Diagnostic_tool	275	285	Heidelberg
I-Diagnostic_tool	286	292	retina
I-Diagnostic_tool	293	302	tomograph
O	303	304	(
B-Diagnostic_tool	304	307	HRT
O	307	308	)
O	309	312	and
O	313	320	compare
O	321	324	the
O	325	335	intervisit
O	335	336	,
O	337	341	test
O	341	342	-
O	342	348	retest
O	349	360	variability
O	361	368	between
O	369	372	the
O	373	384	instruments
O	384	385	.

O	386	397	Prospective
O	397	398	,
O	399	404	cross
O	404	405	-
O	405	414	sectional
O	415	420	study
O	420	421	.

O	422	425	Two
O	426	433	hundred
O	434	439	seven
O	440	448	subjects
O	449	450	(
O	450	453	109
B-Disease	454	462	glaucoma
O	463	466	and
O	467	469	98
O	470	476	normal
O	477	485	subjects
O	485	486	)
O	486	487	.

O	488	491	One
B-Anatomy	492	495	eye
O	496	500	from
O	501	505	each
O	506	516	individual
O	517	520	was
O	521	529	selected
O	530	538	randomly
O	539	542	for
B-Diagnostic_tool	543	548	optic
I-Diagnostic_tool	549	553	disc
I-Diagnostic_tool	554	561	imaging
O	562	564	by
O	565	568	the
B-Diagnostic_tool	569	575	Cirrus
I-Diagnostic_tool	576	578	HD
I-Diagnostic_tool	578	579	-
I-Diagnostic_tool	579	582	OCT
O	583	586	and
O	587	590	the
B-Diagnostic_tool	591	594	HRT
O	594	595	.

B-Characteristic	596	601	Areas
I-Characteristic	602	604	of
I-Characteristic	605	608	the
I-Characteristic	609	614	optic
I-Characteristic	615	619	disc
I-Characteristic	620	623	and
I-Characteristic	624	627	the
I-Characteristic	628	631	cup
O	631	632	,
B-Characteristic	633	636	cup
I-Characteristic	637	643	volume
O	643	644	,
B-Characteristic	645	653	vertical
I-Characteristic	654	657	cup
I-Characteristic	657	658	-
I-Characteristic	658	660	to
I-Characteristic	660	661	-
I-Characteristic	661	665	disc
I-Characteristic	666	671	ratio
O	672	675	and
B-Characteristic	676	679	cup
I-Characteristic	679	680	-
I-Characteristic	680	682	to
I-Characteristic	682	683	-
I-Characteristic	683	687	disc
I-Characteristic	688	692	area
I-Characteristic	693	698	ratio
O	699	703	were
O	704	712	compared
O	713	720	between
O	721	724	the
O	725	736	instruments
O	736	737	.

O	738	741	The
B-Diagnostic_tool	742	745	OCT
O	746	758	measurements
O	759	763	were
O	764	773	corrected
O	774	777	for
O	778	784	ocular
O	785	798	magnification
O	799	804	using
O	805	808	the
O	809	816	Littman
O	816	817	'
O	817	818	s
O	819	826	formula
O	826	827	.

O	828	831	The
O	832	843	measurement
O	844	853	agreement
O	854	857	was
O	858	867	evaluated
O	868	872	with
O	873	876	the
O	877	882	Bland
O	882	883	-
O	883	889	Altman
O	890	895	plots
O	895	896	.

O	897	900	The
O	901	911	intervisit
O	912	916	test
O	916	917	-
O	917	923	retest
O	924	935	variability
O	936	939	was
O	940	948	examined
O	949	951	in
O	952	954	17
O	955	963	randomly
O	964	972	selected
B-Disease	973	981	glaucoma
O	982	990	patients
O	991	994	who
O	995	1004	underwent
B-Diagnostic_tool	1005	1010	optic
I-Diagnostic_tool	1011	1015	disc
I-Diagnostic_tool	1016	1023	imaging
O	1024	1030	weekly
O	1031	1034	for
O	1035	1036	8
O	1037	1048	consecutive
O	1049	1054	weeks
O	1054	1055	.

O	1056	1059	The
B-Characteristic	1060	1070	intraclass
I-Characteristic	1071	1082	correlation
I-Characteristic	1083	1095	coefficients
O	1096	1097	(
B-Characteristic	1097	1100	ICC
O	1100	1101	)
O	1102	1105	and
O	1106	1109	the
O	1110	1125	reproducibility
O	1126	1138	coefficients
O	1139	1141	of
O	1142	1145	the
B-Anatomy	1146	1151	optic
I-Anatomy	1152	1156	disc
O	1157	1167	parameters
O	1168	1172	were
O	1173	1181	computed
O	1181	1182	.

O	1183	1194	Measurement
O	1195	1204	agreement
O	1204	1205	,
O	1206	1221	reproducibility
O	1222	1234	coefficients
O	1234	1235	,
O	1236	1239	and
B-Characteristic	1240	1244	ICCs
O	1245	1247	of
B-Anatomy	1248	1253	optic
I-Anatomy	1254	1258	disc
O	1259	1269	parameters
O	1269	1270	.

O	1271	1274	The
B-Diagnostic_tool	1275	1278	OCT
O	1279	1287	measured
O	1288	1295	smaller
B-Characteristic	1296	1301	optic
I-Characteristic	1302	1306	disc
I-Characteristic	1307	1310	and
I-Characteristic	1311	1314	rim
I-Characteristic	1315	1320	areas
O	1321	1324	and
O	1325	1332	greater
B-Characteristic	1333	1336	cup
I-Characteristic	1337	1343	volume
O	1343	1344	,
B-Characteristic	1345	1353	vertical
I-Characteristic	1354	1357	cup
I-Characteristic	1357	1358	-
I-Characteristic	1358	1360	to
I-Characteristic	1360	1361	-
I-Characteristic	1361	1365	disc
I-Characteristic	1366	1371	ratio
O	1372	1375	and
B-Characteristic	1376	1379	cup
I-Characteristic	1379	1380	-
I-Characteristic	1380	1382	to
I-Characteristic	1382	1383	-
I-Characteristic	1383	1387	disc
I-Characteristic	1388	1392	area
I-Characteristic	1393	1398	ratio
O	1399	1403	than
O	1404	1407	the
B-Diagnostic_tool	1408	1411	HRT
O	1412	1415	did
O	1416	1417	(
O	1417	1420	all
O	1421	1425	with
O	1426	1427	P
O	1428	1429	<
O	1430	1431	0
O	1431	1432	.
O	1432	1435	001
O	1435	1436	)
O	1436	1437	.

O	1438	1443	There
O	1444	1448	were
O	1449	1461	proportional
O	1462	1468	biases
O	1469	1471	in
O	1472	1475	the
O	1476	1481	Bland
O	1481	1482	-
O	1482	1488	Altman
O	1489	1494	plots
O	1495	1502	between
B-Diagnostic_tool	1503	1506	OCT
O	1507	1510	and
B-Diagnostic_tool	1511	1514	HRT
B-Anatomy	1515	1520	optic
I-Anatomy	1521	1525	disc
O	1526	1538	measurements
O	1539	1545	except
O	1546	1549	for
B-Characteristic	1550	1553	rim
I-Characteristic	1554	1558	area
O	1559	1562	and
B-Characteristic	1563	1566	cup
I-Characteristic	1566	1567	-
I-Characteristic	1567	1569	to
I-Characteristic	1569	1570	-
I-Characteristic	1570	1574	disc
I-Characteristic	1575	1579	area
I-Characteristic	1580	1585	ratio
O	1585	1586	.

O	1587	1590	The
O	1591	1593	95
O	1593	1594	%
O	1595	1601	limits
O	1602	1604	of
O	1605	1614	agreement
O	1615	1617	of
B-Characteristic	1618	1621	rim
I-Characteristic	1622	1626	area
O	1627	1633	ranged
O	1634	1641	between
O	1642	1643	-
O	1643	1644	0
O	1644	1645	.
O	1645	1647	28
O	1648	1651	and
O	1652	1653	0
O	1653	1654	.
O	1654	1656	88
O	1657	1659	mm
O	1659	1660	(
O	1660	1661	2
O	1661	1662	)
O	1663	1669	before
O	1669	1670	,
O	1671	1674	and
O	1675	1682	between
O	1683	1684	-
O	1684	1685	0
O	1685	1686	.
O	1686	1688	22
O	1689	1692	and
O	1693	1694	0
O	1694	1695	.
O	1695	1697	92
O	1698	1700	mm
O	1700	1701	(
O	1701	1702	2
O	1702	1703	)
O	1704	1709	after
O	1710	1720	correction
O	1721	1724	for
O	1725	1731	ocular
O	1732	1745	magnification
O	1745	1746	.

O	1747	1751	Both
B-Diagnostic_tool	1752	1755	OCT
O	1756	1759	and
B-Diagnostic_tool	1760	1763	HRT
O	1764	1770	showed
O	1771	1775	high
O	1776	1780	test
O	1780	1781	-
O	1781	1787	retest
O	1788	1803	reproducibility
O	1804	1808	with
B-Characteristic	1809	1813	ICCs
O	1814	1815	
O	1816	1817	0
O	1817	1818	.
O	1818	1821	921
O	1821	1822	.

O	1823	1831	Although
O	1832	1835	the
O	1836	1851	reproducibility
O	1852	1863	coefficient
O	1864	1866	of
B-Characteristic	1867	1870	OCT
I-Characteristic	1871	1874	rim
I-Characteristic	1875	1879	area
O	1880	1881	(
O	1881	1882	0
O	1882	1883	.
O	1883	1886	093
O	1887	1889	mm
O	1889	1890	(
O	1890	1891	2
O	1891	1892	)
O	1892	1893	;
O	1894	1896	95
O	1896	1897	%
O	1898	1908	confidence
O	1909	1917	interval
O	1918	1919	[
O	1919	1921	CI
O	1921	1922	]
O	1922	1923	,
O	1924	1925	0
O	1925	1926	.
O	1926	1929	081
O	1929	1930	-
O	1930	1931	0
O	1931	1932	.
O	1932	1935	105
O	1936	1938	mm
O	1938	1939	(
O	1939	1940	2
O	1940	1941	)
O	1941	1942	)
O	1943	1946	was
O	1947	1960	significantly
O	1961	1968	smaller
O	1969	1973	than
O	1974	1978	that
O	1979	1981	of
O	1982	1985	the
B-Diagnostic_tool	1986	1989	HRT
O	1990	1991	(
O	1991	1992	0
O	1992	1993	.
O	1993	1996	186
O	1997	1999	mm
O	1999	2000	(
O	2000	2001	2
O	2001	2002	)
O	2002	2003	;
O	2004	2006	95
O	2006	2007	%
O	2008	2010	CI
O	2010	2011	,
O	2012	2013	0
O	2013	2014	.
O	2014	2017	163
O	2017	2018	-
O	2018	2019	0
O	2019	2020	.
O	2020	2023	210
O	2024	2026	mm
O	2026	2027	(
O	2027	2028	2
O	2028	2029	)
O	2029	2030	;
O	2031	2032	P
O	2033	2034	=
O	2035	2036	.
O	2036	2039	018
O	2039	2040	)
O	2040	2041	,
O	2042	2047	there
O	2048	2052	were
O	2053	2055	no
O	2056	2067	differences
O	2068	2070	in
O	2071	2074	the
B-Characteristic	2075	2079	ICCs
O	2080	2087	between
O	2088	2091	the
O	2092	2103	instruments
O	2103	2104	.

B-Anatomy	2105	2110	Optic
I-Anatomy	2111	2115	disc
O	2116	2126	assessment
O	2127	2129	by
B-Diagnostic_tool	2130	2138	spectral
I-Diagnostic_tool	2138	2139	-
I-Diagnostic_tool	2139	2145	domain
I-Diagnostic_tool	2146	2149	OCT
O	2150	2153	and
B-Diagnostic_tool	2154	2162	confocal
I-Diagnostic_tool	2163	2171	scanning
I-Diagnostic_tool	2172	2177	laser
I-Diagnostic_tool	2178	2192	ophthalmoscopy
O	2193	2205	demonstrates
O	2206	2210	poor
O	2211	2220	agreement
O	2221	2224	but
O	2225	2234	similarly
O	2235	2238	low
O	2239	2243	test
O	2243	2244	-
O	2244	2250	retest
O	2251	2262	variability
O	2262	2263	.

O	2264	2267	The
O	2268	2274	source
O	2275	2277	of
O	2278	2283	their
O	2284	2296	disagreement
O	2297	2300	and
O	2301	2304	its
O	2305	2312	effects
O	2313	2315	on
O	2316	2319	the
O	2320	2329	detection
O	2330	2332	of
O	2333	2344	progression
O	2345	2352	require
O	2353	2360	further
O	2361	2366	study
O	2366	2367	.

B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	coherence
I-Diagnostic_tool	18	28	tomography
O	29	36	grading
O	37	52	reproducibility
O	53	59	during
O	60	63	the
O	64	74	Comparison
O	75	77	of
B-Disease	78	81	Age
I-Disease	81	82	-
I-Disease	82	89	related
I-Disease	90	97	Macular
I-Disease	98	110	Degeneration
O	111	121	Treatments
O	122	128	Trials
O	128	129	.

O	131	133	To
O	134	140	report
O	141	148	reading
O	149	155	center
O	156	171	reproducibility
O	172	178	during
O	179	186	grading
O	187	189	of
B-Diagnostic_tool	190	197	Stratus
I-Diagnostic_tool	198	205	optical
I-Diagnostic_tool	206	215	coherence
I-Diagnostic_tool	216	226	tomography
O	227	228	(
B-Diagnostic_tool	228	231	OCT
O	231	232	)
O	233	234	(
O	234	238	Carl
O	239	244	Zeiss
O	245	252	Meditec
O	252	253	,
O	254	260	Dublin
O	260	261	,
O	262	264	CA
O	264	265	)
O	266	272	images
O	273	281	obtained
O	282	288	during
O	289	292	the
O	293	303	Comparison
O	304	306	of
B-Disease	307	310	Age
I-Disease	310	311	-
I-Disease	311	318	Related
I-Disease	319	326	Macular
I-Disease	327	339	Degeneration
O	340	350	Treatments
O	351	357	Trials
O	358	359	(
O	359	363	CATT
O	363	364	)
O	364	365	.

O	366	377	Prospective
O	377	378	,
O	379	387	clinical
O	388	393	trial
O	393	394	.

O	395	406	Independent
O	407	414	reading
O	415	420	teams
O	421	432	reevaluated
O	433	436	270
B-Diagnostic_tool	437	440	OCT
O	441	446	scans
O	447	455	randomly
O	456	463	sampled
O	464	468	from
O	469	472	the
O	473	478	first
O	479	480	2
O	481	486	years
O	487	489	of
O	490	494	CATT
O	495	505	enrollment
O	505	506	.

O	507	509	To
O	510	516	assess
O	517	525	temporal
O	526	531	drift
O	531	532	,
O	533	534	a
O	535	541	cohort
O	542	544	of
O	545	547	23
O	548	553	scans
O	554	563	submitted
O	564	570	during
O	571	574	the
O	575	582	initial
O	583	590	portion
O	591	593	of
O	594	597	the
O	598	602	CATT
O	603	608	study
O	609	612	was
O	613	627	longitudinally
O	628	636	followed
O	637	641	with
O	642	648	serial
O	649	664	reproducibility
O	665	673	analysis
O	673	674	.

O	675	678	The
O	679	683	CATT
O	684	691	readers
O	692	701	performed
O	702	714	standardized
O	715	722	grading
O	723	725	of
B-Diagnostic_tool	726	729	OCT
O	730	736	images
O	736	737	.

O	738	739	A
O	740	746	reader
O	747	751	team
O	751	752	,
O	753	761	composed
O	762	764	of
O	765	766	2
O	767	778	independent
O	779	786	readers
O	787	790	and
O	791	792	a
O	793	799	senior
O	800	806	reader
O	806	807	,
O	808	817	evaluated
O	818	822	each
O	823	827	scan
O	827	828	.

O	829	836	Grading
O	837	845	included
O	846	849	the
O	850	854	CATT
B-Diagnostic_tool	855	858	OCT
O	859	862	end
O	863	869	points
O	870	872	of
B-Characteristic	873	878	total
I-Characteristic	879	888	thickness
I-Characteristic	889	891	at
I-Characteristic	892	895	the
I-Characteristic	896	902	foveal
I-Characteristic	903	909	center
I-Characteristic	910	915	point
O	916	919	and
B-Symptom	920	932	intraretinal
I-Symptom	933	938	fluid
O	939	940	(
B-Symptom	940	943	IRF
O	943	944	)
O	944	945	,
B-Symptom	946	956	subretinal
I-Symptom	957	962	fluid
O	963	964	(
B-Symptom	964	967	SRF
O	967	968	)
O	968	969	,
O	970	973	and
B-Symptom	974	984	subretinal
I-Symptom	985	992	pigment
I-Symptom	993	1003	epithelium
I-Symptom	1004	1005	(
I-Symptom	1005	1008	RPE
I-Symptom	1008	1009	)
I-Symptom	1010	1015	fluid
O	1015	1016	.

O	1017	1028	Independent
O	1029	1036	reading
O	1037	1042	teams
O	1043	1049	masked
O	1050	1052	to
O	1053	1056	the
O	1057	1064	results
O	1065	1067	of
O	1068	1075	initial
O	1076	1083	grading
O	1084	1095	reevaluated
O	1096	1101	scans
O	1102	1104	to
O	1105	1114	determine
O	1115	1118	the
O	1119	1134	reproducibility
O	1135	1137	of
O	1138	1149	qualitative
O	1150	1157	grading
O	1158	1161	and
O	1162	1174	measurements
O	1174	1175	.

O	1176	1187	Categorical
O	1188	1195	grading
O	1196	1205	agreement
O	1206	1209	was
O	1210	1218	reported
O	1219	1224	using
O	1225	1232	percent
O	1233	1242	agreement
O	1243	1246	and
O	1247	1252	kappa
O	1253	1262	statistic
O	1262	1263	,
O	1264	1267	and
O	1268	1279	measurement
O	1280	1289	agreement
O	1290	1293	was
O	1294	1302	reported
O	1303	1308	using
O	1309	1319	intraclass
O	1320	1332	correlations
O	1333	1336	and
O	1337	1343	paired
O	1344	1355	differences
O	1355	1356	.

O	1357	1364	Reading
O	1365	1371	center
O	1372	1377	teams
O	1378	1390	reproducibly
O	1391	1397	graded
B-Symptom	1398	1401	IRF
O	1402	1403	(
O	1403	1410	percent
O	1411	1420	agreement
O	1421	1422	=
O	1423	1425	73
O	1425	1426	%
O	1426	1427	,
O	1428	1433	kappa
O	1434	1435	=
O	1436	1437	0
O	1437	1438	.
O	1438	1440	48
O	1440	1441	;
O	1442	1444	95
O	1444	1445	%
O	1446	1456	confidence
O	1457	1465	interval
O	1466	1467	[
O	1467	1469	CI
O	1469	1470	]
O	1470	1471	,
O	1472	1473	0
O	1473	1474	.
O	1474	1476	38
O	1476	1477	-
O	1477	1478	0
O	1478	1479	.
O	1479	1481	58
O	1481	1482	)
O	1482	1483	,
B-Symptom	1484	1487	SRF
O	1488	1489	(
O	1489	1496	percent
O	1497	1506	agreement
O	1507	1508	=
O	1509	1511	90
O	1511	1512	%
O	1512	1513	;
O	1514	1519	kappa
O	1520	1521	=
O	1522	1523	0
O	1523	1524	.
O	1524	1526	80
O	1526	1527	;
O	1528	1530	95
O	1530	1531	%
O	1532	1534	CI
O	1534	1535	,
O	1536	1537	0
O	1537	1538	.
O	1538	1540	73
O	1540	1541	-
O	1541	1542	0
O	1542	1543	.
O	1543	1545	87
O	1545	1546	)
O	1546	1547	,
O	1548	1551	and
B-Symptom	1552	1555	sub
I-Symptom	1555	1556	-
I-Symptom	1556	1559	RPE
I-Symptom	1560	1565	fluid
O	1566	1567	(
O	1567	1574	percent
O	1575	1584	agreement
O	1585	1587	88
O	1587	1588	%
O	1588	1589	;
O	1590	1595	kappa
O	1596	1597	=
O	1598	1599	0
O	1599	1600	.
O	1600	1602	75
O	1602	1603	;
O	1604	1606	95
O	1606	1607	%
O	1608	1610	CI
O	1610	1611	,
O	1612	1613	0
O	1613	1614	.
O	1614	1616	67
O	1616	1617	-
O	1617	1618	0
O	1618	1619	.
O	1619	1621	83
O	1621	1622	)
O	1622	1623	.

O	1624	1627	For
O	1628	1639	independent
O	1640	1647	reading
O	1648	1654	center
O	1655	1659	team
O	1660	1672	measurements
O	1673	1675	of
B-Characteristic	1676	1681	total
I-Characteristic	1682	1691	thickness
I-Characteristic	1692	1694	at
I-Characteristic	1695	1698	the
I-Characteristic	1699	1705	foveal
I-Characteristic	1706	1712	center
I-Characteristic	1713	1718	point
O	1718	1719	,
O	1720	1723	the
O	1724	1734	intraclass
O	1735	1746	correlation
O	1747	1750	was
O	1751	1752	0
O	1752	1753	.
O	1753	1755	99
O	1756	1757	(
O	1757	1759	95
O	1759	1760	%
O	1761	1763	CI
O	1763	1764	,
O	1765	1766	0
O	1766	1767	.
O	1767	1769	99
O	1769	1770	-
O	1770	1771	0
O	1771	1772	.
O	1772	1774	99
O	1774	1775	)
O	1775	1776	,
O	1777	1780	and
O	1781	1784	the
O	1785	1789	mean
O	1790	1796	paired
O	1797	1807	difference
O	1808	1815	between
O	1816	1823	reading
O	1824	1830	center
O	1831	1836	teams
O	1837	1840	was
O	1841	1842	4
O	1843	1844	
O	1844	1845	m
O	1846	1847	(
O	1847	1849	95
O	1849	1850	%
O	1851	1857	limits
O	1858	1860	of
O	1861	1870	agreement
O	1870	1871	,
O	1872	1873	-
O	1873	1875	55
O	1876	1878	to
O	1879	1881	47
O	1882	1883	
O	1883	1884	m
O	1884	1885	)
O	1885	1886	.

O	1887	1892	There
O	1893	1896	was
O	1897	1899	no
O	1900	1911	qualitative
O	1912	1914	or
O	1915	1927	quantitative
O	1928	1935	grading
O	1936	1941	drift
O	1941	1942	.

O	1943	1946	The
O	1947	1959	standardized
O	1960	1969	protocols
O	1970	1974	used
O	1975	1977	to
O	1978	1986	evaluate
B-Diagnostic_tool	1987	1990	OCT
O	1991	1996	scans
O	1997	2001	from
O	2002	2005	the
O	2006	2010	CATT
O	2011	2016	study
O	2017	2021	were
O	2022	2034	reproducible
O	2034	2035	.

O	2036	2039	The
O	2040	2047	methods
O	2048	2052	used
O	2053	2056	are
O	2057	2065	suitable
O	2066	2068	to
O	2069	2076	monitor
B-Diagnostic_tool	2077	2080	OCT
O	2081	2088	imaging
O	2089	2093	data
O	2094	2098	from
O	2099	2100	a
O	2101	2106	large
O	2106	2107	,
B-Disease	2108	2119	neovascular
I-Disease	2120	2123	age
I-Disease	2123	2124	-
I-Disease	2124	2131	related
I-Disease	2132	2139	macular
I-Disease	2140	2152	degeneration
O	2152	2153	,
O	2154	2168	interventional
O	2168	2169	,
O	2170	2181	multicenter
O	2182	2187	study
O	2187	2188	.

O	2189	2192	The
O	2193	2199	author
O	2199	2200	(
O	2200	2201	s
O	2201	2202	)
O	2203	2207	have
O	2208	2210	no
O	2211	2222	proprietary
O	2223	2225	or
O	2226	2236	commercial
O	2237	2245	interest
O	2246	2248	in
O	2249	2252	any
O	2253	2262	materials
O	2263	2272	discussed
O	2273	2275	in
O	2276	2280	this
O	2281	2288	article
O	2288	2289	.

O	0	12	Determinants
O	13	16	and
O	17	20	two
O	20	21	-
O	21	25	year
O	26	32	change
O	33	35	in
B-Characteristic	36	44	anterior
I-Characteristic	45	52	chamber
I-Characteristic	53	58	angle
I-Characteristic	59	64	width
O	65	67	in
O	68	69	a
B-Characteristic	70	77	Chinese
I-Characteristic	78	88	population
O	88	89	.

O	91	93	To
O	94	99	study
O	100	103	the
O	104	114	population
O	115	127	distribution
O	128	131	and
O	132	144	longitudinal
O	145	152	changes
O	153	155	in
B-Characteristic	156	164	anterior
I-Characteristic	165	172	chamber
I-Characteristic	173	178	angle
I-Characteristic	179	184	width
O	185	188	and
O	189	192	its
O	193	205	determinants
O	206	211	among
B-Characteristic	212	219	Chinese
I-Characteristic	220	226	adults
O	226	227	.

O	228	239	Prospective
O	240	246	cohort
O	246	247	,
O	248	258	population
O	258	259	-
O	259	264	based
O	265	270	study
O	270	271	.

B-Characteristic	272	279	Persons
I-Characteristic	280	284	aged
I-Characteristic	285	287	35
I-Characteristic	288	293	years
O	294	296	or
O	297	301	more
B-Characteristic	302	310	residing
I-Characteristic	311	313	in
I-Characteristic	314	323	Guangzhou
I-Characteristic	323	324	,
I-Characteristic	325	330	China
O	330	331	,
O	332	335	who
O	336	339	had
O	340	343	not
O	344	354	previously
O	355	364	undergone
O	365	375	incisional
O	376	378	or
O	379	384	laser
B-Anatomy	385	388	eye
O	389	396	surgery
O	396	397	.

O	398	400	In
O	401	409	December
O	410	414	2008
O	415	418	and
O	419	427	December
O	428	432	2010
O	432	433	,
O	434	437	all
O	438	446	subjects
O	447	456	underwent
O	457	466	automated
B-Diagnostic_tool	467	478	keratometry
O	478	479	,
O	480	483	and
O	484	485	a
O	486	492	random
O	493	495	50
O	495	496	%
O	497	503	sample
O	504	507	had
B-Diagnostic_tool	508	516	anterior
I-Diagnostic_tool	517	524	segment
I-Diagnostic_tool	525	532	optical
I-Diagnostic_tool	533	542	coherence
I-Diagnostic_tool	543	553	tomography
O	554	558	with
O	559	570	measurement
O	571	573	of
B-Characteristic	574	579	angle
I-Characteristic	579	580	-
I-Characteristic	580	587	opening
I-Characteristic	588	596	distance
I-Characteristic	597	599	at
I-Characteristic	600	603	500
I-Characteristic	604	605	
I-Characteristic	605	606	m
O	607	608	(
B-Characteristic	608	614	AOD500
O	614	615	)
O	615	616	,
B-Characteristic	617	622	angle
I-Characteristic	623	629	recess
I-Characteristic	630	634	area
O	635	636	(
B-Characteristic	636	639	ARA
O	639	640	)
O	640	641	,
B-Characteristic	642	646	iris
I-Characteristic	647	656	thickness
I-Characteristic	657	659	at
I-Characteristic	660	663	750
I-Characteristic	664	665	
I-Characteristic	665	666	m
O	667	668	(
B-Characteristic	668	673	IT750
O	673	674	)
O	674	675	,
B-Characteristic	676	680	iris
I-Characteristic	681	690	curvature
O	690	691	,
B-Characteristic	692	697	pupil
I-Characteristic	698	706	diameter
O	706	707	,
B-Characteristic	708	715	corneal
I-Characteristic	716	725	thickness
O	725	726	,
B-Characteristic	727	735	anterior
I-Characteristic	736	743	chamber
I-Characteristic	744	749	width
O	750	751	(
B-Characteristic	751	754	ACW
O	754	755	)
O	755	756	,
B-Characteristic	757	761	lens
I-Characteristic	762	767	vault
O	768	769	(
B-Characteristic	769	771	LV
O	771	772	)
O	772	773	,
O	774	777	and
B-Characteristic	778	782	lens
I-Characteristic	783	792	thickness
O	793	794	(
B-Characteristic	794	796	LT
O	796	797	)
O	798	801	and
O	802	813	measurement
O	814	816	of
B-Characteristic	817	822	axial
I-Characteristic	823	829	length
O	830	831	(
B-Characteristic	831	833	AL
O	833	834	)
O	835	838	and
B-Characteristic	839	847	anterior
I-Characteristic	848	855	chamber
I-Characteristic	856	861	depth
O	862	863	(
B-Characteristic	863	866	ACD
O	866	867	)
O	868	870	by
B-Diagnostic_tool	871	878	partial
I-Diagnostic_tool	879	888	coherence
I-Diagnostic_tool	889	894	laser
I-Diagnostic_tool	895	909	interferometry
O	909	910	.

O	911	919	Baseline
O	920	923	and
O	924	925	2
O	925	926	-
O	926	930	year
O	931	937	change
O	938	940	in
B-Characteristic	941	947	AOD500
O	948	951	and
B-Characteristic	952	955	ARA
O	956	958	in
O	959	962	the
O	963	968	right
B-Anatomy	969	972	eye
O	972	973	.

O	974	975	A
O	976	981	total
O	982	984	of
O	985	988	745
O	989	997	subjects
O	998	1002	were
O	1003	1010	present
O	1011	1014	for
O	1015	1019	full
O	1020	1029	biometric
O	1030	1037	testing
O	1038	1040	in
O	1041	1045	both
O	1046	1050	2008
O	1051	1054	and
O	1055	1059	2010
O	1060	1061	(
B-Characteristic	1061	1065	mean
I-Characteristic	1066	1069	age
O	1070	1072	at
O	1073	1081	baseline
O	1081	1082	,
O	1083	1085	52
O	1085	1086	.
O	1086	1087	2
O	1088	1093	years
O	1093	1094	;
O	1095	1103	standard
O	1104	1113	deviation
O	1114	1115	[
O	1115	1117	SD
O	1117	1118	]
O	1118	1119	,
O	1120	1122	11
O	1122	1123	.
O	1123	1124	5
O	1125	1130	years
O	1130	1131	;
O	1132	1134	53
O	1134	1135	.
O	1135	1136	7
O	1136	1137	%
O	1138	1142	were
B-Characteristic	1143	1149	female
O	1149	1150	)
O	1150	1151	.

O	1152	1156	Test
O	1157	1167	completion
O	1168	1173	rates
O	1174	1176	in
O	1177	1181	2010
O	1182	1188	varied
O	1189	1193	from
O	1194	1196	77
O	1196	1197	.
O	1197	1198	3
O	1198	1199	%
O	1200	1201	(
B-Characteristic	1201	1207	AOD500
O	1207	1208	:
O	1209	1212	576
O	1212	1213	/
O	1213	1216	745
O	1216	1217	)
O	1218	1220	to
O	1221	1224	100
O	1224	1225	%
O	1226	1227	(
B-Characteristic	1227	1229	AL
O	1229	1230	)
O	1230	1231	.

B-Characteristic	1232	1236	Mean
I-Characteristic	1237	1243	AOD500
O	1244	1253	decreased
O	1254	1258	from
O	1259	1260	0
O	1260	1261	.
O	1261	1263	25
O	1264	1266	mm
O	1267	1268	(
O	1268	1270	SD
O	1270	1271	,
O	1272	1273	0
O	1273	1274	.
O	1274	1276	13
O	1277	1279	mm
O	1279	1280	)
O	1281	1283	in
O	1284	1288	2008
O	1289	1291	to
O	1292	1293	0
O	1293	1294	.
O	1294	1296	21
O	1297	1299	mm
O	1300	1301	(
O	1301	1303	SD
O	1303	1304	,
O	1305	1307	13
O	1308	1310	mm
O	1310	1311	)
O	1312	1314	in
O	1315	1319	2010
O	1320	1321	(
O	1321	1331	difference
O	1331	1332	,
O	1333	1334	-
O	1334	1335	0
O	1335	1336	.
O	1336	1338	04
O	1338	1339	;
O	1340	1342	95
O	1342	1343	%
O	1344	1354	confidence
O	1355	1363	interval
O	1364	1365	[
O	1365	1367	CI
O	1367	1368	]
O	1369	1370	,
O	1371	1372	-
O	1372	1373	0
O	1373	1374	.
O	1374	1376	05
O	1377	1379	to
O	1380	1381	-
O	1381	1382	0
O	1382	1383	.
O	1383	1385	03
O	1385	1386	)
O	1386	1387	.

O	1388	1391	The
B-Characteristic	1392	1395	ARA
O	1396	1405	decreased
O	1406	1410	from
O	1411	1413	21
O	1413	1414	.
O	1414	1415	5
O	1416	1417	
O	1418	1419	3
O	1419	1420	.
O	1420	1422	73
O	1423	1425	10
O	1425	1426	(
O	1426	1427	-
O	1427	1428	2
O	1428	1429	)
O	1430	1432	mm
O	1432	1433	(
O	1433	1434	2
O	1434	1435	)
O	1436	1438	to
O	1439	1441	21
O	1441	1442	.
O	1442	1443	0
O	1444	1445	
O	1446	1447	3
O	1447	1448	.
O	1448	1450	64
O	1451	1453	10
O	1453	1454	(
O	1454	1455	-
O	1455	1456	2
O	1456	1457	)
O	1458	1460	mm
O	1460	1461	(
O	1461	1462	2
O	1462	1463	)
O	1464	1465	(
O	1465	1475	difference
O	1475	1476	,
O	1477	1478	-
O	1478	1479	0
O	1479	1480	.
O	1480	1482	46
O	1482	1483	;
O	1484	1486	95
O	1486	1487	%
O	1488	1490	CI
O	1490	1491	,
O	1492	1493	-
O	1493	1494	0
O	1494	1495	.
O	1495	1497	52
O	1498	1500	to
O	1501	1502	-
O	1502	1503	0
O	1503	1504	.
O	1504	1506	41
O	1506	1507	)
O	1507	1508	.

O	1509	1512	The
O	1513	1521	decrease
O	1522	1524	in
O	1525	1529	both
O	1530	1533	was
O	1534	1538	most
O	1539	1549	pronounced
O	1550	1555	among
B-Characteristic	1556	1563	younger
I-Characteristic	1564	1572	subjects
O	1573	1576	and
O	1577	1582	those
O	1583	1587	with
O	1588	1596	baseline
B-Characteristic	1597	1603	AOD500
O	1604	1606	in
O	1607	1610	the
O	1611	1617	widest
O	1618	1626	quartile
O	1627	1629	at
O	1630	1638	baseline
O	1638	1639	.

O	1640	1643	The
O	1644	1653	following
O	1654	1662	baseline
O	1663	1672	variables
O	1673	1677	were
O	1678	1691	significantly
O	1692	1702	associated
O	1703	1707	with
O	1708	1709	a
O	1710	1717	greater
O	1718	1719	2
O	1719	1720	-
O	1720	1724	year
O	1725	1733	decrease
O	1734	1736	in
O	1737	1741	both
B-Characteristic	1742	1748	AOD500
O	1749	1752	and
B-Characteristic	1753	1756	ARA
O	1756	1757	:
B-Characteristic	1758	1764	deeper
I-Characteristic	1765	1768	ACD
O	1768	1769	,
B-Characteristic	1770	1777	steeper
I-Characteristic	1778	1782	iris
I-Characteristic	1783	1792	curvature
O	1792	1793	,
B-Characteristic	1794	1801	smaller
I-Characteristic	1802	1804	LV
O	1804	1805	,
B-Characteristic	1806	1813	greater
I-Characteristic	1814	1817	ARA
O	1817	1818	,
O	1819	1822	and
B-Characteristic	1823	1830	greater
I-Characteristic	1831	1837	AOD500
O	1837	1838	.

O	1839	1841	By
O	1842	1847	using
O	1848	1854	simple
O	1855	1865	regression
O	1866	1872	models
O	1872	1873	,
O	1874	1876	we
O	1877	1882	could
O	1883	1890	explain
O	1891	1893	52
O	1893	1894	%
O	1895	1897	to
O	1898	1900	58
O	1900	1901	%
O	1902	1905	and
O	1906	1908	93
O	1908	1909	%
O	1910	1912	of
O	1913	1922	variation
O	1923	1925	in
O	1926	1934	baseline
B-Characteristic	1935	1941	AOD500
O	1942	1945	and
B-Characteristic	1946	1949	ARA
O	1949	1950	,
O	1951	1963	respectively
O	1963	1964	,
O	1965	1968	but
O	1969	1973	only
O	1974	1976	27
O	1976	1977	%
O	1978	1981	and
O	1982	1984	16
O	1984	1985	%
O	1986	1988	of
O	1989	1998	variation
O	1999	2001	in
O	2002	2003	2
O	2003	2004	-
O	2004	2008	year
O	2009	2015	change
O	2016	2018	in
B-Characteristic	2019	2025	AOD500
O	2026	2029	and
B-Characteristic	2030	2033	ARA
O	2033	2034	,
O	2035	2047	respectively
O	2047	2048	.

B-Characteristic	2049	2056	Younger
I-Characteristic	2057	2064	persons
O	2065	2068	and
O	2069	2074	those
O	2075	2079	with
O	2080	2083	the
B-Characteristic	2084	2089	least
I-Characteristic	2090	2097	crowded
I-Characteristic	2098	2106	anterior
I-Characteristic	2107	2115	chambers
O	2116	2118	at
O	2119	2127	baseline
O	2128	2132	have
O	2133	2136	the
O	2137	2144	largest
O	2145	2146	2
O	2146	2147	-
O	2147	2151	year
O	2152	2161	decreases
O	2162	2164	in
B-Characteristic	2165	2171	AOD500
O	2172	2175	and
B-Characteristic	2176	2179	ARA
O	2179	2180	.

O	2181	2184	The
O	2185	2192	ability
O	2193	2195	to
O	2196	2203	predict
B-Characteristic	2204	2210	change
I-Characteristic	2211	2213	in
I-Characteristic	2214	2219	angle
I-Characteristic	2220	2225	width
O	2226	2231	based
O	2232	2234	on
B-Characteristic	2235	2246	demographic
I-Characteristic	2247	2250	and
I-Characteristic	2251	2260	biometric
I-Characteristic	2261	2268	factors
O	2269	2271	is
O	2272	2282	relatively
O	2283	2287	poor
O	2287	2288	,
O	2289	2294	which
O	2295	2298	may
O	2299	2303	have
O	2304	2316	implications
O	2317	2320	for
O	2321	2330	screening
O	2330	2331	.

O	2332	2335	The
O	2336	2342	author
O	2342	2343	(
O	2343	2344	s
O	2344	2345	)
O	2346	2350	have
O	2351	2353	no
O	2354	2365	proprietary
O	2366	2368	or
O	2369	2379	commercial
O	2380	2388	interest
O	2389	2391	in
O	2392	2395	any
O	2396	2405	materials
O	2406	2415	discussed
O	2416	2418	in
O	2419	2423	this
O	2424	2431	article
O	2431	2432	.

O	0	9	Improving
O	10	19	awareness
O	19	20	,
O	21	35	identification
O	35	36	,
O	37	40	and
O	41	51	management
O	52	54	of
B-Disease	55	64	meibomian
I-Disease	65	70	gland
I-Disease	71	82	dysfunction
O	82	83	.

B-Disease	85	91	Ocular
I-Disease	92	99	surface
I-Disease	100	108	disorder
O	108	109	-
O	109	110	-
O	110	113	and
B-Disease	114	117	dry
I-Disease	118	121	eye
O	121	122	,
O	123	125	in
O	126	136	particular
O	136	137	-
O	137	138	-
O	138	140	is
O	141	142	a
O	143	150	leading
O	151	157	reason
O	158	161	for
O	162	168	visits
O	169	171	to
B-Anatomy	172	175	eye
O	176	180	care
O	181	194	professionals
O	194	195	.

O	196	198	It
O	199	202	has
O	203	207	been
O	208	217	generally
O	218	226	accepted
O	227	231	that
B-Disease	232	241	meibomian
I-Disease	242	247	gland
I-Disease	248	259	dysfunction
O	260	261	(
B-Disease	261	264	MGD
O	264	265	)
O	266	268	is
O	269	270	a
O	271	278	leading
O	279	284	cause
O	285	287	of
B-Disease	288	299	evaporative
I-Disease	300	303	dry
I-Disease	304	307	eye
O	307	308	,
O	309	311	as
O	312	316	well
O	317	319	as
O	320	325	being
O	326	336	associated
O	337	341	with
B-Disease	342	349	aqueous
I-Disease	349	350	-
I-Disease	350	359	deficient
I-Disease	360	363	dry
I-Disease	364	367	eye
O	367	368	.

O	369	372	Yet
O	372	373	,
O	374	385	researchers
O	386	389	and
O	390	400	clinicians
O	401	405	have
O	406	412	lacked
O	413	414	a
O	415	421	global
O	422	431	consensus
O	432	434	on
O	435	438	the
O	439	449	definition
O	450	452	of
B-Disease	453	456	MGD
O	456	457	,
O	458	461	its
O	462	474	epidemiology
O	474	475	,
O	476	491	pathophysiology
O	491	492	,
O	493	496	and
O	497	507	management
O	507	508	.

O	509	516	Various
O	517	525	systemic
O	526	534	diseases
O	535	538	and
O	539	550	medications
O	551	555	have
O	556	560	been
O	561	571	associated
O	572	576	with
O	577	580	the
O	581	592	progression
O	593	595	of
O	596	600	both
B-Disease	601	604	dry
I-Disease	605	608	eye
O	609	612	and
B-Disease	613	616	MGD
O	616	617	,
O	618	620	as
O	621	625	have
O	626	633	several
B-Disease	634	640	ocular
I-Disease	641	650	disorders
O	651	657	beyond
O	658	663	those
O	664	672	directly
O	673	682	affecting
O	683	686	the
O	687	694	surface
O	694	695	.

O	696	698	It
O	699	701	is
O	702	704	in
O	705	708	the
O	709	713	best
O	714	722	interest
O	723	725	of
O	726	734	patients
O	735	738	for
O	739	749	clinicians
O	750	752	to
O	753	755	be
O	756	760	able
O	761	763	to
O	764	770	better
O	771	779	identify
O	780	783	and
O	784	792	diagnose
B-Disease	793	796	MGD
O	796	797	,
O	798	813	differentiating
O	814	816	it
O	817	821	from
O	822	827	other
B-Disease	828	834	ocular
I-Disease	835	842	surface
I-Disease	843	852	disorders
O	852	853	,
O	854	857	and
O	858	860	to
O	861	870	recognize
O	871	874	the
O	875	882	effects
O	883	885	of
B-Disease	886	889	MGD
O	890	892	on
O	893	896	the
B-Anatomy	897	903	ocular
I-Anatomy	904	911	surface
O	911	912	,
O	913	916	and
O	917	921	thus
O	922	930	initiate
O	931	942	appropriate
O	943	950	therapy
O	950	951	.

O	952	956	This
O	957	960	CME
O	961	969	activity
O	970	978	provides
O	979	985	expert
O	986	993	insight
O	994	998	into
O	999	1002	the
O	1003	1007	Tear
O	1008	1012	Film
O	1013	1016	and
O	1017	1023	Ocular
O	1024	1031	Surface
O	1032	1039	Society
O	1039	1040	'
O	1040	1041	s
O	1042	1055	International
O	1056	1064	Workshop
O	1065	1067	on
B-Disease	1068	1071	MGD
O	1072	1081	consensus
O	1082	1088	report
O	1088	1089	,
O	1090	1098	offering
O	1099	1108	practical
O	1109	1120	application
O	1121	1123	of
O	1124	1127	its
O	1128	1136	findings
O	1137	1139	to
O	1140	1146	better
O	1147	1153	manage
B-Disease	1154	1157	MGD
O	1158	1165	patient
O	1166	1170	care
O	1170	1171	,
O	1172	1184	particularly
O	1185	1188	for
O	1189	1194	those
O	1195	1203	patients
O	1204	1210	facing
O	1211	1213	or
O	1214	1224	undergoing
B-Anatomy	1225	1231	ocular
O	1232	1239	surgery
O	1239	1240	.

O	0	8	Clinical
O	9	23	classification
O	24	26	of
B-Disease	27	30	age
I-Disease	30	31	-
I-Disease	31	38	related
I-Disease	39	46	macular
I-Disease	47	59	degeneration
O	59	60	.

O	62	64	To
O	65	72	develop
O	73	74	a
O	75	83	clinical
O	84	98	classification
O	99	105	system
O	106	109	for
B-Disease	110	113	age
I-Disease	113	114	-
I-Disease	114	121	related
I-Disease	122	129	macular
I-Disease	130	142	degeneration
O	143	144	(
B-Disease	144	147	AMD
O	147	148	)
O	148	149	.

O	150	158	Evidence
O	158	159	-
O	159	164	based
O	165	178	investigation
O	178	179	,
O	180	185	using
O	186	187	a
O	188	196	modified
O	197	203	Delphi
O	204	211	process
O	211	212	.

O	213	219	Twenty
O	219	220	-
O	220	223	six
B-Disease	224	227	AMD
O	228	235	experts
O	235	236	,
O	237	238	1
O	239	244	neuro
O	244	245	-
O	245	260	ophthalmologist
O	260	261	,
O	262	263	2
O	264	273	committee
O	274	282	chairmen
O	282	283	,
O	284	287	and
O	288	289	1
O	290	303	methodologist
O	303	304	.

O	305	309	Each
O	310	319	committee
O	320	326	member
O	327	336	completed
O	337	339	an
O	340	346	online
O	347	357	assessment
O	358	360	of
O	361	371	statements
O	372	383	summarizing
O	384	391	current
B-Disease	392	395	AMD
O	396	410	classification
O	411	419	criteria
O	419	420	,
O	421	431	indicating
O	432	441	agreement
O	442	444	or
O	445	457	disagreement
O	458	462	with
O	463	467	each
O	468	477	statement
O	478	480	on
O	481	482	a
O	483	484	9
O	484	485	-
O	485	489	step
O	490	495	scale
O	495	496	.

O	497	500	The
O	501	506	group
O	507	510	met
O	510	511	,
O	512	520	reviewed
O	521	524	the
O	525	531	survey
O	532	539	results
O	539	540	,
O	541	550	discussed
O	551	554	the
O	555	564	important
O	565	575	components
O	576	578	of
O	579	580	a
O	581	589	clinical
O	590	604	classification
O	605	611	system
O	611	612	,
O	613	616	and
O	617	624	defined
O	625	628	new
O	629	633	data
O	634	642	analyses
O	643	649	needed
O	650	652	to
O	653	659	refine
O	660	661	a
O	662	676	classification
O	677	683	system
O	683	684	.

O	685	690	After
O	691	694	the
O	695	702	meeting
O	702	703	,
O	704	714	additional
O	715	719	data
O	720	728	analyses
O	729	733	from
O	734	739	large
O	740	747	studies
O	748	752	were
O	753	761	provided
O	762	764	to
O	765	768	the
O	769	778	committee
O	779	781	to
O	782	789	provide
O	790	794	risk
O	795	804	estimates
O	805	812	related
O	813	815	to
O	816	819	the
O	820	828	presence
O	829	831	of
O	832	839	various
B-Symptom	840	843	AMD
I-Symptom	844	851	lesions
O	851	852	.

O	853	859	Delphi
O	860	866	review
O	867	869	of
O	870	873	the
O	874	875	9
O	875	876	-
O	876	880	item
O	881	884	set
O	885	887	of
O	888	898	statements
O	899	908	resulting
O	909	913	from
O	914	917	the
O	918	925	meeting
O	925	926	.

O	927	936	Consensus
O	937	940	was
O	941	949	achieved
O	950	952	in
O	953	963	generating
O	964	965	a
O	966	971	basic
O	972	980	clinical
O	981	995	classification
O	996	1002	system
O	1003	1008	based
O	1009	1011	on
B-Symptom	1012	1018	fundus
I-Symptom	1019	1026	lesions
O	1027	1035	assessed
B-Anatomy	1036	1042	within
I-Anatomy	1043	1044	2
I-Anatomy	1045	1049	disc
I-Anatomy	1050	1059	diameters
I-Anatomy	1060	1062	of
I-Anatomy	1063	1066	the
I-Anatomy	1067	1072	fovea
O	1073	1075	in
O	1076	1083	persons
B-Characteristic	1084	1089	older
I-Characteristic	1090	1094	than
I-Characteristic	1095	1097	55
I-Characteristic	1098	1103	years
O	1103	1104	.

O	1105	1108	The
O	1109	1118	committee
O	1119	1125	agreed
O	1126	1130	that
O	1131	1132	a
O	1133	1139	single
O	1140	1144	term
O	1144	1145	,
B-Disease	1146	1149	age
I-Disease	1149	1150	-
I-Disease	1150	1157	related
I-Disease	1158	1165	macular
I-Disease	1166	1178	degeneration
O	1178	1179	,
O	1180	1186	should
O	1187	1189	be
O	1190	1194	used
O	1195	1198	for
O	1199	1202	the
O	1203	1210	disease
O	1210	1211	.

O	1212	1219	Persons
O	1220	1224	with
O	1225	1227	no
O	1228	1235	visible
B-Symptom	1236	1242	drusen
O	1243	1245	or
B-Symptom	1246	1256	pigmentary
I-Symptom	1257	1270	abnormalities
O	1271	1277	should
O	1278	1280	be
O	1281	1291	considered
O	1292	1294	to
O	1295	1299	have
O	1300	1302	no
O	1303	1308	signs
O	1309	1311	of
B-Disease	1312	1315	AMD
O	1315	1316	.

O	1317	1324	Persons
O	1325	1329	with
B-Symptom	1330	1335	small
I-Symptom	1336	1342	drusen
O	1343	1344	(
B-Dimension	1345	1346	<
I-Dimension	1347	1349	63
I-Dimension	1350	1351	
I-Dimension	1351	1352	m
O	1352	1353	)
O	1353	1354	,
O	1355	1359	also
O	1360	1366	termed
B-Symptom	1367	1376	drupelets
O	1376	1377	,
O	1378	1384	should
O	1385	1387	be
O	1388	1398	considered
O	1399	1401	to
O	1402	1406	have
B-Disease	1407	1413	normal
I-Disease	1414	1419	aging
O	1420	1427	changes
O	1428	1432	with
O	1433	1435	no
O	1436	1446	clinically
O	1447	1455	relevant
O	1456	1465	increased
O	1466	1470	risk
O	1471	1473	of
B-Disease	1474	1478	late
I-Disease	1479	1482	AMD
O	1483	1493	developing
O	1493	1494	.

O	1495	1502	Persons
O	1503	1507	with
B-Symptom	1508	1514	medium
I-Symptom	1515	1521	drusen
O	1522	1523	(
B-Dimension	1523	1524	
I-Dimension	1525	1527	63
I-Dimension	1527	1528	-
I-Dimension	1529	1530	<
I-Dimension	1531	1534	125
I-Dimension	1535	1536	
I-Dimension	1536	1537	m
O	1537	1538	)
O	1538	1539	,
O	1540	1543	but
O	1544	1551	without
B-Symptom	1552	1562	pigmentary
I-Symptom	1563	1576	abnormalities
O	1577	1584	thought
O	1585	1587	to
O	1588	1590	be
O	1591	1598	related
O	1599	1601	to
B-Disease	1602	1605	AMD
O	1605	1606	,
O	1607	1613	should
O	1614	1616	be
O	1617	1627	considered
O	1628	1630	to
O	1631	1635	have
B-Disease	1636	1641	early
I-Disease	1642	1645	AMD
O	1645	1646	.

O	1647	1654	Persons
O	1655	1659	with
B-Symptom	1660	1665	large
I-Symptom	1666	1672	drusen
O	1673	1675	or
O	1676	1680	with
B-Symptom	1681	1691	pigmentary
I-Symptom	1692	1705	abnormalities
I-Symptom	1706	1716	associated
I-Symptom	1717	1721	with
I-Symptom	1722	1724	at
I-Symptom	1725	1730	least
I-Symptom	1731	1737	medium
I-Symptom	1738	1744	drusen
O	1745	1751	should
O	1752	1754	be
O	1755	1765	considered
O	1766	1768	to
O	1769	1773	have
B-Disease	1774	1786	intermediate
I-Disease	1787	1790	AMD
O	1790	1791	.

O	1792	1799	Persons
O	1800	1804	with
B-Symptom	1805	1812	lesions
I-Symptom	1813	1823	associated
I-Symptom	1824	1828	with
I-Symptom	1829	1840	neovascular
I-Symptom	1841	1844	AMD
O	1845	1847	or
B-Symptom	1848	1858	geographic
I-Symptom	1859	1866	atrophy
O	1867	1873	should
O	1874	1876	be
O	1877	1887	considered
O	1888	1890	to
O	1891	1895	have
B-Disease	1896	1900	late
I-Disease	1901	1904	AMD
O	1904	1905	.

O	1906	1910	Five
O	1910	1911	-
O	1911	1915	year
O	1916	1921	risks
O	1922	1924	of
O	1925	1936	progressing
O	1937	1939	to
B-Disease	1940	1944	late
I-Disease	1945	1948	AMD
O	1949	1952	are
O	1953	1962	estimated
O	1963	1965	to
O	1966	1974	increase
O	1975	1988	approximately
O	1989	1992	100
O	1993	1997	fold
O	1997	1998	,
O	1999	2006	ranging
O	2007	2011	from
O	2012	2013	a
O	2014	2015	0
O	2015	2016	.
O	2016	2017	5
O	2017	2018	%
O	2019	2020	5
O	2020	2021	-
O	2021	2025	year
O	2026	2030	risk
O	2031	2034	for
B-Disease	2035	2041	normal
I-Disease	2042	2047	aging
O	2048	2055	changes
O	2056	2058	to
O	2059	2060	a
O	2061	2063	50
O	2063	2064	%
O	2065	2069	risk
O	2070	2073	for
O	2074	2077	the
O	2078	2085	highest
B-Disease	2086	2098	intermediate
I-Disease	2099	2102	AMD
O	2103	2107	risk
O	2108	2113	group
O	2113	2114	.

O	2115	2118	The
O	2119	2127	proposed
O	2128	2133	basic
O	2134	2142	clinical
O	2143	2157	classification
O	2158	2163	scale
O	2164	2169	seems
O	2170	2172	to
O	2173	2175	be
O	2176	2178	of
O	2179	2184	value
O	2185	2187	in
O	2188	2198	predicting
O	2199	2202	the
O	2203	2207	risk
O	2208	2210	of
B-Disease	2211	2215	late
I-Disease	2216	2219	AMD
O	2219	2220	.

O	2221	2234	Incorporating
O	2235	2245	consistent
O	2246	2258	nomenclature
O	2259	2263	into
O	2264	2267	the
O	2268	2276	practice
O	2277	2285	patterns
O	2286	2288	of
O	2289	2292	all
B-Anatomy	2293	2296	eye
O	2297	2301	care
O	2302	2311	providers
O	2312	2315	may
O	2316	2323	improve
O	2324	2337	communication
O	2338	2341	and
O	2342	2349	patient
O	2350	2354	care
O	2354	2355	.

O	0	3	How
O	4	8	does
B-Disease	9	17	glaucoma
O	18	22	look
O	22	23	?
O	23	24	:
O	25	32	patient
O	33	43	perception
O	44	46	of
B-Symptom	47	53	visual
I-Symptom	54	59	field
I-Symptom	60	64	loss
O	64	65	.

O	67	69	To
O	70	77	explore
O	78	85	patient
O	86	96	perception
O	97	99	of
B-Symptom	100	106	vision
I-Symptom	107	111	loss
O	112	114	in
B-Disease	115	123	glaucoma
O	124	127	and
O	127	128	,
O	129	141	specifically
O	141	142	,
O	143	145	to
O	146	150	test
O	151	154	the
O	155	165	hypothesis
O	166	170	that
O	171	179	patients
O	180	182	do
O	183	186	not
O	187	196	recognize
O	197	202	their
O	203	213	impairment
O	214	216	as
O	217	218	a
B-Symptom	219	224	black
I-Symptom	225	231	tunnel
I-Symptom	232	238	effect
O	239	241	or
O	242	244	as
B-Symptom	245	250	black
I-Symptom	251	258	patches
I-Symptom	259	261	in
I-Symptom	262	267	their
I-Symptom	268	273	field
I-Symptom	274	276	of
I-Symptom	277	281	view
O	281	282	.

O	283	289	Clinic
O	289	290	-
O	290	295	based
O	296	301	cross
O	301	302	-
O	302	311	sectional
O	312	317	study
O	317	318	.

O	319	324	Fifty
O	325	333	patients
O	334	335	(
B-Characteristic	335	338	age
I-Characteristic	339	344	range
I-Characteristic	344	345	,
I-Characteristic	346	348	52
I-Characteristic	348	349	-
I-Characteristic	349	351	82
I-Characteristic	352	357	years
O	357	358	)
O	359	363	with
B-Characteristic	364	370	visual
I-Characteristic	371	377	acuity
I-Characteristic	378	384	better
I-Characteristic	385	389	than
I-Characteristic	390	392	20
I-Characteristic	392	393	/
I-Characteristic	393	395	30
O	396	399	and
O	400	404	with
O	405	406	a
O	407	412	range
O	413	415	of
B-Symptom	416	428	glaucomatous
I-Symptom	429	435	visual
I-Symptom	436	441	field
I-Symptom	442	443	(
I-Symptom	443	445	VF
I-Symptom	445	446	)
I-Symptom	447	454	defects
I-Symptom	455	457	in
I-Symptom	458	462	both
I-Symptom	463	467	eyes
O	467	468	,
O	469	478	excluding
O	479	484	those
O	485	489	with
O	490	494	very
O	495	503	advanced
O	504	511	disease
O	512	513	(
B-Symptom	513	527	perimetrically
I-Symptom	528	533	blind
O	533	534	)
O	534	535	.

O	536	548	Participants
O	549	558	underwent
B-Diagnostic_tool	559	568	monocular
I-Diagnostic_tool	569	571	VF
I-Diagnostic_tool	572	579	testing
O	580	582	in
B-Anatomy	583	587	both
I-Anatomy	588	592	eyes
O	593	598	using
O	599	600	a
B-Diagnostic_tool	601	609	Humphrey
I-Diagnostic_tool	610	615	Field
I-Diagnostic_tool	616	624	Analyzer
O	625	626	(
B-Diagnostic_tool	626	629	HFA
O	629	630	;
O	631	635	Carl
O	636	641	Zeiss
O	642	649	Meditec
O	649	650	,
O	651	657	Dublin
O	657	658	,
O	659	661	CA
O	661	662	;
O	663	665	24
O	665	666	-
O	666	667	2
O	668	675	Swedish
O	676	687	interactive
O	688	697	threshold
O	698	707	algorithm
O	708	716	standard
O	717	722	tests
O	722	723	)
O	724	727	and
O	728	733	other
O	734	739	tests
O	740	742	of
O	743	749	visual
O	750	758	function
O	758	759	.

O	760	772	Participants
O	773	777	took
O	778	782	part
O	783	785	in
O	786	787	a
O	788	796	recorded
O	797	806	interview
O	807	813	during
O	814	819	which
O	820	824	they
O	825	829	were
O	830	835	asked
O	836	838	if
O	839	843	they
O	844	848	were
O	849	854	aware
O	855	857	of
O	858	863	their
B-Symptom	864	866	VF
I-Symptom	867	871	loss
O	871	872	;
O	873	875	if
O	876	878	so
O	878	879	,
O	880	885	there
O	886	890	were
O	891	901	encouraged
O	902	904	to
O	905	913	describe
O	914	916	it
O	917	919	in
O	920	925	their
O	926	929	own
O	930	935	words
O	935	936	.

O	937	949	Participants
O	950	954	were
O	955	960	shown
O	961	962	6
O	963	969	images
O	970	978	modified
O	979	981	in
O	982	983	a
O	984	991	variety
O	992	994	of
O	995	999	ways
O	1000	1002	on
O	1003	1004	a
O	1005	1013	computer
O	1014	1021	monitor
O	1022	1025	and
O	1026	1030	were
O	1031	1036	asked
O	1037	1039	to
O	1040	1046	select
O	1047	1050	the
O	1051	1056	image
O	1057	1061	that
O	1062	1066	most
O	1067	1074	closely
O	1075	1086	represented
O	1087	1092	their
O	1093	1103	perception
O	1104	1106	of
O	1107	1112	their
B-Symptom	1113	1115	VF
I-Symptom	1116	1120	loss
O	1120	1121	.

O	1122	1128	Forced
O	1129	1135	choice
O	1136	1138	of
O	1139	1141	an
O	1142	1147	image
O	1148	1152	best
O	1153	1165	representing
B-Symptom	1166	1178	glaucomatous
I-Symptom	1179	1185	vision
I-Symptom	1186	1196	impairment
O	1196	1197	.

O	1198	1210	Participants
O	1211	1214	had
O	1215	1216	a
O	1217	1222	range
O	1223	1225	of
B-Symptom	1226	1228	VF
I-Symptom	1229	1235	defect
I-Symptom	1236	1244	severity
O	1244	1245	:
O	1246	1253	average
B-Diagnostic_tool	1254	1257	HFA
O	1258	1262	mean
O	1263	1272	deviation
O	1273	1276	was
O	1277	1278	-
O	1278	1279	8
O	1279	1280	.
O	1280	1281	7
O	1282	1284	dB
O	1285	1286	(
O	1286	1294	standard
O	1295	1304	deviation
O	1305	1306	[
O	1306	1308	SD
O	1308	1309	]
O	1309	1310	,
O	1311	1312	5
O	1312	1313	.
O	1313	1314	8
O	1316	1318	dB
O	1318	1319	)
O	1320	1323	and
O	1324	1325	-
O	1325	1327	10
O	1327	1328	.
O	1328	1329	5
O	1330	1332	dB
O	1333	1334	(
O	1334	1336	SD
O	1336	1337	,
O	1338	1339	7
O	1339	1340	.
O	1340	1341	1
O	1342	1344	dB
O	1344	1345	)
O	1346	1348	in
O	1349	1352	the
O	1353	1358	right
O	1359	1362	and
O	1363	1367	left
B-Anatomy	1368	1372	eyes
O	1372	1373	,
O	1374	1386	respectively
O	1386	1387	.

O	1388	1396	Thirteen
O	1397	1405	patients
O	1406	1407	(
O	1407	1409	26
O	1409	1410	%
O	1410	1411	;
O	1412	1414	95
O	1414	1415	%
O	1416	1426	confidence
O	1427	1435	interval
O	1436	1437	[
O	1437	1439	CI
O	1439	1440	]
O	1440	1441	,
O	1442	1444	15
O	1444	1445	%
O	1445	1446	-
O	1446	1448	40
O	1448	1449	%
O	1449	1450	)
O	1451	1459	reported
O	1460	1465	being
O	1466	1476	completely
O	1477	1484	unaware
O	1485	1487	of
O	1488	1493	their
B-Symptom	1494	1500	vision
I-Symptom	1501	1505	loss
O	1505	1506	.

O	1507	1511	None
O	1512	1514	of
O	1515	1518	the
O	1519	1527	patients
O	1528	1533	chose
O	1534	1537	the
O	1538	1544	images
O	1545	1549	with
O	1550	1551	a
O	1552	1560	distinct
B-Symptom	1561	1566	black
I-Symptom	1567	1573	tunnel
I-Symptom	1574	1580	effect
O	1581	1583	or
B-Symptom	1584	1589	black
I-Symptom	1590	1597	patches
O	1597	1598	.

O	1599	1603	Only
O	1604	1605	2
O	1606	1614	patients
O	1615	1616	(
O	1616	1617	4
O	1617	1618	%
O	1618	1619	;
O	1620	1622	95
O	1622	1623	%
O	1624	1626	CI
O	1626	1627	,
O	1628	1629	0
O	1629	1630	%
O	1630	1631	-
O	1631	1633	14
O	1633	1634	%
O	1634	1635	)
O	1636	1641	chose
O	1642	1645	the
O	1646	1651	image
O	1652	1656	with
O	1657	1658	a
O	1659	1665	tunnel
O	1666	1672	effect
O	1673	1677	with
O	1678	1685	blurred
O	1686	1691	edges
O	1691	1692	.

O	1693	1695	An
O	1696	1701	image
O	1702	1711	depicting
O	1712	1719	blurred
O	1720	1727	patches
O	1728	1731	and
O	1732	1739	another
O	1740	1744	with
O	1745	1752	missing
O	1753	1760	patches
O	1761	1764	was
O	1765	1771	chosen
O	1772	1774	by
O	1775	1777	54
O	1777	1778	%
O	1779	1780	(
O	1780	1782	95
O	1782	1783	%
O	1784	1786	CI
O	1786	1787	,
O	1788	1790	39
O	1790	1791	%
O	1791	1792	-
O	1792	1794	68
O	1794	1795	%
O	1795	1796	)
O	1797	1800	and
O	1801	1803	16
O	1803	1804	%
O	1805	1806	(
O	1806	1808	95
O	1808	1809	%
O	1810	1812	CI
O	1812	1813	,
O	1814	1815	7
O	1815	1816	%
O	1816	1817	-
O	1817	1819	29
O	1819	1820	%
O	1820	1821	)
O	1822	1824	of
O	1825	1828	the
O	1829	1837	patients
O	1837	1838	,
O	1839	1851	respectively
O	1851	1852	.

O	1853	1860	Content
O	1861	1869	analysis
O	1870	1872	of
O	1873	1876	the
O	1877	1888	transcripts
O	1889	1893	from
O	1894	1897	the
O	1898	1906	recorded
O	1907	1917	interviews
O	1918	1927	indicated
O	1928	1929	a
O	1930	1938	frequent
O	1939	1942	use
O	1943	1945	of
O	1946	1957	descriptors
O	1958	1960	of
O	1961	1967	visual
O	1968	1976	symptoms
O	1977	1987	associated
O	1988	1992	with
O	1993	2001	reported
O	2002	2006	blur
O	2007	2010	and
O	2011	2018	missing
O	2019	2027	features
O	2027	2028	.

O	2029	2037	Patients
O	2038	2042	with
B-Disease	2043	2051	glaucoma
O	2052	2054	do
O	2055	2058	not
O	2059	2067	perceive
O	2068	2073	their
B-Symptom	2074	2080	vision
I-Symptom	2081	2085	loss
O	2086	2088	as
O	2089	2090	a
B-Symptom	2091	2096	black
I-Symptom	2097	2103	tunnel
I-Symptom	2104	2110	effect
O	2111	2113	or
O	2114	2116	as
B-Symptom	2117	2122	black
I-Symptom	2123	2130	patches
O	2131	2138	masking
O	2139	2144	their
O	2145	2150	field
O	2151	2153	of
O	2154	2158	view
O	2158	2159	.

O	2160	2165	These
O	2166	2174	findings
O	2175	2178	are
O	2179	2188	important
O	2189	2191	in
O	2192	2195	the
O	2196	2203	context
O	2204	2206	of
O	2207	2216	depicting
O	2217	2220	the
O	2221	2228	effects
O	2229	2231	of
B-Symptom	2232	2244	glaucomatous
I-Symptom	2245	2251	vision
I-Symptom	2252	2256	loss
O	2257	2260	and
O	2261	2268	raising
O	2269	2278	awareness
O	2279	2282	for
B-Disease	2283	2291	glaucoma
O	2292	2301	detection
O	2301	2302	.

O	2303	2306	The
O	2307	2313	author
O	2313	2314	(
O	2314	2315	s
O	2315	2316	)
O	2317	2321	have
O	2322	2324	no
O	2325	2336	proprietary
O	2337	2339	or
O	2340	2350	commercial
O	2351	2359	interest
O	2360	2362	in
O	2363	2366	any
O	2367	2376	materials
O	2377	2386	discussed
O	2387	2389	in
O	2390	2394	this
O	2395	2402	article
O	2402	2403	.

B-Anatomy	0	8	Anterior
I-Anatomy	9	16	chamber
I-Anatomy	17	22	angle
O	23	30	imaging
O	31	35	with
B-Diagnostic_tool	36	41	swept
I-Diagnostic_tool	41	42	-
I-Diagnostic_tool	42	48	source
I-Diagnostic_tool	49	56	optical
I-Diagnostic_tool	57	66	coherence
I-Diagnostic_tool	67	77	tomography
O	77	78	:
O	79	88	measuring
B-Symptom	89	99	peripheral
I-Symptom	100	108	anterior
I-Symptom	109	117	synechia
O	118	120	in
B-Disease	121	129	glaucoma
O	129	130	.

O	132	134	To
O	135	146	investigate
O	147	150	the
O	151	154	use
O	155	157	of
B-Diagnostic_tool	158	163	swept
I-Diagnostic_tool	163	164	-
I-Diagnostic_tool	164	170	source
I-Diagnostic_tool	171	178	optical
I-Diagnostic_tool	179	188	coherence
I-Diagnostic_tool	189	199	tomography
O	200	201	(
B-Diagnostic_tool	201	204	OCT
O	204	205	)
O	206	209	for
O	210	219	measuring
O	220	223	the
O	224	228	area
O	229	232	and
O	233	239	degree
O	240	242	of
B-Symptom	243	253	peripheral
I-Symptom	254	262	anterior
I-Symptom	263	271	synechia
O	272	273	(
B-Symptom	273	276	PAS
O	276	277	)
O	278	289	involvement
O	290	292	in
O	293	301	patients
O	302	306	with
B-Disease	307	312	angle
I-Disease	312	313	-
I-Disease	313	320	closure
I-Disease	321	329	glaucoma
O	329	330	.

O	331	336	Cross
O	336	337	-
O	337	346	sectional
O	347	352	study
O	352	353	.

O	354	360	Twenty
O	360	361	-
O	361	366	three
B-Anatomy	367	371	eyes
O	372	376	with
B-Symptom	377	380	PAS
O	381	382	(
O	382	390	detected
O	391	393	by
B-Diagnostic_tool	394	405	indentation
I-Diagnostic_tool	406	416	gonioscopy
O	416	417	)
O	418	422	from
O	423	425	20
O	426	434	patients
O	435	439	with
B-Disease	440	445	angle
I-Disease	445	446	-
I-Disease	446	453	closure
I-Disease	454	462	glaucoma
O	463	464	(
O	464	466	20
B-Anatomy	467	471	eyes
O	472	475	had
B-Disease	476	483	primary
I-Disease	484	489	angle
I-Disease	489	490	-
I-Disease	490	497	closure
I-Disease	498	506	glaucoma
O	507	510	and
O	511	512	3
B-Anatomy	513	517	eyes
O	518	521	had
B-Disease	522	527	angle
I-Disease	527	528	-
I-Disease	528	535	closure
I-Disease	536	544	glaucoma
O	545	554	secondary
O	555	557	to
B-Disease	558	565	chronic
I-Disease	566	574	anterior
I-Disease	575	582	uveitis
O	583	584	[
O	584	585	n
O	586	587	=
O	588	589	2
O	589	590	]
O	591	594	and
B-Disease	595	603	Axenfeld
I-Disease	603	604	-
I-Disease	604	610	Rieger
I-Disease	611	619	syndrome
O	620	621	[
O	621	622	n
O	623	624	=
O	625	626	1
O	626	627	]
O	628	629	)
O	629	630	.

O	631	634	The
B-Anatomy	635	643	anterior
I-Anatomy	644	651	chamber
I-Anatomy	652	658	angles
O	659	663	were
O	664	673	evaluated
O	674	678	with
B-Diagnostic_tool	679	690	indentation
I-Diagnostic_tool	691	701	gonioscopy
O	702	705	and
O	706	712	imaged
O	713	715	by
B-Diagnostic_tool	716	721	swept
I-Diagnostic_tool	721	722	-
I-Diagnostic_tool	722	728	source
I-Diagnostic_tool	729	732	OCT
O	733	734	(
B-Diagnostic_tool	734	739	Casia
I-Diagnostic_tool	740	743	OCT
O	743	744	,
O	745	750	Tomey
O	750	751	,
O	752	758	Nagoya
O	758	759	,
O	760	765	Japan
O	765	766	)
O	767	769	in
O	770	774	room
O	775	780	light
O	781	784	and
O	785	787	in
O	788	791	the
O	792	796	dark
O	797	802	using
O	803	806	the
O	808	809	"
O	810	815	angle
O	816	824	analysis
O	825	826	"
O	828	836	protocol
O	836	837	,
O	838	843	which
O	844	847	was
O	848	856	composed
O	857	859	of
O	860	863	128
O	864	870	radial
O	871	872	B
O	872	873	-
O	873	878	scans
O	879	883	each
O	884	888	with
O	889	892	512
O	893	894	A
O	894	895	-
O	895	900	scans
O	901	902	(
O	902	904	16
O	904	905	-
O	905	907	mm
O	908	912	scan
O	913	919	length
O	919	920	)
O	920	921	.

O	922	925	The
O	926	930	area
O	931	934	and
O	935	941	degree
O	942	944	of
B-Symptom	945	948	PAS
O	949	960	involvement
O	961	965	were
O	966	974	measured
O	975	977	in
O	978	982	each
B-Anatomy	983	986	eye
O	987	992	after
O	993	999	manual
O	1000	1009	detection
O	1010	1012	of
O	1013	1016	the
B-Anatomy	1017	1024	scleral
I-Anatomy	1025	1029	spur
O	1030	1033	and
O	1034	1037	the
B-Anatomy	1038	1046	anterior
I-Anatomy	1047	1052	irido
I-Anatomy	1052	1053	-
I-Anatomy	1053	1058	angle
O	1059	1067	adhesion
O	1068	1070	by
O	1071	1072	2
O	1073	1079	masked
O	1080	1089	observers
O	1089	1090	.

O	1091	1094	The
O	1095	1108	interobserver
O	1109	1120	variability
O	1121	1123	of
O	1124	1127	the
B-Symptom	1128	1131	PAS
O	1132	1144	measurements
O	1145	1148	was
O	1149	1159	calculated
O	1159	1160	.

O	1161	1164	The
O	1165	1174	agreement
O	1175	1177	of
B-Symptom	1178	1181	PAS
O	1182	1192	assessment
O	1193	1195	by
B-Diagnostic_tool	1196	1206	gonioscopy
O	1207	1210	and
B-Diagnostic_tool	1211	1214	OCT
O	1214	1215	,
O	1216	1219	the
O	1220	1224	area
O	1225	1228	and
O	1229	1232	the
O	1233	1239	degree
O	1240	1242	of
B-Symptom	1243	1246	PAS
O	1247	1258	involvement
O	1258	1259	,
O	1260	1263	and
O	1264	1267	the
O	1268	1278	intraclass
O	1279	1290	correlation
O	1291	1302	coefficient
O	1303	1304	(
O	1304	1307	ICC
O	1307	1308	)
O	1309	1311	of
O	1312	1325	interobserver
B-Symptom	1326	1329	PAS
O	1330	1342	measurements
O	1342	1343	.

O	1344	1347	The
O	1348	1352	area
O	1353	1355	of
B-Symptom	1356	1359	PAS
O	1360	1361	(
O	1361	1365	mean
O	1366	1367	
O	1368	1376	standard
O	1377	1386	deviation
O	1386	1387	)
O	1388	1391	was
O	1392	1394	20
O	1394	1395	.
O	1395	1396	8
O	1397	1398	
O	1399	1401	16
O	1401	1402	.
O	1402	1403	9
O	1404	1406	mm
O	1406	1407	(
O	1407	1408	2
O	1408	1409	)
O	1410	1411	(
O	1411	1416	range
O	1416	1417	,
O	1418	1419	3
O	1419	1420	.
O	1420	1421	9
O	1421	1422	-
O	1422	1424	74
O	1424	1425	.
O	1425	1426	9
O	1427	1429	mm
O	1429	1430	(
O	1430	1431	2
O	1431	1432	)
O	1432	1433	)
O	1433	1434	,
O	1435	1438	and
O	1439	1442	the
O	1443	1449	degree
O	1450	1452	of
B-Symptom	1453	1456	PAS
O	1457	1468	involvement
O	1469	1472	was
O	1473	1476	186
O	1476	1477	.
O	1477	1478	5
O	1479	1480	
O	1481	1483	79
O	1483	1484	.
O	1484	1485	9
O	1486	1493	degrees
O	1494	1495	(
O	1495	1500	range
O	1500	1501	,
O	1502	1504	42
O	1504	1505	-
O	1505	1508	314
O	1509	1516	degrees
O	1516	1517	)
O	1517	1518	.

O	1519	1524	There
O	1525	1528	was
O	1529	1531	no
O	1532	1542	difference
O	1543	1545	in
O	1546	1549	the
O	1550	1554	area
O	1555	1557	of
B-Symptom	1558	1561	PAS
O	1562	1563	(
O	1563	1564	P
O	1565	1566	=
O	1567	1568	0
O	1568	1569	.
O	1569	1571	90
O	1571	1572	)
O	1573	1576	and
O	1577	1580	the
O	1581	1587	degree
O	1588	1590	of
B-Symptom	1591	1594	PAS
O	1595	1606	involvement
O	1607	1608	(
O	1608	1609	P
O	1610	1611	=
O	1612	1613	0
O	1613	1614	.
O	1614	1616	95
O	1616	1617	)
O	1618	1625	between
O	1626	1632	images
O	1633	1641	obtained
O	1642	1644	in
O	1645	1649	room
O	1650	1655	light
O	1656	1659	and
O	1660	1662	in
O	1663	1666	the
O	1667	1671	dark
O	1671	1672	.

O	1673	1676	The
O	1677	1690	interobserver
O	1691	1695	ICCs
O	1696	1700	were
O	1701	1702	0
O	1702	1703	.
O	1703	1705	99
O	1706	1707	(
O	1707	1709	95
O	1709	1710	%
O	1711	1721	confidence
O	1722	1730	interval
O	1731	1732	[
O	1732	1734	CI
O	1734	1735	]
O	1735	1736	,
O	1737	1738	0
O	1738	1739	.
O	1739	1741	98
O	1741	1742	-
O	1742	1743	1
O	1743	1744	.
O	1744	1746	00
O	1746	1747	)
O	1748	1751	for
O	1752	1755	the
O	1756	1760	area
O	1761	1763	of
B-Symptom	1764	1767	PAS
O	1768	1771	and
O	1772	1773	0
O	1773	1774	.
O	1774	1776	99
O	1777	1778	(
O	1778	1780	95
O	1780	1781	%
O	1782	1784	CI
O	1784	1785	,
O	1786	1787	0
O	1787	1788	.
O	1788	1790	97
O	1790	1791	-
O	1791	1792	1
O	1792	1793	.
O	1793	1795	00
O	1795	1796	)
O	1797	1800	for
O	1801	1804	the
O	1805	1811	degree
O	1812	1814	of
B-Symptom	1815	1818	PAS
O	1819	1830	involvement
O	1830	1831	.

O	1832	1837	There
O	1838	1841	was
O	1842	1846	good
O	1847	1856	agreement
O	1857	1859	of
B-Symptom	1860	1863	PAS
O	1864	1874	assessment
O	1875	1882	between
B-Diagnostic_tool	1883	1893	gonioscopy
O	1894	1897	and
B-Diagnostic_tool	1898	1901	OCT
O	1902	1908	images
O	1909	1910	(
O	1910	1915	kappa
O	1916	1917	=
O	1918	1919	0
O	1919	1920	.
O	1920	1922	79
O	1922	1923	;
O	1924	1926	95
O	1926	1927	%
O	1928	1930	CI
O	1930	1931	,
O	1932	1933	0
O	1933	1934	.
O	1934	1936	67
O	1936	1937	-
O	1937	1938	0
O	1938	1939	.
O	1939	1941	91
O	1941	1942	)
O	1942	1943	.

B-Diagnostic_tool	1944	1949	Swept
I-Diagnostic_tool	1949	1950	-
I-Diagnostic_tool	1950	1956	source
I-Diagnostic_tool	1957	1960	OCT
O	1961	1967	allows
O	1968	1981	visualization
O	1982	1985	and
O	1986	1998	reproducible
O	1999	2011	measurements
O	2012	2014	of
O	2015	2018	the
O	2019	2023	area
O	2024	2027	and
O	2028	2034	degree
O	2035	2037	of
B-Symptom	2038	2041	PAS
O	2042	2053	involvement
O	2053	2054	,
O	2055	2064	providing
O	2065	2066	a
O	2067	2070	new
O	2071	2079	paradigm
O	2080	2083	for
O	2084	2094	evaluation
O	2095	2097	of
B-Symptom	2098	2101	PAS
O	2102	2113	progression
O	2114	2117	and
O	2118	2122	risk
O	2123	2133	assessment
O	2134	2137	for
O	2138	2149	development
O	2150	2152	of
B-Disease	2153	2158	angle
I-Disease	2158	2159	-
I-Disease	2159	2166	closure
I-Disease	2167	2175	glaucoma
O	2175	2176	.

O	2177	2180	The
O	2181	2187	author
O	2187	2188	(
O	2188	2189	s
O	2189	2190	)
O	2191	2195	have
O	2196	2198	no
O	2199	2210	proprietary
O	2211	2213	or
O	2214	2224	commercial
O	2225	2233	interest
O	2234	2236	in
O	2237	2240	any
O	2241	2250	materials
O	2251	2260	discussed
O	2261	2263	in
O	2264	2268	this
O	2269	2276	article
O	2276	2277	.

O	0	9	Screening
O	10	13	for
B-Disease	14	22	diabetic
I-Disease	23	34	retinopathy
O	35	39	with
O	40	42	or
O	43	50	without
O	51	52	a
O	53	62	copayment
O	63	65	in
O	66	67	a
O	68	78	randomized
O	79	89	controlled
O	90	95	trial
O	95	96	:
O	97	106	influence
O	107	109	of
O	110	113	the
O	114	121	inverse
O	122	126	care
O	127	130	law
O	130	131	.

O	133	135	To
O	136	143	examine
O	144	151	whether
O	152	155	the
O	156	163	inverse
O	164	168	care
O	169	172	law
O	173	181	operates
O	182	184	in
O	185	186	a
O	187	196	screening
O	197	204	program
O	205	208	for
B-Disease	209	217	diabetic
I-Disease	218	229	retinopathy
O	230	231	(
B-Disease	231	233	DR
O	233	234	)
O	235	240	based
O	241	243	on
O	244	247	fee
O	248	251	for
O	252	259	service
O	260	262	in
B-Characteristic	263	267	Hong
I-Characteristic	268	272	Kong
O	272	273	.

O	274	284	Randomized
O	285	295	controlled
O	296	301	trial
O	301	302	.

O	303	306	All
O	307	312	those
O	313	317	with
B-Disease	318	322	type
I-Disease	323	324	1
I-Disease	325	327	or
I-Disease	328	329	2
I-Disease	330	338	diabetes
O	339	343	from
O	344	345	2
O	346	353	clinics
O	354	358	were
O	359	368	recruited
O	368	369	.

B-Disease	370	378	Diabetic
I-Disease	379	390	retinopathy
O	391	400	screening
O	401	405	with
O	406	407	a
O	408	413	small
O	414	423	copayment
O	424	430	versus
O	431	435	free
O	436	442	access
O	443	445	in
O	446	447	a
O	448	456	publicly
O	457	463	funded
O	464	470	family
O	471	479	medicine
O	480	487	service
O	487	488	.

O	489	495	Uptake
O	496	498	of
O	499	508	screening
O	509	512	and
O	513	521	severity
O	522	524	of
B-Disease	525	527	DR
O	528	536	detected
O	536	537	.

O	538	549	Association
O	550	557	between
O	558	563	these
O	564	571	outcome
O	572	581	variables
O	582	585	and
O	586	597	independent
O	598	607	variables
O	608	612	were
O	613	623	determined
O	624	629	using
O	630	642	multivariate
O	643	651	logistic
O	652	662	regression
O	663	669	models
O	670	673	and
O	674	682	reported
O	683	685	as
O	686	690	odds
O	691	697	ratios
O	698	699	(
O	699	702	ORs
O	702	703	)
O	703	704	.

O	705	710	After
O	711	724	randomization
O	724	725	,
O	726	730	1387
O	731	739	subjects
O	740	742	in
O	743	746	the
O	747	751	free
O	752	757	group
O	758	761	and
O	762	766	1379
O	767	775	subjects
O	776	778	in
O	779	782	the
O	783	786	pay
O	787	792	group
O	793	797	were
O	798	806	eligible
O	807	810	for
O	811	820	screening
O	820	821	,
O	822	825	and
O	826	828	94
O	828	829	.
O	829	830	9
O	830	831	%
O	832	833	(
O	833	837	1316
O	837	838	/
O	838	842	1387
O	842	843	)
O	844	847	and
O	848	850	92
O	850	851	.
O	851	852	6
O	852	853	%
O	854	855	(
O	855	859	1277
O	859	860	/
O	860	864	1379
O	864	865	)
O	865	866	,
O	867	879	respectively
O	879	880	,
O	881	887	agreed
O	888	890	to
O	891	902	participate
O	903	905	in
O	906	909	the
O	910	915	study
O	915	916	.

O	917	920	The
O	921	926	offer
O	927	929	of
O	930	939	screening
O	940	943	was
O	944	952	accepted
O	953	955	by
O	956	958	94
O	958	959	.
O	959	960	8
O	960	961	%
O	962	963	(
O	963	967	1247
O	967	968	/
O	968	972	1316
O	972	973	)
O	974	976	in
O	977	980	the
O	981	985	free
O	986	991	group
O	992	995	and
O	996	998	91
O	998	999	.
O	999	1000	2
O	1000	1001	%
O	1002	1003	(
O	1003	1007	1164
O	1007	1008	/
O	1008	1012	1277
O	1012	1013	)
O	1014	1016	in
O	1017	1020	the
O	1021	1024	pay
O	1025	1030	group
O	1030	1031	,
O	1032	1035	and
O	1036	1039	the
O	1040	1045	final
O	1046	1052	uptake
O	1053	1059	ratios
O	1060	1064	were
O	1065	1067	88
O	1067	1068	.
O	1068	1069	5
O	1069	1070	%
O	1071	1072	(
O	1072	1076	1165
O	1076	1077	/
O	1077	1081	1316
O	1081	1082	)
O	1083	1086	and
O	1087	1089	82
O	1089	1090	.
O	1090	1091	4
O	1091	1092	%
O	1093	1094	(
O	1094	1098	1052
O	1098	1099	/
O	1099	1103	1277
O	1103	1104	)
O	1104	1105	,
O	1106	1118	respectively
O	1119	1120	(
O	1120	1127	Pearson
O	1128	1131	chi
O	1132	1133	=
O	1134	1136	19
O	1136	1137	.
O	1137	1139	74
O	1139	1140	,
O	1141	1142	P
O	1143	1144	<
O	1145	1146	0
O	1146	1147	.
O	1147	1150	001
O	1150	1151	)
O	1151	1152	.

O	1153	1158	Being
O	1159	1161	in
O	1162	1165	the
O	1166	1169	pay
O	1170	1175	group
O	1176	1179	was
O	1180	1190	associated
O	1191	1195	with
O	1196	1197	a
O	1198	1203	lower
O	1204	1210	uptake
O	1211	1213	of
O	1214	1223	screening
O	1224	1228	than
O	1229	1234	being
O	1235	1237	in
O	1238	1241	the
O	1242	1246	free
O	1247	1252	group
O	1253	1254	(
O	1254	1256	OR
O	1256	1257	,
O	1258	1259	0
O	1259	1260	.
O	1260	1262	59
O	1262	1263	;
O	1264	1274	confidence
O	1275	1283	interval
O	1284	1285	[
O	1285	1287	CI
O	1287	1288	]
O	1288	1289	,
O	1290	1291	0
O	1291	1292	.
O	1292	1294	47
O	1294	1295	-
O	1295	1296	0
O	1296	1297	.
O	1297	1299	74
O	1299	1300	)
O	1301	1304	and
O	1305	1306	a
O	1307	1312	lower
O	1313	1322	detection
O	1323	1327	rate
O	1328	1330	of
B-Disease	1331	1333	DR
O	1334	1335	(
O	1335	1337	OR
O	1337	1338	,
O	1339	1340	0
O	1340	1341	.
O	1341	1343	73
O	1343	1344	;
O	1345	1347	CI
O	1347	1348	,
O	1349	1350	0
O	1350	1351	.
O	1351	1353	60
O	1353	1354	-
O	1354	1355	0
O	1355	1356	.
O	1356	1358	90
O	1358	1359	)
O	1360	1365	after
O	1366	1376	adjustment
O	1377	1380	for
O	1381	1390	potential
O	1391	1402	confounding
O	1403	1410	factors
O	1410	1411	.

O	1412	1420	Subjects
O	1421	1425	with
B-Characteristic	1426	1432	higher
I-Characteristic	1433	1446	socioeconomic
I-Characteristic	1447	1453	status
O	1454	1458	were
O	1459	1463	more
O	1464	1470	likely
O	1471	1473	to
O	1474	1480	attend
O	1481	1490	screening
O	1491	1494	and
O	1495	1498	had
O	1499	1500	a
O	1501	1506	lower
O	1507	1517	prevalence
O	1518	1520	of
B-Disease	1521	1523	DR
O	1524	1532	detected
O	1532	1533	.

O	1534	1537	The
O	1538	1545	inverse
O	1546	1550	care
O	1551	1554	law
O	1555	1560	seems
O	1561	1563	to
O	1564	1571	operate
O	1572	1574	in
O	1575	1576	a
O	1577	1587	preventive
O	1588	1600	intervention
O	1601	1605	when
O	1606	1607	a
O	1608	1618	relatively
O	1619	1624	small
O	1625	1634	copayment
O	1635	1637	is
O	1638	1645	applied
O	1645	1646	.

O	1647	1652	There
O	1653	1655	is
O	1656	1657	a
O	1658	1662	case
O	1663	1666	for
O	1667	1673	making
O	1674	1683	effective
O	1684	1694	preventive
O	1695	1703	services
O	1704	1708	free
O	1709	1711	of
O	1712	1718	charge
O	1718	1719	.

O	1720	1723	The
O	1724	1730	author
O	1730	1731	(
O	1731	1732	s
O	1732	1733	)
O	1734	1738	have
O	1739	1741	no
O	1742	1753	proprietary
O	1754	1756	or
O	1757	1767	commercial
O	1768	1776	interest
O	1777	1779	in
O	1780	1783	any
O	1784	1793	materials
O	1794	1803	discussed
O	1804	1806	in
O	1807	1811	this
O	1812	1819	article
O	1819	1820	.

O	0	11	Subclinical
B-Anatomy	12	19	macular
O	20	28	findings
O	29	31	in
B-Characteristic	32	39	infants
O	40	48	screened
O	49	52	for
B-Disease	53	64	retinopathy
I-Disease	65	67	of
I-Disease	68	79	prematurity
O	80	84	with
B-Diagnostic_tool	85	93	spectral
I-Diagnostic_tool	93	94	-
I-Diagnostic_tool	94	100	domain
I-Diagnostic_tool	101	108	optical
I-Diagnostic_tool	109	118	coherence
I-Diagnostic_tool	119	129	tomography
O	129	130	.

O	132	134	To
O	135	143	evaluate
O	144	155	subclinical
O	156	163	macular
O	164	172	findings
O	173	175	in
B-Characteristic	176	185	premature
I-Characteristic	186	194	patients
O	195	197	at
O	198	202	risk
O	203	205	of
B-Disease	206	217	retinopathy
I-Disease	218	220	of
I-Disease	221	232	prematurity
O	233	234	(
B-Disease	234	237	ROP
O	237	238	)
O	239	243	with
O	244	247	the
O	248	251	use
O	252	254	of
O	255	263	handheld
B-Diagnostic_tool	264	272	spectral
I-Diagnostic_tool	272	273	-
I-Diagnostic_tool	273	279	domain
I-Diagnostic_tool	280	287	optical
I-Diagnostic_tool	288	297	coherence
I-Diagnostic_tool	298	308	tomography
O	309	310	(
B-Diagnostic_tool	310	312	SD
I-Diagnostic_tool	312	313	-
I-Diagnostic_tool	313	316	OCT
O	316	317	)
O	317	318	.

O	319	330	Prospective
O	330	331	,
O	332	345	observational
O	346	350	case
O	351	357	series
O	357	358	.

O	359	364	Forty
O	364	365	-
O	365	369	nine
B-Characteristic	370	381	prematurely
I-Characteristic	382	386	born
I-Characteristic	387	395	neonates
O	395	396	.

O	397	402	Forty
O	402	403	-
O	403	407	nine
B-Characteristic	408	415	infants
O	416	420	were
O	421	427	imaged
O	428	433	using
O	434	435	a
O	436	444	handheld
B-Diagnostic_tool	445	447	SD
I-Diagnostic_tool	447	448	-
I-Diagnostic_tool	448	451	OCT
O	451	452	.

O	453	459	Images
O	460	464	were
O	465	473	acquired
O	474	476	in
B-Characteristic	477	487	nonsedated
I-Characteristic	488	495	infants
O	496	498	in
O	499	502	the
O	503	511	neonatal
O	512	521	intensive
O	522	526	care
O	527	531	unit
O	532	533	(
O	533	537	NICU
O	537	538	)
O	538	539	.

O	540	544	Some
O	545	553	patients
O	554	558	were
O	559	567	followed
O	568	571	and
O	572	580	reimaged
O	581	585	over
O	586	589	the
O	590	596	course
O	597	599	of
O	600	607	several
O	608	613	weeks
O	613	614	.

O	615	616	A
O	617	622	total
O	623	625	of
O	626	629	300
O	630	635	total
O	636	642	images
O	643	647	were
O	648	656	acquired
O	657	660	and
O	661	670	evaluated
O	671	674	for
B-Disease	675	682	cystoid
I-Disease	683	690	macular
I-Disease	691	696	edema
O	697	698	(
B-Disease	698	701	CME
O	701	702	)
O	703	706	and
O	707	718	persistence
O	719	721	of
B-Symptom	722	727	inner
I-Symptom	728	735	retinal
I-Symptom	736	742	layers
O	742	743	.

O	744	746	In
O	747	751	vivo
O	752	765	determination
O	766	768	of
B-Anatomy	769	775	foveal
I-Anatomy	776	783	retinal
O	784	794	lamination
O	794	795	,
O	796	801	image
O	802	810	analysis
O	810	811	,
O	812	815	and
O	816	824	clinical
O	825	836	observation
O	836	837	.

O	838	839	A
O	840	845	total
O	846	848	of
O	849	852	241
O	853	854	(
O	854	856	80
O	856	857	%
O	857	858	)
O	859	861	of
O	862	865	the
O	866	872	images
O	873	877	from
O	878	880	46
O	881	889	patients
O	890	894	were
O	895	901	usable
O	902	903	(
O	903	910	defined
O	911	913	as
O	914	920	having
O	921	926	scans
O	927	934	passing
O	935	942	through
O	943	946	the
B-Anatomy	947	952	fovea
O	953	957	with
O	958	965	clearly
O	966	978	identifiable
B-Anatomy	979	986	retinal
I-Anatomy	987	993	layers
O	993	994	)
O	994	995	.

B-Symptom	996	1007	Persistence
I-Symptom	1008	1010	of
I-Symptom	1011	1012	1
I-Symptom	1013	1015	or
I-Symptom	1016	1020	more
I-Symptom	1021	1026	inner
I-Symptom	1027	1034	retinal
I-Symptom	1035	1041	layers
O	1042	1045	was
O	1046	1050	seen
O	1051	1053	in
O	1054	1056	43
O	1057	1059	of
O	1060	1063	the
O	1064	1072	patients
O	1073	1077	with
O	1078	1084	usable
O	1085	1091	images
O	1092	1093	(
O	1093	1095	93
O	1095	1096	%
O	1096	1097	)
O	1097	1098	.

O	1099	1101	Of
O	1102	1105	the
O	1106	1114	patients
O	1115	1119	with
O	1120	1122	at
O	1123	1128	least
O	1129	1130	1
B-Symptom	1131	1141	persistent
I-Symptom	1142	1147	layer
O	1147	1148	,
O	1149	1151	17
O	1151	1152	,
O	1153	1154	4
O	1154	1155	,
O	1156	1157	8
O	1157	1158	,
O	1159	1161	12
O	1161	1162	,
O	1163	1166	and
O	1167	1168	1
O	1168	1169	,
O	1170	1173	had
O	1174	1175	a
O	1176	1183	maximum
B-Characteristic	1184	1187	ROP
I-Characteristic	1188	1193	stage
O	1194	1196	of
O	1197	1198	0
O	1198	1199	,
O	1200	1201	1
O	1201	1202	,
O	1203	1204	2
O	1204	1205	,
O	1206	1207	3
O	1207	1208	,
O	1209	1212	and
O	1213	1215	4A
O	1215	1216	,
O	1217	1229	respectively
O	1229	1230	.

B-Disease	1231	1238	Cystoid
I-Disease	1239	1246	macular
I-Disease	1247	1252	edema
O	1253	1256	was
O	1257	1261	seen
O	1262	1264	in
O	1265	1267	25
O	1268	1270	of
O	1271	1274	the
O	1275	1277	46
O	1278	1286	patients
O	1287	1288	(
O	1288	1290	54
O	1290	1291	%
O	1291	1292	)
O	1293	1299	during
O	1300	1301	1
O	1302	1304	or
O	1305	1309	more
O	1310	1317	imaging
O	1318	1326	sessions
O	1326	1327	.

B-Disease	1328	1335	Cystoid
I-Disease	1336	1343	macular
I-Disease	1344	1349	edema
O	1350	1353	was
O	1354	1361	present
O	1362	1364	in
O	1365	1366	9
O	1366	1367	,
O	1368	1369	1
O	1369	1370	,
O	1371	1372	5
O	1372	1373	,
O	1374	1375	9
O	1375	1376	,
O	1377	1380	and
O	1381	1382	1
O	1383	1390	patient
O	1391	1395	with
O	1396	1403	maximum
B-Characteristic	1404	1407	ROP
I-Characteristic	1408	1413	stage
O	1414	1416	of
O	1417	1418	0
O	1418	1419	,
O	1420	1421	1
O	1421	1422	,
O	1423	1424	2
O	1424	1425	,
O	1426	1427	3
O	1427	1428	,
O	1429	1432	and
O	1433	1435	4A
O	1435	1436	,
O	1437	1449	respectively
O	1449	1450	.

O	1451	1454	Our
O	1455	1459	data
O	1460	1467	suggest
O	1468	1473	there
O	1474	1476	is
B-Symptom	1477	1488	persistence
I-Symptom	1489	1491	of
I-Symptom	1492	1497	inner
I-Symptom	1498	1505	retinal
I-Symptom	1506	1512	layers
O	1513	1515	in
B-Characteristic	1516	1525	premature
I-Characteristic	1526	1533	infants
O	1534	1544	regardless
O	1545	1547	of
B-Characteristic	1548	1555	maximal
I-Characteristic	1556	1559	ROP
I-Characteristic	1560	1565	stage
O	1565	1566	.

O	1567	1578	Subclinical
B-Disease	1579	1582	CME
O	1583	1585	is
O	1586	1590	seen
O	1591	1593	in
B-Characteristic	1594	1603	premature
I-Characteristic	1604	1611	infants
O	1611	1612	;
O	1613	1620	however
O	1620	1621	,
B-Disease	1622	1625	CME
O	1626	1630	does
O	1631	1634	not
O	1635	1641	appear
O	1642	1644	to
O	1645	1647	be
O	1648	1658	correlated
O	1659	1663	with
B-Characteristic	1664	1667	ROP
I-Characteristic	1668	1673	stage
O	1673	1674	.

O	1675	1679	This
O	1680	1688	suggests
O	1689	1693	that
O	1694	1699	there
O	1700	1703	may
O	1704	1706	be
O	1707	1712	other
O	1713	1719	causes
O	1720	1723	for
O	1724	1727	the
B-Disease	1728	1731	CME
O	1732	1736	seen
O	1737	1739	in
O	1740	1744	this
O	1745	1752	patient
O	1753	1763	population
O	1763	1764	.

O	1765	1769	Hand
O	1769	1770	-
O	1770	1774	held
B-Diagnostic_tool	1775	1777	SD
I-Diagnostic_tool	1777	1778	-
I-Diagnostic_tool	1778	1781	OCT
I-Diagnostic_tool	1782	1789	imaging
O	1790	1792	is
O	1793	1794	a
O	1795	1801	viable
O	1802	1811	technique
O	1812	1815	for
O	1816	1826	evaluating
B-Symptom	1827	1838	subclinical
I-Symptom	1839	1846	macular
I-Symptom	1847	1855	findings
O	1856	1858	in
B-Characteristic	1859	1868	premature
I-Characteristic	1869	1876	infants
O	1876	1877	,
O	1878	1886	although
O	1887	1893	larger
O	1894	1902	datasets
O	1903	1906	are
O	1907	1913	needed
O	1914	1918	from
O	1919	1927	multiple
O	1928	1935	centers
O	1936	1938	to
O	1939	1946	further
O	1947	1955	evaluate
O	1956	1959	the
O	1960	1976	generalizability
O	1977	1979	of
O	1980	1985	these
O	1986	1994	findings
O	1994	1995	.

O	1996	1999	The
O	2000	2006	author
O	2006	2007	(
O	2007	2008	s
O	2008	2009	)
O	2010	2014	have
O	2015	2017	no
O	2018	2029	proprietary
O	2030	2032	or
O	2033	2043	commercial
O	2044	2052	interest
O	2053	2055	in
O	2056	2059	any
O	2060	2069	materials
O	2070	2079	discussed
O	2080	2082	in
O	2083	2087	this
O	2088	2095	article
O	2095	2096	.

O	0	10	Evaluation
O	11	13	of
B-Disease	14	20	ocular
I-Disease	21	28	surface
I-Disease	29	36	disease
O	37	39	in
O	40	48	patients
O	49	53	with
B-Disease	54	62	glaucoma
O	62	63	.

O	65	67	To
O	68	76	evaluate
O	77	80	the
O	81	91	subjective
O	92	95	and
O	96	105	objective
O	106	114	measures
O	115	117	of
B-Disease	118	124	ocular
I-Disease	125	132	surface
I-Disease	133	140	disease
O	141	143	in
O	144	152	patients
O	153	157	with
B-Disease	158	166	glaucoma
O	166	167	.

O	168	173	Cross
O	173	174	-
O	174	183	sectional
O	184	189	study
O	189	190	.

O	191	196	Sixty
O	196	197	-
O	197	201	four
B-Disease	202	210	glaucoma
O	211	219	subjects
O	220	224	with
B-Symptom	225	234	bilateral
I-Symptom	235	241	visual
I-Symptom	242	247	field
I-Symptom	248	249	(
I-Symptom	249	251	VF
I-Symptom	251	252	)
I-Symptom	253	257	loss
O	258	261	and
O	262	264	59
B-Disease	265	273	glaucoma
I-Disease	274	282	suspects
O	283	287	with
B-Symptom	288	294	normal
I-Symptom	295	298	VFs
O	298	299	.

O	300	311	Consecutive
O	312	320	patients
O	321	325	were
O	326	335	recruited
O	336	349	prospectively
O	350	354	from
O	355	358	the
O	359	365	Wilmer
O	366	369	Eye
O	370	379	Institute
B-Disease	380	388	Glaucoma
O	389	395	Clinic
O	395	396	.

B-Characteristic	397	401	Tear
I-Characteristic	402	406	film
I-Characteristic	407	414	breakup
I-Characteristic	415	419	time
O	420	421	(
B-Characteristic	421	425	TBUT
O	425	426	)
O	426	427	,
B-Characteristic	428	435	corneal
I-Characteristic	436	444	staining
I-Characteristic	445	450	score
O	451	452	(
O	452	453	0
O	453	454	-
O	454	456	15
O	456	457	)
O	457	458	,
O	459	462	and
B-Characteristic	463	471	Schirmer
I-Characteristic	471	472	'
I-Characteristic	472	473	s
I-Characteristic	474	478	test
I-Characteristic	479	486	results
O	487	491	were
O	492	500	included
O	501	503	as
O	504	513	objective
O	514	521	metrics
O	521	522	,
O	523	530	whereas
O	531	534	the
B-Characteristic	535	541	Ocular
I-Characteristic	542	549	Surface
I-Characteristic	550	557	Disease
I-Characteristic	558	563	Index
O	564	565	(
B-Characteristic	565	569	OSDI
O	569	570	)
O	571	584	questionnaire
O	585	588	was
O	589	601	administered
O	602	604	to
O	605	611	assess
O	612	620	symptoms
O	620	621	.

B-Characteristic	622	627	Total
I-Characteristic	628	632	OSDI
I-Characteristic	633	638	score
O	638	639	,
B-Characteristic	640	646	vision
I-Characteristic	646	647	-
I-Characteristic	647	654	related
I-Characteristic	655	663	subscore
O	664	665	(
O	665	672	derived
O	673	677	from
O	678	687	questions
O	688	693	about
O	694	700	vision
O	701	704	and
O	705	709	task
O	710	721	performance
O	721	722	)
O	722	723	,
O	724	727	and
B-Characteristic	728	738	discomfort
I-Characteristic	738	739	-
I-Characteristic	739	746	related
I-Characteristic	747	755	subscore
O	756	757	(
O	757	764	derived
O	765	769	from
O	770	779	questions
O	780	785	about
O	786	792	ocular
O	793	800	surface
O	801	811	discomfort
O	811	812	)
O	813	817	were
O	818	828	calculated
O	829	832	for
O	833	837	each
O	838	845	subject
O	845	846	.

O	847	854	Seventy
O	854	855	-
O	855	859	five
O	860	867	percent
O	868	869	(
O	869	871	48
O	871	872	/
O	872	874	64
O	874	875	)
O	876	878	of
B-Disease	879	887	glaucoma
O	888	896	subjects
O	897	900	and
O	901	903	41
O	903	904	%
O	905	906	(
O	906	908	24
O	908	909	/
O	909	911	59
O	911	912	)
O	913	915	of
B-Disease	916	924	glaucoma
I-Disease	925	933	suspects
O	934	938	were
O	939	948	receiving
O	949	956	topical
O	957	968	medications
O	968	969	.

O	970	973	The
B-Characteristic	974	981	corneal
I-Characteristic	982	990	staining
I-Characteristic	991	996	grade
O	997	1000	was
O	1001	1008	greater
O	1009	1011	in
B-Disease	1012	1020	glaucoma
O	1021	1029	subjects
O	1030	1034	than
O	1035	1037	in
B-Disease	1038	1046	glaucoma
I-Disease	1047	1055	suspects
O	1056	1057	(
O	1057	1058	6
O	1058	1059	.
O	1059	1060	4
O	1061	1063	vs
O	1063	1064	.
O	1065	1066	4
O	1066	1067	.
O	1067	1068	1
O	1068	1069	;
O	1070	1071	P
O	1072	1073	<
O	1074	1075	0
O	1075	1076	.
O	1076	1079	001
O	1079	1080	)
O	1080	1081	,
O	1082	1085	but
O	1086	1092	groups
O	1093	1096	did
O	1097	1100	not
O	1101	1107	differ
O	1108	1112	with
O	1113	1119	regard
O	1120	1122	to
B-Characteristic	1123	1127	TBUT
O	1128	1130	or
B-Characteristic	1131	1139	Schirmer
I-Characteristic	1139	1140	'
I-Characteristic	1140	1141	s
I-Characteristic	1142	1149	results
O	1150	1151	(
O	1151	1152	P
O	1153	1154	>
O	1155	1156	0
O	1156	1157	.
O	1157	1159	20
O	1160	1163	for
O	1164	1168	both
O	1168	1169	)
O	1169	1170	.

O	1171	1183	Multivariate
O	1184	1194	regression
O	1195	1201	models
O	1202	1208	showed
O	1209	1213	that
B-Characteristic	1214	1221	topical
I-Characteristic	1222	1230	glaucoma
I-Characteristic	1231	1238	therapy
I-Characteristic	1239	1245	burden
O	1246	1249	was
O	1250	1260	associated
O	1261	1265	with
O	1266	1267	a
O	1268	1281	significantly
O	1282	1288	higher
B-Characteristic	1289	1294	total
I-Characteristic	1295	1302	corneal
I-Characteristic	1303	1311	staining
I-Characteristic	1312	1317	grade
O	1318	1319	(
O	1319	1320	
O	1320	1321	,
O	1322	1323	+
O	1323	1324	0
O	1324	1325	.
O	1325	1326	9
O	1327	1330	for
O	1331	1335	each
O	1336	1346	additional
O	1347	1355	glaucoma
O	1356	1360	drop
O	1360	1361	;
O	1362	1364	95
O	1364	1365	%
O	1366	1376	confidence
O	1377	1385	interval
O	1386	1387	[
O	1387	1389	CI
O	1389	1390	]
O	1390	1391	,
O	1392	1393	0
O	1393	1394	.
O	1394	1395	5
O	1395	1396	-
O	1396	1397	1
O	1397	1398	.
O	1398	1399	3
O	1399	1400	;
O	1401	1402	P
O	1403	1404	<
O	1405	1406	0
O	1406	1407	.
O	1407	1410	001
O	1410	1411	)
O	1411	1412	,
O	1413	1416	but
O	1417	1420	not
O	1421	1425	with
B-Characteristic	1426	1430	TBUT
O	1431	1433	or
B-Characteristic	1434	1442	Schirmer
I-Characteristic	1442	1443	'
I-Characteristic	1443	1444	s
I-Characteristic	1445	1452	results
O	1453	1454	(
O	1454	1455	P
O	1456	1457	>
O	1458	1459	0
O	1459	1460	.
O	1460	1462	20
O	1463	1466	for
O	1467	1471	both
O	1471	1472	)
O	1472	1473	.

B-Disease	1474	1482	Glaucoma
O	1483	1491	subjects
O	1492	1495	had
O	1496	1509	significantly
O	1510	1516	higher
B-Characteristic	1517	1522	total
I-Characteristic	1523	1527	OSDI
I-Characteristic	1528	1534	scores
O	1535	1539	than
B-Disease	1540	1548	glaucoma
I-Disease	1549	1557	suspects
O	1558	1559	(
O	1559	1561	16
O	1561	1562	.
O	1562	1563	7
O	1564	1566	vs
O	1566	1567	.
O	1568	1569	7
O	1569	1570	.
O	1570	1571	9
O	1571	1572	;
O	1573	1574	P
O	1575	1576	<
O	1577	1578	0
O	1578	1579	.
O	1579	1582	001
O	1582	1583	)
O	1583	1584	.

O	1585	1589	This
O	1590	1597	largely
O	1598	1601	was
O	1602	1605	the
O	1606	1612	result
O	1613	1615	of
O	1616	1622	higher
B-Characteristic	1623	1629	vision
I-Characteristic	1629	1630	-
I-Characteristic	1630	1637	related
I-Characteristic	1638	1647	subscores
O	1648	1650	in
O	1651	1654	the
B-Disease	1655	1663	glaucoma
O	1664	1669	group
O	1670	1671	(
O	1671	1673	11
O	1673	1674	.
O	1674	1675	1
O	1676	1678	vs
O	1678	1679	.
O	1680	1681	3
O	1681	1682	.
O	1682	1683	3
O	1683	1684	;
O	1685	1686	P
O	1687	1688	<
O	1689	1690	0
O	1690	1691	.
O	1691	1694	001
O	1694	1695	)
O	1695	1696	.

B-Characteristic	1697	1703	Ocular
I-Characteristic	1704	1714	discomfort
I-Characteristic	1714	1715	-
I-Characteristic	1715	1722	related
I-Characteristic	1723	1732	subscores
O	1732	1733	,
O	1734	1741	however
O	1741	1742	,
O	1743	1747	were
O	1748	1755	similar
O	1756	1758	in
O	1759	1763	both
O	1764	1770	groups
O	1771	1772	(
O	1772	1773	5
O	1773	1774	.
O	1774	1775	7
O	1776	1778	vs
O	1778	1779	.
O	1780	1781	4
O	1781	1782	.
O	1782	1783	6
O	1783	1784	;
O	1785	1786	P
O	1787	1788	=
O	1789	1790	0
O	1790	1791	.
O	1791	1793	30
O	1793	1794	)
O	1794	1795	.

O	1796	1798	In
O	1799	1811	multivariate
O	1812	1820	analyses
O	1820	1821	,
O	1822	1826	each
O	1827	1828	5
O	1828	1829	-
O	1829	1836	decibel
O	1837	1846	decrement
O	1847	1849	in
B-Characteristic	1850	1856	better
I-Characteristic	1856	1857	-
I-Characteristic	1857	1860	eye
I-Characteristic	1861	1863	VF
I-Characteristic	1864	1868	mean
I-Characteristic	1869	1878	deviation
O	1879	1882	was
O	1883	1893	associated
O	1894	1898	with
O	1899	1900	a
O	1901	1902	4
O	1902	1903	.
O	1903	1904	7
O	1904	1905	-
O	1905	1910	point
O	1911	1919	increase
O	1920	1922	in
B-Characteristic	1923	1928	total
I-Characteristic	1929	1933	OSDI
I-Characteristic	1934	1939	score
O	1940	1941	(
O	1941	1943	95
O	1943	1944	%
O	1945	1947	CI
O	1947	1948	,
O	1949	1950	1
O	1950	1951	.
O	1951	1952	9
O	1952	1953	-
O	1953	1954	7
O	1954	1955	.
O	1955	1956	5
O	1956	1957	;
O	1958	1959	P
O	1960	1961	=
O	1962	1963	0
O	1963	1964	.
O	1964	1967	001
O	1967	1968	)
O	1969	1972	and
O	1973	1974	a
O	1975	1976	3
O	1976	1977	.
O	1977	1978	7
O	1978	1979	-
O	1979	1984	point
O	1985	1993	increase
O	1994	1996	in
O	1997	2000	the
B-Characteristic	2001	2007	vision
I-Characteristic	2007	2008	-
I-Characteristic	2008	2015	related
I-Characteristic	2016	2024	subscore
O	2025	2026	(
O	2026	2028	95
O	2028	2029	%
O	2030	2032	CI
O	2032	2033	,
O	2034	2035	1
O	2035	2036	.
O	2036	2037	7
O	2037	2038	-
O	2038	2039	5
O	2039	2040	.
O	2040	2041	6
O	2041	2042	;
O	2043	2044	P
O	2045	2046	<
O	2047	2048	0
O	2048	2049	.
O	2049	2052	001
O	2052	2053	)
O	2054	2057	but
O	2058	2061	did
O	2062	2065	not
O	2066	2073	predict
O	2074	2075	a
O	2076	2082	higher
B-Characteristic	2083	2093	discomfort
I-Characteristic	2093	2094	-
I-Characteristic	2094	2101	related
I-Characteristic	2102	2110	subscore
O	2111	2112	(
O	2112	2113	
O	2113	2114	,
O	2115	2116	1
O	2116	2117	.
O	2117	2118	1
O	2119	2124	point
O	2124	2125	;
O	2126	2127	P
O	2128	2129	=
O	2130	2131	0
O	2131	2132	.
O	2132	2134	07
O	2134	2135	)
O	2135	2136	.

B-Characteristic	2137	2144	Topical
I-Characteristic	2145	2153	glaucoma
I-Characteristic	2154	2161	therapy
I-Characteristic	2162	2168	burden
O	2169	2172	was
O	2173	2176	not
O	2177	2187	associated
O	2188	2192	with
O	2193	2199	higher
B-Characteristic	2200	2205	total
I-Characteristic	2206	2210	OSDI
I-Characteristic	2211	2216	score
O	2217	2219	or
B-Characteristic	2220	2226	vision
I-Characteristic	2226	2227	-
I-Characteristic	2228	2230	or
I-Characteristic	2231	2241	discomfort
I-Characteristic	2241	2242	-
I-Characteristic	2242	2249	related
I-Characteristic	2250	2258	subscore
O	2259	2260	(
O	2260	2261	P
O	2262	2263	>
O	2264	2265	0
O	2265	2266	.
O	2266	2268	20
O	2269	2272	for
O	2273	2276	all
O	2276	2277	)
O	2277	2278	.

B-Disease	2279	2287	Glaucoma
O	2288	2290	is
O	2291	2301	associated
O	2302	2306	with
O	2307	2318	significant
B-Disease	2319	2325	ocular
I-Disease	2326	2333	surface
I-Disease	2334	2341	disease
O	2341	2342	,
O	2343	2346	and
B-Characteristic	2347	2354	topical
I-Characteristic	2355	2363	glaucoma
I-Characteristic	2364	2371	therapy
I-Characteristic	2372	2378	burden
O	2379	2384	seems
O	2385	2395	predictive
O	2396	2398	of
B-Characteristic	2399	2406	corneal
I-Characteristic	2407	2415	staining
I-Characteristic	2416	2424	severity
O	2424	2425	.

O	2426	2433	However
O	2433	2434	,
B-Characteristic	2435	2439	OSDI
O	2440	2442	is
O	2443	2444	a
O	2445	2449	poor
O	2450	2456	metric
O	2457	2460	for
O	2461	2470	capturing
B-Disease	2471	2477	ocular
I-Disease	2478	2485	surface
I-Disease	2486	2493	disease
O	2494	2496	in
B-Disease	2497	2505	glaucoma
O	2506	2513	because
O	2514	2522	symptoms
O	2523	2527	seem
O	2528	2530	to
O	2531	2533	be
O	2534	2541	related
O	2542	2549	largely
O	2550	2552	to
B-Symptom	2553	2555	VF
I-Symptom	2556	2560	loss
O	2560	2561	.

B-Diagnostic_tool	0	8	Modified
I-Diagnostic_tool	9	14	Allen
I-Diagnostic_tool	15	23	pictures
O	24	26	to
O	27	33	assess
B-Disease	34	43	amblyopia
O	44	46	in
B-Characteristic	47	52	young
I-Characteristic	53	61	children
O	61	62	.

O	64	66	To
O	67	74	produce
O	75	76	a
O	77	81	test
O	82	84	of
B-Characteristic	85	91	visual
I-Characteristic	92	98	acuity
O	99	102	for
B-Characteristic	103	108	young
I-Characteristic	109	117	children
O	118	122	that
O	123	125	is
O	126	130	more
O	131	140	sensitive
O	141	143	to
B-Disease	144	153	amblyopia
O	154	158	than
O	159	166	current
B-Diagnostic_tool	167	176	preschool
I-Diagnostic_tool	177	183	vision
I-Diagnostic_tool	184	189	tests
O	189	190	,
O	191	194	the
O	195	202	authors
O	203	213	surrounded
O	214	218	four
B-Diagnostic_tool	219	224	Allen
I-Diagnostic_tool	225	233	pictures
O	234	238	with
O	240	241	"
O	242	250	crowding
O	251	252	"
O	254	258	bars
O	258	259	.

O	260	264	This
B-Diagnostic_tool	265	273	modified
I-Diagnostic_tool	274	279	Allen
I-Diagnostic_tool	280	284	test
O	285	288	was
O	289	298	evaluated
O	299	301	by
O	302	311	measuring
B-Characteristic	312	318	acuity
I-Characteristic	319	321	of
I-Characteristic	322	331	amblyopic
I-Characteristic	332	340	children
O	341	342	(
O	342	343	n
O	344	345	=
O	346	348	28
O	348	349	)
O	350	353	and
B-Characteristic	354	362	children
O	363	364	(
O	364	365	n
O	366	367	=
O	368	370	10
O	370	371	)
O	372	375	and
B-Characteristic	376	382	adults
O	383	384	(
O	384	385	n
O	386	387	=
O	388	389	5
O	389	390	)
O	391	395	with
O	396	402	normal
B-Anatomy	403	407	eyes
O	407	408	.

B-Characteristic	409	413	Mean
I-Characteristic	414	422	acuities
I-Characteristic	423	425	of
I-Characteristic	426	435	amblyopic
I-Characteristic	436	440	eyes
O	441	444	for
O	445	448	the
O	449	457	modified
O	458	466	pictures
O	467	470	was
O	471	472	0
O	472	473	.
O	473	474	8
O	475	482	octaves
O	483	485	or
O	486	492	nearly
O	493	498	three
B-Diagnostic_tool	499	505	logMar
I-Diagnostic_tool	506	513	Snellen
O	514	519	lines
O	520	526	poorer
O	527	531	than
O	532	535	for
O	536	539	the
O	540	548	isolated
O	549	557	pictures
O	557	558	.

O	559	562	For
B-Characteristic	563	575	nonamblyopic
O	576	579	and
B-Characteristic	580	586	normal
B-Anatomy	587	591	eyes
O	592	600	modified
O	601	608	picture
O	609	615	acuity
O	616	624	averaged
O	625	626	0
O	626	627	.
O	627	628	1
O	629	631	to
O	632	633	0
O	633	634	.
O	634	635	4
O	636	643	octaves
O	644	650	poorer
O	651	655	than
O	656	664	isolated
O	665	672	picture
O	673	679	acuity
O	679	680	.

O	681	688	Average
O	689	697	acuities
O	698	700	of
B-Disease	701	710	amblyopic
B-Anatomy	711	715	eyes
O	716	717	(
O	717	718	n
O	719	720	=
O	721	723	22
O	723	724	)
O	725	728	for
O	729	732	the
O	733	741	modified
O	742	750	pictures
O	751	757	agreed
O	758	762	with
O	763	767	line
O	768	774	letter
O	775	783	acuities
O	783	784	.

O	785	790	These
O	791	798	results
O	799	806	suggest
O	807	811	that
O	812	815	the
B-Diagnostic_tool	816	824	modified
I-Diagnostic_tool	825	832	picture
I-Diagnostic_tool	833	837	test
O	838	845	induces
O	846	853	contour
O	854	865	interaction
O	866	873	similar
O	874	876	to
O	877	881	that
O	882	884	of
B-Diagnostic_tool	885	889	line
I-Diagnostic_tool	890	896	letter
I-Diagnostic_tool	897	902	tests
O	902	903	,
O	904	907	and
O	908	912	thus
O	912	913	,
O	914	916	is
O	917	918	a
O	919	923	more
O	924	933	sensitive
O	934	938	test
O	939	941	of
B-Disease	942	951	amblyopia
O	952	954	in
O	955	958	the
B-Characteristic	959	968	preschool
I-Characteristic	969	974	child
O	975	979	than
O	980	988	isolated
O	989	996	symbols
O	996	997	.

B-Symptom	0	10	Peripheral
I-Symptom	11	18	lesions
O	19	29	identified
O	30	32	by
B-Diagnostic_tool	33	42	mydriatic
I-Diagnostic_tool	43	52	ultrawide
I-Diagnostic_tool	53	58	field
I-Diagnostic_tool	59	66	imaging
O	66	67	:
O	68	80	distribution
O	81	84	and
O	85	94	potential
O	95	101	impact
O	102	104	on
B-Disease	105	113	diabetic
I-Disease	114	125	retinopathy
O	126	134	severity
O	134	135	.

O	137	139	To
O	140	146	assess
B-Disease	147	155	diabetic
I-Disease	156	167	retinopathy
O	168	169	(
B-Disease	169	171	DR
O	171	172	)
O	173	175	as
O	176	186	determined
O	187	189	by
O	190	197	lesions
O	198	208	identified
O	209	214	using
B-Diagnostic_tool	215	224	mydriatic
I-Diagnostic_tool	225	234	ultrawide
I-Diagnostic_tool	235	240	field
I-Diagnostic_tool	241	248	imaging
O	249	250	(
B-Diagnostic_tool	250	258	DiSLO200
O	258	259	;
O	260	265	Optos
O	266	269	plc
O	269	270	,
O	271	279	Scotland
O	279	280	,
O	281	283	UK
O	283	284	)
O	285	293	compared
O	294	298	with
B-Diagnostic_tool	299	304	Early
I-Diagnostic_tool	305	314	Treatment
I-Diagnostic_tool	315	323	Diabetic
I-Diagnostic_tool	324	335	Retinopathy
I-Diagnostic_tool	336	341	Study
I-Diagnostic_tool	342	343	(
I-Diagnostic_tool	343	348	ETDRS
I-Diagnostic_tool	348	349	)
I-Diagnostic_tool	350	351	7
I-Diagnostic_tool	351	352	-
I-Diagnostic_tool	352	360	standard
I-Diagnostic_tool	361	366	field
I-Diagnostic_tool	367	371	film
I-Diagnostic_tool	372	383	photography
O	383	384	.

O	385	396	Prospective
O	397	408	comparative
O	409	414	study
O	415	417	of
B-Diagnostic_tool	418	426	DiSLO200
O	426	427	,
B-Diagnostic_tool	428	433	ETDRS
I-Diagnostic_tool	434	435	7
I-Diagnostic_tool	435	436	-
I-Diagnostic_tool	436	444	standard
I-Diagnostic_tool	445	450	field
I-Diagnostic_tool	451	455	film
I-Diagnostic_tool	456	467	photographs
O	467	468	,
O	469	472	and
B-Diagnostic_tool	473	480	dilated
I-Diagnostic_tool	481	487	fundus
I-Diagnostic_tool	488	499	examination
O	500	501	(
B-Diagnostic_tool	501	504	DFE
O	504	505	)
O	505	506	.

O	507	508	A
O	509	514	total
O	515	517	of
O	518	521	206
B-Anatomy	522	526	eyes
O	527	529	of
O	530	533	103
B-Disease	534	542	diabetic
O	543	551	patients
O	552	560	selected
O	561	563	to
O	564	573	represent
O	574	577	all
O	578	584	levels
O	585	587	of
B-Disease	588	590	DR
O	590	591	.

O	592	600	Subjects
O	601	604	had
B-Diagnostic_tool	605	613	DiSLO200
O	613	614	,
B-Diagnostic_tool	615	620	ETDRS
I-Diagnostic_tool	621	622	7
I-Diagnostic_tool	622	623	-
I-Diagnostic_tool	623	631	standard
I-Diagnostic_tool	632	637	field
I-Diagnostic_tool	638	642	film
I-Diagnostic_tool	643	654	photographs
O	654	655	,
O	656	659	and
B-Diagnostic_tool	660	663	DFE
O	663	664	.

O	665	671	Images
O	672	676	were
O	677	683	graded
O	684	687	for
O	688	696	severity
O	697	700	and
O	701	713	distribution
O	714	716	of
B-Symptom	717	719	DR
I-Symptom	720	727	lesions
O	727	728	.

O	729	742	Discrepancies
O	743	747	were
O	748	759	adjudicated
O	759	760	,
O	761	764	and
O	765	771	images
O	772	776	were
O	777	785	compared
O	786	790	side
O	791	793	by
O	794	798	side
O	798	799	.

O	800	812	Distribution
O	813	815	of
B-Symptom	816	826	hemorrhage
I-Symptom	827	830	and
I-Symptom	830	831	/
I-Symptom	831	833	or
I-Symptom	834	847	microaneurysm
O	848	849	(
B-Symptom	849	850	H
I-Symptom	850	851	/
I-Symptom	851	853	Ma
O	853	854	)
O	854	855	,
B-Symptom	856	862	venous
I-Symptom	863	870	beading
O	871	872	(
B-Symptom	872	874	VB
O	874	875	)
O	875	876	,
B-Symptom	877	889	intraretinal
I-Symptom	890	903	microvascular
I-Symptom	904	915	abnormality
O	916	917	(
B-Symptom	917	921	IRMA
O	921	922	)
O	922	923	,
O	924	927	and
B-Symptom	928	931	new
I-Symptom	932	939	vessels
I-Symptom	940	949	elsewhere
O	950	951	(
B-Symptom	951	954	NVE
O	954	955	)
O	955	956	.

O	957	962	Kappa
O	963	964	(
O	964	965	
O	965	966	)
O	967	970	and
O	971	979	weighted
O	980	981	
O	982	992	statistics
O	993	996	for
O	997	1006	agreement
O	1006	1007	.

O	1008	1011	The
O	1012	1024	distribution
O	1025	1027	of
B-Disease	1028	1030	DR
O	1031	1039	severity
O	1040	1042	by
B-Diagnostic_tool	1043	1048	ETDRS
I-Diagnostic_tool	1049	1050	7
I-Diagnostic_tool	1050	1051	-
I-Diagnostic_tool	1051	1059	standard
I-Diagnostic_tool	1060	1065	field
I-Diagnostic_tool	1066	1070	film
I-Diagnostic_tool	1071	1082	photographs
O	1083	1086	was
B-Characteristic	1087	1089	no
I-Characteristic	1090	1092	DR
O	1093	1095	12
O	1095	1096	.
O	1096	1097	5
O	1097	1098	%
O	1098	1099	;
B-Disease	1100	1116	nonproliferative
I-Disease	1117	1119	DR
O	1120	1124	mild
O	1125	1127	22
O	1127	1128	.
O	1128	1129	5
O	1129	1130	%
O	1130	1131	,
B-Disease	1132	1140	moderate
O	1141	1143	30
O	1143	1144	%
O	1144	1145	,
O	1146	1149	and
B-Disease	1150	1156	severe
I-Disease	1156	1157	/
I-Disease	1157	1161	very
I-Disease	1162	1168	severe
O	1169	1170	8
O	1170	1171	%
O	1171	1172	;
O	1173	1176	and
B-Disease	1177	1190	proliferative
I-Disease	1191	1193	DR
O	1194	1196	27
O	1196	1197	%
O	1197	1198	.

B-Disease	1199	1207	Diabetic
I-Disease	1208	1219	retinopathy
O	1220	1228	severity
O	1229	1236	between
B-Diagnostic_tool	1237	1245	DiSLO200
O	1246	1249	and
B-Diagnostic_tool	1250	1255	ETDRS
I-Diagnostic_tool	1256	1260	film
I-Diagnostic_tool	1261	1272	photographs
O	1273	1280	matched
O	1281	1283	in
O	1284	1286	80
O	1286	1287	%
O	1288	1290	of
B-Anatomy	1291	1295	eyes
O	1296	1297	(
O	1297	1305	weighted
O	1306	1307	
O	1308	1309	=
O	1310	1311	0
O	1311	1312	.
O	1312	1314	74
O	1314	1315	,
O	1315	1316	
O	1317	1318	=
O	1319	1320	0
O	1320	1321	.
O	1321	1323	84
O	1323	1324	)
O	1325	1328	and
O	1329	1332	was
O	1333	1339	within
O	1340	1341	1
O	1342	1347	level
O	1348	1350	in
O	1351	1353	94
O	1353	1354	.
O	1354	1355	5
O	1355	1356	%
O	1357	1359	of
B-Anatomy	1360	1364	eyes
O	1364	1365	.

B-Diagnostic_tool	1366	1374	DiSLO200
O	1375	1378	and
B-Diagnostic_tool	1379	1382	DFE
O	1383	1390	matched
O	1391	1393	in
O	1394	1396	58
O	1396	1397	.
O	1397	1398	8
O	1398	1399	%
O	1400	1402	of
B-Anatomy	1403	1407	eyes
O	1408	1409	(
O	1409	1417	weighted
O	1418	1419	
O	1420	1421	=
O	1422	1423	0
O	1423	1424	.
O	1424	1426	69
O	1426	1427	,
O	1427	1428	
O	1429	1430	=
O	1431	1432	0
O	1432	1433	.
O	1433	1435	47
O	1435	1436	)
O	1437	1440	and
O	1441	1445	were
O	1446	1452	within
O	1453	1454	1
O	1455	1460	level
O	1461	1463	in
O	1464	1466	91
O	1466	1467	.
O	1467	1468	2
O	1468	1469	%
O	1470	1472	of
B-Anatomy	1473	1477	eyes
O	1477	1478	.

O	1479	1484	Forty
B-Anatomy	1485	1489	eyes
O	1490	1491	(
O	1491	1493	20
O	1493	1494	%
O	1494	1495	)
O	1496	1499	had
B-Disease	1500	1502	DR
O	1503	1511	severity
O	1512	1525	discrepancies
O	1526	1533	between
B-Diagnostic_tool	1534	1542	DiSLO200
O	1543	1546	and
B-Diagnostic_tool	1547	1552	ETDRS
I-Diagnostic_tool	1553	1557	film
I-Diagnostic_tool	1558	1569	photographs
O	1569	1570	.

O	1571	1574	The
B-Symptom	1575	1582	retinal
I-Symptom	1583	1590	lesions
O	1591	1598	causing
O	1599	1612	discrepancies
O	1613	1617	were
B-Symptom	1618	1619	H
I-Symptom	1619	1620	/
I-Symptom	1620	1622	Ma
O	1623	1625	52
O	1625	1626	%
O	1626	1627	,
B-Symptom	1628	1632	IRMA
O	1633	1635	26
O	1635	1636	%
O	1636	1637	,
B-Symptom	1638	1641	NVE
O	1642	1644	17
O	1644	1645	%
O	1645	1646	,
O	1647	1650	and
B-Symptom	1651	1653	VB
O	1654	1655	4
O	1655	1656	%
O	1656	1657	.

O	1658	1671	Approximately
O	1672	1675	one
O	1675	1676	-
O	1676	1681	third
O	1682	1684	of
B-Symptom	1685	1686	H
I-Symptom	1686	1687	/
I-Symptom	1687	1689	Ma
O	1689	1690	,
B-Symptom	1691	1695	IRMA
O	1695	1696	,
O	1697	1700	and
B-Symptom	1701	1704	NVE
O	1705	1709	were
O	1710	1723	predominantly
O	1724	1731	outside
O	1732	1737	ETDRS
O	1738	1744	fields
O	1744	1745	.

O	1746	1753	Lesions
O	1754	1764	identified
O	1765	1767	on
B-Diagnostic_tool	1768	1776	DiSLO200
O	1777	1780	but
O	1781	1784	not
B-Diagnostic_tool	1785	1790	ETDRS
I-Diagnostic_tool	1791	1795	film
I-Diagnostic_tool	1796	1807	photographs
O	1808	1817	suggested
O	1818	1819	a
O	1820	1824	more
O	1825	1831	severe
B-Disease	1832	1834	DR
O	1835	1840	level
O	1841	1843	in
O	1844	1846	10
O	1846	1847	%
O	1848	1850	of
B-Anatomy	1851	1855	eyes
O	1855	1856	.

O	1857	1869	Distribution
O	1870	1872	in
O	1873	1876	the
B-Anatomy	1877	1885	temporal
I-Anatomy	1885	1886	,
I-Anatomy	1887	1901	superotemporal
I-Anatomy	1901	1902	,
I-Anatomy	1903	1917	inferotemporal
I-Anatomy	1917	1918	,
I-Anatomy	1919	1930	superonasal
I-Anatomy	1930	1931	,
I-Anatomy	1932	1935	and
I-Anatomy	1936	1947	inferonasal
I-Anatomy	1948	1954	fields
O	1955	1958	was
O	1959	1961	77
O	1961	1962	%
O	1962	1963	,
O	1964	1966	72
O	1966	1967	%
O	1967	1968	,
O	1969	1971	61
O	1971	1972	%
O	1972	1973	,
O	1974	1976	65
O	1976	1977	%
O	1977	1978	,
O	1979	1982	and
O	1983	1985	59
O	1985	1986	%
O	1987	1990	for
B-Symptom	1991	1992	H
I-Symptom	1992	1993	/
I-Symptom	1993	1995	Ma
O	1995	1996	,
O	1997	2009	respectively
O	2010	2011	(
O	2011	2012	P
O	2013	2014	<
O	2015	2016	0
O	2016	2017	.
O	2017	2021	0001
O	2021	2022	)
O	2022	2023	;
O	2024	2026	22
O	2026	2027	%
O	2027	2028	,
O	2029	2031	24
O	2031	2032	%
O	2032	2033	,
O	2034	2036	21
O	2036	2037	%
O	2037	2038	,
O	2039	2041	28
O	2041	2042	%
O	2042	2043	,
O	2044	2047	and
O	2048	2050	22
O	2050	2051	%
O	2052	2055	for
B-Symptom	2056	2058	VB
O	2058	2059	,
O	2060	2072	respectively
O	2073	2074	(
O	2074	2075	P
O	2076	2077	=
O	2078	2079	0
O	2079	2080	.
O	2080	2083	009
O	2083	2084	)
O	2084	2085	;
O	2086	2088	52
O	2088	2089	%
O	2089	2090	,
O	2091	2093	40
O	2093	2094	%
O	2094	2095	,
O	2096	2098	29
O	2098	2099	%
O	2099	2100	,
O	2101	2103	47
O	2103	2104	%
O	2104	2105	,
O	2106	2109	and
O	2110	2112	36
O	2112	2113	%
O	2114	2117	for
B-Symptom	2118	2122	IRMA
O	2122	2123	,
O	2124	2136	respectively
O	2137	2138	(
O	2138	2139	P
O	2140	2141	<
O	2142	2143	0
O	2143	2144	.
O	2144	2148	0001
O	2148	2149	)
O	2149	2150	,
O	2151	2154	and
O	2155	2156	8
O	2156	2157	%
O	2157	2158	,
O	2159	2160	4
O	2160	2161	%
O	2161	2162	,
O	2163	2164	4
O	2164	2165	%
O	2165	2166	,
O	2167	2168	8
O	2168	2169	%
O	2169	2170	,
O	2171	2174	and
O	2175	2176	5
O	2176	2177	%
O	2178	2181	for
B-Symptom	2182	2185	NVE
O	2185	2186	,
O	2187	2199	respectively
O	2200	2201	(
O	2201	2202	P
O	2203	2204	=
O	2205	2206	0
O	2206	2207	.
O	2207	2209	03
O	2209	2210	)
O	2210	2211	.

O	2212	2215	All
O	2216	2223	lesions
O	2224	2228	were
O	2229	2233	more
O	2234	2242	frequent
O	2243	2245	in
O	2246	2249	the
B-Anatomy	2250	2258	temporal
I-Anatomy	2259	2265	fields
O	2266	2274	compared
O	2275	2279	with
O	2280	2283	the
B-Anatomy	2284	2289	nasal
I-Anatomy	2290	2296	fields
O	2297	2298	(
O	2298	2299	P
O	2300	2301	<
O	2302	2303	0
O	2303	2304	.
O	2304	2308	0001
O	2308	2309	)
O	2309	2310	.

B-Diagnostic_tool	2311	2319	DiSLO200
I-Diagnostic_tool	2320	2326	images
O	2327	2330	had
O	2331	2342	substantial
O	2343	2352	agreement
O	2353	2357	with
B-Diagnostic_tool	2358	2363	ETDRS
I-Diagnostic_tool	2364	2368	film
I-Diagnostic_tool	2369	2380	photographs
O	2381	2384	and
B-Diagnostic_tool	2385	2388	DFE
O	2389	2391	in
O	2392	2403	determining
B-Disease	2404	2406	DR
O	2407	2415	severity
O	2415	2416	.

O	2417	2419	On
O	2420	2423	the
O	2424	2429	basis
O	2430	2432	of
B-Diagnostic_tool	2433	2441	DiSLO200
I-Diagnostic_tool	2442	2448	images
O	2448	2449	,
O	2450	2461	significant
O	2462	2472	nonuniform
O	2473	2485	distribution
O	2486	2488	of
B-Symptom	2489	2491	DR
I-Symptom	2492	2499	lesions
O	2500	2503	was
O	2504	2511	evident
O	2512	2518	across
O	2519	2522	the
B-Anatomy	2523	2529	retina
O	2529	2530	.

O	2531	2534	The
O	2535	2545	additional
B-Symptom	2546	2556	peripheral
I-Symptom	2557	2564	lesions
O	2565	2575	identified
O	2576	2578	by
B-Diagnostic_tool	2579	2587	DiSLO200
O	2588	2590	in
O	2591	2595	this
O	2596	2602	cohort
O	2603	2612	suggested
O	2613	2614	a
O	2615	2619	more
O	2620	2626	severe
O	2627	2637	assessment
O	2638	2640	of
B-Disease	2641	2643	DR
O	2644	2646	in
O	2647	2649	10
O	2649	2650	%
O	2651	2653	of
B-Anatomy	2654	2658	eyes
O	2659	2663	than
O	2664	2667	was
O	2668	2677	suggested
O	2678	2680	by
O	2681	2684	the
O	2685	2692	lesions
O	2693	2699	within
O	2700	2703	the
O	2704	2709	ETDRS
O	2710	2716	fields
O	2716	2717	.

O	2718	2725	However
O	2725	2726	,
O	2727	2730	the
O	2731	2743	implications
O	2744	2746	of
B-Symptom	2747	2757	peripheral
I-Symptom	2758	2765	lesions
O	2766	2768	on
B-Characteristic	2769	2771	DR
I-Characteristic	2772	2783	progression
O	2784	2790	within
O	2791	2792	a
O	2793	2801	specific
B-Characteristic	2802	2807	ETDRS
I-Characteristic	2808	2816	severity
O	2817	2822	level
O	2823	2827	over
O	2828	2832	time
O	2833	2836	are
O	2837	2844	unknown
O	2845	2848	and
O	2849	2853	need
O	2854	2856	to
O	2857	2859	be
O	2860	2869	evaluated
O	2870	2883	prospectively
O	2883	2884	.

O	0	8	Accuracy
O	9	11	of
O	12	20	matching
B-Anatomy	21	26	optic
I-Anatomy	27	32	discs
O	33	37	with
B-Characteristic	38	44	visual
I-Characteristic	45	51	fields
O	51	52	:
O	53	56	the
O	57	65	European
O	66	75	Structure
O	76	79	and
O	80	88	Function
O	89	99	Assessment
O	100	105	Trial
O	106	107	(
O	107	113	ESAFAT
O	113	114	)
O	114	115	.

O	117	119	To
O	120	129	determine
O	130	133	the
O	134	141	ability
O	142	144	of
O	145	161	ophthalmologists
O	162	168	across
O	169	175	Europe
O	176	178	to
O	179	184	match
B-Diagnostic_tool	185	197	stereoscopic
I-Diagnostic_tool	198	203	optic
I-Diagnostic_tool	204	208	disc
I-Diagnostic_tool	209	220	photographs
O	221	223	to
B-Characteristic	224	230	visual
I-Characteristic	231	237	fields
O	238	240	of
O	241	248	varying
O	249	257	severity
O	257	258	.

O	259	269	Evaluation
O	270	273	and
O	274	284	comparison
O	285	287	of
O	288	289	2
O	290	300	diagnostic
O	301	306	tests
O	306	307	.

O	308	309	A
O	310	315	total
O	316	318	of
O	319	322	109
O	323	325	of
O	326	329	260
O	330	337	invited
O	338	354	ophthalmologists
O	355	357	in
O	358	360	11
O	361	369	European
O	370	379	countries
O	379	380	.

O	381	386	These
O	387	390	had
O	391	403	participated
O	404	406	in
O	407	410	the
O	411	419	previous
O	420	428	European
B-Anatomy	429	434	Optic
I-Anatomy	435	439	Disc
O	440	450	Assessment
O	451	456	Trial
O	457	458	(
O	458	463	EODAT
O	463	464	)
O	464	465	,
O	466	467	a
O	468	473	trial
O	474	476	on
B-Disease	477	485	glaucoma
O	486	496	diagnostic
O	497	505	accuracy
O	506	511	based
O	512	514	on
B-Anatomy	515	520	optic
I-Anatomy	521	526	discs
O	527	531	only
O	531	532	.

O	533	537	Each
O	538	549	participant
O	550	557	matched
B-Diagnostic_tool	558	564	stereo
I-Diagnostic_tool	565	570	optic
I-Diagnostic_tool	571	575	disc
I-Diagnostic_tool	576	587	photographs
O	588	590	of
O	591	593	40
O	594	601	healthy
O	602	605	and
O	606	608	48
B-Disease	609	621	glaucomatous
B-Anatomy	622	626	eyes
O	627	629	to
O	630	631	a
B-Characteristic	632	638	visual
I-Characteristic	639	644	field
O	645	651	chosen
O	652	656	from
O	657	658	4
O	659	666	options
O	667	670	per
B-Anatomy	671	675	disc
O	675	676	.

O	677	680	The
O	681	682	4
O	683	692	presented
B-Characteristic	693	699	visual
I-Characteristic	700	706	fields
O	707	715	included
O	716	719	the
O	720	733	corresponding
O	734	737	one
O	738	741	and
O	742	743	3
O	744	749	other
B-Characteristic	750	756	visual
I-Characteristic	757	763	fields
O	763	764	,
O	765	772	varying
O	773	775	in
O	776	784	severity
O	784	785	.

O	786	789	The
O	790	798	matching
O	799	807	accuracy
O	808	811	and
O	812	815	any
O	816	826	inaccuracy
O	827	830	per
O	831	838	disease
O	839	847	severity
O	848	852	were
O	853	863	calculated
O	863	864	.

O	865	879	Classification
O	880	888	accuracy
O	889	890	(
O	890	892	as
B-Disease	893	905	glaucomatous
O	906	908	or
O	909	916	healthy
O	916	917	)
O	918	921	was
O	922	930	compared
O	931	935	with
O	936	941	EODAT
O	942	946	data
O	946	947	.

O	948	957	Duplicate
O	958	964	slides
O	965	972	allowed
O	973	976	for
O	977	980	the
O	981	991	assessment
O	992	994	of
O	995	1008	intraobserver
O	1009	1018	agreement
O	1018	1019	.

O	1020	1028	Accuracy
O	1029	1031	of
O	1032	1040	matching
B-Anatomy	1041	1046	optic
I-Anatomy	1047	1052	discs
O	1053	1057	with
O	1058	1063	their
O	1064	1077	corresponding
B-Characteristic	1078	1084	visual
I-Characteristic	1085	1090	field
O	1091	1094	and
O	1095	1097	of
O	1098	1109	classifying
O	1110	1114	them
O	1115	1117	as
O	1118	1125	healthy
O	1126	1128	or
B-Disease	1129	1141	glaucomatous
O	1141	1142	;
O	1143	1156	intraobserver
O	1157	1166	agreement
O	1167	1168	(
O	1168	1169	
O	1169	1170	)
O	1170	1171	.

O	1172	1175	The
O	1176	1183	overall
O	1184	1192	accuracy
O	1193	1195	of
O	1196	1212	ophthalmologists
O	1213	1216	for
O	1217	1226	correctly
O	1227	1235	matching
B-Diagnostic_tool	1236	1248	stereoscopic
I-Diagnostic_tool	1249	1254	optic
I-Diagnostic_tool	1255	1259	disc
I-Diagnostic_tool	1260	1271	photographs
O	1272	1274	to
O	1275	1280	their
B-Characteristic	1281	1287	visual
I-Characteristic	1288	1294	fields
O	1295	1298	was
O	1299	1301	58
O	1301	1302	.
O	1302	1303	7
O	1303	1304	%
O	1304	1305	.

O	1306	1310	When
O	1311	1322	incorrectly
O	1323	1330	matched
O	1330	1331	,
O	1332	1335	the
O	1336	1345	observers
O	1346	1355	generally
O	1356	1369	overestimated
O	1370	1373	the
B-Characteristic	1374	1380	visual
I-Characteristic	1381	1386	field
I-Characteristic	1387	1395	severity
O	1396	1397	(
O	1397	1398	P
O	1399	1400	<
O	1401	1402	0
O	1402	1403	.
O	1403	1406	001
O	1406	1407	)
O	1407	1408	,
O	1409	1416	notably
O	1417	1419	in
B-Anatomy	1420	1424	eyes
O	1425	1429	with
B-Disease	1430	1435	early
I-Disease	1436	1444	glaucoma
O	1444	1445	.

O	1446	1449	The
O	1450	1463	intraobserver
O	1464	1473	agreement
O	1474	1477	was
O	1477	1478	,
O	1479	1481	on
O	1482	1489	average
O	1489	1490	,
O	1491	1499	moderate
O	1500	1501	(
O	1501	1502	0
O	1502	1503	.
O	1503	1505	52
O	1505	1506	)
O	1506	1507	.

O	1508	1516	European
O	1517	1533	ophthalmologists
O	1534	1543	correctly
O	1544	1551	matched
B-Diagnostic_tool	1552	1564	stereoscopic
I-Diagnostic_tool	1565	1570	optic
I-Diagnostic_tool	1571	1575	disc
I-Diagnostic_tool	1576	1587	photographs
O	1588	1590	to
O	1591	1596	their
O	1597	1610	corresponding
B-Characteristic	1611	1617	visual
I-Characteristic	1618	1623	field
O	1624	1626	in
O	1627	1631	only
O	1632	1645	approximately
O	1646	1648	59
O	1648	1649	%
O	1650	1652	of
O	1653	1658	cases
O	1658	1659	.

O	1660	1662	In
O	1663	1667	most
O	1668	1678	mismatches
O	1678	1679	,
O	1680	1683	the
O	1684	1694	clinicians
O	1695	1708	overestimated
O	1709	1712	the
B-Symptom	1713	1719	visual
I-Symptom	1720	1725	field
I-Symptom	1726	1732	damage
O	1732	1733	.

B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	coherence
I-Diagnostic_tool	18	28	tomography
O	28	29	-
O	29	34	based
O	35	46	observation
O	47	49	of
O	50	53	the
O	54	61	natural
O	62	69	history
O	70	72	of
B-Symptom	73	82	drusenoid
I-Symptom	83	89	lesion
O	90	92	in
B-Anatomy	93	97	eyes
O	98	102	with
B-Disease	103	106	dry
I-Disease	107	110	age
I-Disease	110	111	-
I-Disease	111	118	related
I-Disease	119	126	macular
I-Disease	127	139	degeneration
O	139	140	.

O	142	144	To
O	145	148	use
B-Diagnostic_tool	149	157	spectral
I-Diagnostic_tool	158	164	domain
I-Diagnostic_tool	165	172	optical
I-Diagnostic_tool	173	182	coherence
I-Diagnostic_tool	183	193	tomography
O	194	195	(
B-Diagnostic_tool	195	197	SD
I-Diagnostic_tool	197	198	-
I-Diagnostic_tool	198	201	OCT
O	201	202	)
O	203	205	to
O	206	217	investigate
O	218	222	risk
O	223	230	factors
O	231	241	predictive
O	242	245	for
O	246	249	the
O	250	261	development
O	262	264	of
B-Symptom	265	272	atrophy
I-Symptom	273	275	of
I-Symptom	276	285	drusenoid
I-Symptom	286	293	lesions
O	294	295	(
B-Symptom	295	298	DLs
O	298	299	)
O	300	301	(
B-Symptom	301	307	drusen
O	308	311	and
B-Symptom	312	321	drusenoid
I-Symptom	322	329	pigment
I-Symptom	330	340	epithelium
I-Symptom	341	351	detachment
O	351	352	)
O	353	355	in
B-Anatomy	356	360	eyes
O	361	365	with
B-Disease	366	369	non
I-Disease	369	370	-
I-Disease	370	381	neovascular
I-Disease	382	385	age
I-Disease	385	386	-
I-Disease	386	393	related
I-Disease	394	401	macular
I-Disease	402	414	degeneration
O	415	416	(
B-Disease	416	422	NNVAMD
O	422	423	)
O	423	424	.

O	425	431	Cohort
O	432	437	study
O	437	438	.

O	439	444	Forty
O	444	445	-
O	445	448	one
B-Anatomy	449	453	eyes
O	454	458	from
O	459	461	29
O	462	470	patients
O	471	475	with
B-Disease	476	482	NNVAMD
O	482	483	.

O	484	492	Patients
O	493	497	with
B-Disease	498	504	NNVAMD
O	505	508	who
O	509	518	underwent
O	519	529	registered
B-Diagnostic_tool	530	532	SD
I-Diagnostic_tool	532	533	-
I-Diagnostic_tool	533	536	OCT
I-Diagnostic_tool	537	544	imaging
O	545	549	over
O	550	551	a
O	552	559	minimum
O	560	566	period
O	567	569	of
O	570	571	6
O	572	578	months
O	579	583	were
O	584	592	reviewed
O	592	593	.

B-Symptom	594	603	Drusenoid
I-Symptom	604	611	lesions
O	612	616	that
O	617	621	were
O	622	633	accompanied
O	634	636	by
O	637	640	new
B-Symptom	641	648	atrophy
O	649	654	onset
O	655	657	at
O	658	659	6
O	660	666	months
O	667	669	or
O	670	674	last
O	675	681	follow
O	681	682	-
O	682	684	up
O	685	686	(
O	686	689	FUL
O	689	690	)
O	691	695	were
O	696	703	further
O	704	712	analyzed
O	712	713	.

O	714	722	Detailed
O	723	729	lesion
O	730	736	change
O	737	740	was
O	741	750	described
O	751	761	throughout
O	762	765	the
O	766	771	study
O	772	778	period
O	778	779	.

O	780	784	Odds
O	785	791	ratios
O	792	793	(
O	793	796	ORs
O	796	797	)
O	798	801	and
O	802	806	risk
O	807	810	for
O	811	814	new
B-Symptom	815	820	local
I-Symptom	821	828	atrophy
O	829	834	onset
O	835	839	were
O	840	850	calculated
O	850	851	.

B-Symptom	852	861	Drusenoid
I-Symptom	862	868	lesion
O	869	877	features
O	878	881	and
O	882	894	longitudinal
O	895	902	changes
O	903	905	in
O	906	914	features
O	914	915	,
O	916	925	including
B-Characteristic	926	933	maximum
I-Characteristic	934	940	lesion
I-Characteristic	941	947	height
O	947	948	,
B-Characteristic	949	955	lesion
I-Characteristic	956	964	diameter
O	964	965	,
B-Characteristic	966	972	lesion
I-Characteristic	973	981	internal
I-Characteristic	982	994	reflectivity
O	994	995	,
O	996	999	and
O	1000	1008	presence
O	1009	1012	and
O	1013	1019	extent
O	1020	1022	of
B-Symptom	1023	1032	overlying
I-Symptom	1033	1045	intraretinal
I-Symptom	1046	1061	hyperreflective
I-Symptom	1062	1066	foci
O	1067	1068	(
B-Symptom	1068	1071	HRF
O	1071	1072	)
O	1072	1073	.

B-Characteristic	1074	1083	Subfoveal
I-Characteristic	1084	1093	choroidal
I-Characteristic	1094	1103	thickness
O	1104	1105	(
B-Characteristic	1105	1109	SFCT
O	1109	1110	)
O	1111	1114	and
B-Characteristic	1115	1124	choroidal
I-Characteristic	1125	1134	thickness
O	1135	1136	(
B-Characteristic	1136	1138	CT
O	1138	1139	)
O	1140	1144	were
O	1145	1153	measured
O	1154	1159	below
O	1160	1164	each
O	1165	1171	lesion
O	1171	1172	.

O	1173	1174	A
O	1175	1180	total
O	1181	1183	of
O	1184	1187	543
O	1188	1198	individual
B-Symptom	1199	1202	DLs
O	1203	1207	were
O	1208	1218	identified
O	1219	1221	at
O	1222	1230	baseline
O	1230	1231	,
O	1232	1235	and
O	1236	1238	28
O	1239	1246	lesions
O	1247	1256	developed
O	1257	1263	during
O	1264	1270	follow
O	1270	1271	-
O	1271	1273	up
O	1273	1274	.

O	1275	1278	The
O	1279	1283	mean
O	1284	1290	follow
O	1290	1291	-
O	1291	1293	up
O	1294	1298	time
O	1299	1302	was
O	1303	1305	21
O	1305	1306	.
O	1306	1307	3
O	1307	1308	
O	1308	1309	8
O	1309	1310	.
O	1310	1311	6
O	1312	1318	months
O	1319	1320	(
O	1320	1325	range
O	1325	1326	,
O	1327	1328	6
O	1328	1329	-
O	1329	1331	44
O	1332	1338	months
O	1338	1339	)
O	1339	1340	.

O	1341	1345	Some
O	1346	1347	3
O	1347	1348	.
O	1348	1349	2
O	1349	1350	%
O	1351	1353	of
B-Symptom	1354	1357	DLs
O	1358	1359	(
O	1359	1361	18
O	1361	1362	/
O	1362	1365	571
O	1365	1366	)
O	1367	1377	progressed
O	1378	1380	to
B-Symptom	1381	1388	atrophy
O	1389	1395	within
O	1396	1398	18
O	1398	1399	.
O	1399	1400	3
O	1401	1402	
O	1403	1404	9
O	1404	1405	.
O	1405	1406	5
O	1407	1413	months
O	1414	1415	(
O	1415	1420	range
O	1420	1421	,
O	1422	1423	5
O	1423	1424	-
O	1424	1426	28
O	1427	1433	months
O	1433	1434	)
O	1435	1437	of
O	1438	1441	the
O	1442	1449	initial
O	1450	1455	visit
O	1455	1456	.

B-Symptom	1457	1466	Drusenoid
I-Symptom	1467	1474	lesions
I-Symptom	1475	1479	with
I-Symptom	1480	1493	heterogeneous
I-Symptom	1494	1502	internal
I-Symptom	1503	1515	reflectivity
O	1516	1520	were
O	1521	1534	significantly
O	1535	1545	associated
O	1546	1550	with
O	1551	1554	new
B-Symptom	1555	1562	atrophy
O	1563	1568	onset
O	1569	1571	at
O	1572	1573	6
O	1574	1580	months
O	1581	1582	(
O	1582	1584	OR
O	1584	1585	,
O	1586	1587	5
O	1587	1588	.
O	1588	1591	614
O	1591	1592	;
O	1593	1595	95
O	1595	1596	%
O	1597	1607	confidence
O	1608	1616	interval
O	1617	1618	[
O	1618	1620	CI
O	1620	1621	]
O	1621	1622	,
O	1623	1624	1
O	1624	1625	.
O	1625	1628	277
O	1628	1629	-
O	1629	1631	24
O	1631	1632	.
O	1632	1635	673
O	1635	1636	)
O	1637	1640	and
O	1641	1644	new
B-Symptom	1645	1652	atrophy
O	1653	1658	onset
O	1659	1661	at
O	1662	1665	FUL
O	1666	1667	(
O	1667	1669	OR
O	1669	1670	,
O	1671	1672	7
O	1672	1673	.
O	1673	1676	005
O	1676	1677	;
O	1678	1680	95
O	1680	1681	%
O	1682	1684	CI
O	1684	1685	,
O	1686	1687	2
O	1687	1688	.
O	1688	1691	300
O	1691	1692	-
O	1692	1694	21
O	1694	1695	.
O	1695	1698	337
O	1698	1699	)
O	1699	1700	.

O	1701	1708	Lesions
O	1709	1713	with
O	1714	1717	the
O	1718	1726	presence
O	1727	1729	of
B-Symptom	1730	1733	HRF
O	1734	1738	were
O	1739	1750	significant
O	1751	1761	predictors
O	1762	1764	of
O	1765	1768	new
B-Symptom	1769	1776	atrophy
O	1777	1782	onset
O	1783	1785	at
O	1786	1787	6
O	1788	1794	months
O	1795	1796	(
O	1796	1798	OR
O	1798	1799	,
O	1800	1802	30
O	1802	1803	.
O	1803	1806	161
O	1806	1807	;
O	1808	1810	95
O	1810	1811	%
O	1812	1814	CI
O	1814	1815	,
O	1816	1817	4
O	1817	1818	.
O	1818	1821	766
O	1821	1822	-
O	1822	1825	190
O	1825	1826	.
O	1826	1829	860
O	1829	1830	)
O	1831	1834	and
O	1835	1838	FUL
O	1839	1840	(
O	1840	1842	OR
O	1842	1843	,
O	1844	1846	11
O	1846	1847	.
O	1847	1850	211
O	1850	1851	;
O	1852	1854	95
O	1854	1855	%
O	1856	1858	CI
O	1858	1859	,
O	1860	1861	2
O	1861	1862	.
O	1862	1865	513
O	1865	1866	-
O	1866	1868	50
O	1868	1869	.
O	1869	1872	019
O	1872	1873	)
O	1873	1874	.

O	1875	1882	Lesions
O	1883	1887	with
O	1888	1889	a
O	1890	1898	baseline
O	1899	1906	maximum
O	1907	1913	height
B-Dimension	1915	1916	>
I-Dimension	1917	1919	80
I-Dimension	1920	1921	
I-Dimension	1921	1922	m
O	1923	1925	or
B-Characteristic	1926	1928	CT
B-Dimension	1929	1930	
I-Dimension	1931	1934	135
I-Dimension	1935	1936	
I-Dimension	1936	1937	m
O	1938	1944	showed
O	1945	1946	a
O	1947	1955	positive
O	1956	1967	association
O	1968	1972	with
O	1973	1976	the
O	1977	1980	new
B-Symptom	1981	1988	atrophy
O	1989	1994	onset
O	1995	1997	at
O	1998	2001	FUL
O	2002	2003	(
O	2003	2005	OR
O	2005	2006	,
O	2007	2008	7
O	2008	2009	.
O	2009	2012	886
O	2012	2013	;
O	2014	2016	95
O	2016	2017	%
O	2018	2020	CI
O	2020	2021	,
O	2022	2023	2
O	2023	2024	.
O	2024	2027	105
O	2027	2028	-
O	2028	2030	29
O	2030	2031	.
O	2031	2034	538
O	2035	2038	and
O	2039	2041	OR
O	2041	2042	,
O	2043	2044	3
O	2044	2045	.
O	2045	2048	796
O	2048	2049	;
O	2050	2052	95
O	2052	2053	%
O	2054	2056	CI
O	2056	2057	,
O	2058	2059	1
O	2059	2060	.
O	2060	2063	154
O	2063	2064	-
O	2064	2066	12
O	2066	2067	.
O	2067	2070	481
O	2070	2071	,
O	2072	2084	respectively
O	2084	2085	)
O	2085	2086	.

O	2087	2090	The
O	2091	2099	presence
O	2100	2102	of
B-Symptom	2103	2106	HRF
I-Symptom	2107	2116	overlying
I-Symptom	2117	2120	DLs
O	2120	2121	,
O	2122	2123	a
O	2124	2137	heterogeneous
O	2138	2146	internal
O	2147	2159	reflectivity
O	2160	2162	of
O	2163	2168	these
O	2169	2176	lesions
O	2176	2177	,
O	2178	2181	was
O	2182	2187	found
O	2188	2200	consistently
O	2201	2203	to
O	2204	2206	be
O	2207	2217	predictive
O	2218	2220	of
O	2221	2226	local
B-Symptom	2227	2234	atrophy
O	2235	2240	onset
O	2241	2243	in
O	2244	2247	the
O	2248	2255	ensuing
O	2256	2262	months
O	2262	2263	.

O	2264	2269	These
O	2270	2278	findings
O	2279	2286	provide
O	2287	2294	further
O	2295	2302	insight
O	2303	2307	into
O	2308	2311	the
O	2312	2319	natural
O	2320	2327	history
O	2328	2330	of
O	2331	2339	anatomic
O	2340	2346	change
O	2347	2356	occurring
O	2357	2359	in
O	2360	2368	patients
O	2369	2373	with
B-Disease	2374	2380	NNVAMD
O	2380	2381	.

O	0	8	Validity
O	9	11	of
O	12	16	self
O	16	17	-
O	17	23	report
O	24	26	in
B-Disease	27	31	type
I-Disease	32	33	1
I-Disease	34	42	diabetic
O	43	51	subjects
O	52	55	for
O	56	61	laser
O	62	71	treatment
O	72	74	of
B-Disease	75	86	retinopathy
O	86	87	.

O	89	93	This
O	94	99	study
O	100	106	sought
O	107	109	to
O	110	119	determine
O	120	123	the
O	124	132	validity
O	133	135	of
O	136	140	self
O	140	141	-
O	141	147	report
O	148	150	of
O	151	156	prior
O	157	167	panretinal
O	168	184	photocoagulation
O	185	186	(
O	186	189	PRP
O	189	190	)
O	191	194	and
O	195	200	focal
O	201	217	photocoagulation
O	218	219	(
O	219	221	FP
O	221	222	)
O	223	231	compared
O	232	236	with
B-Diagnostic_tool	237	243	fundus
I-Diagnostic_tool	244	255	photography
O	255	256	.

O	257	268	Prospective
O	269	275	cohort
O	276	281	study
O	281	282	.

O	283	286	One
O	287	295	thousand
O	296	301	three
O	302	309	hundred
O	310	315	sixty
O	315	316	-
O	316	321	three
B-Disease	322	326	type
I-Disease	327	328	1
I-Disease	329	337	diabetic
O	338	346	subjects
O	347	351	from
O	352	355	the
O	356	368	Epidemiology
O	369	371	of
B-Disease	372	380	Diabetes
O	381	394	Interventions
O	395	398	and
O	399	412	Complications
O	413	414	(
O	414	418	EDIC
O	418	419	)
O	420	425	study
O	425	426	,
O	427	428	a
O	429	435	subset
O	436	438	of
O	439	442	the
O	443	447	1441
O	448	456	subjects
O	457	467	originally
O	468	476	enrolled
O	477	479	in
O	480	483	the
O	484	495	multicenter
B-Disease	496	504	Diabetes
O	505	512	Control
O	513	516	and
O	517	530	Complications
O	531	536	Trial
O	536	537	.

O	538	540	At
O	541	545	each
O	546	552	annual
O	553	558	visit
O	558	559	,
O	560	568	subjects
O	569	573	were
O	574	579	asked
O	580	582	by
O	583	587	EDIC
O	588	593	staff
O	594	601	whether
O	602	606	they
O	607	610	had
O	611	620	undergone
O	621	624	PRP
O	624	625	,
O	626	628	FP
O	628	629	,
O	630	632	or
O	633	637	both
O	638	643	since
O	644	647	the
O	648	652	last
O	653	662	completed
O	663	669	annual
O	670	676	clinic
O	677	682	visit
O	682	683	.

B-Diagnostic_tool	684	690	Fundus
I-Diagnostic_tool	691	702	photographs
O	703	707	were
O	708	717	collected
O	718	722	from
O	723	726	one
O	727	734	quarter
O	735	737	of
O	738	741	the
O	742	748	cohort
O	749	753	each
O	754	758	year
O	759	762	and
O	763	767	from
O	768	771	the
O	772	778	entire
O	779	785	cohort
O	786	788	at
O	789	793	EDIC
O	794	799	years
O	800	801	4
O	802	805	and
O	806	808	10
O	808	809	.

B-Diagnostic_tool	810	821	Photographs
O	822	826	were
O	827	833	graded
O	834	837	for
O	838	841	the
O	842	850	presence
O	851	854	and
O	855	861	extent
O	862	864	of
O	865	868	PRP
O	869	872	and
O	873	875	FP
O	875	876	.

O	877	886	Seventeen
O	887	892	years
O	893	895	of
O	896	903	subject
O	904	913	reporting
O	914	917	and
B-Diagnostic_tool	918	928	photograph
O	929	936	grading
O	937	939	of
O	940	943	PRP
O	944	947	and
O	948	950	FP
O	951	955	were
O	956	964	compared
O	965	967	in
O	968	972	EDIC
O	973	981	subjects
O	981	982	.

O	983	986	The
O	987	988	
O	988	989	,
O	990	1001	sensitivity
O	1001	1002	,
O	1003	1014	specificity
O	1014	1015	,
O	1016	1019	and
O	1020	1028	positive
O	1029	1032	and
O	1033	1041	negative
O	1042	1052	predictive
O	1053	1059	values
O	1060	1064	were
O	1065	1075	calculated
O	1076	1079	for
O	1080	1087	subject
O	1087	1088	-
O	1088	1096	reported
O	1097	1100	PRP
O	1101	1104	and
O	1105	1107	FP
O	1107	1108	.

O	1109	1116	Factors
O	1117	1128	influencing
O	1129	1136	subject
O	1137	1149	misreporting
O	1150	1154	were
O	1155	1167	investigated
O	1167	1168	.

O	1169	1172	For
O	1173	1180	subject
O	1181	1190	reporting
O	1190	1191	,
O	1192	1196	1244
O	1197	1198	(
O	1198	1200	96
O	1200	1201	%
O	1201	1202	)
O	1203	1205	of
O	1206	1210	1296
O	1211	1219	subjects
O	1220	1224	with
B-Diagnostic_tool	1225	1233	gradable
I-Diagnostic_tool	1234	1245	photographs
O	1246	1256	accurately
O	1257	1265	reported
O	1266	1273	whether
O	1274	1278	they
O	1279	1282	had
O	1283	1284	a
O	1285	1292	history
O	1293	1295	of
O	1296	1299	PRP
O	1300	1302	in
O	1303	1306	one
O	1307	1309	or
O	1310	1314	both
B-Anatomy	1315	1319	eyes
O	1319	1320	,
O	1321	1324	and
O	1325	1329	1259
O	1330	1331	(
O	1331	1333	97
O	1333	1334	.
O	1334	1335	5
O	1335	1336	%
O	1336	1337	)
O	1338	1340	of
O	1341	1345	1291
O	1346	1350	with
O	1351	1356	valid
B-Diagnostic_tool	1357	1368	photographs
O	1369	1378	correctly
O	1379	1387	reported
O	1388	1393	their
O	1394	1401	history
O	1402	1404	of
O	1405	1407	FP
O	1407	1408	.

O	1409	1412	For
O	1413	1416	PRP
O	1417	1420	and
O	1421	1423	FP
O	1423	1424	,
O	1425	1438	sensitivities
O	1439	1443	were
O	1444	1446	90
O	1446	1447	.
O	1447	1448	4
O	1448	1449	%
O	1450	1453	and
O	1454	1456	74
O	1456	1457	.
O	1457	1458	0
O	1458	1459	%
O	1459	1460	,
O	1461	1473	respectively
O	1473	1474	;
O	1475	1488	specificities
O	1489	1493	were
O	1494	1496	96
O	1496	1497	.
O	1497	1498	0
O	1498	1499	%
O	1500	1503	and
O	1504	1506	98
O	1506	1507	.
O	1507	1508	8
O	1508	1509	%
O	1509	1510	,
O	1511	1523	respectively
O	1523	1524	;
O	1525	1533	positive
O	1534	1544	predictive
O	1545	1551	values
O	1552	1556	were
O	1557	1559	75
O	1559	1560	.
O	1560	1561	9
O	1561	1562	%
O	1563	1566	and
O	1567	1569	80
O	1569	1570	.
O	1570	1571	3
O	1571	1572	%
O	1572	1573	,
O	1574	1586	respectively
O	1586	1587	;
O	1588	1596	negative
O	1597	1607	predictive
O	1608	1614	values
O	1615	1619	were
O	1620	1622	98
O	1622	1623	.
O	1623	1624	9
O	1624	1625	%
O	1626	1629	and
O	1630	1632	98
O	1632	1633	.
O	1633	1634	4
O	1634	1635	%
O	1635	1636	,
O	1637	1649	respectively
O	1649	1650	;
O	1651	1654	and
O	1655	1656	
O	1657	1663	values
O	1664	1668	were
O	1669	1670	0
O	1670	1671	.
O	1671	1673	80
O	1674	1677	and
O	1678	1679	0
O	1679	1680	.
O	1680	1682	76
O	1682	1683	,
O	1684	1696	respectively
O	1696	1697	.

O	1698	1702	Risk
O	1703	1710	factors
O	1711	1721	associated
O	1722	1726	with
O	1727	1739	misreporting
O	1740	1748	included
O	1749	1754	prior
O	1755	1760	laser
O	1761	1764	for
B-Disease	1765	1773	diabetic
I-Disease	1774	1785	retinopathy
O	1786	1789	and
O	1790	1795	prior
O	1796	1802	ocular
O	1803	1810	surgery
O	1811	1812	(
O	1812	1816	each
O	1817	1818	P
O	1819	1820	<
O	1821	1822	0
O	1822	1823	.
O	1823	1825	04
O	1825	1826	)
O	1826	1827	.

O	1828	1831	For
O	1832	1840	subjects
O	1841	1845	with
B-Disease	1846	1850	type
I-Disease	1851	1852	1
I-Disease	1853	1861	diabetes
O	1861	1862	,
O	1863	1865	in
O	1866	1869	the
O	1870	1877	absence
O	1878	1880	of
O	1881	1882	a
O	1883	1891	clinical
O	1892	1903	examination
O	1904	1906	or
B-Diagnostic_tool	1907	1913	fundus
I-Diagnostic_tool	1914	1925	photographs
O	1925	1926	,
O	1927	1934	subject
O	1935	1939	self
O	1939	1940	-
O	1940	1946	report
O	1947	1952	could
O	1953	1955	be
O	1956	1957	a
O	1958	1966	reliable
O	1967	1971	tool
O	1972	1974	in
O	1975	1976	a
O	1977	1981	well
O	1981	1982	-
O	1982	1991	monitored
O	1992	1997	study
O	1998	2001	for
O	2002	2011	assessing
O	2012	2017	laser
O	2018	2027	treatment
O	2028	2032	type
O	2033	2035	in
B-Disease	2036	2044	diabetic
I-Disease	2045	2056	retinopathy
O	2056	2057	.

B-Diagnostic_tool	0	7	Fourier
I-Diagnostic_tool	7	8	-
I-Diagnostic_tool	8	14	domain
I-Diagnostic_tool	15	22	optical
I-Diagnostic_tool	23	32	coherence
I-Diagnostic_tool	33	43	tomography
O	44	51	imaging
O	52	54	in
B-Disease	55	66	keratoconus
O	66	67	:
O	68	69	a
B-Anatomy	70	77	corneal
O	78	88	structural
O	89	103	classification
O	103	104	.

O	106	108	To
O	109	114	study
B-Symptom	115	122	corneal
I-Symptom	123	134	morphologic
I-Symptom	135	142	changes
O	143	145	in
O	146	147	a
O	148	153	large
B-Disease	154	165	keratoconic
O	166	176	population
O	177	180	and
O	181	183	to
O	184	193	establish
O	194	195	a
O	196	206	structural
B-Diagnostic_tool	207	214	optical
I-Diagnostic_tool	215	224	coherence
I-Diagnostic_tool	225	235	tomography
O	236	237	(
B-Diagnostic_tool	237	240	OCT
O	240	241	)
O	242	256	classification
O	256	257	.

O	258	263	Cross
O	263	264	-
O	264	273	sectional
O	273	274	,
O	275	288	observational
O	289	294	study
O	294	295	.

O	296	297	A
O	298	303	total
O	304	306	of
O	307	310	218
B-Disease	311	322	keratoconic
B-Anatomy	323	327	eyes
O	328	332	from
O	333	336	218
O	337	345	patients
O	346	349	and
O	350	352	34
B-Anatomy	353	357	eyes
O	358	362	from
O	363	365	34
O	366	372	normal
O	373	381	subjects
O	381	382	.

O	383	384	A
B-Diagnostic_tool	385	392	Fourier
I-Diagnostic_tool	392	393	-
I-Diagnostic_tool	393	399	domain
I-Diagnostic_tool	400	403	OCT
O	404	410	system
O	411	415	with
O	416	417	5
O	417	418	-
O	418	419	
O	419	420	m
O	421	426	axial
O	427	437	resolution
O	438	441	was
O	442	446	used
O	446	447	.

O	448	451	For
O	452	456	each
O	457	464	patient
O	464	465	,
O	466	467	3
O	468	472	high
O	472	473	-
O	473	483	resolution
O	484	489	scans
O	490	494	were
O	495	499	made
O	500	506	across
O	507	510	the
B-Anatomy	511	522	keratoconus
I-Anatomy	523	527	cone
O	527	528	.

O	529	532	All
O	533	538	scans
O	539	543	were
O	544	552	analyzed
O	553	555	by
B-Disease	556	567	keratoconus
O	568	579	specialists
O	580	583	who
O	584	588	were
O	589	592	not
O	593	598	given
O	599	605	access
O	606	608	to
O	609	617	patients
O	617	618	'
O	619	627	clinical
O	628	631	and
O	632	643	topographic
O	644	648	data
O	648	649	,
O	650	653	and
O	654	657	who
O	658	669	established
O	670	672	an
B-Diagnostic_tool	673	676	OCT
O	677	691	classification
O	691	692	.

O	693	696	The
O	697	712	reproducibility
O	713	715	of
O	716	719	the
O	720	734	classification
O	735	738	and
O	739	742	its
O	743	754	correlation
O	755	759	with
O	760	768	clinical
O	769	772	and
O	773	785	paraclinical
O	786	801	characteristics
O	802	804	of
O	805	813	patients
O	814	818	with
B-Disease	819	830	keratoconus
O	831	835	were
O	836	845	evaluated
O	845	846	.

O	847	850	The
B-Diagnostic_tool	851	854	OCT
O	855	867	examinations
O	868	872	were
O	873	882	performed
O	883	888	every
O	889	890	4
O	891	897	months
O	898	900	to
O	901	907	follow
O	908	910	up
B-Symptom	911	921	structural
I-Symptom	922	929	corneal
I-Symptom	930	937	changes
O	937	938	.

O	939	949	Evaluation
O	950	952	of
O	953	956	the
B-Symptom	957	967	structural
I-Symptom	968	975	corneal
I-Symptom	976	983	changes
O	984	993	occurring
O	994	996	in
B-Disease	997	1008	keratoconus
O	1009	1014	cases
O	1015	1019	with
O	1020	1027	various
O	1028	1034	stages
O	1035	1037	of
O	1038	1046	severity
O	1047	1052	based
O	1053	1055	on
B-Diagnostic_tool	1056	1059	OCT
O	1060	1068	findings
O	1068	1069	.

B-Diagnostic_tool	1070	1077	Fourier
I-Diagnostic_tool	1077	1078	-
I-Diagnostic_tool	1078	1084	domain
I-Diagnostic_tool	1085	1088	OCT
O	1089	1103	classification
O	1104	1114	containing
O	1115	1116	5
O	1117	1125	distinct
B-Disease	1126	1137	keratoconus
O	1138	1144	stages
O	1145	1147	is
O	1148	1156	proposed
O	1156	1157	.

B-Disease	1158	1163	Stage
I-Disease	1164	1165	1
O	1166	1178	demonstrates
B-Symptom	1179	1187	thinning
I-Symptom	1188	1190	of
I-Symptom	1191	1201	apparently
I-Symptom	1202	1208	normal
I-Symptom	1209	1219	epithelial
I-Symptom	1220	1223	and
I-Symptom	1224	1231	stromal
I-Symptom	1232	1238	layers
I-Symptom	1239	1241	at
I-Symptom	1242	1245	the
I-Symptom	1246	1251	conus
O	1251	1252	.

B-Disease	1253	1258	Stage
I-Disease	1259	1260	2
O	1261	1273	demonstrates
B-Symptom	1274	1289	hyperreflective
I-Symptom	1290	1299	anomalies
I-Symptom	1300	1309	occurring
I-Symptom	1310	1312	at
I-Symptom	1313	1316	the
I-Symptom	1317	1323	Bowman
I-Symptom	1323	1324	'
I-Symptom	1324	1325	s
I-Symptom	1326	1331	layer
I-Symptom	1332	1337	level
I-Symptom	1338	1342	with
I-Symptom	1343	1353	epithelial
I-Symptom	1354	1364	thickening
I-Symptom	1365	1367	at
I-Symptom	1368	1371	the
I-Symptom	1372	1377	conus
O	1377	1378	.

B-Disease	1379	1384	Stage
I-Disease	1385	1386	3
O	1387	1399	demonstrates
B-Symptom	1400	1409	posterior
I-Symptom	1410	1422	displacement
I-Symptom	1423	1425	of
I-Symptom	1426	1429	the
I-Symptom	1430	1445	hyperreflective
I-Symptom	1446	1456	structures
I-Symptom	1457	1466	occurring
I-Symptom	1467	1469	at
I-Symptom	1470	1473	the
I-Symptom	1474	1480	Bowman
I-Symptom	1480	1481	'
I-Symptom	1481	1482	s
I-Symptom	1483	1488	layer
I-Symptom	1489	1494	level
I-Symptom	1495	1499	with
I-Symptom	1500	1509	increased
I-Symptom	1510	1520	epithelial
I-Symptom	1521	1531	thickening
I-Symptom	1532	1535	and
I-Symptom	1536	1543	stromal
I-Symptom	1544	1552	thinning
O	1552	1553	.

B-Disease	1554	1559	Stage
I-Disease	1560	1561	4
O	1562	1574	demonstrates
B-Symptom	1575	1578	pan
I-Symptom	1578	1579	-
I-Symptom	1579	1586	stromal
I-Symptom	1587	1591	scar
O	1591	1592	.

B-Disease	1593	1598	Stage
I-Disease	1599	1600	5
O	1601	1613	demonstrates
B-Symptom	1614	1621	hydrops
O	1621	1622	;
B-Disease	1623	1625	5a
I-Disease	1625	1626	,
I-Disease	1627	1632	acute
I-Disease	1633	1638	onset
O	1638	1639	:
B-Symptom	1640	1648	Descemet
I-Symptom	1648	1649	'
I-Symptom	1649	1650	s
I-Symptom	1651	1659	membrane
I-Symptom	1660	1667	rupture
I-Symptom	1668	1671	and
I-Symptom	1672	1684	dilaceration
I-Symptom	1685	1687	of
I-Symptom	1688	1696	collagen
I-Symptom	1697	1705	lamellae
I-Symptom	1706	1710	with
I-Symptom	1711	1716	large
I-Symptom	1717	1722	fluid
I-Symptom	1722	1723	-
I-Symptom	1723	1729	filled
I-Symptom	1730	1742	intrastromal
I-Symptom	1743	1748	cysts
O	1748	1749	;
B-Disease	1750	1752	5b
I-Disease	1752	1753	,
I-Disease	1754	1761	healing
I-Disease	1762	1767	stage
O	1767	1768	:
B-Symptom	1769	1772	pan
I-Symptom	1772	1773	-
I-Symptom	1773	1780	stromal
I-Symptom	1781	1789	scarring
I-Symptom	1790	1794	with
I-Symptom	1795	1796	a
I-Symptom	1797	1806	remaining
I-Symptom	1807	1813	aspect
I-Symptom	1814	1816	of
I-Symptom	1817	1825	Descemet
I-Symptom	1825	1826	'
I-Symptom	1826	1827	s
I-Symptom	1828	1836	membrane
I-Symptom	1837	1844	rupture
O	1844	1845	.

O	1846	1849	The
O	1850	1865	reproducibility
O	1866	1868	of
O	1869	1872	the
O	1873	1887	classification
O	1888	1891	was
O	1892	1896	very
O	1897	1901	high
O	1902	1909	between
O	1910	1913	the
B-Anatomy	1914	1921	corneal
O	1922	1932	specialist
O	1933	1942	observers
O	1942	1943	.

O	1944	1952	Clinical
O	1953	1956	and
O	1957	1969	paraclinical
O	1970	1985	characteristics
O	1986	1988	of
B-Disease	1989	2000	keratoconus
O	2000	2001	,
O	2002	2011	including
B-Characteristic	2012	2018	visual
I-Characteristic	2019	2025	acuity
O	2025	2026	,
B-Symptom	2027	2034	corneal
I-Symptom	2035	2045	epithelium
I-Symptom	2046	2049	and
I-Symptom	2050	2057	stromal
I-Symptom	2058	2067	thickness
I-Symptom	2068	2075	changes
O	2075	2076	,
B-Characteristic	2077	2084	corneal
I-Characteristic	2085	2095	topography
O	2095	2096	,
B-Characteristic	2097	2110	biomechanical
I-Characteristic	2111	2118	corneal
I-Characteristic	2119	2134	characteristics
O	2134	2135	,
O	2136	2139	and
B-Symptom	2140	2155	microstructural
I-Symptom	2156	2163	changes
O	2164	2172	observed
O	2173	2175	on
B-Diagnostic_tool	2176	2184	confocal
I-Diagnostic_tool	2185	2195	microscopy
O	2195	2196	,
O	2197	2201	were
O	2202	2212	concordant
O	2213	2217	with
O	2218	2221	our
B-Diagnostic_tool	2222	2225	OCT
O	2226	2233	grading
O	2233	2234	.

B-Diagnostic_tool	2235	2242	Optical
I-Diagnostic_tool	2243	2252	coherence
I-Diagnostic_tool	2253	2263	tomography
O	2264	2272	provides
O	2273	2275	an
O	2276	2284	accurate
O	2285	2295	assessment
O	2296	2298	of
B-Symptom	2299	2309	structural
I-Symptom	2310	2317	changes
O	2318	2327	occurring
O	2328	2330	in
B-Disease	2331	2342	keratoconus
B-Anatomy	2343	2347	eyes
O	2347	2348	.

O	2349	2354	These
O	2355	2362	changes
O	2363	2367	were
O	2368	2378	correlated
O	2379	2383	with
O	2384	2392	clinical
O	2393	2396	and
O	2397	2409	paraclinical
O	2410	2425	characteristics
O	2426	2428	of
O	2429	2437	patients
O	2437	2438	.

O	2439	2442	The
O	2443	2454	established
O	2455	2469	classification
O	2470	2473	not
O	2474	2478	only
O	2479	2485	allows
O	2486	2496	structural
O	2497	2503	follow
O	2503	2504	-
O	2504	2506	up
O	2507	2509	of
O	2510	2518	patients
O	2519	2523	with
B-Disease	2524	2535	keratoconus
O	2536	2539	but
O	2540	2544	also
O	2545	2553	provides
O	2554	2561	insight
O	2562	2566	into
O	2567	2570	the
O	2571	2583	pathogenesis
O	2584	2586	of
B-Disease	2587	2598	keratoconus
O	2599	2602	and
O	2603	2612	treatment
O	2613	2623	strategies
O	2624	2627	for
O	2628	2634	future
O	2635	2643	research
O	2643	2644	.

B-Anatomy	0	6	Ocular
O	7	21	manifestations
O	22	24	of
B-Characteristic	25	30	22q11
I-Characteristic	30	31	.
I-Characteristic	31	32	2
I-Characteristic	33	49	microduplication
O	49	50	.

O	52	54	To
O	55	61	report
O	62	63	a
O	64	67	new
B-Anatomy	68	74	ocular
O	75	88	manifestation
O	89	91	of
O	92	95	the
B-Disease	96	104	dup22q11
I-Disease	105	113	syndrome
O	114	117	and
O	118	125	explore
O	126	134	involved
O	135	140	genes
O	141	145	that
O	146	149	may
O	150	155	offer
O	156	163	insight
O	164	166	to
O	167	177	mechanisms
O	178	180	of
O	181	193	pathogenesis
O	193	194	.

O	195	199	Case
O	200	206	series
O	206	207	.

O	208	211	Two
B-Characteristic	212	216	male
O	217	225	patients
O	226	230	with
O	231	235	this
O	236	244	syndrome
O	245	254	diagnosed
O	255	259	with
B-Characteristic	260	268	dup22q11
I-Characteristic	268	269	.
I-Characteristic	269	270	2
O	270	271	.

O	272	279	Medical
O	280	287	records
O	288	292	were
O	293	301	reviewed
O	301	302	.

O	303	314	Duplication
O	315	318	was
O	319	327	detected
O	328	330	in
O	331	334	the
B-Diagnostic_tool	335	340	oligo
I-Diagnostic_tool	340	341	-
I-Diagnostic_tool	341	347	single
I-Diagnostic_tool	348	358	nucleotide
I-Diagnostic_tool	359	371	polymorphism
I-Diagnostic_tool	372	383	chromosomal
I-Diagnostic_tool	384	394	microarray
O	395	398	and
O	399	409	duplicated
O	410	415	genes
O	416	422	within
O	423	426	the
O	427	434	segment
O	435	440	where
O	441	451	determined
O	452	454	by
O	455	465	literature
O	466	469	and
O	470	478	database
O	479	485	review
O	485	486	.

O	487	496	Potential
O	497	509	associations
O	510	517	between
O	518	521	the
O	522	536	ophthalmologic
O	537	551	manifestations
O	552	555	and
O	556	561	their
O	562	577	physiopathology
O	578	582	were
O	583	595	investigated
O	595	596	.

B-Diagnostic_tool	597	607	Microarray
O	608	615	results
O	616	619	and
O	620	634	identification
O	635	637	of
O	638	647	candidate
O	648	653	genes
O	654	660	within
O	661	664	the
O	665	675	duplicated
O	676	683	segment
O	683	684	.

O	685	688	Our
O	689	697	patients
O	698	709	demonstrate
O	710	720	previously
O	721	731	unreported
O	732	740	findings
O	741	743	of
B-Characteristic	744	752	dup22q11
I-Characteristic	752	753	.
I-Characteristic	753	754	2
O	754	755	,
O	756	765	including
B-Disease	766	772	Marcus
I-Disease	773	777	Gunn
I-Disease	778	781	jaw
I-Disease	782	789	winking
O	789	790	,
B-Disease	791	796	Duane
I-Disease	796	797	'
I-Disease	797	798	s
I-Disease	799	809	retraction
I-Disease	810	818	syndrome
O	818	819	,
O	820	823	and
O	824	829	other
B-Symptom	830	838	abnormal
I-Symptom	839	842	eye
I-Symptom	843	852	movements
O	853	863	consistent
O	864	868	with
O	869	870	a
B-Disease	871	881	congenital
I-Disease	882	889	cranial
I-Disease	890	904	dysinnervation
I-Disease	905	913	disorder
O	914	915	(
B-Disease	915	919	CCDD
O	919	920	)
O	920	921	,
B-Symptom	922	929	retinal
I-Symptom	930	938	vascular
I-Symptom	939	949	tortuosity
O	949	950	,
O	951	954	and
B-Disease	955	962	primary
I-Disease	963	972	infantile
I-Disease	973	981	glaucoma
O	981	982	.

O	983	986	The
O	987	997	duplicated
O	998	1005	segment
O	1006	1008	in
O	1009	1013	case
O	1014	1015	1
O	1016	1024	includes
B-Characteristic	1025	1031	SNAP29
O	1031	1032	,
O	1033	1038	which
O	1039	1044	could
O	1045	1047	be
O	1048	1054	linked
O	1055	1059	with
O	1060	1063	the
O	1064	1075	development
O	1076	1078	of
B-Symptom	1079	1086	retinal
I-Symptom	1087	1095	vascular
I-Symptom	1096	1106	tortuosity
O	1106	1107	,
O	1108	1111	and
B-Characteristic	1112	1117	MAPK1
O	1117	1118	,
O	1119	1124	which
O	1125	1130	seems
O	1131	1133	to
O	1134	1138	play
O	1139	1140	a
O	1141	1145	role
O	1146	1148	in
O	1149	1155	axonal
O	1156	1167	development
O	1168	1175	through
O	1176	1179	the
O	1180	1190	semaphorin
O	1191	1198	pathway
O	1198	1199	,
O	1200	1205	which
O	1206	1209	may
O	1210	1215	serve
O	1216	1218	as
O	1219	1220	a
O	1221	1230	candidate
O	1231	1235	gene
O	1236	1239	for
B-Disease	1240	1244	CCDD
O	1244	1245	.

O	1246	1248	In
O	1249	1253	case
O	1254	1255	2
O	1255	1256	,
O	1257	1260	the
B-Characteristic	1261	1266	CLDN5
I-Characteristic	1267	1271	gene
O	1272	1274	is
O	1275	1281	within
O	1282	1285	the
O	1286	1296	duplicated
O	1297	1304	segment
O	1304	1305	.

B-Characteristic	1306	1311	CLDN5
O	1312	1317	could
O	1318	1320	be
O	1321	1329	involved
O	1330	1332	in
O	1333	1336	the
O	1337	1352	pathophysiology
O	1353	1355	of
B-Disease	1356	1364	glaucoma
O	1364	1365	.

O	1366	1369	Our
O	1370	1375	cases
O	1376	1382	expand
O	1383	1386	the
B-Anatomy	1387	1393	ocular
O	1394	1403	phenotype
O	1404	1407	for
B-Characteristic	1408	1419	duplication
I-Characteristic	1420	1422	of
I-Characteristic	1423	1428	22q11
O	1429	1432	and
O	1433	1438	serve
O	1439	1441	to
O	1442	1450	identify
O	1451	1460	potential
O	1461	1470	candidate
O	1471	1476	genes
O	1477	1480	for
O	1481	1484	the
O	1485	1496	development
O	1497	1499	of
B-Disease	1500	1504	CCDD
O	1504	1505	,
B-Symptom	1506	1513	retinal
I-Symptom	1514	1522	vascular
I-Symptom	1523	1533	tortuosity
O	1533	1534	,
O	1535	1538	and
B-Disease	1539	1547	glaucoma
O	1547	1548	.

O	0	10	Evaluation
O	11	13	of
O	14	26	telemedicine
O	27	30	for
O	31	40	screening
O	41	43	of
B-Disease	44	52	diabetic
I-Disease	53	64	retinopathy
O	65	67	in
O	68	71	the
O	72	80	Veterans
O	81	87	Health
O	88	102	Administration
O	102	103	.

O	105	107	To
O	108	115	explore
O	116	119	the
O	120	124	cost
O	124	125	-
O	125	138	effectiveness
O	139	141	of
O	142	154	telemedicine
O	155	158	for
O	159	162	the
O	163	172	screening
O	173	175	of
B-Disease	176	184	diabetic
I-Disease	185	196	retinopathy
O	197	198	(
B-Disease	198	200	DR
O	200	201	)
O	202	205	and
O	206	214	identify
O	215	222	changes
O	223	229	within
O	230	233	the
O	234	246	demographics
O	247	249	of
O	250	251	a
O	252	259	patient
O	260	270	population
O	271	276	after
O	277	289	telemedicine
O	290	304	implementation
O	304	305	.

O	306	307	A
O	308	321	retrospective
O	322	329	medical
O	330	335	chart
O	336	342	review
O	343	344	(
O	344	350	cohort
O	351	356	study
O	356	357	)
O	358	361	was
O	362	371	conducted
O	371	372	.

O	373	374	A
O	375	380	total
O	381	383	of
O	384	387	900
B-Disease	388	392	type
I-Disease	393	394	1
I-Disease	395	398	and
I-Disease	399	403	type
I-Disease	404	405	2
I-Disease	406	414	diabetic
O	415	423	patients
O	424	432	enrolled
O	433	435	in
O	436	437	a
O	438	445	medical
O	446	452	system
O	453	457	with
O	458	459	a
O	460	472	telemedicine
O	473	482	screening
O	483	490	program
O	491	494	for
B-Disease	495	497	DR
O	497	498	.

O	499	502	The
O	503	507	cost
O	507	508	-
O	508	521	effectiveness
O	522	524	of
O	525	528	the
B-Disease	529	531	DR
O	532	544	telemedicine
O	545	552	program
O	553	556	was
O	557	567	determined
O	568	570	by
O	571	576	using
O	577	578	a
O	579	585	finite
O	585	586	-
O	586	593	horizon
O	593	594	,
O	595	603	discrete
O	604	608	time
O	608	609	,
O	610	620	discounted
B-Diagnostic_tool	621	627	Markov
I-Diagnostic_tool	628	636	decision
I-Diagnostic_tool	637	644	process
I-Diagnostic_tool	645	650	model
O	651	660	populated
O	661	663	by
O	664	674	parameters
O	675	678	and
O	679	686	testing
O	687	696	frequency
O	697	705	obtained
O	706	710	from
O	711	718	patient
O	719	726	records
O	726	727	.

O	728	731	The
O	732	737	model
O	738	747	estimated
O	748	751	the
O	752	763	progression
O	764	766	of
B-Disease	767	769	DR
O	770	773	and
O	774	784	determined
B-Characteristic	785	792	average
I-Characteristic	793	800	quality
I-Characteristic	800	801	-
I-Characteristic	801	809	adjusted
I-Characteristic	810	814	life
I-Characteristic	815	820	years
O	821	822	(
B-Characteristic	822	827	QALYs
O	827	828	)
O	829	834	saved
O	835	838	and
O	839	846	average
O	847	857	additional
O	858	862	cost
O	863	871	incurred
O	872	874	by
O	875	878	the
O	879	891	telemedicine
O	892	901	screening
O	902	909	program
O	909	910	.

B-Disease	911	919	Diabetic
I-Disease	920	931	retinopathy
O	931	932	,
B-Disease	933	940	macular
I-Disease	941	946	edema
O	946	947	,
B-Disease	948	957	blindness
O	957	958	,
O	959	962	and
O	963	973	associated
B-Characteristic	974	979	QALYs
O	979	980	.

O	981	984	The
O	985	992	results
O	993	1001	indicate
O	1002	1006	that
O	1007	1019	telemedicine
O	1020	1029	screening
O	1030	1032	is
O	1033	1037	cost
O	1037	1038	-
O	1038	1047	effective
O	1048	1051	for
B-Disease	1052	1054	DR
O	1055	1060	under
O	1061	1065	most
O	1066	1076	conditions
O	1076	1077	.

O	1078	1080	On
O	1081	1088	average
O	1088	1089	,
O	1090	1092	it
O	1093	1095	is
O	1096	1100	cost
O	1100	1101	-
O	1101	1110	effective
O	1111	1114	for
O	1115	1122	patient
O	1123	1134	populations
O	1135	1137	of
O	1139	1140	>
O	1141	1145	3500
O	1145	1146	,
B-Characteristic	1147	1155	patients
I-Characteristic	1156	1160	aged
I-Characteristic	1162	1163	<
I-Characteristic	1164	1166	80
I-Characteristic	1167	1172	years
O	1172	1173	,
O	1174	1177	and
O	1178	1181	all
O	1182	1188	racial
O	1189	1195	groups
O	1195	1196	.

O	1197	1207	Observable
O	1208	1214	trends
O	1215	1219	were
O	1220	1230	identified
O	1231	1233	in
O	1234	1237	the
O	1238	1247	screening
O	1248	1258	population
O	1259	1264	since
O	1265	1268	the
O	1269	1283	implementation
O	1284	1286	of
O	1287	1299	telemedicine
O	1300	1309	screening
O	1309	1310	:
O	1311	1314	the
O	1315	1321	number
O	1322	1324	of
O	1325	1330	known
B-Disease	1331	1333	DR
O	1334	1339	cases
O	1340	1343	has
O	1344	1353	increased
O	1353	1354	,
O	1355	1358	the
O	1359	1366	overall
O	1367	1370	age
O	1371	1373	of
O	1374	1382	patients
O	1383	1392	receiving
O	1393	1403	screenings
O	1404	1407	has
O	1408	1417	decreased
O	1417	1418	,
O	1419	1422	the
O	1423	1433	percentage
O	1434	1436	of
B-Characteristic	1437	1446	nonwhites
O	1447	1456	receiving
O	1457	1467	screenings
O	1468	1471	has
O	1472	1481	increased
O	1481	1482	,
O	1483	1486	the
O	1487	1494	average
O	1495	1501	number
O	1502	1504	of
O	1505	1510	miles
O	1511	1519	traveled
O	1520	1522	by
O	1523	1524	a
O	1525	1532	patient
O	1533	1535	to
O	1536	1543	receive
O	1544	1545	a
O	1546	1555	screening
O	1556	1559	has
O	1560	1569	decreased
O	1569	1570	,
O	1571	1574	and
O	1575	1578	the
O	1579	1590	teleretinal
O	1591	1600	screening
O	1601	1614	participation
O	1615	1617	is
O	1618	1628	increasing
O	1628	1629	.

O	1630	1633	The
O	1634	1641	current
B-Diagnostic_tool	1642	1653	teleretinal
I-Diagnostic_tool	1654	1663	screening
I-Diagnostic_tool	1664	1671	program
O	1672	1674	is
O	1675	1684	effective
O	1685	1687	in
O	1688	1693	terms
O	1694	1696	of
O	1697	1702	being
O	1703	1707	cost
O	1707	1708	-
O	1708	1717	effective
O	1718	1721	and
O	1722	1732	increasing
O	1733	1743	population
O	1744	1749	reach
O	1749	1750	.

O	1751	1757	Future
O	1758	1767	screening
O	1768	1776	policies
O	1777	1783	should
O	1784	1788	give
O	1789	1802	consideration
O	1803	1805	to
O	1806	1809	the
O	1810	1813	age
O	1814	1816	of
O	1817	1825	patients
O	1826	1835	receiving
O	1836	1846	screenings
O	1847	1850	and
O	1851	1854	the
O	1855	1861	system
O	1861	1862	'
O	1862	1863	s
O	1864	1871	patient
O	1872	1876	pool
O	1877	1881	size
O	1882	1889	because
O	1890	1893	our
O	1894	1901	results
O	1902	1910	indicate
O	1911	1913	it
O	1914	1916	is
O	1917	1920	not
O	1921	1925	cost
O	1925	1926	-
O	1926	1935	effective
O	1936	1938	to
O	1939	1945	screen
O	1946	1954	patients
B-Characteristic	1955	1959	aged
I-Characteristic	1960	1965	older
I-Characteristic	1966	1970	than
I-Characteristic	1971	1973	80
I-Characteristic	1974	1979	years
O	1980	1982	or
O	1983	1985	in
O	1986	1997	populations
O	1998	2002	with
O	2004	2005	<
O	2006	2010	3500
O	2011	2019	patients
O	2019	2020	.

B-Disease	0	5	Aging
I-Disease	6	13	macular
I-Disease	14	26	degeneration
O	26	27	.

O	28	36	Clinical
O	37	45	features
O	46	48	of
O	49	58	treatable
O	59	66	disease
O	66	67	.

O	69	74	Argon
O	75	80	laser
O	81	90	treatment
O	91	98	reduces
B-Symptom	99	105	visual
I-Symptom	106	110	loss
O	111	113	in
O	114	122	patients
O	123	127	with
B-Disease	128	132	aged
I-Disease	133	140	macular
I-Disease	141	153	degeneration
O	154	157	and
B-Symptom	158	169	extrafoveal
I-Symptom	170	180	subretinal
I-Symptom	181	192	neovascular
I-Symptom	193	202	membranes
O	203	204	(
B-Symptom	204	209	SRNVM
O	209	210	)
O	210	211	.

O	212	228	Ophthalmologists
O	229	233	must
O	234	237	now
O	238	245	educate
O	246	254	patients
O	255	265	concerning
O	266	269	the
O	270	278	symptoms
O	279	281	of
B-Symptom	282	292	subretinal
I-Symptom	293	311	neovascularization
O	312	315	and
O	316	320	give
O	321	325	them
O	326	328	an
B-Diagnostic_tool	329	335	Amsler
I-Diagnostic_tool	336	340	grid
O	340	341	.

O	342	344	If
O	345	346	a
O	347	354	patient
O	355	363	develops
O	364	372	symptoms
O	373	375	he
O	376	382	should
O	383	385	be
O	386	394	examined
O	395	403	promptly
O	403	404	.

B-Diagnostic_tool	405	409	High
I-Diagnostic_tool	410	417	quality
I-Diagnostic_tool	418	429	fluorescein
I-Diagnostic_tool	430	440	angiograms
O	441	444	and
O	445	455	meticulous
B-Diagnostic_tool	456	463	contact
I-Diagnostic_tool	464	468	lens
I-Diagnostic_tool	469	481	examinations
O	482	484	of
O	485	488	the
B-Anatomy	489	495	macula
O	496	502	should
O	503	505	be
O	506	515	performed
O	516	518	to
O	519	525	detect
O	526	532	subtle
B-Symptom	533	551	neovascularization
O	551	552	.

O	553	569	Ophthalmologists
O	570	574	must
O	575	577	be
O	578	586	familiar
O	587	591	with
O	592	595	the
B-Characteristic	596	604	clinical
I-Characteristic	605	608	and
I-Characteristic	609	620	fluorescein
I-Characteristic	621	633	angiographic
I-Characteristic	634	641	changes
I-Characteristic	642	644	of
I-Characteristic	645	651	drusen
I-Characteristic	651	652	,
I-Characteristic	653	660	retinal
I-Characteristic	661	668	pigment
I-Characteristic	669	679	epithelial
I-Characteristic	680	687	atrophy
I-Characteristic	687	688	,
I-Characteristic	689	692	and
I-Characteristic	693	700	retinal
I-Characteristic	701	708	pigment
I-Characteristic	709	719	epithelial
I-Characteristic	720	731	detachments
O	732	734	in
O	735	740	order
O	741	743	to
O	744	757	differentiate
O	758	762	them
O	763	767	from
B-Symptom	768	778	subretinal
I-Symptom	779	790	neovascular
I-Symptom	791	800	membranes
O	800	801	.

B-Diagnostic_tool	0	12	Pretreatment
I-Diagnostic_tool	13	21	anterior
I-Diagnostic_tool	22	29	segment
I-Diagnostic_tool	30	37	imaging
O	38	44	during
B-Disease	45	50	acute
I-Disease	51	58	primary
I-Disease	59	64	angle
I-Disease	65	72	closure
O	72	73	:
O	74	82	insights
O	83	87	into
O	88	93	angle
O	94	101	closure
O	102	112	mechanisms
O	113	115	in
O	116	119	the
O	120	125	acute
O	126	131	phase
O	131	132	.

O	134	136	To
O	137	145	describe
B-Diagnostic_tool	146	154	anterior
I-Diagnostic_tool	155	162	segment
I-Diagnostic_tool	163	170	optical
I-Diagnostic_tool	171	180	coherence
I-Diagnostic_tool	181	191	tomography
O	192	193	(
B-Diagnostic_tool	193	198	ASOCT
O	198	199	)
O	200	210	parameters
O	211	217	during
B-Disease	218	223	acute
I-Disease	224	231	primary
I-Disease	232	237	angle
I-Disease	238	245	closure
O	246	247	(
B-Disease	247	251	APAC
O	251	252	)
O	253	259	before
O	260	271	therapeutic
O	272	285	interventions
O	286	289	and
O	290	301	comparative
O	302	310	analyses
O	311	313	of
O	314	323	biometric
O	324	334	parameters
O	335	337	of
B-Disease	338	342	APAC
B-Anatomy	343	347	eyes
O	348	352	with
O	353	359	fellow
B-Anatomy	360	364	eyes
O	364	365	.

O	366	377	Prospective
O	377	378	,
O	379	390	comparative
O	391	395	case
O	396	402	series
O	402	403	.

O	404	410	Thirty
O	410	411	-
O	411	414	one
O	415	426	consecutive
O	427	435	patients
O	436	440	with
B-Disease	441	445	APAC
O	445	446	.

O	447	450	All
O	451	459	patients
O	460	469	underwent
B-Diagnostic_tool	470	475	ASOCT
I-Diagnostic_tool	476	483	imaging
O	484	486	of
O	487	491	both
B-Anatomy	492	496	eyes
O	497	503	during
O	504	507	the
O	508	514	attack
O	514	515	,
O	516	522	before
O	523	534	therapeutic
O	535	548	interventions
O	549	553	were
O	554	566	administered
O	566	567	.

O	568	574	Custom
O	575	583	software
O	584	587	was
O	588	592	used
O	593	595	to
O	596	603	measure
B-Characteristic	604	612	anterior
I-Characteristic	613	620	chamber
I-Characteristic	621	626	depth
O	627	628	(
B-Characteristic	628	631	ACD
O	631	632	)
O	632	633	,
B-Characteristic	634	642	anterior
I-Characteristic	643	650	chamber
I-Characteristic	651	655	area
O	656	657	(
B-Characteristic	657	660	ACA
O	660	661	)
O	661	662	,
B-Characteristic	663	671	anterior
I-Characteristic	672	679	chamber
I-Characteristic	680	686	volume
O	687	688	(
B-Characteristic	688	691	ACV
O	691	692	)
O	692	693	,
B-Characteristic	694	698	iris
I-Characteristic	699	708	curvature
O	709	710	(
B-Characteristic	710	711	I
I-Characteristic	711	712	-
I-Characteristic	712	716	Curv
O	716	717	)
O	717	718	,
B-Characteristic	719	723	iris
I-Characteristic	724	728	area
O	729	730	(
B-Characteristic	730	731	I
I-Characteristic	731	732	-
I-Characteristic	732	736	Area
O	736	737	)
O	737	738	,
B-Characteristic	739	743	lens
I-Characteristic	744	749	vault
O	750	751	(
B-Characteristic	751	753	LV
O	753	754	)
O	754	755	,
O	756	759	and
B-Characteristic	760	765	angle
I-Characteristic	766	773	opening
I-Characteristic	774	782	distance
O	783	784	(
B-Characteristic	784	790	AOD750
O	790	791	)
O	791	792	,
B-Characteristic	793	803	trabecular
I-Characteristic	804	808	iris
I-Characteristic	809	814	space
I-Characteristic	815	819	area
O	820	821	(
B-Characteristic	821	828	TISA750
O	828	829	)
O	829	830	,
O	831	834	and
B-Characteristic	835	839	iris
I-Characteristic	840	849	thickness
I-Characteristic	850	851	(
I-Characteristic	851	856	IT750
I-Characteristic	856	857	)
I-Characteristic	858	860	at
I-Characteristic	861	864	750
I-Characteristic	865	866	
I-Characteristic	866	867	m
I-Characteristic	868	872	from
I-Characteristic	873	876	the
I-Characteristic	877	884	scleral
I-Characteristic	885	889	spur
O	889	890	.

O	891	903	Multivariate
O	904	912	logistic
O	913	923	regression
O	924	932	modeling
O	933	938	using
O	939	946	forward
O	947	956	selection
O	957	960	was
O	961	965	used
O	966	968	to
O	969	978	determine
O	979	982	the
O	983	987	most
O	988	997	important
O	998	1007	biometric
O	1008	1017	variables
O	1018	1028	associated
O	1029	1033	with
B-Disease	1034	1038	APAC
O	1039	1047	compared
O	1048	1052	with
O	1053	1056	the
O	1057	1063	fellow
B-Anatomy	1064	1067	eye
O	1068	1074	during
O	1075	1078	the
O	1079	1085	attack
O	1085	1086	.

B-Characteristic	1087	1095	Anterior
I-Characteristic	1096	1103	segment
I-Characteristic	1104	1113	biometric
I-Characteristic	1114	1124	parameters
O	1125	1135	associated
O	1136	1140	with
B-Disease	1141	1145	APAC
O	1145	1146	.

O	1147	1150	The
B-Characteristic	1151	1155	mean
I-Characteristic	1156	1159	age
I-Characteristic	1160	1162	of
I-Characteristic	1163	1166	the
I-Characteristic	1167	1175	patients
I-Characteristic	1176	1179	was
I-Characteristic	1180	1182	60
I-Characteristic	1182	1183	.
I-Characteristic	1183	1184	9
I-Characteristic	1184	1185	
I-Characteristic	1185	1186	7
I-Characteristic	1186	1187	.
I-Characteristic	1187	1188	5
I-Characteristic	1189	1194	years
O	1194	1195	,
O	1196	1199	and
O	1200	1202	11
O	1203	1211	patients
O	1212	1213	(
O	1213	1215	35
O	1215	1216	.
O	1216	1217	5
O	1217	1218	%
O	1218	1219	)
O	1220	1224	were
B-Characteristic	1225	1229	male
O	1229	1230	.

O	1231	1234	The
B-Characteristic	1235	1239	mean
I-Characteristic	1240	1251	intraocular
I-Characteristic	1252	1260	pressure
O	1261	1264	was
O	1265	1266	3
O	1266	1267	.
O	1267	1268	8
O	1268	1269	
O	1269	1270	9
O	1270	1271	.
O	1271	1272	2
O	1273	1277	mmHg
O	1278	1280	in
O	1281	1284	the
B-Disease	1285	1289	APAC
B-Anatomy	1290	1293	eye
O	1294	1297	and
O	1298	1299	4
O	1299	1300	.
O	1300	1301	2
O	1301	1302	
O	1302	1303	4
O	1303	1304	.
O	1304	1305	3
O	1306	1310	mmHg
O	1311	1313	in
O	1314	1317	the
O	1318	1324	fellow
B-Anatomy	1325	1328	eye
O	1329	1335	before
O	1336	1345	treatment
O	1346	1347	(
O	1347	1348	P
O	1350	1351	<
O	1352	1353	0
O	1353	1354	.
O	1354	1357	001
O	1357	1358	)
O	1358	1359	.

O	1360	1365	After
O	1366	1376	adjustment
O	1377	1380	for
B-Characteristic	1381	1386	pupil
I-Characteristic	1387	1395	diameter
O	1395	1396	,
B-Disease	1397	1401	APAC
B-Anatomy	1402	1406	eyes
O	1407	1410	had
O	1411	1418	smaller
B-Characteristic	1419	1422	ACD
O	1422	1423	,
B-Characteristic	1424	1427	ACA
O	1427	1428	,
B-Characteristic	1429	1432	ACV
O	1432	1433	,
B-Characteristic	1434	1435	I
I-Characteristic	1435	1436	-
I-Characteristic	1436	1440	Curv
O	1441	1442	(
O	1442	1445	all
O	1446	1447	P
O	1449	1450	<
O	1451	1452	0
O	1452	1453	.
O	1453	1456	001
O	1456	1457	)
O	1457	1458	,
B-Characteristic	1459	1465	AOD750
O	1466	1467	(
O	1467	1468	P
O	1469	1470	=
O	1471	1472	0
O	1472	1473	.
O	1473	1476	037
O	1476	1477	)
O	1477	1478	,
B-Characteristic	1479	1486	TISA750
O	1487	1488	(
O	1488	1489	P
O	1490	1491	=
O	1492	1493	0
O	1493	1494	.
O	1494	1497	043
O	1497	1498	)
O	1498	1499	,
B-Characteristic	1500	1501	I
I-Characteristic	1501	1502	-
I-Characteristic	1502	1506	Area
O	1507	1508	(
O	1508	1509	P
O	1510	1511	=
O	1512	1513	0
O	1513	1514	.
O	1514	1517	027
O	1517	1518	)
O	1518	1519	,
O	1520	1523	and
B-Characteristic	1524	1529	IT750
O	1530	1531	(
O	1531	1532	P
O	1533	1534	=
O	1535	1536	0
O	1536	1537	.
O	1537	1540	002
O	1540	1541	)
O	1542	1545	and
O	1546	1552	larger
B-Characteristic	1553	1555	LV
O	1556	1557	(
O	1557	1558	P
O	1559	1560	=
O	1561	1562	0
O	1562	1563	.
O	1563	1566	041
O	1566	1567	)
O	1568	1572	than
O	1573	1579	fellow
B-Anatomy	1580	1584	eyes
O	1584	1585	.

O	1586	1588	An
O	1589	1596	optimal
O	1597	1602	model
O	1603	1613	consisting
O	1614	1616	of
O	1617	1618	3
O	1619	1628	variables
O	1629	1630	(
B-Characteristic	1630	1635	pupil
I-Characteristic	1636	1644	diameter
O	1644	1645	,
B-Characteristic	1646	1649	ACD
O	1649	1650	,
O	1651	1654	and
B-Characteristic	1655	1656	I
I-Characteristic	1656	1657	-
I-Characteristic	1657	1661	Curv
O	1661	1662	)
O	1663	1672	explained
O	1673	1675	36
O	1675	1676	.
O	1676	1677	7
O	1677	1678	%
O	1679	1681	of
O	1682	1685	the
O	1686	1694	variance
O	1695	1697	in
B-Disease	1698	1702	APAC
O	1703	1713	occurrence
O	1713	1714	,
O	1715	1719	with
B-Characteristic	1720	1723	ACD
O	1724	1734	accounting
O	1735	1738	for
O	1739	1741	18
O	1741	1742	.
O	1742	1743	1
O	1743	1744	%
O	1745	1748	and
B-Characteristic	1749	1750	I
I-Characteristic	1750	1751	-
I-Characteristic	1751	1755	Curv
O	1756	1766	accounting
O	1767	1770	for
O	1771	1773	14
O	1773	1774	.
O	1774	1775	1
O	1775	1776	%
O	1777	1779	of
O	1780	1784	this
O	1785	1793	variance
O	1793	1794	.

B-Characteristic	1795	1804	Shallower
I-Characteristic	1805	1808	ACD
O	1809	1812	and
B-Characteristic	1813	1820	smaller
I-Characteristic	1821	1822	I
I-Characteristic	1822	1823	-
I-Characteristic	1823	1827	Curv
O	1828	1832	were
O	1833	1836	the
O	1837	1838	2
O	1839	1843	main
B-Characteristic	1844	1852	anterior
I-Characteristic	1853	1860	segment
I-Characteristic	1861	1870	biometric
I-Characteristic	1871	1881	parameters
O	1882	1892	associated
O	1893	1897	with
B-Disease	1898	1902	APAC
O	1903	1909	during
O	1910	1913	the
O	1914	1920	attack
O	1920	1921	.

O	1922	1927	These
O	1928	1936	findings
O	1937	1944	present
O	1945	1948	new
O	1949	1957	insights
O	1958	1962	into
O	1963	1966	the
B-Characteristic	1967	1975	anterior
I-Characteristic	1976	1983	segment
I-Characteristic	1984	1993	biometric
I-Characteristic	1994	2004	parameters
O	2005	2007	of
B-Disease	2008	2012	APAC
O	2013	2016	and
O	2017	2023	fellow
B-Anatomy	2024	2028	eyes
O	2029	2035	before
O	2036	2047	therapeutic
O	2048	2061	interventions
O	2061	2062	.

B-Symptom	2063	2071	Anatomic
I-Symptom	2072	2079	changes
I-Symptom	2080	2082	in
I-Symptom	2083	2086	the
I-Symptom	2087	2095	anterior
I-Symptom	2096	2103	segment
O	2104	2113	explained
O	2114	2118	only
O	2119	2124	about
O	2125	2128	one
O	2129	2134	third
O	2135	2137	of
O	2138	2141	the
O	2142	2150	variance
O	2151	2153	in
B-Disease	2154	2158	APAC
O	2159	2169	occurrence
O	2169	2170	,
O	2171	2174	and
O	2175	2178	the
O	2179	2183	role
O	2184	2186	of
O	2187	2198	nonanatomic
O	2199	2206	factors
O	2207	2214	require
O	2215	2222	further
O	2223	2236	investigation
O	2236	2237	.

O	0	12	Quantitative
O	13	25	measurements
O	26	28	of
O	29	32	the
B-Anatomy	33	40	ciliary
I-Anatomy	41	45	body
O	46	48	in
B-Anatomy	49	53	eyes
O	54	58	with
B-Disease	59	68	malignant
I-Disease	69	77	glaucoma
O	78	83	after
O	84	98	trabeculectomy
O	99	104	using
B-Diagnostic_tool	105	115	ultrasound
I-Diagnostic_tool	116	129	biomicroscopy
O	129	130	.

O	132	134	To
O	135	143	evaluate
O	144	147	and
O	148	155	compare
O	156	159	the
O	160	170	structural
O	171	182	differences
O	183	185	of
O	186	189	the
B-Anatomy	190	197	ciliary
I-Anatomy	198	202	body
O	203	205	in
B-Anatomy	206	210	eyes
O	211	215	with
O	216	219	and
O	220	227	without
B-Disease	228	237	malignant
I-Disease	238	246	glaucoma
O	246	247	.

O	248	253	Cross
O	253	254	-
O	254	263	sectional
O	264	269	study
O	269	270	.

O	271	277	Twenty
O	277	278	-
O	278	283	seven
O	284	295	consecutive
O	296	304	patients
O	305	314	diagnosed
O	315	319	with
B-Disease	320	329	malignant
I-Disease	330	338	glaucoma
O	339	341	in
O	342	343	1
B-Anatomy	344	347	eye
O	348	353	after
O	354	368	trabeculectomy
O	369	373	were
O	374	383	recruited
O	383	384	.

O	385	389	They
O	390	394	were
O	395	398	all
O	399	409	originally
O	410	419	diagnosed
O	420	424	with
B-Disease	425	432	primary
I-Disease	433	438	angle
I-Disease	439	446	closure
O	447	448	(
B-Disease	448	451	PAC
O	451	452	)
O	453	455	or
B-Disease	456	459	PAC
I-Disease	460	468	glaucoma
O	469	470	(
B-Disease	470	474	PACG
O	474	475	)
O	475	476	.

O	477	483	Twenty
O	483	484	-
O	484	489	seven
B-Disease	490	493	PAC
O	493	494	/
B-Disease	494	498	PACG
B-Anatomy	499	503	eyes
O	504	506	of
O	507	509	27
O	510	518	patients
O	519	522	who
O	523	526	had
O	527	536	undergone
O	537	547	uneventful
O	548	562	trabeculectomy
O	563	565	in
O	566	569	the
O	570	574	same
O	575	581	period
O	582	586	were
O	587	591	also
O	592	601	recruited
O	601	602	.

O	603	607	They
O	608	612	were
O	613	623	comparable
O	624	628	with
O	629	632	the
O	633	639	fellow
B-Anatomy	640	644	eyes
O	645	647	of
O	648	651	the
B-Disease	652	661	malignant
I-Disease	662	670	glaucoma
O	671	679	patients
O	680	682	in
O	683	688	terms
O	689	691	of
O	692	700	surgical
O	701	705	type
O	705	706	,
B-Disease	707	715	glaucoma
O	716	720	type
O	720	721	,
O	722	725	and
O	726	731	stage
O	731	732	.

B-Diagnostic_tool	733	734	A
I-Diagnostic_tool	734	735	-
I-Diagnostic_tool	735	739	scan
I-Diagnostic_tool	740	755	ultrasonography
O	756	759	and
B-Diagnostic_tool	760	770	ultrasound
I-Diagnostic_tool	771	784	biomicroscopy
O	785	797	measurements
O	798	802	were
O	803	812	performed
O	813	815	on
O	816	819	the
B-Anatomy	820	824	eyes
O	825	829	with
B-Disease	830	839	malignant
I-Disease	840	848	glaucoma
O	848	849	,
O	850	853	the
O	854	860	fellow
B-Anatomy	861	865	eyes
O	866	868	of
O	869	872	the
O	873	881	patients
O	882	886	with
B-Disease	887	896	malignant
I-Disease	897	905	glaucoma
O	905	906	,
O	907	910	and
O	911	914	the
O	915	922	matched
B-Anatomy	923	927	eyes
O	927	928	.

B-Characteristic	929	936	Ciliary
I-Characteristic	937	941	body
I-Characteristic	942	952	parameters
O	953	961	included
B-Characteristic	962	969	maximum
I-Characteristic	970	977	ciliary
I-Characteristic	978	982	body
I-Characteristic	983	992	thickness
O	993	994	(
B-Characteristic	994	1000	CBTmax
O	1000	1001	)
O	1001	1002	,
B-Characteristic	1003	1010	ciliary
I-Characteristic	1011	1015	body
I-Characteristic	1016	1025	thickness
I-Characteristic	1026	1028	at
I-Characteristic	1029	1032	the
I-Characteristic	1033	1038	point
I-Characteristic	1039	1041	of
I-Characteristic	1042	1045	the
I-Characteristic	1046	1053	scleral
I-Characteristic	1054	1058	spur
I-Characteristic	1059	1060	(
I-Characteristic	1060	1064	CBT0
I-Characteristic	1064	1065	)
I-Characteristic	1066	1069	and
I-Characteristic	1070	1074	1000
I-Characteristic	1075	1076	
I-Characteristic	1076	1077	m
I-Characteristic	1078	1082	from
I-Characteristic	1083	1086	the
I-Characteristic	1087	1094	scleral
I-Characteristic	1095	1099	spur
I-Characteristic	1100	1101	(
I-Characteristic	1101	1108	CBT1000
I-Characteristic	1108	1109	)
O	1109	1110	,
B-Characteristic	1111	1119	anterior
I-Characteristic	1120	1129	placement
I-Characteristic	1130	1132	of
I-Characteristic	1133	1136	the
I-Characteristic	1137	1144	ciliary
I-Characteristic	1145	1149	body
O	1150	1151	(
B-Characteristic	1151	1155	APCB
O	1155	1156	)
O	1156	1157	,
O	1158	1161	and
O	1162	1165	the
B-Characteristic	1166	1176	trabecular
I-Characteristic	1176	1177	-
I-Characteristic	1177	1184	ciliary
I-Characteristic	1185	1192	process
I-Characteristic	1193	1198	angle
O	1199	1200	(
B-Characteristic	1200	1203	TCA
O	1203	1204	)
O	1204	1205	.

B-Characteristic	1206	1215	Biometric
I-Characteristic	1216	1228	measurements
O	1229	1238	including
B-Characteristic	1239	1244	axial
I-Characteristic	1245	1251	length
O	1251	1252	,
B-Characteristic	1253	1260	central
I-Characteristic	1261	1269	anterior
I-Characteristic	1270	1277	chamber
I-Characteristic	1278	1283	depth
O	1284	1285	(
B-Characteristic	1285	1288	ACD
O	1288	1289	)
O	1289	1290	,
B-Characteristic	1291	1296	pupil
I-Characteristic	1297	1305	diameter
O	1306	1307	(
B-Characteristic	1307	1309	PD
O	1309	1310	)
O	1310	1311	,
B-Characteristic	1312	1320	anterior
I-Characteristic	1321	1328	chamber
I-Characteristic	1329	1334	width
O	1334	1335	,
O	1336	1339	and
B-Characteristic	1340	1344	lens
I-Characteristic	1345	1350	vault
O	1351	1352	(
B-Characteristic	1352	1354	LV
O	1354	1355	)
O	1356	1360	were
O	1361	1365	also
O	1366	1374	recorded
O	1374	1375	.

O	1376	1383	Average
B-Characteristic	1384	1390	CBTmax
O	1391	1395	were
O	1396	1397	0
O	1397	1398	.
O	1398	1401	545
O	1401	1402	
O	1402	1403	0
O	1403	1404	.
O	1404	1407	088
O	1408	1409	(
O	1409	1413	mean
O	1414	1415	
O	1416	1424	standard
O	1425	1434	deviation
O	1434	1435	)
O	1435	1436	,
O	1437	1438	0
O	1438	1439	.
O	1439	1442	855
O	1442	1443	
O	1443	1444	0
O	1444	1445	.
O	1445	1448	170
O	1448	1449	,
O	1450	1453	and
O	1454	1455	0
O	1455	1456	.
O	1456	1459	960
O	1459	1460	
O	1460	1461	0
O	1461	1462	.
O	1462	1465	127
O	1466	1468	mm
O	1469	1471	in
B-Anatomy	1472	1476	eyes
O	1477	1481	with
B-Disease	1482	1491	malignant
I-Disease	1492	1500	glaucoma
O	1500	1501	,
O	1502	1507	their
O	1508	1514	fellow
B-Anatomy	1515	1519	eyes
O	1519	1520	,
O	1521	1524	and
O	1525	1528	the
O	1529	1536	matched
B-Anatomy	1537	1541	eyes
O	1541	1542	,
O	1543	1555	respectively
O	1555	1556	.

O	1557	1564	Average
B-Characteristic	1565	1569	APCB
O	1570	1574	were
O	1575	1576	0
O	1576	1577	.
O	1577	1580	860
O	1580	1581	
O	1581	1582	0
O	1582	1583	.
O	1583	1586	176
O	1586	1587	,
O	1588	1589	0
O	1589	1590	.
O	1590	1593	608
O	1593	1594	
O	1594	1595	0
O	1595	1596	.
O	1596	1599	219
O	1599	1600	,
O	1601	1604	and
O	1605	1606	0
O	1606	1607	.
O	1607	1610	427
O	1610	1611	
O	1611	1612	0
O	1612	1613	.
O	1613	1616	139
O	1617	1619	mm
O	1619	1620	,
O	1621	1633	respectively
O	1633	1634	.

O	1635	1642	Average
B-Characteristic	1643	1646	TCA
O	1647	1651	were
O	1652	1654	18
O	1654	1655	.
O	1655	1657	49
O	1657	1658	
O	1658	1659	4
O	1659	1660	.
O	1660	1662	12
O	1662	1663	,
O	1664	1666	41
O	1666	1667	.
O	1667	1669	79
O	1669	1670	
O	1670	1672	17
O	1672	1673	.
O	1673	1675	27
O	1675	1676	,
O	1677	1680	and
O	1681	1683	48
O	1683	1684	.
O	1684	1686	53
O	1686	1687	
O	1687	1689	10
O	1689	1690	.
O	1690	1692	38
O	1693	1700	degrees
O	1700	1701	,
O	1702	1714	respectively
O	1714	1715	.

O	1716	1719	The
B-Characteristic	1720	1726	CBTmax
O	1726	1727	,
B-Characteristic	1728	1732	CBT0
O	1732	1733	,
B-Characteristic	1734	1741	CBT1000
O	1741	1742	,
O	1743	1746	and
B-Characteristic	1747	1750	TCA
O	1751	1755	were
O	1756	1763	smaller
O	1763	1764	,
O	1765	1772	whereas
B-Characteristic	1773	1777	APCB
O	1778	1781	was
O	1782	1788	larger
O	1789	1791	in
B-Anatomy	1792	1796	eyes
O	1797	1801	with
B-Disease	1802	1811	malignant
I-Disease	1812	1820	glaucoma
O	1821	1829	compared
O	1830	1834	with
O	1835	1840	their
O	1841	1847	fellow
B-Anatomy	1848	1852	eyes
O	1853	1854	(
O	1854	1855	P
O	1857	1858	<
O	1860	1861	0
O	1861	1862	.
O	1862	1864	01
O	1864	1865	)
O	1865	1866	.

O	1867	1870	The
O	1871	1877	fellow
B-Anatomy	1878	1882	eyes
O	1883	1886	had
O	1887	1893	larger
B-Characteristic	1894	1898	APCB
O	1899	1902	and
O	1903	1910	smaller
B-Characteristic	1911	1917	CBTmax
O	1918	1921	and
B-Characteristic	1922	1926	CBT0
O	1927	1931	than
O	1932	1935	the
O	1936	1943	matched
B-Anatomy	1944	1948	eyes
O	1949	1950	(
O	1950	1951	P
O	1953	1954	<
O	1956	1957	0
O	1957	1958	.
O	1958	1960	05
O	1960	1961	)
O	1961	1962	.

O	1963	1966	The
B-Characteristic	1967	1970	ACD
O	1970	1971	,
B-Characteristic	1972	1980	anterior
I-Characteristic	1981	1988	chamber
I-Characteristic	1989	1994	width
O	1994	1995	,
O	1996	1999	and
B-Characteristic	2000	2002	PD
O	2003	2007	were
O	2008	2015	smaller
O	2015	2016	,
O	2017	2024	whereas
B-Characteristic	2025	2027	LV
O	2028	2031	was
O	2032	2038	larger
O	2039	2041	in
B-Anatomy	2042	2046	eyes
O	2047	2051	with
B-Disease	2052	2061	malignant
I-Disease	2062	2070	glaucoma
O	2071	2079	compared
O	2080	2084	with
O	2085	2090	their
O	2091	2097	fellow
B-Anatomy	2098	2102	eyes
O	2103	2104	(
O	2104	2105	P
O	2107	2108	<
O	2110	2111	0
O	2111	2112	.
O	2112	2114	05
O	2114	2115	)
O	2115	2116	.

O	2117	2119	No
O	2120	2131	differences
O	2132	2136	were
O	2137	2142	found
O	2143	2145	in
O	2146	2149	the
B-Characteristic	2150	2153	ACD
O	2153	2154	,
B-Characteristic	2155	2163	anterior
I-Characteristic	2164	2171	chamber
I-Characteristic	2172	2177	width
O	2177	2178	,
B-Characteristic	2179	2181	PD
O	2181	2182	,
O	2183	2185	or
B-Characteristic	2186	2188	LV
O	2189	2196	between
O	2197	2200	the
O	2201	2207	fellow
B-Anatomy	2208	2212	eyes
O	2213	2215	of
B-Disease	2216	2225	malignant
I-Disease	2226	2234	glaucoma
O	2235	2238	and
O	2239	2246	matched
B-Anatomy	2247	2251	eyes
O	2252	2253	(
O	2253	2254	P
O	2256	2257	>
O	2259	2260	0
O	2260	2261	.
O	2261	2262	1
O	2262	2263	)
O	2263	2264	.

O	2265	2268	The
B-Symptom	2269	2276	ciliary
I-Symptom	2277	2283	bodies
I-Symptom	2284	2288	were
I-Symptom	2289	2296	thinner
I-Symptom	2297	2300	and
I-Symptom	2301	2305	more
I-Symptom	2306	2316	anteriorly
I-Symptom	2317	2324	rotated
O	2325	2327	in
B-Anatomy	2328	2332	eyes
O	2333	2337	with
B-Disease	2338	2347	malignant
I-Disease	2348	2356	glaucoma
O	2357	2359	as
O	2360	2364	well
O	2365	2367	as
O	2368	2370	in
O	2371	2376	their
O	2377	2383	fellow
B-Anatomy	2384	2388	eyes
O	2388	2389	,
O	2390	2395	which
O	2396	2399	may
O	2400	2402	be
O	2403	2406	the
O	2407	2419	predisposing
O	2420	2426	factor
O	2427	2430	for
B-Disease	2431	2440	malignant
I-Disease	2441	2449	glaucoma
O	2449	2450	.

O	0	10	Predicting
O	11	20	adherence
O	21	23	to
B-Disease	24	32	diabetic
B-Anatomy	33	36	eye
O	37	49	examinations
O	49	50	:
O	51	62	development
O	63	65	of
O	66	69	the
O	70	80	compliance
B-Classification_system	81	91	withAnnual
I-Classification_system	92	100	Diabetic
I-Classification_system	101	104	Eye
I-Classification_system	105	110	Exams
I-Classification_system	111	117	Survey
O	117	118	.

O	120	122	To
O	123	131	identify
O	132	141	variables
O	142	146	that
O	147	154	predict
O	155	164	adherence
O	165	169	with
O	170	176	annual
B-Anatomy	177	180	eye
O	181	193	examinations
O	194	199	using
O	200	203	the
O	204	214	Compliance
O	215	219	with
B-Classification_system	220	226	Annual
I-Classification_system	227	235	Diabetic
I-Classification_system	236	239	Eye
I-Classification_system	240	245	Exams
I-Classification_system	246	252	Survey
O	253	254	(
B-Classification_system	254	260	CADEES
O	260	261	)
O	261	262	,
O	263	264	a
O	265	268	new
O	269	282	questionnaire
O	283	291	designed
O	292	294	to
O	295	302	measure
O	303	309	health
O	310	317	beliefs
O	318	325	related
O	326	328	to
B-Disease	329	337	diabetic
I-Disease	338	349	retinopathy
O	350	353	and
O	354	360	annual
B-Anatomy	361	364	eye
O	365	377	examinations
O	377	378	.

O	379	392	Questionnaire
O	393	404	development
O	404	405	.

O	406	411	Three
O	412	419	hundred
O	420	427	sixteen
B-Characteristic	428	434	adults
O	435	439	with
B-Disease	440	448	diabetes
O	448	449	.

O	450	452	We
O	453	462	developed
O	463	466	the
B-Classification_system	467	473	CADEES
O	474	479	based
O	480	482	on
O	483	484	a
O	485	491	review
O	492	494	of
O	495	498	the
O	499	509	literature
O	509	510	,
O	511	514	the
O	515	524	framework
O	525	527	of
O	528	531	the
O	532	538	Health
O	539	545	Belief
O	546	551	Model
O	551	552	,
O	553	559	expert
O	560	567	opinion
O	567	568	,
O	569	572	and
O	573	578	pilot
O	579	584	study
O	585	589	data
O	589	590	.

O	591	593	To
O	594	601	examine
O	602	609	content
O	610	618	validity
O	618	619	,
O	620	622	we
O	623	631	analyzed
O	632	643	participant
O	644	653	responses
O	654	656	to
O	657	659	an
O	660	664	open
O	664	665	-
O	665	670	ended
O	671	679	question
O	680	686	asking
O	687	690	for
O	691	698	reasons
O	699	702	why
O	703	709	people
O	710	712	do
O	713	716	not
O	717	723	obtain
O	724	730	annual
B-Anatomy	731	734	eye
O	735	747	examinations
O	747	748	.

O	749	751	We
O	752	761	evaluated
O	762	771	construct
O	772	780	validity
O	781	785	with
O	786	795	principal
O	796	806	components
O	807	815	analysis
O	816	819	and
O	820	828	examined
O	829	837	internal
O	838	849	consistency
O	850	854	with
O	855	863	Cronbach
O	863	864	'
O	864	865	s
O	866	867	
O	867	868	.

O	869	871	To
O	872	878	assess
O	879	889	predictive
O	890	898	validity
O	898	899	,
O	900	902	we
O	903	907	used
O	908	920	multivariate
O	921	929	logistic
O	930	940	regression
O	941	945	with
O	946	950	self
O	950	951	-
O	951	959	reported
O	960	969	adherence
O	970	972	as
O	973	976	the
O	977	986	dependent
O	987	995	variable
O	995	996	.

O	997	1009	Associations
O	1010	1014	with
O	1015	1019	self
O	1019	1020	-
O	1020	1028	reported
O	1029	1038	adherence
O	1039	1040	(
O	1040	1047	defined
O	1048	1050	as
O	1051	1057	having
O	1058	1059	a
O	1060	1067	dilated
B-Anatomy	1068	1071	eye
O	1072	1083	examination
O	1084	1086	in
O	1087	1090	the
O	1091	1095	past
O	1096	1100	year
O	1100	1101	)
O	1101	1102	.

O	1103	1106	The
O	1107	1114	content
O	1115	1123	analysis
O	1124	1130	showed
O	1131	1135	that
B-Classification_system	1136	1142	CADEES
O	1143	1148	items
O	1149	1156	covered
O	1157	1159	89
O	1159	1160	%
O	1161	1163	of
O	1164	1167	the
O	1168	1175	reasons
O	1176	1181	given
O	1182	1184	by
O	1185	1197	participants
O	1198	1201	for
O	1202	1205	not
O	1206	1215	obtaining
O	1216	1218	an
O	1219	1225	annual
B-Anatomy	1226	1229	eye
O	1230	1241	examination
O	1241	1242	.

O	1243	1246	The
O	1247	1256	principal
O	1257	1267	components
O	1268	1276	analysis
O	1277	1287	identified
O	1288	1289	3
O	1290	1301	informative
O	1302	1312	components
O	1313	1317	that
O	1318	1322	made
O	1323	1325	up
O	1326	1328	32
O	1328	1329	%
O	1330	1332	of
O	1333	1336	the
O	1337	1345	variance
O	1345	1346	.

O	1347	1359	Multivariate
O	1360	1368	logistic
O	1369	1379	regression
O	1380	1388	modeling
O	1389	1397	revealed
O	1398	1405	several
O	1406	1417	significant
O	1418	1428	predictors
O	1429	1431	of
O	1432	1441	adherence
O	1441	1442	,
O	1443	1452	including
O	1453	1460	beliefs
O	1461	1471	concerning
O	1472	1479	whether
O	1480	1489	insurance
O	1490	1497	covered
O	1498	1502	most
O	1503	1505	of
O	1506	1509	the
B-Anatomy	1510	1513	eye
O	1514	1525	examination
O	1526	1530	cost
O	1531	1532	(
O	1532	1533	P
O	1535	1536	<
O	1538	1539	0
O	1539	1540	.
O	1540	1542	01
O	1542	1543	)
O	1543	1544	,
O	1545	1552	whether
O	1553	1558	there
O	1559	1563	were
O	1564	1571	general
O	1572	1580	barriers
O	1581	1585	that
O	1586	1590	make
O	1591	1593	it
O	1594	1603	difficult
O	1604	1606	to
O	1607	1613	obtain
O	1614	1616	an
B-Anatomy	1617	1620	eye
O	1621	1632	examination
O	1633	1634	(
O	1634	1635	P
O	1637	1638	<
O	1640	1641	0
O	1641	1642	.
O	1642	1644	01
O	1644	1645	)
O	1645	1646	,
O	1647	1654	whether
O	1655	1664	obtaining
O	1665	1667	an
B-Anatomy	1668	1671	eye
O	1672	1683	examination
O	1684	1687	was
O	1688	1689	a
O	1690	1693	top
O	1694	1702	priority
O	1703	1704	(
O	1704	1705	P
O	1706	1707	=
O	1708	1709	0
O	1709	1710	.
O	1710	1712	02
O	1712	1713	)
O	1713	1714	,
O	1715	1718	and
O	1719	1726	whether
B-Disease	1727	1735	diabetic
I-Disease	1736	1739	eye
I-Disease	1740	1747	disease
O	1748	1751	can
O	1752	1754	be
O	1755	1759	seen
O	1760	1764	with
O	1765	1767	an
O	1768	1779	examination
O	1780	1781	(
O	1781	1782	P
O	1783	1784	=
O	1785	1786	0
O	1786	1787	.
O	1787	1789	05
O	1789	1790	)
O	1790	1791	.

B-Characteristic	1792	1797	Lower
I-Characteristic	1798	1808	hemoglobin
I-Characteristic	1809	1812	A1c
I-Characteristic	1813	1819	levels
O	1820	1821	(
O	1821	1822	P
O	1824	1825	<
O	1827	1828	0
O	1828	1829	.
O	1829	1831	01
O	1831	1832	)
O	1832	1833	,
O	1834	1840	having
O	1841	1850	insurance
O	1851	1852	(
O	1852	1853	P
O	1854	1855	=
O	1856	1857	0
O	1857	1858	.
O	1858	1860	01
O	1860	1861	)
O	1861	1862	,
O	1863	1866	and
O	1867	1868	a
O	1869	1875	longer
B-Characteristic	1876	1884	duration
I-Characteristic	1885	1887	of
I-Characteristic	1888	1896	diabetes
O	1897	1898	(
O	1898	1899	P
O	1900	1901	=
O	1902	1903	0
O	1903	1904	.
O	1904	1906	02
O	1906	1907	)
O	1908	1912	also
O	1913	1917	were
O	1918	1928	associated
O	1929	1933	with
O	1934	1943	adherence
O	1943	1944	.

O	1945	1946	A
O	1947	1959	multivariate
O	1960	1965	model
O	1966	1976	containing
B-Classification_system	1977	1983	CADEES
O	1984	1989	items
O	1990	1993	and
O	1994	2005	demographic
O	2006	2015	variables
O	2016	2026	classified
O	2027	2032	cases
O	2033	2037	with
O	2038	2040	72
O	2040	2041	%
O	2042	2050	accuracy
O	2051	2054	and
O	2055	2064	explained
O	2065	2078	approximately
O	2079	2081	24
O	2081	2082	%
O	2083	2085	of
O	2086	2089	the
O	2090	2098	variance
O	2099	2101	in
O	2102	2111	adherence
O	2111	2112	.

O	2113	2116	The
B-Classification_system	2117	2123	CADEES
O	2124	2130	showed
O	2131	2135	good
O	2136	2143	content
O	2144	2147	and
O	2148	2158	predictive
O	2159	2167	validity
O	2167	2168	.

O	2169	2177	Although
O	2178	2188	additional
O	2189	2197	research
O	2198	2200	is
O	2201	2207	needed
O	2208	2214	before
O	2215	2225	finalizing
O	2226	2227	a
O	2228	2235	shorter
O	2236	2243	version
O	2244	2246	of
O	2247	2250	the
O	2251	2257	survey
O	2257	2258	,
O	2259	2262	our
O	2263	2271	findings
O	2272	2279	suggest
O	2280	2284	that
O	2285	2296	researchers
O	2297	2300	and
O	2301	2311	clinicians
O	2312	2315	may
O	2316	2318	be
O	2319	2323	able
O	2324	2326	to
O	2327	2334	improve
O	2335	2344	adherence
O	2345	2347	by
O	2348	2349	(
O	2349	2350	1
O	2350	2351	)
O	2352	2362	counseling
O	2363	2368	newly
O	2369	2378	diagnosed
O	2379	2387	patients
O	2387	2388	,
O	2389	2391	as
O	2392	2396	well
O	2397	2399	as
O	2400	2405	those
O	2406	2410	with
B-Characteristic	2411	2423	uncontrolled
I-Characteristic	2424	2429	blood
I-Characteristic	2430	2437	glucose
O	2437	2438	,
O	2439	2441	on
O	2442	2445	the
O	2446	2456	importance
O	2457	2459	of
O	2460	2466	annual
B-Anatomy	2467	2470	eye
O	2471	2483	examinations
O	2484	2487	and
O	2488	2489	(
O	2489	2490	2
O	2490	2491	)
O	2492	2502	discussing
O	2503	2512	perceived
O	2513	2521	barriers
O	2522	2525	and
O	2526	2540	misconceptions
O	2540	2541	.

O	0	12	Quantitative
O	13	23	assessment
O	24	26	of
B-Characteristic	27	34	retinal
I-Characteristic	35	40	nerve
I-Characteristic	41	46	fiber
I-Characteristic	47	52	layer
I-Characteristic	53	59	defect
I-Characteristic	60	65	depth
O	66	71	using
B-Diagnostic_tool	72	80	spectral
I-Diagnostic_tool	80	81	-
I-Diagnostic_tool	81	87	domain
I-Diagnostic_tool	88	95	optical
I-Diagnostic_tool	96	105	coherence
I-Diagnostic_tool	106	116	tomography
O	116	117	.

O	119	121	To
O	122	128	assess
O	129	143	quantitatively
O	144	147	the
O	148	153	depth
O	154	156	of
B-Symptom	157	164	retinal
I-Symptom	165	170	nerve
I-Symptom	171	176	fiber
I-Symptom	177	182	layer
I-Symptom	183	184	(
I-Symptom	184	188	RNFL
I-Symptom	188	189	)
I-Symptom	190	197	defects
O	198	203	using
O	204	205	a
B-Diagnostic_tool	206	212	Cirrus
I-Diagnostic_tool	213	217	high
I-Diagnostic_tool	217	218	-
I-Diagnostic_tool	218	228	definition
I-Diagnostic_tool	229	230	(
I-Diagnostic_tool	230	232	HD
I-Diagnostic_tool	232	233	)
I-Diagnostic_tool	234	241	optical
I-Diagnostic_tool	242	251	coherence
I-Diagnostic_tool	252	262	tomography
I-Diagnostic_tool	263	264	(
I-Diagnostic_tool	264	267	OCT
I-Diagnostic_tool	267	268	)
I-Diagnostic_tool	268	269	-
I-Diagnostic_tool	269	276	derived
I-Diagnostic_tool	277	281	RNFL
I-Diagnostic_tool	282	291	thickness
I-Diagnostic_tool	292	301	deviation
I-Diagnostic_tool	302	305	map
O	305	306	.

O	307	318	Prospective
O	318	319	,
O	320	325	cross
O	325	326	-
O	326	335	sectional
O	336	341	study
O	341	342	.

O	343	348	Three
O	348	349	-
O	349	356	hundred
O	357	364	fifteen
B-Anatomy	365	369	eyes
O	370	374	with
O	375	384	localized
O	385	388	and
O	389	396	diffuse
B-Symptom	397	401	RNFL
I-Symptom	402	409	defects
O	410	412	of
O	413	416	315
B-Disease	417	425	glaucoma
O	426	434	patients
O	435	438	and
O	439	442	217
B-Anatomy	443	447	eyes
O	448	450	of
O	451	454	217
O	455	462	healthy
O	463	471	subjects
O	471	472	.

O	473	476	For
O	477	480	the
B-Disease	481	489	glaucoma
O	490	498	subjects
O	498	499	,
O	500	503	the
O	504	512	severity
O	513	515	of
O	516	519	the
B-Symptom	520	524	RNFL
I-Symptom	525	531	defect
O	532	535	was
O	536	542	graded
O	543	545	on
B-Diagnostic_tool	546	549	red
I-Diagnostic_tool	549	550	-
I-Diagnostic_tool	550	554	free
I-Diagnostic_tool	555	561	fundus
I-Diagnostic_tool	562	573	photographs
O	574	576	by
O	577	578	2
O	579	588	observers
O	589	594	using
O	595	596	a
O	597	609	standardized
O	610	618	protocol
O	619	623	with
O	624	625	a
O	626	627	3
O	627	628	-
O	628	633	level
O	634	641	grading
O	642	648	system
O	648	649	.

O	650	653	The
B-Characteristic	654	658	RNFL
I-Characteristic	659	665	defect
I-Characteristic	666	671	depth
O	672	674	on
O	675	678	the
B-Diagnostic_tool	679	683	RNFL
I-Diagnostic_tool	684	693	thickness
I-Diagnostic_tool	694	703	deviation
I-Diagnostic_tool	704	707	map
O	708	711	was
O	712	721	expressed
O	722	724	as
O	725	727	an
B-Characteristic	728	732	RNFL
I-Characteristic	733	739	defect
I-Characteristic	740	745	depth
I-Characteristic	746	756	percentage
I-Characteristic	757	762	index
O	763	764	(
B-Characteristic	764	768	RDPI
O	768	769	)
O	769	770	:
O	771	774	100
O	774	775	
O	775	776	(
O	776	777	1
O	777	778	-
O	778	779	[
O	779	788	summation
O	789	791	of
B-Characteristic	792	803	thicknesses
I-Characteristic	804	806	of
I-Characteristic	807	811	RNFL
I-Characteristic	812	819	defects
O	820	821	{
O	821	824	red
O	825	827	or
O	828	834	yellow
O	835	846	superpixels
O	846	847	}
O	847	848	/
O	848	857	summation
O	858	860	of
B-Characteristic	861	865	RNFL
I-Characteristic	866	877	thicknesses
O	878	880	of
O	881	886	upper
O	887	891	95th
O	892	902	percentile
O	903	908	range
O	909	911	of
B-Characteristic	912	915	age
I-Characteristic	915	916	-
I-Characteristic	916	923	matched
I-Characteristic	924	931	healthy
O	932	940	subjects
O	941	943	in
O	944	949	areas
O	950	963	corresponding
O	964	966	to
B-Symptom	967	971	RNFL
I-Symptom	972	979	defects
O	979	980	]
O	980	981	)
O	981	982	.

B-Characteristic	983	990	Retinal
I-Characteristic	991	996	nerve
I-Characteristic	997	1002	fiber
I-Characteristic	1003	1008	layer
I-Characteristic	1009	1015	defect
I-Characteristic	1016	1021	depth
I-Characteristic	1022	1032	percentage
I-Characteristic	1033	1038	index
O	1038	1039	,
B-Characteristic	1040	1047	average
I-Characteristic	1048	1051	and
I-Characteristic	1052	1061	segmental
I-Characteristic	1062	1063	(
I-Characteristic	1063	1064	4
I-Characteristic	1065	1074	quadrants
I-Characteristic	1075	1078	and
I-Characteristic	1079	1081	12
I-Characteristic	1082	1087	clock
I-Characteristic	1087	1088	-
I-Characteristic	1088	1092	hour
I-Characteristic	1093	1100	sectors
I-Characteristic	1100	1101	)
I-Characteristic	1102	1117	circumpapillary
I-Characteristic	1118	1122	RNFL
I-Characteristic	1123	1124	(
I-Characteristic	1124	1130	cpRNFL
I-Characteristic	1130	1131	)
I-Characteristic	1132	1143	thicknesses
O	1144	1153	according
O	1154	1156	to
O	1157	1160	the
B-Symptom	1161	1165	RNFL
I-Symptom	1166	1172	defect
O	1173	1181	severity
O	1181	1182	,
O	1183	1186	and
O	1187	1190	the
B-Characteristic	1191	1195	area
I-Characteristic	1196	1201	under
I-Characteristic	1202	1205	the
I-Characteristic	1206	1214	receiver
I-Characteristic	1215	1224	operating
I-Characteristic	1225	1239	characteristic
I-Characteristic	1240	1246	curves
O	1247	1248	(
B-Characteristic	1248	1254	AUROCs
O	1254	1255	)
O	1256	1259	for
O	1260	1267	various
B-Diagnostic_tool	1268	1271	OCT
O	1272	1282	parameters
O	1282	1283	.

O	1284	1287	The
B-Characteristic	1288	1293	RDPIs
O	1294	1303	increased
O	1304	1308	with
O	1309	1312	the
O	1313	1323	increasing
O	1324	1332	severity
O	1333	1335	of
O	1336	1339	the
B-Symptom	1340	1344	RNFL
I-Symptom	1345	1351	defect
O	1352	1354	in
O	1355	1359	both
O	1360	1363	the
B-Anatomy	1364	1372	superior
I-Anatomy	1373	1376	and
I-Anatomy	1377	1385	inferior
I-Anatomy	1386	1396	hemifields
O	1397	1398	(
O	1398	1399	P
O	1401	1402	<
O	1403	1404	0
O	1404	1405	.
O	1405	1407	05
O	1407	1408	,
O	1409	1410	1
O	1410	1411	-
O	1411	1414	way
O	1415	1423	analysis
O	1424	1426	of
O	1427	1435	variance
O	1436	1440	test
O	1441	1445	with
O	1446	1456	Bonferroni
O	1457	1467	correction
O	1467	1468	)
O	1468	1469	.

O	1470	1473	The
B-Characteristic	1474	1480	AUROCs
O	1481	1483	of
O	1484	1487	the
B-Characteristic	1488	1493	RDPIs
O	1494	1495	(
O	1495	1496	0
O	1496	1497	.
O	1497	1500	969
O	1501	1504	and
O	1505	1506	0
O	1506	1507	.
O	1507	1510	975
O	1511	1513	in
O	1514	1517	the
O	1518	1526	superior
O	1527	1530	and
O	1531	1539	inferior
O	1540	1550	hemifields
O	1550	1551	,
O	1552	1564	respectively
O	1564	1565	)
O	1566	1570	were
O	1571	1577	larger
O	1578	1582	than
O	1583	1588	those
O	1589	1591	of
O	1592	1595	all
O	1596	1598	of
O	1599	1602	the
B-Characteristic	1603	1609	cpRNFL
I-Characteristic	1610	1621	thicknesses
O	1622	1624	in
O	1625	1639	discriminating
O	1640	1643	the
B-Symptom	1644	1648	mild
I-Symptom	1649	1653	from
I-Symptom	1654	1657	the
I-Symptom	1658	1666	moderate
I-Symptom	1667	1671	RNFL
I-Symptom	1672	1679	defects
O	1680	1681	(
O	1681	1682	P
O	1684	1685	<
O	1686	1687	0
O	1687	1688	.
O	1688	1690	05
O	1690	1691	)
O	1691	1692	.

O	1693	1702	Meanwhile
O	1702	1703	,
O	1704	1706	in
O	1707	1721	discriminating
O	1722	1725	the
B-Symptom	1726	1734	moderate
I-Symptom	1735	1739	from
I-Symptom	1740	1743	the
I-Symptom	1744	1750	severe
I-Symptom	1751	1755	RNFL
I-Symptom	1756	1763	defects
O	1763	1764	,
O	1765	1768	the
B-Characteristic	1769	1775	AUROCs
O	1776	1778	of
O	1779	1782	the
B-Characteristic	1783	1788	RDPIs
O	1789	1790	(
O	1790	1791	0
O	1791	1792	.
O	1792	1795	961
O	1796	1799	and
O	1800	1801	0
O	1801	1802	.
O	1802	1805	891
O	1806	1808	in
O	1809	1812	the
O	1813	1821	superior
O	1822	1825	and
O	1826	1834	inferior
O	1835	1845	hemifields
O	1845	1846	,
O	1847	1859	respectively
O	1859	1860	)
O	1861	1865	were
O	1866	1872	larger
O	1873	1877	than
O	1878	1883	those
O	1884	1886	of
O	1887	1890	the
B-Characteristic	1891	1897	cpRNFL
I-Characteristic	1898	1909	thicknesses
O	1910	1912	in
O	1913	1916	all
O	1917	1922	areas
O	1923	1929	except
O	1930	1933	the
B-Anatomy	1934	1942	inferior
I-Anatomy	1943	1951	quadrant
O	1952	1955	and
O	1956	1959	the
O	1960	1961	6
O	1961	1962	-
O	1962	1963	,
O	1964	1965	7
O	1965	1966	-
O	1966	1967	,
O	1968	1971	and
O	1972	1974	11
O	1974	1975	-
O	1975	1976	o
O	1976	1977	'
O	1977	1982	clock
O	1983	1990	sectors
O	1991	1992	(
O	1992	1993	P
O	1995	1996	<
O	1997	1998	0
O	1998	1999	.
O	1999	2001	05
O	2001	2002	)
O	2002	2003	.

O	2004	2007	The
B-Characteristic	2008	2012	RDPI
O	2012	2013	,
O	2014	2015	a
O	2016	2019	new
O	2020	2029	parameter
O	2030	2035	using
O	2036	2037	a
B-Diagnostic_tool	2038	2044	Cirrus
I-Diagnostic_tool	2045	2047	HD
I-Diagnostic_tool	2048	2051	OCT
I-Diagnostic_tool	2051	2052	-
I-Diagnostic_tool	2052	2059	derived
I-Diagnostic_tool	2060	2064	RNFL
I-Diagnostic_tool	2065	2074	thickness
I-Diagnostic_tool	2075	2084	deviation
I-Diagnostic_tool	2085	2088	map
O	2088	2089	,
O	2090	2093	can
O	2094	2096	be
O	2097	2098	a
O	2099	2105	useful
O	2106	2113	adjunct
O	2114	2118	tool
O	2119	2122	for
O	2123	2132	objective
O	2133	2147	quantification
O	2148	2150	of
B-Characteristic	2151	2155	RNFL
I-Characteristic	2156	2162	defect
I-Characteristic	2163	2168	depth
O	2168	2169	.

O	2170	2174	This
O	2175	2184	parameter
O	2185	2188	has
O	2189	2191	an
O	2192	2201	advantage
O	2202	2206	over
B-Characteristic	2207	2213	cpRNFL
I-Characteristic	2214	2223	thickness
O	2224	2226	in
O	2227	2241	discriminating
O	2242	2249	between
B-Symptom	2250	2254	mild
I-Symptom	2255	2258	and
I-Symptom	2259	2267	moderate
I-Symptom	2268	2272	RNFL
I-Symptom	2273	2280	defects
O	2280	2281	,
O	2282	2285	not
O	2286	2288	in
O	2289	2303	discriminating
O	2304	2311	between
B-Symptom	2312	2320	moderate
I-Symptom	2321	2324	and
I-Symptom	2325	2331	severe
I-Symptom	2332	2339	defects
O	2339	2340	.

O	0	1	A
O	2	6	risk
O	7	12	score
O	13	16	for
O	17	20	the
O	21	31	prediction
O	32	34	of
B-Disease	35	43	advanced
I-Disease	44	47	age
I-Disease	47	48	-
I-Disease	48	55	related
I-Disease	56	63	macular
I-Disease	64	76	degeneration
O	76	77	:
O	78	89	development
O	90	93	and
O	94	104	validation
O	105	107	in
O	108	109	2
O	110	121	prospective
O	122	129	cohorts
O	129	130	.

O	132	134	To
O	135	142	develop
O	143	144	a
O	145	153	clinical
O	154	157	eye
O	157	158	-
O	158	166	specific
O	167	177	prediction
O	178	183	model
O	184	187	for
B-Disease	188	196	advanced
I-Disease	197	200	age
I-Disease	200	201	-
I-Disease	201	208	related
I-Disease	209	216	macular
I-Disease	217	229	degeneration
O	230	231	(
B-Disease	231	234	AMD
O	234	235	)
O	235	236	.

O	237	240	The
B-Classification_system	241	244	Age
I-Classification_system	244	245	-
I-Classification_system	245	252	Related
I-Classification_system	253	256	Eye
I-Classification_system	257	264	Disease
I-Classification_system	265	270	Study
O	271	272	(
B-Classification_system	272	277	AREDS
O	277	278	)
O	279	285	cohort
O	286	294	followed
O	295	297	up
O	298	301	for
O	302	303	8
O	304	309	years
O	310	316	served
O	317	319	as
O	320	323	the
O	324	332	training
O	333	340	dataset
O	340	341	,
O	342	345	and
O	346	349	the
O	350	354	Blue
O	355	364	Mountains
B-Anatomy	365	368	Eye
O	369	374	Study
O	375	376	(
O	376	380	BMES
O	380	381	)
O	382	388	cohort
O	389	397	followed
O	398	400	up
O	401	404	for
O	405	407	10
O	408	413	years
O	414	420	served
O	421	423	as
O	424	427	the
O	428	438	validation
O	439	446	dataset
O	446	447	.

O	448	449	A
O	450	455	total
O	456	458	of
O	459	463	4507
B-Classification_system	464	469	AREDS
O	470	482	participants
O	483	484	(
O	484	496	contributing
O	497	501	1185
O	502	510	affected
O	511	513	vs
O	513	514	.
O	515	519	6992
O	520	530	unaffected
B-Anatomy	531	535	eyes
O	535	536	)
O	537	540	and
O	541	545	2169
O	546	550	BMES
O	551	563	participants
O	564	565	(
O	565	577	contributing
O	578	580	69
O	581	589	affected
O	590	592	vs
O	592	593	.
O	594	598	3694
O	599	609	unaffected
B-Anatomy	610	614	eyes
O	614	615	)
O	615	616	.

O	617	622	Using
B-Diagnostic_tool	623	628	Bayes
I-Diagnostic_tool	628	629	'
I-Diagnostic_tool	630	637	theorem
I-Diagnostic_tool	638	640	in
I-Diagnostic_tool	641	642	a
I-Diagnostic_tool	643	651	logistic
I-Diagnostic_tool	652	657	model
O	657	658	,
O	659	661	we
O	662	666	used
O	667	668	8
O	669	677	baseline
O	678	688	predictors
O	688	689	-
B-Characteristic	689	692	age
O	692	693	,
B-Characteristic	694	697	sex
O	697	698	,
B-Characteristic	699	708	education
I-Characteristic	709	714	level
O	714	715	,
B-Characteristic	716	720	race
O	720	721	,
B-Characteristic	722	729	smoking
I-Characteristic	730	736	status
O	736	737	,
O	738	741	and
B-Symptom	742	750	presence
I-Symptom	751	753	of
I-Symptom	754	761	pigment
I-Symptom	762	773	abnormality
O	773	774	,
B-Symptom	775	779	soft
I-Symptom	780	786	drusen
O	786	787	,
O	788	791	and
B-Characteristic	792	799	maximum
I-Characteristic	800	806	drusen
I-Characteristic	807	811	size
O	811	812	-
O	812	814	to
O	815	821	devise
O	822	825	and
O	826	834	validate
O	835	836	a
B-Classification_system	837	844	macular
I-Classification_system	845	849	risk
I-Classification_system	850	857	scoring
I-Classification_system	858	864	system
O	865	866	(
B-Classification_system	866	870	MRSS
O	870	871	)
O	871	872	.

O	873	875	We
O	876	884	assessed
O	885	888	the
O	889	900	performance
O	901	903	of
O	904	907	the
B-Classification_system	908	912	MRSS
O	913	915	by
O	916	927	calculating
O	928	939	sensitivity
O	939	940	,
O	941	952	specificity
O	952	953	,
O	954	957	and
O	958	961	the
O	962	966	area
O	967	972	under
O	973	976	the
O	977	985	receiver
O	986	995	operating
O	996	1010	characteristic
O	1011	1016	curve
O	1017	1018	(
O	1018	1019	i
O	1019	1020	.
O	1020	1021	e
O	1021	1022	.
O	1022	1023	,
O	1024	1025	c
O	1025	1026	-
O	1026	1031	index
O	1031	1032	)
O	1032	1033	.

B-Disease	1034	1042	Advanced
I-Disease	1043	1046	AMD
O	1046	1047	.

O	1048	1051	The
O	1052	1062	internally
O	1063	1072	validated
O	1073	1074	c
O	1074	1075	-
O	1075	1085	indexAREDS
O	1086	1087	(
O	1087	1088	0
O	1088	1089	.
O	1089	1091	88
O	1091	1092	;
O	1093	1095	95
O	1095	1096	%
O	1097	1107	confidence
O	1108	1116	interval
O	1116	1117	,
O	1118	1119	0
O	1119	1120	.
O	1120	1122	87
O	1122	1123	-
O	1123	1124	0
O	1124	1125	.
O	1125	1127	89
O	1127	1128	)
O	1129	1132	and
O	1133	1136	the
O	1137	1147	externally
O	1148	1157	validated
O	1158	1159	c
O	1159	1160	-
O	1160	1169	indexBMES
O	1170	1171	(
O	1171	1172	0
O	1172	1173	.
O	1173	1175	91
O	1175	1176	;
O	1177	1179	95
O	1179	1180	%
O	1181	1191	confidence
O	1192	1200	interval
O	1200	1201	,
O	1202	1203	0
O	1203	1204	.
O	1204	1206	88
O	1206	1207	-
O	1207	1208	0
O	1208	1209	.
O	1209	1211	95
O	1211	1212	)
O	1213	1222	suggested
O	1223	1232	excellent
O	1233	1244	performance
O	1245	1247	of
O	1248	1251	the
B-Classification_system	1252	1256	MRSS
O	1256	1257	.

O	1258	1261	The
O	1262	1273	sensitivity
O	1274	1277	and
O	1278	1289	specificity
O	1290	1292	at
O	1293	1296	the
O	1297	1304	optimal
B-Characteristic	1305	1312	macular
I-Characteristic	1313	1317	risk
I-Characteristic	1318	1323	score
O	1324	1330	cutoff
O	1331	1336	point
O	1337	1339	of
O	1340	1341	0
O	1342	1346	were
O	1347	1349	87
O	1349	1350	.
O	1350	1351	6
O	1351	1352	%
O	1353	1356	and
O	1357	1359	73
O	1359	1360	.
O	1360	1361	6
O	1361	1362	%
O	1362	1363	,
O	1364	1376	respectively
O	1376	1377	.

O	1378	1380	An
O	1381	1392	application
O	1393	1396	for
O	1397	1400	the
O	1401	1407	iPhone
O	1408	1411	and
O	1412	1416	iPad
O	1417	1421	also
O	1422	1425	was
O	1426	1435	developed
O	1436	1438	as
O	1439	1440	a
O	1441	1450	practical
O	1451	1455	tool
O	1456	1459	for
O	1460	1463	the
B-Classification_system	1464	1468	MRSS
O	1468	1469	.

O	1470	1473	The
B-Classification_system	1474	1478	MRSS
O	1479	1482	was
O	1483	1492	developed
O	1493	1496	and
O	1497	1506	validated
O	1507	1509	to
O	1510	1517	provide
O	1518	1530	satisfactory
O	1531	1539	accuracy
O	1540	1543	and
O	1544	1560	generalizability
O	1560	1561	.

O	1562	1564	It
O	1565	1568	may
O	1569	1571	be
O	1572	1576	used
O	1577	1579	to
O	1580	1586	screen
O	1587	1595	patients
O	1596	1598	at
O	1599	1603	risk
O	1604	1606	of
O	1607	1617	developing
B-Disease	1618	1626	advanced
I-Disease	1627	1630	AMD
O	1630	1631	.

B-Diagnostic_tool	0	7	Macular
I-Diagnostic_tool	8	16	ganglion
I-Diagnostic_tool	17	21	cell
I-Diagnostic_tool	22	30	analysis
O	31	34	for
O	35	40	early
O	41	50	detection
O	51	53	of
B-Disease	54	62	glaucoma
O	62	63	.

O	65	67	To
O	68	79	investigate
O	80	83	the
O	84	91	ability
O	92	94	of
B-Diagnostic_tool	95	101	Cirrus
I-Diagnostic_tool	102	106	high
I-Diagnostic_tool	106	107	-
I-Diagnostic_tool	107	117	definition
I-Diagnostic_tool	118	125	optical
I-Diagnostic_tool	126	135	coherence
I-Diagnostic_tool	136	146	tomography
O	147	148	(
B-Diagnostic_tool	148	154	Cirrus
I-Diagnostic_tool	155	157	HD
I-Diagnostic_tool	157	158	-
I-Diagnostic_tool	158	161	OCT
O	161	162	;
O	163	167	Carl
O	168	173	Zeiss
O	174	181	Meditec
O	181	182	,
O	183	189	Dublin
O	189	190	,
O	191	193	CA
O	193	194	)
B-Diagnostic_tool	195	202	macular
I-Diagnostic_tool	203	211	ganglion
I-Diagnostic_tool	212	216	cell
I-Diagnostic_tool	217	225	analysis
O	226	227	(
B-Diagnostic_tool	227	230	GCA
O	230	231	)
O	232	238	sector
O	238	239	,
O	240	249	deviation
O	249	250	,
O	251	254	and
O	255	264	thickness
O	265	269	maps
O	270	272	to
O	273	279	detect
B-Disease	280	285	early
I-Disease	286	294	glaucoma
O	294	295	.

O	296	301	Cross
O	301	302	-
O	302	311	sectional
O	312	317	study
O	317	318	.

O	319	321	We
O	322	330	enrolled
O	331	334	131
B-Anatomy	335	339	eyes
O	340	344	with
B-Disease	345	350	early
I-Disease	351	359	glaucoma
O	360	361	(
O	361	365	mean
O	366	375	deviation
O	377	378	>
O	379	380	-
O	380	381	6
O	381	382	.
O	382	383	0
O	384	386	dB
O	386	387	)
O	388	391	and
O	392	395	132
B-Characteristic	396	399	age
I-Characteristic	399	400	-
I-Characteristic	401	404	and
I-Characteristic	405	415	refractive
I-Characteristic	416	421	error
I-Characteristic	421	422	-
I-Characteristic	422	429	matched
I-Characteristic	430	437	healthy
I-Characteristic	438	442	eyes
O	442	443	.

B-Diagnostic_tool	444	451	Macular
I-Diagnostic_tool	452	455	GCA
I-Diagnostic_tool	456	460	maps
O	461	465	were
O	466	474	obtained
O	475	480	using
B-Diagnostic_tool	481	487	Cirrus
I-Diagnostic_tool	488	490	HD
I-Diagnostic_tool	490	491	-
I-Diagnostic_tool	491	494	OCT
O	494	495	.

O	496	499	The
O	500	508	location
O	508	509	,
O	510	517	angular
O	518	526	distance
O	526	527	,
O	528	531	and
O	532	537	width
O	538	540	of
B-Symptom	541	556	circumpapillary
I-Symptom	557	564	retinal
I-Symptom	565	570	nerve
I-Symptom	571	576	fiber
I-Symptom	577	582	layer
I-Symptom	583	584	(
I-Symptom	584	588	RNFL
I-Symptom	588	589	)
I-Symptom	590	597	defects
O	598	602	were
O	603	615	investigated
O	616	618	by
O	619	624	using
B-Diagnostic_tool	625	628	red
I-Diagnostic_tool	628	629	-
I-Diagnostic_tool	629	633	free
I-Diagnostic_tool	634	640	fundus
I-Diagnostic_tool	641	652	photographs
O	652	653	.

O	654	657	The
O	658	666	presence
O	667	669	of
O	670	671	a
B-Symptom	672	682	structural
I-Symptom	683	694	abnormality
O	695	697	in
O	698	701	the
B-Diagnostic_tool	702	705	GCA
I-Diagnostic_tool	706	709	map
O	710	713	was
O	714	721	defined
O	722	724	as
O	725	726	(
O	726	727	1
O	727	728	)
O	729	735	yellow
O	735	736	/
O	736	739	red
O	740	745	color
O	746	751	codes
O	752	754	in
O	755	758	the
O	759	765	sector
O	766	769	map
O	769	770	,
O	771	772	(
O	772	773	2
O	773	774	)
O	775	781	yellow
O	781	782	/
O	782	785	red
O	786	792	pixels
O	793	794	(
O	795	796	>
O	797	799	10
O	799	800	)
O	801	803	in
O	804	807	the
O	808	817	deviation
O	818	821	map
O	821	822	,
O	823	826	and
O	827	828	(
O	828	829	3
O	829	830	)
O	831	835	blue
O	836	841	areas
O	842	844	in
O	845	848	the
O	849	858	thickness
O	859	862	map
O	862	863	.

O	864	867	The
O	868	878	prevalence
O	879	881	of
O	882	885	and
O	886	893	factors
O	894	904	associated
O	905	909	with
O	910	913	the
O	914	922	presence
O	923	925	or
O	926	933	absence
O	934	936	of
B-Symptom	937	945	abnormal
I-Symptom	946	949	GCA
O	950	958	findings
O	959	963	were
O	964	972	assessed
O	972	973	.

O	974	979	Among
O	980	983	the
O	984	987	131
B-Disease	988	1000	glaucomatous
B-Anatomy	1001	1005	eyes
O	1005	1006	,
O	1007	1010	105
O	1011	1012	(
O	1012	1014	80
O	1014	1015	.
O	1015	1016	2
O	1016	1017	%
O	1017	1018	)
O	1018	1019	,
O	1020	1023	115
O	1024	1025	(
O	1025	1027	87
O	1027	1028	.
O	1028	1029	8
O	1029	1030	%
O	1030	1031	)
O	1031	1032	,
O	1033	1036	and
O	1037	1040	104
O	1041	1042	(
O	1042	1044	79
O	1044	1045	.
O	1045	1046	4
O	1046	1047	%
O	1047	1048	)
O	1049	1055	showed
B-Symptom	1056	1066	structural
I-Symptom	1067	1080	abnormalities
O	1081	1083	in
O	1084	1087	the
B-Diagnostic_tool	1088	1091	GCA
O	1092	1098	sector
O	1098	1099	,
O	1100	1109	deviation
O	1109	1110	,
O	1111	1114	and
O	1115	1124	thickness
O	1125	1129	maps
O	1129	1130	,
O	1131	1143	respectively
O	1143	1144	.

O	1145	1148	The
O	1149	1156	absence
O	1157	1159	of
B-Symptom	1160	1168	abnormal
I-Symptom	1169	1177	findings
O	1178	1180	in
O	1181	1184	the
B-Diagnostic_tool	1185	1188	GCA
I-Diagnostic_tool	1189	1193	maps
O	1194	1196	of
B-Disease	1197	1209	glaucomatous
B-Anatomy	1210	1214	eyes
O	1215	1218	was
O	1219	1229	associated
O	1230	1234	with
O	1235	1238	the
O	1239	1247	presence
O	1248	1250	of
B-Symptom	1251	1255	RNFL
I-Symptom	1256	1263	defects
I-Symptom	1264	1266	in
I-Symptom	1267	1270	the
I-Symptom	1271	1279	superior
I-Symptom	1280	1290	hemisphere
O	1290	1291	,
O	1292	1293	a
O	1294	1301	greater
B-Symptom	1302	1309	angular
I-Symptom	1310	1318	distance
I-Symptom	1319	1326	between
I-Symptom	1327	1330	the
I-Symptom	1331	1336	fovea
O	1337	1340	and
O	1341	1344	the
B-Symptom	1345	1349	RNFL
I-Symptom	1350	1356	defect
O	1356	1357	,
O	1358	1359	a
B-Symptom	1360	1368	narrower
I-Symptom	1369	1374	width
I-Symptom	1375	1377	of
I-Symptom	1378	1381	the
I-Symptom	1382	1386	RNFL
I-Symptom	1387	1393	defect
O	1393	1394	,
B-Symptom	1395	1399	less
I-Symptom	1400	1406	severe
I-Symptom	1407	1413	visual
I-Symptom	1414	1419	field
I-Symptom	1420	1427	defects
O	1427	1428	,
O	1429	1431	or
O	1432	1434	an
B-Symptom	1435	1443	isolated
I-Symptom	1444	1454	peripheral
I-Symptom	1455	1460	nasal
I-Symptom	1461	1465	step
O	1466	1467	(
O	1467	1474	outside
O	1475	1477	10
O	1478	1485	degrees
O	1486	1488	of
O	1489	1497	fixation
O	1497	1498	)
O	1499	1500	(
O	1500	1501	P
O	1502	1503	<
O	1504	1505	0
O	1505	1506	.
O	1506	1508	05
O	1508	1509	)
O	1509	1510	.

O	1511	1512	A
O	1513	1520	greater
B-Symptom	1521	1528	angular
I-Symptom	1529	1537	distance
I-Symptom	1538	1540	of
I-Symptom	1541	1544	the
I-Symptom	1545	1549	RNFL
I-Symptom	1550	1556	defect
O	1557	1565	remained
O	1566	1577	significant
O	1578	1580	in
O	1581	1593	multivariate
O	1594	1602	analyses
O	1603	1604	(
O	1604	1605	P
O	1606	1607	<
O	1608	1609	0
O	1609	1610	.
O	1610	1612	05
O	1612	1613	)
O	1613	1614	.

O	1615	1620	Among
O	1621	1624	the
O	1625	1628	132
O	1629	1636	healthy
B-Anatomy	1637	1641	eyes
O	1641	1642	,
O	1643	1645	28
O	1646	1647	(
O	1647	1649	21
O	1649	1650	.
O	1650	1651	2
O	1651	1652	%
O	1652	1653	)
O	1653	1654	,
O	1655	1657	37
O	1658	1659	(
O	1659	1661	28
O	1661	1662	.
O	1662	1663	0
O	1663	1664	%
O	1664	1665	)
O	1665	1666	,
O	1667	1670	and
O	1671	1673	20
O	1674	1675	(
O	1675	1677	15
O	1677	1678	.
O	1678	1679	2
O	1679	1680	%
O	1680	1681	)
O	1682	1685	had
O	1686	1694	abnormal
O	1695	1703	findings
O	1704	1706	in
O	1707	1710	the
B-Diagnostic_tool	1711	1714	GCA
O	1715	1721	sector
O	1721	1722	,
O	1723	1732	deviation
O	1732	1733	,
O	1734	1737	and
O	1738	1747	thickness
O	1748	1752	maps
O	1752	1753	,
O	1754	1766	respectively
O	1766	1767	.

O	1768	1771	The
O	1772	1780	presence
O	1781	1783	of
B-Symptom	1784	1792	abnormal
I-Symptom	1793	1796	GCA
I-Symptom	1797	1805	findings
O	1806	1808	in
O	1809	1816	healthy
B-Anatomy	1817	1821	eyes
O	1822	1825	was
O	1826	1836	associated
O	1837	1841	with
O	1842	1843	a
O	1844	1850	higher
O	1851	1857	degree
O	1858	1860	of
B-Characteristic	1861	1867	myopic
I-Characteristic	1868	1878	refractive
I-Characteristic	1879	1884	error
O	1885	1886	(
O	1886	1887	P
O	1888	1889	<
O	1890	1891	0
O	1891	1892	.
O	1892	1894	05
O	1894	1895	)
O	1895	1896	.

B-Diagnostic_tool	1897	1903	Cirrus
I-Diagnostic_tool	1904	1906	HD
I-Diagnostic_tool	1906	1907	-
I-Diagnostic_tool	1907	1910	OCT
I-Diagnostic_tool	1911	1914	GCA
I-Diagnostic_tool	1915	1919	maps
O	1920	1926	showed
O	1927	1928	a
O	1929	1933	good
O	1934	1941	ability
O	1942	1944	to
O	1945	1951	detect
B-Disease	1952	1957	early
I-Disease	1958	1966	glaucoma
O	1966	1967	.

O	1968	1975	However
O	1975	1976	,
B-Diagnostic_tool	1977	1980	GCA
I-Diagnostic_tool	1981	1985	maps
O	1986	1989	did
O	1990	1993	not
O	1994	1998	show
O	1999	2007	abnormal
O	2008	2016	findings
O	2017	2019	in
B-Disease	2020	2032	glaucomatous
B-Anatomy	2033	2037	eyes
O	2038	2042	when
O	2043	2046	the
B-Symptom	2047	2054	angular
I-Symptom	2055	2063	distance
I-Symptom	2064	2071	between
I-Symptom	2072	2077	fovea
I-Symptom	2078	2081	and
I-Symptom	2082	2086	RNFL
I-Symptom	2087	2093	defect
I-Symptom	2094	2097	was
I-Symptom	2098	2103	great
O	2103	2104	.

O	2105	2110	These
O	2111	2119	findings
O	2120	2126	should
O	2127	2129	be
O	2130	2140	considered
O	2141	2145	when
O	2146	2156	diagnosing
B-Disease	2157	2162	early
I-Disease	2163	2171	glaucoma
O	2172	2177	using
B-Diagnostic_tool	2178	2181	GCA
I-Diagnostic_tool	2182	2186	maps
O	2186	2187	.

B-Characteristic	0	6	Visual
I-Characteristic	7	12	field
I-Characteristic	13	24	progression
O	25	27	in
B-Disease	28	36	glaucoma
O	36	37	:
O	38	42	what
O	43	45	is
O	46	49	the
O	50	61	specificity
O	62	64	of
O	65	68	the
B-Diagnostic_tool	69	75	Guided
I-Diagnostic_tool	76	87	Progression
I-Diagnostic_tool	88	96	Analysis
O	96	97	?

O	99	101	To
O	102	110	estimate
O	111	114	the
O	115	126	specificity
O	127	129	of
O	130	133	the
B-Diagnostic_tool	134	140	Guided
I-Diagnostic_tool	141	152	Progression
I-Diagnostic_tool	153	161	Analysis
O	162	163	(
B-Diagnostic_tool	163	166	GPA
O	166	167	)
O	168	169	(
O	169	173	Carl
O	174	179	Zeiss
O	180	187	Meditec
O	187	188	,
O	189	195	Dublin
O	195	196	,
O	197	199	CA
O	199	200	)
O	201	203	in
O	204	214	individual
O	215	223	patients
O	224	228	with
B-Disease	229	237	glaucoma
O	237	238	.

O	239	252	Observational
O	253	259	cohort
O	260	265	study
O	265	266	.

O	267	273	Thirty
O	274	282	patients
O	283	287	with
B-Disease	288	292	open
I-Disease	292	293	-
I-Disease	293	298	angle
I-Disease	299	307	glaucoma
O	307	308	.

O	309	311	In
O	312	314	30
O	315	323	patients
O	324	328	with
B-Disease	329	333	open
I-Disease	333	334	-
I-Disease	334	339	angle
I-Disease	340	348	glaucoma
O	348	349	,
O	350	351	1
B-Anatomy	352	355	eye
O	356	357	(
O	357	363	median
O	364	368	mean
O	369	378	deviation
O	379	380	[
O	380	382	MD
O	382	383	]
O	383	384	,
O	385	386	-
O	386	387	2
O	387	388	.
O	388	389	5
O	390	398	decibels
O	399	400	[
O	400	402	dB
O	402	403	]
O	404	405	;
O	406	419	interquartile
O	420	425	range
O	425	426	,
O	427	428	-
O	428	429	4
O	429	430	.
O	430	431	4
O	432	434	to
O	435	436	-
O	436	437	1
O	437	438	.
O	438	439	3
O	440	442	dB
O	442	443	)
O	444	447	was
O	448	454	tested
O	455	457	12
O	458	463	times
O	464	468	over
O	469	470	3
O	471	477	months
O	478	479	(
B-Diagnostic_tool	479	487	Humphrey
I-Diagnostic_tool	488	493	Field
I-Diagnostic_tool	494	502	Analyzer
O	502	503	,
O	504	508	Carl
O	509	514	Zeiss
O	515	522	Meditec
O	522	523	;
O	524	528	SITA
O	529	537	Standard
O	537	538	,
O	539	541	24
O	541	542	-
O	542	543	2
O	543	544	)
O	544	545	.

O	547	548	"
O	549	557	Possible
O	558	569	progression
O	570	571	"
O	573	576	and
O	578	579	"
O	580	586	likely
O	587	598	progression
O	599	600	"
O	602	606	were
O	607	617	determined
O	618	622	with
O	623	626	the
B-Diagnostic_tool	627	630	GPA
O	630	631	.

O	632	637	These
O	638	646	analyses
O	647	651	were
O	652	660	repeated
O	661	666	after
O	667	670	the
O	671	676	order
O	677	679	of
O	680	683	the
O	684	689	tests
O	690	693	had
O	694	698	been
O	699	707	randomly
O	708	718	rearranged
O	719	720	(
O	720	724	1000
O	725	731	unique
O	732	744	permutations
O	744	745	)
O	745	746	.

O	747	751	Rate
O	752	754	of
O	755	760	false
O	760	761	-
O	761	769	positive
O	770	776	alerts
O	777	779	of
O	781	782	"
O	783	791	possible
O	792	803	progression
O	804	805	"
O	807	810	and
O	812	813	"
O	814	820	likely
O	821	832	progression
O	833	834	"
O	836	840	with
O	841	844	the
B-Diagnostic_tool	845	848	GPA
O	848	849	.

O	850	852	On
O	853	860	average
O	860	861	,
O	862	865	the
O	866	877	specificity
O	878	880	of
O	881	884	the
B-Diagnostic_tool	885	888	GPA
O	890	891	"
O	892	898	likely
O	899	910	progression
O	911	912	"
O	914	919	alert
O	920	923	was
O	924	928	high
O	928	929	-
O	929	932	for
O	933	936	the
O	937	943	entire
O	944	950	sample
O	950	951	,
O	952	955	the
O	956	960	mean
O	961	965	rate
O	966	968	of
O	969	974	false
O	974	975	-
O	975	983	positive
O	984	990	alerts
O	991	996	after
O	997	999	10
O	1000	1006	follow
O	1006	1007	-
O	1007	1009	up
O	1010	1015	tests
O	1016	1019	was
O	1020	1021	2
O	1021	1022	.
O	1022	1023	6
O	1023	1024	%
O	1024	1025	.

O	1026	1030	With
O	1032	1033	"
O	1034	1042	possible
O	1043	1054	progression
O	1054	1055	,
O	1056	1057	"
O	1059	1062	the
O	1063	1074	specificity
O	1075	1078	was
O	1079	1091	considerably
O	1092	1097	lower
O	1098	1099	(
O	1099	1104	false
O	1104	1105	-
O	1105	1113	positive
O	1114	1118	rate
O	1118	1119	,
O	1120	1122	18
O	1122	1123	.
O	1123	1124	5
O	1124	1125	%
O	1125	1126	)
O	1126	1127	.

O	1128	1132	Most
O	1133	1142	important
O	1142	1143	,
O	1144	1147	the
O	1148	1158	cumulative
O	1159	1163	rate
O	1164	1166	of
O	1167	1172	false
O	1172	1173	-
O	1173	1181	positive
O	1182	1188	alerts
O	1189	1195	varied
O	1196	1209	substantially
O	1210	1215	among
O	1216	1224	patients
O	1224	1225	,
O	1226	1230	from
O	1232	1233	<
O	1234	1235	1
O	1235	1236	%
O	1237	1239	to
O	1240	1242	80
O	1242	1243	%
O	1244	1248	with
O	1250	1251	"
O	1252	1260	possible
O	1261	1272	progression
O	1273	1274	"
O	1276	1279	and
O	1280	1284	from
O	1286	1287	<
O	1288	1289	0
O	1289	1290	.
O	1290	1291	1
O	1291	1292	%
O	1293	1295	to
O	1296	1298	20
O	1298	1299	%
O	1300	1304	with
O	1306	1307	"
O	1308	1314	likely
O	1315	1326	progression
O	1326	1327	.

O	1328	1329	"
O	1331	1338	Factors
O	1339	1349	associated
O	1350	1354	with
O	1355	1360	false
O	1360	1361	-
O	1361	1369	positive
O	1370	1376	alerts
O	1377	1381	were
B-Characteristic	1382	1388	visual
I-Characteristic	1389	1394	field
I-Characteristic	1395	1406	variability
O	1407	1408	(
O	1408	1416	standard
O	1417	1426	deviation
O	1427	1429	of
O	1430	1432	MD
O	1432	1433	,
O	1434	1442	Spearman
O	1442	1443	'
O	1443	1444	s
O	1445	1448	rho
O	1449	1450	=
O	1451	1452	0
O	1452	1453	.
O	1453	1455	41
O	1455	1456	,
O	1457	1458	P
O	1459	1460	<
O	1461	1462	0
O	1462	1463	.
O	1463	1466	001
O	1466	1467	)
O	1468	1471	and
O	1472	1475	the
O	1476	1487	reliability
O	1488	1495	indices
O	1496	1497	(
O	1497	1507	proportion
O	1508	1510	of
O	1511	1516	false
O	1516	1517	-
O	1517	1525	positive
O	1526	1529	and
O	1530	1535	false
O	1535	1536	-
O	1536	1544	negative
O	1545	1554	responses
O	1554	1555	,
O	1556	1564	fixation
O	1565	1571	losses
O	1571	1572	,
O	1573	1576	rho
O	1577	1578	>
O	1579	1580	0
O	1580	1581	.
O	1581	1583	31
O	1583	1584	,
O	1585	1586	P
O	1586	1587	
O	1587	1588	0
O	1588	1589	.
O	1589	1591	10
O	1591	1592	)
O	1592	1593	.

O	1594	1596	On
O	1597	1604	average
O	1604	1605	,
O	1606	1617	progression
O	1618	1626	criteria
O	1627	1636	currently
O	1637	1641	used
O	1642	1644	in
O	1645	1648	the
B-Diagnostic_tool	1649	1652	GPA
O	1653	1657	have
O	1658	1662	high
O	1663	1674	specificity
O	1674	1675	,
O	1676	1679	but
O	1680	1684	some
O	1685	1693	patients
O	1694	1697	are
O	1698	1702	more
O	1703	1709	likely
O	1710	1712	to
O	1713	1717	show
O	1718	1723	false
O	1723	1724	-
O	1724	1732	positive
O	1733	1739	alerts
O	1740	1744	than
O	1745	1751	others
O	1751	1752	.

O	1753	1757	This
O	1758	1760	is
O	1761	1762	a
O	1763	1770	natural
O	1771	1782	consequence
O	1783	1785	of
O	1786	1796	population
O	1796	1797	-
O	1797	1802	based
O	1803	1809	change
O	1810	1818	criteria
O	1819	1822	and
O	1823	1826	may
O	1827	1830	not
O	1831	1837	matter
O	1838	1840	in
O	1841	1849	clinical
O	1850	1856	trials
O	1857	1860	and
O	1861	1868	studies
O	1869	1871	in
O	1872	1877	which
O	1878	1883	large
O	1884	1890	groups
O	1891	1893	of
O	1894	1902	patients
O	1903	1906	are
O	1907	1915	compared
O	1915	1916	.

O	1917	1924	However
O	1924	1925	,
O	1926	1928	it
O	1929	1933	must
O	1934	1936	be
O	1937	1947	considered
O	1948	1952	when
O	1953	1956	the
B-Diagnostic_tool	1957	1960	GPA
O	1961	1963	is
O	1964	1968	used
O	1969	1971	in
O	1972	1980	clinical
O	1981	1989	practice
O	1990	1995	where
O	1996	2007	specificity
O	2008	2013	needs
O	2014	2016	to
O	2017	2019	be
O	2020	2030	controlled
O	2031	2034	for
O	2035	2045	individual
O	2046	2054	patients
O	2054	2055	.

B-Disease	0	8	Dominant
I-Disease	9	16	cystoid
I-Disease	17	24	macular
I-Disease	25	34	dystrophy
O	34	35	.

O	37	39	To
O	40	48	describe
O	49	52	the
O	53	61	clinical
O	62	77	characteristics
O	78	81	and
O	82	86	long
O	86	87	-
O	87	91	term
O	92	98	follow
O	98	99	-
O	99	101	up
O	102	104	in
O	105	113	patients
O	114	118	with
B-Disease	119	128	autosomal
I-Disease	129	137	dominant
I-Disease	138	145	cystoid
I-Disease	146	153	macular
I-Disease	154	163	dystrophy
O	164	165	(
B-Disease	165	169	DCMD
O	169	170	)
O	170	171	.

O	172	185	Retrospective
O	186	190	case
O	191	197	series
O	197	198	.

O	199	205	Ninety
O	205	206	-
O	206	211	seven
O	212	220	patients
O	221	225	with
B-Disease	226	230	DCMD
O	230	231	.

O	232	241	Extensive
O	242	252	ophthalmic
O	253	264	examination
O	264	265	,
O	266	275	including
B-Characteristic	276	282	visual
I-Characteristic	283	289	acuity
O	290	291	(
B-Characteristic	291	293	VA
O	293	294	)
O	294	295	,
B-Diagnostic_tool	296	302	fundus
I-Diagnostic_tool	303	314	photography
O	314	315	,
B-Diagnostic_tool	316	327	fluorescein
I-Diagnostic_tool	328	339	angiography
O	340	341	(
B-Diagnostic_tool	341	343	FA
O	343	344	)
O	344	345	,
B-Diagnostic_tool	346	352	fundus
I-Diagnostic_tool	353	369	autofluorescence
I-Diagnostic_tool	370	371	(
I-Diagnostic_tool	371	374	FAF
I-Diagnostic_tool	374	375	)
I-Diagnostic_tool	376	383	imaging
O	383	384	,
B-Diagnostic_tool	385	392	optical
I-Diagnostic_tool	393	402	coherence
I-Diagnostic_tool	403	413	tomography
O	414	415	(
B-Diagnostic_tool	415	418	OCT
O	418	419	)
O	419	420	,
B-Diagnostic_tool	421	426	color
I-Diagnostic_tool	427	433	vision
I-Diagnostic_tool	434	441	testing
O	441	442	,
B-Diagnostic_tool	443	447	dark
I-Diagnostic_tool	448	458	adaptation
I-Diagnostic_tool	459	466	testing
O	466	467	,
B-Diagnostic_tool	468	472	full
I-Diagnostic_tool	472	473	-
I-Diagnostic_tool	473	478	field
I-Diagnostic_tool	479	498	electroretinography
O	499	500	(
B-Diagnostic_tool	500	503	ERG
O	503	504	)
O	504	505	,
O	506	509	and
B-Diagnostic_tool	510	517	electro
I-Diagnostic_tool	517	518	-
I-Diagnostic_tool	518	529	oculography
O	530	531	(
B-Diagnostic_tool	531	534	EOG
O	534	535	)
O	535	536	.

O	537	542	Blood
O	543	550	samples
O	551	555	were
O	556	564	obtained
O	565	568	for
O	569	572	DNA
O	573	583	extraction
O	584	587	and
O	588	598	subsequent
B-Diagnostic_tool	599	608	haplotype
I-Diagnostic_tool	609	617	analysis
O	617	618	.

B-Characteristic	619	622	Age
I-Characteristic	623	625	at
I-Characteristic	626	631	onset
O	631	632	,
B-Characteristic	633	635	VA
O	635	636	,
B-Characteristic	637	643	fundus
I-Characteristic	644	654	appearance
O	654	655	,
O	656	659	and
O	660	675	characteristics
O	676	678	on
B-Diagnostic_tool	679	681	FA
O	681	682	,
B-Diagnostic_tool	683	686	FAF
O	686	687	,
B-Diagnostic_tool	688	691	OCT
O	691	692	,
B-Diagnostic_tool	693	696	ERG
O	696	697	,
O	698	701	and
B-Diagnostic_tool	702	705	EOG
O	705	706	.

B-Symptom	707	714	Cystoid
I-Symptom	715	720	fluid
I-Symptom	721	732	collections
O	733	734	(
B-Symptom	734	738	CFCs
O	738	739	)
O	740	744	were
O	745	748	the
O	749	754	first
B-Symptom	755	762	retinal
I-Symptom	763	776	abnormalities
O	777	787	detectable
O	788	790	in
B-Disease	791	795	DCMD
O	795	796	,
O	797	807	developing
O	808	814	during
B-Characteristic	815	824	childhood
O	824	825	.

O	826	828	At
O	829	833	long
O	833	834	-
O	834	838	term
O	839	845	follow
O	845	846	-
O	846	848	up
O	848	849	,
O	850	853	the
B-Symptom	854	858	CFCs
O	859	868	decreased
O	869	871	in
O	872	876	size
O	877	880	and
O	881	887	number
O	887	888	,
O	889	892	and
O	893	903	eventually
O	904	915	disappeared
O	916	920	with
O	921	931	concurrent
O	932	943	development
O	944	946	of
B-Symptom	947	958	progressive
I-Symptom	959	972	chorioretinal
I-Symptom	973	980	atrophy
O	981	984	and
B-Symptom	985	999	hyperpigmented
I-Symptom	1000	1008	deposits
I-Symptom	1009	1011	in
I-Symptom	1012	1015	the
I-Symptom	1016	1025	posterior
I-Symptom	1026	1030	pole
O	1030	1031	.

B-Disease	1032	1040	Dominant
I-Disease	1041	1048	cystoid
I-Disease	1049	1056	macular
I-Disease	1057	1066	dystrophy
O	1067	1072	could
O	1073	1075	be
O	1076	1086	classified
O	1087	1091	into
O	1092	1093	3
O	1094	1100	stages
O	1100	1101	,
O	1102	1107	based
O	1108	1110	on
O	1111	1126	characteristics
O	1127	1129	on
B-Diagnostic_tool	1130	1144	ophthalmoscopy
O	1144	1145	,
B-Diagnostic_tool	1146	1149	FAF
O	1149	1150	,
B-Diagnostic_tool	1151	1153	FA
O	1153	1154	,
O	1155	1158	and
B-Diagnostic_tool	1159	1162	OCT
O	1162	1163	,
O	1164	1166	as
O	1167	1171	well
O	1172	1174	as
O	1175	1177	on
O	1178	1185	results
O	1186	1188	of
B-Diagnostic_tool	1189	1207	electrophysiologic
I-Diagnostic_tool	1208	1216	analysis
O	1216	1217	.

O	1218	1221	The
O	1222	1229	staging
O	1230	1236	system
O	1237	1247	correlated
O	1248	1252	with
B-Characteristic	1253	1256	age
O	1257	1260	and
B-Characteristic	1261	1263	VA
O	1263	1264	.

O	1265	1267	In
B-Disease	1268	1273	stage
I-Disease	1274	1275	1
I-Disease	1276	1280	DCMD
O	1281	1282	(
O	1282	1284	20
O	1285	1293	patients
O	1293	1294	;
O	1295	1297	22
O	1297	1298	%
O	1298	1299	)
O	1299	1300	,
O	1301	1309	patients
O	1310	1319	generally
O	1320	1324	were
B-Characteristic	1325	1332	younger
I-Characteristic	1333	1337	than
I-Characteristic	1338	1340	20
I-Characteristic	1341	1346	years
O	1347	1350	and
O	1351	1354	had
B-Symptom	1355	1359	CFCs
I-Symptom	1360	1364	with
I-Symptom	1365	1369	fine
I-Symptom	1370	1377	folding
I-Symptom	1378	1380	of
I-Symptom	1381	1384	the
I-Symptom	1385	1393	internal
I-Symptom	1394	1402	limiting
I-Symptom	1403	1411	membrane
O	1412	1415	and
B-Symptom	1416	1420	mild
I-Symptom	1421	1428	pigment
I-Symptom	1429	1436	changes
O	1436	1437	.

O	1438	1440	In
B-Disease	1441	1446	stage
I-Disease	1447	1448	2
I-Disease	1449	1453	DCMD
O	1454	1455	(
O	1455	1457	48
O	1458	1466	patients
O	1466	1467	;
O	1468	1470	52
O	1470	1471	%
O	1471	1472	)
O	1472	1473	,
O	1474	1477	the
B-Symptom	1478	1482	CFCs
O	1483	1489	tended
O	1490	1492	to
O	1493	1501	decrease
O	1502	1504	in
O	1505	1509	size
O	1509	1510	,
O	1511	1514	and
B-Symptom	1515	1523	moderate
I-Symptom	1524	1531	macular
I-Symptom	1532	1545	chorioretinal
I-Symptom	1546	1553	atrophy
O	1554	1563	developed
O	1563	1564	.

O	1565	1573	Patients
O	1574	1578	with
B-Disease	1579	1584	stage
I-Disease	1585	1586	3
I-Disease	1587	1591	DCMD
O	1592	1593	(
O	1593	1595	24
O	1596	1604	patients
O	1604	1605	;
O	1606	1608	26
O	1608	1609	%
O	1609	1610	)
O	1611	1620	generally
O	1621	1625	were
B-Characteristic	1626	1631	older
I-Characteristic	1632	1636	than
I-Characteristic	1637	1639	50
I-Characteristic	1640	1645	years
O	1646	1649	and
O	1650	1656	showed
B-Symptom	1657	1665	profound
I-Symptom	1666	1679	chorioretinal
I-Symptom	1680	1687	atrophy
O	1687	1688	,
O	1689	1691	as
O	1692	1696	well
O	1697	1699	as
B-Symptom	1700	1706	coarse
I-Symptom	1707	1721	hyperpigmented
I-Symptom	1722	1730	deposits
I-Symptom	1731	1733	in
I-Symptom	1734	1737	the
I-Symptom	1738	1747	posterior
I-Symptom	1748	1752	pole
O	1752	1753	.

O	1754	1758	Most
O	1759	1767	patients
O	1768	1772	were
O	1773	1774	(
O	1774	1780	highly
O	1780	1781	)
B-Symptom	1782	1791	hyperopic
O	1792	1793	(
O	1793	1795	72
O	1796	1804	patients
O	1804	1805	;
O	1806	1808	92
O	1808	1809	%
O	1809	1810	)
O	1810	1811	.

O	1812	1815	All
B-Disease	1816	1820	DCMD
O	1821	1829	patients
O	1830	1836	shared
O	1837	1840	the
O	1841	1848	disease
B-Characteristic	1849	1858	haplotype
I-Characteristic	1859	1861	at
I-Characteristic	1862	1865	the
I-Characteristic	1866	1870	DCMD
I-Characteristic	1871	1876	locus
I-Characteristic	1877	1879	at
I-Characteristic	1880	1884	7p15
I-Characteristic	1884	1885	.
I-Characteristic	1885	1886	3
O	1886	1887	.

B-Disease	1888	1896	Dominant
I-Disease	1897	1904	cystoid
I-Disease	1905	1912	macular
I-Disease	1913	1922	dystrophy
O	1923	1925	is
O	1926	1927	a
B-Disease	1928	1939	progressive
I-Disease	1940	1947	retinal
I-Disease	1948	1957	dystrophy
O	1957	1958	,
O	1959	1972	characterized
O	1973	1982	primarily
O	1983	1985	by
B-Symptom	1986	1991	early
I-Symptom	1991	1992	-
I-Symptom	1992	1997	onset
I-Symptom	1998	2005	cystoid
I-Symptom	2006	2011	fluid
I-Symptom	2012	2023	collections
I-Symptom	2024	2026	in
I-Symptom	2027	2030	the
I-Symptom	2031	2042	neuroretina
O	2042	2043	,
O	2044	2049	which
O	2050	2063	distinguishes
O	2064	2068	this
O	2069	2077	disorder
O	2078	2082	from
O	2083	2088	other
B-Disease	2089	2096	retinal
I-Disease	2097	2108	dystrophies
O	2108	2109	.

O	2110	2113	The
O	2114	2124	phenotypic
O	2125	2130	range
O	2131	2133	of
B-Disease	2134	2138	DCMD
O	2139	2142	can
O	2143	2145	be
O	2146	2156	classified
O	2157	2161	into
O	2162	2163	3
O	2164	2170	stages
O	2170	2171	.

O	2172	2175	The
O	2176	2183	genetic
O	2184	2189	locus
O	2190	2193	for
O	2194	2198	this
B-Disease	2199	2206	retinal
I-Disease	2207	2216	dystrophy
O	2217	2220	has
O	2221	2225	been
O	2226	2232	mapped
O	2233	2235	to
O	2236	2240	7p15
O	2240	2241	.
O	2241	2242	3
O	2242	2243	,
O	2244	2247	but
O	2248	2251	the
O	2252	2260	involved
O	2261	2265	gene
O	2266	2268	is
O	2269	2278	currently
O	2279	2286	unknown
O	2286	2287	.

B-Symptom	0	6	Poorer
I-Symptom	7	25	neurodevelopmental
I-Symptom	26	34	outcomes
O	35	45	associated
O	46	50	with
B-Disease	51	58	cystoid
I-Disease	59	66	macular
I-Disease	67	72	edema
O	73	83	identified
O	84	86	in
B-Characteristic	87	94	preterm
I-Characteristic	95	102	infants
O	103	105	in
O	106	109	the
O	110	119	intensive
O	120	124	care
O	125	132	nursery
O	132	133	.

O	135	137	To
O	138	146	evaluate
O	147	150	the
O	151	162	association
O	163	170	between
B-Disease	171	178	cystoid
I-Disease	179	186	macular
I-Disease	187	192	edema
O	193	194	(
B-Disease	194	197	CME
O	197	198	)
O	199	207	observed
O	208	210	in
B-Characteristic	211	215	very
I-Characteristic	216	223	preterm
I-Characteristic	224	231	infants
O	232	235	and
O	236	249	developmental
O	250	258	outcomes
O	259	261	at
B-Characteristic	262	264	18
I-Characteristic	265	267	to
I-Characteristic	268	270	24
I-Characteristic	271	277	months
I-Characteristic	278	287	corrected
I-Characteristic	288	291	age
O	291	292	.

O	293	299	Cohort
O	300	305	study
O	305	306	.

B-Characteristic	307	314	Infants
I-Characteristic	315	319	born
I-Characteristic	320	322	at
I-Characteristic	323	325	or
I-Characteristic	326	330	less
I-Characteristic	331	335	than
I-Characteristic	336	340	1500
I-Characteristic	341	342	g
I-Characteristic	343	345	or
I-Characteristic	346	348	at
I-Characteristic	349	351	or
I-Characteristic	352	356	less
I-Characteristic	357	361	than
I-Characteristic	362	364	30
I-Characteristic	365	370	weeks
I-Characteristic	371	384	postmenstrual
I-Characteristic	385	388	age
O	389	392	who
O	393	402	underwent
O	403	412	screening
O	413	416	for
B-Disease	417	428	retinopathy
I-Disease	429	431	of
I-Disease	432	443	prematurity
O	444	445	(
B-Disease	445	448	ROP
O	448	449	)
O	450	452	in
O	453	455	an
O	456	465	intensive
O	466	470	care
O	471	478	nursery
O	478	479	.

O	480	487	Bedside
O	488	496	handheld
B-Diagnostic_tool	497	505	spectral
I-Diagnostic_tool	505	506	-
I-Diagnostic_tool	506	512	domain
I-Diagnostic_tool	513	520	optical
I-Diagnostic_tool	521	530	coherence
I-Diagnostic_tool	531	541	tomography
O	542	543	(
B-Diagnostic_tool	543	545	SD
I-Diagnostic_tool	546	549	OCT
O	549	550	;
O	551	557	Envisu
O	557	558	,
O	559	568	Bioptigen
O	568	569	,
O	570	573	Inc
O	573	574	,
O	575	583	Research
O	584	592	Triangle
O	593	597	Park
O	597	598	,
O	599	601	NC
O	601	602	)
O	603	610	imaging
O	611	614	was
O	615	623	obtained
O	624	628	from
B-Characteristic	629	636	preterm
I-Characteristic	637	644	infants
O	645	648	who
O	649	653	were
O	654	659	being
O	660	668	screened
O	669	672	for
B-Disease	673	676	ROP
O	677	680	and
O	681	687	graded
O	688	691	for
O	692	700	presence
O	701	703	of
B-Disease	704	707	CME
O	707	708	,
B-Characteristic	709	716	central
I-Characteristic	717	723	foveal
I-Characteristic	724	733	thickness
O	734	735	(
B-Characteristic	735	738	CFT
O	738	739	)
O	739	740	,
B-Characteristic	741	746	inner
I-Characteristic	747	754	nuclear
I-Characteristic	755	760	layer
I-Characteristic	761	770	thickness
O	770	771	,
O	772	775	and
B-Characteristic	776	782	foveal
I-Characteristic	782	783	-
I-Characteristic	783	785	to
I-Characteristic	785	786	-
I-Characteristic	786	796	parafoveal
I-Characteristic	797	806	thickness
I-Characteristic	807	812	ratio
O	812	813	.

O	814	816	At
B-Characteristic	817	819	18
I-Characteristic	820	822	to
I-Characteristic	823	825	24
I-Characteristic	826	832	months
I-Characteristic	833	842	corrected
I-Characteristic	843	846	age
O	846	847	,
O	848	851	the
B-Characteristic	852	860	children
O	861	865	were
O	866	874	assessed
O	875	879	with
O	880	883	the
B-Classification_system	884	890	Bayley
I-Classification_system	891	897	Scales
I-Classification_system	898	900	of
I-Classification_system	901	907	Infant
I-Classification_system	908	911	and
I-Classification_system	912	919	Toddler
I-Classification_system	920	931	Development
I-Classification_system	931	932	,
I-Classification_system	933	938	Third
I-Classification_system	939	946	Edition
O	946	947	.

O	948	954	Scores
O	955	957	on
O	958	961	the
B-Classification_system	962	968	Bayley
I-Classification_system	969	978	cognitive
I-Classification_system	978	979	,
I-Classification_system	980	988	language
I-Classification_system	988	989	,
I-Classification_system	990	993	and
I-Classification_system	994	999	motor
I-Classification_system	1000	1009	subscales
O	1009	1010	.

O	1011	1016	Among
O	1017	1019	77
B-Characteristic	1020	1028	children
O	1029	1033	with
B-Diagnostic_tool	1034	1036	SD
I-Diagnostic_tool	1037	1040	OCT
I-Diagnostic_tool	1041	1048	imaging
O	1048	1049	,
O	1050	1052	53
O	1053	1057	were
O	1058	1067	evaluated
O	1068	1072	with
O	1073	1076	the
B-Classification_system	1077	1083	Bayley
I-Classification_system	1084	1090	Scales
O	1090	1091	.

O	1092	1100	Compared
O	1101	1105	with
B-Characteristic	1106	1114	children
O	1115	1118	who
O	1119	1122	did
O	1123	1126	not
O	1127	1131	have
B-Disease	1132	1135	CME
O	1136	1138	as
B-Characteristic	1139	1146	infants
O	1147	1148	(
O	1148	1149	n
O	1149	1150	=
O	1150	1152	22
O	1152	1153	)
O	1153	1154	,
O	1155	1158	the
O	1159	1163	mean
O	1164	1169	score
O	1170	1173	for
B-Characteristic	1174	1182	children
O	1183	1186	who
O	1187	1190	had
B-Disease	1191	1194	CME
O	1195	1196	(
O	1196	1197	n
O	1197	1198	=
O	1198	1200	31
O	1200	1201	)
O	1202	1205	was
O	1206	1207	7
O	1207	1208	.
O	1208	1209	3
O	1210	1216	points
O	1217	1218	(
O	1218	1220	95
O	1220	1221	%
O	1222	1232	confidence
O	1233	1241	interval
O	1242	1243	[
O	1243	1245	CI
O	1245	1246	]
O	1246	1247	,
O	1248	1249	-
O	1249	1251	15
O	1251	1252	.
O	1252	1253	5
O	1254	1256	to
O	1257	1258	0
O	1258	1259	.
O	1259	1260	9
O	1260	1261	;
O	1262	1263	P
O	1263	1264	=
O	1264	1265	0
O	1265	1266	.
O	1266	1268	08
O	1268	1269	)
O	1270	1275	lower
O	1276	1278	on
O	1279	1282	the
B-Classification_system	1283	1292	cognitive
I-Classification_system	1293	1301	subscale
O	1301	1302	,
O	1303	1305	14
O	1305	1306	.
O	1306	1307	1
O	1308	1314	points
O	1315	1316	(
O	1316	1318	95
O	1318	1319	%
O	1320	1322	CI
O	1322	1323	,
O	1324	1325	-
O	1325	1327	22
O	1327	1328	.
O	1328	1329	7
O	1330	1332	to
O	1333	1334	-
O	1334	1335	5
O	1335	1336	.
O	1336	1337	5
O	1337	1338	;
O	1339	1340	P
O	1340	1341	=
O	1341	1342	0
O	1342	1343	.
O	1343	1346	002
O	1346	1347	)
O	1348	1353	lower
O	1354	1357	for
O	1358	1361	the
B-Classification_system	1362	1370	language
I-Classification_system	1371	1379	subscale
O	1379	1380	,
O	1381	1384	and
O	1385	1387	11
O	1387	1388	.
O	1388	1389	5
O	1390	1396	points
O	1397	1398	(
O	1398	1400	95
O	1400	1401	%
O	1402	1404	CI
O	1404	1405	,
O	1406	1407	-
O	1407	1409	21
O	1409	1410	.
O	1410	1411	6
O	1412	1414	to
O	1415	1416	-
O	1416	1417	1
O	1417	1418	.
O	1418	1419	3
O	1419	1420	;
O	1421	1422	P
O	1422	1423	=
O	1423	1424	0
O	1424	1425	.
O	1425	1427	03
O	1427	1428	)
O	1429	1434	lower
O	1435	1438	for
O	1439	1442	the
B-Classification_system	1443	1448	motor
I-Classification_system	1449	1457	subscale
O	1457	1458	.

O	1459	1470	Differences
O	1471	1475	were
O	1476	1486	maintained
O	1487	1492	after
O	1493	1502	adjusting
O	1503	1506	for
B-Characteristic	1507	1518	gestational
I-Characteristic	1519	1522	age
O	1523	1526	and
B-Characteristic	1527	1532	birth
I-Characteristic	1533	1539	weight
O	1539	1540	.

O	1541	1549	Severity
O	1550	1552	of
B-Disease	1553	1556	CME
O	1556	1557	,
O	1558	1560	as
O	1561	1569	assessed
O	1570	1572	by
B-Characteristic	1573	1579	foveal
I-Characteristic	1579	1580	-
I-Characteristic	1580	1582	to
I-Characteristic	1582	1583	-
I-Characteristic	1583	1593	parafoveal
I-Characteristic	1594	1603	thickness
I-Characteristic	1604	1609	ratio
O	1609	1610	,
O	1611	1617	within
O	1618	1621	the
B-Disease	1622	1625	CME
O	1626	1631	group
O	1632	1642	correlated
O	1643	1647	with
B-Characteristic	1648	1654	poorer
I-Characteristic	1655	1664	cognitive
I-Characteristic	1665	1666	(
I-Characteristic	1666	1668	R2
I-Characteristic	1668	1669	=
I-Characteristic	1669	1670	0
I-Characteristic	1670	1671	.
I-Characteristic	1671	1673	16
I-Characteristic	1673	1674	,
I-Characteristic	1675	1676	P
I-Characteristic	1676	1677	=
I-Characteristic	1677	1678	0
I-Characteristic	1678	1679	.
I-Characteristic	1679	1681	03
I-Characteristic	1681	1682	)
I-Characteristic	1683	1686	and
I-Characteristic	1687	1692	motor
I-Characteristic	1693	1694	(
I-Characteristic	1694	1696	R2
I-Characteristic	1696	1697	=
I-Characteristic	1697	1698	0
I-Characteristic	1698	1699	.
I-Characteristic	1699	1701	15
I-Characteristic	1701	1702	,
I-Characteristic	1703	1704	P
I-Characteristic	1704	1705	=
I-Characteristic	1705	1706	0
I-Characteristic	1706	1707	.
I-Characteristic	1707	1709	03
I-Characteristic	1709	1710	)
I-Characteristic	1711	1722	development
O	1722	1723	.

B-Disease	1724	1731	Cystoid
I-Disease	1732	1739	macular
I-Disease	1740	1745	edema
O	1746	1754	observed
O	1755	1757	on
B-Diagnostic_tool	1758	1760	SD
I-Diagnostic_tool	1761	1764	OCT
O	1765	1767	in
O	1768	1772	very
B-Characteristic	1773	1780	preterm
I-Characteristic	1781	1788	infants
O	1789	1797	screened
O	1798	1801	for
B-Disease	1802	1805	ROP
O	1806	1808	is
O	1809	1819	associated
O	1820	1824	with
B-Characteristic	1825	1831	poorer
I-Characteristic	1832	1840	language
I-Characteristic	1841	1844	and
I-Characteristic	1845	1850	motor
I-Characteristic	1851	1857	skills
I-Characteristic	1858	1860	at
I-Characteristic	1861	1863	18
I-Characteristic	1864	1866	to
I-Characteristic	1867	1869	24
I-Characteristic	1870	1876	months
I-Characteristic	1877	1886	corrected
I-Characteristic	1887	1890	age
O	1890	1891	.

O	1892	1902	Evaluation
O	1903	1905	of
O	1906	1909	the
B-Anatomy	1910	1916	retina
O	1917	1921	with
B-Diagnostic_tool	1922	1924	SD
I-Diagnostic_tool	1924	1925	-
I-Diagnostic_tool	1925	1928	OCT
O	1929	1932	may
O	1933	1938	serve
O	1939	1941	as
O	1942	1944	an
O	1945	1954	indicator
O	1955	1957	of
B-Characteristic	1958	1976	neurodevelopmental
I-Characteristic	1977	1983	health
O	1984	1987	for
B-Characteristic	1988	1992	very
I-Characteristic	1993	2000	preterm
I-Characteristic	2001	2008	infants
O	2009	2011	in
O	2012	2015	the
O	2016	2025	intensive
O	2026	2030	care
O	2031	2038	nursery
O	2038	2039	.

B-Symptom	0	6	Threat
I-Symptom	7	9	to
I-Symptom	10	18	fixation
O	19	21	at
O	22	31	diagnosis
O	32	35	and
O	36	44	lifetime
O	45	49	risk
O	50	52	of
B-Symptom	53	59	visual
I-Symptom	60	70	impairment
O	71	73	in
B-Disease	74	78	open
I-Disease	78	79	-
I-Disease	79	84	angle
I-Disease	85	93	glaucoma
O	93	94	.

O	96	98	To
O	99	110	investigate
O	111	118	whether
B-Symptom	119	125	threat
I-Symptom	126	128	to
I-Symptom	129	137	fixation
O	138	139	(
B-Symptom	139	142	TTF
O	142	143	)
O	144	146	at
O	147	156	diagnosis
O	157	166	increases
O	167	170	the
O	171	175	risk
O	176	178	of
B-Symptom	179	186	central
I-Symptom	187	193	vision
I-Symptom	194	198	loss
O	199	202	and
B-Symptom	203	211	glaucoma
I-Symptom	212	221	blindness
O	221	222	.

O	223	236	Retrospective
O	237	243	cohort
O	244	249	study
O	249	250	.

O	251	252	A
O	253	258	total
O	259	261	of
O	262	265	309
O	266	274	patients
O	275	276	(
O	276	279	309
B-Anatomy	280	284	eyes
O	284	285	)
O	286	290	with
B-Disease	291	299	glaucoma
O	300	304	were
O	305	313	followed
O	314	316	up
O	317	322	until
O	323	328	death
O	328	329	;
O	330	333	203
O	334	342	patients
O	343	344	(
O	344	346	65
O	346	347	.
O	347	348	7
O	348	349	%
O	349	350	)
O	351	354	had
B-Disease	355	362	primary
I-Disease	363	367	open
I-Disease	367	368	-
I-Disease	368	373	angle
I-Disease	374	382	glaucoma
O	382	383	,
O	384	387	and
O	388	391	106
O	392	400	patients
O	401	402	(
O	402	404	34
O	404	405	.
O	405	406	2
O	406	407	%
O	407	408	)
O	409	412	had
B-Disease	413	424	exfoliation
I-Disease	425	433	glaucoma
O	433	434	.

O	435	440	Study
B-Anatomy	441	445	eyes
O	446	450	were
O	451	458	divided
O	459	463	into
O	464	465	2
O	466	472	groups
O	473	482	according
O	483	485	to
B-Symptom	486	489	TTF
O	490	492	in
O	493	496	the
O	497	502	first
B-Disease	503	515	glaucomatous
O	516	522	visual
O	523	528	field
O	528	529	:
O	530	531	(
O	531	532	1
O	532	533	)
B-Anatomy	534	538	eyes
O	539	543	with
B-Symptom	544	547	TTF
O	547	548	,
O	549	556	defined
O	557	559	as
B-Symptom	560	566	visual
I-Symptom	567	572	field
I-Symptom	573	577	loss
O	578	579	(
B-Symptom	579	582	VFL
O	582	583	)
O	584	593	including
O	594	595	
O	595	596	1
O	597	599	of
O	600	603	the
O	604	605	4
O	606	615	innermost
O	616	622	points
O	623	632	depressed
O	633	635	at
O	636	637	P
O	639	640	<
O	642	643	1
O	643	644	%
O	645	650	level
O	651	653	in
O	654	656	24
O	656	657	-
O	657	658	2
O	659	661	or
O	662	664	30
O	664	665	-
O	665	666	2
O	667	675	Humphrey
O	676	682	fields
O	682	683	;
O	684	685	(
O	685	686	2
O	686	687	)
B-Anatomy	688	692	eyes
O	693	700	without
B-Symptom	701	704	TTF
O	704	705	,
O	706	713	defined
O	714	716	as
B-Symptom	717	720	VFL
O	721	725	only
O	726	733	outside
O	734	737	the
O	738	739	4
O	740	749	innermost
O	750	756	points
O	756	757	.

O	758	766	Lifetime
O	767	771	risk
O	772	774	of
B-Symptom	775	781	visual
I-Symptom	782	788	acuity
I-Symptom	789	790	(
I-Symptom	790	792	VA
I-Symptom	792	793	)
I-Symptom	794	798	loss
O	799	802	and
B-Symptom	803	811	glaucoma
I-Symptom	812	821	blindness
O	822	824	in
O	825	828	the
O	829	830	2
O	831	837	groups
O	838	841	was
O	842	850	compared
O	851	853	by
O	854	862	logistic
O	863	873	regression
O	874	882	analysis
O	882	883	.

O	884	885	A
O	886	894	matching
O	895	904	technique
O	905	908	was
O	909	913	used
O	914	916	to
O	917	923	adjust
O	924	927	for
O	928	939	differences
O	940	942	in
O	943	950	disease
O	951	956	stage
O	957	959	at
O	960	972	presentation
O	972	973	.

O	974	977	The
O	978	986	relative
O	987	996	influence
O	997	999	of
B-Symptom	1000	1003	TTF
O	1004	1006	on
O	1007	1010	the
O	1011	1015	risk
O	1016	1018	of
B-Symptom	1019	1028	blindness
O	1029	1031	in
O	1032	1035	the
O	1036	1037	2
O	1038	1045	matched
O	1046	1052	groups
O	1053	1056	was
O	1057	1065	analyzed
O	1066	1068	by
O	1069	1072	the
O	1073	1079	Kaplan
O	1079	1080	-
O	1080	1085	Meier
O	1086	1092	method
O	1092	1093	.

B-Symptom	1094	1100	Visual
I-Symptom	1101	1107	acuity
I-Symptom	1109	1110	<
I-Symptom	1111	1112	0
I-Symptom	1112	1113	.
I-Symptom	1113	1114	3
O	1115	1118	and
B-Symptom	1119	1128	blindness
O	1129	1133	from
B-Disease	1134	1142	glaucoma
O	1143	1144	(
O	1144	1149	World
O	1150	1156	Health
O	1157	1169	Organization
O	1170	1178	criteria
O	1178	1179	)
O	1180	1182	at
O	1183	1187	last
O	1188	1193	visit
O	1193	1194	.

B-Symptom	1195	1201	Threat
I-Symptom	1202	1204	to
I-Symptom	1205	1213	fixation
O	1214	1217	was
O	1218	1226	detected
O	1227	1229	in
O	1230	1232	58
O	1232	1233	.
O	1233	1234	9
O	1234	1235	%
O	1236	1238	of
O	1239	1242	the
B-Anatomy	1243	1247	eyes
O	1248	1250	at
O	1251	1260	diagnosis
O	1260	1261	.

O	1262	1265	The
O	1266	1275	frequency
O	1276	1278	of
B-Symptom	1279	1282	TTF
O	1283	1292	increased
O	1293	1297	with
O	1298	1303	stage
O	1304	1306	of
B-Symptom	1307	1319	glaucomatous
I-Symptom	1320	1324	loss
O	1324	1325	:
O	1326	1328	28
O	1328	1329	.
O	1329	1330	3
O	1330	1331	%
O	1332	1334	in
B-Anatomy	1335	1339	eyes
O	1340	1344	with
O	1345	1349	mean
O	1350	1359	deviation
O	1360	1361	(
O	1361	1363	MD
O	1363	1364	)
O	1366	1367	>
O	1368	1369	-
O	1369	1370	6
O	1370	1371	.
O	1371	1373	00
O	1374	1382	decibels
O	1383	1384	(
O	1384	1386	dB
O	1386	1387	)
O	1388	1394	versus
O	1395	1397	95
O	1397	1398	.
O	1398	1399	7
O	1399	1400	%
O	1401	1405	with
O	1406	1408	MD
O	1410	1411	<
O	1412	1413	-
O	1413	1415	20
O	1415	1416	.
O	1416	1418	00
O	1419	1421	dB
O	1421	1422	.

O	1423	1433	Univariate
O	1434	1442	analysis
O	1443	1455	demonstrated
O	1456	1460	that
B-Anatomy	1461	1465	eyes
O	1466	1470	with
B-Symptom	1471	1474	TTF
O	1475	1477	at
O	1478	1490	presentation
O	1491	1499	compared
O	1500	1504	with
B-Anatomy	1505	1509	eyes
O	1510	1517	without
B-Symptom	1518	1521	TTF
O	1522	1528	became
B-Symptom	1529	1534	blind
O	1535	1539	more
O	1540	1545	often
O	1546	1547	(
O	1547	1549	56
O	1549	1550	/
O	1550	1553	182
O	1554	1555	[
O	1555	1557	30
O	1557	1558	.
O	1558	1559	8
O	1559	1560	%
O	1560	1561	]
O	1562	1564	vs
O	1564	1565	.
O	1566	1568	22
O	1568	1569	/
O	1569	1572	127
O	1573	1574	[
O	1574	1576	17
O	1576	1577	.
O	1577	1578	3
O	1578	1579	%
O	1579	1580	]
O	1581	1582	;
O	1583	1584	P
O	1585	1586	=
O	1587	1588	0
O	1588	1589	.
O	1589	1592	008
O	1592	1593	)
O	1594	1597	and
O	1598	1604	faster
O	1605	1606	(
O	1606	1610	mean
O	1611	1615	time
O	1616	1620	from
O	1621	1630	diagnosis
O	1631	1633	to
B-Symptom	1634	1643	blindness
O	1643	1644	,
O	1645	1647	84
O	1647	1648	.
O	1648	1649	6
O	1649	1650	
O	1650	1652	50
O	1652	1653	.
O	1653	1654	7
O	1655	1657	vs
O	1657	1658	.
O	1659	1662	126
O	1662	1663	.
O	1663	1664	7
O	1664	1665	
O	1665	1667	51
O	1667	1668	.
O	1668	1669	4
O	1670	1676	months
O	1676	1677	;
O	1678	1679	P
O	1681	1682	<
O	1684	1685	0
O	1685	1686	.
O	1686	1689	002
O	1689	1690	)
O	1690	1691	.

O	1692	1699	However
O	1699	1700	,
O	1701	1703	in
O	1704	1716	multivariate
O	1717	1725	analysis
O	1725	1726	,
B-Symptom	1727	1730	TTF
O	1731	1734	was
O	1735	1738	not
O	1739	1741	an
O	1742	1753	independent
O	1754	1758	risk
O	1759	1765	factor
O	1766	1769	for
B-Symptom	1770	1772	VA
I-Symptom	1774	1775	<
I-Symptom	1776	1777	0
I-Symptom	1777	1778	.
I-Symptom	1778	1779	3
O	1780	1781	(
O	1781	1785	odds
O	1786	1791	ratio
O	1791	1792	,
O	1793	1794	1
O	1794	1795	.
O	1795	1797	43
O	1797	1798	;
O	1799	1801	95
O	1801	1802	%
O	1803	1813	confidence
O	1814	1822	interval
O	1822	1823	,
O	1824	1825	0
O	1825	1826	.
O	1826	1828	75
O	1828	1829	-
O	1829	1830	2
O	1830	1831	.
O	1831	1833	74
O	1833	1834	)
O	1835	1837	or
B-Symptom	1838	1847	blindness
O	1848	1849	(
O	1849	1853	odds
O	1854	1859	ratio
O	1859	1860	,
O	1861	1862	1
O	1862	1863	.
O	1863	1865	03
O	1865	1866	;
O	1867	1869	95
O	1869	1870	%
O	1871	1881	confidence
O	1882	1890	interval
O	1890	1891	,
O	1892	1893	0
O	1893	1894	.
O	1894	1896	52
O	1896	1897	-
O	1897	1898	2
O	1898	1899	.
O	1899	1901	01
O	1901	1902	)
O	1902	1903	.

O	1904	1908	With
O	1909	1915	regard
O	1916	1918	to
O	1919	1926	patient
O	1927	1935	survival
O	1936	1940	time
O	1940	1941	,
O	1942	1947	there
O	1948	1952	were
O	1953	1955	no
O	1956	1967	differences
O	1968	1975	between
B-Anatomy	1976	1980	eyes
O	1981	1985	with
B-Symptom	1986	1989	TTF
O	1990	1993	and
B-Anatomy	1994	1998	eyes
O	1999	2006	without
B-Symptom	2007	2010	TTF
O	2011	2016	after
O	2017	2026	adjusting
O	2027	2030	for
O	2031	2042	disparities
O	2043	2045	in
O	2046	2053	disease
O	2054	2062	severity
O	2063	2065	at
O	2066	2078	presentation
O	2079	2080	(
O	2080	2081	P
O	2082	2083	=
O	2084	2085	0
O	2085	2086	.
O	2086	2089	934
O	2089	2090	)
O	2090	2091	.

O	2092	2101	Including
B-Symptom	2102	2105	TTF
O	2106	2108	in
O	2109	2112	the
O	2113	2123	assessment
O	2124	2126	of
O	2127	2131	risk
O	2132	2135	for
B-Symptom	2136	2144	glaucoma
I-Symptom	2145	2154	blindness
O	2155	2158	did
O	2159	2162	not
O	2163	2166	add
O	2167	2170	any
O	2171	2180	important
O	2181	2192	information
O	2193	2197	when
O	2198	2201	the
O	2202	2207	stage
O	2208	2210	of
B-Symptom	2211	2214	VFL
O	2215	2218	was
O	2219	2224	taken
O	2225	2229	into
O	2230	2237	account
O	2237	2238	.

B-Symptom	0	10	Peripheral
I-Symptom	11	18	Lesions
O	19	29	Identified
O	30	32	on
B-Diagnostic_tool	33	42	Ultrawide
I-Diagnostic_tool	43	48	Field
I-Diagnostic_tool	49	56	Imaging
O	57	64	Predict
O	65	74	Increased
O	75	79	Risk
O	80	82	of
B-Disease	83	91	Diabetic
I-Disease	92	103	Retinopathy
O	104	115	Progression
O	116	120	over
O	121	122	4
O	123	128	Years
O	128	129	.

O	131	133	To
O	134	143	determine
O	144	151	whether
B-Symptom	152	162	peripheral
I-Symptom	163	171	diabetic
I-Symptom	172	183	retinopathy
I-Symptom	184	185	(
I-Symptom	185	187	DR
I-Symptom	187	188	)
I-Symptom	189	196	lesions
O	197	207	identified
O	208	210	on
B-Diagnostic_tool	211	220	ultrawide
I-Diagnostic_tool	221	226	field
I-Diagnostic_tool	227	228	(
I-Diagnostic_tool	228	231	UWF
I-Diagnostic_tool	231	232	)
I-Diagnostic_tool	233	240	imaging
O	241	244	are
O	245	255	associated
O	256	260	with
O	261	270	increased
B-Disease	271	273	DR
O	274	285	progression
O	285	286	.

O	287	298	Prospective
O	298	299	,
O	300	312	longitudinal
O	313	319	cohort
O	319	320	.

O	321	324	Two
O	325	332	hundred
B-Anatomy	333	337	eyes
O	338	340	of
O	341	344	100
O	345	357	participants
O	358	368	previously
O	369	377	enrolled
O	378	380	in
O	381	382	a
O	383	394	comparative
O	395	405	instrument
O	406	416	validation
O	417	422	study
O	422	423	.

O	424	432	Baseline
O	433	442	mydriatic
O	443	444	7
O	444	445	-
O	445	453	standard
O	454	459	field
B-Diagnostic_tool	460	465	Early
I-Diagnostic_tool	466	475	Treatment
I-Diagnostic_tool	476	484	Diabetic
I-Diagnostic_tool	485	496	Retinopathy
I-Diagnostic_tool	497	502	Study
I-Diagnostic_tool	503	504	(
I-Diagnostic_tool	504	509	ETDRS
I-Diagnostic_tool	509	510	)
I-Diagnostic_tool	511	522	photographs
O	523	526	and
B-Diagnostic_tool	527	530	UWF
I-Diagnostic_tool	531	537	images
O	538	542	were
O	543	551	obtained
O	551	552	.

O	553	555	On
B-Diagnostic_tool	556	559	UWF
I-Diagnostic_tool	560	566	images
O	566	567	,
B-Symptom	568	570	DR
I-Symptom	571	578	lesions
O	579	583	with
O	584	585	a
O	586	593	greater
O	594	600	extent
O	601	608	outside
O	609	615	versus
O	616	622	inside
O	623	631	standard
O	632	637	ETDRS
O	638	644	fields
O	645	649	were
O	650	657	defined
O	658	660	as
B-Symptom	661	674	predominantly
I-Symptom	675	685	peripheral
I-Symptom	686	693	lesions
O	694	695	(
B-Symptom	695	699	PPLs
O	699	700	)
O	700	701	.

O	702	708	Follow
O	708	709	-
O	709	711	up
B-Diagnostic_tool	712	717	ETDRS
I-Diagnostic_tool	718	729	photographs
O	730	734	were
O	735	743	obtained
O	744	745	4
O	745	746	.
O	746	747	2
O	747	748	
O	748	749	0
O	749	750	.
O	750	751	3
O	752	757	years
O	758	763	after
O	764	772	baseline
O	772	773	.

O	774	782	Baseline
O	783	786	and
O	787	793	follow
O	793	794	-
O	794	796	up
B-Disease	797	799	DR
O	800	808	severity
O	809	813	were
O	814	820	graded
O	821	825	from
B-Diagnostic_tool	826	831	ETDRS
I-Diagnostic_tool	832	843	photographs
O	843	844	.

O	845	850	Rates
O	851	853	of
O	854	855	2
O	855	856	-
O	856	860	step
O	861	863	or
O	864	868	more
O	869	880	progression
O	881	884	and
O	885	896	progression
O	897	899	to
B-Disease	900	913	proliferative
I-Disease	914	916	DR
O	917	918	(
B-Disease	918	921	PDR
O	921	922	)
O	923	925	in
B-Anatomy	926	930	eyes
O	931	935	with
B-Symptom	936	940	PPLs
O	941	949	compared
O	950	954	with
B-Anatomy	955	959	eyes
O	960	967	without
B-Symptom	968	972	PPLs
O	973	983	identified
O	984	986	on
B-Diagnostic_tool	987	990	UWF
I-Diagnostic_tool	991	998	imaging
O	999	1001	at
O	1002	1010	baseline
O	1010	1011	.

O	1012	1014	In
B-Anatomy	1015	1019	eyes
O	1020	1027	without
B-Disease	1028	1031	PDR
O	1032	1033	(
O	1033	1034	n
O	1035	1036	=
O	1037	1040	109
O	1040	1041	)
O	1042	1044	at
O	1045	1053	baseline
O	1053	1054	,
O	1055	1057	56
O	1058	1059	(
O	1059	1061	51
O	1061	1062	%
O	1062	1063	)
O	1064	1067	had
O	1068	1070	at
O	1071	1076	least
O	1077	1078	1
O	1079	1084	field
O	1085	1089	with
B-Symptom	1090	1094	PPLs
O	1095	1098	and
O	1099	1101	43
O	1102	1103	(
O	1103	1105	39
O	1105	1106	%
O	1106	1107	)
O	1108	1111	had
B-Disease	1112	1114	DR
O	1115	1126	progression
O	1126	1127	.

O	1128	1136	Compared
O	1137	1141	with
B-Anatomy	1142	1146	eyes
O	1147	1154	without
B-Symptom	1155	1159	PPLs
O	1159	1160	,
B-Anatomy	1161	1165	eyes
O	1166	1170	with
B-Symptom	1171	1175	PPLs
O	1176	1179	had
O	1180	1181	a
O	1182	1183	3
O	1183	1184	.
O	1184	1185	2
O	1185	1186	-
O	1186	1190	fold
O	1191	1200	increased
O	1201	1205	risk
O	1206	1208	of
O	1209	1210	2
O	1210	1211	-
O	1211	1215	step
O	1216	1218	or
O	1219	1223	more
B-Disease	1224	1226	DR
O	1227	1238	progression
O	1239	1240	(
O	1240	1241	6
O	1242	1243	[
O	1243	1245	11
O	1245	1246	%
O	1246	1247	]
O	1248	1250	vs
O	1250	1251	.
O	1252	1254	19
O	1255	1256	[
O	1256	1258	34
O	1258	1259	%
O	1259	1260	]
O	1261	1262	;
O	1263	1264	P
O	1265	1266	=
O	1267	1268	0
O	1268	1269	.
O	1269	1272	005
O	1272	1273	)
O	1274	1277	and
O	1278	1279	a
O	1280	1281	4
O	1281	1282	.
O	1282	1283	7
O	1283	1284	-
O	1284	1288	fold
O	1289	1298	increased
O	1299	1303	risk
O	1304	1307	for
O	1308	1319	progression
O	1320	1322	to
B-Disease	1323	1326	PDR
O	1327	1328	(
O	1328	1329	3
O	1330	1331	[
O	1331	1332	6
O	1332	1333	%
O	1333	1334	]
O	1335	1337	vs
O	1337	1338	.
O	1339	1341	14
O	1342	1343	[
O	1343	1345	25
O	1345	1346	%
O	1346	1347	]
O	1348	1349	;
O	1350	1351	P
O	1352	1353	=
O	1354	1355	0
O	1355	1356	.
O	1356	1359	005
O	1359	1360	)
O	1360	1361	.

O	1362	1367	These
O	1368	1376	findings
O	1377	1385	remained
O	1386	1399	statistically
O	1400	1411	significant
O	1412	1417	after
O	1418	1427	adjusting
O	1428	1431	for
B-Characteristic	1432	1438	gender
O	1438	1439	,
B-Characteristic	1440	1448	diabetes
I-Characteristic	1449	1453	type
O	1453	1454	,
B-Characteristic	1455	1463	diabetes
I-Characteristic	1464	1472	duration
O	1472	1473	,
B-Characteristic	1474	1484	hemoglobin
I-Characteristic	1485	1488	A1c
I-Characteristic	1489	1490	(
I-Characteristic	1490	1495	HbA1c
I-Characteristic	1495	1496	)
I-Characteristic	1497	1503	levels
O	1503	1504	,
O	1505	1508	and
B-Characteristic	1509	1517	baseline
I-Characteristic	1518	1520	DR
I-Characteristic	1521	1529	severity
O	1529	1530	.

O	1531	1541	Increasing
O	1542	1548	extent
O	1549	1551	of
O	1552	1558	fields
O	1559	1563	with
B-Symptom	1564	1568	PPLs
O	1569	1578	increased
O	1579	1582	the
O	1583	1587	risk
O	1588	1591	for
O	1592	1593	2
O	1593	1594	-
O	1594	1598	step
O	1599	1601	or
O	1602	1606	more
B-Disease	1607	1609	DR
O	1610	1621	progression
O	1622	1623	(
O	1623	1624	P
O	1625	1626	=
O	1627	1628	0
O	1628	1629	.
O	1629	1632	004
O	1632	1633	)
O	1634	1637	and
O	1638	1649	progression
O	1650	1652	to
B-Disease	1653	1656	PDR
O	1657	1658	(
O	1658	1659	P
O	1660	1661	=
O	1662	1663	0
O	1663	1664	.
O	1664	1667	009
O	1667	1668	)
O	1668	1669	.

O	1670	1678	Presence
O	1679	1682	and
O	1683	1693	increasing
O	1694	1700	extent
O	1701	1703	of
B-Symptom	1704	1708	PPLs
O	1709	1713	were
O	1714	1724	associated
O	1725	1729	with
O	1730	1739	increased
O	1740	1744	risk
O	1745	1747	of
B-Disease	1748	1750	DR
O	1751	1762	progression
O	1763	1767	over
O	1768	1769	4
O	1770	1775	years
O	1775	1776	,
O	1777	1788	independent
O	1789	1791	of
O	1792	1800	baseline
B-Disease	1801	1803	DR
O	1804	1812	severity
O	1813	1816	and
B-Characteristic	1817	1822	HbA1c
I-Characteristic	1823	1829	levels
O	1829	1830	.

O	1831	1841	Increasing
O	1842	1848	extent
O	1849	1851	of
B-Symptom	1852	1856	PPLs
O	1857	1870	substantially
O	1871	1880	increased
O	1881	1884	the
O	1885	1889	risk
O	1890	1892	of
B-Disease	1893	1895	DR
O	1896	1907	progression
O	1908	1911	and
O	1912	1923	progression
O	1924	1926	to
B-Disease	1927	1930	PDR
O	1930	1931	,
O	1932	1942	especially
O	1943	1947	with
O	1948	1952	less
O	1953	1959	severe
B-Disease	1960	1962	DR
O	1963	1965	at
O	1966	1974	baseline
O	1974	1975	.

O	1976	1981	These
O	1982	1990	findings
O	1991	2002	demonstrate
O	2003	2007	that
O	2008	2016	detailed
B-Diagnostic_tool	2017	2027	peripheral
I-Diagnostic_tool	2028	2035	retinal
I-Diagnostic_tool	2036	2046	evaluation
O	2047	2055	provides
O	2056	2065	important
O	2066	2077	information
O	2078	2082	that
O	2083	2085	is
O	2086	2095	necessary
O	2096	2098	to
O	2099	2105	assess
O	2106	2116	completely
O	2117	2120	the
O	2121	2125	risk
O	2126	2128	of
B-Disease	2129	2131	DR
O	2132	2143	progression
O	2143	2144	.

O	0	10	Comparison
O	11	18	between
B-Diagnostic_tool	19	33	ophthalmoscopy
O	34	37	and
B-Diagnostic_tool	38	44	fundus
I-Diagnostic_tool	45	56	photography
O	57	59	in
O	60	71	determining
O	72	80	severity
O	81	83	of
B-Disease	84	92	diabetic
I-Disease	93	104	retinopathy
O	104	105	.

B-Disease	107	115	Diabetic
I-Disease	116	127	retinopathy
O	128	131	was
O	132	140	assessed
O	141	143	in
O	144	145	a
O	146	156	population
O	156	157	-
O	157	162	based
O	163	168	study
O	169	171	of
O	172	176	2708
B-Disease	177	185	diabetic
O	186	193	persons
O	194	196	in
B-Characteristic	197	205	southern
I-Characteristic	206	215	Wisconsin
O	215	216	.

O	217	220	The
B-Disease	221	232	retinopathy
O	233	239	levels
O	240	242	as
O	243	253	determined
O	254	256	by
B-Diagnostic_tool	257	271	ophthalmoscopy
O	272	275	and
O	276	278	by
O	279	282	the
O	283	290	grading
O	291	293	of
B-Diagnostic_tool	294	306	stereoscopic
I-Diagnostic_tool	307	313	fundus
I-Diagnostic_tool	314	325	photographs
O	326	330	were
O	331	339	compared
O	340	342	in
O	343	346	the
B-Anatomy	347	351	eyes
O	352	354	of
O	355	359	1949
O	360	367	persons
O	367	368	.

B-Diagnostic_tool	369	383	Ophthalmoscopy
O	384	387	was
O	388	397	performed
O	398	400	by
O	401	403	an
O	404	419	ophthalmologist
O	420	423	and
O	424	425	a
O	426	435	specially
O	436	443	trained
O	444	455	optometrist
O	456	459	and
O	460	470	ophthalmic
O	471	481	technician
O	481	482	.

O	483	495	Consultation
O	496	501	among
O	502	505	the
O	506	511	three
O	512	521	examiners
O	522	525	was
O	526	535	permitted
O	535	536	.

O	537	542	There
O	543	546	was
O	547	552	exact
O	553	562	agreement
O	563	570	between
B-Diagnostic_tool	571	585	ophthalmoscopy
O	586	589	and
O	590	597	grading
O	598	601	for
O	602	611	detecting
B-Disease	612	623	retinopathy
O	624	625	(
O	625	629	none
O	629	630	,
B-Disease	631	647	nonproliferative
O	647	648	,
B-Disease	649	662	proliferative
O	662	663	)
O	664	666	85
O	666	667	.
O	667	668	7
O	668	669	%
O	670	672	of
O	673	676	the
O	677	681	time
O	681	682	.

O	683	686	The
O	687	692	kappa
O	693	702	statistic
O	702	703	,
O	704	709	which
O	710	718	corrects
O	719	722	for
O	723	729	chance
O	730	739	agreement
O	739	740	,
O	741	744	was
O	745	746	0
O	746	747	.
O	747	750	749
O	750	751	.

O	752	757	There
O	758	762	were
O	763	765	no
O	766	777	significant
O	778	789	differences
O	790	795	among
O	796	799	the
O	800	805	three
O	806	823	ophthalmoscopists
O	823	824	.

B-Diagnostic_tool	825	839	Ophthalmoscopy
O	840	843	was
O	844	848	more
O	849	855	likely
O	856	858	to
O	859	867	disagree
O	868	872	with
B-Diagnostic_tool	873	879	fundus
I-Diagnostic_tool	880	891	photography
O	892	899	grading
O	900	902	in
B-Anatomy	903	907	eyes
O	908	912	with
O	913	917	less
O	918	924	severe
O	925	930	forms
O	931	933	of
B-Disease	934	945	retinopathy
O	946	949	and
O	950	952	in
O	953	961	patients
O	962	970	examined
O	971	976	early
O	977	979	in
O	980	983	the
O	984	989	study
O	989	990	.

O	991	996	Other
O	997	1004	factors
O	1005	1010	found
O	1011	1013	to
O	1014	1023	influence
O	1024	1027	the
O	1028	1034	degree
O	1035	1037	of
O	1038	1047	agreement
O	1048	1052	were
B-Characteristic	1053	1056	age
O	1056	1057	,
B-Characteristic	1058	1064	visual
I-Characteristic	1065	1071	acuity
O	1071	1072	,
O	1073	1076	and
B-Characteristic	1077	1085	duration
I-Characteristic	1086	1088	of
I-Characteristic	1089	1097	diabetes
O	1097	1098	.

O	1099	1101	It
O	1102	1104	is
O	1105	1114	concluded
O	1115	1119	that
O	1120	1124	with
O	1125	1131	proper
O	1132	1140	training
B-Diagnostic_tool	1141	1155	ophthalmoscopy
O	1156	1159	can
O	1160	1162	be
O	1163	1165	an
O	1166	1176	acceptable
O	1177	1188	alternative
O	1189	1191	to
B-Diagnostic_tool	1192	1198	fundus
I-Diagnostic_tool	1199	1210	photography
O	1211	1213	in
O	1214	1221	certain
O	1222	1232	situations
O	1232	1233	.

O	0	9	Automated
O	10	19	Detection
O	20	22	of
B-Characteristic	23	32	Hemifield
I-Characteristic	33	43	Difference
O	44	50	across
B-Anatomy	51	61	Horizontal
I-Anatomy	62	67	Raphe
O	68	70	on
B-Diagnostic_tool	71	79	Ganglion
I-Diagnostic_tool	80	84	Cell
I-Diagnostic_tool	84	85	-
I-Diagnostic_tool	85	86	-
I-Diagnostic_tool	86	91	Inner
I-Diagnostic_tool	92	101	Plexiform
I-Diagnostic_tool	102	107	Layer
I-Diagnostic_tool	108	117	Thickness
I-Diagnostic_tool	118	121	Map
O	121	122	.

O	124	125	A
O	126	132	MATLAB
O	132	133	-
O	133	138	based
O	139	140	(
O	140	143	The
O	144	153	MathWorks
O	153	154	,
O	155	158	Inc
O	158	159	,
O	160	166	Natick
O	166	167	,
O	168	170	MA
O	170	171	)
O	172	180	computer
O	181	188	program
O	189	190	(
O	190	193	the
B-Diagnostic_tool	194	202	ganglion
I-Diagnostic_tool	203	207	cell
I-Diagnostic_tool	207	208	-
I-Diagnostic_tool	208	213	inner
I-Diagnostic_tool	214	223	plexiform
I-Diagnostic_tool	224	229	layer
I-Diagnostic_tool	230	231	[
I-Diagnostic_tool	231	236	GCIPL
I-Diagnostic_tool	236	237	]
I-Diagnostic_tool	238	247	hemifield
I-Diagnostic_tool	248	252	test
O	252	253	)
O	254	257	for
O	258	267	automated
O	268	277	detection
O	278	280	of
B-Characteristic	281	286	GCIPL
I-Characteristic	287	296	thickness
I-Characteristic	297	307	difference
I-Characteristic	308	314	across
I-Characteristic	315	318	the
I-Characteristic	319	329	horizontal
I-Characteristic	330	335	raphe
O	336	339	was
O	340	349	developed
O	349	350	,
O	351	354	and
O	355	358	its
B-Disease	359	367	glaucoma
O	368	378	diagnostic
O	379	390	performance
O	391	394	was
O	395	403	assessed
O	403	404	.

O	405	410	Cross
O	410	411	-
O	411	420	sectional
O	421	426	study
O	426	427	.

O	428	429	A
O	430	435	total
O	436	438	of
O	439	441	65
B-Anatomy	442	446	eyes
O	447	449	of
O	450	456	normal
O	456	457	,
O	458	465	healthy
O	466	474	subjects
O	475	480	along
O	481	485	with
O	486	489	162
B-Anatomy	490	494	eyes
O	495	497	of
O	498	506	patients
O	507	511	with
B-Disease	512	520	glaucoma
O	521	522	(
O	522	524	79
O	525	538	preperimetric
O	539	542	and
O	543	545	83
O	546	551	early
O	552	562	perimetric
O	562	563	)
O	563	564	.

B-Diagnostic_tool	565	571	Cirrus
I-Diagnostic_tool	572	576	high
I-Diagnostic_tool	576	577	-
I-Diagnostic_tool	577	587	definition
I-Diagnostic_tool	588	595	optical
I-Diagnostic_tool	596	605	coherence
I-Diagnostic_tool	606	616	tomography
O	617	618	(
B-Diagnostic_tool	618	620	HD
I-Diagnostic_tool	620	621	-
I-Diagnostic_tool	621	624	OCT
O	624	625	)
O	626	627	(
O	627	631	Carl
O	632	637	Zeiss
O	638	645	Meditec
O	645	646	,
O	647	653	Dublin
O	653	654	,
O	655	657	CA
O	657	658	)
O	659	662	was
O	663	667	used
O	668	670	to
O	671	675	scan
O	676	679	all
O	680	682	of
O	683	686	the
O	687	695	subjects
O	695	696	'
B-Anatomy	697	704	macular
I-Anatomy	705	708	and
I-Anatomy	709	714	optic
I-Anatomy	715	720	discs
O	720	721	.

O	722	723	A
O	724	732	positive
O	733	734	(
O	734	735	i
O	735	736	.
O	736	737	e
O	737	738	.
O	738	739	,
O	741	742	"
O	743	750	outside
O	751	757	normal
O	758	764	limits
O	765	766	"
O	767	768	)
B-Diagnostic_tool	769	774	GCIPL
I-Diagnostic_tool	775	784	hemifield
I-Diagnostic_tool	785	789	test
O	790	796	result
O	797	800	was
O	801	809	declared
O	810	812	if
O	813	816	the
O	817	826	following
O	827	828	3
O	829	839	conditions
O	840	844	were
O	845	848	all
O	849	852	met
O	852	853	:
O	854	855	(
O	855	856	1
O	856	857	)
O	858	861	The
O	862	871	reference
O	872	876	line
O	877	878	(
O	878	879	a
O	880	890	horizontal
O	891	895	line
O	896	904	dividing
O	905	908	the
B-Anatomy	909	917	superior
I-Anatomy	918	921	and
I-Anatomy	922	930	inferior
I-Anatomy	931	941	hemifields
O	941	942	)
O	943	945	is
O	946	958	continuously
O	959	967	detected
O	968	971	for
O	972	978	longer
O	979	983	than
O	984	987	one
O	987	988	-
O	988	992	half
O	993	995	of
O	996	999	the
O	1000	1008	distance
O	1009	1013	from
O	1014	1017	the
B-Anatomy	1018	1026	temporal
I-Anatomy	1027	1032	inner
I-Anatomy	1033	1043	elliptical
I-Anatomy	1044	1051	annulus
O	1052	1054	to
O	1055	1058	the
B-Anatomy	1059	1064	outer
I-Anatomy	1065	1075	elliptical
I-Anatomy	1076	1083	annulus
O	1083	1084	;
O	1085	1086	(
O	1086	1087	2
O	1087	1088	)
O	1089	1092	the
B-Characteristic	1093	1100	average
I-Characteristic	1101	1106	GCIPL
I-Characteristic	1107	1116	thickness
I-Characteristic	1117	1127	difference
I-Characteristic	1128	1134	within
I-Characteristic	1135	1137	10
I-Characteristic	1138	1144	pixels
I-Characteristic	1145	1147	of
I-Characteristic	1148	1151	the
I-Characteristic	1152	1161	reference
I-Characteristic	1162	1166	line
O	1166	1167	,
O	1168	1172	both
O	1173	1178	above
O	1179	1182	and
O	1183	1188	below
O	1188	1189	,
O	1190	1192	is
B-Dimension	1193	1194	
I-Dimension	1194	1195	5
I-Dimension	1196	1197	
I-Dimension	1197	1198	m
O	1198	1199	;
O	1200	1203	and
O	1204	1205	(
O	1205	1206	3
O	1206	1207	)
O	1208	1211	the
O	1212	1219	average
O	1220	1223	RGB
O	1224	1229	color
O	1230	1236	ranges
O	1237	1239	of
O	1240	1243	the
O	1244	1246	10
O	1247	1253	pixels
O	1254	1259	above
O	1260	1263	and
O	1264	1269	below
O	1270	1273	the
O	1274	1283	reference
O	1284	1288	line
O	1289	1296	display
O	1297	1301	blue
O	1302	1304	in
O	1305	1306	1
B-Anatomy	1307	1316	hemifield
O	1317	1320	and
O	1321	1324	red
O	1324	1325	/
O	1325	1331	yellow
O	1331	1332	/
O	1332	1337	white
O	1338	1340	in
O	1341	1344	the
O	1345	1350	other
O	1351	1360	hemifield
O	1360	1361	.

O	1362	1372	Comparison
O	1373	1375	of
O	1376	1386	diagnostic
O	1387	1394	ability
O	1395	1400	using
O	1401	1404	the
O	1405	1410	areas
O	1411	1416	under
O	1417	1420	the
O	1421	1429	receiver
O	1430	1439	operating
O	1440	1454	characteristic
O	1455	1461	curves
O	1462	1463	(
O	1463	1467	AUCs
O	1467	1468	)
O	1468	1469	.

O	1470	1471	A
O	1472	1480	positive
B-Diagnostic_tool	1481	1486	GCIPL
I-Diagnostic_tool	1487	1496	hemifield
I-Diagnostic_tool	1497	1501	test
O	1502	1508	result
O	1509	1512	was
O	1513	1521	observed
O	1522	1526	more
O	1527	1537	frequently
O	1538	1540	in
O	1541	1544	the
B-Disease	1545	1557	glaucomatous
B-Anatomy	1558	1562	eyes
O	1563	1564	(
O	1564	1566	74
O	1566	1567	/
O	1567	1569	79
O	1570	1583	preperimetric
O	1583	1584	,
O	1585	1587	78
O	1587	1588	/
O	1588	1590	83
O	1591	1596	early
O	1597	1607	perimetric
O	1607	1608	)
O	1609	1613	than
O	1614	1616	in
O	1617	1620	the
O	1621	1627	normal
B-Anatomy	1628	1632	eyes
O	1633	1634	(
O	1634	1635	1
O	1635	1636	/
O	1636	1638	65
O	1638	1639	)
O	1639	1640	.

O	1641	1643	In
O	1644	1647	the
O	1648	1661	preperimetric
O	1662	1667	group
O	1667	1668	,
O	1669	1672	the
O	1673	1676	AUC
O	1677	1679	of
O	1680	1683	the
B-Diagnostic_tool	1684	1689	GCIPL
I-Diagnostic_tool	1690	1699	hemifield
I-Diagnostic_tool	1700	1704	test
O	1705	1706	(
O	1706	1707	0
O	1707	1708	.
O	1708	1711	967
O	1711	1712	;
O	1713	1724	sensitivity
O	1725	1727	94
O	1727	1728	.
O	1728	1730	94
O	1730	1731	%
O	1731	1732	,
O	1733	1744	specificity
O	1745	1747	98
O	1747	1748	.
O	1748	1750	46
O	1750	1751	%
O	1751	1752	)
O	1753	1756	was
O	1757	1764	greater
O	1765	1769	than
O	1770	1774	that
O	1775	1777	of
O	1778	1781	the
O	1782	1789	minimum
B-Characteristic	1790	1795	GCIPL
I-Characteristic	1796	1805	thickness
O	1806	1807	(
O	1807	1808	0
O	1808	1809	.
O	1809	1812	933
O	1812	1813	)
O	1813	1814	,
O	1815	1818	the
B-Characteristic	1819	1833	inferotemporal
I-Characteristic	1834	1839	GCIPL
I-Characteristic	1840	1849	thickness
O	1850	1851	(
O	1851	1852	0
O	1852	1853	.
O	1853	1856	907
O	1856	1857	)
O	1857	1858	,
O	1859	1862	and
O	1863	1866	the
O	1867	1874	average
B-Characteristic	1875	1880	GCIPL
I-Characteristic	1881	1890	thickness
O	1891	1892	(
O	1892	1893	0
O	1893	1894	.
O	1894	1897	899
O	1897	1898	)
O	1899	1900	(
O	1900	1901	P
O	1901	1902	=
O	1902	1903	0
O	1903	1904	.
O	1904	1906	09
O	1906	1907	,
O	1908	1909	0
O	1909	1910	.
O	1910	1912	06
O	1912	1913	,
O	1914	1917	and
O	1918	1919	0
O	1919	1920	.
O	1920	1922	03
O	1922	1923	,
O	1924	1936	respectively
O	1936	1937	)
O	1937	1938	.

O	1939	1941	In
O	1942	1945	the
O	1946	1951	early
O	1952	1962	perimetric
O	1963	1968	group
O	1968	1969	,
O	1970	1973	the
O	1974	1977	AUC
O	1978	1980	of
O	1981	1984	the
B-Diagnostic_tool	1985	1990	GCIPL
I-Diagnostic_tool	1991	2000	hemifield
I-Diagnostic_tool	2001	2005	test
O	2006	2007	(
O	2007	2008	0
O	2008	2009	.
O	2009	2012	962
O	2012	2013	;
O	2014	2025	sensitivity
O	2026	2028	93
O	2028	2029	.
O	2029	2031	98
O	2031	2032	%
O	2032	2033	,
O	2034	2045	specificity
O	2046	2048	96
O	2048	2049	.
O	2049	2051	46
O	2051	2052	%
O	2052	2053	)
O	2054	2057	was
O	2058	2065	greater
O	2066	2070	than
O	2071	2075	that
O	2076	2078	of
O	2079	2082	the
B-Characteristic	2083	2097	inferotemporal
I-Characteristic	2098	2103	GCIPL
I-Characteristic	2104	2113	thickness
O	2114	2115	(
O	2115	2116	0
O	2116	2117	.
O	2117	2120	938
O	2120	2121	)
O	2121	2122	,
O	2123	2126	the
O	2127	2134	minimum
B-Characteristic	2135	2140	GCIPL
I-Characteristic	2141	2150	thickness
O	2151	2152	(
O	2152	2153	0
O	2153	2154	.
O	2154	2157	919
O	2157	2158	)
O	2158	2159	,
O	2160	2163	and
O	2164	2167	the
O	2168	2175	average
B-Characteristic	2176	2181	GCIPL
I-Characteristic	2182	2191	thickness
O	2192	2193	(
O	2193	2194	0
O	2194	2195	.
O	2195	2198	912
O	2198	2199	)
O	2200	2201	(
O	2201	2202	P
O	2202	2203	=
O	2203	2204	0
O	2204	2205	.
O	2205	2207	38
O	2207	2208	,
O	2209	2210	0
O	2210	2211	.
O	2211	2213	17
O	2213	2214	,
O	2215	2218	and
O	2219	2220	0
O	2220	2221	.
O	2221	2223	11
O	2223	2224	,
O	2225	2237	respectively
O	2237	2238	)
O	2238	2239	.

O	2240	2243	For
O	2244	2258	discrimination
O	2259	2261	of
B-Symptom	2262	2267	early
I-Symptom	2268	2280	glaucomatous
I-Symptom	2281	2291	structural
I-Symptom	2292	2296	loss
O	2296	2297	,
O	2298	2302	most
O	2303	2310	notably
O	2311	2313	in
B-Disease	2314	2327	preperimetric
I-Disease	2328	2336	glaucoma
O	2337	2342	cases
O	2342	2343	,
O	2344	2358	identification
O	2359	2361	of
O	2362	2365	the
B-Characteristic	2366	2371	GCIPL
I-Characteristic	2372	2381	thickness
I-Characteristic	2382	2392	difference
I-Characteristic	2393	2399	across
I-Characteristic	2400	2403	the
I-Characteristic	2404	2414	horizontal
I-Characteristic	2415	2420	raphe
O	2421	2424	was
O	2425	2434	effective
O	2434	2435	.

B-Disease	0	8	Diabetic
I-Disease	9	20	Retinopathy
O	21	29	Severity
O	30	33	and
B-Symptom	34	44	Peripheral
I-Symptom	45	52	Lesions
O	53	56	Are
O	57	67	Associated
O	68	72	with
B-Symptom	73	85	Nonperfusion
O	86	88	on
B-Diagnostic_tool	89	98	Ultrawide
I-Diagnostic_tool	99	104	Field
I-Diagnostic_tool	105	116	Angiography
O	116	117	.

O	119	121	To
O	122	128	assess
O	129	136	whether
O	137	140	the
O	141	149	presence
O	150	152	of
B-Symptom	153	163	peripheral
I-Symptom	164	176	nonperfusion
O	177	179	on
B-Diagnostic_tool	180	189	ultrawide
I-Diagnostic_tool	190	195	field
I-Diagnostic_tool	196	197	(
I-Diagnostic_tool	197	200	UWF
I-Diagnostic_tool	200	201	)
I-Diagnostic_tool	202	213	fluorescein
I-Diagnostic_tool	214	225	angiography
O	226	227	(
B-Diagnostic_tool	227	229	FA
O	229	230	)
O	231	233	is
O	234	244	associated
O	245	249	with
B-Disease	250	258	diabetic
I-Disease	259	270	retinopathy
O	271	272	(
B-Disease	272	274	DR
O	274	275	)
O	276	284	severity
O	285	288	and
O	289	292	the
O	293	301	presence
O	302	304	of
O	305	318	predominantly
B-Symptom	319	329	peripheral
I-Symptom	330	337	lesions
O	338	339	(
B-Symptom	339	343	PPLs
O	343	344	)
O	344	345	.

O	346	352	Single
O	352	353	-
O	353	357	site
O	357	358	,
O	359	364	cross
O	364	365	-
O	365	374	sectional
O	374	375	,
O	376	389	retrospective
O	390	395	study
O	395	396	.

O	397	402	Sixty
O	402	403	-
O	403	408	eight
B-Anatomy	409	413	eyes
O	414	416	of
O	417	419	37
B-Disease	420	428	diabetic
O	429	437	subjects
O	438	442	with
O	443	445	or
O	446	453	without
B-Disease	454	456	DR
O	457	460	and
O	461	463	no
O	464	471	history
O	472	474	of
O	475	480	prior
O	481	491	panretinal
O	492	497	laser
O	498	514	photocoagulation
O	514	515	.

O	516	520	Both
B-Diagnostic_tool	521	524	200
I-Diagnostic_tool	524	525	
I-Diagnostic_tool	526	529	UWF
I-Diagnostic_tool	530	536	images
O	537	540	and
B-Diagnostic_tool	541	544	UWF
I-Diagnostic_tool	545	547	FA
I-Diagnostic_tool	548	554	images
O	555	559	were
O	560	568	acquired
O	569	571	at
O	572	575	the
O	576	580	same
O	581	586	visit
O	586	587	.

B-Classification_system	588	593	Early
I-Classification_system	594	603	Treatment
I-Classification_system	604	612	Diabetic
I-Classification_system	613	624	Retinopathy
I-Classification_system	625	630	Study
O	631	632	(
B-Classification_system	632	637	ETDRS
O	637	638	)
O	639	648	templates
O	649	653	were
O	654	662	overlaid
O	663	672	digitally
O	673	678	based
O	679	681	on
B-Anatomy	682	686	disc
O	687	690	and
B-Anatomy	691	697	macula
O	698	706	location
O	707	711	onto
B-Diagnostic_tool	712	729	stereographically
I-Diagnostic_tool	730	739	projected
I-Diagnostic_tool	740	743	UWF
I-Diagnostic_tool	744	750	images
O	750	751	.

O	752	758	Images
O	759	763	were
O	764	773	evaluated
O	774	777	for
O	778	781	the
O	782	790	presence
O	791	793	of
B-Symptom	794	798	PPLs
O	798	799	,
O	800	807	defined
O	808	810	as
O	811	815	more
O	816	820	than
O	821	823	50
O	823	824	%
O	825	827	of
O	828	831	the
O	832	838	graded
O	839	845	lesion
O	846	853	located
O	854	861	outside
O	862	865	the
B-Classification_system	866	871	ETDRS
O	872	877	field
O	878	880	in
O	881	885	each
O	886	888	of
O	889	892	the
O	893	894	5
O	895	903	extended
O	904	910	fields
O	910	911	.

O	912	915	The
B-Diagnostic_tool	916	919	UWF
I-Diagnostic_tool	919	920	-
I-Diagnostic_tool	920	922	FA
I-Diagnostic_tool	923	929	images
O	930	934	were
O	935	944	evaluated
O	945	947	by
O	948	949	2
O	950	956	masked
O	956	957	,
O	958	969	independent
O	970	977	graders
O	978	981	for
O	982	988	extent
O	989	991	of
B-Characteristic	992	999	retinal
I-Characteristic	1000	1012	nonperfusion
I-Characteristic	1013	1017	area
O	1018	1019	(
B-Characteristic	1019	1022	NPA
O	1022	1023	)
O	1024	1027	and
B-Characteristic	1028	1040	nonperfusion
I-Characteristic	1041	1046	index
O	1047	1048	(
B-Characteristic	1048	1051	NPI
O	1051	1052	;
O	1053	1064	nonperfused
O	1064	1065	/
O	1065	1070	total
O	1071	1079	gradable
O	1080	1084	area
O	1084	1085	)
O	1085	1086	.

O	1087	1098	Association
O	1099	1101	of
B-Characteristic	1102	1105	NPA
O	1106	1109	and
B-Characteristic	1110	1113	NPI
O	1114	1118	with
B-Disease	1119	1121	DR
O	1122	1130	severity
O	1131	1134	and
O	1135	1143	presence
O	1144	1146	of
B-Symptom	1147	1151	PPLs
O	1151	1152	.

O	1153	1165	Distribution
O	1166	1168	of
B-Disease	1169	1171	DR
O	1172	1180	severity
O	1181	1184	was
O	1185	1187	as
O	1188	1195	follows
O	1195	1196	:
O	1197	1199	no
B-Disease	1200	1202	DR
O	1202	1203	,
O	1204	1205	8
O	1205	1206	.
O	1206	1207	8
O	1207	1208	%
O	1209	1213	eyes
O	1213	1214	;
B-Disease	1215	1219	mild
I-Disease	1220	1236	nonproliferative
I-Disease	1237	1239	DR
O	1240	1241	(
B-Disease	1241	1245	NPDR
O	1245	1246	)
O	1246	1247	,
O	1248	1250	17
O	1250	1251	.
O	1251	1252	6
O	1252	1253	%
O	1253	1254	;
B-Disease	1255	1263	moderate
I-Disease	1264	1268	NPDR
O	1268	1269	,
O	1270	1272	32
O	1272	1273	.
O	1273	1274	4
O	1274	1275	%
O	1275	1276	;
B-Disease	1277	1283	severe
I-Disease	1284	1288	NPDR
O	1288	1289	,
O	1290	1292	17
O	1292	1293	.
O	1293	1294	6
O	1294	1295	%
O	1295	1296	;
B-Disease	1297	1310	proliferative
I-Disease	1311	1313	DR
O	1314	1315	(
B-Disease	1315	1318	PDR
O	1318	1319	)
O	1319	1320	,
O	1321	1323	19
O	1323	1324	.
O	1324	1325	1
O	1325	1326	%
O	1326	1327	;
O	1328	1331	and
B-Disease	1332	1336	high
I-Disease	1336	1337	-
I-Disease	1337	1341	risk
I-Disease	1342	1345	PDR
O	1345	1346	,
O	1347	1348	4
O	1348	1349	.
O	1349	1350	4
O	1350	1351	%
O	1351	1352	;
O	1353	1357	with
B-Symptom	1358	1361	PPL
O	1362	1369	present
O	1370	1372	in
O	1373	1375	61
O	1375	1376	.
O	1376	1377	8
O	1377	1378	%
O	1378	1379	.

O	1380	1385	There
O	1386	1389	was
O	1390	1396	strong
O	1397	1408	intragrader
O	1409	1410	(
O	1410	1411	r
O	1412	1413	=
O	1414	1415	0
O	1415	1416	.
O	1416	1418	95
O	1418	1419	)
O	1420	1423	and
O	1424	1435	intergrader
O	1436	1437	(
O	1437	1438	r
O	1439	1440	=
O	1441	1442	0
O	1442	1443	.
O	1443	1445	86
O	1445	1446	)
O	1447	1456	agreement
O	1457	1460	for
B-Characteristic	1461	1464	NPA
O	1464	1465	.

O	1466	1474	Presence
O	1475	1477	of
B-Symptom	1478	1482	PPLs
O	1483	1486	was
O	1487	1497	associated
O	1498	1502	with
O	1503	1512	increased
B-Characteristic	1513	1516	NPA
O	1517	1518	(
O	1518	1521	191
O	1521	1522	.
O	1522	1523	8
O	1524	1526	mm
O	1526	1527	(
O	1527	1528	2
O	1528	1529	)
O	1530	1532	vs
O	1532	1533	.
O	1534	1537	306
O	1537	1538	.
O	1538	1539	1
O	1540	1542	mm
O	1542	1543	(
O	1543	1544	2
O	1544	1545	)
O	1545	1546	;
O	1547	1548	P
O	1549	1550	=
O	1551	1552	0
O	1552	1553	.
O	1553	1557	0019
O	1557	1558	)
O	1559	1562	and
B-Characteristic	1563	1566	NPI
O	1567	1568	(
O	1568	1569	0
O	1569	1570	.
O	1570	1572	25
O	1573	1575	vs
O	1575	1576	.
O	1577	1578	0
O	1578	1579	.
O	1579	1581	43
O	1581	1582	;
O	1583	1584	P
O	1585	1586	=
O	1587	1588	0
O	1588	1589	.
O	1589	1593	0003
O	1593	1594	)
O	1594	1595	.

O	1596	1601	These
O	1602	1615	relationships
O	1616	1624	remained
O	1625	1636	significant
O	1637	1642	after
O	1643	1652	adjusting
O	1653	1656	for
B-Disease	1657	1659	DR
O	1660	1668	severity
O	1669	1672	and
B-Characteristic	1673	1681	diabetes
I-Characteristic	1682	1690	duration
O	1690	1691	.

O	1692	1694	In
B-Anatomy	1695	1699	eyes
O	1700	1707	without
B-Disease	1708	1711	PDR
O	1712	1713	(
O	1713	1714	n
O	1715	1716	=
O	1717	1719	52
O	1719	1720	)
O	1720	1721	,
O	1722	1732	increasing
B-Characteristic	1733	1736	NPA
O	1737	1740	and
B-Characteristic	1741	1744	NPI
O	1745	1748	was
O	1749	1759	associated
O	1760	1764	with
O	1765	1774	worsening
B-Disease	1775	1777	DR
O	1778	1779	(
B-Characteristic	1779	1782	NPA
O	1782	1783	,
O	1784	1785	P
O	1786	1787	=
O	1788	1789	0
O	1789	1790	.
O	1790	1793	001
O	1793	1794	;
O	1795	1798	NPI
O	1798	1799	,
O	1800	1801	P
O	1802	1803	=
O	1804	1805	0
O	1805	1806	.
O	1806	1810	0003
O	1810	1811	)
O	1811	1812	.

B-Characteristic	1813	1816	NPA
O	1817	1820	and
B-Characteristic	1821	1824	NPI
O	1825	1829	were
O	1830	1833	not
O	1834	1844	associated
O	1845	1849	with
B-Disease	1850	1860	clinically
I-Disease	1861	1872	significant
I-Disease	1873	1880	macular
I-Disease	1881	1886	edema
O	1887	1888	(
B-Characteristic	1888	1891	NPA
O	1891	1892	,
O	1893	1894	P
O	1895	1896	=
O	1897	1898	0
O	1898	1899	.
O	1899	1901	99
O	1901	1902	;
O	1903	1906	NPI
O	1906	1907	,
O	1908	1909	P
O	1910	1911	=
O	1912	1913	0
O	1913	1914	.
O	1914	1916	67
O	1916	1917	)
O	1917	1918	,
O	1919	1922	nor
O	1923	1933	correlated
O	1934	1938	with
B-Characteristic	1939	1945	visual
I-Characteristic	1946	1952	acuity
O	1953	1954	(
B-Characteristic	1954	1957	NPA
O	1957	1958	,
O	1959	1960	r
O	1961	1962	=
O	1963	1964	0
O	1964	1965	.
O	1965	1967	14
O	1967	1968	,
O	1969	1970	P
O	1971	1972	=
O	1973	1974	0
O	1974	1975	.
O	1975	1977	23
O	1977	1978	;
B-Characteristic	1979	1982	NPI
O	1982	1983	,
O	1984	1985	r
O	1986	1987	=
O	1988	1989	0
O	1989	1990	.
O	1990	1992	24
O	1992	1993	,
O	1994	1995	P
O	1996	1997	=
O	1998	1999	0
O	1999	2000	.
O	2000	2002	05
O	2002	2003	)
O	2003	2004	.

O	2005	2014	Following
O	2015	2016	a
O	2017	2029	standardized
O	2030	2038	protocol
O	2038	2039	,
O	2040	2043	the
O	2044	2054	evaluation
O	2055	2057	of
B-Diagnostic_tool	2058	2061	UWF
I-Diagnostic_tool	2062	2064	FA
O	2065	2068	for
B-Characteristic	2069	2072	NPA
O	2073	2076	and
B-Characteristic	2077	2080	NPI
O	2081	2083	is
O	2084	2096	reproducible
O	2096	2097	.

O	2098	2102	Both
O	2103	2113	parameters
O	2114	2117	are
O	2118	2128	correlated
O	2129	2135	highly
O	2136	2140	with
O	2141	2144	the
O	2145	2153	presence
O	2154	2156	of
B-Symptom	2157	2161	PPLs
O	2162	2165	and
B-Disease	2166	2168	DR
O	2169	2177	severity
O	2177	2178	.

O	2179	2184	Given
O	2185	2189	that
O	2190	2193	the
O	2194	2202	presence
O	2203	2206	and
O	2207	2213	extent
O	2214	2216	of
B-Symptom	2217	2221	PPLs
O	2222	2226	have
O	2227	2231	been
O	2232	2242	associated
O	2243	2247	with
O	2248	2257	increased
O	2258	2263	risks
O	2264	2266	of
B-Disease	2267	2269	DR
O	2270	2281	progression
O	2281	2282	,
O	2283	2286	the
O	2287	2295	clinical
O	2296	2310	identification
O	2311	2313	of
B-Symptom	2314	2318	PPLs
O	2319	2322	may
O	2323	2330	reflect
O	2331	2338	closely
O	2339	2342	the
O	2343	2349	extent
O	2350	2352	of
B-Symptom	2353	2365	nonperfusion
O	2366	2369	and
B-Disease	2370	2378	ischemia
O	2378	2379	,
O	2380	2384	thus
O	2385	2395	accounting
O	2396	2399	for
O	2400	2403	the
O	2404	2413	increased
O	2414	2418	risk
O	2419	2421	of
O	2422	2433	progression
O	2433	2434	.

O	0	5	First
O	6	15	Incidence
O	16	19	and
O	20	31	Progression
O	32	37	Study
O	38	41	for
B-Disease	42	50	Diabetic
I-Disease	51	62	Retinopathy
O	63	65	in
B-Characteristic	66	74	Portugal
O	74	75	,
O	76	79	the
O	80	90	RETINODIAB
O	91	96	Study
O	96	97	:
O	98	108	Evaluation
O	109	111	of
O	112	115	the
O	116	125	Screening
O	126	133	Program
O	134	137	for
B-Characteristic	138	144	Lisbon
O	145	151	Region
O	151	152	.

O	154	156	To
O	157	165	estimate
O	166	169	the
O	170	171	5
O	171	172	-
O	172	176	year
O	177	186	incidence
O	187	190	and
O	191	202	progression
O	203	205	of
B-Disease	206	214	diabetic
I-Disease	215	226	retinopathy
O	227	228	(
B-Disease	228	230	DR
O	230	231	)
O	232	237	among
O	238	245	persons
O	246	250	with
B-Disease	251	255	type
I-Disease	256	257	2
I-Disease	258	266	diabetes
I-Disease	267	275	mellitus
O	276	277	(
B-Disease	277	279	DM
O	279	280	)
O	280	281	.

O	282	292	Population
O	292	293	-
O	293	298	based
O	298	299	,
O	300	311	prospective
O	311	312	,
O	313	319	cohort
O	320	325	study
O	325	326	.

O	327	330	The
O	331	341	RETINODIAB
O	342	343	(
O	343	348	Study
O	349	354	Group
O	355	358	for
B-Disease	359	367	Diabetic
I-Disease	368	379	Retinopathy
O	380	389	Screening
O	389	390	)
O	391	398	program
O	399	402	was
O	403	414	implemented
O	415	417	in
O	418	421	the
B-Characteristic	422	428	Lisbon
O	429	432	and
B-Characteristic	433	438	Tagus
I-Characteristic	439	445	Valley
O	446	450	area
O	451	458	between
O	459	463	July
O	464	468	2009
O	469	472	and
O	473	481	December
O	482	486	2014
O	486	487	.

O	488	489	A
O	490	495	total
O	496	498	of
O	499	502	109
O	503	506	543
O	507	515	readable
O	516	525	screening
O	526	538	examinations
O	539	543	were
O	544	553	performed
O	554	557	and
O	558	570	corresponded
O	571	573	to
O	574	576	56
O	577	580	903
O	581	589	patients
O	590	593	who
O	594	602	attended
O	603	606	the
O	607	616	screening
O	617	624	program
O	625	627	at
O	628	633	entry
O	633	634	.

O	635	636	A
O	637	642	total
O	643	645	of
O	646	648	30
O	649	652	641
O	653	661	patients
O	662	663	(
O	663	665	53
O	665	666	.
O	666	668	85
O	668	669	%
O	669	670	)
O	671	674	had
O	675	677	at
O	678	683	least
O	684	685	1
O	686	693	further
O	694	703	screening
O	704	709	event
O	710	716	within
O	717	720	the
O	721	726	study
O	727	733	period
O	734	737	and
O	738	742	were
O	743	751	included
O	752	754	in
O	755	758	the
O	759	767	analysis
O	767	768	.

O	769	781	Participants
O	782	791	underwent
O	792	795	two
B-Diagnostic_tool	796	798	45
I-Diagnostic_tool	798	799	
I-Diagnostic_tool	800	815	nonstereoscopic
I-Diagnostic_tool	816	823	retinal
I-Diagnostic_tool	824	831	digital
I-Diagnostic_tool	832	843	photographs
O	844	847	per
B-Anatomy	848	851	eye
O	852	861	according
O	862	864	to
O	865	875	RETINODIAB
O	876	884	protocol
O	884	885	.

O	886	889	All
O	890	896	images
O	897	901	were
O	902	908	graded
O	909	918	according
O	919	921	to
O	922	925	the
B-Classification_system	926	939	International
I-Classification_system	940	948	Clinical
I-Classification_system	949	957	Diabetic
I-Classification_system	958	969	Retinopathy
I-Classification_system	970	975	Scale
O	975	976	.

B-Disease	977	986	Referable
I-Disease	987	995	diabetic
I-Disease	996	1007	retinopathy
O	1008	1009	(
B-Disease	1009	1012	RDR
O	1012	1013	)
O	1014	1017	was
O	1018	1025	defined
O	1026	1029	for
O	1030	1033	all
O	1034	1042	patients
O	1043	1049	graded
O	1050	1052	as
B-Disease	1053	1061	moderate
I-Disease	1062	1078	nonproliferative
I-Disease	1079	1081	DR
O	1082	1083	(
B-Disease	1083	1087	NPDR
O	1087	1088	)
O	1088	1089	,
B-Disease	1090	1096	severe
I-Disease	1097	1101	NPDR
O	1101	1102	,
O	1103	1105	or
B-Disease	1106	1119	proliferative
I-Disease	1120	1122	DR
O	1123	1124	(
B-Disease	1124	1127	PDR
O	1127	1128	)
O	1128	1129	,
O	1130	1134	with
O	1135	1137	or
O	1138	1145	without
B-Disease	1146	1157	maculopathy
O	1158	1160	or
B-Disease	1161	1165	mild
I-Disease	1166	1170	NPDR
O	1171	1175	with
B-Disease	1176	1187	maculopathy
O	1187	1188	.

O	1189	1202	Nonparametric
O	1203	1212	estimates
O	1213	1215	of
O	1216	1219	the
O	1220	1226	annual
O	1227	1230	and
O	1231	1241	cumulative
O	1242	1252	incidences
O	1253	1257	were
O	1258	1266	obtained
O	1267	1269	by
O	1270	1278	Turnbull
O	1278	1279	'
O	1279	1280	s
O	1281	1290	estimator
O	1290	1291	.

O	1292	1304	Associations
O	1305	1312	between
O	1313	1316	the
O	1317	1326	potential
O	1327	1331	risk
O	1332	1339	factors
O	1340	1343	and
O	1344	1347	the
O	1348	1352	time
O	1353	1355	to
O	1356	1361	onset
O	1361	1362	/
O	1362	1373	progression
O	1374	1376	of
B-Disease	1377	1388	retinopathy
O	1389	1393	were
O	1394	1402	assessed
O	1403	1410	through
O	1411	1412	a
O	1413	1423	parametric
O	1424	1432	survival
O	1433	1441	analysis
O	1442	1445	for
O	1446	1454	interval
O	1454	1455	-
O	1455	1463	censored
O	1464	1468	data
O	1468	1469	.

O	1470	1473	The
O	1474	1481	authors
O	1482	1491	estimated
O	1492	1495	the
O	1496	1501	onset
O	1502	1505	and
O	1506	1517	progression
O	1518	1527	incidence
O	1528	1533	rates
O	1534	1536	of
B-Disease	1537	1539	DR
O	1539	1540	.

O	1541	1547	Yearly
O	1548	1557	incidence
O	1558	1560	of
O	1561	1564	any
B-Disease	1565	1567	DR
O	1568	1570	in
O	1571	1579	patients
O	1580	1587	without
B-Disease	1588	1599	retinopathy
O	1600	1602	at
O	1603	1611	baseline
O	1612	1615	was
O	1616	1617	4
O	1617	1618	.
O	1618	1620	60
O	1620	1621	%
O	1622	1623	(
O	1623	1625	95
O	1625	1626	%
O	1627	1637	confidence
O	1638	1646	interval
O	1647	1648	[
O	1648	1650	CI
O	1650	1651	]
O	1651	1652	,
O	1653	1654	3
O	1654	1655	.
O	1655	1657	96
O	1657	1658	-
O	1658	1659	4
O	1659	1660	.
O	1660	1662	76
O	1662	1663	)
O	1664	1666	in
O	1667	1670	the
O	1671	1676	first
O	1677	1681	year
O	1681	1682	,
O	1683	1693	decreasing
O	1694	1696	to
O	1697	1698	3
O	1698	1699	.
O	1699	1701	87
O	1701	1702	%
O	1703	1704	(
O	1704	1706	95
O	1706	1707	%
O	1708	1710	CI
O	1710	1711	,
O	1712	1713	2
O	1713	1714	.
O	1714	1716	57
O	1716	1717	-
O	1717	1718	5
O	1718	1719	.
O	1719	1721	78
O	1721	1722	)
O	1723	1725	in
O	1726	1729	the
O	1730	1735	fifth
O	1736	1740	year
O	1740	1741	.

O	1742	1744	In
O	1745	1757	participants
O	1758	1762	with
B-Disease	1763	1767	mild
I-Disease	1768	1772	NPDR
O	1773	1775	at
O	1776	1784	baseline
O	1784	1785	,
O	1786	1789	the
O	1790	1801	progression
O	1802	1806	rate
O	1807	1809	to
B-Disease	1810	1813	RDR
O	1814	1816	in
O	1817	1821	year
O	1822	1823	1
O	1824	1827	was
O	1828	1829	1
O	1829	1830	.
O	1830	1832	18
O	1832	1833	%
O	1834	1835	(
O	1835	1837	95
O	1837	1838	%
O	1839	1841	CI
O	1841	1842	,
O	1843	1844	0
O	1844	1845	.
O	1845	1847	96
O	1847	1848	-
O	1848	1849	1
O	1849	1850	.
O	1850	1852	33
O	1852	1853	)
O	1853	1854	.

O	1855	1864	Incidence
O	1865	1867	of
O	1868	1871	any
B-Disease	1872	1874	DR
O	1875	1878	and
B-Disease	1879	1882	RDR
O	1883	1886	and
B-Disease	1887	1889	DR
O	1890	1901	progression
O	1902	1906	rate
O	1907	1911	were
O	1912	1922	associated
O	1923	1927	with
O	1928	1933	known
O	1934	1942	duration
O	1943	1945	of
B-Disease	1946	1954	diabetes
O	1954	1955	,
B-Characteristic	1956	1959	age
I-Characteristic	1960	1962	at
I-Characteristic	1963	1972	diagnosis
O	1972	1973	,
O	1974	1977	and
B-Characteristic	1978	1981	use
I-Characteristic	1982	1984	of
I-Characteristic	1985	1992	insulin
I-Characteristic	1993	2002	treatment
O	2002	2003	.

O	2004	2008	This
O	2009	2021	longitudinal
O	2022	2035	epidemiologic
O	2036	2041	study
O	2042	2050	provides
O	2051	2054	the
O	2055	2060	first
B-Characteristic	2061	2071	Portuguese
O	2072	2081	incidence
B-Disease	2082	2084	DR
O	2085	2089	data
O	2090	2092	in
O	2093	2094	a
O	2095	2100	large
O	2100	2101	-
O	2101	2106	scale
O	2107	2117	population
O	2117	2118	-
O	2118	2123	based
O	2124	2130	cohort
O	2131	2133	of
B-Disease	2134	2138	type
I-Disease	2139	2140	2
I-Disease	2141	2149	diabetes
O	2150	2155	after
O	2156	2157	a
O	2158	2159	5
O	2159	2160	-
O	2160	2164	year
O	2165	2171	follow
O	2171	2172	-
O	2172	2174	up
O	2174	2175	.

B-Characteristic	2176	2184	Duration
I-Characteristic	2185	2187	of
I-Characteristic	2188	2196	diabetes
O	2196	2197	,
B-Characteristic	2198	2201	age
I-Characteristic	2202	2204	at
I-Characteristic	2205	2214	diagnosis
O	2214	2215	,
O	2216	2219	and
B-Characteristic	2220	2227	insulin
I-Characteristic	2228	2237	treatment
O	2238	2242	were
O	2243	2253	associated
O	2254	2258	with
O	2259	2269	increasing
O	2270	2274	risk
O	2275	2277	of
O	2278	2287	incidence
O	2288	2291	and
O	2292	2303	progression
O	2304	2306	of
B-Disease	2307	2309	DR
O	2309	2310	.

O	2311	2312	A
O	2313	2325	personalized
O	2326	2334	schedule
O	2335	2347	distribution
O	2348	2350	of
O	2351	2360	screening
O	2361	2370	intervals
O	2371	2380	according
O	2381	2383	to
O	2384	2387	the
O	2388	2398	individual
O	2399	2406	patient
O	2406	2407	'
O	2407	2408	s
O	2409	2416	profile
O	2417	2423	should
O	2424	2426	be
O	2427	2438	implemented
O	2438	2439	,
O	2440	2444	with
O	2445	2454	resulting
O	2455	2463	benefits
O	2464	2466	in
O	2467	2472	terms
O	2473	2475	of
O	2476	2482	health
O	2483	2488	costs
O	2488	2489	.

O	0	3	The
O	4	11	Natural
O	12	19	History
O	20	22	of
O	23	26	the
O	27	38	Progression
O	39	41	of
B-Symptom	42	49	Atrophy
O	50	59	Secondary
O	60	62	to
B-Disease	63	72	Stargardt
I-Disease	73	80	Disease
O	81	82	(
O	82	90	ProgStar
O	90	91	)
O	92	99	Studies
O	99	100	:
O	101	107	Design
O	108	111	and
O	112	120	Baseline
O	121	136	Characteristics
O	136	137	:
O	138	146	ProgStar
O	147	153	Report
O	154	156	No
O	156	157	.
O	158	159	1
O	159	160	.

O	162	164	To
O	165	173	describe
O	174	177	the
O	178	184	design
O	185	188	and
O	189	197	baseline
O	198	213	characteristics
O	214	216	of
O	217	225	patients
O	226	234	enrolled
O	235	239	into
O	240	241	2
O	242	249	natural
O	250	257	history
O	258	265	studies
O	266	268	of
B-Disease	269	278	Stargardt
I-Disease	279	286	disease
O	287	288	(
B-Disease	288	293	STGD1
O	293	294	)
O	294	295	.

O	296	307	Multicenter
O	308	321	retrospective
O	322	325	and
O	326	337	prospective
O	338	344	cohort
O	345	352	studies
O	352	353	.

O	354	359	Three
O	360	367	hundred
O	368	373	sixty
O	373	374	-
O	374	378	five
O	379	385	unique
O	386	394	patients
B-Characteristic	395	399	aged
I-Characteristic	400	401	6
I-Characteristic	402	407	years
I-Characteristic	408	411	and
I-Characteristic	412	417	older
O	418	420	at
O	421	429	baseline
O	430	439	harboring
B-Characteristic	440	447	disease
I-Characteristic	447	448	-
I-Characteristic	448	455	causing
I-Characteristic	456	464	variants
I-Characteristic	465	467	in
I-Characteristic	468	471	the
I-Characteristic	472	477	ABCA4
I-Characteristic	478	482	gene
O	483	486	and
O	487	491	with
O	492	501	specified
B-Symptom	502	508	ocular
I-Symptom	509	516	lesions
O	517	521	were
O	522	530	enrolled
O	531	535	from
O	536	537	9
O	538	545	centers
O	546	548	in
O	549	552	the
B-Characteristic	553	559	United
I-Characteristic	560	566	States
O	567	570	and
B-Characteristic	571	577	Europe
O	577	578	.

O	579	581	In
O	582	585	the
O	586	599	retrospective
O	600	605	study
O	605	606	,
O	607	615	patients
O	616	627	contributed
B-Diagnostic_tool	628	635	medical
I-Diagnostic_tool	636	642	record
I-Diagnostic_tool	643	647	data
O	648	652	from
O	653	655	at
O	656	661	least
O	662	663	2
O	664	667	and
O	668	670	up
O	671	673	to
O	674	675	4
O	676	682	visits
O	683	686	for
O	687	689	at
O	690	695	least
O	696	697	1
O	698	709	examination
O	710	718	modality
O	718	719	:
B-Diagnostic_tool	720	726	fundus
I-Diagnostic_tool	727	743	autofluorescence
O	744	745	(
B-Diagnostic_tool	745	748	FAF
O	748	749	)
O	749	750	,
B-Diagnostic_tool	751	759	spectral
I-Diagnostic_tool	759	760	-
I-Diagnostic_tool	760	766	domain
I-Diagnostic_tool	767	768	(
I-Diagnostic_tool	768	770	SD
I-Diagnostic_tool	770	771	)
I-Diagnostic_tool	772	779	optical
I-Diagnostic_tool	780	789	coherence
I-Diagnostic_tool	790	800	tomography
O	801	802	(
B-Diagnostic_tool	802	804	SD
I-Diagnostic_tool	805	808	OCT
O	808	809	)
O	809	810	,
O	811	814	and
O	814	815	/
O	815	817	or
B-Diagnostic_tool	818	832	microperimetry
O	833	834	(
B-Diagnostic_tool	834	836	MP
O	836	837	)
O	837	838	.

O	839	842	The
O	843	848	total
O	849	862	observational
O	863	869	period
O	870	873	was
O	874	876	at
O	877	882	least
O	883	884	2
O	885	890	years
O	891	894	and
O	895	897	up
O	898	900	to
O	901	902	5
O	903	908	years
O	909	916	between
O	917	923	single
O	924	930	visits
O	930	931	.

B-Characteristic	932	943	Demographic
O	944	947	and
B-Characteristic	948	954	visual
I-Characteristic	955	961	acuity
O	962	963	(
B-Characteristic	963	965	VA
O	965	966	)
O	967	971	data
O	972	976	also
O	977	981	were
O	982	990	obtained
O	990	991	.

O	992	994	In
O	995	998	the
O	999	1010	prospective
O	1011	1016	study
O	1016	1017	,
O	1018	1026	eligible
O	1027	1035	patients
O	1036	1040	were
O	1041	1049	examined
O	1050	1052	at
O	1053	1061	baseline
O	1062	1067	using
O	1068	1069	a
O	1070	1078	standard
O	1079	1087	protocol
O	1087	1088	,
O	1089	1093	with
O	1094	1095	6
O	1095	1096	-
O	1096	1101	month
O	1102	1108	follow
O	1108	1109	-
O	1109	1111	up
O	1112	1118	visits
O	1119	1126	planned
O	1127	1130	for
O	1131	1132	a
O	1133	1134	2
O	1134	1135	-
O	1135	1139	year
O	1140	1146	period
O	1147	1150	for
O	1151	1157	serial
B-Diagnostic_tool	1158	1163	Early
I-Diagnostic_tool	1164	1173	Treatment
I-Diagnostic_tool	1174	1182	Diabetic
I-Diagnostic_tool	1183	1194	Retinopathy
I-Diagnostic_tool	1195	1200	Study
I-Diagnostic_tool	1201	1202	(
I-Diagnostic_tool	1202	1207	ETDRS
I-Diagnostic_tool	1207	1208	)
I-Diagnostic_tool	1209	1213	best
I-Diagnostic_tool	1213	1214	-
I-Diagnostic_tool	1214	1223	corrected
I-Diagnostic_tool	1224	1226	VA
O	1226	1227	,
B-Diagnostic_tool	1228	1230	SD
I-Diagnostic_tool	1231	1234	OCT
O	1234	1235	,
B-Diagnostic_tool	1236	1239	FAF
O	1239	1240	,
O	1241	1244	and
B-Diagnostic_tool	1245	1247	MP
O	1247	1248	.

O	1249	1255	Design
O	1256	1259	and
O	1260	1269	rationale
O	1270	1272	of
O	1273	1274	a
O	1275	1286	multicenter
O	1287	1292	study
O	1293	1295	to
O	1296	1305	determine
O	1306	1309	the
O	1310	1321	progression
O	1322	1324	of
B-Disease	1325	1330	STGD1
O	1331	1333	in
O	1334	1335	2
O	1336	1341	large
O	1342	1355	retrospective
O	1356	1359	and
O	1360	1371	prospective
O	1372	1385	international
O	1386	1393	cohorts
O	1393	1394	.

O	1395	1403	Detailed
O	1404	1412	baseline
O	1413	1428	characteristics
O	1429	1431	of
O	1432	1436	both
O	1437	1444	cohorts
O	1445	1448	are
O	1449	1458	presented
O	1458	1459	,
O	1460	1469	including
B-Characteristic	1470	1482	demographics
O	1482	1483	,
O	1484	1487	and
B-Characteristic	1488	1498	structural
I-Characteristic	1499	1502	and
I-Characteristic	1503	1513	functional
I-Characteristic	1514	1521	retinal
I-Characteristic	1522	1529	metrics
O	1529	1530	.

O	1531	1535	Into
O	1536	1539	the
O	1540	1553	retrospective
O	1554	1559	study
O	1559	1560	,
O	1561	1564	251
O	1565	1573	patients
O	1574	1575	(
O	1575	1578	458
B-Anatomy	1579	1583	eyes
O	1583	1584	)
O	1585	1589	were
O	1590	1598	enrolled
O	1598	1599	;
O	1600	1604	mean
O	1605	1611	follow
O	1611	1612	-
O	1612	1614	up
O	1615	1616	
O	1617	1625	standard
O	1626	1635	deviation
O	1636	1639	was
O	1640	1641	3
O	1641	1642	.
O	1642	1643	9
O	1643	1644	
O	1644	1645	1
O	1645	1646	.
O	1646	1647	6
O	1648	1653	years
O	1653	1654	.

O	1655	1657	At
O	1658	1666	baseline
O	1666	1667	,
O	1668	1670	36
O	1670	1671	%
O	1672	1675	had
O	1676	1678	no
O	1679	1681	or
B-Symptom	1682	1686	mild
I-Symptom	1687	1689	VA
I-Symptom	1690	1694	loss
O	1694	1695	,
O	1696	1699	and
O	1700	1702	47
O	1702	1703	%
O	1704	1706	of
O	1707	1710	the
O	1711	1716	study
B-Anatomy	1717	1721	eyes
O	1722	1725	had
O	1726	1731	areas
O	1732	1734	of
B-Symptom	1735	1745	definitely
I-Symptom	1746	1755	decreased
I-Symptom	1756	1772	autofluorescence
O	1773	1774	(
B-Symptom	1774	1778	DDAF
O	1778	1779	)
O	1780	1784	with
O	1785	1787	an
O	1788	1795	average
O	1796	1802	lesion
O	1803	1807	area
O	1808	1810	of
B-Dimension	1811	1812	2
I-Dimension	1812	1813	.
I-Dimension	1813	1814	5
I-Dimension	1814	1815	
I-Dimension	1815	1816	2
I-Dimension	1816	1817	.
I-Dimension	1817	1818	9
I-Dimension	1819	1821	mm
I-Dimension	1821	1822	(
I-Dimension	1822	1823	2
I-Dimension	1823	1824	)
O	1825	1826	(
O	1826	1831	range
O	1831	1832	,
O	1833	1834	0
O	1834	1835	.
O	1835	1837	02
O	1837	1838	-
O	1838	1840	16
O	1840	1841	.
O	1841	1843	03
O	1844	1846	mm
O	1846	1847	(
O	1847	1848	2
O	1848	1849	)
O	1849	1850	)
O	1850	1851	.

O	1852	1855	Two
O	1856	1863	hundred
O	1864	1869	fifty
O	1869	1870	-
O	1870	1874	nine
O	1875	1883	patients
O	1884	1885	(
O	1885	1888	489
B-Anatomy	1889	1893	eyes
O	1893	1894	)
O	1895	1899	were
O	1900	1908	enrolled
O	1909	1911	in
O	1912	1915	the
O	1916	1927	prospective
O	1928	1933	study
O	1933	1934	.

O	1935	1937	At
O	1938	1946	baseline
O	1946	1947	,
O	1948	1950	20
O	1950	1951	%
O	1952	1955	had
B-Symptom	1956	1958	no
I-Symptom	1959	1961	or
I-Symptom	1962	1966	mild
I-Symptom	1967	1969	VA
I-Symptom	1970	1974	loss
O	1974	1975	,
O	1976	1979	and
O	1980	1982	64
O	1982	1983	%
O	1984	1987	had
O	1988	1993	areas
O	1994	1996	of
B-Symptom	1997	2001	DDAF
O	2002	2006	with
O	2007	2009	an
O	2010	2017	average
O	2018	2024	lesion
O	2025	2029	area
O	2030	2032	of
B-Dimension	2033	2034	4
I-Dimension	2034	2035	.
I-Dimension	2035	2036	0
I-Dimension	2036	2037	
I-Dimension	2037	2038	4
I-Dimension	2038	2039	.
I-Dimension	2039	2040	4
I-Dimension	2041	2043	mm
I-Dimension	2043	2044	(
I-Dimension	2044	2045	2
I-Dimension	2045	2046	)
O	2047	2048	(
O	2048	2053	range
O	2053	2054	,
O	2055	2056	0
O	2056	2057	.
O	2057	2059	03
O	2059	2060	-
O	2060	2062	24
O	2062	2063	.
O	2063	2065	24
O	2066	2068	mm
O	2068	2069	(
O	2069	2070	2
O	2070	2071	)
O	2071	2072	)
O	2072	2073	.

O	2074	2077	The
B-Characteristic	2078	2082	mean
I-Characteristic	2083	2090	retinal
I-Characteristic	2091	2102	sensitivity
O	2103	2107	with
B-Diagnostic_tool	2108	2110	MP
O	2111	2114	was
B-Dimension	2115	2117	10
I-Dimension	2117	2118	.
I-Dimension	2118	2119	8
I-Dimension	2119	2120	
I-Dimension	2120	2121	5
I-Dimension	2121	2122	.
I-Dimension	2122	2123	0
I-Dimension	2124	2126	dB
O	2126	2127	.

O	2128	2131	The
O	2132	2140	ProgStar
O	2141	2148	cohorts
O	2149	2153	have
O	2154	2162	baseline
O	2163	2178	characteristics
O	2179	2183	that
O	2184	2193	encompass
O	2194	2195	a
O	2196	2200	wide
O	2201	2206	range
O	2207	2209	of
O	2210	2217	disease
O	2218	2226	severity
O	2227	2230	and
O	2231	2234	are
O	2235	2243	expected
O	2244	2246	to
O	2247	2254	provide
O	2255	2263	valuable
O	2264	2268	data
O	2269	2271	on
O	2272	2283	progression
O	2284	2289	based
O	2290	2292	on
O	2293	2299	serial
O	2300	2312	quantitative
O	2313	2325	measurements
O	2326	2333	derived
O	2334	2338	from
O	2339	2347	multiple
O	2348	2355	methods
O	2355	2356	,
O	2357	2362	which
O	2363	2367	will
O	2368	2370	be
O	2371	2379	critical
O	2380	2382	to
O	2383	2386	the
O	2387	2393	design
O	2394	2396	of
O	2397	2404	planned
O	2405	2413	clinical
O	2414	2420	trials
O	2420	2421	.

B-Symptom	0	6	Visual
I-Symptom	7	12	Field
I-Symptom	13	19	Change
O	20	23	and
B-Characteristic	24	26	24
I-Characteristic	26	27	-
I-Characteristic	27	31	Hour
I-Characteristic	32	35	IOP
I-Characteristic	35	36	-
I-Characteristic	36	43	Related
I-Characteristic	44	51	Profile
O	52	56	with
O	57	58	a
B-Diagnostic_tool	59	66	Contact
I-Diagnostic_tool	67	71	Lens
I-Diagnostic_tool	72	78	Sensor
O	79	81	in
O	82	89	Treated
B-Disease	90	98	Glaucoma
O	99	107	Patients
O	107	108	.

O	110	112	To
O	113	117	test
O	118	121	the
O	122	132	hypothesis
O	133	137	that
O	138	139	a
O	140	142	24
O	142	143	-
O	143	147	hour
O	148	157	recording
O	158	160	of
B-Characteristic	161	172	intraocular
I-Characteristic	173	181	pressure
O	182	183	(
B-Characteristic	183	186	IOP
O	186	187	)
O	187	188	-
O	188	195	related
O	196	208	measurements
O	209	216	derived
O	217	221	from
O	222	223	a
B-Diagnostic_tool	224	231	contact
I-Diagnostic_tool	232	236	lens
I-Diagnostic_tool	237	243	sensor
O	244	245	(
B-Diagnostic_tool	245	248	CLS
O	248	249	)
O	250	260	correlates
O	261	263	to
O	264	267	the
B-Characteristic	268	272	rate
I-Characteristic	273	275	of
I-Characteristic	276	282	visual
I-Characteristic	283	288	field
I-Characteristic	289	300	progression
O	301	303	in
O	304	311	treated
B-Disease	312	324	glaucomatous
B-Anatomy	325	329	eyes
O	329	330	.

O	331	342	Prospective
O	342	343	,
O	344	349	cross
O	349	350	-
O	350	359	sectional
O	360	365	study
O	365	366	.

O	367	372	Forty
O	373	380	treated
B-Disease	381	393	glaucomatous
O	394	402	patients
O	403	407	with
O	408	409	8
O	410	412	or
O	413	417	more
O	418	420	24
O	420	421	-
O	421	422	2
B-Diagnostic_tool	423	429	visual
I-Diagnostic_tool	430	435	field
I-Diagnostic_tool	436	441	tests
O	441	442	.

O	443	449	Twenty
O	449	450	-
O	450	454	four
O	454	455	-
O	455	459	hour
O	460	469	recording
O	470	474	with
O	475	476	a
B-Diagnostic_tool	477	480	CLS
O	481	485	that
O	486	494	provides
B-Characteristic	495	498	IOP
I-Characteristic	498	499	-
I-Characteristic	499	506	related
I-Characteristic	507	519	measurements
O	519	520	.

O	521	526	Rates
O	527	529	of
B-Characteristic	530	536	visual
I-Characteristic	537	542	field
O	543	547	mean
O	548	557	deviation
O	558	559	(
O	559	561	MD
O	561	562	)
O	563	569	change
O	570	576	before
O	577	580	and
O	581	583	at
O	584	587	the
O	588	592	time
O	593	595	of
B-Diagnostic_tool	596	599	CLS
O	600	609	recording
O	610	613	and
B-Diagnostic_tool	614	617	CLS
O	618	628	parameters
O	628	629	,
O	630	636	namely
O	637	643	number
O	644	646	of
O	647	652	large
O	653	658	peaks
O	658	659	,
O	660	664	mean
O	665	669	peak
O	670	675	ratio
O	675	676	,
O	677	681	wake
O	681	682	-
O	682	684	to
O	684	685	-
O	685	690	sleep
O	691	696	slope
O	696	697	,
O	698	707	amplitude
O	708	711	and
O	712	716	area
O	717	722	under
O	723	726	the
O	727	733	cosine
O	734	739	curve
O	739	740	,
O	741	744	and
O	745	756	variability
O	757	761	from
O	762	765	the
O	766	770	mean
O	770	771	.

O	772	776	When
O	777	786	comparing
O	787	790	the
O	791	795	rate
O	796	798	of
O	799	801	MD
O	802	808	change
O	809	815	before
O	816	819	and
O	820	822	at
O	823	826	the
O	827	831	time
O	832	834	of
B-Diagnostic_tool	835	838	CLS
O	839	848	recording
O	849	851	of
O	852	855	all
O	856	864	patients
O	864	865	,
O	866	869	the
O	870	877	average
O	878	883	slope
O	884	887	was
O	888	889	-
O	889	890	0
O	890	891	.
O	891	893	05
O	894	896	dB
O	896	897	/
O	897	901	year
O	902	908	faster
O	909	911	in
O	912	915	the
O	916	925	beginning
O	926	934	compared
O	935	939	with
O	940	943	the
O	944	947	end
O	948	949	(
O	949	950	P
O	951	952	=
O	953	954	0
O	954	955	.
O	955	958	087
O	958	959	)
O	959	960	,
O	961	971	suggesting
O	972	973	a
O	974	986	deceleration
O	987	989	of
O	990	1001	progression
O	1002	1004	by
O	1005	1008	the
O	1009	1013	time
O	1014	1016	of
B-Diagnostic_tool	1017	1020	CLS
O	1021	1030	recording
O	1030	1031	.

O	1032	1035	The
O	1036	1042	number
O	1043	1045	of
O	1046	1050	long
O	1051	1056	peaks
O	1057	1060	and
O	1061	1064	the
O	1065	1069	mean
O	1070	1074	peak
O	1075	1080	ratio
O	1081	1085	when
O	1086	1094	patients
O	1095	1099	were
O	1100	1105	awake
O	1106	1110	were
O	1111	1114	the
O	1115	1119	best
O	1120	1130	predictors
O	1131	1133	of
O	1134	1140	faster
O	1141	1152	progression
O	1152	1153	.

O	1154	1157	The
O	1158	1169	combination
O	1170	1172	of
B-Diagnostic_tool	1173	1176	CLS
O	1177	1187	parameters
O	1188	1196	provided
O	1197	1203	better
O	1204	1212	measures
O	1213	1215	of
O	1216	1224	goodness
O	1225	1227	of
O	1228	1231	fit
O	1232	1236	than
B-Diagnostic_tool	1237	1245	Goldmann
I-Diagnostic_tool	1246	1249	IOP
O	1250	1260	parameters
O	1261	1262	(
O	1262	1266	mean
O	1266	1267	,
O	1268	1272	peak
O	1272	1273	,
O	1274	1277	and
O	1278	1289	fluctuation
O	1289	1290	)
O	1291	1293	in
O	1294	1297	the
O	1298	1302	same
O	1303	1309	period
O	1309	1310	.

B-Characteristic	1311	1322	Intraocular
I-Characteristic	1323	1331	pressure
I-Characteristic	1331	1332	-
I-Characteristic	1332	1339	related
I-Characteristic	1340	1350	parameters
O	1351	1359	obtained
O	1360	1364	with
O	1365	1367	24
O	1367	1368	-
O	1368	1372	hour
O	1373	1382	recording
O	1383	1387	with
O	1388	1389	a
B-Diagnostic_tool	1390	1393	CLS
O	1394	1398	were
O	1399	1409	associated
O	1410	1414	with
O	1415	1418	the
B-Characteristic	1419	1423	rate
I-Characteristic	1424	1426	of
I-Characteristic	1427	1433	visual
I-Characteristic	1434	1439	field
I-Characteristic	1440	1451	progression
O	1452	1454	in
O	1455	1462	treated
B-Disease	1463	1475	glaucomatous
B-Anatomy	1476	1480	eyes
O	1480	1481	.

O	1482	1486	This
O	1487	1497	technology
O	1498	1501	may
O	1502	1504	be
O	1505	1511	useful
O	1512	1514	in
O	1515	1524	detecting
B-Anatomy	1525	1529	eyes
O	1530	1532	at
O	1533	1539	higher
O	1540	1544	risk
O	1545	1547	of
B-Disease	1548	1556	glaucoma
O	1557	1568	progression
O	1569	1574	while
O	1575	1584	receiving
O	1585	1594	treatment
O	1594	1595	.

B-Characteristic	0	7	Macular
I-Characteristic	8	14	versus
I-Characteristic	15	22	Retinal
I-Characteristic	23	28	Nerve
I-Characteristic	29	34	Fiber
I-Characteristic	35	40	Layer
I-Characteristic	41	51	Parameters
O	52	55	for
O	56	66	Diagnosing
O	67	75	Manifest
B-Disease	76	84	Glaucoma
O	84	85	:
O	86	87	A
O	88	98	Systematic
O	99	105	Review
O	106	108	of
O	109	119	Diagnostic
O	120	128	Accuracy
O	129	136	Studies
O	136	137	.

B-Characteristic	139	146	Macular
I-Characteristic	147	157	parameters
O	158	162	have
O	163	167	been
O	168	176	proposed
O	177	179	as
O	180	182	an
O	183	194	alternative
O	195	197	to
B-Characteristic	198	205	retinal
I-Characteristic	206	211	nerve
I-Characteristic	212	217	fiber
I-Characteristic	218	223	layer
I-Characteristic	224	225	(
I-Characteristic	225	229	RNFL
I-Characteristic	229	230	)
I-Characteristic	231	241	parameters
O	242	244	to
O	245	253	diagnose
B-Disease	254	262	glaucoma
O	262	263	.

O	264	273	Comparing
O	274	277	the
O	278	288	diagnostic
O	289	297	accuracy
O	298	300	of
B-Characteristic	301	308	macular
I-Characteristic	309	319	parameters
O	319	320	,
O	321	333	specifically
O	334	337	the
B-Anatomy	338	346	ganglion
I-Anatomy	347	351	cell
I-Anatomy	352	359	complex
O	360	361	(
B-Anatomy	361	364	GCC
O	364	365	)
O	366	369	and
B-Anatomy	370	378	ganglion
I-Anatomy	379	383	cell
I-Anatomy	384	389	inner
I-Anatomy	390	399	plexiform
I-Anatomy	400	405	layer
O	406	407	(
B-Anatomy	407	412	GCIPL
O	412	413	)
O	413	414	,
O	415	419	with
O	420	423	the
O	424	432	accuracy
O	433	435	of
B-Characteristic	436	440	RNFL
I-Characteristic	441	451	parameters
O	452	455	for
O	456	465	detecting
O	466	474	manifest
B-Disease	475	483	glaucoma
O	484	486	is
O	487	496	important
O	497	499	to
O	500	505	guide
O	506	514	clinical
O	515	523	practice
O	524	527	and
O	528	534	future
O	535	543	research
O	543	544	.

O	545	552	Studies
O	553	558	using
B-Diagnostic_tool	559	567	spectral
I-Diagnostic_tool	568	574	domain
I-Diagnostic_tool	575	582	optical
I-Diagnostic_tool	583	592	coherence
I-Diagnostic_tool	593	603	tomography
O	604	605	(
B-Diagnostic_tool	605	607	SD
I-Diagnostic_tool	608	611	OCT
O	611	612	)
O	613	616	and
O	617	626	reporting
B-Characteristic	627	634	macular
I-Characteristic	635	645	parameters
O	646	650	were
O	651	659	included
O	660	662	if
O	663	667	they
O	668	675	allowed
O	676	679	the
O	680	690	extraction
O	691	693	of
O	694	702	accuracy
O	703	707	data
O	708	711	for
O	712	722	diagnosing
O	723	731	manifest
B-Disease	732	740	glaucoma
O	740	741	,
O	742	744	as
O	745	754	confirmed
O	755	759	with
B-Diagnostic_tool	760	769	automated
I-Diagnostic_tool	770	779	perimetry
O	780	782	or
O	783	784	a
O	785	794	clinician
O	794	795	'
O	795	796	s
B-Diagnostic_tool	797	802	optic
I-Diagnostic_tool	803	808	nerve
I-Diagnostic_tool	809	813	head
I-Diagnostic_tool	814	815	(
I-Diagnostic_tool	815	818	ONH
I-Diagnostic_tool	818	819	)
I-Diagnostic_tool	820	830	assessment
O	830	831	.

O	832	837	Cross
O	837	838	-
O	838	847	sectional
O	848	854	cohort
O	855	862	studies
O	863	866	and
O	867	871	case
O	871	872	-
O	872	879	control
O	880	887	studies
O	888	892	were
O	893	901	included
O	901	902	.

O	903	906	The
O	907	913	QUADAS
O	914	915	2
O	916	920	tool
O	921	924	was
O	925	929	used
O	930	932	to
O	933	939	assess
O	940	954	methodological
O	955	962	quality
O	962	963	.

O	964	968	Only
O	969	975	direct
O	976	987	comparisons
O	988	990	of
B-Characteristic	991	998	macular
I-Characteristic	999	1005	versus
I-Characteristic	1006	1010	RNFL
I-Characteristic	1011	1021	parameters
O	1022	1023	(
O	1023	1024	i
O	1024	1025	.
O	1025	1026	e
O	1026	1027	.
O	1027	1028	,
O	1029	1031	in
O	1032	1035	the
O	1036	1040	same
O	1041	1046	study
O	1046	1047	)
O	1048	1052	were
O	1053	1062	conducted
O	1062	1063	.

O	1064	1071	Summary
O	1072	1083	sensitivity
O	1084	1087	and
O	1088	1099	specificity
O	1100	1102	of
O	1103	1107	each
B-Characteristic	1108	1115	macular
I-Characteristic	1116	1118	or
I-Characteristic	1119	1123	RNFL
I-Characteristic	1124	1133	parameter
O	1134	1138	were
O	1139	1147	reported
O	1147	1148	,
O	1149	1152	and
O	1153	1156	the
O	1157	1165	relative
O	1166	1176	diagnostic
O	1177	1181	odds
O	1182	1187	ratio
O	1188	1189	(
O	1189	1192	DOR
O	1192	1193	)
O	1194	1197	was
O	1198	1208	calculated
O	1209	1211	in
O	1212	1224	hierarchical
O	1225	1232	summary
O	1233	1241	receiver
O	1242	1251	operating
O	1252	1266	characteristic
O	1267	1268	(
O	1268	1273	HSROC
O	1273	1274	)
O	1275	1281	models
O	1282	1284	to
O	1285	1292	compare
O	1293	1297	them
O	1297	1298	.

O	1299	1305	Thirty
O	1305	1306	-
O	1306	1310	four
O	1311	1318	studies
O	1319	1331	investigated
B-Characteristic	1332	1339	macular
I-Characteristic	1340	1350	parameters
O	1351	1356	using
B-Diagnostic_tool	1357	1362	RTVue
I-Diagnostic_tool	1363	1366	OCT
O	1367	1368	(
O	1368	1375	Optovue
O	1376	1379	Inc
O	1379	1380	.
O	1380	1381	,
O	1382	1389	Fremont
O	1389	1390	,
O	1391	1393	CA
O	1393	1394	)
O	1395	1396	(
O	1396	1398	19
O	1399	1406	studies
O	1406	1407	,
O	1408	1412	3094
O	1413	1421	subjects
O	1421	1422	)
O	1422	1423	,
B-Diagnostic_tool	1424	1430	Cirrus
I-Diagnostic_tool	1431	1434	OCT
O	1435	1436	(
O	1436	1440	Carl
O	1441	1446	Zeiss
O	1447	1454	Meditec
O	1455	1458	Inc
O	1458	1459	.
O	1459	1460	,
O	1461	1467	Dublin
O	1467	1468	,
O	1469	1471	CA
O	1471	1472	)
O	1473	1474	(
O	1474	1476	14
O	1477	1484	studies
O	1484	1485	,
O	1486	1490	2164
O	1491	1499	subjects
O	1499	1500	)
O	1500	1501	,
O	1502	1504	or
B-Diagnostic_tool	1505	1507	3D
I-Diagnostic_tool	1508	1514	Topcon
I-Diagnostic_tool	1515	1518	OCT
O	1519	1520	(
O	1520	1526	Topcon
O	1526	1527	,
O	1528	1531	Inc
O	1531	1532	.
O	1532	1533	,
O	1534	1539	Tokyo
O	1539	1540	,
O	1541	1546	Japan
O	1546	1547	)
O	1548	1549	(
O	1549	1550	4
O	1551	1558	studies
O	1558	1559	,
O	1560	1563	522
O	1564	1572	subjects
O	1572	1573	)
O	1573	1574	.

O	1575	1581	Thirty
O	1581	1582	-
O	1582	1585	two
O	1586	1588	of
O	1589	1594	these
O	1595	1602	studies
O	1603	1610	allowed
O	1611	1622	comparisons
O	1623	1630	between
B-Characteristic	1631	1638	macular
I-Characteristic	1639	1642	and
I-Characteristic	1643	1647	RNFL
I-Characteristic	1648	1658	parameters
O	1658	1659	.

O	1660	1667	Studies
O	1668	1677	generally
O	1678	1686	reported
O	1687	1700	sensitivities
O	1701	1703	at
O	1704	1709	fixed
O	1710	1723	specificities
O	1723	1724	,
O	1725	1729	more
O	1730	1738	commonly
O	1739	1740	0
O	1740	1741	.
O	1741	1743	90
O	1744	1746	or
O	1747	1748	0
O	1748	1749	.
O	1749	1751	95
O	1751	1752	,
O	1753	1757	with
O	1758	1771	sensitivities
O	1772	1774	of
O	1775	1779	most
O	1780	1784	best
O	1784	1785	-
O	1785	1795	performing
O	1796	1806	parameters
O	1807	1814	between
O	1815	1816	0
O	1816	1817	.
O	1817	1819	65
O	1820	1823	and
O	1824	1825	0
O	1825	1826	.
O	1826	1828	75
O	1828	1829	.

O	1830	1833	For
O	1834	1837	all
B-Diagnostic_tool	1838	1841	OCT
O	1842	1849	devices
O	1849	1850	,
O	1851	1859	compared
O	1860	1864	with
B-Characteristic	1865	1869	RNFL
I-Characteristic	1870	1880	parameters
O	1880	1881	,
B-Characteristic	1882	1889	macular
I-Characteristic	1890	1900	parameters
O	1901	1905	were
O	1906	1915	similarly
O	1916	1918	or
O	1919	1927	slightly
O	1928	1932	less
O	1933	1941	accurate
O	1942	1945	for
O	1946	1955	detecting
B-Disease	1956	1964	glaucoma
O	1965	1967	at
O	1968	1971	the
O	1972	1979	highest
O	1980	1988	reported
O	1989	2000	specificity
O	2000	2001	,
O	2002	2007	which
O	2008	2011	was
O	2012	2021	confirmed
O	2022	2024	in
O	2025	2033	analyses
O	2034	2036	at
O	2037	2040	the
O	2041	2047	lowest
O	2048	2059	specificity
O	2059	2060	.

O	2061	2069	Included
O	2070	2077	studies
O	2078	2086	suffered
O	2087	2091	from
O	2092	2103	limitations
O	2103	2104	,
O	2105	2115	especially
O	2116	2119	the
O	2120	2124	case
O	2124	2125	-
O	2125	2132	control
O	2133	2138	study
O	2139	2145	design
O	2145	2146	,
O	2147	2152	which
O	2153	2155	is
O	2156	2161	known
O	2162	2164	to
O	2165	2177	overestimate
O	2178	2186	accuracy
O	2186	2187	.

O	2188	2195	However
O	2195	2196	,
O	2197	2201	this
O	2202	2206	flaw
O	2207	2209	is
O	2210	2214	less
O	2215	2223	relevant
O	2224	2226	as
O	2227	2228	a
O	2229	2235	source
O	2236	2238	of
O	2239	2243	bias
O	2244	2246	in
O	2247	2253	direct
O	2254	2265	comparisons
O	2266	2275	conducted
O	2276	2282	within
O	2283	2290	studies
O	2290	2291	.

O	2292	2296	With
O	2297	2300	the
O	2301	2304	use
O	2305	2307	of
B-Diagnostic_tool	2308	2311	OCT
O	2311	2312	,
B-Characteristic	2313	2317	RNFL
I-Characteristic	2318	2328	parameters
O	2329	2332	are
O	2333	2338	still
O	2339	2349	preferable
O	2350	2352	to
B-Characteristic	2353	2360	macular
I-Characteristic	2361	2371	parameters
O	2372	2375	for
O	2376	2386	diagnosing
O	2387	2395	manifest
B-Disease	2396	2404	glaucoma
O	2404	2405	,
O	2406	2409	but
O	2410	2413	the
O	2414	2425	differences
O	2426	2429	are
O	2430	2435	small
O	2435	2436	.

O	2437	2444	Because
O	2445	2447	of
O	2448	2452	high
O	2453	2466	heterogeneity
O	2466	2467	,
O	2468	2474	direct
O	2475	2486	comparative
O	2487	2489	or
O	2490	2500	randomized
O	2501	2508	studies
O	2509	2511	of
B-Diagnostic_tool	2512	2515	OCT
O	2516	2523	devices
O	2524	2526	or
B-Characteristic	2527	2530	OCT
I-Characteristic	2531	2541	parameters
O	2542	2545	and
O	2546	2556	diagnostic
O	2557	2567	strategies
O	2568	2571	are
O	2572	2581	essential
O	2581	2582	.

O	0	14	Identification
O	15	17	of
B-Disease	18	26	Diabetic
I-Disease	27	38	Retinopathy
O	39	42	and
O	43	53	Ungradable
O	54	59	Image
O	60	64	Rate
O	65	69	with
B-Diagnostic_tool	70	79	Ultrawide
I-Diagnostic_tool	80	85	Field
I-Diagnostic_tool	86	93	Imaging
O	94	96	in
O	97	98	a
O	99	107	National
O	108	125	Teleophthalmology
O	126	133	Program
O	133	134	.

O	136	138	To
O	139	146	compare
B-Disease	147	155	diabetic
I-Disease	156	167	retinopathy
O	168	169	(
B-Disease	169	171	DR
O	171	172	)
O	173	187	identification
O	188	191	and
O	192	202	ungradable
O	203	208	image
O	209	214	rates
O	215	222	between
B-Diagnostic_tool	223	235	nonmydriatic
I-Diagnostic_tool	236	245	ultrawide
I-Diagnostic_tool	246	251	field
I-Diagnostic_tool	252	253	(
I-Diagnostic_tool	253	256	UWF
I-Diagnostic_tool	256	257	)
I-Diagnostic_tool	258	265	imaging
O	266	269	and
B-Diagnostic_tool	270	282	nonmydriatic
I-Diagnostic_tool	283	293	multifield
I-Diagnostic_tool	294	300	fundus
I-Diagnostic_tool	301	312	photography
O	313	314	(
B-Diagnostic_tool	314	318	NMFP
O	318	319	)
O	320	322	in
O	323	324	a
O	325	330	large
O	331	341	multistate
O	342	352	population
O	352	353	-
O	353	358	based
B-Disease	359	361	DR
O	362	379	teleophthalmology
O	380	387	program
O	387	388	.

O	389	397	Multiple
O	397	398	-
O	398	402	site
O	402	403	,
O	404	417	nonrandomized
O	417	418	,
O	419	430	consecutive
O	430	431	,
O	432	437	cross
O	437	438	-
O	438	447	sectional
O	447	448	,
O	449	462	retrospective
O	462	463	,
O	464	476	uncontrolled
O	477	484	imaging
O	485	491	device
O	492	502	evaluation
O	502	503	.

O	504	510	Thirty
O	510	511	-
O	511	515	five
O	516	524	thousand
O	525	530	fifty
O	530	531	-
O	531	534	two
B-Anatomy	535	539	eyes
O	540	541	(
O	541	543	17
O	544	547	526
O	548	556	patients
O	556	557	)
O	558	564	imaged
O	565	570	using
B-Diagnostic_tool	571	575	NMFP
O	576	579	and
O	580	582	16
O	583	586	218
B-Anatomy	587	591	eyes
O	592	593	(
O	593	597	8109
O	598	606	patients
O	606	607	)
O	608	614	imaged
O	615	620	using
B-Diagnostic_tool	621	624	UWF
I-Diagnostic_tool	625	632	imaging
O	632	633	.

O	634	637	All
O	638	646	patients
O	647	657	undergoing
B-Diagnostic_tool	658	664	Joslin
I-Diagnostic_tool	665	671	Vision
I-Diagnostic_tool	672	679	Network
I-Diagnostic_tool	680	681	(
I-Diagnostic_tool	681	684	JVN
I-Diagnostic_tool	684	685	)
I-Diagnostic_tool	686	693	imaging
O	694	698	with
O	699	705	either
B-Diagnostic_tool	706	710	NMFP
O	711	713	or
B-Diagnostic_tool	714	717	UWF
I-Diagnostic_tool	718	725	imaging
O	726	730	from
O	731	734	May
O	735	736	1
O	736	737	,
O	738	742	2014
O	742	743	,
O	744	751	through
O	752	758	August
O	759	761	30
O	761	762	,
O	763	767	2015
O	767	768	,
O	769	775	within
O	776	779	the
O	780	786	Indian
O	787	793	Health
O	794	801	Service
O	801	802	-
O	802	805	JVN
O	806	813	program
O	813	814	,
O	815	820	which
O	821	827	serves
B-Characteristic	828	836	American
I-Characteristic	837	843	Indian
O	844	847	and
B-Characteristic	848	854	Alaska
I-Characteristic	855	861	Native
O	862	873	communities
O	874	876	at
O	877	879	97
O	880	885	sites
O	886	892	across
O	893	895	25
O	896	902	states
O	902	903	,
O	904	908	were
O	909	918	evaluated
O	918	919	.

O	920	923	All
B-Diagnostic_tool	924	931	retinal
I-Diagnostic_tool	932	938	images
O	939	943	were
O	944	950	graded
O	951	956	using
O	957	958	a
O	959	971	standardized
O	972	981	validated
O	982	990	protocol
O	991	993	in
O	994	995	a
O	996	1007	centralized
O	1008	1015	reading
O	1016	1022	center
O	1022	1023	.

O	1024	1034	Ungradable
O	1035	1039	rate
O	1040	1043	for
B-Disease	1044	1046	DR
O	1047	1050	and
B-Disease	1051	1059	diabetic
I-Disease	1060	1067	macular
I-Disease	1068	1073	edema
O	1074	1075	(
B-Disease	1075	1078	DME
O	1078	1079	)
O	1079	1080	.

O	1081	1084	The
O	1085	1095	ungradable
O	1096	1100	rate
O	1101	1104	per
O	1105	1112	patient
O	1113	1116	for
B-Disease	1117	1119	DR
O	1120	1123	and
B-Disease	1124	1127	DME
O	1128	1131	was
O	1132	1145	significantly
O	1146	1151	lower
O	1152	1156	with
B-Diagnostic_tool	1157	1160	UWF
I-Diagnostic_tool	1161	1168	imaging
O	1169	1177	compared
O	1178	1182	with
B-Diagnostic_tool	1183	1187	NMFP
O	1188	1189	(
B-Disease	1189	1191	DR
O	1191	1192	,
O	1193	1194	2
O	1194	1195	.
O	1195	1196	8
O	1196	1197	%
O	1198	1200	vs
O	1200	1201	.
O	1202	1204	26
O	1204	1205	.
O	1205	1206	9
O	1206	1207	%
O	1208	1209	[
O	1209	1210	P
O	1212	1213	<
O	1215	1216	0
O	1216	1217	.
O	1217	1221	0001
O	1221	1222	]
O	1222	1223	;
B-Disease	1224	1227	DME
O	1227	1228	,
O	1229	1230	3
O	1230	1231	.
O	1231	1232	8
O	1232	1233	%
O	1234	1236	vs
O	1236	1237	.
O	1238	1240	26
O	1240	1241	.
O	1241	1242	2
O	1242	1243	%
O	1244	1245	[
O	1245	1246	P
O	1248	1249	<
O	1251	1252	0
O	1252	1253	.
O	1253	1257	0001
O	1257	1258	]
O	1258	1259	)
O	1259	1260	.

O	1261	1275	Identification
O	1276	1278	of
B-Anatomy	1279	1283	eyes
O	1284	1288	with
O	1289	1295	either
B-Disease	1296	1298	DR
O	1299	1301	or
B-Disease	1302	1311	referable
I-Disease	1312	1314	DR
O	1315	1316	(
B-Disease	1316	1324	moderate
I-Disease	1325	1341	nonproliferative
I-Disease	1342	1344	DR
O	1345	1347	or
B-Disease	1348	1351	DME
O	1352	1354	or
O	1355	1360	worse
O	1360	1361	)
O	1362	1365	was
O	1366	1375	increased
O	1376	1381	using
B-Diagnostic_tool	1382	1385	UWF
I-Diagnostic_tool	1386	1393	imaging
O	1394	1398	from
O	1399	1401	11
O	1401	1402	.
O	1402	1403	7
O	1403	1404	%
O	1405	1407	to
O	1408	1410	24
O	1410	1411	.
O	1411	1412	2
O	1412	1413	%
O	1414	1415	(
O	1415	1416	P
O	1418	1419	<
O	1421	1422	0
O	1422	1423	.
O	1423	1427	0001
O	1427	1428	)
O	1429	1432	and
O	1433	1437	from
O	1438	1439	6
O	1439	1440	.
O	1440	1441	2
O	1441	1442	%
O	1443	1445	to
O	1446	1448	13
O	1448	1449	.
O	1449	1450	6
O	1450	1451	%
O	1452	1453	(
O	1453	1454	P
O	1456	1457	<
O	1459	1460	0
O	1460	1461	.
O	1461	1465	0001
O	1465	1466	)
O	1466	1467	,
O	1468	1480	respectively
O	1480	1481	.

O	1482	1484	In
B-Anatomy	1485	1489	eyes
O	1490	1494	with
B-Disease	1495	1497	DR
O	1498	1504	imaged
O	1505	1509	with
B-Diagnostic_tool	1510	1513	UWF
I-Diagnostic_tool	1514	1521	imaging
O	1522	1523	(
O	1523	1524	n
O	1525	1526	=
O	1527	1531	3926
B-Anatomy	1532	1536	eyes
O	1537	1539	of
O	1540	1544	2402
O	1545	1553	patients
O	1553	1554	)
O	1554	1555	,
O	1556	1559	the
O	1560	1568	presence
O	1569	1571	of
O	1572	1585	predominantly
B-Symptom	1586	1596	peripheral
I-Symptom	1597	1604	lesions
O	1605	1614	suggested
O	1615	1616	a
O	1617	1621	more
O	1622	1628	severe
O	1629	1634	level
O	1635	1637	of
B-Disease	1638	1640	DR
O	1641	1643	in
O	1644	1645	7
O	1645	1646	.
O	1646	1647	2
O	1647	1648	%
O	1649	1651	of
B-Anatomy	1652	1656	eyes
O	1657	1658	(
O	1658	1659	9
O	1659	1660	.
O	1660	1661	6
O	1661	1662	%
O	1663	1665	of
O	1666	1674	patients
O	1674	1675	)
O	1675	1676	.

O	1677	1679	In
O	1680	1681	a
O	1682	1687	large
O	1687	1688	,
O	1689	1695	widely
O	1696	1707	distributed
B-Disease	1708	1710	DR
O	1711	1717	ocular
O	1718	1728	telehealth
O	1729	1736	program
O	1736	1737	,
O	1738	1740	as
O	1741	1749	compared
O	1750	1754	with
B-Diagnostic_tool	1755	1759	NMFP
O	1759	1760	,
B-Diagnostic_tool	1761	1773	nonmydriatic
I-Diagnostic_tool	1774	1777	UWF
I-Diagnostic_tool	1778	1785	imaging
O	1786	1793	reduced
O	1794	1797	the
O	1798	1804	number
O	1805	1807	of
O	1808	1818	ungradable
B-Anatomy	1819	1823	eyes
O	1824	1826	by
O	1827	1829	81
O	1829	1830	%
O	1830	1831	,
O	1832	1841	increased
O	1842	1845	the
O	1846	1860	identification
O	1861	1863	of
B-Disease	1864	1866	DR
O	1867	1873	nearly
O	1874	1875	2
O	1875	1876	-
O	1876	1880	fold
O	1880	1881	,
O	1882	1885	and
O	1886	1896	identified
B-Symptom	1897	1907	peripheral
I-Symptom	1908	1915	lesions
O	1916	1926	suggesting
O	1927	1931	more
O	1932	1938	severe
B-Disease	1939	1941	DR
O	1942	1944	in
O	1945	1951	almost
O	1952	1954	10
O	1954	1955	%
O	1956	1958	of
O	1959	1967	patients
O	1967	1968	,
O	1969	1973	thus
O	1974	1987	demonstrating
O	1988	1999	significant
O	2000	2008	benefits
O	2009	2011	of
O	2012	2016	this
B-Diagnostic_tool	2017	2024	imaging
I-Diagnostic_tool	2025	2031	method
O	2032	2035	for
O	2036	2041	large
B-Disease	2042	2044	DR
O	2045	2062	teleophthalmology
O	2063	2071	programs
O	2071	2072	.

O	0	11	Prospective
O	12	17	Study
O	18	20	of
B-Characteristic	21	25	Oral
I-Characteristic	26	32	Health
O	33	36	and
O	37	41	Risk
O	42	44	of
B-Disease	45	52	Primary
I-Disease	53	57	Open
I-Disease	57	58	-
I-Disease	58	63	Angle
I-Disease	64	72	Glaucoma
O	73	75	in
B-Characteristic	76	79	Men
O	79	80	:
O	81	85	Data
O	86	90	from
O	91	94	the
O	95	101	Health
O	102	115	Professionals
O	116	122	Follow
O	122	123	-
O	123	125	up
O	126	131	Study
O	131	132	.

B-Disease	134	139	Tooth
I-Disease	140	144	loss
O	145	147	or
B-Disease	148	159	periodontal
I-Disease	160	167	disease
O	168	170	is
O	171	181	associated
O	182	186	with
B-Symptom	187	195	systemic
I-Symptom	196	207	endothelial
I-Symptom	208	219	dysfunction
O	219	220	,
O	221	226	which
O	227	230	has
O	231	235	been
O	236	246	implicated
O	247	249	in
B-Disease	250	257	primary
I-Disease	258	262	open
I-Disease	262	263	-
I-Disease	263	268	angle
I-Disease	269	277	glaucoma
O	278	279	(
B-Disease	279	283	POAG
O	283	284	)
O	284	285	.

O	286	289	The
O	290	302	relationship
O	303	310	between
B-Characteristic	311	315	oral
I-Characteristic	316	322	health
O	323	326	and
B-Disease	327	331	POAG
O	332	335	has
O	336	344	received
O	345	352	limited
O	353	362	attention
O	362	363	.

O	364	368	Thus
O	368	369	,
O	370	372	we
O	373	382	evaluated
O	383	386	the
O	387	398	association
O	399	406	between
B-Characteristic	407	411	oral
I-Characteristic	412	418	health
I-Characteristic	419	426	history
O	427	430	and
O	431	435	risk
O	436	438	of
B-Disease	439	443	POAG
O	444	447	and
B-Disease	448	452	POAG
I-Disease	453	461	subtypes
O	461	462	.

O	463	474	Prospective
O	475	481	cohort
O	482	487	study
O	487	488	.

O	489	495	Health
O	496	509	Professionals
O	510	516	Follow
O	516	517	-
O	517	519	up
O	520	525	Study
O	526	538	participants
O	539	540	(
O	540	542	40
O	543	546	536
B-Characteristic	547	550	men
O	550	551	)
O	552	560	followed
O	561	571	biennially
O	572	576	from
O	577	581	1986
O	582	584	to
O	585	589	2012
O	589	590	.

O	591	593	At
O	594	598	each
O	599	600	2
O	600	601	-
O	601	605	year
O	606	610	risk
O	611	617	period
O	617	618	,
O	619	627	eligible
O	628	640	participants
O	641	645	were
B-Characteristic	646	650	aged
I-Characteristic	651	653	40
I-Characteristic	653	654	+
I-Characteristic	655	660	years
O	660	661	,
O	662	666	were
O	667	671	free
O	672	674	of
B-Disease	675	679	POAG
O	679	680	,
O	681	684	and
O	685	693	reported
B-Anatomy	694	697	eye
O	698	710	examinations
O	710	711	.

O	712	714	By
O	715	720	using
O	721	730	validated
O	731	740	questions
O	740	741	,
O	742	744	we
O	745	752	updated
O	753	765	participants
O	765	766	'
O	767	773	status
O	774	776	on
B-Characteristic	777	783	number
I-Characteristic	784	786	of
I-Characteristic	787	794	natural
I-Characteristic	795	800	teeth
O	800	801	,
B-Characteristic	802	807	teeth
I-Characteristic	808	812	lost
O	812	813	,
B-Symptom	814	825	periodontal
I-Symptom	826	833	disease
I-Symptom	834	838	with
I-Symptom	839	843	bone
I-Symptom	844	848	loss
O	848	849	,
O	850	853	and
B-Characteristic	854	858	root
I-Characteristic	859	864	canal
I-Characteristic	865	875	treatments
O	875	876	.

O	877	883	During
O	884	890	follow
O	890	891	-
O	891	893	up
O	893	894	,
O	895	898	485
O	899	907	incident
O	908	913	cases
O	914	916	of
B-Disease	917	921	POAG
O	922	926	were
O	927	936	confirmed
O	937	941	with
O	942	949	medical
O	950	957	records
O	958	961	and
O	962	972	classified
O	973	977	into
O	978	986	subtypes
O	987	994	defined
O	995	997	by
B-Symptom	998	1009	intraocular
I-Symptom	1010	1018	pressure
O	1019	1020	(
B-Symptom	1020	1023	IOP
O	1023	1024	;
B-Dimension	1025	1026	
I-Dimension	1027	1029	or
I-Dimension	1031	1032	<
I-Dimension	1033	1035	22
I-Dimension	1036	1040	mmHg
O	1040	1041	)
O	1042	1044	or
B-Symptom	1045	1051	visual
I-Symptom	1052	1057	field
I-Symptom	1058	1059	(
I-Symptom	1059	1061	VF
I-Symptom	1061	1062	)
I-Symptom	1063	1067	loss
O	1068	1075	pattern
O	1076	1078	at
O	1079	1088	diagnosis
O	1089	1090	(
B-Symptom	1090	1100	peripheral
I-Symptom	1101	1105	loss
O	1106	1110	only
O	1111	1113	or
B-Symptom	1114	1119	early
I-Symptom	1120	1131	paracentral
I-Symptom	1132	1136	loss
O	1136	1137	)
O	1137	1138	.

O	1139	1152	Multivariable
O	1153	1161	relative
O	1162	1167	risks
O	1168	1169	(
O	1169	1174	MVRRs
O	1174	1175	)
O	1176	1179	and
O	1180	1182	95
O	1182	1183	%
O	1184	1194	confidence
O	1195	1204	intervals
O	1205	1206	(
O	1206	1209	CIs
O	1209	1210	)
O	1211	1215	were
O	1216	1225	estimated
O	1225	1226	.

B-Characteristic	1227	1233	Number
I-Characteristic	1234	1236	of
I-Characteristic	1237	1244	natural
I-Characteristic	1245	1250	teeth
O	1250	1251	,
B-Disease	1252	1263	periodontal
I-Disease	1264	1271	disease
O	1271	1272	,
O	1273	1276	and
B-Characteristic	1277	1281	root
I-Characteristic	1282	1287	canal
I-Characteristic	1288	1297	treatment
O	1298	1302	were
O	1303	1306	not
O	1307	1317	associated
O	1318	1322	with
B-Disease	1323	1327	POAG
O	1327	1328	.

O	1329	1336	However
O	1336	1337	,
O	1338	1346	compared
O	1347	1351	with
O	1352	1354	no
O	1355	1361	report
O	1362	1364	of
B-Symptom	1365	1370	tooth
I-Symptom	1371	1375	loss
O	1375	1376	,
O	1377	1378	a
O	1379	1385	report
O	1386	1388	of
B-Symptom	1389	1395	losing
I-Symptom	1396	1401	teeth
I-Symptom	1402	1408	within
I-Symptom	1409	1412	the
I-Symptom	1413	1417	past
I-Symptom	1418	1419	2
I-Symptom	1420	1425	years
O	1426	1429	was
O	1430	1440	associated
O	1441	1445	with
O	1446	1447	a
O	1448	1449	1
O	1449	1450	.
O	1450	1452	45
O	1452	1453	-
O	1453	1457	fold
O	1458	1467	increased
O	1468	1472	risk
O	1473	1475	of
B-Disease	1476	1480	POAG
O	1481	1482	(
O	1482	1484	95
O	1484	1485	%
O	1486	1488	CI
O	1488	1489	,
O	1490	1491	1
O	1491	1492	.
O	1492	1494	06
O	1494	1495	-
O	1495	1496	1
O	1496	1497	.
O	1497	1499	97
O	1499	1500	)
O	1500	1501	;
O	1502	1504	in
O	1505	1515	particular
O	1515	1516	,
O	1517	1518	a
O	1519	1525	report
O	1526	1532	within
O	1533	1536	the
O	1537	1541	past
O	1542	1543	2
O	1544	1549	years
O	1550	1552	of
O	1553	1557	both
B-Symptom	1558	1564	losing
I-Symptom	1565	1570	teeth
O	1571	1574	and
O	1575	1581	having
O	1582	1583	a
O	1584	1593	prevalent
O	1594	1603	diagnosis
O	1604	1606	of
B-Disease	1607	1618	periodontal
I-Disease	1619	1626	disease
O	1627	1630	was
O	1631	1641	associated
O	1642	1646	with
O	1647	1648	a
O	1649	1650	1
O	1650	1651	.
O	1651	1653	85
O	1653	1654	-
O	1654	1658	fold
O	1659	1668	increased
O	1669	1673	risk
O	1674	1676	of
B-Disease	1677	1681	POAG
O	1682	1683	(
O	1683	1685	95
O	1685	1686	%
O	1687	1689	CI
O	1689	1690	,
O	1691	1692	1
O	1692	1693	.
O	1693	1695	07
O	1695	1696	-
O	1696	1697	3
O	1697	1698	.
O	1698	1700	18
O	1700	1701	)
O	1701	1702	.

O	1703	1706	The
O	1707	1719	associations
O	1720	1724	with
B-Symptom	1725	1731	recent
I-Symptom	1732	1737	tooth
I-Symptom	1738	1742	loss
O	1743	1747	were
O	1748	1751	not
O	1752	1765	significantly
O	1766	1775	different
O	1776	1779	for
O	1780	1783	the
B-Disease	1784	1788	POAG
I-Disease	1789	1797	subtypes
O	1798	1799	(
O	1799	1800	P
O	1801	1804	for
O	1805	1818	heterogeneity
O	1819	1820	
O	1820	1821	0
O	1821	1822	.
O	1822	1824	36
O	1824	1825	)
O	1825	1826	,
O	1827	1835	although
O	1836	1848	associations
O	1849	1853	were
O	1854	1863	strongest
O	1864	1866	in
O	1867	1875	relation
O	1876	1878	to
O	1879	1882	the
B-Disease	1883	1887	POAG
I-Disease	1888	1896	subtypes
O	1897	1901	with
B-Symptom	1902	1905	IOP
B-Dimension	1907	1908	<
I-Dimension	1909	1911	22
I-Dimension	1912	1916	mmHg
O	1917	1918	(
O	1918	1922	MVRR
O	1922	1923	,
O	1924	1925	1
O	1925	1926	.
O	1926	1928	93
O	1928	1929	;
O	1930	1932	95
O	1932	1933	%
O	1934	1936	CI
O	1936	1937	,
O	1938	1939	1
O	1939	1940	.
O	1940	1942	09
O	1942	1943	-
O	1943	1944	3
O	1944	1945	.
O	1945	1947	43
O	1947	1948	)
O	1949	1952	and
B-Symptom	1953	1958	early
I-Symptom	1959	1970	paracentral
I-Symptom	1971	1973	VF
I-Symptom	1974	1978	loss
O	1979	1980	(
O	1980	1984	MVRR
O	1984	1985	,
O	1986	1987	2
O	1987	1988	.
O	1988	1990	27
O	1990	1991	;
O	1992	1994	95
O	1994	1995	%
O	1996	1998	CI
O	1998	1999	,
O	2000	2001	1
O	2001	2002	.
O	2002	2004	32
O	2004	2005	-
O	2005	2006	3
O	2006	2007	.
O	2007	2009	88
O	2009	2010	)
O	2010	2011	.

O	2012	2020	Although
O	2021	2024	the
B-Characteristic	2025	2031	number
I-Characteristic	2032	2034	of
I-Characteristic	2035	2042	natural
I-Characteristic	2043	2048	teeth
O	2049	2052	was
O	2053	2056	not
O	2057	2067	associated
O	2068	2072	with
O	2073	2077	risk
O	2078	2080	of
B-Disease	2081	2085	POAG
O	2085	2086	,
B-Symptom	2087	2093	recent
I-Symptom	2094	2099	tooth
I-Symptom	2100	2104	loss
O	2105	2108	was
O	2109	2119	associated
O	2120	2124	with
O	2125	2127	an
O	2128	2137	increased
O	2138	2142	risk
O	2143	2145	of
B-Disease	2146	2150	POAG
O	2150	2151	.

O	2152	2159	Because
O	2160	2165	these
O	2166	2174	findings
O	2175	2178	may
O	2179	2181	be
O	2182	2185	due
O	2186	2188	to
O	2189	2195	chance
O	2195	2196	,
O	2197	2201	they
O	2202	2206	need
O	2207	2219	confirmation
O	2220	2222	in
O	2223	2229	larger
O	2230	2237	studies
O	2237	2238	.

B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	Coherence
I-Diagnostic_tool	18	28	Tomography
I-Diagnostic_tool	29	40	Angiography
O	41	43	of
B-Disease	44	47	DME
O	48	51	and
O	52	55	Its
O	56	67	Association
O	68	72	with
O	73	77	Anti
O	77	78	-
O	78	82	VEGF
O	83	92	Treatment
O	93	101	Response
O	101	102	.

O	104	106	To
O	107	118	investigate
O	119	122	the
O	123	133	structural
O	134	143	integrity
O	144	146	of
O	147	150	the
B-Anatomy	151	162	superficial
I-Anatomy	163	172	capillary
I-Anatomy	173	181	plexuses
O	182	183	(
B-Anatomy	183	187	SCPs
O	187	188	)
O	189	192	and
B-Anatomy	193	197	deep
I-Anatomy	198	207	capillary
I-Anatomy	208	216	plexuses
O	217	218	(
B-Anatomy	218	222	DCPs
O	222	223	)
O	224	229	using
B-Diagnostic_tool	230	237	optical
I-Diagnostic_tool	238	247	coherence
I-Diagnostic_tool	248	258	tomography
I-Diagnostic_tool	259	260	(
I-Diagnostic_tool	260	263	OCT
I-Diagnostic_tool	263	264	)
I-Diagnostic_tool	265	276	angiography
O	277	278	(
B-Diagnostic_tool	278	282	OCTA
O	282	283	)
O	284	286	in
O	287	295	patients
O	296	300	with
B-Disease	301	309	diabetic
I-Disease	310	317	macular
I-Disease	318	323	edema
O	324	325	(
B-Disease	325	328	DME
O	328	329	)
O	330	333	and
O	334	337	its
O	338	349	association
O	350	354	with
O	355	358	the
O	359	367	response
O	368	370	to
O	371	375	anti
O	375	376	-
O	376	384	vascular
O	385	396	endothelial
O	397	403	growth
O	404	410	factor
O	411	412	(
O	412	416	VEGF
O	416	417	)
O	418	427	treatment
O	427	428	.

O	429	442	Retrospective
O	442	443	,
O	444	448	case
O	448	449	-
O	449	456	control
O	457	462	study
O	462	463	.

O	464	466	We
O	467	475	included
O	476	478	51
B-Disease	479	482	DME
B-Anatomy	483	487	eyes
O	488	492	with
O	493	494	a
O	495	499	poor
O	500	508	response
O	509	511	to
O	512	516	anti
O	516	517	-
O	517	521	VEGF
O	522	528	agents
O	529	532	and
O	533	535	32
B-Characteristic	536	539	age
O	539	540	-
O	540	547	matched
B-Disease	548	551	DME
B-Anatomy	552	556	eyes
O	557	561	with
O	562	563	a
O	564	568	good
O	569	577	response
O	578	580	to
O	581	585	anti
O	585	586	-
O	586	590	VEGF
O	591	600	treatment
O	600	601	,
O	602	607	along
O	608	612	with
O	613	615	20
O	616	622	fellow
B-Anatomy	623	627	eyes
O	628	635	without
B-Disease	636	639	DME
O	640	644	from
O	645	648	the
O	649	654	cases
O	655	658	and
O	659	667	controls
O	667	668	.

O	669	672	The
O	673	680	medical
O	681	688	records
O	688	689	,
O	690	699	including
B-Diagnostic_tool	700	704	OCTA
O	705	708	and
B-Diagnostic_tool	709	717	spectral
I-Diagnostic_tool	717	718	-
I-Diagnostic_tool	718	724	domain
I-Diagnostic_tool	725	728	OCT
O	729	730	(
B-Diagnostic_tool	730	732	SD
I-Diagnostic_tool	733	736	OCT
O	736	737	)
O	737	738	,
O	739	743	were
O	744	752	reviewed
O	753	756	and
O	757	765	compared
O	766	773	between
O	774	777	the
O	778	784	groups
O	784	785	.

O	786	788	En
O	789	793	face
B-Diagnostic_tool	794	798	OCTA
O	799	805	images
O	806	808	of
O	809	812	the
B-Anatomy	813	816	SCP
O	817	820	and
B-Anatomy	821	824	DCP
O	825	829	were
O	830	838	obtained
O	839	842	for
O	843	847	each
B-Anatomy	848	851	eye
O	851	852	.

O	853	855	An
O	856	860	anti
O	860	861	-
O	861	865	VEGF
O	866	875	responder
O	876	879	was
O	880	887	defined
O	888	890	by
O	891	892	a
O	893	902	reduction
O	903	905	of
O	906	910	more
O	911	915	than
O	916	918	50
O	919	920	
O	920	921	m
O	922	924	in
B-Characteristic	925	932	central
I-Characteristic	933	940	retinal
I-Characteristic	941	950	thickness
O	951	956	after
O	957	958	3
O	959	970	consecutive
O	971	975	anti
O	975	976	-
O	976	980	VEGF
O	981	991	treatments
O	991	992	.

O	993	994	A
O	995	999	poor
O	1000	1009	responder
O	1010	1013	was
O	1014	1021	defined
O	1022	1024	by
O	1025	1026	a
O	1027	1036	reduction
O	1037	1039	of
O	1040	1044	less
O	1045	1049	than
O	1050	1052	50
O	1053	1054	
O	1054	1055	m
O	1056	1058	or
O	1059	1061	an
O	1062	1070	increase
O	1071	1073	in
B-Characteristic	1074	1081	central
I-Characteristic	1082	1089	retinal
I-Characteristic	1090	1099	thickness
O	1100	1105	after
O	1106	1107	3
O	1108	1115	monthly
O	1116	1126	injections
O	1126	1127	.

O	1128	1130	We
O	1131	1139	measured
O	1140	1143	the
B-Characteristic	1144	1152	vascular
I-Characteristic	1153	1160	density
O	1161	1164	and
B-Characteristic	1165	1171	foveal
I-Characteristic	1172	1181	avascular
I-Characteristic	1182	1186	zone
I-Characteristic	1187	1188	(
I-Characteristic	1188	1191	FAZ
I-Characteristic	1191	1192	)
I-Characteristic	1193	1197	area
O	1198	1201	and
O	1202	1209	counted
O	1210	1213	the
B-Characteristic	1214	1220	number
I-Characteristic	1221	1223	of
I-Characteristic	1224	1238	microaneurysms
I-Characteristic	1239	1241	in
I-Characteristic	1242	1246	each
I-Characteristic	1247	1252	layer
O	1252	1253	.

O	1254	1257	The
B-Diagnostic_tool	1258	1260	SD
I-Diagnostic_tool	1261	1264	OCT
O	1265	1271	images
O	1272	1276	were
O	1277	1285	compared
O	1286	1290	with
B-Diagnostic_tool	1291	1295	OCTA
O	1296	1304	findings
O	1304	1305	.

O	1306	1314	Compared
O	1315	1319	with
B-Disease	1320	1323	non
I-Disease	1323	1324	-
I-Disease	1324	1327	DME
B-Anatomy	1328	1332	eyes
O	1332	1333	,
B-Disease	1334	1337	DME
B-Anatomy	1338	1342	eyes
O	1343	1346	had
O	1347	1348	a
B-Characteristic	1349	1354	lower
I-Characteristic	1355	1363	vascular
I-Characteristic	1364	1371	density
O	1372	1373	(
O	1373	1374	P
O	1376	1377	<
O	1379	1380	0
O	1380	1381	.
O	1381	1384	001
O	1384	1385	)
O	1386	1389	and
B-Characteristic	1390	1396	larger
I-Characteristic	1397	1400	FAZ
I-Characteristic	1401	1405	area
I-Characteristic	1406	1407	(
I-Characteristic	1407	1408	P
I-Characteristic	1410	1411	<
I-Characteristic	1413	1414	0
I-Characteristic	1414	1415	.
I-Characteristic	1415	1418	001
I-Characteristic	1418	1419	)
I-Characteristic	1420	1422	in
I-Characteristic	1423	1426	the
I-Characteristic	1427	1430	DCP
O	1431	1434	and
B-Symptom	1435	1439	more
I-Symptom	1440	1454	microaneurysms
O	1455	1456	(
O	1456	1457	P
O	1459	1460	<
O	1462	1463	0
O	1463	1464	.
O	1464	1467	001
O	1467	1468	)
O	1469	1471	in
O	1472	1476	both
O	1477	1483	layers
O	1483	1484	.

O	1485	1493	Although
O	1494	1499	there
O	1500	1503	was
O	1504	1506	no
O	1507	1518	significant
O	1519	1529	difference
O	1530	1532	in
O	1533	1536	the
B-Anatomy	1537	1540	SCP
O	1541	1548	between
O	1549	1553	anti
O	1553	1554	-
O	1554	1558	VEGF
O	1559	1569	responders
O	1570	1573	and
O	1574	1578	poor
O	1579	1589	responders
O	1589	1590	,
O	1591	1595	poor
O	1596	1606	responders
O	1607	1613	tended
O	1614	1616	to
O	1617	1621	show
O	1622	1629	greater
O	1630	1636	damage
O	1637	1640	and
B-Symptom	1641	1645	more
I-Symptom	1646	1660	microaneurysms
I-Symptom	1661	1663	in
I-Symptom	1664	1667	the
I-Symptom	1668	1671	DCP
O	1672	1673	(
O	1673	1674	P
O	1676	1677	<
O	1679	1680	0
O	1680	1681	.
O	1681	1684	001
O	1684	1685	)
O	1686	1689	and
O	1690	1691	a
B-Symptom	1692	1698	larger
I-Symptom	1699	1702	FAZ
I-Symptom	1703	1707	area
O	1708	1709	(
O	1709	1710	P
O	1712	1713	<
O	1715	1716	0
O	1716	1717	.
O	1717	1720	001
O	1720	1721	)
O	1721	1722	.

O	1723	1726	The
O	1727	1738	topographic
O	1739	1747	location
O	1748	1750	of
O	1751	1754	the
B-Symptom	1755	1764	disrupted
I-Symptom	1765	1773	synaptic
I-Symptom	1774	1781	portion
I-Symptom	1782	1784	of
I-Symptom	1785	1788	the
I-Symptom	1789	1794	outer
I-Symptom	1795	1804	plexiform
I-Symptom	1805	1810	layer
O	1811	1812	(
B-Anatomy	1812	1815	OPL
O	1815	1816	)
O	1817	1819	in
B-Diagnostic_tool	1820	1822	SD
I-Diagnostic_tool	1823	1826	OCT
O	1827	1834	exactly
O	1835	1847	corresponded
O	1848	1850	to
O	1851	1854	the
O	1855	1862	nonflow
O	1863	1867	area
O	1868	1870	of
O	1871	1874	the
B-Anatomy	1875	1878	DCP
O	1879	1881	in
B-Diagnostic_tool	1882	1886	OCTA
O	1886	1887	.

O	1888	1896	Compared
O	1897	1901	with
B-Disease	1902	1905	DME
B-Anatomy	1906	1910	eyes
O	1911	1915	that
O	1916	1925	responded
O	1926	1928	to
O	1929	1933	anti
O	1933	1934	-
O	1934	1938	VEGF
O	1939	1948	treatment
O	1948	1949	,
O	1950	1954	poor
O	1955	1965	responders
O	1966	1970	show
O	1971	1982	significant
O	1983	1989	damage
O	1990	1992	to
O	1993	1996	the
O	1997	2006	integrity
O	2007	2009	of
O	2010	2013	the
B-Anatomy	2014	2017	DCP
O	2017	2018	,
O	2019	2022	but
O	2023	2026	not
O	2027	2030	the
B-Anatomy	2031	2034	SCP
O	2034	2035	.

O	2036	2039	The
O	2040	2046	degree
O	2047	2049	of
B-Symptom	2050	2053	OPL
I-Symptom	2054	2064	disruption
O	2065	2067	in
B-Diagnostic_tool	2068	2070	SD
I-Diagnostic_tool	2071	2074	OCT
O	2075	2086	corresponds
O	2087	2091	well
O	2092	2096	with
O	2097	2100	the
O	2101	2107	extent
O	2108	2110	of
B-Symptom	2111	2114	DCP
I-Symptom	2115	2119	loss
O	2120	2122	in
B-Disease	2123	2126	DME
B-Anatomy	2127	2131	eyes
O	2131	2132	.

O	2133	2136	The
O	2137	2143	extent
O	2144	2146	of
B-Symptom	2147	2150	DCP
I-Symptom	2151	2155	loss
O	2156	2159	and
O	2160	2163	the
O	2164	2177	corresponding
B-Symptom	2178	2181	OPL
I-Symptom	2182	2192	disruption
O	2193	2198	could
O	2199	2201	be
O	2202	2208	useful
O	2209	2219	predictors
O	2220	2222	of
O	2223	2237	responsiveness
O	2238	2240	to
O	2241	2245	anti
O	2245	2246	-
O	2246	2250	VEGF
O	2251	2260	treatment
O	2260	2261	.

B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	Coherence
I-Diagnostic_tool	18	28	Tomography
B-Symptom	29	39	Reflective
I-Symptom	40	46	Drusen
I-Symptom	47	60	Substructures
O	61	68	Predict
O	69	80	Progression
O	81	83	to
B-Symptom	84	94	Geographic
I-Symptom	95	102	Atrophy
O	103	105	in
B-Disease	106	109	Age
I-Disease	109	110	-
I-Disease	110	117	related
I-Disease	118	125	Macular
I-Disease	126	138	Degeneration
O	138	139	.

O	141	151	Structural
O	152	155	and
O	156	169	compositional
O	170	183	heterogeneity
O	184	190	within
B-Symptom	191	197	drusen
O	198	208	comprising
O	209	215	lipids
O	215	216	,
O	217	230	carbohydrates
O	230	231	,
O	232	235	and
O	236	244	proteins
O	245	249	have
O	250	254	been
O	255	265	previously
O	266	275	described
O	275	276	.

O	277	279	We
O	280	286	sought
O	287	289	to
O	290	296	detect
O	297	300	and
O	301	307	define
O	308	318	phenotypic
O	319	327	patterns
O	328	330	of
B-Symptom	331	337	drusen
O	338	351	heterogeneity
O	352	354	in
O	355	358	the
O	359	363	form
O	364	366	of
B-Diagnostic_tool	367	374	optical
I-Diagnostic_tool	375	384	coherence
I-Diagnostic_tool	385	395	tomography
O	395	396	-
B-Symptom	396	406	reflective
I-Symptom	407	413	drusen
I-Symptom	414	427	substructures
O	428	429	(
B-Symptom	429	432	ODS
O	432	433	)
O	434	437	and
O	438	445	examine
O	446	451	their
O	452	464	associations
O	465	469	with
B-Disease	470	473	age
I-Disease	473	474	-
I-Disease	474	481	related
I-Disease	482	489	macular
I-Disease	490	502	degeneration
O	503	504	(
B-Disease	504	507	AMD
O	507	508	)
O	508	509	-
O	509	516	related
O	517	525	features
O	526	529	and
B-Disease	530	533	AMD
O	534	545	progression
O	545	546	.

O	547	560	Retrospective
O	561	569	analysis
O	570	572	in
O	573	574	a
O	575	586	prospective
O	587	592	study
O	592	593	.

O	594	602	Patients
O	603	607	with
B-Disease	608	620	intermediate
I-Disease	621	624	AMD
O	625	626	(
O	626	627	n
O	628	629	=
O	630	633	349
O	633	634	)
O	635	643	enrolled
O	644	646	in
O	647	650	the
O	651	662	multicenter
O	663	666	Age
O	666	667	-
O	667	674	Related
B-Anatomy	675	678	Eye
O	679	686	Disease
O	687	692	Study
O	693	694	2
O	695	696	(
O	696	702	AREDS2
O	702	703	)
O	704	713	ancillary
B-Diagnostic_tool	714	722	spectral
I-Diagnostic_tool	722	723	-
I-Diagnostic_tool	723	729	domain
I-Diagnostic_tool	730	737	optical
I-Diagnostic_tool	738	747	coherence
I-Diagnostic_tool	748	758	tomography
O	759	760	(
B-Diagnostic_tool	760	762	SD
I-Diagnostic_tool	763	766	OCT
O	766	767	)
O	768	773	study
O	773	774	.

O	775	783	Baseline
B-Diagnostic_tool	784	786	SD
I-Diagnostic_tool	787	790	OCT
O	791	796	scans
O	797	799	of
O	800	801	1
B-Anatomy	802	805	eye
O	806	809	per
O	810	817	patient
O	818	822	were
O	823	831	analyzed
O	832	835	for
O	836	839	the
O	840	848	presence
O	849	851	of
B-Symptom	852	855	ODS
O	855	856	.

O	857	862	Cross
O	862	863	-
O	863	872	sectional
O	873	876	and
O	877	889	longitudinal
O	890	902	associations
O	903	905	of
B-Symptom	906	909	ODS
O	910	918	presence
O	919	923	with
B-Disease	924	927	AMD
O	927	928	-
O	928	935	related
O	936	944	features
O	945	952	visible
O	953	955	on
B-Diagnostic_tool	956	958	SD
I-Diagnostic_tool	959	962	OCT
O	963	966	and
B-Diagnostic_tool	967	972	color
I-Diagnostic_tool	973	984	photographs
O	984	985	,
O	986	995	including
B-Characteristic	996	1002	drusen
I-Characteristic	1003	1009	volume
O	1009	1010	,
B-Symptom	1011	1021	geographic
I-Symptom	1022	1029	atrophy
O	1030	1031	(
B-Symptom	1031	1033	GA
O	1033	1034	)
O	1034	1035	,
O	1036	1039	and
B-Characteristic	1040	1051	preatrophic
I-Characteristic	1052	1060	features
O	1060	1061	,
O	1062	1066	were
O	1067	1076	evaluated
O	1077	1080	for
O	1081	1084	the
O	1085	1091	entire
B-Anatomy	1092	1099	macular
O	1100	1106	region
O	1106	1107	.

O	1108	1115	Similar
O	1116	1128	associations
O	1129	1133	were
O	1134	1138	also
O	1139	1143	made
O	1144	1151	locally
O	1152	1158	within
O	1159	1160	a
O	1161	1162	0
O	1162	1163	.
O	1163	1164	5
O	1164	1165	-
O	1165	1167	mm
O	1167	1168	-
O	1168	1176	diameter
O	1177	1183	region
O	1184	1190	around
O	1191	1201	individual
B-Symptom	1202	1205	ODS
O	1206	1209	and
O	1210	1223	corresponding
O	1224	1231	control
O	1232	1238	region
O	1239	1246	without
B-Symptom	1247	1250	ODS
O	1251	1253	in
O	1254	1257	the
O	1258	1262	same
B-Anatomy	1263	1266	eye
O	1266	1267	.

B-Symptom	1268	1278	Preatrophy
I-Symptom	1279	1281	SD
I-Symptom	1282	1285	OCT
I-Symptom	1286	1293	changes
O	1294	1297	and
B-Symptom	1298	1300	GA
O	1300	1301	,
B-Symptom	1302	1309	central
I-Symptom	1310	1312	GA
O	1312	1313	,
O	1314	1317	and
B-Symptom	1318	1327	choroidal
I-Symptom	1328	1346	neovascularization
O	1347	1348	(
B-Symptom	1348	1351	CNV
O	1351	1352	)
O	1353	1357	from
B-Diagnostic_tool	1358	1363	color
I-Diagnostic_tool	1364	1375	photographs
O	1375	1376	.

O	1377	1381	Four
O	1382	1392	phenotypic
O	1393	1401	subtypes
O	1402	1404	of
B-Symptom	1405	1408	ODS
O	1409	1413	were
O	1414	1421	defined
O	1421	1422	:
B-Symptom	1423	1426	low
I-Symptom	1427	1437	reflective
I-Symptom	1438	1443	cores
O	1443	1444	,
B-Symptom	1445	1449	high
I-Symptom	1450	1460	reflective
I-Symptom	1461	1466	cores
O	1466	1467	,
B-Symptom	1468	1475	conical
I-Symptom	1476	1482	debris
O	1482	1483	,
O	1484	1487	and
B-Symptom	1488	1493	split
I-Symptom	1494	1500	drusen
O	1500	1501	.

O	1502	1507	Among
O	1508	1511	the
O	1512	1515	349
O	1516	1528	participants
O	1528	1529	,
O	1530	1535	there
O	1536	1540	were
O	1541	1544	307
O	1545	1553	eligible
B-Anatomy	1554	1558	eyes
O	1559	1562	and
O	1563	1565	74
O	1566	1567	(
O	1567	1569	24
O	1569	1570	%
O	1570	1571	)
O	1572	1575	had
O	1576	1578	at
O	1579	1584	least
O	1585	1586	1
B-Symptom	1587	1590	ODS
O	1590	1591	.

O	1592	1595	The
B-Symptom	1596	1599	ODS
O	1600	1602	at
O	1603	1611	baseline
O	1612	1616	were
O	1617	1627	associated
O	1628	1632	with
O	1633	1634	(
O	1634	1635	1
O	1635	1636	)
O	1637	1644	greater
B-Symptom	1645	1652	macular
I-Symptom	1653	1659	drusen
O	1660	1666	volume
O	1667	1669	at
O	1670	1678	baseline
O	1679	1680	(
O	1680	1681	P
O	1683	1684	<
O	1686	1687	0
O	1687	1688	.
O	1688	1691	001
O	1691	1692	)
O	1692	1693	,
O	1694	1695	(
O	1695	1696	2
O	1696	1697	)
O	1698	1709	development
O	1710	1712	of
B-Symptom	1713	1724	preatrophic
I-Symptom	1725	1732	changes
O	1733	1735	at
O	1736	1740	year
O	1741	1742	2
O	1743	1744	(
O	1744	1745	P
O	1746	1747	=
O	1748	1749	0
O	1749	1750	.
O	1750	1753	001
O	1753	1754	-
O	1754	1755	0
O	1755	1756	.
O	1756	1758	01
O	1758	1759	)
O	1759	1760	,
O	1761	1764	and
O	1765	1766	(
O	1766	1767	3
O	1767	1768	)
O	1769	1780	development
O	1781	1783	of
B-Symptom	1784	1791	macular
I-Symptom	1792	1794	GA
O	1795	1796	(
O	1796	1797	P
O	1798	1799	=
O	1800	1801	0
O	1801	1802	.
O	1802	1805	005
O	1805	1806	)
O	1807	1810	and
B-Symptom	1811	1822	preatrophic
I-Symptom	1823	1830	changes
O	1831	1833	at
O	1834	1838	year
O	1839	1840	3
O	1841	1842	(
O	1842	1843	P
O	1844	1845	=
O	1846	1847	0
O	1847	1848	.
O	1848	1851	002
O	1851	1852	-
O	1852	1853	0
O	1853	1854	.
O	1854	1857	008
O	1857	1858	)
O	1858	1859	,
O	1860	1863	but
O	1864	1867	not
O	1868	1879	development
O	1880	1882	of
B-Symptom	1883	1886	CNV
O	1886	1887	.

O	1888	1891	The
B-Symptom	1892	1895	ODS
O	1896	1898	at
O	1899	1907	baseline
O	1908	1910	in
O	1911	1912	a
O	1913	1918	local
O	1919	1925	region
O	1926	1930	were
O	1931	1941	associated
O	1942	1946	with
O	1947	1948	(
O	1948	1949	1
O	1949	1950	)
O	1951	1959	presence
O	1960	1962	of
B-Symptom	1963	1973	preatrophy
I-Symptom	1974	1981	changes
O	1982	1984	at
O	1985	1993	baseline
O	1994	1995	(
O	1995	1996	P
O	1997	1998	=
O	1999	2000	0
O	2000	2001	.
O	2001	2003	02
O	2003	2004	-
O	2004	2005	0
O	2005	2006	.
O	2006	2008	03
O	2008	2009	)
O	2010	2013	and
O	2014	2015	(
O	2015	2016	2
O	2016	2017	)
O	2018	2029	development
O	2030	2032	of
B-Symptom	2033	2043	preatrophy
I-Symptom	2044	2051	changes
O	2052	2054	at
O	2055	2060	years
O	2061	2062	2
O	2063	2066	and
O	2067	2068	3
O	2069	2075	within
O	2076	2079	the
O	2080	2086	region
O	2087	2088	(
O	2088	2089	P
O	2090	2091	=
O	2092	2093	0
O	2093	2094	.
O	2094	2097	008
O	2097	2098	-
O	2098	2099	0
O	2099	2100	.
O	2100	2102	05
O	2102	2103	)
O	2103	2104	.

B-Diagnostic_tool	2105	2112	Optical
I-Diagnostic_tool	2113	2122	coherence
I-Diagnostic_tool	2123	2133	tomography
O	2133	2134	-
B-Symptom	2134	2144	reflective
I-Symptom	2145	2151	drusen
I-Symptom	2152	2165	substructures
O	2166	2169	are
B-Diagnostic_tool	2170	2177	optical
I-Diagnostic_tool	2178	2187	coherence
I-Diagnostic_tool	2188	2198	tomography
O	2198	2199	-
O	2199	2204	based
O	2205	2215	biomarkers
O	2216	2218	of
O	2219	2230	progression
O	2231	2233	to
B-Symptom	2234	2236	GA
O	2236	2237	,
O	2238	2241	but
O	2242	2245	not
O	2246	2248	to
B-Symptom	2249	2252	CNV
O	2252	2253	,
O	2254	2256	in
B-Anatomy	2257	2261	eyes
O	2262	2266	with
B-Disease	2267	2279	intermediate
I-Disease	2280	2283	AMD
O	2283	2284	.

B-Diagnostic_tool	2285	2292	Optical
I-Diagnostic_tool	2293	2302	coherence
I-Diagnostic_tool	2303	2313	tomography
O	2313	2314	-
B-Symptom	2314	2324	reflective
I-Symptom	2325	2331	drusen
I-Symptom	2332	2345	substructures
O	2346	2349	may
O	2350	2352	be
O	2353	2354	a
O	2355	2363	clinical
O	2364	2370	entity
O	2371	2378	helpful
O	2379	2381	in
O	2382	2392	monitoring
B-Disease	2393	2396	AMD
O	2397	2408	progression
O	2409	2412	and
O	2413	2422	informing
O	2423	2433	mechanisms
O	2434	2436	in
B-Symptom	2437	2439	GA
O	2440	2452	pathogenesis
O	2452	2453	.

O	0	4	Long
O	4	5	-
O	5	9	term
O	10	17	Effects
O	18	20	of
O	21	33	Intravitreal
O	34	35	0
O	35	36	.
O	36	38	19
O	39	41	mg
O	42	54	Fluocinolone
O	55	64	Acetonide
O	65	72	Implant
O	73	75	on
O	76	87	Progression
O	88	91	and
O	92	102	Regression
O	103	105	of
B-Disease	106	114	Diabetic
I-Disease	115	126	Retinopathy
O	126	127	.

O	129	131	To
O	132	143	investigate
O	144	147	the
O	148	155	effects
O	156	158	of
O	159	171	fluocinolone
O	172	181	acetonide
O	182	183	(
O	183	186	FAc
O	186	187	)
O	188	190	on
O	191	194	the
O	195	206	progression
O	207	209	to
B-Disease	210	223	proliferative
I-Disease	224	232	diabetic
I-Disease	233	244	retinopathy
O	245	246	(
B-Disease	246	249	PDR
O	249	250	)
O	251	254	and
O	255	258	the
O	259	265	impact
O	266	268	of
O	269	272	FAc
O	273	275	on
O	276	283	changes
O	284	286	in
O	287	292	Early
O	293	302	Treatment
B-Disease	303	311	Diabetic
I-Disease	312	323	Retinopathy
O	324	329	Study
O	330	331	(
O	331	336	ETDRS
O	336	337	)
B-Classification_system	338	346	diabetic
I-Classification_system	347	358	retinopathy
I-Classification_system	359	360	(
I-Classification_system	360	362	DR
I-Classification_system	362	363	)
I-Classification_system	364	372	severity
I-Classification_system	373	378	scale
O	379	380	(
B-Classification_system	380	384	DRSS
O	384	385	)
O	386	391	grade
O	392	398	during
O	399	402	the
O	403	415	Fluocinolone
O	416	425	Acetonide
O	426	428	in
B-Disease	429	437	Diabetic
I-Disease	438	445	Macular
I-Disease	446	451	Edema
O	452	453	(
O	453	457	FAME
O	457	458	)
O	459	460	A
O	461	464	and
O	465	466	B
O	467	472	Phase
O	473	476	III
O	477	485	clinical
O	486	492	trials
O	492	493	.

O	494	498	Post
O	499	502	hoc
O	503	511	analysis
O	512	514	of
O	515	519	data
O	520	524	from
O	525	528	the
O	529	531	36
O	531	532	-
O	532	537	month
O	538	549	prospective
O	549	550	,
O	551	561	randomized
O	561	562	,
O	563	567	FAME
O	568	569	A
O	570	573	and
O	574	575	B
O	576	582	trials
O	582	583	.

O	584	592	Patients
O	593	597	with
B-Disease	598	606	diabetic
I-Disease	607	614	macular
I-Disease	615	620	edema
O	621	622	(
B-Disease	622	625	DME
O	625	626	)
O	627	630	who
O	631	639	received
O	640	644	sham
O	645	652	control
O	653	655	or
O	656	659	FAc
O	660	661	0
O	661	662	.
O	662	663	2
O	664	666	or
O	667	668	0
O	668	669	.
O	669	670	5
O	671	672	
O	672	673	g
O	673	674	/
O	674	677	day
O	677	678	.

O	679	680	A
O	681	687	masked
O	688	695	reading
O	696	702	center
O	703	704	(
O	704	714	University
O	715	717	of
O	718	727	Wisconsin
O	727	728	-
O	728	735	Madison
O	735	736	)
O	737	747	determined
B-Classification_system	748	752	DRSS
O	753	758	grade
O	759	762	and
B-Characteristic	763	770	retinal
I-Characteristic	771	780	perfusion
O	781	787	status
O	788	793	using
O	794	802	standard
B-Diagnostic_tool	803	804	7
I-Diagnostic_tool	804	805	-
I-Diagnostic_tool	805	810	field
I-Diagnostic_tool	811	817	stereo
I-Diagnostic_tool	818	824	fundus
I-Diagnostic_tool	825	836	photography
O	837	840	and
B-Diagnostic_tool	841	852	fluorescein
I-Diagnostic_tool	853	864	angiography
O	864	865	,
O	866	878	respectively
O	878	879	.

B-Disease	880	891	Retinopathy
O	892	899	changes
O	900	904	over
O	905	909	time
O	910	914	were
O	915	925	determined
O	926	928	by
B-Classification_system	929	933	DRSS
O	934	938	step
O	939	950	differences
O	951	955	from
O	956	964	baseline
O	965	967	to
O	968	973	month
O	974	976	36
O	976	977	.

O	978	986	Pairwise
O	987	998	comparisons
O	999	1006	between
O	1007	1010	the
O	1011	1012	3
O	1013	1022	treatment
O	1023	1029	groups
O	1030	1034	were
O	1035	1044	performed
O	1045	1050	using
O	1051	1052	a
O	1053	1056	log
O	1056	1057	-
O	1057	1061	rank
O	1062	1066	test
O	1067	1074	without
O	1075	1085	adjustment
O	1086	1089	for
O	1090	1100	covariates
O	1100	1101	,
O	1102	1106	with
O	1107	1110	the
O	1111	1118	primary
O	1119	1129	comparison
O	1130	1137	between
O	1138	1142	sham
O	1143	1150	control
O	1151	1154	and
O	1155	1156	0
O	1156	1157	.
O	1157	1158	2
O	1159	1160	
O	1160	1161	g
O	1161	1162	/
O	1162	1165	day
O	1166	1169	FAc
O	1169	1170	.

O	1171	1176	Study
B-Anatomy	1177	1180	eye
O	1181	1192	progression
O	1193	1195	to
B-Disease	1196	1199	PDR
O	1200	1205	based
O	1206	1208	on
O	1209	1210	a
O	1211	1220	composite
O	1221	1229	clinical
O	1230	1237	outcome
O	1238	1240	of
O	1241	1242	(
O	1242	1243	1
O	1243	1244	)
O	1245	1256	progression
O	1257	1261	from
B-Disease	1262	1278	nonproliferative
I-Disease	1279	1287	diabetic
I-Disease	1288	1299	retinopathy
O	1300	1301	(
B-Disease	1301	1305	NPDR
O	1305	1306	)
O	1307	1309	to
B-Disease	1310	1313	PDR
O	1314	1319	based
O	1320	1322	on
O	1323	1329	graded
B-Diagnostic_tool	1330	1336	fundus
I-Diagnostic_tool	1337	1348	photographs
O	1348	1349	,
O	1350	1351	(
O	1351	1352	2
O	1352	1353	)
B-Diagnostic_tool	1354	1364	panretinal
I-Diagnostic_tool	1365	1381	photocoagulation
O	1382	1383	(
B-Diagnostic_tool	1383	1386	PRP
O	1386	1387	)
O	1387	1388	,
O	1389	1391	or
O	1392	1393	(
O	1393	1394	3
O	1394	1395	)
B-Diagnostic_tool	1396	1400	pars
I-Diagnostic_tool	1401	1406	plana
I-Diagnostic_tool	1407	1417	vitrectomy
O	1418	1419	(
B-Diagnostic_tool	1419	1422	PPV
O	1422	1423	)
O	1424	1427	for
B-Disease	1428	1431	PDR
O	1431	1432	;
O	1433	1436	and
O	1437	1442	study
B-Anatomy	1443	1446	eye
O	1447	1454	changes
O	1455	1457	on
O	1458	1461	the
B-Classification_system	1462	1466	DRSS
O	1466	1467	.

O	1468	1470	In
O	1471	1474	the
O	1475	1485	integrated
O	1486	1490	FAME
O	1491	1495	data
O	1496	1499	set
O	1499	1500	,
O	1501	1509	compared
O	1510	1514	with
O	1515	1519	sham
O	1520	1527	control
O	1527	1528	-
O	1528	1535	treated
O	1536	1544	subjects
O	1544	1545	,
O	1546	1550	time
O	1551	1553	to
O	1554	1559	first
B-Disease	1560	1563	PDR
O	1564	1569	event
O	1570	1573	was
O	1574	1587	significantly
O	1588	1595	delayed
O	1596	1598	in
O	1599	1607	subjects
O	1608	1615	treated
O	1616	1620	with
O	1621	1624	FAc
O	1625	1626	(
O	1626	1627	P
O	1629	1630	<
O	1632	1633	0
O	1633	1634	.
O	1634	1637	001
O	1637	1638	)
O	1638	1639	,
O	1640	1643	and
O	1644	1648	this
O	1649	1655	effect
O	1656	1659	was
O	1660	1669	confirmed
O	1670	1672	in
O	1673	1682	subgroups
O	1683	1687	with
O	1688	1692	more
O	1693	1699	severe
B-Disease	1700	1702	DR
O	1703	1706	and
B-Disease	1707	1714	chronic
I-Disease	1715	1718	DME
O	1719	1721	at
O	1722	1730	baseline
O	1730	1731	.

O	1732	1734	In
O	1735	1743	addition
O	1743	1744	,
O	1745	1753	subjects
O	1754	1758	with
B-Symptom	1759	1766	retinal
I-Symptom	1767	1779	nonperfusion
O	1780	1782	at
O	1783	1791	baseline
O	1792	1798	showed
O	1799	1806	greater
O	1807	1816	reduction
O	1817	1819	in
O	1820	1831	progression
O	1832	1834	to
B-Disease	1835	1838	PDR
O	1839	1843	with
O	1844	1847	FAc
O	1848	1857	treatment
O	1857	1858	.

O	1859	1863	Both
O	1864	1867	FAc
O	1868	1875	dosages
O	1876	1888	demonstrated
O	1889	1902	statistically
O	1903	1914	significant
O	1915	1927	improvements
O	1928	1930	in
O	1931	1935	mean
B-Disease	1936	1938	DR
O	1939	1947	severity
O	1948	1956	compared
O	1957	1961	with
O	1962	1966	sham
O	1967	1976	treatment
O	1977	1979	at
O	1980	1986	months
O	1987	1988	6
O	1988	1989	,
O	1990	1992	12
O	1992	1993	,
O	1994	1997	and
O	1998	2000	18
O	2000	2001	.

O	2002	2013	Numerically
O	2014	2018	more
O	2019	2027	subjects
O	2028	2031	who
O	2032	2040	received
O	2041	2044	FAc
O	2045	2056	experienced
O	2057	2058	2
O	2058	2059	-
O	2059	2061	or
O	2061	2062	-
O	2062	2066	more
O	2066	2067	-
O	2068	2070	or
O	2071	2072	3
O	2072	2073	-
O	2073	2075	or
O	2075	2076	-
O	2076	2080	more
O	2080	2081	-
O	2081	2085	step
O	2086	2098	improvements
O	2099	2101	in
B-Disease	2102	2104	DR
O	2105	2113	severity
O	2114	2122	compared
O	2123	2127	with
O	2128	2136	subjects
O	2137	2140	who
O	2141	2149	received
O	2150	2154	sham
O	2154	2155	;
O	2156	2166	conversely
O	2166	2167	,
O	2168	2173	fewer
O	2174	2182	subjects
O	2183	2190	treated
O	2191	2195	with
O	2196	2199	FAc
O	2200	2211	experienced
O	2212	2213	2
O	2213	2214	-
O	2214	2216	or
O	2216	2217	-
O	2217	2221	more
O	2221	2222	-
O	2223	2225	or
O	2226	2227	3
O	2227	2228	-
O	2228	2230	or
O	2230	2231	-
O	2231	2235	more
O	2235	2236	-
O	2236	2240	step
O	2241	2250	worsening
O	2251	2253	in
B-Disease	2254	2256	DR
O	2257	2265	severity
O	2265	2266	.

O	2267	2270	The
O	2271	2272	3
O	2272	2273	-
O	2273	2275	or
O	2275	2276	-
O	2276	2280	more
O	2280	2281	-
O	2281	2285	step
O	2286	2297	improvement
O	2298	2302	with
O	2303	2304	0
O	2304	2305	.
O	2305	2306	5
O	2307	2308	
O	2308	2309	g
O	2309	2310	/
O	2310	2313	day
O	2314	2317	FAc
O	2318	2321	was
O	2322	2335	statistically
O	2336	2349	significantly
O	2350	2359	different
O	2360	2364	from
O	2365	2369	sham
O	2370	2377	control
O	2377	2378	.

O	2379	2381	In
O	2382	2390	subjects
O	2391	2395	with
B-Disease	2396	2399	DME
O	2399	2400	,
O	2401	2410	sustained
O	2411	2422	intraocular
O	2423	2431	delivery
O	2432	2434	of
O	2435	2438	FAc
O	2439	2444	slows
O	2445	2456	development
O	2457	2459	of
B-Disease	2460	2463	PDR
O	2464	2467	and
O	2468	2473	slows
O	2474	2485	progression
O	2486	2488	of
B-Disease	2489	2497	diabetic
I-Disease	2498	2509	retinopathy
O	2509	2510	.

O	0	7	Imaging
O	8	17	Protocols
O	18	20	in
O	21	29	Clinical
O	30	37	Studies
O	38	40	in
B-Disease	41	49	Advanced
I-Disease	50	53	Age
I-Disease	53	54	-
I-Disease	54	61	Related
I-Disease	62	69	Macular
I-Disease	70	82	Degeneration
O	82	83	:
O	84	99	Recommendations
O	100	104	from
O	105	119	Classification
O	120	122	of
B-Symptom	123	130	Atrophy
O	131	140	Consensus
O	141	149	Meetings
O	149	150	.

O	152	154	To
O	155	164	summarize
O	165	168	the
O	169	176	results
O	177	179	of
O	180	181	2
O	182	191	consensus
O	192	200	meetings
O	201	202	(
O	202	216	Classification
O	217	219	of
B-Symptom	220	227	Atrophy
O	228	235	Meeting
O	236	237	[
O	237	240	CAM
O	240	241	]
O	241	242	)
O	243	245	on
O	246	258	conventional
O	259	262	and
O	263	271	advanced
O	272	279	imaging
O	280	290	modalities
O	291	295	used
O	296	298	to
O	299	305	detect
O	306	309	and
O	310	318	quantify
B-Symptom	319	326	atrophy
O	327	330	due
O	331	333	to
B-Disease	334	338	late
I-Disease	338	339	-
I-Disease	339	344	stage
I-Disease	345	348	non
I-Disease	348	349	-
I-Disease	349	360	neovascular
I-Disease	361	364	and
I-Disease	365	376	neovascular
I-Disease	377	380	age
I-Disease	380	381	-
I-Disease	381	388	related
I-Disease	389	396	macular
I-Disease	397	409	degeneration
O	410	411	(
B-Disease	411	414	AMD
O	414	415	)
O	416	419	and
O	420	422	to
O	423	430	provide
O	431	446	recommendations
O	447	449	on
O	450	453	the
O	454	457	use
O	458	460	of
O	461	466	these
O	467	477	modalities
O	478	480	in
O	481	488	natural
O	489	496	history
O	497	504	studies
O	505	508	and
O	509	523	interventional
O	524	532	clinical
O	533	539	trials
O	539	540	.

O	541	551	Systematic
O	552	558	debate
O	559	561	on
O	562	565	the
O	566	575	relevance
O	576	578	of
O	579	587	distinct
O	588	595	imaging
O	596	606	modalities
O	607	611	held
O	612	614	in
O	615	616	2
O	617	626	consensus
O	627	635	meetings
O	635	636	.

O	637	638	A
O	639	644	panel
O	645	647	of
B-Anatomy	648	654	retina
O	655	666	specialists
O	666	667	.

O	668	674	During
O	675	678	the
O	679	682	CAM
O	682	683	,
O	684	685	a
O	686	696	consortium
O	697	699	of
O	700	713	international
O	714	721	experts
O	722	731	evaluated
O	732	735	the
O	736	746	advantages
O	747	750	and
O	751	764	disadvantages
O	765	767	of
O	768	775	various
O	776	783	imaging
O	784	794	modalities
O	795	797	on
O	798	801	the
O	802	807	basis
O	808	810	of
O	811	814	the
O	815	825	collective
O	826	834	analysis
O	835	837	of
O	838	839	a
O	840	845	large
O	846	852	series
O	853	855	of
O	856	864	clinical
O	865	870	cases
O	870	871	.

O	872	873	A
O	874	884	systematic
O	885	895	discussion
O	896	898	on
O	899	902	the
O	903	907	role
O	908	910	of
O	911	915	each
O	916	924	modality
O	925	927	in
O	928	934	future
O	935	942	studies
O	943	945	in
B-Disease	946	949	non
I-Disease	949	950	-
I-Disease	950	961	neovascular
I-Disease	962	965	and
I-Disease	966	977	neovascular
I-Disease	978	981	AMD
O	982	985	was
O	986	990	held
O	990	991	.

O	992	1002	Advantages
O	1003	1006	and
O	1007	1020	disadvantages
O	1021	1023	of
O	1024	1031	current
B-Diagnostic_tool	1032	1039	retinal
I-Diagnostic_tool	1040	1047	imaging
I-Diagnostic_tool	1048	1060	technologies
O	1061	1064	and
O	1065	1080	recommendations
O	1081	1084	for
O	1085	1090	their
O	1091	1094	use
O	1095	1097	in
B-Disease	1098	1106	advanced
I-Disease	1107	1110	AMD
O	1111	1117	trials
O	1117	1118	.

O	1119	1126	Imaging
O	1127	1136	protocols
O	1137	1139	to
O	1140	1146	detect
O	1146	1147	,
O	1148	1156	quantify
O	1156	1157	,
O	1158	1161	and
O	1162	1169	monitor
O	1170	1181	progression
O	1182	1184	of
B-Symptom	1185	1192	atrophy
O	1193	1199	should
O	1200	1207	include
B-Diagnostic_tool	1208	1213	color
I-Diagnostic_tool	1214	1220	fundus
I-Diagnostic_tool	1221	1232	photography
O	1233	1234	(
B-Diagnostic_tool	1234	1237	CFP
O	1237	1238	)
O	1238	1239	,
B-Diagnostic_tool	1240	1248	confocal
I-Diagnostic_tool	1249	1255	fundus
I-Diagnostic_tool	1256	1272	autofluorescence
O	1273	1274	(
B-Diagnostic_tool	1274	1277	FAF
O	1277	1278	)
O	1278	1279	,
B-Diagnostic_tool	1280	1288	confocal
I-Diagnostic_tool	1289	1293	near
I-Diagnostic_tool	1293	1294	-
I-Diagnostic_tool	1294	1302	infrared
I-Diagnostic_tool	1303	1314	reflectance
O	1315	1316	(
B-Diagnostic_tool	1316	1319	NIR
O	1319	1320	)
O	1320	1321	,
O	1322	1325	and
B-Diagnostic_tool	1326	1330	high
I-Diagnostic_tool	1330	1331	-
I-Diagnostic_tool	1331	1341	resolution
I-Diagnostic_tool	1342	1349	optical
I-Diagnostic_tool	1350	1359	coherence
I-Diagnostic_tool	1360	1370	tomography
I-Diagnostic_tool	1371	1377	volume
I-Diagnostic_tool	1378	1383	scans
O	1383	1384	.

O	1385	1390	These
O	1391	1397	images
O	1398	1404	should
O	1405	1407	be
O	1408	1416	acquired
O	1417	1419	at
O	1420	1427	regular
O	1428	1437	intervals
O	1438	1448	throughout
O	1449	1452	the
O	1453	1458	study
O	1458	1459	.

O	1460	1462	In
O	1463	1470	studies
O	1471	1473	of
B-Disease	1474	1477	non
I-Disease	1477	1478	-
I-Disease	1478	1489	neovascular
I-Disease	1490	1493	AMD
O	1494	1495	(
O	1495	1502	without
O	1503	1510	evident
O	1511	1516	signs
O	1517	1519	of
B-Symptom	1520	1526	active
I-Symptom	1527	1529	or
I-Symptom	1530	1539	regressed
I-Symptom	1540	1558	neovascularization
O	1559	1560	[
B-Symptom	1560	1562	NV
O	1562	1563	]
O	1564	1566	at
O	1567	1575	baseline
O	1575	1576	)
O	1576	1577	,
B-Diagnostic_tool	1578	1581	CFP
O	1582	1585	may
O	1586	1588	be
O	1589	1599	sufficient
O	1600	1602	at
O	1603	1611	baseline
O	1612	1615	and
O	1616	1619	end
O	1619	1620	-
O	1620	1622	of
O	1622	1623	-
O	1623	1628	study
O	1629	1634	visit
O	1634	1635	.

B-Diagnostic_tool	1636	1647	Fluorescein
I-Diagnostic_tool	1648	1659	angiography
O	1660	1661	(
B-Diagnostic_tool	1661	1663	FA
O	1663	1664	)
O	1665	1668	may
O	1669	1675	become
O	1676	1685	necessary
O	1686	1688	to
O	1689	1697	evaluate
O	1698	1701	for
B-Symptom	1702	1704	NV
O	1705	1707	at
O	1708	1711	any
O	1712	1717	visit
O	1718	1724	during
O	1725	1728	the
O	1729	1734	study
O	1734	1735	.

B-Diagnostic_tool	1736	1747	Indocyanine
I-Diagnostic_tool	1747	1748	-
I-Diagnostic_tool	1748	1753	green
I-Diagnostic_tool	1754	1765	angiography
O	1766	1767	(
B-Diagnostic_tool	1767	1770	ICG
I-Diagnostic_tool	1770	1771	-
I-Diagnostic_tool	1771	1772	A
O	1772	1773	)
O	1774	1777	may
O	1778	1780	be
O	1781	1791	considered
O	1792	1794	at
O	1795	1803	baseline
O	1804	1809	under
O	1810	1817	certain
O	1818	1828	conditions
O	1828	1829	.

O	1830	1833	For
O	1834	1841	studies
O	1842	1844	in
O	1845	1853	patients
O	1854	1858	with
B-Disease	1859	1870	neovascular
I-Disease	1871	1874	AMD
O	1874	1875	,
O	1876	1885	increased
O	1886	1890	need
O	1891	1894	for
O	1895	1908	visualization
O	1909	1911	of
O	1912	1915	the
B-Anatomy	1916	1927	vasculature
O	1928	1932	must
O	1933	1935	be
O	1936	1941	taken
O	1942	1946	into
O	1947	1954	account
O	1954	1955	.

O	1956	1967	Accordingly
O	1967	1968	,
O	1969	1974	these
O	1975	1982	studies
O	1983	1989	should
O	1990	1997	include
B-Diagnostic_tool	1998	2000	FA
O	2001	2002	(
O	2002	2013	recommended
O	2014	2016	at
O	2017	2025	baseline
O	2026	2029	and
O	2030	2038	selected
O	2039	2045	follow
O	2045	2046	-
O	2046	2048	up
O	2049	2055	visits
O	2055	2056	)
O	2057	2060	and
B-Diagnostic_tool	2061	2064	ICG
I-Diagnostic_tool	2064	2065	-
I-Diagnostic_tool	2065	2066	A
O	2067	2072	under
O	2073	2080	certain
O	2081	2091	conditions
O	2091	2092	.

O	2093	2094	A
O	2095	2105	multimodal
O	2106	2113	imaging
O	2114	2122	approach
O	2123	2125	is
O	2126	2137	recommended
O	2138	2140	in
O	2141	2149	clinical
O	2150	2157	studies
O	2158	2161	for
O	2162	2165	the
O	2166	2173	optimal
O	2174	2183	detection
O	2184	2187	and
O	2188	2199	measurement
O	2200	2202	of
B-Symptom	2203	2210	atrophy
O	2211	2214	and
O	2215	2218	its
O	2219	2229	associated
O	2230	2238	features
O	2238	2239	.

O	2240	2248	Specific
O	2249	2259	validation
O	2260	2267	studies
O	2268	2272	will
O	2273	2275	be
O	2276	2285	necessary
O	2286	2288	to
O	2289	2298	determine
O	2299	2302	the
O	2303	2307	best
O	2308	2319	combination
O	2320	2322	of
O	2323	2330	imaging
O	2331	2341	modalities
O	2341	2342	,
O	2343	2346	and
O	2347	2352	these
O	2353	2368	recommendations
O	2369	2373	will
O	2374	2378	need
O	2379	2381	to
O	2382	2384	be
O	2385	2392	updated
O	2393	2395	as
O	2396	2399	new
O	2400	2407	imaging
O	2408	2420	technologies
O	2421	2427	become
O	2428	2437	available
O	2438	2440	in
O	2441	2444	the
O	2445	2451	future
O	2451	2452	.

O	0	9	Frequency
O	10	12	of
O	13	20	Testing
O	21	23	to
O	24	30	Detect
B-Characteristic	31	37	Visual
I-Characteristic	38	43	Field
I-Characteristic	44	55	Progression
O	56	63	Derived
O	64	69	Using
O	70	71	a
O	72	84	Longitudinal
O	85	91	Cohort
O	92	94	of
B-Disease	95	103	Glaucoma
O	104	112	Patients
O	112	113	.

O	115	117	To
O	118	127	determine
O	128	131	the
O	132	136	time
O	137	145	required
O	146	148	to
O	149	155	detect
O	156	169	statistically
O	170	181	significant
O	182	193	progression
O	194	197	for
O	198	207	different
O	208	213	rates
O	214	216	of
B-Symptom	217	223	visual
I-Symptom	224	229	field
I-Symptom	230	234	loss
O	235	240	using
B-Diagnostic_tool	241	249	standard
I-Diagnostic_tool	250	259	automated
I-Diagnostic_tool	260	269	perimetry
O	270	271	(
B-Diagnostic_tool	271	274	SAP
O	274	275	)
O	276	280	when
O	281	292	considering
O	293	302	different
O	303	314	frequencies
O	315	317	of
O	318	325	testing
O	326	331	using
O	332	333	a
O	334	340	follow
O	340	341	-
O	341	343	up
O	344	350	scheme
O	351	355	that
O	356	365	resembles
O	366	374	clinical
O	375	383	practice
O	383	384	.

O	385	398	Observational
O	399	405	cohort
O	406	411	study
O	411	412	.

O	413	416	One
O	417	425	thousand
O	426	433	seventy
O	433	434	-
O	434	437	two
B-Anatomy	438	442	eyes
O	443	445	of
O	446	449	665
O	450	458	patients
O	459	463	with
B-Disease	464	472	glaucoma
O	473	481	followed
O	482	484	up
O	485	489	over
O	490	492	an
O	493	500	average
O	501	503	of
O	504	505	4
O	505	506	.
O	506	507	3
O	507	508	
O	508	509	0
O	509	510	.
O	510	511	9
O	512	517	years
O	517	518	.

O	519	531	Participants
O	532	536	with
O	537	538	5
O	539	541	or
O	542	546	more
B-Diagnostic_tool	547	553	visual
I-Diagnostic_tool	554	559	field
I-Diagnostic_tool	560	565	tests
O	566	570	over
O	571	572	a
O	573	574	2
O	574	575	-
O	576	578	to
O	579	580	5
O	580	581	-
O	581	585	year
O	586	592	period
O	593	597	were
O	598	606	included
O	607	609	to
O	610	616	derive
O	617	620	the
O	621	633	longitudinal
O	634	645	measurement
O	646	657	variability
O	658	660	of
B-Characteristic	661	664	SAP
I-Characteristic	665	669	mean
I-Characteristic	670	679	deviation
O	680	681	(
O	681	683	MD
O	683	684	)
O	685	690	using
O	691	697	linear
O	698	709	regressions
O	709	710	.

O	711	720	Estimates
O	721	723	of
O	724	735	variability
O	736	740	then
O	741	745	were
O	746	750	used
O	751	753	to
O	754	765	reconstruct
O	766	770	real
O	770	771	-
O	771	776	world
B-Characteristic	777	783	visual
I-Characteristic	784	789	field
O	790	794	data
O	795	797	by
O	798	806	computer
O	807	817	simulation
O	818	820	to
O	821	829	evaluate
O	830	833	the
O	834	838	time
O	839	847	required
O	848	850	to
O	851	857	detect
O	858	869	progression
O	870	873	for
O	874	881	various
O	882	887	rates
O	888	890	of
B-Symptom	891	897	visual
I-Symptom	898	903	field
I-Symptom	904	908	loss
O	909	912	and
O	913	922	different
O	923	934	frequencies
O	935	937	of
O	938	945	testing
O	945	946	.

O	947	950	The
O	951	961	evaluation
O	962	965	was
O	966	975	performed
O	976	981	using
O	982	983	a
O	984	990	follow
O	990	991	-
O	991	993	up
O	994	1000	scheme
O	1001	1005	that
O	1006	1015	resembled
O	1016	1024	clinical
O	1025	1033	practice
O	1034	1036	by
O	1037	1046	requiring
O	1047	1048	a
O	1049	1052	set
O	1053	1055	of
O	1056	1057	2
O	1058	1066	baseline
O	1067	1072	tests
O	1073	1076	and
O	1077	1078	a
O	1079	1091	confirmatory
O	1092	1096	test
O	1097	1099	to
O	1100	1108	identify
O	1109	1120	progression
O	1120	1121	.

O	1122	1126	Time
O	1127	1128	(
O	1128	1130	in
O	1131	1136	years
O	1136	1137	)
O	1138	1146	required
O	1147	1149	to
O	1150	1156	detect
O	1157	1168	progression
O	1168	1169	.

O	1170	1173	The
O	1174	1178	time
O	1179	1187	required
O	1188	1190	to
O	1191	1197	detect
O	1198	1199	a
O	1200	1213	statistically
O	1214	1225	significant
O	1226	1234	negative
O	1235	1237	MD
O	1238	1243	slope
O	1244	1253	decreased
O	1254	1256	as
O	1257	1260	the
O	1261	1270	frequency
O	1271	1273	of
O	1274	1281	testing
O	1282	1291	increased
O	1291	1292	,
O	1293	1299	albeit
O	1300	1303	not
O	1304	1318	proportionally
O	1318	1319	.

O	1320	1323	For
O	1324	1331	example
O	1331	1332	,
O	1333	1335	80
O	1335	1336	%
O	1337	1339	of
B-Anatomy	1340	1344	eyes
O	1345	1349	with
O	1350	1352	an
O	1353	1355	MD
O	1356	1360	loss
O	1361	1363	of
O	1364	1365	-
O	1365	1366	2
O	1367	1369	dB
O	1369	1370	/
O	1370	1374	year
O	1375	1380	would
O	1381	1383	be
O	1384	1392	detected
O	1393	1398	after
O	1399	1400	3
O	1400	1401	.
O	1401	1402	3
O	1402	1403	,
O	1404	1405	2
O	1405	1406	.
O	1406	1407	4
O	1407	1408	,
O	1409	1412	and
O	1413	1414	2
O	1414	1415	.
O	1415	1416	1
O	1417	1422	years
O	1423	1427	when
O	1428	1435	testing
O	1436	1438	is
O	1439	1448	performed
O	1449	1453	once
O	1453	1454	,
O	1455	1460	twice
O	1460	1461	,
O	1462	1465	and
O	1466	1472	thrice
O	1473	1476	per
O	1477	1481	year
O	1481	1482	,
O	1483	1495	respectively
O	1495	1496	.

O	1497	1500	For
B-Anatomy	1501	1505	eyes
O	1506	1510	with
O	1511	1513	an
O	1514	1516	MD
O	1517	1521	loss
O	1522	1524	of
O	1525	1526	-
O	1526	1527	0
O	1527	1528	.
O	1528	1529	5
O	1530	1532	dB
O	1532	1533	/
O	1533	1537	year
O	1537	1538	,
O	1539	1550	progression
O	1551	1554	can
O	1555	1557	be
O	1558	1566	detected
O	1567	1571	with
O	1572	1574	80
O	1574	1575	%
O	1576	1581	power
O	1582	1587	after
O	1588	1589	7
O	1589	1590	.
O	1590	1591	3
O	1591	1592	,
O	1593	1594	5
O	1594	1595	.
O	1595	1596	7
O	1596	1597	,
O	1598	1601	and
O	1602	1603	5
O	1603	1604	.
O	1604	1605	0
O	1606	1611	years
O	1611	1612	,
O	1613	1625	respectively
O	1625	1626	.

O	1627	1631	This
O	1632	1637	study
O	1638	1646	provides
O	1647	1658	information
O	1659	1661	on
O	1662	1665	the
O	1666	1670	time
O	1671	1679	required
O	1680	1682	to
O	1683	1689	detect
O	1690	1701	progression
O	1702	1707	using
O	1708	1710	MD
O	1711	1716	trend
O	1717	1725	analysis
O	1726	1728	in
B-Disease	1729	1737	glaucoma
B-Anatomy	1738	1742	eyes
O	1743	1747	when
O	1748	1757	different
O	1758	1765	testing
O	1766	1777	frequencies
O	1778	1781	are
O	1782	1786	used
O	1786	1787	.

O	1788	1791	The
O	1792	1799	smaller
O	1800	1805	gains
O	1806	1808	in
O	1809	1812	the
O	1813	1817	time
O	1818	1820	to
O	1821	1827	detect
O	1828	1839	progression
O	1840	1844	when
O	1845	1852	testing
O	1853	1855	is
O	1856	1865	increased
O	1866	1870	from
O	1871	1876	twice
O	1877	1879	to
O	1880	1886	thrice
O	1887	1890	per
O	1891	1895	year
O	1896	1904	suggests
O	1905	1909	that
O	1910	1919	obtaining
O	1920	1921	2
O	1922	1930	reliable
O	1931	1936	tests
O	1937	1939	at
O	1940	1948	baseline
O	1949	1957	followed
O	1958	1960	by
O	1961	1971	semiannual
O	1972	1979	testing
O	1980	1983	and
O	1984	1996	confirmation
O	1997	1999	of
O	2000	2011	progression
O	2012	2019	through
O	2020	2026	repeat
O	2027	2034	testing
O	2035	2037	in
O	2038	2041	the
O	2042	2049	initial
O	2050	2055	years
O	2056	2058	of
O	2059	2065	follow
O	2065	2066	-
O	2066	2068	up
O	2069	2072	may
O	2073	2080	provide
O	2081	2082	a
O	2083	2087	good
O	2088	2098	compromise
O	2099	2102	for
O	2103	2112	detecting
O	2113	2124	progression
O	2124	2125	,
O	2126	2131	while
O	2132	2142	minimizing
O	2143	2146	the
O	2147	2153	burden
O	2154	2156	on
O	2157	2163	health
O	2164	2168	care
O	2169	2178	resources
O	2179	2181	in
O	2182	2190	clinical
O	2191	2199	practice
O	2199	2200	.

B-Characteristic	0	10	Hemorrhage
I-Characteristic	11	14	and
I-Characteristic	14	15	/
I-Characteristic	15	17	or
I-Characteristic	18	31	Microaneurysm
I-Characteristic	32	40	Severity
I-Characteristic	41	44	and
I-Characteristic	45	50	Count
O	51	53	in
B-Diagnostic_tool	54	63	Ultrawide
I-Diagnostic_tool	64	69	Field
I-Diagnostic_tool	70	76	Images
O	77	80	and
B-Diagnostic_tool	81	86	Early
I-Diagnostic_tool	87	96	Treatment
I-Diagnostic_tool	97	105	Diabetic
I-Diagnostic_tool	106	117	Retinopathy
I-Diagnostic_tool	118	123	Study
I-Diagnostic_tool	124	135	Photography
O	135	136	.

O	138	140	To
O	141	149	evaluate
O	150	159	detection
O	160	162	of
B-Symptom	163	173	hemorrhage
I-Symptom	174	177	and
I-Symptom	177	178	/
I-Symptom	178	180	or
I-Symptom	181	194	microaneurysm
O	195	196	(
B-Symptom	196	197	H
I-Symptom	197	198	/
I-Symptom	198	200	Ma
O	200	201	)
O	202	207	using
B-Diagnostic_tool	208	217	ultrawide
I-Diagnostic_tool	218	223	field
I-Diagnostic_tool	224	225	(
I-Diagnostic_tool	225	228	UWF
I-Diagnostic_tool	228	229	)
I-Diagnostic_tool	230	237	retinal
I-Diagnostic_tool	238	245	imaging
O	246	248	as
O	249	257	compared
O	258	262	with
O	263	271	standard
B-Diagnostic_tool	272	277	Early
I-Diagnostic_tool	278	287	Treatment
I-Diagnostic_tool	288	296	Diabetic
I-Diagnostic_tool	297	308	Retinopathy
I-Diagnostic_tool	309	314	Study
I-Diagnostic_tool	315	316	(
I-Diagnostic_tool	316	321	ETDRS
I-Diagnostic_tool	321	322	)
I-Diagnostic_tool	323	324	7
I-Diagnostic_tool	324	325	-
I-Diagnostic_tool	325	330	field
I-Diagnostic_tool	331	342	photographs
O	343	344	(
B-Diagnostic_tool	344	349	ETDRS
I-Diagnostic_tool	350	356	photos
O	356	357	)
O	357	358	.

O	359	365	Single
O	365	366	-
O	366	370	site
O	371	382	comparative
O	383	388	study
O	389	391	of
B-Diagnostic_tool	392	395	UWF
I-Diagnostic_tool	396	402	images
O	403	406	and
B-Diagnostic_tool	407	412	ETDRS
I-Diagnostic_tool	413	419	photos
O	419	420	.

O	421	424	One
O	425	432	hundred
O	433	439	twenty
O	439	440	-
O	440	443	six
B-Anatomy	444	448	eyes
O	449	451	of
O	452	454	69
O	455	463	patients
O	464	468	with
O	469	471	no
B-Disease	472	480	diabetic
I-Disease	481	492	retinopathy
O	493	494	(
B-Disease	494	496	DR
O	496	497	)
O	498	500	or
B-Disease	501	505	mild
I-Disease	506	508	or
I-Disease	509	517	moderate
I-Disease	518	534	nonproliferative
I-Disease	535	537	DR
O	538	539	(
B-Disease	539	543	NPDR
O	543	544	)
O	544	545	.

B-Diagnostic_tool	546	558	Stereoscopic
I-Diagnostic_tool	559	562	200
I-Diagnostic_tool	562	563	
I-Diagnostic_tool	564	567	UWF
I-Diagnostic_tool	568	574	images
O	575	578	and
B-Diagnostic_tool	579	591	stereoscopic
I-Diagnostic_tool	592	596	35mm
I-Diagnostic_tool	597	599	30
I-Diagnostic_tool	599	600	
I-Diagnostic_tool	601	602	7
I-Diagnostic_tool	602	603	-
I-Diagnostic_tool	603	608	field
I-Diagnostic_tool	609	614	color
I-Diagnostic_tool	615	626	photographs
O	627	631	were
O	632	640	acquired
O	641	643	on
O	644	647	the
O	648	652	same
O	653	658	visit
O	658	659	.

O	660	666	Images
O	667	671	were
O	672	678	graded
O	679	682	for
O	683	691	severity
O	692	695	and
O	696	708	distribution
O	709	711	of
B-Symptom	712	713	H
I-Symptom	713	714	/
I-Symptom	714	716	Ma
O	716	717	.

B-Symptom	718	719	H
I-Symptom	719	720	/
I-Symptom	720	723	Mas
O	724	728	were
O	729	736	counted
O	737	739	in
B-Characteristic	740	745	ETDRS
I-Characteristic	746	752	fields
I-Characteristic	753	754	2
I-Characteristic	755	757	to
I-Characteristic	758	759	7
O	760	762	in
O	763	767	both
B-Diagnostic_tool	768	773	ETDRS
I-Diagnostic_tool	774	780	photos
O	781	784	and
B-Diagnostic_tool	785	788	UWF
I-Diagnostic_tool	789	795	images
O	795	796	.

B-Symptom	797	798	H
I-Symptom	798	799	/
I-Symptom	799	802	Mas
O	803	805	in
O	806	809	the
B-Characteristic	810	813	UWF
I-Characteristic	814	824	peripheral
I-Characteristic	825	831	fields
O	832	836	were
O	837	841	also
O	842	849	counted
O	849	850	.

O	851	856	Kappa
O	857	858	(
O	858	859	
O	859	860	)
O	861	864	and
O	865	873	weighted
O	874	875	
O	876	886	statistics
O	887	890	for
O	891	900	agreement
O	900	901	.

O	902	908	Number
O	909	911	of
B-Symptom	912	913	H
I-Symptom	913	914	/
I-Symptom	914	916	Ma
O	917	923	within
O	924	927	and
O	928	935	outside
B-Characteristic	936	941	ETDRS
I-Characteristic	942	948	fields
O	949	959	identified
O	960	962	in
B-Diagnostic_tool	963	966	UWF
I-Diagnostic_tool	967	973	images
O	974	977	and
B-Diagnostic_tool	978	983	ETDRS
I-Diagnostic_tool	984	990	photos
O	990	991	.

O	992	1004	Distribution
O	1005	1007	of
B-Disease	1008	1010	DR
O	1011	1019	severity
O	1020	1022	by
B-Diagnostic_tool	1023	1028	ETDRS
I-Diagnostic_tool	1029	1035	photos
O	1036	1039	was
O	1040	1042	24
O	1043	1044	(
O	1044	1046	19
O	1046	1047	.
O	1047	1048	0
O	1048	1049	%
O	1049	1050	)
O	1051	1053	no
B-Disease	1054	1056	DR
O	1056	1057	,
O	1058	1060	48
O	1061	1062	(
O	1062	1064	38
O	1064	1065	.
O	1065	1066	1
O	1066	1067	%
O	1067	1068	)
B-Disease	1069	1073	mild
I-Disease	1074	1078	NPDR
O	1078	1079	,
O	1080	1083	and
O	1084	1086	54
O	1087	1088	(
O	1088	1090	42
O	1090	1091	.
O	1091	1092	9
O	1092	1093	%
O	1093	1094	)
B-Disease	1095	1103	moderate
I-Disease	1104	1108	NPDR
O	1108	1109	.

O	1110	1111	A
O	1112	1117	total
O	1118	1120	of
O	1121	1124	748
O	1125	1127	of
O	1128	1131	756
O	1132	1138	fields
O	1139	1140	(
O	1140	1142	98
O	1142	1143	.
O	1143	1144	9
O	1144	1145	%
O	1145	1146	)
O	1147	1151	were
O	1152	1160	gradable
O	1161	1164	for
B-Symptom	1165	1166	H
I-Symptom	1166	1167	/
I-Symptom	1167	1170	Mas
O	1171	1173	on
B-Diagnostic_tool	1174	1179	ETDRS
I-Diagnostic_tool	1180	1186	photos
O	1187	1190	and
B-Diagnostic_tool	1191	1194	UWF
I-Diagnostic_tool	1195	1201	images
O	1201	1202	.

O	1203	1209	Simple
O	1210	1211	
O	1211	1212	/
O	1212	1220	weighted
O	1221	1222	
O	1223	1233	statistics
O	1234	1237	for
O	1238	1246	severity
O	1247	1249	of
B-Symptom	1250	1251	H
I-Symptom	1251	1252	/
I-Symptom	1252	1254	Ma
O	1254	1255	:
O	1256	1259	all
O	1260	1266	fields
O	1267	1268	0
O	1268	1269	.
O	1269	1271	61
O	1271	1272	/
O	1272	1273	0
O	1273	1274	.
O	1274	1276	69
O	1276	1277	,
O	1278	1283	field
O	1284	1285	2
O	1286	1287	0
O	1287	1288	.
O	1288	1290	70
O	1290	1291	/
O	1291	1292	0
O	1292	1293	.
O	1293	1295	77
O	1295	1296	,
O	1297	1302	field
O	1303	1304	3
O	1305	1306	0
O	1306	1307	.
O	1307	1309	62
O	1309	1310	/
O	1310	1311	0
O	1311	1312	.
O	1312	1314	73
O	1314	1315	,
O	1316	1321	field
O	1322	1323	4
O	1324	1325	0
O	1325	1326	.
O	1326	1328	50
O	1328	1329	/
O	1329	1330	0
O	1330	1331	.
O	1331	1333	62
O	1333	1334	,
O	1335	1340	field
O	1341	1342	5
O	1343	1344	0
O	1344	1345	.
O	1345	1347	54
O	1347	1348	/
O	1348	1349	0
O	1349	1350	.
O	1350	1352	65
O	1352	1353	,
O	1354	1359	field
O	1360	1361	6
O	1362	1363	0
O	1363	1364	.
O	1364	1366	64
O	1366	1367	/
O	1367	1368	0
O	1368	1369	.
O	1369	1371	70
O	1371	1372	,
O	1373	1376	and
O	1377	1382	field
O	1383	1384	7
O	1385	1386	0
O	1386	1387	.
O	1387	1389	58
O	1389	1390	/
O	1390	1391	0
O	1391	1392	.
O	1392	1394	63
O	1395	1399	with
O	1400	1407	overall
O	1408	1413	exact
O	1414	1423	agreement
O	1424	1426	in
O	1427	1429	81
O	1429	1430	.
O	1430	1431	3
O	1431	1432	%
O	1433	1436	and
O	1437	1443	within
O	1444	1445	1
O	1446	1450	step
O	1451	1453	in
O	1454	1456	97
O	1456	1457	.
O	1457	1458	9
O	1458	1459	%
O	1460	1462	of
O	1463	1469	fields
O	1469	1470	.

O	1471	1472	A
O	1473	1480	greater
O	1481	1491	proportion
O	1492	1494	of
O	1495	1501	fields
O	1502	1505	was
O	1506	1512	graded
O	1513	1514	a
O	1515	1519	more
O	1520	1526	severe
B-Symptom	1527	1528	H
I-Symptom	1528	1529	/
I-Symptom	1529	1531	Ma
O	1532	1537	level
O	1538	1540	in
B-Diagnostic_tool	1541	1544	UWF
I-Diagnostic_tool	1545	1551	images
O	1552	1556	than
O	1557	1559	in
O	1560	1563	the
O	1564	1577	corresponding
B-Diagnostic_tool	1578	1583	ETDRS
I-Diagnostic_tool	1584	1590	photos
O	1591	1592	(
B-Diagnostic_tool	1592	1595	UWF
O	1595	1596	:
O	1597	1599	12
O	1599	1600	.
O	1600	1601	7
O	1601	1602	%
O	1603	1605	vs
O	1605	1606	.
O	1607	1608	6
O	1608	1609	.
O	1609	1610	5
O	1610	1611	%
O	1611	1612	)
O	1612	1613	.

O	1614	1624	Evaluating
O	1625	1635	comparable
O	1636	1641	areas
O	1642	1644	in
B-Diagnostic_tool	1645	1648	UWF
I-Diagnostic_tool	1649	1655	images
O	1656	1659	and
B-Diagnostic_tool	1660	1665	ETDRS
I-Diagnostic_tool	1666	1672	photos
O	1673	1674	(
B-Characteristic	1674	1680	fields
I-Characteristic	1681	1682	2
I-Characteristic	1682	1683	-
I-Characteristic	1683	1684	7
O	1684	1685	)
O	1685	1686	,
O	1687	1688	a
O	1689	1693	mean
O	1694	1696	of
O	1697	1699	42
O	1699	1700	.
O	1700	1701	8
B-Symptom	1702	1703	H
I-Symptom	1703	1704	/
I-Symptom	1704	1707	Mas
O	1708	1712	were
O	1713	1723	identified
O	1724	1729	using
B-Diagnostic_tool	1730	1735	ETDRS
I-Diagnostic_tool	1736	1742	photos
O	1743	1746	and
O	1747	1749	48
O	1749	1750	.
O	1750	1751	8
O	1752	1754	in
B-Diagnostic_tool	1755	1758	UWF
I-Diagnostic_tool	1759	1765	images
O	1766	1767	(
O	1767	1768	P
O	1769	1770	=
O	1771	1772	0
O	1772	1773	.
O	1773	1775	10
O	1775	1776	)
O	1776	1777	.

O	1778	1780	An
O	1781	1791	additional
O	1792	1796	mean
O	1797	1799	of
O	1800	1802	21
O	1802	1803	.
O	1803	1804	3
B-Symptom	1805	1806	H
I-Symptom	1806	1807	/
I-Symptom	1807	1810	Mas
O	1811	1812	(
O	1812	1814	49
O	1814	1815	.
O	1815	1816	8
O	1816	1817	%
O	1818	1826	increase
O	1826	1827	,
O	1828	1829	P
O	1831	1832	<
O	1834	1835	0
O	1835	1836	.
O	1836	1840	0001
O	1840	1841	)
O	1842	1846	were
O	1847	1857	identified
O	1858	1860	in
O	1861	1864	the
O	1865	1875	peripheral
O	1876	1882	fields
O	1883	1885	of
O	1886	1889	the
B-Diagnostic_tool	1890	1893	UWF
I-Diagnostic_tool	1894	1900	images
O	1900	1901	.

O	1902	1907	There
O	1908	1910	is
O	1911	1915	good
O	1916	1918	to
O	1919	1928	excellent
O	1929	1938	agreement
O	1939	1946	between
B-Diagnostic_tool	1947	1950	UWF
I-Diagnostic_tool	1951	1957	images
O	1958	1961	and
B-Diagnostic_tool	1962	1967	ETDRS
I-Diagnostic_tool	1968	1974	photos
O	1975	1977	in
O	1978	1989	determining
B-Symptom	1990	1991	H
I-Symptom	1991	1992	/
I-Symptom	1992	1994	Ma
O	1995	2003	severity
O	2003	2004	,
O	2005	2009	with
O	2010	2019	excellent
O	2020	2031	correlation
O	2032	2034	of
B-Symptom	2035	2036	H
I-Symptom	2036	2037	/
I-Symptom	2037	2039	Ma
O	2040	2046	counts
O	2047	2053	within
B-Characteristic	2054	2059	ETDRS
I-Characteristic	2060	2065	photo
I-Characteristic	2066	2072	fields
O	2072	2073	.

B-Characteristic	2074	2077	UWF
I-Characteristic	2078	2088	peripheral
I-Characteristic	2089	2095	fields
O	2096	2106	identified
O	2107	2109	49
O	2109	2110	.
O	2110	2111	8
O	2111	2112	%
O	2113	2117	more
B-Symptom	2118	2119	H
I-Symptom	2119	2120	/
I-Symptom	2120	2122	Ma
O	2122	2123	,
O	2124	2134	suggesting
O	2135	2136	a
O	2137	2141	more
O	2142	2148	severe
B-Symptom	2149	2150	H
I-Symptom	2150	2151	/
I-Symptom	2151	2153	Ma
O	2154	2156	in
O	2157	2159	12
O	2159	2160	.
O	2160	2161	7
O	2161	2162	%
O	2163	2165	of
B-Anatomy	2166	2170	eyes
O	2170	2171	.

O	2172	2177	Given
O	2178	2181	the
O	2182	2192	additional
O	2193	2200	lesions
O	2201	2209	detected
O	2210	2212	in
B-Characteristic	2213	2223	peripheral
I-Characteristic	2224	2230	fields
O	2231	2234	and
O	2235	2238	the
O	2239	2244	known
O	2245	2250	risks
O	2251	2261	associated
O	2262	2266	with
B-Symptom	2267	2268	H
I-Symptom	2268	2269	/
I-Symptom	2269	2271	Ma
O	2272	2275	and
B-Symptom	2276	2286	peripheral
I-Symptom	2287	2294	lesions
O	2294	2295	,
O	2296	2310	quantification
O	2311	2313	of
B-Symptom	2314	2315	H
I-Symptom	2315	2316	/
I-Symptom	2316	2318	Ma
O	2319	2324	using
B-Diagnostic_tool	2325	2328	UWF
I-Diagnostic_tool	2329	2335	images
O	2336	2339	may
O	2340	2347	provide
O	2348	2349	a
O	2350	2354	more
O	2355	2363	accurate
O	2364	2378	representation
O	2379	2381	of
B-Disease	2382	2384	DR
O	2385	2392	disease
O	2393	2401	activity
O	2402	2405	and
O	2406	2415	potential
O	2416	2423	greater
O	2424	2432	accuracy
O	2433	2435	in
O	2436	2446	predicting
B-Disease	2447	2449	DR
O	2450	2461	progression
O	2461	2462	.

O	0	5	Trend
O	5	6	-
O	6	11	based
O	12	20	Analysis
O	21	23	of
B-Characteristic	24	32	Ganglion
I-Characteristic	33	37	Cell
I-Characteristic	37	38	-
I-Characteristic	38	43	Inner
I-Characteristic	44	53	Plexiform
I-Characteristic	54	59	Layer
I-Characteristic	60	69	Thickness
I-Characteristic	70	77	Changes
O	78	80	on
B-Diagnostic_tool	81	88	Optical
I-Diagnostic_tool	89	98	Coherence
I-Diagnostic_tool	99	109	Tomography
O	110	112	in
B-Characteristic	113	121	Glaucoma
I-Characteristic	122	133	Progression
O	133	134	.

O	136	138	To
O	139	147	evaluate
O	148	151	the
B-Characteristic	152	156	rate
I-Characteristic	157	159	of
I-Characteristic	160	168	thinning
I-Characteristic	169	171	in
I-Characteristic	172	180	ganglion
I-Characteristic	181	185	cell
I-Characteristic	185	186	-
I-Characteristic	186	191	inner
I-Characteristic	192	201	plexiform
I-Characteristic	202	207	layer
I-Characteristic	208	209	(
I-Characteristic	209	214	GCIPL
I-Characteristic	214	215	)
I-Characteristic	216	225	thickness
O	226	228	by
B-Diagnostic_tool	229	236	optical
I-Diagnostic_tool	237	246	coherence
I-Diagnostic_tool	247	257	tomography
O	258	259	(
B-Diagnostic_tool	259	262	OCT
O	262	263	)
O	264	266	in
B-Disease	267	279	glaucomatous
B-Anatomy	280	284	eyes
O	285	288	and
O	289	291	to
O	292	295	use
O	296	297	a
O	298	303	trend
O	303	304	-
O	304	309	based
O	310	318	approach
O	319	321	to
O	322	331	determine
O	332	335	its
O	336	346	diagnostic
O	347	354	ability
O	355	358	for
O	359	368	detecting
B-Characteristic	369	377	glaucoma
I-Characteristic	378	389	progression
O	389	390	.

O	391	402	Prospective
O	402	403	,
O	404	417	observational
O	418	423	study
O	423	424	.

O	425	430	Sixty
O	430	431	-
O	431	435	five
O	436	444	patients
O	445	449	with
B-Disease	450	457	primary
I-Disease	458	462	open
I-Disease	462	463	-
I-Disease	463	468	angle
I-Disease	469	477	glaucoma
O	478	482	with
O	483	484	a
O	485	492	minimum
O	493	494	3
O	494	495	-
O	495	499	year
O	500	506	follow
O	506	507	-
O	507	509	up
O	510	519	involving
O	520	526	serial
B-Diagnostic_tool	527	535	spectral
I-Diagnostic_tool	535	536	-
I-Diagnostic_tool	536	542	domain
I-Diagnostic_tool	543	546	OCT
O	547	558	measurement
O	559	561	of
B-Characteristic	562	567	GCIPL
I-Characteristic	568	577	thickness
O	577	578	.

O	579	587	Patients
O	588	592	were
O	593	600	divided
O	601	605	into
O	606	607	a
B-Characteristic	608	621	nonprogressor
I-Characteristic	622	627	group
O	628	629	(
O	629	630	n
O	631	632	=
O	633	635	38
O	635	636	)
O	637	640	and
O	641	642	a
B-Characteristic	643	653	progressor
I-Characteristic	654	659	group
O	660	661	(
O	661	662	n
O	663	664	=
O	665	667	27
O	667	668	)
O	669	671	on
O	672	675	the
O	676	681	basis
O	682	684	of
O	685	691	serial
B-Diagnostic_tool	692	695	red
I-Diagnostic_tool	695	696	-
I-Diagnostic_tool	696	700	free
I-Diagnostic_tool	701	712	photography
O	713	715	or
B-Diagnostic_tool	716	722	visual
I-Diagnostic_tool	723	728	field
I-Diagnostic_tool	729	734	tests
O	734	735	.

O	736	739	The
B-Characteristic	740	745	rates
I-Characteristic	746	748	of
I-Characteristic	749	754	GCIPL
I-Characteristic	755	763	thinning
I-Characteristic	764	766	in
I-Characteristic	767	770	the
I-Characteristic	771	777	global
I-Characteristic	778	784	region
O	784	785	,
O	786	794	affected
B-Anatomy	795	804	hemifield
O	804	805	,
O	806	809	and
O	810	811	6
B-Anatomy	812	819	macular
O	820	827	sectors
O	827	828	,
O	829	832	and
O	833	836	the
O	837	844	minimum
O	845	854	thickness
O	854	855	,
O	856	860	were
O	861	871	determined
O	872	874	by
O	875	881	linear
O	882	892	regression
O	893	896	and
O	897	905	compared
O	906	913	between
O	914	920	groups
O	920	921	.

O	922	925	The
O	926	930	area
O	931	936	under
O	937	940	the
O	941	949	receiver
O	950	959	operating
O	960	974	characteristic
O	975	981	curves
O	982	983	(
O	983	987	AUCs
O	987	988	)
O	989	993	were
O	994	1004	calculated
O	1005	1008	for
O	1009	1013	each
O	1014	1023	parameter
O	1023	1024	.

O	1025	1028	The
B-Characteristic	1029	1034	GCIPL
I-Characteristic	1035	1043	thinning
I-Characteristic	1044	1049	rates
O	1050	1054	were
O	1055	1063	compared
O	1064	1071	between
O	1072	1080	affected
B-Anatomy	1081	1091	hemifields
O	1092	1095	and
O	1096	1106	unaffected
B-Anatomy	1107	1117	hemifields
O	1117	1118	.

O	1119	1122	The
B-Characteristic	1123	1130	macular
I-Characteristic	1131	1136	GCIPL
I-Characteristic	1137	1145	thinning
I-Characteristic	1146	1151	rates
O	1152	1154	in
O	1155	1158	the
B-Characteristic	1159	1169	progressor
I-Characteristic	1170	1173	and
I-Characteristic	1174	1187	nonprogressor
I-Characteristic	1188	1194	groups
O	1195	1198	and
O	1199	1202	the
O	1203	1210	ability
O	1211	1213	of
O	1214	1217	the
B-Characteristic	1218	1223	GCIPL
I-Characteristic	1224	1232	thinning
I-Characteristic	1233	1237	rate
O	1238	1240	to
O	1241	1249	diagnose
B-Characteristic	1250	1258	glaucoma
I-Characteristic	1259	1270	progression
O	1270	1271	.

O	1272	1275	The
B-Characteristic	1276	1281	GCIPL
I-Characteristic	1282	1290	thinning
I-Characteristic	1291	1295	rate
O	1296	1299	was
O	1300	1313	significantly
O	1314	1320	faster
O	1321	1323	in
B-Characteristic	1324	1335	progressors
O	1336	1340	than
O	1341	1343	in
B-Characteristic	1344	1358	nonprogressors
O	1359	1361	in
O	1362	1365	the
B-Anatomy	1366	1372	global
I-Anatomy	1373	1377	area
O	1378	1379	(
O	1379	1380	P
O	1382	1383	<
O	1385	1386	0
O	1386	1387	.
O	1387	1390	001
O	1390	1391	)
O	1391	1392	;
O	1393	1395	in
O	1396	1399	the
O	1400	1408	affected
B-Anatomy	1409	1418	hemifield
O	1419	1420	(
O	1420	1421	P
O	1422	1423	=
O	1424	1425	0
O	1425	1426	.
O	1426	1429	001
O	1429	1430	)
O	1430	1431	;
O	1432	1434	in
O	1435	1438	the
B-Anatomy	1439	1447	temporal
I-Anatomy	1447	1448	,
I-Anatomy	1449	1457	vertical
I-Anatomy	1457	1458	,
I-Anatomy	1459	1462	and
I-Anatomy	1463	1468	nasal
I-Anatomy	1469	1476	sectors
O	1477	1479	of
O	1480	1483	the
O	1484	1492	affected
B-Anatomy	1493	1502	hemifield
O	1503	1504	(
O	1504	1505	P
O	1506	1507	=
O	1508	1509	0
O	1509	1510	.
O	1510	1513	017
O	1513	1514	,
O	1515	1516	0
O	1516	1517	.
O	1517	1520	032
O	1520	1521	,
O	1522	1525	and
O	1526	1527	0
O	1527	1528	.
O	1528	1531	030
O	1531	1532	,
O	1533	1545	respectively
O	1545	1546	)
O	1546	1547	;
O	1548	1551	and
O	1552	1554	in
O	1555	1558	the
O	1559	1566	minimum
B-Characteristic	1567	1572	GCIPL
I-Characteristic	1573	1582	thickness
O	1583	1584	(
O	1584	1585	P
O	1587	1588	<
O	1590	1591	0
O	1591	1592	.
O	1592	1595	001
O	1595	1596	)
O	1596	1597	.

O	1598	1600	In
O	1601	1604	the
B-Anatomy	1605	1613	temporal
I-Anatomy	1614	1621	sectors
O	1621	1622	,
O	1623	1626	the
B-Characteristic	1627	1632	GCIPL
I-Characteristic	1633	1641	thinning
I-Characteristic	1642	1647	rates
O	1648	1652	were
O	1653	1666	significantly
O	1667	1673	faster
O	1674	1676	in
O	1677	1680	the
O	1681	1689	affected
O	1690	1694	than
O	1695	1697	in
O	1698	1701	the
O	1702	1712	unaffected
B-Anatomy	1713	1722	hemifield
O	1723	1724	(
O	1724	1725	P
O	1726	1727	=
O	1728	1729	0
O	1729	1730	.
O	1730	1733	013
O	1733	1734	)
O	1734	1735	.

O	1736	1739	The
O	1740	1744	best
B-Characteristic	1745	1750	GCIPL
I-Characteristic	1751	1761	parameters
O	1762	1766	were
O	1767	1770	the
B-Characteristic	1771	1777	global
I-Characteristic	1778	1779	(
I-Characteristic	1779	1782	AUC
I-Characteristic	1783	1784	=
I-Characteristic	1785	1786	0
I-Characteristic	1786	1787	.
I-Characteristic	1787	1790	791
I-Characteristic	1790	1791	)
I-Characteristic	1791	1792	,
I-Characteristic	1793	1800	minimum
I-Characteristic	1801	1802	(
I-Characteristic	1802	1805	AUC
I-Characteristic	1806	1807	=
I-Characteristic	1808	1809	0
I-Characteristic	1809	1810	.
I-Characteristic	1810	1813	755
I-Characteristic	1813	1814	)
I-Characteristic	1814	1815	,
I-Characteristic	1816	1824	inferior
I-Characteristic	1825	1834	hemifield
I-Characteristic	1835	1836	(
I-Characteristic	1836	1839	AUC
I-Characteristic	1840	1841	=
I-Characteristic	1842	1843	0
I-Characteristic	1843	1844	.
I-Characteristic	1844	1847	708
I-Characteristic	1847	1848	)
I-Characteristic	1848	1849	,
I-Characteristic	1850	1853	and
I-Characteristic	1854	1862	affected
I-Characteristic	1863	1872	hemifield
I-Characteristic	1873	1874	(
I-Characteristic	1874	1877	AUC
I-Characteristic	1878	1879	=
I-Characteristic	1880	1881	0
I-Characteristic	1881	1882	.
I-Characteristic	1882	1885	702
I-Characteristic	1885	1886	)
I-Characteristic	1887	1895	thinning
I-Characteristic	1896	1901	rates
O	1901	1902	.

O	1903	1906	The
B-Characteristic	1907	1913	global
I-Characteristic	1914	1929	circumpapillary
I-Characteristic	1930	1937	retinal
I-Characteristic	1938	1943	nerve
I-Characteristic	1944	1949	fiber
I-Characteristic	1950	1955	layer
I-Characteristic	1956	1964	thinning
I-Characteristic	1965	1969	rate
O	1970	1980	correlated
O	1981	1994	significantly
O	1995	1999	with
O	2000	2003	the
B-Characteristic	2004	2010	global
I-Characteristic	2011	2014	and
I-Characteristic	2015	2029	inferotemporal
I-Characteristic	2030	2036	sector
I-Characteristic	2037	2042	GCIPL
I-Characteristic	2043	2051	thinning
I-Characteristic	2052	2057	rates
O	2058	2059	(
O	2059	2062	rho
O	2063	2064	=
O	2065	2066	0
O	2066	2067	.
O	2067	2070	259
O	2071	2074	and
O	2075	2076	0
O	2076	2077	.
O	2077	2080	366
O	2080	2081	,
O	2082	2094	respectively
O	2094	2095	)
O	2095	2096	.

O	2097	2100	The
B-Characteristic	2101	2106	GCIPL
I-Characteristic	2107	2115	thinning
I-Characteristic	2116	2120	rate
O	2121	2123	on
B-Diagnostic_tool	2124	2127	OCT
O	2128	2131	was
O	2132	2145	significantly
O	2146	2152	faster
O	2153	2156	for
O	2157	2165	patients
O	2166	2170	with
B-Disease	2171	2179	glaucoma
O	2180	2184	with
O	2185	2196	progression
O	2197	2201	than
O	2202	2205	for
O	2206	2211	those
O	2212	2219	without
O	2220	2231	progression
O	2231	2232	.

O	2233	2236	The
B-Characteristic	2237	2242	GCIPL
I-Characteristic	2243	2251	thinning
I-Characteristic	2252	2256	rate
I-Characteristic	2257	2259	of
I-Characteristic	2260	2263	the
I-Characteristic	2264	2272	temporal
I-Characteristic	2273	2279	sector
O	2280	2283	was
O	2284	2290	faster
O	2291	2293	in
O	2294	2297	the
O	2298	2306	affected
O	2307	2311	than
O	2312	2314	in
O	2315	2318	the
O	2319	2329	unaffected
B-Anatomy	2330	2339	hemifield
O	2339	2340	,
O	2341	2351	suggesting
O	2352	2356	that
O	2357	2360	the
B-Symptom	2361	2373	glaucomatous
I-Symptom	2374	2380	damage
O	2381	2384	may
O	2385	2393	progress
O	2394	2401	locally
O	2402	2404	in
O	2405	2406	a
O	2407	2415	specific
O	2416	2424	sequence
O	2424	2425	.

O	2426	2431	Trend
O	2431	2432	-
O	2432	2437	based
O	2438	2446	analysis
O	2447	2449	of
B-Characteristic	2450	2455	GCIPL
I-Characteristic	2456	2465	thickness
O	2466	2468	on
B-Diagnostic_tool	2469	2472	OCT
O	2473	2476	may
O	2477	2479	be
O	2480	2486	useful
O	2487	2490	for
O	2491	2500	assessing
B-Characteristic	2501	2509	glaucoma
I-Characteristic	2510	2521	progression
O	2522	2533	objectively
O	2534	2537	and
O	2538	2552	quantitatively
O	2552	2553	.

O	0	8	Baseline
O	9	16	Factors
O	17	26	Affecting
O	27	34	Changes
O	35	37	in
B-Classification_system	38	46	Diabetic
I-Classification_system	47	58	Retinopathy
I-Classification_system	59	67	Severity
I-Classification_system	68	73	Scale
I-Classification_system	74	79	Score
O	80	85	After
O	86	98	Intravitreal
O	99	110	Aflibercept
O	111	113	or
O	114	119	Laser
O	120	123	for
B-Disease	124	132	Diabetic
I-Disease	133	140	Macular
I-Disease	141	146	Edema
O	146	147	:
O	148	152	Post
O	153	156	Hoc
O	157	165	Analyses
O	166	170	from
O	171	176	VISTA
O	177	180	and
O	181	186	VIVID
O	186	187	.

O	189	191	To
O	192	200	evaluate
O	201	208	whether
O	209	215	select
O	216	224	baseline
O	225	233	systemic
O	234	237	and
O	238	244	ocular
O	245	252	factors
O	253	262	influence
B-Classification_system	263	264	
I-Classification_system	264	265	2
I-Classification_system	265	266	-
I-Classification_system	266	270	step
I-Classification_system	271	282	improvement
I-Classification_system	283	285	in
I-Classification_system	286	289	the
I-Classification_system	290	298	Diabetic
I-Classification_system	299	310	Retinopathy
I-Classification_system	311	319	Severity
I-Classification_system	320	325	Scale
I-Classification_system	326	327	(
I-Classification_system	327	331	DRSS
I-Classification_system	331	332	)
I-Classification_system	333	338	score
O	339	341	at
O	342	346	week
O	347	350	100
O	351	353	in
O	354	359	VISTA
O	360	363	and
O	364	369	VIVID
O	369	370	.

O	371	375	Post
O	376	379	hoc
O	380	388	analysis
O	389	391	of
O	392	393	2
O	394	403	similarly
O	404	412	designed
O	413	418	phase
O	419	420	3
O	421	427	trials
O	427	428	,
O	429	434	VISTA
O	435	438	and
O	439	444	VIVID
O	444	445	.

O	446	451	Total
O	452	454	of
O	455	458	456
O	459	467	patients
O	468	472	with
O	473	479	center
O	479	480	-
O	480	488	involved
B-Disease	489	497	diabetic
I-Disease	498	505	macular
I-Disease	506	511	edema
O	512	513	(
B-Disease	513	516	DME
O	516	517	)
O	517	518	.

O	519	524	VISTA
O	525	528	and
O	529	534	VIVID
O	535	545	randomized
O	546	549	872
B-Disease	550	553	DME
O	554	562	patients
O	563	565	to
O	566	573	receive
O	574	586	intravitreal
O	587	598	aflibercept
O	599	608	injection
O	609	610	(
O	610	613	IAI
O	613	614	)
O	615	616	2
O	617	619	mg
O	620	625	every
O	626	627	4
O	628	633	weeks
O	634	635	(
O	635	638	2q4
O	638	639	)
O	639	640	,
O	641	644	IAI
O	645	646	2
O	647	649	mg
O	650	655	every
O	656	657	8
O	658	663	weeks
O	664	669	after
O	670	671	5
O	672	679	monthly
O	680	685	doses
O	686	687	(
O	687	690	2q8
O	690	691	)
O	691	692	,
O	693	695	or
O	696	703	macular
O	704	709	laser
O	710	726	photocoagulation
O	726	727	.

O	728	732	This
O	733	737	post
O	738	741	hoc
O	742	750	analysis
O	751	760	evaluated
O	761	764	the
O	765	774	influence
O	775	777	of
O	778	784	select
O	785	793	baseline
O	794	801	factors
O	802	804	on
B-Classification_system	805	806	
I-Classification_system	806	807	2
I-Classification_system	807	808	-
I-Classification_system	808	812	step
I-Classification_system	813	817	DRSS
I-Classification_system	818	823	score
O	824	835	improvement
O	836	838	by
O	839	847	logistic
O	848	858	regression
O	859	861	in
O	862	864	an
O	865	875	integrated
O	876	881	VISTA
O	882	885	and
O	886	891	VIVID
O	892	899	dataset
O	900	905	using
O	906	914	observed
O	915	920	cases
O	921	922	(
O	922	923	n
O	924	925	=
O	926	929	456
O	929	930	)
O	931	935	with
O	936	944	patients
O	945	947	in
O	948	952	each
O	953	962	treatment
O	963	968	group
O	969	976	divided
O	977	981	into
O	982	990	tertiles
O	991	996	based
O	997	999	on
O	1000	1004	each
O	1005	1019	characteristic
O	1019	1020	.

O	1021	1031	Proportion
O	1032	1034	of
O	1035	1043	patients
O	1044	1048	with
B-Classification_system	1049	1050	
I-Classification_system	1050	1051	2
I-Classification_system	1051	1052	-
I-Classification_system	1052	1056	step
I-Classification_system	1057	1068	improvement
I-Classification_system	1069	1071	in
I-Classification_system	1072	1076	DRSS
I-Classification_system	1077	1082	score
O	1083	1087	from
O	1088	1096	baseline
O	1097	1099	at
O	1100	1104	week
O	1105	1108	100
O	1109	1111	by
B-Characteristic	1112	1115	age
O	1115	1116	,
B-Characteristic	1117	1125	duration
I-Characteristic	1126	1128	of
I-Characteristic	1129	1137	diabetes
O	1137	1138	,
B-Characteristic	1139	1149	hemoglobin
I-Characteristic	1150	1153	A1c
O	1154	1155	(
B-Characteristic	1155	1160	HbA1c
O	1160	1161	)
O	1161	1162	,
B-Characteristic	1163	1167	body
I-Characteristic	1168	1172	mass
I-Characteristic	1173	1178	index
O	1179	1180	(
B-Characteristic	1180	1183	BMI
O	1183	1184	)
O	1184	1185	,
B-Characteristic	1186	1190	best
I-Characteristic	1190	1191	-
I-Characteristic	1191	1200	corrected
I-Characteristic	1201	1207	visual
I-Characteristic	1208	1214	acuity
O	1215	1216	(
B-Characteristic	1216	1220	BCVA
O	1220	1221	)
O	1221	1222	,
B-Characteristic	1223	1230	central
I-Characteristic	1231	1239	subfield
I-Characteristic	1240	1249	thickness
O	1250	1251	(
B-Characteristic	1251	1254	CST
O	1254	1255	)
O	1255	1256	,
O	1257	1260	and
B-Classification_system	1261	1265	DRSS
I-Classification_system	1266	1271	score
O	1271	1272	.

O	1273	1275	At
O	1276	1280	week
O	1281	1284	100
O	1284	1285	,
O	1286	1288	10
O	1288	1289	.
O	1289	1290	1
O	1290	1291	%
O	1291	1292	,
O	1293	1295	34
O	1295	1296	.
O	1296	1297	3
O	1297	1298	%
O	1298	1299	,
O	1300	1303	and
O	1304	1306	37
O	1306	1307	.
O	1307	1308	6
O	1308	1309	%
O	1310	1312	of
O	1313	1321	patients
O	1322	1324	in
O	1325	1328	the
O	1329	1334	laser
O	1334	1335	,
O	1336	1339	2q4
O	1339	1340	,
O	1341	1344	and
O	1345	1348	2q8
O	1349	1355	groups
O	1356	1367	experienced
O	1368	1369	a
B-Classification_system	1370	1371	
I-Classification_system	1371	1372	2
I-Classification_system	1372	1373	-
I-Classification_system	1373	1377	step
I-Classification_system	1378	1382	DRSS
I-Classification_system	1383	1388	score
O	1389	1400	improvement
O	1400	1401	,
O	1402	1414	respectively
O	1414	1415	.

B-Characteristic	1416	1419	Age
O	1419	1420	,
B-Characteristic	1421	1429	duration
I-Characteristic	1430	1432	of
I-Characteristic	1433	1441	diabetes
O	1441	1442	,
B-Characteristic	1443	1448	HbA1c
O	1448	1449	,
B-Characteristic	1450	1453	BMI
O	1453	1454	,
B-Characteristic	1455	1459	BCVA
O	1459	1460	,
O	1461	1464	and
B-Characteristic	1465	1468	CST
O	1469	1472	had
O	1473	1475	no
O	1476	1482	impact
O	1483	1485	on
O	1486	1489	the
O	1490	1497	ability
O	1498	1500	to
O	1501	1508	achieve
O	1509	1510	
O	1510	1511	2
O	1511	1512	-
O	1512	1516	step
O	1517	1528	improvement
O	1529	1531	in
B-Classification_system	1532	1536	DRSS
I-Classification_system	1537	1542	score
O	1542	1543	.

O	1544	1551	Initial
B-Classification_system	1552	1556	DRSS
I-Classification_system	1557	1562	score
O	1563	1566	was
O	1567	1570	the
O	1571	1575	only
O	1576	1582	factor
O	1583	1596	significantly
O	1597	1607	associated
O	1608	1612	with
B-Classification_system	1613	1614	
I-Classification_system	1614	1615	2
I-Classification_system	1615	1616	-
I-Classification_system	1616	1620	step
I-Classification_system	1621	1625	DRSS
I-Classification_system	1626	1631	score
O	1632	1643	improvement
O	1644	1646	in
O	1647	1650	all
O	1651	1660	treatment
O	1661	1667	groups
O	1668	1670	at
O	1671	1676	weeks
O	1677	1679	24
O	1679	1680	,
O	1681	1683	52
O	1683	1684	,
O	1685	1687	76
O	1687	1688	,
O	1689	1692	and
O	1693	1696	100
O	1696	1697	.

O	1698	1708	Relatively
O	1709	1715	higher
O	1716	1727	proportions
O	1728	1730	of
O	1731	1734	IAI
O	1734	1735	-
O	1735	1742	treated
O	1743	1751	patients
O	1752	1756	with
O	1757	1762	worse
B-Characteristic	1763	1767	BCVA
O	1768	1770	or
O	1771	1778	thicker
B-Characteristic	1779	1782	CST
O	1783	1794	experienced
B-Classification_system	1795	1796	
I-Classification_system	1796	1797	2
I-Classification_system	1797	1798	-
I-Classification_system	1798	1802	step
I-Classification_system	1803	1807	DRSS
I-Classification_system	1808	1813	score
O	1814	1825	improvement
O	1826	1834	compared
O	1835	1839	with
O	1840	1845	those
O	1846	1850	with
O	1851	1857	better
B-Characteristic	1858	1862	BCVA
O	1863	1865	or
O	1866	1873	thinner
B-Characteristic	1874	1877	CST
O	1877	1878	,
O	1879	1891	respectively
O	1891	1892	,
O	1893	1896	but
O	1897	1902	these
O	1903	1915	associations
O	1916	1920	were
O	1921	1924	not
O	1925	1938	statistically
O	1939	1950	significant
O	1950	1951	.

O	1952	1953	A
O	1954	1960	strong
O	1961	1972	association
O	1973	1976	was
O	1977	1984	present
O	1985	1992	between
B-Classification_system	1993	2001	baseline
I-Classification_system	2002	2006	DRSS
I-Classification_system	2007	2012	score
O	2013	2016	and
B-Classification_system	2017	2018	
I-Classification_system	2018	2019	2
I-Classification_system	2019	2020	-
I-Classification_system	2020	2024	step
I-Classification_system	2025	2029	DRSS
I-Classification_system	2030	2035	score
O	2036	2047	improvement
O	2048	2050	at
O	2051	2055	week
O	2056	2059	100
O	2060	2063	for
B-Disease	2064	2067	DME
O	2068	2076	patients
O	2077	2079	in
O	2080	2085	VISTA
O	2086	2089	and
O	2090	2095	VIVID
O	2095	2096	.

B-Disease	0	10	Idiopathic
I-Disease	11	16	Acute
I-Disease	17	26	Exudative
I-Disease	27	39	Polymorphous
I-Disease	40	51	Vitelliform
I-Disease	52	63	Maculopathy
O	63	64	:
O	65	73	Clinical
O	74	82	Spectrum
O	83	86	and
O	87	97	Multimodal
O	98	105	Imaging
O	106	121	Characteristics
O	121	122	.

O	124	126	To
O	127	135	describe
O	136	144	clinical
O	145	153	findings
O	154	156	in
O	157	165	patients
O	166	170	with
B-Disease	171	176	acute
I-Disease	177	186	exudative
I-Disease	187	199	polymorphous
I-Disease	200	211	vitelliform
I-Disease	212	223	maculopathy
O	224	225	(
B-Disease	225	230	AEPVM
O	230	231	)
O	231	232	.

O	233	246	Retrospective
O	246	247	,
O	248	261	observational
O	261	262	,
O	263	274	multicenter
O	275	279	case
O	280	286	series
O	287	293	review
O	293	294	.

O	295	306	Consecutive
O	307	315	patients
O	316	325	diagnosed
O	326	330	with
B-Disease	331	341	idiopathic
I-Disease	342	347	AEPVM
O	347	348	.

O	349	355	Review
O	356	358	of
B-Diagnostic_tool	359	367	clinical
I-Diagnostic_tool	368	374	charts
O	374	375	,
B-Diagnostic_tool	376	386	multimodal
I-Diagnostic_tool	387	394	imaging
O	394	395	,
B-Characteristic	396	414	electrophysiologic
I-Characteristic	415	423	findings
O	423	424	,
O	425	428	and
B-Characteristic	429	436	genetic
I-Characteristic	437	445	findings
O	446	448	in
O	449	459	previously
O	460	471	unpublished
O	472	480	patients
O	481	484	and
O	485	491	review
O	492	494	of
O	495	498	the
O	499	509	literature
O	509	510	.

O	511	519	Clinical
O	520	528	features
O	529	531	of
B-Disease	532	542	idiopathic
I-Disease	543	548	AEPVM
O	549	552	and
O	553	565	differential
O	566	575	diagnosis
O	575	576	.

O	577	585	Eighteen
O	586	594	patients
O	595	596	(
B-Characteristic	596	599	age
I-Characteristic	600	605	range
I-Characteristic	605	606	,
I-Characteristic	607	609	21
I-Characteristic	609	610	-
I-Characteristic	610	612	74
I-Characteristic	613	618	years
O	618	619	)
O	620	624	with
O	625	632	typical
O	633	641	features
O	642	644	of
B-Disease	645	650	AEPVM
O	650	651	,
O	652	661	including
O	662	669	initial
B-Symptom	670	679	localized
I-Symptom	679	680	,
I-Symptom	681	687	serous
I-Symptom	688	699	detachments
I-Symptom	700	708	followed
I-Symptom	709	711	by
I-Symptom	712	715	the
I-Symptom	716	727	development
I-Symptom	728	730	of
I-Symptom	731	745	characteristic
I-Symptom	746	752	yellow
I-Symptom	752	753	-
I-Symptom	753	758	white
I-Symptom	759	767	deposits
I-Symptom	768	770	in
I-Symptom	771	774	the
I-Symptom	775	786	vitelliform
I-Symptom	787	792	space
O	792	793	.

O	794	798	Over
O	799	803	time
O	803	804	,
O	805	809	this
O	810	830	hyperautofluorescent
O	831	839	material
O	840	850	gravitated
O	851	857	within
O	858	861	the
O	862	868	larger
O	869	876	lesions
O	876	877	,
O	878	887	resulting
O	888	890	in
O	891	898	typical
O	899	910	curvilinear
O	911	919	deposits
O	920	934	characteristic
O	935	937	of
O	938	943	later
O	944	950	stages
O	950	951	.

O	952	960	Symptoms
O	961	964	and
O	965	973	clinical
O	974	982	findings
O	983	989	lasted
O	990	994	from
O	995	1000	weeks
O	1001	1003	to
O	1004	1011	several
O	1012	1017	years
O	1017	1018	.

O	1019	1023	Some
O	1024	1032	patients
O	1033	1039	showed
O	1040	1050	previously
O	1051	1062	undescribed
O	1063	1071	features
O	1072	1076	such
O	1077	1079	as
B-Symptom	1080	1091	fluorescein
I-Symptom	1091	1092	-
I-Symptom	1092	1100	negative
I-Symptom	1101	1113	intraretinal
I-Symptom	1114	1120	cystic
I-Symptom	1121	1128	changes
O	1128	1129	,
B-Symptom	1130	1139	choroidal
I-Symptom	1140	1158	neovascularization
O	1158	1159	,
B-Symptom	1160	1166	serous
I-Symptom	1167	1174	retinal
I-Symptom	1175	1185	elevations
I-Symptom	1186	1195	mimicking
I-Symptom	1196	1203	retinal
I-Symptom	1204	1209	folds
O	1209	1210	,
B-Symptom	1211	1220	increased
I-Symptom	1221	1230	choroidal
I-Symptom	1231	1240	thickness
O	1240	1241	,
B-Symptom	1242	1246	lack
I-Symptom	1247	1249	of
I-Symptom	1250	1255	rapid
I-Symptom	1256	1262	visual
I-Symptom	1263	1271	recovery
O	1271	1272	,
O	1273	1276	and
B-Symptom	1277	1287	recurrence
I-Symptom	1288	1293	years
I-Symptom	1294	1299	after
I-Symptom	1300	1308	complete
I-Symptom	1309	1319	resolution
I-Symptom	1320	1322	of
I-Symptom	1323	1330	initial
I-Symptom	1331	1345	manifestations
O	1345	1346	.

B-Disease	1347	1352	Acute
I-Disease	1353	1362	exudative
I-Disease	1363	1375	polymorphous
I-Disease	1376	1387	vitelliform
I-Disease	1388	1399	maculopathy
O	1400	1403	can
O	1404	1411	present
O	1412	1416	with
O	1417	1418	a
O	1419	1423	more
O	1424	1432	variable
O	1433	1440	natural
O	1441	1447	course
O	1448	1452	than
O	1453	1463	previously
O	1464	1473	described
O	1473	1474	.

B-Disease	1475	1489	Paraneoplastic
I-Disease	1490	1501	retinopathy
O	1502	1505	and
B-Disease	1506	1515	autosomal
I-Disease	1516	1525	recessive
I-Disease	1526	1542	bestrophinopathy
O	1543	1550	closely
O	1551	1559	resemble
B-Disease	1560	1565	AEPVM
O	1565	1566	,
O	1567	1580	necessitating
O	1581	1588	medical
O	1589	1592	and
O	1593	1603	hereditary
O	1604	1614	evaluation
O	1615	1617	to
O	1618	1625	exclude
O	1626	1631	these
O	1632	1640	clinical
O	1641	1654	possibilities
O	1654	1655	.

O	1656	1660	This
O	1661	1667	series
O	1668	1670	of
O	1671	1679	patients
O	1680	1684	with
B-Disease	1685	1690	AEPVM
O	1691	1698	expands
O	1699	1702	the
O	1703	1711	clinical
O	1712	1720	spectrum
O	1721	1723	of
O	1724	1727	the
O	1728	1736	disorder
O	1736	1737	,
O	1738	1747	including
B-Characteristic	1748	1760	demographics
O	1760	1761	,
B-Characteristic	1762	1770	clinical
I-Characteristic	1771	1785	manifestations
O	1785	1786	,
B-Characteristic	1787	1794	imaging
I-Characteristic	1795	1803	features
O	1803	1804	,
B-Characteristic	1805	1812	natural
I-Characteristic	1813	1819	course
O	1819	1820	,
O	1821	1824	and
B-Characteristic	1825	1831	visual
I-Characteristic	1832	1841	prognosis
O	1841	1842	.

O	0	4	Will
B-Diagnostic_tool	5	14	Perimetry
O	15	17	Be
O	18	27	Performed
O	28	30	to
O	31	38	Monitor
B-Disease	39	47	Glaucoma
O	48	50	in
O	51	55	2025
O	55	56	?

B-Diagnostic_tool	58	64	Visual
I-Diagnostic_tool	65	70	field
I-Diagnostic_tool	71	78	testing
O	79	82	has
O	83	89	played
O	90	92	an
O	93	102	essential
O	103	107	role
O	108	110	in
O	111	114	the
O	115	124	diagnosis
O	125	128	and
O	129	139	management
O	140	142	of
B-Disease	143	151	glaucoma
O	152	155	for
O	156	160	more
O	161	165	than
O	166	167	a
O	168	175	century
O	175	176	.

B-Diagnostic_tool	177	184	Methods
I-Diagnostic_tool	185	187	to
I-Diagnostic_tool	188	195	examine
I-Diagnostic_tool	196	199	the
I-Diagnostic_tool	200	206	visual
I-Diagnostic_tool	207	212	field
O	213	217	have
O	218	222	been
O	223	230	refined
O	231	235	from
O	236	241	early
B-Diagnostic_tool	242	249	kinetic
I-Diagnostic_tool	250	259	perimetry
O	260	262	to
O	263	270	current
B-Diagnostic_tool	271	279	standard
I-Diagnostic_tool	280	289	automated
I-Diagnostic_tool	290	299	perimetry
O	300	301	(
B-Diagnostic_tool	301	304	SAP
O	304	305	)
O	305	306	.

O	307	317	Clinicians
O	318	321	now
O	322	325	use
B-Diagnostic_tool	326	329	SAP
O	330	333	for
O	334	337	the
O	338	347	diagnosis
O	348	351	and
O	352	362	management
O	363	365	of
B-Disease	366	374	glaucoma
O	375	385	throughout
O	386	389	the
O	390	395	world
O	395	396	.

O	397	404	Various
O	405	412	testing
O	413	422	paradigms
O	423	426	and
O	427	435	analytic
O	436	443	methods
O	444	448	have
O	449	453	been
O	454	463	developed
O	464	466	to
O	467	475	simplify
O	476	479	the
O	480	489	diagnosis
O	490	492	of
B-Disease	493	501	glaucoma
O	502	505	and
O	506	509	the
O	510	524	interpretation
O	525	527	of
O	528	539	progression
O	539	540	.

O	541	549	Moreover
O	549	550	,
O	551	561	strategies
O	562	566	have
O	567	571	been
O	572	583	implemented
O	584	586	to
O	587	594	improve
O	595	602	patient
O	603	613	experience
O	614	618	with
B-Diagnostic_tool	619	625	visual
I-Diagnostic_tool	626	631	field
I-Diagnostic_tool	632	639	testing
O	640	643	and
O	644	646	to
O	647	655	increase
O	656	667	reliability
O	667	668	.

B-Diagnostic_tool	669	678	Objective
I-Diagnostic_tool	679	689	functional
I-Diagnostic_tool	690	695	tests
O	695	696	,
O	697	701	such
O	702	704	as
B-Diagnostic_tool	705	724	electroretinography
O	724	725	,
O	726	733	provide
O	734	736	an
O	737	748	alternative
O	749	751	to
O	752	762	subjective
B-Diagnostic_tool	763	769	visual
I-Diagnostic_tool	770	775	field
I-Diagnostic_tool	776	783	testing
O	784	787	but
O	788	791	are
O	792	795	not
O	796	799	yet
O	800	805	ready
O	806	809	for
O	810	820	widespread
O	821	829	adoption
O	829	830	.

B-Diagnostic_tool	831	839	Standard
I-Diagnostic_tool	840	849	automated
I-Diagnostic_tool	850	859	perimetry
O	860	862	is
O	863	868	being
O	869	876	adapted
O	877	880	and
O	881	889	improved
O	890	900	constantly
O	900	901	.

O	902	905	New
O	906	913	devices
O	914	917	may
O	918	923	allow
O	924	932	patients
O	933	935	to
O	936	944	complete
B-Diagnostic_tool	945	951	visual
I-Diagnostic_tool	952	957	field
I-Diagnostic_tool	958	963	tests
O	964	966	at
O	967	971	home
O	971	972	,
O	973	978	which
O	979	984	could
O	985	992	relieve
O	993	1001	patients
O	1002	1005	and
O	1006	1016	clinicians
O	1017	1021	from
O	1022	1024	in
O	1024	1025	-
O	1025	1031	office
O	1032	1039	testing
O	1040	1043	and
O	1044	1049	allow
O	1050	1053	for
O	1054	1058	more
O	1059	1067	frequent
O	1068	1080	examinations
O	1080	1081	.

B-Disease	1082	1090	Glaucoma
O	1091	1100	detection
O	1101	1104	and
O	1105	1116	progression
O	1117	1125	analysis
O	1126	1130	also
O	1131	1134	are
O	1135	1148	incorporating
O	1149	1162	progressively
O	1163	1167	more
O	1168	1179	information
O	1180	1183	and
O	1184	1188	will
O	1189	1191	be
O	1192	1200	improved
O	1201	1203	as
O	1204	1208	deep
O	1209	1217	learning
O	1218	1228	strategies
O	1229	1232	are
O	1233	1240	applied
O	1240	1241	.

O	1242	1249	Finally
O	1249	1250	,
B-Diagnostic_tool	1251	1261	perimetric
I-Diagnostic_tool	1262	1265	and
I-Diagnostic_tool	1266	1276	structural
I-Diagnostic_tool	1277	1284	testing
O	1285	1291	likely
O	1292	1296	will
O	1297	1303	become
O	1304	1308	more
O	1309	1316	closely
O	1317	1328	intertwined
O	1329	1331	as
O	1332	1339	testing
O	1340	1349	platforms
O	1350	1353	and
O	1354	1365	progression
O	1366	1374	analysis
O	1375	1386	incorporate
O	1387	1391	both
O	1392	1394	of
O	1395	1400	these
O	1401	1409	measures
O	1409	1410	.

B-Diagnostic_tool	1411	1417	Visual
I-Diagnostic_tool	1418	1423	field
I-Diagnostic_tool	1424	1431	testing
O	1432	1436	will
O	1437	1445	continue
O	1446	1448	to
O	1449	1453	have
O	1454	1456	an
O	1457	1466	important
O	1467	1471	role
O	1472	1474	in
O	1475	1478	the
O	1479	1488	diagnosis
O	1489	1492	and
O	1493	1503	management
O	1504	1506	of
B-Disease	1507	1515	glaucoma
O	1515	1516	.

B-Symptom	0	9	Posterior
I-Symptom	10	18	Vitreous
I-Symptom	19	29	Detachment
O	30	33	and
O	34	37	the
B-Anatomy	38	47	Posterior
I-Anatomy	48	55	Hyaloid
I-Anatomy	56	64	Membrane
O	64	65	.

O	67	74	Despite
B-Symptom	75	84	posterior
I-Symptom	85	93	vitreous
I-Symptom	94	104	detachment
O	105	110	being
O	111	112	a
O	113	119	common
O	120	126	ocular
O	127	132	event
O	133	142	affecting
O	143	147	most
O	148	159	individuals
O	160	162	in
O	163	165	an
B-Characteristic	166	171	aging
I-Characteristic	172	182	population
O	182	183	,
O	184	189	there
O	190	192	is
O	193	199	little
O	200	209	consensus
O	210	219	regarding
O	220	223	its
O	224	231	precise
O	232	240	anatomic
O	241	251	definition
O	251	252	.

O	253	255	We
O	256	268	investigated
O	269	272	the
O	273	284	morphologic
O	285	295	appearance
O	296	299	and
O	300	309	molecular
O	310	321	composition
O	322	324	of
O	325	328	the
B-Anatomy	329	338	posterior
I-Anatomy	339	346	hyaloid
I-Anatomy	347	355	membrane
O	356	358	to
O	359	368	determine
O	369	376	whether
O	377	380	the
O	381	390	structure
O	391	401	clinically
O	402	410	observed
O	411	421	enveloping
O	422	425	the
B-Anatomy	426	435	posterior
I-Anatomy	436	444	vitreous
I-Anatomy	445	452	surface
O	453	458	after
B-Symptom	459	468	posterior
I-Symptom	469	477	vitreous
I-Symptom	478	488	detachment
O	489	491	is
O	492	493	a
O	494	498	true
B-Anatomy	499	507	basement
I-Anatomy	508	516	membrane
O	517	520	and
O	521	523	to
O	524	533	postulate
O	534	537	its
O	538	544	origin
O	544	545	.

O	546	559	Understanding
O	560	563	the
O	564	576	relationship
O	577	584	between
O	585	588	the
B-Anatomy	589	597	vitreous
O	598	599	(
O	599	601	in
O	602	606	both
O	607	610	its
O	611	619	attached
O	620	623	and
O	624	632	detached
O	633	638	state
O	638	639	)
O	640	643	and
O	644	647	the
B-Anatomy	648	656	internal
I-Anatomy	657	665	limiting
I-Anatomy	666	674	membrane
I-Anatomy	675	677	of
I-Anatomy	678	681	the
I-Anatomy	682	688	retina
O	689	691	is
O	692	701	essential
O	702	704	to
O	705	718	understanding
O	719	722	the
O	723	728	cause
O	729	731	of
B-Symptom	732	746	rhegmatogenous
I-Symptom	747	754	retinal
I-Symptom	755	765	detachment
O	766	769	and
B-Disease	770	783	vitreoretinal
I-Disease	784	793	interface
I-Disease	794	803	disorders
O	803	804	,
O	805	807	as
O	808	812	well
O	813	815	as
O	816	825	potential
O	826	832	future
O	833	845	prophylactic
O	846	849	and
O	850	859	treatment
O	860	870	strategies
O	870	871	.

O	872	889	Clinicohistologic
O	890	901	correlation
O	902	907	study
O	907	908	.

O	909	915	Thirty
O	915	916	-
O	916	919	six
O	920	925	human
O	926	931	donor
O	932	938	globes
O	938	939	.

B-Anatomy	940	948	Vitreous
I-Anatomy	949	955	bodies
O	956	966	identified
O	967	969	to
O	970	974	have
B-Symptom	975	984	posterior
I-Symptom	985	993	vitreous
I-Symptom	994	1004	detachment
O	1005	1009	were
O	1010	1018	examined
O	1019	1023	with
B-Diagnostic_tool	1024	1029	phase
I-Diagnostic_tool	1029	1030	-
I-Diagnostic_tool	1030	1038	contrast
I-Diagnostic_tool	1039	1049	microscopy
O	1050	1053	and
B-Diagnostic_tool	1054	1062	confocal
I-Diagnostic_tool	1063	1073	microscopy
O	1074	1079	after
O	1080	1101	immunohistochemically
O	1102	1110	staining
O	1111	1114	for
B-Characteristic	1115	1123	collagen
I-Characteristic	1124	1126	IV
I-Characteristic	1127	1135	basement
I-Characteristic	1136	1144	membrane
I-Characteristic	1145	1152	markers
O	1152	1153	,
O	1154	1156	in
O	1157	1165	addition
O	1166	1168	to
B-Characteristic	1169	1182	extracellular
I-Characteristic	1183	1191	proteins
O	1192	1196	that
O	1197	1209	characterize
O	1210	1213	the
B-Anatomy	1214	1227	vitreoretinal
I-Anatomy	1228	1236	junction
O	1237	1238	(
B-Anatomy	1238	1249	fibronectin
O	1249	1250	,
B-Anatomy	1251	1258	laminin
O	1258	1259	)
O	1260	1263	and
B-Anatomy	1264	1272	vitreous
I-Anatomy	1273	1276	gel
O	1277	1278	(
B-Anatomy	1278	1285	opticin
O	1285	1286	)
O	1287	1294	markers
O	1294	1295	.

O	1296	1299	The
B-Anatomy	1300	1309	posterior
I-Anatomy	1310	1316	retina
O	1317	1326	similarly
O	1327	1330	was
O	1331	1338	stained
O	1339	1341	to
O	1342	1350	evaluate
O	1351	1354	the
B-Anatomy	1355	1363	internal
I-Anatomy	1364	1372	limiting
I-Anatomy	1373	1381	membrane
O	1381	1382	.

O	1383	1391	Findings
O	1392	1396	were
O	1397	1407	correlated
O	1408	1410	to
O	1411	1414	the
O	1415	1423	clinical
O	1424	1434	appearance
O	1435	1437	of
O	1438	1441	the
B-Anatomy	1442	1451	posterior
I-Anatomy	1452	1459	hyaloid
I-Anatomy	1460	1468	membrane
O	1469	1477	observed
O	1478	1484	during
B-Diagnostic_tool	1485	1489	slit
I-Diagnostic_tool	1489	1490	-
I-Diagnostic_tool	1490	1494	lamp
I-Diagnostic_tool	1495	1508	biomicroscopy
O	1509	1514	after
B-Symptom	1515	1524	posterior
I-Symptom	1525	1533	vitreous
I-Symptom	1534	1544	detachment
O	1545	1548	and
O	1549	1557	compared
O	1558	1562	with
O	1563	1573	previously
O	1574	1583	published
O	1584	1591	studies
O	1591	1592	.

O	1593	1604	Morphologic
O	1605	1615	appearance
O	1616	1619	and
O	1620	1629	molecular
O	1630	1641	composition
O	1642	1644	of
O	1645	1648	the
B-Anatomy	1649	1658	posterior
I-Anatomy	1659	1666	hyaloid
I-Anatomy	1667	1675	membrane
O	1675	1676	.

B-Diagnostic_tool	1677	1682	Phase
I-Diagnostic_tool	1682	1683	-
I-Diagnostic_tool	1683	1691	contrast
I-Diagnostic_tool	1692	1702	microscopy
O	1703	1715	consistently
O	1716	1726	identified
O	1727	1728	a
B-Symptom	1729	1736	creased
I-Symptom	1737	1740	and
I-Symptom	1741	1749	distinct
I-Symptom	1750	1756	glassy
I-Symptom	1757	1767	membranous
I-Symptom	1768	1773	sheet
I-Symptom	1774	1784	enveloping
I-Symptom	1785	1788	the
I-Symptom	1789	1798	posterior
I-Symptom	1799	1807	vitreous
I-Symptom	1808	1815	surface
O	1815	1816	,
O	1817	1828	correlating
O	1829	1836	closely
O	1837	1841	with
O	1842	1845	the
B-Anatomy	1846	1855	posterior
I-Anatomy	1856	1863	hyaloid
I-Anatomy	1864	1872	membrane
O	1873	1881	observed
O	1882	1888	during
B-Diagnostic_tool	1889	1893	slit
I-Diagnostic_tool	1893	1894	-
I-Diagnostic_tool	1894	1898	lamp
I-Diagnostic_tool	1899	1912	biomicroscopy
O	1913	1915	in
O	1916	1924	patients
O	1925	1929	with
B-Symptom	1930	1939	posterior
I-Symptom	1940	1948	vitreous
I-Symptom	1949	1959	detachment
O	1959	1960	.

B-Diagnostic_tool	1961	1978	Immunofluorescent
I-Diagnostic_tool	1979	1987	confocal
I-Diagnostic_tool	1988	1999	micrographs
O	2000	2012	demonstrated
O	2013	2016	the
B-Anatomy	2017	2027	enveloping
I-Anatomy	2028	2038	membranous
I-Anatomy	2039	2048	structure
O	2049	2059	identified
O	2060	2062	on
B-Diagnostic_tool	2063	2068	phase
I-Diagnostic_tool	2068	2069	-
I-Diagnostic_tool	2069	2077	contrast
I-Diagnostic_tool	2078	2088	microscopy
O	2089	2091	to
O	2092	2096	show
O	2097	2105	positive
O	2106	2111	stain
O	2112	2119	results
O	2120	2123	for
O	2124	2128	type
O	2129	2131	IV
O	2132	2140	collagen
O	2140	2141	.

B-Diagnostic_tool	2142	2160	Immunofluorescence
O	2161	2163	of
O	2164	2167	the
O	2168	2176	residual
O	2177	2183	intact
B-Anatomy	2184	2192	internal
I-Anatomy	2193	2201	limiting
I-Anatomy	2202	2210	membrane
O	2211	2213	on
O	2214	2217	the
B-Anatomy	2218	2225	retinal
I-Anatomy	2226	2233	surface
O	2234	2238	also
O	2239	2245	showed
O	2246	2254	positive
O	2255	2260	stain
O	2261	2268	results
O	2269	2272	for
O	2273	2277	type
O	2278	2280	IV
O	2281	2289	collagen
O	2289	2290	.

O	2291	2294	The
O	2295	2302	results
O	2303	2305	of
O	2306	2310	this
O	2311	2316	study
O	2317	2324	provide
O	2325	2344	immunohistochemical
O	2345	2353	evidence
O	2354	2358	that
O	2359	2362	the
B-Anatomy	2363	2372	posterior
I-Anatomy	2373	2380	hyaloid
I-Anatomy	2381	2389	membrane
O	2390	2392	is
O	2393	2394	a
O	2395	2399	true
B-Anatomy	2400	2408	basement
I-Anatomy	2409	2417	membrane
O	2418	2428	enveloping
O	2429	2432	the
B-Anatomy	2433	2442	posterior
I-Anatomy	2443	2450	hyaloid
I-Anatomy	2451	2458	surface
O	2458	2459	.

O	2460	2467	Because
O	2468	2472	this
O	2473	2483	membranous
O	2484	2493	structure
O	2494	2496	is
O	2497	2505	observed
O	2506	2510	only
O	2511	2516	after
B-Symptom	2517	2526	posterior
I-Symptom	2527	2535	vitreous
I-Symptom	2536	2546	detachment
O	2546	2547	,
O	2548	2551	the
O	2552	2559	results
O	2560	2562	of
O	2563	2567	this
O	2568	2573	study
O	2574	2582	indicate
O	2583	2587	that
O	2588	2590	it
O	2591	2596	forms
O	2597	2601	part
O	2602	2604	of
O	2605	2608	the
B-Anatomy	2609	2617	internal
I-Anatomy	2618	2626	limiting
I-Anatomy	2627	2635	membrane
O	2636	2640	when
O	2641	2644	the
B-Anatomy	2645	2653	vitreous
O	2654	2656	is
O	2657	2659	in
O	2660	2663	its
O	2664	2672	attached
O	2673	2678	state
O	2678	2679	.

O	0	6	Update
O	7	9	in
O	10	17	Current
O	18	29	Diagnostics
O	30	33	and
O	34	46	Therapeutics
O	47	49	of
B-Disease	50	53	Dry
I-Disease	54	57	Eye
I-Disease	58	65	Disease
O	65	66	.

B-Disease	68	71	Dry
I-Disease	72	75	eye
I-Disease	76	83	disease
O	84	85	(
B-Disease	85	88	DED
O	88	89	)
O	90	100	represents
O	101	102	a
O	103	116	heterogeneous
O	117	122	group
O	123	125	of
O	126	136	conditions
O	137	141	with
B-Symptom	142	146	tear
I-Symptom	147	151	film
I-Symptom	152	165	insufficiency
O	166	169	and
O	170	175	signs
O	176	179	and
O	179	180	/
O	180	182	or
O	183	191	symptoms
O	192	194	of
B-Symptom	195	201	ocular
I-Symptom	202	209	surface
I-Symptom	210	220	irritation
O	220	221	.

O	222	225	The
O	226	234	clinical
O	235	249	manifestations
O	250	252	of
B-Disease	253	256	DED
O	257	260	can
O	261	263	be
O	264	270	highly
O	271	279	variable
O	279	280	;
O	281	286	hence
O	287	290	the
O	291	300	diagnosis
O	301	303	is
O	304	309	often
O	310	315	based
O	316	318	on
O	319	320	a
O	321	332	combination
O	333	335	of
O	336	344	symptoms
O	344	345	,
O	346	351	signs
O	351	352	,
O	353	356	and
O	357	365	clinical
O	366	371	tests
O	371	372	,
O	373	378	given
O	379	383	that
O	384	387	any
O	388	391	one
O	392	394	of
O	395	400	these
O	401	406	alone
O	407	412	would
O	413	417	miss
O	418	419	a
O	420	431	significant
O	432	438	number
O	439	441	of
O	442	450	patients
O	450	451	.

O	452	461	Similarly
O	461	462	,
O	463	466	the
O	467	476	treatment
O	477	481	must
O	482	487	often
O	488	490	be
O	491	499	tailored
O	500	502	to
O	503	507	each
O	508	515	patient
O	516	518	by
O	519	528	targeting
O	529	532	the
O	533	541	specific
O	542	552	mechanisms
O	553	561	involved
O	562	564	in
O	565	568	his
O	569	571	or
O	572	575	her
O	576	583	disease
O	583	584	.

O	585	588	The
O	589	596	purpose
O	597	599	of
O	600	604	this
O	605	611	review
O	612	614	is
O	615	617	to
O	618	627	summarize
O	628	634	recent
O	635	643	advances
O	644	648	that
O	649	653	have
O	654	661	allowed
O	662	664	us
O	665	667	to
O	668	674	better
O	675	684	recognize
O	684	685	,
O	686	696	categorize
O	696	697	,
O	698	701	and
O	702	707	treat
O	708	716	patients
O	717	721	with
B-Disease	722	725	DED
O	725	726	.

O	727	730	The
O	731	735	most
O	736	743	notable
O	744	747	new
O	748	758	diagnostic
O	759	764	tests
O	765	767	in
B-Disease	768	771	DED
O	772	775	are
B-Diagnostic_tool	776	780	tear
I-Diagnostic_tool	781	785	film
I-Diagnostic_tool	786	796	osmolarity
O	796	797	,
B-Diagnostic_tool	798	810	inflammatory
I-Diagnostic_tool	811	821	biomarkers
O	821	822	,
O	823	826	and
B-Diagnostic_tool	827	836	meibomian
I-Diagnostic_tool	837	842	gland
I-Diagnostic_tool	843	850	imaging
O	850	851	.

O	852	867	Therapeutically
O	867	868	,
O	869	873	anti
O	873	874	-
O	874	886	inflammatory
O	887	894	therapy
O	894	895	,
O	896	905	meibomian
O	906	911	gland
O	912	919	heating
O	920	923	and
O	924	934	expression
O	934	935	,
O	936	939	and
O	940	947	scleral
O	948	955	contact
O	956	962	lenses
O	963	966	are
O	967	971	some
O	972	974	of
O	975	978	the
O	979	985	latest
O	986	993	options
O	994	1003	available
O	1004	1007	for
O	1008	1016	treating
B-Disease	1017	1020	DED
O	1020	1021	.

O	0	3	The
O	4	15	Progression
O	16	18	of
B-Disease	19	29	Geographic
I-Disease	30	37	Atrophy
O	38	47	Secondary
O	48	50	to
B-Disease	51	54	Age
I-Disease	54	55	-
I-Disease	55	62	Related
I-Disease	63	70	Macular
I-Disease	71	83	Degeneration
O	83	84	.

B-Disease	86	96	Geographic
I-Disease	97	104	atrophy
O	105	106	(
B-Disease	106	108	GA
O	108	109	)
O	110	112	is
O	113	115	an
O	116	124	advanced
O	125	129	form
O	130	132	of
B-Disease	133	136	age
I-Disease	136	137	-
I-Disease	137	144	related
I-Disease	145	152	macular
I-Disease	153	165	degeneration
O	166	167	(
B-Disease	167	170	AMD
O	170	171	)
O	172	176	that
O	177	182	leads
O	183	185	to
O	186	197	progressive
O	198	201	and
B-Symptom	202	214	irreversible
I-Symptom	215	219	loss
I-Symptom	220	222	of
I-Symptom	223	229	visual
I-Symptom	230	238	function
O	238	239	.

B-Disease	240	250	Geographic
I-Disease	251	258	atrophy
O	259	261	is
O	262	269	defined
O	270	272	by
O	273	276	the
O	277	285	presence
O	286	288	of
B-Symptom	289	296	sharply
I-Symptom	297	307	demarcated
I-Symptom	308	316	atrophic
I-Symptom	317	324	lesions
I-Symptom	325	327	of
I-Symptom	328	331	the
I-Symptom	332	337	outer
I-Symptom	338	344	retina
O	344	345	,
O	346	355	resulting
O	356	360	from
B-Symptom	361	365	loss
I-Symptom	366	368	of
I-Symptom	369	383	photoreceptors
I-Symptom	383	384	,
I-Symptom	385	392	retinal
I-Symptom	393	400	pigment
I-Symptom	401	411	epithelium
I-Symptom	412	413	(
I-Symptom	413	416	RPE
I-Symptom	416	417	)
I-Symptom	417	418	,
I-Symptom	419	422	and
I-Symptom	423	433	underlying
I-Symptom	434	450	choriocapillaris
O	450	451	.

O	452	457	These
O	458	465	lesions
O	466	475	typically
O	476	482	appear
O	483	488	first
O	489	491	in
O	492	495	the
B-Anatomy	496	506	perifoveal
I-Anatomy	507	513	macula
O	513	514	,
O	515	524	initially
O	525	532	sparing
O	533	536	the
B-Anatomy	537	543	foveal
I-Anatomy	544	550	center
O	550	551	,
O	552	555	and
O	556	560	over
O	561	565	time
O	566	571	often
O	572	578	expand
O	579	582	and
O	583	591	coalesce
O	592	594	to
O	595	602	include
O	603	606	the
B-Anatomy	607	612	fovea
O	612	613	.

O	614	622	Although
O	623	626	the
O	627	635	kinetics
O	636	638	of
B-Disease	639	641	GA
O	642	653	progression
O	654	657	are
O	658	664	highly
O	665	673	variable
O	674	679	among
O	680	690	individual
O	691	699	patients
O	699	700	,
O	701	702	a
O	703	710	growing
O	711	715	body
O	716	718	of
O	719	727	evidence
O	728	736	suggests
O	737	741	that
O	742	750	specific
O	751	766	characteristics
O	767	770	may
O	771	773	be
O	774	783	important
O	784	786	in
O	787	797	predicting
O	798	805	disease
O	806	817	progression
O	818	821	and
O	822	830	outcomes
O	830	831	.

O	832	836	This
O	837	843	review
O	844	855	synthesizes
O	856	863	current
O	864	877	understanding
O	878	880	of
B-Disease	881	883	GA
O	884	895	progression
O	896	898	in
B-Disease	899	902	AMD
O	903	906	and
O	907	910	the
O	911	918	factors
O	919	924	known
O	925	927	or
O	928	938	postulated
O	939	941	to
O	942	944	be
O	945	953	relevant
O	954	956	to
B-Symptom	957	959	GA
I-Symptom	960	966	lesion
I-Symptom	967	978	enlargement
O	978	979	,
O	980	989	including
O	990	994	both
O	995	1003	affected
O	1004	1007	and
O	1008	1014	fellow
B-Anatomy	1015	1018	eye
O	1019	1034	characteristics
O	1034	1035	.

O	1036	1038	In
O	1039	1047	addition
O	1047	1048	,
O	1049	1052	the
O	1053	1058	roles
O	1059	1061	of
O	1062	1069	genetic
O	1069	1070	,
O	1071	1084	environmental
O	1084	1085	,
O	1086	1089	and
O	1090	1101	demographic
O	1102	1109	factors
O	1110	1112	in
B-Symptom	1113	1115	GA
I-Symptom	1116	1122	lesion
O	1123	1134	enlargement
O	1135	1138	are
O	1139	1148	discussed
O	1148	1149	.

O	1150	1157	Overall
O	1157	1158	,
B-Disease	1159	1161	GA
O	1162	1173	progression
O	1174	1179	rates
O	1180	1188	reported
O	1189	1191	in
O	1192	1195	the
O	1196	1206	literature
O	1207	1210	for
O	1211	1216	total
O	1217	1222	study
O	1223	1234	populations
O	1235	1240	range
O	1241	1245	from
O	1246	1247	0
O	1247	1248	.
O	1248	1250	53
O	1251	1253	to
O	1254	1255	2
O	1255	1256	.
O	1256	1257	6
O	1258	1260	mm
O	1261	1262	2

O	0	12	Personalized
O	13	23	Prediction
O	24	26	of
B-Disease	27	35	Glaucoma
O	36	47	Progression
O	48	53	Under
O	54	63	Different
O	64	70	Target
B-Characteristic	71	82	Intraocular
I-Characteristic	83	91	Pressure
I-Characteristic	92	98	Levels
O	99	104	Using
B-Diagnostic_tool	105	113	Filtered
I-Diagnostic_tool	114	125	Forecasting
I-Diagnostic_tool	126	133	Methods
O	133	134	.

O	136	138	To
O	139	147	generate
O	148	160	personalized
O	161	170	forecasts
O	171	173	of
O	174	177	how
O	178	186	patients
O	187	191	with
B-Disease	192	196	open
I-Disease	196	197	-
I-Disease	197	202	angle
I-Disease	203	211	glaucoma
O	212	213	(
B-Disease	213	216	OAG
O	216	217	)
O	218	228	experience
O	229	236	disease
O	237	248	progression
O	249	251	at
O	252	261	different
B-Characteristic	262	273	intraocular
I-Characteristic	274	282	pressure
O	283	284	(
B-Characteristic	284	287	IOP
O	287	288	)
O	289	295	levels
O	296	298	to
O	299	302	aid
O	303	313	clinicians
O	314	318	with
O	319	326	setting
O	327	339	personalized
O	340	346	target
B-Characteristic	347	351	IOPs
O	351	352	.

O	353	362	Secondary
O	363	371	analyses
O	372	377	using
O	378	390	longitudinal
O	391	395	data
O	396	400	from
O	401	402	2
O	403	413	randomized
O	414	424	controlled
O	425	431	trials
O	431	432	.

O	433	445	Participants
O	446	450	with
B-Disease	451	459	moderate
I-Disease	460	462	or
I-Disease	463	471	advanced
I-Disease	472	475	OAG
O	476	480	from
O	481	484	the
O	485	498	Collaborative
O	499	506	Initial
B-Disease	507	515	Glaucoma
O	516	525	Treatment
O	526	531	Study
O	532	533	(
O	533	538	CIGTS
O	538	539	)
O	540	542	or
O	543	546	the
B-Disease	547	555	Advanced
I-Disease	556	564	Glaucoma
O	565	577	Intervention
O	578	583	Study
O	584	585	(
O	585	589	AGIS
O	589	590	)
O	590	591	.

O	592	594	By
O	595	600	using
O	601	611	perimetric
O	612	615	and
O	616	626	tonometric
O	627	631	data
O	632	636	from
O	637	642	trial
O	643	655	participants
O	655	656	,
O	657	659	we
O	660	669	developed
O	670	673	and
O	674	683	validated
O	684	690	Kalman
O	691	697	Filter
O	698	699	(
O	699	701	KF
O	701	702	)
O	703	709	models
O	710	713	for
O	714	718	fast
O	718	719	-
O	719	720	,
O	721	725	slow
O	725	726	-
O	726	727	,
O	728	731	and
O	732	746	nonprogressing
O	747	755	patients
O	756	760	with
B-Disease	761	764	OAG
O	764	765	.

O	766	769	The
O	770	772	KF
O	773	776	can
O	777	785	generate
O	786	798	personalized
O	799	802	and
O	803	814	dynamically
O	815	822	updated
O	823	832	forecasts
O	833	835	of
B-Disease	836	839	OAG
O	840	851	progression
O	852	857	under
O	858	867	different
O	868	874	target
B-Characteristic	875	878	IOP
O	879	885	levels
O	885	886	.

O	887	890	For
O	891	895	each
O	896	907	participant
O	907	908	,
O	909	911	we
O	912	922	determined
O	923	926	how
O	927	931	mean
O	932	941	deviation
O	942	943	(
O	943	945	MD
O	945	946	)
O	947	952	would
O	953	959	change
O	960	962	if
O	963	966	the
O	967	974	patient
O	975	984	maintains
O	985	988	his
O	988	989	/
O	989	992	her
B-Characteristic	993	996	IOP
O	997	999	at
O	1000	1001	1
O	1002	1004	of
O	1005	1006	7
O	1007	1013	levels
O	1014	1015	(
O	1015	1016	6
O	1016	1017	,
O	1018	1019	9
O	1019	1020	,
O	1021	1023	12
O	1023	1024	,
O	1025	1027	15
O	1027	1028	,
O	1029	1031	18
O	1031	1032	,
O	1033	1035	21
O	1035	1036	,
O	1037	1039	or
O	1040	1042	24
O	1043	1047	mmHg
O	1047	1048	)
O	1049	1053	over
O	1054	1057	the
O	1058	1062	next
O	1063	1064	5
O	1065	1070	years
O	1070	1071	.

O	1072	1074	We
O	1075	1079	also
O	1080	1085	model
O	1086	1089	and
O	1090	1097	predict
O	1098	1105	changes
O	1106	1108	to
O	1109	1111	MD
O	1112	1116	over
O	1117	1120	the
O	1121	1125	same
O	1126	1130	time
O	1131	1138	horizon
O	1139	1141	if
B-Characteristic	1142	1145	IOP
O	1146	1148	is
O	1149	1158	increased
O	1159	1161	or
O	1162	1171	decreased
O	1172	1174	by
O	1175	1176	3
O	1176	1177	,
O	1178	1179	6
O	1179	1180	,
O	1181	1184	and
O	1185	1186	9
O	1187	1191	mmHg
O	1192	1196	from
O	1197	1200	the
O	1201	1206	level
O	1207	1215	attained
O	1216	1218	in
O	1219	1222	the
O	1223	1229	trials
O	1229	1230	.

O	1231	1243	Personalized
O	1244	1253	estimates
O	1254	1256	of
O	1257	1260	the
O	1261	1267	change
O	1268	1270	in
O	1271	1273	MD
O	1274	1279	under
O	1280	1289	different
O	1290	1296	target
B-Characteristic	1297	1300	IOP
O	1301	1307	levels
O	1307	1308	.

O	1309	1310	A
O	1311	1316	total
O	1317	1319	of
O	1320	1323	571
O	1324	1336	participants
O	1337	1338	(
O	1338	1342	mean
O	1343	1346	age
O	1346	1347	,
O	1348	1350	64
O	1350	1351	.
O	1351	1352	2
O	1353	1358	years
O	1358	1359	;
O	1360	1368	standard
O	1369	1378	deviation
O	1378	1379	,
O	1380	1382	10
O	1382	1383	.
O	1383	1384	9
O	1384	1385	)
O	1386	1390	were
O	1391	1399	followed
O	1400	1403	for
O	1404	1405	a
O	1406	1410	mean
O	1411	1413	of
O	1414	1415	6
O	1415	1416	.
O	1416	1417	5
O	1418	1423	years
O	1424	1425	(
O	1425	1433	standard
O	1434	1443	deviation
O	1443	1444	,
O	1445	1446	2
O	1446	1447	.
O	1447	1448	8
O	1448	1449	)
O	1449	1450	.

O	1451	1454	Our
O	1455	1461	models
O	1462	1471	predicted
O	1472	1476	that
O	1476	1477	,
O	1478	1480	on
O	1481	1488	average
O	1488	1489	,
O	1490	1494	fast
O	1495	1506	progressors
O	1507	1512	would
O	1513	1517	lose
O	1518	1519	2
O	1519	1520	.
O	1520	1521	1
O	1521	1522	,
O	1523	1524	6
O	1524	1525	.
O	1525	1526	7
O	1526	1527	,
O	1528	1531	and
O	1532	1534	11
O	1534	1535	.
O	1535	1536	2
O	1537	1545	decibels
O	1546	1547	(
O	1547	1549	dB
O	1549	1550	)
O	1551	1553	MD
O	1554	1559	under
O	1560	1566	target
B-Characteristic	1567	1571	IOPs
O	1572	1574	of
O	1575	1576	6
O	1576	1577	,
O	1578	1580	15
O	1580	1581	,
O	1582	1585	and
O	1586	1588	24
O	1589	1593	mmHg
O	1593	1594	,
O	1595	1607	respectively
O	1607	1608	,
O	1609	1613	over
O	1614	1615	5
O	1616	1621	years
O	1621	1622	.

O	1623	1625	In
O	1626	1634	contrast
O	1634	1635	,
O	1636	1638	on
O	1639	1646	average
O	1646	1647	,
O	1648	1652	slow
O	1653	1664	progressors
O	1665	1670	would
O	1671	1675	lose
O	1676	1677	0
O	1677	1678	.
O	1678	1679	8
O	1679	1680	,
O	1681	1682	2
O	1682	1683	.
O	1683	1684	1
O	1684	1685	,
O	1686	1689	and
O	1690	1691	4
O	1691	1692	.
O	1692	1693	1
O	1694	1696	dB
O	1697	1699	MD
O	1700	1705	under
O	1706	1709	the
O	1710	1714	same
O	1715	1721	target
B-Characteristic	1722	1726	IOPs
O	1727	1730	and
O	1731	1735	time
O	1736	1741	frame
O	1741	1742	.

O	1743	1747	When
O	1748	1753	using
O	1754	1757	our
O	1758	1762	tool
O	1763	1765	to
O	1766	1774	quantify
O	1775	1778	the
B-Disease	1779	1782	OAG
O	1783	1794	progression
O	1795	1803	dynamics
O	1804	1807	for
O	1808	1811	all
O	1812	1815	571
O	1816	1824	patients
O	1824	1825	,
O	1826	1828	we
O	1829	1834	found
O	1835	1837	no
O	1838	1851	statistically
O	1852	1863	significant
O	1864	1875	differences
O	1876	1880	over
O	1881	1882	5
O	1883	1888	years
O	1889	1896	between
O	1897	1908	progression
O	1909	1912	for
B-Characteristic	1913	1918	black
I-Characteristic	1919	1925	versus
I-Characteristic	1926	1931	white
O	1931	1932	,
B-Characteristic	1933	1937	male
I-Characteristic	1938	1944	versus
I-Characteristic	1945	1951	female
O	1951	1952	,
O	1953	1956	and
O	1957	1962	CIGTS
O	1963	1969	versus
O	1970	1974	AGIS
O	1975	1987	participants
O	1988	1993	under
O	1994	2003	different
O	2004	2010	target
B-Characteristic	2011	2015	IOPs
O	2016	2017	(
O	2017	2018	P
O	2020	2021	>
O	2023	2024	0
O	2024	2025	.
O	2025	2027	05
O	2028	2031	for
O	2032	2035	all
O	2035	2036	)
O	2036	2037	.

O	2038	2040	To
O	2041	2044	our
O	2045	2054	knowledge
O	2054	2055	,
O	2056	2060	this
O	2061	2063	is
O	2064	2067	the
O	2068	2073	first
O	2074	2082	clinical
O	2083	2091	decision
O	2091	2092	-
O	2092	2098	making
O	2099	2103	tool
O	2104	2108	that
O	2109	2118	generates
O	2119	2131	personalized
O	2132	2141	forecasts
O	2142	2144	of
O	2145	2148	the
O	2149	2159	trajectory
O	2160	2162	of
B-Disease	2163	2166	OAG
O	2167	2178	progression
O	2179	2181	at
O	2182	2191	different
O	2192	2198	target
B-Characteristic	2199	2202	IOP
O	2203	2209	levels
O	2209	2210	.

O	2211	2215	This
O	2216	2224	approach
O	2225	2228	can
O	2229	2233	help
O	2234	2244	clinicians
O	2245	2254	determine
O	2255	2266	appropriate
O	2266	2267	,
O	2268	2280	personalized
O	2281	2287	target
B-Characteristic	2288	2292	IOPs
O	2293	2296	for
O	2297	2305	patients
O	2306	2310	with
B-Disease	2311	2314	OAG
O	2314	2315	.

O	0	5	Fully
O	6	15	Automated
O	16	25	Detection
O	26	29	and
O	30	44	Quantification
O	45	47	of
B-Symptom	48	55	Macular
I-Symptom	56	61	Fluid
O	62	64	in
B-Diagnostic_tool	65	68	OCT
O	69	74	Using
B-Diagnostic_tool	75	79	Deep
I-Diagnostic_tool	80	88	Learning
O	88	89	.

O	91	102	Development
O	103	106	and
O	107	117	validation
O	118	120	of
O	121	122	a
O	123	128	fully
O	129	138	automated
O	139	145	method
O	146	148	to
O	149	155	detect
O	156	159	and
O	160	168	quantify
B-Symptom	169	176	macular
I-Symptom	177	182	fluid
O	183	185	in
O	186	198	conventional
B-Diagnostic_tool	199	202	OCT
I-Diagnostic_tool	203	209	images
O	209	210	.

O	211	222	Development
O	223	225	of
O	226	227	a
O	228	238	diagnostic
O	239	247	modality
O	247	248	.

O	249	252	The
O	253	261	clinical
O	262	269	dataset
O	270	273	for
O	274	279	fluid
O	280	289	detection
O	290	299	consisted
O	300	302	of
O	303	307	1200
B-Diagnostic_tool	308	311	OCT
I-Diagnostic_tool	312	319	volumes
O	320	322	of
O	323	331	patients
O	332	336	with
B-Disease	337	348	neovascular
I-Disease	349	352	age
I-Disease	352	353	-
I-Disease	353	360	related
I-Disease	361	368	macular
I-Disease	369	381	degeneration
O	382	383	(
B-Disease	383	386	AMD
O	386	387	,
O	388	389	n
O	390	391	=
O	392	395	400
O	395	396	)
O	396	397	,
B-Disease	398	406	diabetic
I-Disease	407	414	macular
I-Disease	415	420	edema
O	421	422	(
B-Disease	422	425	DME
O	425	426	,
O	427	428	n
O	429	430	=
O	431	434	400
O	434	435	)
O	435	436	,
O	437	439	or
B-Disease	440	447	retinal
I-Disease	448	452	vein
I-Disease	453	462	occlusion
O	463	464	(
B-Disease	464	467	RVO
O	467	468	,
O	469	470	n
O	471	472	=
O	473	476	400
O	476	477	)
O	478	486	acquired
O	487	491	with
B-Diagnostic_tool	492	497	Zeiss
I-Diagnostic_tool	498	504	Cirrus
O	505	506	(
O	506	510	Carl
O	511	516	Zeiss
O	517	524	Meditec
O	524	525	,
O	526	532	Dublin
O	532	533	,
O	534	536	CA
O	536	537	)
O	538	539	(
O	539	540	n
O	541	542	=
O	543	546	600
O	546	547	)
O	548	550	or
B-Diagnostic_tool	551	561	Heidelberg
I-Diagnostic_tool	562	572	Spectralis
O	573	574	(
O	574	584	Heidelberg
O	585	596	Engineering
O	596	597	,
O	598	608	Heidelberg
O	608	609	,
O	610	617	Germany
O	617	618	)
O	619	620	(
O	620	621	n
O	622	623	=
O	624	627	600
O	627	628	)
B-Diagnostic_tool	629	632	OCT
O	633	640	devices
O	640	641	.

O	642	643	A
O	644	650	method
O	651	656	based
O	657	659	on
B-Diagnostic_tool	660	664	deep
I-Diagnostic_tool	665	673	learning
O	674	676	to
O	677	690	automatically
O	691	697	detect
O	698	701	and
O	702	710	quantify
B-Symptom	711	723	intraretinal
I-Symptom	724	731	cystoid
I-Symptom	732	737	fluid
O	738	739	(
B-Symptom	739	742	IRC
O	742	743	)
O	744	747	and
B-Symptom	748	758	subretinal
I-Symptom	759	764	fluid
O	765	766	(
B-Symptom	766	769	SRF
O	769	770	)
O	771	774	was
O	775	784	developed
O	784	785	.

O	786	789	The
O	790	801	performance
O	802	804	of
O	805	808	the
O	809	818	algorithm
O	819	821	in
O	822	832	accurately
O	833	844	identifying
O	845	850	fluid
O	851	863	localization
O	864	867	and
O	868	874	extent
O	875	878	was
O	879	888	evaluated
O	889	896	against
O	897	898	a
O	899	905	manual
O	906	915	consensus
O	916	923	reading
O	924	926	of
O	927	928	2
O	929	935	masked
O	936	943	reading
O	944	950	center
O	951	958	graders
O	958	959	.

O	960	971	Performance
O	972	974	of
O	975	976	a
O	977	982	fully
O	983	992	automated
O	993	999	method
O	1000	1002	to
O	1003	1013	accurately
O	1014	1020	detect
O	1020	1021	,
O	1022	1035	differentiate
O	1035	1036	,
O	1037	1040	and
O	1041	1049	quantify
B-Symptom	1050	1062	intraretinal
I-Symptom	1063	1066	and
I-Symptom	1067	1070	SRF
O	1071	1076	using
O	1077	1081	area
O	1082	1087	under
O	1088	1091	the
O	1092	1100	receiver
O	1101	1110	operating
O	1111	1126	characteristics
O	1127	1133	curves
O	1133	1134	,
O	1135	1144	precision
O	1144	1145	,
O	1146	1149	and
O	1150	1156	recall
O	1156	1157	.

O	1158	1161	The
O	1162	1167	newly
O	1168	1176	designed
O	1176	1177	,
O	1178	1183	fully
O	1184	1193	automated
O	1194	1204	diagnostic
O	1205	1211	method
O	1212	1217	based
O	1218	1220	on
B-Diagnostic_tool	1221	1225	deep
I-Diagnostic_tool	1226	1234	learning
O	1235	1243	achieved
O	1244	1251	optimal
O	1252	1260	accuracy
O	1261	1264	for
O	1265	1268	the
O	1269	1278	detection
O	1279	1282	and
O	1283	1297	quantification
O	1298	1300	of
B-Symptom	1301	1304	IRC
O	1305	1308	for
O	1309	1312	all
O	1313	1314	3
B-Anatomy	1315	1322	macular
O	1323	1334	pathologies
O	1335	1339	with
O	1340	1341	a
O	1342	1346	mean
O	1347	1355	accuracy
O	1356	1357	(
O	1357	1360	AUC
O	1360	1361	)
O	1362	1364	of
O	1365	1366	0
O	1366	1367	.
O	1367	1369	94
O	1370	1371	(
O	1371	1376	range
O	1376	1377	,
O	1378	1379	0
O	1379	1380	.
O	1380	1382	91
O	1382	1383	-
O	1383	1384	0
O	1384	1385	.
O	1385	1387	97
O	1387	1388	)
O	1388	1389	,
O	1390	1391	a
O	1392	1396	mean
O	1397	1406	precision
O	1407	1409	of
O	1410	1411	0
O	1411	1412	.
O	1412	1414	91
O	1414	1415	,
O	1416	1419	and
O	1420	1421	a
O	1422	1426	mean
O	1427	1433	recall
O	1434	1436	of
O	1437	1438	0
O	1438	1439	.
O	1439	1441	84
O	1441	1442	.

O	1443	1446	The
O	1447	1456	detection
O	1457	1460	and
O	1461	1472	measurement
O	1473	1475	of
B-Symptom	1476	1479	SRF
O	1480	1484	were
O	1485	1489	also
O	1490	1496	highly
O	1497	1505	accurate
O	1506	1510	with
O	1511	1513	an
O	1514	1517	AUC
O	1518	1520	of
O	1521	1522	0
O	1522	1523	.
O	1523	1525	92
O	1526	1527	(
O	1527	1532	range
O	1532	1533	,
O	1534	1535	0
O	1535	1536	.
O	1536	1538	86
O	1538	1539	-
O	1539	1540	0
O	1540	1541	.
O	1541	1543	98
O	1543	1544	)
O	1544	1545	,
O	1546	1547	a
O	1548	1552	mean
O	1553	1562	precision
O	1563	1565	of
O	1566	1567	0
O	1567	1568	.
O	1568	1570	61
O	1570	1571	,
O	1572	1575	and
O	1576	1577	a
O	1578	1582	mean
O	1583	1589	recall
O	1590	1592	of
O	1593	1594	0
O	1594	1595	.
O	1595	1597	81
O	1597	1598	,
O	1599	1603	with
O	1604	1612	superior
O	1613	1624	performance
O	1625	1627	in
B-Disease	1628	1639	neovascular
I-Disease	1640	1643	AMD
O	1644	1647	and
B-Disease	1648	1651	RVO
O	1652	1660	compared
O	1661	1665	with
B-Disease	1666	1669	DME
O	1669	1670	,
O	1671	1676	which
O	1677	1680	was
O	1681	1692	represented
O	1693	1699	rarely
O	1700	1702	in
O	1703	1706	the
O	1707	1717	population
O	1718	1725	studied
O	1725	1726	.

O	1727	1731	High
O	1732	1738	linear
O	1739	1750	correlation
O	1751	1754	was
O	1755	1764	confirmed
O	1765	1772	between
O	1773	1782	automated
O	1783	1786	and
O	1787	1793	manual
O	1794	1799	fluid
O	1800	1812	localization
O	1813	1816	and
O	1817	1831	quantification
O	1831	1832	,
O	1833	1841	yielding
O	1842	1844	an
O	1845	1852	average
O	1853	1860	Pearson
O	1860	1861	'
O	1861	1862	s
O	1863	1874	correlation
O	1875	1886	coefficient
O	1887	1889	of
O	1890	1891	0
O	1891	1892	.
O	1892	1894	90
O	1895	1898	for
B-Symptom	1899	1902	IRC
O	1903	1906	and
O	1907	1909	of
O	1910	1911	0
O	1911	1912	.
O	1912	1914	96
O	1915	1918	for
B-Symptom	1919	1922	SRF
O	1922	1923	.

B-Diagnostic_tool	1924	1928	Deep
I-Diagnostic_tool	1929	1937	learning
O	1938	1940	in
B-Diagnostic_tool	1941	1948	retinal
I-Diagnostic_tool	1949	1954	image
I-Diagnostic_tool	1955	1963	analysis
O	1964	1972	achieves
O	1973	1982	excellent
O	1983	1991	accuracy
O	1992	1995	for
O	1996	1999	the
O	2000	2012	differential
O	2013	2022	detection
O	2023	2025	of
B-Symptom	2026	2033	retinal
I-Symptom	2034	2039	fluid
O	2040	2045	types
O	2046	2052	across
O	2053	2056	the
O	2057	2061	most
O	2062	2071	prevalent
B-Disease	2072	2081	exudative
I-Disease	2082	2089	macular
I-Disease	2090	2098	diseases
O	2099	2102	and
B-Diagnostic_tool	2103	2106	OCT
O	2107	2114	devices
O	2114	2115	.

O	2116	2127	Furthermore
O	2127	2128	,
O	2129	2143	quantification
O	2144	2146	of
O	2147	2152	fluid
O	2153	2161	achieves
O	2162	2163	a
O	2164	2168	high
O	2169	2174	level
O	2175	2177	of
O	2178	2189	concordance
O	2190	2194	with
O	2195	2201	manual
O	2202	2208	expert
O	2209	2219	assessment
O	2219	2220	.

O	2221	2226	Fully
O	2227	2236	automated
O	2237	2245	analysis
O	2246	2248	of
B-Diagnostic_tool	2249	2256	retinal
I-Diagnostic_tool	2257	2260	OCT
I-Diagnostic_tool	2261	2267	images
O	2268	2272	from
O	2273	2281	clinical
O	2282	2289	routine
O	2290	2298	provides
O	2299	2300	a
O	2301	2310	promising
O	2311	2318	horizon
O	2319	2321	in
O	2322	2331	improving
O	2332	2340	accuracy
O	2341	2344	and
O	2345	2356	reliability
O	2357	2359	of
B-Anatomy	2360	2367	retinal
O	2368	2377	diagnosis
O	2378	2381	for
O	2382	2390	research
O	2391	2394	and
O	2395	2403	clinical
O	2404	2412	practice
O	2413	2415	in
O	2416	2429	ophthalmology
O	2429	2430	.

O	0	3	The
O	4	12	DISCOVER
O	13	18	Study
O	19	20	3
O	20	21	-
O	21	25	Year
O	26	33	Results
O	33	34	:
O	35	46	Feasibility
O	47	50	and
O	51	61	Usefulness
O	62	64	of
B-Diagnostic_tool	65	75	Microscope
I-Diagnostic_tool	75	76	-
I-Diagnostic_tool	76	86	Integrated
I-Diagnostic_tool	87	101	Intraoperative
I-Diagnostic_tool	102	105	OCT
O	106	112	during
O	113	123	Ophthalmic
O	124	131	Surgery
O	131	132	.

O	134	136	To
O	137	143	report
O	144	147	the
O	148	149	3
O	149	150	-
O	150	154	year
O	155	165	assessment
O	166	168	of
O	169	180	feasibility
O	181	184	and
O	185	195	usefulness
O	196	198	of
B-Diagnostic_tool	199	209	microscope
I-Diagnostic_tool	209	210	-
I-Diagnostic_tool	210	220	integrated
I-Diagnostic_tool	221	235	intraoperative
I-Diagnostic_tool	236	239	OCT
O	240	241	(
B-Diagnostic_tool	241	245	iOCT
O	245	246	)
O	247	253	during
O	254	264	ophthalmic
O	265	272	surgery
O	272	273	.

O	274	285	Prospective
O	285	286	,
O	287	298	consecutive
O	299	303	case
O	304	310	series
O	310	311	.

O	312	317	Adult
O	318	330	participants
O	331	341	undergoing
O	342	352	incisional
O	353	363	ophthalmic
O	364	371	surgery
O	372	376	with
B-Diagnostic_tool	377	381	iOCT
O	382	389	imaging
O	390	393	who
O	394	403	consented
O	404	406	to
O	407	409	be
O	410	418	enrolled
O	419	421	in
O	422	425	the
O	426	439	Determination
O	440	442	of
O	443	454	Feasibility
O	455	457	of
B-Diagnostic_tool	458	472	Intraoperative
I-Diagnostic_tool	473	481	Spectral
I-Diagnostic_tool	481	482	-
I-Diagnostic_tool	482	488	Domain
I-Diagnostic_tool	489	499	Microscope
I-Diagnostic_tool	500	508	Combined
I-Diagnostic_tool	508	509	/
I-Diagnostic_tool	509	519	Integrated
I-Diagnostic_tool	520	523	OCT
O	524	537	Visualization
O	538	544	during
O	545	547	En
O	548	552	Face
O	553	560	Retinal
O	561	564	and
O	565	575	Ophthalmic
O	576	583	Surgery
O	584	585	(
O	585	593	DISCOVER
O	593	594	)
O	595	600	study
O	600	601	.

O	602	605	The
O	606	614	DISCOVER
O	615	620	study
O	621	623	is
O	624	625	a
O	626	632	single
O	632	633	-
O	633	637	site
O	637	638	,
O	639	651	multisurgeon
O	651	652	,
O	653	666	institutional
O	667	673	review
O	674	679	board
O	679	680	-
O	680	688	approved
O	689	704	investigational
O	705	711	device
O	712	723	prospective
O	724	729	study
O	729	730	.

O	731	743	Participants
O	744	752	included
O	753	761	patients
O	762	772	undergoing
O	773	781	anterior
O	782	784	or
O	785	794	posterior
O	795	802	segment
O	803	810	surgery
O	811	814	who
O	815	824	underwent
B-Diagnostic_tool	825	829	iOCT
O	830	837	imaging
O	838	842	with
O	843	844	1
O	845	847	of
O	848	849	3
O	850	859	prototype
B-Diagnostic_tool	860	870	microscope
I-Diagnostic_tool	870	871	-
I-Diagnostic_tool	871	881	integrated
I-Diagnostic_tool	882	886	iOCT
O	887	894	systems
O	895	896	(
O	896	897	i
O	897	898	.
O	898	899	e
O	899	900	.
O	900	901	,
O	902	907	Zeiss
O	908	914	Rescan
O	915	918	700
O	918	919	,
O	920	925	Leica
O	926	933	EnFocus
O	933	934	,
O	935	937	or
O	938	942	Cole
O	943	946	Eye
B-Diagnostic_tool	947	951	iOCT
O	952	959	systems
O	959	960	)
O	960	961	.

O	962	970	Clinical
O	971	986	characteristics
O	987	991	were
O	992	1002	documented
O	1002	1003	,
B-Diagnostic_tool	1004	1008	iOCT
O	1009	1012	was
O	1013	1021	directed
O	1022	1024	by
O	1025	1028	the
O	1029	1038	operating
O	1039	1046	surgeon
O	1047	1049	at
O	1050	1063	predetermined
O	1064	1072	surgical
O	1073	1077	time
O	1078	1084	points
O	1084	1085	,
O	1086	1089	and
O	1090	1094	each
O	1095	1102	surgeon
O	1103	1112	completed
O	1113	1114	a
O	1115	1128	questionnaire
O	1129	1134	after
O	1135	1142	surgery
O	1143	1145	to
O	1146	1154	evaluate
O	1155	1158	the
O	1159	1169	usefulness
O	1170	1172	of
B-Diagnostic_tool	1173	1177	iOCT
O	1178	1184	during
O	1185	1192	surgery
O	1192	1193	.

O	1194	1205	Feasibility
O	1206	1208	of
B-Diagnostic_tool	1209	1213	iOCT
O	1214	1219	based
O	1220	1227	ability
O	1228	1230	to
O	1231	1237	obtain
O	1238	1240	an
B-Diagnostic_tool	1241	1244	OCT
I-Diagnostic_tool	1245	1250	image
O	1251	1257	during
O	1258	1265	surgery
O	1266	1269	and
O	1270	1280	usefulness
O	1281	1283	of
B-Diagnostic_tool	1284	1288	iOCT
O	1289	1294	based
O	1295	1297	on
O	1298	1305	surgeon
O	1306	1315	reporting
O	1316	1322	during
O	1323	1330	surgery
O	1330	1331	.

O	1332	1337	Eight
O	1338	1345	hundred
O	1346	1352	thirty
O	1352	1353	-
O	1353	1358	seven
B-Anatomy	1359	1363	eyes
O	1364	1365	(
O	1365	1368	244
O	1369	1377	anterior
O	1378	1385	segment
O	1386	1391	cases
O	1392	1395	and
O	1396	1399	593
O	1400	1409	posterior
O	1410	1417	segment
O	1418	1423	cases
O	1423	1424	)
O	1425	1429	were
O	1430	1438	enrolled
O	1439	1441	in
O	1442	1445	the
O	1446	1454	DISCOVER
O	1455	1460	study
O	1460	1461	.

B-Diagnostic_tool	1462	1476	Intraoperative
I-Diagnostic_tool	1477	1480	OCT
O	1481	1493	demonstrated
O	1494	1505	feasibility
O	1506	1510	with
O	1511	1521	successful
O	1522	1527	image
O	1528	1539	acquisition
O	1540	1542	in
O	1543	1546	820
B-Anatomy	1547	1551	eyes
O	1552	1553	(
O	1553	1555	98
O	1555	1556	.
O	1556	1557	0
O	1557	1558	%
O	1558	1559	;
O	1560	1562	95
O	1562	1563	%
O	1564	1574	confidence
O	1575	1583	interval
O	1584	1585	[
O	1585	1587	CI
O	1587	1588	]
O	1588	1589	,
O	1590	1592	96
O	1592	1593	.
O	1593	1594	8
O	1594	1595	%
O	1595	1596	-
O	1596	1598	98
O	1598	1599	.
O	1599	1600	8
O	1600	1601	%
O	1601	1602	)
O	1602	1603	.

O	1604	1606	In
O	1607	1610	106
O	1611	1619	anterior
O	1620	1627	segment
O	1628	1633	cases
O	1634	1635	(
O	1635	1637	43
O	1637	1638	.
O	1638	1639	4
O	1639	1640	%
O	1640	1641	;
O	1642	1644	95
O	1644	1645	%
O	1646	1648	CI
O	1648	1649	,
O	1650	1652	37
O	1652	1653	.
O	1653	1654	1
O	1654	1655	%
O	1655	1656	-
O	1656	1658	49
O	1658	1659	.
O	1659	1660	9
O	1660	1661	%
O	1661	1662	)
O	1662	1663	,
O	1664	1667	the
O	1668	1676	surgeons
O	1677	1686	indicated
O	1687	1691	that
O	1692	1695	the
B-Diagnostic_tool	1696	1700	iOCT
O	1701	1712	information
O	1713	1721	impacted
O	1722	1727	their
O	1728	1736	surgical
O	1737	1745	decision
O	1746	1752	making
O	1753	1756	and
O	1757	1764	altered
O	1765	1768	the
O	1769	1778	procedure
O	1778	1779	.

O	1780	1782	In
O	1783	1792	posterior
O	1793	1800	segment
O	1801	1811	procedures
O	1811	1812	,
O	1813	1821	surgeons
O	1822	1830	reported
O	1831	1835	that
B-Diagnostic_tool	1836	1840	iOCT
O	1841	1848	enabled
O	1849	1856	altered
O	1857	1865	surgical
O	1866	1874	decision
O	1875	1881	making
O	1882	1888	during
O	1889	1892	the
O	1893	1902	procedure
O	1903	1905	in
O	1906	1909	173
O	1910	1915	cases
O	1916	1917	(
O	1917	1919	29
O	1919	1920	.
O	1920	1921	2
O	1921	1922	%
O	1922	1923	;
O	1924	1926	95
O	1926	1927	%
O	1928	1930	CI
O	1930	1931	,
O	1932	1934	25
O	1934	1935	.
O	1935	1936	5
O	1936	1937	%
O	1937	1938	-
O	1938	1940	33
O	1940	1941	.
O	1941	1942	0
O	1942	1943	%
O	1943	1944	)
O	1944	1945	.

O	1946	1949	The
O	1950	1958	DISCOVER
B-Diagnostic_tool	1959	1963	iOCT
O	1964	1969	study
O	1970	1982	demonstrated
O	1983	1987	both
O	1988	1999	generalized
O	2000	2011	feasibility
O	2012	2015	and
O	2016	2026	usefulness
O	2027	2032	based
O	2033	2035	on
O	2036	2039	the
O	2040	2047	surgeon
O	2047	2048	-
O	2048	2056	reported
O	2057	2063	impact
O	2064	2066	on
O	2067	2075	surgical
O	2076	2084	decision
O	2085	2091	making
O	2091	2092	.

O	2093	2097	This
O	2098	2103	large
O	2103	2104	-
O	2104	2109	scale
O	2110	2115	study
O	2116	2125	confirmed
O	2126	2133	similar
O	2134	2142	findings
O	2143	2147	from
O	2148	2153	other
O	2154	2161	studies
O	2162	2164	on
O	2165	2168	the
O	2169	2178	potential
O	2179	2184	value
O	2185	2188	and
O	2189	2195	impact
O	2196	2198	of
B-Diagnostic_tool	2199	2203	iOCT
O	2204	2206	on
O	2207	2217	ophthalmic
O	2218	2225	surgery
O	2225	2226	.

O	0	6	Grader
O	7	18	Variability
O	19	22	and
O	23	26	the
O	27	37	Importance
O	38	40	of
O	41	50	Reference
O	51	60	Standards
O	61	64	for
O	65	75	Evaluating
O	76	83	Machine
O	84	92	Learning
O	93	99	Models
O	100	103	for
B-Disease	104	112	Diabetic
I-Disease	113	124	Retinopathy
O	124	125	.

O	127	130	Use
O	131	143	adjudication
O	144	146	to
O	147	155	quantify
O	156	162	errors
O	163	165	in
B-Disease	166	174	diabetic
I-Disease	175	186	retinopathy
O	187	188	(
B-Disease	188	190	DR
O	190	191	)
O	192	199	grading
O	200	205	based
O	206	208	on
O	209	219	individual
O	220	227	graders
O	228	231	and
O	232	240	majority
O	241	249	decision
O	249	250	,
O	251	254	and
O	255	257	to
O	258	263	train
O	264	266	an
O	267	275	improved
O	276	285	automated
O	286	295	algorithm
O	296	299	for
B-Disease	300	302	DR
O	303	310	grading
O	310	311	.

O	312	325	Retrospective
O	326	334	analysis
O	334	335	.

B-Diagnostic_tool	336	343	Retinal
I-Diagnostic_tool	344	350	fundus
I-Diagnostic_tool	351	357	images
O	358	362	from
B-Disease	363	365	DR
O	366	375	screening
O	376	384	programs
O	384	385	.

O	386	392	Images
O	393	397	were
O	398	402	each
O	403	409	graded
O	410	412	by
O	413	416	the
O	417	426	algorithm
O	426	427	,
O	428	429	U
O	429	430	.
O	430	431	S
O	431	432	.
O	433	438	board
O	438	439	-
O	439	448	certified
O	449	465	ophthalmologists
O	465	466	,
O	467	470	and
B-Anatomy	471	478	retinal
O	479	490	specialists
O	490	491	.

O	492	495	The
O	496	507	adjudicated
O	508	517	consensus
O	518	520	of
O	521	524	the
B-Anatomy	525	532	retinal
O	533	544	specialists
O	545	551	served
O	552	554	as
O	555	558	the
O	559	568	reference
O	569	577	standard
O	577	578	.

O	579	582	For
O	583	592	agreement
O	593	600	between
O	601	610	different
O	611	618	graders
O	619	621	as
O	622	626	well
O	627	629	as
O	630	637	between
O	638	641	the
O	642	649	graders
O	650	653	and
O	654	657	the
O	658	667	algorithm
O	667	668	,
O	669	671	we
O	672	680	measured
O	681	684	the
O	685	686	(
O	686	695	quadratic
O	695	696	-
O	696	704	weighted
O	704	705	)
O	706	711	kappa
O	712	717	score
O	717	718	.

O	719	721	To
O	722	729	compare
O	730	733	the
O	734	745	performance
O	746	748	of
O	749	758	different
O	759	764	forms
O	765	767	of
O	768	774	manual
O	775	782	grading
O	783	786	and
O	787	790	the
O	791	800	algorithm
O	801	804	for
O	805	812	various
B-Disease	813	815	DR
O	816	824	severity
O	825	832	cutoffs
O	833	834	(
O	834	835	e
O	835	836	.
O	836	837	g
O	837	838	.
O	838	839	,
B-Disease	840	844	mild
I-Disease	845	847	or
I-Disease	848	853	worse
I-Disease	854	856	DR
O	856	857	,
B-Disease	858	866	moderate
I-Disease	867	869	or
I-Disease	870	875	worse
I-Disease	876	878	DR
O	878	879	)
O	879	880	,
O	881	883	we
O	884	892	measured
O	893	897	area
O	898	903	under
O	904	907	the
O	908	913	curve
O	914	915	(
O	915	918	AUC
O	918	919	)
O	919	920	,
O	921	932	sensitivity
O	932	933	,
O	934	937	and
O	938	949	specificity
O	949	950	.

O	951	953	Of
O	954	957	the
O	958	961	193
O	962	975	discrepancies
O	976	983	between
O	984	996	adjudication
O	997	999	by
O	1000	1007	retinal
O	1008	1019	specialists
O	1020	1023	and
O	1024	1032	majority
O	1033	1041	decision
O	1042	1044	of
O	1045	1061	ophthalmologists
O	1061	1062	,
O	1063	1066	the
O	1067	1071	most
O	1072	1078	common
O	1079	1083	were
O	1084	1091	missing
B-Symptom	1092	1105	microaneurysm
O	1106	1107	(
B-Symptom	1107	1110	MAs
O	1110	1111	)
O	1112	1113	(
O	1113	1115	36
O	1115	1116	%
O	1116	1117	)
O	1117	1118	,
O	1119	1128	artifacts
O	1129	1130	(
O	1130	1132	20
O	1132	1133	%
O	1133	1134	)
O	1134	1135	,
O	1136	1139	and
O	1140	1153	misclassified
B-Symptom	1154	1165	hemorrhages
O	1166	1167	(
O	1167	1169	16
O	1169	1170	%
O	1170	1171	)
O	1171	1172	.

O	1173	1181	Relative
O	1182	1184	to
O	1185	1188	the
O	1189	1198	reference
O	1199	1207	standard
O	1207	1208	,
O	1209	1212	the
O	1213	1218	kappa
O	1219	1222	for
O	1223	1233	individual
B-Anatomy	1234	1241	retinal
O	1242	1253	specialists
O	1253	1254	,
O	1255	1271	ophthalmologists
O	1271	1272	,
O	1273	1276	and
O	1277	1286	algorithm
O	1287	1293	ranged
O	1294	1298	from
O	1299	1300	0
O	1300	1301	.
O	1301	1303	82
O	1304	1306	to
O	1307	1308	0
O	1308	1309	.
O	1309	1311	91
O	1311	1312	,
O	1313	1314	0
O	1314	1315	.
O	1315	1317	80
O	1318	1320	to
O	1321	1322	0
O	1322	1323	.
O	1323	1325	84
O	1325	1326	,
O	1327	1330	and
O	1331	1332	0
O	1332	1333	.
O	1333	1335	84
O	1335	1336	,
O	1337	1349	respectively
O	1349	1350	.

O	1351	1354	For
B-Disease	1355	1363	moderate
I-Disease	1364	1366	or
I-Disease	1367	1372	worse
I-Disease	1373	1375	DR
O	1375	1376	,
O	1377	1380	the
O	1381	1389	majority
O	1390	1398	decision
O	1399	1401	of
O	1402	1418	ophthalmologists
O	1419	1422	had
O	1423	1424	a
O	1425	1436	sensitivity
O	1437	1439	of
O	1440	1441	0
O	1441	1442	.
O	1442	1445	838
O	1446	1449	and
O	1450	1461	specificity
O	1462	1464	of
O	1465	1466	0
O	1466	1467	.
O	1467	1470	981
O	1470	1471	.

O	1472	1475	The
O	1476	1485	algorithm
O	1486	1489	had
O	1490	1491	a
O	1492	1503	sensitivity
O	1504	1506	of
O	1507	1508	0
O	1508	1509	.
O	1509	1512	971
O	1512	1513	,
O	1514	1525	specificity
O	1526	1528	of
O	1529	1530	0
O	1530	1531	.
O	1531	1534	923
O	1534	1535	,
O	1536	1539	and
O	1540	1543	AUC
O	1544	1546	of
O	1547	1548	0
O	1548	1549	.
O	1549	1552	986
O	1552	1553	.

O	1554	1557	For
B-Disease	1558	1562	mild
I-Disease	1563	1565	or
I-Disease	1566	1571	worse
I-Disease	1572	1574	DR
O	1574	1575	,
O	1576	1579	the
O	1580	1589	algorithm
O	1590	1593	had
O	1594	1595	a
O	1596	1607	sensitivity
O	1608	1610	of
O	1611	1612	0
O	1612	1613	.
O	1613	1616	970
O	1616	1617	,
O	1618	1629	specificity
O	1630	1632	of
O	1633	1634	0
O	1634	1635	.
O	1635	1638	917
O	1638	1639	,
O	1640	1643	and
O	1644	1647	AUC
O	1648	1650	of
O	1651	1652	0
O	1652	1653	.
O	1653	1656	986
O	1656	1657	.

O	1658	1660	By
O	1661	1666	using
O	1667	1668	a
O	1669	1674	small
O	1675	1681	number
O	1682	1684	of
O	1685	1696	adjudicated
O	1697	1706	consensus
O	1707	1713	grades
O	1714	1716	as
O	1717	1718	a
O	1719	1725	tuning
O	1726	1733	dataset
O	1734	1737	and
B-Diagnostic_tool	1738	1744	higher
I-Diagnostic_tool	1744	1745	-
I-Diagnostic_tool	1745	1755	resolution
I-Diagnostic_tool	1756	1762	images
O	1763	1765	as
O	1766	1771	input
O	1771	1772	,
O	1773	1776	the
O	1777	1786	algorithm
O	1787	1795	improved
O	1796	1798	in
O	1799	1802	AUC
O	1803	1807	from
O	1808	1809	0
O	1809	1810	.
O	1810	1813	934
O	1814	1816	to
O	1817	1818	0
O	1818	1819	.
O	1819	1822	986
O	1823	1826	for
B-Disease	1827	1835	moderate
I-Disease	1836	1838	or
I-Disease	1839	1844	worse
I-Disease	1845	1847	DR
O	1847	1848	.

O	1849	1861	Adjudication
O	1862	1869	reduces
O	1870	1873	the
O	1874	1880	errors
O	1881	1883	in
B-Disease	1884	1886	DR
O	1887	1894	grading
O	1894	1895	.

O	1896	1897	A
O	1898	1903	small
O	1904	1907	set
O	1908	1910	of
O	1911	1922	adjudicated
B-Disease	1923	1925	DR
O	1926	1932	grades
O	1933	1939	allows
O	1940	1951	substantial
O	1952	1964	improvements
O	1965	1967	in
O	1968	1977	algorithm
O	1978	1989	performance
O	1989	1990	.

O	1991	1994	The
O	1995	2004	resulting
O	2005	2014	algorithm
O	2014	2015	'
O	2015	2016	s
O	2017	2028	performance
O	2029	2032	was
O	2033	2035	on
O	2036	2039	par
O	2040	2044	with
O	2045	2049	that
O	2050	2052	of
O	2053	2063	individual
O	2064	2065	U
O	2065	2066	.
O	2066	2067	S
O	2067	2068	.

O	2069	2074	Board
O	2074	2075	-
O	2075	2084	Certified
O	2085	2101	ophthalmologists
O	2102	2105	and
B-Anatomy	2106	2113	retinal
O	2114	2125	specialists
O	2125	2126	.

O	0	3	The
O	4	16	Relationship
O	17	19	of
B-Characteristic	20	27	Retinal
I-Characteristic	28	34	Vessel
I-Characteristic	35	44	Geometric
I-Characteristic	45	60	Characteristics
O	61	63	to
O	64	67	the
O	68	77	Incidence
O	78	81	and
O	82	93	Progression
O	94	96	of
B-Disease	97	105	Diabetic
I-Disease	106	117	Retinopathy
O	117	118	.

O	120	122	To
O	123	130	examine
O	131	134	the
O	135	148	relationships
O	149	151	of
B-Characteristic	152	159	retinal
I-Characteristic	160	166	vessel
I-Characteristic	167	176	geometric
I-Characteristic	177	192	characteristics
O	193	194	(
B-Characteristic	194	199	RVGCs
O	199	200	)
O	201	203	to
O	204	207	the
O	208	217	incidence
O	218	221	and
O	222	233	progression
O	234	236	of
B-Disease	237	245	diabetic
I-Disease	246	257	retinopathy
O	258	259	(
B-Disease	259	261	DR
O	261	262	)
O	262	263	.

O	264	277	Observational
O	277	278	,
O	279	290	prospective
O	291	297	cohort
O	298	303	study
O	303	304	.

O	305	309	Nine
O	310	317	hundred
O	318	324	ninety
O	324	325	-
O	325	328	six
O	329	336	persons
O	337	341	with
B-Disease	342	346	type
I-Disease	347	348	1
I-Disease	349	357	diabetes
I-Disease	358	366	mellitus
O	367	368	(
B-Disease	368	372	T1DM
O	372	373	)
O	374	377	and
O	378	382	1370
O	383	390	persons
O	391	395	with
B-Disease	396	400	type
I-Disease	401	402	2
I-Disease	403	411	diabetes
I-Disease	412	420	mellitus
O	421	422	(
B-Disease	422	426	T2DM
O	426	427	)
O	428	432	seen
O	433	435	at
O	436	437	a
O	438	446	baseline
O	447	458	examination
O	459	462	who
O	463	467	were
O	468	476	eligible
O	477	480	for
O	481	487	follow
O	487	488	-
O	488	490	up
O	491	503	examinations
O	504	506	at
O	507	517	subsequent
O	518	519	5
O	519	520	-
O	520	524	year
O	525	534	intervals
O	534	535	.

O	536	537	A
O	538	543	total
O	544	546	of
O	547	551	3846
O	552	558	person
O	558	559	-
O	559	567	interval
O	568	572	data
O	573	577	from
O	578	583	these
O	584	590	follow
O	590	591	-
O	591	593	up
O	594	606	examinations
O	607	610	are
O	611	614	the
O	615	620	basis
O	621	624	for
O	625	628	the
O	629	637	analyses
O	637	638	.

B-Disease	639	647	Diabetic
I-Disease	648	659	retinopathy
O	660	663	and
B-Disease	664	671	macular
I-Disease	672	677	edema
O	678	682	were
O	683	691	assessed
O	692	694	by
O	695	702	grading
O	703	705	of
B-Diagnostic_tool	706	708	30
I-Diagnostic_tool	708	709	
I-Diagnostic_tool	710	722	stereoscopic
I-Diagnostic_tool	723	728	color
I-Diagnostic_tool	729	735	fundus
I-Diagnostic_tool	736	747	photographs
O	747	748	.

B-Characteristic	749	756	Retinal
I-Characteristic	757	763	vessel
I-Characteristic	764	773	geometric
I-Characteristic	774	789	characteristics
O	790	794	were
O	795	803	assessed
O	804	809	using
O	810	813	the
O	814	823	Singapore
O	824	825	I
O	826	832	Vessel
O	833	843	Assessment
O	844	851	program
O	852	856	from
O	857	858	a
O	859	868	digitized
O	869	873	copy
O	874	876	of
O	877	878	1
O	879	881	of
O	882	885	the
O	886	891	field
O	892	893	1
B-Diagnostic_tool	894	900	fundus
I-Diagnostic_tool	901	912	photographs
O	913	921	obtained
O	922	924	at
O	925	933	baseline
O	934	937	and
O	938	944	follow
O	944	945	-
O	945	947	up
O	947	948	.

O	949	952	The
O	953	954	5
O	954	955	-
O	955	959	year
O	960	969	incidence
O	970	972	of
O	973	976	any
B-Disease	977	979	DR
O	979	980	,
O	981	992	progression
O	993	995	of
B-Disease	996	998	DR
O	998	999	,
O	1000	1003	and
O	1004	1013	incidence
O	1014	1016	of
B-Disease	1017	1030	proliferative
I-Disease	1031	1039	diabetic
I-Disease	1040	1051	retinopathy
O	1052	1053	(
B-Disease	1053	1056	PDR
O	1056	1057	)
O	1058	1061	and
B-Disease	1062	1072	clinically
I-Disease	1073	1084	significant
I-Disease	1085	1092	macular
I-Disease	1093	1098	edema
O	1099	1100	(
B-Disease	1100	1104	CSME
O	1104	1105	)
O	1106	1108	in
O	1109	1114	right
B-Anatomy	1115	1119	eyes
O	1119	1120	.

O	1121	1129	Incident
B-Disease	1130	1132	DR
O	1133	1141	occurred
O	1142	1144	in
O	1145	1147	45
O	1147	1148	%
O	1148	1149	,
O	1150	1161	progression
O	1162	1164	in
O	1165	1167	32
O	1167	1168	%
O	1168	1169	,
B-Disease	1170	1173	PDR
O	1174	1176	in
O	1177	1179	10
O	1179	1180	%
O	1180	1181	,
O	1182	1185	and
B-Disease	1186	1190	CSME
O	1191	1193	in
O	1194	1195	5
O	1195	1196	%
O	1196	1197	.

O	1198	1203	While
O	1204	1213	adjusting
O	1214	1217	for
O	1218	1226	glycated
O	1227	1237	hemoglobin
O	1237	1238	,
O	1239	1247	duration
O	1248	1250	of
B-Disease	1251	1259	diabetes
O	1259	1260	,
O	1261	1264	and
O	1265	1270	other
O	1271	1278	factors
O	1278	1279	,
B-Characteristic	1280	1287	retinal
I-Characteristic	1288	1298	arteriolar
I-Characteristic	1299	1305	simple
I-Characteristic	1306	1316	tortuosity
O	1317	1320	was
O	1321	1331	associated
O	1332	1345	significantly
O	1346	1350	with
O	1351	1354	the
O	1355	1364	incidence
O	1365	1367	of
O	1368	1371	any
B-Disease	1372	1374	DR
O	1375	1376	(
O	1376	1380	odds
O	1381	1386	ratio
O	1387	1388	[
O	1388	1390	OR
O	1390	1391	]
O	1391	1392	,
O	1393	1394	1
O	1394	1395	.
O	1395	1397	17
O	1397	1398	;
O	1399	1401	95
O	1401	1402	%
O	1403	1413	confidence
O	1414	1422	interval
O	1423	1424	[
O	1424	1426	CI
O	1426	1427	]
O	1428	1429	,
O	1430	1431	1
O	1431	1432	.
O	1432	1434	01
O	1434	1435	-
O	1435	1436	1
O	1436	1437	.
O	1437	1439	35
O	1439	1440	)
O	1440	1441	.

B-Characteristic	1442	1449	Retinal
I-Characteristic	1450	1457	venular
I-Characteristic	1458	1467	branching
I-Characteristic	1468	1473	angle
O	1474	1477	was
O	1478	1488	associated
O	1489	1502	significantly
O	1503	1507	with
O	1508	1519	progression
O	1520	1522	of
B-Disease	1523	1525	DR
O	1526	1527	(
O	1527	1529	OR
O	1529	1530	,
O	1531	1532	1
O	1532	1533	.
O	1533	1535	18
O	1535	1536	;
O	1537	1539	95
O	1539	1540	%
O	1541	1543	CI
O	1543	1544	,
O	1545	1546	1
O	1546	1547	.
O	1547	1549	03
O	1549	1550	-
O	1550	1551	1
O	1551	1552	.
O	1552	1554	36
O	1554	1555	)
O	1555	1556	,
B-Characteristic	1557	1564	retinal
I-Characteristic	1565	1572	venular
I-Characteristic	1573	1582	curvature
I-Characteristic	1583	1593	tortuosity
O	1594	1597	was
O	1598	1608	associated
O	1609	1622	significantly
O	1623	1627	with
O	1628	1631	the
O	1632	1641	incidence
O	1642	1644	of
B-Disease	1645	1648	PDR
O	1649	1650	(
O	1650	1652	OR
O	1652	1653	,
O	1654	1655	1
O	1655	1656	.
O	1656	1658	15
O	1658	1659	;
O	1660	1662	95
O	1662	1663	%
O	1664	1666	CI
O	1666	1667	,
O	1668	1669	1
O	1669	1670	.
O	1670	1672	01
O	1672	1673	-
O	1673	1674	1
O	1674	1675	.
O	1675	1677	30
O	1677	1678	)
O	1678	1679	,
O	1680	1683	and
B-Characteristic	1684	1691	retinal
I-Characteristic	1692	1699	venular
I-Characteristic	1700	1709	branching
I-Characteristic	1710	1715	angle
O	1716	1717	(
O	1717	1719	OR
O	1719	1720	,
O	1721	1722	1
O	1722	1723	.
O	1723	1725	41
O	1725	1726	;
O	1727	1729	95
O	1729	1730	%
O	1731	1733	CI
O	1733	1734	,
O	1735	1736	1
O	1736	1737	.
O	1737	1739	10
O	1739	1740	-
O	1740	1741	1
O	1741	1742	.
O	1742	1744	82
O	1744	1745	)
O	1746	1749	was
O	1750	1760	associated
O	1761	1774	significantly
O	1775	1779	with
O	1780	1783	the
O	1784	1793	incidence
O	1794	1796	of
B-Disease	1797	1801	CSME
O	1801	1802	.

O	1803	1808	There
O	1809	1813	were
O	1814	1816	no
O	1817	1828	significant
O	1829	1841	associations
O	1842	1844	of
O	1845	1850	other
B-Characteristic	1851	1856	RVGCs
O	1857	1861	with
O	1862	1865	any
O	1866	1868	of
O	1869	1872	the
B-Disease	1873	1875	DR
O	1876	1884	outcomes
O	1885	1887	in
O	1888	1891	the
O	1892	1896	full
O	1897	1909	multivariate
O	1910	1915	model
O	1915	1916	.

O	1917	1926	Inclusion
O	1927	1929	of
O	1930	1933	all
O	1934	1942	possible
B-Characteristic	1943	1948	RVGCs
O	1949	1952	did
O	1953	1956	not
O	1957	1964	improve
O	1965	1968	the
O	1969	1979	predictive
O	1980	1985	value
O	1986	1988	of
O	1989	1992	the
O	1993	1999	models
O	2000	2004	that
O	2005	2012	already
O	2013	2021	included
B-Characteristic	2022	2029	retinal
I-Characteristic	2030	2036	vessel
I-Characteristic	2037	2045	diameter
O	2046	2049	and
O	2050	2058	baseline
B-Disease	2059	2061	DR
O	2062	2070	severity
O	2071	2076	level
O	2076	2077	.

B-Characteristic	2078	2085	Retinal
I-Characteristic	2086	2092	vessel
I-Characteristic	2093	2102	geometric
I-Characteristic	2103	2118	characteristics
I-Characteristic	2119	2121	of
I-Characteristic	2122	2125	the
I-Characteristic	2126	2133	retinal
I-Characteristic	2134	2141	venules
O	2142	2146	were
O	2147	2157	associated
O	2158	2162	with
O	2163	2174	progression
O	2175	2177	of
B-Disease	2178	2180	DR
O	2180	2181	;
O	2182	2189	however
O	2189	2190	,
O	2191	2195	most
O	2196	2198	of
O	2199	2202	the
B-Characteristic	2203	2208	RVGCs
O	2209	2217	measured
O	2218	2222	from
B-Diagnostic_tool	2223	2232	digitized
I-Diagnostic_tool	2233	2239	fundus
I-Diagnostic_tool	2240	2251	photographs
O	2252	2257	added
O	2258	2264	little
O	2265	2267	to
O	2268	2271	the
O	2272	2282	assessment
O	2283	2285	of
O	2286	2290	risk
O	2291	2293	of
O	2294	2303	incidence
O	2304	2307	and
O	2308	2319	progression
O	2320	2322	of
B-Disease	2323	2325	DR
O	2326	2330	when
O	2331	2336	other
O	2337	2341	risk
O	2342	2349	factors
O	2350	2354	were
O	2355	2365	considered
O	2366	2368	in
B-Disease	2369	2373	T1DM
O	2374	2377	and
B-Disease	2378	2382	T2DM
O	2382	2383	.

B-Diagnostic_tool	0	10	DeepSeeNet
O	10	11	:
O	12	13	A
B-Diagnostic_tool	14	18	Deep
I-Diagnostic_tool	19	27	Learning
I-Diagnostic_tool	28	33	Model
O	34	37	for
O	38	47	Automated
O	48	62	Classification
O	63	65	of
O	66	73	Patient
O	73	74	-
O	74	79	based
B-Disease	80	83	Age
I-Disease	83	84	-
I-Disease	84	91	related
I-Disease	92	99	Macular
I-Disease	100	112	Degeneration
O	113	121	Severity
O	122	126	from
B-Diagnostic_tool	127	132	Color
I-Diagnostic_tool	133	139	Fundus
I-Diagnostic_tool	140	151	Photographs
O	151	152	.

O	154	156	In
O	157	166	assessing
O	167	170	the
O	171	179	severity
O	180	182	of
B-Disease	183	186	age
I-Disease	186	187	-
I-Disease	187	194	related
I-Disease	195	202	macular
I-Disease	203	215	degeneration
O	216	217	(
B-Disease	217	220	AMD
O	220	221	)
O	221	222	,
O	223	226	the
B-Classification_system	227	230	Age
I-Classification_system	230	231	-
I-Classification_system	231	238	Related
I-Classification_system	239	242	Eye
I-Classification_system	243	250	Disease
I-Classification_system	251	256	Study
I-Classification_system	257	258	(
I-Classification_system	258	263	AREDS
I-Classification_system	263	264	)
I-Classification_system	265	275	Simplified
I-Classification_system	276	284	Severity
I-Classification_system	285	290	Scale
O	291	299	predicts
O	300	303	the
O	304	308	risk
O	309	311	of
O	312	323	progression
O	324	326	to
B-Disease	327	331	late
I-Disease	332	335	AMD
O	335	336	.

O	337	344	However
O	344	345	,
O	346	349	its
O	350	356	manual
O	357	360	use
O	361	369	requires
O	370	373	the
O	374	378	time
O	378	379	-
O	379	388	consuming
O	389	402	participation
O	403	405	of
O	406	412	expert
O	413	426	practitioners
O	426	427	.

O	428	436	Although
O	437	444	several
O	445	454	automated
O	455	459	deep
O	460	468	learning
O	469	476	systems
O	477	481	have
O	482	486	been
O	487	496	developed
O	497	500	for
O	501	512	classifying
B-Diagnostic_tool	513	518	color
I-Diagnostic_tool	519	525	fundus
I-Diagnostic_tool	526	537	photographs
O	538	539	(
B-Diagnostic_tool	539	542	CFP
O	542	543	)
O	544	546	of
O	547	557	individual
B-Anatomy	558	562	eyes
O	563	565	by
O	566	571	AREDS
O	572	580	severity
O	581	586	score
O	586	587	,
O	588	592	none
O	593	595	to
O	596	600	date
O	601	604	has
O	605	609	used
O	610	611	a
O	612	619	patient
O	619	620	-
O	620	625	based
O	626	633	scoring
O	634	640	system
O	641	645	that
O	646	650	uses
O	651	657	images
O	658	662	from
O	663	667	both
B-Anatomy	668	672	eyes
O	673	675	to
O	676	682	assign
O	683	684	a
O	685	693	severity
O	694	699	score
O	699	700	.

B-Diagnostic_tool	701	711	DeepSeeNet
O	711	712	,
O	713	714	a
B-Diagnostic_tool	715	719	deep
I-Diagnostic_tool	720	728	learning
I-Diagnostic_tool	729	734	model
O	734	735	,
O	736	739	was
O	740	749	developed
O	750	752	to
O	753	761	classify
O	762	770	patients
O	771	784	automatically
O	785	787	by
O	788	791	the
B-Classification_system	792	797	AREDS
I-Classification_system	798	808	Simplified
I-Classification_system	809	817	Severity
I-Classification_system	818	823	Scale
O	824	825	(
O	825	830	score
O	831	832	0
O	832	833	-
O	833	834	5
O	834	835	)
O	836	841	using
O	842	851	bilateral
B-Diagnostic_tool	852	855	CFP
O	855	856	.

B-Diagnostic_tool	857	867	DeepSeeNet
O	868	871	was
O	872	879	trained
O	880	882	on
O	883	885	58
O	886	889	402
O	890	893	and
O	894	900	tested
O	901	903	on
O	904	907	900
O	908	914	images
O	915	919	from
O	920	923	the
O	924	936	longitudinal
O	937	943	follow
O	943	944	-
O	944	946	up
O	947	949	of
O	950	954	4549
O	955	967	participants
O	968	972	from
O	973	978	AREDS
O	978	979	.

O	980	984	Gold
O	985	993	standard
O	994	1000	labels
O	1001	1005	were
O	1006	1014	obtained
O	1015	1020	using
O	1021	1028	reading
O	1029	1035	center
O	1036	1042	grades
O	1042	1043	.

B-Diagnostic_tool	1044	1054	DeepSeeNet
O	1055	1064	simulates
O	1065	1068	the
O	1069	1074	human
O	1075	1082	grading
O	1083	1090	process
O	1091	1093	by
O	1094	1099	first
O	1100	1109	detecting
O	1110	1120	individual
B-Disease	1121	1124	AMD
O	1125	1129	risk
O	1130	1137	factors
O	1138	1139	(
B-Symptom	1139	1145	drusen
I-Symptom	1146	1150	size
O	1150	1151	,
B-Symptom	1152	1162	pigmentary
I-Symptom	1163	1176	abnormalities
O	1176	1177	)
O	1178	1181	for
O	1182	1186	each
B-Anatomy	1187	1190	eye
O	1191	1194	and
O	1195	1199	then
O	1200	1211	calculating
O	1212	1213	a
O	1214	1221	patient
O	1221	1222	-
O	1222	1227	based
B-Disease	1228	1231	AMD
O	1232	1240	severity
O	1241	1246	score
O	1247	1252	using
O	1253	1256	the
B-Classification_system	1257	1262	AREDS
I-Classification_system	1263	1273	Simplified
I-Classification_system	1274	1282	Severity
I-Classification_system	1283	1288	Scale
O	1288	1289	.

O	1290	1297	Overall
O	1298	1306	accuracy
O	1306	1307	,
O	1308	1319	specificity
O	1319	1320	,
O	1321	1332	sensitivity
O	1332	1333	,
O	1334	1339	Cohen
O	1339	1340	'
O	1340	1341	s
O	1342	1347	kappa
O	1347	1348	,
O	1349	1352	and
O	1353	1357	area
O	1358	1363	under
O	1364	1367	the
O	1368	1373	curve
O	1374	1375	(
O	1375	1378	AUC
O	1378	1379	)
O	1379	1380	.

O	1381	1384	The
O	1385	1396	performance
O	1397	1399	of
B-Diagnostic_tool	1400	1410	DeepSeeNet
O	1411	1414	was
O	1415	1423	compared
O	1424	1428	with
O	1429	1433	that
O	1434	1436	of
O	1437	1444	retinal
O	1445	1456	specialists
O	1456	1457	.

B-Diagnostic_tool	1458	1468	DeepSeeNet
O	1469	1478	performed
O	1479	1485	better
O	1486	1488	on
O	1489	1496	patient
O	1496	1497	-
O	1497	1502	based
O	1503	1517	classification
O	1518	1519	(
O	1519	1527	accuracy
O	1528	1529	=
O	1530	1531	0
O	1531	1532	.
O	1532	1535	671
O	1535	1536	;
O	1537	1542	kappa
O	1543	1544	=
O	1545	1546	0
O	1546	1547	.
O	1547	1550	558
O	1550	1551	)
O	1552	1556	than
O	1557	1564	retinal
O	1565	1576	specialists
O	1577	1578	(
O	1578	1586	accuracy
O	1587	1588	=
O	1589	1590	0
O	1590	1591	.
O	1591	1594	599
O	1594	1595	;
O	1596	1601	kappa
O	1602	1603	=
O	1604	1605	0
O	1605	1606	.
O	1606	1609	467
O	1609	1610	)
O	1611	1615	with
O	1616	1620	high
O	1621	1624	AUC
O	1625	1627	in
O	1628	1631	the
O	1632	1641	detection
O	1642	1644	of
B-Symptom	1645	1650	large
I-Symptom	1651	1657	drusen
O	1658	1659	(
O	1659	1660	0
O	1660	1661	.
O	1661	1663	94
O	1663	1664	)
O	1664	1665	,
B-Symptom	1666	1676	pigmentary
I-Symptom	1677	1690	abnormalities
O	1691	1692	(
O	1692	1693	0
O	1693	1694	.
O	1694	1696	93
O	1696	1697	)
O	1697	1698	,
O	1699	1702	and
B-Disease	1703	1707	late
I-Disease	1708	1711	AMD
O	1712	1713	(
O	1713	1714	0
O	1714	1715	.
O	1715	1717	97
O	1717	1718	)
O	1718	1719	.

B-Diagnostic_tool	1720	1730	DeepSeeNet
O	1731	1735	also
O	1736	1748	outperformed
O	1749	1756	retinal
O	1757	1768	specialists
O	1769	1771	in
O	1772	1775	the
O	1776	1785	detection
O	1786	1788	of
B-Symptom	1789	1794	large
I-Symptom	1795	1801	drusen
O	1802	1803	(
O	1803	1811	accuracy
O	1812	1813	0
O	1813	1814	.
O	1814	1817	742
O	1818	1820	vs
O	1820	1821	.
O	1822	1823	0
O	1823	1824	.
O	1824	1827	696
O	1827	1828	;
O	1829	1834	kappa
O	1835	1836	0
O	1836	1837	.
O	1837	1840	601
O	1841	1843	vs
O	1843	1844	.
O	1845	1846	0
O	1846	1847	.
O	1847	1850	517
O	1850	1851	)
O	1852	1855	and
B-Symptom	1856	1866	pigmentary
I-Symptom	1867	1880	abnormalities
O	1881	1882	(
O	1882	1890	accuracy
O	1891	1892	0
O	1892	1893	.
O	1893	1896	890
O	1897	1899	vs
O	1899	1900	.
O	1901	1902	0
O	1902	1903	.
O	1903	1906	813
O	1906	1907	;
O	1908	1913	kappa
O	1914	1915	0
O	1915	1916	.
O	1916	1919	723
O	1920	1922	vs
O	1922	1923	.
O	1924	1925	0
O	1925	1926	.
O	1926	1929	535
O	1929	1930	)
O	1931	1934	but
O	1935	1941	showed
O	1942	1947	lower
O	1948	1959	performance
O	1960	1962	in
O	1963	1966	the
O	1967	1976	detection
O	1977	1979	of
B-Disease	1980	1984	late
I-Disease	1985	1988	AMD
O	1989	1990	(
O	1990	1998	accuracy
O	1999	2000	0
O	2000	2001	.
O	2001	2004	967
O	2005	2007	vs
O	2007	2008	.
O	2009	2010	0
O	2010	2011	.
O	2011	2014	973
O	2014	2015	;
O	2016	2021	kappa
O	2022	2023	0
O	2023	2024	.
O	2024	2027	663
O	2028	2030	vs
O	2030	2031	.
O	2032	2033	0
O	2033	2034	.
O	2034	2037	754
O	2037	2038	)
O	2038	2039	.

O	2040	2042	By
O	2043	2053	simulating
O	2054	2057	the
O	2058	2063	human
O	2064	2071	grading
O	2072	2079	process
O	2079	2080	,
B-Diagnostic_tool	2081	2091	DeepSeeNet
O	2092	2104	demonstrated
O	2105	2109	high
O	2110	2118	accuracy
O	2119	2123	with
O	2124	2133	increased
O	2134	2146	transparency
O	2147	2149	in
O	2150	2153	the
O	2154	2163	automated
O	2164	2174	assignment
O	2175	2177	of
O	2178	2188	individual
O	2189	2197	patients
O	2198	2200	to
B-Disease	2201	2204	AMD
O	2205	2209	risk
O	2210	2220	categories
O	2221	2226	based
O	2227	2229	on
O	2230	2233	the
B-Classification_system	2234	2239	AREDS
I-Classification_system	2240	2250	Simplified
I-Classification_system	2251	2259	Severity
I-Classification_system	2260	2265	Scale
O	2265	2266	.

O	2267	2272	These
O	2273	2280	results
O	2281	2290	highlight
O	2291	2294	the
O	2295	2304	potential
O	2305	2307	of
O	2308	2312	deep
O	2313	2321	learning
O	2322	2324	to
O	2325	2331	assist
O	2332	2335	and
O	2336	2343	enhance
O	2344	2352	clinical
O	2353	2361	decision
O	2361	2362	-
O	2362	2368	making
O	2369	2371	in
O	2372	2380	patients
O	2381	2385	with
B-Disease	2386	2389	AMD
O	2389	2390	,
O	2391	2395	such
O	2396	2398	as
B-Disease	2399	2404	early
I-Disease	2405	2408	AMD
O	2409	2418	detection
O	2419	2422	and
O	2423	2427	risk
O	2428	2438	prediction
O	2439	2442	for
O	2443	2453	developing
B-Disease	2454	2458	late
I-Disease	2459	2462	AMD
O	2462	2463	.

B-Diagnostic_tool	2464	2474	DeepSeeNet
O	2475	2477	is
O	2478	2486	publicly
O	2487	2496	available
O	2497	2499	on
O	2500	2505	https
O	2505	2506	:
O	2506	2507	/
O	2507	2508	/
O	2508	2514	github
O	2514	2515	.
O	2515	2518	com
O	2518	2519	/
O	2519	2523	ncbi
O	2523	2524	-
O	2524	2527	nlp
O	2527	2528	/
O	2528	2538	DeepSeeNet
O	2538	2539	.

O	0	5	Using
O	6	7	a
B-Diagnostic_tool	8	12	Deep
I-Diagnostic_tool	13	21	Learning
I-Diagnostic_tool	22	31	Algorithm
I-Diagnostic_tool	32	35	and
I-Diagnostic_tool	36	46	Integrated
I-Diagnostic_tool	47	56	Gradients
I-Diagnostic_tool	57	68	Explanation
O	69	71	to
O	72	78	Assist
O	79	86	Grading
O	87	90	for
B-Disease	91	99	Diabetic
I-Disease	100	111	Retinopathy
O	111	112	.

O	114	116	To
O	117	127	understand
O	128	131	the
O	132	138	impact
O	139	141	of
B-Diagnostic_tool	142	146	deep
I-Diagnostic_tool	147	155	learning
I-Diagnostic_tool	156	164	diabetic
I-Diagnostic_tool	165	176	retinopathy
I-Diagnostic_tool	177	178	(
I-Diagnostic_tool	178	180	DR
I-Diagnostic_tool	180	181	)
I-Diagnostic_tool	182	192	algorithms
O	193	195	on
O	196	205	physician
O	206	213	readers
O	214	216	in
O	217	225	computer
O	225	226	-
O	226	234	assisted
O	235	243	settings
O	243	244	.

O	245	255	Evaluation
O	256	258	of
O	259	269	diagnostic
O	270	280	technology
O	280	281	.

O	282	285	One
O	286	294	thousand
O	295	300	seven
O	301	308	hundred
O	309	315	ninety
O	315	316	-
O	316	319	six
O	320	327	retinal
B-Diagnostic_tool	328	334	fundus
I-Diagnostic_tool	335	341	images
O	342	346	from
O	347	351	1612
B-Disease	352	360	diabetic
O	361	369	patients
O	369	370	.

O	371	374	Ten
O	375	391	ophthalmologists
O	392	393	(
O	393	394	5
O	395	402	general
O	403	419	ophthalmologists
O	419	420	,
O	421	422	4
B-Anatomy	423	429	retina
O	430	441	specialists
O	441	442	,
O	443	444	1
B-Anatomy	445	451	retina
O	452	458	fellow
O	458	459	)
O	460	464	read
O	465	471	images
O	472	475	for
B-Disease	476	478	DR
O	479	487	severity
O	488	493	based
O	494	496	on
O	497	500	the
B-Diagnostic_tool	501	514	International
I-Diagnostic_tool	515	523	Clinical
I-Diagnostic_tool	524	532	Diabetic
I-Diagnostic_tool	533	544	Retinopathy
I-Diagnostic_tool	545	552	disease
I-Diagnostic_tool	553	561	severity
I-Diagnostic_tool	562	567	scale
O	568	570	in
O	571	575	each
O	576	578	of
O	579	580	3
O	581	591	conditions
O	591	592	:
O	593	603	unassisted
O	603	604	,
O	605	611	grades
O	612	616	only
O	616	617	,
O	618	620	or
O	621	627	grades
O	628	632	plus
O	633	640	heatmap
O	640	641	.

O	642	648	Grades
O	648	649	-
O	649	653	only
O	654	664	assistance
O	665	674	comprised
O	675	676	a
O	677	686	histogram
O	687	689	of
B-Disease	690	692	DR
O	693	704	predictions
O	705	706	(
O	706	712	grades
O	712	713	)
O	714	718	from
O	719	720	a
O	721	728	trained
O	729	733	deep
O	733	734	-
O	734	742	learning
O	743	748	model
O	748	749	.

O	750	753	For
O	754	760	grades
O	761	765	plus
O	766	773	heatmap
O	773	774	,
O	775	777	we
O	778	790	additionally
O	791	797	showed
O	798	809	explanatory
O	810	818	heatmaps
O	818	819	.

O	820	823	For
O	824	828	each
O	829	839	experiment
O	840	843	arm
O	843	844	,
O	845	847	we
O	848	856	computed
O	857	868	sensitivity
O	869	872	and
O	873	884	specificity
O	885	887	of
O	888	892	each
O	893	899	reader
O	900	903	and
O	904	907	the
O	908	917	algorithm
O	918	921	for
O	922	931	different
O	932	938	levels
O	939	941	of
B-Disease	942	944	DR
O	945	953	severity
O	954	961	against
O	962	964	an
O	965	976	adjudicated
O	977	986	reference
O	987	995	standard
O	995	996	.

O	997	999	We
O	1000	1004	also
O	1005	1013	measured
O	1014	1022	accuracy
O	1023	1024	(
O	1024	1029	exact
O	1030	1031	5
O	1031	1032	-
O	1032	1037	class
O	1038	1043	level
O	1044	1053	agreement
O	1054	1057	and
O	1058	1063	Cohen
O	1063	1064	'
O	1064	1065	s
O	1066	1079	quadratically
O	1080	1088	weighted
O	1089	1090	
O	1090	1091	)
O	1091	1092	,
O	1093	1099	reader
O	1099	1100	-
O	1100	1108	reported
O	1109	1119	confidence
O	1120	1121	(
O	1121	1122	5
O	1122	1123	-
O	1123	1128	point
O	1129	1135	Likert
O	1136	1141	scale
O	1141	1142	)
O	1142	1143	,
O	1144	1147	and
O	1148	1155	grading
O	1156	1160	time
O	1160	1161	.

O	1162	1169	Readers
O	1170	1176	graded
O	1177	1181	more
O	1182	1192	accurately
O	1193	1197	with
O	1198	1203	model
O	1204	1214	assistance
O	1215	1219	than
O	1220	1227	without
O	1228	1231	for
O	1232	1235	the
O	1236	1242	grades
O	1242	1243	-
O	1243	1247	only
O	1248	1257	condition
O	1258	1259	(
O	1259	1260	P
O	1262	1263	<
O	1265	1266	0
O	1266	1267	.
O	1267	1270	001
O	1270	1271	)
O	1271	1272	.

O	1273	1279	Grades
O	1280	1284	plus
O	1285	1293	heatmaps
O	1294	1302	improved
O	1303	1311	accuracy
O	1312	1315	for
O	1316	1324	patients
O	1325	1329	with
B-Disease	1330	1332	DR
O	1333	1334	(
O	1334	1335	P
O	1337	1338	<
O	1340	1341	0
O	1341	1342	.
O	1342	1345	001
O	1345	1346	)
O	1346	1347	,
O	1348	1351	but
O	1352	1359	reduced
O	1360	1368	accuracy
O	1369	1372	for
O	1373	1381	patients
O	1382	1389	without
B-Disease	1390	1392	DR
O	1393	1394	(
O	1394	1395	P
O	1396	1397	=
O	1398	1399	0
O	1399	1400	.
O	1400	1403	006
O	1403	1404	)
O	1404	1405	.

O	1406	1410	Both
O	1411	1416	forms
O	1417	1419	of
O	1420	1430	assistance
O	1431	1440	increased
O	1441	1448	readers
O	1448	1449	'
O	1450	1461	sensitivity
O	1462	1470	moderate
O	1470	1471	-
O	1471	1473	or
O	1473	1474	-
O	1474	1479	worse
B-Disease	1480	1482	DR
O	1482	1483	:
O	1484	1494	unassisted
O	1494	1495	:
O	1496	1500	mean
O	1500	1501	,
O	1502	1504	79
O	1504	1505	.
O	1505	1506	4
O	1506	1507	%
O	1508	1509	[
O	1509	1511	95
O	1511	1512	%
O	1513	1523	confidence
O	1524	1532	interval
O	1533	1534	(
O	1534	1536	CI
O	1536	1537	)
O	1537	1538	,
O	1539	1541	72
O	1541	1542	.
O	1542	1543	3
O	1543	1544	%
O	1544	1545	-
O	1545	1547	86
O	1547	1548	.
O	1548	1549	5
O	1549	1550	%
O	1550	1551	]
O	1551	1552	;
O	1553	1559	grades
O	1560	1564	only
O	1564	1565	:
O	1566	1570	mean
O	1570	1571	,
O	1572	1574	87
O	1574	1575	.
O	1575	1576	5
O	1576	1577	%
O	1578	1579	[
O	1579	1581	95
O	1581	1582	%
O	1583	1585	CI
O	1585	1586	,
O	1587	1589	85
O	1589	1590	.
O	1590	1591	1
O	1591	1592	%
O	1592	1593	-
O	1593	1595	89
O	1595	1596	.
O	1596	1597	9
O	1597	1598	%
O	1598	1599	]
O	1600	1601	;
O	1602	1608	grades
O	1609	1613	plus
O	1614	1621	heatmap
O	1621	1622	:
O	1623	1627	mean
O	1627	1628	,
O	1629	1631	88
O	1631	1632	.
O	1632	1633	7
O	1633	1634	%
O	1635	1636	[
O	1636	1638	95
O	1638	1639	%
O	1640	1642	CI
O	1642	1643	,
O	1644	1646	84
O	1646	1647	.
O	1647	1648	9
O	1648	1649	%
O	1649	1650	-
O	1650	1652	92
O	1652	1653	.
O	1653	1654	5
O	1654	1655	%
O	1655	1656	]
O	1657	1664	without
O	1665	1666	a
O	1667	1680	corresponding
O	1681	1685	drop
O	1686	1688	in
O	1689	1700	specificity
O	1701	1702	(
O	1702	1712	unassisted
O	1712	1713	:
O	1714	1718	mean
O	1718	1719	,
O	1720	1722	96
O	1722	1723	.
O	1723	1724	6
O	1724	1725	%
O	1726	1727	[
O	1727	1729	95
O	1729	1730	%
O	1731	1733	CI
O	1733	1734	,
O	1735	1737	95
O	1737	1738	.
O	1738	1739	9
O	1739	1740	%
O	1740	1741	-
O	1741	1743	97
O	1743	1744	.
O	1744	1745	4
O	1745	1746	%
O	1746	1747	]
O	1748	1749	;
O	1750	1756	grades
O	1757	1761	only
O	1761	1762	:
O	1763	1767	mean
O	1767	1768	,
O	1769	1771	96
O	1771	1772	.
O	1772	1773	1
O	1773	1774	%
O	1775	1776	[
O	1776	1778	95
O	1778	1779	%
O	1780	1782	CI
O	1782	1783	,
O	1784	1786	95
O	1786	1787	.
O	1787	1788	5
O	1788	1789	%
O	1789	1790	-
O	1790	1792	96
O	1792	1793	.
O	1793	1794	7
O	1794	1795	%
O	1795	1796	]
O	1796	1797	;
O	1798	1804	grades
O	1805	1809	plus
O	1810	1817	heatmap
O	1817	1818	:
O	1819	1823	mean
O	1823	1824	,
O	1825	1827	95
O	1827	1828	.
O	1828	1829	5
O	1829	1830	%
O	1831	1832	[
O	1832	1834	95
O	1834	1835	%
O	1836	1838	CI
O	1838	1839	,
O	1840	1842	94
O	1842	1843	.
O	1843	1844	8
O	1844	1845	%
O	1845	1846	-
O	1846	1848	96
O	1848	1849	.
O	1849	1850	1
O	1850	1851	%
O	1851	1852	]
O	1853	1854	)
O	1854	1855	.

O	1856	1867	Algorithmic
O	1868	1878	assistance
O	1879	1888	increased
O	1889	1892	the
O	1893	1901	accuracy
O	1902	1904	of
B-Anatomy	1905	1911	retina
O	1912	1923	specialists
O	1924	1929	above
O	1930	1934	that
O	1935	1937	of
O	1938	1941	the
O	1942	1952	unassisted
O	1953	1959	reader
O	1960	1962	or
O	1963	1968	model
O	1969	1974	alone
O	1974	1975	;
O	1976	1979	and
O	1980	1989	increased
O	1990	1997	grading
O	1998	2008	confidence
O	2009	2012	and
O	2013	2020	grading
O	2021	2025	time
O	2026	2032	across
O	2033	2036	all
O	2037	2044	readers
O	2044	2045	.

O	2046	2049	For
O	2050	2054	most
O	2055	2060	cases
O	2060	2061	,
O	2062	2068	grades
O	2069	2073	plus
O	2074	2081	heatmap
O	2082	2085	was
O	2086	2090	only
O	2091	2093	as
O	2094	2103	effective
O	2104	2106	as
O	2107	2113	grades
O	2114	2118	only
O	2118	2119	.

O	2120	2124	Over
O	2125	2128	the
O	2129	2135	course
O	2136	2138	of
O	2139	2142	the
O	2143	2153	experiment
O	2153	2154	,
O	2155	2162	grading
O	2163	2167	time
O	2168	2177	decreased
O	2178	2184	across
O	2185	2188	all
O	2189	2199	conditions
O	2199	2200	,
O	2201	2209	although
O	2210	2214	most
O	2215	2222	sharply
O	2223	2226	for
O	2227	2233	grades
O	2234	2238	plus
O	2239	2246	heatmap
O	2246	2247	.

B-Diagnostic_tool	2248	2252	Deep
I-Diagnostic_tool	2253	2261	learning
I-Diagnostic_tool	2262	2272	algorithms
O	2273	2276	can
O	2277	2284	improve
O	2285	2288	the
O	2289	2297	accuracy
O	2298	2300	of
O	2300	2301	,
O	2302	2305	and
O	2306	2316	confidence
O	2317	2319	in
O	2319	2320	,
B-Disease	2321	2323	DR
O	2324	2333	diagnosis
O	2334	2336	in
O	2337	2339	an
O	2340	2348	assisted
O	2349	2353	read
O	2354	2361	setting
O	2361	2362	.

O	2363	2367	They
O	2368	2372	also
O	2373	2376	may
O	2377	2385	increase
O	2386	2393	grading
O	2394	2398	time
O	2398	2399	,
O	2400	2408	although
O	2409	2414	these
O	2415	2422	effects
O	2423	2426	may
O	2427	2429	be
O	2430	2441	ameliorated
O	2442	2446	with
O	2447	2457	experience
O	2457	2458	.

O	0	1	A
B-Diagnostic_tool	2	6	Deep
I-Diagnostic_tool	7	15	Learning
O	16	24	Approach
O	25	28	for
O	29	38	Automated
O	39	48	Detection
O	49	51	of
B-Symptom	52	62	Geographic
I-Symptom	63	70	Atrophy
O	71	75	from
B-Diagnostic_tool	76	81	Color
I-Diagnostic_tool	82	88	Fundus
I-Diagnostic_tool	89	100	Photographs
O	100	101	.

O	103	105	To
O	106	112	assess
O	113	116	the
O	117	124	utility
O	125	127	of
B-Diagnostic_tool	128	132	deep
I-Diagnostic_tool	133	141	learning
O	142	144	in
O	145	148	the
O	149	158	detection
O	159	161	of
B-Symptom	162	172	geographic
I-Symptom	173	180	atrophy
O	181	182	(
B-Symptom	182	184	GA
O	184	185	)
O	186	190	from
B-Diagnostic_tool	191	196	color
I-Diagnostic_tool	197	203	fundus
I-Diagnostic_tool	204	215	photographs
O	216	219	and
O	220	222	to
O	223	230	explore
O	231	240	potential
O	241	248	utility
O	249	251	in
O	252	261	detecting
B-Symptom	262	269	central
I-Symptom	270	272	GA
O	273	274	(
B-Symptom	274	277	CGA
O	277	278	)
O	278	279	.

O	280	281	A
B-Diagnostic_tool	282	286	deep
I-Diagnostic_tool	287	295	learning
I-Diagnostic_tool	296	301	model
O	302	305	was
O	306	315	developed
O	316	318	to
O	319	325	detect
O	326	329	the
O	330	338	presence
O	339	341	of
B-Symptom	342	344	GA
O	345	347	in
B-Diagnostic_tool	348	353	color
I-Diagnostic_tool	354	360	fundus
I-Diagnostic_tool	361	372	photographs
O	372	373	,
O	374	377	and
O	378	379	2
O	380	390	additional
B-Diagnostic_tool	391	397	models
O	398	402	were
O	403	412	developed
O	413	415	to
O	416	422	detect
B-Symptom	423	426	CGA
O	427	429	in
O	430	439	different
O	440	449	scenarios
O	449	450	.

O	451	452	A
O	453	458	total
O	459	461	of
O	462	464	59
O	465	468	812
B-Diagnostic_tool	469	474	color
I-Diagnostic_tool	475	481	fundus
I-Diagnostic_tool	482	493	photographs
O	494	498	from
O	499	511	longitudinal
O	512	518	follow
O	518	519	-
O	519	521	up
O	522	524	of
O	525	529	4582
O	530	542	participants
O	543	545	in
O	546	549	the
B-Disease	550	553	Age
I-Disease	553	554	-
I-Disease	554	561	Related
I-Disease	562	565	Eye
I-Disease	566	573	Disease
O	574	579	Study
O	580	581	(
O	581	586	AREDS
O	586	587	)
O	588	595	dataset
O	595	596	.

O	597	601	Gold
O	602	610	standard
O	611	617	labels
O	618	622	were
O	623	627	from
O	628	633	human
O	634	640	expert
O	641	648	reading
O	649	655	center
O	656	663	graders
O	664	669	using
O	670	671	a
O	672	684	standardized
O	685	693	protocol
O	693	694	.

O	695	696	A
B-Diagnostic_tool	697	701	deep
I-Diagnostic_tool	702	710	learning
I-Diagnostic_tool	711	716	model
O	717	720	was
O	721	728	trained
O	729	731	to
O	732	735	use
B-Diagnostic_tool	736	741	color
I-Diagnostic_tool	742	748	fundus
I-Diagnostic_tool	749	760	photographs
O	761	763	to
O	764	771	predict
B-Symptom	772	774	GA
O	775	783	presence
O	784	788	from
O	789	790	a
O	791	801	population
O	802	804	of
B-Anatomy	805	809	eyes
O	810	814	with
O	815	817	no
B-Disease	818	821	AMD
O	822	824	to
B-Disease	825	833	advanced
I-Disease	834	837	AMD
O	837	838	.

O	839	840	A
O	841	847	second
B-Diagnostic_tool	848	853	model
O	854	857	was
O	858	865	trained
O	866	868	to
O	869	876	predict
B-Symptom	877	880	CGA
O	881	889	presence
O	890	894	from
O	895	898	the
O	899	903	same
O	904	914	population
O	914	915	.

O	916	917	A
O	918	923	third
B-Diagnostic_tool	924	929	model
O	930	933	was
O	934	941	trained
O	942	944	to
O	945	952	predict
B-Symptom	953	956	CGA
O	957	965	presence
O	966	970	from
O	971	974	the
O	975	981	subset
O	982	984	of
B-Anatomy	985	989	eyes
O	990	994	with
B-Symptom	995	997	GA
O	997	998	.

O	999	1002	For
O	1003	1011	training
O	1012	1015	and
O	1016	1023	testing
O	1023	1024	,
O	1025	1026	5
O	1026	1027	-
O	1027	1031	fold
O	1032	1037	cross
O	1037	1038	-
O	1038	1048	validation
O	1049	1052	was
O	1053	1057	used
O	1057	1058	.

O	1059	1062	For
O	1063	1073	comparison
O	1074	1078	with
O	1079	1084	human
O	1085	1094	clinician
O	1095	1106	performance
O	1106	1107	,
O	1108	1113	model
O	1114	1125	performance
O	1126	1129	was
O	1130	1138	compared
O	1139	1143	with
O	1144	1148	that
O	1149	1151	of
O	1152	1154	88
B-Anatomy	1155	1162	retinal
O	1163	1174	specialists
O	1174	1175	.

O	1176	1180	Area
O	1181	1186	under
O	1187	1190	the
O	1191	1196	curve
O	1197	1198	(
O	1198	1201	AUC
O	1201	1202	)
O	1202	1203	,
O	1204	1212	accuracy
O	1212	1213	,
O	1214	1225	sensitivity
O	1225	1226	,
O	1227	1238	specificity
O	1238	1239	,
O	1240	1243	and
O	1244	1253	precision
O	1253	1254	.

O	1255	1258	The
B-Diagnostic_tool	1259	1263	deep
I-Diagnostic_tool	1264	1272	learning
I-Diagnostic_tool	1273	1279	models
O	1280	1281	(
B-Symptom	1281	1283	GA
O	1284	1293	detection
O	1293	1294	,
B-Symptom	1295	1298	CGA
O	1299	1308	detection
O	1309	1313	from
O	1314	1317	all
B-Anatomy	1318	1322	eyes
O	1322	1323	,
O	1324	1327	and
O	1328	1338	centrality
O	1339	1348	detection
O	1349	1353	from
B-Symptom	1354	1356	GA
B-Anatomy	1357	1361	eyes
O	1361	1362	)
O	1363	1366	had
O	1367	1371	AUCs
O	1372	1374	of
O	1375	1376	0
O	1376	1377	.
O	1377	1380	933
O	1380	1381	-
O	1381	1382	0
O	1382	1383	.
O	1383	1386	976
O	1386	1387	,
O	1388	1389	0
O	1389	1390	.
O	1390	1393	939
O	1393	1394	-
O	1394	1395	0
O	1395	1396	.
O	1396	1399	976
O	1399	1400	,
O	1401	1404	and
O	1405	1406	0
O	1406	1407	.
O	1407	1410	827
O	1410	1411	-
O	1411	1412	0
O	1412	1413	.
O	1413	1416	888
O	1416	1417	,
O	1418	1430	respectively
O	1430	1431	.

O	1432	1435	The
B-Diagnostic_tool	1436	1438	GA
I-Diagnostic_tool	1439	1448	detection
I-Diagnostic_tool	1449	1454	model
O	1455	1458	had
O	1459	1467	accuracy
O	1467	1468	,
O	1469	1480	sensitivity
O	1480	1481	,
O	1482	1493	specificity
O	1493	1494	,
O	1495	1498	and
O	1499	1508	precision
O	1509	1511	of
O	1512	1513	0
O	1513	1514	.
O	1514	1517	965
O	1518	1519	(
O	1519	1521	95
O	1521	1522	%
O	1523	1533	confidence
O	1534	1542	interval
O	1543	1544	[
O	1544	1546	CI
O	1546	1547	]
O	1547	1548	,
O	1549	1550	0
O	1550	1551	.
O	1551	1554	959
O	1554	1555	-
O	1555	1556	0
O	1556	1557	.
O	1557	1560	971
O	1560	1561	)
O	1561	1562	,
O	1563	1564	0
O	1564	1565	.
O	1565	1568	692
O	1569	1570	(
O	1570	1571	0
O	1571	1572	.
O	1572	1575	560
O	1575	1576	-
O	1576	1577	0
O	1577	1578	.
O	1578	1581	825
O	1581	1582	)
O	1582	1583	,
O	1584	1585	0
O	1585	1586	.
O	1586	1589	978
O	1590	1591	(
O	1591	1592	0
O	1592	1593	.
O	1593	1596	970
O	1596	1597	-
O	1597	1598	0
O	1598	1599	.
O	1599	1602	985
O	1602	1603	)
O	1603	1604	,
O	1605	1608	and
O	1609	1610	0
O	1610	1611	.
O	1611	1614	584
O	1615	1616	(
O	1616	1617	0
O	1617	1618	.
O	1618	1621	491
O	1621	1622	-
O	1622	1623	0
O	1623	1624	.
O	1624	1627	676
O	1627	1628	)
O	1628	1629	,
O	1630	1642	respectively
O	1642	1643	,
O	1644	1652	compared
O	1653	1657	with
O	1658	1659	0
O	1659	1660	.
O	1660	1663	975
O	1664	1665	(
O	1665	1666	0
O	1666	1667	.
O	1667	1670	971
O	1670	1671	-
O	1671	1672	0
O	1672	1673	.
O	1673	1676	980
O	1676	1677	)
O	1677	1678	,
O	1679	1680	0
O	1680	1681	.
O	1681	1684	588
O	1685	1686	(
O	1686	1687	0
O	1687	1688	.
O	1688	1691	468
O	1691	1692	-
O	1692	1693	0
O	1693	1694	.
O	1694	1697	707
O	1697	1698	)
O	1698	1699	,
O	1700	1701	0
O	1701	1702	.
O	1702	1705	982
O	1706	1707	(
O	1707	1708	0
O	1708	1709	.
O	1709	1712	978
O	1712	1713	-
O	1713	1714	0
O	1714	1715	.
O	1715	1718	985
O	1718	1719	)
O	1719	1720	,
O	1721	1724	and
O	1725	1726	0
O	1726	1727	.
O	1727	1730	368
O	1731	1732	(
O	1732	1733	0
O	1733	1734	.
O	1734	1737	230
O	1737	1738	-
O	1738	1739	0
O	1739	1740	.
O	1740	1743	505
O	1743	1744	)
O	1745	1748	for
O	1749	1752	the
O	1753	1760	retinal
O	1761	1772	specialists
O	1772	1773	.

O	1774	1777	The
B-Diagnostic_tool	1778	1781	CGA
I-Diagnostic_tool	1782	1791	detection
I-Diagnostic_tool	1792	1797	model
O	1798	1801	had
O	1802	1808	values
O	1809	1811	of
O	1812	1813	0
O	1813	1814	.
O	1814	1817	966
O	1818	1819	(
O	1819	1820	0
O	1820	1821	.
O	1821	1824	957
O	1824	1825	-
O	1825	1826	0
O	1826	1827	.
O	1827	1830	975
O	1830	1831	)
O	1831	1832	,
O	1833	1834	0
O	1834	1835	.
O	1835	1838	763
O	1839	1840	(
O	1840	1841	0
O	1841	1842	.
O	1842	1845	641
O	1845	1846	-
O	1846	1847	0
O	1847	1848	.
O	1848	1851	885
O	1851	1852	)
O	1852	1853	,
O	1854	1855	0
O	1855	1856	.
O	1856	1859	971
O	1860	1861	(
O	1861	1862	0
O	1862	1863	.
O	1863	1866	960
O	1866	1867	-
O	1867	1868	0
O	1868	1869	.
O	1869	1872	982
O	1872	1873	)
O	1873	1874	,
O	1875	1878	and
O	1879	1880	0
O	1880	1881	.
O	1881	1884	394
O	1885	1886	(
O	1886	1887	0
O	1887	1888	.
O	1888	1891	341
O	1891	1892	-
O	1892	1893	0
O	1893	1894	.
O	1894	1897	448
O	1897	1898	)
O	1898	1899	.

O	1900	1903	The
B-Diagnostic_tool	1904	1914	centrality
I-Diagnostic_tool	1915	1924	detection
I-Diagnostic_tool	1925	1930	model
O	1931	1934	had
O	1935	1941	values
O	1942	1944	of
O	1945	1946	0
O	1946	1947	.
O	1947	1950	762
O	1951	1952	(
O	1952	1953	0
O	1953	1954	.
O	1954	1957	725
O	1957	1958	-
O	1958	1959	0
O	1959	1960	.
O	1960	1963	799
O	1963	1964	)
O	1964	1965	,
O	1966	1967	0
O	1967	1968	.
O	1968	1971	782
O	1972	1973	(
O	1973	1974	0
O	1974	1975	.
O	1975	1978	618
O	1978	1979	-
O	1979	1980	0
O	1980	1981	.
O	1981	1984	945
O	1984	1985	)
O	1985	1986	,
O	1987	1988	0
O	1988	1989	.
O	1989	1992	729
O	1993	1994	(
O	1994	1995	0
O	1995	1996	.
O	1996	1999	543
O	1999	2000	-
O	2000	2001	0
O	2001	2002	.
O	2002	2005	916
O	2005	2006	)
O	2006	2007	,
O	2008	2011	and
O	2012	2013	0
O	2013	2014	.
O	2014	2017	799
O	2018	2019	(
O	2019	2020	0
O	2020	2021	.
O	2021	2024	710
O	2024	2025	-
O	2025	2026	0
O	2026	2027	.
O	2027	2030	888
O	2030	2031	)
O	2031	2032	.

O	2033	2034	A
B-Diagnostic_tool	2035	2039	deep
I-Diagnostic_tool	2040	2048	learning
I-Diagnostic_tool	2049	2054	model
O	2055	2067	demonstrated
O	2068	2072	high
O	2073	2081	accuracy
O	2082	2085	for
O	2086	2089	the
O	2090	2099	automated
O	2100	2109	detection
O	2110	2112	of
B-Symptom	2113	2115	GA
O	2115	2116	.

O	2117	2120	The
O	2121	2124	AUC
O	2125	2128	was
O	2129	2140	noninferior
O	2141	2143	to
O	2144	2148	that
O	2149	2151	of
O	2152	2157	human
O	2158	2165	retinal
O	2166	2177	specialists
O	2177	2178	.

B-Diagnostic_tool	2179	2183	Deep
I-Diagnostic_tool	2184	2192	learning
O	2193	2203	approaches
O	2204	2207	may
O	2208	2212	also
O	2213	2215	be
O	2216	2223	applied
O	2224	2226	to
O	2227	2230	the
O	2231	2245	identification
O	2246	2248	of
B-Symptom	2249	2252	CGA
O	2252	2253	.

O	2254	2257	The
O	2258	2262	code
O	2263	2266	and
O	2267	2277	pretrained
O	2278	2284	models
O	2285	2288	are
O	2289	2297	publicly
O	2298	2307	available
O	2308	2310	at
O	2311	2316	https
O	2316	2317	:
O	2317	2318	/
O	2318	2319	/
O	2319	2325	github
O	2325	2326	.
O	2326	2329	com
O	2329	2330	/
O	2330	2334	ncbi
O	2334	2335	-
O	2335	2338	nlp
O	2338	2339	/
O	2339	2349	DeepSeeNet
O	2349	2350	.

B-Diagnostic_tool	0	3	OCT
I-Diagnostic_tool	4	15	Angiography
O	16	23	Metrics
O	24	31	Predict
O	32	43	Progression
O	44	46	of
B-Disease	47	55	Diabetic
I-Disease	56	67	Retinopathy
O	68	71	and
O	72	83	Development
O	84	86	of
B-Disease	87	95	Diabetic
I-Disease	96	103	Macular
I-Disease	104	109	Edema
O	109	110	:
O	111	112	A
O	113	124	Prospective
O	125	130	Study
O	130	131	.

O	133	135	To
O	136	149	prospectively
O	150	159	determine
O	160	163	the
O	164	176	relationship
O	177	179	of
B-Diagnostic_tool	180	183	OCT
I-Diagnostic_tool	184	195	angiography
O	196	197	(
B-Diagnostic_tool	197	201	OCTA
O	201	202	)
O	203	210	metrics
O	211	213	to
B-Disease	214	222	diabetic
I-Disease	223	234	retinopathy
O	235	236	(
B-Disease	236	238	DR
O	238	239	)
O	240	251	progression
O	252	255	and
O	256	267	development
O	268	270	of
B-Disease	271	279	diabetic
I-Disease	280	287	macular
I-Disease	288	293	edema
O	294	295	(
B-Disease	295	298	DME
O	298	299	)
O	299	300	.

O	301	312	Prospective
O	312	313	,
O	314	327	observational
O	328	333	study
O	333	334	.

O	335	336	A
O	337	342	total
O	343	345	of
O	346	349	205
B-Anatomy	350	354	eyes
O	355	359	from
O	360	363	129
O	364	372	patients
O	373	377	with
B-Disease	378	386	diabetes
I-Disease	387	395	mellitus
O	396	404	followed
O	405	407	up
O	408	411	for
O	412	414	at
O	415	420	least
O	421	422	2
O	423	428	years
O	428	429	.

O	430	433	All
O	434	446	participants
O	447	456	underwent
B-Diagnostic_tool	457	461	OCTA
O	462	466	with
O	467	468	a
B-Diagnostic_tool	469	474	swept
I-Diagnostic_tool	474	475	-
I-Diagnostic_tool	475	481	source
I-Diagnostic_tool	482	485	OCT
I-Diagnostic_tool	486	492	device
O	493	494	(
B-Diagnostic_tool	494	497	DRI
I-Diagnostic_tool	497	498	-
I-Diagnostic_tool	498	501	OCT
I-Diagnostic_tool	502	508	Triton
O	508	509	,
O	510	516	Topcon
O	516	517	,
O	518	521	Inc
O	521	522	,
O	523	528	Tokyo
O	528	529	,
O	530	535	Japan
O	535	536	)
O	536	537	.

O	538	548	Individual
B-Diagnostic_tool	549	553	OCTA
I-Diagnostic_tool	554	560	images
O	561	563	of
B-Anatomy	564	575	superficial
I-Anatomy	576	585	capillary
I-Anatomy	586	592	plexus
O	593	594	(
B-Anatomy	594	597	SCP
O	597	598	)
O	599	602	and
B-Anatomy	603	607	deep
I-Anatomy	608	617	capillary
I-Anatomy	618	624	plexus
O	625	626	(
B-Anatomy	626	629	DCP
O	629	630	)
O	631	635	were
O	636	645	generated
O	646	648	by
O	649	658	IMAGEnet6
O	659	660	(
O	660	665	Basic
O	666	673	License
O	674	676	10
O	676	677	)
O	677	678	.

O	679	684	After
O	685	686	a
O	687	694	quality
O	695	700	check
O	700	701	,
O	702	711	automated
O	712	724	measurements
O	725	727	of
B-Characteristic	728	734	foveal
I-Characteristic	735	744	avascular
I-Characteristic	745	749	zone
I-Characteristic	750	751	(
I-Characteristic	751	754	FAZ
I-Characteristic	754	755	)
I-Characteristic	756	760	area
O	760	761	,
B-Characteristic	762	765	FAZ
I-Characteristic	766	777	circularity
O	777	778	,
B-Characteristic	779	785	vessel
I-Characteristic	786	793	density
O	794	795	(
B-Characteristic	795	797	VD
O	797	798	)
O	798	799	,
O	800	803	and
B-Characteristic	804	811	fractal
I-Characteristic	812	821	dimension
O	822	823	(
B-Characteristic	823	825	FD
O	825	826	)
O	827	829	of
O	830	834	both
B-Anatomy	835	838	SCP
O	839	842	and
B-Anatomy	843	846	DCP
O	847	851	were
O	852	856	then
O	857	865	obtained
O	865	866	.

O	867	878	Progression
O	879	881	of
B-Disease	882	884	DR
O	885	888	and
O	889	900	development
O	901	903	of
B-Disease	904	907	DME
O	907	908	.

O	909	913	Over
O	914	915	a
O	916	922	median
O	923	929	follow
O	929	930	-
O	930	932	up
O	933	935	of
O	936	938	27
O	938	939	.
O	939	941	14
O	942	948	months
O	949	950	(
O	950	963	interquartile
O	964	969	range
O	969	970	,
O	971	973	24
O	973	974	.
O	974	976	16
O	976	977	-
O	977	979	30
O	979	980	.
O	980	982	41
O	983	989	months
O	989	990	)
O	990	991	,
O	992	994	28
O	995	997	of
O	998	1001	the
O	1002	1005	205
B-Anatomy	1006	1010	eyes
O	1011	1012	(
O	1012	1014	13
O	1014	1015	.
O	1015	1017	66
O	1017	1018	%
O	1018	1019	)
O	1020	1029	developed
B-Disease	1030	1032	DR
O	1033	1044	progression
O	1044	1045	.

O	1046	1048	Of
O	1049	1052	the
O	1053	1056	194
B-Anatomy	1057	1061	eyes
O	1062	1069	without
B-Disease	1070	1073	DME
O	1074	1076	at
O	1077	1085	baseline
O	1085	1086	,
O	1087	1089	17
O	1090	1091	(
O	1091	1092	8
O	1092	1093	.
O	1093	1095	76
O	1095	1096	%
O	1096	1097	)
O	1098	1107	developed
B-Disease	1108	1111	DME
O	1111	1112	.

B-Characteristic	1113	1119	Larger
I-Characteristic	1120	1123	FAZ
I-Characteristic	1124	1128	area
O	1129	1130	(
O	1130	1136	hazard
O	1137	1142	ratio
O	1143	1144	[
O	1144	1146	HR
O	1146	1147	]
O	1147	1148	,
O	1149	1150	1
O	1150	1151	.
O	1151	1154	829
O	1155	1158	per
O	1159	1161	SD
O	1162	1170	increase
O	1170	1171	;
O	1172	1174	95
O	1174	1175	%
O	1176	1186	confidence
O	1187	1195	interval
O	1196	1197	[
O	1197	1199	CI
O	1199	1200	]
O	1201	1202	,
O	1203	1204	1
O	1204	1205	.
O	1205	1208	332
O	1208	1209	-
O	1209	1210	2
O	1210	1211	.
O	1211	1214	512
O	1214	1215	)
O	1215	1216	,
B-Characteristic	1217	1222	lower
I-Characteristic	1223	1225	VD
O	1226	1227	(
O	1227	1229	HR
O	1229	1230	,
O	1231	1232	1
O	1232	1233	.
O	1233	1236	908
O	1237	1240	per
O	1241	1243	SD
O	1244	1252	decrease
O	1252	1253	;
O	1254	1256	95
O	1256	1257	%
O	1258	1260	CI
O	1260	1261	,
O	1262	1263	1
O	1263	1264	.
O	1264	1267	303
O	1267	1268	-
O	1268	1269	2
O	1269	1270	.
O	1270	1273	793
O	1273	1274	)
O	1274	1275	,
O	1276	1279	and
B-Characteristic	1280	1285	lower
I-Characteristic	1286	1288	FD
O	1289	1290	(
O	1290	1292	HR
O	1292	1293	,
O	1294	1295	4
O	1295	1296	.
O	1296	1299	464
O	1300	1303	per
O	1304	1306	SD
O	1307	1315	decrease
O	1315	1316	;
O	1317	1319	95
O	1319	1320	%
O	1321	1323	CI
O	1323	1324	,
O	1325	1326	1
O	1326	1327	.
O	1327	1330	337
O	1330	1331	-
O	1331	1333	14
O	1333	1334	.
O	1334	1337	903
O	1337	1338	)
O	1339	1341	of
B-Anatomy	1342	1345	DCP
O	1346	1350	were
O	1351	1364	significantly
O	1365	1375	associated
O	1376	1380	with
B-Disease	1381	1383	DR
O	1384	1395	progression
O	1396	1401	after
O	1402	1411	adjusting
O	1412	1415	for
O	1416	1427	established
O	1428	1432	risk
O	1433	1440	factors
O	1441	1442	(
B-Characteristic	1442	1444	DR
I-Characteristic	1445	1453	severity
O	1453	1454	,
B-Characteristic	1455	1463	glycated
I-Characteristic	1464	1474	hemoglobin
O	1474	1475	,
B-Characteristic	1476	1484	duration
I-Characteristic	1485	1487	of
I-Characteristic	1488	1496	diabetes
O	1496	1497	,
B-Characteristic	1498	1501	age
O	1501	1502	,
O	1503	1506	and
B-Characteristic	1507	1511	mean
I-Characteristic	1512	1520	arterial
I-Characteristic	1521	1526	blood
I-Characteristic	1527	1535	pressure
O	1536	1538	at
O	1539	1547	baseline
O	1547	1548	)
O	1548	1549	.

B-Characteristic	1550	1555	Lower
I-Characteristic	1556	1558	VD
I-Characteristic	1559	1561	of
I-Characteristic	1562	1565	SCP
O	1566	1567	(
O	1567	1569	HR
O	1569	1570	,
O	1571	1572	1
O	1572	1573	.
O	1573	1576	789
O	1577	1580	per
O	1581	1583	SD
O	1584	1592	decrease
O	1592	1593	;
O	1594	1596	95
O	1596	1597	%
O	1598	1600	CI
O	1600	1601	,
O	1602	1603	1
O	1603	1604	.
O	1604	1607	027
O	1607	1608	-
O	1608	1609	4
O	1609	1610	.
O	1610	1613	512
O	1613	1614	)
O	1615	1618	was
O	1619	1629	associated
O	1630	1634	with
B-Disease	1635	1638	DME
O	1639	1650	development
O	1650	1651	.

O	1652	1660	Compared
O	1661	1665	with
O	1666	1669	the
O	1670	1675	model
O	1676	1680	with
O	1681	1692	established
O	1693	1697	risk
O	1698	1705	factors
O	1706	1711	alone
O	1711	1712	,
O	1713	1716	the
O	1717	1725	addition
O	1726	1728	of
B-Diagnostic_tool	1729	1733	OCTA
O	1734	1741	metrics
O	1742	1750	improved
O	1751	1754	the
O	1755	1765	predictive
O	1766	1780	discrimination
O	1781	1783	of
B-Disease	1784	1786	DR
O	1787	1798	progression
O	1799	1800	(
B-Characteristic	1800	1803	FAZ
I-Characteristic	1804	1808	area
I-Characteristic	1809	1811	of
I-Characteristic	1812	1815	DCP
O	1815	1816	,
O	1817	1818	C
O	1818	1819	-
O	1819	1829	statistics
O	1830	1831	0
O	1831	1832	.
O	1832	1835	723
O	1836	1838	vs
O	1838	1839	.
O	1840	1841	0
O	1841	1842	.
O	1842	1845	677
O	1845	1846	,
O	1847	1848	P
O	1850	1851	<
O	1853	1854	0
O	1854	1855	.
O	1855	1858	001
O	1858	1859	;
B-Characteristic	1860	1862	VD
I-Characteristic	1863	1865	of
I-Characteristic	1866	1869	DCP
O	1869	1870	,
O	1871	1872	C
O	1872	1873	-
O	1873	1883	statistics
O	1884	1885	0
O	1885	1886	.
O	1886	1889	727
O	1890	1892	vs
O	1892	1893	.
O	1894	1895	0
O	1895	1896	.
O	1896	1899	677
O	1899	1900	,
O	1901	1902	P
O	1903	1904	=
O	1905	1906	0
O	1906	1907	.
O	1907	1910	001
O	1910	1911	;
B-Characteristic	1912	1914	FD
I-Characteristic	1915	1917	of
I-Characteristic	1918	1921	DCP
O	1921	1922	,
O	1923	1924	C
O	1924	1925	-
O	1925	1935	statistics
O	1936	1937	0
O	1937	1938	.
O	1938	1941	738
O	1942	1944	vs
O	1944	1945	.
O	1946	1947	0
O	1947	1948	.
O	1948	1951	677
O	1951	1952	,
O	1953	1954	P
O	1956	1957	<
O	1959	1960	0
O	1960	1961	.
O	1961	1964	001
O	1964	1965	)
O	1966	1969	and
B-Disease	1970	1973	DME
O	1974	1985	development
O	1986	1987	(
B-Characteristic	1987	1989	VD
I-Characteristic	1990	1992	of
I-Characteristic	1993	1996	SCP
O	1996	1997	,
O	1998	1999	C
O	1999	2000	-
O	2000	2010	statistics
O	2011	2012	0
O	2012	2013	.
O	2013	2016	904
O	2017	2019	vs
O	2019	2020	.
O	2021	2022	0
O	2022	2023	.
O	2023	2026	875
O	2026	2027	,
O	2028	2029	P
O	2030	2031	=
O	2032	2033	0
O	2033	2034	.
O	2034	2037	036
O	2037	2038	)
O	2038	2039	.

O	2040	2043	The
B-Characteristic	2044	2047	FAZ
I-Characteristic	2048	2052	area
O	2052	2053	,
B-Characteristic	2054	2056	VD
O	2056	2057	,
O	2058	2061	and
B-Characteristic	2062	2064	FD
I-Characteristic	2065	2067	of
I-Characteristic	2068	2071	DCP
O	2072	2079	predict
B-Disease	2080	2082	DR
O	2083	2094	progression
O	2094	2095	,
O	2096	2103	whereas
B-Characteristic	2104	2106	VD
I-Characteristic	2107	2109	of
I-Characteristic	2110	2113	SCP
O	2114	2122	predicts
B-Disease	2123	2126	DME
O	2127	2138	development
O	2138	2139	.

O	2140	2143	Our
O	2144	2152	findings
O	2153	2160	provide
O	2161	2169	evidence
O	2170	2172	to
O	2173	2180	support
O	2181	2185	that
B-Diagnostic_tool	2186	2190	OCTA
O	2191	2198	metrics
O	2199	2206	improve
O	2207	2210	the
O	2211	2221	evaluation
O	2222	2224	of
O	2225	2229	risk
O	2230	2232	of
B-Disease	2233	2235	DR
O	2236	2247	progression
O	2248	2251	and
B-Disease	2252	2255	DME
O	2256	2267	development
O	2268	2274	beyond
O	2275	2286	traditional
O	2287	2291	risk
O	2292	2299	factors
O	2299	2300	.

O	0	10	Diagnostic
O	11	19	Accuracy
O	20	22	of
O	23	33	Technology
O	33	34	-
O	34	39	based
B-Anatomy	40	43	Eye
O	44	48	Care
O	49	57	Services
O	57	58	:
O	59	62	The
O	63	73	Technology
O	73	74	-
O	74	79	based
B-Anatomy	80	83	Eye
O	84	88	Care
O	89	97	Services
O	98	105	Compare
O	106	111	Trial
O	112	116	Part
O	117	118	I
O	118	119	.

O	121	135	Ophthalmologic
O	136	148	telemedicine
O	149	152	has
O	153	156	the
O	157	164	ability
O	165	167	to
O	168	175	provide
B-Anatomy	176	179	eye
O	180	184	care
O	185	188	for
O	189	197	patients
O	198	206	remotely
O	206	207	,
O	208	211	and
O	212	216	many
O	217	226	countries
O	227	231	have
O	232	236	used
O	237	246	screening
O	247	251	tele
O	251	252	-
O	252	265	ophthalmology
O	266	274	programs
O	275	278	for
O	279	286	several
O	287	292	years
O	292	293	.

O	294	297	One
O	298	302	such
O	303	313	initiative
O	314	316	at
O	317	320	the
O	321	329	Veterans
O	330	337	Affairs
O	338	339	(
O	339	341	VA
O	341	342	)
O	343	353	Healthcare
O	354	360	System
O	361	363	is
O	364	374	Technology
O	374	375	-
O	375	380	based
B-Anatomy	381	384	Eye
O	385	389	Care
O	390	398	Services
O	399	400	(
O	400	404	TECS
O	404	405	)
O	405	406	.

O	407	410	The
O	411	415	TECS
O	416	424	services
O	425	428	are
O	429	436	located
O	437	439	in
O	440	447	primary
O	448	452	care
O	453	460	clinics
O	461	464	and
O	465	472	provide
O	473	478	basic
O	479	488	screening
B-Anatomy	489	492	eye
O	493	497	care
O	497	498	,
O	499	508	including
O	509	515	vision
O	515	516	,
O	517	527	refraction
O	527	528	,
O	529	532	and
B-Diagnostic_tool	533	540	retinal
I-Diagnostic_tool	541	552	photography
O	552	553	.

B-Anatomy	554	557	Eye
O	558	562	care
O	563	572	providers
O	573	574	(
O	575	576	"
O	577	584	readers
O	585	586	"
O	587	588	)
O	589	595	review
O	596	599	the
O	600	608	clinical
O	609	613	data
O	614	617	and
O	618	627	recommend
O	628	639	appropriate
O	640	646	follow
O	646	647	-
O	647	649	up
O	649	650	.

O	651	654	One
O	655	657	of
O	658	661	the
O	662	666	most
O	667	673	common
O	674	683	referrals
O	684	688	from
O	689	693	TECS
O	694	697	has
O	698	702	been
O	703	706	for
B-Disease	707	715	glaucoma
O	715	716	,
O	717	720	and
O	721	725	this
O	726	731	study
O	732	735	was
O	736	743	powered
O	744	747	for
B-Disease	748	756	glaucoma
O	756	757	/
B-Disease	757	765	glaucoma
I-Disease	766	773	suspect
O	774	783	detection
O	783	784	.

O	785	788	The
O	789	796	current
O	797	802	study
O	803	806	was
O	807	817	undertaken
O	818	820	to
O	821	829	identify
O	830	837	aspects
O	838	840	of
O	841	844	the
O	845	853	protocol
O	854	858	that
O	859	864	could
O	865	867	be
O	868	875	refined
O	876	878	to
O	879	886	enhance
O	887	895	accuracy
O	895	896	.

O	897	908	Prospective
O	909	919	comparison
O	920	927	between
O	928	931	the
O	932	940	standard
O	941	945	TECS
O	946	954	protocol
O	955	961	versus
O	962	963	a
B-Diagnostic_tool	964	968	face
I-Diagnostic_tool	968	969	-
I-Diagnostic_tool	969	971	to
I-Diagnostic_tool	971	972	-
I-Diagnostic_tool	972	976	face
I-Diagnostic_tool	977	978	(
I-Diagnostic_tool	978	981	FTF
I-Diagnostic_tool	981	982	)
I-Diagnostic_tool	983	994	examination
O	995	997	on
O	998	1001	256
O	1002	1010	patients
O	1010	1011	,
O	1012	1015	all
O	1016	1018	of
O	1019	1023	whom
O	1024	1027	had
O	1028	1030	no
O	1031	1036	known
O	1037	1044	history
O	1045	1047	of
O	1048	1059	significant
B-Disease	1060	1066	ocular
I-Disease	1067	1074	disease
O	1074	1075	.

O	1076	1084	Patients
O	1085	1089	with
O	1090	1092	no
O	1093	1098	known
O	1099	1105	ocular
O	1106	1113	disease
O	1114	1117	who
O	1118	1122	were
O	1123	1132	scheduled
O	1133	1136	for
O	1137	1139	an
O	1140	1142	in
O	1142	1143	-
O	1143	1149	person
B-Anatomy	1150	1153	eye
O	1154	1165	appointment
O	1166	1168	at
O	1169	1172	the
O	1173	1180	Atlanta
O	1181	1183	VA
O	1183	1184	.

O	1185	1193	Patients
O	1194	1203	underwent
O	1204	1213	screening
O	1214	1221	through
O	1222	1225	the
O	1226	1230	TECS
O	1231	1239	protocol
O	1240	1243	and
O	1244	1252	received
O	1253	1255	an
B-Diagnostic_tool	1256	1259	FTF
I-Diagnostic_tool	1260	1271	examination
O	1272	1274	on
O	1275	1278	the
O	1279	1283	same
O	1284	1287	day
O	1288	1289	(
O	1289	1293	gold
O	1294	1302	standard
O	1302	1303	)
O	1303	1304	.

O	1305	1308	The
O	1309	1313	TECS
O	1314	1321	readers
O	1322	1326	were
O	1327	1333	masked
O	1334	1336	to
O	1337	1340	the
O	1341	1348	results
O	1349	1351	of
O	1352	1355	the
B-Diagnostic_tool	1356	1359	FTF
I-Diagnostic_tool	1360	1371	examination
O	1371	1372	.

O	1373	1380	Percent
O	1381	1390	agreement
O	1390	1391	,
O	1392	1397	kappa
O	1397	1398	,
O	1399	1410	sensitivity
O	1410	1411	,
O	1412	1415	and
O	1416	1427	specificity
O	1428	1432	were
O	1433	1443	calculated
O	1444	1447	for
O	1448	1451	the
O	1452	1456	TECS
O	1457	1464	readers
O	1464	1465	'
O	1466	1481	interpretations
O	1482	1488	versus
O	1489	1492	the
B-Diagnostic_tool	1493	1496	FTF
I-Diagnostic_tool	1497	1508	examination
O	1508	1509	.

O	1510	1513	The
O	1514	1518	TECS
O	1519	1526	readers
O	1527	1533	showed
O	1534	1545	substantial
O	1546	1555	agreement
O	1556	1559	for
B-Disease	1560	1568	cataract
O	1569	1570	(
O	1570	1571	
O	1572	1573	
O	1574	1575	0
O	1575	1576	.
O	1576	1578	71
O	1578	1579	)
O	1580	1583	and
B-Disease	1584	1592	diabetic
I-Disease	1593	1604	retinopathy
O	1605	1606	(
O	1606	1607	
O	1608	1609	
O	1610	1611	0
O	1611	1612	.
O	1612	1614	61
O	1614	1615	)
O	1616	1619	and
O	1620	1628	moderate
O	1629	1631	to
O	1632	1643	substantial
O	1644	1653	agreement
O	1654	1657	for
B-Disease	1658	1666	glaucoma
O	1666	1667	/
B-Disease	1667	1675	glaucoma
I-Disease	1676	1683	suspect
O	1684	1685	(
O	1685	1686	
O	1687	1688	
O	1689	1690	0
O	1690	1691	.
O	1691	1693	52
O	1693	1694	)
O	1695	1703	compared
O	1704	1708	with
O	1709	1711	an
B-Diagnostic_tool	1712	1715	FTF
I-Diagnostic_tool	1716	1727	examination
O	1727	1728	.

B-Disease	1729	1732	Age
I-Disease	1732	1733	-
I-Disease	1733	1740	related
I-Disease	1741	1748	macular
I-Disease	1749	1761	degeneration
O	1762	1763	(
B-Disease	1763	1766	AMD
O	1766	1767	)
O	1768	1774	showed
O	1775	1783	moderate
O	1784	1793	agreement
O	1794	1795	(
O	1795	1796	
O	1797	1798	
O	1799	1800	0
O	1800	1801	.
O	1801	1803	34
O	1803	1804	)
O	1804	1805	.

O	1806	1813	Percent
O	1814	1823	agreement
O	1824	1828	with
O	1829	1832	the
B-Diagnostic_tool	1833	1837	TECS
I-Diagnostic_tool	1838	1846	protocol
O	1847	1850	was
O	1851	1855	high
O	1856	1857	(
O	1857	1859	84
O	1859	1860	.
O	1860	1861	3
O	1861	1862	%
O	1862	1863	-
O	1863	1865	98
O	1865	1866	.
O	1866	1867	4
O	1867	1868	%
O	1868	1869	)
O	1870	1873	for
O	1874	1878	each
O	1879	1881	of
O	1882	1885	the
O	1886	1893	disease
O	1894	1904	categories
O	1904	1905	.

O	1906	1913	Overall
O	1914	1925	sensitivity
O	1926	1929	and
O	1930	1941	specificity
O	1942	1946	were
O	1947	1948	
O	1948	1950	75
O	1950	1951	%
O	1952	1955	and
O	1956	1957	
O	1957	1959	55
O	1959	1960	%
O	1960	1961	,
O	1962	1974	respectively
O	1974	1975	,
O	1976	1979	for
O	1980	1983	any
O	1984	1993	diagnosis
O	1994	2003	resulting
O	2004	2006	in
O	2007	2015	referral
O	2015	2016	.

O	2017	2022	Inter
O	2022	2023	-
O	2023	2029	reader
O	2030	2033	and
O	2034	2039	intra
O	2039	2040	-
O	2040	2046	reader
O	2047	2056	agreement
O	2057	2060	was
O	2061	2072	substantial
O	2073	2076	for
O	2077	2081	most
O	2082	2091	diagnoses
O	2092	2093	(
O	2093	2094	
O	2096	2097	>
O	2099	2100	0
O	2100	2101	.
O	2101	2103	61
O	2103	2104	)
O	2105	2109	with
O	2110	2117	percent
O	2118	2128	agreements
O	2129	2136	ranging
O	2137	2141	from
O	2142	2144	66
O	2144	2145	%
O	2146	2148	to
O	2149	2151	99
O	2151	2152	%
O	2152	2153	.

O	2154	2157	Our
O	2158	2165	results
O	2166	2174	indicate
O	2175	2179	that
O	2180	2183	the
O	2184	2192	standard
B-Diagnostic_tool	2193	2197	TECS
I-Diagnostic_tool	2198	2206	protocol
O	2207	2209	is
O	2210	2218	accurate
O	2219	2223	when
O	2224	2232	compared
O	2233	2237	with
O	2238	2240	an
B-Diagnostic_tool	2241	2244	FTF
I-Diagnostic_tool	2245	2256	examination
O	2257	2260	for
O	2261	2264	the
O	2265	2274	detection
O	2275	2277	of
O	2278	2284	common
B-Disease	2285	2288	eye
I-Disease	2289	2297	diseases
O	2297	2298	.

O	2299	2302	The
O	2303	2312	inclusion
O	2313	2315	of
O	2316	2326	additional
O	2327	2334	testing
O	2335	2339	such
O	2340	2342	as
B-Diagnostic_tool	2343	2346	OCT
O	2347	2352	could
O	2353	2360	further
O	2361	2368	enhance
O	2369	2379	diagnostic
O	2380	2390	capability
O	2390	2391	.

B-Diagnostic_tool	0	4	Deep
I-Diagnostic_tool	5	13	Learning
O	14	17	and
B-Disease	18	26	Glaucoma
O	27	38	Specialists
O	38	39	:
O	40	43	The
O	44	52	Relative
O	53	63	Importance
O	64	66	of
B-Anatomy	67	72	Optic
I-Anatomy	73	77	Disc
O	78	86	Features
O	87	89	to
O	90	97	Predict
B-Disease	98	106	Glaucoma
O	107	115	Referral
O	116	118	in
B-Diagnostic_tool	119	125	Fundus
I-Diagnostic_tool	126	137	Photographs
O	137	138	.

O	140	142	To
O	143	150	develop
O	151	154	and
O	155	163	validate
O	164	165	a
B-Diagnostic_tool	166	170	deep
I-Diagnostic_tool	171	179	learning
O	180	181	(
B-Diagnostic_tool	181	183	DL
O	183	184	)
O	185	194	algorithm
O	195	199	that
O	200	208	predicts
B-Disease	209	218	referable
I-Disease	219	231	glaucomatous
I-Disease	232	237	optic
I-Disease	238	248	neuropathy
O	249	250	(
B-Disease	250	253	GON
O	253	254	)
O	255	258	and
B-Anatomy	259	264	optic
I-Anatomy	265	270	nerve
I-Anatomy	271	275	head
O	276	277	(
B-Anatomy	277	280	ONH
O	280	281	)
O	282	290	features
O	291	295	from
B-Diagnostic_tool	296	301	color
I-Diagnostic_tool	302	308	fundus
I-Diagnostic_tool	309	315	images
O	315	316	,
O	317	319	to
O	320	329	determine
O	330	333	the
O	334	342	relative
O	343	353	importance
O	354	356	of
O	357	362	these
O	363	371	features
O	372	374	in
O	375	383	referral
O	384	393	decisions
O	394	396	by
B-Disease	397	405	glaucoma
O	406	417	specialists
O	418	419	(
O	419	422	GSs
O	422	423	)
O	424	427	and
O	428	431	the
O	432	441	algorithm
O	441	442	,
O	443	446	and
O	447	449	to
O	450	457	compare
O	458	461	the
O	462	473	performance
O	474	476	of
O	477	480	the
O	481	490	algorithm
O	491	495	with
B-Anatomy	496	499	eye
O	500	504	care
O	505	514	providers
O	514	515	.

O	516	527	Development
O	528	531	and
O	532	542	validation
O	543	545	of
O	546	548	an
O	549	558	algorithm
O	558	559	.

B-Diagnostic_tool	560	566	Fundus
I-Diagnostic_tool	567	573	images
O	574	578	from
O	579	588	screening
O	589	597	programs
O	597	598	,
O	599	606	studies
O	606	607	,
O	608	611	and
O	612	613	a
B-Disease	614	622	glaucoma
O	623	629	clinic
O	629	630	.

O	631	632	A
B-Diagnostic_tool	633	635	DL
O	636	645	algorithm
O	646	649	was
O	650	657	trained
O	658	663	using
O	664	665	a
O	666	679	retrospective
O	680	687	dataset
O	688	690	of
O	691	693	86
O	694	697	618
O	698	704	images
O	704	705	,
O	706	714	assessed
O	715	718	for
B-Disease	719	731	glaucomatous
B-Anatomy	732	735	ONH
O	736	744	features
O	745	748	and
B-Disease	749	758	referable
I-Disease	759	762	GON
O	763	764	(
O	764	771	defined
O	772	774	as
B-Anatomy	775	778	ONH
O	779	789	appearance
O	790	799	worrisome
O	800	806	enough
O	807	809	to
O	810	817	justify
O	818	826	referral
O	827	830	for
O	831	844	comprehensive
O	845	856	examination
O	856	857	)
O	858	860	by
O	861	863	43
O	864	871	graders
O	871	872	.

O	873	876	The
O	877	886	algorithm
O	887	890	was
O	891	900	validated
O	901	906	using
O	907	908	3
O	909	917	datasets
O	917	918	:
O	919	926	dataset
O	927	928	A
O	929	930	(
O	930	934	1205
O	935	941	images
O	941	942	,
O	943	944	1
O	945	950	image
O	950	951	/
O	951	958	patient
O	958	959	;
O	960	962	18
O	962	963	.
O	963	964	1
O	964	965	%
O	966	975	referable
O	975	976	)
O	976	977	,
O	978	984	images
O	985	996	adjudicated
O	997	999	by
O	1000	1006	panels
O	1007	1009	of
O	1010	1013	GSs
O	1013	1014	;
O	1015	1022	dataset
O	1023	1024	B
O	1025	1026	(
O	1026	1030	9642
O	1031	1037	images
O	1037	1038	,
O	1039	1040	1
O	1041	1046	image
O	1046	1047	/
O	1047	1054	patient
O	1054	1055	;
O	1056	1057	9
O	1057	1058	.
O	1058	1059	2
O	1059	1060	%
O	1061	1070	referable
O	1070	1071	)
O	1071	1072	,
O	1073	1079	images
O	1080	1084	from
O	1085	1086	a
B-Disease	1087	1095	diabetic
O	1096	1107	teleretinal
O	1108	1117	screening
O	1118	1125	program
O	1125	1126	;
O	1127	1130	and
O	1131	1138	dataset
O	1139	1140	C
O	1141	1142	(
O	1142	1145	346
O	1146	1152	images
O	1152	1153	,
O	1154	1155	1
O	1156	1161	image
O	1161	1162	/
O	1162	1169	patient
O	1169	1170	;
O	1171	1173	81
O	1173	1174	.
O	1174	1175	7
O	1175	1176	%
O	1177	1186	referable
O	1186	1187	)
O	1187	1188	,
O	1189	1195	images
O	1196	1200	from
O	1201	1202	a
B-Disease	1203	1211	glaucoma
O	1212	1218	clinic
O	1218	1219	.

O	1220	1223	The
O	1224	1233	algorithm
O	1234	1237	was
O	1238	1247	evaluated
O	1248	1253	using
O	1254	1257	the
O	1258	1262	area
O	1263	1268	under
O	1269	1272	the
O	1273	1281	receiver
O	1282	1291	operating
O	1292	1306	characteristic
O	1307	1312	curve
O	1313	1314	(
O	1314	1317	AUC
O	1317	1318	)
O	1318	1319	,
O	1320	1331	sensitivity
O	1331	1332	,
O	1333	1336	and
O	1337	1348	specificity
O	1349	1352	for
B-Disease	1353	1362	referable
I-Disease	1363	1366	GON
O	1367	1370	and
B-Disease	1371	1383	glaucomatous
B-Anatomy	1384	1387	ONH
O	1388	1396	features
O	1396	1397	.

O	1398	1401	The
O	1402	1411	algorithm
O	1411	1412	'
O	1412	1413	s
O	1414	1417	AUC
O	1418	1421	for
B-Disease	1422	1431	referable
I-Disease	1432	1435	GON
O	1436	1439	was
O	1440	1441	0
O	1441	1442	.
O	1442	1445	945
O	1446	1447	(
O	1447	1449	95
O	1449	1450	%
O	1451	1461	confidence
O	1462	1470	interval
O	1471	1472	[
O	1472	1474	CI
O	1474	1475	]
O	1475	1476	,
O	1477	1478	0
O	1478	1479	.
O	1479	1482	929
O	1482	1483	-
O	1483	1484	0
O	1484	1485	.
O	1485	1488	960
O	1488	1489	)
O	1490	1492	in
O	1493	1500	dataset
O	1501	1502	A
O	1502	1503	,
O	1504	1505	0
O	1505	1506	.
O	1506	1509	855
O	1510	1511	(
O	1511	1513	95
O	1513	1514	%
O	1515	1517	CI
O	1517	1518	,
O	1519	1520	0
O	1520	1521	.
O	1521	1524	841
O	1524	1525	-
O	1525	1526	0
O	1526	1527	.
O	1527	1530	870
O	1530	1531	)
O	1532	1534	in
O	1535	1542	dataset
O	1543	1544	B
O	1544	1545	,
O	1546	1549	and
O	1550	1551	0
O	1551	1552	.
O	1552	1555	881
O	1556	1557	(
O	1557	1559	95
O	1559	1560	%
O	1561	1563	CI
O	1563	1564	,
O	1565	1566	0
O	1566	1567	.
O	1567	1570	838
O	1570	1571	-
O	1571	1572	0
O	1572	1573	.
O	1573	1576	918
O	1576	1577	)
O	1578	1580	in
O	1581	1588	dataset
O	1589	1590	C
O	1590	1591	.

O	1592	1601	Algorithm
O	1602	1606	AUCs
O	1607	1613	ranged
O	1614	1621	between
O	1622	1623	0
O	1623	1624	.
O	1624	1627	661
O	1628	1631	and
O	1632	1633	0
O	1633	1634	.
O	1634	1637	973
O	1638	1641	for
B-Disease	1642	1654	glaucomatous
B-Anatomy	1655	1658	ONH
O	1659	1667	features
O	1667	1668	.

O	1669	1672	The
O	1673	1682	algorithm
O	1683	1689	showed
O	1690	1703	significantly
O	1704	1710	higher
O	1711	1722	sensitivity
O	1723	1727	than
O	1728	1729	7
O	1730	1732	of
O	1733	1735	10
O	1736	1743	graders
O	1744	1747	not
O	1748	1756	involved
O	1757	1759	in
O	1760	1771	determining
O	1772	1775	the
O	1776	1785	reference
O	1786	1794	standard
O	1794	1795	,
O	1796	1805	including
O	1806	1807	2
O	1808	1810	of
O	1811	1812	3
O	1813	1816	GSs
O	1816	1817	,
O	1818	1821	and
O	1822	1828	showed
O	1829	1835	higher
O	1836	1847	specificity
O	1848	1852	than
O	1853	1854	3
O	1855	1862	graders
O	1863	1864	(
O	1864	1873	including
O	1874	1875	1
O	1876	1878	GS
O	1878	1879	)
O	1879	1880	,
O	1881	1886	while
O	1887	1896	remaining
O	1897	1907	comparable
O	1908	1910	to
O	1911	1917	others
O	1917	1918	.

O	1919	1922	For
O	1923	1927	both
O	1928	1931	GSs
O	1932	1935	and
O	1936	1939	the
O	1940	1949	algorithm
O	1949	1950	,
O	1951	1954	the
O	1955	1959	most
O	1960	1967	crucial
O	1968	1976	features
O	1977	1984	related
O	1985	1987	to
B-Disease	1988	1997	referable
I-Disease	1998	2001	GON
O	2002	2006	were
O	2006	2007	:
O	2008	2016	presence
O	2017	2019	of
B-Symptom	2020	2028	vertical
I-Symptom	2029	2032	cup
I-Symptom	2032	2033	-
I-Symptom	2033	2035	to
I-Symptom	2035	2036	-
I-Symptom	2036	2040	disc
I-Symptom	2041	2046	ratio
I-Symptom	2047	2049	of
I-Symptom	2050	2051	0
I-Symptom	2051	2052	.
I-Symptom	2052	2053	7
I-Symptom	2054	2056	or
I-Symptom	2057	2061	more
O	2061	2062	,
B-Symptom	2063	2075	neuroretinal
I-Symptom	2076	2079	rim
I-Symptom	2080	2088	notching
O	2088	2089	,
B-Symptom	2090	2097	retinal
I-Symptom	2098	2103	nerve
I-Symptom	2104	2109	fiber
I-Symptom	2110	2115	layer
I-Symptom	2116	2122	defect
O	2122	2123	,
O	2124	2127	and
B-Symptom	2128	2133	bared
I-Symptom	2134	2146	circumlinear
I-Symptom	2147	2154	vessels
O	2154	2155	.

O	2156	2157	A
B-Diagnostic_tool	2158	2160	DL
O	2161	2170	algorithm
O	2171	2178	trained
O	2179	2181	on
B-Diagnostic_tool	2182	2188	fundus
I-Diagnostic_tool	2189	2195	images
O	2196	2201	alone
O	2202	2205	can
O	2206	2212	detect
B-Disease	2213	2222	referable
I-Disease	2223	2226	GON
O	2227	2231	with
O	2232	2238	higher
O	2239	2250	sensitivity
O	2251	2255	than
O	2256	2259	and
O	2260	2270	comparable
O	2271	2282	specificity
O	2283	2285	to
B-Anatomy	2286	2289	eye
O	2290	2294	care
O	2295	2304	providers
O	2304	2305	.

O	2306	2309	The
O	2310	2319	algorithm
O	2320	2330	maintained
O	2331	2335	good
O	2336	2347	performance
O	2348	2350	on
O	2351	2353	an
O	2354	2365	independent
O	2366	2373	dataset
O	2374	2378	with
O	2379	2388	diagnoses
O	2389	2394	based
O	2395	2397	on
O	2398	2399	a
O	2400	2404	full
B-Disease	2405	2413	glaucoma
O	2414	2420	workup
O	2420	2421	.

B-Diagnostic_tool	0	4	Deep
I-Diagnostic_tool	5	13	Learning
I-Diagnostic_tool	14	24	Approaches
O	25	32	Predict
B-Symptom	33	45	Glaucomatous
I-Symptom	46	52	Visual
I-Symptom	53	58	Field
I-Symptom	59	65	Damage
O	66	70	from
B-Diagnostic_tool	71	74	OCT
I-Diagnostic_tool	75	80	Optic
I-Diagnostic_tool	81	86	Nerve
I-Diagnostic_tool	87	91	Head
I-Diagnostic_tool	92	94	En
I-Diagnostic_tool	95	99	Face
I-Diagnostic_tool	100	106	Images
O	107	110	and
B-Diagnostic_tool	111	118	Retinal
I-Diagnostic_tool	119	124	Nerve
I-Diagnostic_tool	125	130	Fiber
I-Diagnostic_tool	131	136	Layer
I-Diagnostic_tool	137	146	Thickness
I-Diagnostic_tool	147	151	Maps
O	151	152	.

O	154	156	To
O	157	164	develop
O	165	168	and
O	169	177	evaluate
O	178	179	a
O	180	184	deep
O	185	193	learning
O	194	200	system
O	201	204	for
O	205	220	differentiating
O	221	228	between
B-Anatomy	229	233	eyes
O	234	238	with
O	239	242	and
O	243	250	without
B-Symptom	251	263	glaucomatous
I-Symptom	264	270	visual
I-Symptom	271	276	field
I-Symptom	277	283	damage
O	284	285	(
B-Symptom	285	289	GVFD
O	289	290	)
O	291	294	and
O	295	305	predicting
O	306	309	the
O	310	318	severity
O	319	321	of
B-Symptom	322	326	GFVD
O	327	331	from
B-Diagnostic_tool	332	340	spectral
I-Diagnostic_tool	341	347	domain
I-Diagnostic_tool	348	351	OCT
O	352	353	(
B-Diagnostic_tool	353	355	SD
I-Diagnostic_tool	356	359	OCT
O	359	360	)
B-Anatomy	361	366	optic
I-Anatomy	367	372	nerve
I-Anatomy	373	377	head
O	378	384	images
O	384	385	.

O	386	396	Evaluation
O	397	399	of
O	400	401	a
O	402	412	diagnostic
O	413	423	technology
O	423	424	.

O	425	426	A
O	427	432	total
O	433	435	of
O	436	440	9765
B-Diagnostic_tool	441	447	visual
I-Diagnostic_tool	448	453	field
O	454	455	(
B-Diagnostic_tool	455	457	VF
O	457	458	)
B-Diagnostic_tool	459	461	SD
I-Diagnostic_tool	462	465	OCT
O	466	471	pairs
O	472	481	collected
O	482	486	from
O	487	491	1194
O	492	504	participants
O	505	509	with
O	510	513	and
O	514	521	without
B-Symptom	522	526	GVFD
O	527	528	(
O	528	532	1909
B-Anatomy	533	537	eyes
O	537	538	)
O	538	539	.

B-Diagnostic_tool	540	544	Deep
I-Diagnostic_tool	545	553	learning
I-Diagnostic_tool	554	560	models
O	561	565	were
O	566	573	trained
O	574	576	to
O	577	580	use
B-Diagnostic_tool	581	583	SD
I-Diagnostic_tool	584	587	OCT
I-Diagnostic_tool	588	595	retinal
I-Diagnostic_tool	596	601	nerve
I-Diagnostic_tool	602	607	fiber
I-Diagnostic_tool	608	613	layer
I-Diagnostic_tool	614	615	(
I-Diagnostic_tool	615	619	RNFL
I-Diagnostic_tool	619	620	)
I-Diagnostic_tool	621	630	thickness
I-Diagnostic_tool	631	635	maps
I-Diagnostic_tool	635	636	,
I-Diagnostic_tool	637	641	RNFL
I-Diagnostic_tool	642	644	en
I-Diagnostic_tool	645	649	face
I-Diagnostic_tool	650	656	images
O	656	657	,
O	658	661	and
B-Diagnostic_tool	662	670	confocal
I-Diagnostic_tool	671	679	scanning
I-Diagnostic_tool	680	685	laser
I-Diagnostic_tool	686	700	ophthalmoscopy
O	701	702	(
B-Diagnostic_tool	702	706	CSLO
O	706	707	)
O	708	714	images
O	715	717	to
O	718	726	identify
B-Anatomy	727	731	eyes
O	732	736	with
B-Symptom	737	741	GVFD
O	742	745	and
O	746	753	predict
O	754	766	quantitative
B-Diagnostic_tool	767	769	VF
O	770	774	mean
O	775	784	deviation
O	785	786	(
O	786	788	MD
O	788	789	)
O	789	790	,
O	791	798	pattern
O	799	807	standard
O	808	817	deviation
O	818	819	(
O	819	822	PSD
O	822	823	)
O	823	824	,
O	825	828	and
O	829	833	mean
B-Diagnostic_tool	834	836	VF
O	837	845	sectoral
O	846	853	pattern
O	854	863	deviation
O	864	865	(
O	865	867	PD
O	867	868	)
O	869	873	from
B-Diagnostic_tool	874	876	SD
I-Diagnostic_tool	877	880	OCT
O	881	885	data
O	885	886	.

B-Diagnostic_tool	887	891	Deep
I-Diagnostic_tool	892	900	learning
I-Diagnostic_tool	901	907	models
O	908	912	were
O	913	921	compared
O	922	926	with
O	927	931	mean
B-Characteristic	932	936	RNFL
I-Characteristic	937	946	thickness
O	947	950	for
O	951	962	identifying
B-Symptom	963	967	GVFD
O	968	973	using
O	974	978	area
O	979	984	under
O	985	988	the
O	989	994	curve
O	995	996	(
O	996	999	AUC
O	999	1000	)
O	1000	1001	,
O	1002	1013	sensitivity
O	1013	1014	,
O	1015	1018	and
O	1019	1030	specificity
O	1030	1031	.

O	1032	1035	For
O	1036	1046	predicting
O	1047	1049	MD
O	1049	1050	,
O	1051	1054	PSD
O	1054	1055	,
O	1056	1059	and
O	1060	1064	mean
O	1065	1073	sectoral
O	1074	1076	PD
O	1076	1077	,
O	1078	1084	models
O	1085	1089	were
O	1090	1099	evaluated
O	1100	1105	using
O	1106	1107	R
O	1108	1109	2
O	1110	1112	In
O	1113	1116	the
O	1117	1128	independent
O	1129	1133	test
O	1134	1141	dataset
O	1141	1142	,
O	1143	1146	the
B-Diagnostic_tool	1147	1151	deep
I-Diagnostic_tool	1152	1160	learning
I-Diagnostic_tool	1161	1167	models
O	1168	1173	based
O	1174	1176	on
B-Diagnostic_tool	1177	1181	RNFL
I-Diagnostic_tool	1182	1184	en
I-Diagnostic_tool	1185	1189	face
I-Diagnostic_tool	1190	1196	images
O	1197	1205	achieved
O	1206	1208	an
O	1209	1212	AUC
O	1213	1215	of
O	1216	1217	0
O	1217	1218	.
O	1218	1220	88
O	1221	1224	for
O	1225	1236	identifying
B-Anatomy	1237	1241	eyes
O	1242	1246	with
B-Symptom	1247	1251	GVFD
O	1252	1255	and
O	1256	1257	0
O	1257	1258	.
O	1258	1260	82
O	1261	1264	for
O	1265	1274	detecting
B-Symptom	1275	1279	mild
I-Symptom	1280	1284	GVFD
O	1285	1298	significantly
O	1299	1300	(
O	1300	1301	P
O	1303	1304	<
O	1306	1307	0
O	1307	1308	.
O	1308	1311	001
O	1311	1312	)
O	1313	1319	better
O	1320	1324	than
O	1325	1330	using
B-Characteristic	1331	1335	mean
I-Characteristic	1336	1340	RNFL
I-Characteristic	1341	1350	thickness
I-Characteristic	1351	1363	measurements
O	1364	1365	(
O	1365	1368	AUC
O	1369	1370	=
O	1371	1372	0
O	1372	1373	.
O	1373	1375	82
O	1376	1379	and
O	1380	1381	0
O	1381	1382	.
O	1382	1384	73
O	1384	1385	,
O	1386	1398	respectively
O	1398	1399	)
O	1399	1400	.

B-Diagnostic_tool	1401	1405	Deep
I-Diagnostic_tool	1406	1414	learning
I-Diagnostic_tool	1415	1421	models
O	1422	1434	outperformed
O	1435	1443	standard
B-Characteristic	1444	1448	RNFL
I-Characteristic	1449	1458	thickness
I-Characteristic	1459	1471	measurements
O	1472	1474	in
O	1475	1485	predicting
O	1486	1489	all
O	1490	1502	quantitative
B-Diagnostic_tool	1503	1505	VF
O	1506	1513	metrics
O	1513	1514	.

O	1515	1517	In
O	1518	1528	predicting
O	1529	1531	MD
O	1531	1532	,
B-Diagnostic_tool	1533	1537	deep
I-Diagnostic_tool	1538	1546	learning
I-Diagnostic_tool	1547	1553	models
O	1554	1559	based
O	1560	1562	on
B-Diagnostic_tool	1563	1567	RNFL
I-Diagnostic_tool	1568	1570	en
I-Diagnostic_tool	1571	1575	face
I-Diagnostic_tool	1576	1582	images
O	1583	1591	achieved
O	1592	1594	an
O	1595	1596	R
O	1597	1598	2
B-Diagnostic_tool	1599	1603	Deep
I-Diagnostic_tool	1604	1612	learning
I-Diagnostic_tool	1613	1619	models
O	1620	1623	had
O	1624	1628	high
O	1629	1637	accuracy
O	1638	1640	in
O	1641	1652	identifying
B-Anatomy	1653	1657	eyes
O	1658	1662	with
B-Symptom	1663	1667	GFVD
O	1668	1671	and
O	1672	1682	predicting
O	1683	1686	the
O	1687	1695	severity
O	1696	1698	of
B-Symptom	1699	1709	functional
I-Symptom	1710	1714	loss
O	1715	1719	from
B-Diagnostic_tool	1720	1722	SD
I-Diagnostic_tool	1723	1726	OCT
I-Diagnostic_tool	1727	1733	images
O	1733	1734	.

O	1735	1745	Accurately
O	1746	1756	predicting
O	1757	1760	the
O	1761	1769	severity
O	1770	1772	of
B-Symptom	1773	1777	GFVD
O	1778	1782	from
B-Diagnostic_tool	1783	1785	SD
I-Diagnostic_tool	1786	1789	OCT
I-Diagnostic_tool	1790	1797	imaging
O	1798	1801	can
O	1802	1806	help
O	1807	1817	clinicians
O	1818	1822	more
O	1823	1834	effectively
O	1835	1848	individualize
O	1849	1852	the
O	1853	1862	frequency
O	1863	1865	of
B-Diagnostic_tool	1866	1868	VF
I-Diagnostic_tool	1869	1876	testing
O	1877	1879	to
O	1880	1883	the
O	1884	1894	individual
O	1895	1902	patient
O	1902	1903	.

B-Symptom	0	7	Chronic
I-Symptom	8	15	hematic
I-Symptom	16	20	cyst
I-Symptom	21	23	of
I-Symptom	24	27	the
I-Symptom	28	33	orbit
O	33	34	.

O	35	39	Role
O	40	42	of
B-Diagnostic_tool	43	51	magnetic
I-Diagnostic_tool	52	61	resonance
I-Diagnostic_tool	62	69	imaging
O	70	72	in
O	73	82	diagnosis
O	82	83	.

B-Symptom	85	92	Chronic
I-Symptom	93	100	hematic
I-Symptom	101	106	cysts
I-Symptom	107	109	of
I-Symptom	110	113	the
I-Symptom	114	119	orbit
O	120	123	are
O	124	128	rare
O	129	135	causes
O	136	138	of
B-Disease	139	148	proptosis
O	148	149	.

O	150	154	They
O	155	168	progressively
O	169	176	enlarge
O	177	184	causing
B-Symptom	185	194	expansion
I-Symptom	195	197	or
I-Symptom	198	205	erosion
I-Symptom	206	208	of
I-Symptom	209	212	the
I-Symptom	213	220	orbital
I-Symptom	221	226	bones
O	227	230	and
O	231	234	may
O	235	239	give
O	240	243	the
O	244	254	appearance
O	255	257	on
B-Diagnostic_tool	258	266	computed
I-Diagnostic_tool	267	277	tomography
O	278	279	(
B-Diagnostic_tool	279	281	CT
O	281	282	)
O	283	287	scan
O	288	290	of
O	291	292	a
B-Symptom	293	302	malignant
I-Symptom	303	310	orbital
I-Symptom	311	318	process
O	318	319	.

B-Symptom	320	327	Hematic
I-Symptom	328	333	cysts
O	334	338	have
O	339	340	a
O	341	355	characteristic
O	356	366	appearance
O	367	369	on
B-Diagnostic_tool	370	378	magnetic
I-Diagnostic_tool	379	388	resonance
I-Diagnostic_tool	389	396	imaging
O	397	398	(
B-Diagnostic_tool	398	401	MRI
O	401	402	)
O	403	408	which
O	409	411	is
O	412	421	virtually
O	422	433	pathognomic
O	433	434	.

O	435	438	The
O	439	446	authors
O	447	454	present
O	455	458	two
O	459	464	cases
O	465	467	in
O	468	473	which
B-Diagnostic_tool	474	477	MRI
O	478	481	was
O	482	486	used
O	487	489	to
O	490	499	establish
O	500	503	the
O	504	513	diagnosis
O	513	514	.

O	0	10	Evaluation
O	11	13	of
O	14	24	diagnostic
O	25	30	tools
O	31	34	for
B-Disease	35	40	adult
I-Disease	41	51	chlamydial
I-Disease	52	72	keratoconjunctivitis
O	72	73	.

O	75	87	Conjunctival
O	88	94	smears
O	95	98	and
O	99	104	serum
O	105	114	specimens
O	115	117	of
O	118	121	150
O	122	130	patients
O	131	135	with
O	136	144	presumed
B-Disease	145	155	chlamydial
I-Disease	156	176	keratoconjunctivitis
O	177	181	were
O	182	191	evaluated
O	192	196	over
O	197	198	a
O	199	205	period
O	206	208	of
O	209	211	16
O	212	218	months
O	219	222	and
O	223	231	compared
O	232	234	to
B-Characteristic	235	238	age
O	238	239	-
O	240	243	and
B-Characteristic	244	247	sex
O	247	248	-
O	248	255	matched
O	256	263	healthy
O	264	272	controls
O	272	273	.

O	274	285	Sensitivity
O	285	286	,
O	287	298	specificity
O	298	299	,
O	300	303	and
O	304	314	predictive
O	315	321	values
O	322	324	of
B-Diagnostic_tool	325	336	fluorescent
I-Diagnostic_tool	337	347	monoclonal
I-Diagnostic_tool	348	356	antibody
I-Diagnostic_tool	357	358	(
I-Diagnostic_tool	358	362	FMAb
I-Diagnostic_tool	362	363	)
I-Diagnostic_tool	364	370	direct
I-Diagnostic_tool	371	376	tests
O	376	377	,
B-Diagnostic_tool	378	381	IgG
I-Diagnostic_tool	382	388	single
I-Diagnostic_tool	389	396	antigen
I-Diagnostic_tool	397	402	tests
I-Diagnostic_tool	403	406	for
I-Diagnostic_tool	407	410	the
I-Diagnostic_tool	411	420	detection
I-Diagnostic_tool	421	423	of
I-Diagnostic_tool	424	429	serum
I-Diagnostic_tool	430	438	antibody
O	439	440	(
B-Diagnostic_tool	440	443	IgG
I-Diagnostic_tool	443	444	-
I-Diagnostic_tool	444	447	IFT
O	447	448	)
O	448	449	,
O	450	453	and
B-Diagnostic_tool	454	457	IgA
I-Diagnostic_tool	458	461	and
I-Diagnostic_tool	462	465	IgG
I-Diagnostic_tool	466	482	immunoperoxidase
I-Diagnostic_tool	483	488	tests
O	489	490	(
B-Diagnostic_tool	490	493	IgA
I-Diagnostic_tool	493	494	-
I-Diagnostic_tool	494	498	IPAs
I-Diagnostic_tool	499	502	and
I-Diagnostic_tool	503	506	IgG
I-Diagnostic_tool	506	507	-
I-Diagnostic_tool	507	511	IPAs
O	511	512	)
O	513	516	for
O	517	522	serum
O	523	531	antibody
O	532	536	were
O	537	545	compared
O	546	548	to
B-Diagnostic_tool	549	554	McCoy
I-Diagnostic_tool	555	559	cell
I-Diagnostic_tool	560	567	culture
I-Diagnostic_tool	568	578	techniques
O	579	581	in
O	582	583	a
O	584	596	nonoptimized
O	597	605	clinical
O	606	613	setting
O	613	614	.

O	615	619	Thus
O	619	620	,
B-Diagnostic_tool	621	625	FMAb
O	626	637	sensitivity
O	638	641	was
O	642	645	100
O	645	646	%
O	646	647	,
O	648	659	specificity
O	660	663	was
O	664	666	52
O	666	667	%
O	667	668	,
O	669	672	and
O	673	683	predictive
O	684	689	value
O	690	693	was
O	694	696	30
O	696	697	%
O	697	698	.

B-Diagnostic_tool	699	702	IgG
I-Diagnostic_tool	702	703	-
I-Diagnostic_tool	703	706	IFT
O	707	718	sensitivity
O	719	722	was
O	723	725	94
O	725	726	%
O	726	727	,
O	728	739	specificity
O	740	743	was
O	744	746	67
O	746	747	%
O	747	748	,
O	749	752	and
O	753	763	predictive
O	764	769	value
O	770	773	was
O	774	776	37
O	776	777	%
O	777	778	.

B-Diagnostic_tool	779	782	IgA
I-Diagnostic_tool	782	783	-
I-Diagnostic_tool	783	786	IPA
O	787	798	sensitivity
O	799	802	was
O	803	806	100
O	806	807	%
O	807	808	,
O	809	820	specificity
O	821	824	was
O	825	827	70
O	827	828	%
O	828	829	,
O	830	833	and
O	834	844	predictive
O	845	850	value
O	851	854	was
O	855	857	40
O	857	858	%
O	858	859	.

O	860	863	The
B-Diagnostic_tool	864	867	IgG
I-Diagnostic_tool	867	868	-
I-Diagnostic_tool	868	871	IPA
O	872	875	was
O	876	885	sensitive
O	886	889	but
O	890	901	nonspecific
O	901	902	.

O	903	907	With
O	908	915	respect
O	916	918	to
O	919	922	the
O	923	930	current
O	931	944	epidemiologic
O	945	954	situation
O	955	957	in
O	958	961	our
O	962	966	area
O	966	967	,
B-Diagnostic_tool	968	972	FMAb
O	973	976	and
B-Diagnostic_tool	977	980	IgA
I-Diagnostic_tool	980	981	-
I-Diagnostic_tool	981	984	IPA
O	985	987	in
O	988	996	addition
O	997	999	to
B-Diagnostic_tool	1000	1005	McCoy
I-Diagnostic_tool	1006	1010	cell
I-Diagnostic_tool	1011	1018	culture
I-Diagnostic_tool	1019	1029	techniques
O	1030	1033	may
O	1034	1043	represent
O	1044	1052	valuable
O	1053	1063	diagnostic
O	1064	1069	tools
O	1070	1073	for
O	1074	1077	the
O	1078	1087	detection
O	1088	1090	of
B-Disease	1091	1101	chlamydial
I-Disease	1102	1109	disease
O	1109	1110	.

B-Disease	0	10	Infectious
I-Disease	11	20	retinitis
O	20	21	.

O	22	32	Diagnostic
O	33	43	modalities
O	43	44	.

O	46	54	Advances
O	55	57	in
O	58	66	surgical
O	67	77	techniques
O	78	82	have
O	83	87	made
B-Diagnostic_tool	88	101	vitreoretinal
I-Diagnostic_tool	102	105	and
I-Diagnostic_tool	106	118	sclerochorio
I-Diagnostic_tool	118	119	-
I-Diagnostic_tool	119	126	retinal
I-Diagnostic_tool	127	135	biopsies
O	136	140	part
O	141	143	of
O	144	147	the
O	148	157	available
O	158	168	diagnostic
O	169	182	armamentarium
O	183	185	of
O	186	189	the
O	190	205	ophthalmologist
O	205	206	.

O	207	214	Special
O	215	222	studies
O	223	226	can
O	227	229	be
O	230	239	performed
O	240	242	on
O	243	249	tissue
O	250	258	obtained
O	259	261	in
O	262	266	this
O	267	270	way
O	271	273	in
O	274	279	order
O	280	282	to
O	283	290	provide
O	291	292	a
O	293	301	specific
O	302	311	etiologic
O	312	321	diagnosis
O	322	324	of
B-Disease	325	330	virus
I-Disease	331	341	associated
I-Disease	342	351	pathology
O	351	352	.

O	353	356	The
O	357	367	advantages
O	368	371	and
O	372	385	disadvantages
O	386	388	of
B-Diagnostic_tool	389	405	immunopathologic
I-Diagnostic_tool	406	409	and
I-Diagnostic_tool	410	425	ultrastructural
O	426	433	methods
O	433	434	,
O	435	441	tissue
O	442	449	culture
O	449	450	,
O	451	454	and
B-Diagnostic_tool	455	462	nucleic
I-Diagnostic_tool	463	467	acid
I-Diagnostic_tool	468	481	hybridization
I-Diagnostic_tool	482	492	techniques
O	493	496	for
O	497	502	viral
O	503	517	identification
O	518	521	are
O	522	530	compared
O	531	534	and
O	535	544	discussed
O	544	545	.

O	0	3	The
O	4	15	association
O	16	18	of
B-Characteristic	19	23	iris
I-Characteristic	24	29	color
O	30	34	with
B-Disease	35	38	eye
I-Disease	39	46	disease
O	47	49	in
B-Disease	50	58	diabetes
O	58	59	.

B-Characteristic	61	65	Iris
I-Characteristic	66	67	(
I-Characteristic	67	70	eye
I-Characteristic	70	71	)
I-Characteristic	72	77	color
O	78	81	was
O	82	90	examined
O	91	94	for
O	95	98	its
O	99	105	effect
O	106	108	on
B-Disease	109	112	eye
I-Disease	113	120	disease
O	121	123	in
O	124	125	a
O	126	136	population
O	136	137	-
O	137	142	based
O	143	148	study
O	149	151	of
B-Disease	152	160	diabetic
I-Disease	161	172	retinopathy
O	173	175	in
O	176	185	Wisconsin
O	185	186	.

B-Characteristic	187	190	Eye
I-Characteristic	191	196	color
O	197	200	was
O	201	211	determined
O	212	214	by
O	215	224	comparing
O	225	228	the
B-Anatomy	229	233	iris
O	234	236	in
O	237	238	a
B-Diagnostic_tool	239	242	red
I-Diagnostic_tool	243	249	reflex
I-Diagnostic_tool	250	260	photograph
I-Diagnostic_tool	261	265	with
I-Diagnostic_tool	266	274	standard
I-Diagnostic_tool	275	286	photographs
O	286	287	.

O	288	290	In
B-Characteristic	291	298	younger
I-Characteristic	298	299	-
I-Characteristic	299	304	onset
I-Characteristic	305	313	diabetic
I-Characteristic	314	321	persons
O	322	323	(
O	323	324	N
O	325	326	=
O	327	330	996
O	330	331	)
O	331	332	,
B-Disease	333	340	macular
I-Disease	341	346	edema
O	347	350	was
O	351	355	more
O	356	365	prevalent
O	366	368	in
O	369	376	persons
O	377	381	with
B-Characteristic	382	386	blue
I-Characteristic	387	389	or
I-Characteristic	390	394	grey
I-Characteristic	395	399	eyes
O	400	401	(
O	401	403	12
O	403	404	%
O	404	405	)
O	406	414	compared
O	415	419	with
O	420	432	intermediate
O	433	434	(
O	434	435	9
O	435	436	%
O	436	437	)
O	438	440	or
O	441	446	brown
O	447	448	(
O	448	449	6
O	449	450	%
O	450	451	)
O	452	453	(
O	453	454	P
O	455	456	=
O	457	458	0
O	458	459	.
O	459	461	04
O	461	462	)
O	462	463	.

B-Disease	464	473	Cataracts
O	474	478	were
O	479	483	more
O	484	493	prevalent
O	494	496	in
B-Characteristic	497	501	blue
I-Characteristic	502	504	or
I-Characteristic	505	509	grey
I-Characteristic	510	514	eyes
O	515	516	(
O	516	518	32
O	518	519	%
O	519	520	)
O	521	529	compared
O	530	534	with
O	535	547	intermediate
O	548	549	(
O	549	551	22
O	551	552	%
O	552	553	)
O	554	556	or
O	557	562	brown
O	563	564	(
O	564	566	20
O	566	567	%
O	567	568	)
O	569	571	in
O	572	575	the
B-Characteristic	576	583	younger
I-Characteristic	583	584	-
I-Characteristic	584	589	onset
I-Characteristic	590	595	group
O	596	597	(
O	597	598	P
O	599	603	less
O	604	608	than
O	609	610	0
O	610	611	.
O	611	614	001
O	614	615	)
O	615	616	.

O	617	619	In
B-Characteristic	620	625	older
I-Characteristic	625	626	-
I-Characteristic	626	631	onset
I-Characteristic	632	639	persons
O	640	641	(
O	641	642	N
O	643	644	=
O	645	649	1370
O	649	650	)
O	650	651	,
B-Characteristic	652	663	intraocular
I-Characteristic	664	672	pressure
O	673	674	(
B-Characteristic	674	677	IOP
O	677	678	)
O	679	682	was
O	683	689	higher
O	690	692	in
O	693	700	persons
O	701	705	with
B-Characteristic	706	711	brown
I-Characteristic	712	716	eyes
O	717	718	(
B-Dimension	718	720	17
I-Dimension	720	721	.
I-Dimension	721	722	8
I-Dimension	723	727	mmHg
O	727	728	)
O	729	737	compared
O	738	742	with
O	743	747	blue
O	748	750	or
O	751	755	grey
O	756	757	(
B-Dimension	757	759	17
I-Dimension	759	760	.
I-Dimension	760	761	1
I-Dimension	762	766	mmHg
O	766	767	)
O	768	770	or
O	771	783	intermediate
O	784	785	(
O	785	787	16
O	787	788	.
O	788	789	6
O	790	794	mmHg
O	794	795	)
O	796	797	(
O	797	798	P
O	799	800	=
O	801	802	0
O	802	803	.
O	803	806	012
O	806	807	)
O	807	808	.

B-Characteristic	809	812	Eye
I-Characteristic	813	818	color
O	819	822	was
O	823	826	not
O	827	837	associated
O	838	851	significantly
O	852	856	with
B-Disease	857	865	diabetic
I-Disease	866	877	retinopathy
O	878	880	in
O	881	887	either
O	888	891	the
B-Characteristic	892	899	younger
I-Characteristic	899	900	-
I-Characteristic	901	903	or
I-Characteristic	904	909	older
I-Characteristic	909	910	-
I-Characteristic	910	915	onset
I-Characteristic	916	921	group
O	922	924	or
O	925	929	with
B-Disease	930	933	age
I-Disease	933	934	-
I-Disease	934	941	related
I-Disease	942	949	macular
I-Disease	950	962	degeneration
O	963	965	or
B-Disease	966	974	glaucoma
O	975	977	in
O	978	981	the
B-Characteristic	982	987	older
I-Characteristic	987	988	-
I-Characteristic	988	993	onset
I-Characteristic	994	999	group
O	999	1000	.

B-Disease	0	8	Diabetic
I-Disease	9	20	retinopathy
O	21	23	as
O	24	32	detected
O	33	38	using
B-Diagnostic_tool	39	53	ophthalmoscopy
O	53	54	,
O	55	56	a
B-Diagnostic_tool	57	69	nonmydriatic
I-Diagnostic_tool	70	76	camera
O	77	80	and
O	81	82	a
O	83	91	standard
B-Diagnostic_tool	92	98	fundus
I-Diagnostic_tool	99	105	camera
O	105	106	.

O	108	111	The
O	112	117	study
O	118	121	was
O	122	131	performed
O	132	134	to
O	135	143	evaluate
O	144	151	whether
O	152	155	the
B-Characteristic	156	164	severity
I-Characteristic	165	167	of
I-Characteristic	168	176	diabetic
I-Characteristic	177	188	retinopathy
O	189	191	as
O	192	200	assessed
O	201	203	by
O	204	209	three
O	210	221	alternative
O	222	229	methods
O	230	233	was
O	234	244	concordant
O	245	249	with
O	250	253	the
B-Characteristic	254	262	severity
I-Characteristic	263	265	of
I-Characteristic	266	277	retinopathy
O	278	280	as
O	281	291	determined
O	292	296	from
B-Diagnostic_tool	297	299	30
I-Diagnostic_tool	300	307	degrees
I-Diagnostic_tool	308	320	stereoscopic
I-Diagnostic_tool	321	332	photographs
O	332	333	.

O	334	337	The
O	338	343	three
O	344	351	methods
O	352	356	were
O	357	363	direct
B-Diagnostic_tool	364	378	ophthalmoscopy
I-Diagnostic_tool	379	386	through
I-Diagnostic_tool	387	389	an
I-Diagnostic_tool	390	399	undilated
I-Diagnostic_tool	400	405	pupil
O	405	406	,
B-Diagnostic_tool	407	422	nonstereoscopic
I-Diagnostic_tool	423	425	45
I-Diagnostic_tool	426	433	degrees
I-Diagnostic_tool	434	441	retinal
I-Diagnostic_tool	442	453	photography
I-Diagnostic_tool	454	461	through
I-Diagnostic_tool	462	463	a
I-Diagnostic_tool	464	481	pharmacologically
I-Diagnostic_tool	482	491	undilated
I-Diagnostic_tool	492	497	pupil
O	498	501	and
B-Diagnostic_tool	502	517	nonstereoscopic
I-Diagnostic_tool	518	520	45
I-Diagnostic_tool	521	528	degrees
I-Diagnostic_tool	529	540	photography
I-Diagnostic_tool	541	548	through
I-Diagnostic_tool	549	550	a
I-Diagnostic_tool	551	558	dilated
I-Diagnostic_tool	559	564	pupil
O	564	565	.

O	566	567	A
O	568	574	single
B-Diagnostic_tool	575	577	45
I-Diagnostic_tool	578	585	degrees
I-Diagnostic_tool	586	596	photograph
I-Diagnostic_tool	597	605	centered
I-Diagnostic_tool	606	613	between
I-Diagnostic_tool	614	617	the
I-Diagnostic_tool	618	622	disc
I-Diagnostic_tool	623	626	and
I-Diagnostic_tool	627	632	fovea
O	633	636	was
O	637	642	taken
O	643	646	and
O	647	653	direct
B-Diagnostic_tool	654	668	ophthalmoscopy
O	669	672	was
O	673	682	performed
O	683	685	on
O	686	688	99
O	689	696	persons
O	697	702	prior
O	703	705	to
O	706	721	pharmacological
O	722	730	dilation
O	731	733	of
O	734	737	the
B-Anatomy	738	743	pupil
O	743	744	.

O	745	750	After
O	751	759	dilation
O	759	760	,
O	761	768	another
B-Diagnostic_tool	769	771	45
I-Diagnostic_tool	772	779	degrees
I-Diagnostic_tool	780	790	photograph
O	791	794	was
O	795	800	taken
O	801	803	of
O	804	807	the
O	808	812	same
O	813	818	field
O	818	819	,
O	820	822	as
O	823	827	well
O	828	830	as
B-Diagnostic_tool	831	833	30
I-Diagnostic_tool	834	841	degrees
I-Diagnostic_tool	842	854	stereoscopic
I-Diagnostic_tool	855	860	color
I-Diagnostic_tool	861	872	photographs
I-Diagnostic_tool	873	875	of
I-Diagnostic_tool	876	879	DRS
I-Diagnostic_tool	880	886	fields
I-Diagnostic_tool	887	888	1
I-Diagnostic_tool	888	889	,
I-Diagnostic_tool	890	891	2
I-Diagnostic_tool	892	895	and
I-Diagnostic_tool	896	897	4
O	898	899	(
O	899	907	modified
O	907	908	)
O	908	909	.

O	910	923	Corresponding
O	924	936	photographic
O	937	943	fields
O	944	948	were
O	949	955	graded
O	956	958	by
O	959	965	masked
O	965	966	,
O	967	974	trained
O	975	982	graders
O	983	986	for
O	987	990	the
B-Characteristic	991	999	severity
I-Characteristic	1000	1002	of
I-Characteristic	1003	1014	retinopathy
O	1015	1018	and
O	1019	1022	for
O	1023	1026	the
O	1027	1035	presence
O	1036	1038	of
O	1039	1048	specified
B-Symptom	1049	1057	diabetic
I-Symptom	1058	1065	lesions
O	1066	1071	using
O	1072	1075	the
B-Classification_system	1076	1084	Modified
I-Classification_system	1085	1091	Airlie
I-Classification_system	1092	1097	House
I-Classification_system	1098	1112	Classification
O	1113	1119	scheme
O	1119	1120	.

O	1121	1124	For
O	1125	1130	three
O	1131	1137	levels
O	1138	1140	of
B-Characteristic	1141	1149	severity
I-Characteristic	1150	1152	of
I-Characteristic	1153	1164	retinopathy
O	1165	1166	(
O	1166	1170	none
O	1170	1171	,
B-Disease	1172	1188	nonproliferative
O	1189	1191	or
B-Disease	1192	1205	proliferative
O	1205	1206	)
O	1207	1212	exact
O	1213	1222	agreement
O	1223	1230	between
O	1231	1237	direct
B-Diagnostic_tool	1238	1252	ophthalmoscopy
O	1253	1256	and
O	1257	1264	grading
O	1265	1267	of
B-Disease	1268	1279	retinopathy
O	1280	1284	from
B-Diagnostic_tool	1285	1297	stereoscopic
I-Diagnostic_tool	1298	1309	photographs
O	1310	1315	taken
O	1316	1320	with
O	1321	1324	the
O	1325	1333	standard
B-Diagnostic_tool	1334	1336	30
I-Diagnostic_tool	1337	1344	degrees
I-Diagnostic_tool	1345	1351	camera
O	1352	1355	was
O	1356	1358	54
O	1358	1359	.
O	1359	1360	3
O	1360	1361	%
O	1362	1363	(
O	1363	1364	n
O	1365	1366	=
O	1367	1369	94
O	1369	1370	)
O	1370	1371	.

O	1372	1375	For
O	1376	1380	four
O	1381	1387	levels
O	1388	1390	of
B-Characteristic	1391	1399	severity
I-Characteristic	1400	1402	of
I-Characteristic	1403	1414	retinopathy
O	1415	1416	(
O	1416	1420	none
O	1420	1421	,
B-Symptom	1422	1436	microaneurysms
O	1437	1441	only
O	1441	1442	,
O	1443	1446	all
O	1447	1452	other
B-Disease	1453	1469	nonproliferative
I-Disease	1470	1481	retinopathy
O	1482	1485	and
B-Disease	1486	1499	proliferative
I-Disease	1500	1511	retinopathy
O	1511	1512	)
O	1512	1513	,
O	1514	1519	exact
O	1520	1529	agreement
O	1530	1537	between
O	1538	1546	gradings
O	1547	1549	of
B-Disease	1550	1561	retinopathy
O	1562	1564	of
O	1565	1568	the
B-Diagnostic_tool	1569	1571	45
I-Diagnostic_tool	1572	1579	degrees
I-Diagnostic_tool	1580	1591	photographs
I-Diagnostic_tool	1592	1597	taken
I-Diagnostic_tool	1598	1605	through
I-Diagnostic_tool	1606	1615	undilated
I-Diagnostic_tool	1616	1622	pupils
O	1623	1626	and
B-Diagnostic_tool	1627	1629	30
I-Diagnostic_tool	1630	1637	degrees
I-Diagnostic_tool	1638	1649	photographs
I-Diagnostic_tool	1650	1655	taken
I-Diagnostic_tool	1656	1663	through
I-Diagnostic_tool	1664	1671	dilated
I-Diagnostic_tool	1672	1678	pupils
O	1679	1682	was
O	1683	1685	82
O	1685	1686	.
O	1686	1687	5
O	1687	1688	%
O	1689	1690	(
O	1690	1691	n
O	1692	1693	=
O	1694	1696	63
O	1696	1697	)
O	1697	1698	;
O	1699	1702	and
O	1703	1706	for
B-Diagnostic_tool	1707	1709	45
I-Diagnostic_tool	1710	1717	degrees
I-Diagnostic_tool	1718	1729	photographs
I-Diagnostic_tool	1730	1733	and
I-Diagnostic_tool	1734	1736	30
I-Diagnostic_tool	1737	1744	degrees
I-Diagnostic_tool	1745	1756	photographs
I-Diagnostic_tool	1757	1762	taken
I-Diagnostic_tool	1763	1770	through
I-Diagnostic_tool	1771	1778	dilated
I-Diagnostic_tool	1779	1785	pupils
O	1786	1788	it
O	1789	1792	was
O	1793	1795	86
O	1795	1796	.
O	1796	1797	5
O	1797	1798	%
O	1799	1800	(
O	1800	1801	n
O	1802	1803	=
O	1804	1806	74
O	1806	1807	)
O	1807	1808	.

O	1809	1814	These
O	1815	1819	data
O	1820	1827	suggest
O	1828	1832	that
B-Diagnostic_tool	1833	1835	45
I-Diagnostic_tool	1836	1843	degrees
I-Diagnostic_tool	1844	1859	nonstereoscopic
I-Diagnostic_tool	1860	1866	fundus
I-Diagnostic_tool	1867	1878	photographs
O	1878	1879	,
O	1880	1884	when
O	1885	1891	graded
O	1892	1901	according
O	1902	1904	to
O	1905	1906	a
O	1907	1915	standard
O	1916	1930	classification
O	1931	1937	scheme
O	1937	1938	,
O	1939	1946	provide
O	1947	1957	reasonably
O	1958	1966	reliable
O	1967	1979	photographic
O	1980	1994	representation
O	1995	1997	of
O	1998	2001	the
B-Characteristic	2002	2010	severity
I-Characteristic	2011	2013	of
I-Characteristic	2014	2025	retinopathy
O	2026	2030	when
O	2031	2036	broad
O	2037	2044	overall
O	2045	2055	categories
O	2056	2059	are
O	2060	2064	used
O	2064	2065	.

O	0	12	Quantitative
O	13	19	office
B-Diagnostic_tool	20	29	perimetry
O	29	30	.

O	32	36	This
O	37	42	study
O	43	51	presents
O	52	53	a
O	54	65	preliminary
O	66	76	comparison
O	77	79	of
O	80	83	six
O	84	96	commercially
O	96	97	-
O	97	106	available
O	107	116	automated
O	117	126	threshold
O	127	133	static
O	134	144	parameters
O	144	145	,
O	146	156	consisting
O	157	159	of
O	160	165	three
B-Diagnostic_tool	166	176	projection
I-Diagnostic_tool	177	187	perimeters
O	188	189	(
B-Diagnostic_tool	189	197	Humphrey
I-Diagnostic_tool	198	203	Field
I-Diagnostic_tool	204	212	Analyzer
O	212	213	,
B-Diagnostic_tool	214	219	Squid
O	219	220	,
O	221	224	and
B-Diagnostic_tool	225	232	Octopus
I-Diagnostic_tool	233	236	500
O	236	237	)
O	238	241	and
O	242	247	three
B-Diagnostic_tool	248	253	light
I-Diagnostic_tool	253	254	-
I-Diagnostic_tool	254	262	emitting
I-Diagnostic_tool	263	268	diode
I-Diagnostic_tool	269	270	(
I-Diagnostic_tool	270	273	LED
I-Diagnostic_tool	273	274	)
I-Diagnostic_tool	275	285	perimeters
O	286	287	(
B-Diagnostic_tool	287	292	Dicon
I-Diagnostic_tool	293	297	2000
O	297	298	,
B-Diagnostic_tool	299	310	Fieldmaster
I-Diagnostic_tool	311	313	50
O	313	314	,
O	315	318	and
B-Diagnostic_tool	319	326	Digilab
I-Diagnostic_tool	327	330	350
O	330	331	)
O	331	332	.

O	333	341	Eighteen
O	342	353	individuals
O	354	358	were
O	359	367	included
O	368	370	in
O	371	374	the
O	375	380	study
O	380	381	:
O	382	383	6
O	384	390	normal
O	391	400	observers
O	401	402	(
O	402	404	31
O	404	405	-
O	405	407	58
O	408	413	years
O	414	417	old
O	417	418	)
O	418	419	,
O	420	423	six
O	424	432	patients
O	433	437	with
B-Symptom	438	450	glaucomatous
I-Symptom	451	456	field
I-Symptom	457	461	loss
O	462	464	in
O	465	469	both
B-Anatomy	470	474	eyes
O	475	476	(
O	476	478	55
O	478	479	-
O	479	481	70
O	482	487	years
O	488	491	old
O	491	492	)
O	492	493	,
O	494	497	and
O	498	501	six
O	502	510	patients
O	511	515	with
B-Symptom	516	521	neuro
I-Symptom	521	522	-
I-Symptom	522	536	ophthalmologic
I-Symptom	537	539	or
I-Symptom	540	547	retinal
I-Symptom	548	554	visual
I-Symptom	555	560	field
I-Symptom	561	574	abnormalities
O	575	577	in
O	578	582	both
B-Anatomy	583	587	eyes
O	588	589	(
O	589	591	12
O	591	592	-
O	592	594	61
O	595	600	years
O	601	604	old
O	604	605	)
O	605	606	.

O	607	612	Three
O	613	620	aspects
O	621	623	of
O	624	636	quantitative
O	637	644	testing
O	645	649	were
O	650	659	evaluated
O	659	660	:
O	661	662	(
O	662	663	1
O	663	664	)
O	665	668	the
O	669	677	patients
O	677	678	'
O	679	682	and
O	683	689	normal
O	690	699	observers
O	699	700	'
O	701	711	acceptance
O	712	715	and
O	716	726	subjective
O	727	738	impressions
O	739	741	of
O	742	745	the
O	746	750	test
O	751	760	procedure
O	760	761	;
O	762	763	(
O	763	764	2
O	764	765	)
O	766	769	the
O	770	780	technician
O	780	781	'
O	781	782	s
O	783	787	ease
O	788	790	of
O	791	800	operating
O	801	804	the
O	805	811	device
O	812	815	and
O	816	823	related
O	824	829	tasks
O	829	830	;
O	831	834	and
O	835	836	(
O	836	837	3
O	837	838	)
O	839	851	practitioner
O	851	852	-
O	852	860	oriented
O	861	875	considerations
O	876	880	such
O	881	883	as
O	884	888	test
O	888	889	-
O	889	895	retest
O	896	907	reliability
O	907	908	,
O	909	922	comparability
O	923	925	of
O	926	930	test
O	931	938	results
O	939	942	and
O	943	950	testing
O	951	955	time
O	955	956	.

O	957	960	Our
O	961	968	results
O	969	975	showed
O	976	980	that
O	981	983	no
O	984	990	device
O	991	994	was
O	995	1002	clearly
O	1003	1011	superior
O	1012	1014	to
O	1015	1018	the
O	1019	1025	others
O	1026	1028	in
O	1029	1032	all
O	1033	1041	respects
O	1041	1042	.

O	1043	1051	Patients
O	1052	1056	were
O	1057	1061	most
O	1062	1071	favorably
O	1072	1081	impressed
O	1082	1086	with
O	1087	1090	the
B-Diagnostic_tool	1091	1098	Octopus
I-Diagnostic_tool	1099	1102	500
O	1102	1103	,
B-Diagnostic_tool	1104	1109	Squid
O	1109	1110	,
O	1111	1114	and
O	1115	1118	the
B-Diagnostic_tool	1119	1130	Fieldmaster
I-Diagnostic_tool	1131	1133	50
O	1133	1134	,
O	1135	1140	while
O	1141	1151	technician
O	1152	1163	impressions
O	1164	1168	were
O	1169	1173	most
O	1174	1183	favorable
O	1184	1186	to
O	1187	1190	the
B-Diagnostic_tool	1191	1199	Humphrey
I-Diagnostic_tool	1200	1205	Field
I-Diagnostic_tool	1206	1214	Analyzer
O	1215	1218	and
O	1219	1222	the
B-Diagnostic_tool	1223	1228	Squid
O	1228	1229	.

O	1230	1233	The
B-Diagnostic_tool	1234	1244	projection
I-Diagnostic_tool	1245	1255	perimeters
O	1256	1257	(
B-Diagnostic_tool	1257	1265	Humphrey
I-Diagnostic_tool	1266	1271	Field
I-Diagnostic_tool	1272	1280	Analyzer
O	1280	1281	,
B-Diagnostic_tool	1282	1287	Squid
O	1287	1288	,
O	1289	1292	and
B-Diagnostic_tool	1293	1300	Octopus
I-Diagnostic_tool	1301	1304	500
O	1304	1305	)
O	1306	1310	were
O	1311	1314	the
O	1315	1322	easiest
O	1323	1325	to
O	1326	1333	perform
O	1334	1339	cross
O	1339	1340	-
O	1340	1351	comparisons
O	1352	1354	of
O	1355	1359	test
O	1360	1367	results
O	1367	1368	,
O	1369	1377	although
O	1378	1383	there
O	1384	1387	was
O	1388	1400	considerable
O	1401	1410	variation
O	1411	1413	in
O	1414	1417	the
O	1418	1425	clarity
O	1426	1428	of
O	1429	1433	data
O	1434	1448	interpretation
O	1449	1453	from
O	1454	1457	one
O	1458	1462	case
O	1463	1465	to
O	1466	1473	another
O	1473	1474	.

O	1475	1479	Test
O	1479	1480	-
O	1480	1486	retest
O	1487	1498	reliability
O	1499	1502	and
O	1503	1506	the
O	1507	1511	time
O	1512	1514	of
O	1515	1522	testing
O	1523	1529	varied
O	1530	1535	among
O	1536	1539	the
O	1540	1543	six
O	1544	1553	automated
B-Diagnostic_tool	1554	1564	perimeters
O	1564	1565	.

O	0	3	The
O	4	14	occurrence
O	15	17	of
B-Disease	18	25	primary
I-Disease	26	30	open
I-Disease	30	31	-
I-Disease	31	36	angle
I-Disease	37	45	glaucoma
O	46	48	in
O	49	52	the
O	53	59	fellow
B-Anatomy	60	63	eye
O	64	66	of
O	67	75	patients
O	76	80	with
B-Disease	81	91	unilateral
I-Disease	92	97	angle
I-Disease	97	98	-
I-Disease	98	106	cleavage
I-Disease	107	115	glaucoma
O	115	116	.

O	118	121	The
B-Disease	122	126	late
I-Disease	127	132	onset
I-Disease	133	135	of
I-Disease	136	144	glaucoma
O	145	151	occurs
O	152	154	in
O	155	168	approximately
O	169	170	7
O	170	171	%
O	172	174	of
B-Anatomy	175	179	eyes
O	180	184	with
B-Symptom	185	194	traumatic
I-Symptom	195	200	angle
I-Symptom	201	209	cleavage
O	209	210	.

O	211	213	We
O	214	221	studied
O	222	224	13
O	225	233	patients
O	234	237	who
O	238	247	developed
B-Disease	248	256	glaucoma
O	257	259	in
O	260	263	the
B-Symptom	264	269	angle
I-Symptom	269	270	-
I-Symptom	270	278	cleavage
I-Symptom	279	282	eye
O	283	285	at
O	286	288	an
O	289	296	average
O	297	299	of
O	300	302	34
O	303	308	years
O	309	318	following
B-Symptom	319	325	trauma
O	325	326	.

O	327	330	Ten
O	331	333	of
O	334	337	the
O	338	340	13
O	341	349	patients
O	350	353	had
B-Symptom	354	357	270
I-Symptom	358	365	degrees
I-Symptom	366	368	or
I-Symptom	369	373	more
I-Symptom	374	376	of
I-Symptom	377	382	angle
I-Symptom	383	391	cleavage
O	391	392	.

O	393	395	At
O	396	399	the
O	400	404	time
O	405	407	of
O	408	411	the
O	412	419	initial
O	420	429	diagnosis
O	430	432	of
B-Disease	433	438	angle
I-Disease	439	447	cleavage
I-Disease	448	456	glaucoma
O	456	457	,
O	458	463	there
O	464	468	were
O	469	471	no
B-Symptom	472	477	optic
I-Symptom	478	482	disc
I-Symptom	483	485	or
I-Symptom	486	492	visual
I-Symptom	493	498	field
I-Symptom	499	512	abnormalities
O	513	515	in
O	516	519	the
O	520	526	fellow
B-Anatomy	527	531	eyes
O	531	532	.

O	533	538	After
O	539	540	a
O	541	545	mean
O	546	552	follow
O	552	553	-
O	553	555	up
O	556	558	of
O	559	560	7
O	560	561	.
O	561	562	7
O	563	568	years
O	568	569	,
O	570	573	all
O	574	576	13
O	577	585	patients
O	586	590	were
O	591	602	reevaluated
O	602	603	.

O	604	606	In
O	607	615	addition
O	616	618	to
O	619	627	standard
O	628	639	examination
O	640	650	techniques
O	650	651	,
O	652	655	all
O	656	665	underwent
B-Diagnostic_tool	666	670	disc
I-Diagnostic_tool	671	677	photos
O	677	678	,
B-Diagnostic_tool	679	690	goniophotos
O	690	691	,
O	692	695	and
B-Diagnostic_tool	696	703	Octopus
I-Diagnostic_tool	704	713	perimetry
O	713	714	.

O	715	720	Seven
O	721	723	of
O	724	726	13
O	727	735	patients
O	736	737	(
O	737	739	55
O	739	740	%
O	740	741	)
O	742	745	had
O	746	752	either
O	753	758	frank
B-Symptom	759	771	glaucomatous
I-Symptom	772	774	or
I-Symptom	775	785	suspicious
I-Symptom	786	793	Octopus
I-Symptom	794	800	visual
I-Symptom	801	806	field
I-Symptom	807	820	abnormalities
O	821	823	in
O	824	827	the
O	828	834	fellow
B-Anatomy	835	839	eyes
O	839	840	.

O	841	849	Patients
O	850	854	with
B-Disease	855	860	angle
I-Disease	860	861	-
I-Disease	861	869	cleavage
I-Disease	870	878	glaucoma
O	879	885	appear
O	886	888	to
O	889	893	have
O	894	896	at
O	897	902	least
O	903	904	a
O	905	907	50
O	907	908	%
O	909	915	chance
O	916	918	of
O	919	929	developing
B-Disease	930	934	open
I-Disease	934	935	-
I-Disease	935	940	angle
I-Disease	941	949	glaucoma
O	950	952	in
O	953	956	the
O	957	960	non
O	960	961	-
O	961	972	traumatized
O	973	979	fellow
B-Anatomy	980	984	eyes
O	984	985	.

O	0	7	Natural
O	8	15	history
O	16	18	of
B-Disease	19	25	senile
I-Disease	26	35	disciform
I-Disease	36	43	macular
I-Disease	44	53	dystrophy
O	53	54	.

O	56	62	Twenty
O	62	63	-
O	63	67	nine
O	68	76	patients
O	77	81	with
B-Symptom	82	88	severe
I-Symptom	89	95	visual
I-Symptom	96	100	loss
O	101	103	in
O	104	107	one
B-Anatomy	108	111	eye
O	112	116	from
B-Disease	117	126	disciform
I-Disease	127	134	macular
I-Disease	135	144	dystrophy
O	145	149	were
O	150	163	prospectively
O	164	171	studied
O	172	175	for
O	176	179	the
O	180	189	incidence
O	190	192	of
B-Symptom	193	199	visual
I-Symptom	200	204	loss
O	205	207	in
O	208	211	the
O	212	218	fellow
B-Anatomy	219	222	eye
O	222	223	.

O	224	228	Four
O	229	238	developed
O	239	243	such
O	244	248	loss
O	249	251	in
O	252	255	the
O	256	262	second
B-Anatomy	263	266	eye
O	267	273	during
O	274	275	a
O	276	280	mean
O	281	287	period
O	288	290	of
O	291	297	follow
O	297	298	-
O	298	300	up
O	301	303	of
O	304	306	32
O	307	313	months
O	314	318	from
O	319	322	the
O	323	327	time
O	328	330	of
O	331	336	onset
O	337	339	of
B-Symptom	340	346	visual
I-Symptom	347	351	loss
O	352	354	in
O	355	358	the
O	359	364	first
B-Anatomy	365	368	eye
O	368	369	,
O	370	372	an
O	373	379	annual
O	380	389	incidence
O	390	394	rate
O	395	397	of
O	398	399	5
O	399	400	.
O	400	401	2
O	401	402	%
O	402	403	.

O	404	407	The
O	408	414	degree
O	415	417	of
B-Symptom	418	424	drusen
O	425	428	and
B-Symptom	429	436	retinal
I-Symptom	437	444	pigment
I-Symptom	445	455	epithelial
I-Symptom	456	459	and
I-Symptom	460	470	subretinal
I-Symptom	471	478	pigment
I-Symptom	479	489	epithelial
I-Symptom	490	499	pathology
O	500	510	correlated
O	511	521	positively
O	522	526	with
O	527	530	the
O	531	540	incidence
O	541	543	of
B-Symptom	544	550	visual
I-Symptom	551	555	loss
O	556	558	in
O	559	562	the
O	563	569	fellow
B-Anatomy	570	573	eye
O	573	574	.

B-Disease	0	8	Diabetic
I-Disease	9	20	retinopathy
O	21	23	in
O	24	30	Joslin
O	31	37	Clinic
O	38	46	patients
O	47	51	with
B-Disease	52	57	adult
I-Disease	57	58	-
I-Disease	58	63	onset
I-Disease	64	72	diabetes
O	72	73	.

O	75	80	While
O	81	85	only
O	86	87	a
O	88	93	small
O	94	104	proportion
O	105	107	of
B-Disease	108	113	adult
I-Disease	113	114	-
I-Disease	114	119	onset
I-Disease	120	128	diabetic
O	129	137	patients
O	138	145	develop
B-Disease	146	152	vision
I-Disease	153	164	threatening
I-Disease	165	176	retinopathy
O	176	177	,
O	178	182	this
O	183	188	group
O	189	194	makes
O	195	197	up
O	198	199	a
O	200	205	major
O	206	213	portion
O	214	216	of
O	217	222	those
B-Disease	223	232	diabetics
O	233	240	seeking
O	241	255	ophthalmologic
O	256	260	care
O	260	261	.

O	262	267	Fifty
O	267	268	-
O	268	273	three
O	274	281	percent
O	282	284	of
O	285	293	patients
O	294	300	having
B-Diagnostic_tool	301	307	fundus
I-Diagnostic_tool	308	319	photographs
O	320	322	at
O	323	326	the
O	327	328	W
O	328	329	.
O	329	330	P
O	330	331	.

O	332	339	Beetham
B-Anatomy	340	343	Eye
O	344	348	Unit
O	349	351	of
O	352	355	the
O	356	362	Joslin
O	363	369	Clinic
O	370	379	developed
B-Disease	380	388	diabetes
O	389	391	at
O	392	395	the
B-Characteristic	396	399	age
I-Characteristic	400	402	of
I-Characteristic	403	405	20
I-Characteristic	406	408	or
I-Characteristic	409	413	over
O	413	414	,
O	415	418	and
O	419	425	almost
O	426	428	30
O	428	429	%
O	430	432	at
O	433	436	the
B-Characteristic	437	440	age
I-Characteristic	441	443	of
I-Characteristic	444	446	40
I-Characteristic	447	449	or
I-Characteristic	450	454	over
O	454	455	.

O	456	462	Twenty
O	462	463	-
O	463	466	two
O	467	474	percent
O	475	477	of
O	478	481	all
O	482	490	patients
O	491	495	seen
O	496	500	with
B-Disease	501	514	proliferative
I-Disease	515	526	retinopathy
O	527	531	were
O	532	534	in
O	535	539	this
O	540	546	latter
O	547	552	group
O	552	553	.

O	554	557	Ten
O	558	560	of
O	561	563	54
O	564	572	patients
O	573	577	with
B-Disease	578	591	proliferative
I-Disease	592	603	retinopathy
O	604	606	in
O	607	610	the
O	611	618	greater
O	619	623	than
O	624	626	or
O	627	632	equal
O	633	635	to
O	636	638	40
O	639	644	onset
O	645	650	group
O	651	655	were
O	656	659	not
O	660	666	taking
O	667	674	insulin
O	674	675	.

O	676	679	The
B-Characteristic	680	685	older
I-Characteristic	686	691	onset
I-Characteristic	692	700	patients
O	701	704	who
O	705	714	developed
B-Disease	715	728	proliferative
I-Disease	729	740	retinopathy
O	741	744	did
O	745	747	so
O	748	753	after
O	754	761	shorter
O	762	771	durations
O	772	774	of
B-Disease	775	783	diabetes
O	784	787	and
O	788	792	with
O	793	797	more
B-Symptom	798	804	visual
I-Symptom	805	815	disability
O	816	820	than
B-Characteristic	821	828	younger
I-Characteristic	829	834	onset
I-Characteristic	835	843	patients
O	843	844	.

B-Disease	845	852	Macular
I-Disease	853	858	edema
O	859	862	was
O	863	867	more
O	868	874	common
O	875	877	in
B-Characteristic	878	883	adult
I-Characteristic	883	884	-
I-Characteristic	884	889	onset
I-Characteristic	890	898	patients
O	898	899	,
O	900	903	and
O	904	907	its
O	908	916	presence
O	917	919	in
O	920	921	a
B-Characteristic	922	929	patient
I-Characteristic	930	934	less
I-Characteristic	935	939	than
I-Characteristic	940	942	50
I-Characteristic	943	948	years
I-Characteristic	949	952	old
O	953	956	was
O	957	964	usually
O	965	975	associated
O	976	980	with
B-Disease	981	994	proliferative
I-Disease	995	997	or
I-Disease	998	1014	preproliferative
I-Disease	1015	1026	retinopathy
O	1026	1027	.

O	0	9	Prognosis
O	10	12	of
O	13	21	patients
O	22	26	with
B-Symptom	27	36	bilateral
I-Symptom	37	44	macular
I-Symptom	45	51	drusen
O	51	52	.

O	54	56	Of
O	57	59	71
O	60	68	patients
O	69	73	with
O	74	78	only
B-Symptom	79	88	bilateral
I-Symptom	89	96	macular
I-Symptom	97	103	drusen
O	103	104	,
O	105	106	8
B-Anatomy	107	111	eyes
O	112	114	in
O	115	116	7
O	117	125	patients
O	126	127	(
O	127	128	9
O	128	129	.
O	129	130	9
O	130	131	%
O	131	132	)
O	133	142	developed
B-Disease	143	152	exudative
I-Disease	153	164	maculopathy
O	165	169	over
O	170	172	an
O	173	180	average
O	181	187	follow
O	187	188	-
O	188	190	up
O	191	193	of
O	194	195	4
O	195	196	.
O	196	197	3
O	198	203	years
O	204	205	(
O	205	207	14
O	207	208	.
O	208	209	5
O	209	210	%
O	211	221	cumulative
O	222	226	risk
O	226	227	)
O	227	228	.

B-Symptom	229	235	Severe
I-Symptom	236	242	visual
I-Symptom	243	247	loss
O	248	251	due
O	252	254	to
B-Disease	255	264	exudative
I-Disease	265	276	maculopathy
O	277	285	occurred
O	286	288	in
O	289	290	7
B-Anatomy	291	295	eyes
O	296	298	of
O	299	300	6
O	301	309	patients
O	310	311	(
O	311	312	8
O	312	313	.
O	313	314	5
O	314	315	%
O	315	316	)
O	317	320	for
O	321	322	a
O	323	324	5
O	324	325	-
O	325	329	year
O	330	340	cumulative
O	341	345	risk
O	346	348	of
O	349	351	12
O	351	352	.
O	352	353	7
O	353	354	%
O	354	355	.

O	356	364	Features
O	365	367	of
O	368	371	the
B-Symptom	372	378	drusen
O	379	383	were
O	384	392	analyzed
O	392	393	,
O	394	397	but
O	398	402	only
O	403	406	the
O	407	418	association
O	419	423	with
B-Symptom	424	429	focal
I-Symptom	430	447	hyperpigmentation
O	448	449	(
O	449	450	P
O	451	455	less
O	456	460	than
O	461	462	0
O	462	463	.
O	463	466	001
O	466	467	)
O	468	471	and
O	472	476	more
O	477	481	than
O	482	489	minimal
B-Symptom	490	496	drusen
I-Symptom	497	507	confluence
O	508	509	(
O	509	510	P
O	511	515	less
O	516	520	than
O	521	522	0
O	522	523	.
O	523	525	05
O	525	526	)
O	527	531	were
O	532	545	statistically
O	546	557	significant
O	557	558	.

B-Characteristic	559	564	Older
I-Characteristic	565	573	patients
O	574	577	had
O	578	582	more
B-Symptom	583	589	severe
I-Symptom	590	596	drusen
I-Symptom	596	597	.

B-Characteristic	598	609	Photostress
I-Characteristic	610	614	test
I-Characteristic	615	620	delay
O	621	624	did
O	625	628	not
O	629	638	correlate
O	639	643	with
B-Characteristic	644	650	visual
I-Characteristic	651	657	acuity
O	657	658	,
B-Characteristic	659	662	age
O	662	663	,
O	664	666	or
B-Characteristic	667	675	severity
I-Characteristic	676	678	of
I-Characteristic	679	685	drusen
O	685	686	.

B-Disease	0	8	Systemic
I-Disease	9	16	uveitis
I-Disease	17	26	syndromes
O	27	29	in
B-Characteristic	30	39	childhood
O	39	40	:
O	41	43	an
O	44	52	analysis
O	53	55	of
O	56	59	340
O	60	65	cases
O	65	66	.

O	68	73	Three
O	74	81	hundred
O	82	87	forty
O	88	96	patients
O	97	101	with
B-Disease	102	110	anterior
I-Disease	111	118	uveitis
O	119	129	associated
O	130	134	with
O	135	136	a
O	137	145	specific
O	146	154	systemic
O	155	162	disease
O	163	166	are
O	167	176	described
O	176	177	.

O	178	181	All
O	182	190	patients
O	191	200	developed
B-Disease	201	208	uveitis
O	209	211	or
O	212	215	the
O	216	224	systemic
O	225	232	disease
O	232	233	,
O	234	236	or
O	237	241	both
O	241	242	,
B-Characteristic	243	248	prior
I-Characteristic	249	251	to
I-Characteristic	252	255	the
I-Characteristic	256	259	age
I-Characteristic	260	262	of
I-Characteristic	263	265	16
I-Characteristic	266	271	years
O	271	272	,
O	273	275	By
O	276	279	far
O	280	283	the
O	284	288	most
O	289	297	frequent
O	298	306	systemic
O	307	315	disorder
O	316	319	was
O	320	321	a
B-Disease	322	326	sero
I-Disease	326	327	-
I-Disease	327	335	negative
I-Disease	336	345	arthritis
O	345	346	.

O	347	353	Others
O	354	362	included
B-Disease	363	374	sarcoidosis
O	374	375	,
B-Disease	376	379	Beh
I-Disease	379	380	
I-Disease	380	382	et
I-Disease	382	383	'
I-Disease	383	384	s
I-Disease	385	392	disease
O	392	393	,
O	394	397	the
B-Disease	398	402	Vogt
I-Disease	402	403	-
I-Disease	403	411	Koyanagi
I-Disease	411	412	-
I-Disease	412	418	Harada
I-Disease	419	427	syndrome
O	427	428	,
O	429	432	and
B-Disease	433	442	arteritis
O	442	443	.

B-Characteristic	444	452	Children
O	453	457	with
B-Disease	458	472	pauciarticular
I-Disease	473	481	juvenile
I-Disease	482	489	chronic
I-Disease	490	499	arthritis
O	499	500	,
O	501	511	especially
O	512	516	when
O	517	527	associated
O	528	532	with
B-Characteristic	533	544	antinuclear
I-Characteristic	545	555	antibodies
O	555	556	,
O	557	560	are
O	561	563	at
O	564	574	particular
O	575	579	risk
O	580	582	of
O	583	593	developing
B-Disease	594	601	chronic
I-Disease	602	609	uveitis
O	610	613	and
O	614	618	they
O	619	625	should
O	626	628	be
O	629	637	screened
O	638	640	at
O	641	649	frequent
O	650	659	intervals
O	659	660	,
O	661	665	even
O	666	668	if
O	669	681	asymptomatic
O	681	682	.

O	683	692	Treatment
O	693	695	of
B-Disease	696	705	secondary
I-Disease	706	715	cataracts
O	716	718	in
B-Characteristic	719	727	children
O	728	733	using
O	734	742	vitreous
O	743	750	cutters
O	751	758	usually
O	759	764	gives
O	765	769	good
O	770	777	results
O	777	778	.

O	779	782	The
O	783	787	most
O	788	799	devastating
O	800	812	complication
O	813	815	of
B-Disease	816	823	chronic
I-Disease	824	831	uveitis
O	832	834	is
B-Disease	835	844	secondary
I-Disease	845	853	glaucoma
O	853	854	.

B-Characteristic	0	7	Adenoma
I-Characteristic	8	10	of
I-Characteristic	11	14	the
I-Characteristic	15	19	iris
I-Characteristic	19	20	-
I-Characteristic	20	27	pigment
I-Characteristic	28	38	epithelium
O	38	39	.

O	41	43	An
B-Characteristic	44	46	11
I-Characteristic	46	47	-
I-Characteristic	47	51	year
I-Characteristic	51	52	-
I-Characteristic	52	55	old
I-Characteristic	56	59	boy
O	60	63	was
O	64	69	noted
O	70	72	to
O	73	77	have
O	78	79	a
B-Characteristic	80	92	multinodular
I-Characteristic	93	98	tumor
I-Characteristic	99	108	involving
I-Characteristic	109	112	the
I-Characteristic	113	123	peripheral
I-Characteristic	124	128	iris
I-Characteristic	129	132	and
I-Characteristic	133	143	trabecular
I-Characteristic	144	152	meshwork
I-Characteristic	153	155	in
I-Characteristic	156	159	his
I-Characteristic	160	164	left
I-Characteristic	165	168	eye
O	168	169	.

O	170	176	During
O	177	180	the
O	181	185	next
O	186	188	12
O	189	194	years
O	194	195	,
O	196	199	the
O	200	206	lesion
O	207	213	slowly
O	214	222	enlarged
O	223	226	and
O	227	235	produced
B-Symptom	236	246	pigmentary
I-Symptom	247	257	dispersion
I-Symptom	258	260	in
I-Symptom	261	264	the
I-Symptom	265	273	anterior
I-Symptom	274	281	chamber
O	282	285	and
B-Symptom	286	298	glaucomatous
I-Symptom	299	306	changes
I-Symptom	307	309	in
I-Symptom	310	313	the
I-Symptom	314	319	optic
I-Symptom	320	324	disc
O	324	325	.

O	326	341	Histopathologic
O	342	353	examination
O	354	356	of
O	357	360	the
O	361	366	tumor
O	367	372	after
O	373	376	its
O	377	384	removal
O	385	387	by
O	388	403	iridocyclectomy
O	404	412	revealed
O	413	421	features
O	422	432	consistent
O	433	437	with
O	438	441	the
O	442	451	diagnosis
O	452	454	of
B-Characteristic	455	462	adenoma
I-Characteristic	463	465	of
I-Characteristic	466	469	the
I-Characteristic	470	474	iris
I-Characteristic	474	475	-
I-Characteristic	475	482	pigment
I-Characteristic	483	493	epithelium
O	493	494	.

O	495	496	A
O	497	508	correlation
O	509	516	between
O	517	520	the
O	521	529	clinical
O	530	533	and
O	534	549	histopathologic
O	550	558	features
O	559	561	is
O	562	571	presented
O	571	572	.

O	573	581	Clinical
O	582	590	features
O	591	595	that
O	596	599	can
O	600	602	be
O	603	610	helpful
O	611	613	in
O	614	629	differentiating
O	630	632	an
B-Characteristic	633	640	adenoma
I-Characteristic	641	643	of
I-Characteristic	644	647	the
I-Characteristic	648	652	iris
I-Characteristic	652	653	-
I-Characteristic	653	660	pigment
I-Characteristic	661	671	epithelium
O	672	676	from
O	677	678	a
B-Symptom	679	688	malignant
I-Symptom	689	697	melanoma
O	698	701	are
O	702	711	discussed
O	711	712	.

B-Disease	0	11	Retinopathy
O	12	14	in
B-Characteristic	15	26	adolescents
O	27	30	and
B-Characteristic	31	36	young
I-Characteristic	37	43	adults
O	44	48	with
B-Disease	49	54	onset
I-Disease	55	57	of
I-Disease	58	65	insulin
I-Disease	65	66	-
I-Disease	66	75	dependent
I-Disease	76	84	diabetes
O	85	87	in
B-Characteristic	88	97	childhood
O	97	98	.

B-Anatomy	100	107	Retinal
O	108	115	studies
O	116	120	were
O	121	125	done
O	126	128	in
O	129	132	181
O	133	146	postpubescent
O	146	147	,
B-Disease	148	155	insulin
I-Disease	155	156	-
I-Disease	156	165	dependent
I-Disease	166	174	diabetic
O	175	183	patients
O	184	187	who
O	188	197	developed
B-Disease	198	206	diabetes
B-Characteristic	207	213	before
I-Characteristic	214	217	the
I-Characteristic	218	221	age
I-Characteristic	222	224	of
I-Characteristic	225	227	20
O	227	228	.

B-Anatomy	229	236	Retinal
O	237	244	studies
O	245	253	included
O	254	260	serial
B-Diagnostic_tool	261	267	direct
I-Diagnostic_tool	268	283	ophthalmoscopic
I-Diagnostic_tool	284	296	examinations
O	296	297	,
B-Diagnostic_tool	298	310	stereoscopic
I-Diagnostic_tool	311	317	fundus
I-Diagnostic_tool	318	329	photography
O	330	333	and
B-Diagnostic_tool	334	345	fluorescein
I-Diagnostic_tool	346	357	angiography
O	357	358	.

O	359	361	At
O	362	365	the
O	366	370	time
O	371	373	of
B-Anatomy	374	381	retinal
O	382	389	studies
O	389	390	,
B-Diagnostic_tool	391	397	muscle
I-Diagnostic_tool	398	406	biopsies
O	407	411	also
O	412	416	were
O	417	421	done
O	422	424	to
O	425	432	measure
B-Characteristic	433	442	capillary
I-Characteristic	443	451	basement
I-Characteristic	452	460	membrane
I-Characteristic	461	470	thickness
O	471	472	(
B-Characteristic	472	476	CBMT
O	476	477	)
O	478	480	as
O	481	483	an
O	484	489	index
O	490	492	of
O	493	498	early
B-Symptom	499	512	microvascular
I-Symptom	513	520	changes
I-Symptom	521	523	in
I-Symptom	524	532	skeletal
I-Symptom	533	540	muscles
O	540	541	.

O	542	552	Assessment
O	553	555	of
O	556	564	clinical
O	565	574	metabolic
O	575	582	control
O	582	583	,
O	584	598	interpretation
O	599	601	of
B-Anatomy	602	609	retinal
O	610	618	findings
O	618	619	,
O	620	623	and
B-Characteristic	624	628	CBMT
O	629	633	were
O	634	638	done
O	639	652	independently
O	652	653	.

O	654	656	No
B-Disease	657	668	retinopathy
O	669	672	was
O	673	681	detected
O	682	684	in
O	685	693	patients
O	694	702	observed
O	703	715	continuously
O	716	719	and
O	720	725	known
O	726	728	to
O	729	733	have
O	734	738	been
O	739	741	in
O	742	748	higher
O	749	756	degrees
O	757	759	of
O	760	769	metabolic
O	770	777	control
O	777	778	.

O	779	785	Twenty
O	785	786	-
O	786	790	five
O	791	799	patients
O	800	802	in
O	803	808	lower
O	809	816	degrees
O	817	819	of
O	820	827	control
O	828	831	for
O	832	840	extended
O	841	848	periods
O	849	852	had
B-Disease	853	864	retinopathy
O	864	865	.

B-Characteristic	866	870	CBMT
O	871	874	was
O	875	880	found
O	881	883	to
O	884	886	be
O	887	893	labile
O	894	897	and
O	898	900	to
O	901	909	progress
O	910	912	or
O	913	920	regress
O	921	927	within
O	928	929	a
O	930	934	year
O	935	944	depending
O	945	947	on
O	948	951	the
O	952	958	degree
O	959	961	of
O	962	969	control
O	969	970	.

O	971	974	All
O	975	983	patients
O	984	986	in
O	987	992	lower
O	993	1000	degrees
O	1001	1003	of
O	1004	1011	control
O	1012	1016	with
B-Disease	1017	1028	retinopathy
O	1029	1032	had
O	1033	1042	increased
B-Characteristic	1043	1047	CBMT
O	1047	1048	,
O	1049	1052	but
O	1053	1055	if
O	1056	1060	they
O	1061	1073	subsequently
O	1074	1082	attained
O	1083	1086	and
O	1087	1097	maintained
O	1098	1099	a
O	1100	1104	high
O	1105	1111	degree
O	1112	1114	of
O	1115	1122	control
O	1123	1126	for
O	1127	1128	a
O	1129	1133	year
O	1133	1134	,
O	1135	1139	then
B-Characteristic	1140	1144	CBMT
O	1145	1155	diminished
O	1156	1159	and
O	1160	1165	there
O	1166	1169	was
O	1170	1172	no
O	1173	1184	progression
O	1185	1187	of
B-Disease	1188	1199	retinopathy
O	1199	1200	.

O	1201	1204	Our
O	1205	1210	study
O	1211	1223	demonstrates
O	1224	1228	that
O	1229	1230	a
O	1231	1235	high
O	1236	1242	degree
O	1243	1245	of
O	1246	1255	metabolic
O	1256	1263	control
O	1264	1270	delays
O	1270	1271	,
O	1272	1275	and
O	1276	1279	may
O	1280	1287	prevent
O	1287	1288	,
B-Symptom	1289	1302	microvascular
I-Symptom	1303	1310	changes
O	1310	1311	,
O	1312	1315	and
O	1316	1324	confirms
O	1325	1330	other
O	1331	1338	studies
O	1339	1349	indicating
O	1350	1354	that
O	1355	1359	most
B-Characteristic	1360	1373	postpubescent
O	1373	1374	,
B-Disease	1375	1382	insulin
I-Disease	1382	1383	-
I-Disease	1383	1392	dependent
I-Disease	1393	1401	diabetic
O	1402	1410	patients
O	1411	1415	will
O	1416	1423	develop
B-Disease	1424	1435	retinopathy
O	1436	1442	within
O	1443	1445	15
O	1446	1451	years
O	1452	1458	unless
O	1459	1460	a
O	1461	1471	relatively
O	1472	1476	high
O	1477	1483	degree
O	1484	1486	of
O	1487	1494	control
O	1495	1497	is
O	1498	1508	maintained
O	1508	1509	.

B-Disease	0	8	Diabetic
I-Disease	9	20	retinopathy
O	20	21	,
O	22	29	present
O	30	33	and
O	34	40	future
O	40	41	.

O	42	52	Conclusion
O	53	55	of
B-Disease	56	64	diabetic
I-Disease	65	76	retinopathy
O	77	86	symposium
O	86	87	.

O	89	92	The
O	93	102	preceding
O	103	110	reports
O	111	113	of
O	114	117	the
B-Disease	118	126	Diabetic
I-Disease	127	138	Retinopathy
O	139	148	Symposium
O	149	152	are
O	153	161	reviewed
O	161	162	.

B-Disease	163	171	Diabetic
I-Disease	172	183	retinopathy
O	184	194	progresses
O	195	199	with
O	200	203	the
O	204	212	duration
O	213	215	of
O	216	223	disease
O	224	227	and
O	228	233	often
O	234	241	results
O	242	244	in
B-Disease	245	258	proliferative
I-Disease	259	270	retinopathy
O	271	273	in
O	274	277	the
B-Characteristic	278	286	juvenile
I-Characteristic	287	292	onset
O	293	300	patient
O	301	304	and
B-Disease	305	312	macular
I-Disease	313	318	edema
O	319	321	in
O	322	325	the
B-Characteristic	326	331	older
I-Characteristic	332	337	onset
O	338	345	patient
O	345	346	.

B-Diagnostic_tool	347	355	Periodic
I-Diagnostic_tool	356	371	ophthalmoscopic
I-Diagnostic_tool	372	384	examinations
O	385	388	are
O	389	398	essential
O	399	401	in
O	402	411	detecting
O	412	415	the
O	416	427	progression
O	428	430	of
B-Disease	431	442	retinopathy
O	443	446	and
O	447	458	development
O	459	461	of
O	462	469	disease
O	470	485	characteristics
O	486	491	which
O	492	500	indicate
O	501	502	a
O	503	507	need
O	508	511	for
O	512	521	treatment
O	521	522	.

O	523	533	Laboratory
O	534	537	and
O	538	546	clinical
O	547	557	experience
O	558	564	stress
O	565	568	the
O	569	579	importance
O	580	582	of
O	583	588	rigid
O	589	596	glucose
O	597	604	control
O	605	607	in
O	608	618	preventing
B-Disease	619	627	diabetic
I-Disease	628	639	retinopathy
O	639	640	.

B-Symptom	641	649	Ischemia
I-Symptom	650	652	of
I-Symptom	653	656	the
I-Symptom	657	670	midperipheral
I-Symptom	671	677	retina
O	678	688	stimulates
O	689	692	the
O	693	704	development
O	705	707	of
O	708	712	high
O	713	717	risk
O	718	725	factors
O	726	729	for
O	730	735	which
O	736	746	panretinal
O	747	763	photocoagulation
O	764	766	is
O	767	776	indicated
O	777	784	despite
O	785	789	side
O	790	797	effects
O	798	802	such
O	803	805	as
B-Symptom	806	815	decreased
I-Symptom	816	820	dark
I-Symptom	821	831	adaptation
O	831	832	.

O	833	837	Pars
O	838	843	plana
O	844	854	vitrectomy
O	855	862	results
O	863	865	in
O	866	877	substantial
O	878	884	visual
O	885	896	improvement
O	897	899	in
B-Anatomy	900	904	eyes
O	905	909	with
B-Symptom	910	921	nonclearing
I-Symptom	922	930	vitreous
I-Symptom	931	941	hemorrhage
O	942	945	and
O	945	946	/
O	946	948	or
B-Symptom	949	957	traction
I-Symptom	958	965	retinal
I-Symptom	966	977	detachments
I-Symptom	978	987	involving
I-Symptom	988	991	the
I-Symptom	992	998	macula
O	998	999	.

O	1000	1006	Future
O	1007	1015	advances
O	1016	1018	in
O	1019	1022	our
O	1023	1032	knowledge
O	1033	1035	of
B-Disease	1036	1044	diabetic
I-Disease	1045	1056	retinopathy
O	1057	1063	should
O	1064	1068	come
O	1069	1073	from
O	1074	1077	the
O	1078	1086	National
B-Anatomy	1087	1090	Eye
O	1091	1100	Institute
O	1100	1101	'
O	1101	1102	s
O	1103	1116	Collaborative
B-Disease	1117	1125	Diabetic
I-Disease	1126	1137	Retinopathy
O	1138	1148	Vitrectomy
O	1149	1154	Study
O	1155	1158	and
O	1159	1164	Early
O	1165	1174	Treatment
B-Disease	1175	1183	Diabetic
I-Disease	1184	1195	Retinopathy
O	1196	1201	Study
O	1201	1202	,
O	1203	1206	and
O	1207	1210	the
O	1211	1219	analysis
O	1220	1222	of
B-Symptom	1223	1236	vasoformative
I-Symptom	1237	1244	factors
O	1244	1245	.

O	0	3	The
O	4	11	natural
O	12	19	history
O	20	22	of
B-Disease	23	34	retinopathy
O	35	37	in
B-Disease	38	45	insulin
I-Disease	45	46	-
I-Disease	46	55	dependent
I-Disease	56	64	juvenile
I-Disease	64	65	-
I-Disease	65	70	onset
I-Disease	71	79	diabetes
O	79	80	.

O	82	84	We
O	85	95	determined
O	96	99	the
O	100	105	cross
O	105	106	-
O	106	115	sectional
O	116	123	natural
O	124	131	history
O	132	134	of
B-Disease	135	146	retinopathy
O	147	149	by
O	150	161	prospective
O	162	167	study
O	168	170	of
O	171	174	461
B-Disease	175	182	insulin
I-Disease	182	183	-
I-Disease	183	192	dependent
I-Disease	193	201	juvenile
I-Disease	201	202	-
I-Disease	202	207	onset
I-Disease	208	217	diabetics
O	217	218	.

O	219	221	In
O	222	224	so
O	225	230	doing
O	230	231	,
O	232	234	we
O	235	243	compared
O	244	247	the
O	248	259	sensitivity
O	260	262	of
B-Diagnostic_tool	263	277	ophthalmoscopy
O	277	278	,
B-Diagnostic_tool	279	290	photography
O	290	291	,
O	292	295	and
B-Diagnostic_tool	296	307	fluorescein
I-Diagnostic_tool	308	319	angiography
O	320	322	in
O	323	332	detecting
B-Disease	333	344	retinopathy
O	344	345	.

B-Diagnostic_tool	346	357	Photography
O	358	361	was
O	362	365	far
O	366	370	more
O	371	379	reliable
O	380	384	than
B-Diagnostic_tool	385	399	ophthalmoscopy
O	400	402	in
O	403	412	detecting
B-Disease	413	418	early
I-Disease	419	430	retinopathy
O	431	434	and
O	435	445	equivalent
O	446	448	to
B-Diagnostic_tool	449	460	angiography
O	460	461	.

B-Disease	462	473	Retinopathy
O	474	477	was
O	478	481	not
O	482	489	present
O	490	492	at
O	493	502	diagnosis
O	503	505	of
B-Disease	506	514	diabetes
O	514	515	.

O	516	521	After
O	522	523	a
O	524	527	lag
O	528	534	period
O	534	535	,
O	536	539	the
O	540	550	prevalence
O	551	553	of
B-Disease	554	565	retinopathy
O	566	570	rose
O	571	573	in
O	574	583	sigmoidal
O	584	591	fashion
O	591	592	,
O	593	601	reaching
O	602	604	50
O	604	605	%
O	606	608	at
O	609	613	just
O	614	618	over
O	619	624	seven
O	625	630	years
O	631	639	duration
O	639	640	,
O	641	644	and
O	645	659	asymptotically
O	660	671	approaching
O	672	674	90
O	674	675	%
O	676	678	at
O	679	681	17
O	681	682	-
O	682	683	-
O	683	685	50
O	686	691	years
O	691	692	.

B-Disease	693	706	Proliferative
I-Disease	707	718	retinopathy
O	719	722	was
O	723	728	first
O	729	733	seen
O	734	736	at
O	737	739	13
O	740	745	years
O	746	754	duration
O	754	755	,
O	756	759	and
O	760	763	its
O	764	774	prevalence
O	775	779	rose
O	780	782	to
O	783	785	26
O	785	786	%
O	787	789	at
O	790	792	26
O	792	793	-
O	793	794	-
O	794	796	50
O	797	802	years
O	802	803	.

O	804	808	From
O	809	812	the
O	813	820	natural
O	821	828	history
O	829	831	we
O	832	840	computed
O	841	844	the
O	845	855	dimensions
O	856	858	of
O	859	860	a
O	861	869	proposed
O	870	878	clinical
O	879	884	trial
O	885	887	to
O	888	892	test
O	893	896	the
O	897	903	effect
O	904	906	of
O	907	912	tight
O	913	922	metabolic
O	923	930	control
O	931	933	in
O	934	944	prevention
O	945	947	of
B-Disease	948	959	retinopathy
O	959	960	.

O	0	8	Computer
O	8	9	-
O	9	17	enhanced
O	18	25	studies
O	26	28	of
B-Disease	29	37	diabetic
I-Disease	38	49	retinopathy
O	49	50	:
O	51	52	I
O	52	53	.

O	55	56	A
O	57	65	computer
O	66	73	program
O	74	82	designed
O	83	92	according
O	93	95	to
O	96	99	the
O	100	105	needs
O	106	108	of
O	109	117	clinical
O	118	131	investigators
O	132	135	has
O	136	144	recently
O	145	149	been
O	150	161	implemented
O	161	162	.

O	163	167	This
O	168	177	ambitious
O	178	189	undertaking
O	190	196	allows
O	197	200	the
O	201	216	ophthalmologist
O	217	223	direct
O	224	235	interfacing
O	236	239	and
O	240	247	control
O	248	252	over
O	253	256	all
O	257	260	his
O	261	265	data
O	265	266	,
O	267	276	presently
O	277	278	3
O	278	279	,
O	279	282	252
B-Disease	283	291	diabetic
O	292	299	patient
O	300	307	records
O	307	308	,
O	309	312	and
O	313	317	thus
O	318	327	harnesses
O	328	331	his
O	332	342	hypothesis
O	342	343	-
O	343	350	testing
O	351	361	intuitions
O	362	366	with
O	367	370	the
O	371	377	memory
O	377	378	,
O	379	384	speed
O	384	385	,
O	386	389	and
O	390	401	flexibility
O	402	404	of
O	405	411	modern
O	411	412	-
O	412	415	day
O	416	425	computers
O	425	426	.

O	427	432	There
O	433	436	are
O	437	442	three
O	443	450	program
O	451	456	modes
O	456	457	:
O	458	463	QUERY
O	463	464	,
O	465	466	a
O	467	474	disease
O	474	475	-
O	475	486	independent
O	487	495	language
O	496	498	by
O	499	504	which
O	505	508	the
O	509	518	clinician
O	519	526	selects
O	527	530	his
O	531	541	population
O	541	542	;
O	543	549	SELECT
O	549	550	,
O	551	554	the
O	555	561	actual
O	562	570	computer
O	571	580	selection
O	580	581	,
O	582	585	and
O	586	593	DISPLAY
O	593	594	:
O	595	600	where
O	601	608	general
O	609	620	statistical
O	621	630	maneuvers
O	630	631	,
O	632	645	relationships
O	646	651	among
O	652	659	disease
O	660	670	parameters
O	670	671	,
O	672	681	ancillary
O	682	686	data
O	687	699	compilations
O	699	700	,
O	701	704	and
O	705	714	printouts
O	715	718	are
O	719	728	performed
O	728	729	.

O	730	735	Being
O	736	744	computer
O	744	745	-
O	745	756	independent
O	757	760	and
O	761	768	disease
O	768	769	-
O	769	780	independent
O	780	781	,
O	782	785	and
O	786	795	adaptable
O	796	798	to
O	799	803	most
O	804	809	needs
O	810	812	of
O	813	821	clinical
O	822	835	investigators
O	835	836	,
O	837	841	this
O	842	850	computer
O	851	858	program
O	859	865	brings
O	866	867	a
O	868	880	refreshingly
O	881	884	new
O	885	893	approach
O	894	896	to
O	897	900	the
O	901	906	study
O	907	909	of
O	910	917	disease
O	917	918	.

O	0	7	Viewing
O	8	15	through
O	16	19	the
B-Symptom	20	29	asteroids
O	29	30	.

O	32	38	Thirty
O	39	41	to
O	42	49	seventy
O	50	57	percent
O	58	60	of
O	61	69	patients
O	70	74	with
B-Disease	75	83	asteroid
I-Disease	84	92	hyalosis
O	93	97	will
O	98	102	also
O	103	107	have
B-Disease	108	116	diabetes
O	116	117	.

O	118	120	In
O	121	125	this
O	126	131	group
O	132	134	of
O	135	143	patients
O	144	149	where
O	150	154	view
O	155	157	of
O	158	161	the
B-Anatomy	162	168	fundus
O	169	171	is
O	172	181	essential
O	181	182	,
O	183	185	it
O	186	188	is
O	189	194	often
O	195	204	difficult
O	205	207	or
O	208	218	impossible
O	219	221	by
B-Diagnostic_tool	222	234	conventional
I-Diagnostic_tool	235	249	ophthalmoscopy
O	249	250	.

O	251	253	We
O	254	258	have
O	259	264	noted
O	265	268	the
O	269	278	excellent
O	279	292	visualization
O	293	295	of
B-Anatomy	296	302	fundus
O	303	309	detail
O	310	312	in
B-Disease	313	321	asteroid
I-Disease	322	330	hyalosis
O	331	333	on
O	334	341	routine
B-Diagnostic_tool	342	348	fundus
I-Diagnostic_tool	349	360	fluorescein
I-Diagnostic_tool	361	372	angiography
O	372	373	.

O	374	377	The
B-Symptom	378	386	asteroid
I-Symptom	387	393	bodies
O	394	397	are
O	399	400	"
O	401	410	optically
O	411	418	removed
O	419	420	"
O	422	426	from
O	427	430	the
B-Anatomy	431	439	vitreous
O	440	444	with
O	445	449	this
O	450	459	technique
O	459	460	,
O	461	465	thus
O	466	475	affording
O	476	477	a
O	478	482	view
O	483	486	for
O	487	496	diagnosis
O	497	507	previously
O	508	515	thought
O	516	526	impossible
O	527	534	without
O	535	541	actual
O	542	552	vitrectomy
O	552	553	.

O	554	555	A
O	556	562	series
O	563	565	of
O	566	574	patients
O	574	575	,
O	576	583	optimal
O	584	590	camera
O	591	597	filter
O	598	609	combination
O	609	610	,
O	611	614	and
O	615	616	a
O	617	623	theory
O	624	627	for
O	628	632	this
O	633	639	effect
O	640	643	are
O	644	653	presented
O	653	654	.

B-Disease	0	3	Lid
I-Disease	4	15	imbrication
I-Disease	16	24	syndrome
O	24	25	.

O	26	35	Diagnosis
O	36	40	with
B-Diagnostic_tool	41	45	rose
I-Diagnostic_tool	46	52	bengal
I-Diagnostic_tool	53	61	staining
O	61	62	.

B-Disease	64	67	Lid
I-Disease	68	79	imbrication
I-Disease	80	88	syndrome
O	89	91	is
O	92	94	an
B-Symptom	95	106	abnormality
I-Symptom	107	109	of
I-Symptom	110	113	lid
I-Symptom	114	124	apposition
I-Symptom	125	127	in
I-Symptom	128	133	which
I-Symptom	134	137	the
I-Symptom	138	143	upper
I-Symptom	144	147	lid
I-Symptom	148	156	overlies
I-Symptom	157	160	the
I-Symptom	161	166	lower
I-Symptom	167	170	lid
O	170	171	.

O	172	180	Patients
O	181	186	often
O	187	195	complain
O	196	198	of
B-Symptom	199	209	irritation
O	209	210	,
B-Symptom	211	218	tearing
O	218	219	,
O	220	223	and
B-Symptom	224	231	foreign
I-Symptom	232	236	body
I-Symptom	237	246	sensation
O	246	247	.

O	248	251	The
O	252	261	condition
O	262	265	may
O	266	268	be
O	269	278	difficult
O	279	281	to
O	282	290	diagnose
O	290	291	.

O	292	298	Twenty
O	298	299	-
O	299	302	one
O	303	311	patients
O	312	316	with
O	317	326	suspected
B-Disease	327	330	lid
I-Disease	331	342	imbrication
I-Disease	343	351	syndrome
O	352	356	were
O	357	365	compared
O	366	370	with
O	371	373	21
B-Characteristic	374	377	age
I-Characteristic	377	378	-
I-Characteristic	378	385	matched
O	386	394	controls
O	394	395	.

O	396	399	All
O	400	408	patients
O	409	413	were
O	414	419	given
O	420	421	0
O	421	422	.
O	422	423	5
O	423	424	%
B-Diagnostic_tool	425	432	topical
I-Diagnostic_tool	433	437	rose
I-Diagnostic_tool	438	444	bengal
O	444	445	.

O	446	449	The
O	450	459	diagnosis
O	460	462	of
B-Disease	463	466	lid
I-Disease	467	478	imbrication
I-Disease	479	487	syndrome
O	488	491	was
O	492	501	confirmed
O	502	504	by
O	505	508	the
O	509	517	presence
O	518	520	of
B-Diagnostic_tool	521	525	rose
I-Diagnostic_tool	526	532	bengal
I-Diagnostic_tool	533	541	staining
O	542	544	of
O	545	548	the
B-Anatomy	549	555	tarsal
I-Anatomy	556	567	conjunctiva
I-Anatomy	568	570	of
I-Anatomy	571	574	the
I-Anatomy	575	580	upper
I-Anatomy	581	584	lid
I-Anatomy	585	591	margin
O	591	592	.

O	593	596	The
O	597	603	amount
O	604	606	of
B-Diagnostic_tool	607	611	rose
I-Diagnostic_tool	612	618	bengal
I-Diagnostic_tool	619	627	staining
O	628	638	correlated
O	639	643	with
O	644	647	the
O	648	656	severity
O	657	659	of
B-Disease	660	663	lid
I-Disease	664	675	imbrication
O	675	676	.

O	677	685	Eighteen
O	686	688	of
O	689	691	21
O	692	700	patients
O	701	704	had
O	705	713	received
O	714	715	a
O	716	725	diagnosis
O	726	736	previously
O	737	739	of
B-Disease	740	743	dry
I-Disease	744	747	eye
I-Disease	748	756	syndrome
O	756	757	.

O	758	762	Four
O	763	771	patients
O	772	775	had
B-Symptom	776	786	persistent
I-Symptom	787	797	epithelial
I-Symptom	798	805	defects
O	805	806	.

B-Diagnostic_tool	807	811	Rose
I-Diagnostic_tool	812	818	bengal
I-Diagnostic_tool	819	827	staining
O	828	830	of
O	831	834	the
B-Anatomy	835	843	superior
I-Anatomy	844	847	lid
I-Anatomy	848	854	margin
I-Anatomy	855	861	tarsal
I-Anatomy	862	873	conjunctiva
O	874	880	offers
O	881	883	an
O	884	893	extremely
O	894	902	reliable
O	903	906	aid
O	907	910	for
O	911	921	diagnosing
B-Disease	922	925	lid
I-Disease	926	937	imbrication
I-Disease	938	946	syndrome
O	946	947	.

O	948	951	The
O	952	961	condition
O	962	970	commonly
O	971	979	presents
O	980	982	as
O	983	984	a
B-Disease	985	988	dry
I-Disease	989	992	eye
O	993	995	or
B-Symptom	996	1006	persistent
I-Symptom	1007	1017	epithelial
I-Symptom	1018	1024	defect
O	1024	1025	.

O	1026	1035	Treatment
O	1036	1042	ranges
O	1043	1047	from
O	1048	1055	viscous
O	1056	1060	tear
O	1061	1072	substitutes
O	1073	1075	to
O	1076	1086	horizontal
O	1087	1090	lid
O	1091	1101	shortening
O	1102	1104	of
O	1105	1108	the
B-Anatomy	1109	1114	upper
I-Anatomy	1115	1118	lid
O	1118	1119	.

O	0	12	Standardized
B-Diagnostic_tool	13	18	color
I-Diagnostic_tool	18	19	-
I-Diagnostic_tool	19	24	coded
I-Diagnostic_tool	25	29	maps
O	30	33	for
B-Anatomy	34	41	corneal
O	42	52	topography
O	52	53	.

O	55	61	Modern
B-Diagnostic_tool	62	78	videokeratoscopy
O	79	81	is
O	82	88	useful
O	89	91	in
O	92	101	assessing
B-Characteristic	102	109	corneal
I-Characteristic	110	115	shape
O	115	116	.

O	117	120	The
O	121	128	purpose
O	129	131	of
O	132	136	this
O	137	142	study
O	143	145	is
O	146	148	to
O	149	156	compare
B-Diagnostic_tool	157	162	color
I-Diagnostic_tool	162	163	-
I-Diagnostic_tool	163	168	coded
I-Diagnostic_tool	169	180	topographic
I-Diagnostic_tool	181	185	maps
O	186	191	using
O	192	204	standardized
O	205	211	scales
O	212	216	with
O	217	218	1
O	218	219	.
O	219	220	0
O	220	221	-
O	222	225	and
O	226	227	1
O	227	228	.
O	228	229	5
O	229	230	-
O	230	237	diopter
O	238	239	(
O	239	240	D
O	240	241	)
O	242	251	intervals
O	251	252	.

O	253	256	The
O	257	264	authors
O	265	273	assessed
O	274	277	the
O	278	281	use
O	282	284	of
O	285	288	the
O	289	292	two
O	293	299	scales
O	300	303	for
O	304	313	detecting
O	314	324	clinically
O	325	333	relevant
O	334	342	features
O	343	345	of
B-Characteristic	346	353	corneal
I-Characteristic	354	364	topography
O	365	369	such
O	370	372	as
B-Symptom	373	380	regular
I-Symptom	381	392	astigmatism
O	392	393	,
B-Symptom	394	403	irregular
I-Symptom	404	415	astigmatism
O	415	416	,
B-Symptom	417	422	early
I-Symptom	423	434	keratoconus
O	434	435	,
O	436	439	and
B-Symptom	440	447	contact
I-Symptom	448	452	lens
I-Symptom	452	453	-
I-Symptom	453	460	induced
I-Symptom	461	468	corneal
I-Symptom	469	476	warpage
O	476	477	.

O	478	479	A
O	480	485	total
O	486	488	of
O	489	491	50
O	492	498	normal
B-Anatomy	499	506	corneas
O	506	507	,
O	508	510	50
B-Anatomy	511	518	corneas
O	519	523	with
O	524	531	contact
O	532	538	lenses
O	538	539	,
O	540	542	50
O	543	547	that
O	548	551	had
B-Disease	552	563	keratoconus
O	564	565	(
O	565	567	25
O	568	573	early
O	574	576	to
B-Disease	577	585	moderate
O	586	589	and
O	590	592	25
B-Disease	593	601	advanced
O	601	602	)
O	602	603	,
O	604	606	50
O	607	611	that
O	612	615	had
O	616	627	penetrating
O	628	640	keratoplasty
O	640	641	,
O	642	644	20
O	645	649	that
O	650	653	had
B-Disease	654	667	extracapsular
I-Disease	668	676	cataract
O	677	684	surgery
O	684	685	,
O	686	688	17
O	689	693	that
O	694	697	had
O	698	705	excimer
O	706	711	laser
O	712	727	photorefractive
O	728	739	keratectomy
O	740	743	for
B-Disease	744	750	myopia
O	750	751	,
O	752	754	10
O	755	759	that
O	760	763	had
O	764	770	radial
O	771	781	keratotomy
O	781	782	,
O	783	784	3
O	785	789	that
O	790	793	had
O	794	801	aphakic
O	802	817	epikeratophakia
O	817	818	,
O	819	822	and
O	823	824	2
O	825	829	that
O	830	833	had
O	834	840	myopic
O	841	856	epikeratophakia
O	857	861	were
O	862	870	analyzed
O	871	875	with
O	876	877	a
B-Diagnostic_tool	878	885	corneal
I-Diagnostic_tool	886	897	topographic
O	898	906	analysis
O	907	913	system
O	913	914	.

B-Diagnostic_tool	915	920	Color
I-Diagnostic_tool	920	921	-
I-Diagnostic_tool	921	926	coded
I-Diagnostic_tool	927	931	maps
O	932	936	with
O	937	938	1
O	938	939	.
O	939	940	0
O	940	941	-
O	941	942	D
O	943	952	intervals
O	953	954	(
O	954	961	Maguire
O	961	962	/
O	962	968	Waring
O	969	974	scale
O	974	975	)
O	976	979	and
O	980	981	1
O	981	982	.
O	982	983	5
O	983	984	-
O	984	985	D
O	986	995	intervals
O	996	997	(
O	997	1002	Klyce
O	1002	1003	/
O	1003	1009	Wilson
O	1010	1015	scale
O	1015	1016	)
O	1017	1021	were
O	1022	1030	compared
O	1030	1031	.

O	1032	1037	There
O	1038	1042	were
O	1043	1045	no
O	1046	1057	topographic
O	1058	1073	characteristics
O	1074	1078	that
O	1079	1083	were
O	1084	1087	not
O	1088	1099	appreciated
O	1100	1104	with
O	1105	1111	either
O	1112	1117	scale
O	1118	1121	for
B-Anatomy	1122	1129	corneas
O	1130	1134	with
O	1135	1143	dioptric
O	1144	1150	powers
O	1151	1155	that
O	1156	1160	fell
O	1161	1167	within
O	1168	1173	their
O	1174	1180	ranges
O	1180	1181	.

O	1182	1192	Conversely
O	1192	1193	,
O	1194	1197	for
B-Anatomy	1198	1205	corneas
O	1206	1210	that
O	1211	1214	had
O	1215	1221	powers
O	1222	1229	outside
O	1230	1233	the
O	1234	1239	range
O	1240	1242	of
O	1243	1246	the
O	1247	1248	1
O	1248	1249	.
O	1249	1250	0
O	1250	1251	-
O	1251	1258	diopter
O	1259	1264	scale
O	1264	1265	,
O	1266	1269	but
O	1270	1276	within
O	1277	1280	the
O	1281	1286	range
O	1287	1289	of
O	1290	1293	the
O	1294	1295	1
O	1295	1296	.
O	1296	1297	5
O	1297	1298	-
O	1298	1305	diopter
O	1306	1311	scale
O	1311	1312	,
O	1313	1316	the
O	1317	1323	former
O	1324	1332	produced
O	1333	1334	a
O	1335	1338	map
O	1339	1341	in
O	1342	1347	which
O	1348	1351	the
O	1352	1360	flattest
O	1361	1363	or
O	1364	1372	steepest
O	1373	1378	areas
O	1379	1383	were
O	1384	1397	artifactually
O	1398	1406	smoothed
O	1406	1407	.

O	1408	1412	This
O	1413	1418	study
O	1419	1427	suggests
O	1428	1432	that
O	1433	1436	the
O	1437	1442	Klyce
O	1442	1443	/
O	1443	1449	Wilson
O	1450	1455	scale
O	1456	1457	(
O	1457	1465	constant
O	1465	1466	,
O	1467	1468	1
O	1468	1469	.
O	1469	1470	5
O	1470	1471	-
O	1471	1472	D
O	1473	1482	intervals
O	1482	1483	)
O	1484	1492	provides
O	1493	1496	the
O	1497	1501	best
O	1502	1513	combination
O	1514	1516	of
O	1517	1528	sensitivity
O	1529	1532	for
O	1533	1542	detection
O	1543	1545	of
O	1546	1556	clinically
O	1557	1568	significant
O	1569	1580	topographic
O	1581	1589	features
O	1590	1593	and
O	1594	1597	the
O	1598	1604	widest
O	1605	1610	range
O	1611	1613	of
O	1614	1622	coverage
O	1623	1625	of
O	1626	1632	powers
O	1633	1637	that
O	1638	1641	are
O	1642	1647	found
O	1648	1650	on
O	1651	1652	a
O	1653	1660	variety
O	1661	1663	of
O	1664	1670	normal
O	1670	1671	,
O	1672	1682	pathologic
O	1682	1683	,
O	1684	1687	and
O	1688	1698	surgically
O	1699	1706	altered
B-Anatomy	1707	1714	corneas
O	1714	1715	.

O	1716	1719	The
O	1720	1728	adoption
O	1729	1731	of
O	1732	1735	the
O	1736	1741	Klyce
O	1741	1742	/
O	1742	1748	Wilson
O	1749	1754	scale
O	1755	1757	by
O	1758	1761	all
O	1762	1775	manufacturers
O	1776	1778	of
B-Diagnostic_tool	1779	1786	corneal
I-Diagnostic_tool	1787	1798	topographic
O	1799	1810	instruments
O	1811	1813	as
O	1814	1815	a
O	1816	1823	primary
O	1824	1832	standard
O	1833	1837	will
O	1838	1848	facilitate
O	1849	1862	communication
O	1863	1866	and
O	1867	1871	will
O	1872	1876	make
O	1877	1880	the
O	1881	1895	interpretation
O	1896	1898	of
B-Characteristic	1899	1906	corneal
I-Characteristic	1907	1917	topography
O	1918	1924	easier
O	1925	1928	for
O	1929	1933	both
O	1934	1937	the
O	1938	1944	expert
O	1945	1948	and
O	1949	1952	the
O	1953	1959	novice
O	1959	1960	.

O	0	3	The
O	4	13	diagnosis
O	14	16	of
B-Disease	17	25	diabetic
I-Disease	26	37	retinopathy
O	37	38	.

B-Diagnostic_tool	39	53	Ophthalmoscopy
O	54	60	versus
B-Diagnostic_tool	61	67	fundus
I-Diagnostic_tool	68	79	photography
O	79	80	.

O	82	84	To
O	85	92	compare
B-Diagnostic_tool	93	99	fundus
I-Diagnostic_tool	100	111	photography
O	112	116	with
B-Diagnostic_tool	117	131	ophthalmoscopy
O	132	134	in
O	135	138	the
O	139	148	detection
O	149	151	of
B-Disease	152	160	diabetic
I-Disease	161	172	retinopathy
O	172	173	.

B-Diagnostic_tool	174	188	Ophthalmoscopy
O	189	192	and
B-Diagnostic_tool	193	199	fundus
I-Diagnostic_tool	200	211	photographs
I-Diagnostic_tool	212	216	with
I-Diagnostic_tool	217	218	a
I-Diagnostic_tool	219	231	nonmydriatic
I-Diagnostic_tool	232	238	camera
O	238	239	,
O	240	244	both
O	245	254	performed
O	255	262	through
O	263	270	dilated
B-Anatomy	271	277	pupils
O	277	278	,
O	279	283	were
O	284	292	compared
O	293	295	to
O	296	304	diagnose
B-Disease	305	316	retinopathy
O	317	319	in
O	320	321	a
O	322	328	cohort
O	329	331	of
O	332	335	410
B-Characteristic	336	344	Oklahoma
I-Characteristic	345	352	Indians
O	353	357	with
B-Disease	358	368	noninsulin
I-Disease	368	369	-
I-Disease	369	378	dependent
I-Disease	379	387	diabetes
I-Disease	388	396	mellitus
O	396	397	.

O	398	399	A
O	400	405	total
O	406	408	of
O	409	412	795
B-Anatomy	413	417	eyes
O	418	422	were
O	423	431	examined
O	432	437	using
O	438	442	both
O	443	450	methods
O	450	451	.

O	452	455	The
B-Characteristic	456	460	mean
I-Characteristic	461	464	age
I-Characteristic	465	467	of
I-Characteristic	468	480	participants
I-Characteristic	481	484	was
I-Characteristic	485	487	60
I-Characteristic	487	488	.
I-Characteristic	488	489	3
I-Characteristic	490	495	years
O	495	496	,
O	497	501	with
O	502	503	a
O	504	508	mean
O	509	517	duration
O	518	520	of
B-Disease	521	529	diabetes
O	530	532	of
O	533	535	17
O	535	536	.
O	536	537	3
O	538	543	years
O	543	544	.

O	545	547	An
O	548	555	overall
O	556	565	agreement
O	566	568	of
O	569	571	86
O	571	572	.
O	572	573	3
O	573	574	%
O	575	579	with
O	580	581	a
O	582	587	kappa
O	588	597	statistic
O	598	603	kappa
O	604	606	of
O	607	608	0
O	608	609	.
O	609	611	74
O	612	615	was
O	616	621	found
O	622	629	between
B-Diagnostic_tool	630	644	ophthalmoscopy
O	645	648	and
B-Diagnostic_tool	649	655	fundus
I-Diagnostic_tool	656	667	photography
I-Diagnostic_tool	668	672	with
I-Diagnostic_tool	673	674	a
I-Diagnostic_tool	675	687	nonmydriatic
I-Diagnostic_tool	688	694	camera
O	694	695	.

O	696	699	For
O	700	703	the
O	704	713	diagnosis
O	714	716	of
B-Disease	717	730	proliferative
I-Disease	731	739	diabetic
I-Disease	740	751	retinopathy
O	751	752	,
O	753	758	kappa
O	759	760	=
O	761	762	0
O	762	763	.
O	763	765	84
O	766	770	with
O	771	773	an
O	774	783	agreement
O	784	786	of
O	787	789	98
O	789	790	.
O	790	791	1
O	791	792	%
O	792	793	.

O	794	798	With
O	799	800	a
O	801	806	total
O	807	809	of
O	810	812	61
O	813	818	cases
O	819	821	of
B-Disease	822	835	proliferative
I-Disease	836	847	retinopathy
O	848	857	diagnosed
O	858	860	by
O	861	867	either
O	868	874	method
O	875	877	in
O	878	881	our
O	882	887	study
O	887	888	,
B-Diagnostic_tool	889	903	ophthalmoscopy
O	904	909	alone
O	910	918	detected
O	919	921	88
O	921	922	.
O	922	923	5
O	923	924	%
O	925	928	and
B-Diagnostic_tool	929	935	fundus
I-Diagnostic_tool	936	947	photography
O	947	948	,
O	949	951	78
O	951	952	.
O	952	953	7
O	953	954	%
O	954	955	.

O	956	960	When
O	961	969	compared
O	970	972	on
O	973	974	a
O	975	981	lesion
O	981	982	-
O	982	984	by
O	984	985	-
O	985	991	lesion
O	992	997	basis
O	997	998	,
O	999	1008	agreement
O	1009	1016	between
O	1017	1020	the
O	1021	1024	two
O	1025	1035	diagnostic
O	1036	1043	methods
O	1044	1047	was
O	1048	1055	highest
O	1056	1059	for
B-Disease	1060	1076	nonproliferative
I-Disease	1077	1088	retinopathy
O	1088	1089	,
O	1090	1092	as
O	1093	1097	well
O	1098	1100	as
B-Symptom	1101	1108	fibrous
I-Symptom	1109	1122	proliferation
O	1122	1123	.

O	1124	1127	The
B-Diagnostic_tool	1128	1134	fundus
I-Diagnostic_tool	1135	1146	photography
I-Diagnostic_tool	1147	1151	with
I-Diagnostic_tool	1152	1153	a
I-Diagnostic_tool	1154	1166	nonmydriatic
I-Diagnostic_tool	1167	1173	camera
O	1173	1174	,
O	1175	1184	performed
O	1185	1189	with
B-Disease	1190	1199	mydriasis
O	1199	1200	,
O	1201	1203	is
O	1204	1214	comparable
O	1215	1217	to
B-Diagnostic_tool	1218	1232	ophthalmoscopy
O	1233	1236	for
O	1237	1240	the
O	1241	1250	detection
O	1251	1253	of
B-Disease	1254	1265	retinopathy
O	1265	1266	.

O	1267	1269	It
O	1270	1273	may
O	1274	1279	prove
O	1280	1282	to
O	1283	1285	be
O	1286	1287	a
O	1288	1296	suitable
O	1296	1297	,
O	1298	1302	cost
O	1302	1303	-
O	1303	1312	effective
O	1313	1319	method
O	1320	1323	for
O	1324	1331	routine
O	1332	1341	screening
O	1342	1344	in
B-Disease	1345	1353	diabetes
O	1354	1361	clinics
O	1361	1362	,
O	1363	1371	provided
O	1372	1386	ophthalmologic
O	1387	1395	referral
O	1396	1398	is
O	1399	1406	ensured
O	1407	1410	for
O	1411	1416	those
O	1417	1421	with
O	1422	1423	a
O	1424	1433	diagnosis
O	1434	1436	of
O	1437	1440	any
O	1441	1445	form
O	1446	1448	of
B-Disease	1449	1460	retinopathy
O	1460	1461	,
O	1462	1474	questionable
B-Disease	1475	1486	retinopathy
O	1486	1487	,
B-Disease	1488	1499	nondiabetic
I-Disease	1500	1511	retinopathy
O	1511	1512	,
O	1513	1518	those
O	1519	1523	with
O	1524	1528	poor
O	1529	1536	quality
B-Diagnostic_tool	1537	1548	photographs
O	1548	1549	,
O	1550	1552	as
O	1553	1557	well
O	1558	1560	as
O	1561	1566	those
O	1567	1571	with
B-Symptom	1572	1577	acute
I-Symptom	1578	1585	changes
I-Symptom	1586	1588	in
I-Symptom	1589	1595	visual
I-Symptom	1596	1602	acuity
O	1602	1603	.

O	0	9	Detection
O	10	12	of
B-Characteristic	13	20	Epstein
I-Characteristic	20	21	-
I-Characteristic	21	25	Barr
I-Characteristic	26	31	virus
I-Characteristic	32	38	genome
O	39	41	in
B-Anatomy	42	48	ocular
I-Anatomy	49	56	tissues
O	56	57	.

B-Characteristic	59	66	Epstein
I-Characteristic	66	67	-
I-Characteristic	67	71	Barr
I-Characteristic	72	77	virus
O	78	79	(
B-Characteristic	79	82	EBV
O	82	83	)
O	84	86	is
O	87	88	a
O	89	99	ubiquitous
O	100	107	mucosal
O	108	116	pathogen
O	117	121	with
O	122	123	a
O	124	134	propensity
O	135	138	for
O	139	147	lifelong
O	147	148	,
O	149	161	asymptomatic
O	162	173	persistence
O	173	174	.

O	175	182	Because
O	183	185	of
O	186	194	reported
O	195	206	association
O	207	214	between
B-Characteristic	215	218	EBV
O	219	222	and
B-Disease	223	229	ocular
I-Disease	230	242	inflammatory
I-Disease	243	252	disorders
O	252	253	,
O	254	256	we
O	257	263	tested
O	264	270	ocular
O	271	278	tissues
O	279	283	from
O	284	290	normal
B-Anatomy	291	295	eyes
O	296	299	for
O	300	308	presence
O	309	311	of
O	312	315	the
B-Characteristic	316	319	EBV
I-Characteristic	320	326	genome
O	326	327	.

O	328	331	Ten
O	332	339	freshly
O	340	349	harvested
O	350	359	cadaveric
O	360	365	human
B-Anatomy	366	370	eyes
O	371	375	were
O	376	385	dissected
O	386	390	into
B-Anatomy	391	397	limbal
I-Anatomy	398	404	cornea
O	404	405	,
B-Anatomy	406	413	central
I-Anatomy	414	420	cornea
O	420	421	,
B-Anatomy	422	429	aqueous
I-Anatomy	430	435	humor
O	435	436	,
B-Anatomy	437	441	iris
O	441	442	,
B-Anatomy	443	451	vitreous
I-Anatomy	452	457	humor
O	457	458	,
O	459	462	and
B-Anatomy	463	468	optic
I-Anatomy	469	474	nerve
O	474	475	.

O	476	481	Total
O	482	490	cellular
O	491	494	DNA
O	495	507	preparations
O	508	512	were
O	513	521	screened
O	522	525	for
O	526	529	DNA
O	530	539	sequences
O	540	548	specific
O	549	551	to
B-Characteristic	552	555	EBV
I-Characteristic	555	556	'
I-Characteristic	556	557	s
O	558	563	large
O	564	572	internal
O	573	579	repeat
O	580	586	region
O	586	587	.

O	588	593	After
O	594	602	Southern
O	603	611	transfer
O	611	612	,
O	613	623	polymerase
O	624	629	chain
O	630	638	reaction
O	639	647	products
O	648	652	were
O	653	661	detected
O	662	664	by
O	665	666	a
O	667	670	32P
O	670	671	-
O	671	678	labeled
O	679	694	oligonucleotide
O	695	700	probe
O	701	709	specific
O	710	712	to
O	713	722	amplified
O	723	732	sequences
O	733	741	internal
O	742	744	to
O	745	748	the
O	749	759	polymerase
O	760	765	chain
O	766	774	reaction
O	775	782	primers
O	782	783	.

O	784	789	Seven
O	790	792	of
O	793	796	ten
B-Anatomy	797	801	eyes
O	802	806	from
O	807	815	deceased
O	816	822	donors
O	823	830	yielded
O	831	832	a
O	833	843	polymerase
O	844	849	chain
O	850	858	reaction
O	859	866	product
O	866	867	,
O	868	878	indicating
O	879	887	presence
O	888	890	of
B-Characteristic	891	894	EBV
I-Characteristic	895	901	genome
O	901	902	.

O	903	905	In
O	906	909	all
O	909	910	,
O	911	913	12
O	914	915	(
O	915	917	20
O	917	918	%
O	918	919	)
O	920	922	of
O	923	925	60
O	926	935	cadaveric
B-Anatomy	936	942	ocular
O	943	950	samples
O	951	960	contained
B-Characteristic	961	964	EBV
I-Characteristic	965	968	DNA
O	968	969	.

O	970	974	Only
O	975	978	the
B-Anatomy	979	984	optic
I-Anatomy	985	990	nerve
O	991	994	was
O	995	1007	consistently
O	1008	1016	negative
O	1017	1020	for
B-Characteristic	1021	1024	EBV
I-Characteristic	1025	1028	DNA
O	1028	1029	.

O	1030	1039	Detection
O	1040	1042	of
B-Characteristic	1043	1046	EBV
I-Characteristic	1047	1050	DNA
O	1051	1053	in
O	1054	1063	cadaveric
B-Anatomy	1064	1070	ocular
I-Anatomy	1071	1078	tissues
O	1079	1088	indicates
O	1089	1090	a
O	1091	1096	broad
O	1097	1105	anatomic
O	1106	1118	distribution
O	1119	1121	of
O	1122	1126	this
O	1127	1137	persistent
O	1138	1145	mucosal
O	1146	1154	pathogen
O	1154	1155	.

O	1156	1159	The
O	1160	1169	frequency
O	1170	1174	with
O	1175	1180	which
B-Characteristic	1181	1184	EBV
O	1185	1188	was
O	1189	1194	found
O	1195	1197	at
O	1198	1208	apparently
O	1209	1215	normal
B-Anatomy	1216	1222	ocular
O	1223	1228	sites
O	1229	1235	raises
O	1236	1239	the
O	1240	1251	possibility
O	1252	1255	for
O	1256	1261	viral
O	1262	1273	involvement
O	1274	1276	in
O	1277	1284	disease
O	1285	1291	states
O	1291	1292	,
O	1293	1296	but
O	1297	1307	emphasizes
O	1308	1311	the
O	1312	1316	need
O	1317	1320	for
O	1321	1329	specific
O	1330	1338	criteria
O	1339	1341	to
O	1342	1351	implicate
B-Characteristic	1352	1355	EBV
O	1356	1358	in
B-Anatomy	1359	1365	ocular
O	1366	1375	pathology
O	1375	1376	.

O	0	5	Value
O	6	8	of
B-Diagnostic_tool	9	17	logistic
I-Diagnostic_tool	18	30	discriminant
I-Diagnostic_tool	31	39	analysis
O	40	43	for
O	44	56	interpreting
O	57	64	initial
B-Symptom	65	71	visual
I-Symptom	72	77	field
I-Symptom	78	85	defects
O	85	86	.

O	88	91	The
O	92	99	authors
O	100	108	evaluate
B-Diagnostic_tool	109	117	logistic
I-Diagnostic_tool	118	130	discriminant
I-Diagnostic_tool	131	139	analysis
O	140	142	as
O	143	144	a
O	145	151	method
O	152	155	for
O	156	168	interpreting
B-Characteristic	169	175	visual
I-Characteristic	176	181	field
O	182	189	results
O	190	192	in
O	193	200	initial
O	201	207	stages
O	208	210	of
O	211	218	several
B-Disease	219	229	ophthalmic
I-Disease	230	238	diseases
O	238	239	.

O	240	243	The
O	244	251	authors
O	252	267	retrospectively
O	268	275	studied
O	276	279	the
B-Symptom	280	286	visual
I-Symptom	287	292	field
I-Symptom	293	300	defects
O	301	303	of
O	304	306	96
O	307	315	patients
O	316	320	with
B-Symptom	321	326	early
I-Symptom	327	339	glaucomatous
I-Symptom	340	346	damage
O	347	350	and
O	351	364	prospectively
O	365	372	studied
O	373	375	84
O	376	384	subjects
O	385	389	with
O	390	396	normal
B-Anatomy	397	401	eyes
O	402	403	(
O	403	404	n
O	405	406	=
O	407	409	28
O	409	410	)
O	410	411	,
B-Disease	412	421	cataracts
O	422	423	(
O	423	424	n
O	425	426	=
O	427	429	27
O	429	430	)
O	430	431	,
B-Disease	432	440	diabetic
I-Disease	441	452	retinopathy
O	453	454	(
O	454	455	n
O	456	457	=
O	458	460	14
O	460	461	)
O	461	462	,
O	463	465	or
B-Disease	466	478	hypertensive
I-Disease	479	490	retinopathy
O	491	492	(
O	492	493	n
O	494	495	=
O	496	498	15
O	498	499	)
O	499	500	.

O	501	504	The
B-Characteristic	505	511	visual
I-Characteristic	512	518	fields
O	519	523	were
O	524	532	examined
O	533	535	at
O	536	541	least
O	542	547	twice
O	548	552	with
B-Diagnostic_tool	553	560	program
I-Diagnostic_tool	561	563	G1
I-Diagnostic_tool	564	566	of
I-Diagnostic_tool	567	574	Octopus
I-Diagnostic_tool	575	578	500
O	579	580	(
O	580	589	Interzeag
O	590	592	AG
O	592	593	,
O	594	603	Schlieren
O	603	604	,
O	605	616	Switzerland
O	616	617	)
O	617	618	.

O	619	623	Only
O	624	627	one
B-Anatomy	628	631	eye
O	632	635	per
O	636	643	patient
O	644	647	was
O	648	656	randomly
O	657	665	selected
O	666	669	and
O	670	678	included
O	679	681	in
O	682	685	the
O	686	691	study
O	691	692	.

O	693	696	The
O	697	704	authors
O	705	712	created
O	713	714	a
O	715	723	database
O	724	728	with
O	729	732	all
B-Characteristic	733	739	visual
I-Characteristic	740	745	field
O	746	757	information
O	758	766	provided
O	767	769	by
B-Diagnostic_tool	770	777	Octopus
O	778	781	and
O	782	789	applied
B-Diagnostic_tool	790	798	logistic
I-Diagnostic_tool	799	811	discriminant
I-Diagnostic_tool	812	820	analysis
O	821	822	(
O	822	825	SAS
O	826	834	Logistic
O	835	845	Procedures
O	845	846	,
O	847	850	SAS
O	851	860	Institute
O	860	861	,
O	862	866	Cary
O	866	867	,
O	868	870	NC
O	870	871	)
O	872	874	to
O	875	881	obtain
O	882	896	classification
O	897	902	rules
O	903	910	capable
O	911	913	of
O	914	924	qualifying
B-Symptom	925	931	visual
I-Symptom	932	937	field
I-Symptom	938	945	defects
O	946	948	as
B-Disease	949	961	glaucomatous
O	962	964	or
O	965	980	nonglaucomatous
O	980	981	.

O	982	985	The
O	986	991	rules
O	992	996	were
O	997	1003	tested
O	1004	1008	with
O	1009	1011	an
O	1012	1023	independent
O	1024	1030	sample
O	1030	1031	.

O	1032	1037	There
O	1038	1042	were
O	1043	1054	significant
O	1055	1066	differences
O	1067	1074	between
O	1075	1078	the
O	1079	1085	groups
O	1086	1088	in
O	1089	1092	the
O	1093	1105	distribution
O	1106	1108	of
B-Symptom	1109	1115	visual
I-Symptom	1116	1121	field
I-Symptom	1122	1129	defects
O	1130	1136	tested
O	1137	1139	by
B-Diagnostic_tool	1140	1147	program
I-Diagnostic_tool	1148	1150	G1
O	1150	1151	.

B-Diagnostic_tool	1152	1160	Logistic
I-Diagnostic_tool	1161	1173	discriminant
I-Diagnostic_tool	1174	1182	analysis
O	1183	1192	correctly
O	1193	1203	identified
O	1204	1207	the
B-Disease	1208	1220	glaucomatous
O	1221	1223	or
O	1224	1239	nonglaucomatous
O	1240	1246	origin
O	1247	1249	of
O	1250	1253	the
O	1254	1261	defects
O	1262	1266	with
O	1267	1268	a
O	1269	1280	sensitivity
O	1281	1283	of
O	1284	1286	65
O	1286	1287	%
O	1288	1290	to
O	1291	1293	85
O	1293	1294	%
O	1295	1298	and
O	1299	1300	a
O	1301	1312	specificity
O	1313	1315	of
O	1316	1318	60
O	1318	1319	%
O	1320	1322	to
O	1323	1325	92
O	1325	1326	%
O	1326	1327	.

B-Diagnostic_tool	1328	1336	Logistic
I-Diagnostic_tool	1337	1349	discriminant
I-Diagnostic_tool	1350	1358	analysis
O	1359	1361	is
O	1362	1363	a
O	1364	1370	useful
O	1371	1375	tool
O	1376	1378	to
O	1379	1382	aid
O	1383	1385	in
O	1386	1389	the
O	1390	1404	interpretation
O	1405	1407	of
B-Disease	1408	1413	early
I-Disease	1414	1426	glaucomatous
O	1427	1430	and
B-Symptom	1431	1446	nonglaucomatous
I-Symptom	1447	1453	visual
I-Symptom	1454	1459	field
I-Symptom	1460	1467	defects
O	1467	1468	.

O	0	10	Evaluation
O	11	13	of
O	14	24	coexisting
B-Symptom	25	30	optic
I-Symptom	31	36	nerve
I-Symptom	37	41	head
I-Symptom	42	48	drusen
O	49	52	and
B-Disease	53	61	glaucoma
O	62	66	with
B-Diagnostic_tool	67	74	optical
I-Diagnostic_tool	75	84	coherence
I-Diagnostic_tool	85	95	tomography
O	95	96	.

B-Symptom	98	103	Optic
I-Symptom	104	109	nerve
I-Symptom	110	114	head
I-Symptom	115	121	drusen
O	122	127	often
O	128	132	make
O	133	143	evaluation
O	144	146	of
O	147	150	the
B-Anatomy	151	156	nerve
I-Anatomy	157	161	head
O	162	171	difficult
O	172	174	to
O	175	184	interpret
O	184	185	.

O	186	188	In
O	189	197	addition
O	197	198	,
B-Symptom	199	205	visual
I-Symptom	206	211	field
I-Symptom	212	219	defects
O	220	223	are
O	224	229	known
O	230	232	to
O	233	238	occur
O	239	241	in
O	242	250	patients
O	251	255	with
B-Symptom	256	261	optic
I-Symptom	262	266	disk
I-Symptom	267	273	drusen
O	273	274	,
O	275	285	resembling
B-Symptom	286	298	glaucomatous
I-Symptom	299	305	damage
O	305	306	.

O	307	310	The
O	311	318	authors
O	319	325	report
O	326	329	two
O	330	335	cases
O	336	338	of
O	339	349	coincident
B-Symptom	350	355	optic
I-Symptom	356	361	nerve
I-Symptom	362	366	head
I-Symptom	367	373	drusen
O	374	377	and
B-Disease	378	386	glaucoma
O	386	387	,
O	388	390	in
O	391	396	which
O	397	400	the
O	401	404	use
O	405	407	of
B-Diagnostic_tool	408	415	optical
I-Diagnostic_tool	416	425	coherence
I-Diagnostic_tool	426	436	tomography
O	437	438	(
B-Diagnostic_tool	438	441	OCT
O	441	442	)
O	443	445	in
O	446	456	evaluating
O	457	460	the
B-Anatomy	461	466	nerve
I-Anatomy	467	472	fiber
I-Anatomy	473	478	layer
O	479	482	was
O	483	493	beneficial
O	493	494	.

O	495	498	Two
O	499	507	patients
O	508	512	with
O	513	517	both
B-Symptom	518	523	optic
I-Symptom	524	529	nerve
I-Symptom	530	534	head
I-Symptom	535	541	drusen
O	542	545	and
B-Disease	546	554	glaucoma
O	554	555	,
O	556	559	one
O	560	564	with
B-Disease	565	572	primary
I-Disease	573	577	open
I-Disease	578	583	angle
I-Disease	584	592	glaucoma
O	592	593	,
O	594	597	the
O	598	603	other
O	604	608	with
B-Disease	609	626	pseudoexfoliation
I-Disease	627	635	glaucoma
O	636	640	were
O	641	650	evaluated
O	650	651	.

O	652	656	Both
O	657	665	patients
O	666	669	had
B-Symptom	670	680	asymmetric
I-Symptom	681	686	optic
I-Symptom	687	691	disk
I-Symptom	692	698	drusen
O	698	699	,
O	700	704	with
O	705	715	clinically
O	716	723	visible
B-Symptom	724	730	drusen
O	731	735	only
O	736	738	in
O	739	742	one
B-Anatomy	743	746	eye
O	746	747	.

B-Diagnostic_tool	748	762	Ophthalmologic
I-Diagnostic_tool	763	774	examination
O	774	775	,
B-Diagnostic_tool	776	781	color
I-Diagnostic_tool	782	785	and
I-Diagnostic_tool	786	789	red
I-Diagnostic_tool	789	790	-
I-Diagnostic_tool	790	794	free
I-Diagnostic_tool	795	806	photography
O	806	807	,
B-Diagnostic_tool	808	817	automated
I-Diagnostic_tool	818	826	Humphrey
I-Diagnostic_tool	827	833	visual
I-Diagnostic_tool	834	839	field
I-Diagnostic_tool	840	847	testing
O	848	851	and
B-Diagnostic_tool	852	855	OCT
O	856	860	were
O	861	870	performed
O	870	871	.

B-Symptom	872	877	Nerve
I-Symptom	878	883	fiber
I-Symptom	884	889	layer
I-Symptom	890	894	loss
O	895	897	as
O	898	906	measured
O	907	909	by
B-Diagnostic_tool	910	913	OCT
O	914	917	was
O	918	923	found
O	924	926	to
O	927	929	be
O	930	937	greater
O	938	942	than
O	943	951	expected
O	952	954	by
O	955	958	the
O	959	969	appearance
O	970	972	of
O	973	976	the
B-Anatomy	977	982	optic
I-Anatomy	983	988	nerve
I-Anatomy	989	993	head
O	994	997	and
B-Diagnostic_tool	998	1001	red
I-Diagnostic_tool	1001	1002	-
I-Diagnostic_tool	1002	1006	free
I-Diagnostic_tool	1007	1018	photography
O	1018	1019	,
O	1020	1024	with
B-Characteristic	1025	1031	visual
I-Characteristic	1032	1038	fields
O	1039	1049	consistent
O	1050	1054	with
O	1055	1063	findings
O	1064	1066	in
O	1067	1071	case
O	1072	1073	1
O	1073	1074	.

O	1075	1077	In
O	1078	1082	case
O	1083	1084	2
O	1084	1085	,
B-Characteristic	1086	1092	visual
I-Characteristic	1093	1099	fields
O	1100	1104	were
O	1105	1109	full
O	1109	1110	,
O	1111	1118	despite
B-Symptom	1119	1124	nerve
I-Symptom	1125	1130	fiber
I-Symptom	1131	1136	layer
I-Symptom	1137	1145	thinning
O	1146	1150	seen
O	1151	1153	by
B-Diagnostic_tool	1154	1157	OCT
O	1158	1161	and
B-Diagnostic_tool	1162	1165	red
I-Diagnostic_tool	1165	1166	-
I-Diagnostic_tool	1166	1170	free
I-Diagnostic_tool	1171	1182	photography
O	1182	1183	.

O	1184	1189	There
O	1190	1193	can
O	1194	1196	be
O	1197	1208	significant
B-Symptom	1209	1214	nerve
I-Symptom	1215	1220	fiber
I-Symptom	1221	1226	layer
I-Symptom	1227	1235	thinning
O	1236	1238	in
O	1239	1247	patients
O	1248	1252	with
O	1253	1257	both
B-Disease	1258	1266	glaucoma
O	1267	1270	and
B-Symptom	1271	1276	optic
I-Symptom	1277	1281	disk
I-Symptom	1282	1288	drusen
O	1288	1289	,
O	1290	1297	despite
O	1298	1301	the
O	1302	1312	appearance
O	1313	1315	of
O	1316	1319	the
B-Anatomy	1320	1325	optic
I-Anatomy	1326	1331	nerve
I-Anatomy	1332	1336	head
O	1337	1339	in
O	1340	1345	these
O	1346	1354	patients
O	1354	1355	.

O	1356	1359	The
O	1360	1363	cup
O	1364	1370	margin
O	1371	1374	may
O	1375	1377	be
O	1378	1386	obscured
O	1387	1389	by
O	1390	1393	the
B-Symptom	1394	1400	drusen
O	1400	1401	,
O	1402	1408	giving
O	1409	1413	rise
O	1414	1416	to
O	1417	1418	a
O	1419	1426	falsely
O	1427	1431	full
O	1431	1432	-
O	1432	1441	appearing
O	1442	1446	disk
O	1446	1447	.

O	1448	1450	In
O	1451	1455	such
O	1456	1461	cases
O	1461	1462	,
B-Diagnostic_tool	1463	1466	OCT
O	1467	1470	may
O	1471	1478	provide
O	1479	1480	a
O	1481	1487	useful
O	1488	1493	means
O	1494	1496	to
O	1497	1511	quantitatively
O	1512	1519	measure
O	1520	1523	the
B-Characteristic	1524	1529	nerve
I-Characteristic	1530	1535	fiber
I-Characteristic	1536	1541	layer
I-Characteristic	1542	1551	thickness
O	1552	1555	and
O	1556	1558	to
O	1559	1562	aid
O	1563	1565	in
O	1566	1569	the
O	1570	1580	management
O	1581	1583	of
O	1584	1589	these
O	1590	1598	patients
O	1599	1601	by
O	1602	1611	detecting
B-Symptom	1612	1617	nerve
I-Symptom	1618	1623	fiber
I-Symptom	1624	1629	layer
I-Symptom	1630	1638	thinning
O	1639	1646	earlier
O	1647	1651	than
O	1652	1657	would
O	1658	1667	otherwise
O	1668	1670	be
O	1671	1679	possible
O	1679	1680	.

O	0	12	Quantitative
O	13	22	detection
O	23	25	of
B-Symptom	26	38	glaucomatous
I-Symptom	39	45	damage
I-Symptom	46	48	at
I-Symptom	49	52	the
I-Symptom	53	62	posterior
I-Symptom	63	67	pole
O	68	70	by
B-Diagnostic_tool	71	78	retinal
I-Diagnostic_tool	79	88	thickness
I-Diagnostic_tool	89	96	mapping
O	96	97	.

O	98	99	A
O	100	105	pilot
O	106	111	study
O	111	112	.

O	114	117	The
B-Anatomy	118	127	posterior
I-Anatomy	128	132	pole
I-Anatomy	133	141	ganglion
I-Anatomy	142	146	cell
I-Anatomy	147	153	bodies
O	154	158	form
O	159	160	a
O	161	172	substantial
O	173	181	fraction
O	182	184	of
O	185	188	the
B-Characteristic	189	196	retinal
I-Characteristic	197	206	thickness
O	206	207	,
O	208	217	prompting
O	218	221	the
O	222	229	authors
O	230	232	to
O	233	238	study
O	239	242	the
O	243	254	feasibility
O	255	257	of
O	258	267	detecting
O	267	268	,
O	269	271	by
O	272	280	scanning
B-Characteristic	281	288	retinal
I-Characteristic	289	298	thickness
O	299	307	analysis
O	307	308	,
B-Symptom	309	316	retinal
I-Symptom	317	324	changes
I-Symptom	325	327	at
I-Symptom	328	331	the
I-Symptom	332	341	posterior
I-Symptom	342	346	pole
I-Symptom	347	350	due
I-Symptom	351	353	to
I-Symptom	354	366	glaucomatous
I-Symptom	367	373	damage
O	373	374	.

O	375	389	Nonconsecutive
O	390	394	case
O	395	401	series
O	401	402	.

O	403	406	One
O	407	409	or
O	410	414	both
B-Anatomy	415	419	eyes
O	420	422	of
O	423	431	patients
O	432	436	with
B-Disease	437	444	chronic
I-Disease	445	449	open
I-Disease	449	450	-
I-Disease	450	455	angle
I-Disease	456	464	glaucoma
O	465	468	who
O	469	478	presented
O	479	483	with
O	484	490	either
O	491	492	a
B-Symptom	493	507	superoinferior
I-Symptom	508	517	asymmetry
I-Symptom	518	520	in
I-Symptom	521	527	visual
I-Symptom	528	534	fields
O	535	537	or
O	538	539	a
B-Symptom	540	549	localized
I-Symptom	550	555	field
I-Symptom	556	560	loss
O	561	563	or
O	564	565	a
B-Symptom	566	571	nerve
I-Symptom	572	577	fiber
I-Symptom	578	583	layer
I-Symptom	584	590	defect
O	591	598	visible
O	599	601	on
B-Diagnostic_tool	602	613	photography
O	614	618	were
O	619	628	recruited
O	628	629	.

O	630	636	Twenty
O	636	637	-
O	637	641	nine
O	642	646	eyes
O	647	649	of
O	650	652	18
O	653	661	patients
O	662	666	were
O	667	674	studied
O	674	675	.

O	676	677	A
O	678	683	laser
O	684	688	slit
O	689	692	was
O	693	702	projected
O	703	705	on
O	706	709	the
B-Anatomy	710	716	retina
O	717	720	and
O	721	728	scanned
O	728	729	,
O	730	732	in
O	733	736	400
O	737	741	msec
O	741	742	,
O	743	749	across
O	750	751	a
O	752	753	2
O	753	754	-
O	755	756	x
O	757	758	2
O	758	759	-
O	759	761	mm
O	762	766	area
O	767	769	of
O	770	773	the
B-Anatomy	774	780	fundus
O	780	781	,
O	782	790	yielding
O	791	798	optical
O	799	804	cross
O	804	805	-
O	805	813	sections
O	814	818	that
O	819	823	were
O	824	833	digitally
O	834	842	recorded
O	842	843	.

O	844	848	Nine
O	849	853	such
O	854	859	scans
O	860	867	covered
O	868	871	the
O	872	879	central
O	880	882	20
O	883	890	degrees
O	891	893	of
O	894	897	the
B-Anatomy	898	904	fundus
O	904	905	.

O	906	909	The
O	910	917	optical
O	918	923	cross
O	923	924	-
O	924	932	sections
O	933	937	were
O	938	946	analyzed
O	947	949	by
O	950	952	an
O	953	961	operator
O	961	962	-
O	962	966	free
O	967	976	algorithm
O	977	979	to
O	980	985	yield
O	986	987	a
O	988	993	three
O	993	994	-
O	994	996	or
O	997	1000	two
O	1000	1001	-
O	1001	1012	dimensional
O	1013	1018	color
O	1019	1022	map
O	1022	1023	.

O	1024	1027	The
O	1028	1037	asymmetry
O	1038	1039	(
O	1039	1049	difference
O	1049	1050	)
O	1051	1058	between
O	1059	1062	the
O	1063	1069	visual
O	1070	1081	sensitivity
O	1082	1084	of
O	1085	1088	the
B-Anatomy	1089	1094	upper
I-Anatomy	1095	1098	and
I-Anatomy	1099	1104	lower
I-Anatomy	1105	1115	hemifields
O	1116	1119	was
O	1120	1128	compared
O	1129	1133	with
O	1134	1137	the
O	1138	1147	asymmetry
O	1148	1150	in
B-Characteristic	1151	1158	retinal
I-Characteristic	1159	1168	thickness
O	1169	1178	deviation
O	1179	1183	from
O	1184	1190	normal
O	1190	1191	.

B-Symptom	1192	1197	Large
I-Symptom	1198	1204	losses
I-Symptom	1205	1206	(
I-Symptom	1206	1208	up
I-Symptom	1209	1211	to
I-Symptom	1212	1214	34
I-Symptom	1214	1215	%
I-Symptom	1215	1216	)
I-Symptom	1217	1219	in
I-Symptom	1220	1227	retinal
I-Symptom	1228	1237	thickness
I-Symptom	1238	1242	were
I-Symptom	1243	1251	detected
I-Symptom	1252	1254	at
I-Symptom	1255	1258	the
I-Symptom	1259	1268	posterior
I-Symptom	1269	1273	pole
O	1274	1276	of
O	1277	1285	patients
O	1286	1290	with
B-Disease	1291	1299	glaucoma
O	1300	1303	due
O	1304	1306	to
O	1307	1310	the
B-Symptom	1311	1315	loss
I-Symptom	1316	1318	of
I-Symptom	1319	1327	ganglion
I-Symptom	1328	1333	cells
I-Symptom	1334	1337	and
I-Symptom	1338	1343	nerve
I-Symptom	1344	1350	fibers
O	1350	1351	.

O	1352	1353	A
O	1354	1367	statistically
O	1368	1379	significant
O	1380	1391	correlation
O	1392	1395	was
O	1396	1401	found
O	1402	1409	between
O	1410	1413	the
O	1414	1423	asymmetry
O	1424	1426	in
B-Symptom	1427	1433	visual
I-Symptom	1434	1445	sensitivity
I-Symptom	1446	1450	loss
O	1451	1454	and
O	1455	1458	the
O	1459	1468	asymmetry
O	1469	1471	in
O	1472	1481	deviation
O	1482	1486	from
O	1487	1493	normal
O	1494	1503	thickness
O	1504	1505	(
O	1505	1506	r
O	1507	1508	=
O	1509	1510	0
O	1510	1511	.
O	1511	1513	72
O	1513	1514	;
O	1515	1516	P
O	1518	1519	<
O	1521	1522	0
O	1522	1523	.
O	1523	1527	0005
O	1527	1528	)
O	1528	1529	.

O	1530	1537	Mapping
O	1538	1540	of
O	1541	1544	the
B-Characteristic	1545	1552	retinal
I-Characteristic	1553	1562	thickness
O	1563	1566	may
O	1567	1574	provide
O	1575	1576	a
O	1577	1586	sensitive
O	1587	1593	method
O	1594	1597	for
O	1598	1601	the
O	1602	1611	detection
O	1612	1615	and
O	1616	1626	monitoring
O	1627	1629	of
B-Symptom	1630	1635	early
I-Symptom	1636	1648	glaucomatous
I-Symptom	1649	1655	tissue
I-Symptom	1656	1660	loss
I-Symptom	1661	1663	in
I-Symptom	1664	1667	the
I-Symptom	1668	1677	posterior
I-Symptom	1678	1682	pole
O	1682	1683	,
O	1684	1689	which
O	1690	1692	is
O	1693	1699	unique
O	1700	1703	due
O	1704	1706	to
O	1707	1710	the
O	1711	1722	combination
O	1723	1725	of
O	1726	1727	(
O	1727	1728	1
O	1728	1729	)
O	1730	1733	the
O	1734	1740	direct
O	1741	1752	measurement
O	1753	1755	of
B-Symptom	1756	1768	neuroretinal
I-Symptom	1769	1773	loss
I-Symptom	1774	1776	in
I-Symptom	1777	1780	the
I-Symptom	1781	1788	central
I-Symptom	1789	1794	field
I-Symptom	1795	1797	of
I-Symptom	1798	1804	vision
O	1804	1805	;
O	1806	1807	(
O	1807	1808	2
O	1808	1809	)
O	1810	1813	the
O	1814	1821	mapping
O	1822	1832	capability
O	1832	1833	;
O	1834	1837	and
O	1838	1839	(
O	1839	1840	3
O	1840	1841	)
O	1842	1845	the
O	1846	1851	rapid
O	1852	1857	image
O	1858	1869	acquisition
O	1869	1870	.

